data_2mbs_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mbs _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.612 0 N-CA-C 112.758 0.651 . . . . 74.33 112.758 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.2 116.77 0.99 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 127.004 2.121 . . . . 74.02 105.799 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.8 pt -130.72 168.66 23.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 126.51 1.924 . . . . 75.31 108.514 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.9 m -139.58 135.15 33.08 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.549 1.139 . . . . 73.05 108.954 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -60.25 111.54 1.58 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.542 2.337 . . . . 63.11 108.263 169.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 107.69 -16.1 37.34 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 126.12 1.819 . . . . 72.21 112.921 -173.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -100.63 -86.48 0.4 Allowed 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 119.411 1.606 . . . . 71.43 108.056 -174.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -87.89 -18.01 30.14 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.435 1.094 . . . . 73.23 111.303 -176.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -138.83 161.13 38.01 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.144 0.978 . . . . 72.14 109.024 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mm -127.85 160.42 37.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 105.874 -1.898 . . . . 72.32 105.874 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.6 m -81.29 152.08 27.76 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.637 -1.246 . . . . 74.01 107.637 167.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 32.8 mt -62.01 163.83 7.39 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.751 -0.463 . . . . 74.41 109.751 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -71.64 -37.4 70.85 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.648 0.779 . . . . 73.33 109.313 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.4 mmtp -140.83 78.72 19.83 Favored Pre-proline 0 CA--C 1.529 0.166 0 C-N-CA 126.005 1.722 . . . . 74.03 108.073 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 N--CA 1.445 -1.328 0 C-N-CA 122.171 1.914 . . . . 75.33 107.646 172.726 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.1 t . . . . . 0 C--O 1.233 0.209 0 N-CA-C 106.15 -1.796 . . . . 62.23 106.15 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 tp -156.66 161.65 39.86 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.99 1.316 . . . . 73.25 107.94 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -139.74 126.43 20.57 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 106.511 -1.662 . . . . 75.03 106.511 -163.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -128.79 127.7 42.48 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.191 0.996 . . . . 74.15 112.174 -173.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -169.67 173.96 6.04 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.371 2.269 . . . . 72.24 112.233 176.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.8 t -135.84 151.11 49.71 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.078 -1.013 . . . . 74.25 109.073 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.425 ' CD2' HG22 ' A' ' 95' ' ' VAL 0.307 0.0 OUTLIER -62.12 -19.67 63.25 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 120.599 1.545 . . . . 63.42 113.44 -175.158 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -92.26 1.45 57.21 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 120.928 1.695 . . . . 75.05 112.506 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.4 p -75.85 141.68 72.14 Favored Pre-proline 0 C--N 1.354 0.762 0 CA-C-N 122.162 2.256 . . . . 64.04 108.547 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -89.07 -31.27 0.16 Allowed 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 121.319 1.346 . . . . 60.13 111.338 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -62.03 -40.81 96.99 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.156 -0.965 . . . . 72.45 110.957 174.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.9 p -70.43 -28.46 65.06 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-O 118.146 -0.93 . . . . 72.41 110.971 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -54.85 -56.06 23.57 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.767 1.167 . . . . 73.24 110.263 175.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.16 -46.88 79.13 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-O 118.514 -0.755 . . . . 74.41 109.022 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -66.64 -10.35 45.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 117.005 -1.474 . . . . 74.11 113.386 -175.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -134.25 0.46 3.1 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 120.616 1.553 . . . . 72.42 112.67 -163.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -139.58 -36.37 0.52 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 126.687 1.995 . . . . 73.34 110.765 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.3 t -102.56 -76.84 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 107.284 -1.376 . . . . 74.25 107.284 -173.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 71.7 mt -68.19 -21.73 64.86 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.432 1.493 . . . . 71.31 113.614 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 13.8 m80 44.66 58.96 3.59 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.92 1.688 . . . . 73.33 113.062 176.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 96.4 t -63.74 -41.3 92.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.976 1.311 . . . . 73.14 110.861 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.5 t -56.42 -45.03 80.9 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.477 1.49 . . . . 74.01 110.696 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.18 -37.97 78.45 Favored 'General case' 0 C--O 1.233 0.189 0 O-C-N 121.253 -0.905 . . . . 71.23 110.2 -176.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.47 -39.7 85.3 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.461 1.105 . . . . 74.35 112.299 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.1 t -60.86 -49.17 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.283 1.433 . . . . 72.33 109.254 171.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -52.57 -42.49 64.52 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 119.546 1.066 . . . . 74.43 113.66 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -57.17 -13.31 2.92 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.614 1.339 . . . . 71.23 114.614 173.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -120.74 -4.2 9.73 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.585 1.954 . . . . 65.33 112.457 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.6 mt -70.8 144.24 90.49 Favored Pre-proline 0 C--O 1.239 0.538 0 CA-C-N 119.947 1.249 . . . . 74.21 109.791 -171.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -84.38 161.27 12.99 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 123.74 2.96 . . . . 73.34 109.825 169.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.75 40.85 0.82 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.262 1.208 . . . . 74.04 114.262 -165.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.93 -37.64 0.65 Allowed Glycine 0 CA--C 1.524 0.633 0 O-C-N 121.052 -1.03 . . . . 55.32 111.419 167.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 58.2 m -44.79 -59.09 2.69 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.404 2.282 . . . . 73.01 114.534 -163.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.2 tptt 57.87 126.72 0.01 OUTLIER 'General case' 0 C--N 1.344 0.351 0 C-N-CA 126.547 1.939 . . . . 75.25 111.469 -168.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -75.82 128.67 35.63 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.713 -0.847 . . . . 75.11 108.713 175.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.41 -177.35 3.11 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 124.171 0.988 . . . . 75.42 110.104 173.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.7 104.8 0.59 Allowed 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 106.008 -1.849 . . . . 75.11 106.008 166.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.425 ' CD2' ' HG3' ' A' ' 137' ' ' GLN . 9.5 m-30 -85.69 170.86 12.1 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.956 -1.127 . . . . 74.05 107.956 161.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.479 ' CE1' HG22 ' A' ' 72' ' ' THR . 1.5 p80 -108.76 171.48 7.4 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.239 1.416 . . . . 72.01 108.1 176.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.2 m -148.29 157.73 8.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 119.832 1.196 . . . . 72.44 108.99 162.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.6 -8.98 14.19 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 129.345 3.058 . . . . 72.31 111.897 -166.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -60.92 1.09 0.16 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.792 1.637 . . . . 75.23 113.528 173.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 35.6 mt -129.4 119.36 23.71 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 119.879 -1.763 . . . . 75.42 108.282 -170.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.85 166.89 25.81 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 125.508 1.528 . . . . 63.44 112.816 175.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.58 -40.42 5.62 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.754 2.303 . . . . 75.43 111.132 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 58.7 mt -72.54 16.23 0.15 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.907 0.883 . . . . 61.15 112.012 174.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -45.31 -64.33 2.32 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.369 1.461 . . . . 72.24 110.999 172.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -59.74 -33.41 71.62 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.385 1.092 . . . . 73.13 112.472 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.58 -44.53 86.38 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.873 0.869 . . . . 75.02 109.779 176.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.2 mt -58.32 -46.06 86.89 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.668 1.187 . . . . 73.32 111.476 -176.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.479 HG22 ' CE1' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -46.08 -46.36 16.81 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.346 1.858 . . . . 73.35 109.477 174.542 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -76.5 -50.98 12.63 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 118.412 -0.804 . . . . 75.32 110.715 -172.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.69 -35.05 75.32 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.705 1.593 . . . . 75.11 112.662 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 28.8 t-105 -59.3 -36.9 76.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.002 0.365 . . . . 73.43 111.147 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.31 -29.0 69.12 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 112.708 0.633 . . . . 73.41 112.708 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.2 t -57.23 -52.62 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 120.244 1.384 . . . . 72.22 109.495 162.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.89 -56.94 15.44 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 118.216 -0.897 . . . . 73.12 110.753 -174.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.4 mt -52.61 -41.27 36.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.497 1.119 . . . . 71.42 110.489 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.87 -33.75 76.55 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 120.017 -0.673 . . . . 74.41 110.933 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.9 mt -86.41 -23.9 25.92 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.253 0.464 . . . . 73.35 112.253 175.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.1 69.72 1.34 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.946 1.736 . . . . 75.21 110.116 -171.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.7 m -133.52 8.3 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.464 1.105 . . . . 73.23 112.563 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -53.56 -51.84 61.65 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 125.069 1.348 . . . . 75.44 112.055 -169.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -55.31 -45.29 76.3 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.037 0.935 . . . . 71.33 109.257 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -66.17 -21.83 66.34 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.825 1.65 . . . . 75.12 111.44 -176.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.5 pp -121.6 26.77 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.579 1.551 . . . . 73.03 110.014 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 96.6 m -95.2 -48.76 5.79 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.131 0.878 . . . . 71.21 108.963 166.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.35 -62.31 6.18 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 119.267 0.94 . . . . 42.35 112.211 -175.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.32 -23.69 44.34 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 121.633 1.556 . . . . 74.25 111.624 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 32.8 tpp -64.16 -52.63 58.09 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.539 1.136 . . . . 75.32 109.101 174.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -69.43 -32.7 71.82 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 124.163 0.914 . . . . 72.25 110.469 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -63.2 -33.21 74.99 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 118.272 0.487 . . . . 74.33 110.39 171.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.47 -12.89 33.33 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.87 1.214 . . . . 65.24 113.403 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.425 HG22 ' CD2' ' A' ' 28' ' ' PHE . 41.4 t -100.08 -39.59 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 C-N-CA 124.184 0.994 . . . . 74.43 109.746 -178.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -111.53 -53.58 2.69 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.72 0.808 . . . . 63.44 110.044 -171.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -67.77 -60.16 2.74 Favored 'General case' 0 C--N 1.339 0.142 0 O-C-N 121.453 -0.779 . . . . 74.35 109.909 -173.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.4 p -90.56 -25.71 20.08 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.547 0.573 . . . . 74.34 112.547 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 49.44 61.46 3.13 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 128.521 2.728 . . . . 73.43 112.393 -174.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.3 t -101.7 -14.52 17.33 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.762 1.225 . . . . 72.02 113.171 174.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.6 t -69.96 123.46 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 119.875 1.216 . . . . 75.44 108.834 171.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -144.35 -26.61 0.52 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.42 1.088 . . . . 74.04 111.714 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.82 167.32 21.98 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.308 0.958 . . . . 74.02 108.747 174.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 43.8 t -56.2 -40.28 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 123.709 0.804 . . . . 73.01 110.68 -175.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.26 -24.99 61.22 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.674 0.79 . . . . 75.33 112.617 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -79.83 -34.09 39.73 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.16 0.891 . . . . 74.35 110.807 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.8 mt -75.01 -48.23 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 108.716 -0.846 . . . . 75.22 108.716 -176.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -17.14 63.75 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.289 -0.862 . . . . 72.32 111.428 -176.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -58.87 -58.12 10.03 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.61 0.764 . . . . 73.21 110.012 168.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.3 t -57.24 -38.81 63.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 123.445 0.698 . . . . 74.25 111.565 -174.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -54.51 -53.03 59.84 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.839 -0.538 . . . . 75.45 109.765 173.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 97.5 t -60.62 -46.05 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 123.717 0.807 . . . . 74.42 110.186 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -55.39 -45.67 76.59 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.832 1.253 . . . . 64.03 109.425 -176.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.91 -15.05 60.25 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.703 1.201 . . . . 72.14 113.102 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 114.18 51.5 0.47 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.487 1.042 . . . . 65.32 113.213 172.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.8 t -111.6 142.78 22.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 124.374 1.07 . . . . 73.41 108.513 168.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.7 mmtm -61.57 148.67 41.51 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.831 0.824 . . . . 75.22 110.804 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.0 -18.17 74.29 Favored Glycine 0 CA--C 1.518 0.235 0 CA-C-N 114.985 -1.007 . . . . 61.31 113.15 167.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -87.57 -36.04 17.78 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 109.326 -0.62 . . . . 63.44 109.326 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.72 -43.3 72.64 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 106.25 -1.759 . . . . 75.15 106.25 -169.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -63.18 -52.93 60.39 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 123.693 0.621 . . . . 75.32 110.202 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -71.7 -17.05 62.25 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.963 0.505 . . . . 73.03 112.297 -174.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -87.15 -63.96 1.22 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.61 1.164 . . . . 71.35 109.597 172.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.32 -34.56 66.65 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.196 0.998 . . . . 73.43 111.463 -170.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -49.47 -33.53 14.54 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.862 0.865 . . . . 73.32 112.658 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -111.27 6.51 20.6 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.584 1.553 . . . . 75.25 112.848 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 43.3 t -82.73 157.21 23.37 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.283 1.433 . . . . 72.43 111.048 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -62.21 -34.53 76.65 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.373 1.469 . . . . 74.14 111.469 172.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 72.2 t -50.41 -50.98 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 108.843 -0.799 . . . . 75.02 108.843 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 22.1 t -65.91 -44.31 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 124.369 1.067 . . . . 73.14 111.723 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.499 ' HA ' ' HE2' ' A' ' 131' ' ' LYS . 10.8 mmpt? -51.55 -52.69 45.02 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.041 0.837 . . . . 75.14 110.921 176.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.6 -34.48 77.98 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.359 1.064 . . . . 64.24 110.955 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.0 mt -63.21 -54.99 28.81 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 117.141 -1.409 . . . . 75.35 110.848 175.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 87.4 t -54.07 -39.11 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 119.819 1.191 . . . . 72.04 109.601 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.68 -22.81 66.76 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 118.188 -0.91 . . . . 73.45 113.067 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -58.1 -53.1 62.02 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 119.638 1.108 . . . . 71.44 109.35 172.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.425 ' HG3' ' CD2' ' A' ' 59' ' ' TYR . 20.9 mp0 -78.88 -30.43 45.0 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.229 -0.919 . . . . 73.25 110.113 -175.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -68.87 11.67 0.18 Allowed 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.143 -1.598 . . . . 73.44 112.81 163.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -125.24 -19.93 4.98 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 124.775 1.23 . . . . 74.15 111.925 162.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -115.07 -10.41 12.22 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 114.557 1.317 . . . . 75.01 114.557 -172.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -96.66 -38.79 9.79 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.524 1.057 . . . . 74.31 108.343 157.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.9 -28.05 69.78 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.908 1.077 . . . . 63.43 113.908 -170.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -80.71 26.87 0.39 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.656 0.984 . . . . 63.22 113.656 -169.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.5 mt 65.16 28.3 12.2 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.815 -1.178 . . . . 75.04 111.504 165.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -104.68 -20.9 13.49 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.451 1.501 . . . . 74.44 112.216 -171.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 tt -168.15 137.03 2.4 Favored 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 128.738 2.815 . . . . 64.32 106.864 -176.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -140.94 5.83 1.96 Allowed 'General case' 0 CA--C 1.546 0.802 0 O-C-N 124.017 0.823 . . . . 71.22 111.121 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -143.55 152.22 23.94 Favored Glycine 0 C--N 1.343 0.966 0 CA-C-N 119.624 1.102 . . . . 72.35 110.903 172.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.408 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 35.7 m -132.83 174.84 4.24 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 125.818 1.647 . . . . 75.22 110.717 -170.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.408 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 15.8 Cg_endo -61.98 152.04 61.76 Favored 'Cis proline' 0 C--N 1.352 0.746 0 CA-C-N 121.475 1.562 . . . . 74.31 112.165 -10.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -152.65 152.66 32.02 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.587 0.554 . . . . 64.01 111.111 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 77.1 mmm -151.78 121.51 6.99 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.673 1.189 . . . . 71.04 107.813 -167.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 12.0 m-30 -100.02 152.8 19.79 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.005 0.922 . . . . 61.11 110.361 -172.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.4 t -139.87 151.76 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.566 0.746 . . . . 74.21 110.202 174.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 44.88 24.12 0.1 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 129.273 3.029 . . . . 52.52 114.494 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 53.03 24.67 21.5 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.194 -0.941 . . . . 74.41 112.996 -173.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.542 ' HE2' ' CE2' ' A' ' 158' ' ' TYR . 9.3 pttt -150.24 -3.55 0.36 Allowed 'General case' 0 C--N 1.344 0.335 0 N-CA-C 114.527 1.306 . . . . 75.03 114.527 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.542 ' CE2' ' HE2' ' A' ' 157' ' ' LYS . 49.8 m-85 -126.59 159.93 32.1 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 124.73 1.212 . . . . 64.42 110.953 -176.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -126.22 149.2 49.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.654 1.982 . . . . 74.43 107.044 170.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -74.47 154.26 38.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.995 -0.742 . . . . 73.14 108.995 167.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -125.18 80.61 64.41 Favored Pre-proline 0 C--O 1.232 0.18 0 C-N-CA 123.353 0.661 . . . . 75.01 110.808 177.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.36 -4.84 10.09 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 121.986 1.791 . . . . 72.44 113.212 175.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -86.82 -2.66 58.74 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.16 1.384 . . . . 75.11 113.127 173.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -132.47 46.16 1.08 Allowed Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 109.584 -1.406 . . . . 71.14 109.584 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 36.6 mtt -130.97 174.97 9.47 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 118.172 0.986 . . . . 73.01 111.851 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.32 90.35 4.97 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.945 -1.131 . . . . 73.13 107.945 174.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.344 6.4 t -118.53 48.13 1.5 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.78 1.232 . . . . 73.12 107.965 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.6 m -84.16 -47.79 10.49 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.074 -0.966 . . . . 74.11 110.338 159.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.513 HD21 ' CG2' ' A' ' 172' ' ' VAL . 0.0 OUTLIER -113.05 -9.9 13.52 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 117.962 -1.018 . . . . 73.04 113.065 -162.401 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 33.6 mmm 75.47 -53.94 0.64 Allowed 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 126.451 1.901 . . . . 74.34 112.705 170.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.22 -31.35 72.48 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.656 1.116 . . . . 72.15 109.512 176.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.513 ' CG2' HD21 ' A' ' 169' ' ' ASN . 89.0 t -80.68 -25.04 11.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.65 1.58 . . . . 64.04 111.8 175.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -63.54 -58.06 8.2 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.014 -1.476 . . . . 73.05 107.014 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 14.3 t -61.83 -38.88 81.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 122.999 0.52 . . . . 74.05 110.195 -174.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.71 -46.06 70.65 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.437 1.095 . . . . 53.32 110.754 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -83.75 -31.29 26.06 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.165 0.986 . . . . 71.31 112.493 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -54.61 -54.8 36.67 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.227 -0.921 . . . . 64.24 109.242 175.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.96 -27.63 66.97 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.084 0.772 . . . . 62.11 113.084 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.2 -54.85 14.93 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.632 1.173 . . . . 64.24 110.614 177.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.6 t -62.21 -30.91 71.41 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 118.553 -0.737 . . . . 73.25 110.615 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 94.8 t -59.66 -51.81 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.519 -0.919 . . . . 60.45 108.519 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -62.0 -47.63 83.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.181 0.593 . . . . 75.42 109.8 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -58.29 -37.23 74.62 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 118.638 0.654 . . . . 75.44 111.932 -172.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 72.0 mt -65.51 -28.72 69.39 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.45 -0.781 . . . . 72.32 112.192 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.21 -22.55 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.403 0.681 . . . . 72.23 111.646 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -98.87 -16.47 18.82 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.652 0.66 . . . . 75.13 110.509 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -93.15 13.66 20.36 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.708 1.373 . . . . 75.41 114.708 -170.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 35.1 mttt . . . . . 0 C--O 1.246 0.898 0 C-N-CA 127.933 2.493 . . . . 75.05 113.886 -175.611 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.573 0 N-CA-C 112.195 0.442 . . . . 64.41 112.195 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -156.24 118.22 3.98 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.902 -1.148 . . . . 75.14 107.902 164.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.4 pt -115.63 164.62 11.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 126.217 1.807 . . . . 72.31 108.604 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.2 m -137.55 139.41 40.44 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.079 -1.823 . . . . 74.52 106.079 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -55.08 138.66 43.71 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.149 1.78 . . . . 72.34 109.739 167.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.45 -25.71 3.23 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.445 1.498 . . . . 54.52 113.41 -171.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -91.8 -77.35 0.43 Allowed 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 119.211 1.506 . . . . 75.54 107.227 -165.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -97.4 -15.38 20.7 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.543 0.737 . . . . 60.24 111.166 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -142.95 160.69 39.86 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.34 0.656 . . . . 75.32 110.246 173.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.3 mm -123.8 157.2 30.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 106.818 -1.549 . . . . 72.52 106.818 172.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.9 m -101.79 152.9 20.33 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.199 1.4 . . . . 75.52 107.633 174.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.3 mt -91.27 148.83 22.07 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 106.705 -1.591 . . . . 73.55 106.705 169.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -72.58 -34.43 67.45 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.128 1.371 . . . . 73.33 109.765 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.9 mmtm -125.68 82.31 63.91 Favored Pre-proline 0 C--O 1.232 0.136 0 C-N-CA 126.7 2.0 . . . . 75.22 108.166 175.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 N--CA 1.451 -1.017 0 C-N-CA 123.645 2.897 . . . . 71.52 107.844 168.975 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.469 0.498 0 CA-C-O 119.279 -0.391 . . . . 73.41 110.008 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -172.14 164.53 6.06 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.274 1.03 . . . . 74.22 110.536 -167.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -123.46 158.94 30.09 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.903 1.281 . . . . 75.22 109.435 173.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -142.04 134.18 27.59 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.731 1.613 . . . . 74.21 113.221 174.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -139.69 177.77 7.71 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.352 1.461 . . . . 73.33 111.125 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.9 t -136.61 162.33 33.42 Favored 'General case' 0 CA--C 1.527 0.09 0 N-CA-C 109.457 -0.571 . . . . 73.31 109.457 157.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.465 ' CD2' HD22 ' A' ' 71' ' ' LEU 0.257 0.0 OUTLIER -71.59 -20.14 62.04 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.502 -0.749 . . . . 63.12 112.834 171.232 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -89.03 -9.21 52.12 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 117.724 -1.131 . . . . 75.41 112.725 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.7 p -84.63 142.27 39.63 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 121.416 1.916 . . . . 40.22 110.284 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -91.72 -31.23 0.1 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 121.384 1.389 . . . . 75.54 112.395 -170.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -58.54 -44.02 89.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.143 -0.688 . . . . 74.42 109.143 169.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 25.7 m -55.62 -39.95 71.49 Favored 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 123.979 0.912 . . . . 74.52 110.742 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -52.47 -60.83 2.76 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 119.523 1.056 . . . . 64.24 109.813 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -54.54 -41.8 70.16 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 119.026 -0.511 . . . . 63.33 109.755 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -68.89 -24.41 64.31 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 118.347 -0.835 . . . . 71.52 112.526 -174.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -116.24 -3.82 11.95 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.689 0.677 . . . . 74.42 111.635 -167.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -138.38 -35.07 0.61 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.879 1.672 . . . . 74.41 114.016 -168.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 86.8 t -111.05 -78.79 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 N-CA-C 105.458 -2.053 . . . . 75.52 105.458 -172.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.6 mt -57.4 -29.15 63.87 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.48 1.912 . . . . 75.12 111.159 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 44.1 54.89 5.72 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.005 1.722 . . . . 72.43 110.23 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.4 t -53.38 -51.47 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 126.099 1.76 . . . . 74.33 107.898 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.9 t -44.09 -53.2 6.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.669 1.987 . . . . 54.12 111.404 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -76.64 -30.29 56.78 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.462 0.649 . . . . 74.52 111.332 -173.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -72.86 -37.39 67.39 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.318 -0.864 . . . . 71.21 111.78 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.9 t -60.68 -49.97 82.33 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 N-CA-C 107.93 -1.137 . . . . 72.45 107.93 173.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -47.62 -45.49 27.72 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 124.588 1.155 . . . . 73.24 112.335 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -63.6 -5.14 3.53 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 115.468 1.655 . . . . 75.31 115.468 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -123.4 -10.26 7.98 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.351 2.26 . . . . 75.11 113.03 174.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.6 mt -73.17 145.39 85.81 Favored Pre-proline 0 C--O 1.238 0.478 0 CA-C-N 120.109 1.322 . . . . 72.41 112.306 -163.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.76 160.49 31.04 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 124.49 3.46 . . . . 63.13 112.348 175.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -76.97 45.44 0.43 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.541 1.936 . . . . 72.25 112.451 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -155.54 -6.59 0.08 OUTLIER Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.329 1.443 . . . . 73.31 113.523 175.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.2 t -56.4 -43.63 79.49 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.496 1.648 . . . . 74.51 112.092 174.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.8 tptt 44.66 90.94 0.01 OUTLIER 'General case' 0 C--N 1.346 0.417 0 C-N-CA 126.305 1.842 . . . . 74.15 110.196 -165.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.33 105.57 0.3 Allowed 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 127.342 2.257 . . . . 75.42 108.945 -175.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.0 m -143.36 115.3 8.29 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 107.138 -1.43 . . . . 72.13 107.138 -172.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.72 137.55 54.34 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.857 1.263 . . . . 64.41 108.459 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.1 m-30 -104.86 -174.94 2.65 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.936 1.694 . . . . 73.43 108.744 173.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -139.99 133.34 29.92 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.073 1.349 . . . . 73.53 107.644 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.3 m -85.99 170.77 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 119.096 0.862 . . . . 74.51 112.254 -172.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.11 0.77 9.11 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.888 2.075 . . . . 73.12 112.558 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -71.32 -34.26 70.4 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.253 1.021 . . . . 62.42 112.638 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 mt -91.91 126.44 36.99 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.372 -0.973 . . . . 73.54 108.372 -171.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.25 167.52 33.85 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 115.336 -0.847 . . . . 61.33 112.829 168.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -66.66 -48.19 2.33 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 124.424 3.416 . . . . 75.52 109.604 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.5 mt -73.22 13.62 0.41 Allowed 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 127.2 2.2 . . . . 73.52 112.514 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -50.48 -46.99 45.44 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 119.823 1.192 . . . . 55.11 111.697 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.1 tptp -71.42 -36.52 71.33 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.401 1.101 . . . . 75.52 111.414 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -63.83 -33.41 75.61 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.58 0.627 . . . . 72.12 110.189 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.465 HD22 ' CD2' ' A' ' 28' ' ' PHE . 15.1 mt -62.13 -49.66 74.99 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 118.416 -0.802 . . . . 71.35 113.038 175.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.5 m -57.2 -45.29 83.9 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.795 -1.187 . . . . 71.23 107.795 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -57.36 -47.3 82.0 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.189 0.904 . . . . 65.22 110.527 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.09 -41.11 82.77 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.949 1.249 . . . . 75.34 112.862 176.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 35.6 t-105 -57.93 -38.89 76.76 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.654 0.782 . . . . 74.24 110.681 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.69 -40.78 80.23 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 117.504 -1.236 . . . . 52.33 113.487 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.0 -43.47 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 120.532 1.514 . . . . 75.21 108.783 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.12 -43.31 87.54 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 118.255 -0.878 . . . . 72.52 111.545 -175.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 59.2 mt -63.02 -46.34 96.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.03 0.932 . . . . 72.52 109.634 172.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.21 -24.4 63.1 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.691 0.678 . . . . 71.13 111.477 -174.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.1 mt -107.17 -16.65 14.36 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 113.916 1.08 . . . . 74.33 113.916 176.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.56 69.96 1.16 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.285 0.945 . . . . 65.34 110.792 -166.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.4 m -135.61 13.5 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.753 1.221 . . . . 74.53 112.285 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -50.06 -50.78 46.75 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 125.563 1.545 . . . . 73.21 111.77 -173.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.78 -37.93 89.26 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.319 0.647 . . . . 72.33 110.221 -178.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -65.23 -43.68 90.68 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.17 0.509 . . . . 74.13 110.0 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.8 pp -92.44 17.33 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 C-N-CA 124.803 1.241 . . . . 64.11 111.633 -175.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 38.9 m -88.36 -48.12 7.88 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.032 0.833 . . . . 74.41 110.019 169.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.79 -60.85 8.18 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 113.907 1.077 . . . . 73.52 113.907 -169.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -68.43 -25.74 35.32 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.299 1.332 . . . . 74.44 111.643 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 20.2 tpp -65.25 -50.63 65.05 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 124.89 1.276 . . . . 72.54 110.826 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -69.64 -30.57 68.31 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.852 -0.796 . . . . 71.32 108.852 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -57.8 -46.97 83.87 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 118.648 0.658 . . . . 75.33 110.332 167.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.41 2.81 23.54 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 120.538 -1.351 . . . . 75.22 113.014 -174.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.426 HG21 ' CD2' ' A' ' 28' ' ' PHE . 38.8 t -123.59 -39.44 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 125.026 1.331 . . . . 63.35 110.826 -173.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -107.75 -47.59 3.57 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.12 -0.696 . . . . 71.25 109.12 -175.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -77.3 -52.42 9.21 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.24 0.616 . . . . 71.12 110.703 -171.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.5 p -103.86 -24.59 13.27 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.536 1.134 . . . . 73.41 112.18 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 57.31 26.12 12.0 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.58 2.352 . . . . 64.24 114.552 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.3 t -68.36 -20.58 64.72 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.937 0.718 . . . . 72.24 112.937 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.1 t -67.43 123.71 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 O-C-N 120.87 -1.144 . . . . 74.11 109.444 173.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -145.84 -25.06 0.46 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.712 1.605 . . . . 75.51 111.326 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.17 164.93 26.56 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.793 -0.817 . . . . 74.45 108.793 176.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 25.3 t -55.07 -40.89 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.227 1.011 . . . . 74.45 109.432 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.16 8.48 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.539 1.935 . . . . 63.43 114.885 173.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -113.69 -46.9 3.01 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 125.045 1.338 . . . . 61.53 109.117 168.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.3 mt -59.01 -37.56 68.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 123.55 0.74 . . . . 72.55 110.356 -177.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.0 -19.59 64.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 117.54 -1.219 . . . . 74.23 112.845 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -57.6 -58.37 8.62 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 119.703 1.138 . . . . 74.31 110.024 164.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 55.2 t -57.13 -37.31 54.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 122.564 0.345 . . . . 65.14 111.732 -167.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -50.98 -56.81 10.61 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.417 -0.586 . . . . 65.25 109.417 171.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 39.8 t -64.57 -38.06 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 123.952 0.901 . . . . 74.42 110.699 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.66 -42.96 98.09 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.499 0.719 . . . . 73.21 109.511 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.48 2.89 12.49 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.353 1.461 . . . . 73.53 112.478 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.58 61.95 1.66 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 125.06 1.314 . . . . 53.05 111.468 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 77.7 t -119.57 145.43 25.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 123.273 0.629 . . . . 74.13 109.935 169.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -62.02 118.61 7.52 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.671 1.189 . . . . 74.42 108.661 169.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.61 -28.71 70.24 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-O 118.3 -1.278 . . . . 73.33 111.677 166.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -73.05 -25.64 61.0 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 118.93 1.365 . . . . 64.12 109.59 -177.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.03 -39.55 29.66 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.075 0.95 . . . . 73.31 109.393 176.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -64.5 -59.61 4.12 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.266 -1.383 . . . . 74.33 107.266 -177.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -60.68 -28.54 68.69 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.661 1.184 . . . . 63.43 110.302 -175.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -80.56 -64.43 1.19 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.473 -0.565 . . . . 73.45 109.473 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.91 -40.05 69.45 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 117.494 -1.241 . . . . 74.52 110.325 -172.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 46.0 t-105 -47.54 -37.6 12.47 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 124.503 1.121 . . . . 75.23 112.76 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -105.16 -5.03 21.1 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.579 1.152 . . . . 73.33 111.219 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 10.9 t -88.59 149.69 23.44 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.29 1.836 . . . . 64.42 109.753 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -50.24 -34.02 21.59 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.138 1.775 . . . . 73.15 111.622 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 76.7 t -45.49 -59.64 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 125.838 1.655 . . . . 52.41 109.461 176.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 18.3 t -64.69 -46.04 93.46 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.682 0 CA-C-O 117.788 -1.101 . . . . 72.25 109.164 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -50.27 -50.33 50.64 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 120.247 1.385 . . . . 75.21 110.719 -177.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.4 t -69.73 -35.62 75.17 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 118.184 -0.912 . . . . 74.34 109.94 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.411 ' HA ' ' HG2' ' A' ' 136' ' ' GLN . 66.0 mt -64.51 -37.23 86.83 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 119.453 1.024 . . . . 74.42 112.225 177.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.7 t -56.06 -49.18 77.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 N-CA-C 107.908 -1.145 . . . . 74.43 107.908 173.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.92 -49.89 70.18 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.308 0.503 . . . . 74.14 111.641 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.411 ' HG2' ' HA ' ' A' ' 133' ' ' LEU . 1.4 pt20 -58.76 -34.32 71.28 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 123.498 0.499 . . . . 75.24 111.82 -173.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -89.9 -48.12 7.43 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 126.391 1.877 . . . . 60.34 111.129 -173.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -62.66 -46.36 88.56 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.2 1.0 . . . . 74.43 109.159 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -58.72 -46.18 87.94 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.796 -0.816 . . . . 75.42 108.796 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.63 -9.06 16.88 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.586 0.958 . . . . 60.32 113.586 -174.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.67 5.44 10.55 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 120.755 1.616 . . . . 73.51 112.942 174.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.5 -3.41 5.45 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.01 0.924 . . . . 75.23 112.489 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -56.05 -85.68 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.922 2.489 . . . . 72.34 109.978 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.1 pp 179.18 41.49 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.062 1.745 . . . . 75.31 110.873 176.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.548 ' NE2' ' H ' ' A' ' 146' ' ' LEU . 1.4 pp0? -133.56 -45.27 0.82 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.254 1.205 . . . . 72.53 114.254 -172.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.548 ' H ' ' NE2' ' A' ' 145' ' ' GLN . 16.1 tp -85.11 -85.3 0.14 Allowed 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 125.347 1.459 . . . . 72.53 109.746 -166.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 56.72 33.51 23.03 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.202 0.601 . . . . 73.33 111.628 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 178.31 155.81 15.27 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.856 1.693 . . . . 60.55 110.965 174.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 16.2 m -149.06 161.78 31.24 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 124.693 1.197 . . . . 74.21 108.931 175.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -65.14 141.12 46.56 Favored 'Cis proline' 0 C--N 1.35 0.626 0 CA-C-N 120.227 1.117 . . . . 71.34 112.504 -8.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -131.2 142.8 50.24 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.764 -1.107 . . . . 65.32 109.625 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 50.8 mtp -148.23 113.99 5.72 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 102.469 -3.16 . . . . 74.54 102.469 -176.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -100.95 165.66 11.22 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.4 0.68 . . . . 64.31 109.387 -175.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.6 t -138.07 133.44 44.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.667 0.746 . . . . 71.42 110.668 172.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 44.9 30.84 0.6 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 130.754 3.621 . . . . 60.34 115.417 171.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 64.59 34.41 89.82 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 124.823 1.202 . . . . 64.35 111.395 177.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.406 ' HG3' ' CE2' ' A' ' 158' ' ' TYR . 9.7 ptmt -160.52 -10.4 0.05 OUTLIER 'General case' 0 C--N 1.345 0.389 0 N-CA-C 116.742 2.126 . . . . 74.42 116.742 177.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.406 ' CE2' ' HG3' ' A' ' 157' ' ' LYS . 60.2 m-85 -128.89 160.88 31.24 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 120.376 1.444 . . . . 73.43 110.598 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -136.01 131.77 35.42 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 105.694 -1.965 . . . . 75.42 105.694 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.57 145.89 55.52 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.718 -1.216 . . . . 71.15 107.718 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -115.13 85.58 12.66 Favored Pre-proline 0 CA--C 1.522 -0.134 0 N-CA-C 113.034 0.753 . . . . 64.32 113.034 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -61.92 -24.19 76.74 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 CA-C-N 119.659 0.914 . . . . 75.31 112.059 173.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.28 2.58 27.44 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.139 1.376 . . . . 72.14 112.398 -170.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -130.24 22.02 4.8 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.229 1.395 . . . . 74.13 110.423 175.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 63.3 mtt -106.42 169.82 8.29 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 117.932 0.866 . . . . 73.41 110.335 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 168' ' ' SER . 0.3 OUTLIER -83.2 63.82 7.39 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 124.626 2.155 . . . . 72.53 109.98 -174.131 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.6 p -73.65 32.51 0.08 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 129.376 3.07 . . . . 65.21 111.393 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.41 ' H ' ' C ' ' A' ' 166' ' ' ASP . 17.8 m -117.04 -3.02 11.61 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.031 1.732 . . . . 73.22 112.053 177.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.43 -9.67 2.87 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-O 117.678 -1.153 . . . . 60.45 111.744 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 13.2 mmt 65.49 -52.53 0.36 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 127.671 2.388 . . . . 73.44 115.282 172.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.38 -44.35 62.67 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.153 -1.425 . . . . 63.14 107.153 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 97.1 t -59.05 -39.14 77.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 124.02 0.928 . . . . 62.32 110.423 174.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -56.44 -59.78 4.48 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.838 -0.601 . . . . 73.25 109.736 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 20.2 t -66.54 -38.18 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 118.793 0.724 . . . . 74.43 110.807 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.46 -40.22 62.01 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.104 0.562 . . . . 75.53 110.903 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -86.37 -35.96 19.48 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 117.95 -1.024 . . . . 54.44 112.548 174.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -52.01 -60.85 2.71 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 121.039 1.745 . . . . 74.35 110.233 176.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -53.8 -35.27 61.19 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.459 1.104 . . . . 61.15 111.803 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -71.73 -48.52 46.51 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.505 1.122 . . . . 74.14 111.376 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.9 t -62.08 -31.09 71.48 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 117.071 -1.442 . . . . 72.31 109.782 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 30.7 t -58.56 -58.42 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 120.105 1.32 . . . . 71.33 108.929 171.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.96 -11.85 61.2 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 114.135 1.161 . . . . 74.25 114.135 -172.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -87.75 -33.11 18.8 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 123.972 0.909 . . . . 73.14 112.625 166.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 28.7 mt -66.51 -30.78 71.18 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 119.816 -1.803 . . . . 74.41 111.408 -177.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 69.3 t -61.89 -23.46 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.377 0.671 . . . . 73.24 112.549 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -101.25 -14.05 17.83 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 120.983 -1.073 . . . . 73.15 110.47 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -104.8 70.76 0.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 105.237 -2.134 . . . . 71.15 105.237 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? . . . . . 0 CA--C 1.508 -0.672 0 N-CA-C 103.162 -2.903 . . . . 75.44 103.162 170.466 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.46 0 N-CA-C 115.703 1.742 . . . . 75.03 115.703 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -161.1 107.36 1.42 Allowed 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.693 1.597 . . . . 72.1 108.917 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.1 pt -111.68 170.87 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.604 1.562 . . . . 74.04 109.609 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.9 m -140.52 139.3 35.04 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 106.606 -1.627 . . . . 70.41 106.606 177.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -61.55 118.64 7.3 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.508 2.323 . . . . 73.34 109.102 172.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.01 -18.66 56.48 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.328 1.918 . . . . 74.13 112.404 -174.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -89.72 -84.8 0.22 Allowed 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.822 1.311 . . . . 73.2 108.725 -171.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -92.14 -10.91 37.12 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.449 1.1 . . . . 72.43 111.469 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -140.08 164.37 30.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.413 -0.803 . . . . 74.04 109.424 171.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.6 mm -125.12 161.22 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.383 1.473 . . . . 71.32 107.032 169.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -94.74 171.61 8.68 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.562 1.545 . . . . 70.12 108.737 174.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 50.5 mt -117.2 148.63 41.45 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.543 1.137 . . . . 64.3 109.902 162.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -75.21 -43.02 54.22 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.836 2.054 . . . . 70.24 109.062 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.4 mmtm -119.0 84.51 26.6 Favored Pre-proline 0 N--CA 1.454 -0.246 0 C-N-CA 126.76 2.024 . . . . 71.24 107.237 175.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo . . . . . 0 CA--C 1.538 0.7 0 C-N-CA 124.717 3.611 . . . . 74.13 113.424 174.826 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.31 3.5 p . . . . . 0 N--CA 1.467 0.409 0 CA-C-O 123.357 1.551 . . . . 71.32 111.533 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.0 tp -140.96 142.3 34.35 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 113.61 -1.632 . . . . 73.44 108.224 -169.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -125.65 167.83 14.56 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 126.357 1.863 . . . . 65.4 108.448 -175.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.455 ' CD1' HG12 ' A' ' 149' ' ' VAL . 1.4 t80 -164.69 128.27 2.43 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 113.882 -1.508 . . . . 73.04 110.13 -167.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -149.82 160.34 43.64 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 129.396 3.079 . . . . 71.3 109.719 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 t -124.0 159.1 30.56 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.8 -0.815 . . . . 73.1 108.8 164.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -77.17 -23.05 51.62 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.363 -0.836 . . . . 74.23 111.255 176.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.452 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 49.8 m-85 -102.06 5.29 40.44 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.076 1.35 . . . . 72.25 114.225 -178.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 11.2 p -91.51 145.0 30.46 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 120.683 1.583 . . . . 53.23 112.646 -173.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.08 165.76 31.22 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.375 2.05 . . . . 74.44 109.191 172.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.0 m80 69.04 -48.28 0.58 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 127.057 2.143 . . . . 73.42 110.243 -169.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 39.2 m -50.63 -43.2 56.89 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.969 1.708 . . . . 73.0 111.845 -176.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -51.12 -58.05 7.12 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.624 0.77 . . . . 70.41 111.29 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -56.74 -45.3 82.05 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.193 -1.04 . . . . 73.24 108.193 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -62.55 -22.54 66.41 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 117.27 -1.348 . . . . 73.44 113.009 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -120.67 -0.45 10.22 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 121.259 1.845 . . . . 72.02 112.87 -169.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -142.71 -26.4 0.61 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.031 0.933 . . . . 74.44 112.909 -173.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 54.2 t -115.23 -69.81 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 108.035 -1.098 . . . . 74.44 108.035 -173.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.6 mt -66.07 -26.4 67.47 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.233 1.013 . . . . 74.23 110.622 173.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 44.35 53.21 6.96 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.725 1.61 . . . . 74.02 111.924 173.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.2 t -58.13 -52.0 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 114.876 -1.057 . . . . 65.42 110.743 -166.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 p -58.5 -38.49 77.76 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 119.359 0.981 . . . . 74.04 111.681 -167.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -74.34 -36.95 63.67 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.215 0.606 . . . . 72.0 110.665 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -60.36 -45.04 94.9 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.841 -0.537 . . . . 51.2 110.182 169.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.2 t -61.8 -50.39 80.4 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 CA-C-N 118.651 0.659 . . . . 73.21 109.32 175.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -51.11 -43.61 61.14 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 126.606 1.962 . . . . 75.03 111.201 -176.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -59.62 -20.05 53.29 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 114.156 1.169 . . . . 75.13 114.156 175.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -115.77 -6.52 12.11 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.35 1.46 . . . . 74.0 112.038 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mt -70.62 144.11 90.82 Favored Pre-proline 0 C--O 1.239 0.522 0 CA-C-N 119.385 0.993 . . . . 73.04 109.792 -168.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.25 152.46 30.82 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.155 2.57 . . . . 73.02 109.668 174.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.268 1.6 pt-20 -81.22 87.43 6.1 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 123.859 1.79 . . . . 74.13 109.715 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.37 -7.58 0.36 Allowed Glycine 0 C--O 1.221 -0.66 0 CA-C-N 114.792 -1.094 . . . . 73.2 111.606 -174.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.2 t -58.52 -59.66 5.02 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.515 1.657 . . . . 72.23 109.48 166.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.14 86.64 0.03 OUTLIER 'General case' 0 C--N 1.346 0.448 0 C-N-CA 126.175 1.79 . . . . 74.34 109.685 -169.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 13.7 ptp -64.18 173.28 2.02 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 112.248 -2.251 . . . . 75.23 111.039 175.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.452 HG23 ' H ' ' A' ' 58' ' ' LYS . 1.5 m -144.57 -170.33 3.36 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.118 1.767 . . . . 74.11 108.95 177.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.452 ' H ' HG23 ' A' ' 57' ' ' THR . 25.3 tttt -176.81 103.51 0.06 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.759 2.023 . . . . 74.14 108.77 -172.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -114.76 111.0 20.57 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 121.008 1.731 . . . . 70.32 108.982 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.494 ' HB2' ' CG ' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -80.7 150.39 29.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 118.813 -0.613 . . . . 73.14 110.494 176.423 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.1 m -132.99 152.45 36.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 124.508 1.123 . . . . 70.4 111.298 -171.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.18 10.59 40.67 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.987 1.315 . . . . 73.34 114.231 -171.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -62.68 -8.26 6.31 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.414 1.635 . . . . 74.42 115.414 -170.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.52 165.35 29.72 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 120.044 -1.66 . . . . 72.04 111.017 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.452 ' HA3' ' CD2' ' A' ' 29' ' ' TYR . . . 71.98 159.61 4.22 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.474 1.512 . . . . 74.12 112.373 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.1 -55.56 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.737 2.291 . . . . 71.01 109.79 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.4 mt -75.37 22.38 0.12 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.657 1.583 . . . . 65.45 112.968 -178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -52.06 -56.84 14.76 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 124.865 1.221 . . . . 72.21 111.002 -176.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -62.04 -42.03 98.74 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 117.871 0.835 . . . . 74.22 109.776 -173.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -67.79 -38.84 83.87 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.992 1.717 . . . . 61.44 108.908 -174.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.7 mt -64.75 -40.58 95.53 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.469 1.108 . . . . 74.21 112.016 172.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.7 m -61.41 -41.38 97.05 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.732 0.696 . . . . 72.01 109.694 172.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.63 -39.91 95.54 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.459 1.027 . . . . 72.43 110.624 176.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.03 -36.26 81.05 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.586 0.754 . . . . 64.22 112.317 176.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.494 ' CG ' ' HB2' ' A' ' 60' ' ' HIS . 59.6 t-105 -59.58 -40.56 87.81 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.022 0.439 . . . . 70.02 111.658 -176.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.35 -29.89 71.12 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 118.745 -0.645 . . . . 70.43 112.388 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.3 t -59.91 -44.02 93.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 119.642 1.11 . . . . 73.12 109.312 169.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.1 84.92 Favored 'General case' 0 C--N 1.34 0.176 0 O-C-N 121.665 -0.647 . . . . 73.23 111.229 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 79.3 mt -71.49 -39.87 71.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 119.136 -0.459 . . . . 73.13 109.944 176.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.87 -34.63 71.83 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.079 0.854 . . . . 72.45 111.31 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.8 mt -102.49 -3.06 27.46 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.181 0.808 . . . . 74.32 113.181 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 58.45 57.22 21.01 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.426 1.489 . . . . 64.13 111.814 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.6 m -131.15 13.65 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 126.216 1.806 . . . . 74.05 111.719 -175.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -46.92 -48.24 21.38 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 126.604 1.961 . . . . 74.41 111.682 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -68.07 -28.68 67.57 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.048 1.339 . . . . 64.3 111.196 -174.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -82.3 -27.12 32.51 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.882 1.273 . . . . 72.05 110.69 -172.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.4 pp -112.07 -2.19 10.21 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-O 117.805 -1.093 . . . . 73.03 112.347 -171.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.4 m -64.82 -56.55 12.81 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 119.784 1.175 . . . . 64.24 109.346 176.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.8 -62.03 5.31 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 123.523 0.729 . . . . 73.35 111.885 -165.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -65.69 -22.46 57.5 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.456 1.438 . . . . 73.21 113.045 -173.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 6.0 tpp -64.79 -47.41 78.19 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 124.148 0.979 . . . . 74.13 110.919 171.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -65.05 -35.12 80.14 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.197 0.908 . . . . 74.0 108.891 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -60.05 -38.3 82.4 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.451 0.569 . . . . 73.14 110.393 169.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.75 -16.58 47.44 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.04 -1.037 . . . . 73.32 112.751 -172.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.3 t -111.89 -33.94 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 124.966 1.306 . . . . 73.25 110.495 -171.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -108.57 -54.03 2.56 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.534 1.134 . . . . 64.24 110.93 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt -69.2 -55.79 9.56 Favored 'General case' 0 N--CA 1.462 0.17 0 O-C-N 121.096 -1.002 . . . . 74.45 110.66 -171.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.4 p -104.5 -23.79 13.1 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.726 0.811 . . . . 74.23 112.551 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 55.93 30.86 16.78 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.89 2.076 . . . . 72.32 112.775 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.0 t -62.69 -25.8 68.34 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.602 1.561 . . . . 65.44 112.362 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.1 t -63.01 109.8 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 122.387 1.089 . . . . 70.31 108.22 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.97 -26.4 0.79 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.121 1.769 . . . . 73.31 110.804 -171.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 m -136.99 163.95 29.5 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.577 -1.268 . . . . 74.14 107.577 168.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 85.7 t -53.75 -33.47 23.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 125.961 1.704 . . . . 65.34 109.408 173.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.8 -20.04 65.86 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.067 1.747 . . . . 70.51 112.361 -177.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.29 -49.0 8.01 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.986 0.914 . . . . 45.32 108.9 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -55.57 -48.59 77.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 125.654 1.582 . . . . 73.24 109.122 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -20.9 66.72 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.519 -0.753 . . . . 74.25 112.381 -175.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -64.32 -52.77 56.83 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 118.898 0.772 . . . . 74.43 109.594 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.4 t -55.87 -44.15 76.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 123.753 0.658 . . . . 71.22 109.571 -174.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -51.12 -55.68 16.55 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.751 0.42 . . . . 72.21 110.428 175.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 82.6 t -59.32 -47.16 91.47 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-N 118.454 0.57 . . . . 72.34 111.332 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -73.86 -30.84 62.88 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 124.068 0.855 . . . . 74.23 110.369 -168.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.0 -32.41 67.17 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.528 0.731 . . . . 65.21 110.268 170.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 145.09 23.11 0.13 Allowed Glycine 0 CA--C 1.531 1.068 0 N-CA-C 116.768 1.467 . . . . 63.45 116.768 165.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.7 t -94.2 127.42 46.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 119.245 1.522 . . . . 72.41 110.595 -177.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -53.89 116.57 2.62 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.777 0.831 . . . . 75.34 108.78 172.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.36 -24.91 64.21 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-O 118.663 -1.076 . . . . 64.52 111.243 171.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -74.75 -23.31 58.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.168 1.484 . . . . 63.15 112.27 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.86 -43.73 8.84 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 108.656 -0.868 . . . . 71.04 108.656 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -51.77 -60.65 2.92 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.271 1.428 . . . . 74.35 109.584 172.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -69.84 -14.59 62.82 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 119.718 -0.182 . . . . 72.35 111.091 -168.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -88.42 -58.72 2.45 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.72 1.208 . . . . 62.35 109.873 172.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.5 -36.82 67.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.962 1.705 . . . . 65.34 111.298 -176.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -45.11 -37.68 4.52 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 125.346 1.458 . . . . 73.33 112.189 176.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -108.43 -3.5 18.16 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.823 1.649 . . . . 73.44 113.498 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 32.6 t -81.41 155.38 25.93 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 127.563 2.345 . . . . 74.41 111.706 173.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.85 -21.52 64.28 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 112.599 -2.091 . . . . 73.14 115.778 -171.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.9 t -47.68 -55.42 2.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 C-N-CA 127.42 2.288 . . . . 74.35 106.83 167.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.1 t -71.81 -42.21 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.532 -0.758 . . . . 70.31 109.415 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -54.82 -51.08 66.96 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.448 1.022 . . . . 73.13 112.462 -177.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 67.7 m -69.83 -34.15 73.27 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.144 0.978 . . . . 72.01 111.563 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 11.9 mt -68.62 -46.46 69.19 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.647 1.112 . . . . 73.34 112.113 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 24.7 t -48.67 -53.67 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 C-N-CA 124.399 1.08 . . . . 71.22 109.681 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.35 -40.53 93.72 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 116.351 -1.785 . . . . 72.05 110.87 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -56.39 -45.91 80.37 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 122.235 2.289 . . . . 74.22 112.918 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -53.95 -57.25 11.68 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.184 -1.043 . . . . 74.21 108.184 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -79.82 -9.91 59.72 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.862 1.265 . . . . 70.05 113.983 -171.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.1 tptt -86.21 -55.23 4.02 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 107.716 -1.216 . . . . 74.21 107.716 176.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.93 -62.23 2.01 Favored 'General case' 0 N--CA 1.444 -0.733 0 O-C-N 124.646 1.216 . . . . 70.0 108.66 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -82.84 0.59 43.32 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.699 1.0 . . . . 64.43 113.699 -162.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -122.06 2.29 9.85 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 117.733 -1.127 . . . . 74.3 112.936 177.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -57.31 -85.77 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.066 0.848 . . . . 65.12 110.651 174.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 174.74 43.03 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.926 2.49 . . . . 73.12 110.705 174.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.69 -26.54 6.53 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 120.55 -1.344 . . . . 71.21 112.019 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.73 -85.96 0.58 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.571 -1.27 . . . . 74.32 107.571 -167.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 48.22 29.24 1.8 Allowed 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.428 1.091 . . . . 74.22 112.565 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -154.98 95.62 0.15 Allowed Glycine 0 C--N 1.347 1.152 0 O-C-N 120.337 -1.477 . . . . 62.02 114.826 -164.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.455 HG12 ' CD1' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -95.91 162.38 24.22 Favored Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 113.589 0.959 . . . . 74.32 113.589 -170.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.51 123.08 8.76 Favored 'Cis proline' 0 C--N 1.352 0.729 0 CA-C-N 119.025 0.687 . . . . 71.21 112.841 -5.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -103.23 141.21 36.29 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 114.6 -1.182 . . . . 70.12 112.471 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 44.5 tpp -146.44 108.63 4.42 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 127.143 2.177 . . . . 71.2 106.355 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -96.71 158.42 15.44 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 123.006 0.191 . . . . 70.12 111.502 172.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.9 t -140.75 146.93 23.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 124.352 1.061 . . . . 74.14 108.56 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 46.71 19.18 0.08 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 128.686 2.794 . . . . 54.4 114.689 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.88 -2.92 58.47 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 120.783 -1.198 . . . . 72.34 113.328 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -140.57 -7.01 1.14 Allowed 'General case' 0 C--O 1.233 0.229 0 N-CA-C 114.434 1.272 . . . . 74.2 114.434 -159.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -124.3 146.08 49.01 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.161 -1.052 . . . . 73.04 108.161 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -113.91 147.71 38.02 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.32 -1.363 . . . . 74.4 107.32 162.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -68.84 140.09 55.22 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.128 -1.064 . . . . 74.33 108.128 170.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -113.81 86.13 10.51 Favored Pre-proline 0 C--O 1.234 0.262 0 C-N-CA 123.254 0.622 . . . . 73.02 111.216 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -61.61 -24.08 77.37 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.111 1.207 . . . . 74.31 112.565 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -66.23 -31.3 72.05 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.786 1.176 . . . . 73.21 110.416 -168.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -90.52 -4.77 70.1 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.737 -1.035 . . . . 61.01 111.823 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 43.8 mtt -78.99 166.18 22.63 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 119.58 1.69 . . . . 73.11 108.69 175.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -79.4 108.96 13.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 104.663 -2.347 . . . . 71.01 104.663 171.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 40.8 p -112.96 50.23 0.89 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.948 2.099 . . . . 74.2 107.019 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 13.9 m -131.31 3.39 4.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.095 -1.412 . . . . 72.32 111.098 -167.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.03 -20.67 1.11 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 126.751 2.02 . . . . 73.34 110.645 174.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 7.9 mmt 73.09 -54.96 0.69 Allowed 'General case' 0 C--N 1.347 0.484 0 C-N-CA 126.063 1.745 . . . . 74.22 110.568 -174.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.79 -50.22 69.03 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.142 1.377 . . . . 70.04 110.531 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 79.1 t -72.18 -24.07 22.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 125.53 1.532 . . . . 71.23 111.574 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -60.16 -61.85 2.3 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.331 -0.989 . . . . 73.03 108.331 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.9 t -64.92 -33.47 63.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 O-C-N 123.367 0.417 . . . . 72.21 110.474 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.98 -42.91 69.51 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.368 0.667 . . . . 73.33 112.329 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -81.63 -40.41 22.98 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 118.492 -0.766 . . . . 65.01 110.874 176.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -54.85 -57.8 10.13 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.479 1.112 . . . . 74.31 110.154 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -55.69 -32.03 62.94 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.925 0.89 . . . . 65.44 111.571 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -65.88 -58.4 5.68 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.936 -0.394 . . . . 71.0 109.936 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.4 t -63.1 -29.96 71.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 116.93 -1.51 . . . . 65.12 110.771 -173.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 47.5 t -56.49 -56.95 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 120.138 1.335 . . . . 71.43 108.189 173.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.31 -43.46 83.28 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 124.649 1.18 . . . . 73.23 111.093 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -64.65 -30.1 71.11 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 119.001 0.819 . . . . 75.1 112.244 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 52.6 mt -74.27 -23.68 59.15 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 120.44 -1.412 . . . . 74.23 111.833 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 84.7 t -62.71 -30.21 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.646 -0.501 . . . . 73.22 109.646 174.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -99.17 -8.11 25.59 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.885 0.874 . . . . 74.04 110.872 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -110.82 77.26 1.03 Allowed 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 120.668 -1.27 . . . . 74.13 109.406 -174.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.043 0 C-N-CA 127.52 2.328 . . . . 75.22 112.634 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 113.996 1.11 . . . . 71.44 113.996 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -166.25 109.74 0.77 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.12 1.768 . . . . 72.04 106.894 -177.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.422 ' C ' ' HG1' ' A' ' 4' ' ' THR . 6.4 pt -117.24 166.32 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.499 1.119 . . . . 72.43 110.349 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.422 ' HG1' ' C ' ' A' ' 3' ' ' ILE . 85.6 m -149.28 141.85 24.41 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.297 -1.372 . . . . 73.33 107.297 -177.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -59.41 149.27 29.8 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.744 0.783 . . . . 75.33 109.399 174.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.81 -21.34 2.08 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-O 117.587 -1.674 . . . . 71.45 112.629 -172.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -99.56 -69.5 0.76 Allowed 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 120.966 2.383 . . . . 74.44 110.224 -165.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -107.95 -15.91 14.42 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 123.684 0.794 . . . . 73.04 110.637 -177.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -141.86 167.99 20.83 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 108.49 -0.93 . . . . 72.15 108.49 171.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 mm -131.26 142.29 43.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 104.652 -2.351 . . . . 74.13 104.652 168.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.1 m -78.4 171.13 15.54 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 125.144 1.378 . . . . 64.34 108.354 170.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 32.9 mt -113.14 161.65 16.88 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.99 0.916 . . . . 73.33 110.467 171.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -80.37 -37.75 31.72 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.287 1.035 . . . . 75.45 108.716 -174.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -133.26 71.33 76.91 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 125.42 1.488 . . . . 74.3 110.807 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 CA--C 1.535 0.551 1 C-N-CA 125.547 4.165 . . . . 74.45 111.033 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 CA--C 1.542 0.66 0 N-CA-C 112.776 0.658 . . . . 63.44 112.776 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.406 HD21 ' CZ ' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -122.92 154.77 37.92 Favored 'General case' 0 CA--C 1.518 -0.287 0 O-C-N 121.352 -0.843 . . . . 65.43 113.249 -163.01 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -135.83 141.19 44.65 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 125.244 1.418 . . . . 74.01 108.101 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.406 ' CZ ' HD21 ' A' ' 23' ' ' LEU . 98.0 m-85 -127.75 137.77 52.54 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.738 1.215 . . . . 73.23 109.62 -176.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -165.38 -178.48 5.01 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.988 1.715 . . . . 74.42 109.749 -177.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.7 t -143.94 -174.48 4.28 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.776 1.23 . . . . 72.03 108.142 171.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.453 ' CD2' HD21 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -92.23 -7.66 47.58 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.507 1.299 . . . . 74.44 114.507 175.273 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.403 ' CE2' ' HA3' ' A' ' 65' ' ' GLY . 42.0 m-85 -100.29 -4.92 28.31 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.922 0.889 . . . . 73.2 112.826 175.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.7 p -80.07 140.83 53.75 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 120.681 1.582 . . . . 71.04 108.764 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -92.07 -30.74 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 CA-C-N 120.133 1.083 . . . . 75.05 111.055 -168.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -64.25 -50.08 69.38 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.952 1.701 . . . . 75.22 109.517 171.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.5 p -67.0 -22.93 65.88 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 117.582 -1.199 . . . . 70.44 111.706 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -57.21 -55.08 39.39 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 120.338 1.427 . . . . 70.34 109.312 170.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -55.05 -46.46 75.36 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 108.804 -0.813 . . . . 71.05 108.804 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -65.58 -16.45 63.72 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 116.796 -1.574 . . . . 73.21 113.324 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -116.29 -8.13 11.71 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 121.105 1.775 . . . . 74.25 111.762 -173.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -141.38 -30.15 0.62 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.75 0.82 . . . . 73.02 112.907 -163.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.2 t -115.4 -68.02 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 N-CA-C 107.466 -1.309 . . . . 72.03 107.466 -172.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.8 mt -66.44 -28.41 68.58 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.843 -1.071 . . . . 72.15 111.075 171.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 45.14 41.6 5.94 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.438 1.495 . . . . 65.22 111.833 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.2 t -50.88 -48.2 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 C-N-CA 125.79 1.636 . . . . 73.21 108.696 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.3 p -46.08 -55.71 6.58 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 124.791 1.307 . . . . 65.14 112.293 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -75.36 -34.86 61.19 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 119.913 -1.742 . . . . 64.43 110.665 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.45 -54.58 45.22 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 123.035 0.534 . . . . 65.41 110.474 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.5 t -60.82 -43.02 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 109.253 -0.647 . . . . 74.45 109.253 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.7 ttt-85 -53.72 -29.5 39.6 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.391 1.256 . . . . 74.43 114.391 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -89.78 -3.56 58.1 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.186 1.18 . . . . 65.21 114.186 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -128.12 0.03 5.83 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.929 2.092 . . . . 74.45 113.032 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.3 mt -63.11 154.37 77.79 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.378 1.471 . . . . 63.31 108.988 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.12 151.33 26.9 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.32 2.68 . . . . 74.34 108.837 172.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 45.46 24.01 0.16 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.236 2.615 . . . . 62.31 115.645 174.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.27 33.34 75.0 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-O 117.851 -1.527 . . . . 72.35 113.659 -172.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.0 m -61.59 69.62 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.775 1.63 . . . . 73.34 111.191 172.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -63.63 132.19 50.37 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 120.385 -1.447 . . . . 74.2 108.357 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -75.57 173.56 10.85 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.037 0.935 . . . . 73.11 112.178 -174.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.84 154.01 26.97 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.557 0.743 . . . . 65.04 109.368 170.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.78 102.0 6.36 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.306 1.042 . . . . 73.13 108.488 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -97.0 168.22 10.6 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.348 1.059 . . . . 74.3 110.336 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.56 ' CE1' ' HB2' ' A' ' 137' ' ' GLN . 0.3 OUTLIER -101.18 172.05 7.24 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.986 1.314 . . . . 65.4 108.569 -179.249 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.9 m -140.42 145.8 25.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 107.445 -1.317 . . . . 73.21 107.445 162.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . 0.293 0.0 OUTLIER -102.37 17.97 22.21 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 129.084 2.953 . . . . 75.1 113.54 -177.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -84.18 -4.33 58.74 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.294 1.438 . . . . 62.4 114.367 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.59 145.48 51.13 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 119.827 -1.796 . . . . 74.42 110.29 -166.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.403 ' HA3' ' CE2' ' A' ' 29' ' ' TYR . . . 63.87 -178.69 7.2 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 121.375 0.431 . . . . 75.33 112.517 174.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -78.36 -46.63 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.316 2.677 . . . . 62.3 113.308 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.8 mt -79.17 31.69 0.22 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.655 1.116 . . . . 75.41 112.518 -174.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -43.24 -63.71 1.99 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 126.053 1.787 . . . . 75.2 110.689 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -63.02 -40.06 96.62 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 117.548 0.674 . . . . 73.1 110.647 -172.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.51 -42.43 92.18 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.263 1.425 . . . . 73.41 110.458 -175.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.453 HD21 ' CD2' ' A' ' 28' ' ' PHE . 18.6 mt -65.33 -45.17 85.33 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 118.533 -0.746 . . . . 73.22 111.392 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.443 ' CG2' ' CE1' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -46.78 -53.73 11.3 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.057 -1.09 . . . . 70.22 108.057 175.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -58.17 -55.89 29.09 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.945 0.898 . . . . 74.33 110.418 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.88 -43.18 72.95 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 120.186 1.357 . . . . 72.2 113.838 -176.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 14.0 t-105 -59.8 -38.0 80.71 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.341 -0.85 . . . . 74.12 111.355 -174.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.39 -38.57 71.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 118.062 -0.971 . . . . 73.2 112.557 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.6 t -57.03 -47.77 82.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 120.031 1.287 . . . . 74.21 109.933 171.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.22 -40.53 94.24 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.868 -0.52 . . . . 65.33 111.237 -176.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 85.8 mt -67.01 -38.2 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.736 0.815 . . . . 64.41 109.68 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.86 -50.61 72.73 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.858 0.863 . . . . 74.5 110.111 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 77.4 mt -76.2 -27.75 56.99 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.805 -0.559 . . . . 73.53 112.098 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.51 62.4 2.72 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 126.566 2.032 . . . . 45.42 110.603 -173.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.0 m -129.81 14.07 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 125.226 1.41 . . . . 72.2 112.303 -174.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -49.99 -51.87 38.26 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 125.064 1.346 . . . . 72.02 112.307 -169.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.62 -43.02 79.78 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.37 1.468 . . . . 73.44 110.373 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -64.05 -27.12 68.89 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 124.456 1.102 . . . . 74.1 110.609 -176.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.3 pp -116.48 27.19 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 126.847 2.059 . . . . 72.04 109.876 -176.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 89.9 m -97.67 -54.58 3.07 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.755 -1.202 . . . . 73.24 107.755 164.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.52 -62.09 3.74 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 113.721 1.008 . . . . 73.0 113.721 -172.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.37 -27.29 23.75 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.194 1.263 . . . . 72.34 111.557 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 32.6 tpp -65.07 -49.9 68.25 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.557 1.143 . . . . 73.12 109.635 -177.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -69.34 -35.63 76.09 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.49 -0.93 . . . . 74.04 108.49 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.455 ' CG ' ' HE3' ' A' ' 97' ' ' LYS . 2.6 mt-10 -65.68 -11.19 42.96 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 114.367 1.247 . . . . 70.4 114.367 169.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -109.15 1.52 20.41 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.576 1.08 . . . . 71.02 113.488 172.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.451 HG21 ' CD2' ' A' ' 28' ' ' PHE . 95.8 t -115.38 -34.66 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 117.392 -1.289 . . . . 74.43 114.04 175.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -108.84 -53.0 2.7 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 120.547 1.521 . . . . 71.34 113.401 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.455 ' HE3' ' CG ' ' A' ' 93' ' ' GLU . 2.9 mmmt -62.08 -64.54 0.9 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.479 1.911 . . . . 64.01 112.713 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.9 p -87.88 -30.66 19.97 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.736 1.384 . . . . 74.32 114.736 174.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 56.1 35.73 26.16 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 128.348 2.659 . . . . 73.42 114.432 -173.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.5 t -71.31 -22.36 61.94 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.342 0.867 . . . . 74.1 113.342 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.4 t -66.71 120.33 13.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 O-C-N 120.625 -1.297 . . . . 74.44 110.217 172.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -140.63 -28.8 0.7 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.063 -0.971 . . . . 75.01 111.633 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.83 174.39 10.58 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.539 1.063 . . . . 64.01 110.178 168.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.5 t -57.68 -41.32 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.139 0.975 . . . . 72.4 111.267 -169.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.28 -23.77 62.7 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 119.204 -0.427 . . . . 74.04 111.679 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -78.19 -30.54 49.06 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 119.044 0.838 . . . . 73.04 111.207 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.4 mt -81.8 -48.26 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 108.293 -1.003 . . . . 73.23 108.293 -174.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -18.23 60.41 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.577 0.751 . . . . 73.0 112.356 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -62.5 -56.85 14.14 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 125.43 1.492 . . . . 63.23 109.837 169.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.7 t -61.77 -34.47 62.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 118.645 -0.693 . . . . 70.14 110.804 -175.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -49.62 -60.46 2.85 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.016 -0.735 . . . . 74.33 109.016 169.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.1 t -57.09 -49.03 80.82 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-O 118.922 -0.561 . . . . 73.43 109.814 -176.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.23 -43.22 96.23 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 124.062 0.851 . . . . 73.1 110.159 -170.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.87 0.25 7.66 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.73 1.612 . . . . 74.11 112.852 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.49 44.76 1.41 Allowed Glycine 0 CA--C 1.523 0.566 0 C-N-CA 124.973 1.273 . . . . 71.5 112.917 171.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.0 t -112.38 140.8 30.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 118.977 1.388 . . . . 65.1 110.765 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -64.28 110.12 2.12 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.307 1.443 . . . . 74.5 109.134 165.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.92 -23.37 65.64 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-O 118.162 -1.354 . . . . 74.44 110.931 168.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -70.95 -23.05 62.15 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.621 1.211 . . . . 74.24 110.977 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -87.79 -46.34 9.54 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.701 -1.222 . . . . 72.41 107.701 176.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -51.97 -57.31 9.83 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.622 0.769 . . . . 65.4 109.603 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -74.7 -9.48 58.61 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.88 0.872 . . . . 65.12 112.43 -171.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -87.78 -66.15 0.94 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.909 1.283 . . . . 53.31 109.355 166.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -49.34 -43.06 43.44 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.397 2.279 . . . . 71.14 111.45 -174.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -45.55 -35.69 4.1 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 126.303 1.841 . . . . 74.23 113.507 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -116.91 8.45 13.51 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.713 1.205 . . . . 71.23 111.828 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 21.3 t -95.69 159.85 14.78 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 127.16 2.184 . . . . 72.23 110.226 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -57.14 -33.03 66.98 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.301 1.44 . . . . 65.44 111.892 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.8 t -49.57 -54.27 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 124.107 0.963 . . . . 73.22 109.912 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.5 t -63.87 -49.54 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 123.803 0.841 . . . . 65.23 110.694 176.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -49.61 -54.35 18.86 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.926 0.784 . . . . 73.24 111.549 -177.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.12 -40.0 93.89 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.102 0.561 . . . . 74.3 111.998 177.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.8 mt -60.6 -49.36 77.84 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-O 116.61 -1.662 . . . . 73.3 110.891 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 99.1 t -56.78 -37.26 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 120.199 1.363 . . . . 71.03 110.428 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.65 -28.83 70.18 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 117.763 -1.113 . . . . 72.21 112.329 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -53.47 -49.48 67.36 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 119.803 1.183 . . . . 64.31 112.097 175.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.56 ' HB2' ' CE1' ' A' ' 60' ' ' HIS . 0.5 OUTLIER -103.77 -18.96 14.46 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 118.54 -0.743 . . . . 64.11 110.636 -166.07 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -60.07 -52.82 63.73 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.922 -1.14 . . . . 75.1 107.922 158.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 32.1 tttp -61.15 -18.7 59.46 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.268 0.94 . . . . 73.11 113.181 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -114.9 1.19 13.97 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 115.816 1.784 . . . . 72.43 115.816 -176.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -139.18 -19.1 0.99 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 119.462 1.028 . . . . 72.22 111.609 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -104.7 -4.77 22.02 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 117.942 -1.027 . . . . 74.22 110.94 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -59.81 -83.03 0.02 OUTLIER 'General case' 0 C--N 1.345 0.401 0 C-N-CA 125.929 1.692 . . . . 75.32 109.934 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.2 pp -172.92 -11.18 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.106 1.521 . . . . 75.03 115.106 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -44.27 76.23 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.321 1.418 . . . . 73.23 112.556 -162.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.24 -70.05 0.79 Allowed 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 125.736 1.614 . . . . 75.02 109.561 -157.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 68.26 -3.75 1.22 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.676 1.991 . . . . 75.31 115.367 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -146.16 160.39 28.15 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 122.731 2.514 . . . . 73.0 112.709 174.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.3 m -142.23 167.01 17.8 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-N 118.532 1.166 . . . . 72.21 112.61 -174.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.35 165.21 33.51 Favored 'Cis proline' 0 C--N 1.353 0.812 0 CA-C-N 119.743 0.944 . . . . 70.33 111.911 -11.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -149.67 151.49 33.8 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.563 -0.903 . . . . 72.12 108.563 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 6.6 ttm -149.25 117.97 6.61 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.531 -1.285 . . . . 74.14 107.531 -172.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -124.22 107.04 10.78 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 125.038 1.335 . . . . 73.32 110.015 -169.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 81.5 t -64.06 -65.16 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.177 0.591 . . . . 72.32 111.672 -170.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -132.96 25.02 4.28 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.793 2.037 . . . . 74.41 108.136 -171.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 68.0 20.2 72.51 Favored Glycine 0 C--N 1.343 0.951 0 C-N-CA 124.774 1.178 . . . . 72.01 113.988 -177.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.495 ' HE2' ' CZ ' ' A' ' 158' ' ' TYR . 18.7 ptmt -138.43 -7.65 1.51 Allowed 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 115.089 1.514 . . . . 73.33 115.089 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.495 ' CZ ' ' HE2' ' A' ' 157' ' ' LYS . 22.9 m-85 -133.94 122.09 22.61 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.457 -1.683 . . . . 73.02 106.457 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.12 143.87 27.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 105.518 -2.03 . . . . 74.35 105.518 161.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -69.9 142.73 52.93 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.88 -1.155 . . . . 73.13 107.88 166.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -112.57 85.76 7.69 Favored Pre-proline 0 N--CA 1.453 -0.292 0 N-CA-C 113.024 0.75 . . . . 72.04 113.024 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.39 -19.74 37.52 Favored 'Trans proline' 0 N--CA 1.443 -1.486 0 C-N-CA 120.454 0.769 . . . . 74.23 111.1 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -61.86 -20.48 63.75 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 119.626 1.103 . . . . 75.41 112.821 -175.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -108.75 3.72 32.25 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 117.641 -1.644 . . . . 72.45 113.326 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 56.3 mtt -93.01 173.57 7.67 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.91 2.355 . . . . 70.04 111.794 -168.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.57 58.54 3.75 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 123.568 1.651 . . . . 73.41 111.764 -171.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 72.2 p -72.96 16.07 0.17 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.474 2.31 . . . . 65.34 112.851 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.4 m -94.43 -8.79 37.58 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.945 1.698 . . . . 73.32 112.707 173.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.0 -14.08 4.47 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 119.5 1.045 . . . . 73.34 113.181 -174.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 4.5 mmt 70.6 -57.66 0.58 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.591 1.957 . . . . 74.34 113.926 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.22 -48.95 68.93 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.694 -1.225 . . . . 70.33 107.694 -178.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 21.2 t -65.05 -36.81 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 124.928 1.291 . . . . 70.33 109.567 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -52.14 -60.73 2.86 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 118.262 -0.875 . . . . 74.33 110.135 172.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 8.9 t -66.76 -39.26 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 119.198 0.908 . . . . 61.11 111.392 -175.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.42 -33.97 64.01 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.617 0.767 . . . . 71.33 111.419 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -88.94 -31.4 18.19 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.393 1.077 . . . . 72.41 112.159 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -58.68 -59.64 5.09 Favored 'General case' 0 CA--C 1.528 0.099 0 O-C-N 120.8 -1.187 . . . . 73.34 108.965 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.27 -32.7 72.52 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.873 -0.517 . . . . 72.04 111.795 -175.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.96 -52.01 67.23 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.879 1.272 . . . . 74.44 111.835 174.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.0 t -64.88 -30.22 71.21 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 117.403 -1.284 . . . . 72.44 110.491 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 99.9 t -60.07 -55.89 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 120.455 1.479 . . . . 74.05 108.302 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -62.42 -33.93 75.76 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-O 118.903 -0.57 . . . . 74.42 111.979 -177.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -68.92 -33.8 74.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.645 0.657 . . . . 71.14 111.342 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 34.4 mt -67.99 -29.36 68.36 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 120.957 -1.09 . . . . 74.25 111.936 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 62.2 t -62.06 -26.03 38.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.437 0.695 . . . . 72.43 111.506 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -98.34 -18.35 18.38 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.508 0.595 . . . . 65.12 110.531 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -96.32 76.56 2.98 Favored 'General case' 0 CA--C 1.516 -0.349 0 O-C-N 121.035 -1.041 . . . . 73.01 108.851 -172.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.246 0.896 0 C-N-CA 127.832 2.453 . . . . 74.01 112.023 -174.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.524 0 N-CA-C 114.207 1.188 . . . . 74.0 114.207 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -163.78 120.75 1.75 Allowed 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.344 -1.724 . . . . 73.32 106.344 174.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.8 pt -133.14 160.7 42.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 126.444 1.898 . . . . 74.03 109.592 177.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.5 m -140.4 144.51 36.23 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 121.607 -0.683 . . . . 73.41 109.551 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -51.37 142.04 14.18 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 127.238 2.215 . . . . 71.15 111.117 168.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.09 -22.79 2.32 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.415 1.007 . . . . 74.14 112.582 -176.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -102.38 -77.79 0.55 Allowed 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 124.129 0.971 . . . . 74.31 108.672 -165.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -100.24 -15.84 17.94 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.413 1.085 . . . . 71.14 110.719 -174.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -140.95 159.34 42.42 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.217 -0.66 . . . . 71.13 109.217 165.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.4 mm -113.55 162.55 11.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 124.762 1.225 . . . . 72.43 107.695 173.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 m -117.24 147.9 42.12 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.426 1.49 . . . . 65.45 107.603 176.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.2 mt -86.18 154.66 21.16 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.52 -0.548 . . . . 74.33 109.52 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -72.28 -37.33 69.06 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.878 1.671 . . . . 73.44 109.693 176.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -127.59 85.12 61.56 Favored Pre-proline 0 C--N 1.34 0.178 0 C-N-CA 127.479 2.312 . . . . 73.54 108.331 173.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo . . . . . 0 N--CA 1.45 -1.031 0 C-N-CA 123.732 2.954 . . . . 74.04 109.583 168.583 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.8 t . . . . . 0 CA--C 1.537 0.45 0 CA-C-O 121.395 0.617 . . . . 73.24 111.206 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.3 tp -157.24 148.22 21.64 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.724 0.81 . . . . 73.04 109.747 -174.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -140.52 153.12 46.05 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.946 1.698 . . . . 73.43 109.262 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -133.35 139.32 46.76 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.727 1.211 . . . . 74.31 108.527 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.81 -179.71 7.81 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.285 1.834 . . . . 70.24 108.512 -177.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -158.68 161.87 37.16 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.872 0.76 . . . . 74.51 111.366 174.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -70.47 -39.83 74.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.461 1.504 . . . . 74.34 112.111 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -93.6 18.09 10.6 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.567 1.147 . . . . 74.2 111.793 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 33.8 t -88.73 141.68 30.18 Favored Pre-proline 0 CA--C 1.538 0.503 0 O-C-N 120.136 -1.603 . . . . 72.11 110.042 171.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -83.68 -46.56 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 121.73 1.62 . . . . 73.54 112.165 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -61.45 -44.06 97.77 Favored 'General case' 0 CA--C 1.528 0.115 0 O-C-N 121.56 -0.712 . . . . 74.32 109.537 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.7 m -57.02 -33.34 67.08 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.566 0.746 . . . . 72.24 112.097 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -58.93 -53.55 57.17 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.438 0.695 . . . . 70.21 110.105 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.54 -47.73 78.79 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 118.431 -0.795 . . . . 73.1 109.432 177.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -62.13 -19.83 63.43 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 116.83 -1.557 . . . . 74.12 112.341 -174.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -134.84 10.12 3.61 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 120.925 1.693 . . . . 64.43 112.11 -164.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -135.7 -41.21 0.69 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.868 2.067 . . . . 71.33 111.209 169.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 83.7 t -98.47 -74.57 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.11 0 N-CA-C 107.89 -1.152 . . . . 65.23 107.89 -168.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 65.7 mt -62.0 -28.19 69.4 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.985 1.314 . . . . 73.2 111.663 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 1.2 m170 44.36 56.76 4.76 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.669 1.988 . . . . 71.11 111.783 177.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.6 t -62.06 -44.59 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 125.293 1.437 . . . . 74.13 109.752 -174.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.9 t -53.05 -44.77 67.68 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.333 0.97 . . . . 72.12 111.99 -175.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -76.89 -29.71 55.88 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 121.194 -0.941 . . . . 72.33 111.447 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -63.23 -46.99 84.38 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.492 0.717 . . . . 73.4 110.607 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.9 t -59.53 -51.24 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 108.238 -1.023 . . . . 70.14 108.238 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 37.8 ttt-85 -47.36 -46.32 25.63 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.378 1.071 . . . . 74.44 111.948 177.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -64.89 -2.8 2.82 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.155 1.169 . . . . 74.32 114.155 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.6 mmtt -132.01 -9.9 3.42 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 127.466 2.306 . . . . 71.22 113.724 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.7 mt -66.95 144.81 98.73 Favored Pre-proline 0 C--O 1.237 0.4 0 CA-C-N 119.306 0.957 . . . . 74.15 110.882 -164.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.69 165.38 32.89 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.988 2.459 . . . . 73.25 109.78 167.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.88 23.29 0.7 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.774 1.027 . . . . 65.22 113.774 -173.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.67 18.21 22.56 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 127.139 2.304 . . . . 71.34 112.057 -173.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 t -130.08 129.39 43.53 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.462 -1.31 . . . . 72.14 107.462 -163.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -96.29 121.1 37.71 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 104.8 -2.296 . . . . 74.34 104.8 166.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 6.2 ttm -66.39 102.49 0.88 Allowed 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 125.074 1.35 . . . . 74.35 108.02 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 58' ' ' LYS . 1.5 m -120.0 -171.73 2.21 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.215 -1.032 . . . . 73.31 108.215 -173.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.413 ' H ' HG22 ' A' ' 57' ' ' THR . 0.0 OUTLIER 174.58 108.99 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.423 1.489 . . . . 71.24 108.102 -173.053 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -108.59 146.67 32.96 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.795 1.18 . . . . 74.15 109.855 174.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -82.01 168.54 17.72 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.242 1.017 . . . . 74.31 109.543 -174.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.6 m -139.03 111.12 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 119.528 1.058 . . . . 74.45 108.521 158.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.461 ' HB3' ' HG1' ' A' ' 72' ' ' THR . 0.0 OUTLIER -78.89 4.68 13.44 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 124.719 1.208 . . . . 74.31 113.183 176.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -55.77 -8.48 0.41 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.173 1.789 . . . . 73.24 113.376 169.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.8 132.07 34.19 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 125.425 1.49 . . . . 73.42 109.996 -176.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.59 156.54 10.7 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 126.443 1.973 . . . . 62.32 112.014 168.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -62.99 -56.12 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.47 2.113 . . . . 65.42 109.544 167.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.6 mt -91.21 34.99 0.92 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.652 1.581 . . . . 72.23 109.912 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.95 -51.89 50.41 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.508 -1.037 . . . . 70.54 110.508 175.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.9 tppm? -57.14 -40.2 76.72 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.291 1.036 . . . . 72.41 112.181 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.88 -38.63 89.29 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.852 1.661 . . . . 72.33 110.31 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.7 mt -67.36 -41.05 85.73 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 117.808 -1.092 . . . . 73.05 111.641 174.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.461 ' HG1' ' HB3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -53.03 -56.65 14.49 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.922 1.289 . . . . 72.31 108.975 -177.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -62.4 -41.93 99.05 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.409 0.684 . . . . 70.22 109.477 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.14 -30.96 69.64 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 113.443 0.905 . . . . 72.42 113.443 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 33.7 t-105 -61.56 -41.04 96.8 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 118.507 0.594 . . . . 74.45 111.518 -176.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.89 -36.31 76.67 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 117.665 -1.16 . . . . 65.23 112.492 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.2 t -55.72 -46.69 79.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 120.711 1.596 . . . . 73.12 110.796 171.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.01 -43.16 88.49 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-O 119.137 -0.459 . . . . 64.42 110.628 -175.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.2 mt -63.65 -39.87 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 118.758 -0.639 . . . . 71.34 109.965 176.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.74 -22.84 66.04 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.622 0.646 . . . . 61.21 112.279 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.2 mt -99.49 -11.78 20.76 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.214 0.916 . . . . 73.22 112.631 169.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 64.11 56.06 20.41 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 124.346 0.974 . . . . 74.03 111.372 -173.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.7 m -133.88 14.46 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 124.174 0.99 . . . . 73.34 112.107 -176.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -45.36 -56.82 4.54 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.664 1.186 . . . . 74.35 109.386 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.31 -10.33 59.64 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 125.438 1.495 . . . . 74.45 111.886 -172.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -87.32 -30.73 20.62 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 120.827 -1.17 . . . . 74.03 110.715 171.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.5 pp -100.55 -14.58 7.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 CA-C-O 117.374 -1.298 . . . . 65.21 111.463 -171.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.1 m -59.09 -51.62 69.24 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 119.967 1.258 . . . . 73.12 110.583 -175.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.15 -62.14 5.77 Favored Pre-proline 0 N--CA 1.452 -0.357 0 C-N-CA 124.569 1.147 . . . . 62.21 110.734 -168.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.05 -26.83 42.86 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 120.911 1.074 . . . . 72.2 112.397 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 4.5 tpp -60.5 -49.55 77.09 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.221 0.464 . . . . 70.43 110.185 170.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -64.58 -37.13 86.51 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.029 0.831 . . . . 74.01 109.077 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.33 -32.83 72.71 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.68 0.673 . . . . 73.24 111.666 171.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.13 -17.17 29.75 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.355 -1.466 . . . . 65.11 112.817 -176.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.4 t -100.54 -43.4 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 124.9 1.28 . . . . 73.44 109.488 -176.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -98.59 -60.62 1.51 Allowed 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.161 0.984 . . . . 61.21 110.215 -177.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.5 mmmt -65.94 -58.45 5.51 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 118.902 -0.57 . . . . 74.11 110.581 -167.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.2 p -97.18 -16.51 20.39 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.672 0.619 . . . . 73.41 112.672 -176.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 48.12 25.62 0.86 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.659 2.384 . . . . 74.14 113.885 -175.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.9 t -62.76 -16.0 55.9 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.62 1.968 . . . . 73.13 112.013 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 70.1 t -68.5 111.87 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 O-C-N 121.182 -0.949 . . . . 64.2 109.236 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -136.81 -30.12 0.9 Allowed 'General case' 0 C--O 1.239 0.524 0 C-N-CA 125.058 1.343 . . . . 73.42 110.275 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.26 162.28 33.44 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.15 -0.685 . . . . 71.55 109.15 174.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.82 -30.27 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.819 0.847 . . . . 73.13 110.138 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -47.4 -39.94 16.53 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.442 2.297 . . . . 72.51 113.31 168.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -77.55 -38.93 47.53 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.691 -0.855 . . . . 74.24 108.691 -175.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 mt -66.76 -48.33 80.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 125.103 1.361 . . . . 74.24 107.864 -174.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -57.76 -31.74 66.8 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-O 117.341 -1.314 . . . . 64.43 112.765 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -57.33 -57.12 14.04 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 119.601 1.091 . . . . 73.35 109.153 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.19 -37.73 78.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 123.371 0.419 . . . . 71.41 110.678 -173.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -53.92 -51.7 62.9 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 118.373 0.533 . . . . 70.15 110.659 172.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 90.2 t -64.18 -44.91 97.6 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-N 118.37 0.532 . . . . 71.34 110.631 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -63.14 -41.54 99.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.808 0.813 . . . . 74.24 108.939 -170.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.29 -4.31 50.17 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.144 1.378 . . . . 72.33 112.866 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 123.21 22.66 2.31 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 117.163 1.625 . . . . 71.02 117.163 160.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.5 t -97.61 134.23 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 119.551 1.675 . . . . 72.05 109.667 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.421 ' HE2' ' OE2' ' A' ' 119' ' ' GLU . 0.8 OUTLIER -63.51 143.59 57.7 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 121.635 -0.666 . . . . 63.15 110.138 176.31 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.54 -10.89 76.36 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 119.565 -0.575 . . . . 71.34 112.749 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.421 ' OE2' ' HE2' ' A' ' 117' ' ' LYS . 6.9 pt-20 -92.3 -32.22 15.09 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 123.903 0.881 . . . . 74.42 110.326 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -70.09 -46.59 64.55 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 107.375 -1.343 . . . . 74.41 107.375 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -54.08 -60.12 3.75 Favored 'General case' 0 N--CA 1.438 -1.046 0 O-C-N 123.876 0.735 . . . . 74.15 109.437 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -75.22 -19.47 59.76 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 118.183 -0.913 . . . . 74.35 112.145 -171.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.64 -63.91 1.24 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.374 0.988 . . . . 73.43 108.876 172.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.77 -37.86 63.88 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.359 1.064 . . . . 70.04 110.581 -173.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -45.33 -36.72 4.33 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.675 1.59 . . . . 65.04 113.308 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -114.69 1.04 14.08 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.535 1.134 . . . . 72.32 112.976 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.8 t -77.36 147.18 36.24 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 126.215 1.806 . . . . 73.42 111.097 171.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.42 -27.79 26.36 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 118.703 2.853 . . . . 72.04 118.703 174.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 46.1 t -45.48 -57.15 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 C-N-CA 126.186 1.794 . . . . 74.35 107.924 167.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.3 t -68.65 -45.45 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 123.81 0.844 . . . . 71.15 109.576 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 58.3 mttt -54.41 -48.7 71.3 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.453 1.024 . . . . 74.13 112.428 -174.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 66.0 m -79.09 -22.0 45.88 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 113.183 0.809 . . . . 73.44 113.183 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 13.4 mt -69.15 -51.41 38.53 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 119.668 1.122 . . . . 70.11 110.172 167.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 52.9 t -49.84 -51.54 15.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.162 0 C-N-CA 125.209 1.404 . . . . 74.21 108.298 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.55 -39.09 75.89 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 118.067 -0.968 . . . . 65.15 113.101 -176.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -57.9 -46.56 84.76 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 119.399 0.999 . . . . 72.05 111.169 172.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -82.22 -31.61 30.18 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.901 -1.045 . . . . 71.01 109.226 -163.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -66.12 -52.74 45.74 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.635 -0.876 . . . . 73.52 108.635 167.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.9 ttmm -61.6 -7.77 3.68 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.132 -0.98 . . . . 73.21 113.449 177.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.4 -12.07 9.42 Favored 'General case' 0 CA--C 1.515 -0.394 0 O-C-N 120.27 -1.519 . . . . 72.21 114.545 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -134.17 1.01 3.18 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 119.038 0.835 . . . . 72.15 112.633 -175.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.32 0.85 4.6 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.835 1.654 . . . . 71.42 111.248 171.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -65.12 -86.56 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.878 0.871 . . . . 74.25 111.676 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.5 pp -175.81 23.95 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.351 0.978 . . . . 74.43 112.003 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -103.75 -71.91 0.72 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 120.151 1.341 . . . . 74.13 109.539 -168.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.53 -74.12 0.4 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 126.512 1.925 . . . . 70.14 110.431 -169.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 60.27 7.62 1.32 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 128.239 2.616 . . . . 71.45 115.304 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -147.18 146.42 16.22 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 109.034 -1.627 . . . . 72.13 109.034 176.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.2 m -137.14 169.15 13.99 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 118.271 1.035 . . . . 73.54 111.005 -172.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -71.86 162.45 89.31 Favored 'Cis proline' 0 C--N 1.348 0.522 0 CA-C-N 119.596 0.892 . . . . 73.23 112.719 -10.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -150.56 156.53 41.57 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 124.252 0.97 . . . . 74.21 111.457 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 43.1 ttm -143.55 119.06 10.34 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.04 1.336 . . . . 74.33 107.749 169.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -97.36 132.02 43.48 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.927 1.291 . . . . 72.42 107.629 175.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 95.8 t -96.23 -35.8 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 113.549 0.944 . . . . 72.41 113.549 -173.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -150.9 31.61 0.62 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.819 0.819 . . . . 70.45 109.571 -177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 69.35 -64.73 0.57 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 126.194 1.854 . . . . 61.31 110.147 -162.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -58.95 -18.46 33.87 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 116.767 2.136 . . . . 74.32 116.767 -170.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -128.57 133.94 48.5 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 119.154 0.888 . . . . 74.35 111.252 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.79 137.15 52.28 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 105.773 -1.936 . . . . 74.25 105.773 175.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.07 143.11 58.07 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.744 -1.206 . . . . 73.01 107.744 176.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -124.66 75.55 64.03 Favored Pre-proline 0 C--O 1.234 0.275 0 C-N-CA 122.851 0.46 . . . . 70.03 110.22 -175.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -68.32 -22.56 39.62 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 120.831 1.021 . . . . 65.33 111.346 -172.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.55 -32.43 28.15 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 114.029 1.122 . . . . 73.43 114.029 171.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -103.13 4.78 48.98 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-O 118.325 -1.264 . . . . 70.04 112.687 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 62.1 mtt -80.3 174.49 11.55 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 119.814 1.807 . . . . 74.0 109.241 172.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -75.06 106.89 6.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.703 -1.592 . . . . 70.04 106.703 166.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 80.7 p -114.99 28.8 8.47 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.927 1.691 . . . . 72.44 109.444 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 75.2 m -108.95 -1.09 19.28 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 114.224 1.194 . . . . 54.21 114.224 -175.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.26 -9.93 4.7 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 124.386 1.074 . . . . 73.3 110.999 177.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 5.5 mmt 70.67 -58.97 0.54 Allowed 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.304 2.242 . . . . 74.4 112.262 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -58.52 -49.29 77.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 122.836 1.303 . . . . 72.1 109.699 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 93.3 t -63.56 -27.77 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 125.935 1.694 . . . . 74.14 111.433 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -64.12 -59.24 4.69 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 107.8 -1.185 . . . . 71.11 107.8 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 5.9 t -69.19 -33.0 56.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 117.626 0.194 . . . . 74.04 110.913 -172.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.13 77.87 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.036 0.534 . . . . 73.32 111.23 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -82.6 -34.35 27.66 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 118.544 -0.741 . . . . 63.34 112.218 172.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -55.9 -57.64 11.25 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 120.208 1.367 . . . . 72.04 110.471 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.67 -30.46 67.38 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.411 0.684 . . . . 62.12 111.979 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -72.38 -50.83 23.68 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.44 1.496 . . . . 73.33 109.956 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 96.2 m -55.39 -39.16 69.8 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.165 1.386 . . . . 74.22 110.731 174.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 91.3 t -59.48 -58.41 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 108.101 -1.074 . . . . 73.34 108.101 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -59.99 -35.06 74.21 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.278 -0.868 . . . . 73.3 111.309 -177.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -59.96 -44.21 94.57 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 119.523 1.056 . . . . 73.11 110.78 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 77.9 mt -67.9 -25.5 65.53 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 121.047 -1.033 . . . . 73.01 111.835 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 93.1 t -66.19 -22.08 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 O-C-N 121.253 -0.904 . . . . 74.31 111.177 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -102.96 -7.34 21.55 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.622 0.769 . . . . 72.21 110.401 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -125.94 75.72 1.53 Allowed 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.574 1.549 . . . . 74.03 109.24 -172.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.245 0.86 0 N-CA-C 106.019 -1.845 . . . . 73.45 106.019 167.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.407 0 N-CA-C 114.182 1.178 . . . . 72.33 114.182 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -159.89 120.74 3.09 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.588 -1.634 . . . . 63.13 106.588 171.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.2 pt -122.47 154.04 27.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 127.54 2.336 . . . . 73.13 106.869 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.0 m -129.21 134.77 48.14 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.075 -1.454 . . . . 72.34 107.075 -175.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -57.31 140.29 50.47 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 123.723 0.639 . . . . 72.23 109.667 170.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 84.61 -23.14 7.79 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.275 1.417 . . . . 73.34 112.587 -172.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.7 tptp -95.05 -85.53 0.31 Allowed 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 119.472 1.636 . . . . 72.31 109.092 -169.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -90.17 -19.13 24.59 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.983 0.913 . . . . 74.41 110.899 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -135.18 163.74 29.26 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.937 0.895 . . . . 73.0 109.53 171.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.5 mm -124.97 161.25 29.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 127.337 2.255 . . . . 72.31 105.525 174.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.6 m -119.68 147.61 44.36 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.804 1.242 . . . . 72.2 108.362 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 31.3 mt -76.35 155.74 33.88 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.022 -0.732 . . . . 70.41 109.022 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -71.81 -37.41 70.38 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 122.308 1.051 . . . . 74.14 109.681 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -132.91 74.76 73.6 Favored Pre-proline 0 C--N 1.339 0.129 0 C-N-CA 126.463 1.905 . . . . 74.12 109.356 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 N--CA 1.449 -1.094 0 C-N-CA 122.113 1.875 . . . . 73.01 107.588 171.068 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 C--O 1.239 0.515 0 N-CA-C 106.683 -1.599 . . . . 71.24 106.683 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.411 HD23 ' CE2' ' A' ' 25' ' ' PHE . 5.7 tp -162.05 169.69 20.55 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.165 -0.679 . . . . 65.32 109.165 163.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -136.72 131.02 32.91 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 106.715 -1.587 . . . . 74.02 106.715 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.411 ' CE2' HD23 ' A' ' 23' ' ' LEU . 96.0 m-85 -119.14 128.13 53.98 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 118.57 0.623 . . . . 71.21 109.82 171.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -141.18 173.32 11.6 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.503 1.121 . . . . 70.12 108.821 164.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.488 ' HA ' ' CE1' ' A' ' 60' ' ' HIS . 3.5 t -128.37 179.7 5.49 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.509 -0.552 . . . . 64.04 109.509 168.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.498 ' CD2' ' CE1' ' A' ' 60' ' ' HIS . 46.8 m-85 -87.5 -35.17 18.36 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 118.241 -0.885 . . . . 74.33 111.845 177.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.412 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 96.9 m-85 -83.84 -3.12 57.64 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 121.157 1.799 . . . . 71.05 112.891 -177.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.7 p -80.04 141.01 53.98 Favored Pre-proline 0 CA--C 1.541 0.615 0 O-C-N 119.97 -1.706 . . . . 61.31 110.143 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -83.65 -35.3 0.24 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 121.866 1.711 . . . . 73.11 113.071 -170.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.82 -48.96 72.15 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 109.464 -0.569 . . . . 71.23 109.464 172.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.6 m -52.36 -33.88 45.13 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.065 1.346 . . . . 65.14 111.556 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -63.49 -55.73 21.73 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.819 0.736 . . . . 74.11 110.863 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.79 -44.29 77.63 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 121.185 -0.947 . . . . 74.2 109.024 175.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -64.71 -15.69 61.8 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 116.057 -1.925 . . . . 74.13 111.071 -174.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -141.54 12.79 2.13 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 121.457 1.935 . . . . 73.42 114.333 -171.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -135.69 -14.63 1.88 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.653 1.581 . . . . 72.12 112.115 167.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.2 t -124.34 -82.12 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.079 0 N-CA-C 107.795 -1.187 . . . . 74.1 107.795 -175.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.03 -29.36 67.22 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.714 2.006 . . . . 74.1 111.973 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 44.34 62.48 1.99 Allowed 'General case' 0 C--O 1.241 0.621 0 C-N-CA 126.005 1.722 . . . . 74.43 110.837 178.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.7 t -63.05 -46.83 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 113.983 -1.462 . . . . 62.23 108.026 -173.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 95.2 p -49.72 -52.61 30.13 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.824 0.849 . . . . 63.4 111.014 -177.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.85 -31.8 65.01 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.132 0.573 . . . . 74.34 109.965 -171.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -64.73 -43.18 94.2 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 118.774 -0.632 . . . . 70.2 110.965 171.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.9 t -59.57 -46.89 92.65 Favored 'Isoleucine or valine' 0 C--N 1.342 0.258 0 CA-C-N 119.251 0.932 . . . . 72.11 108.993 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -50.99 -42.13 60.09 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.193 0.997 . . . . 74.13 112.262 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -61.66 -5.43 1.91 Allowed 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.998 1.481 . . . . 74.04 114.998 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -127.08 -15.63 5.25 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.969 1.708 . . . . 73.32 113.219 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.1 mt -67.71 149.68 98.17 Favored Pre-proline 0 N--CA 1.469 0.511 0 CA-C-N 119.964 1.256 . . . . 54.42 112.497 -164.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.19 151.83 27.04 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.449 2.766 . . . . 73.2 111.17 171.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -82.11 81.68 7.95 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 122.636 1.208 . . . . 74.32 109.091 -176.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 175.44 -30.42 0.08 OUTLIER Glycine 0 CA--C 1.521 0.439 0 C-N-CA 125.131 1.348 . . . . 52.33 110.665 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.7 t -44.02 -45.21 7.81 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.911 1.684 . . . . 74.44 113.398 -173.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? 59.48 99.63 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.626 1.97 . . . . 65.41 110.045 -169.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.79 125.67 25.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.361 -1.29 . . . . 73.3 107.65 172.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 m -137.32 161.71 35.51 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.075 -1.454 . . . . 74.25 107.075 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -151.51 110.45 3.87 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 104.335 -2.468 . . . . 71.25 104.335 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -104.36 136.68 43.48 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.836 -1.913 . . . . 73.22 105.836 168.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.532 ' H ' ' NE2' ' A' ' 137' ' ' GLN . 15.3 t60 -82.86 169.68 15.81 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.043 -1.095 . . . . 74.34 108.043 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.3 m -131.22 136.22 58.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 108.698 -0.853 . . . . 74.04 108.698 170.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.47 5.18 11.29 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.626 1.17 . . . . 72.13 113.015 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -72.15 -177.43 2.09 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 122.71 1.243 . . . . 73.05 112.421 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 mp 63.8 -86.37 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 130.199 3.4 . . . . 73.21 112.588 177.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.412 ' HA3' ' CD2' ' A' ' 29' ' ' TYR . . . -72.7 160.87 54.23 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 124.03 0.824 . . . . 72.41 111.323 -176.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -65.27 -54.04 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.895 3.064 . . . . 71.33 110.052 -175.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.5 mt -73.62 8.78 1.68 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 117.777 -1.106 . . . . 73.01 113.425 -176.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -47.7 -33.19 8.87 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 120.135 1.334 . . . . 72.42 113.446 -177.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -58.61 -39.97 81.98 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.768 1.025 . . . . 74.11 113.768 175.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -62.21 -47.44 84.41 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.391 -0.966 . . . . 74.23 108.391 171.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.0 mt -54.18 -50.12 67.76 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 123.893 0.746 . . . . 74.23 110.191 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.7 m -57.29 -39.48 75.82 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.277 1.431 . . . . 72.44 112.955 173.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -68.04 -50.84 52.81 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.663 0.665 . . . . 74.03 110.375 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.78 -40.26 75.57 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 126.166 1.786 . . . . 65.25 111.678 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 46.2 t-105 -56.27 -35.21 67.19 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.041 0.536 . . . . 73.14 111.821 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.45 -40.36 94.2 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.246 -0.883 . . . . 74.11 111.798 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.5 t -57.46 -46.85 85.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 119.362 0.983 . . . . 72.35 108.896 172.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.16 -41.1 97.28 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-O 118.416 -0.802 . . . . 74.14 111.701 -176.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.7 mt -66.82 -43.36 89.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 118.107 -0.949 . . . . 70.04 109.765 175.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.29 93.81 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 119.185 0.902 . . . . 64.34 110.949 -174.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.8 mt -87.62 -12.52 45.32 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 119.038 -0.506 . . . . 73.02 112.265 175.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.44 61.83 6.66 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 126.148 1.832 . . . . 53.43 111.709 -174.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.9 m -134.18 20.23 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 125.361 1.464 . . . . 72.05 111.205 -177.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -50.38 -50.47 51.44 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.225 1.01 . . . . 71.25 110.0 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.18 -28.44 69.75 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.13 1.772 . . . . 52.33 110.623 -176.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -84.72 -25.24 28.48 Favored 'General case' 0 C--O 1.227 -0.11 0 C-N-CA 123.783 0.833 . . . . 74.35 111.671 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.1 pp -99.22 -15.4 7.44 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 CA-C-O 117.315 -1.326 . . . . 73.32 112.637 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.0 m -62.68 -45.7 91.57 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 119.863 1.21 . . . . 61.45 110.264 -170.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.8 -61.37 7.04 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 123.266 0.627 . . . . 61.42 111.385 -173.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.72 -21.84 50.96 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.603 1.535 . . . . 73.13 112.735 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.98 -53.77 53.98 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.08 0.952 . . . . 74.25 110.556 173.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -66.35 -33.32 75.47 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 118.083 0.401 . . . . 73.01 111.103 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.86 -38.25 81.59 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 120.15 -0.62 . . . . 64.41 110.925 169.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -86.52 -18.4 31.66 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 121.265 -0.897 . . . . 65.22 112.214 -168.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.7 t -107.93 -28.46 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 124.758 1.223 . . . . 73.05 109.822 -173.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -118.96 -53.5 2.27 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 118.887 0.767 . . . . 74.44 111.536 -173.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -64.99 -65.48 0.67 Allowed 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 118.62 0.645 . . . . 74.13 109.27 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.6 p -94.85 -18.29 21.31 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.04 0.536 . . . . 72.34 111.733 -170.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 45.34 39.79 4.71 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.503 2.321 . . . . 74.24 112.165 -175.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.0 t -73.77 -20.16 60.57 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.588 1.155 . . . . 74.04 111.466 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 31.9 t -69.38 117.87 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 108.29 -1.004 . . . . 65.42 108.29 172.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -137.6 -24.0 1.06 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.407 1.083 . . . . 74.14 111.575 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.43 177.34 11.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.079 2.152 . . . . 65.44 109.411 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.8 t -53.47 -46.0 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.264 1.826 . . . . 70.24 109.42 -173.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.04 -23.79 35.46 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.283 1.433 . . . . 65.02 112.713 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -91.83 -28.88 17.05 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 118.261 0.482 . . . . 73.41 110.091 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.95 -46.34 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 123.205 0.602 . . . . 72.25 109.433 -175.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -25.35 61.83 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 112.932 0.715 . . . . 73.45 112.932 175.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -58.83 -52.46 65.62 Favored 'General case' 0 C--O 1.222 -0.342 0 N-CA-C 109.323 -0.621 . . . . 74.01 109.323 175.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.7 t -52.94 -43.69 47.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 123.862 0.865 . . . . 63.04 110.734 -176.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -55.1 -52.91 61.76 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.405 0.682 . . . . 74.43 110.392 175.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 96.7 t -65.64 -42.15 92.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 124.126 0.97 . . . . 72.15 111.242 -177.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.39 -51.26 65.4 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.673 1.589 . . . . 73.31 108.259 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.02 -13.64 60.89 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.408 1.083 . . . . 70.14 112.913 -178.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 118.08 32.89 1.32 Allowed Glycine 0 CA--C 1.524 0.612 0 C-N-CA 124.456 1.027 . . . . 74.25 114.92 165.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.9 t -97.96 134.96 34.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 119.452 1.626 . . . . 70.35 109.372 174.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -62.42 133.23 54.75 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.54 -1.209 . . . . 74.24 110.384 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.85 -20.73 66.81 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.061 -0.815 . . . . 70.13 111.061 168.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -76.84 -41.05 45.67 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.817 0.809 . . . . 74.44 111.163 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -69.84 -47.09 64.05 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 107.343 -1.354 . . . . 65.13 107.343 175.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -54.94 -52.48 62.87 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 123.778 0.673 . . . . 74.11 109.652 -172.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -72.24 -17.35 61.91 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.083 -1.011 . . . . 65.21 113.503 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.17 -71.56 0.47 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.074 -0.713 . . . . 74.45 109.074 172.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -46.46 -47.33 19.19 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 127.352 2.261 . . . . 64.31 109.886 -175.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 30.7 t-105 -48.77 -31.64 7.33 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.581 1.152 . . . . 73.43 113.288 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -113.05 3.18 16.01 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.277 2.231 . . . . 74.35 111.928 -176.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 21.8 m -93.93 159.11 15.32 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 126.266 1.827 . . . . 72.15 112.356 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -55.02 -34.11 63.21 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.259 1.823 . . . . 73.24 112.709 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.5 t -51.71 -47.6 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.259 1.024 . . . . 72.34 110.166 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.3 t -72.77 -39.87 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 117.826 -1.083 . . . . 72.05 109.547 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.45 ' HA ' ' HE2' ' A' ' 131' ' ' LYS . 8.6 mmpt? -50.86 -48.78 60.07 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 120.713 1.597 . . . . 72.12 111.697 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 64.8 m -64.01 -49.87 70.75 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 122.217 -0.302 . . . . 73.25 111.546 175.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.4 mt -65.72 -32.06 73.41 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.202 0.816 . . . . 71.21 113.202 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 37.9 t -65.51 -62.58 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 126.169 1.788 . . . . 73.14 107.765 170.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.44 -39.89 58.29 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.649 0.78 . . . . 61.25 111.39 -175.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -47.62 -62.72 1.31 Allowed 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 117.383 -1.294 . . . . 73.02 110.574 175.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.532 ' NE2' ' H ' ' A' ' 60' ' ' HIS . 3.8 pt20 -81.41 -28.39 34.32 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 120.115 1.325 . . . . 74.12 113.997 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -59.19 -38.67 80.42 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 120.189 1.359 . . . . 74.14 108.736 176.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 8.4 tttt -79.46 -53.71 6.62 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.534 -0.729 . . . . 72.24 111.427 171.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.73 -6.95 6.35 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 117.255 -1.355 . . . . 73.24 113.704 -171.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.97 16.71 10.89 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.053 1.341 . . . . 65.22 113.457 172.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.13 4.61 1.08 Allowed 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.468 -0.77 . . . . 70.34 112.71 174.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.13 -79.04 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.535 1.134 . . . . 70.24 110.891 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -174.86 50.73 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.146 2.179 . . . . 71.05 110.359 175.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.506 ' NE2' ' H ' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -127.65 -55.2 1.32 Allowed 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.199 -0.938 . . . . 71.01 112.898 -175.24 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.506 ' H ' ' NE2' ' A' ' 145' ' ' GLN . 0.9 OUTLIER -147.18 143.69 28.39 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 128.08 2.552 . . . . 74.43 105.915 -172.435 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -137.33 14.91 3.0 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.11 0.964 . . . . 74.42 111.664 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -155.84 168.83 33.46 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.795 -1.322 . . . . 63.34 109.795 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.9 m -147.6 168.88 10.28 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.469 1.108 . . . . 73.42 111.102 -166.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.18 160.87 88.55 Favored 'Cis proline' 0 C--N 1.35 0.648 0 CA-C-N 119.953 1.019 . . . . 74.02 112.696 -9.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -149.61 154.51 38.77 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.611 0.764 . . . . 71.01 111.262 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 29.8 ttm -142.24 121.92 13.41 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.301 1.44 . . . . 70.32 107.258 172.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -94.28 152.62 18.54 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.737 1.615 . . . . 74.24 109.271 177.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.1 t -140.26 140.72 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.181 0.592 . . . . 73.04 109.948 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 44.67 30.34 0.51 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 129.17 2.988 . . . . 73.34 114.017 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 64.91 9.36 39.74 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.937 -0.924 . . . . 63.41 114.684 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -148.3 -2.8 0.51 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.431 1.615 . . . . 71.1 114.982 -165.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -131.07 161.84 31.15 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.931 1.292 . . . . 74.2 108.682 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -136.86 141.39 42.81 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.418 -1.697 . . . . 65.0 106.418 171.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.17 151.44 46.98 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 107.318 -1.364 . . . . 71.12 107.318 176.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -120.37 82.97 32.4 Favored Pre-proline 0 N--CA 1.462 0.138 0 CA-C-N 118.497 0.59 . . . . 72.03 111.474 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.48 -15.02 45.94 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 121.602 1.534 . . . . 74.32 113.608 175.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -90.21 -5.63 56.16 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 125.686 1.594 . . . . 74.41 111.225 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -117.67 18.01 11.91 Favored Glycine 0 CA--C 1.526 0.724 0 O-C-N 121.081 -1.012 . . . . 65.12 112.518 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 64.0 mtt -101.37 170.01 8.51 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.711 1.256 . . . . 70.23 110.398 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -66.05 120.92 13.99 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 105.893 -1.892 . . . . 74.13 105.893 158.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.432 1.1 t -136.38 63.01 1.6 Allowed 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 105.652 -1.981 . . . . 70.22 105.652 175.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.2 t -129.91 -15.77 3.79 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.171 1.788 . . . . 65.1 113.258 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -127.28 -3.32 6.24 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.0 1.273 . . . . 71.41 112.334 -174.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 7.9 mmt 62.81 -43.04 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 131.543 3.937 . . . . 74.3 114.618 -177.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.98 -48.84 33.0 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.281 -1.007 . . . . 73.22 108.281 -176.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 71.5 t -61.32 -28.57 44.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 125.342 1.457 . . . . 74.13 111.769 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -63.39 -57.69 9.51 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.167 -1.049 . . . . 74.1 108.167 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.9 t -74.67 -28.62 22.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 119.472 -0.299 . . . . 73.43 110.947 -175.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.97 -40.82 73.82 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.123 0.969 . . . . 65.01 110.761 175.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -83.87 -42.55 16.26 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 117.803 -1.094 . . . . 74.21 111.413 174.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -50.48 -55.65 15.04 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 120.202 1.365 . . . . 70.44 110.224 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -54.27 -34.51 60.98 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.902 0.881 . . . . 70.34 112.401 -177.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -78.47 -52.27 8.78 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.208 0.603 . . . . 74.32 109.852 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.2 t -58.03 -28.77 64.78 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-O 117.74 -1.124 . . . . 71.4 110.861 -176.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 61.0 t -54.95 -57.4 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 118.777 0.717 . . . . 74.22 109.463 170.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -32.2 71.84 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 119.1 0.864 . . . . 70.44 111.96 -178.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -60.11 -31.88 70.46 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 119.045 0.839 . . . . 73.0 110.527 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 29.0 mt -73.39 -28.41 62.0 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.342 -0.849 . . . . 65.23 111.793 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 74.9 t -65.53 -23.25 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.901 0.88 . . . . 73.0 111.306 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -99.15 -17.9 17.95 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.127 0.571 . . . . 74.43 109.962 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -102.77 77.74 1.62 Allowed 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 125.232 1.413 . . . . 72.34 108.526 -171.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? . . . . . 0 C--O 1.249 1.046 0 CA-C-O 114.502 -2.666 . . . . 73.04 112.962 -178.715 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.72 0.295 . . . . 71.04 111.112 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -175.17 110.45 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 71.44 110.933 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 pt -122.12 164.08 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 72.32 111.115 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.7 m -138.24 142.74 39.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 74.2 111.101 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -65.1 132.9 50.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 70.01 110.873 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.15 6.22 81.97 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.753 . . . . 72.52 112.518 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -117.47 -74.59 0.6 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.717 0.294 . . . . 72.23 110.839 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -101.19 -19.36 15.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.433 . . . . 74.14 110.918 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -144.66 157.9 44.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 73.03 110.942 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.8 mm -129.69 160.76 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 74.31 111.149 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.54 138.21 52.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 74.11 111.154 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 19.7 mt -67.84 151.67 46.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 75.12 110.827 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.14 -27.03 48.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 74.22 110.858 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -140.11 66.58 31.94 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.597 0.713 . . . . 75.55 110.913 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--N 1.341 0.183 0 C-N-CA 122.652 2.234 . . . . 75.44 112.419 179.864 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.883 0.373 . . . . 71.42 111.154 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.7 tp -178.03 151.99 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 75.11 110.898 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -128.55 166.42 18.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 70.25 110.902 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -144.45 136.69 26.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 74.44 110.866 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -173.14 147.63 1.6 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 64.51 110.931 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.3 t -101.1 -168.28 1.54 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 52.04 110.863 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -115.8 -8.45 11.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 74.1 110.884 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -113.76 18.59 17.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 74.43 110.911 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.8 p -103.38 138.61 19.59 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.567 0.698 . . . . 72.52 110.892 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.91 -41.84 3.75 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.707 2.271 . . . . 74.52 112.268 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -59.42 -64.22 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 72.22 110.789 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.6 p -49.78 -32.55 14.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.464 . . . . 74.51 110.885 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -63.75 -53.07 56.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 65.24 110.896 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -67.61 -11.01 57.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 74.41 110.864 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -104.08 0.94 30.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.31 -0.404 . . . . 73.1 110.924 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -141.53 13.1 2.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 74.14 110.913 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -141.99 -52.39 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 71.14 110.921 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 67.6 t -92.8 -78.42 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 72.23 111.114 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.8 mt -59.33 -41.44 89.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 73.11 110.841 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 53.8 72.43 0.44 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 73.01 110.856 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 80.0 t -72.51 -33.89 46.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 74.4 111.124 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.5 t -52.74 -42.59 65.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 70.22 110.796 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -82.72 2.29 34.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.119 -0.492 . . . . 73.23 110.939 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -102.7 -21.36 14.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 73.33 110.867 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -85.14 -53.92 9.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 73.3 110.929 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -46.59 -33.57 4.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 74.11 110.922 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -71.16 -30.95 67.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.481 . . . . 74.13 110.947 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 46' ' ' VAL . 4.2 mmmt -121.17 28.13 8.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 74.23 110.915 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 46' ' ' VAL . 12.5 mt -104.42 144.24 28.31 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.59 0.709 . . . . 71.13 110.885 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.82 159.12 54.54 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.713 2.275 . . . . 74.34 112.23 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.94 59.35 2.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 73.25 110.848 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.45 35.68 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.779 -0.724 . . . . 71.01 112.438 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.9 t -103.07 -30.71 10.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.811 0.339 . . . . 60.03 111.129 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 62.89 107.65 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 73.25 110.928 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.75 102.03 8.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 72.22 110.93 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.36 -178.94 3.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 72.34 111.185 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.7 mttm 178.33 110.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 72.43 110.888 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -101.14 124.49 46.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 74.22 110.939 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.84 175.14 0.52 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 71.34 110.862 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.6 m -154.97 129.72 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 74.22 111.115 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.24 75.46 0.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 74.13 110.91 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -135.94 3.81 2.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 74.54 110.908 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.05 163.65 32.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.481 . . . . 72.31 110.906 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.84 155.25 0.12 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 70.52 112.465 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -42.83 3.09 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.642 2.228 . . . . 74.23 112.418 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.7 mt -93.83 38.7 1.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.457 . . . . 74.53 110.968 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.32 -20.32 75.08 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.804 -0.713 . . . . 63.51 112.498 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -85.38 -33.94 21.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.801 0.334 . . . . 73.53 110.903 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.38 -46.82 72.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 65.52 110.849 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mt -60.74 -37.49 81.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 72.24 110.918 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -50.14 -65.41 0.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 71.35 111.156 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -51.16 -44.33 61.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 74.24 110.837 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.91 -35.92 64.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.406 . . . . 63.15 111.138 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 13.0 t-105 -53.66 -48.55 69.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 72.54 110.949 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.44 -41.83 41.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 75.25 111.1 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 74.7 t -61.33 -34.35 60.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.263 -0.426 . . . . 72.42 111.122 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.92 -35.59 64.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 61.23 111.103 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -79.12 -33.13 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 74.34 111.092 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.77 -34.34 77.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 75.13 111.064 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.5 mt -98.86 -21.66 16.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 74.12 110.915 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.98 57.05 3.12 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.806 -0.711 . . . . 75.21 112.512 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.5 m -143.97 39.87 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.735 0.303 . . . . 64.15 111.115 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.04 -54.07 30.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 73.43 110.839 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.73 -17.82 57.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 65.44 110.827 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.8 mtpt -83.62 -27.18 29.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 71.04 110.891 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.5 pp -114.08 41.32 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 74.41 111.122 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 66.8 m -118.46 -26.82 6.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 73.51 111.147 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.454 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -69.9 -60.99 3.22 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.593 0.711 . . . . 65.02 111.033 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 89' ' ' ALA . 53.4 Cg_endo -69.72 -30.59 22.24 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.721 2.281 . . . . 73.42 112.309 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 33.4 tpp -60.39 -29.73 69.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.439 . . . . 71.32 110.869 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -90.41 -33.94 15.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.288 -0.414 . . . . 74.44 110.883 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -76.8 -8.69 57.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 73.43 110.881 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -111.69 0.83 16.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 70.52 111.088 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 65.7 t -121.15 -30.65 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 74.22 111.149 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -110.5 -57.99 2.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 74.5 110.853 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -58.54 -76.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 74.22 110.838 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.4 p -83.49 -33.49 25.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 74.4 111.089 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 62.11 34.52 16.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 74.12 110.948 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.3 t -66.35 -19.79 65.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 72.54 111.142 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.5 t -64.36 115.29 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.32 -0.4 . . . . 73.32 111.07 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -131.4 -39.68 1.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 65.23 110.937 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.49 166.04 22.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 62.13 110.817 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.0 t -57.87 -21.69 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.112 -0.495 . . . . 71.12 111.129 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.78 -5.29 52.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 62.15 111.128 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -108.42 -24.37 11.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 74.54 110.864 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.3 mt -84.37 -25.17 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 73.43 111.111 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.83 -26.61 49.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 74.34 110.811 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -62.5 -53.99 46.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.42 . . . . 72.34 110.883 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.8 t -50.62 -45.02 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.255 -0.429 . . . . 74.3 111.114 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -54.38 -48.28 71.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 74.45 110.905 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 89.7 t -69.37 -42.15 81.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 74.23 111.156 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.81 -22.33 35.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 72.5 110.877 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -86.09 -27.82 24.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 63.34 111.096 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.8 -20.54 1.63 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.787 -0.72 . . . . 65.13 112.523 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 93.9 t -51.46 133.79 12.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.896 0.379 . . . . 71.44 111.123 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.59 139.56 37.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 73.42 110.878 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.69 -8.18 59.87 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.693 -0.765 . . . . 53.13 112.481 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -90.0 -30.14 17.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.829 0.347 . . . . 75.25 110.908 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -88.69 -34.56 17.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 75.23 110.855 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -75.73 -30.63 59.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.472 . . . . 75.54 110.931 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -88.55 -10.84 47.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 73.45 110.834 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -106.12 -60.29 1.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 42.43 111.058 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.17 -38.33 57.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 71.05 111.141 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 21.7 t-105 -48.45 -39.68 23.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.43 . . . . 75.42 110.956 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -110.84 39.13 2.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 73.31 110.932 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 75.2 m -123.87 166.17 16.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 74.24 110.913 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -64.38 -34.63 78.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 75.41 110.862 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 38.6 t -50.15 -50.81 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 75.31 111.108 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 41.0 t -72.8 -33.78 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.125 -0.488 . . . . 71.45 111.103 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.4 -59.01 6.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 73.13 110.895 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.19 -42.45 63.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 75.55 110.869 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.5 mt -58.66 -59.99 4.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 75.51 110.888 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 39.9 t -48.4 -36.46 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 71.24 111.046 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.81 -49.3 71.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 64.22 111.093 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 47.4 mm-40 -54.15 -51.17 65.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 75.11 110.977 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -67.19 -50.39 61.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 74.14 110.957 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -59.16 -20.09 50.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 74.25 110.877 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -101.96 -15.36 16.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 63.35 110.893 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -100.5 -6.16 25.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 63.44 111.1 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.65 -4.45 8.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 74.53 111.143 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -120.47 0.11 10.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 73.23 111.138 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -69.98 -84.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 71.13 110.838 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 174.63 36.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.405 . . . . 74.55 110.896 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.7 -15.37 8.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 74.44 110.945 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -164.15 146.87 9.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 73.43 110.837 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -152.56 20.05 0.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 74.11 110.906 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -144.9 167.1 27.3 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.793 -0.718 . . . . 65.54 112.467 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.498 ' HA ' ' C ' ' A' ' 150' ' ' PRO . 2.3 m -154.28 158.48 32.38 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.579 0.704 . . . . 73.23 111.187 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 149' ' ' VAL . 54.4 Cg_endo -69.64 167.74 69.62 Favored 'Cis proline' 0 C--N 1.341 0.153 0 C-N-CA 122.644 -1.815 . . . . 72.12 112.4 -0.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -157.27 109.26 2.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 74.45 111.04 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 2.5 ttm -106.11 114.93 29.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.419 . . . . 74.41 110.888 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -94.33 129.21 41.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 75.23 110.898 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 31.9 t -108.9 121.86 62.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.49 . . . . 75.25 111.09 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 74.39 -60.16 0.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 75.25 110.88 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 151.02 -15.9 0.9 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.841 -0.695 . . . . 73.43 112.476 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.75 39.18 4.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.756 0.312 . . . . 74.11 110.904 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -153.29 155.93 37.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 72.04 110.926 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -144.68 115.43 7.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 64.35 110.89 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -51.34 140.36 17.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 74.02 110.903 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -122.33 76.62 43.68 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.607 0.718 . . . . 70.21 110.873 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -7.52 21.26 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.656 2.237 . . . . 63.51 112.393 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.27 -25.33 54.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 72.51 110.896 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -95.36 -8.95 58.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.777 -0.725 . . . . 70.22 112.503 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 6.9 mtt -77.6 173.35 12.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.784 0.326 . . . . 74.54 110.858 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -85.16 87.35 7.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 70.3 110.897 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 19.4 p -93.05 39.44 1.04 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 74.33 111.162 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.8 m -109.37 -14.16 14.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 73.2 110.864 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.38 -16.51 9.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 73.34 110.851 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 7.4 mmt 71.94 -64.85 0.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 73.43 110.882 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.42 -45.68 69.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 73.44 110.849 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 63.6 t -69.83 -36.35 69.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 72.42 111.105 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -55.53 -70.06 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 64.01 110.822 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 21.7 t -54.59 -37.95 40.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 72.31 111.13 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.2 -43.67 61.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 70.43 111.129 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -80.62 -33.48 35.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 70.3 110.884 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -51.35 -65.94 0.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 74.34 110.923 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.85 -25.12 10.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 65.11 111.056 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -70.55 -55.12 9.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 72.24 110.86 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.1 t -65.36 -29.06 69.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 73.23 111.13 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 84.1 t -68.39 -39.28 80.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 73.31 111.073 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.54 -21.89 41.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 75.44 110.907 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.3 -20.87 39.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.422 . . . . 70.12 110.853 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.74 -35.56 38.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.302 -0.408 . . . . 74.13 110.889 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 87.0 t -59.77 -23.25 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 75.42 111.15 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -109.69 -5.24 15.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 73.22 110.846 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -105.7 28.96 6.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 75.41 110.921 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 74.35 110.832 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.593 0 N-CA-C 114.781 1.4 . . . . 74.31 114.781 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -155.51 106.47 2.53 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 127.979 2.512 . . . . 70.32 107.255 -161.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.7 pt -129.44 149.45 33.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 127.219 2.208 . . . . 71.21 106.884 178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.4 m -109.35 130.48 55.49 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.209 -1.034 . . . . 74.14 108.209 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -44.3 124.31 3.95 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 126.505 1.922 . . . . 70.35 110.155 159.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.67 -15.06 53.92 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 126.945 2.212 . . . . 74.41 113.653 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -95.02 -85.88 0.3 Allowed 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 119.98 1.89 . . . . 74.14 108.154 -174.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -85.75 -16.64 38.24 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.971 0.805 . . . . 71.23 111.394 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -139.64 163.1 33.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.637 0.375 . . . . 73.44 110.601 172.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.8 mm -120.64 158.18 23.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.651 -1.611 . . . . 74.23 106.651 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.4 m -109.56 134.47 51.88 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 126.001 1.72 . . . . 71.35 107.606 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.2 mt -84.04 144.9 28.78 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 108.031 -1.1 . . . . 73.33 108.031 172.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -76.08 -31.61 58.84 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.191 1.396 . . . . 74.44 111.397 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm -127.84 74.29 78.63 Favored Pre-proline 0 N--CA 1.455 -0.19 0 C-N-CA 125.439 1.496 . . . . 74.42 109.026 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo . . . . . 0 N--CA 1.45 -1.035 0 C-N-CA 123.319 2.679 . . . . 63.41 109.511 174.102 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.3 p . . . . . 0 C--O 1.242 0.68 0 N-CA-C 109.67 -0.493 . . . . 72.13 109.67 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -169.2 172.17 7.53 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.394 1.078 . . . . 74.03 110.953 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -130.75 148.55 52.55 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.585 1.954 . . . . 74.24 107.632 154.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -115.24 143.0 45.91 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.502 1.521 . . . . 73.43 107.658 164.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -153.77 165.63 35.41 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.326 1.451 . . . . 73.34 108.607 175.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.86 179.15 4.05 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.918 1.287 . . . . 74.31 108.249 175.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -97.54 -23.71 15.89 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.913 -0.492 . . . . 72.33 110.638 171.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -105.82 12.64 30.57 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.748 1.619 . . . . 74.45 111.876 -177.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.7 p -84.11 143.76 43.11 Favored Pre-proline 0 CA--C 1.541 0.602 0 O-C-N 120.274 -1.516 . . . . 74.15 109.562 167.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -83.11 -33.69 0.39 Allowed 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 121.832 1.688 . . . . 74.33 110.005 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -49.48 -60.57 2.73 Favored 'General case' 0 C--N 1.337 0.062 0 C-N-CA 125.881 1.673 . . . . 74.11 110.155 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 23.6 p -62.74 -34.72 77.78 Favored 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 123.227 0.611 . . . . 74.02 111.088 -176.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -56.45 -52.27 65.31 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.886 -0.783 . . . . 74.44 108.886 173.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -57.66 -44.78 85.96 Favored 'General case' 0 C--O 1.224 -0.248 0 O-C-N 121.081 -1.012 . . . . 71.2 109.174 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -68.05 -12.99 61.85 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.411 1.084 . . . . 74.11 113.231 -174.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -130.76 2.77 4.46 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.181 1.355 . . . . 73.43 110.747 -166.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -144.44 -48.01 0.26 Allowed 'General case' 0 C--N 1.345 0.408 0 C-N-CA 125.574 1.549 . . . . 72.44 112.527 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.1 t -91.87 -72.63 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 105.898 -1.89 . . . . 74.42 105.898 -173.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.8 mt -73.1 -26.08 61.12 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.043 1.737 . . . . 74.01 111.981 -175.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 29.2 m80 44.72 60.07 3.08 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 122.752 1.263 . . . . 71.24 112.118 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.4 t -57.92 -54.8 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.437 1.495 . . . . 65.02 107.334 170.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.71 -43.18 36.96 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.338 1.055 . . . . 72.32 113.329 -178.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -73.61 -42.55 61.35 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.256 -0.903 . . . . 74.24 110.836 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -56.77 -51.99 66.78 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 123.507 0.723 . . . . 72.41 110.098 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.6 t -61.64 -43.88 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 108.364 -0.976 . . . . 73.23 108.364 -175.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -49.93 -46.03 51.71 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.717 1.598 . . . . 74.22 112.553 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -61.4 -20.97 63.66 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.751 1.019 . . . . 74.4 113.751 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -114.01 -7.17 13.12 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.089 0.956 . . . . 71.42 111.816 -175.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.1 mt -70.65 143.75 90.25 Favored Pre-proline 0 C--O 1.239 0.501 0 O-C-N 120.881 -1.137 . . . . 74.42 109.416 -173.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -76.31 169.57 21.71 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.777 2.318 . . . . 71.23 108.905 167.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.46 ' CD ' ' H ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -82.82 23.09 0.85 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 124.774 1.229 . . . . 73.02 113.44 -176.11 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -119.81 -19.04 4.17 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 126.61 2.052 . . . . 61.35 111.725 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 77.6 m -121.09 101.55 7.74 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 106.838 -1.541 . . . . 72.15 106.838 -164.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -87.68 126.62 35.07 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.55 0.74 . . . . 74.42 109.913 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.02 45.75 0.28 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.415 1.886 . . . . 74.42 112.426 171.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.4 m -53.99 145.04 17.49 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.926 1.291 . . . . 74.24 108.651 173.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -131.55 99.46 4.81 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.152 -1.055 . . . . 73.32 108.152 -166.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -95.37 150.61 20.09 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.319 1.048 . . . . 75.04 110.066 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.469 ' CE1' ' HB2' ' A' ' 137' ' ' GLN . 0.3 OUTLIER -88.0 175.58 7.7 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.451 -0.944 . . . . 65.13 108.451 -176.153 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -145.0 163.28 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 107.563 -1.273 . . . . 74.51 107.563 156.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.61 -5.42 10.72 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.654 1.182 . . . . 71.11 113.607 -174.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -58.15 -11.23 2.41 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.489 1.915 . . . . 74.32 115.244 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 mp -127.81 137.61 52.44 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 120.916 1.689 . . . . 73.54 110.702 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.96 170.44 45.27 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.746 2.117 . . . . 50.03 112.291 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.72 -53.21 0.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 124.514 3.476 . . . . 73.31 111.675 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mt -84.4 14.32 4.57 Favored 'General case' 0 CA--C 1.528 0.104 0 N-CA-C 113.887 1.069 . . . . 73.54 113.887 -165.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -53.57 -38.9 59.33 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-O 118.873 -0.96 . . . . 65.22 112.846 -163.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp -53.6 -38.1 63.65 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.937 1.695 . . . . 61.25 113.327 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -76.3 -45.35 32.81 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 118.614 -0.707 . . . . 72.13 109.154 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.4 mt -54.98 -37.32 66.38 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 118.789 -0.624 . . . . 73.25 110.646 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.435 ' CG2' ' CE1' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -57.49 -52.9 63.52 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.987 0.915 . . . . 74.33 109.086 177.292 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -69.18 -50.44 47.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.294 -0.632 . . . . 74.43 109.294 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.0 -37.17 63.73 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.553 1.07 . . . . 71.34 113.607 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 29.8 t-105 -59.85 -38.37 81.89 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 119.759 1.163 . . . . 74.55 112.016 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.94 -39.66 74.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 118.633 -0.698 . . . . 73.43 111.31 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.3 t -56.41 -49.22 78.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 118.817 0.735 . . . . 74.53 109.543 174.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.97 -40.27 97.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 118.677 -0.678 . . . . 74.45 111.018 -175.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.0 mt -69.24 -40.27 80.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 118.157 -0.925 . . . . 73.45 110.417 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.36 -30.83 69.8 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.097 0.862 . . . . 74.05 110.818 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.7 mt -94.29 -14.99 24.86 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.824 0.85 . . . . 74.44 112.532 175.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 59.94 64.32 4.29 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 126.306 1.908 . . . . 71.43 112.3 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.9 m -137.42 19.9 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 124.362 1.065 . . . . 71.45 112.217 -177.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -50.69 -52.34 40.95 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.563 1.074 . . . . 74.42 111.251 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -60.07 -17.08 36.93 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.866 1.666 . . . . 72.14 114.219 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -94.85 -9.16 35.19 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.275 1.03 . . . . 73.21 110.748 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.5 pp -136.1 33.53 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 125.033 1.333 . . . . 72.44 110.875 -173.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 52.5 m -111.47 -41.62 4.07 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 118.8 -0.619 . . . . 73.22 110.382 177.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.85 -60.64 5.98 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 119.183 0.901 . . . . 74.1 110.958 -175.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -62.53 -28.1 77.23 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 120.541 0.828 . . . . 72.51 111.286 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 29.4 tpp -59.41 -50.55 73.53 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.374 1.07 . . . . 74.24 110.846 176.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -72.34 -31.21 65.45 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.949 0.9 . . . . 74.13 109.786 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.65 -36.8 81.85 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.726 0.694 . . . . 74.41 109.626 171.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -85.91 -13.1 48.82 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.322 -0.861 . . . . 74.33 112.239 -176.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.7 t -101.5 -39.29 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 125.382 1.473 . . . . 72.23 111.722 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -109.78 -59.35 1.93 Allowed 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.544 1.137 . . . . 71.34 109.296 -172.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -67.0 -50.96 60.61 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 118.45 -0.786 . . . . 74.14 111.164 -169.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.9 p -104.86 -19.68 13.81 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 123.691 0.619 . . . . 74.53 112.658 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 53.72 23.76 3.9 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.51 1.924 . . . . 71.31 113.903 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -66.14 -18.16 65.17 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.361 1.064 . . . . 73.4 111.539 -173.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.0 t -62.13 119.56 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 121.141 -0.975 . . . . 71.25 108.479 171.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -141.54 -26.52 0.69 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.899 1.28 . . . . 71.42 111.377 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.37 160.92 39.11 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.179 -1.415 . . . . 73.51 107.179 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.2 t -57.65 -28.05 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.722 0.809 . . . . 74.22 110.718 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.9 -29.91 71.04 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.365 1.466 . . . . 74.43 110.185 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.92 -19.36 24.64 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.266 0.626 . . . . 65.51 111.385 -175.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.4 mt -82.57 -45.03 19.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 123.855 0.862 . . . . 72.21 108.958 174.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -59.57 -26.49 65.45 Favored 'General case' 0 C--N 1.346 0.441 0 O-C-N 121.557 -0.715 . . . . 74.53 112.299 -176.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -54.93 -55.24 32.86 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.301 1.04 . . . . 74.43 110.442 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.9 t -52.84 -45.64 50.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 124.933 1.293 . . . . 73.32 109.975 -175.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -55.8 -54.07 48.91 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.659 0.784 . . . . 74.15 110.149 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 17.5 t -66.59 -38.51 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 118.024 0.375 . . . . 73.41 110.27 -174.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -63.5 -32.01 73.34 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.126 0.971 . . . . 74.23 111.068 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -83.8 -3.38 57.81 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.673 1.189 . . . . 74.34 113.838 173.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.2 14.48 16.55 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-N 119.558 1.072 . . . . 70.13 115.332 171.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.9 t -77.66 128.28 38.15 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.055 0 CA-C-N 119.593 1.696 . . . . 71.11 108.545 172.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -57.26 129.38 41.5 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.686 -0.857 . . . . 73.35 108.686 170.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -59.55 -22.82 57.41 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 118.173 -1.349 . . . . 61.51 112.341 173.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.4 -23.41 21.07 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.876 1.338 . . . . 75.25 110.764 -177.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -70.59 -42.49 70.96 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 107.457 -1.312 . . . . 64.55 107.457 177.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -61.54 -59.47 5.17 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 124.181 0.926 . . . . 73.21 110.028 177.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -66.55 -16.73 64.37 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.276 0.489 . . . . 61.42 111.336 -176.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.43 -64.98 0.95 Allowed 'General case' 0 C--N 1.341 0.21 0 O-C-N 121.092 -1.005 . . . . 73.54 109.023 169.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.28 -43.35 64.4 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.272 1.029 . . . . 72.44 110.246 -175.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -46.07 -41.54 12.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.675 1.59 . . . . 73.25 112.23 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -103.94 -2.47 26.08 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.995 1.318 . . . . 63.14 111.553 -173.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.8 t -84.91 157.05 20.96 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 127.017 2.127 . . . . 72.21 111.495 -175.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -57.76 -31.15 66.22 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 125.505 1.522 . . . . 73.53 111.552 169.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 42.3 t -52.68 -50.1 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 119.248 0.931 . . . . 75.15 108.933 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.4 t -68.99 -39.89 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-O 118.923 -0.561 . . . . 75.34 110.42 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -53.71 -51.48 63.14 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.187 0.903 . . . . 74.44 110.685 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 t -67.34 -37.07 82.68 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.346 1.059 . . . . 64.51 111.207 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.88 -53.24 49.78 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-O 117.493 -1.241 . . . . 75.11 110.753 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 53.4 t -52.19 -38.74 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.178 1.391 . . . . 72.14 110.405 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.7 -34.77 76.34 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 118.361 -0.828 . . . . 75.14 112.777 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -55.32 -58.52 7.39 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.795 0.725 . . . . 73.45 110.655 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.469 ' HB2' ' CE1' ' A' ' 60' ' ' HIS . 0.9 OUTLIER -84.68 -33.3 23.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.182 -0.913 . . . . 75.35 110.951 -168.344 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -57.43 -52.92 63.41 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 119.145 0.884 . . . . 75.34 109.11 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -55.06 -48.49 73.4 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 110.144 -0.317 . . . . 75.42 110.144 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.9 -12.04 15.99 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 113.763 1.023 . . . . 75.25 113.763 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -130.14 18.65 5.46 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.809 1.244 . . . . 75.33 111.724 176.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -132.23 2.39 3.9 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.424 1.89 . . . . 73.42 111.651 173.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -83.51 22.77 1.01 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.036 1.734 . . . . 71.51 111.276 169.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 62.92 -16.89 0.05 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 130.375 3.47 . . . . 73.12 117.342 -175.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.56 -26.22 50.69 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 119.997 1.271 . . . . 73.43 111.942 -167.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 tt -134.56 111.98 10.49 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 126.2 1.8 . . . . 73.24 106.414 -173.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -140.63 22.09 2.33 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 127.306 2.242 . . . . 73.12 108.619 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -162.86 114.21 0.59 Allowed Glycine 0 C--N 1.337 0.595 0 N-CA-C 109.943 -1.263 . . . . 64.15 109.943 -171.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.7 m -120.91 171.01 6.37 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 118.239 1.02 . . . . 73.21 110.386 -176.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -68.97 153.65 90.99 Favored 'Cis proline' 0 N--CA 1.456 -0.679 0 CA-C-N 120.342 1.158 . . . . 71.53 111.237 -4.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -146.81 108.6 4.36 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.564 -0.902 . . . . 64.43 108.564 -173.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 39.0 ttm -101.57 135.02 43.79 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.963 -1.125 . . . . 73.42 107.963 173.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -123.18 154.23 38.98 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.534 1.534 . . . . 74.23 107.982 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 96.6 t -115.23 -48.09 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 112.9 0.704 . . . . 73.11 112.9 -163.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -144.55 33.2 1.17 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 128.16 2.584 . . . . 74.44 107.609 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 65.63 5.33 23.27 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.469 1.509 . . . . 74.13 115.759 -175.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -124.57 -16.3 6.32 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 120.357 2.079 . . . . 75.12 114.725 -172.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -126.79 124.28 39.32 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.701 -1.592 . . . . 73.01 106.701 -176.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -98.69 135.47 40.14 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 105.706 -1.961 . . . . 74.22 105.706 172.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -74.91 146.0 42.2 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.936 -0.765 . . . . 73.33 108.936 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -119.6 85.24 32.16 Favored Pre-proline 0 C--O 1.233 0.211 0 N-CA-C 112.864 0.691 . . . . 72.33 112.864 -175.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -67.11 -22.13 47.79 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 121.282 1.321 . . . . 73.3 113.614 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.7 tp60 -68.68 -34.29 75.42 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 119.79 1.177 . . . . 73.0 110.093 176.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -92.02 30.76 6.4 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-O 118.966 -0.908 . . . . 64.44 111.177 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.6 mtt -122.04 176.35 5.85 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 118.681 1.241 . . . . 72.11 109.567 173.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.424 ' C ' ' H ' ' A' ' 168' ' ' SER . 0.4 OUTLIER -86.64 64.89 8.76 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 123.279 1.514 . . . . 74.44 111.075 -172.39 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 21.0 p -74.9 40.53 0.15 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 129.217 3.007 . . . . 70.42 110.901 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.424 ' H ' ' C ' ' A' ' 166' ' ' ASP . 3.8 m -124.06 -3.5 8.07 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.34 1.456 . . . . 72.22 111.646 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.78 -10.31 2.08 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.484 1.114 . . . . 70.03 112.029 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 8.7 mmt 70.81 -56.69 0.61 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.625 1.97 . . . . 74.0 114.315 174.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.34 -45.61 75.87 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.782 -1.192 . . . . 74.23 107.782 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 82.5 t -63.15 -31.37 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.488 1.515 . . . . 74.14 111.577 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -60.21 -56.01 26.84 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.014 -0.736 . . . . 73.01 109.014 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 t -70.74 -34.43 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 119.145 -0.455 . . . . 74.34 110.775 -176.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.72 -35.31 63.54 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.507 0.723 . . . . 74.31 110.77 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.405 HE22 ' HB2' ' A' ' 166' ' ' ASP . 39.7 mt-30 -78.87 -44.67 22.34 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.699 1.199 . . . . 74.34 112.741 168.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -56.97 -58.04 9.9 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.716 1.144 . . . . 73.1 111.349 -173.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -55.68 -31.84 62.74 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.561 -0.733 . . . . 54.2 112.149 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -68.34 -58.15 4.82 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.8 0.727 . . . . 74.42 109.869 177.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.9 t -60.53 -29.26 69.01 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 119.064 -0.493 . . . . 74.11 110.554 -172.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 98.0 t -55.42 -57.23 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.318 -0.993 . . . . 74.23 108.318 171.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.63 -46.3 90.39 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.129 0.972 . . . . 74.14 111.16 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -60.26 -18.49 49.39 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.267 1.427 . . . . 73.4 113.383 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 69.1 mt -92.56 -23.33 19.09 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 121.508 -0.745 . . . . 75.43 112.927 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 66.8 t -63.14 -35.81 73.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.068 -0.716 . . . . 72.15 109.068 174.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -83.58 -18.41 38.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.417 -0.81 . . . . 71.12 110.142 -172.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.305 0.0 OUTLIER -77.75 15.78 0.79 Allowed 'General case' 0 CA--C 1.545 0.759 0 O-C-N 120.751 -1.218 . . . . 74.32 113.776 -168.101 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.433 -1.279 0 C-N-CA 129.4 3.08 . . . . 75.01 109.422 -152.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 112.815 0.672 . . . . 70.14 112.815 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.22 122.2 4.98 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 104.205 -2.517 . . . . 72.43 104.205 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.1 pt -126.77 156.89 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 126.519 1.927 . . . . 74.25 107.33 170.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 99.4 m -135.08 130.34 35.39 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.639 1.575 . . . . 72.43 106.76 -171.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -57.35 137.43 56.1 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.315 -0.624 . . . . 73.43 109.315 171.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.74 -21.97 12.97 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.21 1.386 . . . . 64.42 113.217 -171.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -99.9 -85.58 0.4 Allowed 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 119.895 1.848 . . . . 74.52 109.004 -172.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -88.93 -14.17 37.31 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.656 1.116 . . . . 72.42 111.509 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -138.24 170.77 15.44 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.766 0.826 . . . . 71.24 109.587 169.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.4 mm -128.4 154.24 38.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 105.771 -1.937 . . . . 74.55 105.771 170.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.0 m -108.88 140.22 42.65 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.711 1.605 . . . . 73.42 108.357 175.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 74.5 mt -79.38 142.07 36.33 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.176 -1.046 . . . . 74.42 108.176 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -70.72 -40.91 72.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 122.612 1.196 . . . . 74.41 109.17 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -125.73 83.82 61.71 Favored Pre-proline 0 N--CA 1.455 -0.193 0 C-N-CA 127.345 2.258 . . . . 70.41 107.12 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo . . . . . 0 N--CA 1.444 -1.408 0 C-N-CA 123.923 3.082 . . . . 74.51 108.579 170.245 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 CA--C 1.535 0.4 0 N-CA-C 107.337 -1.356 . . . . 73.43 107.337 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.431 HD22 ' CE2' ' A' ' 25' ' ' PHE . 2.8 tp -166.53 160.56 15.4 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 120.036 1.289 . . . . 73.53 112.456 172.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -141.36 136.04 31.07 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.045 1.338 . . . . 74.33 108.237 -171.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.431 ' CE2' HD22 ' A' ' 23' ' ' LEU . 83.3 m-85 -128.63 140.98 51.5 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.981 2.112 . . . . 74.13 109.874 -176.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -151.39 177.55 10.17 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 128.54 2.736 . . . . 74.25 107.97 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.3 t -139.29 -177.07 4.75 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.474 -0.766 . . . . 73.05 109.852 155.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -84.11 -51.79 6.79 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.626 1.57 . . . . 74.41 109.473 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -80.44 -13.83 58.8 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.265 0.839 . . . . 73.35 113.265 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.7 p -69.51 145.0 94.96 Favored Pre-proline 0 C--O 1.237 0.409 0 CA-C-N 119.743 1.156 . . . . 53.43 110.867 -175.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -70.7 175.61 8.64 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 121.251 1.301 . . . . 72.55 109.682 164.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 68.85 -55.08 0.55 Allowed 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 127.495 2.318 . . . . 71.41 111.218 -175.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 32.4 m -44.67 -41.03 6.37 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.133 2.173 . . . . 75.33 110.741 174.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -53.52 -68.4 0.18 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.303 1.841 . . . . 74.42 111.036 174.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.14 -44.28 71.27 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.726 -0.842 . . . . 75.53 108.726 -175.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -64.86 -13.11 55.19 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 116.532 -1.699 . . . . 74.53 113.046 -175.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -139.79 19.46 2.5 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 121.022 1.737 . . . . 73.43 112.62 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -136.58 -46.56 0.61 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.412 1.485 . . . . 75.13 111.685 171.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.5 t -101.16 -69.29 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.124 0 N-CA-C 107.753 -1.203 . . . . 75.34 107.753 -168.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 73.5 mt -71.01 -33.83 70.75 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.435 1.094 . . . . 74.13 111.813 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 44.36 54.18 6.39 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.313 1.445 . . . . 74.55 111.326 -169.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 81.9 t -52.26 -47.28 45.43 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 C-N-CA 125.285 1.434 . . . . 75.33 109.554 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.4 t -49.47 -43.74 45.35 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.33 2.252 . . . . 72.23 112.122 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -87.02 -17.6 32.58 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.156 -1.59 . . . . 65.03 112.952 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -74.3 -46.34 41.74 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.058 -0.719 . . . . 72.43 109.058 169.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 95.0 t -57.66 -44.31 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 124.789 1.235 . . . . 73.42 109.61 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -46.59 -43.97 17.73 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.833 0.853 . . . . 74.55 112.305 177.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -67.6 -12.65 60.89 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.281 1.586 . . . . 73.45 115.281 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -111.36 -7.65 14.37 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.044 1.338 . . . . 74.21 113.312 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.7 mt -68.89 144.87 96.29 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 118.996 0.816 . . . . 74.14 112.057 -168.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.0 160.0 37.23 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.096 2.531 . . . . 73.14 111.019 168.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.98 27.7 0.07 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.264 1.426 . . . . 65.44 114.312 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -144.72 25.4 1.96 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 126.292 1.901 . . . . 73.21 112.262 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.2 m -146.16 73.19 1.32 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.683 -1.228 . . . . 73.34 107.683 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.6 mttm -59.92 145.95 44.05 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 122.043 0.925 . . . . 74.43 112.014 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -76.3 114.33 14.88 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.387 -1.338 . . . . 74.01 107.387 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.7 m -124.27 163.72 21.06 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.065 -1.087 . . . . 72.05 108.065 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -161.68 100.11 1.15 Allowed 'General case' 0 C--N 1.332 -0.165 0 O-C-N 120.022 -1.674 . . . . 74.42 107.306 -165.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -98.7 160.83 14.0 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.03 -1.044 . . . . 73.24 109.769 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.548 ' CD2' ' HA ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -102.93 165.36 11.08 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.612 1.565 . . . . 74.21 109.321 174.524 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.6 m -132.96 153.03 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 122.229 1.014 . . . . 75.34 110.217 156.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.68 2.78 55.64 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 130.244 3.418 . . . . 62.44 113.765 176.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -69.14 -8.99 50.55 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 115.41 1.633 . . . . 74.25 115.41 -168.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 mp -137.92 153.37 49.52 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 120.614 1.552 . . . . 62.12 110.543 -171.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.65 170.99 29.69 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 123.93 0.776 . . . . 55.54 113.751 173.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.52 -44.69 4.23 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.928 3.085 . . . . 74.32 111.851 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.9 mt -97.0 27.41 4.05 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 125.258 1.423 . . . . 74.2 110.868 -167.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -44.83 -56.77 5.65 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.01 1.291 . . . . 75.1 111.595 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.8 tptt -63.34 -40.0 96.1 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 118.024 0.912 . . . . 55.31 111.841 -177.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -65.21 -44.82 87.09 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.423 1.089 . . . . 74.43 109.731 -176.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.3 mt -62.17 -33.35 74.36 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.974 0.91 . . . . 74.1 110.824 174.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.548 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 27.3 m -77.88 3.52 14.23 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 127.689 2.396 . . . . 72.04 111.429 175.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -116.75 -24.61 7.64 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 119.181 -2.2 . . . . 73.43 110.747 169.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.65 -28.31 61.71 Favored 'General case' 0 N--CA 1.457 -0.112 0 O-C-N 120.758 -1.213 . . . . 52.53 114.053 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 39.2 t-105 -65.87 -40.01 91.24 Favored 'General case' 0 C--N 1.331 -0.201 0 O-C-N 121.386 -0.821 . . . . 74.22 110.377 -173.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.13 -37.98 84.76 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.707 1.203 . . . . 65.33 111.969 -178.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.4 t -51.44 -51.57 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 119.277 0.944 . . . . 74.13 109.412 171.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.43 -32.17 62.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 117.152 -1.404 . . . . 70.2 112.091 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.1 mt -63.56 -38.91 83.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 120.903 1.683 . . . . 72.45 110.406 170.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.09 -49.69 76.3 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 119.043 0.838 . . . . 73.2 110.057 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.21 -9.76 59.73 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 112.137 0.421 . . . . 73.31 112.137 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.61 57.9 13.08 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 126.872 2.177 . . . . 72.24 111.757 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.3 m -129.46 18.64 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 125.507 1.523 . . . . 74.12 111.071 -175.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -51.88 -48.06 64.26 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.42 1.009 . . . . 74.35 110.072 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -61.81 -15.25 40.15 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 128.041 2.536 . . . . 74.25 114.997 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -98.13 -16.02 19.7 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.857 0.863 . . . . 73.11 109.514 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp -126.72 21.34 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 125.282 1.433 . . . . 72.11 110.646 -175.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 93.6 m -80.31 -59.85 2.55 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 109.143 -0.688 . . . . 74.42 109.143 173.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.71 -61.78 6.66 Favored Pre-proline 0 N--CA 1.453 -0.321 0 C-N-CA 125.384 1.474 . . . . 62.34 110.272 -166.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.14 -22.31 54.44 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 120.645 0.897 . . . . 64.4 112.505 -174.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 5.2 tpp -59.61 -49.81 76.31 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.981 0.513 . . . . 75.03 110.702 170.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -64.23 -39.5 94.1 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.127 -0.983 . . . . 75.32 111.558 176.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.91 -27.82 68.46 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 120.491 -0.483 . . . . 71.24 111.497 171.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.19 -11.23 33.21 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 120.952 -1.092 . . . . 73.4 112.748 -173.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.5 t -117.39 -27.47 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 C-N-CA 124.633 1.173 . . . . 73.2 110.629 -173.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -115.44 -48.71 2.78 Favored 'General case' 0 C--N 1.336 -0.02 0 CA-C-N 118.87 0.759 . . . . 75.22 110.789 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -73.8 -65.51 0.82 Allowed 'General case' 0 C--O 1.23 0.06 0 CA-C-N 118.692 0.678 . . . . 73.43 111.015 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.4 p -83.43 -31.99 26.32 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.713 -0.617 . . . . 64.33 110.29 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 56.53 23.72 7.89 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.198 1.799 . . . . 75.42 112.558 -171.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -71.27 -12.22 61.34 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.588 1.155 . . . . 75.21 112.601 -171.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 26.7 t -63.97 109.3 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 O-C-N 120.808 -1.182 . . . . 75.4 109.329 168.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -132.04 -22.22 2.32 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.751 0.82 . . . . 71.44 112.624 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.26 165.77 26.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.68 1.992 . . . . 72.22 107.413 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 91.7 t -51.78 -44.96 37.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.393 1.077 . . . . 75.04 108.971 172.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.51 1.39 0.56 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.016 2.126 . . . . 72.21 115.422 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -106.91 -29.52 9.42 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 119.653 1.115 . . . . 64.41 109.321 170.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -81.81 -24.1 9.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 O-C-N 121.057 -1.027 . . . . 61.41 111.01 -172.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -40.5 97.43 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.345 -0.983 . . . . 75.33 108.345 172.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -55.41 -49.46 72.31 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 123.929 0.768 . . . . 72.32 109.703 -164.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 47.0 t -54.47 -48.31 69.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.286 1.434 . . . . 73.31 111.511 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -56.41 -55.54 32.3 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 109.175 -0.676 . . . . 73.42 109.175 176.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 93.3 t -59.01 -44.53 91.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 122.917 0.487 . . . . 74.42 109.868 -172.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -62.02 -45.79 92.03 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.176 1.391 . . . . 74.22 108.526 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.22 -0.11 11.23 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.965 1.306 . . . . 71.0 112.723 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 109.86 36.12 2.08 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 119.879 1.218 . . . . 43.3 114.154 173.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.1 t -107.55 130.47 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 118.556 1.178 . . . . 74.24 109.536 173.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt -62.15 118.92 8.01 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.321 -0.992 . . . . 73.1 108.321 166.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.69 -22.51 68.17 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 119.063 -0.854 . . . . 74.21 111.138 173.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -65.52 -35.14 79.99 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.151 0.975 . . . . 73.22 111.25 175.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -83.25 -34.18 25.88 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.872 -1.159 . . . . 73.11 107.872 -172.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -51.01 -67.64 0.24 Allowed 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.995 1.318 . . . . 74.3 110.3 165.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -66.39 -11.55 52.05 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.248 0.547 . . . . 62.14 111.656 -170.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.38 -74.85 0.35 Allowed 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.315 1.046 . . . . 74.3 109.484 169.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.4 -32.28 68.48 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 118.966 -0.54 . . . . 73.23 111.758 -169.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 60.6 t-105 -47.76 -34.81 8.96 Favored 'General case' 0 CA--C 1.523 -0.069 0 C-N-CA 124.718 1.207 . . . . 74.2 112.199 174.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -109.28 1.31 20.06 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.999 1.319 . . . . 73.02 111.728 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 5.7 t -105.98 151.64 24.35 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 124.197 1.951 . . . . 73.4 110.492 -174.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . 0.268 0.1 OUTLIER -57.12 -26.04 59.84 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 117.781 2.511 . . . . 71.43 117.781 -171.66 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 86.4 t -44.37 -56.82 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 C-N-CA 127.667 2.387 . . . . 74.4 108.159 167.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.2 t -73.35 -42.72 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 124.169 0.988 . . . . 73.42 109.277 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -56.11 -49.04 74.98 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.683 1.129 . . . . 72.3 111.45 -173.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 72.3 m -77.48 -25.36 50.36 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 117.999 -1.0 . . . . 74.24 112.89 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.6 mt -65.02 -52.38 56.33 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 120.335 1.425 . . . . 73.42 110.25 170.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 40.9 t -45.81 -43.44 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.757 2.023 . . . . 71.33 110.937 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.57 -41.67 70.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.165 0.586 . . . . 62.41 111.877 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -53.13 -49.82 65.77 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 123.723 0.809 . . . . 61.34 112.737 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.438 ' HB2' ' CE1' ' A' ' 60' ' ' HIS . 0.6 OUTLIER -98.08 -20.26 17.46 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 118.883 -0.58 . . . . 65.14 110.967 -171.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -62.5 -50.48 71.24 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 107.855 -1.165 . . . . 71.42 107.855 167.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -55.83 -57.27 12.73 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.956 0.903 . . . . 73.45 110.94 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.76 6.36 2.58 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.424 1.268 . . . . 74.41 114.424 -175.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -106.25 -40.9 5.48 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.884 1.274 . . . . 71.14 110.601 160.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.03 -32.6 74.21 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.418 1.087 . . . . 75.55 112.889 -171.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -71.15 3.99 3.11 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.045 1.338 . . . . 60.54 113.125 -175.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.6 mt 74.78 1.94 3.91 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.746 2.018 . . . . 75.44 112.159 170.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.402 HE21 ' N ' ' A' ' 146' ' ' LEU . 0.0 OUTLIER -61.25 -16.9 50.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 129.851 3.26 . . . . 74.34 113.729 -179.133 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.402 ' N ' HE21 ' A' ' 145' ' ' GLN . 0.6 OUTLIER -155.55 126.27 6.92 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 128.773 2.829 . . . . 75.51 103.52 -172.068 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -139.29 5.08 2.26 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.142 0.577 . . . . 73.24 111.591 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -133.91 163.08 24.53 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.951 1.262 . . . . 73.13 109.957 171.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.26 164.69 33.86 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.095 0.958 . . . . 75.55 109.34 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.71 162.33 81.15 Favored 'Cis proline' 0 N--CA 1.455 -0.747 0 CA-C-N 119.313 0.79 . . . . 72.44 111.506 -13.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -146.41 127.19 14.37 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.076 -0.965 . . . . 72.21 109.026 175.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 42.7 ttm -112.78 109.99 19.82 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 105.587 -2.005 . . . . 73.24 105.587 169.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -77.94 165.7 23.76 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.678 -1.23 . . . . 74.41 107.678 166.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.4 t -125.46 -86.37 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 N-CA-C 107.635 -1.246 . . . . 70.24 107.635 167.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -88.96 35.94 0.8 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 120.565 1.53 . . . . 73.11 111.256 -171.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 68.13 -73.57 0.29 Allowed Glycine 0 C--N 1.338 0.646 0 N-CA-C 109.265 -1.534 . . . . 65.55 109.265 -160.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 12.7 ptmt -55.47 -4.92 0.11 Allowed 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 128.533 2.733 . . . . 74.12 116.641 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -124.34 143.94 50.3 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 120.2 1.364 . . . . 74.45 109.106 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -128.32 138.45 52.39 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.075 -1.454 . . . . 73.25 107.075 171.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -65.42 133.19 50.79 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.108 -1.441 . . . . 75.25 107.108 175.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -104.52 86.08 1.31 Allowed Pre-proline 0 C--O 1.236 0.355 0 C-N-CA 124.171 0.988 . . . . 72.53 112.035 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.02 -20.93 43.9 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 CA-C-N 119.931 1.011 . . . . 73.25 113.479 -177.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -72.61 -38.45 67.79 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 120.838 1.654 . . . . 74.54 109.406 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -78.48 3.78 62.02 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 118.762 0.71 . . . . 71.42 113.051 -177.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 55.3 mtt -90.29 168.14 12.13 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 118.746 1.273 . . . . 72.23 109.367 174.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -81.04 114.54 19.97 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 105.999 -1.852 . . . . 74.32 105.999 167.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.1 p -107.6 6.73 28.17 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 127.298 2.239 . . . . 61.54 109.983 -175.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.5 m -92.84 3.56 55.46 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 113.616 0.969 . . . . 64.34 113.616 -166.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.0 -4.71 1.52 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.499 1.12 . . . . 73.44 111.657 -176.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 7.6 mmt 67.64 -61.89 0.35 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.416 1.886 . . . . 75.51 112.926 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.28 -42.53 88.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 119.978 1.263 . . . . 75.22 109.229 -176.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 66.5 t -61.92 -28.34 44.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 123.713 0.805 . . . . 74.53 110.951 174.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -64.27 -61.28 2.34 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 107.974 -1.121 . . . . 73.24 107.974 177.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.3 t -67.89 -32.2 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 119.289 -0.386 . . . . 73.44 111.086 -174.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.06 -47.12 68.72 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.76 1.224 . . . . 71.11 110.86 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -81.46 -38.27 26.66 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 118.252 -0.88 . . . . 64.54 111.658 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -54.82 -60.2 3.69 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.593 1.088 . . . . 75.41 110.209 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.14 -26.09 64.43 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.825 0.85 . . . . 62.22 112.249 -173.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -77.29 -54.42 6.5 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.101 0.56 . . . . 71.52 109.815 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.2 t -58.94 -25.57 63.61 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-O 117.741 -1.123 . . . . 75.14 111.516 -176.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 59.3 t -54.55 -57.64 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 118.944 0.793 . . . . 72.53 109.046 171.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? -62.89 -36.95 85.0 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.993 -0.442 . . . . 74.21 110.222 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -66.6 -30.73 71.08 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 123.859 0.864 . . . . 70.41 110.821 -173.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 47.1 mt -71.01 -31.84 68.46 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.027 -1.046 . . . . 73.42 111.375 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 85.4 t -66.1 -24.21 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 O-C-N 121.756 -0.59 . . . . 72.43 110.876 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -97.07 -5.77 36.72 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.332 1.053 . . . . 73.15 110.253 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -120.79 87.14 2.7 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 125.925 1.69 . . . . 72.55 107.871 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 37.5 mttm . . . . . 0 C--O 1.251 1.158 0 C-N-CA 127.069 2.147 . . . . 71.24 110.917 175.51 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.327 0 N-CA-C 112.871 0.693 . . . . 70.23 112.871 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -141.97 110.77 6.19 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.873 -1.899 . . . . 65.1 105.873 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.437 HG21 HE22 ' A' ' 183' ' ' GLN . 4.8 pt -143.09 164.97 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 130.966 3.706 . . . . 72.22 107.721 -178.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.9 m -139.17 148.86 43.74 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.876 1.67 . . . . 72.42 108.247 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -57.76 148.72 24.08 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.174 1.79 . . . . 64.01 111.065 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.63 -23.38 0.81 Allowed Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.832 1.206 . . . . 74.24 112.878 -171.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.2 tttp -90.23 -85.21 0.22 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 118.831 1.316 . . . . 74.12 108.539 -160.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -98.88 -7.13 27.73 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.021 0.929 . . . . 74.32 111.337 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -144.6 163.55 33.59 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.81 -1.182 . . . . 71.44 107.81 169.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.6 mm -124.8 157.09 33.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 106.264 -1.754 . . . . 74.33 106.264 169.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.45 171.53 14.61 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 127.295 2.238 . . . . 74.23 109.3 165.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.9 mt -108.24 159.6 16.5 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.359 1.064 . . . . 74.03 111.02 173.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -62.73 -44.6 95.79 Favored 'General case' 0 C--O 1.227 -0.096 0 N-CA-C 108.9 -0.778 . . . . 73.23 108.9 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -131.24 81.55 65.47 Favored Pre-proline 0 C--N 1.339 0.112 0 C-N-CA 127.015 2.126 . . . . 72.42 107.547 -173.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo . . . . . 0 N--CA 1.455 -0.761 0 C-N-CA 122.662 2.242 . . . . 70.31 110.812 -178.561 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.0 t . . . . . 0 N--CA 1.447 -0.602 0 N-CA-C 105.929 -1.878 . . . . 72.5 105.929 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 tt -147.15 157.82 43.73 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.221 -1.029 . . . . 72.31 108.221 -172.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -125.44 149.58 48.09 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.92 1.288 . . . . 62.3 107.958 170.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -127.38 145.55 50.77 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.16 0.984 . . . . 73.43 108.95 169.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -153.72 -177.8 6.62 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 128.326 2.651 . . . . 74.53 106.98 168.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.6 t -133.4 179.85 5.95 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 121.351 -0.843 . . . . 72.4 108.745 170.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -82.43 -28.8 31.12 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.995 2.518 . . . . 74.21 110.583 -176.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -109.66 1.89 19.85 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.56 1.144 . . . . 74.54 112.231 -169.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.1 p -87.26 143.48 34.59 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 120.111 1.323 . . . . 74.5 110.453 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -83.66 -38.63 0.13 Allowed 'Trans proline' 0 CA--C 1.533 0.437 0 CA-C-N 119.901 1.0 . . . . 64.5 112.481 -166.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -52.31 -47.68 65.84 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 118.798 0.726 . . . . 53.41 109.661 172.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 14.2 m -54.77 -37.86 66.51 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.74 1.616 . . . . 73.1 111.482 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -62.49 -51.32 67.93 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.679 0.391 . . . . 73.53 110.861 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.446 ' HA ' HE21 ' A' ' 35' ' ' GLN . 0.0 OUTLIER -59.61 -45.45 91.88 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 119.67 -0.812 . . . . 64.23 109.054 176.029 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -66.13 -10.39 40.46 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 116.919 -1.515 . . . . 64.3 112.015 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -140.26 10.47 2.33 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 121.86 2.118 . . . . 53.31 113.086 -174.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -134.13 -45.0 0.78 Allowed 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 123.903 0.881 . . . . 63.12 110.41 170.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.8 t -88.9 -69.81 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 108.255 -1.017 . . . . 74.41 108.255 -175.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.6 mt -77.81 -25.53 48.97 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.732 1.613 . . . . 74.52 113.333 -174.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 44.67 59.31 3.42 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.538 1.535 . . . . 73.41 112.911 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.4 t -55.48 -50.35 66.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 124.061 0.944 . . . . 70.3 109.302 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.2 t -47.17 -52.36 15.83 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.143 1.377 . . . . 73.43 112.308 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -79.37 -23.39 43.38 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 110.588 -0.152 . . . . 74.43 110.588 -169.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -69.93 -48.8 57.02 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.639 -1.245 . . . . 73.43 107.639 169.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 37.8 t -55.69 -49.83 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 125.162 1.385 . . . . 74.04 110.914 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -56.94 -28.02 61.67 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 119.87 -1.769 . . . . 72.51 113.297 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -71.14 -8.62 54.73 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.202 0.91 . . . . 73.1 113.192 177.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -119.83 -14.71 8.95 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 126.321 1.848 . . . . 72.41 111.968 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.3 mt -69.53 151.11 96.78 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 119.222 0.919 . . . . 74.44 112.496 -169.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -85.95 159.19 10.22 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.625 2.883 . . . . 73.31 113.078 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -83.62 59.34 5.08 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.307 1.843 . . . . 74.11 111.031 -172.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.71 -23.98 0.02 OUTLIER Glycine 0 CA--C 1.527 0.802 0 CA-C-N 113.592 -1.64 . . . . 62.44 112.1 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.3 t -47.85 -57.1 6.09 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.561 1.544 . . . . 73.11 112.632 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? 56.84 123.55 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.779 2.032 . . . . 71.2 111.04 -157.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.7 ttm -68.27 108.18 3.09 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 125.881 1.672 . . . . 74.3 108.253 172.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.18 115.03 21.69 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 107.127 -1.434 . . . . 73.24 107.127 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.27 122.04 35.78 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.18 -1.415 . . . . 74.2 107.18 -178.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.1 m-30 -113.35 145.85 40.42 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.488 -1.301 . . . . 72.43 107.488 172.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.0 117.85 32.47 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.258 1.423 . . . . 74.14 107.669 -167.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.8 m -93.88 157.78 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 O-C-N 121.472 -0.768 . . . . 72.2 110.747 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.43 -8.46 13.89 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.748 1.219 . . . . 73.12 113.448 -161.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -63.17 5.16 0.16 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.815 2.046 . . . . 74.1 115.346 -170.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.1 mt -138.11 132.39 31.96 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 119.955 -1.715 . . . . 70.43 107.593 -165.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.76 174.76 30.25 Favored Glycine 0 CA--C 1.541 1.672 0 O-C-N 123.493 0.496 . . . . 62.32 111.877 -172.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.92 -55.33 0.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.92 3.08 . . . . 73.34 112.692 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.4 mt -87.34 24.85 1.52 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.958 1.303 . . . . 74.23 112.201 -167.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.04 -42.77 98.05 Favored Glycine 0 C--O 1.228 -0.247 0 N-CA-C 110.174 -1.17 . . . . 74.23 110.174 -167.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -61.42 -44.55 96.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.499 0.32 . . . . 73.34 110.689 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.43 -46.77 87.79 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.446 1.898 . . . . 74.43 109.012 177.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.9 mt -64.64 -40.53 95.62 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.751 0.82 . . . . 70.22 111.623 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.8 m -60.7 -40.45 92.27 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 120.272 1.396 . . . . 71.51 110.388 171.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -64.62 -39.28 93.43 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.26 -0.9 . . . . 70.15 108.876 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.61 -36.43 78.57 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 120.964 -1.085 . . . . 73.23 111.913 173.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 25.3 t-105 -58.42 -35.74 72.53 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 118.882 0.764 . . . . 71.5 111.996 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.36 -40.55 82.53 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 118.695 -0.669 . . . . 65.54 111.912 175.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 69.7 t -59.54 -44.89 94.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 119.657 1.117 . . . . 64.41 109.544 170.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.51 -42.04 98.21 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 118.364 -0.827 . . . . 74.53 111.6 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 76.3 mt -69.45 -38.51 77.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.899 0.88 . . . . 74.44 110.52 176.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.8 -40.21 91.81 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.488 1.04 . . . . 74.23 110.582 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.8 mt -93.0 -8.02 44.21 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.75 0.648 . . . . 74.52 112.75 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 53.83 62.91 5.61 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 125.485 1.517 . . . . 72.3 111.378 -172.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.1 m -125.54 18.97 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.49 1.116 . . . . 65.5 112.046 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -51.3 -49.54 61.1 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.341 1.456 . . . . 74.43 111.504 -174.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.407 ' OD1' ' HE2' ' A' ' 86' ' ' LYS . 1.2 p-10 -63.36 -31.47 72.63 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 125.167 1.387 . . . . 74.11 113.807 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.407 ' HE2' ' OD1' ' A' ' 85' ' ' ASP . 21.6 mttm -75.24 -34.38 61.4 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.258 -0.645 . . . . 74.54 109.258 -176.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.1 pp -103.52 -16.37 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.967 0.729 . . . . 74.44 112.967 -166.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.7 m -58.93 -49.47 77.72 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 119.17 0.895 . . . . 70.42 111.116 -172.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.47 -58.76 15.36 Favored Pre-proline 0 N--CA 1.45 -0.458 0 C-N-CA 123.712 0.805 . . . . 73.22 110.181 -164.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.25 -26.0 49.48 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 121.095 1.197 . . . . 72.52 112.222 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 10.8 tpp -61.7 -44.64 96.55 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.577 0.626 . . . . 73.32 111.051 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -69.69 -35.69 75.32 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.243 -0.911 . . . . 73.5 109.047 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -54.85 -48.34 73.01 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.388 0.54 . . . . 71.32 110.242 166.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.55 -16.09 60.83 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 121.73 -0.606 . . . . 73.32 111.154 -165.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 63.8 t -112.15 -33.86 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.368 1.467 . . . . 74.23 110.799 -173.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -109.73 -55.96 2.37 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.522 1.056 . . . . 72.42 110.744 -174.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -64.35 -63.93 1.01 Allowed 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.907 0.883 . . . . 74.41 110.784 -176.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.4 t -99.44 -27.6 13.66 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.672 1.189 . . . . 73.13 110.761 -173.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 59.43 29.4 18.96 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.811 1.244 . . . . 73.33 112.889 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.4 t -69.38 -12.63 61.82 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.782 1.633 . . . . 73.12 112.815 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.6 t -67.52 108.49 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.647 -1.242 . . . . 74.45 107.647 171.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -132.88 -28.09 1.6 Allowed 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 124.471 1.108 . . . . 73.31 111.623 -174.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.85 169.65 17.18 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.553 -1.277 . . . . 70.12 107.553 169.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.6 t -57.18 -25.69 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.138 0.975 . . . . 74.14 111.23 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.69 -29.57 70.18 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 126.316 1.847 . . . . 71.32 111.205 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.72 -22.26 22.29 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.111 0.481 . . . . 73.45 110.232 -176.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.0 mt -76.63 -49.11 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 126.314 1.846 . . . . 71.52 108.158 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -56.78 -30.69 63.9 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-O 118.205 -0.902 . . . . 71.25 112.719 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -57.47 -57.99 10.26 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 123.586 0.755 . . . . 74.21 109.578 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.1 t -48.43 -47.33 14.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 O-C-N 124.457 1.098 . . . . 73.3 109.804 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -55.21 -51.9 65.08 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.864 0.466 . . . . 71.12 110.741 177.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.2 t -62.42 -44.05 98.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 118.61 0.641 . . . . 72.34 111.114 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -64.74 -42.17 95.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 122.147 0.975 . . . . 72.21 108.758 -172.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -82.14 7.33 13.8 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.579 1.552 . . . . 74.42 112.572 176.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.93 29.04 4.22 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-N 119.751 1.16 . . . . 74.33 115.976 160.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.7 t -106.55 143.97 16.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 122.571 1.176 . . . . 73.11 111.026 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -62.4 126.89 28.88 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.268 1.427 . . . . 73.15 110.383 170.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.31 -23.96 74.91 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 118.483 -1.176 . . . . 62.53 111.896 169.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -69.13 -40.87 78.02 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 119.131 1.465 . . . . 72.52 109.249 170.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -79.36 -37.66 36.9 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 107.597 -1.26 . . . . 72.15 107.597 -166.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -56.65 -60.65 3.23 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.619 -0.512 . . . . 74.15 109.619 171.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.69 -13.84 61.05 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.454 0.538 . . . . 71.33 112.454 -170.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.19 -65.97 0.95 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.332 1.053 . . . . 65.13 109.202 168.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -50.4 -39.81 48.13 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.543 1.537 . . . . 73.25 110.848 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -46.19 -37.65 7.35 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.555 1.542 . . . . 74.35 112.801 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -114.35 4.3 15.33 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.917 1.287 . . . . 72.12 112.889 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.7 t -80.22 151.99 29.36 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.724 1.61 . . . . 74.53 111.492 175.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -51.99 -28.89 18.47 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.022 2.529 . . . . 73.34 113.081 175.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 93.3 t -52.75 -54.52 15.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 124.748 1.219 . . . . 51.22 109.836 174.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.3 t -69.66 -34.78 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 114.816 -1.083 . . . . 72.11 109.851 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -52.63 -47.88 66.75 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.914 1.233 . . . . 74.41 111.186 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.1 t -59.71 -55.54 33.09 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.605 0.762 . . . . 74.44 109.222 176.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 32.3 mt -64.47 -32.71 74.45 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.004 0.922 . . . . 71.31 113.483 -173.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.31 -64.45 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 C-N-CA 126.022 1.729 . . . . 70.43 107.451 166.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.42 -29.3 67.66 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 120.286 1.403 . . . . 73.43 113.744 -172.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -61.4 -51.95 66.65 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.401 0.68 . . . . 65.24 109.991 170.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -70.07 -34.08 72.74 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.41 1.084 . . . . 73.43 112.633 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -60.08 -59.04 6.05 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 107.39 -1.337 . . . . 74.42 107.39 174.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.7 ttpt -53.3 -52.03 60.41 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.318 0.647 . . . . 72.24 110.452 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.68 -2.2 4.65 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.07 1.137 . . . . 73.42 114.07 -174.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -116.65 -20.87 9.38 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.881 1.218 . . . . 72.31 112.025 164.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.54 -22.55 47.11 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 126.202 1.801 . . . . 73.52 112.434 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.05 4.13 13.1 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.104 -0.998 . . . . 72.32 112.386 -175.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.0 mt 71.43 -0.23 3.21 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.522 1.929 . . . . 73.22 111.437 171.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.23 -9.96 59.74 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.728 1.611 . . . . 73.33 112.567 -173.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.4 tp -142.15 105.44 4.62 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.606 1.562 . . . . 74.13 108.193 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -130.94 17.81 5.09 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.217 0.607 . . . . 65.34 110.605 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -134.47 160.21 24.12 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 109.621 -1.392 . . . . 72.13 109.621 163.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.4 m -144.45 167.08 15.93 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 125.658 1.583 . . . . 73.52 109.348 169.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -72.24 150.4 94.74 Favored 'Cis proline' 0 N--CA 1.46 -0.472 0 N-CA-C 110.057 -0.786 . . . . 73.22 110.057 -14.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -136.7 126.9 26.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 117.435 -1.269 . . . . 71.34 108.64 -172.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 47.5 ttm -124.12 124.74 43.15 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 119.205 0.911 . . . . 74.5 108.675 173.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -100.37 155.58 17.73 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 125.117 1.367 . . . . 74.13 110.086 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.8 t -140.54 144.71 26.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 124.259 1.024 . . . . 73.32 108.975 175.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 50.11 23.21 1.08 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.905 2.082 . . . . 72.41 113.91 169.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 61.58 17.2 53.11 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 118.681 -1.066 . . . . 71.42 113.777 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -149.2 -7.37 0.36 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.078 1.439 . . . . 74.33 114.571 -174.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -128.95 152.38 48.63 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 119.151 0.887 . . . . 70.23 110.401 -176.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -119.4 141.58 48.97 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.715 2.006 . . . . 73.1 107.819 168.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.89 132.54 45.41 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 107.772 -1.196 . . . . 74.2 107.772 170.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -106.39 86.95 2.35 Favored Pre-proline 0 C--O 1.235 0.291 0 C-N-CA 123.51 0.724 . . . . 71.52 111.954 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -65.77 -21.39 58.31 Favored 'Trans proline' 0 N--CA 1.444 -1.417 0 CA-C-O 117.911 -0.954 . . . . 72.54 112.32 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -64.79 -44.37 90.19 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 120.097 1.317 . . . . 74.53 110.942 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -82.0 1.68 86.01 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 118.87 -0.961 . . . . 73.4 112.876 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 46.6 mtt -79.3 168.05 20.07 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.958 1.879 . . . . 73.33 108.719 170.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -79.58 120.93 24.61 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 106.028 -1.841 . . . . 73.44 106.028 167.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 28.2 p -124.69 45.71 2.47 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.672 1.989 . . . . 74.22 106.76 -171.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 16.1 m -135.66 0.23 2.69 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 114.229 -1.351 . . . . 73.5 111.963 -164.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.423 HD21 ' HB ' ' A' ' 172' ' ' VAL . 0.5 OUTLIER -133.74 -4.99 2.85 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.298 1.439 . . . . 72.04 110.899 174.216 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 1.7 mmt 66.83 -59.3 0.38 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.908 2.083 . . . . 72.43 112.897 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.39 -48.75 80.41 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 122.397 1.094 . . . . 73.34 109.121 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.423 ' HB ' HD21 ' A' ' 169' ' ' ASN . 99.3 t -64.04 -27.5 42.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 126.638 1.975 . . . . 74.2 111.674 -178.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -61.44 -59.22 5.59 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.065 -1.087 . . . . 73.44 108.065 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.92 -27.73 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 O-C-N 123.496 0.498 . . . . 72.2 110.906 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.45 -47.61 63.02 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.901 0.881 . . . . 73.1 111.022 171.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -79.6 -41.74 26.46 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 118.694 -0.67 . . . . 73.1 111.053 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -53.13 -59.26 4.77 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.274 0.943 . . . . 73.23 110.291 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.03 -29.07 68.26 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.521 1.128 . . . . 74.32 112.344 -175.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -65.54 -62.68 1.38 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.149 -0.686 . . . . 65.04 109.149 171.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 12.4 t -60.6 -28.43 68.5 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 118.837 -0.602 . . . . 73.22 112.186 -170.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 94.8 t -53.62 -47.08 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.821 0.737 . . . . 72.33 109.725 173.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 3.0 tmmt? -80.14 -32.75 38.92 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.152 -0.928 . . . . 65.32 110.778 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . 0.437 HE22 HG21 ' A' ' 3' ' ' ILE . 35.0 mt-30 -57.25 -36.75 71.34 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.226 1.376 . . . . 72.42 110.661 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 59.1 mt -70.84 -27.09 63.6 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.037 -1.039 . . . . 70.23 112.776 -176.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 75.7 t -63.68 -30.89 51.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 122.8 0.44 . . . . 71.12 110.374 -178.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -87.84 -29.37 20.99 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.097 -0.705 . . . . 74.2 109.097 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 31.7 mttp -93.41 48.88 1.33 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.075 1.35 . . . . 74.31 110.04 -175.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 20.6 pttm . . . . . 0 C--O 1.245 0.836 0 N-CA-C 106.856 -1.535 . . . . 73.2 106.856 155.432 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.264 0 N-CA-C 112.053 0.39 . . . . 73.12 112.053 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.55 125.03 3.67 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 105.464 -2.05 . . . . 74.1 105.464 173.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.8 pt -131.3 147.15 32.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 127.974 2.51 . . . . 70.51 108.398 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.7 m -115.55 126.42 54.23 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.66 -1.237 . . . . 64.31 107.66 -176.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.45 121.41 3.42 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 127.77 2.428 . . . . 74.52 108.641 162.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.01 -11.77 71.25 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-O 117.834 -1.537 . . . . 65.31 113.707 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -102.7 -85.52 0.44 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 119.828 1.814 . . . . 74.5 108.972 -177.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -87.95 -16.68 33.13 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.552 1.141 . . . . 72.11 110.768 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -136.69 163.09 31.39 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.309 1.044 . . . . 73.51 109.801 172.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.4 mm -129.78 158.54 42.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 105.265 -2.124 . . . . 73.1 105.265 171.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.9 m -108.91 168.82 9.08 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.693 -1.225 . . . . 72.32 107.693 173.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.1 mt -92.03 161.08 14.93 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.518 -1.29 . . . . 73.1 107.518 166.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -79.1 -29.31 43.22 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 122.549 1.166 . . . . 74.13 108.201 174.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -133.68 71.67 74.66 Favored Pre-proline 0 N--CA 1.446 -0.626 0 O-C-N 120.187 -1.57 . . . . 73.31 110.757 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo . . . . . 0 N--CA 1.456 -0.727 0 C-N-CA 123.523 2.816 . . . . 72.4 110.571 176.983 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.277 2.9 p . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 112.942 0.719 . . . . 74.43 112.942 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.0 tp -165.44 169.45 15.6 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 121.216 -0.928 . . . . 74.2 112.356 -172.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -145.5 125.35 13.48 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 127.915 2.486 . . . . 61.44 104.591 170.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -115.41 131.75 56.83 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 119.808 1.185 . . . . 73.4 110.428 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.85 176.55 11.33 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.109 0.564 . . . . 74.22 110.812 178.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.9 t -129.46 172.61 11.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.598 -1.63 . . . . 72.43 106.598 169.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.417 ' CD2' HG23 ' A' ' 95' ' ' VAL 0.253 0.0 OUTLIER -86.45 -18.76 30.86 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.288 0.635 . . . . 72.43 111.545 164.952 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -91.31 -6.37 53.22 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 119.742 -1.849 . . . . 73.52 113.335 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.1 p -77.83 141.36 63.87 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 121.2 1.818 . . . . 73.1 108.031 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -84.08 -40.3 0.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.86 1.707 . . . . 72.1 111.776 -174.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -56.08 -40.19 73.25 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 120.096 1.316 . . . . 74.3 110.105 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.2 m -51.36 -30.28 18.26 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.082 1.353 . . . . 74.21 112.719 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -62.11 -56.85 14.7 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 118.668 0.667 . . . . 71.3 111.698 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -57.6 -42.68 83.73 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.856 -0.794 . . . . 74.53 108.856 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -62.46 -18.15 61.1 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 115.294 -2.289 . . . . 71.2 112.173 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -139.69 9.14 2.4 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-N 122.122 2.237 . . . . 71.43 114.959 -170.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -136.44 -11.78 1.85 Allowed 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.86 1.264 . . . . 72.3 111.371 172.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.3 t -123.92 -81.39 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 107.401 -1.333 . . . . 75.14 107.401 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 49.8 mt -59.67 -31.09 69.23 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.771 2.028 . . . . 72.22 112.005 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 43.99 60.09 2.88 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.299 1.84 . . . . 71.04 110.536 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 86.7 t -63.02 -36.92 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.181 -0.918 . . . . 73.4 109.895 -174.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 t -51.07 -55.6 16.77 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.994 1.317 . . . . 73.4 110.39 173.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.34 -29.51 65.08 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 121.043 -1.036 . . . . 75.4 111.395 -174.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.57 -33.73 74.59 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.042 0.537 . . . . 73.3 112.05 175.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.6 t -70.97 -50.19 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.572 1.549 . . . . 74.13 109.158 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.6 ptm85 -61.72 -21.17 64.26 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 120.63 1.559 . . . . 73.11 113.883 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -68.04 -11.08 58.29 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.006 1.113 . . . . 72.53 114.006 172.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp -136.03 2.42 2.82 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.578 1.551 . . . . 74.14 112.117 -171.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.7 mt -72.35 145.71 88.33 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 119.725 1.148 . . . . 75.44 109.584 -176.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.94 150.16 29.78 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.427 2.085 . . . . 64.14 110.131 169.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -76.65 80.81 3.3 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 122.759 1.266 . . . . 75.43 111.029 -168.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.01 -49.53 0.23 Allowed Glycine 0 C--O 1.233 0.092 0 N-CA-C 109.595 -1.402 . . . . 74.03 109.595 -175.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.455 ' HG1' ' CG2' ' A' ' 185' ' ' VAL . 32.3 m -69.29 90.68 0.51 Allowed 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 107.767 -1.197 . . . . 74.52 107.767 173.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -80.12 129.92 34.86 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.469 -1.678 . . . . 75.44 106.469 173.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.4 mtm -66.26 161.93 21.15 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.258 -0.645 . . . . 74.32 109.258 173.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.39 -173.71 3.49 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.339 1.056 . . . . 73.34 108.155 178.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.41 91.89 0.46 Allowed 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.221 -1.029 . . . . 74.32 108.221 -173.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.469 ' CD2' ' HG3' ' A' ' 137' ' ' GLN . 6.4 m-30 -104.42 163.53 12.38 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.549 -0.908 . . . . 74.12 108.549 177.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.552 ' CE1' ' CG2' ' A' ' 72' ' ' THR . 2.0 p80 -104.67 171.5 7.29 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 126.527 1.931 . . . . 72.2 108.071 -175.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.6 m -137.96 146.96 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.1 -1.074 . . . . 73.33 108.1 167.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -94.18 -0.47 55.19 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.076 0.853 . . . . 74.32 111.994 -175.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -73.99 167.64 21.1 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.575 1.15 . . . . 73.22 108.364 165.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 74.69 131.85 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 128.328 2.651 . . . . 74.44 111.093 177.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.6 173.59 3.51 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 122.472 1.04 . . . . 72.14 113.037 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -72.43 -45.27 0.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.473 2.115 . . . . 74.33 111.757 175.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.7 mt -80.85 19.65 0.84 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.537 1.535 . . . . 74.21 113.65 -171.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.07 -32.43 49.83 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-O 118.156 -1.358 . . . . 73.12 112.311 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.3 tmtp? -85.11 -7.46 59.08 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.16 1.48 . . . . 73.23 113.728 178.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -46.81 18.25 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-N 121.001 1.728 . . . . 72.14 107.893 162.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.8 mt -57.75 -39.14 76.7 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 124.58 1.175 . . . . 73.42 111.145 -165.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.552 ' CG2' ' CE1' ' A' ' 60' ' ' HIS . 0.3 OUTLIER -50.38 -51.7 43.74 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 128.542 2.737 . . . . 73.35 109.738 177.168 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -69.62 -58.96 3.29 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 114.149 -1.387 . . . . 72.42 107.308 -176.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.65 -28.65 68.64 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 121.264 1.847 . . . . 53.31 114.226 -171.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 36.4 t-105 -58.6 -36.68 74.4 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.79 0.723 . . . . 73.2 110.921 177.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.89 -41.29 97.71 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 118.055 -0.974 . . . . 74.01 111.032 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.4 t -54.62 -45.58 72.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 119.354 0.979 . . . . 74.04 110.1 171.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.96 -47.14 87.82 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.603 0.638 . . . . 70.22 111.306 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.8 mt -60.22 -44.73 96.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.736 1.214 . . . . 71.42 109.698 176.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.3 -31.76 72.4 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 123.945 0.898 . . . . 74.44 111.095 -175.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 75.2 mt -94.22 -12.41 28.28 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 119.008 -0.52 . . . . 72.32 111.819 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.67 54.87 32.18 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 126.907 2.194 . . . . 74.23 110.943 -172.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.71 11.62 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 124.141 0.976 . . . . 75.14 112.133 -176.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -56.24 -53.53 56.13 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 120.071 1.305 . . . . 75.11 110.491 -172.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -63.13 -8.09 7.12 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.755 1.622 . . . . 75.01 112.333 176.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -100.06 -18.03 17.19 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.434 1.494 . . . . 75.22 112.023 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.6 pp -127.51 33.3 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.036 1.335 . . . . 75.32 109.443 -175.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 76.1 m -107.23 -43.83 4.5 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 117.973 -1.013 . . . . 72.41 109.651 171.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.31 -63.36 4.36 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 120.736 1.607 . . . . 74.43 111.775 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.27 -26.37 56.5 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 121.518 1.479 . . . . 74.21 111.81 -176.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 34.8 tpp -63.51 -49.61 72.85 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.584 0.754 . . . . 74.14 109.416 176.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -68.1 -35.14 77.67 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.874 0.87 . . . . 64.03 108.913 -176.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -60.97 -40.05 91.93 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.656 0.662 . . . . 62.3 110.423 171.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.18 -5.01 58.65 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 120.074 -1.642 . . . . 63.13 113.584 -174.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.417 HG23 ' CD2' ' A' ' 28' ' ' PHE . 50.2 t -111.01 -41.35 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 124.499 1.119 . . . . 74.22 109.709 -176.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -106.07 -53.77 2.58 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.42 0.688 . . . . 74.42 109.337 -172.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt -70.39 -54.12 13.74 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-O 118.675 -0.679 . . . . 72.33 110.61 -171.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.4 p -100.86 -18.49 16.37 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.176 0.99 . . . . 74.22 113.382 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 45.75 40.62 6.53 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.475 2.31 . . . . 72.22 114.228 -175.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.9 t -79.88 -8.0 59.05 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.288 -0.883 . . . . 70.11 112.557 178.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.6 t -74.54 122.46 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 O-C-N 120.858 -1.151 . . . . 74.41 109.785 168.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -140.68 -23.41 0.79 Allowed 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.084 0.954 . . . . 74.04 112.303 175.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.21 175.4 11.09 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.307 0.643 . . . . 74.33 109.56 174.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.0 t -55.55 -44.09 75.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 126.182 1.793 . . . . 72.35 109.941 -172.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.5 -14.34 40.43 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.212 0.605 . . . . 45.41 112.628 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -94.36 -27.65 15.96 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 119.421 1.01 . . . . 71.41 110.034 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.2 mt -81.52 -41.77 19.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 123.286 0.634 . . . . 65.24 109.378 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -55.32 -25.08 32.42 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.441 -0.787 . . . . 74.45 113.055 176.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -62.23 -56.51 17.91 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.803 1.241 . . . . 70.31 110.78 -177.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 54.3 t -57.15 -43.1 80.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 119.165 -0.445 . . . . 62.41 110.369 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -50.68 -56.77 10.38 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.707 0.803 . . . . 74.24 109.482 175.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.74 -46.86 95.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 123.132 0.573 . . . . 72.03 109.811 -174.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.05 -43.57 91.7 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 123.652 0.595 . . . . 74.31 109.475 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.95 -17.32 62.08 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.425 1.09 . . . . 72.14 112.612 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 113.61 64.24 0.44 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.393 -1.083 . . . . 75.42 110.393 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.7 t -127.69 141.1 47.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 123.819 0.848 . . . . 74.22 109.976 163.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -66.04 148.2 52.17 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.905 -0.497 . . . . 73.11 112.027 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -73.5 1.84 41.71 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 124.775 1.179 . . . . 73.22 114.904 165.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -100.98 -39.98 7.47 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 117.367 0.584 . . . . 74.25 111.158 174.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.9 -35.04 62.27 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.014 -1.106 . . . . 62.42 108.014 -167.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -61.45 -59.93 4.5 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 116.067 -0.515 . . . . 74.45 109.857 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -59.64 -36.98 77.44 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.622 0.769 . . . . 74.45 110.969 -176.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.55 -65.49 0.71 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.916 0.886 . . . . 72.15 110.186 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.53 -37.08 64.96 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.175 0.99 . . . . 73.31 110.347 -173.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -45.08 -41.59 7.86 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.051 1.341 . . . . 74.33 112.904 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -112.83 19.78 17.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.703 1.201 . . . . 72.23 112.338 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.9 t -115.85 149.19 39.02 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 123.721 1.724 . . . . 64.01 110.783 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.84 -27.0 49.32 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 119.754 3.242 . . . . 72.33 119.754 -171.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 29.3 t -45.22 -56.31 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 C-N-CA 127.064 2.145 . . . . 74.31 107.996 168.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.25 -43.34 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 125.644 1.578 . . . . 71.11 109.398 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp -52.84 -46.31 67.72 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.544 -0.723 . . . . 71.43 112.089 177.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -49.11 71.89 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 118.724 -0.655 . . . . 71.34 110.055 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 13.5 mt -59.29 -42.17 90.65 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.777 -0.63 . . . . 74.15 111.469 -176.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 52.9 t -55.73 -48.96 77.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.672 -0.862 . . . . 74.33 108.672 176.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.59 -40.11 95.86 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 113.394 0.887 . . . . 65.05 113.394 -177.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -56.26 -50.93 69.94 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.934 0.894 . . . . 65.14 109.427 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.512 ' CB ' ' CE1' ' A' ' 60' ' ' HIS . 0.5 OUTLIER -70.31 -38.12 74.88 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 117.454 -1.26 . . . . 74.33 111.148 -176.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -58.76 -44.41 90.56 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 120.535 1.516 . . . . 44.12 109.54 170.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.8 ttmm -67.12 -10.57 51.53 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.081 -1.012 . . . . 70.44 113.273 175.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.8 2.7 11.1 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 117.416 -1.278 . . . . 74.41 114.239 178.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -134.77 -12.28 2.29 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.154 1.343 . . . . 72.52 112.995 174.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -121.21 6.43 10.23 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.378 1.071 . . . . 73.12 111.121 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -70.83 -85.38 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.358 0.663 . . . . 70.21 112.364 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.1 pp -164.59 33.24 0.07 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.08 0.952 . . . . 73.32 113.438 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.565 ' CD ' ' H ' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -126.69 -69.41 0.76 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.298 0.954 . . . . 74.51 112.391 -163.368 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.565 ' H ' ' CD ' ' A' ' 145' ' ' GLN . 0.7 OUTLIER -133.91 142.22 47.66 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.556 2.742 . . . . 70.44 107.046 -171.208 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -143.68 13.11 1.71 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.222 1.009 . . . . 70.2 111.981 -178.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -141.02 176.89 21.32 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 109.36 -1.496 . . . . 70.24 109.36 173.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.2 m -147.7 171.15 6.66 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 124.417 1.087 . . . . 74.43 111.202 -169.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.37 162.86 60.4 Favored 'Cis proline' 0 C--N 1.349 0.605 0 CA-C-N 120.376 1.17 . . . . 74.3 110.585 -14.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -146.78 147.31 30.77 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 122.89 0.476 . . . . 73.53 110.268 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 50.9 tpp -142.6 118.45 10.55 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.122 -2.177 . . . . 74.53 105.122 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -100.91 167.72 10.09 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.088 -0.708 . . . . 74.41 109.088 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.6 t -139.49 143.16 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.473 1.109 . . . . 71.1 108.393 170.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 49.45 18.17 0.27 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 128.108 2.563 . . . . 71.43 115.106 176.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 62.5 34.31 89.06 Favored Glycine 0 CA--C 1.534 1.232 0 O-C-N 120.765 -1.209 . . . . 71.21 111.687 -176.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -155.88 -22.0 0.11 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.346 1.61 . . . . 73.33 115.346 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -119.08 154.51 33.06 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 119.234 0.925 . . . . 74.23 109.044 -175.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.0 125.75 44.37 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.988 2.515 . . . . 72.42 107.833 176.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.78 147.19 53.66 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 106.685 -1.598 . . . . 70.3 106.685 176.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -123.78 76.67 56.92 Favored Pre-proline 0 C--O 1.233 0.223 0 O-C-N 122.091 -0.38 . . . . 71.22 111.436 -176.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.58 -17.19 58.75 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.501 1.468 . . . . 74.4 112.198 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.96 -12.21 61.41 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.136 1.774 . . . . 73.34 113.087 177.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -121.28 35.47 3.62 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.854 1.216 . . . . 45.3 110.113 175.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 46.0 mtt -122.37 165.04 16.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 122.278 1.037 . . . . 74.2 109.596 176.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -82.83 76.4 9.68 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.562 -1.199 . . . . 72.43 110.771 -176.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 21.4 p -73.22 -1.06 16.23 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.256 2.222 . . . . 70.31 112.8 177.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 39.7 m -72.83 -6.34 44.24 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 113.851 1.056 . . . . 70.33 113.851 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.59 -9.6 1.42 Allowed 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 117.772 -1.109 . . . . 65.44 113.311 -167.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 3.0 mmt 66.36 -56.85 0.38 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.272 1.829 . . . . 74.23 114.998 174.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.76 -51.37 62.65 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 106.987 -1.486 . . . . 71.24 106.987 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 48.6 t -57.93 -36.43 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.881 1.272 . . . . 75.22 110.121 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -58.77 -60.98 2.98 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 118.214 -0.898 . . . . 74.2 109.771 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.5 t -70.73 -33.97 54.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 118.476 0.58 . . . . 74.4 110.931 -175.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -49.94 -46.5 52.25 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.76 1.224 . . . . 71.32 110.155 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -87.43 -28.74 21.94 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 113.349 0.87 . . . . 74.43 113.349 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -56.61 -60.54 3.39 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.054 1.297 . . . . 70.41 110.513 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.77 -32.22 70.39 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.039 0.536 . . . . 72.13 111.951 -177.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -60.12 -50.93 71.76 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.773 1.229 . . . . 74.23 110.275 175.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.0 t -68.44 -30.17 68.98 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 116.73 -1.605 . . . . 72.44 110.912 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 58.7 t -56.44 -52.06 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 120.512 1.506 . . . . 73.33 108.578 173.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -59.38 -53.54 56.98 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-O 118.39 -0.815 . . . . 74.5 110.682 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -53.03 -40.94 64.26 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.74 0.7 . . . . 73.41 111.796 -171.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.85 -20.59 63.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.739 1.014 . . . . 74.5 113.739 -176.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.455 ' CG2' ' HG1' ' A' ' 54' ' ' THR . 84.7 t -65.08 -33.74 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 109.109 -0.7 . . . . 71.53 109.109 171.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -80.1 -41.64 25.14 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.877 -1.157 . . . . 72.21 107.877 -171.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -85.86 51.38 2.19 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.802 2.041 . . . . 74.11 110.24 -178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 20.4 pttt . . . . . 0 C--O 1.246 0.893 0 CA-C-O 117.264 -1.35 . . . . 74.54 110.158 172.094 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.484 0 N-CA-C 113.105 0.779 . . . . 71.42 113.105 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.52 122.47 3.58 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 105.613 -1.995 . . . . 71.14 105.613 170.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -126.68 158.35 37.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 126.318 1.847 . . . . 64.44 106.636 171.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.6 m -136.08 135.43 39.33 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.767 -1.197 . . . . 74.11 107.767 -176.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -51.74 104.15 0.08 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 131.52 3.928 . . . . 74.34 108.796 167.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 110.0 -22.17 23.74 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 126.998 2.237 . . . . 65.34 112.501 -177.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -90.7 -85.49 0.22 Allowed 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 119.776 1.788 . . . . 70.45 108.433 -172.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -89.4 -15.56 32.96 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.896 1.279 . . . . 72.15 109.915 -176.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -137.2 162.85 32.35 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.599 0.76 . . . . 71.31 110.709 172.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.0 mm -128.66 166.81 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 127.542 2.337 . . . . 74.25 105.97 171.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.1 174.22 5.98 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 127.605 2.362 . . . . 72.55 109.68 176.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 57.9 mt -116.4 148.63 40.48 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.524 1.13 . . . . 72.55 110.013 171.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -73.06 -35.81 66.76 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.474 1.11 . . . . 71.32 110.152 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.6 mmtm -122.05 77.99 41.85 Favored Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 126.522 1.929 . . . . 74.51 109.354 177.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo . . . . . 0 N--CA 1.458 -0.597 0 C-N-CA 124.553 3.502 . . . . 62.53 112.858 172.049 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 C--O 1.238 0.46 0 CA-C-O 121.917 0.865 . . . . 73.34 111.148 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.3 154.2 37.46 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.614 1.566 . . . . 70.15 107.015 -173.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -120.53 141.77 49.94 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.369 -1.345 . . . . 71.43 107.369 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -130.69 134.98 47.38 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.787 1.635 . . . . 72.2 109.339 176.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.3 179.27 7.5 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.784 1.234 . . . . 72.43 108.434 167.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.0 t -134.4 153.43 51.91 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.379 -0.971 . . . . 71.21 108.379 168.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.487 ' CE2' ' HG2' ' A' ' 91' ' ' MET . 12.2 m-30 -64.94 -24.39 67.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 118.483 -0.77 . . . . 74.21 111.705 172.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -89.26 -5.2 57.8 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 120.283 1.401 . . . . 71.11 113.667 178.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.9 p -90.4 144.42 30.81 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 122.059 2.209 . . . . 73.54 111.298 -174.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -81.84 -43.19 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 121.935 1.756 . . . . 73.14 112.394 -166.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -54.48 -45.67 73.24 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 109.136 -0.69 . . . . 73.11 109.136 173.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 15.3 m -55.44 -35.86 65.91 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.503 1.921 . . . . 71.25 112.048 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -64.79 -48.53 74.12 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.822 0.737 . . . . 73.55 110.674 176.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.407 ' HA ' HE21 ' A' ' 35' ' ' GLN . 0.0 OUTLIER -59.37 -44.5 92.71 Favored 'General case' 0 C--O 1.223 -0.302 0 O-C-N 121.091 -1.005 . . . . 74.15 108.908 172.673 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -60.3 -16.55 35.57 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 115.735 -2.079 . . . . 71.54 112.41 -178.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -142.83 12.21 1.85 Allowed 'General case' 0 C--N 1.347 0.461 0 CA-C-N 122.111 2.232 . . . . 74.43 114.438 -172.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -131.7 -13.04 3.34 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.15 0.98 . . . . 72.44 112.282 165.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.1 t -128.26 -77.12 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 108.353 -0.98 . . . . 72.51 108.353 -170.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.8 mt -67.18 -26.8 66.81 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.787 1.635 . . . . 74.45 111.838 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 44.03 56.25 4.85 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.128 1.371 . . . . 74.14 110.915 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.1 t -61.64 -46.53 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 117.506 -1.235 . . . . 74.42 107.967 -169.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.5 t -56.86 -37.99 72.09 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 120.318 1.417 . . . . 71.31 112.283 -177.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.22 -49.07 63.18 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.103 0.961 . . . . 71.13 109.745 177.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -62.23 -41.28 98.26 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.625 1.17 . . . . 54.15 112.088 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 t -62.97 -51.01 77.31 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 N-CA-C 107.553 -1.277 . . . . 72.32 107.553 175.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -50.01 -47.83 52.84 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.285 0.948 . . . . 73.35 111.578 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -66.5 -1.45 3.6 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 115.284 1.587 . . . . 71.12 115.284 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -130.01 -4.23 4.52 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.94 2.096 . . . . 73.34 112.891 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.6 mt -69.33 151.28 96.95 Favored Pre-proline 0 N--CA 1.466 0.35 0 CA-C-N 120.065 1.302 . . . . 53.45 110.769 -172.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -81.07 146.3 15.93 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 122.275 1.984 . . . . 74.52 110.036 172.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -71.93 105.38 3.82 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.015 -1.448 . . . . 73.12 109.211 -175.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 131.79 -9.54 5.48 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.728 -1.04 . . . . 71.14 113.337 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.9 t -52.81 -46.79 67.85 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.705 1.253 . . . . 72.44 112.228 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? 46.5 83.54 0.03 OUTLIER 'General case' 0 C--N 1.346 0.417 0 C-N-CA 127.305 2.242 . . . . 74.22 110.3 -174.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 19.9 ptp -65.53 -175.74 0.29 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 112.317 -2.219 . . . . 73.52 111.89 176.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 m -154.75 174.98 14.29 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.278 1.831 . . . . 73.14 108.482 165.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -140.3 126.14 19.41 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.994 -1.113 . . . . 74.23 107.994 152.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -106.09 -176.98 3.23 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.499 -0.926 . . . . 74.3 108.499 162.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -134.75 135.12 41.65 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.015 1.726 . . . . 70.33 106.656 176.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.0 m -81.6 151.89 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.813 0.845 . . . . 65.14 110.399 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.65 -5.56 22.49 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.675 1.19 . . . . 72.32 112.314 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -68.49 -45.63 71.84 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.576 -0.702 . . . . 74.52 112.583 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.0 mt -78.18 132.17 37.49 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 121.838 -0.539 . . . . 74.32 109.689 -171.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.64 160.85 31.05 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 124.924 1.25 . . . . 71.12 112.39 169.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.71 -39.47 6.57 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.449 2.099 . . . . 74.24 110.276 173.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.5 mt -84.59 24.4 1.02 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.507 1.923 . . . . 74.31 110.661 172.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.39 -52.22 51.28 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 120.972 -1.08 . . . . 34.51 112.162 -175.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -56.17 -44.91 79.77 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.964 0.882 . . . . 72.22 110.994 174.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -63.44 -35.7 81.31 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 124.756 1.222 . . . . 73.14 111.396 -178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.8 mt -60.02 -52.13 66.68 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 123.803 0.841 . . . . 74.2 110.76 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.9 m -62.96 -37.49 87.3 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.403 0.547 . . . . 73.22 110.339 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -58.51 -44.18 89.4 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.812 -0.555 . . . . 74.33 109.775 172.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.32 96.39 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.355 -1.466 . . . . 65.5 112.897 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 49.3 t-105 -57.93 -37.96 75.06 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.837 0.855 . . . . 71.11 109.786 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.09 -43.98 87.34 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 117.55 -1.214 . . . . 63.33 112.513 175.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.1 t -54.01 -46.35 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 120.632 1.56 . . . . 64.21 110.714 170.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.71 -45.04 94.58 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-O 118.951 -0.547 . . . . 71.44 110.864 -175.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 91.6 mt -57.69 -46.82 86.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.956 0.902 . . . . 74.11 109.43 174.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.45 -3.69 44.67 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.515 1.302 . . . . 65.54 114.515 -169.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 88.5 mt -106.23 -21.48 13.1 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.597 1.089 . . . . 70.51 111.696 156.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.11 64.08 2.77 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 125.573 1.559 . . . . 63.54 109.218 -169.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.22 13.76 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.745 1.218 . . . . 70.51 112.16 -176.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -51.13 -60.2 3.36 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.541 1.137 . . . . 73.42 109.766 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.12 -8.59 3.59 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.002 1.721 . . . . 72.15 113.291 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -102.56 -10.78 19.01 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 120.379 -1.45 . . . . 73.44 112.043 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.2 pp -126.77 -14.12 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 116.96 -1.495 . . . . 74.14 112.102 -174.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 34.3 m -55.18 -54.96 36.7 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 119.652 1.115 . . . . 70.32 109.503 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.45 -62.43 4.03 Favored Pre-proline 0 N--CA 1.449 -0.507 0 C-N-CA 124.866 1.266 . . . . 73.41 111.296 -170.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.05 -26.01 66.03 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.112 1.208 . . . . 72.23 112.357 -177.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.487 ' HG2' ' CE2' ' A' ' 28' ' ' PHE . 8.5 tpp -62.44 -48.03 81.45 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-O 118.193 -0.908 . . . . 74.24 111.215 172.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -66.71 -35.96 81.37 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 120.412 1.46 . . . . 74.42 109.139 -178.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -62.39 -33.56 74.99 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.422 0.556 . . . . 74.13 111.324 170.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.93 -11.12 45.37 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.894 -1.129 . . . . 74.51 113.388 -176.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.3 t -109.52 -42.87 5.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 125.338 1.455 . . . . 74.24 110.61 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -103.52 -46.37 4.58 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.179 0.592 . . . . 72.55 110.133 -174.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt -77.13 -68.65 0.59 Allowed 'General case' 0 N--CA 1.457 -0.088 0 CA-C-O 119.03 -0.509 . . . . 74.25 109.897 -172.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.5 p -79.85 -30.91 40.43 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.296 0.953 . . . . 72.41 110.548 177.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 60.43 20.97 10.62 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.228 1.811 . . . . 65.54 113.317 -174.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -69.23 -12.77 61.96 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.324 1.05 . . . . 53.04 112.812 -174.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.6 t -65.41 115.07 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 O-C-N 120.998 -1.064 . . . . 74.5 109.189 170.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -136.68 -31.14 0.87 Allowed 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.762 1.225 . . . . 74.54 112.083 -173.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.67 170.1 16.64 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.904 0.882 . . . . 72.52 109.355 167.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 67.3 t -54.23 -37.52 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.016 1.326 . . . . 70.14 111.205 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.28 -31.18 42.5 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.385 1.074 . . . . 72.44 112.709 176.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -82.4 -27.73 31.84 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 123.242 0.617 . . . . 61.52 110.504 -177.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.2 mt -76.22 -50.43 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.808 1.643 . . . . 70.2 108.014 -177.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -21.35 66.77 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.525 -0.734 . . . . 73.32 111.792 -177.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -56.45 21.75 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 124.552 1.141 . . . . 73.2 110.217 168.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.8 t -51.51 -45.53 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 123.654 0.781 . . . . 74.44 110.002 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -53.1 -55.71 21.89 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.808 0.443 . . . . 73.12 109.859 176.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 64.6 t -57.29 -42.91 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 O-C-N 121.7 -0.625 . . . . 73.32 110.232 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -61.6 -41.77 97.91 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 124.283 0.989 . . . . 71.41 109.534 -171.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.34 -2.21 30.58 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.008 1.723 . . . . 63.11 113.199 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 99.61 55.78 1.0 Allowed Glycine 0 CA--C 1.524 0.618 0 CA-C-N 119.257 0.935 . . . . 71.51 112.587 177.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 66.8 t -119.84 142.31 35.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 117.687 0.743 . . . . 73.54 109.668 170.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.84 126.32 29.05 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.048 0.939 . . . . 72.42 109.769 170.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.94 -24.04 69.82 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-O 118.017 -1.435 . . . . 71.42 112.413 175.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.54 -38.25 89.07 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.941 1.37 . . . . 74.43 109.752 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -73.4 -44.99 57.34 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 105.794 -1.928 . . . . 71.42 105.794 -171.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -60.32 -40.2 89.74 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.452 0.644 . . . . 71.24 110.045 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -79.61 -11.2 59.88 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.395 0.887 . . . . 72.41 113.395 -177.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -103.44 -63.55 1.17 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.985 1.314 . . . . 62.52 109.251 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -44.89 -45.07 10.13 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 128.001 2.521 . . . . 65.3 110.752 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 44.5 t-105 -50.9 -29.7 12.68 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.279 1.032 . . . . 73.53 113.563 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -119.33 5.78 11.18 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.895 1.678 . . . . 74.23 112.434 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.1 t -88.77 149.85 23.23 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.814 1.645 . . . . 70.34 109.466 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -49.2 -33.68 12.99 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.963 1.705 . . . . 74.3 112.121 177.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.0 t -46.09 -56.53 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 125.338 1.455 . . . . 73.43 110.426 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.1 t -67.4 -47.45 80.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 C-N-CA 125.016 1.326 . . . . 74.43 109.454 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -54.39 -44.54 72.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.213 0.53 . . . . 73.42 110.314 -172.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.05 -45.77 84.01 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.68 1.192 . . . . 73.32 111.534 176.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 16.3 mt -60.42 -48.62 80.95 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.86 0.864 . . . . 74.53 111.203 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.9 t -49.96 -45.26 22.37 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 C-N-CA 124.819 1.248 . . . . 73.42 109.3 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.5 -32.5 74.16 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.693 0.627 . . . . 74.43 112.693 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -62.85 -51.8 65.62 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.059 0.845 . . . . 73.53 110.588 171.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -63.44 -47.14 83.1 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.793 0.27 . . . . 54.24 111.235 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -58.73 -47.16 85.57 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.938 1.295 . . . . 70.11 110.553 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -57.23 -45.06 84.24 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 118.492 0.587 . . . . 73.23 110.172 175.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.95 1.37 10.96 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.653 0.983 . . . . 74.3 113.653 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -86.37 -59.36 2.3 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.132 -1.605 . . . . 71.14 110.36 149.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.2 -7.87 40.51 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.028 2.131 . . . . 74.41 114.28 -163.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.08 -6.26 48.55 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.064 1.346 . . . . 73.53 112.343 172.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.0 mt 67.71 63.17 0.41 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 122.727 1.251 . . . . 73.12 109.494 167.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -144.58 -48.11 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.505 -1.225 . . . . 74.34 111.435 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 9.4 tp -78.69 -85.76 0.07 Allowed 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.76 0.709 . . . . 72.53 110.654 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 57.82 24.7 11.09 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.475 1.11 . . . . 71.51 112.515 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -169.39 162.47 36.06 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.682 1.61 . . . . 65.31 109.835 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 18.9 m -150.69 165.19 17.93 Favored Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 118.47 1.135 . . . . 74.53 109.852 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -65.31 157.31 76.63 Favored 'Cis proline' 0 C--N 1.351 0.665 0 CA-C-N 119.902 1.001 . . . . 64.45 110.592 -13.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -144.59 141.8 29.69 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.973 -0.558 . . . . 73.42 110.058 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 34.7 mtp -148.94 95.31 2.38 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 105.855 -1.905 . . . . 74.21 105.855 -169.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -82.13 169.31 16.79 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.996 -0.372 . . . . 73.42 109.996 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.2 t -147.38 150.31 14.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 O-C-N 121.128 -0.982 . . . . 64.54 109.602 169.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 60.31 6.1 0.97 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 128.431 2.692 . . . . 73.33 114.241 166.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.4 -1.47 84.25 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.298 -1.279 . . . . 72.34 112.455 -173.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -147.05 -7.12 0.48 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 116.252 1.945 . . . . 74.34 116.252 -164.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -121.48 155.6 34.57 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 118.517 0.599 . . . . 74.51 109.898 -175.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.67 130.02 50.74 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 128.159 2.584 . . . . 74.44 107.302 172.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.61 153.74 38.43 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.67 -1.233 . . . . 71.44 107.67 174.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -126.48 85.59 59.97 Favored Pre-proline 0 C--O 1.234 0.272 0 O-C-N 122.241 -0.287 . . . . 63.21 110.93 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -63.11 -22.81 73.33 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 CA-C-N 118.948 0.66 . . . . 70.21 111.794 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.5 -2.59 23.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.875 1.27 . . . . 73.52 111.955 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -131.93 30.92 3.14 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.596 1.569 . . . . 72.53 111.021 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 20.8 mtm -127.15 165.18 20.05 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.439 1.496 . . . . 73.14 108.74 172.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -83.18 67.73 9.31 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 124.978 2.323 . . . . 74.14 110.762 -166.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.5 p -66.53 6.09 0.5 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 131.55 3.94 . . . . 74.55 112.204 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 23.0 m -91.74 -5.47 53.55 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 124.112 0.965 . . . . 74.41 113.458 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.44 -10.69 2.48 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 118.376 -0.821 . . . . 73.34 112.626 -172.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 10.1 mmt 70.25 -59.1 0.53 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 126.33 1.852 . . . . 65.33 112.978 177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -67.4 -43.07 82.19 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.84 1.2 . . . . 74.55 108.774 -174.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 40.0 t -65.33 -30.56 50.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 124.516 1.127 . . . . 71.35 110.925 176.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -61.96 -62.53 1.72 Allowed 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.791 -0.818 . . . . 71.25 108.791 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 12.7 t -63.55 -39.01 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 119.079 -0.486 . . . . 73.54 110.271 -172.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -50.6 -49.52 56.36 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.627 1.171 . . . . 74.32 110.612 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -78.62 -40.36 34.57 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 118.342 -0.837 . . . . 73.31 112.005 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -54.1 -56.48 17.67 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.953 0.901 . . . . 74.52 110.289 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -53.86 -35.89 62.0 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.438 1.095 . . . . 73.31 112.326 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -73.29 -51.77 16.36 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.363 0.665 . . . . 72.53 109.829 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.0 t -62.15 -25.34 67.7 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 117.483 -1.246 . . . . 72.22 111.374 -176.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 57.8 t -56.62 -56.28 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 119.369 0.986 . . . . 73.22 108.896 168.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 13.6 tttm -55.8 -46.23 78.07 Favored 'General case' 0 N--CA 1.461 0.088 0 C-N-CA 123.512 0.725 . . . . 71.51 111.518 177.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -58.25 -29.18 65.56 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.442 0.697 . . . . 73.22 111.361 -175.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 50.9 mt -82.04 -25.77 34.35 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 120.964 -1.085 . . . . 74.14 113.222 -176.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 89.3 t -59.74 -36.14 64.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.732 -0.84 . . . . 73.51 108.732 175.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -91.43 -19.65 22.63 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 122.218 -0.301 . . . . 74.24 111.094 -173.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -95.17 65.78 2.87 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.947 1.299 . . . . 73.14 108.932 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt . . . . . 0 C--O 1.242 0.706 0 N-CA-C 108.47 -0.937 . . . . 64.52 108.47 165.337 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.387 0 N-CA-C 115.232 1.568 . . . . 74.44 115.232 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -165.37 113.74 1.01 Allowed 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.238 1.015 . . . . 73.34 110.398 169.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.0 pt -112.93 172.02 3.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 127.593 2.357 . . . . 74.32 109.612 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.9 m -142.68 141.52 31.86 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.138 -0.976 . . . . 63.31 108.86 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -53.21 135.55 37.93 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 126.174 1.79 . . . . 75.33 110.155 172.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.48 -18.02 7.51 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.376 1.465 . . . . 74.24 113.889 -175.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -93.41 -85.12 0.28 Allowed 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.569 1.684 . . . . 64.14 108.904 -167.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -89.43 -12.05 41.34 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.948 0.899 . . . . 71.42 111.381 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -141.69 160.83 39.36 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.494 0.718 . . . . 74.25 109.658 171.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.6 mm -121.74 162.77 20.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 107.407 -1.331 . . . . 73.21 107.407 170.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.4 m -119.57 127.46 53.0 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 127.137 2.175 . . . . 74.22 106.126 -178.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.4 mt -70.5 159.36 34.42 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.236 -0.653 . . . . 74.11 109.236 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -83.07 -30.1 28.28 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.847 0.459 . . . . 71.44 111.608 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -138.13 73.06 45.43 Favored Pre-proline 0 C--O 1.232 0.149 0 C-N-CA 124.903 1.281 . . . . 75.21 108.58 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo . . . . . 0 N--CA 1.451 -0.973 0 C-N-CA 123.161 2.574 . . . . 74.35 106.953 173.688 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.471 0.62 0 CA-C-O 122.165 0.983 . . . . 74.05 111.639 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.7 160.17 41.64 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.48 -0.933 . . . . 64.25 108.48 -173.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -126.77 161.36 28.37 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 125.083 1.353 . . . . 73.02 107.458 167.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -121.09 174.04 6.9 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.982 -1.488 . . . . 75.31 106.982 167.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -166.01 -179.03 4.97 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.669 2.388 . . . . 72.42 109.264 168.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.07 -168.63 2.4 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 106.729 -1.582 . . . . 71.43 106.729 158.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -104.47 -45.9 4.52 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.587 0.708 . . . . 74.32 109.256 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.483 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 69.4 m-85 -83.39 -4.09 58.15 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.544 -0.723 . . . . 73.31 111.814 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.2 p -62.36 144.09 95.36 Favored Pre-proline 0 C--N 1.343 0.283 0 CA-C-N 119.782 1.174 . . . . 72.2 109.841 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.0 173.93 13.66 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 121.461 1.441 . . . . 65.4 109.365 163.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 66.17 -40.63 0.35 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 128.936 2.895 . . . . 74.21 112.762 -174.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 60.2 m -54.84 -41.09 70.32 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.834 1.654 . . . . 73.1 112.128 -177.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -54.5 -63.69 1.07 Allowed 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 128.199 2.6 . . . . 74.01 108.854 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.16 -39.97 76.3 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 108.434 -0.95 . . . . 72.44 108.434 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -57.09 -26.46 60.45 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 115.292 -2.289 . . . . 74.44 113.282 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.64 -24.57 4.5 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 122.158 2.254 . . . . 73.24 109.552 -174.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -105.76 -17.06 14.5 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.512 1.505 . . . . 74.31 113.757 -170.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.6 t -121.68 -63.73 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 108.187 -1.042 . . . . 70.44 108.187 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 42.6 mt -70.88 -18.39 62.69 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 118.147 -0.93 . . . . 74.02 111.966 175.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 44.89 39.59 3.71 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 121.139 1.79 . . . . 74.1 112.899 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 69.4 t -61.23 -45.41 98.65 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 O-C-N 121.091 -1.006 . . . . 71.23 109.864 -175.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.4 t -47.1 -53.27 13.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.86 1.264 . . . . 74.14 109.942 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.95 -31.89 69.85 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 113.558 0.948 . . . . 74.44 113.558 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -73.88 -51.69 15.39 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.702 0.683 . . . . 74.34 109.297 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 50.4 t -52.66 -52.68 25.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 126.055 1.742 . . . . 74.44 109.609 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.4 ptt85 -64.85 -14.01 58.03 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 116.795 -1.574 . . . . 74.43 114.015 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -75.75 -17.64 59.83 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 120.667 1.576 . . . . 73.41 112.55 170.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -123.34 -9.18 8.07 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.445 1.098 . . . . 73.43 113.34 -171.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.8 mt -61.64 146.16 90.62 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 123.929 0.892 . . . . 73.24 112.184 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -83.47 162.1 14.79 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.879 3.053 . . . . 71.14 114.081 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -79.51 64.83 4.5 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 127.094 2.158 . . . . 71.24 110.257 -171.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -176.25 -30.41 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 125.174 1.368 . . . . 74.45 111.615 -169.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.8 t -58.04 -29.61 65.49 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 115.233 1.568 . . . . 74.43 115.233 -176.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.3 tptp 44.37 88.62 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.43 1.892 . . . . 74.33 112.185 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 4.5 ttm -49.77 100.71 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 129.388 3.075 . . . . 70.32 110.692 -175.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.4 m -139.84 121.31 15.1 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 107.337 -1.357 . . . . 73.24 107.337 -172.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -130.46 120.01 23.51 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 106.986 -1.487 . . . . 64.0 106.986 -176.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -95.52 157.11 16.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 123.13 1.443 . . . . 74.43 110.056 174.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.69 ' CD2' ' H ' ' A' ' 60' ' ' HIS . 5.4 p80 -98.0 167.06 11.13 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 129.176 2.99 . . . . 71.2 108.901 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.2 m -131.92 165.83 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.032 0.933 . . . . 74.02 108.507 176.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -100.68 16.65 24.21 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.53 1.132 . . . . 73.2 111.675 -169.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -115.73 162.6 17.04 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 126.436 1.895 . . . . 74.43 109.322 -169.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 75.3 124.34 0.04 OUTLIER 'General case' 0 C--O 1.232 0.153 0 C-N-CA 128.676 2.79 . . . . 63.04 110.519 174.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.483 ' HA3' ' CD2' ' A' ' 29' ' ' TYR . . . 90.19 173.47 44.93 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 124.302 0.953 . . . . 75.42 112.098 175.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -65.52 -55.15 0.47 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.348 2.699 . . . . 74.21 109.737 173.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.5 mt -86.54 17.0 4.1 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 125.174 1.39 . . . . 73.42 112.862 -167.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -48.16 -45.12 27.21 Favored Glycine 0 CA--C 1.542 1.739 0 CA-C-N 120.005 1.275 . . . . 72.13 113.715 -174.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.1 tptt -59.85 -46.37 89.5 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.887 1.275 . . . . 75.22 111.541 174.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -71.03 -38.18 72.58 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.749 -1.219 . . . . 72.41 109.026 -176.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.1 mt -62.46 -34.1 76.14 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.091 1.756 . . . . 71.21 111.915 173.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.7 m -54.04 -58.19 8.24 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 106.934 -1.506 . . . . 75.1 106.934 170.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -57.25 -50.56 72.51 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.968 0.907 . . . . 73.14 111.595 -169.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.5 -24.4 67.46 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.883 1.068 . . . . 70.34 113.883 -171.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.571 ' CD1' ' CD2' ' A' ' 60' ' ' HIS . 52.0 t-105 -57.7 -35.04 70.09 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.453 -0.779 . . . . 74.22 111.168 175.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.05 95.04 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.34 -0.838 . . . . 72.34 111.915 178.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.2 t -53.38 -43.73 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 119.177 0.898 . . . . 73.4 110.159 175.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.93 -26.24 40.2 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 117.362 -1.304 . . . . 74.02 113.088 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 76.8 mt -67.14 -41.75 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 120.835 1.652 . . . . 74.23 108.343 166.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.01 -44.36 94.63 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.623 0.647 . . . . 74.04 110.464 -172.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.4 mt -81.04 -18.07 48.01 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 112.902 0.705 . . . . 72.1 112.902 174.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.29 70.16 1.13 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.907 1.717 . . . . 54.22 110.789 -171.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.9 m -138.11 19.18 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 125.735 1.614 . . . . 74.2 111.432 -175.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -52.43 -51.52 58.78 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 126.03 1.732 . . . . 72.14 110.151 -178.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -68.36 -0.86 5.33 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.562 1.945 . . . . 65.0 113.393 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -104.42 -26.07 12.57 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 120.835 -1.165 . . . . 74.32 109.66 176.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.1 pt -112.04 9.93 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 C-N-CA 125.013 1.325 . . . . 73.33 111.698 -174.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 56.0 m -80.92 -44.71 17.84 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 120.931 1.696 . . . . 63.4 109.22 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.07 -63.5 2.1 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 124.081 0.952 . . . . 71.33 111.686 -165.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.01 -21.41 73.16 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 121.355 1.37 . . . . 73.43 112.08 -176.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 15.0 ttm -74.26 -37.69 63.67 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 125.875 1.67 . . . . 72.44 110.52 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -64.08 -42.29 97.01 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 119.047 -0.502 . . . . 74.01 110.304 164.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -64.75 -13.79 56.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 118.321 -0.847 . . . . 65.01 113.189 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.99 -14.12 15.28 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.782 1.173 . . . . 71.4 112.36 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 78.9 t -105.86 -45.04 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.251 1.02 . . . . 74.42 112.371 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -103.88 -48.54 3.88 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 114.587 1.329 . . . . 71.02 114.587 -174.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -70.31 -59.18 3.02 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.875 1.27 . . . . 74.11 113.587 -177.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 48.5 p -94.05 -30.26 14.78 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.779 1.232 . . . . 73.1 113.435 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 60.95 27.11 16.99 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.001 2.921 . . . . 71.43 113.569 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.5 t -59.78 -25.75 65.16 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.398 1.479 . . . . 73.42 112.438 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 42.7 t -62.58 109.91 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 108.528 -0.916 . . . . 72.22 108.528 175.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -141.66 -20.41 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.945 1.298 . . . . 74.3 110.841 -175.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.93 167.4 22.21 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.679 -1.6 . . . . 72.44 106.679 167.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.5 t -55.74 -28.8 24.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.11 0.564 . . . . 74.43 109.698 172.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.86 -15.04 57.96 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.972 1.709 . . . . 63.2 112.191 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.84 -23.67 13.37 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 118.635 0.652 . . . . 71.41 111.086 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.5 mt -71.52 -51.41 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 C-N-CA 125.4 1.48 . . . . 65.42 108.236 174.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.76 -22.36 62.0 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.269 1.028 . . . . 72.22 112.22 -175.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -62.06 -59.35 5.21 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 126.682 1.993 . . . . 74.44 111.076 170.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 71.1 t -54.53 -40.49 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.523 1.129 . . . . 74.11 110.354 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -54.06 -53.27 55.36 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 119.05 -0.5 . . . . 71.12 110.644 173.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.4 t -61.98 -46.72 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 119.617 1.098 . . . . 71.23 110.645 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -54.39 -44.2 72.1 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.164 0.986 . . . . 72.11 109.772 -176.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.1 -13.19 60.45 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.522 1.529 . . . . 53.32 114.907 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 126.42 6.47 5.67 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 117.402 1.721 . . . . 71.22 117.402 176.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 93.7 t -93.71 120.04 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-N 119.958 1.879 . . . . 74.41 110.051 -175.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.441 ' HG3' ' CB ' ' A' ' 120' ' ' ASP . 3.6 pttp -52.2 125.92 17.24 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.593 -0.73 . . . . 63.3 109.927 172.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.21 -30.6 61.24 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 109.41 -1.476 . . . . 52.33 109.41 166.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -30.38 66.56 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 119.371 1.585 . . . . 74.34 110.653 -175.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.441 ' CB ' ' HG3' ' A' ' 117' ' ' LYS . 23.3 t0 -83.31 -43.31 16.14 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.842 -0.799 . . . . 74.04 108.842 175.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -50.81 -54.62 22.13 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 123.58 0.752 . . . . 74.3 111.047 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -73.66 -9.95 59.2 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.619 1.568 . . . . 74.02 111.413 -173.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.29 -63.3 1.14 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.431 1.892 . . . . 72.2 109.501 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.49 -36.08 68.72 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.681 1.592 . . . . 72.33 112.893 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 65.3 t-105 -44.64 -39.26 4.9 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.562 1.145 . . . . 63.1 111.065 174.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.28 0.97 41.22 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.881 1.672 . . . . 74.42 113.657 -177.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.4 t -97.66 165.72 11.83 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.593 1.557 . . . . 74.2 112.676 -173.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -62.97 -36.64 84.16 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.001 1.72 . . . . 75.1 111.445 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.4 t -50.58 -47.75 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 122.342 1.068 . . . . 72.14 109.064 -178.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.6 t -68.84 -42.89 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-N 114.818 -1.083 . . . . 71.3 111.476 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -50.98 -53.87 29.42 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 118.98 0.809 . . . . 74.42 110.451 175.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.84 -42.96 99.95 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.214 0.606 . . . . 71.02 110.091 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.5 mt -64.4 -40.08 95.1 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 119.326 0.966 . . . . 72.13 112.823 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 74.2 t -59.23 -53.79 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 107.406 -1.331 . . . . 73.12 107.406 171.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.42 -34.35 68.82 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.385 0.883 . . . . 73.14 113.385 -174.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -53.28 -46.03 69.15 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 124.523 1.129 . . . . 71.44 111.565 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.402 ' HG2' ' CD2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -94.18 -31.19 14.24 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 113.102 0.778 . . . . 75.23 113.102 -170.556 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -64.87 -38.08 89.78 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.796 0.726 . . . . 75.14 109.169 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -54.56 -48.83 71.58 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 126.404 1.882 . . . . 75.42 111.386 165.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.66 -17.0 60.75 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 118.513 -0.756 . . . . 71.41 112.596 -175.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.25 -44.91 35.26 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 120.839 1.654 . . . . 75.01 109.819 164.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.5 -5.11 21.93 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.428 1.491 . . . . 75.31 114.236 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.0 -2.46 51.66 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.67 1.123 . . . . 72.25 112.355 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 10.2 mt 74.56 54.84 0.08 Allowed 'General case' 0 C--N 1.342 0.245 0 C-N-CA 126.353 1.861 . . . . 75.15 110.454 164.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.41 -23.39 2.13 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.611 0.967 . . . . 73.15 113.611 -173.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.91 -80.85 0.51 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.613 1.097 . . . . 73.34 111.382 -168.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 62.77 -3.58 0.3 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.707 2.003 . . . . 72.15 115.534 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -137.83 162.19 25.53 Favored Glycine 0 CA--C 1.526 0.727 0 O-C-N 120.395 -1.441 . . . . 61.13 110.858 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.1 m -142.39 166.93 18.15 Favored Pre-proline 0 C--O 1.239 0.504 0 N-CA-C 107.976 -1.12 . . . . 74.14 107.976 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.59 155.7 99.73 Favored 'Cis proline' 0 CA--C 1.536 0.625 0 CA-C-N 119.79 0.961 . . . . 74.44 113.532 -9.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -152.17 142.47 22.45 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 126.062 1.745 . . . . 73.04 110.079 -177.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 32.4 ttm -140.67 133.81 29.47 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 126.505 1.922 . . . . 74.21 106.43 172.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -117.42 159.58 22.56 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.836 0.854 . . . . 74.14 111.216 -177.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.5 t -141.23 145.74 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.407 1.083 . . . . 73.03 108.549 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 48.28 11.91 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.317 2.647 . . . . 71.03 116.124 177.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 62.56 41.93 99.75 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 119.705 1.138 . . . . 64.25 110.59 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -165.71 -21.93 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.778 1.231 . . . . 74.12 112.488 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -112.89 146.44 38.94 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 118.756 0.707 . . . . 74.13 109.362 177.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -117.78 139.36 51.19 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 104.933 -2.247 . . . . 73.14 104.933 167.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.38 142.91 57.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.777 -1.564 . . . . 72.34 106.777 173.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -115.75 85.58 14.48 Favored Pre-proline 0 CA--C 1.516 -0.344 0 CA-C-N 117.84 0.291 . . . . 74.11 110.97 177.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -64.87 -27.13 59.11 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 CA-C-N 118.652 0.554 . . . . 62.32 111.139 174.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.93 -0.56 16.5 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.397 1.479 . . . . 74.45 112.825 -173.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -133.22 12.49 4.98 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.66 1.6 . . . . 73.34 111.699 175.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 17.5 mtt -87.73 172.32 9.77 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 120.129 1.965 . . . . 74.32 109.264 165.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.16 106.68 7.91 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.055 -1.461 . . . . 71.35 107.055 169.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.4 HG23 ' CD1' ' A' ' 173' ' ' PHE . 54.5 p -112.59 18.39 18.4 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.107 2.163 . . . . 70.11 110.368 -178.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 40.0 m -99.52 5.56 46.06 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.451 1.101 . . . . 74.41 112.77 -172.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -137.43 -15.22 1.45 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.554 1.142 . . . . 70.35 111.825 -177.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 2.2 mmt 69.17 -62.99 0.39 Allowed 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 126.246 1.819 . . . . 74.32 110.454 -175.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.99 -38.55 86.4 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.17 -0.956 . . . . 74.13 111.657 -172.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 65.5 t -75.29 -27.49 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 123.809 0.844 . . . . 63.21 111.161 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.4 ' CD1' HG23 ' A' ' 167' ' ' THR . 42.0 t80 -59.32 -52.03 67.4 Favored 'General case' 0 C--O 1.226 -0.158 0 N-CA-C 108.655 -0.868 . . . . 74.34 108.655 -177.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.7 t -77.28 -25.04 15.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 117.518 0.145 . . . . 74.21 111.11 -175.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.53 -31.25 67.76 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.3 0.482 . . . . 70.11 112.3 168.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -86.32 -44.94 11.69 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.25 1.02 . . . . 74.03 110.985 172.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -58.44 -56.74 18.21 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.519 0.728 . . . . 73.41 110.569 -167.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.15 -21.23 59.04 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 113.683 0.994 . . . . 71.04 113.683 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -77.96 -52.58 8.59 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 123.346 0.658 . . . . 71.32 110.321 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.0 t -62.16 -30.71 71.24 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 117.832 -1.08 . . . . 72.15 110.653 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 85.5 t -60.63 -54.57 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 119.987 1.267 . . . . 74.31 108.483 177.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -59.51 -48.17 82.67 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-O 118.777 -0.63 . . . . 72.32 110.255 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -60.13 -29.46 68.64 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 112.481 0.549 . . . . 74.45 112.481 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 60.2 mt -74.79 -23.13 58.45 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 120.826 -1.171 . . . . 73.33 112.309 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 92.9 t -66.05 -29.5 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 118.34 0.518 . . . . 70.12 109.671 174.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -95.46 -9.36 32.83 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.816 0.846 . . . . 74.31 110.428 -175.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 21.0 mttp -108.61 61.91 0.6 Allowed 'General case' 0 C--O 1.225 -0.186 0 O-C-N 120.661 -1.274 . . . . 72.44 109.664 -177.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.6 mmtm . . . . . 0 C--O 1.254 1.317 0 C-N-CA 127.179 2.191 . . . . 74.05 112.223 171.253 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 -0.069 0 CA-C-O 121.561 0.696 . . . . 74.42 112.691 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -156.35 105.95 2.32 Favored 'General case' 0 N--CA 1.425 -1.711 0 C-N-CA 125.563 1.545 . . . . 65.41 107.791 -175.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.9 pt -106.16 167.0 3.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 127.185 2.194 . . . . 73.02 109.119 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.7 m -143.89 145.8 32.55 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 106.598 -1.63 . . . . 74.02 106.598 175.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -58.56 150.06 23.94 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 127.566 2.347 . . . . 72.31 109.758 167.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.56 -29.37 0.36 Allowed Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.546 1.07 . . . . 64.32 113.826 -168.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -94.85 -84.44 0.33 Allowed 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 118.951 1.375 . . . . 74.05 108.551 -165.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -92.7 -14.92 27.35 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.459 0.703 . . . . 73.13 110.852 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -143.48 165.31 27.9 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.544 0.611 . . . . 74.01 110.705 167.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.3 mm -122.17 162.61 21.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 126.827 2.051 . . . . 74.04 106.605 175.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.0 m -126.66 136.45 52.5 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 106.004 -1.85 . . . . 63.22 106.004 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.0 mt -81.07 156.4 25.84 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 118.541 0.61 . . . . 75.04 109.606 -178.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -71.7 -34.94 70.05 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.303 1.441 . . . . 71.44 110.509 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.4 mmtm -137.01 78.82 39.94 Favored Pre-proline 0 N--CA 1.453 -0.279 0 C-N-CA 125.112 1.365 . . . . 75.43 108.403 -175.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.448 -1.174 0 C-N-CA 123.391 2.728 . . . . 63.15 108.763 174.18 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.422 HG21 ' H ' ' A' ' 55' ' ' LYS . 14.8 m . . . . . 0 CA--C 1.543 0.697 0 N-CA-C 105.442 -2.058 . . . . 65.03 105.442 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -169.61 171.06 7.75 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.573 1.549 . . . . 65.04 108.46 169.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -130.45 145.14 51.78 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 128.509 2.723 . . . . 72.11 108.875 176.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -132.52 125.44 30.6 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.833 1.253 . . . . 74.01 108.291 174.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -135.82 178.63 6.9 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.947 1.699 . . . . 74.44 109.527 174.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.465 ' HA ' ' CE1' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -146.59 -174.89 4.59 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.155 0.982 . . . . 70.3 110.5 164.435 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.518 ' CZ ' ' HG3' ' A' ' 91' ' ' MET . 50.9 m-85 -93.93 -41.39 9.62 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.654 -0.654 . . . . 74.12 112.73 176.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -80.72 -7.53 59.38 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.808 0.67 . . . . 74.11 112.808 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.0 p -74.7 149.2 85.78 Favored Pre-proline 0 CA--C 1.532 0.269 0 O-C-N 120.744 -1.223 . . . . 73.14 111.979 173.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.25 167.87 25.69 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.618 2.212 . . . . 73.31 109.184 164.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.2 m80 68.98 -51.32 0.59 Allowed 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 127.114 2.165 . . . . 73.23 110.738 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 61.0 m -44.42 -40.45 5.48 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 126.555 1.942 . . . . 73.15 112.046 177.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.95 -70.91 0.08 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.291 1.037 . . . . 74.23 108.229 175.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.447 ' HA ' HE21 ' A' ' 35' ' ' GLN . 0.0 OUTLIER -65.98 -37.47 86.05 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.084 -1.01 . . . . 73.35 110.141 -169.717 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -61.58 -20.64 63.53 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 116.878 -1.534 . . . . 72.13 112.483 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -120.68 -11.25 9.06 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 119.395 0.998 . . . . 72.11 110.928 -170.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.48 ' HA ' ' CE1' ' A' ' 41' ' ' HIS . 0.0 OUTLIER -134.56 -16.54 2.05 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 114.666 1.358 . . . . 64.01 114.666 -173.765 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 77.7 t -117.64 -68.23 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.272 0.558 . . . . 74.04 110.368 174.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.4 mt -69.08 -21.76 64.05 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.247 1.419 . . . . 74.42 111.314 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.48 ' CE1' ' HA ' ' A' ' 38' ' ' GLU . 39.7 m-70 44.08 56.24 4.89 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 126.0 1.72 . . . . 74.22 111.074 171.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 68.2 t -59.18 -49.13 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 117.184 -1.389 . . . . 74.04 107.754 -172.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.3 t -45.61 -53.47 9.1 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-N 119.685 1.13 . . . . 74.14 112.111 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.477 ' CG ' HH12 ' A' ' 47' ' ' ARG . 1.5 t70 -88.5 5.66 41.5 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.921 0.712 . . . . 72.42 112.921 -174.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -92.01 -49.06 6.42 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.733 0.813 . . . . 72.14 109.992 157.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 t -63.49 -40.12 87.88 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-N 119.632 1.106 . . . . 74.11 110.392 -170.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.477 HH12 ' CG ' ' A' ' 44' ' ' ASP . 0.7 OUTLIER -51.58 -38.43 54.41 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 118.049 -0.977 . . . . 70.14 111.709 -179.045 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -64.76 -2.96 2.82 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 115.207 1.558 . . . . 73.25 115.207 176.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -129.05 -5.62 4.97 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.107 1.763 . . . . 74.14 111.603 -178.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.6 mt -87.67 152.7 52.05 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 127.334 2.254 . . . . 73.42 111.119 -165.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -81.21 175.6 9.59 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.209 2.606 . . . . 61.34 112.015 -178.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -84.63 23.03 1.2 Allowed 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.478 -1.389 . . . . 74.15 114.524 -169.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -143.19 -15.08 0.29 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.308 1.432 . . . . 63.24 113.724 -172.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.6 t -60.04 128.12 35.25 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 107.388 -1.338 . . . . 71.13 107.388 175.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.422 ' H ' HG21 ' A' ' 22' ' ' VAL . 48.0 tptt -118.61 72.78 0.89 Allowed 'General case' 0 C--N 1.341 0.196 0 CA-C-O 123.279 1.514 . . . . 71.11 109.535 173.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 18.4 ptp -52.96 -31.85 42.71 Favored 'General case' 0 CA--C 1.496 -1.1 0 C-N-CA 125.331 1.452 . . . . 71.05 114.339 -173.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.5 m 46.82 -167.33 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 126.101 1.761 . . . . 74.21 113.063 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.09 104.72 1.71 Allowed 'General case' 0 CA--C 1.54 0.563 0 O-C-N 119.977 -1.702 . . . . 73.44 107.65 167.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.7 m-30 -102.63 174.81 5.73 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.635 1.561 . . . . 74.21 111.013 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.465 ' CE1' ' HA ' ' A' ' 27' ' ' SER . 6.2 t60 -135.02 118.5 16.86 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 118.722 0.692 . . . . 73.31 111.417 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.8 m -81.93 172.07 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 123.252 0.621 . . . . 75.43 110.042 178.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.27 3.39 6.36 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.625 1.57 . . . . 74.03 113.096 -169.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -81.32 1.23 33.55 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.414 1.265 . . . . 75.01 114.414 -172.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 mt -125.59 132.09 52.59 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.655 1.116 . . . . 75.3 110.44 -164.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.76 177.37 35.33 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.666 0.65 . . . . 75.32 111.66 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.77 -55.13 0.92 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.186 2.591 . . . . 73.22 110.453 173.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.1 mt -91.84 22.37 4.25 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.375 -0.828 . . . . 73.11 112.875 -166.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -48.65 -48.43 29.03 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 119.101 0.864 . . . . 63.3 112.206 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.507 ' HZ3' ' CD ' ' A' ' 138' ' ' GLU . 15.6 mmtt -56.52 -42.53 78.58 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.482 1.513 . . . . 75.14 113.307 176.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -78.71 -33.37 46.86 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.332 0.653 . . . . 72.14 110.259 -176.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.6 mt -62.4 -41.03 98.35 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.886 -0.783 . . . . 72.4 108.886 171.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.9 m -55.65 -50.11 71.07 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.594 1.088 . . . . 53.44 110.171 168.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -61.71 -35.16 77.24 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 120.621 1.555 . . . . 74.33 113.012 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.27 -35.06 79.87 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.668 0.667 . . . . 65.34 111.914 174.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 11.3 t-105 -57.46 -42.71 83.09 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 118.619 0.645 . . . . 74.43 111.026 -176.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.96 -36.38 74.72 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 117.517 -1.23 . . . . 65.21 112.872 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.0 t -59.7 -47.12 92.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 120.065 1.302 . . . . 72.21 108.626 172.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.55 -47.21 86.58 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 121.806 -0.559 . . . . 72.14 111.142 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.39 -42.54 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.137 0.975 . . . . 71.5 110.509 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.62 -47.25 86.34 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.576 0.625 . . . . 73.12 109.441 -174.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 87.3 mt -80.2 -20.34 44.95 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 119.195 -0.431 . . . . 71.5 112.065 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.69 66.68 2.4 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 125.9 1.715 . . . . 72.32 110.261 -167.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.1 m -134.85 18.29 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.742 1.617 . . . . 71.52 111.048 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -51.07 -53.57 32.77 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 124.466 1.107 . . . . 65.23 110.09 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -77.0 -5.79 50.08 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.066 0.946 . . . . 61.41 111.29 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -90.21 -8.49 50.97 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.224 1.01 . . . . 73.31 111.216 166.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.7 pp -133.19 38.12 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 124.901 1.28 . . . . 64.52 111.715 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.0 m -92.39 -52.33 4.72 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.748 -0.595 . . . . 72.33 110.753 171.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.83 -64.05 3.49 Favored Pre-proline 0 CA--C 1.532 0.276 0 C-N-CA 123.318 0.647 . . . . 74.54 112.295 -163.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.33 -20.77 31.74 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 CA-C-N 119.575 0.884 . . . . 70.12 112.602 -173.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.518 ' HG3' ' CZ ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -54.47 -58.8 6.04 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 127.481 2.312 . . . . 70.33 108.116 170.705 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -59.09 -41.69 88.67 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 124.105 0.962 . . . . 70.13 111.817 177.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -56.62 -36.68 69.73 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.076 -0.511 . . . . 74.14 110.676 172.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.39 -17.03 43.65 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 121.4 -0.812 . . . . 71.45 112.541 -169.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.0 t -114.3 -23.17 4.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 C-N-CA 124.613 1.165 . . . . 74.04 111.064 -172.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -120.48 -52.36 2.15 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.678 0.791 . . . . 74.25 112.289 -178.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -69.27 -52.85 23.49 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 121.583 -0.698 . . . . 74.33 111.244 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 37.2 p -98.62 -31.69 11.81 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.14 0.976 . . . . 72.52 110.489 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 52.59 34.78 16.45 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.882 2.073 . . . . 61.04 111.534 -173.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 t -75.91 -12.76 60.21 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.648 1.179 . . . . 73.53 112.67 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.9 t -67.31 118.17 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 O-C-N 120.913 -1.117 . . . . 70.51 108.963 172.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -141.93 -25.13 0.68 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.463 1.105 . . . . 74.04 111.799 -178.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.13 160.78 38.49 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.584 1.553 . . . . 73.1 107.166 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 63.9 t -58.59 -32.34 45.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.566 1.146 . . . . 74.41 110.221 177.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.32 -29.06 57.54 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.287 1.435 . . . . 73.32 112.743 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -88.33 -25.41 22.77 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.598 0.635 . . . . 72.11 109.293 -176.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.2 mt -78.39 -47.74 23.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 124.963 1.305 . . . . 71.54 109.582 -178.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -56.11 -28.08 56.37 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-O 118.342 -0.837 . . . . 74.52 111.406 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -58.88 -53.61 56.46 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 123.86 0.864 . . . . 73.12 110.113 -176.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 17.4 t -56.07 -41.44 68.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.164 0.586 . . . . 71.43 110.716 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -60.47 -49.32 78.04 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.127 0.971 . . . . 74.44 110.009 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 83.5 t -63.41 -35.87 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 121.581 -0.699 . . . . 73.4 110.194 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.67 -44.05 97.25 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.466 0.706 . . . . 62.22 109.3 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.52 -21.42 62.73 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.612 1.165 . . . . 50.22 112.497 175.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 131.62 2.29 4.46 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 115.908 1.123 . . . . 73.2 115.908 167.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 65.1 t -66.26 143.73 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 123.363 1.554 . . . . 73.54 108.354 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.65 145.53 50.57 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.626 -1.17 . . . . 72.53 110.446 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -78.47 -0.2 78.0 Favored Glycine 0 N--CA 1.467 0.708 0 C-N-CA 124.035 0.826 . . . . 74.44 114.241 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -94.88 -36.97 11.42 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 123.198 0.599 . . . . 73.33 111.449 172.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -86.79 -41.1 14.36 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 107.348 -1.353 . . . . 73.23 107.348 -160.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -60.61 -53.2 60.37 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.957 -0.757 . . . . 74.31 108.957 172.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -73.14 -20.47 60.91 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 118.77 -0.634 . . . . 72.31 111.48 -170.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.56 -65.24 1.01 Allowed 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.138 -1.06 . . . . 51.41 108.138 171.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.53 -35.19 65.39 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.106 0.962 . . . . 70.1 111.626 -171.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -44.86 -36.97 3.55 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 125.08 1.352 . . . . 74.3 111.83 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -114.35 8.42 16.65 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.744 1.618 . . . . 72.42 113.484 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.6 t -79.09 148.8 32.28 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.06 1.744 . . . . 64.43 110.53 169.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -54.92 -33.36 62.06 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.232 1.813 . . . . 75.21 112.532 -177.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 22.3 t -54.63 -48.22 71.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 124.14 0.976 . . . . 73.2 109.742 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 32.7 t -69.98 -44.41 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-O 117.956 -1.021 . . . . 72.53 108.667 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -49.21 -49.92 40.66 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.267 1.394 . . . . 74.13 111.373 175.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.1 t -61.59 -49.05 78.18 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 123.481 0.713 . . . . 72.12 109.897 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 13.6 mt -65.04 -38.71 91.73 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 118.606 0.639 . . . . 73.32 111.988 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 49.1 t -58.31 -60.8 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 125.797 1.639 . . . . 75.43 107.695 173.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.65 -42.06 70.84 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 119.007 -0.521 . . . . 74.3 110.856 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -57.28 -53.11 61.87 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 123.435 0.694 . . . . 74.2 111.654 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -67.03 -48.67 67.64 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 119.158 0.89 . . . . 74.13 110.774 -175.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.507 ' CD ' ' HZ3' ' A' ' 69' ' ' LYS . 93.0 mt-10 -63.29 -27.76 69.56 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.362 0.665 . . . . 74.43 112.043 -178.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -82.24 -54.75 5.0 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.512 0.725 . . . . 75.34 109.647 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.08 0.74 1.77 Allowed 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 125.574 1.549 . . . . 54.34 113.399 -175.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.58 -0.16 8.69 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 114.216 1.191 . . . . 75.24 114.216 169.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.38 -13.01 7.24 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.99 0.814 . . . . 52.54 113.167 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -51.75 -66.7 0.34 Allowed 'General case' 0 C--O 1.231 0.086 0 C-N-CA 125.893 1.677 . . . . 62.34 110.773 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.9 pp 174.19 -4.66 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 129.117 2.967 . . . . 74.24 112.154 169.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.407 ' NE2' ' H ' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -78.63 -27.23 45.38 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.519 1.128 . . . . 75.44 111.735 -158.634 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.407 ' H ' ' NE2' ' A' ' 145' ' ' GLN . 0.9 OUTLIER -159.57 140.91 12.82 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 128.641 2.776 . . . . 74.0 106.759 -179.5 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -145.4 12.27 1.34 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.202 1.401 . . . . 75.3 110.502 -172.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -151.53 147.89 18.3 Favored Glycine 0 C--N 1.342 0.862 0 O-C-N 120.255 -1.528 . . . . 61.42 110.901 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 35.5 m -133.83 165.46 36.54 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 118.45 1.125 . . . . 74.13 111.102 -168.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.0 157.91 95.16 Favored 'Cis proline' 0 C--N 1.35 0.631 0 CA-C-N 119.233 0.762 . . . . 73.04 112.263 -11.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -138.59 146.63 42.04 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.639 -0.709 . . . . 73.43 111.472 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 7.8 ttm -145.14 119.22 9.42 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.667 -1.605 . . . . 70.11 106.667 174.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -88.21 164.74 15.49 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.367 0.667 . . . . 74.22 109.825 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.485 ' CG1' ' HB2' ' A' ' 158' ' ' TYR . 0.5 OUTLIER -149.55 150.31 13.93 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 O-C-N 121.067 -1.021 . . . . 73.45 108.719 175.291 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 48.3 15.21 0.07 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.328 1.603 . . . . 73.22 115.328 -175.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 50.79 38.33 36.88 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 120.039 1.291 . . . . 73.33 112.425 -167.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 42.7 pttt -162.27 -14.21 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.946 1.299 . . . . 74.05 114.038 173.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.485 ' HB2' ' CG1' ' A' ' 154' ' ' VAL 0.276 14.3 m-85 -106.42 158.86 16.59 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 127.041 2.136 . . . . 74.23 110.834 178.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -139.24 130.62 26.96 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 105.063 -2.199 . . . . 65.13 105.063 174.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.92 142.49 56.02 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.518 -1.29 . . . . 70.41 107.518 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -114.26 85.28 10.31 Favored Pre-proline 0 C--O 1.236 0.376 0 N-CA-C 110.339 -0.245 . . . . 74.44 110.339 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.11 -16.02 43.99 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 N-CA-C 110.342 -0.676 . . . . 71.03 110.342 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -77.65 2.49 16.53 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.283 1.833 . . . . 71.13 112.477 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -135.3 35.5 2.17 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 119.422 1.01 . . . . 70.21 111.12 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 62.5 mtt -120.84 167.38 12.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.446 1.098 . . . . 74.45 110.403 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -62.21 112.42 2.38 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.237 1.015 . . . . 71.33 108.937 169.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 82.3 p -119.57 22.08 11.81 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.434 1.094 . . . . 72.03 110.186 175.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.23 -48.22 36.8 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 118.664 0.665 . . . . 74.24 109.934 172.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.49 HD21 ' HB ' ' A' ' 172' ' ' VAL . 0.4 OUTLIER -107.82 -10.85 15.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 118.07 -0.966 . . . . 74.43 111.608 -156.172 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 16.6 mmm 73.47 -44.85 0.59 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 127.748 2.419 . . . . 74.42 111.935 169.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -55.54 23.17 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 127.179 2.191 . . . . 74.44 107.941 173.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.49 ' HB ' HD21 ' A' ' 169' ' ' ASN . 61.5 t -67.81 -26.47 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 127.057 2.143 . . . . 74.24 110.538 -174.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.68 -59.12 5.95 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.189 -1.041 . . . . 74.25 108.189 173.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 10.8 t -66.58 -32.03 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.101 0.56 . . . . 72.34 110.521 -177.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.66 -41.86 82.36 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.645 0.778 . . . . 73.23 111.607 176.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -85.35 -32.35 22.49 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.587 1.155 . . . . 73.05 112.69 177.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -56.8 -63.29 1.25 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.376 -0.972 . . . . 74.44 108.376 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.86 -26.95 69.02 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.562 0.578 . . . . 64.34 112.562 -170.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -71.24 -52.23 20.17 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.222 1.409 . . . . 71.42 109.878 177.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 92.4 m -53.78 -40.11 66.0 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.248 1.019 . . . . 72.41 110.155 176.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 46.1 t -57.75 -53.27 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 108.934 -0.765 . . . . 73.15 108.934 178.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.3 tttt -59.95 -43.47 95.0 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 124.065 0.946 . . . . 73.31 110.543 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -63.33 -32.62 74.09 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 123.14 0.576 . . . . 71.04 111.202 -171.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 19.5 mt -68.79 -25.97 64.97 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 112.756 0.65 . . . . 71.04 112.756 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 61.1 t -65.72 -25.91 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 O-C-N 121.188 -0.945 . . . . 73.44 109.442 173.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -92.02 -9.56 42.37 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.152 1.381 . . . . 65.35 110.967 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -129.56 70.52 1.42 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.78 2.032 . . . . 64.33 108.79 -174.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 21.6 pttp . . . . . 0 C--O 1.257 1.481 0 CA-C-O 117.064 -1.446 . . . . 74.23 109.814 -176.234 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.293 0 N-CA-C 115.786 1.772 . . . . 74.01 115.786 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.52 115.06 4.51 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 104.755 -2.313 . . . . 65.3 104.755 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.9 pt -127.37 142.13 44.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 126.111 1.764 . . . . 74.33 107.861 175.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.8 m -129.53 145.54 51.45 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.977 -1.12 . . . . 74.03 107.977 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -47.33 146.32 2.02 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 127.38 2.272 . . . . 73.02 111.395 165.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.22 -19.15 0.25 Allowed Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.365 1.46 . . . . 74.23 114.428 -172.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -100.43 -86.26 0.4 Allowed 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 106.736 -1.579 . . . . 72.34 106.736 -165.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -92.15 -14.21 29.47 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.379 1.071 . . . . 53.13 110.522 -175.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -144.81 159.7 42.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.728 0.811 . . . . 74.0 111.04 172.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.3 mm -125.07 164.44 23.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 124.615 1.166 . . . . 72.21 108.323 178.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 m -109.97 152.56 25.71 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.624 1.97 . . . . 74.2 108.236 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 35.5 mt -84.33 160.84 20.61 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 108.008 -1.108 . . . . 71.1 108.008 164.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.95 -35.39 64.53 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 122.404 1.097 . . . . 73.51 110.088 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -123.49 78.29 54.68 Favored Pre-proline 0 N--CA 1.455 -0.211 0 C-N-CA 125.458 1.503 . . . . 74.22 108.032 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo . . . . . 0 N--CA 1.444 -1.395 0 N-CA-C 106.348 -2.212 . . . . 73.21 106.348 164.25 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 66.7 t . . . . . 0 C--O 1.234 0.252 0 CA-C-O 120.823 0.344 . . . . 63.2 110.699 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.9 tp -136.57 153.82 50.86 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 126.664 1.986 . . . . 74.23 106.108 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 2.6 mp0 -143.91 149.43 36.85 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.363 1.865 . . . . 73.44 109.893 -169.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -145.6 161.99 38.52 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.197 1.362 . . . . 74.43 108.457 174.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -163.63 -175.0 3.94 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.949 2.899 . . . . 72.2 107.144 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.1 t -138.94 173.11 11.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 123.101 1.429 . . . . 72.13 109.407 163.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -79.81 -34.93 39.14 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 126.902 2.081 . . . . 71.3 110.11 -175.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -90.8 -1.97 57.81 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.104 1.362 . . . . 74.42 112.578 -176.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 p -90.03 144.22 31.04 Favored Pre-proline 0 N--CA 1.471 0.622 0 CA-C-N 120.928 1.694 . . . . 72.53 112.112 -173.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -84.71 -40.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.047 1.831 . . . . 50.41 114.339 -170.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -59.07 -43.32 91.77 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.489 1.041 . . . . 73.12 108.437 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 32.1 m -48.35 -45.88 35.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.393 1.877 . . . . 74.44 111.233 175.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -51.16 -62.06 1.85 Allowed 'General case' 0 C--N 1.346 0.438 0 C-N-CA 123.628 0.771 . . . . 64.33 109.631 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -55.1 -41.63 71.86 Favored 'General case' 0 C--O 1.222 -0.345 0 O-C-N 121.08 -1.013 . . . . 72.23 110.587 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -68.18 -20.15 64.84 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 117.986 -1.007 . . . . 72.24 111.928 -172.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.79 -4.91 7.56 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.275 0.943 . . . . 73.44 112.756 -167.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -133.95 -26.93 1.49 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.629 1.572 . . . . 72.32 111.548 -168.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 83.0 t -119.81 -76.45 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 107.009 -1.478 . . . . 74.41 107.009 -175.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.1 mt -68.27 -17.54 64.31 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.56 1.544 . . . . 71.52 112.95 -176.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 44.08 60.38 2.78 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.437 1.895 . . . . 71.22 112.185 172.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.2 t -66.76 -52.13 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 116.519 -1.705 . . . . 72.1 108.909 -173.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.0 t -53.99 -45.76 71.52 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 121.044 1.747 . . . . 70.34 110.501 -175.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -61.85 -40.56 95.75 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.761 0.825 . . . . 65.01 111.468 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -68.2 -36.88 80.25 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 124.488 1.115 . . . . 71.31 112.102 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 t -66.54 -46.84 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.455 -1.313 . . . . 71.32 107.455 178.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 66.8 ttt-85 -48.0 -47.05 33.38 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-O 118.231 -0.89 . . . . 74.41 111.204 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -56.14 -10.74 0.91 Allowed 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 115.726 1.75 . . . . 71.0 115.726 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -130.31 7.25 4.96 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.653 1.981 . . . . 73.23 112.848 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.0 mt -79.82 161.65 65.48 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 120.194 1.361 . . . . 63.03 111.352 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -72.61 -161.92 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.75 1 C-N-CA 127.355 5.37 . . . . 55.52 110.739 172.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.32 24.05 10.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 114.489 1.292 . . . . 74.22 114.489 176.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -143.08 -40.78 0.06 OUTLIER Glycine 0 CA--C 1.52 0.406 0 O-C-N 121.607 -0.683 . . . . 74.44 113.567 -172.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.0 m -71.55 95.19 1.38 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.597 1.559 . . . . 73.0 108.056 175.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.03 162.5 24.82 Favored 'General case' 0 CA--C 1.519 -0.25 0 O-C-N 120.478 -1.389 . . . . 73.41 109.014 169.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.89 109.04 21.83 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 106.805 -1.554 . . . . 72.44 106.805 175.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.36 -176.91 5.8 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 124.076 0.86 . . . . 72.34 109.237 171.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.23 109.31 0.14 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 128.288 2.635 . . . . 74.21 105.612 174.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -74.76 -166.53 0.47 Allowed 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.006 -1.059 . . . . 74.34 109.532 163.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.512 ' CD2' ' HB3' ' A' ' 75' ' ' TRP 0.262 2.7 p-80 -136.77 156.88 47.93 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 129.709 3.204 . . . . 74.12 108.347 170.58 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.5 m -146.7 170.35 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 119.614 1.097 . . . . 73.34 108.398 169.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.99 -80.88 0.08 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 107.026 -1.472 . . . . 74.41 107.026 171.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 68.13 -44.15 0.49 Allowed 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 130.136 3.375 . . . . 74.4 115.011 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.36 171.01 16.13 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 119.842 1.201 . . . . 61.34 110.65 -175.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.16 175.55 33.18 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 115.717 -0.674 . . . . 71.1 112.54 175.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -73.67 -55.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.673 2.915 . . . . 65.32 111.219 175.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.4 mt -89.38 30.18 1.02 Allowed 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.295 0.638 . . . . 74.45 111.844 -164.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -45.6 -56.3 6.53 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.929 1.252 . . . . 42.11 110.581 176.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -56.13 -46.46 79.18 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.601 1.161 . . . . 73.43 110.736 -174.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.49 -45.8 91.37 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 127.106 2.163 . . . . 65.35 109.329 -174.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 mt -64.98 -43.84 91.28 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.855 0.862 . . . . 74.45 109.431 176.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.5 m -66.37 -1.31 3.31 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 126.653 1.981 . . . . 74.51 110.582 177.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -111.9 -22.12 11.24 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 118.971 -2.33 . . . . 74.15 111.599 171.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.09 -35.8 48.94 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.698 0.999 . . . . 73.13 113.698 176.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.512 ' HB3' ' CD2' ' A' ' 60' ' ' HIS . 40.8 t-105 -58.23 -35.42 71.67 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.265 0.939 . . . . 73.51 110.949 -175.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.53 -34.33 77.56 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 118.206 -0.902 . . . . 61.42 110.814 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.1 t -60.98 -47.02 95.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 119.467 1.03 . . . . 73.24 108.964 167.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.16 -45.97 89.59 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 119.056 -0.497 . . . . 71.55 111.467 -177.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.5 mt -65.84 -42.84 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 124.602 1.161 . . . . 73.12 110.557 176.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.1 -32.44 70.98 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.054 0.843 . . . . 74.13 110.909 -177.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 43.2 mt -95.37 -15.24 23.2 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.261 0.837 . . . . 54.22 113.261 173.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 65.12 63.3 4.25 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.231 1.396 . . . . 74.22 111.667 -173.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.3 m -129.48 16.42 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.586 1.154 . . . . 74.11 111.852 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -52.86 -54.53 33.19 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.133 0.879 . . . . 71.21 111.016 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.56 -9.09 11.59 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.604 0.762 . . . . 74.12 112.648 -179.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -96.34 -13.92 22.92 Favored 'General case' 0 CA--C 1.519 -0.233 0 O-C-N 120.585 -1.322 . . . . 73.53 111.284 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.2 pt -121.21 -1.14 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 116.712 -1.613 . . . . 74.3 113.347 -175.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.2 m -64.38 -54.5 31.83 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 120.632 1.56 . . . . 64.43 109.096 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.54 -56.24 24.62 Favored Pre-proline 0 C--O 1.241 0.623 0 C-N-CA 124.614 1.166 . . . . 74.54 112.633 -169.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -72.08 -26.97 17.6 Favored 'Trans proline' 0 N--CA 1.443 -1.443 0 C-N-CA 120.714 0.943 . . . . 73.42 112.653 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 17.1 tpp -54.42 -51.34 65.22 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.09 0.956 . . . . 71.2 109.288 174.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -68.99 -33.57 73.88 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 121.872 -0.518 . . . . 71.52 111.191 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.39 -38.82 85.15 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 118.964 -1.094 . . . . 70.5 109.594 171.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.99 -11.41 58.15 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.275 -0.891 . . . . 65.5 112.05 -167.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.3 t -119.93 -35.44 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.184 1.393 . . . . 73.54 110.36 -171.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -122.39 -38.38 2.68 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.098 0.959 . . . . 71.2 111.974 -164.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -76.01 -58.72 3.11 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 118.619 0.645 . . . . 74.2 110.733 174.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . 0.261 5.6 t -114.45 -18.23 11.56 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.095 0.776 . . . . 70.52 113.095 -176.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 65.87 19.73 11.32 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.521 0.934 . . . . 71.42 113.521 169.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 t -62.52 -16.48 56.05 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.247 2.219 . . . . 63.13 113.717 -173.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 26.9 t -64.46 115.05 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 124.434 1.094 . . . . 74.41 109.391 173.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -132.52 -23.12 2.12 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.502 1.121 . . . . 74.11 112.078 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.97 161.44 41.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.734 1.614 . . . . 62.21 107.291 -177.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.3 t -54.36 -36.15 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 118.973 0.806 . . . . 74.54 110.236 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.66 -34.17 57.75 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.378 1.471 . . . . 70.55 112.676 176.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -78.46 -34.75 47.5 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.518 -0.919 . . . . 73.44 108.518 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.9 mt -72.35 -49.27 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 124.085 0.954 . . . . 73.31 108.732 -174.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -17.28 64.53 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.569 0.748 . . . . 71.33 112.62 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -58.4 -54.18 49.93 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.24 1.016 . . . . 63.34 109.908 168.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.0 t -55.11 -36.78 40.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.519 1.128 . . . . 73.43 110.82 -175.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -57.36 -57.27 13.37 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.319 0.648 . . . . 73.22 109.536 173.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 89.2 t -60.88 -41.36 88.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 O-C-N 121.454 -0.779 . . . . 74.54 111.005 -175.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -55.44 -51.05 68.2 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.193 0.997 . . . . 70.33 109.237 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.36 -11.32 60.84 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.073 1.349 . . . . 71.52 112.506 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 112.02 48.06 0.68 Allowed Glycine 0 C--N 1.336 0.528 0 CA-C-N 118.84 0.745 . . . . 70.13 112.729 175.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.6 t -116.37 141.66 33.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 117.91 0.855 . . . . 71.23 109.741 177.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -70.27 118.43 13.08 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.188 0.995 . . . . 74.33 109.27 169.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.85 -9.28 52.28 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 117.347 -1.807 . . . . 70.22 112.479 167.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -74.98 -41.42 59.57 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 120.607 2.204 . . . . 71.13 108.67 168.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.71 -25.65 44.69 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.441 -0.948 . . . . 63.23 108.441 -171.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -70.31 -62.21 1.47 Allowed 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 107.59 -1.263 . . . . 71.55 107.59 175.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -64.41 -24.77 67.75 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.787 -0.625 . . . . 74.23 111.69 -173.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.78 -68.11 0.6 Allowed 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.667 1.187 . . . . 70.22 111.259 168.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.11 -27.71 67.25 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 118.223 -0.894 . . . . 53.32 111.517 -167.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -44.14 -39.4 4.29 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.851 1.66 . . . . 74.12 112.047 176.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -112.53 3.62 16.88 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.83 1.252 . . . . 73.11 113.147 -177.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 13.2 t -74.68 152.84 39.11 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.841 1.256 . . . . 73.35 111.252 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -52.61 -33.2 45.42 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.202 1.801 . . . . 74.45 112.581 170.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 46.8 t -53.16 -48.53 53.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 O-C-N 121.201 -0.937 . . . . 71.24 109.772 177.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.3 t -72.59 -38.16 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-O 118.311 -0.852 . . . . 73.41 109.868 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -52.46 -49.83 63.88 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.78 1.173 . . . . 73.33 111.234 174.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.3 t -58.06 -51.07 71.22 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.122 -0.696 . . . . 65.44 109.122 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 14.8 mt -66.26 -37.93 86.64 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.271 0.629 . . . . 73.14 112.658 -174.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.1 t -56.31 -59.21 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 125.16 1.384 . . . . 74.53 108.66 168.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.05 -40.35 60.98 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.799 0.839 . . . . 74.34 112.27 -174.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -51.9 -60.92 2.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 117.668 -1.158 . . . . 74.21 110.291 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.415 HE21 ' CE1' ' A' ' 60' ' ' HIS . 0.9 OUTLIER -78.34 -32.95 49.38 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 120.576 1.534 . . . . 73.52 113.659 -179.621 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.92 -24.21 65.17 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.502 1.046 . . . . 65.5 109.766 -169.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 24.1 ttpt -82.2 -57.38 3.41 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 125.262 1.425 . . . . 73.43 109.305 160.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.86 -17.69 61.82 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.931 1.456 . . . . 64.22 114.931 -164.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -117.4 2.35 12.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 119.965 1.257 . . . . 70.54 113.257 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.98 6.42 3.38 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.628 0.771 . . . . 73.53 111.727 -178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -68.1 -85.88 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.874 0.87 . . . . 74.24 109.678 172.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 175.58 48.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.658 2.383 . . . . 71.5 109.244 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.47 -50.47 0.51 Allowed 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.782 -1.199 . . . . 74.53 109.493 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.13 109.05 14.98 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 127.029 2.132 . . . . 73.41 106.827 -171.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -149.84 28.62 0.76 Allowed 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 126.636 1.974 . . . . 71.44 111.144 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -138.38 91.2 0.2 Allowed Glycine 0 C--N 1.341 0.811 0 O-C-N 120.876 -1.14 . . . . 65.12 112.44 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 34.1 m -73.38 163.55 67.63 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 113.331 0.863 . . . . 74.12 113.331 174.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -77.94 118.07 5.52 Favored 'Cis proline' 0 N--CA 1.446 -1.286 0 N-CA-C 108.666 -1.321 . . . . 71.2 108.666 -21.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 24' ' ' GLU . . . -88.49 129.18 35.51 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 106.203 -1.777 . . . . 74.11 106.203 -174.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 80.0 mmm -138.19 89.26 2.38 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 104.245 -2.502 . . . . 70.41 104.245 -172.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -73.74 170.23 15.7 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 120.853 -1.155 . . . . 74.04 109.974 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 56.8 t -131.07 -41.41 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 113.252 0.834 . . . . 72.41 113.252 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.36 24.22 1.13 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.76 -0.588 . . . . 71.44 109.728 -171.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 77.44 -28.37 1.76 Allowed Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.237 1.875 . . . . 74.23 113.055 -174.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.55 -7.48 19.7 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.966 1.469 . . . . 71.14 114.966 -174.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -126.95 142.15 51.62 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.947 0.899 . . . . 72.33 109.531 -174.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -117.9 137.54 52.74 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 106.392 -1.707 . . . . 74.42 106.392 169.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.02 144.04 55.29 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.21 -0.663 . . . . 71.13 109.21 171.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -111.55 86.95 7.36 Favored Pre-proline 0 C--O 1.232 0.149 0 N-CA-C 113.519 0.933 . . . . 62.43 113.519 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -63.13 0.04 1.91 Allowed 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 121.041 1.161 . . . . 73.43 114.253 172.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -111.74 18.65 18.76 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.117 1.367 . . . . 74.42 112.287 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -146.06 52.24 0.57 Allowed Glycine 0 C--N 1.334 0.42 0 N-CA-C 108.681 -1.768 . . . . 70.24 108.681 171.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 35.6 mtt -144.58 176.02 9.71 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.931 1.292 . . . . 72.02 109.399 -176.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.411 ' C ' ' H ' ' A' ' 168' ' ' SER . 2.6 t70 -85.24 44.52 1.1 Allowed 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 123.527 0.731 . . . . 71.21 112.269 -164.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.408 ' HB ' ' CD2' ' A' ' 173' ' ' PHE 0.257 10.7 t -67.79 30.91 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 129.102 2.961 . . . . 70.23 113.169 -177.163 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 166' ' ' ASP . 0.0 OUTLIER -85.19 -20.43 30.2 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 127.536 2.334 . . . . 72.02 112.4 169.595 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.18 -8.68 2.63 Favored 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 113.386 0.884 . . . . 72.02 113.386 -166.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 6.0 mmt 69.19 -61.88 0.42 Allowed 'General case' 0 C--O 1.231 0.129 0 C-N-CA 127.654 2.382 . . . . 61.13 113.003 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -63.66 -46.11 87.12 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.375 1.083 . . . . 72.32 109.682 -172.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.02 -26.48 40.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.386 1.474 . . . . 70.11 110.853 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . 0.408 ' CD2' ' HB ' ' A' ' 167' ' ' THR . 15.9 t80 -68.51 -57.72 5.38 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.267 -1.383 . . . . 74.43 107.267 -177.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.3 t -67.23 -33.85 65.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 117.899 0.318 . . . . 71.24 110.152 -174.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.42 -51.07 61.05 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.49 0.716 . . . . 72.32 110.987 174.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -73.3 -32.73 64.79 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.715 0.806 . . . . 74.32 112.559 177.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -59.06 -60.82 3.26 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.239 1.016 . . . . 73.33 108.429 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.7 -27.65 66.63 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.575 0.75 . . . . 73.12 111.981 -174.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.67 -47.96 28.85 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 121.75 -0.594 . . . . 73.03 111.248 176.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 90.9 m -53.63 -37.5 63.13 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.439 0.696 . . . . 72.11 109.697 173.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 93.4 t -58.22 -54.43 32.68 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 N-CA-C 109.206 -0.664 . . . . 74.43 109.206 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 13.3 pttp -64.71 -34.99 79.61 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 118.989 -1.085 . . . . 70.44 111.305 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -62.98 -31.11 72.16 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-N 118.739 0.7 . . . . 74.34 111.451 -172.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 75.4 mt -76.0 -18.98 59.06 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.075 -1.05 . . . . 73.13 112.636 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 76.8 t -67.5 -22.51 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 O-C-N 120.951 -1.093 . . . . 73.03 110.383 176.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -103.61 -12.23 17.2 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.325 1.05 . . . . 71.41 110.869 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 42.2 mttp -115.33 82.41 1.74 Allowed 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 126.125 1.77 . . . . 73.23 107.958 -173.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-N 114.208 -1.36 . . . . 71.23 109.111 164.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.464 0 N-CA-C 112.162 0.43 . . . . 71.44 112.162 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -148.52 118.33 7.11 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 106.105 -1.813 . . . . 73.45 106.105 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.3 pt -122.51 149.12 25.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 C-N-CA 126.753 2.021 . . . . 74.05 108.676 178.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.1 m -119.05 130.91 55.88 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.792 -0.818 . . . . 62.35 108.792 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -46.65 111.47 0.39 Allowed 'General case' 0 C--O 1.232 0.183 0 C-N-CA 126.812 2.045 . . . . 62.21 109.638 162.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 102.97 -5.9 50.83 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.263 -1.298 . . . . 75.11 112.939 176.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -104.57 -86.33 0.46 Allowed 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 118.916 1.358 . . . . 72.45 107.773 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -92.87 -11.65 33.01 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.441 1.496 . . . . 73.33 112.287 -172.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -144.97 157.36 44.16 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 122.984 0.514 . . . . 74.24 110.499 170.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.0 mm -124.57 157.91 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 124.572 1.149 . . . . 74.15 108.071 177.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.24 143.55 41.84 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.69 1.596 . . . . 73.03 107.134 177.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.0 mt -81.91 147.36 29.32 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.885 -0.783 . . . . 75.01 108.885 170.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -73.49 -36.14 65.76 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.356 1.462 . . . . 71.21 109.885 173.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -131.03 84.1 58.88 Favored Pre-proline 0 CA--C 1.519 -0.227 0 C-N-CA 126.296 1.838 . . . . 75.41 108.173 177.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo . . . . . 0 N--CA 1.445 -1.333 0 C-N-CA 123.159 2.573 . . . . 75.15 110.029 173.285 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.241 0.634 0 N-CA-C 106.92 -1.511 . . . . 71.22 106.92 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.4 tp -159.77 154.8 24.82 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.501 1.046 . . . . 71.05 112.053 171.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -134.92 143.4 46.9 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 127.24 2.216 . . . . 70.55 107.272 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -133.64 137.11 45.21 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.069 0.947 . . . . 71.31 110.768 174.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -162.34 165.85 26.01 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.75 1.62 . . . . 72.52 109.491 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.8 t -124.43 169.14 12.14 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.653 0.781 . . . . 72.22 109.842 167.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.47 ' CE2' HD21 ' A' ' 71' ' ' LEU 0.275 0.0 OUTLIER -76.58 -18.77 58.47 Favored 'General case' 0 N--CA 1.435 -1.196 0 C-N-CA 124.081 0.953 . . . . 71.33 112.597 175.726 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -96.06 0.34 51.39 Favored 'General case' 0 C--N 1.346 0.446 0 O-C-N 120.232 -1.543 . . . . 73.11 111.655 -175.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.7 p -97.97 142.09 24.01 Favored Pre-proline 0 CA--C 1.534 0.341 0 O-C-N 121.121 -0.987 . . . . 72.12 108.773 -168.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -91.44 -28.25 0.19 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 120.314 0.676 . . . . 74.42 111.503 -162.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -59.9 -49.63 76.93 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.409 -0.96 . . . . 75.25 108.409 165.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.9 m -55.33 -36.7 66.53 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 124.609 1.164 . . . . 61.32 111.953 -178.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -58.82 -56.69 18.97 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 122.994 0.518 . . . . 72.2 109.694 175.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.89 -30.22 68.86 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-O 116.171 -1.871 . . . . 73.42 110.193 177.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -75.03 -6.01 47.12 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 121.245 1.839 . . . . 70.05 113.037 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -146.24 8.56 1.06 Allowed 'General case' 0 C--N 1.345 0.375 0 CA-C-N 120.51 1.505 . . . . 72.13 112.824 -175.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -139.97 -12.48 1.1 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.948 1.299 . . . . 65.21 111.341 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 80.9 t -129.27 -81.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 105.911 -1.885 . . . . 74.25 105.911 173.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 mt -76.55 61.77 1.82 Allowed 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 128.335 2.654 . . . . 72.41 109.474 173.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -50.98 77.38 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 129.628 3.171 . . . . 61.44 110.444 172.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 83.2 t -67.2 -48.31 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 114.709 -1.132 . . . . 63.33 108.111 -172.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.1 t -71.6 15.45 0.14 Allowed 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.076 1.139 . . . . 74.12 114.076 -172.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -129.36 -20.81 3.28 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 119.404 -2.06 . . . . 72.24 111.863 170.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -62.28 -30.83 71.41 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 121.95 -0.469 . . . . 74.01 111.243 164.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.405 HG13 ' HG ' ' A' ' 50' ' ' LEU . 1.7 t -75.69 -52.14 18.92 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.649 0 N-CA-C 107.123 -1.436 . . . . 73.41 107.123 -162.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -52.95 -39.38 62.88 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.043 1.337 . . . . 73.03 109.915 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -56.35 -21.63 25.81 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.039 1.496 . . . . 72.01 115.039 174.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.6 mmtt -127.37 -5.17 6.0 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.618 2.767 . . . . 74.15 112.526 -176.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.405 ' HG ' HG13 ' A' ' 46' ' ' VAL . 12.7 mt -75.88 151.98 84.54 Favored Pre-proline 0 CA--C 1.518 -0.252 0 CA-C-N 120.43 1.468 . . . . 72.43 108.236 -174.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -78.24 148.54 24.19 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 122.098 1.865 . . . . 74.12 109.646 165.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -67.63 91.89 0.31 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.131 1.772 . . . . 72.21 112.12 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 137.17 -25.19 3.05 Favored Glycine 0 C--N 1.334 0.428 0 O-C-N 120.602 -1.311 . . . . 73.14 113.603 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 73.0 m -71.27 86.94 0.81 Allowed 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 104.075 -2.565 . . . . 71.23 104.075 151.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -82.68 157.31 23.4 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.574 -1.639 . . . . 72.34 106.574 169.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.07 169.24 8.86 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.92 -0.77 . . . . 73.43 108.92 -177.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 58' ' ' LYS . 1.3 m -140.48 -171.63 3.26 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.247 1.419 . . . . 72.53 108.105 -167.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.446 ' H ' HG22 ' A' ' 57' ' ' THR . 0.1 OUTLIER -173.62 85.45 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.291 1.436 . . . . 72.55 108.237 -178.091 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -89.61 163.72 15.04 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 120.902 -1.124 . . . . 73.23 108.77 173.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.433 ' CE1' ' CG2' ' A' ' 72' ' ' THR . 0.1 OUTLIER -102.26 174.7 5.8 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 127.83 2.452 . . . . 75.43 110.133 -174.198 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.0 m -144.06 150.44 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 CA-C-N 122.407 2.367 . . . . 72.4 112.765 168.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . 0.304 0.0 OUTLIER -103.29 1.11 32.41 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.19 1.796 . . . . 74.41 114.776 176.87 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -70.8 9.06 0.73 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.199 1.399 . . . . 71.21 113.984 173.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.1 mt -141.77 148.44 38.95 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 119.68 -1.888 . . . . 75.11 109.221 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.54 166.41 12.03 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 115.082 -0.963 . . . . 72.42 111.725 171.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.44 -39.66 1.01 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.471 2.114 . . . . 61.12 110.119 170.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 57.3 mt -82.72 23.89 0.77 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.811 1.245 . . . . 71.53 112.032 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -43.91 -63.52 2.24 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 117.222 -1.876 . . . . 74.32 109.863 169.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.8 tptp -59.82 -26.23 65.61 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 121.399 2.6 . . . . 75.42 114.126 -172.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -54.71 30.61 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 117.995 -1.002 . . . . 75.4 111.412 168.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.47 HD21 ' CE2' ' A' ' 28' ' ' PHE . 34.6 mt -60.26 -40.95 92.15 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.252 0.933 . . . . 74.34 109.269 -164.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.433 ' CG2' ' CE1' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -49.61 -37.84 29.44 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 126.735 2.014 . . . . 72.51 109.682 -179.499 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.04 -51.48 6.31 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 126.62 1.968 . . . . 73.52 110.895 -176.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.44 -31.13 72.06 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.513 1.051 . . . . 74.53 112.1 -177.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.44 ' CH2' ' HB3' ' A' ' 84' ' ' GLU . 43.3 t-105 -56.59 -36.39 69.31 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 119.139 0.881 . . . . 74.11 111.328 173.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.87 -42.46 94.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.624 -0.673 . . . . 65.3 110.125 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 82.6 t -52.8 -43.5 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 122.953 0.501 . . . . 74.22 109.83 170.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.37 -50.14 66.66 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 121.239 -0.913 . . . . 73.54 111.13 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.464 ' CD1' HE22 ' A' ' 137' ' ' GLN . 86.6 mt -59.31 -37.28 68.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.344 1.058 . . . . 73.21 109.877 178.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.26 -50.13 74.27 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.505 0.593 . . . . 71.24 110.17 -174.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.0 mt -81.66 -12.2 58.78 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 118.32 -0.848 . . . . 74.54 112.791 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.03 63.87 3.58 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 126.14 1.828 . . . . 65.4 110.681 -175.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.2 m -130.14 11.9 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 117.67 -1.157 . . . . 74.32 112.838 -177.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.44 ' HB3' ' CH2' ' A' ' 75' ' ' TRP . 2.4 mp0 -51.58 -51.7 53.4 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.912 1.233 . . . . 70.14 111.629 -166.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -49.31 -47.67 46.86 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.681 1.592 . . . . 73.1 111.506 177.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -65.46 -26.73 68.08 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 124.342 1.057 . . . . 73.21 109.472 -170.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.5 pp -114.42 29.66 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 126.914 2.086 . . . . 65.54 109.322 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.449 HG21 ' CE1' ' A' ' 92' ' ' PHE . 18.6 m -108.97 -53.46 2.64 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 118.029 -0.986 . . . . 72.34 108.439 168.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.86 -54.55 42.5 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 113.602 0.964 . . . . 74.44 113.602 -174.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -73.45 -29.37 11.16 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.363 1.375 . . . . 72.54 112.032 178.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 34.0 tpp -60.45 -50.11 74.89 Favored 'General case' 0 CA--C 1.515 -0.404 0 C-N-CA 125.225 1.41 . . . . 74.51 110.936 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.449 ' CE1' HG21 ' A' ' 88' ' ' THR . 6.2 m-85 -70.13 -33.15 71.46 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.938 -0.553 . . . . 74.21 109.56 -176.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -58.17 -37.27 74.4 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.353 0.979 . . . . 71.44 109.607 168.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.31 -0.9 57.66 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.062 -1.649 . . . . 74.14 113.578 -176.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.445 HG12 ' CD1' ' A' ' 28' ' ' PHE . 54.2 t -116.76 -33.77 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.531 1.533 . . . . 74.44 109.688 -177.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -116.06 -48.38 2.74 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 124.696 1.199 . . . . 74.54 111.577 -173.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -72.66 -62.26 1.51 Allowed 'General case' 0 C--N 1.334 -0.082 0 O-C-N 121.695 -0.628 . . . . 73.44 109.49 -176.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 28.2 p -86.43 -35.83 19.47 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.318 0.508 . . . . 74.51 110.659 -178.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 66.48 23.83 10.44 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.701 2.401 . . . . 75.1 113.174 -175.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -70.33 -19.51 63.06 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.503 0.592 . . . . 74.33 112.487 -173.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 26.8 t -64.3 124.63 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 O-C-N 121.354 -0.841 . . . . 72.21 109.046 171.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -147.04 -24.77 0.4 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.499 1.52 . . . . 72.31 111.44 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.6 162.56 32.36 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.802 0.728 . . . . 75.12 109.546 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.2 t -55.45 -38.74 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.309 1.044 . . . . 60.54 110.006 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.17 -11.77 23.1 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 114.064 1.135 . . . . 74.53 114.064 178.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -94.72 -33.73 12.82 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 124.979 1.311 . . . . 74.3 110.311 175.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 mt -71.62 -37.96 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.013 -0.736 . . . . 73.23 109.013 -177.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -68.62 -23.37 64.43 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.342 -0.849 . . . . 73.43 111.474 -174.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -55.4 -54.52 42.68 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.469 -0.938 . . . . 74.32 108.469 176.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 29.0 t -58.52 -38.14 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 123.853 0.861 . . . . 72.42 110.625 -174.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -53.25 -57.75 9.45 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.463 -0.569 . . . . 74.14 109.463 172.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -63.92 -41.23 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 O-C-N 121.452 -0.78 . . . . 72.12 111.142 -175.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.25 -41.38 88.63 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.127 1.371 . . . . 72.2 109.746 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.64 0.18 18.46 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.795 1.238 . . . . 73.44 112.504 175.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.04 62.46 1.43 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 124.81 1.195 . . . . 63.54 111.118 175.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.5 t -121.66 149.47 24.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 124.181 0.992 . . . . 65.53 109.28 170.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -68.48 135.88 52.32 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.196 0.522 . . . . 72.53 110.106 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.22 -30.54 71.69 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 114.868 -1.06 . . . . 63.21 110.556 171.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -74.76 -17.8 60.58 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 123.447 0.699 . . . . 71.32 111.905 -172.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.74 -51.81 5.46 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.105 -1.072 . . . . 63.53 108.105 176.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -50.89 -53.22 34.48 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.227 1.411 . . . . 72.33 109.978 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -76.61 -10.76 59.62 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 114.239 -1.346 . . . . 74.51 113.14 -172.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.65 -57.06 2.18 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 125.408 1.483 . . . . 63.51 110.407 176.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -50.23 -40.37 47.3 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.898 2.079 . . . . 72.33 110.89 -178.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 61.3 t-105 -45.97 -42.87 13.58 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.29 1.036 . . . . 73.24 111.972 173.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -102.41 8.04 40.25 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.367 -1.458 . . . . 72.42 112.901 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 8.8 t -89.3 151.38 22.13 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 127.019 2.128 . . . . 74.11 111.773 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -60.13 -28.71 68.1 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 125.493 1.517 . . . . 74.11 111.854 174.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 66.4 t -49.33 -54.3 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 119.363 0.983 . . . . 72.51 109.777 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.0 t -69.1 -39.28 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-N 115.22 -0.9 . . . . 72.2 108.668 -176.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.4 mmpt? -55.77 -48.58 75.04 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.059 0.845 . . . . 75.5 111.078 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.42 -36.96 85.47 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.068 0.947 . . . . 65.4 110.76 -178.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 13.9 mt -71.06 -58.72 3.29 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 124.882 1.273 . . . . 70.44 110.754 178.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 53.9 t -45.47 -49.38 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 C-N-CA 125.133 1.373 . . . . 75.23 108.595 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.1 -45.19 87.63 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 117.292 -1.337 . . . . 54.41 112.708 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -51.06 -46.57 61.76 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 120.409 1.459 . . . . 72.33 111.305 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.464 HE22 ' CD1' ' A' ' 79' ' ' ILE . 43.0 mt-30 -88.54 -36.51 16.34 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.926 -1.034 . . . . 73.2 109.801 -162.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -63.56 -47.99 79.3 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.276 -1.009 . . . . 73.34 108.276 171.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 54.7 tttt -60.87 -7.7 2.57 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.675 1.19 . . . . 73.41 113.88 171.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -112.09 -18.05 12.68 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-O 117.189 -1.386 . . . . 73.55 113.728 173.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -113.86 -11.68 12.81 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 121.956 2.162 . . . . 72.35 112.688 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -117.36 -8.03 11.11 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.954 1.302 . . . . 71.54 111.751 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.25 8.81 3.0 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 114.239 1.199 . . . . 73.2 114.239 -178.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 12.3 mt 76.54 57.29 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.431 2.692 . . . . 75.32 111.828 174.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.27 -84.27 0.63 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.045 -1.094 . . . . 74.41 108.045 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.5 ' HG ' ' H ' ' A' ' 148' ' ' GLY . 11.4 tp -74.68 -73.12 0.25 Allowed 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 124.63 1.172 . . . . 74.44 112.931 -171.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 70.11 2.34 3.9 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.856 2.062 . . . . 75.33 115.217 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.5 ' H ' ' HG ' ' A' ' 146' ' ' LEU . . . -145.38 134.64 5.6 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 120.737 1.608 . . . . 72.42 111.327 176.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 35.5 m -126.42 164.33 34.84 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 119.183 1.492 . . . . 74.33 111.722 -173.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -66.07 156.06 80.38 Favored 'Cis proline' 0 C--N 1.352 0.723 0 CA-C-N 119.712 0.933 . . . . 73.25 112.841 -6.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -141.36 156.94 45.78 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.454 0.702 . . . . 72.34 110.473 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 43.8 tpp -156.6 110.13 2.66 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.169 -1.789 . . . . 74.42 106.169 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -100.6 155.81 17.66 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.458 0.703 . . . . 71.12 109.54 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.1 t -137.76 139.53 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.612 -1.255 . . . . 74.12 107.612 177.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 64.67 -2.63 0.64 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.806 2.043 . . . . 72.25 114.874 171.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.48 -28.1 15.7 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.752 1.644 . . . . 63.12 112.169 -173.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.34 -6.67 12.35 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.925 1.863 . . . . 75.12 115.81 -169.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -121.81 148.82 44.19 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 108.901 -0.777 . . . . 72.43 108.901 -171.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -126.88 143.5 51.25 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.402 -0.962 . . . . 64.02 108.402 169.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -66.77 138.62 57.5 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 106.585 -1.635 . . . . 72.12 106.585 172.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -119.18 85.05 29.23 Favored Pre-proline 0 N--CA 1.452 -0.336 0 N-CA-C 111.7 0.259 . . . . 75.35 111.7 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.32 -21.77 71.78 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 121.27 1.313 . . . . 72.32 112.604 173.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -67.25 -10.61 52.39 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.147 0.979 . . . . 74.45 112.011 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -129.05 37.02 2.28 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 126.186 1.851 . . . . 75.02 109.752 171.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 40.4 mtt -114.12 162.37 16.57 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 119.128 1.464 . . . . 72.41 108.122 164.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -77.02 119.85 21.31 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 113.817 -1.538 . . . . 73.42 107.406 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.6 p -125.15 35.33 4.79 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.242 2.217 . . . . 72.01 108.795 -172.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 8.6 t -99.28 -12.09 20.67 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.761 -0.587 . . . . 73.34 112.195 178.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.4 -17.15 3.0 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 118.917 -0.564 . . . . 74.43 111.375 -167.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 5.5 mmt 70.78 -50.2 0.67 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.339 1.856 . . . . 72.14 112.076 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.66 -47.73 71.6 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 120.785 -1.197 . . . . 72.25 107.922 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 78.6 t -60.18 -32.85 51.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 124.792 1.237 . . . . 74.12 110.672 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -63.29 -62.69 1.52 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 118.769 -0.634 . . . . 74.21 109.487 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.4 t -71.69 -25.18 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 119.241 0.928 . . . . 73.43 111.685 -175.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.82 -40.04 82.99 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 111.865 0.32 . . . . 74.32 111.865 172.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -75.82 -21.21 57.53 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 118.042 -0.98 . . . . 72.44 113.147 171.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -67.95 -81.05 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 117.008 -1.472 . . . . 73.35 114.642 174.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . 0.359 . . -44.85 -18.4 0.02 OUTLIER 'General case' 0 CA--C 1.598 2.799 0 C-N-CA 126.672 1.989 . . . . 63.33 109.241 176.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -79.27 -63.98 1.29 Allowed 'General case' 0 C--N 1.382 1.98 0 C-N-CA 128.073 2.549 . . . . 65.45 113.533 169.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.2 t -59.01 -30.31 67.9 Favored 'General case' 0 C--N 1.347 0.488 0 CA-C-O 116.915 -1.517 . . . . 72.42 110.047 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 39.9 t -56.72 -44.23 81.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 120.462 1.483 . . . . 74.14 109.139 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 6.3 ptmt -75.15 -33.32 61.5 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-O 118.268 -0.872 . . . . 74.12 112.208 -177.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -62.36 -37.58 86.23 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 120.404 1.456 . . . . 61.35 112.035 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 77.1 mt -67.41 -20.61 65.55 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 119.069 -1.052 . . . . 74.42 111.808 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.03 -23.79 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 O-C-N 121.694 -0.629 . . . . 74.44 110.521 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -106.37 -2.49 22.14 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.364 0.983 . . . . 73.32 111.146 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -123.45 78.09 1.56 Allowed 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.862 1.265 . . . . 73.22 109.971 -176.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.95 0 CA-C-O 115.702 -2.094 . . . . 74.13 107.176 166.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 113.131 0.789 . . . . 74.13 113.131 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -161.84 119.53 2.22 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 127.16 2.184 . . . . 73.13 105.302 166.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.2 pt -124.45 143.15 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 126.108 1.763 . . . . 73.42 106.546 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.6 m -118.07 139.1 51.71 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.416 -1.328 . . . . 73.34 107.416 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -53.13 118.04 3.46 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.31 2.244 . . . . 70.2 108.724 164.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.27 -6.17 65.85 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 118.22 -1.322 . . . . 73.42 113.346 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.7 tptp -103.66 -85.33 0.46 Allowed 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 119.253 1.527 . . . . 74.24 107.304 177.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -89.45 -20.55 23.76 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 124.219 1.008 . . . . 72.1 110.777 -170.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -140.66 163.81 31.87 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.93 -0.767 . . . . 73.04 108.93 175.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.4 mm -127.84 159.72 38.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 106.006 -1.85 . . . . 70.02 106.006 176.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.6 m -90.53 154.25 19.75 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.498 -1.668 . . . . 74.1 106.498 168.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.8 mt -67.22 152.8 45.08 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.117 -1.068 . . . . 74.14 108.117 163.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -73.64 -28.13 61.62 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.67 -0.493 . . . . 65.34 109.67 171.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -126.37 72.98 72.97 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 126.13 1.772 . . . . 73.03 109.756 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo . . . . . 0 N--CA 1.454 -0.851 0 C-N-CA 124.287 3.325 . . . . 72.24 110.869 177.647 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.448 -0.564 0 N-CA-C 108.129 -1.063 . . . . 70.33 108.129 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.1 tp -161.19 159.04 28.37 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.588 0.708 . . . . 73.41 112.462 172.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -139.83 150.38 44.61 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 127.567 2.347 . . . . 72.04 106.48 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -135.42 133.07 38.25 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.644 1.578 . . . . 73.23 108.536 173.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -156.6 -176.78 6.16 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.477 1.511 . . . . 65.02 110.858 177.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.1 t -135.38 176.43 8.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.665 1.586 . . . . 53.13 109.032 174.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.462 ' CD2' HG21 ' A' ' 95' ' ' VAL 0.278 0.0 OUTLIER -89.46 -7.5 54.92 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.976 1.102 . . . . 73.42 113.976 164.729 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.427 ' CE2' ' HA3' ' A' ' 65' ' ' GLY . 51.4 m-85 -103.24 0.72 32.0 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 120.146 1.339 . . . . 73.23 112.728 173.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.2 p -78.04 140.57 62.09 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 121.437 1.926 . . . . 74.12 108.857 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -91.45 -25.77 0.3 Allowed 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 120.869 1.046 . . . . 70.1 112.668 -176.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -57.77 -57.39 12.96 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 119.022 0.828 . . . . 74.33 109.813 166.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 24.9 p -65.02 -23.73 67.29 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.448 -0.796 . . . . 73.43 111.648 -170.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -58.07 -54.47 46.54 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 118.883 0.765 . . . . 72.32 110.534 169.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.71 -45.81 77.81 Favored 'General case' 0 C--O 1.221 -0.423 0 N-CA-C 107.894 -1.15 . . . . 71.14 107.894 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -66.26 -10.45 42.34 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 115.647 -2.121 . . . . 64.42 113.858 -176.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -132.19 -2.45 3.55 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 122.044 2.202 . . . . 74.43 112.445 -173.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -133.04 -20.23 2.19 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.432 1.093 . . . . 72.2 112.426 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.0 t -121.35 -76.2 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 107.183 -1.414 . . . . 74.43 107.183 -173.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.1 mt -73.99 -18.2 60.9 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.116 2.166 . . . . 71.14 113.022 -177.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 54.5 m-70 43.75 53.87 5.86 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.291 1.836 . . . . 73.41 112.818 172.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 86.1 t -62.68 -51.23 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 116.997 -1.478 . . . . 74.22 109.895 -172.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.1 t -45.41 -52.35 10.16 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.061 1.345 . . . . 65.43 110.143 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -63.77 -40.1 95.86 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.246 1.018 . . . . 61.31 110.691 -177.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.81 -35.33 74.74 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.542 1.137 . . . . 63.33 113.156 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.9 t -67.53 -50.33 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 106.682 -1.599 . . . . 71.42 106.682 174.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 38.3 ttt-85 -47.47 -46.9 27.31 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.413 1.085 . . . . 73.14 111.608 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -60.31 -13.57 13.63 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.185 1.18 . . . . 74.0 114.185 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -118.37 -8.83 10.49 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.548 1.939 . . . . 73.41 111.507 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.8 mt -76.16 143.83 74.17 Favored Pre-proline 0 C--O 1.237 0.401 0 CA-C-N 119.41 1.005 . . . . 73.1 109.579 -169.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.01 167.35 20.13 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.043 1.829 . . . . 73.14 111.142 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -73.14 68.4 0.98 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.375 1.07 . . . . 73.12 112.176 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.46 -7.06 0.05 OUTLIER Glycine 0 CA--C 1.524 0.635 0 O-C-N 119.748 -1.845 . . . . 65.2 114.773 176.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.47 -45.08 89.34 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.042 1.421 . . . . 72.02 110.998 175.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . 0.294 19.0 ttpt 56.91 151.4 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.79 2.036 . . . . 73.04 111.725 -162.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.42 113.09 16.4 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 120.037 -1.664 . . . . 73.22 107.773 -167.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.92 -177.69 3.22 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.882 1.673 . . . . 70.21 109.347 -174.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -179.23 87.04 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 106.737 -1.579 . . . . 64.33 106.737 -170.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 -95.22 162.74 13.57 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.41 -0.806 . . . . 74.03 109.967 174.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.413 ' CE1' HG21 ' A' ' 72' ' ' THR . 0.1 OUTLIER -100.15 174.39 6.18 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.779 2.031 . . . . 74.2 110.615 -176.724 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.5 m -135.07 145.86 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 120.418 1.463 . . . . 74.14 110.534 164.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -82.42 29.6 0.43 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.468 1.107 . . . . 73.01 111.396 -178.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -134.68 165.91 24.15 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.851 1.66 . . . . 72.1 107.652 -172.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.6 mt 75.79 128.61 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 127.007 2.123 . . . . 72.22 109.766 -172.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.427 ' HA3' ' CE2' ' A' ' 29' ' ' TYR . . . 66.72 171.31 4.46 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 121.944 0.747 . . . . 63.43 112.55 175.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.02 -40.99 1.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 123.069 2.513 . . . . 74.22 112.62 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.4 mt -81.88 16.6 1.79 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.248 1.419 . . . . 74.3 112.356 -174.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.19 -34.64 58.97 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 117.742 -1.588 . . . . 52.32 113.607 -173.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.2 -35.7 55.45 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 120.473 2.136 . . . . 74.32 110.28 176.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.37 -37.96 86.47 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 120.976 -1.078 . . . . 64.22 108.703 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.458 HD22 ' CD2' ' A' ' 28' ' ' PHE . 22.4 mt -53.91 -45.04 71.04 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 123.82 0.848 . . . . 73.5 111.093 169.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.413 HG21 ' CE1' ' A' ' 60' ' ' HIS . 2.6 m -57.12 -51.07 70.76 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 124.348 1.03 . . . . 73.22 109.314 -177.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -63.22 -49.11 75.46 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 118.587 -0.721 . . . . 72.32 109.919 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.22 -37.87 75.68 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 120.416 1.462 . . . . 70.22 114.363 -177.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 10.6 t-105 -61.09 -37.77 83.88 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.633 0.652 . . . . 72.54 111.371 -172.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.72 -34.68 71.62 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 117.832 -1.08 . . . . 71.22 112.373 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.09 -46.76 84.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 120.198 1.363 . . . . 74.2 109.779 171.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.23 -43.28 82.37 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 118.81 -0.614 . . . . 72.51 111.068 -177.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 75.0 mt -60.23 -41.9 88.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.145 0.978 . . . . 74.34 109.784 176.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.94 -48.23 81.33 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.885 0.474 . . . . 70.42 110.175 -173.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 71.7 mt -76.66 -20.89 56.16 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 121.825 -0.547 . . . . 73.23 112.347 174.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.57 70.55 1.13 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 126.937 2.208 . . . . 44.11 110.097 -173.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.6 m -134.18 15.64 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 125.157 1.383 . . . . 70.24 112.804 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -52.43 -48.65 65.65 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.316 1.046 . . . . 74.2 110.66 -178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.48 -7.93 16.75 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.948 1.699 . . . . 71.12 113.304 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -104.21 -19.92 13.97 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 125.124 1.37 . . . . 72.22 111.283 176.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.6 pp -124.04 28.53 2.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 C-N-CA 125.838 1.655 . . . . 74.43 110.416 -172.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 43.1 m -93.96 -51.15 4.99 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.742 -0.836 . . . . 70.33 108.742 165.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.66 -65.81 1.62 Allowed Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 124.007 0.923 . . . . 71.44 112.006 -171.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -66.13 -26.28 50.16 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 121.161 1.241 . . . . 72.21 111.556 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 24.0 tpp -61.76 -50.21 73.29 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.691 -0.855 . . . . 74.53 108.691 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -67.88 -35.13 77.98 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 123.974 0.91 . . . . 70.21 109.685 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -56.47 -45.31 80.97 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.599 0.636 . . . . 65.5 109.615 171.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.28 -1.76 42.24 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 120.727 -1.233 . . . . 72.13 112.993 -174.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.462 HG21 ' CD2' ' A' ' 28' ' ' PHE . 61.2 t -119.26 -33.74 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 C-N-CA 124.614 1.165 . . . . 73.03 110.949 -174.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -113.79 -52.92 2.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.105 1.362 . . . . 74.13 108.725 -173.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -71.99 -51.97 19.33 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 118.027 0.376 . . . . 74.32 110.338 -173.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.8 p -100.89 -27.04 13.53 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.056 0.942 . . . . 63.13 112.531 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 52.28 32.98 11.76 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.646 2.379 . . . . 74.24 114.979 -177.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 t -74.26 -21.02 59.95 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.749 0.82 . . . . 74.12 112.199 178.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.4 t -65.28 122.97 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 O-C-N 121.568 -0.708 . . . . 72.23 109.197 170.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -149.4 -19.99 0.28 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 114.068 -1.424 . . . . 74.43 111.63 -178.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.04 165.88 24.66 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.152 0.981 . . . . 71.5 109.64 173.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 39.1 t -57.57 -42.18 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.744 1.217 . . . . 53.31 108.388 175.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.02 13.89 0.05 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 128.809 2.843 . . . . 73.54 113.155 174.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -115.47 -48.68 2.78 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.42 1.488 . . . . 63.54 109.196 163.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.4 mt -52.66 -45.2 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.99 1.316 . . . . 65.42 110.907 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -22.36 65.72 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.651 0.982 . . . . 74.2 113.651 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -56.05 -56.02 25.9 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.981 1.264 . . . . 74.14 110.11 171.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 39.7 t -62.45 -34.55 65.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.83 -0.623 . . . . 74.53 110.789 -171.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -53.19 -58.6 6.5 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.716 -0.846 . . . . 73.24 108.716 171.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.1 t -65.71 -37.51 80.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 119.364 -0.35 . . . . 73.44 111.124 -173.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -60.84 -48.4 82.0 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.679 -0.86 . . . . 73.1 108.679 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.82 -0.39 7.11 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.612 1.565 . . . . 70.42 112.565 177.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.27 58.58 1.14 Allowed Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 124.428 1.013 . . . . 73.21 111.846 172.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.3 t -118.54 149.27 21.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 124.143 0.977 . . . . 70.23 109.832 169.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt -67.34 120.5 13.95 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.413 1.085 . . . . 74.44 110.49 168.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.68 -31.04 78.67 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-O 118.37 -1.239 . . . . 72.42 111.239 170.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -66.72 -36.58 82.82 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.846 1.323 . . . . 74.42 110.194 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -73.32 -42.49 62.28 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 106.766 -1.568 . . . . 73.44 106.766 -174.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -58.45 -55.43 35.07 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.996 0.903 . . . . 74.53 109.202 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -70.27 -12.61 61.71 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.004 0.922 . . . . 45.3 112.856 -173.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.98 -64.91 1.01 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.23 1.412 . . . . 61.12 109.946 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.64 -36.56 64.68 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.652 1.581 . . . . 63.32 111.491 -170.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 44.0 t-105 -45.14 -45.9 11.64 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.998 1.319 . . . . 73.5 112.067 176.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -102.35 11.22 38.4 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.206 1.402 . . . . 74.14 112.144 -177.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 7.0 t -99.27 163.79 12.4 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.281 1.832 . . . . 75.3 111.527 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -60.72 -28.31 68.58 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 128.177 2.591 . . . . 71.4 112.553 173.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 23.6 t -50.99 -53.28 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 122.78 1.276 . . . . 74.12 109.256 177.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.3 t -70.04 -32.51 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 114.923 -1.035 . . . . 74.22 110.624 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -56.47 -59.35 5.11 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.896 1.225 . . . . 74.5 110.045 176.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.0 m -68.45 -20.3 64.62 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.995 0.739 . . . . 74.23 112.995 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 26.2 mt -87.98 -33.48 18.39 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 113.642 0.979 . . . . 73.3 113.642 177.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 41.4 t -59.13 -52.77 56.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 107.064 -1.458 . . . . 73.32 107.064 165.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -46.67 -51.41 16.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.679 1.592 . . . . 63.5 112.893 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -58.04 -28.94 64.94 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.129 0.49 . . . . 75.12 112.017 -169.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -97.09 -47.56 5.73 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 128.095 2.558 . . . . 65.43 111.753 -176.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -62.89 -38.7 91.93 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 118.537 0.608 . . . . 74.44 109.653 -177.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -51.36 -45.7 62.48 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.486 1.114 . . . . 62.13 110.272 172.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.11 -52.97 35.29 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 124.392 1.058 . . . . 65.3 109.677 -175.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.29 -43.16 70.84 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.913 0.485 . . . . 74.32 111.42 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.16 7.51 9.15 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.218 1.807 . . . . 64.2 112.686 -177.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -86.18 -8.75 57.59 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.175 -0.953 . . . . 72.23 111.431 169.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 11.9 mt 68.43 58.53 0.42 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.921 1.344 . . . . 74.02 110.908 160.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.502 ' NE2' ' H ' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -144.38 -34.86 0.36 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.646 1.178 . . . . 51.52 112.094 -173.337 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.502 ' H ' ' NE2' ' A' ' 145' ' ' GLN . 2.3 tp -79.12 -85.09 0.08 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 125.437 1.495 . . . . 72.23 109.244 178.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 51.03 37.49 17.97 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.445 1.098 . . . . 74.12 111.852 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.63 132.77 3.29 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 107.803 -2.119 . . . . 65.13 107.803 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.13 160.45 64.17 Favored Pre-proline 0 C--O 1.241 0.632 0 N-CA-C 108.509 -0.923 . . . . 73.22 108.509 171.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -74.21 142.52 75.0 Favored 'Cis proline' 0 N--CA 1.46 -0.494 0 C-N-CA 125.356 -0.685 . . . . 63.23 111.975 -10.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -126.25 138.7 53.64 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 125.516 1.526 . . . . 63.22 108.621 -175.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 34.5 mtp -140.12 108.61 5.87 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 106.471 -1.677 . . . . 73.14 106.471 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -81.36 173.04 12.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.857 -0.61 . . . . 72.34 110.232 -175.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.401 ' C ' ' H ' ' A' ' 156' ' ' GLY . 59.3 t -133.36 -86.05 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 CA-C-O 119.034 -0.508 . . . . 73.4 110.47 160.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -84.57 30.86 0.54 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.859 1.209 . . . . 72.3 110.379 -167.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 154' ' ' VAL . . . 68.53 -68.0 0.4 Allowed Glycine 0 C--O 1.22 -0.74 0 C-N-CA 127.882 2.658 . . . . 71.4 109.201 -164.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.407 ' HE2' ' CZ ' ' A' ' 158' ' ' TYR . 36.5 pttt -60.44 -0.7 0.27 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 115.432 1.641 . . . . 72.01 115.432 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.407 ' CZ ' ' HE2' ' A' ' 157' ' ' LYS . 18.0 m-85 -121.68 139.31 53.72 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 120.473 1.488 . . . . 65.12 111.972 -177.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -118.86 132.36 56.1 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.471 2.308 . . . . 74.23 106.378 174.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -67.95 143.76 55.49 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.598 -0.89 . . . . 70.42 108.598 175.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -117.56 83.92 18.14 Favored Pre-proline 0 C--O 1.236 0.385 0 N-CA-C 112.406 0.521 . . . . 73.2 112.406 -174.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.405 ' HA ' ' SD ' ' A' ' 165' ' ' MET . 45.7 Cg_endo -62.92 -28.87 75.55 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 120.297 0.665 . . . . 72.13 112.102 179.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -64.16 -7.25 8.43 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 116.756 2.132 . . . . 72.21 116.756 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -107.69 -3.88 34.52 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-N 119.733 1.151 . . . . 52.12 113.776 170.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.405 ' SD ' ' HA ' ' A' ' 162' ' ' PRO . 1.1 mtt -85.82 166.37 16.09 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 119.952 1.876 . . . . 73.4 109.399 -174.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -79.32 65.83 4.61 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 122.674 1.226 . . . . 73.32 111.25 -172.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 41.6 p -67.04 3.57 1.09 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.59 1.956 . . . . 65.24 112.654 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 6.1 t -73.22 -18.63 61.22 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 119.799 1.182 . . . . 74.41 111.827 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.85 -11.74 8.11 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 117.557 -1.211 . . . . 74.02 114.043 -170.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 3.6 mmt 68.98 -63.36 0.37 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.483 1.913 . . . . 73.41 111.809 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.27 -31.07 71.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.767 1.27 . . . . 73.2 110.389 -170.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 76.0 t -75.71 -33.47 26.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 124.546 1.138 . . . . 74.32 111.133 173.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -60.27 -56.88 16.13 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.614 -0.884 . . . . 72.4 108.614 -176.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.0 t -65.01 -35.47 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 109.981 -0.377 . . . . 74.21 109.981 -175.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.09 -27.34 68.29 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.2 1.0 . . . . 74.01 112.301 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -93.92 -33.34 13.53 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.148 0.885 . . . . 72.2 112.105 171.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -56.34 -58.05 9.67 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 124.214 1.006 . . . . 72.22 110.277 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.01 -22.27 62.37 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.162 0.585 . . . . 72.04 112.433 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -70.97 -61.65 1.69 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.446 1.098 . . . . 71.22 109.54 178.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.1 t -61.71 -21.11 64.21 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 118.026 -0.988 . . . . 74.1 112.262 -174.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 57.3 t -56.58 -57.14 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 119.364 0.984 . . . . 74.12 108.667 169.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -56.8 -43.93 81.43 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.771 0.828 . . . . 71.13 109.578 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -61.55 -34.03 74.87 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 123.3 0.64 . . . . 65.12 111.318 -171.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 58.4 mt -79.78 -21.89 43.82 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 121.322 -0.861 . . . . 74.2 112.687 -178.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 72.3 t -61.46 -31.38 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 108.78 -0.822 . . . . 73.31 108.78 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -98.04 -14.53 20.47 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.14 0.976 . . . . 71.2 111.149 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -112.52 63.75 0.63 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.695 1.198 . . . . 74.13 111.198 -174.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt . . . . . 0 C--O 1.248 0.987 0 CA-C-O 119.094 -0.479 . . . . 72.04 110.098 160.605 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.394 0 N-CA-C 115.161 1.541 . . . . 73.31 115.161 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -161.57 117.32 2.09 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 107.097 -1.446 . . . . 74.45 107.097 -173.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.4 pt -126.41 150.84 32.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 126.174 1.79 . . . . 72.24 109.671 -172.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.9 m -132.14 133.93 44.84 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 105.965 -1.865 . . . . 74.25 105.965 176.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -59.85 144.14 49.45 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.49 1.516 . . . . 73.25 108.913 169.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.9 4.89 73.27 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 118.363 -1.243 . . . . 52.35 112.662 -174.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -129.28 -70.07 0.67 Allowed 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 119.308 1.554 . . . . 73.43 113.497 -176.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -101.17 -27.52 13.18 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.161 -0.681 . . . . 74.0 109.161 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -132.46 170.89 14.49 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 122.563 0.345 . . . . 75.25 110.505 171.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.72 147.82 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 105.535 -2.024 . . . . 72.44 105.535 177.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.09 169.89 17.2 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.733 -1.21 . . . . 73.03 107.733 163.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 36.2 mt -110.26 150.15 29.13 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.795 -1.557 . . . . 63.35 106.795 168.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -75.83 -30.96 59.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.101 0.477 . . . . 75.34 111.216 -174.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.5 mmmt -126.84 76.51 75.25 Favored Pre-proline 0 N--CA 1.464 0.245 0 C-N-CA 124.298 1.039 . . . . 74.34 108.535 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo . . . . . 0 N--CA 1.453 -0.867 0 C-N-CA 124.14 3.227 . . . . 64.33 111.157 -175.997 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.274 1.4 p . . . . . 0 CA--C 1.539 0.544 0 N-CA-C 115.387 1.625 . . . . 74.12 115.387 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -160.17 165.37 31.73 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 120.625 -1.297 . . . . 65.12 110.738 -172.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -137.14 132.85 34.58 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 126.007 1.723 . . . . 73.23 107.48 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -127.41 139.02 53.11 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.466 1.506 . . . . 75.33 109.393 -176.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.67 173.13 11.82 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.354 1.462 . . . . 70.14 109.283 -174.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.75 179.47 6.4 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.404 -0.591 . . . . 63.12 109.404 161.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -100.69 -17.15 17.12 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 123.733 0.813 . . . . 75.23 111.714 -173.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.427 ' CD1' ' HA3' ' A' ' 65' ' ' GLY . 64.3 m-85 -111.87 8.12 20.31 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 127.547 2.339 . . . . 75.12 111.854 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.9 p -88.47 144.5 33.85 Favored Pre-proline 0 N--CA 1.468 0.455 0 O-C-N 120.237 -1.54 . . . . 71.01 111.561 -176.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -73.38 -50.2 0.19 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.708 2.272 . . . . 75.11 112.371 -168.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -56.11 -35.52 67.16 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.239 0.616 . . . . 72.04 110.4 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.9 m -63.26 -32.72 74.2 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 124.184 0.994 . . . . 73.41 111.557 -174.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -57.27 -61.96 2.1 Favored 'General case' 0 C--O 1.216 -0.701 0 C-N-CA 123.535 0.734 . . . . 75.03 110.784 172.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.638 ' HA ' HE21 ' A' ' 35' ' ' GLN . 0.0 OUTLIER -47.45 -53.12 14.99 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 120.263 -1.523 . . . . 75.02 110.633 173.198 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -65.5 -13.74 59.51 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 116.015 -1.945 . . . . 62.21 110.908 -163.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -141.11 20.21 2.27 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.667 1.576 . . . . 71.43 113.53 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -142.26 -28.86 0.6 Allowed 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.222 1.009 . . . . 71.04 113.163 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.0 t -116.18 -44.02 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 105.796 -1.927 . . . . 75.4 105.796 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mp -96.1 -32.89 12.3 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.431 1.892 . . . . 75.43 112.326 -170.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 44.11 60.65 2.67 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.49 1.116 . . . . 72.31 112.272 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.71 -35.52 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 124.651 1.18 . . . . 64.42 109.163 -175.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.4 t -57.82 -51.25 70.35 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.8 1.182 . . . . 74.44 108.794 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -66.1 -47.28 74.72 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 124.494 1.117 . . . . 73.43 110.53 -177.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -58.26 -56.19 25.32 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 125.157 1.383 . . . . 72.13 111.579 -178.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.7 t -67.45 -42.14 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.529 -1.286 . . . . 74.21 107.529 -175.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 61.9 ttt-85 -51.27 -43.26 61.54 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.008 1.276 . . . . 71.41 111.865 174.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -61.71 -13.17 20.64 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.689 1.596 . . . . 74.34 114.778 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -120.58 -11.48 9.06 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.035 1.334 . . . . 74.3 112.912 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.7 mt -69.25 143.91 94.34 Favored Pre-proline 0 C--O 1.239 0.529 0 CA-C-N 119.224 0.92 . . . . 73.22 108.921 -163.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.69 145.98 33.44 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.937 2.424 . . . . 73.22 110.565 176.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.58 76.1 6.21 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.489 -1.232 . . . . 72.11 109.346 -168.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 166.49 -17.41 0.09 OUTLIER Glycine 0 CA--C 1.525 0.676 0 CA-C-O 117.769 -1.573 . . . . 65.42 112.255 -172.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.0 t -45.18 -46.06 11.9 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.372 1.586 . . . . 73.43 113.742 174.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.8 tptt 66.23 147.15 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.942 2.897 . . . . 73.25 112.964 -149.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 3.2 mtm -135.08 137.61 43.04 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 127.159 2.184 . . . . 65.43 108.378 175.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.8 m -146.82 168.15 22.12 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.006 1.323 . . . . 71.04 108.714 -177.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.93 106.74 3.07 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.289 -1.507 . . . . 74.44 109.366 -177.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.9 m-30 -112.23 169.48 8.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.194 1.398 . . . . 73.31 111.886 -176.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.427 ' CE1' HG22 ' A' ' 72' ' ' THR . 0.5 OUTLIER -114.82 173.29 6.55 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.04 1.736 . . . . 75.33 109.686 -177.099 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.3 m -136.78 169.77 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 119.692 1.133 . . . . 71.32 109.591 163.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -125.37 65.0 1.16 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.794 1.637 . . . . 71.04 109.806 -174.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -146.7 -13.29 0.44 Allowed 'General case' 0 C--N 1.328 -0.362 0 O-C-N 120.733 -1.23 . . . . 75.31 113.168 -168.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mt -128.24 125.45 38.96 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 119.972 1.26 . . . . 75.43 108.904 -176.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.427 ' HA3' ' CD1' ' A' ' 29' ' ' TYR . . . 89.06 158.08 33.72 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.442 1.496 . . . . 60.12 110.647 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -64.69 -48.57 3.98 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.415 2.077 . . . . 73.24 110.274 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mt -74.36 10.39 1.31 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.471 1.285 . . . . 75.34 114.471 -175.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.23 -2.46 0.41 Allowed Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.176 1.369 . . . . 73.41 115.751 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -90.87 -42.33 10.68 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 120.172 1.986 . . . . 75.12 112.383 169.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -60.92 -54.73 41.45 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 118.595 0.634 . . . . 72.23 109.826 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.3 mt -55.63 -37.68 68.51 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 124.989 1.43 . . . . 74.14 111.682 -164.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.427 HG22 ' CE1' ' A' ' 60' ' ' HIS . 52.3 m -55.74 -49.58 72.68 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 129.506 3.122 . . . . 71.31 110.716 174.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -65.42 -54.73 24.32 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.466 -0.771 . . . . 71.43 109.248 174.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.8 -36.6 48.36 Favored 'General case' 0 C--O 1.227 -0.097 0 N-CA-C 114.042 1.127 . . . . 64.41 114.042 -177.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 35.7 t-105 -50.3 -41.43 50.91 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.058 1.343 . . . . 73.42 110.394 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.66 -36.57 83.3 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 117.628 -1.177 . . . . 72.23 113.314 179.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.1 t -54.69 -49.28 69.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 120.324 1.42 . . . . 74.01 109.475 169.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.55 -46.2 89.46 Favored 'General case' 0 C--N 1.342 0.242 0 O-C-N 122.007 -0.433 . . . . 65.01 110.495 -175.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 79.4 mt -62.43 -39.52 84.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 123.603 0.761 . . . . 73.42 110.153 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.62 -45.03 85.9 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.076 0.853 . . . . 64.12 110.135 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 89.5 mt -86.96 -11.6 50.09 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 112.945 0.72 . . . . 70.31 112.945 -177.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.77 60.89 6.73 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 126.326 1.917 . . . . 62.12 112.184 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.8 m -134.84 11.74 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.134 0 C-N-CA 125.045 1.338 . . . . 62.44 113.097 -174.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -44.42 -60.71 1.82 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.751 1.62 . . . . 73.03 109.911 175.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.8 -8.06 0.54 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.934 2.093 . . . . 73.13 114.183 176.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -108.2 -29.03 9.14 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.536 1.516 . . . . 74.44 112.311 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.9 pp -100.31 -14.07 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 C-N-CA 123.884 0.874 . . . . 72.42 111.619 -175.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.25 3.2 m -63.31 -41.82 98.98 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 116.868 -1.539 . . . . 74.02 112.319 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -50.76 -64.47 1.31 Allowed Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.477 1.111 . . . . 74.43 112.09 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.07 -20.46 44.18 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 120.508 0.805 . . . . 73.0 112.387 -177.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 6.1 tpp -59.98 -55.17 37.37 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 126.539 1.935 . . . . 72.23 110.576 174.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -69.84 -32.02 70.2 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 121.348 -0.845 . . . . 74.42 110.96 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -60.97 -36.97 80.8 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 117.915 -1.514 . . . . 74.12 108.887 169.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.17 -15.12 56.68 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 120.376 -1.453 . . . . 75.32 112.408 -171.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 99.1 t -116.91 -22.73 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 125.232 1.413 . . . . 75.2 111.635 -171.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -120.55 -50.89 2.19 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.772 1.169 . . . . 74.01 110.582 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.588 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 1.7 mmpt? -72.44 -40.89 66.72 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 113.696 0.999 . . . . 74.31 113.696 -171.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.4 p -112.3 -34.98 5.74 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 124.809 1.318 . . . . 64.43 111.221 178.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 57.62 23.65 9.59 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.662 1.985 . . . . 75.31 113.308 -171.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -66.79 -13.42 61.46 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.927 0.785 . . . . 64.43 112.22 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 27.7 t -64.47 108.73 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 108.44 -0.948 . . . . 74.33 108.44 169.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -135.11 -26.96 1.26 Allowed 'General case' 0 C--O 1.237 0.399 0 CA-C-O 118.558 -0.734 . . . . 73.23 112.618 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.5 m -131.63 169.94 15.46 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 108.63 -0.878 . . . . 63.03 108.63 169.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 87.8 t -55.92 -36.1 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.019 0.928 . . . . 75.13 110.411 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.81 -16.38 16.81 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.504 1.522 . . . . 74.23 114.053 175.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -91.21 -35.12 14.69 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 119.335 0.97 . . . . 74.3 110.142 175.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.2 mt -78.84 -36.79 19.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 121.256 -0.902 . . . . 75.44 109.394 -169.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -54.39 -36.13 63.58 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-O 117.96 -1.019 . . . . 72.42 111.598 169.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -58.43 -51.63 69.01 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 118.853 0.752 . . . . 73.31 109.475 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 18.8 t -49.69 -48.12 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.427 1.091 . . . . 65.4 110.901 -177.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -55.07 -51.85 65.06 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.442 0.697 . . . . 74.13 110.369 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.2 t -69.94 -32.0 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 CA-C-O 119.098 -0.477 . . . . 74.2 110.205 -175.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -65.91 -41.57 91.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 118.593 0.633 . . . . 70.04 110.712 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.33 -43.86 92.67 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.538 -0.542 . . . . 73.42 109.538 171.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 144.35 3.94 0.7 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.519 1.057 . . . . 53.24 114.869 168.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 65.9 t -62.66 136.6 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 118.763 1.282 . . . . 74.14 108.836 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.4 mtmt -62.32 125.0 22.39 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.443 -0.947 . . . . 74.14 108.443 176.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.71 -27.08 69.34 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-O 118.83 -0.983 . . . . 73.44 111.301 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -70.65 -26.46 63.47 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 118.134 0.967 . . . . 71.23 112.373 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -87.42 -38.65 15.94 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.667 1.987 . . . . 73.13 107.565 -168.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -60.05 -56.05 26.39 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.482 1.513 . . . . 74.22 109.148 166.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -72.04 -8.01 52.11 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.139 0.792 . . . . 61.31 113.139 -173.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -85.89 -61.83 1.66 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.529 1.132 . . . . 74.3 109.598 164.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.09 -37.83 67.31 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 123.435 0.694 . . . . 63.11 112.636 -172.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -49.64 -38.66 33.17 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.097 0.959 . . . . 74.32 111.658 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.56 -11.15 40.91 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 120.487 -1.383 . . . . 73.23 113.965 177.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.7 t -77.07 155.22 32.63 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 126.835 2.054 . . . . 74.41 112.263 -169.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -66.29 -26.17 67.2 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.582 1.553 . . . . 74.02 111.274 175.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 68.0 t -50.04 -52.78 13.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 124.142 0.977 . . . . 63.4 109.19 172.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.2 t -69.45 -42.75 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 C-N-CA 123.383 0.673 . . . . 65.34 110.084 -177.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -51.44 -52.53 45.51 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.172 0.896 . . . . 65.1 111.256 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 36.1 t -63.22 -42.68 99.3 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 123.337 0.655 . . . . 61.4 109.714 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.0 mt -60.35 -52.07 66.84 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-O 118.256 -0.878 . . . . 74.1 109.957 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 95.1 t -51.13 -44.18 28.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 118.964 0.802 . . . . 71.2 108.953 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.41 -28.97 70.34 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 114.282 1.216 . . . . 70.04 114.282 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -63.42 -47.67 81.0 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 121.146 -0.971 . . . . 74.3 110.352 177.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -78.52 -41.11 33.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 124.189 0.931 . . . . 73.12 110.95 -178.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -54.43 -46.78 73.3 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.385 0.993 . . . . 74.11 108.603 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -63.0 -45.87 90.37 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.517 0.727 . . . . 74.04 112.565 175.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.7 -49.92 74.53 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.707 0.685 . . . . 64.35 109.52 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.73 -30.17 71.22 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.136 -1.603 . . . . 75.43 110.895 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -76.57 -8.04 56.4 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.263 0.938 . . . . 71.42 113.405 173.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.68 -18.49 62.17 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 120.728 -1.232 . . . . 73.22 109.743 162.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 11.6 mt 75.42 -8.36 1.6 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 128.154 2.582 . . . . 73.12 112.394 171.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.451 HE21 ' N ' ' A' ' 146' ' ' LEU . 0.0 OUTLIER -64.13 -0.61 1.24 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.126 2.57 . . . . 75.04 115.008 -176.438 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.451 ' N ' HE21 ' A' ' 145' ' ' GLN . 1.2 tt -152.06 119.67 6.07 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 124.323 1.049 . . . . 75.01 108.692 -172.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -146.23 16.91 1.36 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.491 1.116 . . . . 72.33 110.671 -174.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -152.97 97.55 0.17 Allowed Glycine 0 C--N 1.34 0.798 0 O-C-N 121.084 -1.01 . . . . 61.34 111.611 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.4 m -91.03 174.77 4.15 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.153 0.981 . . . . 64.43 110.161 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -64.25 140.94 42.42 Favored 'Cis proline' 0 N--CA 1.456 -0.728 0 N-CA-C 109.218 -1.109 . . . . 62.31 109.218 -19.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -133.8 124.71 27.04 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.264 1.026 . . . . 73.44 108.62 -169.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 28.3 mtp -132.7 107.76 8.6 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.222 1.809 . . . . 75.3 106.471 -168.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -97.56 168.48 10.34 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.302 1.041 . . . . 72.14 109.859 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.0 t -125.35 -37.52 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 118.567 -0.73 . . . . 65.02 112.91 171.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.66 13.85 0.35 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.166 1.543 . . . . 73.15 115.166 -175.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 77.22 2.26 78.09 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 121.621 -0.674 . . . . 73.25 112.617 -175.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -128.11 -4.83 5.59 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 121.333 -1.098 . . . . 75.13 113.803 170.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -133.95 140.29 46.66 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.925 0.89 . . . . 74.45 108.688 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -122.11 154.86 36.81 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.934 1.693 . . . . 75.25 106.546 168.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -76.16 157.4 32.79 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.144 -0.973 . . . . 75.23 108.764 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.25 66.36 1.55 Allowed Pre-proline 0 N--CA 1.468 0.434 0 C-N-CA 123.371 0.668 . . . . 75.14 110.176 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -55.47 -36.62 94.54 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.707 1.605 . . . . 75.04 111.302 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -79.17 24.73 0.32 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.99 0.916 . . . . 63.22 112.921 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -136.13 7.55 4.08 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 121.12 -0.987 . . . . 54.41 113.043 161.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 12.6 mtt -92.25 158.84 15.91 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 119.161 1.48 . . . . 55.4 110.628 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.412 ' HB3' HE22 ' A' ' 176' ' ' GLN . 10.4 t0 -62.72 106.01 0.73 Allowed 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.735 1.214 . . . . 75.42 109.935 176.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 24.2 p -106.48 28.84 7.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.008 1.323 . . . . 75.23 110.247 174.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.3 m -72.49 -29.15 63.38 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 120.988 -1.07 . . . . 71.4 111.496 175.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -133.37 -20.45 2.1 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 112.876 0.695 . . . . 75.44 112.876 -171.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 39.5 mmm 74.2 -31.26 0.21 Allowed 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 126.423 1.889 . . . . 71.34 112.118 173.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -70.59 -48.16 56.58 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 120.188 1.358 . . . . 72.32 108.322 174.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 59.5 t -65.04 -29.82 48.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 114.825 -1.08 . . . . 74.33 111.172 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -56.56 -51.56 68.13 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.533 -0.914 . . . . 75.22 108.533 174.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.8 t -68.45 -34.53 66.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 118.477 0.58 . . . . 73.41 111.014 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.79 -28.1 68.51 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.103 0.561 . . . . 74.0 112.06 177.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.412 HE22 ' HB3' ' A' ' 166' ' ' ASP . 31.1 mt-30 -91.47 -31.16 16.09 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.376 1.07 . . . . 73.14 111.988 174.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -63.51 -58.63 6.39 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.925 -1.109 . . . . 73.32 109.778 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -55.55 -27.84 51.31 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.483 1.113 . . . . 64.32 113.808 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -70.7 -57.76 4.35 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.879 -0.513 . . . . 72.01 110.373 173.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 t -66.9 -30.12 70.19 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.43 -0.582 . . . . 71.22 109.43 -169.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 78.1 t -55.74 -56.54 11.84 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 N-CA-C 108.948 -0.76 . . . . 72.04 108.948 170.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -64.14 -39.23 93.59 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-O 119.015 -0.517 . . . . 73.03 111.315 -172.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -52.53 -33.0 43.38 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 122.75 0.42 . . . . 73.32 112.091 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 80.5 mt -81.19 -16.57 52.45 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 120.756 -1.215 . . . . 70.21 113.065 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 91.6 t -69.44 -20.31 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 120.997 -1.064 . . . . 70.21 110.288 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -105.96 -21.17 13.21 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.273 -0.892 . . . . 74.32 109.566 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 35.2 mttt -105.05 74.42 1.11 Allowed 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 125.954 1.702 . . . . 74.13 109.884 -171.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 33.4 tttt . . . . . 0 N--CA 1.432 -1.372 0 C-N-CA 126.879 2.072 . . . . 71.15 107.665 176.261 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.293 0 CA-C-O 121.723 0.773 . . . . 75.41 112.799 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -157.23 122.53 4.59 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 104.884 -2.265 . . . . 73.0 104.884 -178.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.5 pt -127.14 152.29 34.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 128.303 2.641 . . . . 75.34 107.203 175.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.2 m -121.3 137.31 54.75 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.081 1.352 . . . . 75.34 107.399 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -57.59 152.09 15.72 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.267 1.427 . . . . 62.3 110.224 166.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.48 -31.56 0.84 Allowed Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.415 1.007 . . . . 73.13 112.693 -171.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -87.33 -71.39 0.56 Allowed 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 106.725 -1.583 . . . . 72.32 106.725 -164.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -123.67 -14.03 7.36 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.081 1.752 . . . . 74.22 110.016 -165.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -138.74 168.72 19.19 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.948 -0.47 . . . . 73.22 110.512 155.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.1 mm -125.79 158.35 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 127.955 2.502 . . . . 74.03 106.046 172.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.53 172.81 8.04 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.476 1.51 . . . . 64.24 108.813 178.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.9 mt -124.11 135.1 53.29 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 119.603 1.092 . . . . 73.41 108.784 162.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -66.33 -38.42 87.63 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 129.377 3.071 . . . . 64.31 110.343 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.22 64.81 7.5 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 125.483 1.513 . . . . 73.32 110.362 -177.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo . . . . . 0 N--CA 1.446 -1.271 0 C-N-CA 123.335 2.69 . . . . 74.3 113.626 -175.777 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.237 0.425 0 N-CA-C 107.129 -1.434 . . . . 74.21 107.129 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -165.28 161.28 19.07 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.812 0.845 . . . . 74.13 110.467 171.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -139.26 147.02 41.14 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.756 1.222 . . . . 72.34 110.013 174.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -127.22 145.94 50.59 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.397 1.079 . . . . 73.32 109.788 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -161.16 174.82 13.11 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.167 1.387 . . . . 74.33 109.314 177.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.3 t -129.79 179.62 5.74 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.998 1.319 . . . . 72.33 109.22 173.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -94.28 -21.66 18.87 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 128.007 2.523 . . . . 75.32 111.377 176.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.463 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 49.7 m-85 -104.35 9.72 35.71 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.697 1.599 . . . . 73.54 114.642 177.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.5 p -88.42 143.24 32.09 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 121.047 1.749 . . . . 74.5 111.014 175.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -80.44 -43.51 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 120.936 1.091 . . . . 74.51 112.352 -171.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -53.84 -44.81 70.62 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 118.447 0.567 . . . . 73.14 109.708 175.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.5 m -52.54 -42.47 64.43 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 125.092 1.357 . . . . 54.41 111.557 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -61.24 -52.09 66.21 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 110.114 -0.328 . . . . 75.23 110.114 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.22 -45.68 87.25 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.515 -0.92 . . . . 70.11 108.515 177.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -67.77 -6.26 20.29 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 116.319 -1.8 . . . . 73.33 113.691 -177.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -134.44 -1.02 2.88 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 121.901 2.137 . . . . 54.31 113.219 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -136.14 -12.51 1.9 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.854 1.262 . . . . 72.21 112.746 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.8 t -126.96 -79.89 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.089 0 N-CA-C 107.052 -1.462 . . . . 64.23 107.052 -176.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.6 mt -65.63 -24.78 67.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.287 2.235 . . . . 73.3 111.993 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 44.36 48.13 8.06 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.99 1.716 . . . . 74.03 111.817 176.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.7 t -54.44 -49.56 64.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.361 0 C-N-CA 125.01 1.324 . . . . 74.21 110.184 -174.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.1 t -48.95 -49.95 37.92 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.4 1.48 . . . . 72.44 110.839 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -73.29 -36.45 66.3 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.654 0.782 . . . . 60.34 112.078 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -57.87 -49.61 76.11 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.486 0.715 . . . . 71.24 109.65 172.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 t -59.02 -49.06 84.6 Favored 'Isoleucine or valine' 0 C--N 1.343 0.313 0 CA-C-N 119.024 0.829 . . . . 73.14 108.874 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.1 ptt180 -61.3 -26.67 67.94 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 121.741 -0.6 . . . . 74.31 112.443 -169.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -64.28 -15.57 60.45 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.391 0.886 . . . . 71.33 113.391 174.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -126.51 -6.13 6.41 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.956 1.702 . . . . 72.44 112.17 -170.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.5 mt -70.08 144.27 92.5 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-O 118.904 -0.57 . . . . 74.04 110.988 -169.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.88 153.25 42.25 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.043 2.495 . . . . 72.2 111.295 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -79.24 81.59 5.49 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.834 0.826 . . . . 75.34 109.072 -172.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 166.64 -23.62 0.13 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.11 1.338 . . . . 73.34 113.891 -177.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.8 t -48.35 -46.79 37.17 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 118.926 1.363 . . . . 75.12 113.991 177.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? 60.01 124.47 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.407 2.283 . . . . 75.32 111.867 -170.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.6 ttm -75.48 102.06 5.07 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 106.286 -1.746 . . . . 73.43 106.286 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.1 m -129.66 101.39 5.89 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 107.649 -1.241 . . . . 62.11 107.649 -167.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.64 105.63 9.88 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.821 1.248 . . . . 72.1 108.151 -162.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -94.86 152.69 18.18 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.185 0.517 . . . . 75.22 109.974 175.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.575 ' HD1' ' HB3' ' A' ' 75' ' ' TRP . 1.6 p-80 -81.62 176.09 9.94 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.513 1.525 . . . . 72.04 108.761 172.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.5 m -145.18 152.09 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 107.659 -1.237 . . . . 73.32 107.659 158.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.449 ' C ' ' H ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER -101.0 -14.7 17.74 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.23 1.012 . . . . 73.14 112.755 -172.09 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -57.8 5.66 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 129.144 2.978 . . . . 74.31 114.719 -177.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.449 ' H ' ' C ' ' A' ' 62' ' ' GLU . 30.5 mt -145.47 110.16 5.08 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 126.763 2.025 . . . . 65.51 106.963 -164.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.463 ' HA3' ' CD2' ' A' ' 29' ' ' TYR . . . 100.85 154.62 26.98 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 126.692 2.091 . . . . 45.41 110.75 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.56 -44.4 0.52 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 121.788 1.658 . . . . 73.44 110.093 173.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.1 mt -83.26 24.28 0.82 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.782 0.833 . . . . 74.11 111.151 174.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -50.78 -46.46 48.26 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.427 1.013 . . . . 72.23 111.191 176.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -58.75 -47.74 83.59 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.923 0.889 . . . . 70.34 111.689 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.68 -44.12 97.08 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.696 1.598 . . . . 62.42 108.509 -174.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.6 mt -61.86 -44.45 96.8 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.464 1.106 . . . . 73.01 111.019 174.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 82.6 m -58.14 -48.89 78.86 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.71 1.604 . . . . 74.23 110.937 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -62.59 -42.86 99.82 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 120.906 -1.121 . . . . 75.35 109.877 175.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.83 -35.74 75.36 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 120.663 -1.273 . . . . 72.05 112.569 178.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.575 ' HB3' ' HD1' ' A' ' 60' ' ' HIS . 52.9 t-105 -55.09 -34.62 63.8 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.228 1.011 . . . . 75.25 111.08 -178.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.12 -36.73 83.93 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 118.382 -0.818 . . . . 62.04 111.481 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.7 t -56.92 -47.31 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 119.445 1.02 . . . . 75.44 109.309 172.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.51 -26.75 61.02 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 117.238 -1.363 . . . . 71.34 112.748 -175.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.12 -42.46 79.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 120.952 1.706 . . . . 75.43 108.937 167.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.04 -40.26 84.52 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.423 1.01 . . . . 75.42 110.771 -176.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.2 mt -87.56 -14.59 39.79 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.127 0.417 . . . . 75.45 112.127 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.98 67.03 2.25 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 126.563 2.03 . . . . 75.21 111.089 -176.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.5 m -136.86 17.07 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.628 1.171 . . . . 74.45 112.51 -176.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -49.29 -50.46 39.12 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.026 1.73 . . . . 73.42 111.772 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -80.09 5.77 13.36 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.677 1.591 . . . . 64.1 111.037 -176.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.8 mtpp -104.5 -20.29 13.74 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.604 1.562 . . . . 74.43 110.527 170.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.1 pp -119.25 13.08 6.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 C-N-CA 124.245 1.018 . . . . 74.45 111.487 -170.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.2 m -86.97 -42.22 13.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 119.542 1.065 . . . . 74.44 111.087 175.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.14 -64.25 2.26 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 118.906 0.776 . . . . 75.11 111.581 -177.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -69.61 -27.75 26.81 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.428 1.419 . . . . 75.01 111.467 -171.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 23.0 tpp -56.16 -49.26 74.48 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.169 0.988 . . . . 71.3 109.038 175.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -73.7 -31.7 63.55 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 118.43 -0.795 . . . . 75.32 110.008 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -60.15 -33.73 72.57 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 119.143 0.883 . . . . 73.2 110.977 170.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -99.45 -12.4 20.25 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.871 1.214 . . . . 62.1 113.438 -174.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.7 t -97.52 -45.52 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.308 1.043 . . . . 72.23 109.216 177.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -98.07 -63.78 1.1 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.886 0.875 . . . . 74.04 109.576 -176.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -63.62 -59.18 4.94 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 119.188 0.904 . . . . 74.1 111.116 -166.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.5 p -95.6 -16.43 22.1 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.884 0.698 . . . . 73.14 112.884 -176.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 55.31 22.57 4.93 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.151 1.381 . . . . 73.41 113.806 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.1 t -68.39 -14.54 63.07 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.4 1.48 . . . . 70.31 112.143 -178.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 38.6 t -66.79 110.84 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 O-C-N 120.52 -1.362 . . . . 64.25 109.094 171.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -139.28 -23.21 0.9 Allowed 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.914 1.686 . . . . 71.42 111.616 -172.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 t -151.44 179.95 7.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.007 -1.058 . . . . 63.51 109.394 159.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.3 t -54.58 -34.34 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 124.664 1.185 . . . . 72.33 110.064 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.38 -23.86 17.31 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.867 1.667 . . . . 63.32 113.04 176.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -94.08 -37.66 11.51 Favored 'General case' 0 CA--C 1.518 -0.266 0 O-C-N 121.33 -0.856 . . . . 75.05 108.998 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.8 mt -65.4 -47.23 87.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 125.152 1.381 . . . . 71.43 108.096 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -62.51 -26.16 68.4 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.019 0.748 . . . . 74.24 113.019 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -65.08 -51.81 59.27 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 109.577 -0.527 . . . . 71.45 109.577 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.2 t -55.83 -41.7 67.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 123.549 0.53 . . . . 75.4 111.062 -176.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -54.11 -54.4 40.03 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.496 -0.557 . . . . 64.42 109.496 175.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 54.4 t -58.67 -47.34 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 C-N-CA 123.036 0.534 . . . . 75.03 110.436 -177.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -70.25 -37.91 75.02 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.437 -0.949 . . . . 74.32 108.437 -166.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.89 -9.9 59.21 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.607 1.163 . . . . 75.34 112.354 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 118.4 36.37 0.93 Allowed Glycine 0 C--N 1.336 0.577 0 CA-C-O 117.793 -1.56 . . . . 74.24 115.08 168.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 99.5 t -102.61 144.81 13.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 119.648 1.724 . . . . 62.22 109.204 172.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.504 ' HG3' ' H ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -67.53 133.14 48.92 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.53 -0.759 . . . . 75.32 110.23 171.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.42 -21.91 69.01 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-O 118.903 -0.943 . . . . 71.35 111.736 172.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -73.22 -49.8 25.93 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 118.147 -0.93 . . . . 73.02 111.917 175.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.504 ' H ' ' HG3' ' A' ' 117' ' ' LYS . 33.3 t70 -66.07 -40.67 91.05 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.181 -1.414 . . . . 75.41 107.181 -178.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -59.29 -51.38 70.19 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 123.907 0.754 . . . . 72.25 110.105 -174.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -77.88 -12.83 60.02 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 113.002 0.741 . . . . 73.32 113.002 -175.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.43 -61.7 1.46 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.979 1.312 . . . . 75.23 110.387 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.79 -34.22 58.41 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.57 1.548 . . . . 74.21 110.934 -177.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 61.7 t-105 -45.54 -37.02 5.0 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.017 1.727 . . . . 73.01 112.934 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -113.21 2.54 15.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.935 1.294 . . . . 75.02 113.162 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 10.0 t -77.34 156.0 31.58 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.441 1.097 . . . . 73.11 109.887 173.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -58.88 -30.86 68.07 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.448 1.499 . . . . 74.32 111.941 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 84.9 t -54.33 -48.54 67.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 O-C-N 121.606 -0.683 . . . . 74.41 109.391 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.4 t -65.32 -43.47 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-O 119.08 -0.486 . . . . 74.41 110.504 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -53.4 -51.55 62.19 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.68 0.673 . . . . 74.35 111.51 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.0 t -69.63 -38.15 77.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 117.863 -1.065 . . . . 62.41 110.285 -177.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.1 mt -58.92 -56.4 22.78 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 117.453 -1.26 . . . . 75.42 110.429 176.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 37.6 t -45.41 -46.72 4.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.245 0 C-N-CA 124.533 1.133 . . . . 71.22 109.98 174.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.02 -35.13 70.83 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 113.038 0.755 . . . . 63.31 113.038 -176.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -61.53 -38.37 87.16 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.048 0.539 . . . . 75.34 110.755 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 10.0 mp0 -85.9 -50.28 7.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.254 1.022 . . . . 75.11 110.746 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -52.72 -44.94 66.71 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.057 0.844 . . . . 75.04 109.69 -176.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -60.89 -61.89 2.26 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.092 0.472 . . . . 72.33 109.878 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.55 1.55 3.04 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.792 1.405 . . . . 74.35 114.792 -173.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -129.88 6.12 5.05 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.282 1.433 . . . . 74.23 112.279 174.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -120.81 -6.25 9.62 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 124.714 1.206 . . . . 70.15 113.085 168.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.97 5.06 0.25 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.317 2.247 . . . . 70.43 112.781 175.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 73.25 -5.68 1.9 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 131.682 3.993 . . . . 64.54 114.126 -178.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.76 -15.92 62.19 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 127.964 2.505 . . . . 74.45 113.468 -164.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.4 tp -164.17 125.01 2.17 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 128.16 2.584 . . . . 74.4 105.545 -176.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -142.13 21.95 2.08 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.475 0.655 . . . . 72.44 111.265 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -136.43 158.97 24.28 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 107.498 -2.241 . . . . 73.32 107.498 164.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.46 171.67 7.39 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 107.993 -1.114 . . . . 61.5 107.993 174.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -63.21 156.16 69.21 Favored 'Cis proline' 0 N--CA 1.457 -0.639 0 CA-C-N 120.453 1.197 . . . . 63.33 111.27 -8.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -141.22 144.73 34.9 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.107 0.963 . . . . 71.34 108.766 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 29.2 ttm -151.08 109.94 3.87 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.001 -1.481 . . . . 75.4 107.001 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -93.15 156.23 16.98 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.595 -0.73 . . . . 75.12 109.31 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.6 t -139.48 140.0 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.614 -0.884 . . . . 75.32 108.614 175.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 45.78 28.84 0.61 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.967 2.507 . . . . 74.41 114.562 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 63.53 7.39 20.13 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.88 1.705 . . . . 74.41 113.488 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -141.5 -5.39 1.07 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 119.044 1.422 . . . . 75.3 113.648 -165.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -129.45 150.13 50.93 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.38 -0.97 . . . . 74.02 108.38 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.31 123.99 37.65 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 128.401 2.68 . . . . 75.21 107.998 177.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.5 139.73 57.61 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.513 -1.662 . . . . 73.3 106.513 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -114.66 86.09 12.3 Favored Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 123.256 0.622 . . . . 70.4 110.969 174.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.78 -17.9 47.39 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 120.706 0.937 . . . . 73.3 111.705 177.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -78.66 -6.02 54.6 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.09 1.756 . . . . 74.3 112.773 -172.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -130.35 13.46 5.68 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.573 1.082 . . . . 72.44 111.366 177.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 45.3 mtt -85.5 163.19 18.57 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.33 1.065 . . . . 63.1 109.192 170.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.57 108.73 6.59 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.705 -1.591 . . . . 73.32 106.705 170.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 31.9 p -102.1 -6.74 22.95 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 127.016 2.127 . . . . 74.21 110.94 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 46.5 m -61.74 -17.9 57.64 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 125.683 1.593 . . . . 64.3 114.491 -170.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -128.78 -6.3 5.09 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 117.76 -1.114 . . . . 75.33 111.197 -164.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 65.92 -63.73 0.22 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.348 1.859 . . . . 74.21 111.865 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.55 -44.49 94.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 119.114 0.87 . . . . 74.33 108.954 -171.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 91.9 t -62.12 -30.0 47.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 125.084 1.354 . . . . 74.41 111.587 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -66.78 -60.11 2.97 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 107.624 -1.25 . . . . 75.44 107.624 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.2 t -68.04 -35.4 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 O-C-N 123.72 0.637 . . . . 75.21 110.664 -174.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.02 -52.18 63.95 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.491 0.716 . . . . 74.31 109.799 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -72.64 -38.32 67.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.245 -0.883 . . . . 75.01 111.598 177.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -55.46 -58.41 7.88 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.745 1.157 . . . . 73.21 109.714 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.58 -42.07 61.62 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 125.989 1.716 . . . . 71.33 111.514 -176.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -71.44 -51.0 26.29 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.955 0.902 . . . . 63.32 108.935 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 31.1 m -59.81 -26.45 65.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.461 1.105 . . . . 64.1 112.229 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 97.2 t -60.05 -51.43 73.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 108.912 -0.773 . . . . 75.02 108.912 169.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 31.1 tttm -61.35 -44.29 97.42 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 118.008 -0.996 . . . . 75.31 110.986 174.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -57.15 -28.98 63.23 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 119.599 1.091 . . . . 75.01 111.426 -169.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 58.5 mt -81.12 -24.61 37.56 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.874 0.694 . . . . 75.03 112.874 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.47 -28.22 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 O-C-N 121.027 -1.045 . . . . 75.23 110.508 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -89.28 -29.61 19.07 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 122.048 0.928 . . . . 73.04 109.45 178.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 45.6 mttp -95.64 66.42 2.73 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 125.094 1.358 . . . . 72.44 109.051 -176.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? . . . . . 0 C--O 1.247 0.968 0 N-CA-C 107.427 -1.323 . . . . 64.34 107.427 154.207 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 114.023 1.12 . . . . 71.32 114.023 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -157.58 122.98 4.55 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 129.153 2.981 . . . . 71.3 103.533 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.3 pt -127.85 149.59 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 126.735 2.014 . . . . 75.54 108.152 175.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.0 m -132.03 143.33 49.98 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.054 -1.091 . . . . 71.54 108.054 174.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -59.11 151.91 21.45 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.919 1.287 . . . . 64.13 110.151 170.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.86 -25.82 0.78 Allowed Glycine 0 CA--C 1.532 1.125 0 CA-C-O 118.873 -0.96 . . . . 64.34 112.783 -169.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -98.04 -85.61 0.37 Allowed 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 119.246 1.523 . . . . 75.32 107.565 -170.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -90.05 -17.92 26.89 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.505 0.722 . . . . 75.24 111.751 -176.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -140.76 164.91 28.95 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 118.208 0.458 . . . . 74.22 110.245 173.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.2 mm -127.87 163.12 32.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 105.761 -1.941 . . . . 71.14 105.761 173.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.21 164.26 11.74 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 124.998 1.319 . . . . 71.23 110.058 171.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 27.2 mt -79.67 154.53 28.57 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.929 -1.137 . . . . 75.32 107.929 161.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.62 -27.12 51.06 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.809 -0.812 . . . . 73.4 108.809 171.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -121.81 71.34 29.6 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.774 1.629 . . . . 74.24 108.987 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo . . . . . 0 CA--C 1.538 0.69 0 C-N-CA 124.079 3.186 . . . . 74.21 111.579 -177.565 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 N--CA 1.463 0.189 0 CA-C-O 121.653 0.739 . . . . 75.41 109.655 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 tp -150.64 161.83 41.84 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.374 -0.973 . . . . 74.0 108.374 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -146.15 136.58 23.95 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.496 -1.298 . . . . 75.11 107.496 -169.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -137.22 136.27 37.99 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 123.889 0.876 . . . . 73.11 110.505 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.03 171.64 18.75 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.606 1.962 . . . . 64.21 108.177 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.02 153.78 50.56 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 119.031 -0.509 . . . . 73.02 109.898 169.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.415 ' CD2' HG21 ' A' ' 95' ' ' VAL 0.296 0.0 OUTLIER -67.19 -15.61 63.8 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 113.306 0.854 . . . . 75.03 113.306 177.911 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.462 ' CE2' ' HA3' ' A' ' 65' ' ' GLY . 41.6 m-85 -93.45 -0.52 56.4 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.277 0.944 . . . . 74.22 112.248 176.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.9 t -82.05 141.04 46.52 Favored Pre-proline 0 CA--C 1.534 0.36 0 O-C-N 120.592 -1.317 . . . . 63.34 110.446 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -88.78 -37.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 121.769 1.646 . . . . 75.23 112.542 -175.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -62.95 -48.09 80.4 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 124.702 1.201 . . . . 75.13 108.778 176.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 21.0 m -57.44 -30.54 65.09 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.204 -0.907 . . . . 75.2 111.089 -178.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -59.81 -56.94 15.54 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 119.612 1.096 . . . . 75.21 110.109 173.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.93 -42.14 68.49 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.065 -0.717 . . . . 75.03 109.065 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -69.49 -16.18 63.41 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 116.641 -1.647 . . . . 72.03 112.67 -176.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -124.17 -10.44 7.57 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 121.245 1.839 . . . . 74.31 111.9 -172.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -136.97 -11.8 1.72 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.986 1.715 . . . . 74.13 112.972 -170.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.6 t -127.24 -81.76 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 O-C-N 120.315 -1.49 . . . . 75.34 107.718 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.2 mt -56.9 -28.18 61.59 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.498 1.919 . . . . 75.42 111.67 175.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 67.9 m80 44.57 46.51 8.26 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.942 1.697 . . . . 72.43 110.918 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.7 t -51.0 -53.78 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 C-N-CA 126.614 1.966 . . . . 64.3 108.631 -175.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.5 t -45.44 -47.95 13.78 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.644 1.978 . . . . 73.14 111.587 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.64 -18.45 27.94 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.011 -1.055 . . . . 74.42 111.835 -176.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.5 -40.94 93.64 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.208 -0.932 . . . . 74.02 109.582 167.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.9 t -59.61 -46.39 93.23 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 N-CA-C 109.437 -0.579 . . . . 75.44 109.437 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -47.93 -44.48 30.07 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.229 1.012 . . . . 73.3 112.033 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -62.57 -10.62 12.71 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.001 1.482 . . . . 72.24 115.001 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -125.44 -9.03 6.9 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 126.925 2.09 . . . . 73.34 113.199 -174.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.5 mt -72.33 150.43 91.83 Favored Pre-proline 0 C--O 1.234 0.269 0 CA-C-N 119.328 0.967 . . . . 75.43 111.246 -167.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -71.82 156.63 56.59 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.146 1.898 . . . . 72.33 109.402 169.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.28 28.57 0.06 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 126.007 1.723 . . . . 73.2 114.974 -174.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -154.19 21.08 0.66 Allowed Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 124.708 1.147 . . . . 21.05 112.979 -168.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.9 t -89.72 -45.3 9.41 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 117.887 0.843 . . . . 62.02 110.908 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? 55.52 95.55 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 124.155 1.931 . . . . 74.14 110.704 -162.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.8 mtm -62.29 122.84 16.65 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 113.84 -1.527 . . . . 53.14 108.765 169.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.3 m -123.24 179.87 4.55 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.317 -0.994 . . . . 74.02 108.317 174.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -172.35 88.1 0.09 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 106.78 -1.563 . . . . 73.31 106.78 -171.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.494 ' CD2' ' HG3' ' A' ' 137' ' ' GLN . 4.1 m-30 -89.02 176.02 7.17 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.992 1.317 . . . . 75.31 109.299 175.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.586 ' HD1' ' CB ' ' A' ' 75' ' ' TRP . 2.1 p-80 -117.04 175.42 5.6 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.154 1.381 . . . . 75.12 110.081 174.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.8 m -131.24 175.97 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.255 1.422 . . . . 75.24 109.036 169.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.71 59.74 1.72 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.693 2.397 . . . . 72.14 111.134 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -148.33 -163.71 1.84 Allowed 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.237 1.415 . . . . 75.13 109.82 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.8 mt 75.54 -85.03 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 128.616 2.767 . . . . 73.43 109.175 -176.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.462 ' HA3' ' CE2' ' A' ' 29' ' ' TYR . . . -95.32 174.46 32.36 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 125.43 1.491 . . . . 74.05 111.452 -178.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.88 -36.63 30.39 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 124.945 3.763 . . . . 74.41 113.124 -169.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.2 mt -83.68 24.82 0.83 Allowed 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 124.332 1.053 . . . . 75.14 112.721 -174.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -46.28 -51.6 11.53 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-N 118.72 0.691 . . . . 63.41 111.81 179.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -70.76 -6.38 37.13 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.49 1.116 . . . . 74.42 113.596 -177.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -111.44 -24.57 10.09 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.257 1.423 . . . . 73.23 109.389 -177.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.401 HD23 ' CG ' ' A' ' 28' ' ' PHE . 9.5 mt -63.67 -46.97 83.12 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.912 0.885 . . . . 72.43 109.368 165.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -50.86 -52.11 44.82 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.414 1.486 . . . . 71.15 108.75 171.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -62.03 -54.47 41.03 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.551 -0.718 . . . . 73.31 110.5 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.24 -33.38 73.18 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.631 1.105 . . . . 74.45 113.435 -167.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.586 ' CB ' ' HD1' ' A' ' 60' ' ' HIS . 40.5 t-105 -56.73 -38.13 71.95 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 123.1 0.56 . . . . 75.14 110.367 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.27 84.7 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 117.505 -1.236 . . . . 73.45 112.055 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.9 t -56.35 -45.22 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 121.072 1.76 . . . . 71.21 110.986 167.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.37 -45.55 90.65 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 118.094 -0.955 . . . . 74.25 111.073 -177.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 60.2 mt -62.54 -40.44 88.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 124.263 1.025 . . . . 73.24 110.207 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.85 -42.17 83.9 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.758 0.708 . . . . 71.35 110.362 -175.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.5 mt -85.18 -29.92 24.34 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 111.732 0.271 . . . . 75.04 111.732 174.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.74 52.08 3.43 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 126.183 1.849 . . . . 74.24 111.853 -175.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -127.25 21.16 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.761 1.224 . . . . 74.01 111.403 -173.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -53.05 -53.2 53.74 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 123.757 0.823 . . . . 72.02 111.074 -175.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.18 -42.7 77.54 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.224 1.409 . . . . 74.15 109.687 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.7 mtpm? -72.64 -5.23 35.95 Favored 'General case' 0 N--CA 1.46 0.066 0 C-N-CA 125.012 1.325 . . . . 74.34 112.171 -176.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.6 pp -134.1 23.3 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 C-N-CA 125.669 1.587 . . . . 75.32 109.386 173.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 99.5 m -87.53 -57.56 2.9 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.222 -1.399 . . . . 71.41 107.222 168.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.89 -60.15 11.44 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 112.88 0.696 . . . . 62.14 112.88 -164.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.92 -26.61 43.94 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.288 1.325 . . . . 75.31 111.579 -177.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 5.0 ttm -64.92 -43.5 92.59 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.56 0.744 . . . . 71.42 109.258 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -69.69 -40.19 76.5 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.496 1.118 . . . . 72.11 109.473 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.12 -27.25 66.88 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.223 0.465 . . . . 72.25 111.196 172.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -97.59 3.98 50.35 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 120.361 -1.462 . . . . 71.22 113.304 -177.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.415 HG21 ' CD2' ' A' ' 28' ' ' PHE . 65.6 t -119.73 -41.23 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 124.073 0.949 . . . . 73.15 110.067 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -101.4 -51.66 3.43 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 109.404 -0.591 . . . . 61.44 109.404 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -75.35 -60.02 2.49 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.88 -0.6 . . . . 71.35 109.432 -168.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.3 p -98.1 -19.13 18.13 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.775 0.83 . . . . 74.21 112.491 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 64.95 18.51 11.53 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.869 1.668 . . . . 54.12 114.163 166.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.1 t -74.78 -17.39 60.63 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.991 1.317 . . . . 74.15 113.486 -172.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.6 t -66.84 126.58 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.555 -0.716 . . . . 64.45 109.13 167.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -146.1 -25.71 0.44 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.239 1.415 . . . . 75.05 111.075 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.1 t -143.38 175.81 9.63 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.899 0.772 . . . . 75.05 110.25 171.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.4 t -52.39 -44.82 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.932 1.693 . . . . 74.44 110.028 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -52.77 -23.72 7.39 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.712 1.605 . . . . 75.03 112.862 177.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -94.38 -24.72 17.25 Favored 'General case' 0 CA--C 1.523 -0.078 0 CA-C-N 118.972 0.806 . . . . 75.34 111.123 -178.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.4 mt -82.45 -43.28 19.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.594 -0.891 . . . . 75.42 108.594 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -55.15 -31.79 61.59 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 118.534 -0.746 . . . . 74.43 111.479 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -57.51 -61.76 2.26 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.287 1.435 . . . . 73.22 109.85 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.7 t -55.33 -40.07 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 122.767 0.427 . . . . 75.41 110.756 -175.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -53.79 -53.48 51.8 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.472 0.578 . . . . 73.24 110.65 173.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.24 -41.36 91.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 123.876 0.87 . . . . 71.15 109.99 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -67.27 -37.71 83.9 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.678 -0.86 . . . . 73.44 108.678 -170.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.3 -24.71 61.36 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.443 1.097 . . . . 73.31 112.428 175.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.57 56.47 0.35 Allowed Glycine 0 C--N 1.332 0.315 0 N-CA-C 111.242 -0.743 . . . . 64.42 111.242 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.3 t -118.98 126.36 75.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 109.087 -0.708 . . . . 73.05 109.087 166.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -54.13 128.03 29.19 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.212 -0.662 . . . . 75.22 109.212 176.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.41 -21.19 66.34 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-O 117.6 -1.667 . . . . 73.04 110.434 170.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -68.83 -37.57 79.25 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 119.875 1.838 . . . . 75.41 108.826 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.74 -45.51 28.95 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 126.08 1.752 . . . . 72.23 107.164 -171.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -55.93 -57.4 12.27 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 109.501 -0.555 . . . . 72.44 109.501 174.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -66.23 -28.8 69.01 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 119.314 -0.374 . . . . 72.04 111.145 -172.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.27 -64.05 1.1 Allowed 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.859 0.864 . . . . 71.13 110.587 174.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.99 -36.37 65.33 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.585 1.154 . . . . 72.25 110.572 -171.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 59.9 t-105 -45.62 -42.83 11.78 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.744 1.218 . . . . 75.12 112.57 177.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -105.71 1.25 26.98 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.639 1.176 . . . . 64.05 112.872 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.2 t -77.97 150.24 33.99 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.51 1.524 . . . . 75.01 109.805 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -56.45 -35.27 67.7 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 124.429 1.092 . . . . 64.43 111.0 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.9 t -51.53 -52.51 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 CA-C-N 118.847 0.749 . . . . 64.42 109.581 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.13 -45.61 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-N 115.942 -0.572 . . . . 74.43 110.269 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -46.22 81.98 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.342 0.657 . . . . 73.35 111.109 -176.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.4 t -67.07 -48.39 68.39 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.638 1.175 . . . . 73.41 110.371 175.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.7 mt -53.8 -50.38 66.24 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-O 117.321 -1.324 . . . . 75.32 110.029 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.8 t -48.27 -51.74 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 120.573 1.533 . . . . 74.05 109.986 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.57 -27.45 64.62 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.514 0.931 . . . . 74.23 113.514 -177.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -63.99 -32.95 74.67 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 113.774 1.027 . . . . 74.13 113.774 172.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.55 HE21 ' CE1' ' A' ' 60' ' ' HIS . 4.1 mp0 -89.72 -35.94 15.48 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 117.652 -1.166 . . . . 75.14 111.85 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -56.64 -51.6 68.07 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 108.041 -1.096 . . . . 74.45 108.041 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 23.9 ttpt -59.66 -16.43 26.4 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 113.765 1.024 . . . . 73.12 113.765 174.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -117.26 -1.86 11.73 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 120.486 1.494 . . . . 72.43 114.828 -174.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.07 -29.86 4.16 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 119.145 0.884 . . . . 73.21 111.038 172.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -107.67 2.04 23.56 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.789 0.836 . . . . 73.01 112.034 -170.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -63.62 -85.82 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.504 1.121 . . . . 74.3 111.255 176.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -175.56 50.0 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.032 1.733 . . . . 74.02 109.216 177.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.276 0.6 OUTLIER -143.7 -50.0 0.31 Allowed 'General case' 0 C--N 1.344 0.332 0 N-CA-C 114.071 1.138 . . . . 74.03 114.071 -178.262 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 40.5 tp -70.07 -83.1 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 119.572 1.078 . . . . 72.44 110.071 -176.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 55.15 33.52 20.67 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.618 0.767 . . . . 64.42 112.477 173.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 176.35 159.44 21.93 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.681 1.61 . . . . 74.03 109.587 170.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.9 m -141.69 159.03 61.49 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 119.61 1.705 . . . . 75.44 110.582 173.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.29 161.57 94.22 Favored 'Cis proline' 0 C--N 1.349 0.572 0 CA-C-N 118.987 0.674 . . . . 73.34 112.897 -4.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -144.36 146.07 32.33 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.858 -1.065 . . . . 71.22 110.055 175.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 38.8 tpp -135.96 105.43 6.07 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 105.006 -2.22 . . . . 74.24 105.006 175.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -82.81 149.51 27.14 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.084 0.953 . . . . 75.21 109.444 175.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.8 t -140.08 145.93 25.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 108.195 -1.039 . . . . 75.12 108.195 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 50.67 24.16 1.59 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.992 2.117 . . . . 60.43 113.765 173.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 68.36 4.29 36.58 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 120.336 -1.478 . . . . 72.02 113.612 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.416 ' HE2' ' CE2' ' A' ' 158' ' ' TYR . 11.1 pttt -147.26 -6.48 0.48 Allowed 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.442 1.621 . . . . 75.22 115.183 -166.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.416 ' CE2' ' HE2' ' A' ' 157' ' ' LYS . 63.0 m-85 -124.04 162.38 23.59 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.332 0.969 . . . . 72.02 110.288 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -129.63 139.94 51.29 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.815 1.646 . . . . 71.41 106.895 165.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.89 142.34 57.94 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 107.946 -1.131 . . . . 74.13 107.946 167.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -118.67 85.52 27.41 Favored Pre-proline 0 C--O 1.235 0.333 0 C-N-CA 123.603 0.761 . . . . 74.41 111.651 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.01 -24.87 52.23 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 CA-C-N 119.544 0.873 . . . . 75.03 111.493 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.99 -8.65 39.13 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.876 1.27 . . . . 75.24 112.642 -178.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -112.9 7.9 25.57 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-O 118.519 -1.156 . . . . 75.03 112.202 176.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 59.1 mtt -98.13 158.91 15.27 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 119.351 1.576 . . . . 74.14 110.528 -176.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -66.94 109.37 2.93 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 106.524 -1.658 . . . . 75.33 106.524 170.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.16 11.91 15.34 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 128.156 2.582 . . . . 75.4 108.632 -171.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.67 -4.33 56.84 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 125.693 1.597 . . . . 60.4 113.189 -169.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.06 -7.28 1.38 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.783 0.833 . . . . 75.1 111.491 -168.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 8.1 mmt 65.94 -62.78 0.24 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 127.142 2.177 . . . . 75.21 112.23 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.44 -36.65 74.09 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 120.371 1.441 . . . . 64.03 109.803 -171.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 79.9 t -58.68 -37.32 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.687 1.195 . . . . 74.02 110.162 172.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -60.16 -56.52 20.56 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.674 -0.861 . . . . 75.32 108.674 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.2 t -64.93 -37.82 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 123.314 0.384 . . . . 74.04 110.536 -178.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.42 -47.67 69.39 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.542 1.137 . . . . 74.23 110.657 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -80.75 -40.25 25.54 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 118.504 -0.76 . . . . 73.41 111.882 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -50.38 -59.69 3.74 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.486 1.039 . . . . 75.03 110.2 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.27 -37.48 75.07 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.229 1.012 . . . . 75.23 111.74 -172.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -67.39 -50.4 59.78 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.912 0.885 . . . . 74.53 109.994 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 22.0 m -57.03 -29.73 63.62 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.647 1.179 . . . . 75.13 111.964 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 3.7 t -60.38 -52.79 57.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 119.396 0.998 . . . . 73.23 109.354 172.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -62.55 -27.88 69.47 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 121.499 -0.751 . . . . 74.4 112.089 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -68.92 -33.62 74.04 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 119.214 0.915 . . . . 75.22 112.528 176.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 66.1 mt -71.21 -32.86 69.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 120.159 1.345 . . . . 72.51 110.98 -177.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 99.3 t -62.36 -23.68 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.163 0.985 . . . . 60.32 112.144 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -99.0 -19.42 17.28 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.453 -0.78 . . . . 74.3 110.203 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -98.89 77.54 2.22 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 125.197 1.399 . . . . 75.14 107.398 -168.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.967 0 C-N-CA 126.923 2.089 . . . . 74.33 111.563 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.469 0.502 0 CA-C-O 117.582 -1.199 . . . . 74.23 109.512 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 70.22 166.01 0.28 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 128.388 2.675 . . . . 74.45 112.96 172.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 50.94 37.58 17.9 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.176 1.39 . . . . 74.33 112.758 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.2 116.77 0.99 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 127.004 2.121 . . . . 74.02 105.799 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.8 pt -130.72 168.66 23.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 126.51 1.924 . . . . 75.31 108.514 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.9 m -139.58 135.15 33.08 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.549 1.139 . . . . 73.05 108.954 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -60.25 111.54 1.58 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.542 2.337 . . . . 63.11 108.263 169.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 107.69 -16.1 37.34 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 126.12 1.819 . . . . 72.21 112.921 -173.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -100.63 -86.48 0.4 Allowed 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 119.411 1.606 . . . . 71.43 108.056 -174.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -87.89 -18.01 30.14 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.435 1.094 . . . . 73.23 111.303 -176.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -138.83 161.13 38.01 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.144 0.978 . . . . 72.14 109.024 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mm -127.85 160.42 37.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 105.874 -1.898 . . . . 72.32 105.874 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.6 m -81.29 152.08 27.76 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.637 -1.246 . . . . 74.01 107.637 167.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 32.8 mt -62.01 163.83 7.39 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.751 -0.463 . . . . 74.41 109.751 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -71.64 -37.4 70.85 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.648 0.779 . . . . 73.33 109.313 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.4 mmtp -140.83 78.72 19.83 Favored Pre-proline 0 CA--C 1.529 0.166 0 C-N-CA 126.005 1.722 . . . . 74.03 108.073 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.4 108.03 2.53 Favored 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.171 1.914 . . . . 75.33 107.646 172.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.7 tt -154.48 170.39 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 118.955 0.798 . . . . 73.45 109.43 173.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 65.51 -176.93 0.18 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.114 2.166 . . . . 64.05 113.827 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.2 -83.15 0.15 Allowed Glycine 0 C--N 1.34 0.795 0 N-CA-C 108.22 -1.952 . . . . 75.25 108.22 170.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.23 166.5 0.1 OUTLIER Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 125.262 1.425 . . . . 72.21 113.15 174.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -64.44 120.39 7.69 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.558 1.505 . . . . 44.24 109.558 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -61.81 -25.75 67.69 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.368 1.467 . . . . 74.03 112.268 -174.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.1 t -145.12 140.88 22.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 126.73 2.012 . . . . 62.23 106.15 173.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 tp -156.66 161.65 39.86 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.99 1.316 . . . . 73.25 107.94 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -139.74 126.43 20.57 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 106.511 -1.662 . . . . 75.03 106.511 -163.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -128.79 127.7 42.48 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.191 0.996 . . . . 74.15 112.174 -173.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -169.67 173.96 6.04 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.371 2.269 . . . . 72.24 112.233 176.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.8 t -135.84 151.11 49.71 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.078 -1.013 . . . . 74.25 109.073 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.425 ' CD2' HG22 ' A' ' 95' ' ' VAL 0.307 0.0 OUTLIER -62.12 -19.67 63.25 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 120.599 1.545 . . . . 63.42 113.44 -175.158 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -92.26 1.45 57.21 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 120.928 1.695 . . . . 75.05 112.506 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.4 p -75.85 141.68 72.14 Favored Pre-proline 0 C--N 1.354 0.762 0 CA-C-N 122.162 2.256 . . . . 64.04 108.547 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -89.07 -31.27 0.16 Allowed 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 121.319 1.346 . . . . 60.13 111.338 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -62.03 -40.81 96.99 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.156 -0.965 . . . . 72.45 110.957 174.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.9 p -70.43 -28.46 65.06 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-O 118.146 -0.93 . . . . 72.41 110.971 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -54.85 -56.06 23.57 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.767 1.167 . . . . 73.24 110.263 175.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.16 -46.88 79.13 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-O 118.514 -0.755 . . . . 74.41 109.022 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -66.64 -10.35 45.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 117.005 -1.474 . . . . 74.11 113.386 -175.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -134.25 0.46 3.1 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 120.616 1.553 . . . . 72.42 112.67 -163.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -139.58 -36.37 0.52 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 126.687 1.995 . . . . 73.34 110.765 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.3 t -102.56 -76.84 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 107.284 -1.376 . . . . 74.25 107.284 -173.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 71.7 mt -68.19 -21.73 64.86 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.432 1.493 . . . . 71.31 113.614 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 13.8 m80 44.66 58.96 3.59 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.92 1.688 . . . . 73.33 113.062 176.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 96.4 t -63.74 -41.3 92.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.976 1.311 . . . . 73.14 110.861 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.5 t -56.42 -45.03 80.9 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.477 1.49 . . . . 74.01 110.696 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.18 -37.97 78.45 Favored 'General case' 0 C--O 1.233 0.189 0 O-C-N 121.253 -0.905 . . . . 71.23 110.2 -176.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.47 -39.7 85.3 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.461 1.105 . . . . 74.35 112.299 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.1 t -60.86 -49.17 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.283 1.433 . . . . 72.33 109.254 171.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -52.57 -42.49 64.52 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 119.546 1.066 . . . . 74.43 113.66 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -57.17 -13.31 2.92 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.614 1.339 . . . . 71.23 114.614 173.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -120.74 -4.2 9.73 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.585 1.954 . . . . 65.33 112.457 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.6 mt -70.8 144.24 90.49 Favored Pre-proline 0 C--O 1.239 0.538 0 CA-C-N 119.947 1.249 . . . . 74.21 109.791 -171.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -84.38 161.27 12.99 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 123.74 2.96 . . . . 73.34 109.825 169.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.75 40.85 0.82 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.262 1.208 . . . . 74.04 114.262 -165.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.93 -37.64 0.65 Allowed Glycine 0 CA--C 1.524 0.633 0 O-C-N 121.052 -1.03 . . . . 55.32 111.419 167.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 58.2 m -44.79 -59.09 2.69 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.404 2.282 . . . . 73.01 114.534 -163.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.2 tptt 57.87 126.72 0.01 OUTLIER 'General case' 0 C--N 1.344 0.351 0 C-N-CA 126.547 1.939 . . . . 75.25 111.469 -168.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -75.82 128.67 35.63 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.713 -0.847 . . . . 75.11 108.713 175.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.41 -177.35 3.11 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 124.171 0.988 . . . . 75.42 110.104 173.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.7 104.8 0.59 Allowed 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 106.008 -1.849 . . . . 75.11 106.008 166.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.425 ' CD2' ' HG3' ' A' ' 137' ' ' GLN . 9.5 m-30 -85.69 170.86 12.1 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.956 -1.127 . . . . 74.05 107.956 161.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.479 ' CE1' HG22 ' A' ' 72' ' ' THR . 1.5 p80 -108.76 171.48 7.4 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.239 1.416 . . . . 72.01 108.1 176.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.2 m -148.29 157.73 8.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 119.832 1.196 . . . . 72.44 108.99 162.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.6 -8.98 14.19 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 129.345 3.058 . . . . 72.31 111.897 -166.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -60.92 1.09 0.16 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.792 1.637 . . . . 75.23 113.528 173.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 35.6 mt -129.4 119.36 23.71 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 119.879 -1.763 . . . . 75.42 108.282 -170.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.85 166.89 25.81 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 125.508 1.528 . . . . 63.44 112.816 175.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.58 -40.42 5.62 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.754 2.303 . . . . 75.43 111.132 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 58.7 mt -72.54 16.23 0.15 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.907 0.883 . . . . 61.15 112.012 174.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -45.31 -64.33 2.32 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.369 1.461 . . . . 72.24 110.999 172.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -59.74 -33.41 71.62 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.385 1.092 . . . . 73.13 112.472 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.58 -44.53 86.38 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.873 0.869 . . . . 75.02 109.779 176.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.2 mt -58.32 -46.06 86.89 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.668 1.187 . . . . 73.32 111.476 -176.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.479 HG22 ' CE1' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -46.08 -46.36 16.81 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.346 1.858 . . . . 73.35 109.477 174.542 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -76.5 -50.98 12.63 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 118.412 -0.804 . . . . 75.32 110.715 -172.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.69 -35.05 75.32 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.705 1.593 . . . . 75.11 112.662 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 28.8 t-105 -59.3 -36.9 76.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.002 0.365 . . . . 73.43 111.147 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.31 -29.0 69.12 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 112.708 0.633 . . . . 73.41 112.708 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.2 t -57.23 -52.62 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 120.244 1.384 . . . . 72.22 109.495 162.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.89 -56.94 15.44 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 118.216 -0.897 . . . . 73.12 110.753 -174.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.4 mt -52.61 -41.27 36.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.497 1.119 . . . . 71.42 110.489 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.87 -33.75 76.55 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 120.017 -0.673 . . . . 74.41 110.933 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.9 mt -86.41 -23.9 25.92 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.253 0.464 . . . . 73.35 112.253 175.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.1 69.72 1.34 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.946 1.736 . . . . 75.21 110.116 -171.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.7 m -133.52 8.3 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.464 1.105 . . . . 73.23 112.563 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -53.56 -51.84 61.65 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 125.069 1.348 . . . . 75.44 112.055 -169.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -55.31 -45.29 76.3 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.037 0.935 . . . . 71.33 109.257 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -66.17 -21.83 66.34 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.825 1.65 . . . . 75.12 111.44 -176.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.5 pp -121.6 26.77 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.579 1.551 . . . . 73.03 110.014 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 96.6 m -95.2 -48.76 5.79 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.131 0.878 . . . . 71.21 108.963 166.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.35 -62.31 6.18 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 119.267 0.94 . . . . 42.35 112.211 -175.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.32 -23.69 44.34 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 121.633 1.556 . . . . 74.25 111.624 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 32.8 tpp -64.16 -52.63 58.09 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.539 1.136 . . . . 75.32 109.101 174.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -69.43 -32.7 71.82 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 124.163 0.914 . . . . 72.25 110.469 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -63.2 -33.21 74.99 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 118.272 0.487 . . . . 74.33 110.39 171.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.47 -12.89 33.33 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.87 1.214 . . . . 65.24 113.403 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.425 HG22 ' CD2' ' A' ' 28' ' ' PHE . 41.4 t -100.08 -39.59 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 C-N-CA 124.184 0.994 . . . . 74.43 109.746 -178.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -111.53 -53.58 2.69 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.72 0.808 . . . . 63.44 110.044 -171.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -67.77 -60.16 2.74 Favored 'General case' 0 C--N 1.339 0.142 0 O-C-N 121.453 -0.779 . . . . 74.35 109.909 -173.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.4 p -90.56 -25.71 20.08 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.547 0.573 . . . . 74.34 112.547 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 49.44 61.46 3.13 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 128.521 2.728 . . . . 73.43 112.393 -174.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.3 t -101.7 -14.52 17.33 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.762 1.225 . . . . 72.02 113.171 174.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.6 t -69.96 123.46 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 119.875 1.216 . . . . 75.44 108.834 171.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -144.35 -26.61 0.52 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.42 1.088 . . . . 74.04 111.714 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.82 167.32 21.98 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.308 0.958 . . . . 74.02 108.747 174.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 43.8 t -56.2 -40.28 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 123.709 0.804 . . . . 73.01 110.68 -175.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.26 -24.99 61.22 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.674 0.79 . . . . 75.33 112.617 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -79.83 -34.09 39.73 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.16 0.891 . . . . 74.35 110.807 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.8 mt -75.01 -48.23 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 108.716 -0.846 . . . . 75.22 108.716 -176.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -17.14 63.75 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.289 -0.862 . . . . 72.32 111.428 -176.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -58.87 -58.12 10.03 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.61 0.764 . . . . 73.21 110.012 168.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.3 t -57.24 -38.81 63.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 123.445 0.698 . . . . 74.25 111.565 -174.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -54.51 -53.03 59.84 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.839 -0.538 . . . . 75.45 109.765 173.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 97.5 t -60.62 -46.05 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 123.717 0.807 . . . . 74.42 110.186 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -55.39 -45.67 76.59 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.832 1.253 . . . . 64.03 109.425 -176.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.91 -15.05 60.25 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.703 1.201 . . . . 72.14 113.102 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 114.18 51.5 0.47 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.487 1.042 . . . . 65.32 113.213 172.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.8 t -111.6 142.78 22.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 124.374 1.07 . . . . 73.41 108.513 168.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.7 mmtm -61.57 148.67 41.51 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.831 0.824 . . . . 75.22 110.804 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.0 -18.17 74.29 Favored Glycine 0 CA--C 1.518 0.235 0 CA-C-N 114.985 -1.007 . . . . 61.31 113.15 167.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -87.57 -36.04 17.78 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 109.326 -0.62 . . . . 63.44 109.326 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.72 -43.3 72.64 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 106.25 -1.759 . . . . 75.15 106.25 -169.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -63.18 -52.93 60.39 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 123.693 0.621 . . . . 75.32 110.202 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -71.7 -17.05 62.25 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.963 0.505 . . . . 73.03 112.297 -174.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -87.15 -63.96 1.22 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.61 1.164 . . . . 71.35 109.597 172.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.32 -34.56 66.65 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.196 0.998 . . . . 73.43 111.463 -170.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -49.47 -33.53 14.54 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.862 0.865 . . . . 73.32 112.658 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -111.27 6.51 20.6 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.584 1.553 . . . . 75.25 112.848 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 43.3 t -82.73 157.21 23.37 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.283 1.433 . . . . 72.43 111.048 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -62.21 -34.53 76.65 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.373 1.469 . . . . 74.14 111.469 172.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 72.2 t -50.41 -50.98 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 108.843 -0.799 . . . . 75.02 108.843 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 22.1 t -65.91 -44.31 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 124.369 1.067 . . . . 73.14 111.723 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.499 ' HA ' ' HE2' ' A' ' 131' ' ' LYS . 10.8 mmpt? -51.55 -52.69 45.02 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.041 0.837 . . . . 75.14 110.921 176.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.6 -34.48 77.98 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.359 1.064 . . . . 64.24 110.955 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.0 mt -63.21 -54.99 28.81 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 117.141 -1.409 . . . . 75.35 110.848 175.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 87.4 t -54.07 -39.11 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 119.819 1.191 . . . . 72.04 109.601 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.68 -22.81 66.76 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 118.188 -0.91 . . . . 73.45 113.067 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -58.1 -53.1 62.02 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 119.638 1.108 . . . . 71.44 109.35 172.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.425 ' HG3' ' CD2' ' A' ' 59' ' ' TYR . 20.9 mp0 -78.88 -30.43 45.0 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.229 -0.919 . . . . 73.25 110.113 -175.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -68.87 11.67 0.18 Allowed 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.143 -1.598 . . . . 73.44 112.81 163.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -125.24 -19.93 4.98 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 124.775 1.23 . . . . 74.15 111.925 162.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -115.07 -10.41 12.22 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 114.557 1.317 . . . . 75.01 114.557 -172.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -96.66 -38.79 9.79 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.524 1.057 . . . . 74.31 108.343 157.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.9 -28.05 69.78 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.908 1.077 . . . . 63.43 113.908 -170.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -80.71 26.87 0.39 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.656 0.984 . . . . 63.22 113.656 -169.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.5 mt 65.16 28.3 12.2 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.815 -1.178 . . . . 75.04 111.504 165.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -104.68 -20.9 13.49 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.451 1.501 . . . . 74.44 112.216 -171.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.3 tt -168.15 137.03 2.4 Favored 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 128.738 2.815 . . . . 64.32 106.864 -176.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -140.94 5.83 1.96 Allowed 'General case' 0 CA--C 1.546 0.802 0 O-C-N 124.017 0.823 . . . . 71.22 111.121 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -143.55 152.22 23.94 Favored Glycine 0 C--N 1.343 0.966 0 CA-C-N 119.624 1.102 . . . . 72.35 110.903 172.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.408 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 35.7 m -132.83 174.84 4.24 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 125.818 1.647 . . . . 75.22 110.717 -170.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.408 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 15.8 Cg_endo -61.98 152.04 61.76 Favored 'Cis proline' 0 C--N 1.352 0.746 0 CA-C-N 121.475 1.562 . . . . 74.31 112.165 -10.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -152.65 152.66 32.02 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.587 0.554 . . . . 64.01 111.111 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 77.1 mmm -151.78 121.51 6.99 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.673 1.189 . . . . 71.04 107.813 -167.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 12.0 m-30 -100.02 152.8 19.79 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.005 0.922 . . . . 61.11 110.361 -172.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.4 t -139.87 151.76 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.566 0.746 . . . . 74.21 110.202 174.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 44.88 24.12 0.1 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 129.273 3.029 . . . . 52.52 114.494 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 53.03 24.67 21.5 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.194 -0.941 . . . . 74.41 112.996 -173.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.542 ' HE2' ' CE2' ' A' ' 158' ' ' TYR . 9.3 pttt -150.24 -3.55 0.36 Allowed 'General case' 0 C--N 1.344 0.335 0 N-CA-C 114.527 1.306 . . . . 75.03 114.527 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.542 ' CE2' ' HE2' ' A' ' 157' ' ' LYS . 49.8 m-85 -126.59 159.93 32.1 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 124.73 1.212 . . . . 64.42 110.953 -176.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -126.22 149.2 49.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.654 1.982 . . . . 74.43 107.044 170.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -74.47 154.26 38.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.995 -0.742 . . . . 73.14 108.995 167.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -125.18 80.61 64.41 Favored Pre-proline 0 C--O 1.232 0.18 0 C-N-CA 123.353 0.661 . . . . 75.01 110.808 177.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.36 -4.84 10.09 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 121.986 1.791 . . . . 72.44 113.212 175.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -86.82 -2.66 58.74 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.16 1.384 . . . . 75.11 113.127 173.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -132.47 46.16 1.08 Allowed Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 109.584 -1.406 . . . . 71.14 109.584 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 36.6 mtt -130.97 174.97 9.47 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 118.172 0.986 . . . . 73.01 111.851 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.32 90.35 4.97 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.945 -1.131 . . . . 73.13 107.945 174.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.344 6.4 t -118.53 48.13 1.5 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.78 1.232 . . . . 73.12 107.965 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.6 m -84.16 -47.79 10.49 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.074 -0.966 . . . . 74.11 110.338 159.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.513 HD21 ' CG2' ' A' ' 172' ' ' VAL . 0.0 OUTLIER -113.05 -9.9 13.52 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 117.962 -1.018 . . . . 73.04 113.065 -162.401 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 33.6 mmm 75.47 -53.94 0.64 Allowed 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 126.451 1.901 . . . . 74.34 112.705 170.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.22 -31.35 72.48 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.656 1.116 . . . . 72.15 109.512 176.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.513 ' CG2' HD21 ' A' ' 169' ' ' ASN . 89.0 t -80.68 -25.04 11.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.65 1.58 . . . . 64.04 111.8 175.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -63.54 -58.06 8.2 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.014 -1.476 . . . . 73.05 107.014 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 14.3 t -61.83 -38.88 81.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 122.999 0.52 . . . . 74.05 110.195 -174.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.71 -46.06 70.65 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.437 1.095 . . . . 53.32 110.754 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -83.75 -31.29 26.06 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.165 0.986 . . . . 71.31 112.493 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -54.61 -54.8 36.67 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.227 -0.921 . . . . 64.24 109.242 175.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.96 -27.63 66.97 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.084 0.772 . . . . 62.11 113.084 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.2 -54.85 14.93 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.632 1.173 . . . . 64.24 110.614 177.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.6 t -62.21 -30.91 71.41 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 118.553 -0.737 . . . . 73.25 110.615 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 94.8 t -59.66 -51.81 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.519 -0.919 . . . . 60.45 108.519 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -62.0 -47.63 83.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.181 0.593 . . . . 75.42 109.8 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -58.29 -37.23 74.62 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 118.638 0.654 . . . . 75.44 111.932 -172.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 72.0 mt -65.51 -28.72 69.39 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.45 -0.781 . . . . 72.32 112.192 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.21 -22.55 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.403 0.681 . . . . 72.23 111.646 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -98.87 -16.47 18.82 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.652 0.66 . . . . 75.13 110.509 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -93.15 13.66 20.36 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.708 1.373 . . . . 75.41 114.708 -170.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 35.1 mttt . . . . . 0 C--O 1.246 0.898 0 C-N-CA 127.933 2.493 . . . . 75.05 113.886 -175.611 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.467 0.383 0 N-CA-C 109.408 -0.59 . . . . 74.34 109.408 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 75.79 -10.18 1.31 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 128.865 2.866 . . . . 60.41 113.697 165.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -76.31 48.74 0.54 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.86 2.064 . . . . 64.41 112.195 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -156.24 118.22 3.98 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.902 -1.148 . . . . 75.14 107.902 164.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.4 pt -115.63 164.62 11.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 126.217 1.807 . . . . 72.31 108.604 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.2 m -137.55 139.41 40.44 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.079 -1.823 . . . . 74.52 106.079 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -55.08 138.66 43.71 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.149 1.78 . . . . 72.34 109.739 167.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.45 -25.71 3.23 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.445 1.498 . . . . 54.52 113.41 -171.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -91.8 -77.35 0.43 Allowed 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 119.211 1.506 . . . . 75.54 107.227 -165.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -97.4 -15.38 20.7 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.543 0.737 . . . . 60.24 111.166 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -142.95 160.69 39.86 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.34 0.656 . . . . 75.32 110.246 173.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.3 mm -123.8 157.2 30.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 106.818 -1.549 . . . . 72.52 106.818 172.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.9 m -101.79 152.9 20.33 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.199 1.4 . . . . 75.52 107.633 174.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.3 mt -91.27 148.83 22.07 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 106.705 -1.591 . . . . 73.55 106.705 169.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -72.58 -34.43 67.45 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.128 1.371 . . . . 73.33 109.765 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.9 mmtm -125.68 82.31 63.91 Favored Pre-proline 0 C--O 1.232 0.136 0 C-N-CA 126.7 2.0 . . . . 75.22 108.166 175.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.51 86.63 1.45 Allowed 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 123.645 2.897 . . . . 71.52 107.844 168.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 15.7 tt -157.86 141.16 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 O-C-N 121.055 -1.028 . . . . 72.11 109.1 173.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 50.65 -173.69 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.657 1.983 . . . . 61.53 114.026 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.89 121.93 1.71 Allowed Glycine 0 CA--C 1.52 0.399 0 N-CA-C 109.997 -1.241 . . . . 62.14 109.997 -175.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 60.74 166.39 0.09 OUTLIER Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 126.147 1.779 . . . . 71.42 115.527 166.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -67.61 64.68 0.83 Allowed 'Trans proline' 0 CA--C 1.55 1.311 0 C-N-CA 123.768 2.979 . . . . 71.13 113.696 175.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 54.06 -28.64 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.799 1 C-N-CA 132.85 4.46 . . . . 73.15 118.442 174.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.7 p -151.91 147.72 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 122.3 2.318 . . . . 73.41 110.008 165.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -172.14 164.53 6.06 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.274 1.03 . . . . 74.22 110.536 -167.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -123.46 158.94 30.09 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.903 1.281 . . . . 75.22 109.435 173.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -142.04 134.18 27.59 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.731 1.613 . . . . 74.21 113.221 174.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -139.69 177.77 7.71 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.352 1.461 . . . . 73.33 111.125 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.9 t -136.61 162.33 33.42 Favored 'General case' 0 CA--C 1.527 0.09 0 N-CA-C 109.457 -0.571 . . . . 73.31 109.457 157.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.465 ' CD2' HD22 ' A' ' 71' ' ' LEU 0.257 0.0 OUTLIER -71.59 -20.14 62.04 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.502 -0.749 . . . . 63.12 112.834 171.232 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -89.03 -9.21 52.12 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 117.724 -1.131 . . . . 75.41 112.725 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.7 p -84.63 142.27 39.63 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 121.416 1.916 . . . . 40.22 110.284 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -91.72 -31.23 0.1 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 121.384 1.389 . . . . 75.54 112.395 -170.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -58.54 -44.02 89.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.143 -0.688 . . . . 74.42 109.143 169.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 25.7 m -55.62 -39.95 71.49 Favored 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 123.979 0.912 . . . . 74.52 110.742 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -52.47 -60.83 2.76 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 119.523 1.056 . . . . 64.24 109.813 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -54.54 -41.8 70.16 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 119.026 -0.511 . . . . 63.33 109.755 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -68.89 -24.41 64.31 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 118.347 -0.835 . . . . 71.52 112.526 -174.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -116.24 -3.82 11.95 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.689 0.677 . . . . 74.42 111.635 -167.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -138.38 -35.07 0.61 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.879 1.672 . . . . 74.41 114.016 -168.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 86.8 t -111.05 -78.79 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 N-CA-C 105.458 -2.053 . . . . 75.52 105.458 -172.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.6 mt -57.4 -29.15 63.87 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.48 1.912 . . . . 75.12 111.159 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 44.1 54.89 5.72 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.005 1.722 . . . . 72.43 110.23 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.4 t -53.38 -51.47 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 126.099 1.76 . . . . 74.33 107.898 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.9 t -44.09 -53.2 6.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.669 1.987 . . . . 54.12 111.404 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -76.64 -30.29 56.78 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.462 0.649 . . . . 74.52 111.332 -173.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -72.86 -37.39 67.39 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.318 -0.864 . . . . 71.21 111.78 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.9 t -60.68 -49.97 82.33 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 N-CA-C 107.93 -1.137 . . . . 72.45 107.93 173.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -47.62 -45.49 27.72 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 124.588 1.155 . . . . 73.24 112.335 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -63.6 -5.14 3.53 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 115.468 1.655 . . . . 75.31 115.468 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -123.4 -10.26 7.98 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.351 2.26 . . . . 75.11 113.03 174.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.6 mt -73.17 145.39 85.81 Favored Pre-proline 0 C--O 1.238 0.478 0 CA-C-N 120.109 1.322 . . . . 72.41 112.306 -163.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.76 160.49 31.04 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 124.49 3.46 . . . . 63.13 112.348 175.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -76.97 45.44 0.43 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.541 1.936 . . . . 72.25 112.451 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -155.54 -6.59 0.08 OUTLIER Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.329 1.443 . . . . 73.31 113.523 175.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.2 t -56.4 -43.63 79.49 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.496 1.648 . . . . 74.51 112.092 174.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.8 tptt 44.66 90.94 0.01 OUTLIER 'General case' 0 C--N 1.346 0.417 0 C-N-CA 126.305 1.842 . . . . 74.15 110.196 -165.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.33 105.57 0.3 Allowed 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 127.342 2.257 . . . . 75.42 108.945 -175.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.0 m -143.36 115.3 8.29 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 107.138 -1.43 . . . . 72.13 107.138 -172.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.72 137.55 54.34 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.857 1.263 . . . . 64.41 108.459 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.1 m-30 -104.86 -174.94 2.65 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.936 1.694 . . . . 73.43 108.744 173.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -139.99 133.34 29.92 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.073 1.349 . . . . 73.53 107.644 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.3 m -85.99 170.77 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 119.096 0.862 . . . . 74.51 112.254 -172.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.11 0.77 9.11 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.888 2.075 . . . . 73.12 112.558 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -71.32 -34.26 70.4 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.253 1.021 . . . . 62.42 112.638 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 mt -91.91 126.44 36.99 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.372 -0.973 . . . . 73.54 108.372 -171.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.25 167.52 33.85 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 115.336 -0.847 . . . . 61.33 112.829 168.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -66.66 -48.19 2.33 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 124.424 3.416 . . . . 75.52 109.604 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.5 mt -73.22 13.62 0.41 Allowed 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 127.2 2.2 . . . . 73.52 112.514 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -50.48 -46.99 45.44 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 119.823 1.192 . . . . 55.11 111.697 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.1 tptp -71.42 -36.52 71.33 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.401 1.101 . . . . 75.52 111.414 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -63.83 -33.41 75.61 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.58 0.627 . . . . 72.12 110.189 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.465 HD22 ' CD2' ' A' ' 28' ' ' PHE . 15.1 mt -62.13 -49.66 74.99 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 118.416 -0.802 . . . . 71.35 113.038 175.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.5 m -57.2 -45.29 83.9 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.795 -1.187 . . . . 71.23 107.795 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -57.36 -47.3 82.0 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.189 0.904 . . . . 65.22 110.527 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.09 -41.11 82.77 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.949 1.249 . . . . 75.34 112.862 176.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 35.6 t-105 -57.93 -38.89 76.76 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.654 0.782 . . . . 74.24 110.681 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.69 -40.78 80.23 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 117.504 -1.236 . . . . 52.33 113.487 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.0 -43.47 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 120.532 1.514 . . . . 75.21 108.783 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.12 -43.31 87.54 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 118.255 -0.878 . . . . 72.52 111.545 -175.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 59.2 mt -63.02 -46.34 96.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.03 0.932 . . . . 72.52 109.634 172.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.21 -24.4 63.1 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.691 0.678 . . . . 71.13 111.477 -174.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.1 mt -107.17 -16.65 14.36 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 113.916 1.08 . . . . 74.33 113.916 176.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.56 69.96 1.16 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.285 0.945 . . . . 65.34 110.792 -166.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.4 m -135.61 13.5 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.753 1.221 . . . . 74.53 112.285 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -50.06 -50.78 46.75 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 125.563 1.545 . . . . 73.21 111.77 -173.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.78 -37.93 89.26 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.319 0.647 . . . . 72.33 110.221 -178.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -65.23 -43.68 90.68 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.17 0.509 . . . . 74.13 110.0 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.8 pp -92.44 17.33 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 C-N-CA 124.803 1.241 . . . . 64.11 111.633 -175.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 38.9 m -88.36 -48.12 7.88 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.032 0.833 . . . . 74.41 110.019 169.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.79 -60.85 8.18 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 113.907 1.077 . . . . 73.52 113.907 -169.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -68.43 -25.74 35.32 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.299 1.332 . . . . 74.44 111.643 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 20.2 tpp -65.25 -50.63 65.05 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 124.89 1.276 . . . . 72.54 110.826 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -69.64 -30.57 68.31 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.852 -0.796 . . . . 71.32 108.852 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -57.8 -46.97 83.87 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 118.648 0.658 . . . . 75.33 110.332 167.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.41 2.81 23.54 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 120.538 -1.351 . . . . 75.22 113.014 -174.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.426 HG21 ' CD2' ' A' ' 28' ' ' PHE . 38.8 t -123.59 -39.44 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 125.026 1.331 . . . . 63.35 110.826 -173.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -107.75 -47.59 3.57 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.12 -0.696 . . . . 71.25 109.12 -175.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -77.3 -52.42 9.21 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.24 0.616 . . . . 71.12 110.703 -171.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.5 p -103.86 -24.59 13.27 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.536 1.134 . . . . 73.41 112.18 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 57.31 26.12 12.0 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.58 2.352 . . . . 64.24 114.552 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.3 t -68.36 -20.58 64.72 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.937 0.718 . . . . 72.24 112.937 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.1 t -67.43 123.71 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 O-C-N 120.87 -1.144 . . . . 74.11 109.444 173.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -145.84 -25.06 0.46 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.712 1.605 . . . . 75.51 111.326 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.17 164.93 26.56 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.793 -0.817 . . . . 74.45 108.793 176.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 25.3 t -55.07 -40.89 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.227 1.011 . . . . 74.45 109.432 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.16 8.48 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.539 1.935 . . . . 63.43 114.885 173.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -113.69 -46.9 3.01 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 125.045 1.338 . . . . 61.53 109.117 168.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.3 mt -59.01 -37.56 68.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 123.55 0.74 . . . . 72.55 110.356 -177.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.0 -19.59 64.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 117.54 -1.219 . . . . 74.23 112.845 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -57.6 -58.37 8.62 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 119.703 1.138 . . . . 74.31 110.024 164.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 55.2 t -57.13 -37.31 54.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 122.564 0.345 . . . . 65.14 111.732 -167.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -50.98 -56.81 10.61 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.417 -0.586 . . . . 65.25 109.417 171.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 39.8 t -64.57 -38.06 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 123.952 0.901 . . . . 74.42 110.699 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.66 -42.96 98.09 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.499 0.719 . . . . 73.21 109.511 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.48 2.89 12.49 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.353 1.461 . . . . 73.53 112.478 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.58 61.95 1.66 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 125.06 1.314 . . . . 53.05 111.468 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 77.7 t -119.57 145.43 25.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 123.273 0.629 . . . . 74.13 109.935 169.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -62.02 118.61 7.52 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.671 1.189 . . . . 74.42 108.661 169.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.61 -28.71 70.24 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-O 118.3 -1.278 . . . . 73.33 111.677 166.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -73.05 -25.64 61.0 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 118.93 1.365 . . . . 64.12 109.59 -177.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.03 -39.55 29.66 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.075 0.95 . . . . 73.31 109.393 176.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -64.5 -59.61 4.12 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.266 -1.383 . . . . 74.33 107.266 -177.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -60.68 -28.54 68.69 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.661 1.184 . . . . 63.43 110.302 -175.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -80.56 -64.43 1.19 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.473 -0.565 . . . . 73.45 109.473 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.91 -40.05 69.45 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 117.494 -1.241 . . . . 74.52 110.325 -172.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 46.0 t-105 -47.54 -37.6 12.47 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 124.503 1.121 . . . . 75.23 112.76 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -105.16 -5.03 21.1 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.579 1.152 . . . . 73.33 111.219 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 10.9 t -88.59 149.69 23.44 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.29 1.836 . . . . 64.42 109.753 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -50.24 -34.02 21.59 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.138 1.775 . . . . 73.15 111.622 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 76.7 t -45.49 -59.64 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 125.838 1.655 . . . . 52.41 109.461 176.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 18.3 t -64.69 -46.04 93.46 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.682 0 CA-C-O 117.788 -1.101 . . . . 72.25 109.164 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -50.27 -50.33 50.64 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 120.247 1.385 . . . . 75.21 110.719 -177.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.4 t -69.73 -35.62 75.17 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 118.184 -0.912 . . . . 74.34 109.94 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.411 ' HA ' ' HG2' ' A' ' 136' ' ' GLN . 66.0 mt -64.51 -37.23 86.83 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 119.453 1.024 . . . . 74.42 112.225 177.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.7 t -56.06 -49.18 77.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 N-CA-C 107.908 -1.145 . . . . 74.43 107.908 173.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.92 -49.89 70.18 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.308 0.503 . . . . 74.14 111.641 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.411 ' HG2' ' HA ' ' A' ' 133' ' ' LEU . 1.4 pt20 -58.76 -34.32 71.28 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 123.498 0.499 . . . . 75.24 111.82 -173.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -89.9 -48.12 7.43 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 126.391 1.877 . . . . 60.34 111.129 -173.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -62.66 -46.36 88.56 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.2 1.0 . . . . 74.43 109.159 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -58.72 -46.18 87.94 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.796 -0.816 . . . . 75.42 108.796 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.63 -9.06 16.88 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.586 0.958 . . . . 60.32 113.586 -174.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.67 5.44 10.55 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 120.755 1.616 . . . . 73.51 112.942 174.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.5 -3.41 5.45 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.01 0.924 . . . . 75.23 112.489 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -56.05 -85.68 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.922 2.489 . . . . 72.34 109.978 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.1 pp 179.18 41.49 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.062 1.745 . . . . 75.31 110.873 176.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.548 ' NE2' ' H ' ' A' ' 146' ' ' LEU . 1.4 pp0? -133.56 -45.27 0.82 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.254 1.205 . . . . 72.53 114.254 -172.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.548 ' H ' ' NE2' ' A' ' 145' ' ' GLN . 16.1 tp -85.11 -85.3 0.14 Allowed 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 125.347 1.459 . . . . 72.53 109.746 -166.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 56.72 33.51 23.03 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.202 0.601 . . . . 73.33 111.628 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 178.31 155.81 15.27 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.856 1.693 . . . . 60.55 110.965 174.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 16.2 m -149.06 161.78 31.24 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 124.693 1.197 . . . . 74.21 108.931 175.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -65.14 141.12 46.56 Favored 'Cis proline' 0 C--N 1.35 0.626 0 CA-C-N 120.227 1.117 . . . . 71.34 112.504 -8.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -131.2 142.8 50.24 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.764 -1.107 . . . . 65.32 109.625 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 50.8 mtp -148.23 113.99 5.72 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 102.469 -3.16 . . . . 74.54 102.469 -176.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -100.95 165.66 11.22 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.4 0.68 . . . . 64.31 109.387 -175.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.6 t -138.07 133.44 44.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.667 0.746 . . . . 71.42 110.668 172.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 44.9 30.84 0.6 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 130.754 3.621 . . . . 60.34 115.417 171.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 64.59 34.41 89.82 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 124.823 1.202 . . . . 64.35 111.395 177.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.406 ' HG3' ' CE2' ' A' ' 158' ' ' TYR . 9.7 ptmt -160.52 -10.4 0.05 OUTLIER 'General case' 0 C--N 1.345 0.389 0 N-CA-C 116.742 2.126 . . . . 74.42 116.742 177.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.406 ' CE2' ' HG3' ' A' ' 157' ' ' LYS . 60.2 m-85 -128.89 160.88 31.24 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 120.376 1.444 . . . . 73.43 110.598 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -136.01 131.77 35.42 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 105.694 -1.965 . . . . 75.42 105.694 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.57 145.89 55.52 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.718 -1.216 . . . . 71.15 107.718 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -115.13 85.58 12.66 Favored Pre-proline 0 CA--C 1.522 -0.134 0 N-CA-C 113.034 0.753 . . . . 64.32 113.034 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -61.92 -24.19 76.74 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 CA-C-N 119.659 0.914 . . . . 75.31 112.059 173.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.28 2.58 27.44 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.139 1.376 . . . . 72.14 112.398 -170.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -130.24 22.02 4.8 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.229 1.395 . . . . 74.13 110.423 175.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 63.3 mtt -106.42 169.82 8.29 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 117.932 0.866 . . . . 73.41 110.335 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 168' ' ' SER . 0.3 OUTLIER -83.2 63.82 7.39 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 124.626 2.155 . . . . 72.53 109.98 -174.131 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.6 p -73.65 32.51 0.08 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 129.376 3.07 . . . . 65.21 111.393 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.41 ' H ' ' C ' ' A' ' 166' ' ' ASP . 17.8 m -117.04 -3.02 11.61 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.031 1.732 . . . . 73.22 112.053 177.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.43 -9.67 2.87 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-O 117.678 -1.153 . . . . 60.45 111.744 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 13.2 mmt 65.49 -52.53 0.36 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 127.671 2.388 . . . . 73.44 115.282 172.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.38 -44.35 62.67 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.153 -1.425 . . . . 63.14 107.153 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 97.1 t -59.05 -39.14 77.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 124.02 0.928 . . . . 62.32 110.423 174.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -56.44 -59.78 4.48 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.838 -0.601 . . . . 73.25 109.736 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 20.2 t -66.54 -38.18 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 118.793 0.724 . . . . 74.43 110.807 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.46 -40.22 62.01 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.104 0.562 . . . . 75.53 110.903 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -86.37 -35.96 19.48 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 117.95 -1.024 . . . . 54.44 112.548 174.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -52.01 -60.85 2.71 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 121.039 1.745 . . . . 74.35 110.233 176.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -53.8 -35.27 61.19 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.459 1.104 . . . . 61.15 111.803 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -71.73 -48.52 46.51 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.505 1.122 . . . . 74.14 111.376 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.9 t -62.08 -31.09 71.48 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 117.071 -1.442 . . . . 72.31 109.782 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 30.7 t -58.56 -58.42 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 120.105 1.32 . . . . 71.33 108.929 171.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.96 -11.85 61.2 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 114.135 1.161 . . . . 74.25 114.135 -172.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -87.75 -33.11 18.8 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 123.972 0.909 . . . . 73.14 112.625 166.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 28.7 mt -66.51 -30.78 71.18 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 119.816 -1.803 . . . . 74.41 111.408 -177.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 69.3 t -61.89 -23.46 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.377 0.671 . . . . 73.24 112.549 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -101.25 -14.05 17.83 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 120.983 -1.073 . . . . 73.15 110.47 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -104.8 70.76 0.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 105.237 -2.134 . . . . 71.15 105.237 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? . . . . . 0 CA--C 1.508 -0.672 0 N-CA-C 103.162 -2.903 . . . . 75.44 103.162 170.466 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.468 0.43 0 N-CA-C 109.058 -0.719 . . . . 72.12 109.058 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -127.17 178.54 5.96 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.655 1.982 . . . . 73.43 107.032 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 56.57 25.07 9.44 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.415 1.886 . . . . 75.03 115.703 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -161.1 107.36 1.42 Allowed 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.693 1.597 . . . . 72.1 108.917 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.1 pt -111.68 170.87 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.604 1.562 . . . . 74.04 109.609 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.9 m -140.52 139.3 35.04 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 106.606 -1.627 . . . . 70.41 106.606 177.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -61.55 118.64 7.3 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.508 2.323 . . . . 73.34 109.102 172.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.01 -18.66 56.48 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.328 1.918 . . . . 74.13 112.404 -174.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -89.72 -84.8 0.22 Allowed 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.822 1.311 . . . . 73.2 108.725 -171.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -92.14 -10.91 37.12 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.449 1.1 . . . . 72.43 111.469 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -140.08 164.37 30.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.413 -0.803 . . . . 74.04 109.424 171.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.6 mm -125.12 161.22 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.383 1.473 . . . . 71.32 107.032 169.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -94.74 171.61 8.68 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.562 1.545 . . . . 70.12 108.737 174.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 50.5 mt -117.2 148.63 41.45 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.543 1.137 . . . . 64.3 109.902 162.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -75.21 -43.02 54.22 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.836 2.054 . . . . 70.24 109.062 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.4 mmtm -119.0 84.51 26.6 Favored Pre-proline 0 N--CA 1.454 -0.246 0 C-N-CA 126.76 2.024 . . . . 71.24 107.237 175.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -81.76 -6.73 12.47 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 124.717 3.611 . . . . 74.13 113.424 174.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.1 tt -150.94 116.4 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.455 0 O-C-N 121.063 -1.023 . . . . 72.23 108.552 -166.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -151.68 -43.28 0.11 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.666 1.186 . . . . 62.42 110.414 170.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.11 -21.67 0.02 OUTLIER Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.677 -1.068 . . . . 64.24 115.015 175.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -71.74 162.23 74.32 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-N 119.065 1.432 . . . . 74.43 112.864 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -78.36 -174.99 2.48 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.476 2.784 . . . . 74.21 111.113 175.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -114.44 158.48 21.51 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.616 1.166 . . . . 72.41 109.978 -175.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.31 3.5 p 51.41 91.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 129.896 3.278 . . . . 71.32 111.533 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.0 tp -140.96 142.3 34.35 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 113.61 -1.632 . . . . 73.44 108.224 -169.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -125.65 167.83 14.56 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 126.357 1.863 . . . . 65.4 108.448 -175.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.455 ' CD1' HG12 ' A' ' 149' ' ' VAL . 1.4 t80 -164.69 128.27 2.43 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 113.882 -1.508 . . . . 73.04 110.13 -167.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -149.82 160.34 43.64 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 129.396 3.079 . . . . 71.3 109.719 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 t -124.0 159.1 30.56 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.8 -0.815 . . . . 73.1 108.8 164.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -77.17 -23.05 51.62 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.363 -0.836 . . . . 74.23 111.255 176.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.452 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 49.8 m-85 -102.06 5.29 40.44 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.076 1.35 . . . . 72.25 114.225 -178.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 11.2 p -91.51 145.0 30.46 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 120.683 1.583 . . . . 53.23 112.646 -173.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.08 165.76 31.22 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.375 2.05 . . . . 74.44 109.191 172.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.0 m80 69.04 -48.28 0.58 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 127.057 2.143 . . . . 73.42 110.243 -169.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 39.2 m -50.63 -43.2 56.89 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.969 1.708 . . . . 73.0 111.845 -176.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -51.12 -58.05 7.12 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.624 0.77 . . . . 70.41 111.29 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -56.74 -45.3 82.05 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.193 -1.04 . . . . 73.24 108.193 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -62.55 -22.54 66.41 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 117.27 -1.348 . . . . 73.44 113.009 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -120.67 -0.45 10.22 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 121.259 1.845 . . . . 72.02 112.87 -169.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -142.71 -26.4 0.61 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.031 0.933 . . . . 74.44 112.909 -173.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 54.2 t -115.23 -69.81 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 108.035 -1.098 . . . . 74.44 108.035 -173.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.6 mt -66.07 -26.4 67.47 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.233 1.013 . . . . 74.23 110.622 173.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 44.35 53.21 6.96 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.725 1.61 . . . . 74.02 111.924 173.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.2 t -58.13 -52.0 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 114.876 -1.057 . . . . 65.42 110.743 -166.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 p -58.5 -38.49 77.76 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 119.359 0.981 . . . . 74.04 111.681 -167.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -74.34 -36.95 63.67 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.215 0.606 . . . . 72.0 110.665 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -60.36 -45.04 94.9 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.841 -0.537 . . . . 51.2 110.182 169.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.2 t -61.8 -50.39 80.4 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 CA-C-N 118.651 0.659 . . . . 73.21 109.32 175.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -51.11 -43.61 61.14 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 126.606 1.962 . . . . 75.03 111.201 -176.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -59.62 -20.05 53.29 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 114.156 1.169 . . . . 75.13 114.156 175.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -115.77 -6.52 12.11 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.35 1.46 . . . . 74.0 112.038 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mt -70.62 144.11 90.82 Favored Pre-proline 0 C--O 1.239 0.522 0 CA-C-N 119.385 0.993 . . . . 73.04 109.792 -168.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.25 152.46 30.82 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.155 2.57 . . . . 73.02 109.668 174.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.268 1.6 pt-20 -81.22 87.43 6.1 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 123.859 1.79 . . . . 74.13 109.715 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.37 -7.58 0.36 Allowed Glycine 0 C--O 1.221 -0.66 0 CA-C-N 114.792 -1.094 . . . . 73.2 111.606 -174.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.2 t -58.52 -59.66 5.02 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.515 1.657 . . . . 72.23 109.48 166.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.14 86.64 0.03 OUTLIER 'General case' 0 C--N 1.346 0.448 0 C-N-CA 126.175 1.79 . . . . 74.34 109.685 -169.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 13.7 ptp -64.18 173.28 2.02 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 112.248 -2.251 . . . . 75.23 111.039 175.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.452 HG23 ' H ' ' A' ' 58' ' ' LYS . 1.5 m -144.57 -170.33 3.36 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.118 1.767 . . . . 74.11 108.95 177.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.452 ' H ' HG23 ' A' ' 57' ' ' THR . 25.3 tttt -176.81 103.51 0.06 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.759 2.023 . . . . 74.14 108.77 -172.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -114.76 111.0 20.57 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 121.008 1.731 . . . . 70.32 108.982 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.494 ' HB2' ' CG ' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -80.7 150.39 29.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 118.813 -0.613 . . . . 73.14 110.494 176.423 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.1 m -132.99 152.45 36.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 124.508 1.123 . . . . 70.4 111.298 -171.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.18 10.59 40.67 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.987 1.315 . . . . 73.34 114.231 -171.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -62.68 -8.26 6.31 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.414 1.635 . . . . 74.42 115.414 -170.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.52 165.35 29.72 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 120.044 -1.66 . . . . 72.04 111.017 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.452 ' HA3' ' CD2' ' A' ' 29' ' ' TYR . . . 71.98 159.61 4.22 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.474 1.512 . . . . 74.12 112.373 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.1 -55.56 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.737 2.291 . . . . 71.01 109.79 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.4 mt -75.37 22.38 0.12 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.657 1.583 . . . . 65.45 112.968 -178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -52.06 -56.84 14.76 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 124.865 1.221 . . . . 72.21 111.002 -176.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -62.04 -42.03 98.74 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 117.871 0.835 . . . . 74.22 109.776 -173.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -67.79 -38.84 83.87 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.992 1.717 . . . . 61.44 108.908 -174.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.7 mt -64.75 -40.58 95.53 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.469 1.108 . . . . 74.21 112.016 172.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.7 m -61.41 -41.38 97.05 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.732 0.696 . . . . 72.01 109.694 172.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.63 -39.91 95.54 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.459 1.027 . . . . 72.43 110.624 176.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.03 -36.26 81.05 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.586 0.754 . . . . 64.22 112.317 176.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.494 ' CG ' ' HB2' ' A' ' 60' ' ' HIS . 59.6 t-105 -59.58 -40.56 87.81 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.022 0.439 . . . . 70.02 111.658 -176.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.35 -29.89 71.12 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 118.745 -0.645 . . . . 70.43 112.388 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.3 t -59.91 -44.02 93.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 119.642 1.11 . . . . 73.12 109.312 169.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.1 84.92 Favored 'General case' 0 C--N 1.34 0.176 0 O-C-N 121.665 -0.647 . . . . 73.23 111.229 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 79.3 mt -71.49 -39.87 71.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 119.136 -0.459 . . . . 73.13 109.944 176.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.87 -34.63 71.83 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.079 0.854 . . . . 72.45 111.31 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.8 mt -102.49 -3.06 27.46 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.181 0.808 . . . . 74.32 113.181 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 58.45 57.22 21.01 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.426 1.489 . . . . 64.13 111.814 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.6 m -131.15 13.65 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 126.216 1.806 . . . . 74.05 111.719 -175.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -46.92 -48.24 21.38 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 126.604 1.961 . . . . 74.41 111.682 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -68.07 -28.68 67.57 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.048 1.339 . . . . 64.3 111.196 -174.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -82.3 -27.12 32.51 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.882 1.273 . . . . 72.05 110.69 -172.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.4 pp -112.07 -2.19 10.21 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-O 117.805 -1.093 . . . . 73.03 112.347 -171.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.4 m -64.82 -56.55 12.81 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 119.784 1.175 . . . . 64.24 109.346 176.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.8 -62.03 5.31 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 123.523 0.729 . . . . 73.35 111.885 -165.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -65.69 -22.46 57.5 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.456 1.438 . . . . 73.21 113.045 -173.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 6.0 tpp -64.79 -47.41 78.19 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 124.148 0.979 . . . . 74.13 110.919 171.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -65.05 -35.12 80.14 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.197 0.908 . . . . 74.0 108.891 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -60.05 -38.3 82.4 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.451 0.569 . . . . 73.14 110.393 169.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.75 -16.58 47.44 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.04 -1.037 . . . . 73.32 112.751 -172.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.3 t -111.89 -33.94 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 124.966 1.306 . . . . 73.25 110.495 -171.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -108.57 -54.03 2.56 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.534 1.134 . . . . 64.24 110.93 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt -69.2 -55.79 9.56 Favored 'General case' 0 N--CA 1.462 0.17 0 O-C-N 121.096 -1.002 . . . . 74.45 110.66 -171.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.4 p -104.5 -23.79 13.1 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.726 0.811 . . . . 74.23 112.551 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 55.93 30.86 16.78 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.89 2.076 . . . . 72.32 112.775 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.0 t -62.69 -25.8 68.34 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.602 1.561 . . . . 65.44 112.362 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.1 t -63.01 109.8 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 122.387 1.089 . . . . 70.31 108.22 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.97 -26.4 0.79 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.121 1.769 . . . . 73.31 110.804 -171.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 m -136.99 163.95 29.5 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.577 -1.268 . . . . 74.14 107.577 168.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 85.7 t -53.75 -33.47 23.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 125.961 1.704 . . . . 65.34 109.408 173.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.8 -20.04 65.86 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.067 1.747 . . . . 70.51 112.361 -177.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.29 -49.0 8.01 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.986 0.914 . . . . 45.32 108.9 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -55.57 -48.59 77.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 125.654 1.582 . . . . 73.24 109.122 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -20.9 66.72 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.519 -0.753 . . . . 74.25 112.381 -175.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -64.32 -52.77 56.83 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 118.898 0.772 . . . . 74.43 109.594 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.4 t -55.87 -44.15 76.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 123.753 0.658 . . . . 71.22 109.571 -174.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -51.12 -55.68 16.55 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.751 0.42 . . . . 72.21 110.428 175.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 82.6 t -59.32 -47.16 91.47 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-N 118.454 0.57 . . . . 72.34 111.332 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -73.86 -30.84 62.88 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 124.068 0.855 . . . . 74.23 110.369 -168.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.0 -32.41 67.17 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.528 0.731 . . . . 65.21 110.268 170.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 145.09 23.11 0.13 Allowed Glycine 0 CA--C 1.531 1.068 0 N-CA-C 116.768 1.467 . . . . 63.45 116.768 165.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.7 t -94.2 127.42 46.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 119.245 1.522 . . . . 72.41 110.595 -177.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -53.89 116.57 2.62 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.777 0.831 . . . . 75.34 108.78 172.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.36 -24.91 64.21 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-O 118.663 -1.076 . . . . 64.52 111.243 171.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -74.75 -23.31 58.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.168 1.484 . . . . 63.15 112.27 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.86 -43.73 8.84 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 108.656 -0.868 . . . . 71.04 108.656 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -51.77 -60.65 2.92 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.271 1.428 . . . . 74.35 109.584 172.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -69.84 -14.59 62.82 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 119.718 -0.182 . . . . 72.35 111.091 -168.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -88.42 -58.72 2.45 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.72 1.208 . . . . 62.35 109.873 172.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.5 -36.82 67.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.962 1.705 . . . . 65.34 111.298 -176.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -45.11 -37.68 4.52 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 125.346 1.458 . . . . 73.33 112.189 176.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -108.43 -3.5 18.16 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.823 1.649 . . . . 73.44 113.498 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 32.6 t -81.41 155.38 25.93 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 127.563 2.345 . . . . 74.41 111.706 173.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.85 -21.52 64.28 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 112.599 -2.091 . . . . 73.14 115.778 -171.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.9 t -47.68 -55.42 2.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 C-N-CA 127.42 2.288 . . . . 74.35 106.83 167.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.1 t -71.81 -42.21 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.532 -0.758 . . . . 70.31 109.415 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -54.82 -51.08 66.96 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.448 1.022 . . . . 73.13 112.462 -177.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 67.7 m -69.83 -34.15 73.27 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.144 0.978 . . . . 72.01 111.563 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 11.9 mt -68.62 -46.46 69.19 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.647 1.112 . . . . 73.34 112.113 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 24.7 t -48.67 -53.67 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 C-N-CA 124.399 1.08 . . . . 71.22 109.681 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.35 -40.53 93.72 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 116.351 -1.785 . . . . 72.05 110.87 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -56.39 -45.91 80.37 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 122.235 2.289 . . . . 74.22 112.918 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -53.95 -57.25 11.68 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.184 -1.043 . . . . 74.21 108.184 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -79.82 -9.91 59.72 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.862 1.265 . . . . 70.05 113.983 -171.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.1 tptt -86.21 -55.23 4.02 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 107.716 -1.216 . . . . 74.21 107.716 176.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.93 -62.23 2.01 Favored 'General case' 0 N--CA 1.444 -0.733 0 O-C-N 124.646 1.216 . . . . 70.0 108.66 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -82.84 0.59 43.32 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.699 1.0 . . . . 64.43 113.699 -162.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -122.06 2.29 9.85 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 117.733 -1.127 . . . . 74.3 112.936 177.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -57.31 -85.77 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.066 0.848 . . . . 65.12 110.651 174.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 174.74 43.03 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.926 2.49 . . . . 73.12 110.705 174.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.69 -26.54 6.53 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 120.55 -1.344 . . . . 71.21 112.019 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.73 -85.96 0.58 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.571 -1.27 . . . . 74.32 107.571 -167.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 48.22 29.24 1.8 Allowed 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.428 1.091 . . . . 74.22 112.565 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -154.98 95.62 0.15 Allowed Glycine 0 C--N 1.347 1.152 0 O-C-N 120.337 -1.477 . . . . 62.02 114.826 -164.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.455 HG12 ' CD1' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -95.91 162.38 24.22 Favored Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 113.589 0.959 . . . . 74.32 113.589 -170.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.51 123.08 8.76 Favored 'Cis proline' 0 C--N 1.352 0.729 0 CA-C-N 119.025 0.687 . . . . 71.21 112.841 -5.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -103.23 141.21 36.29 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 114.6 -1.182 . . . . 70.12 112.471 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 44.5 tpp -146.44 108.63 4.42 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 127.143 2.177 . . . . 71.2 106.355 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -96.71 158.42 15.44 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 123.006 0.191 . . . . 70.12 111.502 172.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.9 t -140.75 146.93 23.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 124.352 1.061 . . . . 74.14 108.56 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 46.71 19.18 0.08 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 128.686 2.794 . . . . 54.4 114.689 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.88 -2.92 58.47 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 120.783 -1.198 . . . . 72.34 113.328 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -140.57 -7.01 1.14 Allowed 'General case' 0 C--O 1.233 0.229 0 N-CA-C 114.434 1.272 . . . . 74.2 114.434 -159.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -124.3 146.08 49.01 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.161 -1.052 . . . . 73.04 108.161 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -113.91 147.71 38.02 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.32 -1.363 . . . . 74.4 107.32 162.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -68.84 140.09 55.22 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.128 -1.064 . . . . 74.33 108.128 170.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -113.81 86.13 10.51 Favored Pre-proline 0 C--O 1.234 0.262 0 C-N-CA 123.254 0.622 . . . . 73.02 111.216 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -61.61 -24.08 77.37 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.111 1.207 . . . . 74.31 112.565 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -66.23 -31.3 72.05 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.786 1.176 . . . . 73.21 110.416 -168.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -90.52 -4.77 70.1 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.737 -1.035 . . . . 61.01 111.823 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 43.8 mtt -78.99 166.18 22.63 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 119.58 1.69 . . . . 73.11 108.69 175.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -79.4 108.96 13.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 104.663 -2.347 . . . . 71.01 104.663 171.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 40.8 p -112.96 50.23 0.89 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.948 2.099 . . . . 74.2 107.019 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 13.9 m -131.31 3.39 4.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.095 -1.412 . . . . 72.32 111.098 -167.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.03 -20.67 1.11 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 126.751 2.02 . . . . 73.34 110.645 174.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 7.9 mmt 73.09 -54.96 0.69 Allowed 'General case' 0 C--N 1.347 0.484 0 C-N-CA 126.063 1.745 . . . . 74.22 110.568 -174.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.79 -50.22 69.03 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.142 1.377 . . . . 70.04 110.531 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 79.1 t -72.18 -24.07 22.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 125.53 1.532 . . . . 71.23 111.574 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -60.16 -61.85 2.3 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.331 -0.989 . . . . 73.03 108.331 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.9 t -64.92 -33.47 63.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 O-C-N 123.367 0.417 . . . . 72.21 110.474 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.98 -42.91 69.51 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.368 0.667 . . . . 73.33 112.329 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -81.63 -40.41 22.98 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 118.492 -0.766 . . . . 65.01 110.874 176.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -54.85 -57.8 10.13 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.479 1.112 . . . . 74.31 110.154 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -55.69 -32.03 62.94 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.925 0.89 . . . . 65.44 111.571 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -65.88 -58.4 5.68 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.936 -0.394 . . . . 71.0 109.936 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.4 t -63.1 -29.96 71.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 116.93 -1.51 . . . . 65.12 110.771 -173.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 47.5 t -56.49 -56.95 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 120.138 1.335 . . . . 71.43 108.189 173.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.31 -43.46 83.28 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 124.649 1.18 . . . . 73.23 111.093 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -64.65 -30.1 71.11 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 119.001 0.819 . . . . 75.1 112.244 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 52.6 mt -74.27 -23.68 59.15 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 120.44 -1.412 . . . . 74.23 111.833 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 84.7 t -62.71 -30.21 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.646 -0.501 . . . . 73.22 109.646 174.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -99.17 -8.11 25.59 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.885 0.874 . . . . 74.04 110.872 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -110.82 77.26 1.03 Allowed 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 120.668 -1.27 . . . . 74.13 109.406 -174.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.043 0 C-N-CA 127.52 2.328 . . . . 75.22 112.634 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.468 0.44 0 N-CA-C 108.712 -0.848 . . . . 61.11 108.712 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -118.5 179.3 4.16 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 127.479 2.312 . . . . 72.21 108.383 -170.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 50.51 30.84 5.0 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.925 2.09 . . . . 71.44 113.996 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -166.25 109.74 0.77 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.12 1.768 . . . . 72.04 106.894 -177.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.422 ' C ' ' HG1' ' A' ' 4' ' ' THR . 6.4 pt -117.24 166.32 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.499 1.119 . . . . 72.43 110.349 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.422 ' HG1' ' C ' ' A' ' 3' ' ' ILE . 85.6 m -149.28 141.85 24.41 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.297 -1.372 . . . . 73.33 107.297 -177.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -59.41 149.27 29.8 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.744 0.783 . . . . 75.33 109.399 174.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.81 -21.34 2.08 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-O 117.587 -1.674 . . . . 71.45 112.629 -172.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -99.56 -69.5 0.76 Allowed 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 120.966 2.383 . . . . 74.44 110.224 -165.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -107.95 -15.91 14.42 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 123.684 0.794 . . . . 73.04 110.637 -177.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -141.86 167.99 20.83 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 108.49 -0.93 . . . . 72.15 108.49 171.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 mm -131.26 142.29 43.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 104.652 -2.351 . . . . 74.13 104.652 168.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.1 m -78.4 171.13 15.54 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 125.144 1.378 . . . . 64.34 108.354 170.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 32.9 mt -113.14 161.65 16.88 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.99 0.916 . . . . 73.33 110.467 171.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -80.37 -37.75 31.72 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.287 1.035 . . . . 75.45 108.716 -174.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -133.26 71.33 76.91 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 125.42 1.488 . . . . 74.3 110.807 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.08 74.95 5.07 Favored 'Trans proline' 0 CA--C 1.535 0.551 1 C-N-CA 125.547 4.165 . . . . 74.45 111.033 176.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.8 tt -155.0 112.5 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 O-C-N 120.656 -1.278 . . . . 63.04 109.981 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 53.38 -153.59 0.26 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.992 0.917 . . . . 70.42 109.706 -168.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.49 -61.99 0.63 Allowed Glycine 0 C--N 1.333 0.389 0 N-CA-C 108.362 -1.895 . . . . 74.13 108.362 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -121.56 162.78 34.55 Favored Pre-proline 0 C--N 1.325 -0.473 0 C-N-CA 125.987 1.715 . . . . 74.13 111.451 -173.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -72.14 -7.29 20.73 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.947 3.098 . . . . 74.42 114.262 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 63.24 179.61 0.15 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.867 1.667 . . . . 73.33 112.077 -175.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.5 m 46.36 33.87 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 127.555 2.342 . . . . 63.44 112.776 -173.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.406 HD21 ' CZ ' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -122.92 154.77 37.92 Favored 'General case' 0 CA--C 1.518 -0.287 0 O-C-N 121.352 -0.843 . . . . 65.43 113.249 -163.01 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -135.83 141.19 44.65 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 125.244 1.418 . . . . 74.01 108.101 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.406 ' CZ ' HD21 ' A' ' 23' ' ' LEU . 98.0 m-85 -127.75 137.77 52.54 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.738 1.215 . . . . 73.23 109.62 -176.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -165.38 -178.48 5.01 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.988 1.715 . . . . 74.42 109.749 -177.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.7 t -143.94 -174.48 4.28 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.776 1.23 . . . . 72.03 108.142 171.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.453 ' CD2' HD21 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -92.23 -7.66 47.58 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.507 1.299 . . . . 74.44 114.507 175.273 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.403 ' CE2' ' HA3' ' A' ' 65' ' ' GLY . 42.0 m-85 -100.29 -4.92 28.31 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.922 0.889 . . . . 73.2 112.826 175.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.7 p -80.07 140.83 53.75 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 120.681 1.582 . . . . 71.04 108.764 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -92.07 -30.74 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 CA-C-N 120.133 1.083 . . . . 75.05 111.055 -168.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -64.25 -50.08 69.38 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.952 1.701 . . . . 75.22 109.517 171.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.5 p -67.0 -22.93 65.88 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 117.582 -1.199 . . . . 70.44 111.706 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -57.21 -55.08 39.39 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 120.338 1.427 . . . . 70.34 109.312 170.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -55.05 -46.46 75.36 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 108.804 -0.813 . . . . 71.05 108.804 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -65.58 -16.45 63.72 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 116.796 -1.574 . . . . 73.21 113.324 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -116.29 -8.13 11.71 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 121.105 1.775 . . . . 74.25 111.762 -173.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -141.38 -30.15 0.62 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.75 0.82 . . . . 73.02 112.907 -163.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.2 t -115.4 -68.02 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 N-CA-C 107.466 -1.309 . . . . 72.03 107.466 -172.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.8 mt -66.44 -28.41 68.58 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.843 -1.071 . . . . 72.15 111.075 171.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 45.14 41.6 5.94 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.438 1.495 . . . . 65.22 111.833 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.2 t -50.88 -48.2 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 C-N-CA 125.79 1.636 . . . . 73.21 108.696 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.3 p -46.08 -55.71 6.58 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 124.791 1.307 . . . . 65.14 112.293 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -75.36 -34.86 61.19 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 119.913 -1.742 . . . . 64.43 110.665 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.45 -54.58 45.22 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 123.035 0.534 . . . . 65.41 110.474 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.5 t -60.82 -43.02 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 109.253 -0.647 . . . . 74.45 109.253 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.7 ttt-85 -53.72 -29.5 39.6 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.391 1.256 . . . . 74.43 114.391 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -89.78 -3.56 58.1 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.186 1.18 . . . . 65.21 114.186 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -128.12 0.03 5.83 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.929 2.092 . . . . 74.45 113.032 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.3 mt -63.11 154.37 77.79 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.378 1.471 . . . . 63.31 108.988 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.12 151.33 26.9 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.32 2.68 . . . . 74.34 108.837 172.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 45.46 24.01 0.16 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.236 2.615 . . . . 62.31 115.645 174.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.27 33.34 75.0 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-O 117.851 -1.527 . . . . 72.35 113.659 -172.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.0 m -61.59 69.62 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.775 1.63 . . . . 73.34 111.191 172.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -63.63 132.19 50.37 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 120.385 -1.447 . . . . 74.2 108.357 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -75.57 173.56 10.85 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.037 0.935 . . . . 73.11 112.178 -174.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.84 154.01 26.97 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.557 0.743 . . . . 65.04 109.368 170.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.78 102.0 6.36 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.306 1.042 . . . . 73.13 108.488 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.6 m-30 -97.0 168.22 10.6 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.348 1.059 . . . . 74.3 110.336 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.56 ' CE1' ' HB2' ' A' ' 137' ' ' GLN . 0.3 OUTLIER -101.18 172.05 7.24 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.986 1.314 . . . . 65.4 108.569 -179.249 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.9 m -140.42 145.8 25.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 107.445 -1.317 . . . . 73.21 107.445 162.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . 0.293 0.0 OUTLIER -102.37 17.97 22.21 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 129.084 2.953 . . . . 75.1 113.54 -177.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -84.18 -4.33 58.74 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.294 1.438 . . . . 62.4 114.367 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.59 145.48 51.13 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 119.827 -1.796 . . . . 74.42 110.29 -166.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.403 ' HA3' ' CE2' ' A' ' 29' ' ' TYR . . . 63.87 -178.69 7.2 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 121.375 0.431 . . . . 75.33 112.517 174.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -78.36 -46.63 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.316 2.677 . . . . 62.3 113.308 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.8 mt -79.17 31.69 0.22 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.655 1.116 . . . . 75.41 112.518 -174.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -43.24 -63.71 1.99 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 126.053 1.787 . . . . 75.2 110.689 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -63.02 -40.06 96.62 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 117.548 0.674 . . . . 73.1 110.647 -172.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.51 -42.43 92.18 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.263 1.425 . . . . 73.41 110.458 -175.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.453 HD21 ' CD2' ' A' ' 28' ' ' PHE . 18.6 mt -65.33 -45.17 85.33 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 118.533 -0.746 . . . . 73.22 111.392 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.443 ' CG2' ' CE1' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -46.78 -53.73 11.3 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.057 -1.09 . . . . 70.22 108.057 175.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -58.17 -55.89 29.09 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.945 0.898 . . . . 74.33 110.418 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.88 -43.18 72.95 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 120.186 1.357 . . . . 72.2 113.838 -176.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 14.0 t-105 -59.8 -38.0 80.71 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.341 -0.85 . . . . 74.12 111.355 -174.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.39 -38.57 71.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 118.062 -0.971 . . . . 73.2 112.557 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.6 t -57.03 -47.77 82.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 120.031 1.287 . . . . 74.21 109.933 171.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.22 -40.53 94.24 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.868 -0.52 . . . . 65.33 111.237 -176.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 85.8 mt -67.01 -38.2 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.736 0.815 . . . . 64.41 109.68 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.86 -50.61 72.73 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.858 0.863 . . . . 74.5 110.111 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 77.4 mt -76.2 -27.75 56.99 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.805 -0.559 . . . . 73.53 112.098 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.51 62.4 2.72 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 126.566 2.032 . . . . 45.42 110.603 -173.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.0 m -129.81 14.07 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 125.226 1.41 . . . . 72.2 112.303 -174.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -49.99 -51.87 38.26 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 125.064 1.346 . . . . 72.02 112.307 -169.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.62 -43.02 79.78 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.37 1.468 . . . . 73.44 110.373 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -64.05 -27.12 68.89 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 124.456 1.102 . . . . 74.1 110.609 -176.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.3 pp -116.48 27.19 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 126.847 2.059 . . . . 72.04 109.876 -176.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 89.9 m -97.67 -54.58 3.07 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.755 -1.202 . . . . 73.24 107.755 164.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.52 -62.09 3.74 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 113.721 1.008 . . . . 73.0 113.721 -172.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.37 -27.29 23.75 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.194 1.263 . . . . 72.34 111.557 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 32.6 tpp -65.07 -49.9 68.25 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.557 1.143 . . . . 73.12 109.635 -177.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -69.34 -35.63 76.09 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.49 -0.93 . . . . 74.04 108.49 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.455 ' CG ' ' HE3' ' A' ' 97' ' ' LYS . 2.6 mt-10 -65.68 -11.19 42.96 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 114.367 1.247 . . . . 70.4 114.367 169.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -109.15 1.52 20.41 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.576 1.08 . . . . 71.02 113.488 172.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.451 HG21 ' CD2' ' A' ' 28' ' ' PHE . 95.8 t -115.38 -34.66 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 117.392 -1.289 . . . . 74.43 114.04 175.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -108.84 -53.0 2.7 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 120.547 1.521 . . . . 71.34 113.401 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.455 ' HE3' ' CG ' ' A' ' 93' ' ' GLU . 2.9 mmmt -62.08 -64.54 0.9 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.479 1.911 . . . . 64.01 112.713 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.9 p -87.88 -30.66 19.97 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.736 1.384 . . . . 74.32 114.736 174.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 56.1 35.73 26.16 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 128.348 2.659 . . . . 73.42 114.432 -173.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.5 t -71.31 -22.36 61.94 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.342 0.867 . . . . 74.1 113.342 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.4 t -66.71 120.33 13.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 O-C-N 120.625 -1.297 . . . . 74.44 110.217 172.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -140.63 -28.8 0.7 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.063 -0.971 . . . . 75.01 111.633 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.83 174.39 10.58 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.539 1.063 . . . . 64.01 110.178 168.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.5 t -57.68 -41.32 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.139 0.975 . . . . 72.4 111.267 -169.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.28 -23.77 62.7 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 119.204 -0.427 . . . . 74.04 111.679 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -78.19 -30.54 49.06 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 119.044 0.838 . . . . 73.04 111.207 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.4 mt -81.8 -48.26 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 108.293 -1.003 . . . . 73.23 108.293 -174.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -18.23 60.41 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.577 0.751 . . . . 73.0 112.356 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -62.5 -56.85 14.14 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 125.43 1.492 . . . . 63.23 109.837 169.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.7 t -61.77 -34.47 62.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 118.645 -0.693 . . . . 70.14 110.804 -175.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -49.62 -60.46 2.85 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.016 -0.735 . . . . 74.33 109.016 169.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.1 t -57.09 -49.03 80.82 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-O 118.922 -0.561 . . . . 73.43 109.814 -176.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.23 -43.22 96.23 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 124.062 0.851 . . . . 73.1 110.159 -170.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.87 0.25 7.66 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.73 1.612 . . . . 74.11 112.852 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.49 44.76 1.41 Allowed Glycine 0 CA--C 1.523 0.566 0 C-N-CA 124.973 1.273 . . . . 71.5 112.917 171.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.0 t -112.38 140.8 30.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 118.977 1.388 . . . . 65.1 110.765 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -64.28 110.12 2.12 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.307 1.443 . . . . 74.5 109.134 165.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.92 -23.37 65.64 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-O 118.162 -1.354 . . . . 74.44 110.931 168.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -70.95 -23.05 62.15 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.621 1.211 . . . . 74.24 110.977 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -87.79 -46.34 9.54 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.701 -1.222 . . . . 72.41 107.701 176.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -51.97 -57.31 9.83 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.622 0.769 . . . . 65.4 109.603 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -74.7 -9.48 58.61 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.88 0.872 . . . . 65.12 112.43 -171.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -87.78 -66.15 0.94 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.909 1.283 . . . . 53.31 109.355 166.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -49.34 -43.06 43.44 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.397 2.279 . . . . 71.14 111.45 -174.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -45.55 -35.69 4.1 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 126.303 1.841 . . . . 74.23 113.507 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -116.91 8.45 13.51 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.713 1.205 . . . . 71.23 111.828 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 21.3 t -95.69 159.85 14.78 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 127.16 2.184 . . . . 72.23 110.226 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -57.14 -33.03 66.98 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.301 1.44 . . . . 65.44 111.892 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.8 t -49.57 -54.27 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 124.107 0.963 . . . . 73.22 109.912 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.5 t -63.87 -49.54 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 123.803 0.841 . . . . 65.23 110.694 176.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -49.61 -54.35 18.86 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.926 0.784 . . . . 73.24 111.549 -177.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.12 -40.0 93.89 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.102 0.561 . . . . 74.3 111.998 177.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.8 mt -60.6 -49.36 77.84 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-O 116.61 -1.662 . . . . 73.3 110.891 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 99.1 t -56.78 -37.26 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 120.199 1.363 . . . . 71.03 110.428 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.65 -28.83 70.18 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 117.763 -1.113 . . . . 72.21 112.329 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -53.47 -49.48 67.36 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 119.803 1.183 . . . . 64.31 112.097 175.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.56 ' HB2' ' CE1' ' A' ' 60' ' ' HIS . 0.5 OUTLIER -103.77 -18.96 14.46 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 118.54 -0.743 . . . . 64.11 110.636 -166.07 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -60.07 -52.82 63.73 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.922 -1.14 . . . . 75.1 107.922 158.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 32.1 tttp -61.15 -18.7 59.46 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.268 0.94 . . . . 73.11 113.181 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -114.9 1.19 13.97 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 115.816 1.784 . . . . 72.43 115.816 -176.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -139.18 -19.1 0.99 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 119.462 1.028 . . . . 72.22 111.609 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -104.7 -4.77 22.02 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 117.942 -1.027 . . . . 74.22 110.94 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -59.81 -83.03 0.02 OUTLIER 'General case' 0 C--N 1.345 0.401 0 C-N-CA 125.929 1.692 . . . . 75.32 109.934 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.2 pp -172.92 -11.18 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.106 1.521 . . . . 75.03 115.106 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -44.27 76.23 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.321 1.418 . . . . 73.23 112.556 -162.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.24 -70.05 0.79 Allowed 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 125.736 1.614 . . . . 75.02 109.561 -157.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 68.26 -3.75 1.22 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.676 1.991 . . . . 75.31 115.367 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -146.16 160.39 28.15 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 122.731 2.514 . . . . 73.0 112.709 174.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.3 m -142.23 167.01 17.8 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-N 118.532 1.166 . . . . 72.21 112.61 -174.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.35 165.21 33.51 Favored 'Cis proline' 0 C--N 1.353 0.812 0 CA-C-N 119.743 0.944 . . . . 70.33 111.911 -11.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -149.67 151.49 33.8 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.563 -0.903 . . . . 72.12 108.563 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 6.6 ttm -149.25 117.97 6.61 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.531 -1.285 . . . . 74.14 107.531 -172.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -124.22 107.04 10.78 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 125.038 1.335 . . . . 73.32 110.015 -169.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 81.5 t -64.06 -65.16 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.177 0.591 . . . . 72.32 111.672 -170.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -132.96 25.02 4.28 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.793 2.037 . . . . 74.41 108.136 -171.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 68.0 20.2 72.51 Favored Glycine 0 C--N 1.343 0.951 0 C-N-CA 124.774 1.178 . . . . 72.01 113.988 -177.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.495 ' HE2' ' CZ ' ' A' ' 158' ' ' TYR . 18.7 ptmt -138.43 -7.65 1.51 Allowed 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 115.089 1.514 . . . . 73.33 115.089 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.495 ' CZ ' ' HE2' ' A' ' 157' ' ' LYS . 22.9 m-85 -133.94 122.09 22.61 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.457 -1.683 . . . . 73.02 106.457 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.12 143.87 27.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 105.518 -2.03 . . . . 74.35 105.518 161.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -69.9 142.73 52.93 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.88 -1.155 . . . . 73.13 107.88 166.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -112.57 85.76 7.69 Favored Pre-proline 0 N--CA 1.453 -0.292 0 N-CA-C 113.024 0.75 . . . . 72.04 113.024 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.39 -19.74 37.52 Favored 'Trans proline' 0 N--CA 1.443 -1.486 0 C-N-CA 120.454 0.769 . . . . 74.23 111.1 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -61.86 -20.48 63.75 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 119.626 1.103 . . . . 75.41 112.821 -175.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -108.75 3.72 32.25 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 117.641 -1.644 . . . . 72.45 113.326 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 56.3 mtt -93.01 173.57 7.67 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.91 2.355 . . . . 70.04 111.794 -168.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.57 58.54 3.75 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 123.568 1.651 . . . . 73.41 111.764 -171.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 72.2 p -72.96 16.07 0.17 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.474 2.31 . . . . 65.34 112.851 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.4 m -94.43 -8.79 37.58 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.945 1.698 . . . . 73.32 112.707 173.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.0 -14.08 4.47 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 119.5 1.045 . . . . 73.34 113.181 -174.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 4.5 mmt 70.6 -57.66 0.58 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.591 1.957 . . . . 74.34 113.926 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.22 -48.95 68.93 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.694 -1.225 . . . . 70.33 107.694 -178.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 21.2 t -65.05 -36.81 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 124.928 1.291 . . . . 70.33 109.567 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -52.14 -60.73 2.86 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 118.262 -0.875 . . . . 74.33 110.135 172.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 8.9 t -66.76 -39.26 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 119.198 0.908 . . . . 61.11 111.392 -175.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.42 -33.97 64.01 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.617 0.767 . . . . 71.33 111.419 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -88.94 -31.4 18.19 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.393 1.077 . . . . 72.41 112.159 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -58.68 -59.64 5.09 Favored 'General case' 0 CA--C 1.528 0.099 0 O-C-N 120.8 -1.187 . . . . 73.34 108.965 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.27 -32.7 72.52 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.873 -0.517 . . . . 72.04 111.795 -175.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.96 -52.01 67.23 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.879 1.272 . . . . 74.44 111.835 174.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.0 t -64.88 -30.22 71.21 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 117.403 -1.284 . . . . 72.44 110.491 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 99.9 t -60.07 -55.89 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 120.455 1.479 . . . . 74.05 108.302 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -62.42 -33.93 75.76 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-O 118.903 -0.57 . . . . 74.42 111.979 -177.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -68.92 -33.8 74.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.645 0.657 . . . . 71.14 111.342 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 34.4 mt -67.99 -29.36 68.36 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 120.957 -1.09 . . . . 74.25 111.936 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 62.2 t -62.06 -26.03 38.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.437 0.695 . . . . 72.43 111.506 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -98.34 -18.35 18.38 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.508 0.595 . . . . 65.12 110.531 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -96.32 76.56 2.98 Favored 'General case' 0 CA--C 1.516 -0.349 0 O-C-N 121.035 -1.041 . . . . 73.01 108.851 -172.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.246 0.896 0 C-N-CA 127.832 2.453 . . . . 74.01 112.023 -174.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 16.7 m . . . . . 0 N--CA 1.464 0.273 0 CA-C-O 121.929 0.871 . . . . 71.13 109.499 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -72.47 162.57 29.3 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.788 -0.819 . . . . 64.3 108.788 164.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 49.55 34.8 7.38 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.075 1.75 . . . . 74.0 114.207 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -163.78 120.75 1.75 Allowed 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.344 -1.724 . . . . 73.32 106.344 174.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.8 pt -133.14 160.7 42.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 126.444 1.898 . . . . 74.03 109.592 177.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.5 m -140.4 144.51 36.23 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 121.607 -0.683 . . . . 73.41 109.551 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -51.37 142.04 14.18 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 127.238 2.215 . . . . 71.15 111.117 168.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.09 -22.79 2.32 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.415 1.007 . . . . 74.14 112.582 -176.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -102.38 -77.79 0.55 Allowed 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 124.129 0.971 . . . . 74.31 108.672 -165.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -100.24 -15.84 17.94 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.413 1.085 . . . . 71.14 110.719 -174.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -140.95 159.34 42.42 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.217 -0.66 . . . . 71.13 109.217 165.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.4 mm -113.55 162.55 11.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 124.762 1.225 . . . . 72.43 107.695 173.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 m -117.24 147.9 42.12 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.426 1.49 . . . . 65.45 107.603 176.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.2 mt -86.18 154.66 21.16 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.52 -0.548 . . . . 74.33 109.52 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -72.28 -37.33 69.06 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.878 1.671 . . . . 73.44 109.693 176.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -127.59 85.12 61.56 Favored Pre-proline 0 C--N 1.34 0.178 0 C-N-CA 127.479 2.312 . . . . 73.54 108.331 173.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -79.55 85.41 1.85 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.732 2.954 . . . . 74.04 109.583 168.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.4 tt -160.26 111.58 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 119.292 0.951 . . . . 73.22 109.796 170.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -157.38 -7.85 0.09 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.361 1.245 . . . . 70.12 114.361 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.69 -101.85 0.57 Allowed Glycine 0 C--N 1.338 0.645 0 O-C-N 120.524 -1.36 . . . . 70.02 109.877 -165.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 64.73 166.53 0.11 Allowed Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 125.006 1.322 . . . . 73.23 112.008 -175.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.55 178.98 6.87 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.651 2.234 . . . . 73.32 111.051 -169.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -66.86 92.4 0.23 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.38 1.072 . . . . 74.43 109.773 174.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.8 t 75.04 145.12 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 128.672 2.789 . . . . 73.24 111.206 170.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.3 tp -157.24 148.22 21.64 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.724 0.81 . . . . 73.04 109.747 -174.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -140.52 153.12 46.05 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.946 1.698 . . . . 73.43 109.262 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -133.35 139.32 46.76 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.727 1.211 . . . . 74.31 108.527 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.81 -179.71 7.81 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.285 1.834 . . . . 70.24 108.512 -177.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -158.68 161.87 37.16 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.872 0.76 . . . . 74.51 111.366 174.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -70.47 -39.83 74.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.461 1.504 . . . . 74.34 112.111 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -93.6 18.09 10.6 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.567 1.147 . . . . 74.2 111.793 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 33.8 t -88.73 141.68 30.18 Favored Pre-proline 0 CA--C 1.538 0.503 0 O-C-N 120.136 -1.603 . . . . 72.11 110.042 171.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -83.68 -46.56 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 121.73 1.62 . . . . 73.54 112.165 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -61.45 -44.06 97.77 Favored 'General case' 0 CA--C 1.528 0.115 0 O-C-N 121.56 -0.712 . . . . 74.32 109.537 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.7 m -57.02 -33.34 67.08 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.566 0.746 . . . . 72.24 112.097 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -58.93 -53.55 57.17 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.438 0.695 . . . . 70.21 110.105 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.54 -47.73 78.79 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 118.431 -0.795 . . . . 73.1 109.432 177.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -62.13 -19.83 63.43 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 116.83 -1.557 . . . . 74.12 112.341 -174.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -134.84 10.12 3.61 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 120.925 1.693 . . . . 64.43 112.11 -164.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -135.7 -41.21 0.69 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.868 2.067 . . . . 71.33 111.209 169.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 83.7 t -98.47 -74.57 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.11 0 N-CA-C 107.89 -1.152 . . . . 65.23 107.89 -168.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 65.7 mt -62.0 -28.19 69.4 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.985 1.314 . . . . 73.2 111.663 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 1.2 m170 44.36 56.76 4.76 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.669 1.988 . . . . 71.11 111.783 177.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.6 t -62.06 -44.59 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 125.293 1.437 . . . . 74.13 109.752 -174.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.9 t -53.05 -44.77 67.68 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.333 0.97 . . . . 72.12 111.99 -175.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -76.89 -29.71 55.88 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 121.194 -0.941 . . . . 72.33 111.447 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -63.23 -46.99 84.38 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.492 0.717 . . . . 73.4 110.607 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.9 t -59.53 -51.24 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 108.238 -1.023 . . . . 70.14 108.238 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 37.8 ttt-85 -47.36 -46.32 25.63 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.378 1.071 . . . . 74.44 111.948 177.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -64.89 -2.8 2.82 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.155 1.169 . . . . 74.32 114.155 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.6 mmtt -132.01 -9.9 3.42 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 127.466 2.306 . . . . 71.22 113.724 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.7 mt -66.95 144.81 98.73 Favored Pre-proline 0 C--O 1.237 0.4 0 CA-C-N 119.306 0.957 . . . . 74.15 110.882 -164.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.69 165.38 32.89 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.988 2.459 . . . . 73.25 109.78 167.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.88 23.29 0.7 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.774 1.027 . . . . 65.22 113.774 -173.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.67 18.21 22.56 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 127.139 2.304 . . . . 71.34 112.057 -173.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 t -130.08 129.39 43.53 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.462 -1.31 . . . . 72.14 107.462 -163.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -96.29 121.1 37.71 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 104.8 -2.296 . . . . 74.34 104.8 166.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 6.2 ttm -66.39 102.49 0.88 Allowed 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 125.074 1.35 . . . . 74.35 108.02 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 58' ' ' LYS . 1.5 m -120.0 -171.73 2.21 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.215 -1.032 . . . . 73.31 108.215 -173.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.413 ' H ' HG22 ' A' ' 57' ' ' THR . 0.0 OUTLIER 174.58 108.99 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.423 1.489 . . . . 71.24 108.102 -173.053 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -108.59 146.67 32.96 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.795 1.18 . . . . 74.15 109.855 174.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -82.01 168.54 17.72 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.242 1.017 . . . . 74.31 109.543 -174.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.6 m -139.03 111.12 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 119.528 1.058 . . . . 74.45 108.521 158.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.461 ' HB3' ' HG1' ' A' ' 72' ' ' THR . 0.0 OUTLIER -78.89 4.68 13.44 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 124.719 1.208 . . . . 74.31 113.183 176.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -55.77 -8.48 0.41 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.173 1.789 . . . . 73.24 113.376 169.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.8 132.07 34.19 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 125.425 1.49 . . . . 73.42 109.996 -176.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 116.59 156.54 10.7 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 126.443 1.973 . . . . 62.32 112.014 168.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -62.99 -56.12 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.47 2.113 . . . . 65.42 109.544 167.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.6 mt -91.21 34.99 0.92 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.652 1.581 . . . . 72.23 109.912 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.95 -51.89 50.41 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.508 -1.037 . . . . 70.54 110.508 175.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.9 tppm? -57.14 -40.2 76.72 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.291 1.036 . . . . 72.41 112.181 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.88 -38.63 89.29 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.852 1.661 . . . . 72.33 110.31 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.7 mt -67.36 -41.05 85.73 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 117.808 -1.092 . . . . 73.05 111.641 174.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.461 ' HG1' ' HB3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -53.03 -56.65 14.49 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.922 1.289 . . . . 72.31 108.975 -177.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -62.4 -41.93 99.05 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.409 0.684 . . . . 70.22 109.477 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.14 -30.96 69.64 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 113.443 0.905 . . . . 72.42 113.443 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 33.7 t-105 -61.56 -41.04 96.8 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 118.507 0.594 . . . . 74.45 111.518 -176.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.89 -36.31 76.67 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 117.665 -1.16 . . . . 65.23 112.492 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.2 t -55.72 -46.69 79.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 120.711 1.596 . . . . 73.12 110.796 171.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.01 -43.16 88.49 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-O 119.137 -0.459 . . . . 64.42 110.628 -175.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.2 mt -63.65 -39.87 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 118.758 -0.639 . . . . 71.34 109.965 176.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.74 -22.84 66.04 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.622 0.646 . . . . 61.21 112.279 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.2 mt -99.49 -11.78 20.76 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.214 0.916 . . . . 73.22 112.631 169.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 64.11 56.06 20.41 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 124.346 0.974 . . . . 74.03 111.372 -173.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.7 m -133.88 14.46 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 124.174 0.99 . . . . 73.34 112.107 -176.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -45.36 -56.82 4.54 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.664 1.186 . . . . 74.35 109.386 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.31 -10.33 59.64 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 125.438 1.495 . . . . 74.45 111.886 -172.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -87.32 -30.73 20.62 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 120.827 -1.17 . . . . 74.03 110.715 171.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.5 pp -100.55 -14.58 7.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 CA-C-O 117.374 -1.298 . . . . 65.21 111.463 -171.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.1 m -59.09 -51.62 69.24 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 119.967 1.258 . . . . 73.12 110.583 -175.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.15 -62.14 5.77 Favored Pre-proline 0 N--CA 1.452 -0.357 0 C-N-CA 124.569 1.147 . . . . 62.21 110.734 -168.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.05 -26.83 42.86 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 120.911 1.074 . . . . 72.2 112.397 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 4.5 tpp -60.5 -49.55 77.09 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.221 0.464 . . . . 70.43 110.185 170.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -64.58 -37.13 86.51 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.029 0.831 . . . . 74.01 109.077 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.33 -32.83 72.71 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.68 0.673 . . . . 73.24 111.666 171.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.13 -17.17 29.75 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.355 -1.466 . . . . 65.11 112.817 -176.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.4 t -100.54 -43.4 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 124.9 1.28 . . . . 73.44 109.488 -176.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -98.59 -60.62 1.51 Allowed 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.161 0.984 . . . . 61.21 110.215 -177.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.5 mmmt -65.94 -58.45 5.51 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 118.902 -0.57 . . . . 74.11 110.581 -167.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.2 p -97.18 -16.51 20.39 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.672 0.619 . . . . 73.41 112.672 -176.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 48.12 25.62 0.86 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.659 2.384 . . . . 74.14 113.885 -175.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.9 t -62.76 -16.0 55.9 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.62 1.968 . . . . 73.13 112.013 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 70.1 t -68.5 111.87 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 O-C-N 121.182 -0.949 . . . . 64.2 109.236 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -136.81 -30.12 0.9 Allowed 'General case' 0 C--O 1.239 0.524 0 C-N-CA 125.058 1.343 . . . . 73.42 110.275 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.26 162.28 33.44 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.15 -0.685 . . . . 71.55 109.15 174.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.82 -30.27 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.819 0.847 . . . . 73.13 110.138 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -47.4 -39.94 16.53 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.442 2.297 . . . . 72.51 113.31 168.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -77.55 -38.93 47.53 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.691 -0.855 . . . . 74.24 108.691 -175.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 mt -66.76 -48.33 80.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 125.103 1.361 . . . . 74.24 107.864 -174.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -57.76 -31.74 66.8 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-O 117.341 -1.314 . . . . 64.43 112.765 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -57.33 -57.12 14.04 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 119.601 1.091 . . . . 73.35 109.153 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.19 -37.73 78.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 123.371 0.419 . . . . 71.41 110.678 -173.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -53.92 -51.7 62.9 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 118.373 0.533 . . . . 70.15 110.659 172.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 90.2 t -64.18 -44.91 97.6 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-N 118.37 0.532 . . . . 71.34 110.631 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -63.14 -41.54 99.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.808 0.813 . . . . 74.24 108.939 -170.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.29 -4.31 50.17 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.144 1.378 . . . . 72.33 112.866 176.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 123.21 22.66 2.31 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 117.163 1.625 . . . . 71.02 117.163 160.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.5 t -97.61 134.23 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 119.551 1.675 . . . . 72.05 109.667 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.421 ' HE2' ' OE2' ' A' ' 119' ' ' GLU . 0.8 OUTLIER -63.51 143.59 57.7 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 121.635 -0.666 . . . . 63.15 110.138 176.31 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.54 -10.89 76.36 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 119.565 -0.575 . . . . 71.34 112.749 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.421 ' OE2' ' HE2' ' A' ' 117' ' ' LYS . 6.9 pt-20 -92.3 -32.22 15.09 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 123.903 0.881 . . . . 74.42 110.326 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -70.09 -46.59 64.55 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 107.375 -1.343 . . . . 74.41 107.375 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -54.08 -60.12 3.75 Favored 'General case' 0 N--CA 1.438 -1.046 0 O-C-N 123.876 0.735 . . . . 74.15 109.437 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -75.22 -19.47 59.76 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 118.183 -0.913 . . . . 74.35 112.145 -171.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.64 -63.91 1.24 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.374 0.988 . . . . 73.43 108.876 172.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.77 -37.86 63.88 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.359 1.064 . . . . 70.04 110.581 -173.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -45.33 -36.72 4.33 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.675 1.59 . . . . 65.04 113.308 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -114.69 1.04 14.08 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.535 1.134 . . . . 72.32 112.976 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.8 t -77.36 147.18 36.24 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 126.215 1.806 . . . . 73.42 111.097 171.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.42 -27.79 26.36 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 118.703 2.853 . . . . 72.04 118.703 174.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 46.1 t -45.48 -57.15 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 C-N-CA 126.186 1.794 . . . . 74.35 107.924 167.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.3 t -68.65 -45.45 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 123.81 0.844 . . . . 71.15 109.576 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 58.3 mttt -54.41 -48.7 71.3 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.453 1.024 . . . . 74.13 112.428 -174.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 66.0 m -79.09 -22.0 45.88 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 113.183 0.809 . . . . 73.44 113.183 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 13.4 mt -69.15 -51.41 38.53 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 119.668 1.122 . . . . 70.11 110.172 167.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 52.9 t -49.84 -51.54 15.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.162 0 C-N-CA 125.209 1.404 . . . . 74.21 108.298 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.55 -39.09 75.89 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 118.067 -0.968 . . . . 65.15 113.101 -176.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -57.9 -46.56 84.76 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 119.399 0.999 . . . . 72.05 111.169 172.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -82.22 -31.61 30.18 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.901 -1.045 . . . . 71.01 109.226 -163.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -66.12 -52.74 45.74 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.635 -0.876 . . . . 73.52 108.635 167.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.9 ttmm -61.6 -7.77 3.68 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.132 -0.98 . . . . 73.21 113.449 177.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.4 -12.07 9.42 Favored 'General case' 0 CA--C 1.515 -0.394 0 O-C-N 120.27 -1.519 . . . . 72.21 114.545 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -134.17 1.01 3.18 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 119.038 0.835 . . . . 72.15 112.633 -175.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.32 0.85 4.6 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.835 1.654 . . . . 71.42 111.248 171.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -65.12 -86.56 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.878 0.871 . . . . 74.25 111.676 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.5 pp -175.81 23.95 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.351 0.978 . . . . 74.43 112.003 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -103.75 -71.91 0.72 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 120.151 1.341 . . . . 74.13 109.539 -168.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.53 -74.12 0.4 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 126.512 1.925 . . . . 70.14 110.431 -169.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 60.27 7.62 1.32 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 128.239 2.616 . . . . 71.45 115.304 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -147.18 146.42 16.22 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 109.034 -1.627 . . . . 72.13 109.034 176.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.2 m -137.14 169.15 13.99 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 118.271 1.035 . . . . 73.54 111.005 -172.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -71.86 162.45 89.31 Favored 'Cis proline' 0 C--N 1.348 0.522 0 CA-C-N 119.596 0.892 . . . . 73.23 112.719 -10.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -150.56 156.53 41.57 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 124.252 0.97 . . . . 74.21 111.457 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 43.1 ttm -143.55 119.06 10.34 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.04 1.336 . . . . 74.33 107.749 169.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -97.36 132.02 43.48 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.927 1.291 . . . . 72.42 107.629 175.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 95.8 t -96.23 -35.8 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 113.549 0.944 . . . . 72.41 113.549 -173.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -150.9 31.61 0.62 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.819 0.819 . . . . 70.45 109.571 -177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 69.35 -64.73 0.57 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 126.194 1.854 . . . . 61.31 110.147 -162.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -58.95 -18.46 33.87 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 116.767 2.136 . . . . 74.32 116.767 -170.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -128.57 133.94 48.5 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 119.154 0.888 . . . . 74.35 111.252 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.79 137.15 52.28 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 105.773 -1.936 . . . . 74.25 105.773 175.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.07 143.11 58.07 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.744 -1.206 . . . . 73.01 107.744 176.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -124.66 75.55 64.03 Favored Pre-proline 0 C--O 1.234 0.275 0 C-N-CA 122.851 0.46 . . . . 70.03 110.22 -175.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -68.32 -22.56 39.62 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 120.831 1.021 . . . . 65.33 111.346 -172.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.55 -32.43 28.15 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 114.029 1.122 . . . . 73.43 114.029 171.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -103.13 4.78 48.98 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-O 118.325 -1.264 . . . . 70.04 112.687 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 62.1 mtt -80.3 174.49 11.55 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 119.814 1.807 . . . . 74.0 109.241 172.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -75.06 106.89 6.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.703 -1.592 . . . . 70.04 106.703 166.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 80.7 p -114.99 28.8 8.47 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.927 1.691 . . . . 72.44 109.444 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 75.2 m -108.95 -1.09 19.28 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 114.224 1.194 . . . . 54.21 114.224 -175.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.26 -9.93 4.7 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 124.386 1.074 . . . . 73.3 110.999 177.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 5.5 mmt 70.67 -58.97 0.54 Allowed 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.304 2.242 . . . . 74.4 112.262 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -58.52 -49.29 77.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 122.836 1.303 . . . . 72.1 109.699 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 93.3 t -63.56 -27.77 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 125.935 1.694 . . . . 74.14 111.433 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -64.12 -59.24 4.69 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 107.8 -1.185 . . . . 71.11 107.8 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 5.9 t -69.19 -33.0 56.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 117.626 0.194 . . . . 74.04 110.913 -172.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.13 77.87 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.036 0.534 . . . . 73.32 111.23 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -82.6 -34.35 27.66 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 118.544 -0.741 . . . . 63.34 112.218 172.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -55.9 -57.64 11.25 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 120.208 1.367 . . . . 72.04 110.471 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.67 -30.46 67.38 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.411 0.684 . . . . 62.12 111.979 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -72.38 -50.83 23.68 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.44 1.496 . . . . 73.33 109.956 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 96.2 m -55.39 -39.16 69.8 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.165 1.386 . . . . 74.22 110.731 174.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 91.3 t -59.48 -58.41 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 108.101 -1.074 . . . . 73.34 108.101 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -59.99 -35.06 74.21 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.278 -0.868 . . . . 73.3 111.309 -177.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -59.96 -44.21 94.57 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 119.523 1.056 . . . . 73.11 110.78 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 77.9 mt -67.9 -25.5 65.53 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 121.047 -1.033 . . . . 73.01 111.835 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 93.1 t -66.19 -22.08 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 O-C-N 121.253 -0.904 . . . . 74.31 111.177 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -102.96 -7.34 21.55 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.622 0.769 . . . . 72.21 110.401 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -125.94 75.72 1.53 Allowed 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.574 1.549 . . . . 74.03 109.24 -172.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.245 0.86 0 N-CA-C 106.019 -1.845 . . . . 73.45 106.019 167.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 44.8 m . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 110.511 -0.181 . . . . 65.14 110.511 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -79.65 -12.19 59.83 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.225 1.195 . . . . 74.41 114.225 -173.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -73.27 33.91 0.08 Allowed 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.377 1.471 . . . . 72.33 114.182 -166.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -159.89 120.74 3.09 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.588 -1.634 . . . . 63.13 106.588 171.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.2 pt -122.47 154.04 27.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 127.54 2.336 . . . . 73.13 106.869 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.0 m -129.21 134.77 48.14 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.075 -1.454 . . . . 72.34 107.075 -175.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -57.31 140.29 50.47 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 123.723 0.639 . . . . 72.23 109.667 170.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 84.61 -23.14 7.79 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.275 1.417 . . . . 73.34 112.587 -172.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.7 tptp -95.05 -85.53 0.31 Allowed 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 119.472 1.636 . . . . 72.31 109.092 -169.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -90.17 -19.13 24.59 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.983 0.913 . . . . 74.41 110.899 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -135.18 163.74 29.26 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.937 0.895 . . . . 73.0 109.53 171.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.5 mm -124.97 161.25 29.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 127.337 2.255 . . . . 72.31 105.525 174.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.6 m -119.68 147.61 44.36 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.804 1.242 . . . . 72.2 108.362 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 31.3 mt -76.35 155.74 33.88 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.022 -0.732 . . . . 70.41 109.022 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -71.81 -37.41 70.38 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 122.308 1.051 . . . . 74.14 109.681 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -132.91 74.76 73.6 Favored Pre-proline 0 C--N 1.339 0.129 0 C-N-CA 126.463 1.905 . . . . 74.12 109.356 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.2 137.05 39.32 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.113 1.875 . . . . 73.01 107.588 171.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.7 tp -149.71 164.85 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 108.355 -0.98 . . . . 72.13 108.355 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.01 158.04 33.89 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.991 -0.744 . . . . 65.31 108.991 167.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 122.53 -10.03 9.23 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-O 119.12 -0.822 . . . . 53.51 113.835 176.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -105.79 165.18 13.54 Favored Pre-proline 0 C--O 1.241 0.64 0 C-N-CA 125.546 1.539 . . . . 64.22 108.531 172.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -72.31 -179.71 4.27 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.46 2.107 . . . . 73.35 112.988 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.57 -46.34 90.32 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.523 1.529 . . . . 71.31 111.634 -174.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.6 m -151.06 173.14 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 127.781 2.433 . . . . 71.24 106.683 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.411 HD23 ' CE2' ' A' ' 25' ' ' PHE . 5.7 tp -162.05 169.69 20.55 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.165 -0.679 . . . . 65.32 109.165 163.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -136.72 131.02 32.91 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 106.715 -1.587 . . . . 74.02 106.715 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.411 ' CE2' HD23 ' A' ' 23' ' ' LEU . 96.0 m-85 -119.14 128.13 53.98 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 118.57 0.623 . . . . 71.21 109.82 171.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -141.18 173.32 11.6 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.503 1.121 . . . . 70.12 108.821 164.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.488 ' HA ' ' CE1' ' A' ' 60' ' ' HIS . 3.5 t -128.37 179.7 5.49 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.509 -0.552 . . . . 64.04 109.509 168.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.498 ' CD2' ' CE1' ' A' ' 60' ' ' HIS . 46.8 m-85 -87.5 -35.17 18.36 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 118.241 -0.885 . . . . 74.33 111.845 177.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.412 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 96.9 m-85 -83.84 -3.12 57.64 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 121.157 1.799 . . . . 71.05 112.891 -177.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.7 p -80.04 141.01 53.98 Favored Pre-proline 0 CA--C 1.541 0.615 0 O-C-N 119.97 -1.706 . . . . 61.31 110.143 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -83.65 -35.3 0.24 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 121.866 1.711 . . . . 73.11 113.071 -170.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.82 -48.96 72.15 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 109.464 -0.569 . . . . 71.23 109.464 172.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.6 m -52.36 -33.88 45.13 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.065 1.346 . . . . 65.14 111.556 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -63.49 -55.73 21.73 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.819 0.736 . . . . 74.11 110.863 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.79 -44.29 77.63 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 121.185 -0.947 . . . . 74.2 109.024 175.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -64.71 -15.69 61.8 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 116.057 -1.925 . . . . 74.13 111.071 -174.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -141.54 12.79 2.13 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 121.457 1.935 . . . . 73.42 114.333 -171.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -135.69 -14.63 1.88 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.653 1.581 . . . . 72.12 112.115 167.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.2 t -124.34 -82.12 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.079 0 N-CA-C 107.795 -1.187 . . . . 74.1 107.795 -175.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.03 -29.36 67.22 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.714 2.006 . . . . 74.1 111.973 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 44.34 62.48 1.99 Allowed 'General case' 0 C--O 1.241 0.621 0 C-N-CA 126.005 1.722 . . . . 74.43 110.837 178.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.7 t -63.05 -46.83 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 113.983 -1.462 . . . . 62.23 108.026 -173.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 95.2 p -49.72 -52.61 30.13 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.824 0.849 . . . . 63.4 111.014 -177.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.85 -31.8 65.01 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.132 0.573 . . . . 74.34 109.965 -171.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -64.73 -43.18 94.2 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 118.774 -0.632 . . . . 70.2 110.965 171.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.9 t -59.57 -46.89 92.65 Favored 'Isoleucine or valine' 0 C--N 1.342 0.258 0 CA-C-N 119.251 0.932 . . . . 72.11 108.993 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -50.99 -42.13 60.09 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.193 0.997 . . . . 74.13 112.262 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -61.66 -5.43 1.91 Allowed 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.998 1.481 . . . . 74.04 114.998 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -127.08 -15.63 5.25 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.969 1.708 . . . . 73.32 113.219 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.1 mt -67.71 149.68 98.17 Favored Pre-proline 0 N--CA 1.469 0.511 0 CA-C-N 119.964 1.256 . . . . 54.42 112.497 -164.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.19 151.83 27.04 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.449 2.766 . . . . 73.2 111.17 171.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -82.11 81.68 7.95 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 122.636 1.208 . . . . 74.32 109.091 -176.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 175.44 -30.42 0.08 OUTLIER Glycine 0 CA--C 1.521 0.439 0 C-N-CA 125.131 1.348 . . . . 52.33 110.665 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.7 t -44.02 -45.21 7.81 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.911 1.684 . . . . 74.44 113.398 -173.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? 59.48 99.63 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.626 1.97 . . . . 65.41 110.045 -169.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.79 125.67 25.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.361 -1.29 . . . . 73.3 107.65 172.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 m -137.32 161.71 35.51 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.075 -1.454 . . . . 74.25 107.075 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -151.51 110.45 3.87 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 104.335 -2.468 . . . . 71.25 104.335 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -104.36 136.68 43.48 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.836 -1.913 . . . . 73.22 105.836 168.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.532 ' H ' ' NE2' ' A' ' 137' ' ' GLN . 15.3 t60 -82.86 169.68 15.81 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.043 -1.095 . . . . 74.34 108.043 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.3 m -131.22 136.22 58.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 108.698 -0.853 . . . . 74.04 108.698 170.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.47 5.18 11.29 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.626 1.17 . . . . 72.13 113.015 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -72.15 -177.43 2.09 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 122.71 1.243 . . . . 73.05 112.421 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 mp 63.8 -86.37 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 130.199 3.4 . . . . 73.21 112.588 177.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.412 ' HA3' ' CD2' ' A' ' 29' ' ' TYR . . . -72.7 160.87 54.23 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 124.03 0.824 . . . . 72.41 111.323 -176.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -65.27 -54.04 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.895 3.064 . . . . 71.33 110.052 -175.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.5 mt -73.62 8.78 1.68 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 117.777 -1.106 . . . . 73.01 113.425 -176.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -47.7 -33.19 8.87 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 120.135 1.334 . . . . 72.42 113.446 -177.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -58.61 -39.97 81.98 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.768 1.025 . . . . 74.11 113.768 175.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -62.21 -47.44 84.41 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.391 -0.966 . . . . 74.23 108.391 171.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.0 mt -54.18 -50.12 67.76 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 123.893 0.746 . . . . 74.23 110.191 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.7 m -57.29 -39.48 75.82 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.277 1.431 . . . . 72.44 112.955 173.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -68.04 -50.84 52.81 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.663 0.665 . . . . 74.03 110.375 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.78 -40.26 75.57 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 126.166 1.786 . . . . 65.25 111.678 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 46.2 t-105 -56.27 -35.21 67.19 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.041 0.536 . . . . 73.14 111.821 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.45 -40.36 94.2 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.246 -0.883 . . . . 74.11 111.798 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.5 t -57.46 -46.85 85.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 119.362 0.983 . . . . 72.35 108.896 172.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.16 -41.1 97.28 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-O 118.416 -0.802 . . . . 74.14 111.701 -176.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.7 mt -66.82 -43.36 89.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 118.107 -0.949 . . . . 70.04 109.765 175.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.29 93.81 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 119.185 0.902 . . . . 64.34 110.949 -174.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.8 mt -87.62 -12.52 45.32 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 119.038 -0.506 . . . . 73.02 112.265 175.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.44 61.83 6.66 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 126.148 1.832 . . . . 53.43 111.709 -174.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.9 m -134.18 20.23 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 125.361 1.464 . . . . 72.05 111.205 -177.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -50.38 -50.47 51.44 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.225 1.01 . . . . 71.25 110.0 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.18 -28.44 69.75 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.13 1.772 . . . . 52.33 110.623 -176.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -84.72 -25.24 28.48 Favored 'General case' 0 C--O 1.227 -0.11 0 C-N-CA 123.783 0.833 . . . . 74.35 111.671 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.1 pp -99.22 -15.4 7.44 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 CA-C-O 117.315 -1.326 . . . . 73.32 112.637 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.0 m -62.68 -45.7 91.57 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 119.863 1.21 . . . . 61.45 110.264 -170.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.8 -61.37 7.04 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 123.266 0.627 . . . . 61.42 111.385 -173.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.72 -21.84 50.96 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.603 1.535 . . . . 73.13 112.735 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.98 -53.77 53.98 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.08 0.952 . . . . 74.25 110.556 173.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -66.35 -33.32 75.47 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 118.083 0.401 . . . . 73.01 111.103 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.86 -38.25 81.59 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 120.15 -0.62 . . . . 64.41 110.925 169.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -86.52 -18.4 31.66 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 121.265 -0.897 . . . . 65.22 112.214 -168.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.7 t -107.93 -28.46 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 124.758 1.223 . . . . 73.05 109.822 -173.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -118.96 -53.5 2.27 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 118.887 0.767 . . . . 74.44 111.536 -173.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -64.99 -65.48 0.67 Allowed 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 118.62 0.645 . . . . 74.13 109.27 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.6 p -94.85 -18.29 21.31 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.04 0.536 . . . . 72.34 111.733 -170.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 45.34 39.79 4.71 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.503 2.321 . . . . 74.24 112.165 -175.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.0 t -73.77 -20.16 60.57 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.588 1.155 . . . . 74.04 111.466 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 31.9 t -69.38 117.87 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 108.29 -1.004 . . . . 65.42 108.29 172.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -137.6 -24.0 1.06 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.407 1.083 . . . . 74.14 111.575 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.43 177.34 11.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.079 2.152 . . . . 65.44 109.411 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.8 t -53.47 -46.0 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.264 1.826 . . . . 70.24 109.42 -173.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.04 -23.79 35.46 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.283 1.433 . . . . 65.02 112.713 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -91.83 -28.88 17.05 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 118.261 0.482 . . . . 73.41 110.091 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.95 -46.34 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 123.205 0.602 . . . . 72.25 109.433 -175.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -25.35 61.83 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 112.932 0.715 . . . . 73.45 112.932 175.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -58.83 -52.46 65.62 Favored 'General case' 0 C--O 1.222 -0.342 0 N-CA-C 109.323 -0.621 . . . . 74.01 109.323 175.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.7 t -52.94 -43.69 47.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 123.862 0.865 . . . . 63.04 110.734 -176.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -55.1 -52.91 61.76 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.405 0.682 . . . . 74.43 110.392 175.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 96.7 t -65.64 -42.15 92.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 124.126 0.97 . . . . 72.15 111.242 -177.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.39 -51.26 65.4 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.673 1.589 . . . . 73.31 108.259 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.02 -13.64 60.89 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.408 1.083 . . . . 70.14 112.913 -178.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 118.08 32.89 1.32 Allowed Glycine 0 CA--C 1.524 0.612 0 C-N-CA 124.456 1.027 . . . . 74.25 114.92 165.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.9 t -97.96 134.96 34.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 119.452 1.626 . . . . 70.35 109.372 174.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -62.42 133.23 54.75 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.54 -1.209 . . . . 74.24 110.384 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.85 -20.73 66.81 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.061 -0.815 . . . . 70.13 111.061 168.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -76.84 -41.05 45.67 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.817 0.809 . . . . 74.44 111.163 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -69.84 -47.09 64.05 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 107.343 -1.354 . . . . 65.13 107.343 175.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -54.94 -52.48 62.87 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 123.778 0.673 . . . . 74.11 109.652 -172.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -72.24 -17.35 61.91 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.083 -1.011 . . . . 65.21 113.503 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.17 -71.56 0.47 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.074 -0.713 . . . . 74.45 109.074 172.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -46.46 -47.33 19.19 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 127.352 2.261 . . . . 64.31 109.886 -175.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 30.7 t-105 -48.77 -31.64 7.33 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.581 1.152 . . . . 73.43 113.288 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -113.05 3.18 16.01 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.277 2.231 . . . . 74.35 111.928 -176.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 21.8 m -93.93 159.11 15.32 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 126.266 1.827 . . . . 72.15 112.356 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -55.02 -34.11 63.21 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.259 1.823 . . . . 73.24 112.709 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 14.5 t -51.71 -47.6 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.259 1.024 . . . . 72.34 110.166 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.3 t -72.77 -39.87 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 117.826 -1.083 . . . . 72.05 109.547 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.45 ' HA ' ' HE2' ' A' ' 131' ' ' LYS . 8.6 mmpt? -50.86 -48.78 60.07 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 120.713 1.597 . . . . 72.12 111.697 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 64.8 m -64.01 -49.87 70.75 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 122.217 -0.302 . . . . 73.25 111.546 175.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.4 mt -65.72 -32.06 73.41 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.202 0.816 . . . . 71.21 113.202 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 37.9 t -65.51 -62.58 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 126.169 1.788 . . . . 73.14 107.765 170.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.44 -39.89 58.29 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.649 0.78 . . . . 61.25 111.39 -175.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -47.62 -62.72 1.31 Allowed 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 117.383 -1.294 . . . . 73.02 110.574 175.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.532 ' NE2' ' H ' ' A' ' 60' ' ' HIS . 3.8 pt20 -81.41 -28.39 34.32 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 120.115 1.325 . . . . 74.12 113.997 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -59.19 -38.67 80.42 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 120.189 1.359 . . . . 74.14 108.736 176.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 8.4 tttt -79.46 -53.71 6.62 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.534 -0.729 . . . . 72.24 111.427 171.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.73 -6.95 6.35 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 117.255 -1.355 . . . . 73.24 113.704 -171.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.97 16.71 10.89 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.053 1.341 . . . . 65.22 113.457 172.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.13 4.61 1.08 Allowed 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.468 -0.77 . . . . 70.34 112.71 174.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.13 -79.04 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.535 1.134 . . . . 70.24 110.891 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -174.86 50.73 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.146 2.179 . . . . 71.05 110.359 175.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.506 ' NE2' ' H ' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -127.65 -55.2 1.32 Allowed 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.199 -0.938 . . . . 71.01 112.898 -175.24 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.506 ' H ' ' NE2' ' A' ' 145' ' ' GLN . 0.9 OUTLIER -147.18 143.69 28.39 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 128.08 2.552 . . . . 74.43 105.915 -172.435 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -137.33 14.91 3.0 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.11 0.964 . . . . 74.42 111.664 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -155.84 168.83 33.46 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.795 -1.322 . . . . 63.34 109.795 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.9 m -147.6 168.88 10.28 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.469 1.108 . . . . 73.42 111.102 -166.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.18 160.87 88.55 Favored 'Cis proline' 0 C--N 1.35 0.648 0 CA-C-N 119.953 1.019 . . . . 74.02 112.696 -9.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -149.61 154.51 38.77 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.611 0.764 . . . . 71.01 111.262 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 29.8 ttm -142.24 121.92 13.41 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.301 1.44 . . . . 70.32 107.258 172.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -94.28 152.62 18.54 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.737 1.615 . . . . 74.24 109.271 177.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.1 t -140.26 140.72 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.181 0.592 . . . . 73.04 109.948 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 44.67 30.34 0.51 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 129.17 2.988 . . . . 73.34 114.017 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 64.91 9.36 39.74 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.937 -0.924 . . . . 63.41 114.684 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -148.3 -2.8 0.51 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.431 1.615 . . . . 71.1 114.982 -165.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -131.07 161.84 31.15 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.931 1.292 . . . . 74.2 108.682 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -136.86 141.39 42.81 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.418 -1.697 . . . . 65.0 106.418 171.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.17 151.44 46.98 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 107.318 -1.364 . . . . 71.12 107.318 176.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -120.37 82.97 32.4 Favored Pre-proline 0 N--CA 1.462 0.138 0 CA-C-N 118.497 0.59 . . . . 72.03 111.474 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.48 -15.02 45.94 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 121.602 1.534 . . . . 74.32 113.608 175.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -90.21 -5.63 56.16 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 125.686 1.594 . . . . 74.41 111.225 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -117.67 18.01 11.91 Favored Glycine 0 CA--C 1.526 0.724 0 O-C-N 121.081 -1.012 . . . . 65.12 112.518 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 64.0 mtt -101.37 170.01 8.51 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.711 1.256 . . . . 70.23 110.398 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -66.05 120.92 13.99 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 105.893 -1.892 . . . . 74.13 105.893 158.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.432 1.1 t -136.38 63.01 1.6 Allowed 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 105.652 -1.981 . . . . 70.22 105.652 175.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.2 t -129.91 -15.77 3.79 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.171 1.788 . . . . 65.1 113.258 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -127.28 -3.32 6.24 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.0 1.273 . . . . 71.41 112.334 -174.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 7.9 mmt 62.81 -43.04 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 131.543 3.937 . . . . 74.3 114.618 -177.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.98 -48.84 33.0 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.281 -1.007 . . . . 73.22 108.281 -176.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 71.5 t -61.32 -28.57 44.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 125.342 1.457 . . . . 74.13 111.769 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -63.39 -57.69 9.51 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.167 -1.049 . . . . 74.1 108.167 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.9 t -74.67 -28.62 22.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 119.472 -0.299 . . . . 73.43 110.947 -175.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.97 -40.82 73.82 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.123 0.969 . . . . 65.01 110.761 175.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -83.87 -42.55 16.26 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 117.803 -1.094 . . . . 74.21 111.413 174.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -50.48 -55.65 15.04 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 120.202 1.365 . . . . 70.44 110.224 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -54.27 -34.51 60.98 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.902 0.881 . . . . 70.34 112.401 -177.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -78.47 -52.27 8.78 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.208 0.603 . . . . 74.32 109.852 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.2 t -58.03 -28.77 64.78 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-O 117.74 -1.124 . . . . 71.4 110.861 -176.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 61.0 t -54.95 -57.4 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 118.777 0.717 . . . . 74.22 109.463 170.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -32.2 71.84 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 119.1 0.864 . . . . 70.44 111.96 -178.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -60.11 -31.88 70.46 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 119.045 0.839 . . . . 73.0 110.527 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 29.0 mt -73.39 -28.41 62.0 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.342 -0.849 . . . . 65.23 111.793 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 74.9 t -65.53 -23.25 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.901 0.88 . . . . 73.0 111.306 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -99.15 -17.9 17.95 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.127 0.571 . . . . 74.43 109.962 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -102.77 77.74 1.62 Allowed 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 125.232 1.413 . . . . 72.34 108.526 -171.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? . . . . . 0 C--O 1.249 1.046 0 CA-C-O 114.502 -2.666 . . . . 73.04 112.962 -178.715 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.826 0.346 . . . . 73.04 110.87 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 58.47 178.42 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 61.0 110.889 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 51.75 42.58 29.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 71.04 111.112 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -175.17 110.45 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 71.44 110.933 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 pt -122.12 164.08 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 72.32 111.115 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.7 m -138.24 142.74 39.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 74.2 111.101 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -65.1 132.9 50.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 70.01 110.873 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.15 6.22 81.97 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.753 . . . . 72.52 112.518 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -117.47 -74.59 0.6 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.717 0.294 . . . . 72.23 110.839 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -101.19 -19.36 15.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.433 . . . . 74.14 110.918 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -144.66 157.9 44.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 73.03 110.942 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.8 mm -129.69 160.76 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 74.31 111.149 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.54 138.21 52.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 74.11 111.154 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 19.7 mt -67.84 151.67 46.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 75.12 110.827 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.14 -27.03 48.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 74.22 110.858 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -140.11 66.58 31.94 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.597 0.713 . . . . 75.55 110.913 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 77.07 1.08 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.652 2.234 . . . . 75.44 112.419 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.6 tt -158.29 122.1 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 73.45 111.123 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -179.29 -67.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 64.33 111.077 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -141.01 -60.53 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.861 -0.685 . . . . 75.02 112.541 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 51.44 66.65 5.04 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.665 0.745 . . . . 74.04 110.875 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -54.55 0.22 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.619 2.213 . . . . 74.21 112.35 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.515 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 1.9 tt0 177.38 79.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 74.11 110.858 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.515 ' CG2' ' O ' ' A' ' 21' ' ' GLN . 2.9 m 51.8 167.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.426 . . . . 71.42 111.154 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.7 tp -178.03 151.99 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 75.11 110.898 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -128.55 166.42 18.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 70.25 110.902 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -144.45 136.69 26.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 74.44 110.866 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -173.14 147.63 1.6 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 64.51 110.931 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.3 t -101.1 -168.28 1.54 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 52.04 110.863 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -115.8 -8.45 11.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 74.1 110.884 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -113.76 18.59 17.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 74.43 110.911 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.8 p -103.38 138.61 19.59 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.567 0.698 . . . . 72.52 110.892 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.91 -41.84 3.75 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.707 2.271 . . . . 74.52 112.268 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -59.42 -64.22 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 72.22 110.789 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.6 p -49.78 -32.55 14.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.464 . . . . 74.51 110.885 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -63.75 -53.07 56.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 65.24 110.896 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -67.61 -11.01 57.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 74.41 110.864 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -104.08 0.94 30.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.31 -0.404 . . . . 73.1 110.924 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -141.53 13.1 2.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 74.14 110.913 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -141.99 -52.39 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 71.14 110.921 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 67.6 t -92.8 -78.42 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 72.23 111.114 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.8 mt -59.33 -41.44 89.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 73.11 110.841 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 53.8 72.43 0.44 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 73.01 110.856 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 80.0 t -72.51 -33.89 46.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 74.4 111.124 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.5 t -52.74 -42.59 65.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 70.22 110.796 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -82.72 2.29 34.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.119 -0.492 . . . . 73.23 110.939 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -102.7 -21.36 14.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 73.33 110.867 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -85.14 -53.92 9.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 73.3 110.929 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -46.59 -33.57 4.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 74.11 110.922 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -71.16 -30.95 67.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.481 . . . . 74.13 110.947 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 46' ' ' VAL . 4.2 mmmt -121.17 28.13 8.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 74.23 110.915 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 46' ' ' VAL . 12.5 mt -104.42 144.24 28.31 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.59 0.709 . . . . 71.13 110.885 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.82 159.12 54.54 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.713 2.275 . . . . 74.34 112.23 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.94 59.35 2.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 73.25 110.848 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.45 35.68 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.779 -0.724 . . . . 71.01 112.438 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.9 t -103.07 -30.71 10.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.811 0.339 . . . . 60.03 111.129 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 62.89 107.65 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 73.25 110.928 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.75 102.03 8.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 72.22 110.93 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.36 -178.94 3.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 72.34 111.185 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.7 mttm 178.33 110.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 72.43 110.888 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -101.14 124.49 46.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 74.22 110.939 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.84 175.14 0.52 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 71.34 110.862 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.6 m -154.97 129.72 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 74.22 111.115 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.24 75.46 0.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 74.13 110.91 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -135.94 3.81 2.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 74.54 110.908 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.05 163.65 32.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.481 . . . . 72.31 110.906 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.84 155.25 0.12 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 70.52 112.465 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -42.83 3.09 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.642 2.228 . . . . 74.23 112.418 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.7 mt -93.83 38.7 1.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.457 . . . . 74.53 110.968 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.32 -20.32 75.08 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.804 -0.713 . . . . 63.51 112.498 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -85.38 -33.94 21.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.801 0.334 . . . . 73.53 110.903 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.38 -46.82 72.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 65.52 110.849 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mt -60.74 -37.49 81.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 72.24 110.918 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -50.14 -65.41 0.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 71.35 111.156 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -51.16 -44.33 61.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 74.24 110.837 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.91 -35.92 64.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.406 . . . . 63.15 111.138 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 13.0 t-105 -53.66 -48.55 69.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 72.54 110.949 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.44 -41.83 41.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 75.25 111.1 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 74.7 t -61.33 -34.35 60.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.263 -0.426 . . . . 72.42 111.122 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.92 -35.59 64.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 61.23 111.103 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -79.12 -33.13 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 74.34 111.092 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.77 -34.34 77.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 75.13 111.064 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.5 mt -98.86 -21.66 16.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 74.12 110.915 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.98 57.05 3.12 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.806 -0.711 . . . . 75.21 112.512 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.5 m -143.97 39.87 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.735 0.303 . . . . 64.15 111.115 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.04 -54.07 30.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 73.43 110.839 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.73 -17.82 57.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 65.44 110.827 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.8 mtpt -83.62 -27.18 29.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 71.04 110.891 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.5 pp -114.08 41.32 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 74.41 111.122 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 66.8 m -118.46 -26.82 6.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 73.51 111.147 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.454 ' N ' ' HD2' ' A' ' 90' ' ' PRO . . . -69.9 -60.99 3.22 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.593 0.711 . . . . 65.02 111.033 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 89' ' ' ALA . 53.4 Cg_endo -69.72 -30.59 22.24 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.721 2.281 . . . . 73.42 112.309 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 33.4 tpp -60.39 -29.73 69.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.439 . . . . 71.32 110.869 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -90.41 -33.94 15.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.288 -0.414 . . . . 74.44 110.883 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -76.8 -8.69 57.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 73.43 110.881 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -111.69 0.83 16.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 70.52 111.088 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 65.7 t -121.15 -30.65 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 74.22 111.149 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -110.5 -57.99 2.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 74.5 110.853 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -58.54 -76.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 74.22 110.838 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.4 p -83.49 -33.49 25.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 74.4 111.089 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 62.11 34.52 16.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 74.12 110.948 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.3 t -66.35 -19.79 65.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 72.54 111.142 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.5 t -64.36 115.29 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.32 -0.4 . . . . 73.32 111.07 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -131.4 -39.68 1.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 65.23 110.937 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.49 166.04 22.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 62.13 110.817 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.0 t -57.87 -21.69 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.112 -0.495 . . . . 71.12 111.129 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.78 -5.29 52.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 62.15 111.128 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -108.42 -24.37 11.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 74.54 110.864 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.3 mt -84.37 -25.17 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 73.43 111.111 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.83 -26.61 49.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 74.34 110.811 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -62.5 -53.99 46.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.42 . . . . 72.34 110.883 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.8 t -50.62 -45.02 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.255 -0.429 . . . . 74.3 111.114 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -54.38 -48.28 71.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 74.45 110.905 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 89.7 t -69.37 -42.15 81.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 74.23 111.156 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.81 -22.33 35.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 72.5 110.877 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -86.09 -27.82 24.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 63.34 111.096 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.8 -20.54 1.63 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.787 -0.72 . . . . 65.13 112.523 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 93.9 t -51.46 133.79 12.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.896 0.379 . . . . 71.44 111.123 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.59 139.56 37.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 73.42 110.878 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.69 -8.18 59.87 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.693 -0.765 . . . . 53.13 112.481 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -90.0 -30.14 17.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.829 0.347 . . . . 75.25 110.908 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -88.69 -34.56 17.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 75.23 110.855 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -75.73 -30.63 59.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.472 . . . . 75.54 110.931 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -88.55 -10.84 47.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 73.45 110.834 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -106.12 -60.29 1.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 42.43 111.058 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.17 -38.33 57.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 71.05 111.141 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 21.7 t-105 -48.45 -39.68 23.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.43 . . . . 75.42 110.956 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -110.84 39.13 2.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 73.31 110.932 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 75.2 m -123.87 166.17 16.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 74.24 110.913 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -64.38 -34.63 78.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 75.41 110.862 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 38.6 t -50.15 -50.81 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 75.31 111.108 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 41.0 t -72.8 -33.78 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.125 -0.488 . . . . 71.45 111.103 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.4 -59.01 6.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 73.13 110.895 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.19 -42.45 63.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 75.55 110.869 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.5 mt -58.66 -59.99 4.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 75.51 110.888 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 39.9 t -48.4 -36.46 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 71.24 111.046 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.81 -49.3 71.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 64.22 111.093 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 47.4 mm-40 -54.15 -51.17 65.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 75.11 110.977 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -67.19 -50.39 61.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 74.14 110.957 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -59.16 -20.09 50.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 74.25 110.877 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -101.96 -15.36 16.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 63.35 110.893 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -100.5 -6.16 25.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 63.44 111.1 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.65 -4.45 8.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 74.53 111.143 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -120.47 0.11 10.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 73.23 111.138 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -69.98 -84.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 71.13 110.838 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 174.63 36.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.405 . . . . 74.55 110.896 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.7 -15.37 8.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 74.44 110.945 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -164.15 146.87 9.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 73.43 110.837 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -152.56 20.05 0.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 74.11 110.906 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -144.9 167.1 27.3 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.793 -0.718 . . . . 65.54 112.467 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.498 ' HA ' ' C ' ' A' ' 150' ' ' PRO . 2.3 m -154.28 158.48 32.38 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.579 0.704 . . . . 73.23 111.187 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 149' ' ' VAL . 54.4 Cg_endo -69.64 167.74 69.62 Favored 'Cis proline' 0 C--N 1.341 0.153 0 C-N-CA 122.644 -1.815 . . . . 72.12 112.4 -0.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -157.27 109.26 2.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 74.45 111.04 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 2.5 ttm -106.11 114.93 29.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.419 . . . . 74.41 110.888 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -94.33 129.21 41.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 75.23 110.898 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 31.9 t -108.9 121.86 62.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.49 . . . . 75.25 111.09 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 74.39 -60.16 0.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 75.25 110.88 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 151.02 -15.9 0.9 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.841 -0.695 . . . . 73.43 112.476 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.75 39.18 4.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.756 0.312 . . . . 74.11 110.904 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -153.29 155.93 37.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 72.04 110.926 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -144.68 115.43 7.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 64.35 110.89 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -51.34 140.36 17.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 74.02 110.903 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -122.33 76.62 43.68 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.607 0.718 . . . . 70.21 110.873 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -7.52 21.26 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.656 2.237 . . . . 63.51 112.393 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.27 -25.33 54.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 72.51 110.896 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -95.36 -8.95 58.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.777 -0.725 . . . . 70.22 112.503 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 6.9 mtt -77.6 173.35 12.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.784 0.326 . . . . 74.54 110.858 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -85.16 87.35 7.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 70.3 110.897 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 19.4 p -93.05 39.44 1.04 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 74.33 111.162 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.8 m -109.37 -14.16 14.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 73.2 110.864 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.38 -16.51 9.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 73.34 110.851 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 7.4 mmt 71.94 -64.85 0.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 73.43 110.882 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.42 -45.68 69.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 73.44 110.849 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 63.6 t -69.83 -36.35 69.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 72.42 111.105 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -55.53 -70.06 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 64.01 110.822 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 21.7 t -54.59 -37.95 40.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 72.31 111.13 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.2 -43.67 61.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 70.43 111.129 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -80.62 -33.48 35.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 70.3 110.884 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -51.35 -65.94 0.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 74.34 110.923 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.85 -25.12 10.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 65.11 111.056 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -70.55 -55.12 9.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 72.24 110.86 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.1 t -65.36 -29.06 69.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 73.23 111.13 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 84.1 t -68.39 -39.28 80.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 73.31 111.073 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.54 -21.89 41.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 75.44 110.907 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.3 -20.87 39.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.422 . . . . 70.12 110.853 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.74 -35.56 38.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.302 -0.408 . . . . 74.13 110.889 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 87.0 t -59.77 -23.25 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 75.42 111.15 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -109.69 -5.24 15.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 73.22 110.846 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -105.7 28.96 6.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 75.41 110.921 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 74.35 110.832 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 14.6 t . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 118.683 -0.675 . . . . 74.31 109.968 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -138.96 21.01 2.64 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.793 1.179 . . . . 65.43 112.89 -164.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -68.17 38.52 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.931 1.693 . . . . 74.31 114.781 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -155.51 106.47 2.53 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 127.979 2.512 . . . . 70.32 107.255 -161.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.7 pt -129.44 149.45 33.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 127.219 2.208 . . . . 71.21 106.884 178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.4 m -109.35 130.48 55.49 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.209 -1.034 . . . . 74.14 108.209 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -44.3 124.31 3.95 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 126.505 1.922 . . . . 70.35 110.155 159.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.67 -15.06 53.92 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 126.945 2.212 . . . . 74.41 113.653 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -95.02 -85.88 0.3 Allowed 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 119.98 1.89 . . . . 74.14 108.154 -174.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -85.75 -16.64 38.24 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.971 0.805 . . . . 71.23 111.394 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -139.64 163.1 33.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.637 0.375 . . . . 73.44 110.601 172.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.8 mm -120.64 158.18 23.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.651 -1.611 . . . . 74.23 106.651 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.4 m -109.56 134.47 51.88 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 126.001 1.72 . . . . 71.35 107.606 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.2 mt -84.04 144.9 28.78 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 108.031 -1.1 . . . . 73.33 108.031 172.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -76.08 -31.61 58.84 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.191 1.396 . . . . 74.44 111.397 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm -127.84 74.29 78.63 Favored Pre-proline 0 N--CA 1.455 -0.19 0 C-N-CA 125.439 1.496 . . . . 74.42 109.026 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -79.71 63.14 8.7 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.319 2.679 . . . . 63.41 109.511 174.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.6 tt -162.26 99.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 O-C-N 120.935 -1.103 . . . . 75.33 109.436 172.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.29 -169.33 2.93 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.035 2.134 . . . . 74.15 107.133 166.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.27 22.59 37.82 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 124.615 1.102 . . . . 64.13 112.725 -177.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -69.74 158.98 85.72 Favored Pre-proline 0 N--CA 1.451 -0.396 0 CA-C-N 117.649 0.724 . . . . 72.44 110.497 170.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.88 154.85 66.79 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 121.145 1.23 . . . . 74.12 110.47 173.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -66.69 -19.09 65.68 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 118.114 -0.946 . . . . 75.14 112.705 -175.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.3 p -154.85 141.91 12.26 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 CA-C-N 120.194 1.361 . . . . 72.13 109.67 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -169.2 172.17 7.53 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.394 1.078 . . . . 74.03 110.953 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -130.75 148.55 52.55 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.585 1.954 . . . . 74.24 107.632 154.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -115.24 143.0 45.91 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.502 1.521 . . . . 73.43 107.658 164.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -153.77 165.63 35.41 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.326 1.451 . . . . 73.34 108.607 175.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.86 179.15 4.05 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.918 1.287 . . . . 74.31 108.249 175.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -97.54 -23.71 15.89 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.913 -0.492 . . . . 72.33 110.638 171.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -105.82 12.64 30.57 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.748 1.619 . . . . 74.45 111.876 -177.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.7 p -84.11 143.76 43.11 Favored Pre-proline 0 CA--C 1.541 0.602 0 O-C-N 120.274 -1.516 . . . . 74.15 109.562 167.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -83.11 -33.69 0.39 Allowed 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 121.832 1.688 . . . . 74.33 110.005 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -49.48 -60.57 2.73 Favored 'General case' 0 C--N 1.337 0.062 0 C-N-CA 125.881 1.673 . . . . 74.11 110.155 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 23.6 p -62.74 -34.72 77.78 Favored 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 123.227 0.611 . . . . 74.02 111.088 -176.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -56.45 -52.27 65.31 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.886 -0.783 . . . . 74.44 108.886 173.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -57.66 -44.78 85.96 Favored 'General case' 0 C--O 1.224 -0.248 0 O-C-N 121.081 -1.012 . . . . 71.2 109.174 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -68.05 -12.99 61.85 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.411 1.084 . . . . 74.11 113.231 -174.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -130.76 2.77 4.46 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.181 1.355 . . . . 73.43 110.747 -166.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -144.44 -48.01 0.26 Allowed 'General case' 0 C--N 1.345 0.408 0 C-N-CA 125.574 1.549 . . . . 72.44 112.527 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.1 t -91.87 -72.63 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 105.898 -1.89 . . . . 74.42 105.898 -173.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.8 mt -73.1 -26.08 61.12 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.043 1.737 . . . . 74.01 111.981 -175.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 29.2 m80 44.72 60.07 3.08 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 122.752 1.263 . . . . 71.24 112.118 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.4 t -57.92 -54.8 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.437 1.495 . . . . 65.02 107.334 170.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.71 -43.18 36.96 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.338 1.055 . . . . 72.32 113.329 -178.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -73.61 -42.55 61.35 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.256 -0.903 . . . . 74.24 110.836 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -56.77 -51.99 66.78 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 123.507 0.723 . . . . 72.41 110.098 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.6 t -61.64 -43.88 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 108.364 -0.976 . . . . 73.23 108.364 -175.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -49.93 -46.03 51.71 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.717 1.598 . . . . 74.22 112.553 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -61.4 -20.97 63.66 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.751 1.019 . . . . 74.4 113.751 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -114.01 -7.17 13.12 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.089 0.956 . . . . 71.42 111.816 -175.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.1 mt -70.65 143.75 90.25 Favored Pre-proline 0 C--O 1.239 0.501 0 O-C-N 120.881 -1.137 . . . . 74.42 109.416 -173.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -76.31 169.57 21.71 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.777 2.318 . . . . 71.23 108.905 167.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.46 ' CD ' ' H ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -82.82 23.09 0.85 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 124.774 1.229 . . . . 73.02 113.44 -176.11 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -119.81 -19.04 4.17 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 126.61 2.052 . . . . 61.35 111.725 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 77.6 m -121.09 101.55 7.74 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 106.838 -1.541 . . . . 72.15 106.838 -164.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -87.68 126.62 35.07 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.55 0.74 . . . . 74.42 109.913 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.02 45.75 0.28 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.415 1.886 . . . . 74.42 112.426 171.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.4 m -53.99 145.04 17.49 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.926 1.291 . . . . 74.24 108.651 173.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -131.55 99.46 4.81 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.152 -1.055 . . . . 73.32 108.152 -166.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -95.37 150.61 20.09 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.319 1.048 . . . . 75.04 110.066 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.469 ' CE1' ' HB2' ' A' ' 137' ' ' GLN . 0.3 OUTLIER -88.0 175.58 7.7 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.451 -0.944 . . . . 65.13 108.451 -176.153 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -145.0 163.28 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 107.563 -1.273 . . . . 74.51 107.563 156.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.61 -5.42 10.72 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.654 1.182 . . . . 71.11 113.607 -174.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -58.15 -11.23 2.41 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.489 1.915 . . . . 74.32 115.244 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 mp -127.81 137.61 52.44 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 120.916 1.689 . . . . 73.54 110.702 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.96 170.44 45.27 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.746 2.117 . . . . 50.03 112.291 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.72 -53.21 0.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 124.514 3.476 . . . . 73.31 111.675 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mt -84.4 14.32 4.57 Favored 'General case' 0 CA--C 1.528 0.104 0 N-CA-C 113.887 1.069 . . . . 73.54 113.887 -165.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -53.57 -38.9 59.33 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-O 118.873 -0.96 . . . . 65.22 112.846 -163.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp -53.6 -38.1 63.65 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.937 1.695 . . . . 61.25 113.327 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -76.3 -45.35 32.81 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 118.614 -0.707 . . . . 72.13 109.154 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.4 mt -54.98 -37.32 66.38 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 118.789 -0.624 . . . . 73.25 110.646 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.435 ' CG2' ' CE1' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -57.49 -52.9 63.52 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.987 0.915 . . . . 74.33 109.086 177.292 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -69.18 -50.44 47.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.294 -0.632 . . . . 74.43 109.294 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.0 -37.17 63.73 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.553 1.07 . . . . 71.34 113.607 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 29.8 t-105 -59.85 -38.37 81.89 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 119.759 1.163 . . . . 74.55 112.016 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.94 -39.66 74.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 118.633 -0.698 . . . . 73.43 111.31 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.3 t -56.41 -49.22 78.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 118.817 0.735 . . . . 74.53 109.543 174.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.97 -40.27 97.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 118.677 -0.678 . . . . 74.45 111.018 -175.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.0 mt -69.24 -40.27 80.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 118.157 -0.925 . . . . 73.45 110.417 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.36 -30.83 69.8 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.097 0.862 . . . . 74.05 110.818 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.7 mt -94.29 -14.99 24.86 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.824 0.85 . . . . 74.44 112.532 175.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 59.94 64.32 4.29 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 126.306 1.908 . . . . 71.43 112.3 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.9 m -137.42 19.9 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 124.362 1.065 . . . . 71.45 112.217 -177.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -50.69 -52.34 40.95 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.563 1.074 . . . . 74.42 111.251 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -60.07 -17.08 36.93 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.866 1.666 . . . . 72.14 114.219 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -94.85 -9.16 35.19 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.275 1.03 . . . . 73.21 110.748 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.5 pp -136.1 33.53 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 125.033 1.333 . . . . 72.44 110.875 -173.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 52.5 m -111.47 -41.62 4.07 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 118.8 -0.619 . . . . 73.22 110.382 177.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.85 -60.64 5.98 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 119.183 0.901 . . . . 74.1 110.958 -175.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -62.53 -28.1 77.23 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 120.541 0.828 . . . . 72.51 111.286 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 29.4 tpp -59.41 -50.55 73.53 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.374 1.07 . . . . 74.24 110.846 176.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -72.34 -31.21 65.45 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.949 0.9 . . . . 74.13 109.786 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.65 -36.8 81.85 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.726 0.694 . . . . 74.41 109.626 171.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -85.91 -13.1 48.82 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.322 -0.861 . . . . 74.33 112.239 -176.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.7 t -101.5 -39.29 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 125.382 1.473 . . . . 72.23 111.722 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -109.78 -59.35 1.93 Allowed 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.544 1.137 . . . . 71.34 109.296 -172.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -67.0 -50.96 60.61 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 118.45 -0.786 . . . . 74.14 111.164 -169.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.9 p -104.86 -19.68 13.81 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 123.691 0.619 . . . . 74.53 112.658 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 53.72 23.76 3.9 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.51 1.924 . . . . 71.31 113.903 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -66.14 -18.16 65.17 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.361 1.064 . . . . 73.4 111.539 -173.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.0 t -62.13 119.56 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 121.141 -0.975 . . . . 71.25 108.479 171.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -141.54 -26.52 0.69 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.899 1.28 . . . . 71.42 111.377 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.37 160.92 39.11 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.179 -1.415 . . . . 73.51 107.179 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.2 t -57.65 -28.05 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.722 0.809 . . . . 74.22 110.718 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.9 -29.91 71.04 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.365 1.466 . . . . 74.43 110.185 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.92 -19.36 24.64 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.266 0.626 . . . . 65.51 111.385 -175.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.4 mt -82.57 -45.03 19.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 123.855 0.862 . . . . 72.21 108.958 174.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -59.57 -26.49 65.45 Favored 'General case' 0 C--N 1.346 0.441 0 O-C-N 121.557 -0.715 . . . . 74.53 112.299 -176.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -54.93 -55.24 32.86 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.301 1.04 . . . . 74.43 110.442 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.9 t -52.84 -45.64 50.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 124.933 1.293 . . . . 73.32 109.975 -175.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -55.8 -54.07 48.91 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.659 0.784 . . . . 74.15 110.149 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 17.5 t -66.59 -38.51 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 118.024 0.375 . . . . 73.41 110.27 -174.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -63.5 -32.01 73.34 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.126 0.971 . . . . 74.23 111.068 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -83.8 -3.38 57.81 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.673 1.189 . . . . 74.34 113.838 173.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.2 14.48 16.55 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-N 119.558 1.072 . . . . 70.13 115.332 171.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.9 t -77.66 128.28 38.15 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.055 0 CA-C-N 119.593 1.696 . . . . 71.11 108.545 172.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -57.26 129.38 41.5 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.686 -0.857 . . . . 73.35 108.686 170.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -59.55 -22.82 57.41 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 118.173 -1.349 . . . . 61.51 112.341 173.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.4 -23.41 21.07 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.876 1.338 . . . . 75.25 110.764 -177.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -70.59 -42.49 70.96 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 107.457 -1.312 . . . . 64.55 107.457 177.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -61.54 -59.47 5.17 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 124.181 0.926 . . . . 73.21 110.028 177.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -66.55 -16.73 64.37 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.276 0.489 . . . . 61.42 111.336 -176.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.43 -64.98 0.95 Allowed 'General case' 0 C--N 1.341 0.21 0 O-C-N 121.092 -1.005 . . . . 73.54 109.023 169.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.28 -43.35 64.4 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.272 1.029 . . . . 72.44 110.246 -175.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -46.07 -41.54 12.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.675 1.59 . . . . 73.25 112.23 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -103.94 -2.47 26.08 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.995 1.318 . . . . 63.14 111.553 -173.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.8 t -84.91 157.05 20.96 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 127.017 2.127 . . . . 72.21 111.495 -175.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -57.76 -31.15 66.22 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 125.505 1.522 . . . . 73.53 111.552 169.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 42.3 t -52.68 -50.1 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 119.248 0.931 . . . . 75.15 108.933 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.4 t -68.99 -39.89 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-O 118.923 -0.561 . . . . 75.34 110.42 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -53.71 -51.48 63.14 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.187 0.903 . . . . 74.44 110.685 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 t -67.34 -37.07 82.68 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.346 1.059 . . . . 64.51 111.207 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.88 -53.24 49.78 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-O 117.493 -1.241 . . . . 75.11 110.753 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 53.4 t -52.19 -38.74 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.178 1.391 . . . . 72.14 110.405 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.7 -34.77 76.34 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 118.361 -0.828 . . . . 75.14 112.777 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -55.32 -58.52 7.39 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.795 0.725 . . . . 73.45 110.655 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.469 ' HB2' ' CE1' ' A' ' 60' ' ' HIS . 0.9 OUTLIER -84.68 -33.3 23.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.182 -0.913 . . . . 75.35 110.951 -168.344 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -57.43 -52.92 63.41 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 119.145 0.884 . . . . 75.34 109.11 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -55.06 -48.49 73.4 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 110.144 -0.317 . . . . 75.42 110.144 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.9 -12.04 15.99 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 113.763 1.023 . . . . 75.25 113.763 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -130.14 18.65 5.46 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.809 1.244 . . . . 75.33 111.724 176.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -132.23 2.39 3.9 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.424 1.89 . . . . 73.42 111.651 173.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -83.51 22.77 1.01 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.036 1.734 . . . . 71.51 111.276 169.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 62.92 -16.89 0.05 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 130.375 3.47 . . . . 73.12 117.342 -175.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.56 -26.22 50.69 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 119.997 1.271 . . . . 73.43 111.942 -167.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 tt -134.56 111.98 10.49 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 126.2 1.8 . . . . 73.24 106.414 -173.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -140.63 22.09 2.33 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 127.306 2.242 . . . . 73.12 108.619 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -162.86 114.21 0.59 Allowed Glycine 0 C--N 1.337 0.595 0 N-CA-C 109.943 -1.263 . . . . 64.15 109.943 -171.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.7 m -120.91 171.01 6.37 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 118.239 1.02 . . . . 73.21 110.386 -176.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -68.97 153.65 90.99 Favored 'Cis proline' 0 N--CA 1.456 -0.679 0 CA-C-N 120.342 1.158 . . . . 71.53 111.237 -4.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -146.81 108.6 4.36 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.564 -0.902 . . . . 64.43 108.564 -173.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 39.0 ttm -101.57 135.02 43.79 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.963 -1.125 . . . . 73.42 107.963 173.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -123.18 154.23 38.98 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.534 1.534 . . . . 74.23 107.982 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 96.6 t -115.23 -48.09 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 112.9 0.704 . . . . 73.11 112.9 -163.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -144.55 33.2 1.17 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 128.16 2.584 . . . . 74.44 107.609 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 65.63 5.33 23.27 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.469 1.509 . . . . 74.13 115.759 -175.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -124.57 -16.3 6.32 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 120.357 2.079 . . . . 75.12 114.725 -172.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -126.79 124.28 39.32 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.701 -1.592 . . . . 73.01 106.701 -176.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -98.69 135.47 40.14 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 105.706 -1.961 . . . . 74.22 105.706 172.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -74.91 146.0 42.2 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.936 -0.765 . . . . 73.33 108.936 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -119.6 85.24 32.16 Favored Pre-proline 0 C--O 1.233 0.211 0 N-CA-C 112.864 0.691 . . . . 72.33 112.864 -175.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -67.11 -22.13 47.79 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 121.282 1.321 . . . . 73.3 113.614 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.7 tp60 -68.68 -34.29 75.42 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 119.79 1.177 . . . . 73.0 110.093 176.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -92.02 30.76 6.4 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-O 118.966 -0.908 . . . . 64.44 111.177 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.6 mtt -122.04 176.35 5.85 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 118.681 1.241 . . . . 72.11 109.567 173.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.424 ' C ' ' H ' ' A' ' 168' ' ' SER . 0.4 OUTLIER -86.64 64.89 8.76 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 123.279 1.514 . . . . 74.44 111.075 -172.39 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 21.0 p -74.9 40.53 0.15 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 129.217 3.007 . . . . 70.42 110.901 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.424 ' H ' ' C ' ' A' ' 166' ' ' ASP . 3.8 m -124.06 -3.5 8.07 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.34 1.456 . . . . 72.22 111.646 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.78 -10.31 2.08 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.484 1.114 . . . . 70.03 112.029 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 8.7 mmt 70.81 -56.69 0.61 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.625 1.97 . . . . 74.0 114.315 174.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.34 -45.61 75.87 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.782 -1.192 . . . . 74.23 107.782 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 82.5 t -63.15 -31.37 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.488 1.515 . . . . 74.14 111.577 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -60.21 -56.01 26.84 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.014 -0.736 . . . . 73.01 109.014 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 t -70.74 -34.43 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 119.145 -0.455 . . . . 74.34 110.775 -176.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.72 -35.31 63.54 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.507 0.723 . . . . 74.31 110.77 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.405 HE22 ' HB2' ' A' ' 166' ' ' ASP . 39.7 mt-30 -78.87 -44.67 22.34 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.699 1.199 . . . . 74.34 112.741 168.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -56.97 -58.04 9.9 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.716 1.144 . . . . 73.1 111.349 -173.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -55.68 -31.84 62.74 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.561 -0.733 . . . . 54.2 112.149 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -68.34 -58.15 4.82 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.8 0.727 . . . . 74.42 109.869 177.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.9 t -60.53 -29.26 69.01 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 119.064 -0.493 . . . . 74.11 110.554 -172.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 98.0 t -55.42 -57.23 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.318 -0.993 . . . . 74.23 108.318 171.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.63 -46.3 90.39 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.129 0.972 . . . . 74.14 111.16 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -60.26 -18.49 49.39 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.267 1.427 . . . . 73.4 113.383 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 69.1 mt -92.56 -23.33 19.09 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 121.508 -0.745 . . . . 75.43 112.927 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 66.8 t -63.14 -35.81 73.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.068 -0.716 . . . . 72.15 109.068 174.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -83.58 -18.41 38.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.417 -0.81 . . . . 71.12 110.142 -172.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.305 0.0 OUTLIER -77.75 15.78 0.79 Allowed 'General case' 0 CA--C 1.545 0.759 0 O-C-N 120.751 -1.218 . . . . 74.32 113.776 -168.101 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.433 -1.279 0 C-N-CA 129.4 3.08 . . . . 75.01 109.422 -152.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.468 0.453 0 N-CA-C 109.05 -0.722 . . . . 74.23 109.05 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -112.58 7.73 18.94 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.351 1.461 . . . . 75.43 112.096 -171.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -72.24 43.44 0.1 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.301 1.84 . . . . 70.14 112.815 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.22 122.2 4.98 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 104.205 -2.517 . . . . 72.43 104.205 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.1 pt -126.77 156.89 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 126.519 1.927 . . . . 74.25 107.33 170.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 99.4 m -135.08 130.34 35.39 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.639 1.575 . . . . 72.43 106.76 -171.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -57.35 137.43 56.1 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.315 -0.624 . . . . 73.43 109.315 171.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.74 -21.97 12.97 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.21 1.386 . . . . 64.42 113.217 -171.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -99.9 -85.58 0.4 Allowed 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 119.895 1.848 . . . . 74.52 109.004 -172.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -88.93 -14.17 37.31 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.656 1.116 . . . . 72.42 111.509 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -138.24 170.77 15.44 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.766 0.826 . . . . 71.24 109.587 169.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.4 mm -128.4 154.24 38.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 105.771 -1.937 . . . . 74.55 105.771 170.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.0 m -108.88 140.22 42.65 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.711 1.605 . . . . 73.42 108.357 175.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 74.5 mt -79.38 142.07 36.33 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.176 -1.046 . . . . 74.42 108.176 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -70.72 -40.91 72.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 122.612 1.196 . . . . 74.41 109.17 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -125.73 83.82 61.71 Favored Pre-proline 0 N--CA 1.455 -0.193 0 C-N-CA 127.345 2.258 . . . . 70.41 107.12 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -77.46 69.45 7.22 Favored 'Trans proline' 0 N--CA 1.444 -1.408 0 C-N-CA 123.923 3.082 . . . . 74.51 108.579 170.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.6 mt -134.08 148.48 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 107.118 -1.438 . . . . 74.52 107.118 172.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 174.46 -80.13 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.925 2.49 . . . . 65.42 108.679 147.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 159.04 37.76 0.02 OUTLIER Glycine 0 C--N 1.333 0.416 0 CA-C-O 118.575 -1.125 . . . . 73.11 113.826 -174.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -113.73 161.61 26.75 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 107.184 -1.413 . . . . 74.13 107.184 168.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.11 169.81 21.76 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 CA-C-N 120.128 1.081 . . . . 70.21 113.514 -157.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -68.49 16.64 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 127.699 2.4 . . . . 71.34 114.47 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.5 p -171.88 125.62 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 127.402 2.281 . . . . 73.43 107.337 177.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.431 HD22 ' CE2' ' A' ' 25' ' ' PHE . 2.8 tp -166.53 160.56 15.4 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 120.036 1.289 . . . . 73.53 112.456 172.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -141.36 136.04 31.07 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.045 1.338 . . . . 74.33 108.237 -171.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.431 ' CE2' HD22 ' A' ' 23' ' ' LEU . 83.3 m-85 -128.63 140.98 51.5 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.981 2.112 . . . . 74.13 109.874 -176.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -151.39 177.55 10.17 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 128.54 2.736 . . . . 74.25 107.97 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.3 t -139.29 -177.07 4.75 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.474 -0.766 . . . . 73.05 109.852 155.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -84.11 -51.79 6.79 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.626 1.57 . . . . 74.41 109.473 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -80.44 -13.83 58.8 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.265 0.839 . . . . 73.35 113.265 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.7 p -69.51 145.0 94.96 Favored Pre-proline 0 C--O 1.237 0.409 0 CA-C-N 119.743 1.156 . . . . 53.43 110.867 -175.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -70.7 175.61 8.64 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 121.251 1.301 . . . . 72.55 109.682 164.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 68.85 -55.08 0.55 Allowed 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 127.495 2.318 . . . . 71.41 111.218 -175.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 32.4 m -44.67 -41.03 6.37 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.133 2.173 . . . . 75.33 110.741 174.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -53.52 -68.4 0.18 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.303 1.841 . . . . 74.42 111.036 174.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.14 -44.28 71.27 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.726 -0.842 . . . . 75.53 108.726 -175.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -64.86 -13.11 55.19 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 116.532 -1.699 . . . . 74.53 113.046 -175.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -139.79 19.46 2.5 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 121.022 1.737 . . . . 73.43 112.62 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -136.58 -46.56 0.61 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.412 1.485 . . . . 75.13 111.685 171.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.5 t -101.16 -69.29 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.124 0 N-CA-C 107.753 -1.203 . . . . 75.34 107.753 -168.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 73.5 mt -71.01 -33.83 70.75 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.435 1.094 . . . . 74.13 111.813 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 44.36 54.18 6.39 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.313 1.445 . . . . 74.55 111.326 -169.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 81.9 t -52.26 -47.28 45.43 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 C-N-CA 125.285 1.434 . . . . 75.33 109.554 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.4 t -49.47 -43.74 45.35 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.33 2.252 . . . . 72.23 112.122 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -87.02 -17.6 32.58 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.156 -1.59 . . . . 65.03 112.952 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -74.3 -46.34 41.74 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.058 -0.719 . . . . 72.43 109.058 169.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 95.0 t -57.66 -44.31 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 124.789 1.235 . . . . 73.42 109.61 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -46.59 -43.97 17.73 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.833 0.853 . . . . 74.55 112.305 177.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -67.6 -12.65 60.89 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.281 1.586 . . . . 73.45 115.281 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -111.36 -7.65 14.37 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.044 1.338 . . . . 74.21 113.312 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.7 mt -68.89 144.87 96.29 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 118.996 0.816 . . . . 74.14 112.057 -168.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.0 160.0 37.23 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.096 2.531 . . . . 73.14 111.019 168.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.98 27.7 0.07 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.264 1.426 . . . . 65.44 114.312 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -144.72 25.4 1.96 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 126.292 1.901 . . . . 73.21 112.262 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.2 m -146.16 73.19 1.32 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.683 -1.228 . . . . 73.34 107.683 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.6 mttm -59.92 145.95 44.05 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 122.043 0.925 . . . . 74.43 112.014 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -76.3 114.33 14.88 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.387 -1.338 . . . . 74.01 107.387 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.7 m -124.27 163.72 21.06 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.065 -1.087 . . . . 72.05 108.065 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -161.68 100.11 1.15 Allowed 'General case' 0 C--N 1.332 -0.165 0 O-C-N 120.022 -1.674 . . . . 74.42 107.306 -165.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -98.7 160.83 14.0 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.03 -1.044 . . . . 73.24 109.769 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.548 ' CD2' ' HA ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -102.93 165.36 11.08 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.612 1.565 . . . . 74.21 109.321 174.524 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.6 m -132.96 153.03 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 122.229 1.014 . . . . 75.34 110.217 156.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.68 2.78 55.64 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 130.244 3.418 . . . . 62.44 113.765 176.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -69.14 -8.99 50.55 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 115.41 1.633 . . . . 74.25 115.41 -168.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 mp -137.92 153.37 49.52 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 120.614 1.552 . . . . 62.12 110.543 -171.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.65 170.99 29.69 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 123.93 0.776 . . . . 55.54 113.751 173.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.52 -44.69 4.23 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.928 3.085 . . . . 74.32 111.851 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.9 mt -97.0 27.41 4.05 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 125.258 1.423 . . . . 74.2 110.868 -167.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -44.83 -56.77 5.65 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.01 1.291 . . . . 75.1 111.595 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.8 tptt -63.34 -40.0 96.1 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 118.024 0.912 . . . . 55.31 111.841 -177.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -65.21 -44.82 87.09 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.423 1.089 . . . . 74.43 109.731 -176.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.3 mt -62.17 -33.35 74.36 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.974 0.91 . . . . 74.1 110.824 174.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.548 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 27.3 m -77.88 3.52 14.23 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 127.689 2.396 . . . . 72.04 111.429 175.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -116.75 -24.61 7.64 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 119.181 -2.2 . . . . 73.43 110.747 169.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.65 -28.31 61.71 Favored 'General case' 0 N--CA 1.457 -0.112 0 O-C-N 120.758 -1.213 . . . . 52.53 114.053 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 39.2 t-105 -65.87 -40.01 91.24 Favored 'General case' 0 C--N 1.331 -0.201 0 O-C-N 121.386 -0.821 . . . . 74.22 110.377 -173.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.13 -37.98 84.76 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.707 1.203 . . . . 65.33 111.969 -178.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.4 t -51.44 -51.57 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 119.277 0.944 . . . . 74.13 109.412 171.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.43 -32.17 62.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 117.152 -1.404 . . . . 70.2 112.091 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.1 mt -63.56 -38.91 83.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 120.903 1.683 . . . . 72.45 110.406 170.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.09 -49.69 76.3 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 119.043 0.838 . . . . 73.2 110.057 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.21 -9.76 59.73 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 112.137 0.421 . . . . 73.31 112.137 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.61 57.9 13.08 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 126.872 2.177 . . . . 72.24 111.757 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.3 m -129.46 18.64 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 125.507 1.523 . . . . 74.12 111.071 -175.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -51.88 -48.06 64.26 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.42 1.009 . . . . 74.35 110.072 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -61.81 -15.25 40.15 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 128.041 2.536 . . . . 74.25 114.997 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -98.13 -16.02 19.7 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.857 0.863 . . . . 73.11 109.514 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp -126.72 21.34 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 125.282 1.433 . . . . 72.11 110.646 -175.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 93.6 m -80.31 -59.85 2.55 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 109.143 -0.688 . . . . 74.42 109.143 173.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.71 -61.78 6.66 Favored Pre-proline 0 N--CA 1.453 -0.321 0 C-N-CA 125.384 1.474 . . . . 62.34 110.272 -166.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.14 -22.31 54.44 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 120.645 0.897 . . . . 64.4 112.505 -174.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 5.2 tpp -59.61 -49.81 76.31 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.981 0.513 . . . . 75.03 110.702 170.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -64.23 -39.5 94.1 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.127 -0.983 . . . . 75.32 111.558 176.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.91 -27.82 68.46 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 120.491 -0.483 . . . . 71.24 111.497 171.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.19 -11.23 33.21 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 120.952 -1.092 . . . . 73.4 112.748 -173.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.5 t -117.39 -27.47 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 C-N-CA 124.633 1.173 . . . . 73.2 110.629 -173.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -115.44 -48.71 2.78 Favored 'General case' 0 C--N 1.336 -0.02 0 CA-C-N 118.87 0.759 . . . . 75.22 110.789 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -73.8 -65.51 0.82 Allowed 'General case' 0 C--O 1.23 0.06 0 CA-C-N 118.692 0.678 . . . . 73.43 111.015 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.4 p -83.43 -31.99 26.32 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.713 -0.617 . . . . 64.33 110.29 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 56.53 23.72 7.89 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.198 1.799 . . . . 75.42 112.558 -171.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -71.27 -12.22 61.34 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.588 1.155 . . . . 75.21 112.601 -171.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 26.7 t -63.97 109.3 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 O-C-N 120.808 -1.182 . . . . 75.4 109.329 168.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -132.04 -22.22 2.32 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.751 0.82 . . . . 71.44 112.624 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.26 165.77 26.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.68 1.992 . . . . 72.22 107.413 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 91.7 t -51.78 -44.96 37.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.393 1.077 . . . . 75.04 108.971 172.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.51 1.39 0.56 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.016 2.126 . . . . 72.21 115.422 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -106.91 -29.52 9.42 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 119.653 1.115 . . . . 64.41 109.321 170.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -81.81 -24.1 9.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 O-C-N 121.057 -1.027 . . . . 61.41 111.01 -172.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -40.5 97.43 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.345 -0.983 . . . . 75.33 108.345 172.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -55.41 -49.46 72.31 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 123.929 0.768 . . . . 72.32 109.703 -164.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 47.0 t -54.47 -48.31 69.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.286 1.434 . . . . 73.31 111.511 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -56.41 -55.54 32.3 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 109.175 -0.676 . . . . 73.42 109.175 176.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 93.3 t -59.01 -44.53 91.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 122.917 0.487 . . . . 74.42 109.868 -172.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -62.02 -45.79 92.03 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.176 1.391 . . . . 74.22 108.526 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.22 -0.11 11.23 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.965 1.306 . . . . 71.0 112.723 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 109.86 36.12 2.08 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 119.879 1.218 . . . . 43.3 114.154 173.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.1 t -107.55 130.47 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 118.556 1.178 . . . . 74.24 109.536 173.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt -62.15 118.92 8.01 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.321 -0.992 . . . . 73.1 108.321 166.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.69 -22.51 68.17 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 119.063 -0.854 . . . . 74.21 111.138 173.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -65.52 -35.14 79.99 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.151 0.975 . . . . 73.22 111.25 175.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -83.25 -34.18 25.88 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.872 -1.159 . . . . 73.11 107.872 -172.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -51.01 -67.64 0.24 Allowed 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.995 1.318 . . . . 74.3 110.3 165.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -66.39 -11.55 52.05 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.248 0.547 . . . . 62.14 111.656 -170.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.38 -74.85 0.35 Allowed 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.315 1.046 . . . . 74.3 109.484 169.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.4 -32.28 68.48 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 118.966 -0.54 . . . . 73.23 111.758 -169.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 60.6 t-105 -47.76 -34.81 8.96 Favored 'General case' 0 CA--C 1.523 -0.069 0 C-N-CA 124.718 1.207 . . . . 74.2 112.199 174.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -109.28 1.31 20.06 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.999 1.319 . . . . 73.02 111.728 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 5.7 t -105.98 151.64 24.35 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 124.197 1.951 . . . . 73.4 110.492 -174.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . 0.268 0.1 OUTLIER -57.12 -26.04 59.84 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 117.781 2.511 . . . . 71.43 117.781 -171.66 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 86.4 t -44.37 -56.82 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 C-N-CA 127.667 2.387 . . . . 74.4 108.159 167.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.2 t -73.35 -42.72 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 124.169 0.988 . . . . 73.42 109.277 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -56.11 -49.04 74.98 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.683 1.129 . . . . 72.3 111.45 -173.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 72.3 m -77.48 -25.36 50.36 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 117.999 -1.0 . . . . 74.24 112.89 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.6 mt -65.02 -52.38 56.33 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 120.335 1.425 . . . . 73.42 110.25 170.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 40.9 t -45.81 -43.44 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.757 2.023 . . . . 71.33 110.937 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.57 -41.67 70.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.165 0.586 . . . . 62.41 111.877 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -53.13 -49.82 65.77 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 123.723 0.809 . . . . 61.34 112.737 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.438 ' HB2' ' CE1' ' A' ' 60' ' ' HIS . 0.6 OUTLIER -98.08 -20.26 17.46 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 118.883 -0.58 . . . . 65.14 110.967 -171.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -62.5 -50.48 71.24 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 107.855 -1.165 . . . . 71.42 107.855 167.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -55.83 -57.27 12.73 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.956 0.903 . . . . 73.45 110.94 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.76 6.36 2.58 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.424 1.268 . . . . 74.41 114.424 -175.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -106.25 -40.9 5.48 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.884 1.274 . . . . 71.14 110.601 160.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.03 -32.6 74.21 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.418 1.087 . . . . 75.55 112.889 -171.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -71.15 3.99 3.11 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.045 1.338 . . . . 60.54 113.125 -175.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.6 mt 74.78 1.94 3.91 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.746 2.018 . . . . 75.44 112.159 170.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.402 HE21 ' N ' ' A' ' 146' ' ' LEU . 0.0 OUTLIER -61.25 -16.9 50.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 129.851 3.26 . . . . 74.34 113.729 -179.133 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.402 ' N ' HE21 ' A' ' 145' ' ' GLN . 0.6 OUTLIER -155.55 126.27 6.92 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 128.773 2.829 . . . . 75.51 103.52 -172.068 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -139.29 5.08 2.26 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.142 0.577 . . . . 73.24 111.591 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -133.91 163.08 24.53 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.951 1.262 . . . . 73.13 109.957 171.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.26 164.69 33.86 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.095 0.958 . . . . 75.55 109.34 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.71 162.33 81.15 Favored 'Cis proline' 0 N--CA 1.455 -0.747 0 CA-C-N 119.313 0.79 . . . . 72.44 111.506 -13.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -146.41 127.19 14.37 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.076 -0.965 . . . . 72.21 109.026 175.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 42.7 ttm -112.78 109.99 19.82 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 105.587 -2.005 . . . . 73.24 105.587 169.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -77.94 165.7 23.76 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.678 -1.23 . . . . 74.41 107.678 166.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.4 t -125.46 -86.37 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 N-CA-C 107.635 -1.246 . . . . 70.24 107.635 167.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -88.96 35.94 0.8 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 120.565 1.53 . . . . 73.11 111.256 -171.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 68.13 -73.57 0.29 Allowed Glycine 0 C--N 1.338 0.646 0 N-CA-C 109.265 -1.534 . . . . 65.55 109.265 -160.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 12.7 ptmt -55.47 -4.92 0.11 Allowed 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 128.533 2.733 . . . . 74.12 116.641 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -124.34 143.94 50.3 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 120.2 1.364 . . . . 74.45 109.106 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -128.32 138.45 52.39 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.075 -1.454 . . . . 73.25 107.075 171.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -65.42 133.19 50.79 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.108 -1.441 . . . . 75.25 107.108 175.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -104.52 86.08 1.31 Allowed Pre-proline 0 C--O 1.236 0.355 0 C-N-CA 124.171 0.988 . . . . 72.53 112.035 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.02 -20.93 43.9 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 CA-C-N 119.931 1.011 . . . . 73.25 113.479 -177.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -72.61 -38.45 67.79 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 120.838 1.654 . . . . 74.54 109.406 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -78.48 3.78 62.02 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 118.762 0.71 . . . . 71.42 113.051 -177.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 55.3 mtt -90.29 168.14 12.13 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 118.746 1.273 . . . . 72.23 109.367 174.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -81.04 114.54 19.97 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 105.999 -1.852 . . . . 74.32 105.999 167.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.1 p -107.6 6.73 28.17 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 127.298 2.239 . . . . 61.54 109.983 -175.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.5 m -92.84 3.56 55.46 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 113.616 0.969 . . . . 64.34 113.616 -166.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.0 -4.71 1.52 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.499 1.12 . . . . 73.44 111.657 -176.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 7.6 mmt 67.64 -61.89 0.35 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.416 1.886 . . . . 75.51 112.926 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.28 -42.53 88.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 119.978 1.263 . . . . 75.22 109.229 -176.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 66.5 t -61.92 -28.34 44.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 123.713 0.805 . . . . 74.53 110.951 174.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -64.27 -61.28 2.34 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 107.974 -1.121 . . . . 73.24 107.974 177.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.3 t -67.89 -32.2 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 119.289 -0.386 . . . . 73.44 111.086 -174.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.06 -47.12 68.72 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.76 1.224 . . . . 71.11 110.86 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -81.46 -38.27 26.66 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 118.252 -0.88 . . . . 64.54 111.658 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -54.82 -60.2 3.69 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.593 1.088 . . . . 75.41 110.209 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.14 -26.09 64.43 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.825 0.85 . . . . 62.22 112.249 -173.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -77.29 -54.42 6.5 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.101 0.56 . . . . 71.52 109.815 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.2 t -58.94 -25.57 63.61 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-O 117.741 -1.123 . . . . 75.14 111.516 -176.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 59.3 t -54.55 -57.64 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 118.944 0.793 . . . . 72.53 109.046 171.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? -62.89 -36.95 85.0 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.993 -0.442 . . . . 74.21 110.222 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -66.6 -30.73 71.08 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 123.859 0.864 . . . . 70.41 110.821 -173.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 47.1 mt -71.01 -31.84 68.46 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.027 -1.046 . . . . 73.42 111.375 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 85.4 t -66.1 -24.21 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 O-C-N 121.756 -0.59 . . . . 72.43 110.876 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -97.07 -5.77 36.72 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.332 1.053 . . . . 73.15 110.253 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -120.79 87.14 2.7 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 125.925 1.69 . . . . 72.55 107.871 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 37.5 mttm . . . . . 0 C--O 1.251 1.158 0 C-N-CA 127.069 2.147 . . . . 71.24 110.917 175.51 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.465 0.325 0 N-CA-C 107.265 -1.383 . . . . 72.43 107.265 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -68.67 170.7 8.86 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 118.313 0.506 . . . . 73.13 109.67 -174.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 56.88 38.18 29.26 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.051 0.94 . . . . 70.23 112.871 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -141.97 110.77 6.19 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.873 -1.899 . . . . 65.1 105.873 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.437 HG21 HE22 ' A' ' 183' ' ' GLN . 4.8 pt -143.09 164.97 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 130.966 3.706 . . . . 72.22 107.721 -178.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.9 m -139.17 148.86 43.74 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.876 1.67 . . . . 72.42 108.247 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -57.76 148.72 24.08 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.174 1.79 . . . . 64.01 111.065 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.63 -23.38 0.81 Allowed Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.832 1.206 . . . . 74.24 112.878 -171.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.2 tttp -90.23 -85.21 0.22 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 118.831 1.316 . . . . 74.12 108.539 -160.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -98.88 -7.13 27.73 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.021 0.929 . . . . 74.32 111.337 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -144.6 163.55 33.59 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.81 -1.182 . . . . 71.44 107.81 169.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.6 mm -124.8 157.09 33.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 106.264 -1.754 . . . . 74.33 106.264 169.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.45 171.53 14.61 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 127.295 2.238 . . . . 74.23 109.3 165.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.9 mt -108.24 159.6 16.5 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.359 1.064 . . . . 74.03 111.02 173.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -62.73 -44.6 95.79 Favored 'General case' 0 C--O 1.227 -0.096 0 N-CA-C 108.9 -0.778 . . . . 73.23 108.9 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -131.24 81.55 65.47 Favored Pre-proline 0 C--N 1.339 0.112 0 C-N-CA 127.015 2.126 . . . . 72.42 107.547 -173.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -80.16 63.82 8.8 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.662 2.242 . . . . 70.31 110.812 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.9 mp -96.18 152.79 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 O-C-N 120.55 -1.344 . . . . 72.11 109.899 -174.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.08 113.99 3.45 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.986 1.314 . . . . 64.03 109.281 175.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.52 -171.44 39.2 Favored Glycine 0 C--O 1.226 -0.406 0 N-CA-C 108.527 -1.829 . . . . 70.12 108.527 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . 0.308 0.8 OUTLIER 59.05 166.67 0.08 OUTLIER Pre-proline 0 C--O 1.241 0.638 0 N-CA-C 114.986 1.476 . . . . 72.54 114.986 176.02 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -66.86 78.81 0.38 Allowed 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.305 2.003 . . . . 71.42 109.717 167.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -51.62 -21.24 2.45 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 127.414 2.286 . . . . 70.1 115.509 -169.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.0 t -134.51 87.64 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 105.929 -1.878 . . . . 72.5 105.929 -175.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 tt -147.15 157.82 43.73 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.221 -1.029 . . . . 72.31 108.221 -172.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -125.44 149.58 48.09 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.92 1.288 . . . . 62.3 107.958 170.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -127.38 145.55 50.77 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.16 0.984 . . . . 73.43 108.95 169.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -153.72 -177.8 6.62 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 128.326 2.651 . . . . 74.53 106.98 168.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 10.6 t -133.4 179.85 5.95 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 121.351 -0.843 . . . . 72.4 108.745 170.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -82.43 -28.8 31.12 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.995 2.518 . . . . 74.21 110.583 -176.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -109.66 1.89 19.85 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.56 1.144 . . . . 74.54 112.231 -169.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.1 p -87.26 143.48 34.59 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 120.111 1.323 . . . . 74.5 110.453 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -83.66 -38.63 0.13 Allowed 'Trans proline' 0 CA--C 1.533 0.437 0 CA-C-N 119.901 1.0 . . . . 64.5 112.481 -166.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -52.31 -47.68 65.84 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 118.798 0.726 . . . . 53.41 109.661 172.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 14.2 m -54.77 -37.86 66.51 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.74 1.616 . . . . 73.1 111.482 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -62.49 -51.32 67.93 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.679 0.391 . . . . 73.53 110.861 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.446 ' HA ' HE21 ' A' ' 35' ' ' GLN . 0.0 OUTLIER -59.61 -45.45 91.88 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 119.67 -0.812 . . . . 64.23 109.054 176.029 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -66.13 -10.39 40.46 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 116.919 -1.515 . . . . 64.3 112.015 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -140.26 10.47 2.33 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 121.86 2.118 . . . . 53.31 113.086 -174.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -134.13 -45.0 0.78 Allowed 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 123.903 0.881 . . . . 63.12 110.41 170.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.8 t -88.9 -69.81 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 108.255 -1.017 . . . . 74.41 108.255 -175.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.6 mt -77.81 -25.53 48.97 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.732 1.613 . . . . 74.52 113.333 -174.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 44.67 59.31 3.42 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.538 1.535 . . . . 73.41 112.911 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.4 t -55.48 -50.35 66.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 124.061 0.944 . . . . 70.3 109.302 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.2 t -47.17 -52.36 15.83 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.143 1.377 . . . . 73.43 112.308 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -79.37 -23.39 43.38 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 110.588 -0.152 . . . . 74.43 110.588 -169.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -69.93 -48.8 57.02 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.639 -1.245 . . . . 73.43 107.639 169.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 37.8 t -55.69 -49.83 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 125.162 1.385 . . . . 74.04 110.914 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -56.94 -28.02 61.67 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 119.87 -1.769 . . . . 72.51 113.297 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -71.14 -8.62 54.73 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.202 0.91 . . . . 73.1 113.192 177.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -119.83 -14.71 8.95 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 126.321 1.848 . . . . 72.41 111.968 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.3 mt -69.53 151.11 96.78 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 119.222 0.919 . . . . 74.44 112.496 -169.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -85.95 159.19 10.22 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.625 2.883 . . . . 73.31 113.078 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -83.62 59.34 5.08 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.307 1.843 . . . . 74.11 111.031 -172.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.71 -23.98 0.02 OUTLIER Glycine 0 CA--C 1.527 0.802 0 CA-C-N 113.592 -1.64 . . . . 62.44 112.1 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.3 t -47.85 -57.1 6.09 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.561 1.544 . . . . 73.11 112.632 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? 56.84 123.55 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.779 2.032 . . . . 71.2 111.04 -157.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.7 ttm -68.27 108.18 3.09 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 125.881 1.672 . . . . 74.3 108.253 172.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.18 115.03 21.69 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 107.127 -1.434 . . . . 73.24 107.127 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.27 122.04 35.78 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.18 -1.415 . . . . 74.2 107.18 -178.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.1 m-30 -113.35 145.85 40.42 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.488 -1.301 . . . . 72.43 107.488 172.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.0 117.85 32.47 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.258 1.423 . . . . 74.14 107.669 -167.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.8 m -93.88 157.78 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 O-C-N 121.472 -0.768 . . . . 72.2 110.747 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.43 -8.46 13.89 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.748 1.219 . . . . 73.12 113.448 -161.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -63.17 5.16 0.16 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.815 2.046 . . . . 74.1 115.346 -170.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.1 mt -138.11 132.39 31.96 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 119.955 -1.715 . . . . 70.43 107.593 -165.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.76 174.76 30.25 Favored Glycine 0 CA--C 1.541 1.672 0 O-C-N 123.493 0.496 . . . . 62.32 111.877 -172.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.92 -55.33 0.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.92 3.08 . . . . 73.34 112.692 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.4 mt -87.34 24.85 1.52 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.958 1.303 . . . . 74.23 112.201 -167.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.04 -42.77 98.05 Favored Glycine 0 C--O 1.228 -0.247 0 N-CA-C 110.174 -1.17 . . . . 74.23 110.174 -167.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -61.42 -44.55 96.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.499 0.32 . . . . 73.34 110.689 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.43 -46.77 87.79 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.446 1.898 . . . . 74.43 109.012 177.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.9 mt -64.64 -40.53 95.62 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.751 0.82 . . . . 70.22 111.623 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.8 m -60.7 -40.45 92.27 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 120.272 1.396 . . . . 71.51 110.388 171.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -64.62 -39.28 93.43 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.26 -0.9 . . . . 70.15 108.876 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.61 -36.43 78.57 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 120.964 -1.085 . . . . 73.23 111.913 173.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 25.3 t-105 -58.42 -35.74 72.53 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 118.882 0.764 . . . . 71.5 111.996 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.36 -40.55 82.53 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 118.695 -0.669 . . . . 65.54 111.912 175.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 69.7 t -59.54 -44.89 94.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 119.657 1.117 . . . . 64.41 109.544 170.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.51 -42.04 98.21 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 118.364 -0.827 . . . . 74.53 111.6 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 76.3 mt -69.45 -38.51 77.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.899 0.88 . . . . 74.44 110.52 176.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.8 -40.21 91.81 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.488 1.04 . . . . 74.23 110.582 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.8 mt -93.0 -8.02 44.21 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.75 0.648 . . . . 74.52 112.75 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 53.83 62.91 5.61 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 125.485 1.517 . . . . 72.3 111.378 -172.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.1 m -125.54 18.97 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.49 1.116 . . . . 65.5 112.046 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -51.3 -49.54 61.1 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.341 1.456 . . . . 74.43 111.504 -174.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.407 ' OD1' ' HE2' ' A' ' 86' ' ' LYS . 1.2 p-10 -63.36 -31.47 72.63 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 125.167 1.387 . . . . 74.11 113.807 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.407 ' HE2' ' OD1' ' A' ' 85' ' ' ASP . 21.6 mttm -75.24 -34.38 61.4 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.258 -0.645 . . . . 74.54 109.258 -176.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.1 pp -103.52 -16.37 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.967 0.729 . . . . 74.44 112.967 -166.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.7 m -58.93 -49.47 77.72 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 119.17 0.895 . . . . 70.42 111.116 -172.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.47 -58.76 15.36 Favored Pre-proline 0 N--CA 1.45 -0.458 0 C-N-CA 123.712 0.805 . . . . 73.22 110.181 -164.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.25 -26.0 49.48 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 121.095 1.197 . . . . 72.52 112.222 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 10.8 tpp -61.7 -44.64 96.55 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.577 0.626 . . . . 73.32 111.051 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -69.69 -35.69 75.32 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.243 -0.911 . . . . 73.5 109.047 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -54.85 -48.34 73.01 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.388 0.54 . . . . 71.32 110.242 166.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.55 -16.09 60.83 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 121.73 -0.606 . . . . 73.32 111.154 -165.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 63.8 t -112.15 -33.86 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.368 1.467 . . . . 74.23 110.799 -173.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -109.73 -55.96 2.37 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.522 1.056 . . . . 72.42 110.744 -174.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -64.35 -63.93 1.01 Allowed 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.907 0.883 . . . . 74.41 110.784 -176.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.4 t -99.44 -27.6 13.66 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.672 1.189 . . . . 73.13 110.761 -173.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 59.43 29.4 18.96 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.811 1.244 . . . . 73.33 112.889 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.4 t -69.38 -12.63 61.82 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.782 1.633 . . . . 73.12 112.815 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.6 t -67.52 108.49 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.647 -1.242 . . . . 74.45 107.647 171.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -132.88 -28.09 1.6 Allowed 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 124.471 1.108 . . . . 73.31 111.623 -174.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.85 169.65 17.18 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.553 -1.277 . . . . 70.12 107.553 169.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.6 t -57.18 -25.69 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.138 0.975 . . . . 74.14 111.23 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.69 -29.57 70.18 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 126.316 1.847 . . . . 71.32 111.205 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.72 -22.26 22.29 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.111 0.481 . . . . 73.45 110.232 -176.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.0 mt -76.63 -49.11 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 126.314 1.846 . . . . 71.52 108.158 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -56.78 -30.69 63.9 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-O 118.205 -0.902 . . . . 71.25 112.719 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -57.47 -57.99 10.26 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 123.586 0.755 . . . . 74.21 109.578 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.1 t -48.43 -47.33 14.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 O-C-N 124.457 1.098 . . . . 73.3 109.804 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -55.21 -51.9 65.08 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.864 0.466 . . . . 71.12 110.741 177.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.2 t -62.42 -44.05 98.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 118.61 0.641 . . . . 72.34 111.114 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -64.74 -42.17 95.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 122.147 0.975 . . . . 72.21 108.758 -172.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -82.14 7.33 13.8 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.579 1.552 . . . . 74.42 112.572 176.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.93 29.04 4.22 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-N 119.751 1.16 . . . . 74.33 115.976 160.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.7 t -106.55 143.97 16.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 122.571 1.176 . . . . 73.11 111.026 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -62.4 126.89 28.88 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.268 1.427 . . . . 73.15 110.383 170.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.31 -23.96 74.91 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 118.483 -1.176 . . . . 62.53 111.896 169.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -69.13 -40.87 78.02 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 119.131 1.465 . . . . 72.52 109.249 170.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -79.36 -37.66 36.9 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 107.597 -1.26 . . . . 72.15 107.597 -166.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -56.65 -60.65 3.23 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.619 -0.512 . . . . 74.15 109.619 171.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.69 -13.84 61.05 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.454 0.538 . . . . 71.33 112.454 -170.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.19 -65.97 0.95 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.332 1.053 . . . . 65.13 109.202 168.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -50.4 -39.81 48.13 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.543 1.537 . . . . 73.25 110.848 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -46.19 -37.65 7.35 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.555 1.542 . . . . 74.35 112.801 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -114.35 4.3 15.33 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.917 1.287 . . . . 72.12 112.889 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.7 t -80.22 151.99 29.36 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.724 1.61 . . . . 74.53 111.492 175.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -51.99 -28.89 18.47 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.022 2.529 . . . . 73.34 113.081 175.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 93.3 t -52.75 -54.52 15.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 124.748 1.219 . . . . 51.22 109.836 174.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.3 t -69.66 -34.78 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 114.816 -1.083 . . . . 72.11 109.851 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -52.63 -47.88 66.75 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.914 1.233 . . . . 74.41 111.186 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.1 t -59.71 -55.54 33.09 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.605 0.762 . . . . 74.44 109.222 176.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 32.3 mt -64.47 -32.71 74.45 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.004 0.922 . . . . 71.31 113.483 -173.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.31 -64.45 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 C-N-CA 126.022 1.729 . . . . 70.43 107.451 166.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.42 -29.3 67.66 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 120.286 1.403 . . . . 73.43 113.744 -172.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -61.4 -51.95 66.65 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.401 0.68 . . . . 65.24 109.991 170.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -70.07 -34.08 72.74 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.41 1.084 . . . . 73.43 112.633 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -60.08 -59.04 6.05 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 107.39 -1.337 . . . . 74.42 107.39 174.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.7 ttpt -53.3 -52.03 60.41 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.318 0.647 . . . . 72.24 110.452 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.68 -2.2 4.65 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.07 1.137 . . . . 73.42 114.07 -174.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -116.65 -20.87 9.38 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.881 1.218 . . . . 72.31 112.025 164.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.54 -22.55 47.11 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 126.202 1.801 . . . . 73.52 112.434 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.05 4.13 13.1 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.104 -0.998 . . . . 72.32 112.386 -175.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.0 mt 71.43 -0.23 3.21 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.522 1.929 . . . . 73.22 111.437 171.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.23 -9.96 59.74 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.728 1.611 . . . . 73.33 112.567 -173.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.4 tp -142.15 105.44 4.62 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.606 1.562 . . . . 74.13 108.193 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -130.94 17.81 5.09 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.217 0.607 . . . . 65.34 110.605 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -134.47 160.21 24.12 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 109.621 -1.392 . . . . 72.13 109.621 163.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.4 m -144.45 167.08 15.93 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 125.658 1.583 . . . . 73.52 109.348 169.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -72.24 150.4 94.74 Favored 'Cis proline' 0 N--CA 1.46 -0.472 0 N-CA-C 110.057 -0.786 . . . . 73.22 110.057 -14.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -136.7 126.9 26.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 117.435 -1.269 . . . . 71.34 108.64 -172.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 47.5 ttm -124.12 124.74 43.15 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 119.205 0.911 . . . . 74.5 108.675 173.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -100.37 155.58 17.73 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 125.117 1.367 . . . . 74.13 110.086 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.8 t -140.54 144.71 26.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 124.259 1.024 . . . . 73.32 108.975 175.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 50.11 23.21 1.08 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.905 2.082 . . . . 72.41 113.91 169.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 61.58 17.2 53.11 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 118.681 -1.066 . . . . 71.42 113.777 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -149.2 -7.37 0.36 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.078 1.439 . . . . 74.33 114.571 -174.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -128.95 152.38 48.63 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 119.151 0.887 . . . . 70.23 110.401 -176.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -119.4 141.58 48.97 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.715 2.006 . . . . 73.1 107.819 168.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.89 132.54 45.41 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 107.772 -1.196 . . . . 74.2 107.772 170.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -106.39 86.95 2.35 Favored Pre-proline 0 C--O 1.235 0.291 0 C-N-CA 123.51 0.724 . . . . 71.52 111.954 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -65.77 -21.39 58.31 Favored 'Trans proline' 0 N--CA 1.444 -1.417 0 CA-C-O 117.911 -0.954 . . . . 72.54 112.32 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -64.79 -44.37 90.19 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 120.097 1.317 . . . . 74.53 110.942 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -82.0 1.68 86.01 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 118.87 -0.961 . . . . 73.4 112.876 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 46.6 mtt -79.3 168.05 20.07 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.958 1.879 . . . . 73.33 108.719 170.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -79.58 120.93 24.61 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 106.028 -1.841 . . . . 73.44 106.028 167.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 28.2 p -124.69 45.71 2.47 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.672 1.989 . . . . 74.22 106.76 -171.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 16.1 m -135.66 0.23 2.69 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 114.229 -1.351 . . . . 73.5 111.963 -164.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.423 HD21 ' HB ' ' A' ' 172' ' ' VAL . 0.5 OUTLIER -133.74 -4.99 2.85 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.298 1.439 . . . . 72.04 110.899 174.216 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 1.7 mmt 66.83 -59.3 0.38 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.908 2.083 . . . . 72.43 112.897 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.39 -48.75 80.41 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 122.397 1.094 . . . . 73.34 109.121 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.423 ' HB ' HD21 ' A' ' 169' ' ' ASN . 99.3 t -64.04 -27.5 42.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 126.638 1.975 . . . . 74.2 111.674 -178.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -61.44 -59.22 5.59 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.065 -1.087 . . . . 73.44 108.065 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.92 -27.73 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 O-C-N 123.496 0.498 . . . . 72.2 110.906 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.45 -47.61 63.02 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.901 0.881 . . . . 73.1 111.022 171.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -79.6 -41.74 26.46 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 118.694 -0.67 . . . . 73.1 111.053 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -53.13 -59.26 4.77 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.274 0.943 . . . . 73.23 110.291 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.03 -29.07 68.26 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.521 1.128 . . . . 74.32 112.344 -175.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -65.54 -62.68 1.38 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.149 -0.686 . . . . 65.04 109.149 171.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 12.4 t -60.6 -28.43 68.5 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 118.837 -0.602 . . . . 73.22 112.186 -170.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 94.8 t -53.62 -47.08 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.821 0.737 . . . . 72.33 109.725 173.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 3.0 tmmt? -80.14 -32.75 38.92 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.152 -0.928 . . . . 65.32 110.778 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . 0.437 HE22 HG21 ' A' ' 3' ' ' ILE . 35.0 mt-30 -57.25 -36.75 71.34 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.226 1.376 . . . . 72.42 110.661 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 59.1 mt -70.84 -27.09 63.6 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.037 -1.039 . . . . 70.23 112.776 -176.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 75.7 t -63.68 -30.89 51.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 122.8 0.44 . . . . 71.12 110.374 -178.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -87.84 -29.37 20.99 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.097 -0.705 . . . . 74.2 109.097 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 31.7 mttp -93.41 48.88 1.33 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.075 1.35 . . . . 74.31 110.04 -175.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 20.6 pttm . . . . . 0 C--O 1.245 0.836 0 N-CA-C 106.856 -1.535 . . . . 73.2 106.856 155.432 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 8.6 m . . . . . 0 N--CA 1.467 0.425 0 CA-C-O 119.02 -0.514 . . . . 73.4 111.682 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -67.59 177.41 2.0 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.41 1.484 . . . . 63.14 111.926 173.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 52.29 33.71 13.27 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 126.638 1.975 . . . . 73.12 112.053 174.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.55 125.03 3.67 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 105.464 -2.05 . . . . 74.1 105.464 173.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.8 pt -131.3 147.15 32.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 127.974 2.51 . . . . 70.51 108.398 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.7 m -115.55 126.42 54.23 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.66 -1.237 . . . . 64.31 107.66 -176.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.45 121.41 3.42 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 127.77 2.428 . . . . 74.52 108.641 162.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.01 -11.77 71.25 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-O 117.834 -1.537 . . . . 65.31 113.707 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -102.7 -85.52 0.44 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 119.828 1.814 . . . . 74.5 108.972 -177.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -87.95 -16.68 33.13 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.552 1.141 . . . . 72.11 110.768 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -136.69 163.09 31.39 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.309 1.044 . . . . 73.51 109.801 172.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.4 mm -129.78 158.54 42.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 105.265 -2.124 . . . . 73.1 105.265 171.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.9 m -108.91 168.82 9.08 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.693 -1.225 . . . . 72.32 107.693 173.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.1 mt -92.03 161.08 14.93 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.518 -1.29 . . . . 73.1 107.518 166.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -79.1 -29.31 43.22 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 122.549 1.166 . . . . 74.13 108.201 174.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -133.68 71.67 74.66 Favored Pre-proline 0 N--CA 1.446 -0.626 0 O-C-N 120.187 -1.57 . . . . 73.31 110.757 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.66 63.45 7.36 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.523 2.816 . . . . 72.4 110.571 176.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.4 mt -136.42 144.15 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 O-C-N 120.696 -1.253 . . . . 73.44 107.708 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 47.48 12.23 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 128.898 2.879 . . . . 73.51 116.781 171.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -89.29 -110.79 1.24 Allowed Glycine 0 C--N 1.333 0.398 0 CA-C-N 119.493 1.042 . . . . 74.24 110.679 -169.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -67.18 162.99 49.76 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 114.133 1.161 . . . . 74.23 114.133 -171.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.12 -164.92 0.12 Allowed 'Trans proline' 0 CA--C 1.545 1.055 1 C-N-CA 125.47 4.114 . . . . 62.5 114.069 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -66.59 77.74 0.11 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.295 1.838 . . . . 74.32 110.884 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.277 2.9 p 56.15 169.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 128.926 2.89 . . . . 74.43 112.942 -174.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.0 tp -165.44 169.45 15.6 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 121.216 -0.928 . . . . 74.2 112.356 -172.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -145.5 125.35 13.48 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 127.915 2.486 . . . . 61.44 104.591 170.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -115.41 131.75 56.83 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 119.808 1.185 . . . . 73.4 110.428 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.85 176.55 11.33 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.109 0.564 . . . . 74.22 110.812 178.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.9 t -129.46 172.61 11.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.598 -1.63 . . . . 72.43 106.598 169.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.417 ' CD2' HG23 ' A' ' 95' ' ' VAL 0.253 0.0 OUTLIER -86.45 -18.76 30.86 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.288 0.635 . . . . 72.43 111.545 164.952 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -91.31 -6.37 53.22 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 119.742 -1.849 . . . . 73.52 113.335 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.1 p -77.83 141.36 63.87 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 121.2 1.818 . . . . 73.1 108.031 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -84.08 -40.3 0.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.86 1.707 . . . . 72.1 111.776 -174.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -56.08 -40.19 73.25 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 120.096 1.316 . . . . 74.3 110.105 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.2 m -51.36 -30.28 18.26 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.082 1.353 . . . . 74.21 112.719 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -62.11 -56.85 14.7 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 118.668 0.667 . . . . 71.3 111.698 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -57.6 -42.68 83.73 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.856 -0.794 . . . . 74.53 108.856 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -62.46 -18.15 61.1 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 115.294 -2.289 . . . . 71.2 112.173 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -139.69 9.14 2.4 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-N 122.122 2.237 . . . . 71.43 114.959 -170.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -136.44 -11.78 1.85 Allowed 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.86 1.264 . . . . 72.3 111.371 172.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.3 t -123.92 -81.39 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 107.401 -1.333 . . . . 75.14 107.401 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 49.8 mt -59.67 -31.09 69.23 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.771 2.028 . . . . 72.22 112.005 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 43.99 60.09 2.88 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.299 1.84 . . . . 71.04 110.536 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 86.7 t -63.02 -36.92 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.181 -0.918 . . . . 73.4 109.895 -174.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 t -51.07 -55.6 16.77 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.994 1.317 . . . . 73.4 110.39 173.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.34 -29.51 65.08 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 121.043 -1.036 . . . . 75.4 111.395 -174.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.57 -33.73 74.59 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.042 0.537 . . . . 73.3 112.05 175.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.6 t -70.97 -50.19 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.572 1.549 . . . . 74.13 109.158 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.6 ptm85 -61.72 -21.17 64.26 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 120.63 1.559 . . . . 73.11 113.883 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -68.04 -11.08 58.29 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.006 1.113 . . . . 72.53 114.006 172.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp -136.03 2.42 2.82 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.578 1.551 . . . . 74.14 112.117 -171.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.7 mt -72.35 145.71 88.33 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 119.725 1.148 . . . . 75.44 109.584 -176.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.94 150.16 29.78 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.427 2.085 . . . . 64.14 110.131 169.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -76.65 80.81 3.3 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 122.759 1.266 . . . . 75.43 111.029 -168.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.01 -49.53 0.23 Allowed Glycine 0 C--O 1.233 0.092 0 N-CA-C 109.595 -1.402 . . . . 74.03 109.595 -175.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.455 ' HG1' ' CG2' ' A' ' 185' ' ' VAL . 32.3 m -69.29 90.68 0.51 Allowed 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 107.767 -1.197 . . . . 74.52 107.767 173.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -80.12 129.92 34.86 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.469 -1.678 . . . . 75.44 106.469 173.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.4 mtm -66.26 161.93 21.15 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.258 -0.645 . . . . 74.32 109.258 173.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.39 -173.71 3.49 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.339 1.056 . . . . 73.34 108.155 178.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.41 91.89 0.46 Allowed 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.221 -1.029 . . . . 74.32 108.221 -173.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.469 ' CD2' ' HG3' ' A' ' 137' ' ' GLN . 6.4 m-30 -104.42 163.53 12.38 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.549 -0.908 . . . . 74.12 108.549 177.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.552 ' CE1' ' CG2' ' A' ' 72' ' ' THR . 2.0 p80 -104.67 171.5 7.29 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 126.527 1.931 . . . . 72.2 108.071 -175.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.6 m -137.96 146.96 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.1 -1.074 . . . . 73.33 108.1 167.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -94.18 -0.47 55.19 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.076 0.853 . . . . 74.32 111.994 -175.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -73.99 167.64 21.1 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.575 1.15 . . . . 73.22 108.364 165.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 74.69 131.85 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 128.328 2.651 . . . . 74.44 111.093 177.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.6 173.59 3.51 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 122.472 1.04 . . . . 72.14 113.037 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -72.43 -45.27 0.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.473 2.115 . . . . 74.33 111.757 175.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.7 mt -80.85 19.65 0.84 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.537 1.535 . . . . 74.21 113.65 -171.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.07 -32.43 49.83 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-O 118.156 -1.358 . . . . 73.12 112.311 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.3 tmtp? -85.11 -7.46 59.08 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.16 1.48 . . . . 73.23 113.728 178.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -46.81 18.25 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-N 121.001 1.728 . . . . 72.14 107.893 162.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.8 mt -57.75 -39.14 76.7 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 124.58 1.175 . . . . 73.42 111.145 -165.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.552 ' CG2' ' CE1' ' A' ' 60' ' ' HIS . 0.3 OUTLIER -50.38 -51.7 43.74 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 128.542 2.737 . . . . 73.35 109.738 177.168 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -69.62 -58.96 3.29 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 114.149 -1.387 . . . . 72.42 107.308 -176.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.65 -28.65 68.64 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 121.264 1.847 . . . . 53.31 114.226 -171.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 36.4 t-105 -58.6 -36.68 74.4 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.79 0.723 . . . . 73.2 110.921 177.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.89 -41.29 97.71 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 118.055 -0.974 . . . . 74.01 111.032 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.4 t -54.62 -45.58 72.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 119.354 0.979 . . . . 74.04 110.1 171.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.96 -47.14 87.82 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.603 0.638 . . . . 70.22 111.306 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.8 mt -60.22 -44.73 96.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.736 1.214 . . . . 71.42 109.698 176.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.3 -31.76 72.4 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 123.945 0.898 . . . . 74.44 111.095 -175.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 75.2 mt -94.22 -12.41 28.28 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 119.008 -0.52 . . . . 72.32 111.819 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.67 54.87 32.18 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 126.907 2.194 . . . . 74.23 110.943 -172.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.71 11.62 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 124.141 0.976 . . . . 75.14 112.133 -176.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -56.24 -53.53 56.13 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 120.071 1.305 . . . . 75.11 110.491 -172.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -63.13 -8.09 7.12 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.755 1.622 . . . . 75.01 112.333 176.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -100.06 -18.03 17.19 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.434 1.494 . . . . 75.22 112.023 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.6 pp -127.51 33.3 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.036 1.335 . . . . 75.32 109.443 -175.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 76.1 m -107.23 -43.83 4.5 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 117.973 -1.013 . . . . 72.41 109.651 171.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.31 -63.36 4.36 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 120.736 1.607 . . . . 74.43 111.775 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.27 -26.37 56.5 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 121.518 1.479 . . . . 74.21 111.81 -176.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 34.8 tpp -63.51 -49.61 72.85 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.584 0.754 . . . . 74.14 109.416 176.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -68.1 -35.14 77.67 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.874 0.87 . . . . 64.03 108.913 -176.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -60.97 -40.05 91.93 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.656 0.662 . . . . 62.3 110.423 171.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.18 -5.01 58.65 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 120.074 -1.642 . . . . 63.13 113.584 -174.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.417 HG23 ' CD2' ' A' ' 28' ' ' PHE . 50.2 t -111.01 -41.35 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 124.499 1.119 . . . . 74.22 109.709 -176.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -106.07 -53.77 2.58 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.42 0.688 . . . . 74.42 109.337 -172.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt -70.39 -54.12 13.74 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-O 118.675 -0.679 . . . . 72.33 110.61 -171.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.4 p -100.86 -18.49 16.37 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.176 0.99 . . . . 74.22 113.382 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 45.75 40.62 6.53 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.475 2.31 . . . . 72.22 114.228 -175.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.9 t -79.88 -8.0 59.05 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.288 -0.883 . . . . 70.11 112.557 178.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.6 t -74.54 122.46 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 O-C-N 120.858 -1.151 . . . . 74.41 109.785 168.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -140.68 -23.41 0.79 Allowed 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.084 0.954 . . . . 74.04 112.303 175.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.21 175.4 11.09 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.307 0.643 . . . . 74.33 109.56 174.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.0 t -55.55 -44.09 75.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 126.182 1.793 . . . . 72.35 109.941 -172.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.5 -14.34 40.43 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.212 0.605 . . . . 45.41 112.628 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -94.36 -27.65 15.96 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 119.421 1.01 . . . . 71.41 110.034 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.2 mt -81.52 -41.77 19.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 123.286 0.634 . . . . 65.24 109.378 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -55.32 -25.08 32.42 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.441 -0.787 . . . . 74.45 113.055 176.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -62.23 -56.51 17.91 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.803 1.241 . . . . 70.31 110.78 -177.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 54.3 t -57.15 -43.1 80.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 119.165 -0.445 . . . . 62.41 110.369 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -50.68 -56.77 10.38 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.707 0.803 . . . . 74.24 109.482 175.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.74 -46.86 95.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 123.132 0.573 . . . . 72.03 109.811 -174.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.05 -43.57 91.7 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 123.652 0.595 . . . . 74.31 109.475 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.95 -17.32 62.08 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.425 1.09 . . . . 72.14 112.612 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 113.61 64.24 0.44 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.393 -1.083 . . . . 75.42 110.393 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.7 t -127.69 141.1 47.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 123.819 0.848 . . . . 74.22 109.976 163.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -66.04 148.2 52.17 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.905 -0.497 . . . . 73.11 112.027 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -73.5 1.84 41.71 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 124.775 1.179 . . . . 73.22 114.904 165.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -100.98 -39.98 7.47 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 117.367 0.584 . . . . 74.25 111.158 174.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.9 -35.04 62.27 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.014 -1.106 . . . . 62.42 108.014 -167.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -61.45 -59.93 4.5 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 116.067 -0.515 . . . . 74.45 109.857 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -59.64 -36.98 77.44 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.622 0.769 . . . . 74.45 110.969 -176.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.55 -65.49 0.71 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.916 0.886 . . . . 72.15 110.186 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.53 -37.08 64.96 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.175 0.99 . . . . 73.31 110.347 -173.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -45.08 -41.59 7.86 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.051 1.341 . . . . 74.33 112.904 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -112.83 19.78 17.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.703 1.201 . . . . 72.23 112.338 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.9 t -115.85 149.19 39.02 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 123.721 1.724 . . . . 64.01 110.783 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.84 -27.0 49.32 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 119.754 3.242 . . . . 72.33 119.754 -171.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 29.3 t -45.22 -56.31 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 C-N-CA 127.064 2.145 . . . . 74.31 107.996 168.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.25 -43.34 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 125.644 1.578 . . . . 71.11 109.398 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp -52.84 -46.31 67.72 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.544 -0.723 . . . . 71.43 112.089 177.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -49.11 71.89 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 118.724 -0.655 . . . . 71.34 110.055 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 13.5 mt -59.29 -42.17 90.65 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.777 -0.63 . . . . 74.15 111.469 -176.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 52.9 t -55.73 -48.96 77.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.672 -0.862 . . . . 74.33 108.672 176.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.59 -40.11 95.86 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 113.394 0.887 . . . . 65.05 113.394 -177.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -56.26 -50.93 69.94 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.934 0.894 . . . . 65.14 109.427 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.512 ' CB ' ' CE1' ' A' ' 60' ' ' HIS . 0.5 OUTLIER -70.31 -38.12 74.88 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 117.454 -1.26 . . . . 74.33 111.148 -176.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -58.76 -44.41 90.56 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 120.535 1.516 . . . . 44.12 109.54 170.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.8 ttmm -67.12 -10.57 51.53 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.081 -1.012 . . . . 70.44 113.273 175.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.8 2.7 11.1 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 117.416 -1.278 . . . . 74.41 114.239 178.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -134.77 -12.28 2.29 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.154 1.343 . . . . 72.52 112.995 174.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -121.21 6.43 10.23 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.378 1.071 . . . . 73.12 111.121 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -70.83 -85.38 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.358 0.663 . . . . 70.21 112.364 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.1 pp -164.59 33.24 0.07 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.08 0.952 . . . . 73.32 113.438 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.565 ' CD ' ' H ' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -126.69 -69.41 0.76 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.298 0.954 . . . . 74.51 112.391 -163.368 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.565 ' H ' ' CD ' ' A' ' 145' ' ' GLN . 0.7 OUTLIER -133.91 142.22 47.66 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.556 2.742 . . . . 70.44 107.046 -171.208 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -143.68 13.11 1.71 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.222 1.009 . . . . 70.2 111.981 -178.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -141.02 176.89 21.32 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 109.36 -1.496 . . . . 70.24 109.36 173.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 19.2 m -147.7 171.15 6.66 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 124.417 1.087 . . . . 74.43 111.202 -169.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.37 162.86 60.4 Favored 'Cis proline' 0 C--N 1.349 0.605 0 CA-C-N 120.376 1.17 . . . . 74.3 110.585 -14.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -146.78 147.31 30.77 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 122.89 0.476 . . . . 73.53 110.268 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 50.9 tpp -142.6 118.45 10.55 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.122 -2.177 . . . . 74.53 105.122 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -100.91 167.72 10.09 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.088 -0.708 . . . . 74.41 109.088 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.6 t -139.49 143.16 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.473 1.109 . . . . 71.1 108.393 170.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 49.45 18.17 0.27 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 128.108 2.563 . . . . 71.43 115.106 176.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 62.5 34.31 89.06 Favored Glycine 0 CA--C 1.534 1.232 0 O-C-N 120.765 -1.209 . . . . 71.21 111.687 -176.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -155.88 -22.0 0.11 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.346 1.61 . . . . 73.33 115.346 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -119.08 154.51 33.06 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 119.234 0.925 . . . . 74.23 109.044 -175.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.0 125.75 44.37 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.988 2.515 . . . . 72.42 107.833 176.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.78 147.19 53.66 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 106.685 -1.598 . . . . 70.3 106.685 176.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -123.78 76.67 56.92 Favored Pre-proline 0 C--O 1.233 0.223 0 O-C-N 122.091 -0.38 . . . . 71.22 111.436 -176.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.58 -17.19 58.75 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.501 1.468 . . . . 74.4 112.198 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.96 -12.21 61.41 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.136 1.774 . . . . 73.34 113.087 177.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -121.28 35.47 3.62 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.854 1.216 . . . . 45.3 110.113 175.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 46.0 mtt -122.37 165.04 16.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 122.278 1.037 . . . . 74.2 109.596 176.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -82.83 76.4 9.68 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.562 -1.199 . . . . 72.43 110.771 -176.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 21.4 p -73.22 -1.06 16.23 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.256 2.222 . . . . 70.31 112.8 177.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 39.7 m -72.83 -6.34 44.24 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 113.851 1.056 . . . . 70.33 113.851 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.59 -9.6 1.42 Allowed 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 117.772 -1.109 . . . . 65.44 113.311 -167.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 3.0 mmt 66.36 -56.85 0.38 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.272 1.829 . . . . 74.23 114.998 174.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.76 -51.37 62.65 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 106.987 -1.486 . . . . 71.24 106.987 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 48.6 t -57.93 -36.43 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.881 1.272 . . . . 75.22 110.121 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -58.77 -60.98 2.98 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 118.214 -0.898 . . . . 74.2 109.771 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.5 t -70.73 -33.97 54.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 118.476 0.58 . . . . 74.4 110.931 -175.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -49.94 -46.5 52.25 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.76 1.224 . . . . 71.32 110.155 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -87.43 -28.74 21.94 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 113.349 0.87 . . . . 74.43 113.349 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -56.61 -60.54 3.39 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.054 1.297 . . . . 70.41 110.513 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.77 -32.22 70.39 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.039 0.536 . . . . 72.13 111.951 -177.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -60.12 -50.93 71.76 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.773 1.229 . . . . 74.23 110.275 175.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.0 t -68.44 -30.17 68.98 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 116.73 -1.605 . . . . 72.44 110.912 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 58.7 t -56.44 -52.06 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 120.512 1.506 . . . . 73.33 108.578 173.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -59.38 -53.54 56.98 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-O 118.39 -0.815 . . . . 74.5 110.682 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -53.03 -40.94 64.26 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.74 0.7 . . . . 73.41 111.796 -171.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.85 -20.59 63.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.739 1.014 . . . . 74.5 113.739 -176.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.455 ' CG2' ' HG1' ' A' ' 54' ' ' THR . 84.7 t -65.08 -33.74 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 109.109 -0.7 . . . . 71.53 109.109 171.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -80.1 -41.64 25.14 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.877 -1.157 . . . . 72.21 107.877 -171.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -85.86 51.38 2.19 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.802 2.041 . . . . 74.11 110.24 -178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 20.4 pttt . . . . . 0 C--O 1.246 0.893 0 CA-C-O 117.264 -1.35 . . . . 74.54 110.158 172.094 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 119.774 -0.155 . . . . 74.14 110.676 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -98.02 1.92 48.3 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.814 -1.179 . . . . 73.34 112.753 -175.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -72.15 46.31 0.14 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.676 1.19 . . . . 71.42 113.105 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.52 122.47 3.58 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 105.613 -1.995 . . . . 71.14 105.613 170.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -126.68 158.35 37.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 126.318 1.847 . . . . 64.44 106.636 171.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.6 m -136.08 135.43 39.33 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.767 -1.197 . . . . 74.11 107.767 -176.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -51.74 104.15 0.08 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 131.52 3.928 . . . . 74.34 108.796 167.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 110.0 -22.17 23.74 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 126.998 2.237 . . . . 65.34 112.501 -177.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -90.7 -85.49 0.22 Allowed 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 119.776 1.788 . . . . 70.45 108.433 -172.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -89.4 -15.56 32.96 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.896 1.279 . . . . 72.15 109.915 -176.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -137.2 162.85 32.35 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.599 0.76 . . . . 71.31 110.709 172.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.0 mm -128.66 166.81 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 127.542 2.337 . . . . 74.25 105.97 171.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.1 174.22 5.98 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 127.605 2.362 . . . . 72.55 109.68 176.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 57.9 mt -116.4 148.63 40.48 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.524 1.13 . . . . 72.55 110.013 171.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -73.06 -35.81 66.76 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.474 1.11 . . . . 71.32 110.152 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.6 mmtm -122.05 77.99 41.85 Favored Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 126.522 1.929 . . . . 74.51 109.354 177.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -80.25 1.65 9.09 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 124.553 3.502 . . . . 62.53 112.858 172.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 15.8 tt -141.12 154.53 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 O-C-N 120.334 -1.479 . . . . 70.55 107.936 -171.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 64.69 -9.24 0.19 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.343 2.257 . . . . 72.43 113.545 -166.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -105.32 154.11 17.19 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 124.687 1.137 . . . . 65.14 110.739 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 52.13 165.36 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 130.395 3.478 . . . . 73.14 116.868 175.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -71.99 -54.49 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.125 1.883 . . . . 64.44 110.878 172.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -174.66 -171.88 0.6 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.808 2.043 . . . . 73.25 107.336 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 p -44.24 130.25 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 126.262 1.825 . . . . 73.34 111.148 173.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.3 154.2 37.46 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.614 1.566 . . . . 70.15 107.015 -173.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -120.53 141.77 49.94 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.369 -1.345 . . . . 71.43 107.369 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -130.69 134.98 47.38 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.787 1.635 . . . . 72.2 109.339 176.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.3 179.27 7.5 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.784 1.234 . . . . 72.43 108.434 167.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.0 t -134.4 153.43 51.91 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.379 -0.971 . . . . 71.21 108.379 168.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.487 ' CE2' ' HG2' ' A' ' 91' ' ' MET . 12.2 m-30 -64.94 -24.39 67.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 118.483 -0.77 . . . . 74.21 111.705 172.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -89.26 -5.2 57.8 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 120.283 1.401 . . . . 71.11 113.667 178.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.9 p -90.4 144.42 30.81 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 122.059 2.209 . . . . 73.54 111.298 -174.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -81.84 -43.19 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 121.935 1.756 . . . . 73.14 112.394 -166.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -54.48 -45.67 73.24 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 109.136 -0.69 . . . . 73.11 109.136 173.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 15.3 m -55.44 -35.86 65.91 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.503 1.921 . . . . 71.25 112.048 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -64.79 -48.53 74.12 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.822 0.737 . . . . 73.55 110.674 176.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.407 ' HA ' HE21 ' A' ' 35' ' ' GLN . 0.0 OUTLIER -59.37 -44.5 92.71 Favored 'General case' 0 C--O 1.223 -0.302 0 O-C-N 121.091 -1.005 . . . . 74.15 108.908 172.673 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -60.3 -16.55 35.57 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 115.735 -2.079 . . . . 71.54 112.41 -178.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -142.83 12.21 1.85 Allowed 'General case' 0 C--N 1.347 0.461 0 CA-C-N 122.111 2.232 . . . . 74.43 114.438 -172.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -131.7 -13.04 3.34 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.15 0.98 . . . . 72.44 112.282 165.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.1 t -128.26 -77.12 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 108.353 -0.98 . . . . 72.51 108.353 -170.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.8 mt -67.18 -26.8 66.81 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.787 1.635 . . . . 74.45 111.838 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 44.03 56.25 4.85 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.128 1.371 . . . . 74.14 110.915 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.1 t -61.64 -46.53 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 117.506 -1.235 . . . . 74.42 107.967 -169.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.5 t -56.86 -37.99 72.09 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 120.318 1.417 . . . . 71.31 112.283 -177.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.22 -49.07 63.18 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.103 0.961 . . . . 71.13 109.745 177.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -62.23 -41.28 98.26 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.625 1.17 . . . . 54.15 112.088 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 t -62.97 -51.01 77.31 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 N-CA-C 107.553 -1.277 . . . . 72.32 107.553 175.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -50.01 -47.83 52.84 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.285 0.948 . . . . 73.35 111.578 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -66.5 -1.45 3.6 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 115.284 1.587 . . . . 71.12 115.284 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -130.01 -4.23 4.52 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.94 2.096 . . . . 73.34 112.891 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.6 mt -69.33 151.28 96.95 Favored Pre-proline 0 N--CA 1.466 0.35 0 CA-C-N 120.065 1.302 . . . . 53.45 110.769 -172.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -81.07 146.3 15.93 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 122.275 1.984 . . . . 74.52 110.036 172.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -71.93 105.38 3.82 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.015 -1.448 . . . . 73.12 109.211 -175.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 131.79 -9.54 5.48 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.728 -1.04 . . . . 71.14 113.337 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.9 t -52.81 -46.79 67.85 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.705 1.253 . . . . 72.44 112.228 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? 46.5 83.54 0.03 OUTLIER 'General case' 0 C--N 1.346 0.417 0 C-N-CA 127.305 2.242 . . . . 74.22 110.3 -174.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 19.9 ptp -65.53 -175.74 0.29 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 112.317 -2.219 . . . . 73.52 111.89 176.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 m -154.75 174.98 14.29 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.278 1.831 . . . . 73.14 108.482 165.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -140.3 126.14 19.41 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.994 -1.113 . . . . 74.23 107.994 152.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -106.09 -176.98 3.23 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.499 -0.926 . . . . 74.3 108.499 162.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -134.75 135.12 41.65 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.015 1.726 . . . . 70.33 106.656 176.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.0 m -81.6 151.89 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.813 0.845 . . . . 65.14 110.399 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.65 -5.56 22.49 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.675 1.19 . . . . 72.32 112.314 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -68.49 -45.63 71.84 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.576 -0.702 . . . . 74.52 112.583 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.0 mt -78.18 132.17 37.49 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 121.838 -0.539 . . . . 74.32 109.689 -171.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.64 160.85 31.05 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 124.924 1.25 . . . . 71.12 112.39 169.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.71 -39.47 6.57 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.449 2.099 . . . . 74.24 110.276 173.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.5 mt -84.59 24.4 1.02 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.507 1.923 . . . . 74.31 110.661 172.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.39 -52.22 51.28 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 120.972 -1.08 . . . . 34.51 112.162 -175.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -56.17 -44.91 79.77 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.964 0.882 . . . . 72.22 110.994 174.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -63.44 -35.7 81.31 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 124.756 1.222 . . . . 73.14 111.396 -178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.8 mt -60.02 -52.13 66.68 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 123.803 0.841 . . . . 74.2 110.76 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.9 m -62.96 -37.49 87.3 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.403 0.547 . . . . 73.22 110.339 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -58.51 -44.18 89.4 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.812 -0.555 . . . . 74.33 109.775 172.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.32 96.39 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.355 -1.466 . . . . 65.5 112.897 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 49.3 t-105 -57.93 -37.96 75.06 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.837 0.855 . . . . 71.11 109.786 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.09 -43.98 87.34 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 117.55 -1.214 . . . . 63.33 112.513 175.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.1 t -54.01 -46.35 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 120.632 1.56 . . . . 64.21 110.714 170.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.71 -45.04 94.58 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-O 118.951 -0.547 . . . . 71.44 110.864 -175.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 91.6 mt -57.69 -46.82 86.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.956 0.902 . . . . 74.11 109.43 174.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.45 -3.69 44.67 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.515 1.302 . . . . 65.54 114.515 -169.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 88.5 mt -106.23 -21.48 13.1 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.597 1.089 . . . . 70.51 111.696 156.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.11 64.08 2.77 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 125.573 1.559 . . . . 63.54 109.218 -169.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.22 13.76 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.745 1.218 . . . . 70.51 112.16 -176.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -51.13 -60.2 3.36 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.541 1.137 . . . . 73.42 109.766 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.12 -8.59 3.59 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.002 1.721 . . . . 72.15 113.291 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -102.56 -10.78 19.01 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 120.379 -1.45 . . . . 73.44 112.043 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.2 pp -126.77 -14.12 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 116.96 -1.495 . . . . 74.14 112.102 -174.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 34.3 m -55.18 -54.96 36.7 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 119.652 1.115 . . . . 70.32 109.503 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -54.45 -62.43 4.03 Favored Pre-proline 0 N--CA 1.449 -0.507 0 C-N-CA 124.866 1.266 . . . . 73.41 111.296 -170.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.05 -26.01 66.03 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.112 1.208 . . . . 72.23 112.357 -177.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.487 ' HG2' ' CE2' ' A' ' 28' ' ' PHE . 8.5 tpp -62.44 -48.03 81.45 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-O 118.193 -0.908 . . . . 74.24 111.215 172.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -66.71 -35.96 81.37 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 120.412 1.46 . . . . 74.42 109.139 -178.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -62.39 -33.56 74.99 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.422 0.556 . . . . 74.13 111.324 170.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.93 -11.12 45.37 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.894 -1.129 . . . . 74.51 113.388 -176.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.3 t -109.52 -42.87 5.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 125.338 1.455 . . . . 74.24 110.61 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -103.52 -46.37 4.58 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.179 0.592 . . . . 72.55 110.133 -174.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt -77.13 -68.65 0.59 Allowed 'General case' 0 N--CA 1.457 -0.088 0 CA-C-O 119.03 -0.509 . . . . 74.25 109.897 -172.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.5 p -79.85 -30.91 40.43 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.296 0.953 . . . . 72.41 110.548 177.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 60.43 20.97 10.62 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.228 1.811 . . . . 65.54 113.317 -174.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -69.23 -12.77 61.96 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.324 1.05 . . . . 53.04 112.812 -174.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 29.6 t -65.41 115.07 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 O-C-N 120.998 -1.064 . . . . 74.5 109.189 170.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -136.68 -31.14 0.87 Allowed 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.762 1.225 . . . . 74.54 112.083 -173.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.67 170.1 16.64 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.904 0.882 . . . . 72.52 109.355 167.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 67.3 t -54.23 -37.52 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.016 1.326 . . . . 70.14 111.205 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.28 -31.18 42.5 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.385 1.074 . . . . 72.44 112.709 176.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -82.4 -27.73 31.84 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 123.242 0.617 . . . . 61.52 110.504 -177.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.2 mt -76.22 -50.43 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.808 1.643 . . . . 70.2 108.014 -177.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -21.35 66.77 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.525 -0.734 . . . . 73.32 111.792 -177.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -56.45 21.75 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 124.552 1.141 . . . . 73.2 110.217 168.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.8 t -51.51 -45.53 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 123.654 0.781 . . . . 74.44 110.002 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -53.1 -55.71 21.89 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.808 0.443 . . . . 73.12 109.859 176.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 64.6 t -57.29 -42.91 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 O-C-N 121.7 -0.625 . . . . 73.32 110.232 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -61.6 -41.77 97.91 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 124.283 0.989 . . . . 71.41 109.534 -171.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.34 -2.21 30.58 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.008 1.723 . . . . 63.11 113.199 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 99.61 55.78 1.0 Allowed Glycine 0 CA--C 1.524 0.618 0 CA-C-N 119.257 0.935 . . . . 71.51 112.587 177.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 66.8 t -119.84 142.31 35.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 117.687 0.743 . . . . 73.54 109.668 170.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.84 126.32 29.05 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.048 0.939 . . . . 72.42 109.769 170.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.94 -24.04 69.82 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-O 118.017 -1.435 . . . . 71.42 112.413 175.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.54 -38.25 89.07 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.941 1.37 . . . . 74.43 109.752 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -73.4 -44.99 57.34 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 105.794 -1.928 . . . . 71.42 105.794 -171.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -60.32 -40.2 89.74 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.452 0.644 . . . . 71.24 110.045 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -79.61 -11.2 59.88 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.395 0.887 . . . . 72.41 113.395 -177.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -103.44 -63.55 1.17 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.985 1.314 . . . . 62.52 109.251 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -44.89 -45.07 10.13 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 128.001 2.521 . . . . 65.3 110.752 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 44.5 t-105 -50.9 -29.7 12.68 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.279 1.032 . . . . 73.53 113.563 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -119.33 5.78 11.18 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.895 1.678 . . . . 74.23 112.434 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.1 t -88.77 149.85 23.23 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.814 1.645 . . . . 70.34 109.466 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -49.2 -33.68 12.99 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.963 1.705 . . . . 74.3 112.121 177.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.0 t -46.09 -56.53 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 125.338 1.455 . . . . 73.43 110.426 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.1 t -67.4 -47.45 80.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 C-N-CA 125.016 1.326 . . . . 74.43 109.454 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -54.39 -44.54 72.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.213 0.53 . . . . 73.42 110.314 -172.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.05 -45.77 84.01 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.68 1.192 . . . . 73.32 111.534 176.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 16.3 mt -60.42 -48.62 80.95 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.86 0.864 . . . . 74.53 111.203 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.9 t -49.96 -45.26 22.37 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 C-N-CA 124.819 1.248 . . . . 73.42 109.3 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.5 -32.5 74.16 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.693 0.627 . . . . 74.43 112.693 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -62.85 -51.8 65.62 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.059 0.845 . . . . 73.53 110.588 171.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -63.44 -47.14 83.1 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.793 0.27 . . . . 54.24 111.235 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -58.73 -47.16 85.57 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.938 1.295 . . . . 70.11 110.553 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -57.23 -45.06 84.24 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 118.492 0.587 . . . . 73.23 110.172 175.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.95 1.37 10.96 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.653 0.983 . . . . 74.3 113.653 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -86.37 -59.36 2.3 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.132 -1.605 . . . . 71.14 110.36 149.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.2 -7.87 40.51 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.028 2.131 . . . . 74.41 114.28 -163.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.08 -6.26 48.55 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.064 1.346 . . . . 73.53 112.343 172.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.0 mt 67.71 63.17 0.41 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 122.727 1.251 . . . . 73.12 109.494 167.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -144.58 -48.11 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.505 -1.225 . . . . 74.34 111.435 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 9.4 tp -78.69 -85.76 0.07 Allowed 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.76 0.709 . . . . 72.53 110.654 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 57.82 24.7 11.09 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.475 1.11 . . . . 71.51 112.515 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -169.39 162.47 36.06 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.682 1.61 . . . . 65.31 109.835 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 18.9 m -150.69 165.19 17.93 Favored Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 118.47 1.135 . . . . 74.53 109.852 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -65.31 157.31 76.63 Favored 'Cis proline' 0 C--N 1.351 0.665 0 CA-C-N 119.902 1.001 . . . . 64.45 110.592 -13.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -144.59 141.8 29.69 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.973 -0.558 . . . . 73.42 110.058 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 34.7 mtp -148.94 95.31 2.38 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 105.855 -1.905 . . . . 74.21 105.855 -169.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -82.13 169.31 16.79 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.996 -0.372 . . . . 73.42 109.996 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.2 t -147.38 150.31 14.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 O-C-N 121.128 -0.982 . . . . 64.54 109.602 169.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 60.31 6.1 0.97 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 128.431 2.692 . . . . 73.33 114.241 166.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.4 -1.47 84.25 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.298 -1.279 . . . . 72.34 112.455 -173.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -147.05 -7.12 0.48 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 116.252 1.945 . . . . 74.34 116.252 -164.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -121.48 155.6 34.57 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 118.517 0.599 . . . . 74.51 109.898 -175.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.67 130.02 50.74 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 128.159 2.584 . . . . 74.44 107.302 172.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.61 153.74 38.43 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.67 -1.233 . . . . 71.44 107.67 174.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -126.48 85.59 59.97 Favored Pre-proline 0 C--O 1.234 0.272 0 O-C-N 122.241 -0.287 . . . . 63.21 110.93 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -63.11 -22.81 73.33 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 CA-C-N 118.948 0.66 . . . . 70.21 111.794 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.5 -2.59 23.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.875 1.27 . . . . 73.52 111.955 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -131.93 30.92 3.14 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.596 1.569 . . . . 72.53 111.021 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 20.8 mtm -127.15 165.18 20.05 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.439 1.496 . . . . 73.14 108.74 172.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -83.18 67.73 9.31 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 124.978 2.323 . . . . 74.14 110.762 -166.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.5 p -66.53 6.09 0.5 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 131.55 3.94 . . . . 74.55 112.204 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 23.0 m -91.74 -5.47 53.55 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 124.112 0.965 . . . . 74.41 113.458 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.44 -10.69 2.48 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 118.376 -0.821 . . . . 73.34 112.626 -172.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 10.1 mmt 70.25 -59.1 0.53 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 126.33 1.852 . . . . 65.33 112.978 177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -67.4 -43.07 82.19 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.84 1.2 . . . . 74.55 108.774 -174.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 40.0 t -65.33 -30.56 50.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 124.516 1.127 . . . . 71.35 110.925 176.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -61.96 -62.53 1.72 Allowed 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.791 -0.818 . . . . 71.25 108.791 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 12.7 t -63.55 -39.01 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 119.079 -0.486 . . . . 73.54 110.271 -172.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -50.6 -49.52 56.36 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.627 1.171 . . . . 74.32 110.612 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -78.62 -40.36 34.57 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 118.342 -0.837 . . . . 73.31 112.005 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -54.1 -56.48 17.67 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.953 0.901 . . . . 74.52 110.289 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -53.86 -35.89 62.0 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.438 1.095 . . . . 73.31 112.326 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -73.29 -51.77 16.36 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.363 0.665 . . . . 72.53 109.829 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.0 t -62.15 -25.34 67.7 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 117.483 -1.246 . . . . 72.22 111.374 -176.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 57.8 t -56.62 -56.28 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 119.369 0.986 . . . . 73.22 108.896 168.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 13.6 tttm -55.8 -46.23 78.07 Favored 'General case' 0 N--CA 1.461 0.088 0 C-N-CA 123.512 0.725 . . . . 71.51 111.518 177.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -58.25 -29.18 65.56 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.442 0.697 . . . . 73.22 111.361 -175.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 50.9 mt -82.04 -25.77 34.35 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 120.964 -1.085 . . . . 74.14 113.222 -176.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 89.3 t -59.74 -36.14 64.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.732 -0.84 . . . . 73.51 108.732 175.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -91.43 -19.65 22.63 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 122.218 -0.301 . . . . 74.24 111.094 -173.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -95.17 65.78 2.87 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.947 1.299 . . . . 73.14 108.932 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt . . . . . 0 C--O 1.242 0.706 0 N-CA-C 108.47 -0.937 . . . . 64.52 108.47 165.337 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 56.0 p . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 111.489 0.181 . . . . 74.33 111.489 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -65.62 175.65 1.77 Allowed 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.464 -0.773 . . . . 53.34 109.07 170.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 50.15 28.55 3.11 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.388 1.875 . . . . 74.44 115.232 -176.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -165.37 113.74 1.01 Allowed 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.238 1.015 . . . . 73.34 110.398 169.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.0 pt -112.93 172.02 3.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 127.593 2.357 . . . . 74.32 109.612 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.9 m -142.68 141.52 31.86 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.138 -0.976 . . . . 63.31 108.86 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -53.21 135.55 37.93 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 126.174 1.79 . . . . 75.33 110.155 172.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.48 -18.02 7.51 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.376 1.465 . . . . 74.24 113.889 -175.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -93.41 -85.12 0.28 Allowed 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.569 1.684 . . . . 64.14 108.904 -167.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -89.43 -12.05 41.34 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.948 0.899 . . . . 71.42 111.381 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -141.69 160.83 39.36 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.494 0.718 . . . . 74.25 109.658 171.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.6 mm -121.74 162.77 20.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 107.407 -1.331 . . . . 73.21 107.407 170.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.4 m -119.57 127.46 53.0 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 127.137 2.175 . . . . 74.22 106.126 -178.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.4 mt -70.5 159.36 34.42 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.236 -0.653 . . . . 74.11 109.236 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -83.07 -30.1 28.28 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.847 0.459 . . . . 71.44 111.608 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -138.13 73.06 45.43 Favored Pre-proline 0 C--O 1.232 0.149 0 C-N-CA 124.903 1.281 . . . . 75.21 108.58 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -69.5 107.31 1.78 Allowed 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.161 2.574 . . . . 74.35 106.953 173.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.8 tt -137.34 149.24 25.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 O-C-N 121.1 -1.0 . . . . 73.42 110.189 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.68 148.46 24.49 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.572 -0.899 . . . . 74.24 108.572 173.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 124.74 -17.83 7.22 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-O 118.809 -0.995 . . . . 74.13 111.537 -170.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -84.69 159.53 57.89 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 119.21 1.505 . . . . 72.42 109.185 161.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.33 -22.26 46.27 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.616 2.211 . . . . 61.03 112.55 173.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 65.66 152.58 0.06 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 128.05 2.54 . . . . 73.12 111.991 -171.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.4 m 44.59 72.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 127.514 2.326 . . . . 74.05 111.639 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.7 160.17 41.64 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.48 -0.933 . . . . 64.25 108.48 -173.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -126.77 161.36 28.37 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 125.083 1.353 . . . . 73.02 107.458 167.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -121.09 174.04 6.9 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.982 -1.488 . . . . 75.31 106.982 167.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -166.01 -179.03 4.97 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.669 2.388 . . . . 72.42 109.264 168.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.07 -168.63 2.4 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 106.729 -1.582 . . . . 71.43 106.729 158.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -104.47 -45.9 4.52 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.587 0.708 . . . . 74.32 109.256 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.483 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 69.4 m-85 -83.39 -4.09 58.15 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.544 -0.723 . . . . 73.31 111.814 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.2 p -62.36 144.09 95.36 Favored Pre-proline 0 C--N 1.343 0.283 0 CA-C-N 119.782 1.174 . . . . 72.2 109.841 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.0 173.93 13.66 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 121.461 1.441 . . . . 65.4 109.365 163.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 66.17 -40.63 0.35 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 128.936 2.895 . . . . 74.21 112.762 -174.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 60.2 m -54.84 -41.09 70.32 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.834 1.654 . . . . 73.1 112.128 -177.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -54.5 -63.69 1.07 Allowed 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 128.199 2.6 . . . . 74.01 108.854 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.16 -39.97 76.3 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 108.434 -0.95 . . . . 72.44 108.434 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -57.09 -26.46 60.45 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 115.292 -2.289 . . . . 74.44 113.282 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.64 -24.57 4.5 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 122.158 2.254 . . . . 73.24 109.552 -174.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -105.76 -17.06 14.5 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.512 1.505 . . . . 74.31 113.757 -170.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.6 t -121.68 -63.73 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 108.187 -1.042 . . . . 70.44 108.187 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 42.6 mt -70.88 -18.39 62.69 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 118.147 -0.93 . . . . 74.02 111.966 175.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 44.89 39.59 3.71 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 121.139 1.79 . . . . 74.1 112.899 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 69.4 t -61.23 -45.41 98.65 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 O-C-N 121.091 -1.006 . . . . 71.23 109.864 -175.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.4 t -47.1 -53.27 13.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.86 1.264 . . . . 74.14 109.942 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.95 -31.89 69.85 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 113.558 0.948 . . . . 74.44 113.558 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -73.88 -51.69 15.39 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.702 0.683 . . . . 74.34 109.297 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 50.4 t -52.66 -52.68 25.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 126.055 1.742 . . . . 74.44 109.609 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.4 ptt85 -64.85 -14.01 58.03 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 116.795 -1.574 . . . . 74.43 114.015 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -75.75 -17.64 59.83 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 120.667 1.576 . . . . 73.41 112.55 170.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -123.34 -9.18 8.07 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.445 1.098 . . . . 73.43 113.34 -171.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.8 mt -61.64 146.16 90.62 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 123.929 0.892 . . . . 73.24 112.184 -179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -83.47 162.1 14.79 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.879 3.053 . . . . 71.14 114.081 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -79.51 64.83 4.5 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 127.094 2.158 . . . . 71.24 110.257 -171.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -176.25 -30.41 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 125.174 1.368 . . . . 74.45 111.615 -169.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.8 t -58.04 -29.61 65.49 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 115.233 1.568 . . . . 74.43 115.233 -176.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.3 tptp 44.37 88.62 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.43 1.892 . . . . 74.33 112.185 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 4.5 ttm -49.77 100.71 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 129.388 3.075 . . . . 70.32 110.692 -175.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.4 m -139.84 121.31 15.1 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 107.337 -1.357 . . . . 73.24 107.337 -172.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -130.46 120.01 23.51 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 106.986 -1.487 . . . . 64.0 106.986 -176.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -95.52 157.11 16.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 123.13 1.443 . . . . 74.43 110.056 174.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.69 ' CD2' ' H ' ' A' ' 60' ' ' HIS . 5.4 p80 -98.0 167.06 11.13 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 129.176 2.99 . . . . 71.2 108.901 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.2 m -131.92 165.83 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.032 0.933 . . . . 74.02 108.507 176.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -100.68 16.65 24.21 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.53 1.132 . . . . 73.2 111.675 -169.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -115.73 162.6 17.04 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 126.436 1.895 . . . . 74.43 109.322 -169.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 75.3 124.34 0.04 OUTLIER 'General case' 0 C--O 1.232 0.153 0 C-N-CA 128.676 2.79 . . . . 63.04 110.519 174.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.483 ' HA3' ' CD2' ' A' ' 29' ' ' TYR . . . 90.19 173.47 44.93 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 124.302 0.953 . . . . 75.42 112.098 175.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -65.52 -55.15 0.47 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.348 2.699 . . . . 74.21 109.737 173.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.5 mt -86.54 17.0 4.1 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 125.174 1.39 . . . . 73.42 112.862 -167.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -48.16 -45.12 27.21 Favored Glycine 0 CA--C 1.542 1.739 0 CA-C-N 120.005 1.275 . . . . 72.13 113.715 -174.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.1 tptt -59.85 -46.37 89.5 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.887 1.275 . . . . 75.22 111.541 174.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -71.03 -38.18 72.58 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.749 -1.219 . . . . 72.41 109.026 -176.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.1 mt -62.46 -34.1 76.14 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.091 1.756 . . . . 71.21 111.915 173.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.7 m -54.04 -58.19 8.24 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 106.934 -1.506 . . . . 75.1 106.934 170.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -57.25 -50.56 72.51 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.968 0.907 . . . . 73.14 111.595 -169.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.5 -24.4 67.46 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.883 1.068 . . . . 70.34 113.883 -171.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.571 ' CD1' ' CD2' ' A' ' 60' ' ' HIS . 52.0 t-105 -57.7 -35.04 70.09 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.453 -0.779 . . . . 74.22 111.168 175.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.05 95.04 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.34 -0.838 . . . . 72.34 111.915 178.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.2 t -53.38 -43.73 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 119.177 0.898 . . . . 73.4 110.159 175.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.93 -26.24 40.2 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 117.362 -1.304 . . . . 74.02 113.088 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 76.8 mt -67.14 -41.75 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 120.835 1.652 . . . . 74.23 108.343 166.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.01 -44.36 94.63 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.623 0.647 . . . . 74.04 110.464 -172.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.4 mt -81.04 -18.07 48.01 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 112.902 0.705 . . . . 72.1 112.902 174.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.29 70.16 1.13 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.907 1.717 . . . . 54.22 110.789 -171.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.9 m -138.11 19.18 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 125.735 1.614 . . . . 74.2 111.432 -175.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -52.43 -51.52 58.78 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 126.03 1.732 . . . . 72.14 110.151 -178.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -68.36 -0.86 5.33 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.562 1.945 . . . . 65.0 113.393 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -104.42 -26.07 12.57 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 120.835 -1.165 . . . . 74.32 109.66 176.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.1 pt -112.04 9.93 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 C-N-CA 125.013 1.325 . . . . 73.33 111.698 -174.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 56.0 m -80.92 -44.71 17.84 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 120.931 1.696 . . . . 63.4 109.22 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.07 -63.5 2.1 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 124.081 0.952 . . . . 71.33 111.686 -165.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.01 -21.41 73.16 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 121.355 1.37 . . . . 73.43 112.08 -176.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 15.0 ttm -74.26 -37.69 63.67 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 125.875 1.67 . . . . 72.44 110.52 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -64.08 -42.29 97.01 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 119.047 -0.502 . . . . 74.01 110.304 164.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -64.75 -13.79 56.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 118.321 -0.847 . . . . 65.01 113.189 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.99 -14.12 15.28 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.782 1.173 . . . . 71.4 112.36 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 78.9 t -105.86 -45.04 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.251 1.02 . . . . 74.42 112.371 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -103.88 -48.54 3.88 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 114.587 1.329 . . . . 71.02 114.587 -174.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -70.31 -59.18 3.02 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.875 1.27 . . . . 74.11 113.587 -177.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 48.5 p -94.05 -30.26 14.78 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.779 1.232 . . . . 73.1 113.435 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 60.95 27.11 16.99 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.001 2.921 . . . . 71.43 113.569 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.5 t -59.78 -25.75 65.16 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.398 1.479 . . . . 73.42 112.438 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 42.7 t -62.58 109.91 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 108.528 -0.916 . . . . 72.22 108.528 175.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -141.66 -20.41 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.945 1.298 . . . . 74.3 110.841 -175.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.93 167.4 22.21 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.679 -1.6 . . . . 72.44 106.679 167.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.5 t -55.74 -28.8 24.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.11 0.564 . . . . 74.43 109.698 172.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.86 -15.04 57.96 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.972 1.709 . . . . 63.2 112.191 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.84 -23.67 13.37 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 118.635 0.652 . . . . 71.41 111.086 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.5 mt -71.52 -51.41 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 C-N-CA 125.4 1.48 . . . . 65.42 108.236 174.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.76 -22.36 62.0 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.269 1.028 . . . . 72.22 112.22 -175.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -62.06 -59.35 5.21 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 126.682 1.993 . . . . 74.44 111.076 170.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 71.1 t -54.53 -40.49 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.523 1.129 . . . . 74.11 110.354 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -54.06 -53.27 55.36 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 119.05 -0.5 . . . . 71.12 110.644 173.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.4 t -61.98 -46.72 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 119.617 1.098 . . . . 71.23 110.645 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -54.39 -44.2 72.1 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.164 0.986 . . . . 72.11 109.772 -176.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.1 -13.19 60.45 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.522 1.529 . . . . 53.32 114.907 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 126.42 6.47 5.67 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 117.402 1.721 . . . . 71.22 117.402 176.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 93.7 t -93.71 120.04 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-N 119.958 1.879 . . . . 74.41 110.051 -175.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.441 ' HG3' ' CB ' ' A' ' 120' ' ' ASP . 3.6 pttp -52.2 125.92 17.24 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.593 -0.73 . . . . 63.3 109.927 172.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.21 -30.6 61.24 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 109.41 -1.476 . . . . 52.33 109.41 166.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -30.38 66.56 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 119.371 1.585 . . . . 74.34 110.653 -175.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.441 ' CB ' ' HG3' ' A' ' 117' ' ' LYS . 23.3 t0 -83.31 -43.31 16.14 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.842 -0.799 . . . . 74.04 108.842 175.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -50.81 -54.62 22.13 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 123.58 0.752 . . . . 74.3 111.047 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -73.66 -9.95 59.2 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.619 1.568 . . . . 74.02 111.413 -173.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.29 -63.3 1.14 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.431 1.892 . . . . 72.2 109.501 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.49 -36.08 68.72 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.681 1.592 . . . . 72.33 112.893 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 65.3 t-105 -44.64 -39.26 4.9 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.562 1.145 . . . . 63.1 111.065 174.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.28 0.97 41.22 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.881 1.672 . . . . 74.42 113.657 -177.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.4 t -97.66 165.72 11.83 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.593 1.557 . . . . 74.2 112.676 -173.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -62.97 -36.64 84.16 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.001 1.72 . . . . 75.1 111.445 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.4 t -50.58 -47.75 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 122.342 1.068 . . . . 72.14 109.064 -178.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.6 t -68.84 -42.89 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-N 114.818 -1.083 . . . . 71.3 111.476 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -50.98 -53.87 29.42 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 118.98 0.809 . . . . 74.42 110.451 175.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.84 -42.96 99.95 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.214 0.606 . . . . 71.02 110.091 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.5 mt -64.4 -40.08 95.1 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 119.326 0.966 . . . . 72.13 112.823 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 74.2 t -59.23 -53.79 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 107.406 -1.331 . . . . 73.12 107.406 171.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.42 -34.35 68.82 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.385 0.883 . . . . 73.14 113.385 -174.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -53.28 -46.03 69.15 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 124.523 1.129 . . . . 71.44 111.565 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.402 ' HG2' ' CD2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -94.18 -31.19 14.24 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 113.102 0.778 . . . . 75.23 113.102 -170.556 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -64.87 -38.08 89.78 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.796 0.726 . . . . 75.14 109.169 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -54.56 -48.83 71.58 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 126.404 1.882 . . . . 75.42 111.386 165.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.66 -17.0 60.75 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 118.513 -0.756 . . . . 71.41 112.596 -175.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.25 -44.91 35.26 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 120.839 1.654 . . . . 75.01 109.819 164.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.5 -5.11 21.93 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.428 1.491 . . . . 75.31 114.236 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.0 -2.46 51.66 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.67 1.123 . . . . 72.25 112.355 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 10.2 mt 74.56 54.84 0.08 Allowed 'General case' 0 C--N 1.342 0.245 0 C-N-CA 126.353 1.861 . . . . 75.15 110.454 164.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.41 -23.39 2.13 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.611 0.967 . . . . 73.15 113.611 -173.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.91 -80.85 0.51 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.613 1.097 . . . . 73.34 111.382 -168.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 62.77 -3.58 0.3 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.707 2.003 . . . . 72.15 115.534 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -137.83 162.19 25.53 Favored Glycine 0 CA--C 1.526 0.727 0 O-C-N 120.395 -1.441 . . . . 61.13 110.858 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.1 m -142.39 166.93 18.15 Favored Pre-proline 0 C--O 1.239 0.504 0 N-CA-C 107.976 -1.12 . . . . 74.14 107.976 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.59 155.7 99.73 Favored 'Cis proline' 0 CA--C 1.536 0.625 0 CA-C-N 119.79 0.961 . . . . 74.44 113.532 -9.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -152.17 142.47 22.45 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 126.062 1.745 . . . . 73.04 110.079 -177.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 32.4 ttm -140.67 133.81 29.47 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 126.505 1.922 . . . . 74.21 106.43 172.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -117.42 159.58 22.56 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.836 0.854 . . . . 74.14 111.216 -177.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.5 t -141.23 145.74 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.407 1.083 . . . . 73.03 108.549 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 48.28 11.91 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.317 2.647 . . . . 71.03 116.124 177.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 62.56 41.93 99.75 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 119.705 1.138 . . . . 64.25 110.59 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -165.71 -21.93 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.778 1.231 . . . . 74.12 112.488 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -112.89 146.44 38.94 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 118.756 0.707 . . . . 74.13 109.362 177.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -117.78 139.36 51.19 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 104.933 -2.247 . . . . 73.14 104.933 167.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.38 142.91 57.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.777 -1.564 . . . . 72.34 106.777 173.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -115.75 85.58 14.48 Favored Pre-proline 0 CA--C 1.516 -0.344 0 CA-C-N 117.84 0.291 . . . . 74.11 110.97 177.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -64.87 -27.13 59.11 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 CA-C-N 118.652 0.554 . . . . 62.32 111.139 174.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.93 -0.56 16.5 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.397 1.479 . . . . 74.45 112.825 -173.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -133.22 12.49 4.98 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.66 1.6 . . . . 73.34 111.699 175.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 17.5 mtt -87.73 172.32 9.77 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 120.129 1.965 . . . . 74.32 109.264 165.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.16 106.68 7.91 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.055 -1.461 . . . . 71.35 107.055 169.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.4 HG23 ' CD1' ' A' ' 173' ' ' PHE . 54.5 p -112.59 18.39 18.4 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.107 2.163 . . . . 70.11 110.368 -178.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 40.0 m -99.52 5.56 46.06 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.451 1.101 . . . . 74.41 112.77 -172.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -137.43 -15.22 1.45 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.554 1.142 . . . . 70.35 111.825 -177.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 2.2 mmt 69.17 -62.99 0.39 Allowed 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 126.246 1.819 . . . . 74.32 110.454 -175.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.99 -38.55 86.4 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.17 -0.956 . . . . 74.13 111.657 -172.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 65.5 t -75.29 -27.49 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 123.809 0.844 . . . . 63.21 111.161 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.4 ' CD1' HG23 ' A' ' 167' ' ' THR . 42.0 t80 -59.32 -52.03 67.4 Favored 'General case' 0 C--O 1.226 -0.158 0 N-CA-C 108.655 -0.868 . . . . 74.34 108.655 -177.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.7 t -77.28 -25.04 15.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 117.518 0.145 . . . . 74.21 111.11 -175.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.53 -31.25 67.76 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.3 0.482 . . . . 70.11 112.3 168.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -86.32 -44.94 11.69 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.25 1.02 . . . . 74.03 110.985 172.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -58.44 -56.74 18.21 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.519 0.728 . . . . 73.41 110.569 -167.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.15 -21.23 59.04 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 113.683 0.994 . . . . 71.04 113.683 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -77.96 -52.58 8.59 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 123.346 0.658 . . . . 71.32 110.321 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.0 t -62.16 -30.71 71.24 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 117.832 -1.08 . . . . 72.15 110.653 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 85.5 t -60.63 -54.57 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 119.987 1.267 . . . . 74.31 108.483 177.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -59.51 -48.17 82.67 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-O 118.777 -0.63 . . . . 72.32 110.255 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -60.13 -29.46 68.64 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 112.481 0.549 . . . . 74.45 112.481 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 60.2 mt -74.79 -23.13 58.45 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 120.826 -1.171 . . . . 73.33 112.309 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 92.9 t -66.05 -29.5 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 118.34 0.518 . . . . 70.12 109.671 174.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -95.46 -9.36 32.83 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.816 0.846 . . . . 74.31 110.428 -175.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 21.0 mttp -108.61 61.91 0.6 Allowed 'General case' 0 C--O 1.225 -0.186 0 O-C-N 120.661 -1.274 . . . . 72.44 109.664 -177.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.6 mmtm . . . . . 0 C--O 1.254 1.317 0 C-N-CA 127.179 2.191 . . . . 74.05 112.223 171.253 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 44.0 t . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 109.548 -0.538 . . . . 74.34 109.548 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -143.85 -175.52 4.62 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.662 1.585 . . . . 72.33 107.146 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 61.72 32.57 18.28 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 125.918 1.687 . . . . 74.42 112.691 -177.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -156.35 105.95 2.32 Favored 'General case' 0 N--CA 1.425 -1.711 0 C-N-CA 125.563 1.545 . . . . 65.41 107.791 -175.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.9 pt -106.16 167.0 3.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 127.185 2.194 . . . . 73.02 109.119 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.7 m -143.89 145.8 32.55 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 106.598 -1.63 . . . . 74.02 106.598 175.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -58.56 150.06 23.94 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 127.566 2.347 . . . . 72.31 109.758 167.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.56 -29.37 0.36 Allowed Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.546 1.07 . . . . 64.32 113.826 -168.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -94.85 -84.44 0.33 Allowed 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 118.951 1.375 . . . . 74.05 108.551 -165.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -92.7 -14.92 27.35 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.459 0.703 . . . . 73.13 110.852 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -143.48 165.31 27.9 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.544 0.611 . . . . 74.01 110.705 167.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.3 mm -122.17 162.61 21.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 126.827 2.051 . . . . 74.04 106.605 175.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.0 m -126.66 136.45 52.5 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 106.004 -1.85 . . . . 63.22 106.004 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.0 mt -81.07 156.4 25.84 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 118.541 0.61 . . . . 75.04 109.606 -178.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -71.7 -34.94 70.05 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.303 1.441 . . . . 71.44 110.509 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.4 mmtm -137.01 78.82 39.94 Favored Pre-proline 0 N--CA 1.453 -0.279 0 C-N-CA 125.112 1.365 . . . . 75.43 108.403 -175.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -77.45 73.96 5.34 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 123.391 2.728 . . . . 63.15 108.763 174.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.1 tt -157.21 95.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 107.969 -1.123 . . . . 72.04 107.969 165.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.77 -176.68 4.86 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.732 2.013 . . . . 72.44 106.918 169.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.34 -108.62 0.79 Allowed Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 108.953 -1.659 . . . . 74.01 108.953 172.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 60.57 165.85 0.09 OUTLIER Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.812 1.245 . . . . 74.44 112.993 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.41 164.7 24.95 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 120.914 1.076 . . . . 74.22 109.922 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.78 -32.06 59.63 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.696 1.198 . . . . 74.13 113.268 -170.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.422 HG21 ' H ' ' A' ' 55' ' ' LYS . 14.8 m -150.51 -176.41 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 128.769 2.828 . . . . 65.03 105.442 166.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -169.61 171.06 7.75 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.573 1.549 . . . . 65.04 108.46 169.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -130.45 145.14 51.78 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 128.509 2.723 . . . . 72.11 108.875 176.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -132.52 125.44 30.6 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.833 1.253 . . . . 74.01 108.291 174.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -135.82 178.63 6.9 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.947 1.699 . . . . 74.44 109.527 174.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.465 ' HA ' ' CE1' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -146.59 -174.89 4.59 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.155 0.982 . . . . 70.3 110.5 164.435 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.518 ' CZ ' ' HG3' ' A' ' 91' ' ' MET . 50.9 m-85 -93.93 -41.39 9.62 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.654 -0.654 . . . . 74.12 112.73 176.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -80.72 -7.53 59.38 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.808 0.67 . . . . 74.11 112.808 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.0 p -74.7 149.2 85.78 Favored Pre-proline 0 CA--C 1.532 0.269 0 O-C-N 120.744 -1.223 . . . . 73.14 111.979 173.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.25 167.87 25.69 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.618 2.212 . . . . 73.31 109.184 164.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.2 m80 68.98 -51.32 0.59 Allowed 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 127.114 2.165 . . . . 73.23 110.738 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 61.0 m -44.42 -40.45 5.48 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 126.555 1.942 . . . . 73.15 112.046 177.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.95 -70.91 0.08 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.291 1.037 . . . . 74.23 108.229 175.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.447 ' HA ' HE21 ' A' ' 35' ' ' GLN . 0.0 OUTLIER -65.98 -37.47 86.05 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.084 -1.01 . . . . 73.35 110.141 -169.717 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -61.58 -20.64 63.53 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 116.878 -1.534 . . . . 72.13 112.483 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -120.68 -11.25 9.06 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 119.395 0.998 . . . . 72.11 110.928 -170.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.48 ' HA ' ' CE1' ' A' ' 41' ' ' HIS . 0.0 OUTLIER -134.56 -16.54 2.05 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 114.666 1.358 . . . . 64.01 114.666 -173.765 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 77.7 t -117.64 -68.23 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.272 0.558 . . . . 74.04 110.368 174.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.4 mt -69.08 -21.76 64.05 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.247 1.419 . . . . 74.42 111.314 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.48 ' CE1' ' HA ' ' A' ' 38' ' ' GLU . 39.7 m-70 44.08 56.24 4.89 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 126.0 1.72 . . . . 74.22 111.074 171.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 68.2 t -59.18 -49.13 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 117.184 -1.389 . . . . 74.04 107.754 -172.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.3 t -45.61 -53.47 9.1 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-N 119.685 1.13 . . . . 74.14 112.111 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.477 ' CG ' HH12 ' A' ' 47' ' ' ARG . 1.5 t70 -88.5 5.66 41.5 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.921 0.712 . . . . 72.42 112.921 -174.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -92.01 -49.06 6.42 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.733 0.813 . . . . 72.14 109.992 157.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 t -63.49 -40.12 87.88 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-N 119.632 1.106 . . . . 74.11 110.392 -170.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.477 HH12 ' CG ' ' A' ' 44' ' ' ASP . 0.7 OUTLIER -51.58 -38.43 54.41 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 118.049 -0.977 . . . . 70.14 111.709 -179.045 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -64.76 -2.96 2.82 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 115.207 1.558 . . . . 73.25 115.207 176.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -129.05 -5.62 4.97 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.107 1.763 . . . . 74.14 111.603 -178.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.6 mt -87.67 152.7 52.05 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 127.334 2.254 . . . . 73.42 111.119 -165.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -81.21 175.6 9.59 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.209 2.606 . . . . 61.34 112.015 -178.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -84.63 23.03 1.2 Allowed 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.478 -1.389 . . . . 74.15 114.524 -169.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -143.19 -15.08 0.29 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.308 1.432 . . . . 63.24 113.724 -172.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.6 t -60.04 128.12 35.25 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 107.388 -1.338 . . . . 71.13 107.388 175.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.422 ' H ' HG21 ' A' ' 22' ' ' VAL . 48.0 tptt -118.61 72.78 0.89 Allowed 'General case' 0 C--N 1.341 0.196 0 CA-C-O 123.279 1.514 . . . . 71.11 109.535 173.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 18.4 ptp -52.96 -31.85 42.71 Favored 'General case' 0 CA--C 1.496 -1.1 0 C-N-CA 125.331 1.452 . . . . 71.05 114.339 -173.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.5 m 46.82 -167.33 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 126.101 1.761 . . . . 74.21 113.063 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.09 104.72 1.71 Allowed 'General case' 0 CA--C 1.54 0.563 0 O-C-N 119.977 -1.702 . . . . 73.44 107.65 167.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.7 m-30 -102.63 174.81 5.73 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.635 1.561 . . . . 74.21 111.013 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.465 ' CE1' ' HA ' ' A' ' 27' ' ' SER . 6.2 t60 -135.02 118.5 16.86 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 118.722 0.692 . . . . 73.31 111.417 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.8 m -81.93 172.07 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 123.252 0.621 . . . . 75.43 110.042 178.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.27 3.39 6.36 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.625 1.57 . . . . 74.03 113.096 -169.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -81.32 1.23 33.55 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.414 1.265 . . . . 75.01 114.414 -172.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 mt -125.59 132.09 52.59 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.655 1.116 . . . . 75.3 110.44 -164.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.76 177.37 35.33 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.666 0.65 . . . . 75.32 111.66 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.77 -55.13 0.92 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.186 2.591 . . . . 73.22 110.453 173.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.1 mt -91.84 22.37 4.25 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.375 -0.828 . . . . 73.11 112.875 -166.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -48.65 -48.43 29.03 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 119.101 0.864 . . . . 63.3 112.206 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.507 ' HZ3' ' CD ' ' A' ' 138' ' ' GLU . 15.6 mmtt -56.52 -42.53 78.58 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.482 1.513 . . . . 75.14 113.307 176.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -78.71 -33.37 46.86 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.332 0.653 . . . . 72.14 110.259 -176.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.6 mt -62.4 -41.03 98.35 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.886 -0.783 . . . . 72.4 108.886 171.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.9 m -55.65 -50.11 71.07 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.594 1.088 . . . . 53.44 110.171 168.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -61.71 -35.16 77.24 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 120.621 1.555 . . . . 74.33 113.012 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.27 -35.06 79.87 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.668 0.667 . . . . 65.34 111.914 174.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 11.3 t-105 -57.46 -42.71 83.09 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 118.619 0.645 . . . . 74.43 111.026 -176.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.96 -36.38 74.72 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 117.517 -1.23 . . . . 65.21 112.872 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.0 t -59.7 -47.12 92.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 120.065 1.302 . . . . 72.21 108.626 172.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.55 -47.21 86.58 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 121.806 -0.559 . . . . 72.14 111.142 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 92.7 mt -62.39 -42.54 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.137 0.975 . . . . 71.5 110.509 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.62 -47.25 86.34 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.576 0.625 . . . . 73.12 109.441 -174.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 87.3 mt -80.2 -20.34 44.95 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 119.195 -0.431 . . . . 71.5 112.065 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.69 66.68 2.4 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 125.9 1.715 . . . . 72.32 110.261 -167.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.1 m -134.85 18.29 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.742 1.617 . . . . 71.52 111.048 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -51.07 -53.57 32.77 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 124.466 1.107 . . . . 65.23 110.09 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -77.0 -5.79 50.08 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.066 0.946 . . . . 61.41 111.29 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -90.21 -8.49 50.97 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.224 1.01 . . . . 73.31 111.216 166.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.7 pp -133.19 38.12 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 124.901 1.28 . . . . 64.52 111.715 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.0 m -92.39 -52.33 4.72 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.748 -0.595 . . . . 72.33 110.753 171.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.83 -64.05 3.49 Favored Pre-proline 0 CA--C 1.532 0.276 0 C-N-CA 123.318 0.647 . . . . 74.54 112.295 -163.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.33 -20.77 31.74 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 CA-C-N 119.575 0.884 . . . . 70.12 112.602 -173.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.518 ' HG3' ' CZ ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -54.47 -58.8 6.04 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 127.481 2.312 . . . . 70.33 108.116 170.705 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -59.09 -41.69 88.67 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 124.105 0.962 . . . . 70.13 111.817 177.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -56.62 -36.68 69.73 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.076 -0.511 . . . . 74.14 110.676 172.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.39 -17.03 43.65 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 121.4 -0.812 . . . . 71.45 112.541 -169.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.0 t -114.3 -23.17 4.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 C-N-CA 124.613 1.165 . . . . 74.04 111.064 -172.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -120.48 -52.36 2.15 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.678 0.791 . . . . 74.25 112.289 -178.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -69.27 -52.85 23.49 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 121.583 -0.698 . . . . 74.33 111.244 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 37.2 p -98.62 -31.69 11.81 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.14 0.976 . . . . 72.52 110.489 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 52.59 34.78 16.45 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.882 2.073 . . . . 61.04 111.534 -173.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 t -75.91 -12.76 60.21 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.648 1.179 . . . . 73.53 112.67 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.9 t -67.31 118.17 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 O-C-N 120.913 -1.117 . . . . 70.51 108.963 172.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -141.93 -25.13 0.68 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.463 1.105 . . . . 74.04 111.799 -178.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.13 160.78 38.49 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.584 1.553 . . . . 73.1 107.166 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 63.9 t -58.59 -32.34 45.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.566 1.146 . . . . 74.41 110.221 177.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.32 -29.06 57.54 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.287 1.435 . . . . 73.32 112.743 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -88.33 -25.41 22.77 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.598 0.635 . . . . 72.11 109.293 -176.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.2 mt -78.39 -47.74 23.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 124.963 1.305 . . . . 71.54 109.582 -178.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -56.11 -28.08 56.37 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-O 118.342 -0.837 . . . . 74.52 111.406 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -58.88 -53.61 56.46 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 123.86 0.864 . . . . 73.12 110.113 -176.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 17.4 t -56.07 -41.44 68.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.164 0.586 . . . . 71.43 110.716 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -60.47 -49.32 78.04 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.127 0.971 . . . . 74.44 110.009 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 83.5 t -63.41 -35.87 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 121.581 -0.699 . . . . 73.4 110.194 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.67 -44.05 97.25 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.466 0.706 . . . . 62.22 109.3 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.52 -21.42 62.73 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.612 1.165 . . . . 50.22 112.497 175.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 131.62 2.29 4.46 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 115.908 1.123 . . . . 73.2 115.908 167.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 65.1 t -66.26 143.73 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 123.363 1.554 . . . . 73.54 108.354 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.65 145.53 50.57 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.626 -1.17 . . . . 72.53 110.446 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -78.47 -0.2 78.0 Favored Glycine 0 N--CA 1.467 0.708 0 C-N-CA 124.035 0.826 . . . . 74.44 114.241 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -94.88 -36.97 11.42 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 123.198 0.599 . . . . 73.33 111.449 172.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -86.79 -41.1 14.36 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 107.348 -1.353 . . . . 73.23 107.348 -160.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -60.61 -53.2 60.37 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.957 -0.757 . . . . 74.31 108.957 172.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -73.14 -20.47 60.91 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 118.77 -0.634 . . . . 72.31 111.48 -170.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.56 -65.24 1.01 Allowed 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.138 -1.06 . . . . 51.41 108.138 171.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.53 -35.19 65.39 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.106 0.962 . . . . 70.1 111.626 -171.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -44.86 -36.97 3.55 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 125.08 1.352 . . . . 74.3 111.83 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -114.35 8.42 16.65 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.744 1.618 . . . . 72.42 113.484 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.6 t -79.09 148.8 32.28 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.06 1.744 . . . . 64.43 110.53 169.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -54.92 -33.36 62.06 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.232 1.813 . . . . 75.21 112.532 -177.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 22.3 t -54.63 -48.22 71.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 124.14 0.976 . . . . 73.2 109.742 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 32.7 t -69.98 -44.41 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-O 117.956 -1.021 . . . . 72.53 108.667 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -49.21 -49.92 40.66 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.267 1.394 . . . . 74.13 111.373 175.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.1 t -61.59 -49.05 78.18 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 123.481 0.713 . . . . 72.12 109.897 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 13.6 mt -65.04 -38.71 91.73 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 118.606 0.639 . . . . 73.32 111.988 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 49.1 t -58.31 -60.8 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 125.797 1.639 . . . . 75.43 107.695 173.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.65 -42.06 70.84 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 119.007 -0.521 . . . . 74.3 110.856 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -57.28 -53.11 61.87 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 123.435 0.694 . . . . 74.2 111.654 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -67.03 -48.67 67.64 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 119.158 0.89 . . . . 74.13 110.774 -175.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.507 ' CD ' ' HZ3' ' A' ' 69' ' ' LYS . 93.0 mt-10 -63.29 -27.76 69.56 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.362 0.665 . . . . 74.43 112.043 -178.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -82.24 -54.75 5.0 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.512 0.725 . . . . 75.34 109.647 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.08 0.74 1.77 Allowed 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 125.574 1.549 . . . . 54.34 113.399 -175.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.58 -0.16 8.69 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 114.216 1.191 . . . . 75.24 114.216 169.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.38 -13.01 7.24 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.99 0.814 . . . . 52.54 113.167 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -51.75 -66.7 0.34 Allowed 'General case' 0 C--O 1.231 0.086 0 C-N-CA 125.893 1.677 . . . . 62.34 110.773 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.9 pp 174.19 -4.66 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 129.117 2.967 . . . . 74.24 112.154 169.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.407 ' NE2' ' H ' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -78.63 -27.23 45.38 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.519 1.128 . . . . 75.44 111.735 -158.634 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.407 ' H ' ' NE2' ' A' ' 145' ' ' GLN . 0.9 OUTLIER -159.57 140.91 12.82 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 128.641 2.776 . . . . 74.0 106.759 -179.5 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -145.4 12.27 1.34 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.202 1.401 . . . . 75.3 110.502 -172.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -151.53 147.89 18.3 Favored Glycine 0 C--N 1.342 0.862 0 O-C-N 120.255 -1.528 . . . . 61.42 110.901 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 35.5 m -133.83 165.46 36.54 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 118.45 1.125 . . . . 74.13 111.102 -168.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.0 157.91 95.16 Favored 'Cis proline' 0 C--N 1.35 0.631 0 CA-C-N 119.233 0.762 . . . . 73.04 112.263 -11.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -138.59 146.63 42.04 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.639 -0.709 . . . . 73.43 111.472 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 7.8 ttm -145.14 119.22 9.42 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.667 -1.605 . . . . 70.11 106.667 174.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -88.21 164.74 15.49 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.367 0.667 . . . . 74.22 109.825 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.485 ' CG1' ' HB2' ' A' ' 158' ' ' TYR . 0.5 OUTLIER -149.55 150.31 13.93 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 O-C-N 121.067 -1.021 . . . . 73.45 108.719 175.291 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 48.3 15.21 0.07 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.328 1.603 . . . . 73.22 115.328 -175.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 50.79 38.33 36.88 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 120.039 1.291 . . . . 73.33 112.425 -167.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 42.7 pttt -162.27 -14.21 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.946 1.299 . . . . 74.05 114.038 173.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.485 ' HB2' ' CG1' ' A' ' 154' ' ' VAL 0.276 14.3 m-85 -106.42 158.86 16.59 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 127.041 2.136 . . . . 74.23 110.834 178.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -139.24 130.62 26.96 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 105.063 -2.199 . . . . 65.13 105.063 174.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.92 142.49 56.02 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.518 -1.29 . . . . 70.41 107.518 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -114.26 85.28 10.31 Favored Pre-proline 0 C--O 1.236 0.376 0 N-CA-C 110.339 -0.245 . . . . 74.44 110.339 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.11 -16.02 43.99 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 N-CA-C 110.342 -0.676 . . . . 71.03 110.342 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -77.65 2.49 16.53 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.283 1.833 . . . . 71.13 112.477 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -135.3 35.5 2.17 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 119.422 1.01 . . . . 70.21 111.12 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 62.5 mtt -120.84 167.38 12.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.446 1.098 . . . . 74.45 110.403 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -62.21 112.42 2.38 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.237 1.015 . . . . 71.33 108.937 169.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 82.3 p -119.57 22.08 11.81 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.434 1.094 . . . . 72.03 110.186 175.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.23 -48.22 36.8 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 118.664 0.665 . . . . 74.24 109.934 172.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.49 HD21 ' HB ' ' A' ' 172' ' ' VAL . 0.4 OUTLIER -107.82 -10.85 15.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 118.07 -0.966 . . . . 74.43 111.608 -156.172 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 16.6 mmm 73.47 -44.85 0.59 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 127.748 2.419 . . . . 74.42 111.935 169.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -55.54 23.17 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 127.179 2.191 . . . . 74.44 107.941 173.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.49 ' HB ' HD21 ' A' ' 169' ' ' ASN . 61.5 t -67.81 -26.47 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 127.057 2.143 . . . . 74.24 110.538 -174.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.68 -59.12 5.95 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.189 -1.041 . . . . 74.25 108.189 173.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 10.8 t -66.58 -32.03 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.101 0.56 . . . . 72.34 110.521 -177.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.66 -41.86 82.36 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.645 0.778 . . . . 73.23 111.607 176.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -85.35 -32.35 22.49 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.587 1.155 . . . . 73.05 112.69 177.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -56.8 -63.29 1.25 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.376 -0.972 . . . . 74.44 108.376 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.86 -26.95 69.02 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.562 0.578 . . . . 64.34 112.562 -170.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -71.24 -52.23 20.17 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.222 1.409 . . . . 71.42 109.878 177.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 92.4 m -53.78 -40.11 66.0 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.248 1.019 . . . . 72.41 110.155 176.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 46.1 t -57.75 -53.27 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 108.934 -0.765 . . . . 73.15 108.934 178.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.3 tttt -59.95 -43.47 95.0 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 124.065 0.946 . . . . 73.31 110.543 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -63.33 -32.62 74.09 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 123.14 0.576 . . . . 71.04 111.202 -171.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 19.5 mt -68.79 -25.97 64.97 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 112.756 0.65 . . . . 71.04 112.756 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 61.1 t -65.72 -25.91 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 O-C-N 121.188 -0.945 . . . . 73.44 109.442 173.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -92.02 -9.56 42.37 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.152 1.381 . . . . 65.35 110.967 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -129.56 70.52 1.42 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.78 2.032 . . . . 64.33 108.79 -174.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 21.6 pttp . . . . . 0 C--O 1.257 1.481 0 CA-C-O 117.064 -1.446 . . . . 74.23 109.814 -176.234 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 C--O 1.236 0.372 0 N-CA-C 109.105 -0.702 . . . . 72.42 109.105 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -168.12 -178.21 3.6 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.177 2.191 . . . . 74.34 108.633 172.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 50.9 25.88 2.4 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 127.45 2.3 . . . . 74.01 115.786 173.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.52 115.06 4.51 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 104.755 -2.313 . . . . 65.3 104.755 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.9 pt -127.37 142.13 44.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 126.111 1.764 . . . . 74.33 107.861 175.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.8 m -129.53 145.54 51.45 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.977 -1.12 . . . . 74.03 107.977 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -47.33 146.32 2.02 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 127.38 2.272 . . . . 73.02 111.395 165.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.22 -19.15 0.25 Allowed Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.365 1.46 . . . . 74.23 114.428 -172.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -100.43 -86.26 0.4 Allowed 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 106.736 -1.579 . . . . 72.34 106.736 -165.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -92.15 -14.21 29.47 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.379 1.071 . . . . 53.13 110.522 -175.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -144.81 159.7 42.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.728 0.811 . . . . 74.0 111.04 172.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.3 mm -125.07 164.44 23.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 124.615 1.166 . . . . 72.21 108.323 178.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 m -109.97 152.56 25.71 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.624 1.97 . . . . 74.2 108.236 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 35.5 mt -84.33 160.84 20.61 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 108.008 -1.108 . . . . 71.1 108.008 164.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.95 -35.39 64.53 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 122.404 1.097 . . . . 73.51 110.088 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -123.49 78.29 54.68 Favored Pre-proline 0 N--CA 1.455 -0.211 0 C-N-CA 125.458 1.503 . . . . 74.22 108.032 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -72.37 117.18 5.01 Favored 'Trans proline' 0 N--CA 1.444 -1.395 0 N-CA-C 106.348 -2.212 . . . . 73.21 106.348 164.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.0 tt -145.85 158.14 12.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 106.734 -1.58 . . . . 72.24 106.734 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.42 103.98 1.14 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.318 0.508 . . . . 65.01 110.451 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.02 -170.06 18.88 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 108.347 -1.901 . . . . 72.11 108.347 173.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 61.08 164.58 0.1 Allowed Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 127.637 2.375 . . . . 74.22 113.824 176.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -68.66 -165.76 0.14 Allowed 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.472 2.781 . . . . 74.51 110.06 158.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -69.97 -164.63 0.08 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.965 1.306 . . . . 74.34 110.53 176.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 66.7 t -47.52 130.61 4.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 125.055 1.342 . . . . 63.2 110.699 -177.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.9 tp -136.57 153.82 50.86 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 126.664 1.986 . . . . 74.23 106.108 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 2.6 mp0 -143.91 149.43 36.85 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.363 1.865 . . . . 73.44 109.893 -169.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -145.6 161.99 38.52 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.197 1.362 . . . . 74.43 108.457 174.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -163.63 -175.0 3.94 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.949 2.899 . . . . 72.2 107.144 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.1 t -138.94 173.11 11.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 123.101 1.429 . . . . 72.13 109.407 163.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -79.81 -34.93 39.14 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 126.902 2.081 . . . . 71.3 110.11 -175.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -90.8 -1.97 57.81 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.104 1.362 . . . . 74.42 112.578 -176.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 p -90.03 144.22 31.04 Favored Pre-proline 0 N--CA 1.471 0.622 0 CA-C-N 120.928 1.694 . . . . 72.53 112.112 -173.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -84.71 -40.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.047 1.831 . . . . 50.41 114.339 -170.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -59.07 -43.32 91.77 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.489 1.041 . . . . 73.12 108.437 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 32.1 m -48.35 -45.88 35.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.393 1.877 . . . . 74.44 111.233 175.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -51.16 -62.06 1.85 Allowed 'General case' 0 C--N 1.346 0.438 0 C-N-CA 123.628 0.771 . . . . 64.33 109.631 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -55.1 -41.63 71.86 Favored 'General case' 0 C--O 1.222 -0.345 0 O-C-N 121.08 -1.013 . . . . 72.23 110.587 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -68.18 -20.15 64.84 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 117.986 -1.007 . . . . 72.24 111.928 -172.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.79 -4.91 7.56 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.275 0.943 . . . . 73.44 112.756 -167.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -133.95 -26.93 1.49 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.629 1.572 . . . . 72.32 111.548 -168.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 83.0 t -119.81 -76.45 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 107.009 -1.478 . . . . 74.41 107.009 -175.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.1 mt -68.27 -17.54 64.31 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.56 1.544 . . . . 71.52 112.95 -176.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 44.08 60.38 2.78 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.437 1.895 . . . . 71.22 112.185 172.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.2 t -66.76 -52.13 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 116.519 -1.705 . . . . 72.1 108.909 -173.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.0 t -53.99 -45.76 71.52 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 121.044 1.747 . . . . 70.34 110.501 -175.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -61.85 -40.56 95.75 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.761 0.825 . . . . 65.01 111.468 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -68.2 -36.88 80.25 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 124.488 1.115 . . . . 71.31 112.102 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 t -66.54 -46.84 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.455 -1.313 . . . . 71.32 107.455 178.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 66.8 ttt-85 -48.0 -47.05 33.38 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-O 118.231 -0.89 . . . . 74.41 111.204 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -56.14 -10.74 0.91 Allowed 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 115.726 1.75 . . . . 71.0 115.726 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -130.31 7.25 4.96 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.653 1.981 . . . . 73.23 112.848 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.0 mt -79.82 161.65 65.48 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 120.194 1.361 . . . . 63.03 111.352 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -72.61 -161.92 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.75 1 C-N-CA 127.355 5.37 . . . . 55.52 110.739 172.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -102.32 24.05 10.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 114.489 1.292 . . . . 74.22 114.489 176.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -143.08 -40.78 0.06 OUTLIER Glycine 0 CA--C 1.52 0.406 0 O-C-N 121.607 -0.683 . . . . 74.44 113.567 -172.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.0 m -71.55 95.19 1.38 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.597 1.559 . . . . 73.0 108.056 175.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.03 162.5 24.82 Favored 'General case' 0 CA--C 1.519 -0.25 0 O-C-N 120.478 -1.389 . . . . 73.41 109.014 169.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.89 109.04 21.83 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 106.805 -1.554 . . . . 72.44 106.805 175.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.36 -176.91 5.8 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 124.076 0.86 . . . . 72.34 109.237 171.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.23 109.31 0.14 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 128.288 2.635 . . . . 74.21 105.612 174.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -74.76 -166.53 0.47 Allowed 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.006 -1.059 . . . . 74.34 109.532 163.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.512 ' CD2' ' HB3' ' A' ' 75' ' ' TRP 0.262 2.7 p-80 -136.77 156.88 47.93 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 129.709 3.204 . . . . 74.12 108.347 170.58 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.5 m -146.7 170.35 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 119.614 1.097 . . . . 73.34 108.398 169.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.99 -80.88 0.08 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 107.026 -1.472 . . . . 74.41 107.026 171.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 68.13 -44.15 0.49 Allowed 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 130.136 3.375 . . . . 74.4 115.011 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.36 171.01 16.13 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 119.842 1.201 . . . . 61.34 110.65 -175.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.16 175.55 33.18 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 115.717 -0.674 . . . . 71.1 112.54 175.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -73.67 -55.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.673 2.915 . . . . 65.32 111.219 175.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.4 mt -89.38 30.18 1.02 Allowed 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.295 0.638 . . . . 74.45 111.844 -164.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -45.6 -56.3 6.53 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.929 1.252 . . . . 42.11 110.581 176.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -56.13 -46.46 79.18 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.601 1.161 . . . . 73.43 110.736 -174.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.49 -45.8 91.37 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 127.106 2.163 . . . . 65.35 109.329 -174.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 mt -64.98 -43.84 91.28 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.855 0.862 . . . . 74.45 109.431 176.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.5 m -66.37 -1.31 3.31 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 126.653 1.981 . . . . 74.51 110.582 177.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -111.9 -22.12 11.24 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 118.971 -2.33 . . . . 74.15 111.599 171.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.09 -35.8 48.94 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.698 0.999 . . . . 73.13 113.698 176.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.512 ' HB3' ' CD2' ' A' ' 60' ' ' HIS . 40.8 t-105 -58.23 -35.42 71.67 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.265 0.939 . . . . 73.51 110.949 -175.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.53 -34.33 77.56 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 118.206 -0.902 . . . . 61.42 110.814 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.1 t -60.98 -47.02 95.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 119.467 1.03 . . . . 73.24 108.964 167.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.16 -45.97 89.59 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 119.056 -0.497 . . . . 71.55 111.467 -177.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.5 mt -65.84 -42.84 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 124.602 1.161 . . . . 73.12 110.557 176.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.1 -32.44 70.98 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.054 0.843 . . . . 74.13 110.909 -177.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 43.2 mt -95.37 -15.24 23.2 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.261 0.837 . . . . 54.22 113.261 173.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 65.12 63.3 4.25 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.231 1.396 . . . . 74.22 111.667 -173.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.3 m -129.48 16.42 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.586 1.154 . . . . 74.11 111.852 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -52.86 -54.53 33.19 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.133 0.879 . . . . 71.21 111.016 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.56 -9.09 11.59 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.604 0.762 . . . . 74.12 112.648 -179.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -96.34 -13.92 22.92 Favored 'General case' 0 CA--C 1.519 -0.233 0 O-C-N 120.585 -1.322 . . . . 73.53 111.284 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.2 pt -121.21 -1.14 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 116.712 -1.613 . . . . 74.3 113.347 -175.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.2 m -64.38 -54.5 31.83 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 120.632 1.56 . . . . 64.43 109.096 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.54 -56.24 24.62 Favored Pre-proline 0 C--O 1.241 0.623 0 C-N-CA 124.614 1.166 . . . . 74.54 112.633 -169.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -72.08 -26.97 17.6 Favored 'Trans proline' 0 N--CA 1.443 -1.443 0 C-N-CA 120.714 0.943 . . . . 73.42 112.653 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 17.1 tpp -54.42 -51.34 65.22 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.09 0.956 . . . . 71.2 109.288 174.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -68.99 -33.57 73.88 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 121.872 -0.518 . . . . 71.52 111.191 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.39 -38.82 85.15 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 118.964 -1.094 . . . . 70.5 109.594 171.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.99 -11.41 58.15 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.275 -0.891 . . . . 65.5 112.05 -167.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.3 t -119.93 -35.44 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.184 1.393 . . . . 73.54 110.36 -171.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -122.39 -38.38 2.68 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.098 0.959 . . . . 71.2 111.974 -164.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -76.01 -58.72 3.11 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 118.619 0.645 . . . . 74.2 110.733 174.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . 0.261 5.6 t -114.45 -18.23 11.56 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.095 0.776 . . . . 70.52 113.095 -176.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 65.87 19.73 11.32 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.521 0.934 . . . . 71.42 113.521 169.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 t -62.52 -16.48 56.05 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.247 2.219 . . . . 63.13 113.717 -173.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 26.9 t -64.46 115.05 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 124.434 1.094 . . . . 74.41 109.391 173.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -132.52 -23.12 2.12 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.502 1.121 . . . . 74.11 112.078 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.97 161.44 41.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.734 1.614 . . . . 62.21 107.291 -177.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.3 t -54.36 -36.15 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 118.973 0.806 . . . . 74.54 110.236 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.66 -34.17 57.75 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.378 1.471 . . . . 70.55 112.676 176.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -78.46 -34.75 47.5 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.518 -0.919 . . . . 73.44 108.518 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.9 mt -72.35 -49.27 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 124.085 0.954 . . . . 73.31 108.732 -174.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -17.28 64.53 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.569 0.748 . . . . 71.33 112.62 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -58.4 -54.18 49.93 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.24 1.016 . . . . 63.34 109.908 168.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.0 t -55.11 -36.78 40.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.519 1.128 . . . . 73.43 110.82 -175.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -57.36 -57.27 13.37 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.319 0.648 . . . . 73.22 109.536 173.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 89.2 t -60.88 -41.36 88.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 O-C-N 121.454 -0.779 . . . . 74.54 111.005 -175.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -55.44 -51.05 68.2 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.193 0.997 . . . . 70.33 109.237 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.36 -11.32 60.84 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.073 1.349 . . . . 71.52 112.506 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 112.02 48.06 0.68 Allowed Glycine 0 C--N 1.336 0.528 0 CA-C-N 118.84 0.745 . . . . 70.13 112.729 175.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.6 t -116.37 141.66 33.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 117.91 0.855 . . . . 71.23 109.741 177.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -70.27 118.43 13.08 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.188 0.995 . . . . 74.33 109.27 169.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.85 -9.28 52.28 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 117.347 -1.807 . . . . 70.22 112.479 167.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -74.98 -41.42 59.57 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 120.607 2.204 . . . . 71.13 108.67 168.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.71 -25.65 44.69 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.441 -0.948 . . . . 63.23 108.441 -171.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -70.31 -62.21 1.47 Allowed 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 107.59 -1.263 . . . . 71.55 107.59 175.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -64.41 -24.77 67.75 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.787 -0.625 . . . . 74.23 111.69 -173.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.78 -68.11 0.6 Allowed 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.667 1.187 . . . . 70.22 111.259 168.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.11 -27.71 67.25 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 118.223 -0.894 . . . . 53.32 111.517 -167.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -44.14 -39.4 4.29 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.851 1.66 . . . . 74.12 112.047 176.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -112.53 3.62 16.88 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.83 1.252 . . . . 73.11 113.147 -177.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 13.2 t -74.68 152.84 39.11 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.841 1.256 . . . . 73.35 111.252 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -52.61 -33.2 45.42 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.202 1.801 . . . . 74.45 112.581 170.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 46.8 t -53.16 -48.53 53.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 O-C-N 121.201 -0.937 . . . . 71.24 109.772 177.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.3 t -72.59 -38.16 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-O 118.311 -0.852 . . . . 73.41 109.868 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -52.46 -49.83 63.88 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.78 1.173 . . . . 73.33 111.234 174.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.3 t -58.06 -51.07 71.22 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.122 -0.696 . . . . 65.44 109.122 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 14.8 mt -66.26 -37.93 86.64 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.271 0.629 . . . . 73.14 112.658 -174.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.1 t -56.31 -59.21 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 125.16 1.384 . . . . 74.53 108.66 168.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.05 -40.35 60.98 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.799 0.839 . . . . 74.34 112.27 -174.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -51.9 -60.92 2.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 117.668 -1.158 . . . . 74.21 110.291 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.415 HE21 ' CE1' ' A' ' 60' ' ' HIS . 0.9 OUTLIER -78.34 -32.95 49.38 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 120.576 1.534 . . . . 73.52 113.659 -179.621 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.92 -24.21 65.17 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.502 1.046 . . . . 65.5 109.766 -169.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 24.1 ttpt -82.2 -57.38 3.41 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 125.262 1.425 . . . . 73.43 109.305 160.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.86 -17.69 61.82 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.931 1.456 . . . . 64.22 114.931 -164.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -117.4 2.35 12.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 119.965 1.257 . . . . 70.54 113.257 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.98 6.42 3.38 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.628 0.771 . . . . 73.53 111.727 -178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -68.1 -85.88 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.874 0.87 . . . . 74.24 109.678 172.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 175.58 48.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.658 2.383 . . . . 71.5 109.244 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.47 -50.47 0.51 Allowed 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.782 -1.199 . . . . 74.53 109.493 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.13 109.05 14.98 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 127.029 2.132 . . . . 73.41 106.827 -171.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -149.84 28.62 0.76 Allowed 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 126.636 1.974 . . . . 71.44 111.144 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -138.38 91.2 0.2 Allowed Glycine 0 C--N 1.341 0.811 0 O-C-N 120.876 -1.14 . . . . 65.12 112.44 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 34.1 m -73.38 163.55 67.63 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 113.331 0.863 . . . . 74.12 113.331 174.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -77.94 118.07 5.52 Favored 'Cis proline' 0 N--CA 1.446 -1.286 0 N-CA-C 108.666 -1.321 . . . . 71.2 108.666 -21.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 24' ' ' GLU . . . -88.49 129.18 35.51 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 106.203 -1.777 . . . . 74.11 106.203 -174.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 80.0 mmm -138.19 89.26 2.38 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 104.245 -2.502 . . . . 70.41 104.245 -172.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -73.74 170.23 15.7 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 120.853 -1.155 . . . . 74.04 109.974 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 56.8 t -131.07 -41.41 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 113.252 0.834 . . . . 72.41 113.252 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.36 24.22 1.13 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.76 -0.588 . . . . 71.44 109.728 -171.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 77.44 -28.37 1.76 Allowed Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.237 1.875 . . . . 74.23 113.055 -174.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.55 -7.48 19.7 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.966 1.469 . . . . 71.14 114.966 -174.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -126.95 142.15 51.62 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.947 0.899 . . . . 72.33 109.531 -174.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -117.9 137.54 52.74 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 106.392 -1.707 . . . . 74.42 106.392 169.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.02 144.04 55.29 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.21 -0.663 . . . . 71.13 109.21 171.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -111.55 86.95 7.36 Favored Pre-proline 0 C--O 1.232 0.149 0 N-CA-C 113.519 0.933 . . . . 62.43 113.519 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -63.13 0.04 1.91 Allowed 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 121.041 1.161 . . . . 73.43 114.253 172.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -111.74 18.65 18.76 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.117 1.367 . . . . 74.42 112.287 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -146.06 52.24 0.57 Allowed Glycine 0 C--N 1.334 0.42 0 N-CA-C 108.681 -1.768 . . . . 70.24 108.681 171.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 35.6 mtt -144.58 176.02 9.71 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.931 1.292 . . . . 72.02 109.399 -176.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.411 ' C ' ' H ' ' A' ' 168' ' ' SER . 2.6 t70 -85.24 44.52 1.1 Allowed 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 123.527 0.731 . . . . 71.21 112.269 -164.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.408 ' HB ' ' CD2' ' A' ' 173' ' ' PHE 0.257 10.7 t -67.79 30.91 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 129.102 2.961 . . . . 70.23 113.169 -177.163 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 166' ' ' ASP . 0.0 OUTLIER -85.19 -20.43 30.2 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 127.536 2.334 . . . . 72.02 112.4 169.595 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.18 -8.68 2.63 Favored 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 113.386 0.884 . . . . 72.02 113.386 -166.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 6.0 mmt 69.19 -61.88 0.42 Allowed 'General case' 0 C--O 1.231 0.129 0 C-N-CA 127.654 2.382 . . . . 61.13 113.003 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -63.66 -46.11 87.12 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.375 1.083 . . . . 72.32 109.682 -172.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.02 -26.48 40.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.386 1.474 . . . . 70.11 110.853 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.408 ' CD2' ' HB ' ' A' ' 167' ' ' THR . 15.9 t80 -68.51 -57.72 5.38 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.267 -1.383 . . . . 74.43 107.267 -177.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.3 t -67.23 -33.85 65.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 117.899 0.318 . . . . 71.24 110.152 -174.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.42 -51.07 61.05 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.49 0.716 . . . . 72.32 110.987 174.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -73.3 -32.73 64.79 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.715 0.806 . . . . 74.32 112.559 177.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -59.06 -60.82 3.26 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.239 1.016 . . . . 73.33 108.429 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.7 -27.65 66.63 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.575 0.75 . . . . 73.12 111.981 -174.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.67 -47.96 28.85 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 121.75 -0.594 . . . . 73.03 111.248 176.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 90.9 m -53.63 -37.5 63.13 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.439 0.696 . . . . 72.11 109.697 173.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 93.4 t -58.22 -54.43 32.68 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 N-CA-C 109.206 -0.664 . . . . 74.43 109.206 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 13.3 pttp -64.71 -34.99 79.61 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 118.989 -1.085 . . . . 70.44 111.305 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -62.98 -31.11 72.16 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-N 118.739 0.7 . . . . 74.34 111.451 -172.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 75.4 mt -76.0 -18.98 59.06 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.075 -1.05 . . . . 73.13 112.636 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 76.8 t -67.5 -22.51 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 O-C-N 120.951 -1.093 . . . . 73.03 110.383 176.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -103.61 -12.23 17.2 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.325 1.05 . . . . 71.41 110.869 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 42.2 mttp -115.33 82.41 1.74 Allowed 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 126.125 1.77 . . . . 73.23 107.958 -173.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-N 114.208 -1.36 . . . . 71.23 109.111 164.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 117.311 -1.328 . . . . 70.44 109.981 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' ASN . . . . . 0.532 ' ND2' ' H ' ' A' ' 1' ' ' ALA . 4.0 t30 45.73 -156.46 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 120.152 1.342 . . . . 70.42 111.842 -176.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.532 ' H ' ' ND2' ' A' ' 0' ' ' ASN . . . 44.8 50.11 8.8 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.225 2.21 . . . . 71.44 112.162 -175.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -148.52 118.33 7.11 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 106.105 -1.813 . . . . 73.45 106.105 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.3 pt -122.51 149.12 25.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 C-N-CA 126.753 2.021 . . . . 74.05 108.676 178.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.1 m -119.05 130.91 55.88 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.792 -0.818 . . . . 62.35 108.792 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -46.65 111.47 0.39 Allowed 'General case' 0 C--O 1.232 0.183 0 C-N-CA 126.812 2.045 . . . . 62.21 109.638 162.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 102.97 -5.9 50.83 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.263 -1.298 . . . . 75.11 112.939 176.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -104.57 -86.33 0.46 Allowed 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 118.916 1.358 . . . . 72.45 107.773 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -92.87 -11.65 33.01 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.441 1.496 . . . . 73.33 112.287 -172.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -144.97 157.36 44.16 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 122.984 0.514 . . . . 74.24 110.499 170.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.0 mm -124.57 157.91 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 124.572 1.149 . . . . 74.15 108.071 177.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.24 143.55 41.84 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.69 1.596 . . . . 73.03 107.134 177.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.0 mt -81.91 147.36 29.32 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.885 -0.783 . . . . 75.01 108.885 170.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -73.49 -36.14 65.76 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.356 1.462 . . . . 71.21 109.885 173.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -131.03 84.1 58.88 Favored Pre-proline 0 CA--C 1.519 -0.227 0 C-N-CA 126.296 1.838 . . . . 75.41 108.173 177.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.41 74.68 4.61 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 123.159 2.573 . . . . 75.15 110.029 173.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -160.06 101.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 107.247 -1.39 . . . . 75.13 107.247 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -171.39 -86.5 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.238 1.015 . . . . 75.23 110.947 164.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -122.8 32.2 4.51 Favored Glycine 0 C--N 1.336 0.559 0 C-N-CA 124.366 0.984 . . . . 75.44 111.98 -163.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -126.9 85.32 61.21 Favored Pre-proline 0 C--O 1.241 0.606 0 C-N-CA 123.963 0.905 . . . . 75.44 109.242 -150.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -79.34 -164.03 0.26 Allowed 'Trans proline' 0 CA--C 1.541 0.872 1 C-N-CA 126.168 4.579 . . . . 72.15 111.703 -171.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -44.65 -56.6 4.26 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.554 1.942 . . . . 61.13 113.098 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.8 t -150.99 148.08 15.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 127.124 2.17 . . . . 71.22 106.92 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.4 tp -159.77 154.8 24.82 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.501 1.046 . . . . 71.05 112.053 171.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -134.92 143.4 46.9 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 127.24 2.216 . . . . 70.55 107.272 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -133.64 137.11 45.21 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.069 0.947 . . . . 71.31 110.768 174.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -162.34 165.85 26.01 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.75 1.62 . . . . 72.52 109.491 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.8 t -124.43 169.14 12.14 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.653 0.781 . . . . 72.22 109.842 167.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.47 ' CE2' HD21 ' A' ' 71' ' ' LEU 0.275 0.0 OUTLIER -76.58 -18.77 58.47 Favored 'General case' 0 N--CA 1.435 -1.196 0 C-N-CA 124.081 0.953 . . . . 71.33 112.597 175.726 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -96.06 0.34 51.39 Favored 'General case' 0 C--N 1.346 0.446 0 O-C-N 120.232 -1.543 . . . . 73.11 111.655 -175.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.7 p -97.97 142.09 24.01 Favored Pre-proline 0 CA--C 1.534 0.341 0 O-C-N 121.121 -0.987 . . . . 72.12 108.773 -168.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -91.44 -28.25 0.19 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 120.314 0.676 . . . . 74.42 111.503 -162.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -59.9 -49.63 76.93 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.409 -0.96 . . . . 75.25 108.409 165.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.9 m -55.33 -36.7 66.53 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 124.609 1.164 . . . . 61.32 111.953 -178.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -58.82 -56.69 18.97 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 122.994 0.518 . . . . 72.2 109.694 175.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.89 -30.22 68.86 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-O 116.171 -1.871 . . . . 73.42 110.193 177.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -75.03 -6.01 47.12 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 121.245 1.839 . . . . 70.05 113.037 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -146.24 8.56 1.06 Allowed 'General case' 0 C--N 1.345 0.375 0 CA-C-N 120.51 1.505 . . . . 72.13 112.824 -175.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -139.97 -12.48 1.1 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.948 1.299 . . . . 65.21 111.341 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 80.9 t -129.27 -81.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 105.911 -1.885 . . . . 74.25 105.911 173.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.4 mt -76.55 61.77 1.82 Allowed 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 128.335 2.654 . . . . 72.41 109.474 173.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -50.98 77.38 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 129.628 3.171 . . . . 61.44 110.444 172.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 83.2 t -67.2 -48.31 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 114.709 -1.132 . . . . 63.33 108.111 -172.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.1 t -71.6 15.45 0.14 Allowed 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.076 1.139 . . . . 74.12 114.076 -172.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -129.36 -20.81 3.28 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 119.404 -2.06 . . . . 72.24 111.863 170.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -62.28 -30.83 71.41 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 121.95 -0.469 . . . . 74.01 111.243 164.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.405 HG13 ' HG ' ' A' ' 50' ' ' LEU . 1.7 t -75.69 -52.14 18.92 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.649 0 N-CA-C 107.123 -1.436 . . . . 73.41 107.123 -162.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -52.95 -39.38 62.88 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.043 1.337 . . . . 73.03 109.915 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -56.35 -21.63 25.81 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.039 1.496 . . . . 72.01 115.039 174.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.6 mmtt -127.37 -5.17 6.0 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.618 2.767 . . . . 74.15 112.526 -176.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.405 ' HG ' HG13 ' A' ' 46' ' ' VAL . 12.7 mt -75.88 151.98 84.54 Favored Pre-proline 0 CA--C 1.518 -0.252 0 CA-C-N 120.43 1.468 . . . . 72.43 108.236 -174.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -78.24 148.54 24.19 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 122.098 1.865 . . . . 74.12 109.646 165.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -67.63 91.89 0.31 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.131 1.772 . . . . 72.21 112.12 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 137.17 -25.19 3.05 Favored Glycine 0 C--N 1.334 0.428 0 O-C-N 120.602 -1.311 . . . . 73.14 113.603 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 73.0 m -71.27 86.94 0.81 Allowed 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 104.075 -2.565 . . . . 71.23 104.075 151.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -82.68 157.31 23.4 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.574 -1.639 . . . . 72.34 106.574 169.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.07 169.24 8.86 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.92 -0.77 . . . . 73.43 108.92 -177.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 58' ' ' LYS . 1.3 m -140.48 -171.63 3.26 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.247 1.419 . . . . 72.53 108.105 -167.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.446 ' H ' HG22 ' A' ' 57' ' ' THR . 0.1 OUTLIER -173.62 85.45 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.291 1.436 . . . . 72.55 108.237 -178.091 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.2 m-30 -89.61 163.72 15.04 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 120.902 -1.124 . . . . 73.23 108.77 173.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.433 ' CE1' ' CG2' ' A' ' 72' ' ' THR . 0.1 OUTLIER -102.26 174.7 5.8 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 127.83 2.452 . . . . 75.43 110.133 -174.198 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.0 m -144.06 150.44 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 CA-C-N 122.407 2.367 . . . . 72.4 112.765 168.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . 0.304 0.0 OUTLIER -103.29 1.11 32.41 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.19 1.796 . . . . 74.41 114.776 176.87 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -70.8 9.06 0.73 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.199 1.399 . . . . 71.21 113.984 173.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.1 mt -141.77 148.44 38.95 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 119.68 -1.888 . . . . 75.11 109.221 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.54 166.41 12.03 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 115.082 -0.963 . . . . 72.42 111.725 171.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.44 -39.66 1.01 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.471 2.114 . . . . 61.12 110.119 170.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 57.3 mt -82.72 23.89 0.77 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.811 1.245 . . . . 71.53 112.032 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -43.91 -63.52 2.24 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 117.222 -1.876 . . . . 74.32 109.863 169.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.8 tptp -59.82 -26.23 65.61 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 121.399 2.6 . . . . 75.42 114.126 -172.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -54.71 30.61 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 117.995 -1.002 . . . . 75.4 111.412 168.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.47 HD21 ' CE2' ' A' ' 28' ' ' PHE . 34.6 mt -60.26 -40.95 92.15 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.252 0.933 . . . . 74.34 109.269 -164.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.433 ' CG2' ' CE1' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -49.61 -37.84 29.44 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 126.735 2.014 . . . . 72.51 109.682 -179.499 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.04 -51.48 6.31 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 126.62 1.968 . . . . 73.52 110.895 -176.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.44 -31.13 72.06 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.513 1.051 . . . . 74.53 112.1 -177.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.44 ' CH2' ' HB3' ' A' ' 84' ' ' GLU . 43.3 t-105 -56.59 -36.39 69.31 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 119.139 0.881 . . . . 74.11 111.328 173.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.87 -42.46 94.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.624 -0.673 . . . . 65.3 110.125 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 82.6 t -52.8 -43.5 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 122.953 0.501 . . . . 74.22 109.83 170.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.37 -50.14 66.66 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 121.239 -0.913 . . . . 73.54 111.13 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.464 ' CD1' HE22 ' A' ' 137' ' ' GLN . 86.6 mt -59.31 -37.28 68.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.344 1.058 . . . . 73.21 109.877 178.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.26 -50.13 74.27 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.505 0.593 . . . . 71.24 110.17 -174.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.0 mt -81.66 -12.2 58.78 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 118.32 -0.848 . . . . 74.54 112.791 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.03 63.87 3.58 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 126.14 1.828 . . . . 65.4 110.681 -175.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.2 m -130.14 11.9 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 117.67 -1.157 . . . . 74.32 112.838 -177.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.44 ' HB3' ' CH2' ' A' ' 75' ' ' TRP . 2.4 mp0 -51.58 -51.7 53.4 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.912 1.233 . . . . 70.14 111.629 -166.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -49.31 -47.67 46.86 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.681 1.592 . . . . 73.1 111.506 177.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -65.46 -26.73 68.08 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 124.342 1.057 . . . . 73.21 109.472 -170.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.5 pp -114.42 29.66 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 126.914 2.086 . . . . 65.54 109.322 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.449 HG21 ' CE1' ' A' ' 92' ' ' PHE . 18.6 m -108.97 -53.46 2.64 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 118.029 -0.986 . . . . 72.34 108.439 168.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -52.86 -54.55 42.5 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 113.602 0.964 . . . . 74.44 113.602 -174.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -73.45 -29.37 11.16 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.363 1.375 . . . . 72.54 112.032 178.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 34.0 tpp -60.45 -50.11 74.89 Favored 'General case' 0 CA--C 1.515 -0.404 0 C-N-CA 125.225 1.41 . . . . 74.51 110.936 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.449 ' CE1' HG21 ' A' ' 88' ' ' THR . 6.2 m-85 -70.13 -33.15 71.46 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.938 -0.553 . . . . 74.21 109.56 -176.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -58.17 -37.27 74.4 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.353 0.979 . . . . 71.44 109.607 168.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.31 -0.9 57.66 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.062 -1.649 . . . . 74.14 113.578 -176.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.445 HG12 ' CD1' ' A' ' 28' ' ' PHE . 54.2 t -116.76 -33.77 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.531 1.533 . . . . 74.44 109.688 -177.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -116.06 -48.38 2.74 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 124.696 1.199 . . . . 74.54 111.577 -173.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -72.66 -62.26 1.51 Allowed 'General case' 0 C--N 1.334 -0.082 0 O-C-N 121.695 -0.628 . . . . 73.44 109.49 -176.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 28.2 p -86.43 -35.83 19.47 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.318 0.508 . . . . 74.51 110.659 -178.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 66.48 23.83 10.44 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.701 2.401 . . . . 75.1 113.174 -175.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -70.33 -19.51 63.06 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.503 0.592 . . . . 74.33 112.487 -173.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 26.8 t -64.3 124.63 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 O-C-N 121.354 -0.841 . . . . 72.21 109.046 171.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -147.04 -24.77 0.4 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.499 1.52 . . . . 72.31 111.44 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.6 162.56 32.36 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.802 0.728 . . . . 75.12 109.546 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.2 t -55.45 -38.74 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.309 1.044 . . . . 60.54 110.006 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.17 -11.77 23.1 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 114.064 1.135 . . . . 74.53 114.064 178.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -94.72 -33.73 12.82 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 124.979 1.311 . . . . 74.3 110.311 175.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 mt -71.62 -37.96 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.013 -0.736 . . . . 73.23 109.013 -177.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -68.62 -23.37 64.43 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.342 -0.849 . . . . 73.43 111.474 -174.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -55.4 -54.52 42.68 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.469 -0.938 . . . . 74.32 108.469 176.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 29.0 t -58.52 -38.14 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 123.853 0.861 . . . . 72.42 110.625 -174.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -53.25 -57.75 9.45 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.463 -0.569 . . . . 74.14 109.463 172.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -63.92 -41.23 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 O-C-N 121.452 -0.78 . . . . 72.12 111.142 -175.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.25 -41.38 88.63 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.127 1.371 . . . . 72.2 109.746 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.64 0.18 18.46 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.795 1.238 . . . . 73.44 112.504 175.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.04 62.46 1.43 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 124.81 1.195 . . . . 63.54 111.118 175.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.5 t -121.66 149.47 24.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 124.181 0.992 . . . . 65.53 109.28 170.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -68.48 135.88 52.32 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.196 0.522 . . . . 72.53 110.106 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.22 -30.54 71.69 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 114.868 -1.06 . . . . 63.21 110.556 171.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -74.76 -17.8 60.58 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 123.447 0.699 . . . . 71.32 111.905 -172.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.74 -51.81 5.46 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.105 -1.072 . . . . 63.53 108.105 176.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -50.89 -53.22 34.48 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.227 1.411 . . . . 72.33 109.978 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -76.61 -10.76 59.62 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 114.239 -1.346 . . . . 74.51 113.14 -172.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.65 -57.06 2.18 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 125.408 1.483 . . . . 63.51 110.407 176.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -50.23 -40.37 47.3 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.898 2.079 . . . . 72.33 110.89 -178.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 61.3 t-105 -45.97 -42.87 13.58 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.29 1.036 . . . . 73.24 111.972 173.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -102.41 8.04 40.25 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.367 -1.458 . . . . 72.42 112.901 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 8.8 t -89.3 151.38 22.13 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 127.019 2.128 . . . . 74.11 111.773 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -60.13 -28.71 68.1 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 125.493 1.517 . . . . 74.11 111.854 174.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 66.4 t -49.33 -54.3 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 119.363 0.983 . . . . 72.51 109.777 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.0 t -69.1 -39.28 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-N 115.22 -0.9 . . . . 72.2 108.668 -176.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.4 mmpt? -55.77 -48.58 75.04 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.059 0.845 . . . . 75.5 111.078 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.42 -36.96 85.47 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.068 0.947 . . . . 65.4 110.76 -178.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 13.9 mt -71.06 -58.72 3.29 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 124.882 1.273 . . . . 70.44 110.754 178.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 53.9 t -45.47 -49.38 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 C-N-CA 125.133 1.373 . . . . 75.23 108.595 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.1 -45.19 87.63 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 117.292 -1.337 . . . . 54.41 112.708 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -51.06 -46.57 61.76 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 120.409 1.459 . . . . 72.33 111.305 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.464 HE22 ' CD1' ' A' ' 79' ' ' ILE . 43.0 mt-30 -88.54 -36.51 16.34 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.926 -1.034 . . . . 73.2 109.801 -162.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -63.56 -47.99 79.3 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.276 -1.009 . . . . 73.34 108.276 171.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 54.7 tttt -60.87 -7.7 2.57 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.675 1.19 . . . . 73.41 113.88 171.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -112.09 -18.05 12.68 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-O 117.189 -1.386 . . . . 73.55 113.728 173.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -113.86 -11.68 12.81 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 121.956 2.162 . . . . 72.35 112.688 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -117.36 -8.03 11.11 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.954 1.302 . . . . 71.54 111.751 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.25 8.81 3.0 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 114.239 1.199 . . . . 73.2 114.239 -178.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 12.3 mt 76.54 57.29 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.431 2.692 . . . . 75.32 111.828 174.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.27 -84.27 0.63 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.045 -1.094 . . . . 74.41 108.045 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.5 ' HG ' ' H ' ' A' ' 148' ' ' GLY . 11.4 tp -74.68 -73.12 0.25 Allowed 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 124.63 1.172 . . . . 74.44 112.931 -171.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 70.11 2.34 3.9 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.856 2.062 . . . . 75.33 115.217 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.5 ' H ' ' HG ' ' A' ' 146' ' ' LEU . . . -145.38 134.64 5.6 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 120.737 1.608 . . . . 72.42 111.327 176.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 35.5 m -126.42 164.33 34.84 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 119.183 1.492 . . . . 74.33 111.722 -173.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -66.07 156.06 80.38 Favored 'Cis proline' 0 C--N 1.352 0.723 0 CA-C-N 119.712 0.933 . . . . 73.25 112.841 -6.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -141.36 156.94 45.78 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.454 0.702 . . . . 72.34 110.473 178.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 43.8 tpp -156.6 110.13 2.66 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.169 -1.789 . . . . 74.42 106.169 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -100.6 155.81 17.66 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.458 0.703 . . . . 71.12 109.54 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.1 t -137.76 139.53 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.612 -1.255 . . . . 74.12 107.612 177.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 64.67 -2.63 0.64 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.806 2.043 . . . . 72.25 114.874 171.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.48 -28.1 15.7 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.752 1.644 . . . . 63.12 112.169 -173.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.34 -6.67 12.35 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.925 1.863 . . . . 75.12 115.81 -169.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -121.81 148.82 44.19 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 108.901 -0.777 . . . . 72.43 108.901 -171.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -126.88 143.5 51.25 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.402 -0.962 . . . . 64.02 108.402 169.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -66.77 138.62 57.5 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 106.585 -1.635 . . . . 72.12 106.585 172.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -119.18 85.05 29.23 Favored Pre-proline 0 N--CA 1.452 -0.336 0 N-CA-C 111.7 0.259 . . . . 75.35 111.7 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.32 -21.77 71.78 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 121.27 1.313 . . . . 72.32 112.604 173.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -67.25 -10.61 52.39 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.147 0.979 . . . . 74.45 112.011 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -129.05 37.02 2.28 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 126.186 1.851 . . . . 75.02 109.752 171.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 40.4 mtt -114.12 162.37 16.57 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 119.128 1.464 . . . . 72.41 108.122 164.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -77.02 119.85 21.31 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 113.817 -1.538 . . . . 73.42 107.406 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.6 p -125.15 35.33 4.79 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.242 2.217 . . . . 72.01 108.795 -172.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 8.6 t -99.28 -12.09 20.67 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.761 -0.587 . . . . 73.34 112.195 178.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.4 -17.15 3.0 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 118.917 -0.564 . . . . 74.43 111.375 -167.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 5.5 mmt 70.78 -50.2 0.67 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.339 1.856 . . . . 72.14 112.076 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.66 -47.73 71.6 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 120.785 -1.197 . . . . 72.25 107.922 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 78.6 t -60.18 -32.85 51.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 124.792 1.237 . . . . 74.12 110.672 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -63.29 -62.69 1.52 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 118.769 -0.634 . . . . 74.21 109.487 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.4 t -71.69 -25.18 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 119.241 0.928 . . . . 73.43 111.685 -175.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.82 -40.04 82.99 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 111.865 0.32 . . . . 74.32 111.865 172.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -75.82 -21.21 57.53 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 118.042 -0.98 . . . . 72.44 113.147 171.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -67.95 -81.05 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 117.008 -1.472 . . . . 73.35 114.642 174.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . 0.359 . . -44.85 -18.4 0.02 OUTLIER 'General case' 0 CA--C 1.598 2.799 0 C-N-CA 126.672 1.989 . . . . 63.33 109.241 176.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -79.27 -63.98 1.29 Allowed 'General case' 0 C--N 1.382 1.98 0 C-N-CA 128.073 2.549 . . . . 65.45 113.533 169.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.2 t -59.01 -30.31 67.9 Favored 'General case' 0 C--N 1.347 0.488 0 CA-C-O 116.915 -1.517 . . . . 72.42 110.047 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 39.9 t -56.72 -44.23 81.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 120.462 1.483 . . . . 74.14 109.139 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 6.3 ptmt -75.15 -33.32 61.5 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-O 118.268 -0.872 . . . . 74.12 112.208 -177.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -62.36 -37.58 86.23 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 120.404 1.456 . . . . 61.35 112.035 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 77.1 mt -67.41 -20.61 65.55 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 119.069 -1.052 . . . . 74.42 111.808 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.03 -23.79 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 O-C-N 121.694 -0.629 . . . . 74.44 110.521 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -106.37 -2.49 22.14 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.364 0.983 . . . . 73.32 111.146 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -123.45 78.09 1.56 Allowed 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.862 1.265 . . . . 73.22 109.971 -176.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.95 0 CA-C-O 115.702 -2.094 . . . . 74.13 107.176 166.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 9.2 m . . . . . 0 C--O 1.236 0.35 0 N-CA-C 108.836 -0.802 . . . . 65.21 108.836 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 16.3 m-20 -106.79 1.68 25.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 118.908 -0.568 . . . . 73.01 111.547 -162.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -67.04 45.06 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.358 2.263 . . . . 74.13 113.131 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -161.84 119.53 2.22 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 127.16 2.184 . . . . 73.13 105.302 166.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.2 pt -124.45 143.15 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 126.108 1.763 . . . . 73.42 106.546 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.6 m -118.07 139.1 51.71 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.416 -1.328 . . . . 73.34 107.416 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -53.13 118.04 3.46 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.31 2.244 . . . . 70.2 108.724 164.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.27 -6.17 65.85 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 118.22 -1.322 . . . . 73.42 113.346 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.7 tptp -103.66 -85.33 0.46 Allowed 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 119.253 1.527 . . . . 74.24 107.304 177.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -89.45 -20.55 23.76 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 124.219 1.008 . . . . 72.1 110.777 -170.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -140.66 163.81 31.87 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.93 -0.767 . . . . 73.04 108.93 175.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.4 mm -127.84 159.72 38.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 106.006 -1.85 . . . . 70.02 106.006 176.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.6 m -90.53 154.25 19.75 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.498 -1.668 . . . . 74.1 106.498 168.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.8 mt -67.22 152.8 45.08 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.117 -1.068 . . . . 74.14 108.117 163.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -73.64 -28.13 61.62 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.67 -0.493 . . . . 65.34 109.67 171.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -126.37 72.98 72.97 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 126.13 1.772 . . . . 73.03 109.756 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.39 70.53 6.76 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 124.287 3.325 . . . . 72.24 110.869 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.1 mt -105.77 164.98 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 O-C-N 121.444 -0.785 . . . . 74.43 109.083 -175.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 57.81 4.15 0.25 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.103 2.161 . . . . 73.04 114.866 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.1 -9.0 3.28 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 116.48 -2.289 . . . . 75.2 113.725 -169.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 53.21 166.67 0.04 OUTLIER Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 127.704 2.402 . . . . 73.04 113.798 -168.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.18 -11.42 31.18 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 121.66 1.573 . . . . 75.44 113.271 -174.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 66.89 11.08 8.1 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 128.344 2.658 . . . . 74.13 113.868 -175.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.8 p -156.54 97.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.129 -1.063 . . . . 70.33 108.129 -178.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.1 tp -161.19 159.04 28.37 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.588 0.708 . . . . 73.41 112.462 172.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -139.83 150.38 44.61 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 127.567 2.347 . . . . 72.04 106.48 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -135.42 133.07 38.25 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.644 1.578 . . . . 73.23 108.536 173.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -156.6 -176.78 6.16 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.477 1.511 . . . . 65.02 110.858 177.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.1 t -135.38 176.43 8.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.665 1.586 . . . . 53.13 109.032 174.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.462 ' CD2' HG21 ' A' ' 95' ' ' VAL 0.278 0.0 OUTLIER -89.46 -7.5 54.92 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.976 1.102 . . . . 73.42 113.976 164.729 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.427 ' CE2' ' HA3' ' A' ' 65' ' ' GLY . 51.4 m-85 -103.24 0.72 32.0 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 120.146 1.339 . . . . 73.23 112.728 173.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.2 p -78.04 140.57 62.09 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 121.437 1.926 . . . . 74.12 108.857 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -91.45 -25.77 0.3 Allowed 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 120.869 1.046 . . . . 70.1 112.668 -176.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -57.77 -57.39 12.96 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 119.022 0.828 . . . . 74.33 109.813 166.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 24.9 p -65.02 -23.73 67.29 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.448 -0.796 . . . . 73.43 111.648 -170.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -58.07 -54.47 46.54 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 118.883 0.765 . . . . 72.32 110.534 169.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.71 -45.81 77.81 Favored 'General case' 0 C--O 1.221 -0.423 0 N-CA-C 107.894 -1.15 . . . . 71.14 107.894 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -66.26 -10.45 42.34 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 115.647 -2.121 . . . . 64.42 113.858 -176.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -132.19 -2.45 3.55 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 122.044 2.202 . . . . 74.43 112.445 -173.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -133.04 -20.23 2.19 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.432 1.093 . . . . 72.2 112.426 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.0 t -121.35 -76.2 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 107.183 -1.414 . . . . 74.43 107.183 -173.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.1 mt -73.99 -18.2 60.9 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.116 2.166 . . . . 71.14 113.022 -177.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 54.5 m-70 43.75 53.87 5.86 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.291 1.836 . . . . 73.41 112.818 172.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 86.1 t -62.68 -51.23 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 116.997 -1.478 . . . . 74.22 109.895 -172.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.1 t -45.41 -52.35 10.16 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.061 1.345 . . . . 65.43 110.143 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -63.77 -40.1 95.86 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.246 1.018 . . . . 61.31 110.691 -177.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.81 -35.33 74.74 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.542 1.137 . . . . 63.33 113.156 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.9 t -67.53 -50.33 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 106.682 -1.599 . . . . 71.42 106.682 174.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 38.3 ttt-85 -47.47 -46.9 27.31 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.413 1.085 . . . . 73.14 111.608 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -60.31 -13.57 13.63 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.185 1.18 . . . . 74.0 114.185 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -118.37 -8.83 10.49 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.548 1.939 . . . . 73.41 111.507 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.8 mt -76.16 143.83 74.17 Favored Pre-proline 0 C--O 1.237 0.401 0 CA-C-N 119.41 1.005 . . . . 73.1 109.579 -169.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.01 167.35 20.13 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.043 1.829 . . . . 73.14 111.142 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -73.14 68.4 0.98 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.375 1.07 . . . . 73.12 112.176 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.46 -7.06 0.05 OUTLIER Glycine 0 CA--C 1.524 0.635 0 O-C-N 119.748 -1.845 . . . . 65.2 114.773 176.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.47 -45.08 89.34 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.042 1.421 . . . . 72.02 110.998 175.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . 0.294 19.0 ttpt 56.91 151.4 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.79 2.036 . . . . 73.04 111.725 -162.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.42 113.09 16.4 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 120.037 -1.664 . . . . 73.22 107.773 -167.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.92 -177.69 3.22 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.882 1.673 . . . . 70.21 109.347 -174.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -179.23 87.04 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 106.737 -1.579 . . . . 64.33 106.737 -170.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 -95.22 162.74 13.57 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.41 -0.806 . . . . 74.03 109.967 174.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.413 ' CE1' HG21 ' A' ' 72' ' ' THR . 0.1 OUTLIER -100.15 174.39 6.18 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.779 2.031 . . . . 74.2 110.615 -176.724 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.5 m -135.07 145.86 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 120.418 1.463 . . . . 74.14 110.534 164.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -82.42 29.6 0.43 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.468 1.107 . . . . 73.01 111.396 -178.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -134.68 165.91 24.15 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.851 1.66 . . . . 72.1 107.652 -172.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.6 mt 75.79 128.61 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 127.007 2.123 . . . . 72.22 109.766 -172.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.427 ' HA3' ' CE2' ' A' ' 29' ' ' TYR . . . 66.72 171.31 4.46 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 121.944 0.747 . . . . 63.43 112.55 175.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.02 -40.99 1.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 123.069 2.513 . . . . 74.22 112.62 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.4 mt -81.88 16.6 1.79 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.248 1.419 . . . . 74.3 112.356 -174.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.19 -34.64 58.97 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 117.742 -1.588 . . . . 52.32 113.607 -173.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.2 -35.7 55.45 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 120.473 2.136 . . . . 74.32 110.28 176.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.37 -37.96 86.47 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 120.976 -1.078 . . . . 64.22 108.703 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.458 HD22 ' CD2' ' A' ' 28' ' ' PHE . 22.4 mt -53.91 -45.04 71.04 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 123.82 0.848 . . . . 73.5 111.093 169.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.413 HG21 ' CE1' ' A' ' 60' ' ' HIS . 2.6 m -57.12 -51.07 70.76 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 124.348 1.03 . . . . 73.22 109.314 -177.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -63.22 -49.11 75.46 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 118.587 -0.721 . . . . 72.32 109.919 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.22 -37.87 75.68 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 120.416 1.462 . . . . 70.22 114.363 -177.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 10.6 t-105 -61.09 -37.77 83.88 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.633 0.652 . . . . 72.54 111.371 -172.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.72 -34.68 71.62 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 117.832 -1.08 . . . . 71.22 112.373 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.09 -46.76 84.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 120.198 1.363 . . . . 74.2 109.779 171.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.23 -43.28 82.37 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 118.81 -0.614 . . . . 72.51 111.068 -177.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 75.0 mt -60.23 -41.9 88.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.145 0.978 . . . . 74.34 109.784 176.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.94 -48.23 81.33 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.885 0.474 . . . . 70.42 110.175 -173.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 71.7 mt -76.66 -20.89 56.16 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 121.825 -0.547 . . . . 73.23 112.347 174.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.57 70.55 1.13 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 126.937 2.208 . . . . 44.11 110.097 -173.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.6 m -134.18 15.64 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 125.157 1.383 . . . . 70.24 112.804 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -52.43 -48.65 65.65 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.316 1.046 . . . . 74.2 110.66 -178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.48 -7.93 16.75 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.948 1.699 . . . . 71.12 113.304 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -104.21 -19.92 13.97 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 125.124 1.37 . . . . 72.22 111.283 176.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.6 pp -124.04 28.53 2.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 C-N-CA 125.838 1.655 . . . . 74.43 110.416 -172.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 43.1 m -93.96 -51.15 4.99 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.742 -0.836 . . . . 70.33 108.742 165.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.66 -65.81 1.62 Allowed Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 124.007 0.923 . . . . 71.44 112.006 -171.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -66.13 -26.28 50.16 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 121.161 1.241 . . . . 72.21 111.556 -174.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 24.0 tpp -61.76 -50.21 73.29 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.691 -0.855 . . . . 74.53 108.691 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -67.88 -35.13 77.98 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 123.974 0.91 . . . . 70.21 109.685 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -56.47 -45.31 80.97 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.599 0.636 . . . . 65.5 109.615 171.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.28 -1.76 42.24 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 120.727 -1.233 . . . . 72.13 112.993 -174.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.462 HG21 ' CD2' ' A' ' 28' ' ' PHE . 61.2 t -119.26 -33.74 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 C-N-CA 124.614 1.165 . . . . 73.03 110.949 -174.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -113.79 -52.92 2.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.105 1.362 . . . . 74.13 108.725 -173.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -71.99 -51.97 19.33 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 118.027 0.376 . . . . 74.32 110.338 -173.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.8 p -100.89 -27.04 13.53 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.056 0.942 . . . . 63.13 112.531 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 52.28 32.98 11.76 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.646 2.379 . . . . 74.24 114.979 -177.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 t -74.26 -21.02 59.95 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.749 0.82 . . . . 74.12 112.199 178.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.4 t -65.28 122.97 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 O-C-N 121.568 -0.708 . . . . 72.23 109.197 170.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -149.4 -19.99 0.28 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 114.068 -1.424 . . . . 74.43 111.63 -178.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.04 165.88 24.66 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.152 0.981 . . . . 71.5 109.64 173.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 39.1 t -57.57 -42.18 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.744 1.217 . . . . 53.31 108.388 175.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.02 13.89 0.05 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 128.809 2.843 . . . . 73.54 113.155 174.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -115.47 -48.68 2.78 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.42 1.488 . . . . 63.54 109.196 163.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.4 mt -52.66 -45.2 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.99 1.316 . . . . 65.42 110.907 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -22.36 65.72 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.651 0.982 . . . . 74.2 113.651 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -56.05 -56.02 25.9 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.981 1.264 . . . . 74.14 110.11 171.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 39.7 t -62.45 -34.55 65.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.83 -0.623 . . . . 74.53 110.789 -171.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -53.19 -58.6 6.5 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.716 -0.846 . . . . 73.24 108.716 171.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.1 t -65.71 -37.51 80.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 119.364 -0.35 . . . . 73.44 111.124 -173.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -60.84 -48.4 82.0 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.679 -0.86 . . . . 73.1 108.679 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.82 -0.39 7.11 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.612 1.565 . . . . 70.42 112.565 177.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.27 58.58 1.14 Allowed Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 124.428 1.013 . . . . 73.21 111.846 172.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.3 t -118.54 149.27 21.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 124.143 0.977 . . . . 70.23 109.832 169.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt -67.34 120.5 13.95 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.413 1.085 . . . . 74.44 110.49 168.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.68 -31.04 78.67 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-O 118.37 -1.239 . . . . 72.42 111.239 170.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -66.72 -36.58 82.82 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.846 1.323 . . . . 74.42 110.194 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -73.32 -42.49 62.28 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 106.766 -1.568 . . . . 73.44 106.766 -174.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -58.45 -55.43 35.07 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.996 0.903 . . . . 74.53 109.202 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -70.27 -12.61 61.71 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.004 0.922 . . . . 45.3 112.856 -173.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.98 -64.91 1.01 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.23 1.412 . . . . 61.12 109.946 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.64 -36.56 64.68 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.652 1.581 . . . . 63.32 111.491 -170.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 44.0 t-105 -45.14 -45.9 11.64 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.998 1.319 . . . . 73.5 112.067 176.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -102.35 11.22 38.4 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.206 1.402 . . . . 74.14 112.144 -177.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 7.0 t -99.27 163.79 12.4 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.281 1.832 . . . . 75.3 111.527 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -60.72 -28.31 68.58 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 128.177 2.591 . . . . 71.4 112.553 173.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 23.6 t -50.99 -53.28 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 122.78 1.276 . . . . 74.12 109.256 177.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.3 t -70.04 -32.51 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 114.923 -1.035 . . . . 74.22 110.624 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -56.47 -59.35 5.11 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.896 1.225 . . . . 74.5 110.045 176.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.0 m -68.45 -20.3 64.62 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.995 0.739 . . . . 74.23 112.995 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 26.2 mt -87.98 -33.48 18.39 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 113.642 0.979 . . . . 73.3 113.642 177.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 41.4 t -59.13 -52.77 56.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 107.064 -1.458 . . . . 73.32 107.064 165.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -46.67 -51.41 16.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.679 1.592 . . . . 63.5 112.893 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -58.04 -28.94 64.94 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.129 0.49 . . . . 75.12 112.017 -169.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -97.09 -47.56 5.73 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 128.095 2.558 . . . . 65.43 111.753 -176.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -62.89 -38.7 91.93 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 118.537 0.608 . . . . 74.44 109.653 -177.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -51.36 -45.7 62.48 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.486 1.114 . . . . 62.13 110.272 172.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.11 -52.97 35.29 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 124.392 1.058 . . . . 65.3 109.677 -175.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.29 -43.16 70.84 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.913 0.485 . . . . 74.32 111.42 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.16 7.51 9.15 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.218 1.807 . . . . 64.2 112.686 -177.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -86.18 -8.75 57.59 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.175 -0.953 . . . . 72.23 111.431 169.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 11.9 mt 68.43 58.53 0.42 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.921 1.344 . . . . 74.02 110.908 160.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.502 ' NE2' ' H ' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -144.38 -34.86 0.36 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.646 1.178 . . . . 51.52 112.094 -173.337 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.502 ' H ' ' NE2' ' A' ' 145' ' ' GLN . 2.3 tp -79.12 -85.09 0.08 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 125.437 1.495 . . . . 72.23 109.244 178.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 51.03 37.49 17.97 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.445 1.098 . . . . 74.12 111.852 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.63 132.77 3.29 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 107.803 -2.119 . . . . 65.13 107.803 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.13 160.45 64.17 Favored Pre-proline 0 C--O 1.241 0.632 0 N-CA-C 108.509 -0.923 . . . . 73.22 108.509 171.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -74.21 142.52 75.0 Favored 'Cis proline' 0 N--CA 1.46 -0.494 0 C-N-CA 125.356 -0.685 . . . . 63.23 111.975 -10.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -126.25 138.7 53.64 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 125.516 1.526 . . . . 63.22 108.621 -175.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 34.5 mtp -140.12 108.61 5.87 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 106.471 -1.677 . . . . 73.14 106.471 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -81.36 173.04 12.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.857 -0.61 . . . . 72.34 110.232 -175.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.401 ' C ' ' H ' ' A' ' 156' ' ' GLY . 59.3 t -133.36 -86.05 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 CA-C-O 119.034 -0.508 . . . . 73.4 110.47 160.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -84.57 30.86 0.54 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.859 1.209 . . . . 72.3 110.379 -167.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 154' ' ' VAL . . . 68.53 -68.0 0.4 Allowed Glycine 0 C--O 1.22 -0.74 0 C-N-CA 127.882 2.658 . . . . 71.4 109.201 -164.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.407 ' HE2' ' CZ ' ' A' ' 158' ' ' TYR . 36.5 pttt -60.44 -0.7 0.27 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 115.432 1.641 . . . . 72.01 115.432 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.407 ' CZ ' ' HE2' ' A' ' 157' ' ' LYS . 18.0 m-85 -121.68 139.31 53.72 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 120.473 1.488 . . . . 65.12 111.972 -177.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -118.86 132.36 56.1 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.471 2.308 . . . . 74.23 106.378 174.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -67.95 143.76 55.49 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.598 -0.89 . . . . 70.42 108.598 175.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -117.56 83.92 18.14 Favored Pre-proline 0 C--O 1.236 0.385 0 N-CA-C 112.406 0.521 . . . . 73.2 112.406 -174.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.405 ' HA ' ' SD ' ' A' ' 165' ' ' MET . 45.7 Cg_endo -62.92 -28.87 75.55 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 120.297 0.665 . . . . 72.13 112.102 179.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -64.16 -7.25 8.43 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 116.756 2.132 . . . . 72.21 116.756 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -107.69 -3.88 34.52 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-N 119.733 1.151 . . . . 52.12 113.776 170.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.405 ' SD ' ' HA ' ' A' ' 162' ' ' PRO . 1.1 mtt -85.82 166.37 16.09 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 119.952 1.876 . . . . 73.4 109.399 -174.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -79.32 65.83 4.61 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 122.674 1.226 . . . . 73.32 111.25 -172.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 41.6 p -67.04 3.57 1.09 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.59 1.956 . . . . 65.24 112.654 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 6.1 t -73.22 -18.63 61.22 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 119.799 1.182 . . . . 74.41 111.827 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.85 -11.74 8.11 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 117.557 -1.211 . . . . 74.02 114.043 -170.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 3.6 mmt 68.98 -63.36 0.37 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.483 1.913 . . . . 73.41 111.809 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.27 -31.07 71.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.767 1.27 . . . . 73.2 110.389 -170.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 76.0 t -75.71 -33.47 26.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 124.546 1.138 . . . . 74.32 111.133 173.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -60.27 -56.88 16.13 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.614 -0.884 . . . . 72.4 108.614 -176.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.0 t -65.01 -35.47 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 109.981 -0.377 . . . . 74.21 109.981 -175.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.09 -27.34 68.29 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.2 1.0 . . . . 74.01 112.301 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -93.92 -33.34 13.53 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.148 0.885 . . . . 72.2 112.105 171.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -56.34 -58.05 9.67 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 124.214 1.006 . . . . 72.22 110.277 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.01 -22.27 62.37 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.162 0.585 . . . . 72.04 112.433 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -70.97 -61.65 1.69 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.446 1.098 . . . . 71.22 109.54 178.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.1 t -61.71 -21.11 64.21 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 118.026 -0.988 . . . . 74.1 112.262 -174.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 57.3 t -56.58 -57.14 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 119.364 0.984 . . . . 74.12 108.667 169.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -56.8 -43.93 81.43 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.771 0.828 . . . . 71.13 109.578 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -61.55 -34.03 74.87 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 123.3 0.64 . . . . 65.12 111.318 -171.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 58.4 mt -79.78 -21.89 43.82 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 121.322 -0.861 . . . . 74.2 112.687 -178.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 72.3 t -61.46 -31.38 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 108.78 -0.822 . . . . 73.31 108.78 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -98.04 -14.53 20.47 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.14 0.976 . . . . 71.2 111.149 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -112.52 63.75 0.63 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.695 1.198 . . . . 74.13 111.198 -174.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt . . . . . 0 C--O 1.248 0.987 0 CA-C-O 119.094 -0.479 . . . . 72.04 110.098 160.605 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 106.965 -1.495 . . . . 74.14 106.965 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -117.95 173.03 7.0 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 123.467 0.48 . . . . 72.33 110.705 -154.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 46.8 25.23 0.42 Allowed 'General case' 0 C--O 1.236 0.394 0 C-N-CA 127.801 2.44 . . . . 73.31 115.161 171.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -161.57 117.32 2.09 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 107.097 -1.446 . . . . 74.45 107.097 -173.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.4 pt -126.41 150.84 32.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 126.174 1.79 . . . . 72.24 109.671 -172.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.9 m -132.14 133.93 44.84 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 105.965 -1.865 . . . . 74.25 105.965 176.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -59.85 144.14 49.45 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.49 1.516 . . . . 73.25 108.913 169.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.9 4.89 73.27 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 118.363 -1.243 . . . . 52.35 112.662 -174.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -129.28 -70.07 0.67 Allowed 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 119.308 1.554 . . . . 73.43 113.497 -176.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -101.17 -27.52 13.18 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.161 -0.681 . . . . 74.0 109.161 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -132.46 170.89 14.49 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 122.563 0.345 . . . . 75.25 110.505 171.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.72 147.82 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 105.535 -2.024 . . . . 72.44 105.535 177.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.09 169.89 17.2 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.733 -1.21 . . . . 73.03 107.733 163.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 36.2 mt -110.26 150.15 29.13 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.795 -1.557 . . . . 63.35 106.795 168.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -75.83 -30.96 59.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.101 0.477 . . . . 75.34 111.216 -174.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.5 mmmt -126.84 76.51 75.25 Favored Pre-proline 0 N--CA 1.464 0.245 0 C-N-CA 124.298 1.039 . . . . 74.34 108.535 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -79.38 71.54 6.98 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 124.14 3.227 . . . . 64.33 111.157 -175.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.7 tp -160.35 144.2 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 O-C-N 120.664 -1.272 . . . . 74.22 109.578 172.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 53.62 -161.45 0.12 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.385 1.874 . . . . 71.12 111.637 171.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.58 -24.97 2.12 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.221 1.391 . . . . 73.45 112.905 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -138.82 160.66 62.13 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 119.351 1.575 . . . . 65.45 111.705 -167.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -76.46 -165.15 0.29 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.865 3.043 . . . . 65.43 111.673 172.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -71.06 90.51 0.85 Allowed 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.579 -1.326 . . . . 65.33 108.467 164.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.274 1.4 p 52.07 151.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.544 1 C-N-CA 131.91 4.084 . . . . 74.12 115.387 174.477 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -160.17 165.37 31.73 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 120.625 -1.297 . . . . 65.12 110.738 -172.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -137.14 132.85 34.58 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 126.007 1.723 . . . . 73.23 107.48 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -127.41 139.02 53.11 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.466 1.506 . . . . 75.33 109.393 -176.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.67 173.13 11.82 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.354 1.462 . . . . 70.14 109.283 -174.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.75 179.47 6.4 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.404 -0.591 . . . . 63.12 109.404 161.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -100.69 -17.15 17.12 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 123.733 0.813 . . . . 75.23 111.714 -173.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.427 ' CD1' ' HA3' ' A' ' 65' ' ' GLY . 64.3 m-85 -111.87 8.12 20.31 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 127.547 2.339 . . . . 75.12 111.854 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.9 p -88.47 144.5 33.85 Favored Pre-proline 0 N--CA 1.468 0.455 0 O-C-N 120.237 -1.54 . . . . 71.01 111.561 -176.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -73.38 -50.2 0.19 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.708 2.272 . . . . 75.11 112.371 -168.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -56.11 -35.52 67.16 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.239 0.616 . . . . 72.04 110.4 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.9 m -63.26 -32.72 74.2 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 124.184 0.994 . . . . 73.41 111.557 -174.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -57.27 -61.96 2.1 Favored 'General case' 0 C--O 1.216 -0.701 0 C-N-CA 123.535 0.734 . . . . 75.03 110.784 172.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.638 ' HA ' HE21 ' A' ' 35' ' ' GLN . 0.0 OUTLIER -47.45 -53.12 14.99 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 120.263 -1.523 . . . . 75.02 110.633 173.198 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -65.5 -13.74 59.51 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 116.015 -1.945 . . . . 62.21 110.908 -163.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -141.11 20.21 2.27 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.667 1.576 . . . . 71.43 113.53 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -142.26 -28.86 0.6 Allowed 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.222 1.009 . . . . 71.04 113.163 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.0 t -116.18 -44.02 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 105.796 -1.927 . . . . 75.4 105.796 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mp -96.1 -32.89 12.3 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.431 1.892 . . . . 75.43 112.326 -170.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 44.11 60.65 2.67 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.49 1.116 . . . . 72.31 112.272 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.71 -35.52 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 124.651 1.18 . . . . 64.42 109.163 -175.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.4 t -57.82 -51.25 70.35 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.8 1.182 . . . . 74.44 108.794 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -66.1 -47.28 74.72 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 124.494 1.117 . . . . 73.43 110.53 -177.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -58.26 -56.19 25.32 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 125.157 1.383 . . . . 72.13 111.579 -178.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.7 t -67.45 -42.14 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.529 -1.286 . . . . 74.21 107.529 -175.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 61.9 ttt-85 -51.27 -43.26 61.54 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.008 1.276 . . . . 71.41 111.865 174.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -61.71 -13.17 20.64 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.689 1.596 . . . . 74.34 114.778 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -120.58 -11.48 9.06 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.035 1.334 . . . . 74.3 112.912 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.7 mt -69.25 143.91 94.34 Favored Pre-proline 0 C--O 1.239 0.529 0 CA-C-N 119.224 0.92 . . . . 73.22 108.921 -163.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.69 145.98 33.44 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.937 2.424 . . . . 73.22 110.565 176.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.58 76.1 6.21 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.489 -1.232 . . . . 72.11 109.346 -168.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 166.49 -17.41 0.09 OUTLIER Glycine 0 CA--C 1.525 0.676 0 CA-C-O 117.769 -1.573 . . . . 65.42 112.255 -172.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.0 t -45.18 -46.06 11.9 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.372 1.586 . . . . 73.43 113.742 174.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.8 tptt 66.23 147.15 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.942 2.897 . . . . 73.25 112.964 -149.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 3.2 mtm -135.08 137.61 43.04 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 127.159 2.184 . . . . 65.43 108.378 175.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.8 m -146.82 168.15 22.12 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.006 1.323 . . . . 71.04 108.714 -177.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.93 106.74 3.07 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.289 -1.507 . . . . 74.44 109.366 -177.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.9 m-30 -112.23 169.48 8.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.194 1.398 . . . . 73.31 111.886 -176.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.427 ' CE1' HG22 ' A' ' 72' ' ' THR . 0.5 OUTLIER -114.82 173.29 6.55 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.04 1.736 . . . . 75.33 109.686 -177.099 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.3 m -136.78 169.77 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 119.692 1.133 . . . . 71.32 109.591 163.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -125.37 65.0 1.16 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.794 1.637 . . . . 71.04 109.806 -174.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -146.7 -13.29 0.44 Allowed 'General case' 0 C--N 1.328 -0.362 0 O-C-N 120.733 -1.23 . . . . 75.31 113.168 -168.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mt -128.24 125.45 38.96 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 119.972 1.26 . . . . 75.43 108.904 -176.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.427 ' HA3' ' CD1' ' A' ' 29' ' ' TYR . . . 89.06 158.08 33.72 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.442 1.496 . . . . 60.12 110.647 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -64.69 -48.57 3.98 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.415 2.077 . . . . 73.24 110.274 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mt -74.36 10.39 1.31 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.471 1.285 . . . . 75.34 114.471 -175.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.23 -2.46 0.41 Allowed Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.176 1.369 . . . . 73.41 115.751 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -90.87 -42.33 10.68 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 120.172 1.986 . . . . 75.12 112.383 169.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -60.92 -54.73 41.45 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 118.595 0.634 . . . . 72.23 109.826 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.3 mt -55.63 -37.68 68.51 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 124.989 1.43 . . . . 74.14 111.682 -164.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.427 HG22 ' CE1' ' A' ' 60' ' ' HIS . 52.3 m -55.74 -49.58 72.68 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 129.506 3.122 . . . . 71.31 110.716 174.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -65.42 -54.73 24.32 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.466 -0.771 . . . . 71.43 109.248 174.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.8 -36.6 48.36 Favored 'General case' 0 C--O 1.227 -0.097 0 N-CA-C 114.042 1.127 . . . . 64.41 114.042 -177.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 35.7 t-105 -50.3 -41.43 50.91 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.058 1.343 . . . . 73.42 110.394 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.66 -36.57 83.3 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 117.628 -1.177 . . . . 72.23 113.314 179.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.1 t -54.69 -49.28 69.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 120.324 1.42 . . . . 74.01 109.475 169.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.55 -46.2 89.46 Favored 'General case' 0 C--N 1.342 0.242 0 O-C-N 122.007 -0.433 . . . . 65.01 110.495 -175.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 79.4 mt -62.43 -39.52 84.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 123.603 0.761 . . . . 73.42 110.153 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.62 -45.03 85.9 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.076 0.853 . . . . 64.12 110.135 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 89.5 mt -86.96 -11.6 50.09 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 112.945 0.72 . . . . 70.31 112.945 -177.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.77 60.89 6.73 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 126.326 1.917 . . . . 62.12 112.184 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.8 m -134.84 11.74 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.134 0 C-N-CA 125.045 1.338 . . . . 62.44 113.097 -174.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -44.42 -60.71 1.82 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.751 1.62 . . . . 73.03 109.911 175.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.8 -8.06 0.54 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.934 2.093 . . . . 73.13 114.183 176.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -108.2 -29.03 9.14 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.536 1.516 . . . . 74.44 112.311 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.9 pp -100.31 -14.07 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 C-N-CA 123.884 0.874 . . . . 72.42 111.619 -175.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.25 3.2 m -63.31 -41.82 98.98 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 116.868 -1.539 . . . . 74.02 112.319 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -50.76 -64.47 1.31 Allowed Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.477 1.111 . . . . 74.43 112.09 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.07 -20.46 44.18 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 120.508 0.805 . . . . 73.0 112.387 -177.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 6.1 tpp -59.98 -55.17 37.37 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 126.539 1.935 . . . . 72.23 110.576 174.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -69.84 -32.02 70.2 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 121.348 -0.845 . . . . 74.42 110.96 -177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -60.97 -36.97 80.8 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 117.915 -1.514 . . . . 74.12 108.887 169.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.17 -15.12 56.68 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 120.376 -1.453 . . . . 75.32 112.408 -171.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 99.1 t -116.91 -22.73 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 125.232 1.413 . . . . 75.2 111.635 -171.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -120.55 -50.89 2.19 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.772 1.169 . . . . 74.01 110.582 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.588 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 1.7 mmpt? -72.44 -40.89 66.72 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 113.696 0.999 . . . . 74.31 113.696 -171.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.4 p -112.3 -34.98 5.74 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 124.809 1.318 . . . . 64.43 111.221 178.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 57.62 23.65 9.59 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.662 1.985 . . . . 75.31 113.308 -171.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -66.79 -13.42 61.46 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.927 0.785 . . . . 64.43 112.22 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 27.7 t -64.47 108.73 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 108.44 -0.948 . . . . 74.33 108.44 169.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -135.11 -26.96 1.26 Allowed 'General case' 0 C--O 1.237 0.399 0 CA-C-O 118.558 -0.734 . . . . 73.23 112.618 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.5 m -131.63 169.94 15.46 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 108.63 -0.878 . . . . 63.03 108.63 169.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 87.8 t -55.92 -36.1 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.019 0.928 . . . . 75.13 110.411 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.81 -16.38 16.81 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.504 1.522 . . . . 74.23 114.053 175.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -91.21 -35.12 14.69 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 119.335 0.97 . . . . 74.3 110.142 175.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.2 mt -78.84 -36.79 19.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 121.256 -0.902 . . . . 75.44 109.394 -169.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -54.39 -36.13 63.58 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-O 117.96 -1.019 . . . . 72.42 111.598 169.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -58.43 -51.63 69.01 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 118.853 0.752 . . . . 73.31 109.475 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 18.8 t -49.69 -48.12 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.427 1.091 . . . . 65.4 110.901 -177.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -55.07 -51.85 65.06 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.442 0.697 . . . . 74.13 110.369 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.2 t -69.94 -32.0 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 CA-C-O 119.098 -0.477 . . . . 74.2 110.205 -175.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -65.91 -41.57 91.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 118.593 0.633 . . . . 70.04 110.712 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.33 -43.86 92.67 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.538 -0.542 . . . . 73.42 109.538 171.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 144.35 3.94 0.7 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.519 1.057 . . . . 53.24 114.869 168.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 65.9 t -62.66 136.6 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 118.763 1.282 . . . . 74.14 108.836 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.4 mtmt -62.32 125.0 22.39 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.443 -0.947 . . . . 74.14 108.443 176.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.71 -27.08 69.34 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-O 118.83 -0.983 . . . . 73.44 111.301 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -70.65 -26.46 63.47 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 118.134 0.967 . . . . 71.23 112.373 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -87.42 -38.65 15.94 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.667 1.987 . . . . 73.13 107.565 -168.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -60.05 -56.05 26.39 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.482 1.513 . . . . 74.22 109.148 166.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -72.04 -8.01 52.11 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.139 0.792 . . . . 61.31 113.139 -173.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -85.89 -61.83 1.66 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.529 1.132 . . . . 74.3 109.598 164.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.09 -37.83 67.31 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 123.435 0.694 . . . . 63.11 112.636 -172.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -49.64 -38.66 33.17 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.097 0.959 . . . . 74.32 111.658 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.56 -11.15 40.91 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 120.487 -1.383 . . . . 73.23 113.965 177.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.7 t -77.07 155.22 32.63 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 126.835 2.054 . . . . 74.41 112.263 -169.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -66.29 -26.17 67.2 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.582 1.553 . . . . 74.02 111.274 175.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 68.0 t -50.04 -52.78 13.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 124.142 0.977 . . . . 63.4 109.19 172.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.2 t -69.45 -42.75 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 C-N-CA 123.383 0.673 . . . . 65.34 110.084 -177.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -51.44 -52.53 45.51 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.172 0.896 . . . . 65.1 111.256 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 36.1 t -63.22 -42.68 99.3 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 123.337 0.655 . . . . 61.4 109.714 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.0 mt -60.35 -52.07 66.84 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-O 118.256 -0.878 . . . . 74.1 109.957 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 95.1 t -51.13 -44.18 28.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 118.964 0.802 . . . . 71.2 108.953 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.41 -28.97 70.34 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 114.282 1.216 . . . . 70.04 114.282 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -63.42 -47.67 81.0 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 121.146 -0.971 . . . . 74.3 110.352 177.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -78.52 -41.11 33.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 124.189 0.931 . . . . 73.12 110.95 -178.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -54.43 -46.78 73.3 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.385 0.993 . . . . 74.11 108.603 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -63.0 -45.87 90.37 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.517 0.727 . . . . 74.04 112.565 175.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.7 -49.92 74.53 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.707 0.685 . . . . 64.35 109.52 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.73 -30.17 71.22 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.136 -1.603 . . . . 75.43 110.895 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -76.57 -8.04 56.4 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.263 0.938 . . . . 71.42 113.405 173.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.68 -18.49 62.17 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 120.728 -1.232 . . . . 73.22 109.743 162.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 11.6 mt 75.42 -8.36 1.6 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 128.154 2.582 . . . . 73.12 112.394 171.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.451 HE21 ' N ' ' A' ' 146' ' ' LEU . 0.0 OUTLIER -64.13 -0.61 1.24 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.126 2.57 . . . . 75.04 115.008 -176.438 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.451 ' N ' HE21 ' A' ' 145' ' ' GLN . 1.2 tt -152.06 119.67 6.07 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 124.323 1.049 . . . . 75.01 108.692 -172.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -146.23 16.91 1.36 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.491 1.116 . . . . 72.33 110.671 -174.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -152.97 97.55 0.17 Allowed Glycine 0 C--N 1.34 0.798 0 O-C-N 121.084 -1.01 . . . . 61.34 111.611 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.4 m -91.03 174.77 4.15 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.153 0.981 . . . . 64.43 110.161 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -64.25 140.94 42.42 Favored 'Cis proline' 0 N--CA 1.456 -0.728 0 N-CA-C 109.218 -1.109 . . . . 62.31 109.218 -19.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -133.8 124.71 27.04 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.264 1.026 . . . . 73.44 108.62 -169.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 28.3 mtp -132.7 107.76 8.6 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.222 1.809 . . . . 75.3 106.471 -168.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -97.56 168.48 10.34 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.302 1.041 . . . . 72.14 109.859 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.0 t -125.35 -37.52 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 118.567 -0.73 . . . . 65.02 112.91 171.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.66 13.85 0.35 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.166 1.543 . . . . 73.15 115.166 -175.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 77.22 2.26 78.09 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 121.621 -0.674 . . . . 73.25 112.617 -175.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -128.11 -4.83 5.59 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 121.333 -1.098 . . . . 75.13 113.803 170.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -133.95 140.29 46.66 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.925 0.89 . . . . 74.45 108.688 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -122.11 154.86 36.81 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.934 1.693 . . . . 75.25 106.546 168.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -76.16 157.4 32.79 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.144 -0.973 . . . . 75.23 108.764 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.25 66.36 1.55 Allowed Pre-proline 0 N--CA 1.468 0.434 0 C-N-CA 123.371 0.668 . . . . 75.14 110.176 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -55.47 -36.62 94.54 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.707 1.605 . . . . 75.04 111.302 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -79.17 24.73 0.32 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.99 0.916 . . . . 63.22 112.921 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -136.13 7.55 4.08 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 121.12 -0.987 . . . . 54.41 113.043 161.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 12.6 mtt -92.25 158.84 15.91 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 119.161 1.48 . . . . 55.4 110.628 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.412 ' HB3' HE22 ' A' ' 176' ' ' GLN . 10.4 t0 -62.72 106.01 0.73 Allowed 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.735 1.214 . . . . 75.42 109.935 176.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 24.2 p -106.48 28.84 7.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.008 1.323 . . . . 75.23 110.247 174.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.3 m -72.49 -29.15 63.38 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 120.988 -1.07 . . . . 71.4 111.496 175.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -133.37 -20.45 2.1 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 112.876 0.695 . . . . 75.44 112.876 -171.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 39.5 mmm 74.2 -31.26 0.21 Allowed 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 126.423 1.889 . . . . 71.34 112.118 173.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -70.59 -48.16 56.58 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 120.188 1.358 . . . . 72.32 108.322 174.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 59.5 t -65.04 -29.82 48.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 114.825 -1.08 . . . . 74.33 111.172 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -56.56 -51.56 68.13 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.533 -0.914 . . . . 75.22 108.533 174.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.8 t -68.45 -34.53 66.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 118.477 0.58 . . . . 73.41 111.014 -175.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.79 -28.1 68.51 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.103 0.561 . . . . 74.0 112.06 177.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.412 HE22 ' HB3' ' A' ' 166' ' ' ASP . 31.1 mt-30 -91.47 -31.16 16.09 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.376 1.07 . . . . 73.14 111.988 174.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -63.51 -58.63 6.39 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.925 -1.109 . . . . 73.32 109.778 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -55.55 -27.84 51.31 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.483 1.113 . . . . 64.32 113.808 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -70.7 -57.76 4.35 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.879 -0.513 . . . . 72.01 110.373 173.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 t -66.9 -30.12 70.19 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.43 -0.582 . . . . 71.22 109.43 -169.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 78.1 t -55.74 -56.54 11.84 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 N-CA-C 108.948 -0.76 . . . . 72.04 108.948 170.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -64.14 -39.23 93.59 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-O 119.015 -0.517 . . . . 73.03 111.315 -172.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -52.53 -33.0 43.38 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 122.75 0.42 . . . . 73.32 112.091 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 80.5 mt -81.19 -16.57 52.45 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 120.756 -1.215 . . . . 70.21 113.065 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 91.6 t -69.44 -20.31 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 120.997 -1.064 . . . . 70.21 110.288 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -105.96 -21.17 13.21 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.273 -0.892 . . . . 74.32 109.566 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 35.2 mttt -105.05 74.42 1.11 Allowed 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 125.954 1.702 . . . . 74.13 109.884 -171.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 33.4 tttt . . . . . 0 N--CA 1.432 -1.372 0 C-N-CA 126.879 2.072 . . . . 71.15 107.665 176.261 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.468 0.443 0 CA-C-O 119.843 -0.122 . . . . 73.41 110.678 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 13.3 m-20 -104.82 94.66 5.39 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.661 -1.237 . . . . 75.41 107.661 -173.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -161.76 23.97 0.12 Allowed 'General case' 0 C--O 1.235 0.293 0 O-C-N 120.977 -1.077 . . . . 75.41 112.799 169.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -157.23 122.53 4.59 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 104.884 -2.265 . . . . 73.0 104.884 -178.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.5 pt -127.14 152.29 34.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 128.303 2.641 . . . . 75.34 107.203 175.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.2 m -121.3 137.31 54.75 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.081 1.352 . . . . 75.34 107.399 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -57.59 152.09 15.72 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.267 1.427 . . . . 62.3 110.224 166.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.48 -31.56 0.84 Allowed Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.415 1.007 . . . . 73.13 112.693 -171.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -87.33 -71.39 0.56 Allowed 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 106.725 -1.583 . . . . 72.32 106.725 -164.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -123.67 -14.03 7.36 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.081 1.752 . . . . 74.22 110.016 -165.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -138.74 168.72 19.19 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.948 -0.47 . . . . 73.22 110.512 155.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.1 mm -125.79 158.35 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 127.955 2.502 . . . . 74.03 106.046 172.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.53 172.81 8.04 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.476 1.51 . . . . 64.24 108.813 178.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.9 mt -124.11 135.1 53.29 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 119.603 1.092 . . . . 73.41 108.784 162.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -66.33 -38.42 87.63 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 129.377 3.071 . . . . 64.31 110.343 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.22 64.81 7.5 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 125.483 1.513 . . . . 73.32 110.362 -177.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -73.15 -9.06 22.98 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 123.335 2.69 . . . . 74.3 113.626 -175.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.4 tt -141.8 105.41 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 121.171 -0.956 . . . . 74.04 110.035 -173.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.03 -53.22 0.29 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.149 1.38 . . . . 53.42 109.914 166.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -160.01 -6.2 0.05 OUTLIER Glycine 0 CA--C 1.526 0.72 0 C-N-CA 123.516 0.579 . . . . 74.13 114.196 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.6 mp0 -68.17 148.31 98.3 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 126.652 1.981 . . . . 74.35 109.676 -173.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.99 152.25 81.73 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.309 2.006 . . . . 73.05 109.042 174.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -78.66 -16.31 57.46 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.52 -0.737 . . . . 71.42 111.625 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.25 117.67 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.129 -1.434 . . . . 74.21 107.129 -175.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -165.28 161.28 19.07 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.812 0.845 . . . . 74.13 110.467 171.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -139.26 147.02 41.14 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.756 1.222 . . . . 72.34 110.013 174.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -127.22 145.94 50.59 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.397 1.079 . . . . 73.32 109.788 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -161.16 174.82 13.11 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.167 1.387 . . . . 74.33 109.314 177.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.3 t -129.79 179.62 5.74 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.998 1.319 . . . . 72.33 109.22 173.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -94.28 -21.66 18.87 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 128.007 2.523 . . . . 75.32 111.377 176.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.463 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 49.7 m-85 -104.35 9.72 35.71 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.697 1.599 . . . . 73.54 114.642 177.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.5 p -88.42 143.24 32.09 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 121.047 1.749 . . . . 74.5 111.014 175.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -80.44 -43.51 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 120.936 1.091 . . . . 74.51 112.352 -171.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -53.84 -44.81 70.62 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 118.447 0.567 . . . . 73.14 109.708 175.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.5 m -52.54 -42.47 64.43 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 125.092 1.357 . . . . 54.41 111.557 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -61.24 -52.09 66.21 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 110.114 -0.328 . . . . 75.23 110.114 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.22 -45.68 87.25 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.515 -0.92 . . . . 70.11 108.515 177.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -67.77 -6.26 20.29 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 116.319 -1.8 . . . . 73.33 113.691 -177.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -134.44 -1.02 2.88 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 121.901 2.137 . . . . 54.31 113.219 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -136.14 -12.51 1.9 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.854 1.262 . . . . 72.21 112.746 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.8 t -126.96 -79.89 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.089 0 N-CA-C 107.052 -1.462 . . . . 64.23 107.052 -176.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.6 mt -65.63 -24.78 67.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.287 2.235 . . . . 73.3 111.993 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 44.36 48.13 8.06 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.99 1.716 . . . . 74.03 111.817 176.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.7 t -54.44 -49.56 64.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.361 0 C-N-CA 125.01 1.324 . . . . 74.21 110.184 -174.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.1 t -48.95 -49.95 37.92 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.4 1.48 . . . . 72.44 110.839 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -73.29 -36.45 66.3 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.654 0.782 . . . . 60.34 112.078 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -57.87 -49.61 76.11 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.486 0.715 . . . . 71.24 109.65 172.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 t -59.02 -49.06 84.6 Favored 'Isoleucine or valine' 0 C--N 1.343 0.313 0 CA-C-N 119.024 0.829 . . . . 73.14 108.874 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.1 ptt180 -61.3 -26.67 67.94 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 121.741 -0.6 . . . . 74.31 112.443 -169.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -64.28 -15.57 60.45 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.391 0.886 . . . . 71.33 113.391 174.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -126.51 -6.13 6.41 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.956 1.702 . . . . 72.44 112.17 -170.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.5 mt -70.08 144.27 92.5 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-O 118.904 -0.57 . . . . 74.04 110.988 -169.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.88 153.25 42.25 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.043 2.495 . . . . 72.2 111.295 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -79.24 81.59 5.49 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.834 0.826 . . . . 75.34 109.072 -172.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 166.64 -23.62 0.13 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.11 1.338 . . . . 73.34 113.891 -177.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.8 t -48.35 -46.79 37.17 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 118.926 1.363 . . . . 75.12 113.991 177.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? 60.01 124.47 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.407 2.283 . . . . 75.32 111.867 -170.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.6 ttm -75.48 102.06 5.07 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 106.286 -1.746 . . . . 73.43 106.286 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.1 m -129.66 101.39 5.89 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 107.649 -1.241 . . . . 62.11 107.649 -167.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.64 105.63 9.88 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.821 1.248 . . . . 72.1 108.151 -162.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -94.86 152.69 18.18 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.185 0.517 . . . . 75.22 109.974 175.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.575 ' HD1' ' HB3' ' A' ' 75' ' ' TRP . 1.6 p-80 -81.62 176.09 9.94 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.513 1.525 . . . . 72.04 108.761 172.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.5 m -145.18 152.09 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 107.659 -1.237 . . . . 73.32 107.659 158.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.449 ' C ' ' H ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER -101.0 -14.7 17.74 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.23 1.012 . . . . 73.14 112.755 -172.09 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -57.8 5.66 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 129.144 2.978 . . . . 74.31 114.719 -177.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.449 ' H ' ' C ' ' A' ' 62' ' ' GLU . 30.5 mt -145.47 110.16 5.08 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 126.763 2.025 . . . . 65.51 106.963 -164.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.463 ' HA3' ' CD2' ' A' ' 29' ' ' TYR . . . 100.85 154.62 26.98 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 126.692 2.091 . . . . 45.41 110.75 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.56 -44.4 0.52 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 121.788 1.658 . . . . 73.44 110.093 173.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.1 mt -83.26 24.28 0.82 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.782 0.833 . . . . 74.11 111.151 174.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -50.78 -46.46 48.26 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.427 1.013 . . . . 72.23 111.191 176.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -58.75 -47.74 83.59 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.923 0.889 . . . . 70.34 111.689 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.68 -44.12 97.08 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.696 1.598 . . . . 62.42 108.509 -174.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.6 mt -61.86 -44.45 96.8 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.464 1.106 . . . . 73.01 111.019 174.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 82.6 m -58.14 -48.89 78.86 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.71 1.604 . . . . 74.23 110.937 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -62.59 -42.86 99.82 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 120.906 -1.121 . . . . 75.35 109.877 175.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.83 -35.74 75.36 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 120.663 -1.273 . . . . 72.05 112.569 178.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.575 ' HB3' ' HD1' ' A' ' 60' ' ' HIS . 52.9 t-105 -55.09 -34.62 63.8 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.228 1.011 . . . . 75.25 111.08 -178.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.12 -36.73 83.93 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 118.382 -0.818 . . . . 62.04 111.481 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.7 t -56.92 -47.31 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 119.445 1.02 . . . . 75.44 109.309 172.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.51 -26.75 61.02 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 117.238 -1.363 . . . . 71.34 112.748 -175.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.12 -42.46 79.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 120.952 1.706 . . . . 75.43 108.937 167.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.04 -40.26 84.52 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.423 1.01 . . . . 75.42 110.771 -176.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.2 mt -87.56 -14.59 39.79 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.127 0.417 . . . . 75.45 112.127 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.98 67.03 2.25 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 126.563 2.03 . . . . 75.21 111.089 -176.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.5 m -136.86 17.07 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.628 1.171 . . . . 74.45 112.51 -176.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -49.29 -50.46 39.12 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.026 1.73 . . . . 73.42 111.772 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -80.09 5.77 13.36 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.677 1.591 . . . . 64.1 111.037 -176.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.8 mtpp -104.5 -20.29 13.74 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.604 1.562 . . . . 74.43 110.527 170.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.1 pp -119.25 13.08 6.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 C-N-CA 124.245 1.018 . . . . 74.45 111.487 -170.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.2 m -86.97 -42.22 13.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 119.542 1.065 . . . . 74.44 111.087 175.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.14 -64.25 2.26 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 118.906 0.776 . . . . 75.11 111.581 -177.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -69.61 -27.75 26.81 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.428 1.419 . . . . 75.01 111.467 -171.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 23.0 tpp -56.16 -49.26 74.48 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.169 0.988 . . . . 71.3 109.038 175.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -73.7 -31.7 63.55 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 118.43 -0.795 . . . . 75.32 110.008 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -60.15 -33.73 72.57 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 119.143 0.883 . . . . 73.2 110.977 170.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -99.45 -12.4 20.25 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.871 1.214 . . . . 62.1 113.438 -174.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.7 t -97.52 -45.52 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.308 1.043 . . . . 72.23 109.216 177.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -98.07 -63.78 1.1 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.886 0.875 . . . . 74.04 109.576 -176.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -63.62 -59.18 4.94 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 119.188 0.904 . . . . 74.1 111.116 -166.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.5 p -95.6 -16.43 22.1 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.884 0.698 . . . . 73.14 112.884 -176.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 55.31 22.57 4.93 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.151 1.381 . . . . 73.41 113.806 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.1 t -68.39 -14.54 63.07 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.4 1.48 . . . . 70.31 112.143 -178.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 38.6 t -66.79 110.84 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 O-C-N 120.52 -1.362 . . . . 64.25 109.094 171.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -139.28 -23.21 0.9 Allowed 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.914 1.686 . . . . 71.42 111.616 -172.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 t -151.44 179.95 7.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.007 -1.058 . . . . 63.51 109.394 159.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.3 t -54.58 -34.34 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 124.664 1.185 . . . . 72.33 110.064 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.38 -23.86 17.31 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.867 1.667 . . . . 63.32 113.04 176.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -94.08 -37.66 11.51 Favored 'General case' 0 CA--C 1.518 -0.266 0 O-C-N 121.33 -0.856 . . . . 75.05 108.998 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.8 mt -65.4 -47.23 87.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 125.152 1.381 . . . . 71.43 108.096 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -62.51 -26.16 68.4 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.019 0.748 . . . . 74.24 113.019 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -65.08 -51.81 59.27 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 109.577 -0.527 . . . . 71.45 109.577 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.2 t -55.83 -41.7 67.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 123.549 0.53 . . . . 75.4 111.062 -176.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -54.11 -54.4 40.03 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.496 -0.557 . . . . 64.42 109.496 175.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 54.4 t -58.67 -47.34 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 C-N-CA 123.036 0.534 . . . . 75.03 110.436 -177.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -70.25 -37.91 75.02 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.437 -0.949 . . . . 74.32 108.437 -166.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.89 -9.9 59.21 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.607 1.163 . . . . 75.34 112.354 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 118.4 36.37 0.93 Allowed Glycine 0 C--N 1.336 0.577 0 CA-C-O 117.793 -1.56 . . . . 74.24 115.08 168.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 99.5 t -102.61 144.81 13.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 119.648 1.724 . . . . 62.22 109.204 172.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.504 ' HG3' ' H ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -67.53 133.14 48.92 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.53 -0.759 . . . . 75.32 110.23 171.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.42 -21.91 69.01 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-O 118.903 -0.943 . . . . 71.35 111.736 172.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -73.22 -49.8 25.93 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 118.147 -0.93 . . . . 73.02 111.917 175.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.504 ' H ' ' HG3' ' A' ' 117' ' ' LYS . 33.3 t70 -66.07 -40.67 91.05 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.181 -1.414 . . . . 75.41 107.181 -178.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -59.29 -51.38 70.19 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 123.907 0.754 . . . . 72.25 110.105 -174.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -77.88 -12.83 60.02 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 113.002 0.741 . . . . 73.32 113.002 -175.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.43 -61.7 1.46 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.979 1.312 . . . . 75.23 110.387 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.79 -34.22 58.41 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.57 1.548 . . . . 74.21 110.934 -177.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 61.7 t-105 -45.54 -37.02 5.0 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.017 1.727 . . . . 73.01 112.934 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -113.21 2.54 15.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.935 1.294 . . . . 75.02 113.162 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 10.0 t -77.34 156.0 31.58 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.441 1.097 . . . . 73.11 109.887 173.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -58.88 -30.86 68.07 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.448 1.499 . . . . 74.32 111.941 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 84.9 t -54.33 -48.54 67.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 O-C-N 121.606 -0.683 . . . . 74.41 109.391 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.4 t -65.32 -43.47 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-O 119.08 -0.486 . . . . 74.41 110.504 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -53.4 -51.55 62.19 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.68 0.673 . . . . 74.35 111.51 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.0 t -69.63 -38.15 77.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 117.863 -1.065 . . . . 62.41 110.285 -177.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.1 mt -58.92 -56.4 22.78 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 117.453 -1.26 . . . . 75.42 110.429 176.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 37.6 t -45.41 -46.72 4.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.245 0 C-N-CA 124.533 1.133 . . . . 71.22 109.98 174.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.02 -35.13 70.83 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 113.038 0.755 . . . . 63.31 113.038 -176.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -61.53 -38.37 87.16 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.048 0.539 . . . . 75.34 110.755 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 10.0 mp0 -85.9 -50.28 7.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.254 1.022 . . . . 75.11 110.746 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -52.72 -44.94 66.71 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.057 0.844 . . . . 75.04 109.69 -176.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -60.89 -61.89 2.26 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.092 0.472 . . . . 72.33 109.878 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.55 1.55 3.04 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.792 1.405 . . . . 74.35 114.792 -173.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -129.88 6.12 5.05 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.282 1.433 . . . . 74.23 112.279 174.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -120.81 -6.25 9.62 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 124.714 1.206 . . . . 70.15 113.085 168.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.97 5.06 0.25 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.317 2.247 . . . . 70.43 112.781 175.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 73.25 -5.68 1.9 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 131.682 3.993 . . . . 64.54 114.126 -178.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.76 -15.92 62.19 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 127.964 2.505 . . . . 74.45 113.468 -164.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.4 tp -164.17 125.01 2.17 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 128.16 2.584 . . . . 74.4 105.545 -176.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -142.13 21.95 2.08 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.475 0.655 . . . . 72.44 111.265 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -136.43 158.97 24.28 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 107.498 -2.241 . . . . 73.32 107.498 164.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.46 171.67 7.39 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 107.993 -1.114 . . . . 61.5 107.993 174.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -63.21 156.16 69.21 Favored 'Cis proline' 0 N--CA 1.457 -0.639 0 CA-C-N 120.453 1.197 . . . . 63.33 111.27 -8.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -141.22 144.73 34.9 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.107 0.963 . . . . 71.34 108.766 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 29.2 ttm -151.08 109.94 3.87 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.001 -1.481 . . . . 75.4 107.001 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -93.15 156.23 16.98 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.595 -0.73 . . . . 75.12 109.31 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.6 t -139.48 140.0 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.614 -0.884 . . . . 75.32 108.614 175.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 45.78 28.84 0.61 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.967 2.507 . . . . 74.41 114.562 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 63.53 7.39 20.13 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.88 1.705 . . . . 74.41 113.488 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -141.5 -5.39 1.07 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 119.044 1.422 . . . . 75.3 113.648 -165.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -129.45 150.13 50.93 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.38 -0.97 . . . . 74.02 108.38 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.31 123.99 37.65 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 128.401 2.68 . . . . 75.21 107.998 177.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.5 139.73 57.61 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.513 -1.662 . . . . 73.3 106.513 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -114.66 86.09 12.3 Favored Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 123.256 0.622 . . . . 70.4 110.969 174.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.78 -17.9 47.39 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 120.706 0.937 . . . . 73.3 111.705 177.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -78.66 -6.02 54.6 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.09 1.756 . . . . 74.3 112.773 -172.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -130.35 13.46 5.68 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.573 1.082 . . . . 72.44 111.366 177.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 45.3 mtt -85.5 163.19 18.57 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.33 1.065 . . . . 63.1 109.192 170.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.57 108.73 6.59 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.705 -1.591 . . . . 73.32 106.705 170.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 31.9 p -102.1 -6.74 22.95 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 127.016 2.127 . . . . 74.21 110.94 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 46.5 m -61.74 -17.9 57.64 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 125.683 1.593 . . . . 64.3 114.491 -170.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -128.78 -6.3 5.09 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 117.76 -1.114 . . . . 75.33 111.197 -164.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 65.92 -63.73 0.22 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.348 1.859 . . . . 74.21 111.865 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.55 -44.49 94.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 119.114 0.87 . . . . 74.33 108.954 -171.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 91.9 t -62.12 -30.0 47.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 125.084 1.354 . . . . 74.41 111.587 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -66.78 -60.11 2.97 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 107.624 -1.25 . . . . 75.44 107.624 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.2 t -68.04 -35.4 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 O-C-N 123.72 0.637 . . . . 75.21 110.664 -174.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.02 -52.18 63.95 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.491 0.716 . . . . 74.31 109.799 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -72.64 -38.32 67.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.245 -0.883 . . . . 75.01 111.598 177.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -55.46 -58.41 7.88 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.745 1.157 . . . . 73.21 109.714 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.58 -42.07 61.62 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 125.989 1.716 . . . . 71.33 111.514 -176.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -71.44 -51.0 26.29 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.955 0.902 . . . . 63.32 108.935 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 31.1 m -59.81 -26.45 65.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.461 1.105 . . . . 64.1 112.229 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 97.2 t -60.05 -51.43 73.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 108.912 -0.773 . . . . 75.02 108.912 169.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 31.1 tttm -61.35 -44.29 97.42 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 118.008 -0.996 . . . . 75.31 110.986 174.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -57.15 -28.98 63.23 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 119.599 1.091 . . . . 75.01 111.426 -169.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 58.5 mt -81.12 -24.61 37.56 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.874 0.694 . . . . 75.03 112.874 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.47 -28.22 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 O-C-N 121.027 -1.045 . . . . 75.23 110.508 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -89.28 -29.61 19.07 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 122.048 0.928 . . . . 73.04 109.45 178.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 45.6 mttp -95.64 66.42 2.73 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 125.094 1.358 . . . . 72.44 109.051 -176.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? . . . . . 0 C--O 1.247 0.968 0 N-CA-C 107.427 -1.323 . . . . 64.34 107.427 154.207 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 31.4 m . . . . . 0 CA--C 1.514 -0.404 0 N-CA-C 108.931 -0.766 . . . . 74.41 108.931 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -140.51 -25.11 0.77 Allowed 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 114.821 1.415 . . . . 74.34 114.821 -174.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -76.32 28.71 0.12 Allowed 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 125.865 1.666 . . . . 71.32 114.023 -164.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -157.58 122.98 4.55 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 129.153 2.981 . . . . 71.3 103.533 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.3 pt -127.85 149.59 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 126.735 2.014 . . . . 75.54 108.152 175.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.0 m -132.03 143.33 49.98 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.054 -1.091 . . . . 71.54 108.054 174.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -59.11 151.91 21.45 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.919 1.287 . . . . 64.13 110.151 170.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.86 -25.82 0.78 Allowed Glycine 0 CA--C 1.532 1.125 0 CA-C-O 118.873 -0.96 . . . . 64.34 112.783 -169.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -98.04 -85.61 0.37 Allowed 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 119.246 1.523 . . . . 75.32 107.565 -170.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -90.05 -17.92 26.89 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.505 0.722 . . . . 75.24 111.751 -176.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -140.76 164.91 28.95 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 118.208 0.458 . . . . 74.22 110.245 173.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.2 mm -127.87 163.12 32.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 105.761 -1.941 . . . . 71.14 105.761 173.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.21 164.26 11.74 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 124.998 1.319 . . . . 71.23 110.058 171.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 27.2 mt -79.67 154.53 28.57 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.929 -1.137 . . . . 75.32 107.929 161.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.62 -27.12 51.06 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.809 -0.812 . . . . 73.4 108.809 171.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -121.81 71.34 29.6 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.774 1.629 . . . . 74.24 108.987 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -84.19 63.56 6.89 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 124.079 3.186 . . . . 74.21 111.579 -177.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.5 mp -123.29 152.93 28.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 O-C-N 120.054 -1.654 . . . . 73.13 109.046 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.54 110.03 0.46 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.428 1.891 . . . . 73.1 109.111 175.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.65 -37.59 0.05 OUTLIER Glycine 0 CA--C 1.521 0.454 0 N-CA-C 111.02 -0.832 . . . . 75.44 111.02 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.76 165.85 39.35 Favored Pre-proline 0 C--O 1.242 0.674 0 C-N-CA 124.698 1.199 . . . . 71.33 110.332 166.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -58.72 172.37 1.58 Allowed 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.579 2.186 . . . . 73.33 110.671 161.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -120.17 119.15 32.43 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.661 -1.237 . . . . 74.12 107.661 -174.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t 69.19 113.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 127.936 2.494 . . . . 75.41 109.655 -170.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 tp -150.64 161.83 41.84 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.374 -0.973 . . . . 74.0 108.374 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -146.15 136.58 23.95 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.496 -1.298 . . . . 75.11 107.496 -169.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -137.22 136.27 37.99 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 123.889 0.876 . . . . 73.11 110.505 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.03 171.64 18.75 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.606 1.962 . . . . 64.21 108.177 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.02 153.78 50.56 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 119.031 -0.509 . . . . 73.02 109.898 169.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.415 ' CD2' HG21 ' A' ' 95' ' ' VAL 0.296 0.0 OUTLIER -67.19 -15.61 63.8 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 113.306 0.854 . . . . 75.03 113.306 177.911 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.462 ' CE2' ' HA3' ' A' ' 65' ' ' GLY . 41.6 m-85 -93.45 -0.52 56.4 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.277 0.944 . . . . 74.22 112.248 176.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.9 t -82.05 141.04 46.52 Favored Pre-proline 0 CA--C 1.534 0.36 0 O-C-N 120.592 -1.317 . . . . 63.34 110.446 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -88.78 -37.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 121.769 1.646 . . . . 75.23 112.542 -175.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -62.95 -48.09 80.4 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 124.702 1.201 . . . . 75.13 108.778 176.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 21.0 m -57.44 -30.54 65.09 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.204 -0.907 . . . . 75.2 111.089 -178.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -59.81 -56.94 15.54 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 119.612 1.096 . . . . 75.21 110.109 173.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.93 -42.14 68.49 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.065 -0.717 . . . . 75.03 109.065 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -69.49 -16.18 63.41 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 116.641 -1.647 . . . . 72.03 112.67 -176.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -124.17 -10.44 7.57 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 121.245 1.839 . . . . 74.31 111.9 -172.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -136.97 -11.8 1.72 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.986 1.715 . . . . 74.13 112.972 -170.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.6 t -127.24 -81.76 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 O-C-N 120.315 -1.49 . . . . 75.34 107.718 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.2 mt -56.9 -28.18 61.59 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.498 1.919 . . . . 75.42 111.67 175.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 67.9 m80 44.57 46.51 8.26 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.942 1.697 . . . . 72.43 110.918 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.7 t -51.0 -53.78 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 C-N-CA 126.614 1.966 . . . . 64.3 108.631 -175.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.5 t -45.44 -47.95 13.78 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.644 1.978 . . . . 73.14 111.587 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.64 -18.45 27.94 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.011 -1.055 . . . . 74.42 111.835 -176.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.5 -40.94 93.64 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.208 -0.932 . . . . 74.02 109.582 167.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.9 t -59.61 -46.39 93.23 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 N-CA-C 109.437 -0.579 . . . . 75.44 109.437 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -47.93 -44.48 30.07 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.229 1.012 . . . . 73.3 112.033 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -62.57 -10.62 12.71 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.001 1.482 . . . . 72.24 115.001 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -125.44 -9.03 6.9 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 126.925 2.09 . . . . 73.34 113.199 -174.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.5 mt -72.33 150.43 91.83 Favored Pre-proline 0 C--O 1.234 0.269 0 CA-C-N 119.328 0.967 . . . . 75.43 111.246 -167.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -71.82 156.63 56.59 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.146 1.898 . . . . 72.33 109.402 169.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.28 28.57 0.06 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 126.007 1.723 . . . . 73.2 114.974 -174.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -154.19 21.08 0.66 Allowed Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 124.708 1.147 . . . . 21.05 112.979 -168.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.9 t -89.72 -45.3 9.41 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 117.887 0.843 . . . . 62.02 110.908 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? 55.52 95.55 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 124.155 1.931 . . . . 74.14 110.704 -162.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.8 mtm -62.29 122.84 16.65 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 113.84 -1.527 . . . . 53.14 108.765 169.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.3 m -123.24 179.87 4.55 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.317 -0.994 . . . . 74.02 108.317 174.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -172.35 88.1 0.09 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 106.78 -1.563 . . . . 73.31 106.78 -171.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.494 ' CD2' ' HG3' ' A' ' 137' ' ' GLN . 4.1 m-30 -89.02 176.02 7.17 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.992 1.317 . . . . 75.31 109.299 175.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.586 ' HD1' ' CB ' ' A' ' 75' ' ' TRP . 2.1 p-80 -117.04 175.42 5.6 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.154 1.381 . . . . 75.12 110.081 174.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.8 m -131.24 175.97 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.255 1.422 . . . . 75.24 109.036 169.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.71 59.74 1.72 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.693 2.397 . . . . 72.14 111.134 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -148.33 -163.71 1.84 Allowed 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.237 1.415 . . . . 75.13 109.82 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.8 mt 75.54 -85.03 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 128.616 2.767 . . . . 73.43 109.175 -176.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.462 ' HA3' ' CE2' ' A' ' 29' ' ' TYR . . . -95.32 174.46 32.36 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 125.43 1.491 . . . . 74.05 111.452 -178.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.88 -36.63 30.39 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 124.945 3.763 . . . . 74.41 113.124 -169.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.2 mt -83.68 24.82 0.83 Allowed 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 124.332 1.053 . . . . 75.14 112.721 -174.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -46.28 -51.6 11.53 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-N 118.72 0.691 . . . . 63.41 111.81 179.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -70.76 -6.38 37.13 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.49 1.116 . . . . 74.42 113.596 -177.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -111.44 -24.57 10.09 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.257 1.423 . . . . 73.23 109.389 -177.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.401 HD23 ' CG ' ' A' ' 28' ' ' PHE . 9.5 mt -63.67 -46.97 83.12 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.912 0.885 . . . . 72.43 109.368 165.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -50.86 -52.11 44.82 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.414 1.486 . . . . 71.15 108.75 171.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -62.03 -54.47 41.03 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.551 -0.718 . . . . 73.31 110.5 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.24 -33.38 73.18 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.631 1.105 . . . . 74.45 113.435 -167.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.586 ' CB ' ' HD1' ' A' ' 60' ' ' HIS . 40.5 t-105 -56.73 -38.13 71.95 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 123.1 0.56 . . . . 75.14 110.367 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.27 84.7 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 117.505 -1.236 . . . . 73.45 112.055 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 93.9 t -56.35 -45.22 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 121.072 1.76 . . . . 71.21 110.986 167.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.37 -45.55 90.65 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 118.094 -0.955 . . . . 74.25 111.073 -177.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 60.2 mt -62.54 -40.44 88.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 124.263 1.025 . . . . 73.24 110.207 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.85 -42.17 83.9 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.758 0.708 . . . . 71.35 110.362 -175.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.5 mt -85.18 -29.92 24.34 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 111.732 0.271 . . . . 75.04 111.732 174.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.74 52.08 3.43 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 126.183 1.849 . . . . 74.24 111.853 -175.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -127.25 21.16 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.761 1.224 . . . . 74.01 111.403 -173.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -53.05 -53.2 53.74 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 123.757 0.823 . . . . 72.02 111.074 -175.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.18 -42.7 77.54 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.224 1.409 . . . . 74.15 109.687 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.7 mtpm? -72.64 -5.23 35.95 Favored 'General case' 0 N--CA 1.46 0.066 0 C-N-CA 125.012 1.325 . . . . 74.34 112.171 -176.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.6 pp -134.1 23.3 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 C-N-CA 125.669 1.587 . . . . 75.32 109.386 173.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 99.5 m -87.53 -57.56 2.9 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.222 -1.399 . . . . 71.41 107.222 168.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.89 -60.15 11.44 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 112.88 0.696 . . . . 62.14 112.88 -164.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.92 -26.61 43.94 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.288 1.325 . . . . 75.31 111.579 -177.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 5.0 ttm -64.92 -43.5 92.59 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.56 0.744 . . . . 71.42 109.258 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -69.69 -40.19 76.5 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.496 1.118 . . . . 72.11 109.473 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.12 -27.25 66.88 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.223 0.465 . . . . 72.25 111.196 172.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -97.59 3.98 50.35 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 120.361 -1.462 . . . . 71.22 113.304 -177.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.415 HG21 ' CD2' ' A' ' 28' ' ' PHE . 65.6 t -119.73 -41.23 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 124.073 0.949 . . . . 73.15 110.067 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -101.4 -51.66 3.43 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 109.404 -0.591 . . . . 61.44 109.404 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -75.35 -60.02 2.49 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.88 -0.6 . . . . 71.35 109.432 -168.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.3 p -98.1 -19.13 18.13 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.775 0.83 . . . . 74.21 112.491 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 64.95 18.51 11.53 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.869 1.668 . . . . 54.12 114.163 166.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.1 t -74.78 -17.39 60.63 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.991 1.317 . . . . 74.15 113.486 -172.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.6 t -66.84 126.58 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.555 -0.716 . . . . 64.45 109.13 167.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -146.1 -25.71 0.44 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.239 1.415 . . . . 75.05 111.075 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.1 t -143.38 175.81 9.63 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.899 0.772 . . . . 75.05 110.25 171.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.4 t -52.39 -44.82 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.932 1.693 . . . . 74.44 110.028 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -52.77 -23.72 7.39 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.712 1.605 . . . . 75.03 112.862 177.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -94.38 -24.72 17.25 Favored 'General case' 0 CA--C 1.523 -0.078 0 CA-C-N 118.972 0.806 . . . . 75.34 111.123 -178.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.4 mt -82.45 -43.28 19.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.594 -0.891 . . . . 75.42 108.594 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -55.15 -31.79 61.59 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 118.534 -0.746 . . . . 74.43 111.479 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -57.51 -61.76 2.26 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.287 1.435 . . . . 73.22 109.85 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.7 t -55.33 -40.07 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 122.767 0.427 . . . . 75.41 110.756 -175.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -53.79 -53.48 51.8 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.472 0.578 . . . . 73.24 110.65 173.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.24 -41.36 91.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 123.876 0.87 . . . . 71.15 109.99 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -67.27 -37.71 83.9 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.678 -0.86 . . . . 73.44 108.678 -170.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.3 -24.71 61.36 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.443 1.097 . . . . 73.31 112.428 175.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.57 56.47 0.35 Allowed Glycine 0 C--N 1.332 0.315 0 N-CA-C 111.242 -0.743 . . . . 64.42 111.242 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.3 t -118.98 126.36 75.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 109.087 -0.708 . . . . 73.05 109.087 166.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -54.13 128.03 29.19 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.212 -0.662 . . . . 75.22 109.212 176.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.41 -21.19 66.34 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-O 117.6 -1.667 . . . . 73.04 110.434 170.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -68.83 -37.57 79.25 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 119.875 1.838 . . . . 75.41 108.826 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.74 -45.51 28.95 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 126.08 1.752 . . . . 72.23 107.164 -171.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -55.93 -57.4 12.27 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 109.501 -0.555 . . . . 72.44 109.501 174.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -66.23 -28.8 69.01 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 119.314 -0.374 . . . . 72.04 111.145 -172.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.27 -64.05 1.1 Allowed 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.859 0.864 . . . . 71.13 110.587 174.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.99 -36.37 65.33 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.585 1.154 . . . . 72.25 110.572 -171.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 59.9 t-105 -45.62 -42.83 11.78 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.744 1.218 . . . . 75.12 112.57 177.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -105.71 1.25 26.98 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.639 1.176 . . . . 64.05 112.872 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.2 t -77.97 150.24 33.99 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.51 1.524 . . . . 75.01 109.805 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -56.45 -35.27 67.7 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 124.429 1.092 . . . . 64.43 111.0 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.9 t -51.53 -52.51 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 CA-C-N 118.847 0.749 . . . . 64.42 109.581 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.13 -45.61 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-N 115.942 -0.572 . . . . 74.43 110.269 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -46.22 81.98 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.342 0.657 . . . . 73.35 111.109 -176.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.4 t -67.07 -48.39 68.39 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.638 1.175 . . . . 73.41 110.371 175.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.7 mt -53.8 -50.38 66.24 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-O 117.321 -1.324 . . . . 75.32 110.029 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.8 t -48.27 -51.74 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 120.573 1.533 . . . . 74.05 109.986 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.57 -27.45 64.62 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.514 0.931 . . . . 74.23 113.514 -177.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -63.99 -32.95 74.67 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 113.774 1.027 . . . . 74.13 113.774 172.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.55 HE21 ' CE1' ' A' ' 60' ' ' HIS . 4.1 mp0 -89.72 -35.94 15.48 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 117.652 -1.166 . . . . 75.14 111.85 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -56.64 -51.6 68.07 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 108.041 -1.096 . . . . 74.45 108.041 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 23.9 ttpt -59.66 -16.43 26.4 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 113.765 1.024 . . . . 73.12 113.765 174.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -117.26 -1.86 11.73 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 120.486 1.494 . . . . 72.43 114.828 -174.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.07 -29.86 4.16 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 119.145 0.884 . . . . 73.21 111.038 172.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -107.67 2.04 23.56 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.789 0.836 . . . . 73.01 112.034 -170.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -63.62 -85.82 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.504 1.121 . . . . 74.3 111.255 176.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -175.56 50.0 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.032 1.733 . . . . 74.02 109.216 177.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.276 0.6 OUTLIER -143.7 -50.0 0.31 Allowed 'General case' 0 C--N 1.344 0.332 0 N-CA-C 114.071 1.138 . . . . 74.03 114.071 -178.262 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 40.5 tp -70.07 -83.1 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 119.572 1.078 . . . . 72.44 110.071 -176.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 55.15 33.52 20.67 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.618 0.767 . . . . 64.42 112.477 173.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 176.35 159.44 21.93 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.681 1.61 . . . . 74.03 109.587 170.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 9.9 m -141.69 159.03 61.49 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 119.61 1.705 . . . . 75.44 110.582 173.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.29 161.57 94.22 Favored 'Cis proline' 0 C--N 1.349 0.572 0 CA-C-N 118.987 0.674 . . . . 73.34 112.897 -4.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -144.36 146.07 32.33 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.858 -1.065 . . . . 71.22 110.055 175.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 38.8 tpp -135.96 105.43 6.07 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 105.006 -2.22 . . . . 74.24 105.006 175.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -82.81 149.51 27.14 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.084 0.953 . . . . 75.21 109.444 175.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.8 t -140.08 145.93 25.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 108.195 -1.039 . . . . 75.12 108.195 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 50.67 24.16 1.59 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.992 2.117 . . . . 60.43 113.765 173.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 68.36 4.29 36.58 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 120.336 -1.478 . . . . 72.02 113.612 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.416 ' HE2' ' CE2' ' A' ' 158' ' ' TYR . 11.1 pttt -147.26 -6.48 0.48 Allowed 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.442 1.621 . . . . 75.22 115.183 -166.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.416 ' CE2' ' HE2' ' A' ' 157' ' ' LYS . 63.0 m-85 -124.04 162.38 23.59 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.332 0.969 . . . . 72.02 110.288 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -129.63 139.94 51.29 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.815 1.646 . . . . 71.41 106.895 165.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.89 142.34 57.94 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 107.946 -1.131 . . . . 74.13 107.946 167.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -118.67 85.52 27.41 Favored Pre-proline 0 C--O 1.235 0.333 0 C-N-CA 123.603 0.761 . . . . 74.41 111.651 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.01 -24.87 52.23 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 CA-C-N 119.544 0.873 . . . . 75.03 111.493 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.99 -8.65 39.13 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.876 1.27 . . . . 75.24 112.642 -178.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -112.9 7.9 25.57 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-O 118.519 -1.156 . . . . 75.03 112.202 176.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 59.1 mtt -98.13 158.91 15.27 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 119.351 1.576 . . . . 74.14 110.528 -176.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -66.94 109.37 2.93 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 106.524 -1.658 . . . . 75.33 106.524 170.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.16 11.91 15.34 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 128.156 2.582 . . . . 75.4 108.632 -171.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.67 -4.33 56.84 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 125.693 1.597 . . . . 60.4 113.189 -169.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.06 -7.28 1.38 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.783 0.833 . . . . 75.1 111.491 -168.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 8.1 mmt 65.94 -62.78 0.24 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 127.142 2.177 . . . . 75.21 112.23 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.44 -36.65 74.09 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 120.371 1.441 . . . . 64.03 109.803 -171.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 79.9 t -58.68 -37.32 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.687 1.195 . . . . 74.02 110.162 172.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -60.16 -56.52 20.56 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.674 -0.861 . . . . 75.32 108.674 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.2 t -64.93 -37.82 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 123.314 0.384 . . . . 74.04 110.536 -178.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.42 -47.67 69.39 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.542 1.137 . . . . 74.23 110.657 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -80.75 -40.25 25.54 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 118.504 -0.76 . . . . 73.41 111.882 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -50.38 -59.69 3.74 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.486 1.039 . . . . 75.03 110.2 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.27 -37.48 75.07 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.229 1.012 . . . . 75.23 111.74 -172.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -67.39 -50.4 59.78 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.912 0.885 . . . . 74.53 109.994 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 22.0 m -57.03 -29.73 63.62 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.647 1.179 . . . . 75.13 111.964 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 3.7 t -60.38 -52.79 57.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 119.396 0.998 . . . . 73.23 109.354 172.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -62.55 -27.88 69.47 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 121.499 -0.751 . . . . 74.4 112.089 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -68.92 -33.62 74.04 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 119.214 0.915 . . . . 75.22 112.528 176.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 66.1 mt -71.21 -32.86 69.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 120.159 1.345 . . . . 72.51 110.98 -177.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 99.3 t -62.36 -23.68 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.163 0.985 . . . . 60.32 112.144 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -99.0 -19.42 17.28 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.453 -0.78 . . . . 74.3 110.203 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -98.89 77.54 2.22 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 125.197 1.399 . . . . 75.14 107.398 -168.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.967 0 C-N-CA 126.923 2.089 . . . . 74.33 111.563 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.612 0 N-CA-C 112.758 0.651 . . . . 74.329999999999998 112.758 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.2 116.77 0.99 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 127.004 2.121 . . . . 74.019999999999996 105.799 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.8 pt -130.72 168.66 23.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 126.51 1.924 . . . . 73.109999999999999 108.514 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.9 m -139.58 135.15 33.08 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.549 1.139 . . . . 73.049999999999997 108.954 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -60.25 111.54 1.58 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.542 2.337 . . . . 54.439999999999998 108.263 169.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 107.69 -16.1 37.34 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 126.12 1.819 . . . . 72.209999999999994 112.921 -173.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -100.63 -86.48 0.4 Allowed 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 119.411 1.606 . . . . 71.430000000000007 108.056 -174.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -87.89 -18.01 30.14 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.435 1.094 . . . . 71.140000000000001 111.303 -176.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -138.83 161.13 38.01 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.144 0.978 . . . . 72.140000000000001 109.024 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mm -127.85 160.42 37.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 105.874 -1.898 . . . . 53.420000000000002 105.874 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.6 m -81.29 152.08 27.76 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.637 -1.246 . . . . 71.219999999999999 107.637 167.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 32.8 mt -62.01 163.83 7.39 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.751 -0.463 . . . . 62.240000000000002 109.751 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -71.64 -37.4 70.85 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.648 0.779 . . . . 71.040000000000006 109.313 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.4 mmtp -140.83 78.72 19.83 Favored Pre-proline 0 CA--C 1.529 0.166 0 C-N-CA 126.005 1.722 . . . . 72.439999999999998 108.073 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 N--CA 1.445 -1.328 0 C-N-CA 122.171 1.914 . . . . 75.329999999999998 107.646 172.726 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.829 HG21 HG23 ' A' ' 54' ' ' THR . 75.1 t . . . . . 0 C--O 1.233 0.209 0 N-CA-C 106.15 -1.796 . . . . 44.549999999999997 106.15 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 tp -156.66 161.65 39.86 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.99 1.316 . . . . 73.25 107.94 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -139.74 126.43 20.57 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 106.511 -1.662 . . . . 63.32 106.511 -163.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -128.79 127.7 42.48 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.191 0.996 . . . . 74.150000000000006 112.174 -173.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -169.67 173.96 6.04 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.371 2.269 . . . . 63.219999999999999 112.233 176.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.8 t -135.84 151.11 49.71 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.078 -1.013 . . . . 74.25 109.073 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.722 ' CD1' HD11 ' A' ' 71' ' ' LEU 0.307 0.0 OUTLIER -62.12 -19.67 63.25 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 120.599 1.545 . . . . 63.420000000000002 113.44 -175.158 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.401 ' CE2' ' HA3' ' A' ' 65' ' ' GLY . 59.3 m-85 -92.26 1.45 57.21 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 120.928 1.695 . . . . 75.049999999999997 112.506 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.4 p -75.85 141.68 72.14 Favored Pre-proline 0 C--N 1.354 0.762 0 CA-C-N 122.162 2.256 . . . . 40.420000000000002 108.547 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -89.07 -31.27 0.16 Allowed 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 121.319 1.346 . . . . 60.130000000000003 111.338 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -62.03 -40.81 96.99 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.156 -0.965 . . . . 72.450000000000003 110.957 174.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.9 p -70.43 -28.46 65.06 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-O 118.146 -0.93 . . . . 61.049999999999997 110.971 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -54.85 -56.06 23.57 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.767 1.167 . . . . 73.239999999999995 110.263 175.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -56.16 -46.88 79.13 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-O 118.514 -0.755 . . . . 74.409999999999997 109.022 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -66.64 -10.35 45.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 117.005 -1.474 . . . . 53.32 113.386 -175.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -134.25 0.46 3.1 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 120.616 1.553 . . . . 72.420000000000002 112.67 -163.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -139.58 -36.37 0.52 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 126.687 1.995 . . . . 72.129999999999995 110.765 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.3 t -102.56 -76.84 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 107.284 -1.376 . . . . 52.109999999999999 107.284 -173.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 71.7 mt -68.19 -21.73 64.86 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.432 1.493 . . . . 71.310000000000002 113.614 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 13.8 m80 44.66 58.96 3.59 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.92 1.688 . . . . 73.329999999999998 113.062 176.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 96.4 t -63.74 -41.3 92.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.976 1.311 . . . . 55.310000000000002 110.861 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.5 t -56.42 -45.03 80.9 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.477 1.49 . . . . 74.010000000000005 110.696 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.18 -37.97 78.45 Favored 'General case' 0 C--O 1.233 0.189 0 O-C-N 121.253 -0.905 . . . . 64.109999999999999 110.2 -176.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.47 -39.7 85.3 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.461 1.105 . . . . 74.349999999999994 112.299 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.1 t -60.86 -49.17 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.283 1.433 . . . . 71.140000000000001 109.254 171.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -52.57 -42.49 64.52 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 119.546 1.066 . . . . 64.329999999999998 113.66 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -57.17 -13.31 2.92 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.614 1.339 . . . . 71.230000000000004 114.614 173.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -120.74 -4.2 9.73 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.585 1.954 . . . . 54.229999999999997 112.457 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.619 HD22 HG21 ' A' ' 54' ' ' THR . 14.6 mt -70.8 144.24 90.49 Favored Pre-proline 0 C--O 1.239 0.538 0 CA-C-N 119.947 1.249 . . . . 72.319999999999993 109.791 -171.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -84.38 161.27 12.99 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 123.74 2.96 . . . . 73.340000000000003 109.825 169.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.75 40.85 0.82 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.262 1.208 . . . . 74.040000000000006 114.262 -165.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.93 -37.64 0.65 Allowed Glycine 0 CA--C 1.524 0.633 0 O-C-N 121.052 -1.03 . . . . 24.02 111.419 167.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.829 HG23 HG21 ' A' ' 22' ' ' VAL . 58.2 m -44.79 -59.09 2.69 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.404 2.282 . . . . 32.210000000000001 114.534 -163.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.2 tptt 57.87 126.72 0.01 OUTLIER 'General case' 0 C--N 1.344 0.351 0 C-N-CA 126.547 1.939 . . . . 60.130000000000003 111.469 -168.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -75.82 128.67 35.63 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.713 -0.847 . . . . 72.120000000000005 108.713 175.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.41 -177.35 3.11 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 124.171 0.988 . . . . 75.420000000000002 110.104 173.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.7 104.8 0.59 Allowed 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 106.008 -1.849 . . . . 63.229999999999997 106.008 166.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.439 ' CD2' ' HG3' ' A' ' 137' ' ' GLN . 9.5 m-30 -85.69 170.86 12.1 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.956 -1.127 . . . . 74.049999999999997 107.956 161.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.558 ' NE2' HG22 ' A' ' 72' ' ' THR . 2.1 p-80 -108.76 171.48 7.4 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.239 1.416 . . . . 72.010000000000005 108.1 176.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 60' ' ' HIS . 2.2 m -148.29 157.73 8.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 119.832 1.196 . . . . 61.329999999999998 108.99 162.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.6 -8.98 14.19 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 129.345 3.058 . . . . 72.310000000000002 111.897 -166.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -60.92 1.09 0.16 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.792 1.637 . . . . 55.509999999999998 113.528 173.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 35.6 mt -129.4 119.36 23.71 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 119.879 -1.763 . . . . 75.150000000000006 108.282 -170.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.401 ' HA3' ' CE2' ' A' ' 29' ' ' TYR . . . 76.85 166.89 25.81 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 125.508 1.528 . . . . 61.340000000000003 112.816 175.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.58 -40.42 5.62 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.754 2.303 . . . . 75.430000000000007 111.132 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 58.7 mt -72.54 16.23 0.15 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.907 0.883 . . . . 52.149999999999999 112.012 174.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -45.31 -64.33 2.32 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.369 1.461 . . . . 72.239999999999995 110.999 172.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -59.74 -33.41 71.62 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.385 1.092 . . . . 62.020000000000003 112.472 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.58 -44.53 86.38 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.873 0.869 . . . . 75.019999999999996 109.779 176.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.722 HD11 ' CD1' ' A' ' 28' ' ' PHE . 16.2 mt -58.32 -46.06 86.89 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.668 1.187 . . . . 73.319999999999993 111.476 -176.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.558 HG22 ' NE2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -46.08 -46.36 16.81 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.346 1.858 . . . . 64.329999999999998 109.477 174.542 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -76.5 -50.98 12.63 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 118.412 -0.804 . . . . 75.319999999999993 110.715 -172.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.69 -35.05 75.32 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.705 1.593 . . . . 71.040000000000006 112.662 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 28.8 t-105 -59.3 -36.9 76.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.002 0.365 . . . . 73.319999999999993 111.147 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.31 -29.0 69.12 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 112.708 0.633 . . . . 54.530000000000001 112.708 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.2 t -57.23 -52.62 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 120.244 1.384 . . . . 51.530000000000001 109.495 162.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.89 -56.94 15.44 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 118.216 -0.897 . . . . 72.319999999999993 110.753 -174.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.4 mt -52.61 -41.27 36.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.497 1.119 . . . . 71.420000000000002 110.489 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.87 -33.75 76.55 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 120.017 -0.673 . . . . 74.409999999999997 110.933 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.9 mt -86.41 -23.9 25.92 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.253 0.464 . . . . 72.310000000000002 112.253 175.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.1 69.72 1.34 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.946 1.736 . . . . 75.209999999999994 110.116 -171.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.7 m -133.52 8.3 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.464 1.105 . . . . 60.32 112.563 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -53.56 -51.84 61.65 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 125.069 1.348 . . . . 75.439999999999998 112.055 -169.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -55.31 -45.29 76.3 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.037 0.935 . . . . 71.329999999999998 109.257 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.402 ' H ' ' HG3' ' A' ' 86' ' ' LYS . 17.5 mtpt -66.17 -21.83 66.34 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.825 1.65 . . . . 60.119999999999997 111.44 -176.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.5 pp -121.6 26.77 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.579 1.551 . . . . 73.030000000000001 110.014 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 96.6 m -95.2 -48.76 5.79 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.131 0.878 . . . . 61.43 108.963 166.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.486 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -61.35 -62.31 6.18 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 119.267 0.94 . . . . 42.350000000000001 112.211 -175.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.486 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 56.6 Cg_endo -67.32 -23.69 44.34 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 121.633 1.556 . . . . 74.25 111.624 -174.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 32.8 tpp -64.16 -52.63 58.09 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.539 1.136 . . . . 75.319999999999993 109.101 174.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -69.43 -32.7 71.82 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 124.163 0.914 . . . . 65.120000000000005 110.469 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -63.2 -33.21 74.99 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 118.272 0.487 . . . . 72.010000000000005 110.39 171.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.47 -12.89 33.33 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.87 1.214 . . . . 64.340000000000003 113.403 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.667 HG21 ' CD2' ' A' ' 28' ' ' PHE . 41.4 t -100.08 -39.59 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 C-N-CA 124.184 0.994 . . . . 74.430000000000007 109.746 -178.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -111.53 -53.58 2.69 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.72 0.808 . . . . 63.439999999999998 110.044 -171.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -67.77 -60.16 2.74 Favored 'General case' 0 C--N 1.339 0.142 0 O-C-N 121.453 -0.779 . . . . 73.109999999999999 109.909 -173.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.4 p -90.56 -25.71 20.08 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.547 0.573 . . . . 71.129999999999995 112.547 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 49.44 61.46 3.13 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 128.521 2.728 . . . . 73.430000000000007 112.393 -174.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.3 t -101.7 -14.52 17.33 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.762 1.225 . . . . 72.019999999999996 113.171 174.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.499 HG13 HG12 ' A' ' 107' ' ' ILE . 25.6 t -69.96 123.46 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 119.875 1.216 . . . . 51.310000000000002 108.834 171.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -144.35 -26.61 0.52 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.42 1.088 . . . . 53.439999999999998 111.714 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.82 167.32 21.98 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.308 0.958 . . . . 74.019999999999996 108.747 174.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 43.8 t -56.2 -40.28 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 123.709 0.804 . . . . 60.119999999999997 110.68 -175.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.26 -24.99 61.22 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.674 0.79 . . . . 75.329999999999998 112.617 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -79.83 -34.09 39.73 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.16 0.891 . . . . 74.140000000000001 110.807 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.499 HG12 HG13 ' A' ' 101' ' ' VAL . 1.8 mt -75.01 -48.23 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 108.716 -0.846 . . . . 61.32 108.716 -176.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -17.14 63.75 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.289 -0.862 . . . . 72.319999999999993 111.428 -176.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -58.87 -58.12 10.03 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.61 0.764 . . . . 73.120000000000005 110.012 168.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.3 t -57.24 -38.81 63.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 123.445 0.698 . . . . 74.25 111.565 -174.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -54.51 -53.03 59.84 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.839 -0.538 . . . . 75.450000000000003 109.765 173.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 97.5 t -60.62 -46.05 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 123.717 0.807 . . . . 72.439999999999998 110.186 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -55.39 -45.67 76.59 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.832 1.253 . . . . 64.030000000000001 109.425 -176.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.91 -15.05 60.25 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.703 1.201 . . . . 72.140000000000001 113.102 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 114.18 51.5 0.47 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.487 1.042 . . . . 65.319999999999993 113.213 172.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.8 t -111.6 142.78 22.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 124.374 1.07 . . . . 73.409999999999997 108.513 168.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.7 mmtm -61.57 148.67 41.51 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.831 0.824 . . . . 72.439999999999998 110.804 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.0 -18.17 74.29 Favored Glycine 0 CA--C 1.518 0.235 0 CA-C-N 114.985 -1.007 . . . . 61.310000000000002 113.15 167.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -87.57 -36.04 17.78 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 109.326 -0.62 . . . . 63.439999999999998 109.326 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.72 -43.3 72.64 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 106.25 -1.759 . . . . 63.039999999999999 106.25 -169.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -63.18 -52.93 60.39 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 123.693 0.621 . . . . 73.030000000000001 110.202 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -71.7 -17.05 62.25 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.963 0.505 . . . . 73.030000000000001 112.297 -174.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -87.15 -63.96 1.22 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.61 1.164 . . . . 51.509999999999998 109.597 172.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.32 -34.56 66.65 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.196 0.998 . . . . 73.430000000000007 111.463 -170.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -49.47 -33.53 14.54 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.862 0.865 . . . . 73.319999999999993 112.658 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -111.27 6.51 20.6 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.584 1.553 . . . . 75.25 112.848 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 43.3 t -82.73 157.21 23.37 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.283 1.433 . . . . 72.430000000000007 111.048 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -62.21 -34.53 76.65 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.373 1.469 . . . . 74.140000000000001 111.469 172.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 72.2 t -50.41 -50.98 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 108.843 -0.799 . . . . 73.310000000000002 108.843 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 22.1 t -65.91 -44.31 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 124.369 1.067 . . . . 64.219999999999999 111.723 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.538 ' HA ' ' HE2' ' A' ' 131' ' ' LYS . 10.8 mmpt? -51.55 -52.69 45.02 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.041 0.837 . . . . 75.140000000000001 110.921 176.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.6 -34.48 77.98 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.359 1.064 . . . . 63.240000000000002 110.955 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.0 mt -63.21 -54.99 28.81 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 117.141 -1.409 . . . . 63.420000000000002 110.848 175.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 87.4 t -54.07 -39.11 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 119.819 1.191 . . . . 61.229999999999997 109.601 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.68 -22.81 66.76 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 118.188 -0.91 . . . . 73.450000000000003 113.067 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -58.1 -53.1 62.02 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 119.638 1.108 . . . . 71.439999999999998 109.35 172.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.439 ' HG3' ' CD2' ' A' ' 59' ' ' TYR . 20.9 mp0 -78.88 -30.43 45.0 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.229 -0.919 . . . . 73.25 110.113 -175.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -68.87 11.67 0.18 Allowed 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.143 -1.598 . . . . 73.439999999999998 112.81 163.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -125.24 -19.93 4.98 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 124.775 1.23 . . . . 73.150000000000006 111.925 162.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -115.07 -10.41 12.22 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 114.557 1.317 . . . . 75.010000000000005 114.557 -172.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -96.66 -38.79 9.79 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.524 1.057 . . . . 74.310000000000002 108.343 157.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.9 -28.05 69.78 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.908 1.077 . . . . 63.43 113.908 -170.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -80.71 26.87 0.39 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.656 0.984 . . . . 63.219999999999999 113.656 -169.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.5 mt 65.16 28.3 12.2 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.815 -1.178 . . . . 62.219999999999999 111.504 165.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -104.68 -20.9 13.49 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.451 1.501 . . . . 74.019999999999996 112.216 -171.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.44 HD11 ' CB ' ' A' ' 151' ' ' ALA . 1.3 tt -168.15 137.03 2.4 Favored 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 128.738 2.815 . . . . 64.319999999999993 106.864 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -140.94 5.83 1.96 Allowed 'General case' 0 CA--C 1.546 0.802 0 O-C-N 124.017 0.823 . . . . 53.32 111.121 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -143.55 152.22 23.94 Favored Glycine 0 C--N 1.343 0.966 0 CA-C-N 119.624 1.102 . . . . 72.349999999999994 110.903 172.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.524 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 35.7 m -132.83 174.84 4.24 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 125.818 1.647 . . . . 75.019999999999996 110.717 -170.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.524 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 15.8 Cg_endo -61.98 152.04 61.76 Favored 'Cis proline' 0 C--N 1.352 0.746 0 CA-C-N 121.475 1.562 . . . . 73.049999999999997 112.165 -10.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.44 ' CB ' HD11 ' A' ' 146' ' ' LEU . . . -152.65 152.66 32.02 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.587 0.554 . . . . 63.140000000000001 111.111 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 77.1 mmm -151.78 121.51 6.99 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.673 1.189 . . . . 64.340000000000003 107.813 -167.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 12.0 m-30 -100.02 152.8 19.79 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.005 0.922 . . . . 54.409999999999997 110.361 -172.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.4 t -139.87 151.76 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.566 0.746 . . . . 72.25 110.202 174.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 44.88 24.12 0.1 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 129.273 3.029 . . . . 52.520000000000003 114.494 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 53.03 24.67 21.5 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.194 -0.941 . . . . 74.409999999999997 112.996 -173.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.584 ' HE2' ' CE2' ' A' ' 158' ' ' TYR . 9.3 pttt -150.24 -3.55 0.36 Allowed 'General case' 0 C--N 1.344 0.335 0 N-CA-C 114.527 1.306 . . . . 74.120000000000005 114.527 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.584 ' CE2' ' HE2' ' A' ' 157' ' ' LYS . 49.8 m-85 -126.59 159.93 32.1 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 124.73 1.212 . . . . 64.420000000000002 110.953 -176.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -126.22 149.2 49.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.654 1.982 . . . . 43.219999999999999 107.044 170.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.568 HD11 HG23 ' A' ' 180' ' ' THR . 2.2 mm? -74.47 154.26 38.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.995 -0.742 . . . . 63.039999999999999 108.995 167.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -125.18 80.61 64.41 Favored Pre-proline 0 C--O 1.232 0.18 0 C-N-CA 123.353 0.661 . . . . 63.439999999999998 110.808 177.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.36 -4.84 10.09 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 121.986 1.791 . . . . 72.040000000000006 113.212 175.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -86.82 -2.66 58.74 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.16 1.384 . . . . 71.430000000000007 113.127 173.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -132.47 46.16 1.08 Allowed Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 109.584 -1.406 . . . . 63.149999999999999 109.584 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 36.6 mtt -130.97 174.97 9.47 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 118.172 0.986 . . . . 72.319999999999993 111.851 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.32 90.35 4.97 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.945 -1.131 . . . . 73.129999999999995 107.945 174.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.344 6.4 t -118.53 48.13 1.5 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.78 1.232 . . . . 73.120000000000005 107.965 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.6 m -84.16 -47.79 10.49 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.074 -0.966 . . . . 74.109999999999999 110.338 159.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.05 -9.9 13.52 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 117.962 -1.018 . . . . 70.239999999999995 113.065 -162.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 33.6 mmm 75.47 -53.94 0.64 Allowed 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 126.451 1.901 . . . . 72.319999999999993 112.705 170.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.22 -31.35 72.48 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.656 1.116 . . . . 72.150000000000006 109.512 176.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 89.0 t -80.68 -25.04 11.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.65 1.58 . . . . 64.040000000000006 111.8 175.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -63.54 -58.06 8.2 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.014 -1.476 . . . . 73.049999999999997 107.014 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 14.3 t -61.83 -38.88 81.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 122.999 0.52 . . . . 73.019999999999996 110.195 -174.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.71 -46.06 70.65 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.437 1.095 . . . . 51.32 110.754 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -83.75 -31.29 26.06 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.165 0.986 . . . . 65.150000000000006 112.493 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -54.61 -54.8 36.67 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.227 -0.921 . . . . 64.239999999999995 109.242 175.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.96 -27.63 66.97 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.084 0.772 . . . . 62.109999999999999 113.084 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.2 -54.85 14.93 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.632 1.173 . . . . 64.239999999999995 110.614 177.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.568 HG23 HD11 ' A' ' 160' ' ' LEU . 13.6 t -62.21 -30.91 71.41 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 118.553 -0.737 . . . . 73.25 110.615 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 94.8 t -59.66 -51.81 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.519 -0.919 . . . . 54.240000000000002 108.519 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -62.0 -47.63 83.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.181 0.593 . . . . 75.25 109.8 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -58.29 -37.23 74.62 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 118.638 0.654 . . . . 75.439999999999998 111.932 -172.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 72.0 mt -65.51 -28.72 69.39 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.45 -0.781 . . . . 72.319999999999993 112.192 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.21 -22.55 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.403 0.681 . . . . 72.230000000000004 111.646 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -98.87 -16.47 18.82 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.652 0.66 . . . . 75.129999999999995 110.509 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -93.15 13.66 20.36 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.708 1.373 . . . . 75.409999999999997 114.708 -170.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 35.1 mttt . . . . . 0 C--O 1.246 0.898 0 C-N-CA 127.933 2.493 . . . . 64.310000000000002 113.886 -175.611 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.573 0 N-CA-C 112.195 0.442 . . . . 64.409999999999997 112.195 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -156.24 118.22 3.98 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.902 -1.148 . . . . 62.210000000000001 107.902 164.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.4 pt -115.63 164.62 11.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 126.217 1.807 . . . . 71.549999999999997 108.604 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.2 m -137.55 139.41 40.44 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.079 -1.823 . . . . 63.329999999999998 106.079 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -55.08 138.66 43.71 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.149 1.78 . . . . 72.340000000000003 109.739 167.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.45 -25.71 3.23 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.445 1.498 . . . . 41.340000000000003 113.41 -171.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -91.8 -77.35 0.43 Allowed 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 119.211 1.506 . . . . 65.420000000000002 107.227 -165.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -97.4 -15.38 20.7 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.543 0.737 . . . . 54.25 111.166 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -142.95 160.69 39.86 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.34 0.656 . . . . 75.319999999999993 110.246 173.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.3 mm -123.8 157.2 30.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 106.818 -1.549 . . . . 65.430000000000007 106.818 172.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.9 m -101.79 152.9 20.33 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.199 1.4 . . . . 75.519999999999996 107.633 174.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.3 mt -91.27 148.83 22.07 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 106.705 -1.591 . . . . 73.549999999999997 106.705 169.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -72.58 -34.43 67.45 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.128 1.371 . . . . 71.129999999999995 109.765 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.9 mmtm -125.68 82.31 63.91 Favored Pre-proline 0 C--O 1.232 0.136 0 C-N-CA 126.7 2.0 . . . . 73.120000000000005 108.166 175.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 N--CA 1.451 -1.017 0 C-N-CA 123.645 2.897 . . . . 71.519999999999996 107.844 168.975 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.469 0.498 0 CA-C-O 119.279 -0.391 . . . . 65.430000000000007 110.008 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.416 HD21 ' CD2' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -172.14 164.53 6.06 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.274 1.03 . . . . 64.430000000000007 110.536 -167.454 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -123.46 158.94 30.09 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.903 1.281 . . . . 54.130000000000003 109.435 173.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -142.04 134.18 27.59 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.731 1.613 . . . . 73.519999999999996 113.221 174.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -139.69 177.77 7.71 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.352 1.461 . . . . 52.509999999999998 111.125 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.9 t -136.61 162.33 33.42 Favored 'General case' 0 CA--C 1.527 0.09 0 N-CA-C 109.457 -0.571 . . . . 62.43 109.457 157.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.784 ' CD1' HD11 ' A' ' 71' ' ' LEU 0.257 0.0 OUTLIER -71.59 -20.14 62.04 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.502 -0.749 . . . . 63.119999999999997 112.834 171.232 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -89.03 -9.21 52.12 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 117.724 -1.131 . . . . 75.409999999999997 112.725 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.7 p -84.63 142.27 39.63 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 121.416 1.916 . . . . 40.219999999999999 110.284 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -91.72 -31.23 0.1 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 121.384 1.389 . . . . 75.109999999999999 112.395 -170.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -58.54 -44.02 89.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.143 -0.688 . . . . 74.409999999999997 109.143 169.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 25.7 m -55.62 -39.95 71.49 Favored 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 123.979 0.912 . . . . 74.519999999999996 110.742 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -52.47 -60.83 2.76 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 119.523 1.056 . . . . 64.239999999999995 109.813 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -54.54 -41.8 70.16 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 119.026 -0.511 . . . . 62.329999999999998 109.755 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -68.89 -24.41 64.31 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 118.347 -0.835 . . . . 71.519999999999996 112.526 -174.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -116.24 -3.82 11.95 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.689 0.677 . . . . 72.310000000000002 111.635 -167.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -138.38 -35.07 0.61 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.879 1.672 . . . . 60.119999999999997 114.016 -168.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 86.8 t -111.05 -78.79 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 N-CA-C 105.458 -2.053 . . . . 75.519999999999996 105.458 -172.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.6 mt -57.4 -29.15 63.87 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.48 1.912 . . . . 75.120000000000005 111.159 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 44.1 54.89 5.72 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.005 1.722 . . . . 72.430000000000007 110.23 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.543 ' O ' HG23 ' A' ' 46' ' ' VAL . 97.4 t -53.38 -51.47 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 126.099 1.76 . . . . 43.240000000000002 107.898 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.9 t -44.09 -53.2 6.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.669 1.987 . . . . 54.119999999999997 111.404 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -76.64 -30.29 56.78 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.462 0.649 . . . . 74.519999999999996 111.332 -173.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -72.86 -37.39 67.39 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.318 -0.864 . . . . 60.229999999999997 111.78 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 42' ' ' VAL . 1.9 t -60.68 -49.97 82.33 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 N-CA-C 107.93 -1.137 . . . . 72.450000000000003 107.93 173.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -47.62 -45.49 27.72 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 124.588 1.155 . . . . 73.239999999999995 112.335 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -63.6 -5.14 3.53 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 115.468 1.655 . . . . 75.310000000000002 115.468 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -123.4 -10.26 7.98 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.351 2.26 . . . . 60.43 113.03 174.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.453 HD13 HG21 ' A' ' 54' ' ' THR . 13.6 mt -73.17 145.39 85.81 Favored Pre-proline 0 C--O 1.238 0.478 0 CA-C-N 120.109 1.322 . . . . 44.530000000000001 112.306 -163.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.76 160.49 31.04 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 124.49 3.46 . . . . 63.130000000000003 112.348 175.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -76.97 45.44 0.43 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.541 1.936 . . . . 62.130000000000003 112.451 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -155.54 -6.59 0.08 OUTLIER Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.329 1.443 . . . . 73.310000000000002 113.523 175.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.453 HG21 HD13 ' A' ' 50' ' ' LEU . 14.2 t -56.4 -43.63 79.49 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.496 1.648 . . . . 74.150000000000006 112.092 174.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.8 tptt 44.66 90.94 0.01 OUTLIER 'General case' 0 C--N 1.346 0.417 0 C-N-CA 126.305 1.842 . . . . 73.219999999999999 110.196 -165.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.33 105.57 0.3 Allowed 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 127.342 2.257 . . . . 73.209999999999994 108.945 -175.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.0 m -143.36 115.3 8.29 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 107.138 -1.43 . . . . 72.129999999999995 107.138 -172.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.72 137.55 54.34 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.857 1.263 . . . . 61.109999999999999 108.459 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.462 ' CG ' ' HG2' ' A' ' 137' ' ' GLN . 17.1 m-30 -104.86 -174.94 2.65 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.936 1.694 . . . . 73.430000000000007 108.744 173.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -139.99 133.34 29.92 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.073 1.349 . . . . 63.329999999999998 107.644 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.3 m -85.99 170.77 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 119.096 0.862 . . . . 74.510000000000005 112.254 -172.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.11 0.77 9.11 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.888 2.075 . . . . 73.120000000000005 112.558 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -71.32 -34.26 70.4 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.253 1.021 . . . . 52.119999999999997 112.638 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 mt -91.91 126.44 36.99 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.372 -0.973 . . . . 73.540000000000006 108.372 -171.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.25 167.52 33.85 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 115.336 -0.847 . . . . 61.329999999999998 112.829 168.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -66.66 -48.19 2.33 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 124.424 3.416 . . . . 65.319999999999993 109.604 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.5 mt -73.22 13.62 0.41 Allowed 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 127.2 2.2 . . . . 73.519999999999996 112.514 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -50.48 -46.99 45.44 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 119.823 1.192 . . . . 55.030000000000001 111.697 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.1 tptp -71.42 -36.52 71.33 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.401 1.101 . . . . 75.310000000000002 111.414 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -63.83 -33.41 75.61 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.58 0.627 . . . . 72.120000000000005 110.189 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.784 HD11 ' CD1' ' A' ' 28' ' ' PHE . 15.1 mt -62.13 -49.66 74.99 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 118.416 -0.802 . . . . 51.140000000000001 113.038 175.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.5 m -57.2 -45.29 83.9 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.795 -1.187 . . . . 33.310000000000002 107.795 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -57.36 -47.3 82.0 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.189 0.904 . . . . 65.219999999999999 110.527 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.09 -41.11 82.77 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.949 1.249 . . . . 75.340000000000003 112.862 176.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 35.6 t-105 -57.93 -38.89 76.76 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.654 0.782 . . . . 74.239999999999995 110.681 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.69 -40.78 80.23 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 117.504 -1.236 . . . . 52.329999999999998 113.487 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.0 -43.47 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 120.532 1.514 . . . . 75.109999999999999 108.783 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.12 -43.31 87.54 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 118.255 -0.878 . . . . 72.519999999999996 111.545 -175.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 59.2 mt -63.02 -46.34 96.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.03 0.932 . . . . 71.219999999999999 109.634 172.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.21 -24.4 63.1 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.691 0.678 . . . . 71.129999999999995 111.477 -174.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.1 mt -107.17 -16.65 14.36 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 113.916 1.08 . . . . 53.439999999999998 113.916 176.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.56 69.96 1.16 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.285 0.945 . . . . 32.310000000000002 110.792 -166.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.4 m -135.61 13.5 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.753 1.221 . . . . 62.530000000000001 112.285 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -50.06 -50.78 46.75 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 125.563 1.545 . . . . 73.209999999999994 111.77 -173.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.78 -37.93 89.26 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.319 0.647 . . . . 64.230000000000004 110.221 -178.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -65.23 -43.68 90.68 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.17 0.509 . . . . 64.219999999999999 110.0 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.8 pp -92.44 17.33 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 C-N-CA 124.803 1.241 . . . . 62.350000000000001 111.633 -175.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 38.9 m -88.36 -48.12 7.88 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.032 0.833 . . . . 74.409999999999997 110.019 169.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.509 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -56.79 -60.85 8.18 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 113.907 1.077 . . . . 60.119999999999997 113.907 -169.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 30.2 Cg_endo -68.43 -25.74 35.32 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.299 1.332 . . . . 73.109999999999999 111.643 -178.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 20.2 tpp -65.25 -50.63 65.05 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 124.89 1.276 . . . . 72.540000000000006 110.826 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -69.64 -30.57 68.31 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.852 -0.796 . . . . 71.319999999999993 108.852 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -57.8 -46.97 83.87 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 118.648 0.658 . . . . 75.329999999999998 110.332 167.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.41 2.81 23.54 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 120.538 -1.351 . . . . 65.120000000000005 113.014 -174.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.739 HG21 ' CD2' ' A' ' 28' ' ' PHE . 38.8 t -123.59 -39.44 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 125.026 1.331 . . . . 62.32 110.826 -173.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -107.75 -47.59 3.57 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.12 -0.696 . . . . 71.25 109.12 -175.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -77.3 -52.42 9.21 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.24 0.616 . . . . 71.120000000000005 110.703 -171.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.5 p -103.86 -24.59 13.27 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.536 1.134 . . . . 53.409999999999997 112.18 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 57.31 26.12 12.0 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.58 2.352 . . . . 64.239999999999995 114.552 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.3 t -68.36 -20.58 64.72 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.937 0.718 . . . . 51.329999999999998 112.937 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.427 HG11 ' CZ ' ' A' ' 28' ' ' PHE . 25.1 t -67.43 123.71 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 O-C-N 120.87 -1.144 . . . . 54.509999999999998 109.444 173.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -145.84 -25.06 0.46 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.712 1.605 . . . . 75.510000000000005 111.326 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.17 164.93 26.56 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.793 -0.817 . . . . 74.450000000000003 108.793 176.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 25.3 t -55.07 -40.89 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.227 1.011 . . . . 73.25 109.432 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.16 8.48 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.539 1.935 . . . . 63.43 114.885 173.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -113.69 -46.9 3.01 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 125.045 1.338 . . . . 61.530000000000001 109.117 168.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.3 mt -59.01 -37.56 68.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 123.55 0.74 . . . . 64.420000000000002 110.356 -177.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.0 -19.59 64.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 117.54 -1.219 . . . . 72.540000000000006 112.845 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -57.6 -58.37 8.62 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 119.703 1.138 . . . . 74.310000000000002 110.024 164.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 55.2 t -57.13 -37.31 54.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 122.564 0.345 . . . . 60.310000000000002 111.732 -167.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -50.98 -56.81 10.61 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.417 -0.586 . . . . 65.25 109.417 171.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 39.8 t -64.57 -38.06 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 123.952 0.901 . . . . 74.120000000000005 110.699 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.66 -42.96 98.09 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.499 0.719 . . . . 73.209999999999994 109.511 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.48 2.89 12.49 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.353 1.461 . . . . 43.329999999999998 112.478 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.58 61.95 1.66 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 125.06 1.314 . . . . 53.049999999999997 111.468 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 77.7 t -119.57 145.43 25.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 123.273 0.629 . . . . 54.409999999999997 109.935 169.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -62.02 118.61 7.52 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.671 1.189 . . . . 74.25 108.661 169.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.61 -28.71 70.24 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-O 118.3 -1.278 . . . . 73.329999999999998 111.677 166.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -73.05 -25.64 61.0 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 118.93 1.365 . . . . 52.450000000000003 109.59 -177.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.03 -39.55 29.66 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.075 0.95 . . . . 73.310000000000002 109.393 176.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -64.5 -59.61 4.12 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.266 -1.383 . . . . 74.329999999999998 107.266 -177.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -60.68 -28.54 68.69 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.661 1.184 . . . . 42.350000000000001 110.302 -175.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -80.56 -64.43 1.19 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.473 -0.565 . . . . 73.450000000000003 109.473 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.91 -40.05 69.45 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 117.494 -1.241 . . . . 74.519999999999996 110.325 -172.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 46.0 t-105 -47.54 -37.6 12.47 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 124.503 1.121 . . . . 75.230000000000004 112.76 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -105.16 -5.03 21.1 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.579 1.152 . . . . 73.329999999999998 111.219 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 10.9 t -88.59 149.69 23.44 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.29 1.836 . . . . 55.030000000000001 109.753 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -50.24 -34.02 21.59 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.138 1.775 . . . . 73.150000000000006 111.622 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 76.7 t -45.49 -59.64 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 125.838 1.655 . . . . 44.219999999999999 109.461 176.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 134' ' ' VAL . 18.3 t -64.69 -46.04 93.46 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.682 0 CA-C-O 117.788 -1.101 . . . . 62.32 109.164 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -50.27 -50.33 50.64 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 120.247 1.385 . . . . 73.439999999999998 110.719 -177.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.4 t -69.73 -35.62 75.17 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 118.184 -0.912 . . . . 55.130000000000003 109.94 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.497 ' HA ' ' HG2' ' A' ' 136' ' ' GLN . 66.0 mt -64.51 -37.23 86.83 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 119.453 1.024 . . . . 73.239999999999995 112.225 177.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 130' ' ' VAL . 42.7 t -56.06 -49.18 77.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 N-CA-C 107.908 -1.145 . . . . 63.25 107.908 173.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.92 -49.89 70.18 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.308 0.503 . . . . 42.530000000000001 111.641 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.497 ' HG2' ' HA ' ' A' ' 133' ' ' LEU . 1.4 pt20 -58.76 -34.32 71.28 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 123.498 0.499 . . . . 75.239999999999995 111.82 -173.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.462 ' HG2' ' CG ' ' A' ' 59' ' ' TYR . 23.6 mt-30 -89.9 -48.12 7.43 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 126.391 1.877 . . . . 45.340000000000003 111.129 -173.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -62.66 -46.36 88.56 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.2 1.0 . . . . 74.430000000000007 109.159 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -58.72 -46.18 87.94 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.796 -0.816 . . . . 74.150000000000006 108.796 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.63 -9.06 16.88 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.586 0.958 . . . . 51.32 113.586 -174.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.67 5.44 10.55 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 120.755 1.616 . . . . 73.510000000000005 112.942 174.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.5 -3.41 5.45 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.01 0.924 . . . . 75.230000000000004 112.489 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -56.05 -85.68 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.922 2.489 . . . . 72.340000000000003 109.978 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.1 pp 179.18 41.49 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.062 1.745 . . . . 75.310000000000002 110.873 176.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -133.56 -45.27 0.82 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.254 1.205 . . . . 72.530000000000001 114.254 -172.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 16.1 tp -85.11 -85.3 0.14 Allowed 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 125.347 1.459 . . . . 72.530000000000001 109.746 -166.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 56.72 33.51 23.03 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.202 0.601 . . . . 73.329999999999998 111.628 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 178.31 155.81 15.27 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.856 1.693 . . . . 60.549999999999997 110.965 174.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 16.2 m -149.06 161.78 31.24 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 124.693 1.197 . . . . 74.209999999999994 108.931 175.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -65.14 141.12 46.56 Favored 'Cis proline' 0 C--N 1.35 0.626 0 CA-C-N 120.227 1.117 . . . . 64.230000000000004 112.504 -8.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -131.2 142.8 50.24 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.764 -1.107 . . . . 65.319999999999993 109.625 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 50.8 mtp -148.23 113.99 5.72 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 102.469 -3.16 . . . . 74.540000000000006 102.469 -176.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -100.95 165.66 11.22 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.4 0.68 . . . . 52.409999999999997 109.387 -175.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.6 t -138.07 133.44 44.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.667 0.746 . . . . 71.420000000000002 110.668 172.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 44.9 30.84 0.6 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 130.754 3.621 . . . . 60.340000000000003 115.417 171.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 64.59 34.41 89.82 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 124.823 1.202 . . . . 54.119999999999997 111.395 177.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.444 ' HG3' ' CE2' ' A' ' 158' ' ' TYR . 9.7 ptmt -160.52 -10.4 0.05 OUTLIER 'General case' 0 C--N 1.345 0.389 0 N-CA-C 116.742 2.126 . . . . 74.420000000000002 116.742 177.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.444 ' CE2' ' HG3' ' A' ' 157' ' ' LYS . 60.2 m-85 -128.89 160.88 31.24 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 120.376 1.444 . . . . 73.430000000000007 110.598 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -136.01 131.77 35.42 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 105.694 -1.965 . . . . 43.219999999999999 105.694 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.57 145.89 55.52 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.718 -1.216 . . . . 52.409999999999997 107.718 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -115.13 85.58 12.66 Favored Pre-proline 0 CA--C 1.522 -0.134 0 N-CA-C 113.034 0.753 . . . . 51.140000000000001 113.034 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -61.92 -24.19 76.74 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 CA-C-N 119.659 0.914 . . . . 72.349999999999994 112.059 173.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.28 2.58 27.44 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.139 1.376 . . . . 72.140000000000001 112.398 -170.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -130.24 22.02 4.8 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.229 1.395 . . . . 74.129999999999995 110.423 175.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 63.3 mtt -106.42 169.82 8.29 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 117.932 0.866 . . . . 73.409999999999997 110.335 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.2 63.82 7.39 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 124.626 2.155 . . . . 72.530000000000001 109.98 -174.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.6 p -73.65 32.51 0.08 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 129.376 3.07 . . . . 65.209999999999994 111.393 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.8 m -117.04 -3.02 11.61 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.031 1.732 . . . . 73.219999999999999 112.053 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.43 -9.67 2.87 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-O 117.678 -1.153 . . . . 53.109999999999999 111.744 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 13.2 mmt 65.49 -52.53 0.36 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 127.671 2.388 . . . . 61.530000000000001 115.282 172.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.38 -44.35 62.67 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.153 -1.425 . . . . 63.140000000000001 107.153 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 97.1 t -59.05 -39.14 77.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 124.02 0.928 . . . . 60.420000000000002 110.423 174.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -56.44 -59.78 4.48 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.838 -0.601 . . . . 73.25 109.736 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 20.2 t -66.54 -38.18 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 118.793 0.724 . . . . 72.349999999999994 110.807 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.46 -40.22 62.01 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.104 0.562 . . . . 75.530000000000001 110.903 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -86.37 -35.96 19.48 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 117.95 -1.024 . . . . 53.149999999999999 112.548 174.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -52.01 -60.85 2.71 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 121.039 1.745 . . . . 74.349999999999994 110.233 176.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -53.8 -35.27 61.19 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.459 1.104 . . . . 33.439999999999998 111.803 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -71.73 -48.52 46.51 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.505 1.122 . . . . 74.140000000000001 111.376 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.9 t -62.08 -31.09 71.48 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 117.071 -1.442 . . . . 52.43 109.782 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 30.7 t -58.56 -58.42 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 120.105 1.32 . . . . 71.329999999999998 108.929 171.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.96 -11.85 61.2 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 114.135 1.161 . . . . 74.25 114.135 -172.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -87.75 -33.11 18.8 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 123.972 0.909 . . . . 73.140000000000001 112.625 166.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 28.7 mt -66.51 -30.78 71.18 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 119.816 -1.803 . . . . 31.23 111.408 -177.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 69.3 t -61.89 -23.46 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.377 0.671 . . . . 73.239999999999995 112.549 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -101.25 -14.05 17.83 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 120.983 -1.073 . . . . 73.150000000000006 110.47 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -104.8 70.76 0.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 105.237 -2.134 . . . . 64.230000000000004 105.237 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? . . . . . 0 CA--C 1.508 -0.672 0 N-CA-C 103.162 -2.903 . . . . 75.439999999999998 103.162 170.466 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.46 0 N-CA-C 115.703 1.742 . . . . 64.0 115.703 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -161.1 107.36 1.42 Allowed 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.693 1.597 . . . . 72.099999999999994 108.917 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.504 HD12 ' CE1' ' A' ' 9' ' ' TYR . 10.1 pt -111.68 170.87 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.604 1.562 . . . . 73.230000000000004 109.609 177.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.9 m -140.52 139.3 35.04 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 106.606 -1.627 . . . . 65.209999999999994 106.606 177.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -61.55 118.64 7.3 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.508 2.323 . . . . 72.019999999999996 109.102 172.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.01 -18.66 56.48 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.328 1.918 . . . . 71.420000000000002 112.404 -174.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -89.72 -84.8 0.22 Allowed 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.822 1.311 . . . . 63.020000000000003 108.725 -171.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -92.14 -10.91 37.12 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.449 1.1 . . . . 72.430000000000007 111.469 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.504 ' CE1' HD12 ' A' ' 3' ' ' ILE . 22.8 p90 -140.08 164.37 30.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.413 -0.803 . . . . 71.340000000000003 109.424 171.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.6 mm -125.12 161.22 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.383 1.473 . . . . 71.319999999999993 107.032 169.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -94.74 171.61 8.68 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.562 1.545 . . . . 54.420000000000002 108.737 174.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 50.5 mt -117.2 148.63 41.45 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.543 1.137 . . . . 63.229999999999997 109.902 162.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -75.21 -43.02 54.22 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.836 2.054 . . . . 70.239999999999995 109.062 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.4 mmtm -119.0 84.51 26.6 Favored Pre-proline 0 N--CA 1.454 -0.246 0 C-N-CA 126.76 2.024 . . . . 71.239999999999995 107.237 175.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo . . . . . 0 CA--C 1.538 0.7 0 C-N-CA 124.717 3.611 . . . . 74.129999999999995 113.424 174.826 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.31 3.5 p . . . . . 0 N--CA 1.467 0.409 0 CA-C-O 123.357 1.551 . . . . 45.409999999999997 111.533 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.0 tp -140.96 142.3 34.35 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 113.61 -1.632 . . . . 72.120000000000005 108.224 -169.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -125.65 167.83 14.56 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 126.357 1.863 . . . . 65.200000000000003 108.448 -175.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.867 ' CE1' HG13 ' A' ' 149' ' ' VAL . 1.4 t80 -164.69 128.27 2.43 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 113.882 -1.508 . . . . 62.020000000000003 110.13 -167.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.6 ' HA ' HG11 ' A' ' 149' ' ' VAL . 27.8 m-85 -149.82 160.34 43.64 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 129.396 3.079 . . . . 65.120000000000005 109.719 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 t -124.0 159.1 30.56 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.8 -0.815 . . . . 73.099999999999994 108.8 164.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -77.17 -23.05 51.62 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.363 -0.836 . . . . 74.230000000000004 111.255 176.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.462 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 49.8 m-85 -102.06 5.29 40.44 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.076 1.35 . . . . 72.25 114.225 -178.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 11.2 p -91.51 145.0 30.46 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 120.683 1.583 . . . . 50.219999999999999 112.646 -173.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.08 165.76 31.22 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.375 2.05 . . . . 74.439999999999998 109.191 172.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.0 m80 69.04 -48.28 0.58 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 127.057 2.143 . . . . 73.420000000000002 110.243 -169.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 39.2 m -50.63 -43.2 56.89 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.969 1.708 . . . . 73.0 111.845 -176.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -51.12 -58.05 7.12 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.624 0.77 . . . . 70.409999999999997 111.29 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -56.74 -45.3 82.05 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.193 -1.04 . . . . 62.399999999999999 108.193 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -62.55 -22.54 66.41 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 117.27 -1.348 . . . . 70.310000000000002 113.009 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -120.67 -0.45 10.22 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 121.259 1.845 . . . . 72.019999999999996 112.87 -169.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -142.71 -26.4 0.61 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.031 0.933 . . . . 74.230000000000004 112.909 -173.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 54.2 t -115.23 -69.81 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 108.035 -1.098 . . . . 74.200000000000003 108.035 -173.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.6 mt -66.07 -26.4 67.47 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.233 1.013 . . . . 73.030000000000001 110.622 173.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 44.35 53.21 6.96 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.725 1.61 . . . . 74.019999999999996 111.924 173.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 46' ' ' VAL . 77.2 t -58.13 -52.0 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 114.876 -1.057 . . . . 65.120000000000005 110.743 -166.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 p -58.5 -38.49 77.76 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 119.359 0.981 . . . . 65.420000000000002 111.681 -167.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -74.34 -36.95 63.67 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.215 0.606 . . . . 63.229999999999997 110.665 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -60.36 -45.04 94.9 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.841 -0.537 . . . . 44.299999999999997 110.182 169.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 42' ' ' VAL . 2.2 t -61.8 -50.39 80.4 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 CA-C-N 118.651 0.659 . . . . 73.209999999999994 109.32 175.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -51.11 -43.61 61.14 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 126.606 1.962 . . . . 75.030000000000001 111.201 -176.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -59.62 -20.05 53.29 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 114.156 1.169 . . . . 75.129999999999995 114.156 175.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -115.77 -6.52 12.11 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.35 1.46 . . . . 74.0 112.038 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.61 HD13 HG21 ' A' ' 54' ' ' THR . 11.2 mt -70.62 144.11 90.82 Favored Pre-proline 0 C--O 1.239 0.522 0 CA-C-N 119.385 0.993 . . . . 72.0 109.792 -168.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.25 152.46 30.82 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.155 2.57 . . . . 73.019999999999996 109.668 174.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.268 1.6 pt-20 -81.22 87.43 6.1 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 123.859 1.79 . . . . 73.239999999999995 109.715 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.37 -7.58 0.36 Allowed Glycine 0 C--O 1.221 -0.66 0 CA-C-N 114.792 -1.094 . . . . 61.420000000000002 111.606 -174.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.61 HG21 HD13 ' A' ' 50' ' ' LEU . 15.2 t -58.52 -59.66 5.02 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.515 1.657 . . . . 72.230000000000004 109.48 166.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.421 ' N ' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER 50.14 86.64 0.03 OUTLIER 'General case' 0 C--N 1.346 0.448 0 C-N-CA 126.175 1.79 . . . . 74.340000000000003 109.685 -169.611 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 13.7 ptp -64.18 173.28 2.02 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 112.248 -2.251 . . . . 61.420000000000002 111.039 175.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.525 HG22 ' H ' ' A' ' 58' ' ' LYS . 1.5 m -144.57 -170.33 3.36 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.118 1.767 . . . . 71.099999999999994 108.95 177.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.525 ' H ' HG22 ' A' ' 57' ' ' THR . 25.3 tttt -176.81 103.51 0.06 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.759 2.023 . . . . 71.109999999999999 108.77 -172.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -114.76 111.0 20.57 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 121.008 1.731 . . . . 70.319999999999993 108.982 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.526 ' HB2' ' CG ' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -80.7 150.39 29.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 118.813 -0.613 . . . . 73.019999999999996 110.494 176.423 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.731 HG21 ' CE2' ' A' ' 25' ' ' PHE . 19.1 m -132.99 152.45 36.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 124.508 1.123 . . . . 64.450000000000003 111.298 -171.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.18 10.59 40.67 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.987 1.315 . . . . 73.340000000000003 114.231 -171.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -62.68 -8.26 6.31 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.414 1.635 . . . . 74.25 115.414 -170.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.52 165.35 29.72 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 120.044 -1.66 . . . . 71.019999999999996 111.017 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.462 ' HA3' ' CD2' ' A' ' 29' ' ' TYR . . . 71.98 159.61 4.22 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.474 1.512 . . . . 74.120000000000005 112.373 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.1 -55.56 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.737 2.291 . . . . 61.229999999999997 109.79 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.4 mt -75.37 22.38 0.12 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.657 1.583 . . . . 65.450000000000003 112.968 -178.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -52.06 -56.84 14.76 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 124.865 1.221 . . . . 72.209999999999994 111.002 -176.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -62.04 -42.03 98.74 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 117.871 0.835 . . . . 65.340000000000003 109.776 -173.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -67.79 -38.84 83.87 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.992 1.717 . . . . 61.439999999999998 108.908 -174.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.7 mt -64.75 -40.58 95.53 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.469 1.108 . . . . 72.25 112.016 172.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.7 m -61.41 -41.38 97.05 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.732 0.696 . . . . 65.329999999999998 109.694 172.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.63 -39.91 95.54 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.459 1.027 . . . . 63.219999999999999 110.624 176.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.03 -36.26 81.05 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.586 0.754 . . . . 64.219999999999999 112.317 176.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.526 ' CG ' ' HB2' ' A' ' 60' ' ' HIS . 59.6 t-105 -59.58 -40.56 87.81 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.022 0.439 . . . . 70.019999999999996 111.658 -176.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.35 -29.89 71.12 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 118.745 -0.645 . . . . 70.430000000000007 112.388 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.3 t -59.91 -44.02 93.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 119.642 1.11 . . . . 72.349999999999994 109.312 169.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.1 84.92 Favored 'General case' 0 C--N 1.34 0.176 0 O-C-N 121.665 -0.647 . . . . 73.230000000000004 111.229 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 79.3 mt -71.49 -39.87 71.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 119.136 -0.459 . . . . 73.129999999999995 109.944 176.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.87 -34.63 71.83 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.079 0.854 . . . . 72.450000000000003 111.31 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.689 HD12 HG13 ' A' ' 116' ' ' VAL . 15.8 mt -102.49 -3.06 27.46 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.181 0.808 . . . . 74.319999999999993 113.181 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 58.45 57.22 21.01 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.426 1.489 . . . . 62.420000000000002 111.814 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.501 HG21 HG22 ' A' ' 116' ' ' VAL . 22.6 m -131.15 13.65 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 126.216 1.806 . . . . 74.049999999999997 111.719 -175.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -46.92 -48.24 21.38 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 126.604 1.961 . . . . 74.409999999999997 111.682 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -68.07 -28.68 67.57 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.048 1.339 . . . . 63.0 111.196 -174.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -82.3 -27.12 32.51 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.882 1.273 . . . . 71.019999999999996 110.69 -172.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.4 pp -112.07 -2.19 10.21 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-O 117.805 -1.093 . . . . 71.430000000000007 112.347 -171.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.4 m -64.82 -56.55 12.81 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 119.784 1.175 . . . . 64.239999999999995 109.346 176.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.529 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -55.8 -62.03 5.31 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 123.523 0.729 . . . . 52.420000000000002 111.885 -165.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 34.6 Cg_endo -65.69 -22.46 57.5 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.456 1.438 . . . . 63.210000000000001 113.045 -173.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 6.0 tpp -64.79 -47.41 78.19 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 124.148 0.979 . . . . 74.129999999999995 110.919 171.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -65.05 -35.12 80.14 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.197 0.908 . . . . 73.340000000000003 108.891 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -60.05 -38.3 82.4 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.451 0.569 . . . . 73.140000000000001 110.393 169.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.75 -16.58 47.44 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.04 -1.037 . . . . 70.109999999999999 112.751 -172.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.3 t -111.89 -33.94 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 124.966 1.306 . . . . 73.230000000000004 110.495 -171.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -108.57 -54.03 2.56 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.534 1.134 . . . . 63.109999999999999 110.93 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt -69.2 -55.79 9.56 Favored 'General case' 0 N--CA 1.462 0.17 0 O-C-N 121.096 -1.002 . . . . 65.25 110.66 -171.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.4 p -104.5 -23.79 13.1 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.726 0.811 . . . . 74.230000000000004 112.551 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 55.93 30.86 16.78 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.89 2.076 . . . . 71.239999999999995 112.775 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.0 t -62.69 -25.8 68.34 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.602 1.561 . . . . 65.439999999999998 112.362 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.508 HG13 HG12 ' A' ' 107' ' ' ILE . 45.1 t -63.01 109.8 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 122.387 1.089 . . . . 70.310000000000002 108.22 -177.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.97 -26.4 0.79 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.121 1.769 . . . . 73.310000000000002 110.804 -171.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 m -136.99 163.95 29.5 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.577 -1.268 . . . . 74.140000000000001 107.577 168.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 85.7 t -53.75 -33.47 23.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 125.961 1.704 . . . . 64.540000000000006 109.408 173.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.8 -20.04 65.86 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.067 1.747 . . . . 61.539999999999999 112.361 -177.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.29 -49.0 8.01 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.986 0.914 . . . . 45.32 108.9 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.508 HG12 HG13 ' A' ' 101' ' ' VAL . 0.8 OUTLIER -55.57 -48.59 77.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 125.654 1.582 . . . . 63.130000000000003 109.122 178.935 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -20.9 66.72 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.519 -0.753 . . . . 64.120000000000005 112.381 -175.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -64.32 -52.77 56.83 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 118.898 0.772 . . . . 74.209999999999994 109.594 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.4 t -55.87 -44.15 76.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 123.753 0.658 . . . . 62.350000000000001 109.571 -174.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -51.12 -55.68 16.55 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.751 0.42 . . . . 65.310000000000002 110.428 175.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 82.6 t -59.32 -47.16 91.47 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-N 118.454 0.57 . . . . 72.340000000000003 111.332 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -73.86 -30.84 62.88 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 124.068 0.855 . . . . 74.230000000000004 110.369 -168.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.0 -32.41 67.17 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.528 0.731 . . . . 65.209999999999994 110.268 170.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 145.09 23.11 0.13 Allowed Glycine 0 CA--C 1.531 1.068 0 N-CA-C 116.768 1.467 . . . . 63.450000000000003 116.768 165.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.689 HG13 HD12 ' A' ' 81' ' ' LEU . 48.7 t -94.2 127.42 46.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 119.245 1.522 . . . . 61.229999999999997 110.595 -177.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -53.89 116.57 2.62 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.777 0.831 . . . . 74.230000000000004 108.78 172.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.36 -24.91 64.21 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-O 118.663 -1.076 . . . . 64.519999999999996 111.243 171.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -74.75 -23.31 58.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.168 1.484 . . . . 55.329999999999998 112.27 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.528 ' HB3' HD11 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -92.86 -43.73 8.84 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 108.656 -0.868 . . . . 64.129999999999995 108.656 -178.806 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -51.77 -60.65 2.92 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.271 1.428 . . . . 74.349999999999994 109.584 172.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -69.84 -14.59 62.82 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 119.718 -0.182 . . . . 72.349999999999994 111.091 -168.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -88.42 -58.72 2.45 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.72 1.208 . . . . 54.25 109.873 172.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.5 -36.82 67.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.962 1.705 . . . . 65.340000000000003 111.298 -176.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -45.11 -37.68 4.52 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 125.346 1.458 . . . . 70.230000000000004 112.189 176.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -108.43 -3.5 18.16 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.823 1.649 . . . . 64.439999999999998 113.498 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 32.6 t -81.41 155.38 25.93 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 127.563 2.345 . . . . 74.409999999999997 111.706 173.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.85 -21.52 64.28 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 112.599 -2.091 . . . . 65.030000000000001 115.778 -171.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.9 t -47.68 -55.42 2.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 C-N-CA 127.42 2.288 . . . . 73.329999999999998 106.83 167.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.1 t -71.81 -42.21 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.532 -0.758 . . . . 64.040000000000006 109.415 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -54.82 -51.08 66.96 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.448 1.022 . . . . 73.120000000000005 112.462 -177.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 67.7 m -69.83 -34.15 73.27 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.144 0.978 . . . . 71.049999999999997 111.563 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 11.9 mt -68.62 -46.46 69.19 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.647 1.112 . . . . 72.140000000000001 112.113 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 24.7 t -48.67 -53.67 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 C-N-CA 124.399 1.08 . . . . 62.450000000000003 109.681 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.35 -40.53 93.72 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 116.351 -1.785 . . . . 72.049999999999997 110.87 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -56.39 -45.91 80.37 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 122.235 2.289 . . . . 64.239999999999995 112.918 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -53.95 -57.25 11.68 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.184 -1.043 . . . . 74.209999999999994 108.184 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 77.6 mm-40 -79.82 -9.91 59.72 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.862 1.265 . . . . 70.049999999999997 113.983 -171.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.1 tptt -86.21 -55.23 4.02 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 107.716 -1.216 . . . . 74.049999999999997 107.716 176.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.93 -62.23 2.01 Favored 'General case' 0 N--CA 1.444 -0.733 0 O-C-N 124.646 1.216 . . . . 50.240000000000002 108.66 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -82.84 0.59 43.32 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.699 1.0 . . . . 64.430000000000007 113.699 -162.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -122.06 2.29 9.85 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 117.733 -1.127 . . . . 73.420000000000002 112.936 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -57.31 -85.77 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.066 0.848 . . . . 44.210000000000001 110.651 174.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 174.74 43.03 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.926 2.49 . . . . 71.120000000000005 110.705 174.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.69 -26.54 6.53 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 120.55 -1.344 . . . . 71.209999999999994 112.019 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.661 HD23 ' H ' ' A' ' 147' ' ' GLN . 0.1 OUTLIER -127.73 -85.96 0.58 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.571 -1.27 . . . . 74.319999999999993 107.571 -167.128 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.661 ' H ' HD23 ' A' ' 146' ' ' LEU . 7.9 mt-30 48.22 29.24 1.8 Allowed 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.428 1.091 . . . . 74.219999999999999 112.565 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -154.98 95.62 0.15 Allowed Glycine 0 C--N 1.347 1.152 0 O-C-N 120.337 -1.477 . . . . 62.020000000000003 114.826 -164.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.867 HG13 ' CE1' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -95.91 162.38 24.22 Favored Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 113.589 0.959 . . . . 64.230000000000004 113.589 -170.94 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.669 ' HA ' HG12 ' A' ' 149' ' ' VAL . 72.7 Cg_endo -81.51 123.08 8.76 Favored 'Cis proline' 0 C--N 1.352 0.729 0 CA-C-N 119.025 0.687 . . . . 70.099999999999994 112.841 -5.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -103.23 141.21 36.29 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 114.6 -1.182 . . . . 62.43 112.471 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 44.5 tpp -146.44 108.63 4.42 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 127.143 2.177 . . . . 61.0 106.355 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -96.71 158.42 15.44 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 123.006 0.191 . . . . 63.32 111.502 172.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.9 t -140.75 146.93 23.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 124.352 1.061 . . . . 72.430000000000007 108.56 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 46.71 19.18 0.08 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 128.686 2.794 . . . . 54.399999999999999 114.689 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.88 -2.92 58.47 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 120.783 -1.198 . . . . 64.140000000000001 113.328 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -140.57 -7.01 1.14 Allowed 'General case' 0 C--O 1.233 0.229 0 N-CA-C 114.434 1.272 . . . . 74.200000000000003 114.434 -159.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -124.3 146.08 49.01 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.161 -1.052 . . . . 73.040000000000006 108.161 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -113.91 147.71 38.02 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.32 -1.363 . . . . 61.299999999999997 107.32 162.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -68.84 140.09 55.22 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.128 -1.064 . . . . 74.109999999999999 108.128 170.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -113.81 86.13 10.51 Favored Pre-proline 0 C--O 1.234 0.262 0 C-N-CA 123.254 0.622 . . . . 73.019999999999996 111.216 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -61.61 -24.08 77.37 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.111 1.207 . . . . 71.329999999999998 112.565 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -66.23 -31.3 72.05 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.786 1.176 . . . . 50.310000000000002 110.416 -168.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -90.52 -4.77 70.1 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.737 -1.035 . . . . 51.509999999999998 111.823 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 43.8 mtt -78.99 166.18 22.63 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 119.58 1.69 . . . . 73.109999999999999 108.69 175.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -79.4 108.96 13.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 104.663 -2.347 . . . . 53.310000000000002 104.663 171.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.446 HG22 ' CD1' ' A' ' 173' ' ' PHE . 40.8 p -112.96 50.23 0.89 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.948 2.099 . . . . 74.200000000000003 107.019 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 13.9 m -131.31 3.39 4.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.095 -1.412 . . . . 72.319999999999993 111.098 -167.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.03 -20.67 1.11 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 126.751 2.02 . . . . 73.239999999999995 110.645 174.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 7.9 mmt 73.09 -54.96 0.69 Allowed 'General case' 0 C--N 1.347 0.484 0 C-N-CA 126.063 1.745 . . . . 72.0 110.568 -174.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.79 -50.22 69.03 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.142 1.377 . . . . 61.210000000000001 110.531 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 79.1 t -72.18 -24.07 22.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 125.53 1.532 . . . . 64.120000000000005 111.574 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.446 ' CD1' HG22 ' A' ' 167' ' ' THR . 35.2 t80 -60.16 -61.85 2.3 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.331 -0.989 . . . . 73.030000000000001 108.331 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.9 t -64.92 -33.47 63.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 O-C-N 123.367 0.417 . . . . 52.43 110.474 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.98 -42.91 69.51 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.368 0.667 . . . . 73.329999999999998 112.329 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -81.63 -40.41 22.98 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 118.492 -0.766 . . . . 65.010000000000005 110.874 176.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -54.85 -57.8 10.13 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.479 1.112 . . . . 74.310000000000002 110.154 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -55.69 -32.03 62.94 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.925 0.89 . . . . 65.439999999999998 111.571 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -65.88 -58.4 5.68 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.936 -0.394 . . . . 62.109999999999999 109.936 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.4 t -63.1 -29.96 71.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 116.93 -1.51 . . . . 65.120000000000005 110.771 -173.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 47.5 t -56.49 -56.95 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 120.138 1.335 . . . . 45.340000000000003 108.189 173.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.31 -43.46 83.28 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 124.649 1.18 . . . . 61.039999999999999 111.093 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -64.65 -30.1 71.11 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 119.001 0.819 . . . . 75.040000000000006 112.244 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 52.6 mt -74.27 -23.68 59.15 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 120.44 -1.412 . . . . 74.230000000000004 111.833 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 84.7 t -62.71 -30.21 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.646 -0.501 . . . . 72.239999999999995 109.646 174.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -99.17 -8.11 25.59 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.885 0.874 . . . . 74.040000000000006 110.872 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -110.82 77.26 1.03 Allowed 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 120.668 -1.27 . . . . 71.319999999999993 109.406 -174.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.043 0 C-N-CA 127.52 2.328 . . . . 75.219999999999999 112.634 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 113.996 1.11 . . . . 71.150000000000006 113.996 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -166.25 109.74 0.77 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.12 1.768 . . . . 71.310000000000002 106.894 -177.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.458 HD12 ' CD2' ' A' ' 9' ' ' TYR . 6.4 pt -117.24 166.32 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.499 1.119 . . . . 72.430000000000007 110.349 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.6 m -149.28 141.85 24.41 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.297 -1.372 . . . . 73.329999999999998 107.297 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -59.41 149.27 29.8 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.744 0.783 . . . . 71.230000000000004 109.399 174.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.81 -21.34 2.08 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-O 117.587 -1.674 . . . . 71.450000000000003 112.629 -172.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -99.56 -69.5 0.76 Allowed 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 120.966 2.383 . . . . 74.439999999999998 110.224 -165.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -107.95 -15.91 14.42 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 123.684 0.794 . . . . 64.140000000000001 110.637 -177.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.458 ' CD2' HD12 ' A' ' 3' ' ' ILE . 38.0 p90 -141.86 167.99 20.83 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 108.49 -0.93 . . . . 72.150000000000006 108.49 171.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 mm -131.26 142.29 43.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 104.652 -2.351 . . . . 72.140000000000001 104.652 168.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.1 m -78.4 171.13 15.54 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 125.144 1.378 . . . . 62.329999999999998 108.354 170.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 32.9 mt -113.14 161.65 16.88 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.99 0.916 . . . . 73.150000000000006 110.467 171.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -80.37 -37.75 31.72 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.287 1.035 . . . . 75.450000000000003 108.716 -174.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -133.26 71.33 76.91 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 125.42 1.488 . . . . 74.299999999999997 110.807 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 CA--C 1.535 0.551 1 C-N-CA 125.547 4.165 . . . . 74.349999999999994 111.033 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 CA--C 1.542 0.66 0 N-CA-C 112.776 0.658 . . . . 63.009999999999998 112.776 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.519 HD22 ' CZ ' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -122.92 154.77 37.92 Favored 'General case' 0 CA--C 1.518 -0.287 0 O-C-N 121.352 -0.843 . . . . 65.430000000000007 113.249 -163.01 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -135.83 141.19 44.65 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 125.244 1.418 . . . . 71.219999999999999 108.101 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.519 ' CZ ' HD22 ' A' ' 23' ' ' LEU . 98.0 m-85 -127.75 137.77 52.54 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.738 1.215 . . . . 73.230000000000004 109.62 -176.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -165.38 -178.48 5.01 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.988 1.715 . . . . 74.420000000000002 109.749 -177.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.7 t -143.94 -174.48 4.28 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.776 1.23 . . . . 72.030000000000001 108.142 171.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.868 ' CD1' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -92.23 -7.66 47.58 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.507 1.299 . . . . 74.439999999999998 114.507 175.273 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -100.29 -4.92 28.31 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.922 0.889 . . . . 73.200000000000003 112.826 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.7 p -80.07 140.83 53.75 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 120.681 1.582 . . . . 71.040000000000006 108.764 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -92.07 -30.74 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 CA-C-N 120.133 1.083 . . . . 63.130000000000003 111.055 -168.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -64.25 -50.08 69.38 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.952 1.701 . . . . 75.219999999999999 109.517 171.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.5 p -67.0 -22.93 65.88 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 117.582 -1.199 . . . . 70.439999999999998 111.706 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -57.21 -55.08 39.39 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 120.338 1.427 . . . . 62.32 109.312 170.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -55.05 -46.46 75.36 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 108.804 -0.813 . . . . 71.049999999999997 108.804 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -65.58 -16.45 63.72 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 116.796 -1.574 . . . . 73.209999999999994 113.324 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -116.29 -8.13 11.71 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 121.105 1.775 . . . . 73.109999999999999 111.762 -173.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -141.38 -30.15 0.62 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.75 0.82 . . . . 72.049999999999997 112.907 -163.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.2 t -115.4 -68.02 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 N-CA-C 107.466 -1.309 . . . . 65.219999999999999 107.466 -172.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.8 mt -66.44 -28.41 68.58 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.843 -1.071 . . . . 72.150000000000006 111.075 171.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 45.14 41.6 5.94 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.438 1.495 . . . . 52.420000000000002 111.833 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.2 t -50.88 -48.2 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 C-N-CA 125.79 1.636 . . . . 73.120000000000005 108.696 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.3 p -46.08 -55.71 6.58 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 124.791 1.307 . . . . 65.140000000000001 112.293 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -75.36 -34.86 61.19 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 119.913 -1.742 . . . . 64.430000000000007 110.665 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.45 -54.58 45.22 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 123.035 0.534 . . . . 64.239999999999995 110.474 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.602 HG12 ' HG ' ' A' ' 50' ' ' LEU . 23.5 t -60.82 -43.02 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 109.253 -0.647 . . . . 74.010000000000005 109.253 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.685 ' HA ' HD12 ' A' ' 50' ' ' LEU . 40.7 ttt-85 -53.72 -29.5 39.6 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.391 1.256 . . . . 74.430000000000007 114.391 176.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -89.78 -3.56 58.1 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.186 1.18 . . . . 65.209999999999994 114.186 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -128.12 0.03 5.83 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.929 2.092 . . . . 70.219999999999999 113.032 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.693 HD13 ' O ' ' A' ' 54' ' ' THR . 6.3 mt -63.11 154.37 77.79 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.378 1.471 . . . . 63.109999999999999 108.988 -177.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.12 151.33 26.9 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.32 2.68 . . . . 70.049999999999997 108.837 172.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 45.46 24.01 0.16 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.236 2.615 . . . . 50.119999999999997 115.645 174.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.27 33.34 75.0 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-O 117.851 -1.527 . . . . 72.349999999999994 113.659 -172.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.693 ' O ' HD13 ' A' ' 50' ' ' LEU . 26.0 m -61.59 69.62 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.775 1.63 . . . . 73.340000000000003 111.191 172.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -63.63 132.19 50.37 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 120.385 -1.447 . . . . 74.200000000000003 108.357 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -75.57 173.56 10.85 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.037 0.935 . . . . 73.109999999999999 112.178 -174.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.84 154.01 26.97 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.557 0.743 . . . . 65.040000000000006 109.368 170.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.78 102.0 6.36 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.306 1.042 . . . . 54.210000000000001 108.488 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.421 ' HB2' HD21 ' A' ' 23' ' ' LEU . 10.6 m-30 -97.0 168.22 10.6 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.348 1.059 . . . . 74.299999999999997 110.336 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.515 ' CE1' HG22 ' A' ' 72' ' ' THR . 1.4 p-80 -101.18 172.05 7.24 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.986 1.314 . . . . 65.400000000000006 108.569 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.666 HG12 ' HB1' ' A' ' 141' ' ' ALA . 11.9 m -140.42 145.8 25.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 107.445 -1.317 . . . . 73.209999999999994 107.445 162.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . 0.293 0.0 OUTLIER -102.37 17.97 22.21 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 129.084 2.953 . . . . 71.230000000000004 113.54 -177.876 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -84.18 -4.33 58.74 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.294 1.438 . . . . 54.32 114.367 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.59 145.48 51.13 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 119.827 -1.796 . . . . 74.420000000000002 110.29 -166.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.87 -178.69 7.2 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 121.375 0.431 . . . . 55.539999999999999 112.517 174.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -78.36 -46.63 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.316 2.677 . . . . 62.130000000000003 113.308 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.8 mt -79.17 31.69 0.22 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.655 1.116 . . . . 72.439999999999998 112.518 -174.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -43.24 -63.71 1.99 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 126.053 1.787 . . . . 75.200000000000003 110.689 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -63.02 -40.06 96.62 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 117.548 0.674 . . . . 73.099999999999994 110.647 -172.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.51 -42.43 92.18 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.263 1.425 . . . . 73.409999999999997 110.458 -175.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.868 HD11 ' CD1' ' A' ' 28' ' ' PHE . 18.6 mt -65.33 -45.17 85.33 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 118.533 -0.746 . . . . 73.219999999999999 111.392 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.515 HG22 ' CE1' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -46.78 -53.73 11.3 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.057 -1.09 . . . . 65.040000000000006 108.057 175.697 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -58.17 -55.89 29.09 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.945 0.898 . . . . 73.430000000000007 110.418 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.88 -43.18 72.95 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 120.186 1.357 . . . . 61.420000000000002 113.838 -176.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 14.0 t-105 -59.8 -38.0 80.71 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.341 -0.85 . . . . 74.120000000000005 111.355 -174.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.39 -38.57 71.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 118.062 -0.971 . . . . 73.200000000000003 112.557 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.6 t -57.03 -47.77 82.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 120.031 1.287 . . . . 65.109999999999999 109.933 171.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.22 -40.53 94.24 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.868 -0.52 . . . . 65.329999999999998 111.237 -176.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 85.8 mt -67.01 -38.2 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.736 0.815 . . . . 42.210000000000001 109.68 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.86 -50.61 72.73 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.858 0.863 . . . . 74.5 110.111 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 77.4 mt -76.2 -27.75 56.99 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.805 -0.559 . . . . 73.530000000000001 112.098 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.51 62.4 2.72 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 126.566 2.032 . . . . 44.329999999999998 110.603 -173.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.0 m -129.81 14.07 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 125.226 1.41 . . . . 72.200000000000003 112.303 -174.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -49.99 -51.87 38.26 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 125.064 1.346 . . . . 72.019999999999996 112.307 -169.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.62 -43.02 79.78 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.37 1.468 . . . . 71.340000000000003 110.373 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -64.05 -27.12 68.89 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 124.456 1.102 . . . . 74.099999999999994 110.609 -176.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.3 pp -116.48 27.19 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 126.847 2.059 . . . . 42.130000000000003 109.876 -176.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 89.9 m -97.67 -54.58 3.07 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.755 -1.202 . . . . 64.0 107.755 164.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.501 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -52.52 -62.09 3.74 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 113.721 1.008 . . . . 53.200000000000003 113.721 -172.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 56.8 Cg_endo -70.37 -27.29 23.75 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.194 1.263 . . . . 72.340000000000003 111.557 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 32.6 tpp -65.07 -49.9 68.25 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.557 1.143 . . . . 73.120000000000005 109.635 -177.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -69.34 -35.63 76.09 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.49 -0.93 . . . . 63.020000000000003 108.49 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.494 ' CG ' ' HE3' ' A' ' 97' ' ' LYS . 2.6 mt-10 -65.68 -11.19 42.96 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 114.367 1.247 . . . . 70.400000000000006 114.367 169.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -109.15 1.52 20.41 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.576 1.08 . . . . 71.010000000000005 113.488 172.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.859 HG21 ' CD2' ' A' ' 28' ' ' PHE . 95.8 t -115.38 -34.66 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 117.392 -1.289 . . . . 33.409999999999997 114.04 175.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -108.84 -53.0 2.7 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 120.547 1.521 . . . . 65.439999999999998 113.401 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.494 ' HE3' ' CG ' ' A' ' 93' ' ' GLU . 2.9 mmmt -62.08 -64.54 0.9 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.479 1.911 . . . . 63.229999999999997 112.713 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.9 p -87.88 -30.66 19.97 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.736 1.384 . . . . 64.209999999999994 114.736 174.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 56.1 35.73 26.16 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 128.348 2.659 . . . . 72.0 114.432 -173.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.5 t -71.31 -22.36 61.94 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.342 0.867 . . . . 73.340000000000003 113.342 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.486 HG13 HG12 ' A' ' 107' ' ' ILE . 25.4 t -66.71 120.33 13.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 O-C-N 120.625 -1.297 . . . . 74.439999999999998 110.217 172.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -140.63 -28.8 0.7 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.063 -0.971 . . . . 74.310000000000002 111.633 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.83 174.39 10.58 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.539 1.063 . . . . 63.119999999999997 110.178 168.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.5 t -57.68 -41.32 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.139 0.975 . . . . 72.400000000000006 111.267 -169.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.28 -23.77 62.7 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 119.204 -0.427 . . . . 73.099999999999994 111.679 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -78.19 -30.54 49.06 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 119.044 0.838 . . . . 73.040000000000006 111.207 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.486 HG12 HG13 ' A' ' 101' ' ' VAL . 1.4 mt -81.8 -48.26 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 108.293 -1.003 . . . . 72.019999999999996 108.293 -174.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -62.18 -18.23 60.41 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.577 0.751 . . . . 73.0 112.356 179.336 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -62.5 -56.85 14.14 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 125.43 1.492 . . . . 61.439999999999998 109.837 169.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.7 t -61.77 -34.47 62.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 118.645 -0.693 . . . . 62.100000000000001 110.804 -175.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -49.62 -60.46 2.85 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.016 -0.735 . . . . 73.310000000000002 109.016 169.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.1 t -57.09 -49.03 80.82 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-O 118.922 -0.561 . . . . 71.409999999999997 109.814 -176.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.23 -43.22 96.23 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 124.062 0.851 . . . . 73.099999999999994 110.159 -170.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.87 0.25 7.66 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.73 1.612 . . . . 71.310000000000002 112.852 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.49 44.76 1.41 Allowed Glycine 0 CA--C 1.523 0.566 0 C-N-CA 124.973 1.273 . . . . 71.5 112.917 171.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.0 t -112.38 140.8 30.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 118.977 1.388 . . . . 65.099999999999994 110.765 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -64.28 110.12 2.12 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.307 1.443 . . . . 74.5 109.134 165.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.92 -23.37 65.64 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-O 118.162 -1.354 . . . . 74.439999999999998 110.931 168.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -70.95 -23.05 62.15 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.621 1.211 . . . . 74.239999999999995 110.977 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -87.79 -46.34 9.54 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.701 -1.222 . . . . 72.409999999999997 107.701 176.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 108' ' ' ARG . 14.9 t80 -51.97 -57.31 9.83 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.622 0.769 . . . . 65.400000000000006 109.603 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -74.7 -9.48 58.61 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.88 0.872 . . . . 62.399999999999999 112.43 -171.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -87.78 -66.15 0.94 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.909 1.283 . . . . 50.399999999999999 109.355 166.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -49.34 -43.06 43.44 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.397 2.279 . . . . 71.140000000000001 111.45 -174.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -45.55 -35.69 4.1 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 126.303 1.841 . . . . 72.030000000000001 113.507 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -116.91 8.45 13.51 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.713 1.205 . . . . 64.030000000000001 111.828 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 21.3 t -95.69 159.85 14.78 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 127.16 2.184 . . . . 72.230000000000004 110.226 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -57.14 -33.03 66.98 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.301 1.44 . . . . 63.340000000000003 111.892 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.8 t -49.57 -54.27 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 124.107 0.963 . . . . 61.109999999999999 109.912 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.5 t -63.87 -49.54 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 123.803 0.841 . . . . 61.229999999999997 110.694 176.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -49.61 -54.35 18.86 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.926 0.784 . . . . 72.040000000000006 111.549 -177.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.12 -40.0 93.89 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.102 0.561 . . . . 74.299999999999997 111.998 177.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.8 mt -60.6 -49.36 77.84 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-O 116.61 -1.662 . . . . 53.409999999999997 110.891 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 99.1 t -56.78 -37.26 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 120.199 1.363 . . . . 70.430000000000007 110.428 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.65 -28.83 70.18 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 117.763 -1.113 . . . . 72.209999999999994 112.329 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -53.47 -49.48 67.36 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 119.803 1.183 . . . . 64.0 112.097 175.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -103.77 -18.96 14.46 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 118.54 -0.743 . . . . 64.109999999999999 110.636 -166.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -60.07 -52.82 63.73 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.922 -1.14 . . . . 64.420000000000002 107.922 158.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 32.1 tttp -61.15 -18.7 59.46 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.268 0.94 . . . . 72.299999999999997 113.181 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -114.9 1.19 13.97 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 115.816 1.784 . . . . 65.329999999999998 115.816 -176.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.666 ' HB1' HG12 ' A' ' 61' ' ' VAL . . . -139.18 -19.1 0.99 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 119.462 1.028 . . . . 62.340000000000003 111.609 177.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -104.7 -4.77 22.02 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 117.942 -1.027 . . . . 63.229999999999997 110.94 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -59.81 -83.03 0.02 OUTLIER 'General case' 0 C--N 1.345 0.401 0 C-N-CA 125.929 1.692 . . . . 75.319999999999993 109.934 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.2 pp -172.92 -11.18 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.106 1.521 . . . . 64.019999999999996 115.106 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.2 -44.27 76.23 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.321 1.418 . . . . 73.219999999999999 112.556 -162.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.24 -70.05 0.79 Allowed 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 125.736 1.614 . . . . 75.019999999999996 109.561 -157.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 68.26 -3.75 1.22 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.676 1.991 . . . . 75.310000000000002 115.367 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -146.16 160.39 28.15 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 122.731 2.514 . . . . 51.100000000000001 112.709 174.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.446 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 19.3 m -142.23 167.01 17.8 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-N 118.532 1.166 . . . . 72.209999999999994 112.61 -174.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.446 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 36.5 Cg_endo -61.35 165.21 33.51 Favored 'Cis proline' 0 C--N 1.353 0.812 0 CA-C-N 119.743 0.944 . . . . 53.43 111.911 -11.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -149.67 151.49 33.8 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.563 -0.903 . . . . 65.409999999999997 108.563 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 6.6 ttm -149.25 117.97 6.61 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.531 -1.285 . . . . 74.140000000000001 107.531 -172.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -124.22 107.04 10.78 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 125.038 1.335 . . . . 73.319999999999993 110.015 -169.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 81.5 t -64.06 -65.16 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.177 0.591 . . . . 52.219999999999999 111.672 -170.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -132.96 25.02 4.28 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.793 2.037 . . . . 74.409999999999997 108.136 -171.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 68.0 20.2 72.51 Favored Glycine 0 C--N 1.343 0.951 0 C-N-CA 124.774 1.178 . . . . 51.439999999999998 113.988 -177.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.52 ' HE2' ' CZ ' ' A' ' 158' ' ' TYR . 18.7 ptmt -138.43 -7.65 1.51 Allowed 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 115.089 1.514 . . . . 44.229999999999997 115.089 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.52 ' CZ ' ' HE2' ' A' ' 157' ' ' LYS . 22.9 m-85 -133.94 122.09 22.61 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.457 -1.683 . . . . 72.239999999999995 106.457 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.12 143.87 27.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 105.518 -2.03 . . . . 70.439999999999998 105.518 161.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.442 ' CD1' HG23 ' A' ' 180' ' ' THR . 3.5 mm? -69.9 142.73 52.93 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.88 -1.155 . . . . 73.129999999999995 107.88 166.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -112.57 85.76 7.69 Favored Pre-proline 0 N--CA 1.453 -0.292 0 N-CA-C 113.024 0.75 . . . . 53.549999999999997 113.024 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.39 -19.74 37.52 Favored 'Trans proline' 0 N--CA 1.443 -1.486 0 C-N-CA 120.454 0.769 . . . . 74.230000000000004 111.1 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -61.86 -20.48 63.75 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 119.626 1.103 . . . . 75.409999999999997 112.821 -175.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -108.75 3.72 32.25 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 117.641 -1.644 . . . . 72.420000000000002 113.326 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 56.3 mtt -93.01 173.57 7.67 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.91 2.355 . . . . 70.040000000000006 111.794 -168.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.57 58.54 3.75 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 123.568 1.651 . . . . 73.409999999999997 111.764 -171.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 72.2 p -72.96 16.07 0.17 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.474 2.31 . . . . 65.340000000000003 112.851 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.4 m -94.43 -8.79 37.58 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.945 1.698 . . . . 65.230000000000004 112.707 173.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.0 -14.08 4.47 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 119.5 1.045 . . . . 73.340000000000003 113.181 -174.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 4.5 mmt 70.6 -57.66 0.58 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.591 1.957 . . . . 74.340000000000003 113.926 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.22 -48.95 68.93 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.694 -1.225 . . . . 70.329999999999998 107.694 -178.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 21.2 t -65.05 -36.81 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 124.928 1.291 . . . . 70.329999999999998 109.567 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -52.14 -60.73 2.86 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 118.262 -0.875 . . . . 74.319999999999993 110.135 172.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 8.9 t -66.76 -39.26 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 119.198 0.908 . . . . 61.109999999999999 111.392 -175.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.42 -33.97 64.01 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.617 0.767 . . . . 63.009999999999998 111.419 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -88.94 -31.4 18.19 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.393 1.077 . . . . 71.129999999999995 112.159 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -58.68 -59.64 5.09 Favored 'General case' 0 CA--C 1.528 0.099 0 O-C-N 120.8 -1.187 . . . . 73.340000000000003 108.965 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.27 -32.7 72.52 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.873 -0.517 . . . . 72.040000000000006 111.795 -175.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.96 -52.01 67.23 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.879 1.272 . . . . 74.439999999999998 111.835 174.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.442 HG23 ' CD1' ' A' ' 160' ' ' LEU . 9.0 t -64.88 -30.22 71.21 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 117.403 -1.284 . . . . 72.439999999999998 110.491 177.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 99.9 t -60.07 -55.89 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 120.455 1.479 . . . . 74.049999999999997 108.302 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -62.42 -33.93 75.76 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-O 118.903 -0.57 . . . . 74.420000000000002 111.979 -177.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -68.92 -33.8 74.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.645 0.657 . . . . 71.140000000000001 111.342 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 34.4 mt -67.99 -29.36 68.36 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 120.957 -1.09 . . . . 73.129999999999995 111.936 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 62.2 t -62.06 -26.03 38.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.437 0.695 . . . . 72.430000000000007 111.506 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -98.34 -18.35 18.38 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.508 0.595 . . . . 54.229999999999997 110.531 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -96.32 76.56 2.98 Favored 'General case' 0 CA--C 1.516 -0.349 0 O-C-N 121.035 -1.041 . . . . 70.129999999999995 108.851 -172.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.246 0.896 0 C-N-CA 127.832 2.453 . . . . 73.239999999999995 112.023 -174.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.524 0 N-CA-C 114.207 1.188 . . . . 72.209999999999994 114.207 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -163.78 120.75 1.75 Allowed 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.344 -1.724 . . . . 72.129999999999995 106.344 174.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.71 HG21 HG23 ' A' ' 180' ' ' THR . 9.8 pt -133.14 160.7 42.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 126.444 1.898 . . . . 51.409999999999997 109.592 177.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.5 m -140.4 144.51 36.23 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 121.607 -0.683 . . . . 61.329999999999998 109.551 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -51.37 142.04 14.18 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 127.238 2.215 . . . . 71.150000000000006 111.117 168.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.09 -22.79 2.32 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.415 1.007 . . . . 53.530000000000001 112.582 -176.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -102.38 -77.79 0.55 Allowed 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 124.129 0.971 . . . . 62.130000000000003 108.672 -165.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -100.24 -15.84 17.94 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.413 1.085 . . . . 71.140000000000001 110.719 -174.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -140.95 159.34 42.42 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.217 -0.66 . . . . 71.129999999999995 109.217 165.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.4 mm -113.55 162.55 11.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 124.762 1.225 . . . . 71.019999999999996 107.695 173.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 m -117.24 147.9 42.12 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.426 1.49 . . . . 65.120000000000005 107.603 176.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.2 mt -86.18 154.66 21.16 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.52 -0.548 . . . . 73.349999999999994 109.52 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -72.28 -37.33 69.06 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.878 1.671 . . . . 73.439999999999998 109.693 176.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -127.59 85.12 61.56 Favored Pre-proline 0 C--N 1.34 0.178 0 C-N-CA 127.479 2.312 . . . . 73.540000000000006 108.331 173.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo . . . . . 0 N--CA 1.45 -1.031 0 C-N-CA 123.732 2.954 . . . . 74.040000000000006 109.583 168.583 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.8 t . . . . . 0 CA--C 1.537 0.45 0 CA-C-O 121.395 0.617 . . . . 72.239999999999995 111.206 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.3 tp -157.24 148.22 21.64 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.724 0.81 . . . . 73.040000000000006 109.747 -174.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -140.52 153.12 46.05 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.946 1.698 . . . . 73.430000000000007 109.262 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -133.35 139.32 46.76 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.727 1.211 . . . . 74.310000000000002 108.527 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.81 -179.71 7.81 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.285 1.834 . . . . 70.239999999999995 108.512 -177.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -158.68 161.87 37.16 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.872 0.76 . . . . 53.539999999999999 111.366 174.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -70.47 -39.83 74.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.461 1.504 . . . . 70.239999999999995 112.111 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.456 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 80.3 m-85 -93.6 18.09 10.6 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.567 1.147 . . . . 74.200000000000003 111.793 177.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 33.8 t -88.73 141.68 30.18 Favored Pre-proline 0 CA--C 1.538 0.503 0 O-C-N 120.136 -1.603 . . . . 72.109999999999999 110.042 171.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -83.68 -46.56 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 121.73 1.62 . . . . 71.409999999999997 112.165 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -61.45 -44.06 97.77 Favored 'General case' 0 CA--C 1.528 0.115 0 O-C-N 121.56 -0.712 . . . . 73.439999999999998 109.537 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.7 m -57.02 -33.34 67.08 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.566 0.746 . . . . 72.239999999999995 112.097 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -58.93 -53.55 57.17 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.438 0.695 . . . . 64.120000000000005 110.105 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -56.54 -47.73 78.79 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 118.431 -0.795 . . . . 72.530000000000001 109.432 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.434 ' CD2' HG21 ' A' ' 42' ' ' VAL . 10.4 m-85 -62.13 -19.83 63.43 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 116.83 -1.557 . . . . 74.120000000000005 112.341 -174.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -134.84 10.12 3.61 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 120.925 1.693 . . . . 62.32 112.11 -164.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -135.7 -41.21 0.69 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.868 2.067 . . . . 71.329999999999998 111.209 169.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 83.7 t -98.47 -74.57 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.11 0 N-CA-C 107.89 -1.152 . . . . 64.019999999999996 107.89 -168.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 65.7 mt -62.0 -28.19 69.4 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.985 1.314 . . . . 63.329999999999998 111.663 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 1.2 m170 44.36 56.76 4.76 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.669 1.988 . . . . 65.430000000000007 111.783 177.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.509 ' O ' HG23 ' A' ' 46' ' ' VAL . 63.6 t -62.06 -44.59 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 125.293 1.437 . . . . 74.129999999999995 109.752 -174.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.9 t -53.05 -44.77 67.68 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.333 0.97 . . . . 62.140000000000001 111.99 -175.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -76.89 -29.71 55.88 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 121.194 -0.941 . . . . 72.329999999999998 111.447 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -63.23 -46.99 84.38 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.492 0.717 . . . . 53.409999999999997 110.607 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 42' ' ' VAL . 1.9 t -59.53 -51.24 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 108.238 -1.023 . . . . 61.020000000000003 108.238 177.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 37.8 ttt-85 -47.36 -46.32 25.63 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.378 1.071 . . . . 72.400000000000006 111.948 177.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -64.89 -2.8 2.82 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.155 1.169 . . . . 73.120000000000005 114.155 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.6 mmtt -132.01 -9.9 3.42 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 127.466 2.306 . . . . 65.099999999999994 113.724 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.535 HD13 HG21 ' A' ' 54' ' ' THR . 7.7 mt -66.95 144.81 98.73 Favored Pre-proline 0 C--O 1.237 0.4 0 CA-C-N 119.306 0.957 . . . . 74.150000000000006 110.882 -164.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.69 165.38 32.89 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.988 2.459 . . . . 50.310000000000002 109.78 167.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.88 23.29 0.7 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.774 1.027 . . . . 65.219999999999999 113.774 -173.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.67 18.21 22.56 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 127.139 2.304 . . . . 71.340000000000003 112.057 -173.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.535 HG21 HD13 ' A' ' 50' ' ' LEU . 1.3 t -130.08 129.39 43.53 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.462 -1.31 . . . . 72.140000000000001 107.462 -163.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -96.29 121.1 37.71 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 104.8 -2.296 . . . . 65.409999999999997 104.8 166.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 6.2 ttm -66.39 102.49 0.88 Allowed 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 125.074 1.35 . . . . 74.349999999999994 108.02 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 58' ' ' LYS . 1.5 m -120.0 -171.73 2.21 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.215 -1.032 . . . . 73.310000000000002 108.215 -173.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.452 ' H ' HG22 ' A' ' 57' ' ' THR . 0.0 OUTLIER 174.58 108.99 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.423 1.489 . . . . 71.239999999999995 108.102 -173.053 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -108.59 146.67 32.96 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.795 1.18 . . . . 74.150000000000006 109.855 174.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.41 ' CE1' ' HB3' ' A' ' 137' ' ' GLN . 0.2 OUTLIER -82.01 168.54 17.72 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.242 1.017 . . . . 74.019999999999996 109.543 -174.482 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.508 HG12 ' HB1' ' A' ' 141' ' ' ALA . 6.6 m -139.03 111.12 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 119.528 1.058 . . . . 74.450000000000003 108.521 158.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.89 4.68 13.44 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 124.719 1.208 . . . . 44.25 113.183 176.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -55.77 -8.48 0.41 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.173 1.789 . . . . 72.150000000000006 113.376 169.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.8 132.07 34.19 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 125.425 1.49 . . . . 70.340000000000003 109.996 -176.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.456 ' HA3' ' CD2' ' A' ' 29' ' ' TYR . . . 116.59 156.54 10.7 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 126.443 1.973 . . . . 62.32 112.014 168.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -62.99 -56.12 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.47 2.113 . . . . 61.539999999999999 109.544 167.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.6 mt -91.21 34.99 0.92 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.652 1.581 . . . . 61.32 109.912 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.95 -51.89 50.41 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.508 -1.037 . . . . 70.540000000000006 110.508 175.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.9 tppm? -57.14 -40.2 76.72 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.291 1.036 . . . . 72.409999999999997 112.181 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.88 -38.63 89.29 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.852 1.661 . . . . 72.329999999999998 110.31 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.7 mt -67.36 -41.05 85.73 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 117.808 -1.092 . . . . 53.310000000000002 111.641 174.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.03 -56.65 14.49 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.922 1.289 . . . . 72.310000000000002 108.975 -177.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -62.4 -41.93 99.05 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.409 0.684 . . . . 61.25 109.477 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.14 -30.96 69.64 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 113.443 0.905 . . . . 72.420000000000002 113.443 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 33.7 t-105 -61.56 -41.04 96.8 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 118.507 0.594 . . . . 71.129999999999995 111.518 -176.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.89 -36.31 76.67 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 117.665 -1.16 . . . . 65.230000000000004 112.492 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.2 t -55.72 -46.69 79.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 120.711 1.596 . . . . 73.120000000000005 110.796 171.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.01 -43.16 88.49 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-O 119.137 -0.459 . . . . 61.140000000000001 110.628 -175.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.2 mt -63.65 -39.87 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 118.758 -0.639 . . . . 71.340000000000003 109.965 176.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.74 -22.84 66.04 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.622 0.646 . . . . 32.420000000000002 112.279 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.2 mt -99.49 -11.78 20.76 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.214 0.916 . . . . 73.140000000000001 112.631 169.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 64.11 56.06 20.41 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 124.346 0.974 . . . . 74.030000000000001 111.372 -173.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.7 m -133.88 14.46 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 124.174 0.99 . . . . 73.340000000000003 112.107 -176.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -45.36 -56.82 4.54 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.664 1.186 . . . . 74.349999999999994 109.386 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.31 -10.33 59.64 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 125.438 1.495 . . . . 74.450000000000003 111.886 -172.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -87.32 -30.73 20.62 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 120.827 -1.17 . . . . 52.340000000000003 110.715 171.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.447 HG22 ' HB3' ' A' ' 114' ' ' ALA . 2.5 pp -100.55 -14.58 7.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 CA-C-O 117.374 -1.298 . . . . 33.43 111.463 -171.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.1 m -59.09 -51.62 69.24 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 119.967 1.258 . . . . 73.120000000000005 110.583 -175.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.563 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -57.15 -62.14 5.77 Favored Pre-proline 0 N--CA 1.452 -0.357 0 C-N-CA 124.569 1.147 . . . . 33.25 110.734 -168.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 57.0 Cg_endo -67.05 -26.83 42.86 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 120.911 1.074 . . . . 72.200000000000003 112.397 -176.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 4.5 tpp -60.5 -49.55 77.09 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.221 0.464 . . . . 70.430000000000007 110.185 170.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -64.58 -37.13 86.51 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.029 0.831 . . . . 74.010000000000005 109.077 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.33 -32.83 72.71 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.68 0.673 . . . . 73.239999999999995 111.666 171.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.13 -17.17 29.75 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.355 -1.466 . . . . 65.109999999999999 112.817 -176.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.4 t -100.54 -43.4 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 124.9 1.28 . . . . 51.409999999999997 109.488 -176.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -98.59 -60.62 1.51 Allowed 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.161 0.984 . . . . 53.100000000000001 110.215 -177.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.5 mmmt -65.94 -58.45 5.51 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 118.902 -0.57 . . . . 65.120000000000005 110.581 -167.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.2 p -97.18 -16.51 20.39 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.672 0.619 . . . . 64.409999999999997 112.672 -176.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 48.12 25.62 0.86 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.659 2.384 . . . . 74.140000000000001 113.885 -175.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.9 t -62.76 -16.0 55.9 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.62 1.968 . . . . 73.109999999999999 112.013 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.411 HG13 HG12 ' A' ' 107' ' ' ILE . 70.1 t -68.5 111.87 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 O-C-N 121.182 -0.949 . . . . 64.200000000000003 109.236 175.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -136.81 -30.12 0.9 Allowed 'General case' 0 C--O 1.239 0.524 0 C-N-CA 125.058 1.343 . . . . 70.25 110.275 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.26 162.28 33.44 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.15 -0.685 . . . . 71.549999999999997 109.15 174.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.82 -30.27 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.819 0.847 . . . . 53.450000000000003 110.138 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -47.4 -39.94 16.53 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.442 2.297 . . . . 71.549999999999997 113.31 168.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -77.55 -38.93 47.53 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.691 -0.855 . . . . 74.239999999999995 108.691 -175.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.411 HG12 HG13 ' A' ' 101' ' ' VAL . 2.7 mt -66.76 -48.33 80.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 125.103 1.361 . . . . 71.109999999999999 107.864 -174.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -57.76 -31.74 66.8 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-O 117.341 -1.314 . . . . 63.340000000000003 112.765 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -57.33 -57.12 14.04 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 119.601 1.091 . . . . 73.349999999999994 109.153 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.19 -37.73 78.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 123.371 0.419 . . . . 53.130000000000003 110.678 -173.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -53.92 -51.7 62.9 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 118.373 0.533 . . . . 70.150000000000006 110.659 172.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 90.2 t -64.18 -44.91 97.6 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-N 118.37 0.532 . . . . 71.340000000000003 110.631 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -63.14 -41.54 99.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.808 0.813 . . . . 74.239999999999995 108.939 -170.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.447 ' HB3' HG22 ' A' ' 87' ' ' ILE . . . -79.29 -4.31 50.17 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.144 1.378 . . . . 72.329999999999998 112.866 176.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 123.21 22.66 2.31 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 117.163 1.625 . . . . 64.019999999999996 117.163 160.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.5 t -97.61 134.23 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 119.551 1.675 . . . . 70.420000000000002 109.667 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.422 ' HE2' ' OE2' ' A' ' 119' ' ' GLU . 0.8 OUTLIER -63.51 143.59 57.7 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 121.635 -0.666 . . . . 63.149999999999999 110.138 176.31 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.54 -10.89 76.36 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 119.565 -0.575 . . . . 71.340000000000003 112.749 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.422 ' OE2' ' HE2' ' A' ' 117' ' ' LYS . 6.9 pt-20 -92.3 -32.22 15.09 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 123.903 0.881 . . . . 63.030000000000001 110.326 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -70.09 -46.59 64.55 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 107.375 -1.343 . . . . 74.409999999999997 107.375 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -54.08 -60.12 3.75 Favored 'General case' 0 N--CA 1.438 -1.046 0 O-C-N 123.876 0.735 . . . . 73.439999999999998 109.437 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -75.22 -19.47 59.76 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 118.183 -0.913 . . . . 74.349999999999994 112.145 -171.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.64 -63.91 1.24 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.374 0.988 . . . . 73.430000000000007 108.876 172.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.77 -37.86 63.88 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.359 1.064 . . . . 70.040000000000006 110.581 -173.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -45.33 -36.72 4.33 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.675 1.59 . . . . 61.340000000000003 113.308 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -114.69 1.04 14.08 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.535 1.134 . . . . 72.319999999999993 112.976 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.8 t -77.36 147.18 36.24 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 126.215 1.806 . . . . 73.420000000000002 111.097 171.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.42 -27.79 26.36 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 118.703 2.853 . . . . 72.040000000000006 118.703 174.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 46.1 t -45.48 -57.15 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 C-N-CA 126.186 1.794 . . . . 74.349999999999994 107.924 167.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.3 t -68.65 -45.45 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 123.81 0.844 . . . . 70.209999999999994 109.576 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 58.3 mttt -54.41 -48.7 71.3 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.453 1.024 . . . . 74.129999999999995 112.428 -174.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 66.0 m -79.09 -22.0 45.88 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 113.183 0.809 . . . . 71.439999999999998 113.183 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 13.4 mt -69.15 -51.41 38.53 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 119.668 1.122 . . . . 63.119999999999997 110.172 167.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 52.9 t -49.84 -51.54 15.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.162 0 C-N-CA 125.209 1.404 . . . . 70.439999999999998 108.298 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.55 -39.09 75.89 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 118.067 -0.968 . . . . 65.150000000000006 113.101 -176.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -57.9 -46.56 84.76 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 119.399 0.999 . . . . 72.049999999999997 111.169 172.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.41 ' HB3' ' CE1' ' A' ' 60' ' ' HIS . 56.2 mt-30 -82.22 -31.61 30.18 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.901 -1.045 . . . . 71.010000000000005 109.226 -163.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -66.12 -52.74 45.74 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.635 -0.876 . . . . 73.519999999999996 108.635 167.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.9 ttmm -61.6 -7.77 3.68 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.132 -0.98 . . . . 63.350000000000001 113.449 177.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.4 -12.07 9.42 Favored 'General case' 0 CA--C 1.515 -0.394 0 O-C-N 120.27 -1.519 . . . . 72.209999999999994 114.545 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.508 ' HB1' HG12 ' A' ' 61' ' ' VAL . . . -134.17 1.01 3.18 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 119.038 0.835 . . . . 63.340000000000003 112.633 -175.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.32 0.85 4.6 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.835 1.654 . . . . 63.450000000000003 111.248 171.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -65.12 -86.56 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.878 0.871 . . . . 73.510000000000005 111.676 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.5 pp -175.81 23.95 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.351 0.978 . . . . 74.430000000000007 112.003 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -103.75 -71.91 0.72 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 120.151 1.341 . . . . 73.120000000000005 109.539 -168.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.53 -74.12 0.4 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 126.512 1.925 . . . . 61.43 110.431 -169.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 60.27 7.62 1.32 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 128.239 2.616 . . . . 71.450000000000003 115.304 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -147.18 146.42 16.22 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 109.034 -1.627 . . . . 63.310000000000002 109.034 176.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 5.2 m -137.14 169.15 13.99 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 118.271 1.035 . . . . 45.049999999999997 111.005 -172.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.426 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 69.3 Cg_endo -71.86 162.45 89.31 Favored 'Cis proline' 0 C--N 1.348 0.522 0 CA-C-N 119.596 0.892 . . . . 71.150000000000006 112.719 -10.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -150.56 156.53 41.57 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 124.252 0.97 . . . . 52.130000000000003 111.457 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 43.1 ttm -143.55 119.06 10.34 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.04 1.336 . . . . 63.030000000000001 107.749 169.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -97.36 132.02 43.48 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.927 1.291 . . . . 72.420000000000002 107.629 175.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 184' ' ' LEU . 95.8 t -96.23 -35.8 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 113.549 0.944 . . . . 65.030000000000001 113.549 -173.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -150.9 31.61 0.62 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.819 0.819 . . . . 64.010000000000005 109.571 -177.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 69.35 -64.73 0.57 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 126.194 1.854 . . . . 30.41 110.147 -162.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -58.95 -18.46 33.87 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 116.767 2.136 . . . . 71.230000000000004 116.767 -170.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -128.57 133.94 48.5 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 119.154 0.888 . . . . 74.349999999999994 111.252 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.79 137.15 52.28 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 105.773 -1.936 . . . . 63.009999999999998 105.773 175.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.07 143.11 58.07 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.744 -1.206 . . . . 72.010000000000005 107.744 176.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -124.66 75.55 64.03 Favored Pre-proline 0 C--O 1.234 0.275 0 C-N-CA 122.851 0.46 . . . . 61.039999999999999 110.22 -175.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -68.32 -22.56 39.62 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 120.831 1.021 . . . . 65.329999999999998 111.346 -172.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.55 -32.43 28.15 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 114.029 1.122 . . . . 50.240000000000002 114.029 171.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -103.13 4.78 48.98 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-O 118.325 -1.264 . . . . 70.040000000000006 112.687 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 62.1 mtt -80.3 174.49 11.55 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 119.814 1.807 . . . . 71.299999999999997 109.241 172.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -75.06 106.89 6.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.703 -1.592 . . . . 70.040000000000006 106.703 166.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.455 HG22 ' CD1' ' A' ' 173' ' ' PHE . 80.7 p -114.99 28.8 8.47 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.927 1.691 . . . . 72.439999999999998 109.444 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 75.2 m -108.95 -1.09 19.28 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 114.224 1.194 . . . . 31.140000000000001 114.224 -175.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -129.26 -9.93 4.7 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 124.386 1.074 . . . . 63.0 110.999 177.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 5.5 mmt 70.67 -58.97 0.54 Allowed 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.304 2.242 . . . . 74.400000000000006 112.262 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -58.52 -49.29 77.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 122.836 1.303 . . . . 72.099999999999994 109.699 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 93.3 t -63.56 -27.77 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 125.935 1.694 . . . . 52.420000000000002 111.433 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.455 ' CD1' HG22 ' A' ' 167' ' ' THR . 30.5 t80 -64.12 -59.24 4.69 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 107.8 -1.185 . . . . 71.109999999999999 107.8 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 5.9 t -69.19 -33.0 56.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 117.626 0.194 . . . . 74.040000000000006 110.913 -172.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.13 77.87 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.036 0.534 . . . . 73.239999999999995 111.23 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -82.6 -34.35 27.66 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 118.544 -0.741 . . . . 63.340000000000003 112.218 172.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -55.9 -57.64 11.25 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 120.208 1.367 . . . . 72.040000000000006 110.471 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.67 -30.46 67.38 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.411 0.684 . . . . 44.439999999999998 111.979 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -72.38 -50.83 23.68 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.44 1.496 . . . . 71.319999999999993 109.956 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.71 HG23 HG21 ' A' ' 3' ' ' ILE . 96.2 m -55.39 -39.16 69.8 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.165 1.386 . . . . 74.219999999999999 110.731 174.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 91.3 t -59.48 -58.41 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 108.101 -1.074 . . . . 64.299999999999997 108.101 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -59.99 -35.06 74.21 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.278 -0.868 . . . . 72.439999999999998 111.309 -177.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -59.96 -44.21 94.57 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 119.523 1.056 . . . . 70.219999999999999 110.78 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.443 ' HB2' HG11 ' A' ' 154' ' ' VAL . 77.9 mt -67.9 -25.5 65.53 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 121.047 -1.033 . . . . 65.109999999999999 111.835 -176.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 93.1 t -66.19 -22.08 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 O-C-N 121.253 -0.904 . . . . 64.129999999999995 111.177 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -102.96 -7.34 21.55 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.622 0.769 . . . . 72.209999999999994 110.401 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -125.94 75.72 1.53 Allowed 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.574 1.549 . . . . 74.030000000000001 109.24 -172.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.245 0.86 0 N-CA-C 106.019 -1.845 . . . . 62.140000000000001 106.019 167.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.407 0 N-CA-C 114.182 1.178 . . . . 72.329999999999998 114.182 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -159.89 120.74 3.09 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.588 -1.634 . . . . 62.43 106.588 171.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.2 pt -122.47 154.04 27.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 127.54 2.336 . . . . 72.430000000000007 106.869 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.0 m -129.21 134.77 48.14 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.075 -1.454 . . . . 71.319999999999993 107.075 -175.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -57.31 140.29 50.47 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 123.723 0.639 . . . . 54.5 109.667 170.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 84.61 -23.14 7.79 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.275 1.417 . . . . 73.340000000000003 112.587 -172.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.7 tptp -95.05 -85.53 0.31 Allowed 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 119.472 1.636 . . . . 72.310000000000002 109.092 -169.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -90.17 -19.13 24.59 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.983 0.913 . . . . 74.409999999999997 110.899 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -135.18 163.74 29.26 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.937 0.895 . . . . 73.0 109.53 171.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.5 mm -124.97 161.25 29.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 127.337 2.255 . . . . 61.329999999999998 105.525 174.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.6 m -119.68 147.61 44.36 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.804 1.242 . . . . 54.439999999999998 108.362 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 31.3 mt -76.35 155.74 33.88 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.022 -0.732 . . . . 70.0 109.022 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -71.81 -37.41 70.38 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 122.308 1.051 . . . . 74.140000000000001 109.681 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -132.91 74.76 73.6 Favored Pre-proline 0 C--N 1.339 0.129 0 C-N-CA 126.463 1.905 . . . . 74.120000000000005 109.356 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 N--CA 1.449 -1.094 0 C-N-CA 122.113 1.875 . . . . 53.420000000000002 107.588 171.068 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 C--O 1.239 0.515 0 N-CA-C 106.683 -1.599 . . . . 65.299999999999997 106.683 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.436 HD23 ' CE2' ' A' ' 25' ' ' PHE . 5.7 tp -162.05 169.69 20.55 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.165 -0.679 . . . . 65.319999999999993 109.165 163.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -136.72 131.02 32.91 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 106.715 -1.587 . . . . 74.019999999999996 106.715 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.436 ' CE2' HD23 ' A' ' 23' ' ' LEU . 96.0 m-85 -119.14 128.13 53.98 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 118.57 0.623 . . . . 71.209999999999994 109.82 171.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -141.18 173.32 11.6 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.503 1.121 . . . . 70.120000000000005 108.821 164.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.5 t -128.37 179.7 5.49 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.509 -0.552 . . . . 45.329999999999998 109.509 168.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -87.5 -35.17 18.36 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 118.241 -0.885 . . . . 74.329999999999998 111.845 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.411 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 96.9 m-85 -83.84 -3.12 57.64 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 121.157 1.799 . . . . 61.329999999999998 112.891 -177.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.7 p -80.04 141.01 53.98 Favored Pre-proline 0 CA--C 1.541 0.615 0 O-C-N 119.97 -1.706 . . . . 52.240000000000002 110.143 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -83.65 -35.3 0.24 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 121.866 1.711 . . . . 70.140000000000001 113.071 -170.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.82 -48.96 72.15 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 109.464 -0.569 . . . . 70.340000000000003 109.464 172.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.6 m -52.36 -33.88 45.13 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.065 1.346 . . . . 65.140000000000001 111.556 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -63.49 -55.73 21.73 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.819 0.736 . . . . 74.109999999999999 110.863 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -55.79 -44.29 77.63 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 121.185 -0.947 . . . . 65.299999999999997 109.024 175.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -64.71 -15.69 61.8 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 116.057 -1.925 . . . . 54.509999999999998 111.071 -174.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -141.54 12.79 2.13 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 121.457 1.935 . . . . 73.420000000000002 114.333 -171.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -135.69 -14.63 1.88 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.653 1.581 . . . . 72.120000000000005 112.115 167.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.2 t -124.34 -82.12 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.079 0 N-CA-C 107.795 -1.187 . . . . 65.310000000000002 107.795 -175.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.03 -29.36 67.22 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.714 2.006 . . . . 73.230000000000004 111.973 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 44.34 62.48 1.99 Allowed 'General case' 0 C--O 1.241 0.621 0 C-N-CA 126.005 1.722 . . . . 65.040000000000006 110.837 178.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.549 ' O ' HG23 ' A' ' 46' ' ' VAL . 99.7 t -63.05 -46.83 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 113.983 -1.462 . . . . 62.229999999999997 108.026 -173.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 95.2 p -49.72 -52.61 30.13 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.824 0.849 . . . . 54.340000000000003 111.014 -177.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.85 -31.8 65.01 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.132 0.573 . . . . 72.329999999999998 109.965 -171.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -64.73 -43.18 94.2 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 118.774 -0.632 . . . . 70.200000000000003 110.965 171.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 42' ' ' VAL . 1.9 t -59.57 -46.89 92.65 Favored 'Isoleucine or valine' 0 C--N 1.342 0.258 0 CA-C-N 119.251 0.932 . . . . 71.010000000000005 108.993 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -50.99 -42.13 60.09 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.193 0.997 . . . . 74.129999999999995 112.262 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -61.66 -5.43 1.91 Allowed 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.998 1.481 . . . . 63.409999999999997 114.998 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -127.08 -15.63 5.25 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.969 1.708 . . . . 71.329999999999998 113.219 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.553 HD13 HG21 ' A' ' 54' ' ' THR . 14.1 mt -67.71 149.68 98.17 Favored Pre-proline 0 N--CA 1.469 0.511 0 CA-C-N 119.964 1.256 . . . . 54.219999999999999 112.497 -164.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.19 151.83 27.04 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.449 2.766 . . . . 73.200000000000003 111.17 171.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -82.11 81.68 7.95 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 122.636 1.208 . . . . 73.129999999999995 109.091 -176.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 175.44 -30.42 0.08 OUTLIER Glycine 0 CA--C 1.521 0.439 0 C-N-CA 125.131 1.348 . . . . 52.329999999999998 110.665 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.553 HG21 HD13 ' A' ' 50' ' ' LEU . 10.7 t -44.02 -45.21 7.81 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.911 1.684 . . . . 74.439999999999998 113.398 -173.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? 59.48 99.63 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.626 1.97 . . . . 62.149999999999999 110.045 -169.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.79 125.67 25.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.361 -1.29 . . . . 43.450000000000003 107.65 172.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 m -137.32 161.71 35.51 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.075 -1.454 . . . . 74.030000000000001 107.075 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -151.51 110.45 3.87 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 104.335 -2.468 . . . . 71.25 104.335 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -104.36 136.68 43.48 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.836 -1.913 . . . . 73.129999999999995 105.836 168.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.54 ' H ' ' NE2' ' A' ' 137' ' ' GLN . 16.5 t-80 -82.86 169.68 15.81 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.043 -1.095 . . . . 71.450000000000003 108.043 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.3 m -131.22 136.22 58.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 108.698 -0.853 . . . . 74.040000000000006 108.698 170.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.47 5.18 11.29 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.626 1.17 . . . . 33.119999999999997 113.015 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -72.15 -177.43 2.09 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 122.71 1.243 . . . . 73.049999999999997 112.421 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 mp 63.8 -86.37 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 130.199 3.4 . . . . 71.219999999999999 112.588 177.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.411 ' HA3' ' CD2' ' A' ' 29' ' ' TYR . . . -72.7 160.87 54.23 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 124.03 0.824 . . . . 72.409999999999997 111.323 -176.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -65.27 -54.04 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.895 3.064 . . . . 45.310000000000002 110.052 -175.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.5 mt -73.62 8.78 1.68 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 117.777 -1.106 . . . . 73.010000000000005 113.425 -176.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -47.7 -33.19 8.87 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 120.135 1.334 . . . . 52.450000000000003 113.446 -177.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -58.61 -39.97 81.98 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.768 1.025 . . . . 74.109999999999999 113.768 175.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -62.21 -47.44 84.41 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.391 -0.966 . . . . 74.030000000000001 108.391 171.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.0 mt -54.18 -50.12 67.76 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 123.893 0.746 . . . . 52.549999999999997 110.191 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.7 m -57.29 -39.48 75.82 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.277 1.431 . . . . 72.439999999999998 112.955 173.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -68.04 -50.84 52.81 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.663 0.665 . . . . 74.030000000000001 110.375 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.78 -40.26 75.57 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 126.166 1.786 . . . . 52.310000000000002 111.678 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 46.2 t-105 -56.27 -35.21 67.19 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.041 0.536 . . . . 73.140000000000001 111.821 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.45 -40.36 94.2 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.246 -0.883 . . . . 65.340000000000003 111.798 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.5 t -57.46 -46.85 85.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 119.362 0.983 . . . . 72.349999999999994 108.896 172.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.16 -41.1 97.28 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-O 118.416 -0.802 . . . . 74.140000000000001 111.701 -176.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.7 mt -66.82 -43.36 89.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 118.107 -0.949 . . . . 65.219999999999999 109.765 175.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.29 93.81 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 119.185 0.902 . . . . 61.109999999999999 110.949 -174.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.8 mt -87.62 -12.52 45.32 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 119.038 -0.506 . . . . 73.019999999999996 112.265 175.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.44 61.83 6.66 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 126.148 1.832 . . . . 53.43 111.709 -174.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.9 m -134.18 20.23 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 125.361 1.464 . . . . 70.329999999999998 111.205 -177.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -50.38 -50.47 51.44 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.225 1.01 . . . . 71.25 110.0 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.18 -28.44 69.75 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.13 1.772 . . . . 52.329999999999998 110.623 -176.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -84.72 -25.24 28.48 Favored 'General case' 0 C--O 1.227 -0.11 0 C-N-CA 123.783 0.833 . . . . 74.349999999999994 111.671 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.1 pp -99.22 -15.4 7.44 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 CA-C-O 117.315 -1.326 . . . . 63.229999999999997 112.637 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.0 m -62.68 -45.7 91.57 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 119.863 1.21 . . . . 61.450000000000003 110.264 -170.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.526 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -56.8 -61.37 7.04 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 123.266 0.627 . . . . 61.420000000000002 111.385 -173.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 41.6 Cg_endo -66.72 -21.84 50.96 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.603 1.535 . . . . 72.140000000000001 112.735 -177.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.98 -53.77 53.98 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.08 0.952 . . . . 74.25 110.556 173.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -66.35 -33.32 75.47 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 118.083 0.401 . . . . 73.010000000000005 111.103 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.86 -38.25 81.59 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 120.15 -0.62 . . . . 64.409999999999997 110.925 169.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -86.52 -18.4 31.66 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 121.265 -0.897 . . . . 41.329999999999998 112.214 -168.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.7 t -107.93 -28.46 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 124.758 1.223 . . . . 73.049999999999997 109.822 -173.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -118.96 -53.5 2.27 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 118.887 0.767 . . . . 74.439999999999998 111.536 -173.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -64.99 -65.48 0.67 Allowed 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 118.62 0.645 . . . . 74.129999999999995 109.27 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.6 p -94.85 -18.29 21.31 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.04 0.536 . . . . 72.340000000000003 111.733 -170.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 45.34 39.79 4.71 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.503 2.321 . . . . 74.239999999999995 112.165 -175.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.0 t -73.77 -20.16 60.57 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.588 1.155 . . . . 72.420000000000002 111.466 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.417 HG13 HG12 ' A' ' 107' ' ' ILE . 31.9 t -69.38 117.87 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 108.29 -1.004 . . . . 65.420000000000002 108.29 172.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -137.6 -24.0 1.06 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.407 1.083 . . . . 74.109999999999999 111.575 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.43 177.34 11.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.079 2.152 . . . . 65.439999999999998 109.411 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.8 t -53.47 -46.0 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.264 1.826 . . . . 70.239999999999995 109.42 -173.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.04 -23.79 35.46 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.283 1.433 . . . . 65.019999999999996 112.713 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -91.83 -28.88 17.05 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 118.261 0.482 . . . . 54.240000000000002 110.091 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.417 HG12 HG13 ' A' ' 101' ' ' VAL . 0.5 OUTLIER -79.95 -46.34 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 123.205 0.602 . . . . 72.25 109.433 -175.093 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -25.35 61.83 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 112.932 0.715 . . . . 73.450000000000003 112.932 175.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -58.83 -52.46 65.62 Favored 'General case' 0 C--O 1.222 -0.342 0 N-CA-C 109.323 -0.621 . . . . 74.010000000000005 109.323 175.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.7 t -52.94 -43.69 47.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 123.862 0.865 . . . . 62.450000000000003 110.734 -176.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -55.1 -52.91 61.76 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.405 0.682 . . . . 73.430000000000007 110.392 175.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 96.7 t -65.64 -42.15 92.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 124.126 0.97 . . . . 72.150000000000006 111.242 -177.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.39 -51.26 65.4 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.673 1.589 . . . . 73.310000000000002 108.259 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.02 -13.64 60.89 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.408 1.083 . . . . 41.509999999999998 112.913 -178.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 118.08 32.89 1.32 Allowed Glycine 0 CA--C 1.524 0.612 0 C-N-CA 124.456 1.027 . . . . 64.150000000000006 114.92 165.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.9 t -97.96 134.96 34.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 119.452 1.626 . . . . 62.149999999999999 109.372 174.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.421 ' HG3' ' CB ' ' A' ' 120' ' ' ASP . 1.2 pttm -62.42 133.23 54.75 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.54 -1.209 . . . . 74.239999999999995 110.384 176.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.85 -20.73 66.81 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.061 -0.815 . . . . 70.129999999999995 111.061 168.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -76.84 -41.05 45.67 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.817 0.809 . . . . 74.439999999999998 111.163 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.421 ' CB ' ' HG3' ' A' ' 117' ' ' LYS . 36.8 t70 -69.84 -47.09 64.05 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 107.343 -1.354 . . . . 62.240000000000002 107.343 175.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -54.94 -52.48 62.87 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 123.778 0.673 . . . . 65.329999999999998 109.652 -172.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -72.24 -17.35 61.91 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.083 -1.011 . . . . 65.209999999999994 113.503 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.17 -71.56 0.47 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.074 -0.713 . . . . 74.450000000000003 109.074 172.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -46.46 -47.33 19.19 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 127.352 2.261 . . . . 61.310000000000002 109.886 -175.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 30.7 t-105 -48.77 -31.64 7.33 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.581 1.152 . . . . 64.209999999999994 113.288 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -113.05 3.18 16.01 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.277 2.231 . . . . 64.209999999999994 111.928 -176.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 21.8 m -93.93 159.11 15.32 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 126.266 1.827 . . . . 72.150000000000006 112.356 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -55.02 -34.11 63.21 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.259 1.823 . . . . 72.150000000000006 112.709 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.411 ' H ' HG23 ' A' ' 129' ' ' VAL . 14.5 t -51.71 -47.6 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.259 1.024 . . . . 72.340000000000003 110.166 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.3 t -72.77 -39.87 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 117.826 -1.083 . . . . 53.340000000000003 109.547 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.502 ' HA ' ' HE2' ' A' ' 131' ' ' LYS . 8.6 mmpt? -50.86 -48.78 60.07 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 120.713 1.597 . . . . 63.310000000000002 111.697 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 64.8 m -64.01 -49.87 70.75 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 122.217 -0.302 . . . . 70.010000000000005 111.546 175.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.4 mt -65.72 -32.06 73.41 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.202 0.816 . . . . 64.109999999999999 113.202 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 37.9 t -65.51 -62.58 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 126.169 1.788 . . . . 73.140000000000001 107.765 170.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.44 -39.89 58.29 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.649 0.78 . . . . 61.25 111.39 -175.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -47.62 -62.72 1.31 Allowed 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 117.383 -1.294 . . . . 71.150000000000006 110.574 175.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.54 ' NE2' ' H ' ' A' ' 60' ' ' HIS . 3.8 pt20 -81.41 -28.39 34.32 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 120.115 1.325 . . . . 74.120000000000005 113.997 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -59.19 -38.67 80.42 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 120.189 1.359 . . . . 74.140000000000001 108.736 176.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 8.4 tttt -79.46 -53.71 6.62 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.534 -0.729 . . . . 72.239999999999995 111.427 171.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.73 -6.95 6.35 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 117.255 -1.355 . . . . 73.239999999999995 113.704 -171.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.97 16.71 10.89 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.053 1.341 . . . . 54.329999999999998 113.457 172.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.13 4.61 1.08 Allowed 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.468 -0.77 . . . . 62.009999999999998 112.71 174.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.13 -79.04 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.535 1.134 . . . . 70.239999999999995 110.891 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -174.86 50.73 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.146 2.179 . . . . 34.43 110.359 175.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.479 ' NE2' ' H ' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -127.65 -55.2 1.32 Allowed 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.199 -0.938 . . . . 70.239999999999995 112.898 -175.24 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.479 ' H ' ' NE2' ' A' ' 145' ' ' GLN . 0.9 OUTLIER -147.18 143.69 28.39 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 128.08 2.552 . . . . 71.319999999999993 105.915 -172.435 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -137.33 14.91 3.0 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.11 0.964 . . . . 74.420000000000002 111.664 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -155.84 168.83 33.46 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.795 -1.322 . . . . 62.049999999999997 109.795 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.9 m -147.6 168.88 10.28 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.469 1.108 . . . . 73.420000000000002 111.102 -166.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.18 160.87 88.55 Favored 'Cis proline' 0 C--N 1.35 0.648 0 CA-C-N 119.953 1.019 . . . . 73.140000000000001 112.696 -9.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -149.61 154.51 38.77 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.611 0.764 . . . . 71.010000000000005 111.262 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 29.8 ttm -142.24 121.92 13.41 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.301 1.44 . . . . 70.319999999999993 107.258 172.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -94.28 152.62 18.54 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.737 1.615 . . . . 74.239999999999995 109.271 177.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.1 t -140.26 140.72 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.181 0.592 . . . . 65.430000000000007 109.948 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 44.67 30.34 0.51 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 129.17 2.988 . . . . 73.340000000000003 114.017 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 64.91 9.36 39.74 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.937 -0.924 . . . . 50.439999999999998 114.684 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -148.3 -2.8 0.51 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.431 1.615 . . . . 64.129999999999995 114.982 -165.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -131.07 161.84 31.15 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.931 1.292 . . . . 72.420000000000002 108.682 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -136.86 141.39 42.81 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.418 -1.697 . . . . 65.0 106.418 171.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.17 151.44 46.98 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 107.318 -1.364 . . . . 70.299999999999997 107.318 176.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -120.37 82.97 32.4 Favored Pre-proline 0 N--CA 1.462 0.138 0 CA-C-N 118.497 0.59 . . . . 72.030000000000001 111.474 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.48 -15.02 45.94 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 121.602 1.534 . . . . 74.219999999999999 113.608 175.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -90.21 -5.63 56.16 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 125.686 1.594 . . . . 74.409999999999997 111.225 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -117.67 18.01 11.91 Favored Glycine 0 CA--C 1.526 0.724 0 O-C-N 121.081 -1.012 . . . . 62.0 112.518 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 64.0 mtt -101.37 170.01 8.51 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.711 1.256 . . . . 63.030000000000001 110.398 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -66.05 120.92 13.99 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 105.893 -1.892 . . . . 74.129999999999995 105.893 158.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.432 1.1 t -136.38 63.01 1.6 Allowed 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 105.652 -1.981 . . . . 70.219999999999999 105.652 175.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.2 t -129.91 -15.77 3.79 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.171 1.788 . . . . 63.020000000000003 113.258 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -127.28 -3.32 6.24 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.0 1.273 . . . . 71.409999999999997 112.334 -174.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 7.9 mmt 62.81 -43.04 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 131.543 3.937 . . . . 53.140000000000001 114.618 -177.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.98 -48.84 33.0 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.281 -1.007 . . . . 50.409999999999997 108.281 -176.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 71.5 t -61.32 -28.57 44.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 125.342 1.457 . . . . 74.129999999999995 111.769 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -63.39 -57.69 9.51 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.167 -1.049 . . . . 74.099999999999994 108.167 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.9 t -74.67 -28.62 22.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 119.472 -0.299 . . . . 73.299999999999997 110.947 -175.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.97 -40.82 73.82 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.123 0.969 . . . . 65.010000000000005 110.761 175.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -83.87 -42.55 16.26 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 117.803 -1.094 . . . . 73.019999999999996 111.413 174.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -50.48 -55.65 15.04 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 120.202 1.365 . . . . 70.439999999999998 110.224 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -54.27 -34.51 60.98 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.902 0.881 . . . . 70.340000000000003 112.401 -177.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -78.47 -52.27 8.78 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.208 0.603 . . . . 74.319999999999993 109.852 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.2 t -58.03 -28.77 64.78 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-O 117.74 -1.124 . . . . 54.520000000000003 110.861 -176.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 61.0 t -54.95 -57.4 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 118.777 0.717 . . . . 74.219999999999999 109.463 170.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -32.2 71.84 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 119.1 0.864 . . . . 70.439999999999998 111.96 -178.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -60.11 -31.88 70.46 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 119.045 0.839 . . . . 72.409999999999997 110.527 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 29.0 mt -73.39 -28.41 62.0 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.342 -0.849 . . . . 65.230000000000004 111.793 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 74.9 t -65.53 -23.25 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.901 0.88 . . . . 73.0 111.306 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -99.15 -17.9 17.95 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.127 0.571 . . . . 74.430000000000007 109.962 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -102.77 77.74 1.62 Allowed 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 125.232 1.413 . . . . 65.400000000000006 108.526 -171.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? . . . . . 0 C--O 1.249 1.046 0 CA-C-O 114.502 -2.666 . . . . 65.109999999999999 112.962 -178.715 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.72 0.295 . . . . 71.040000000000006 111.112 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -175.17 110.45 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 71.439999999999998 110.933 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.746 HD12 ' CE2' ' A' ' 9' ' ' TYR . 5.0 pt -122.12 164.08 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 72.109999999999999 111.115 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.7 m -138.24 142.74 39.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 74.200000000000003 111.101 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -65.1 132.9 50.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 70.010000000000005 110.873 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.15 6.22 81.97 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.753 . . . . 72.519999999999996 112.518 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -117.47 -74.59 0.6 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.717 0.294 . . . . 33.109999999999999 110.839 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -101.19 -19.36 15.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.433 . . . . 65.439999999999998 110.918 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.746 ' CE2' HD12 ' A' ' 3' ' ' ILE . 20.3 p90 -144.66 157.9 44.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 70.439999999999998 110.942 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.738 HD13 ' O ' ' A' ' 9' ' ' TYR . 7.8 mm -129.69 160.76 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 64.549999999999997 111.149 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.408 ' N ' HG22 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -118.54 138.21 52.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 70.530000000000001 111.154 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' A' ' 157' ' ' LYS . 19.7 mt -67.84 151.67 46.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 51.25 110.827 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.14 -27.03 48.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 44.219999999999999 110.858 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -140.11 66.58 31.94 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.597 0.713 . . . . 75.549999999999997 110.913 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--N 1.341 0.183 0 C-N-CA 122.652 2.234 . . . . 75.439999999999998 112.419 179.864 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.487 HG12 ' H ' ' A' ' 155' ' ' ASN . 2.9 m . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.883 0.373 . . . . 71.049999999999997 111.154 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.77 HD11 ' CD1' ' A' ' 59' ' ' TYR . 15.7 tp -178.03 151.99 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 44.409999999999997 110.898 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -128.55 166.42 18.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 70.25 110.902 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.43 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 47.6 m-85 -144.45 136.69 26.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 73.530000000000001 110.866 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -173.14 147.63 1.6 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 64.409999999999997 110.931 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.3 t -101.1 -168.28 1.54 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 52.039999999999999 110.863 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.412 ' CD1' HD13 ' A' ' 71' ' ' LEU . 18.0 m-85 -115.8 -8.45 11.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 74.099999999999994 110.884 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.562 ' HE1' HD11 ' A' ' 71' ' ' LEU . 54.8 m-85 -113.76 18.59 17.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 74.430000000000007 110.911 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.8 p -103.38 138.61 19.59 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.567 0.698 . . . . 72.519999999999996 110.892 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.91 -41.84 3.75 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.707 2.271 . . . . 74.519999999999996 112.268 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -59.42 -64.22 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 72.219999999999999 110.789 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.6 p -49.78 -32.55 14.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.464 . . . . 74.510000000000005 110.885 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -63.75 -53.07 56.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 63.140000000000001 110.896 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -67.61 -11.01 57.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 74.409999999999997 110.864 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -104.08 0.94 30.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.31 -0.404 . . . . 73.099999999999994 110.924 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -141.53 13.1 2.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 74.140000000000001 110.913 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -141.99 -52.39 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 65.200000000000003 110.921 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 67.6 t -92.8 -78.42 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 64.340000000000003 111.114 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.8 mt -59.33 -41.44 89.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 44.439999999999998 110.841 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 2.2 m80 53.8 72.43 0.44 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 70.040000000000006 110.856 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.489 HG22 HG13 ' A' ' 174' ' ' VAL . 80.0 t -72.51 -33.89 46.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 61.229999999999997 111.124 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.5 t -52.74 -42.59 65.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 70.219999999999999 110.796 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -82.72 2.29 34.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.119 -0.492 . . . . 72.439999999999998 110.939 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -102.7 -21.36 14.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 73.329999999999998 110.867 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.67 HG12 ' HG ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -85.14 -53.92 9.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 65.219999999999999 110.929 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -46.59 -33.57 4.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 74.109999999999999 110.922 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -71.16 -30.95 67.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.481 . . . . 62.32 110.947 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 46' ' ' VAL . 4.2 mmmt -121.17 28.13 8.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 74.230000000000004 110.915 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.67 ' HG ' HG12 ' A' ' 46' ' ' VAL . 12.5 mt -104.42 144.24 28.31 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.59 0.709 . . . . 63.409999999999997 110.885 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.82 159.12 54.54 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.713 2.275 . . . . 74.340000000000003 112.23 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.94 59.35 2.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 73.25 110.848 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.45 35.68 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.779 -0.724 . . . . 62.219999999999999 112.438 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.666 HG21 HD13 ' A' ' 50' ' ' LEU . 10.9 t -103.07 -30.71 10.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.811 0.339 . . . . 60.030000000000001 111.129 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 62.89 107.65 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 63.119999999999997 110.928 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.75 102.03 8.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 63.049999999999997 110.93 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -105.36 -178.94 3.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 72.340000000000003 111.185 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.422 ' H ' HG22 ' A' ' 57' ' ' THR . 5.7 mttm 178.33 110.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 71.439999999999998 110.888 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.77 ' CD1' HD11 ' A' ' 23' ' ' LEU . 2.7 m-30 -101.14 124.49 46.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 74.219999999999999 110.939 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.853 ' CE1' HG22 ' A' ' 72' ' ' THR . 0.7 OUTLIER -60.84 175.14 0.52 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 61.530000000000001 110.862 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 60' ' ' HIS . 3.6 m -154.97 129.72 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 74.219999999999999 111.115 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.24 75.46 0.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 73.150000000000006 110.91 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -135.94 3.81 2.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 64.519999999999996 110.908 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.05 163.65 32.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.481 . . . . 54.229999999999997 110.906 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.84 155.25 0.12 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 42.32 112.465 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -42.83 3.09 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.642 2.228 . . . . 70.219999999999999 112.418 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.744 HD11 ' O ' ' A' ' 102' ' ' GLN . 92.7 mt -93.83 38.7 1.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.457 . . . . 63.210000000000001 110.968 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.32 -20.32 75.08 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.804 -0.713 . . . . 63.509999999999998 112.498 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -85.38 -33.94 21.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.801 0.334 . . . . 73.349999999999994 110.903 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.38 -46.82 72.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 65.519999999999996 110.849 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.594 HD23 HG21 ' A' ' 107' ' ' ILE . 3.6 mt -60.74 -37.49 81.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 71.439999999999998 110.918 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.853 HG22 ' CE1' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -50.14 -65.41 0.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 71.349999999999994 111.156 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -51.16 -44.33 61.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 74.239999999999995 110.837 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.413 ' HB1' ' CZ ' ' A' ' 111' ' ' PHE . . . -54.91 -35.92 64.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.406 . . . . 63.149999999999999 111.138 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 13.0 t-105 -53.66 -48.55 69.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 72.540000000000006 110.949 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.664 ' HB3' HG13 ' A' ' 130' ' ' VAL . . . -49.44 -41.83 41.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 72.049999999999997 111.1 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.509 HG11 ' CD2' ' A' ' 121' ' ' TYR . 74.7 t -61.33 -34.35 60.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.263 -0.426 . . . . 62.450000000000003 111.122 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.92 -35.59 64.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 44.549999999999997 111.103 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -79.12 -33.13 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 74.340000000000003 111.092 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.77 -34.34 77.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 74.340000000000003 111.064 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.629 HD21 ' CG ' ' A' ' 120' ' ' ASP . 91.5 mt -98.86 -21.66 16.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 55.140000000000001 110.915 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.98 57.05 3.12 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.806 -0.711 . . . . 75.209999999999994 112.512 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.708 HG12 ' HD2' ' A' ' 86' ' ' LYS . 13.5 m -143.97 39.87 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.735 0.303 . . . . 64.150000000000006 111.115 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.04 -54.07 30.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 73.430000000000007 110.839 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.73 -17.82 57.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 51.420000000000002 110.827 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.708 ' HD2' HG12 ' A' ' 83' ' ' VAL . 14.8 mtpt -83.62 -27.18 29.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 71.040000000000006 110.891 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.712 HD13 ' CZ ' ' A' ' 111' ' ' PHE . 1.5 pp -114.08 41.32 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 73.310000000000002 111.122 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 66.8 m -118.46 -26.82 6.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 65.319999999999993 111.147 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.788 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -69.9 -60.99 3.22 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.593 0.711 . . . . 50.439999999999998 111.033 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 53.4 Cg_endo -69.72 -30.59 22.24 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.721 2.281 . . . . 70.420000000000002 112.309 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 33.4 tpp -60.39 -29.73 69.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.439 . . . . 52.009999999999998 110.869 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -90.41 -33.94 15.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.288 -0.414 . . . . 74.439999999999998 110.883 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -76.8 -8.69 57.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 73.430000000000007 110.881 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.604 ' HB1' HG22 ' A' ' 100' ' ' THR . . . -111.69 0.83 16.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 53.310000000000002 111.088 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.441 ' CG2' HG21 ' A' ' 101' ' ' VAL . 65.7 t -121.15 -30.65 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 65.299999999999997 111.149 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -110.5 -57.99 2.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 74.5 110.853 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -58.54 -76.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 64.420000000000002 110.838 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.4 p -83.49 -33.49 25.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 74.400000000000006 111.089 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 62.11 34.52 16.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 71.120000000000005 110.948 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.604 HG22 ' HB1' ' A' ' 94' ' ' ALA . 12.3 t -66.35 -19.79 65.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 72.540000000000006 111.142 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.697 HG13 HG12 ' A' ' 107' ' ' ILE . 53.5 t -64.36 115.29 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.32 -0.4 . . . . 62.329999999999998 111.07 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.744 ' O ' HD11 ' A' ' 67' ' ' LEU . 11.7 mt-30 -131.4 -39.68 1.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 65.230000000000004 110.937 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.49 166.04 22.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 62.130000000000003 110.817 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.0 t -57.87 -21.69 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.112 -0.495 . . . . 53.310000000000002 111.129 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.78 -5.29 52.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 32.32 111.128 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -108.42 -24.37 11.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 74.540000000000006 110.864 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.697 HG12 HG13 ' A' ' 101' ' ' VAL . 2.3 mt -84.37 -25.17 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 73.430000000000007 111.111 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.83 -26.61 49.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 74.340000000000003 110.811 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -62.5 -53.99 46.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.42 . . . . 71.150000000000006 110.883 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.475 HG13 ' HB2' ' A' ' 90' ' ' PRO . 99.8 t -50.62 -45.02 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.255 -0.429 . . . . 73.129999999999995 111.114 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.712 ' CZ ' HD13 ' A' ' 87' ' ' ILE . 7.9 m-85 -54.38 -48.28 71.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 74.450000000000003 110.905 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 89.7 t -69.37 -42.15 81.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 52.229999999999997 111.156 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.81 -22.33 35.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 72.5 110.877 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -86.09 -27.82 24.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 63.340000000000003 111.096 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.8 -20.54 1.63 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.787 -0.72 . . . . 65.129999999999995 112.523 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 93.9 t -51.46 133.79 12.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.896 0.379 . . . . 71.439999999999998 111.123 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.554 ' HE2' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -79.59 139.56 37.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 60.049999999999997 110.878 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.69 -8.18 59.87 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.693 -0.765 . . . . 44.240000000000002 112.481 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -90.0 -30.14 17.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.829 0.347 . . . . 74.450000000000003 110.908 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.629 ' CG ' HD21 ' A' ' 81' ' ' LEU . 17.6 t70 -88.69 -34.56 17.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 75.230000000000004 110.855 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.509 ' CD2' HG11 ' A' ' 77' ' ' VAL . 24.7 t80 -75.73 -30.63 59.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.472 . . . . 75.540000000000006 110.931 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -88.55 -10.84 47.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 73.319999999999993 110.834 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -106.12 -60.29 1.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 13.4 111.058 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.17 -38.33 57.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 61.140000000000001 111.141 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 21.7 t-105 -48.45 -39.68 23.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.43 . . . . 65.150000000000006 110.956 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -110.84 39.13 2.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 73.310000000000002 110.932 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 75.2 m -123.87 166.17 16.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 71.349999999999994 110.913 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -64.38 -34.63 78.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 75.409999999999997 110.862 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 38.6 t -50.15 -50.81 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 71.109999999999999 111.108 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.718 ' O ' HG23 ' A' ' 134' ' ' VAL . 41.0 t -72.8 -33.78 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.125 -0.488 . . . . 71.340000000000003 111.103 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.4 -59.01 6.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 52.049999999999997 110.895 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.19 -42.45 63.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 75.549999999999997 110.869 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.493 HD13 ' HA ' ' A' ' 76' ' ' ALA . 5.5 mt -58.66 -59.99 4.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 75.510000000000005 110.888 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 130' ' ' VAL . 39.9 t -48.4 -36.46 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 71.239999999999995 111.046 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.81 -49.3 71.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 64.219999999999999 111.093 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 47.4 mm-40 -54.15 -51.17 65.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 75.109999999999999 110.977 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -67.19 -50.39 61.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 74.140000000000001 110.957 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.492 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 20.0 mm-40 -59.16 -20.09 50.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 61.32 110.877 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -101.96 -15.36 16.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 63.350000000000001 110.893 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -100.5 -6.16 25.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 43.340000000000003 111.1 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.65 -4.45 8.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 74.319999999999993 111.143 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -120.47 0.11 10.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 52.009999999999998 111.138 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -69.98 -84.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 62.530000000000001 110.838 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 174.63 36.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.405 . . . . 74.549999999999997 110.896 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.457 ' NE2' ' H ' ' A' ' 145' ' ' GLN . 0.1 OUTLIER -120.7 -15.37 8.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 72.140000000000001 110.945 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.637 HD11 ' CB ' ' A' ' 151' ' ' ALA . 0.6 OUTLIER -164.15 146.87 9.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 65.420000000000002 110.837 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -152.56 20.05 0.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 74.109999999999999 110.906 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -144.9 167.1 27.3 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.793 -0.718 . . . . 65.540000000000006 112.467 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.492 ' HA ' ' C ' ' A' ' 150' ' ' PRO . 2.3 m -154.28 158.48 32.38 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.579 0.704 . . . . 65.129999999999995 111.187 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 149' ' ' VAL . 54.4 Cg_endo -69.64 167.74 69.62 Favored 'Cis proline' 0 C--N 1.341 0.153 0 C-N-CA 122.644 -1.815 . . . . 62.229999999999997 112.4 -0.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.637 ' CB ' HD11 ' A' ' 146' ' ' LEU . . . -157.27 109.26 2.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 42.329999999999998 111.04 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 2.5 ttm -106.11 114.93 29.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.419 . . . . 74.409999999999997 110.888 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.603 ' HE2' HD13 ' A' ' 146' ' ' LEU . 35.1 m-85 -94.33 129.21 41.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 70.25 110.898 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.706 HG11 ' HB2' ' A' ' 184' ' ' LEU . 31.9 t -108.9 121.86 62.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.49 . . . . 60.329999999999998 111.09 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.487 ' H ' HG12 ' A' ' 22' ' ' VAL . 0.7 OUTLIER 74.39 -60.16 0.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 75.25 110.88 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 151.02 -15.9 0.9 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.841 -0.695 . . . . 73.430000000000007 112.476 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.475 ' HA ' HD12 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -125.75 39.18 4.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.756 0.312 . . . . 74.109999999999999 110.904 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.421 ' CG ' HD22 ' A' ' 184' ' ' LEU . 78.3 m-85 -153.29 155.93 37.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 71.450000000000003 110.926 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -144.68 115.43 7.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 64.329999999999998 110.89 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.635 HD11 HG23 ' A' ' 180' ' ' THR . 3.4 mm? -51.34 140.36 17.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 63.509999999999998 110.903 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -122.33 76.62 43.68 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.607 0.718 . . . . 70.209999999999994 110.873 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -7.52 21.26 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.656 2.237 . . . . 63.509999999999998 112.393 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.27 -25.33 54.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 72.510000000000005 110.896 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -95.36 -8.95 58.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.777 -0.725 . . . . 50.219999999999999 112.503 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 6.9 mtt -77.6 173.35 12.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.784 0.326 . . . . 62.409999999999997 110.858 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -85.16 87.35 7.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 70.299999999999997 110.897 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.639 HG22 ' CD1' ' A' ' 173' ' ' PHE . 19.4 p -93.05 39.44 1.04 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 74.329999999999998 111.162 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.8 m -109.37 -14.16 14.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 73.200000000000003 110.864 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.38 -16.51 9.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 73.340000000000003 110.851 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.439 ' HE2' ' HA ' ' A' ' 170' ' ' MET . 7.4 mmt 71.94 -64.85 0.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 73.430000000000007 110.882 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.42 -45.68 69.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 53.539999999999999 110.849 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 63.6 t -69.83 -36.35 69.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 71.230000000000004 111.105 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.639 ' CD1' HG22 ' A' ' 167' ' ' THR . 30.2 t80 -55.53 -70.06 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 63.420000000000002 110.822 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.489 HG13 HG22 ' A' ' 42' ' ' VAL . 21.7 t -54.59 -37.95 40.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 64.230000000000004 111.13 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.2 -43.67 61.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 62.240000000000002 111.129 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -80.62 -33.48 35.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 70.299999999999997 110.884 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.626 ' O ' HG23 ' A' ' 181' ' ' VAL . 49.1 t80 -51.35 -65.94 0.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 74.340000000000003 110.923 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.85 -25.12 10.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 61.409999999999997 111.056 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -70.55 -55.12 9.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 72.239999999999995 110.86 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.635 HG23 HD11 ' A' ' 160' ' ' LEU . 7.1 t -65.36 -29.06 69.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 73.230000000000004 111.13 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 177' ' ' TYR . 84.1 t -68.39 -39.28 80.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 71.120000000000005 111.073 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.54 -21.89 41.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 75.439999999999998 110.907 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -81.3 -20.87 39.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.422 . . . . 70.120000000000005 110.853 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.706 ' HB2' HG11 ' A' ' 154' ' ' VAL . 20.0 mt -79.74 -35.56 38.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.302 -0.408 . . . . 74.129999999999995 110.889 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 87.0 t -59.77 -23.25 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 72.209999999999994 111.15 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -109.69 -5.24 15.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 73.219999999999999 110.846 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -105.7 28.96 6.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 75.019999999999996 110.921 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 74.049999999999997 110.832 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.593 0 N-CA-C 114.781 1.4 . . . . 74.310000000000002 114.781 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -155.51 106.47 2.53 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 127.979 2.512 . . . . 65.010000000000005 107.255 -161.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.7 pt -129.44 149.45 33.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 127.219 2.208 . . . . 71.209999999999994 106.884 178.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.4 m -109.35 130.48 55.49 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.209 -1.034 . . . . 63.329999999999998 108.209 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -44.3 124.31 3.95 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 126.505 1.922 . . . . 70.349999999999994 110.155 159.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.67 -15.06 53.92 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 126.945 2.212 . . . . 74.409999999999997 113.653 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -95.02 -85.88 0.3 Allowed 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 119.98 1.89 . . . . 74.140000000000001 108.154 -174.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -85.75 -16.64 38.24 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.971 0.805 . . . . 71.230000000000004 111.394 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -139.64 163.1 33.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.637 0.375 . . . . 73.439999999999998 110.601 172.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.8 mm -120.64 158.18 23.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.651 -1.611 . . . . 74.019999999999996 106.651 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.4 m -109.56 134.47 51.88 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 126.001 1.72 . . . . 71.349999999999994 107.606 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.2 mt -84.04 144.9 28.78 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 108.031 -1.1 . . . . 64.219999999999999 108.031 172.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -76.08 -31.61 58.84 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.191 1.396 . . . . 74.439999999999998 111.397 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm -127.84 74.29 78.63 Favored Pre-proline 0 N--CA 1.455 -0.19 0 C-N-CA 125.439 1.496 . . . . 74.420000000000002 109.026 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo . . . . . 0 N--CA 1.45 -1.035 0 C-N-CA 123.319 2.679 . . . . 62.450000000000003 109.511 174.102 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.614 HG11 ' H ' ' A' ' 55' ' ' LYS . 14.3 p . . . . . 0 C--O 1.242 0.68 0 N-CA-C 109.67 -0.493 . . . . 55.520000000000003 109.67 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -169.2 172.17 7.53 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.394 1.078 . . . . 74.030000000000001 110.953 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -130.75 148.55 52.55 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.585 1.954 . . . . 74.239999999999995 107.632 154.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -115.24 143.0 45.91 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.502 1.521 . . . . 73.430000000000007 107.658 164.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -153.77 165.63 35.41 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.326 1.451 . . . . 73.340000000000003 108.607 175.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.86 179.15 4.05 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.918 1.287 . . . . 74.310000000000002 108.249 175.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -97.54 -23.71 15.89 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.913 -0.492 . . . . 72.329999999999998 110.638 171.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -105.82 12.64 30.57 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.748 1.619 . . . . 74.450000000000003 111.876 -177.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.7 p -84.11 143.76 43.11 Favored Pre-proline 0 CA--C 1.541 0.602 0 O-C-N 120.274 -1.516 . . . . 72.519999999999996 109.562 167.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -83.11 -33.69 0.39 Allowed 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 121.832 1.688 . . . . 74.329999999999998 110.005 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -49.48 -60.57 2.73 Favored 'General case' 0 C--N 1.337 0.062 0 C-N-CA 125.881 1.673 . . . . 74.109999999999999 110.155 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 23.6 p -62.74 -34.72 77.78 Favored 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 123.227 0.611 . . . . 73.409999999999997 111.088 -176.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -56.45 -52.27 65.31 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.886 -0.783 . . . . 74.439999999999998 108.886 173.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -57.66 -44.78 85.96 Favored 'General case' 0 C--O 1.224 -0.248 0 O-C-N 121.081 -1.012 . . . . 71.200000000000003 109.174 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -68.05 -12.99 61.85 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.411 1.084 . . . . 74.109999999999999 113.231 -174.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -130.76 2.77 4.46 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.181 1.355 . . . . 73.430000000000007 110.747 -166.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -144.44 -48.01 0.26 Allowed 'General case' 0 C--N 1.345 0.408 0 C-N-CA 125.574 1.549 . . . . 72.439999999999998 112.527 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.1 t -91.87 -72.63 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 105.898 -1.89 . . . . 52.439999999999998 105.898 -173.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.8 mt -73.1 -26.08 61.12 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.043 1.737 . . . . 73.200000000000003 111.981 -175.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 29.2 m80 44.72 60.07 3.08 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 122.752 1.263 . . . . 71.239999999999995 112.118 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 46' ' ' VAL . 93.4 t -57.92 -54.8 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.437 1.495 . . . . 65.019999999999996 107.334 170.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.71 -43.18 36.96 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.338 1.055 . . . . 70.219999999999999 113.329 -178.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -73.61 -42.55 61.35 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.256 -0.903 . . . . 74.239999999999995 110.836 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -56.77 -51.99 66.78 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 123.507 0.723 . . . . 72.409999999999997 110.098 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.679 HG12 ' HG ' ' A' ' 50' ' ' LEU . 15.6 t -61.64 -43.88 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 108.364 -0.976 . . . . 73.230000000000004 108.364 -175.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -49.93 -46.03 51.71 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.717 1.598 . . . . 74.219999999999999 112.553 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -61.4 -20.97 63.66 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.751 1.019 . . . . 74.400000000000006 113.751 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -114.01 -7.17 13.12 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.089 0.956 . . . . 71.319999999999993 111.816 -175.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.679 ' HG ' HG12 ' A' ' 46' ' ' VAL . 13.1 mt -70.65 143.75 90.25 Favored Pre-proline 0 C--O 1.239 0.501 0 O-C-N 120.881 -1.137 . . . . 73.319999999999993 109.416 -173.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -76.31 169.57 21.71 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.777 2.318 . . . . 71.230000000000004 108.905 167.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.531 ' CD ' ' H ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -82.82 23.09 0.85 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 124.774 1.229 . . . . 73.019999999999996 113.44 -176.11 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -119.81 -19.04 4.17 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 126.61 2.052 . . . . 60.109999999999999 111.725 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 77.6 m -121.09 101.55 7.74 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 106.838 -1.541 . . . . 72.150000000000006 106.838 -164.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.614 ' H ' HG11 ' A' ' 22' ' ' VAL . 3.2 tppt? -87.68 126.62 35.07 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.55 0.74 . . . . 74.329999999999998 109.913 -177.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.02 45.75 0.28 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.415 1.886 . . . . 73.030000000000001 112.426 171.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.4 m -53.99 145.04 17.49 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.926 1.291 . . . . 74.239999999999995 108.651 173.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -131.55 99.46 4.81 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.152 -1.055 . . . . 73.120000000000005 108.152 -166.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -95.37 150.61 20.09 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.319 1.048 . . . . 73.219999999999999 110.066 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.586 ' CE1' HG22 ' A' ' 72' ' ' THR . 0.3 OUTLIER -88.0 175.58 7.7 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.451 -0.944 . . . . 65.129999999999995 108.451 -176.153 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -145.0 163.28 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 107.563 -1.273 . . . . 70.430000000000007 107.563 156.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.61 -5.42 10.72 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.654 1.182 . . . . 71.109999999999999 113.607 -174.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -58.15 -11.23 2.41 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.489 1.915 . . . . 74.109999999999999 115.244 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 mp -127.81 137.61 52.44 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 120.916 1.689 . . . . 73.439999999999998 110.702 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.96 170.44 45.27 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.746 2.117 . . . . 50.030000000000001 112.291 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.72 -53.21 0.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 124.514 3.476 . . . . 64.239999999999995 111.675 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.473 HD13 HD11 ' A' ' 107' ' ' ILE . 5.2 mt -84.4 14.32 4.57 Favored 'General case' 0 CA--C 1.528 0.104 0 N-CA-C 113.887 1.069 . . . . 73.450000000000003 113.887 -165.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.639 ' HA2' HD12 ' A' ' 71' ' ' LEU . . . -53.57 -38.9 59.33 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-O 118.873 -0.96 . . . . 33.229999999999997 112.846 -163.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp -53.6 -38.1 63.65 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.937 1.695 . . . . 61.25 113.327 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.435 ' OD1' HG22 ' A' ' 104' ' ' VAL . 9.8 t70 -76.3 -45.35 32.81 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 118.614 -0.707 . . . . 72.129999999999995 109.154 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.639 HD12 ' HA2' ' A' ' 68' ' ' GLY . 15.4 mt -54.98 -37.32 66.38 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 118.789 -0.624 . . . . 73.25 110.646 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.586 HG22 ' CE1' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -57.49 -52.9 63.52 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.987 0.915 . . . . 74.329999999999998 109.086 177.292 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -69.18 -50.44 47.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.294 -0.632 . . . . 74.430000000000007 109.294 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.0 -37.17 63.73 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.553 1.07 . . . . 71.310000000000002 113.607 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 29.8 t-105 -59.85 -38.37 81.89 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 119.759 1.163 . . . . 74.549999999999997 112.016 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.94 -39.66 74.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 118.633 -0.698 . . . . 73.430000000000007 111.31 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' A' ' 124' ' ' ALA . 56.3 t -56.41 -49.22 78.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 118.817 0.735 . . . . 74.530000000000001 109.543 174.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.97 -40.27 97.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 118.677 -0.678 . . . . 74.450000000000003 111.018 -175.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.0 mt -69.24 -40.27 80.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 118.157 -0.925 . . . . 65.230000000000004 110.417 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.36 -30.83 69.8 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.097 0.862 . . . . 74.049999999999997 110.818 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.7 mt -94.29 -14.99 24.86 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.824 0.85 . . . . 74.439999999999998 112.532 175.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 59.94 64.32 4.29 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 126.306 1.908 . . . . 71.430000000000007 112.3 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.9 m -137.42 19.9 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 124.362 1.065 . . . . 61.420000000000002 112.217 -177.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -50.69 -52.34 40.95 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.563 1.074 . . . . 73.030000000000001 111.251 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -60.07 -17.08 36.93 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.866 1.666 . . . . 72.109999999999999 114.219 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -94.85 -9.16 35.19 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.275 1.03 . . . . 72.439999999999998 110.748 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.5 pp -136.1 33.53 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 125.033 1.333 . . . . 65.319999999999993 110.875 -173.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 52.5 m -111.47 -41.62 4.07 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 118.8 -0.619 . . . . 71.109999999999999 110.382 177.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.44 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -66.85 -60.64 5.98 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 119.183 0.901 . . . . 70.409999999999997 110.958 -175.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 33.2 Cg_endo -62.53 -28.1 77.23 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 120.541 0.828 . . . . 72.510000000000005 111.286 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 29.4 tpp -59.41 -50.55 73.53 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.374 1.07 . . . . 71.510000000000005 110.846 176.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -72.34 -31.21 65.45 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.949 0.9 . . . . 50.439999999999998 109.786 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.65 -36.8 81.85 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.726 0.694 . . . . 74.409999999999997 109.626 171.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -85.91 -13.1 48.82 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.322 -0.861 . . . . 70.120000000000005 112.239 -176.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.7 t -101.5 -39.29 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 125.382 1.473 . . . . 72.230000000000004 111.722 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -109.78 -59.35 1.93 Allowed 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.544 1.137 . . . . 61.409999999999997 109.296 -172.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -67.0 -50.96 60.61 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 118.45 -0.786 . . . . 72.329999999999998 111.164 -169.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.9 p -104.86 -19.68 13.81 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 123.691 0.619 . . . . 64.400000000000006 112.658 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 53.72 23.76 3.9 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.51 1.924 . . . . 71.310000000000002 113.903 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -66.14 -18.16 65.17 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.361 1.064 . . . . 73.400000000000006 111.539 -173.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.405 HG13 HG12 ' A' ' 107' ' ' ILE . 53.0 t -62.13 119.56 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 121.141 -0.975 . . . . 53.109999999999999 108.479 171.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -141.54 -26.52 0.69 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.899 1.28 . . . . 71.420000000000002 111.377 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.37 160.92 39.11 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.179 -1.415 . . . . 72.239999999999995 107.179 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.435 HG22 ' OD1' ' A' ' 70' ' ' ASP . 24.2 t -57.65 -28.05 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.722 0.809 . . . . 71.310000000000002 110.718 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.9 -29.91 71.04 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.365 1.466 . . . . 74.430000000000007 110.185 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.92 -19.36 24.64 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.266 0.626 . . . . 65.510000000000005 111.385 -175.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.473 HD11 HD13 ' A' ' 67' ' ' LEU . 1.4 mt -82.57 -45.03 19.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 123.855 0.862 . . . . 72.209999999999994 108.958 174.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -59.57 -26.49 65.45 Favored 'General case' 0 C--N 1.346 0.441 0 O-C-N 121.557 -0.715 . . . . 72.129999999999995 112.299 -176.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -54.93 -55.24 32.86 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.301 1.04 . . . . 74.430000000000007 110.442 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.9 t -52.84 -45.64 50.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 124.933 1.293 . . . . 73.319999999999993 109.975 -175.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -55.8 -54.07 48.91 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.659 0.784 . . . . 74.150000000000006 110.149 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 17.5 t -66.59 -38.51 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 118.024 0.375 . . . . 50.130000000000003 110.27 -174.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -63.5 -32.01 73.34 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.126 0.971 . . . . 74.230000000000004 111.068 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -83.8 -3.38 57.81 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.673 1.189 . . . . 64.329999999999998 113.838 173.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.2 14.48 16.55 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-N 119.558 1.072 . . . . 53.530000000000001 115.332 171.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.9 t -77.66 128.28 38.15 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.055 0 CA-C-N 119.593 1.696 . . . . 43.219999999999999 108.545 172.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -57.26 129.38 41.5 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.686 -0.857 . . . . 70.349999999999994 108.686 170.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -59.55 -22.82 57.41 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 118.173 -1.349 . . . . 51.340000000000003 112.341 173.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.4 -23.41 21.07 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.876 1.338 . . . . 75.25 110.764 -177.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -70.59 -42.49 70.96 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 107.457 -1.312 . . . . 64.549999999999997 107.457 177.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.417 ' CD1' HG21 ' A' ' 77' ' ' VAL . 53.7 t80 -61.54 -59.47 5.17 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 124.181 0.926 . . . . 73.209999999999994 110.028 177.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -66.55 -16.73 64.37 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.276 0.489 . . . . 61.420000000000002 111.336 -176.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.43 -64.98 0.95 Allowed 'General case' 0 C--N 1.341 0.21 0 O-C-N 121.092 -1.005 . . . . 73.540000000000006 109.023 169.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.565 ' HB3' HG22 ' A' ' 77' ' ' VAL . . . -52.28 -43.35 64.4 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.272 1.029 . . . . 71.319999999999993 110.246 -175.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -46.07 -41.54 12.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.675 1.59 . . . . 73.25 112.23 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -103.94 -2.47 26.08 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.995 1.318 . . . . 63.140000000000001 111.553 -173.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.8 t -84.91 157.05 20.96 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 127.017 2.127 . . . . 72.209999999999994 111.495 -175.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -57.76 -31.15 66.22 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 125.505 1.522 . . . . 73.530000000000001 111.552 169.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 42.3 t -52.68 -50.1 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 119.248 0.931 . . . . 75.150000000000006 108.933 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.4 t -68.99 -39.89 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-O 118.923 -0.561 . . . . 74.129999999999995 110.42 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -53.71 -51.48 63.14 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.187 0.903 . . . . 74.439999999999998 110.685 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 t -67.34 -37.07 82.68 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.346 1.059 . . . . 64.510000000000005 111.207 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.88 -53.24 49.78 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-O 117.493 -1.241 . . . . 75.109999999999999 110.753 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 53.4 t -52.19 -38.74 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.178 1.391 . . . . 72.140000000000001 110.405 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.7 -34.77 76.34 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 118.361 -0.828 . . . . 75.140000000000001 112.777 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -55.32 -58.52 7.39 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.795 0.725 . . . . 71.319999999999993 110.655 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.485 ' HB2' ' CE1' ' A' ' 60' ' ' HIS . 0.9 OUTLIER -84.68 -33.3 23.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.182 -0.913 . . . . 62.310000000000002 110.951 -168.344 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -57.43 -52.92 63.41 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 119.145 0.884 . . . . 74.129999999999995 109.11 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -55.06 -48.49 73.4 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 110.144 -0.317 . . . . 75.129999999999995 110.144 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.9 -12.04 15.99 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 113.763 1.023 . . . . 75.25 113.763 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -130.14 18.65 5.46 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.809 1.244 . . . . 75.329999999999998 111.724 176.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -132.23 2.39 3.9 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.424 1.89 . . . . 72.530000000000001 111.651 173.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -83.51 22.77 1.01 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.036 1.734 . . . . 71.510000000000005 111.276 169.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 62.92 -16.89 0.05 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 130.375 3.47 . . . . 73.120000000000005 117.342 -175.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.56 -26.22 50.69 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 119.997 1.271 . . . . 61.549999999999997 111.942 -167.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 tt -134.56 111.98 10.49 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 126.2 1.8 . . . . 73.239999999999995 106.414 -173.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -140.63 22.09 2.33 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 127.306 2.242 . . . . 73.120000000000005 108.619 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -162.86 114.21 0.59 Allowed Glycine 0 C--N 1.337 0.595 0 N-CA-C 109.943 -1.263 . . . . 45.109999999999999 109.943 -171.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.521 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 2.7 m -120.91 171.01 6.37 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 118.239 1.02 . . . . 73.209999999999994 110.386 -176.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.521 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 91.2 Cg_endo -68.97 153.65 90.99 Favored 'Cis proline' 0 N--CA 1.456 -0.679 0 CA-C-N 120.342 1.158 . . . . 61.450000000000003 111.237 -4.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -146.81 108.6 4.36 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.564 -0.902 . . . . 54.329999999999998 108.564 -173.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 39.0 ttm -101.57 135.02 43.79 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.963 -1.125 . . . . 73.420000000000002 107.963 173.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -123.18 154.23 38.98 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.534 1.534 . . . . 74.230000000000004 107.982 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 96.6 t -115.23 -48.09 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 112.9 0.704 . . . . 72.310000000000002 112.9 -163.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -144.55 33.2 1.17 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 128.16 2.584 . . . . 74.439999999999998 107.609 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 65.63 5.33 23.27 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.469 1.509 . . . . 72.150000000000006 115.759 -175.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.416 ' HE2' ' CZ ' ' A' ' 158' ' ' TYR . 9.9 ptmt -124.57 -16.3 6.32 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 120.357 2.079 . . . . 71.439999999999998 114.725 -172.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.416 ' CZ ' ' HE2' ' A' ' 157' ' ' LYS . 23.3 m-85 -126.79 124.28 39.32 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.701 -1.592 . . . . 73.010000000000005 106.701 -176.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -98.69 135.47 40.14 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 105.706 -1.961 . . . . 53.310000000000002 105.706 172.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -74.91 146.0 42.2 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.936 -0.765 . . . . 73.329999999999998 108.936 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -119.6 85.24 32.16 Favored Pre-proline 0 C--O 1.233 0.211 0 N-CA-C 112.864 0.691 . . . . 72.329999999999998 112.864 -175.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -67.11 -22.13 47.79 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 121.282 1.321 . . . . 73.299999999999997 113.614 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.7 tp60 -68.68 -34.29 75.42 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 119.79 1.177 . . . . 73.0 110.093 176.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -92.02 30.76 6.4 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-O 118.966 -0.908 . . . . 64.439999999999998 111.177 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.6 mtt -122.04 176.35 5.85 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 118.681 1.241 . . . . 72.109999999999999 109.567 173.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.64 64.89 8.76 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 123.279 1.514 . . . . 73.299999999999997 111.075 -172.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 21.0 p -74.9 40.53 0.15 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 129.217 3.007 . . . . 70.420000000000002 110.901 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 3.8 m -124.06 -3.5 8.07 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.34 1.456 . . . . 71.040000000000006 111.646 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.78 -10.31 2.08 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.484 1.114 . . . . 70.030000000000001 112.029 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 8.7 mmt 70.81 -56.69 0.61 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.625 1.97 . . . . 74.0 114.315 174.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.34 -45.61 75.87 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.782 -1.192 . . . . 74.230000000000004 107.782 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 82.5 t -63.15 -31.37 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.488 1.515 . . . . 74.140000000000001 111.577 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -60.21 -56.01 26.84 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.014 -0.736 . . . . 73.010000000000005 109.014 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 t -70.74 -34.43 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 119.145 -0.455 . . . . 74.340000000000003 110.775 -176.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.72 -35.31 63.54 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.507 0.723 . . . . 74.310000000000002 110.77 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -78.87 -44.67 22.34 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.699 1.199 . . . . 74.340000000000003 112.741 168.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -56.97 -58.04 9.9 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.716 1.144 . . . . 73.099999999999994 111.349 -173.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -55.68 -31.84 62.74 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.561 -0.733 . . . . 54.200000000000003 112.149 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -68.34 -58.15 4.82 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.8 0.727 . . . . 74.420000000000002 109.869 177.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.9 t -60.53 -29.26 69.01 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 119.064 -0.493 . . . . 74.109999999999999 110.554 -172.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 98.0 t -55.42 -57.23 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.318 -0.993 . . . . 71.349999999999994 108.318 171.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.63 -46.3 90.39 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.129 0.972 . . . . 73.0 111.16 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -60.26 -18.49 49.39 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.267 1.427 . . . . 73.400000000000006 113.383 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.622 HD23 ' HD3' ' A' ' 187' ' ' LYS . 69.1 mt -92.56 -23.33 19.09 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 121.508 -0.745 . . . . 75.430000000000007 112.927 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 66.8 t -63.14 -35.81 73.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.068 -0.716 . . . . 62.130000000000003 109.068 174.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -83.58 -18.41 38.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.417 -0.81 . . . . 65.319999999999993 110.142 -172.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.622 ' HD3' HD23 ' A' ' 184' ' ' LEU 0.305 0.0 OUTLIER -77.75 15.78 0.79 Allowed 'General case' 0 CA--C 1.545 0.759 0 O-C-N 120.751 -1.218 . . . . 74.319999999999993 113.776 -168.101 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.433 -1.279 0 C-N-CA 129.4 3.08 . . . . 64.209999999999994 109.422 -152.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 112.815 0.672 . . . . 70.140000000000001 112.815 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.22 122.2 4.98 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 104.205 -2.517 . . . . 71.519999999999996 104.205 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.1 pt -126.77 156.89 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 126.519 1.927 . . . . 72.120000000000005 107.33 170.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 99.4 m -135.08 130.34 35.39 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.639 1.575 . . . . 72.430000000000007 106.76 -171.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -57.35 137.43 56.1 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.315 -0.624 . . . . 72.239999999999995 109.315 171.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.74 -21.97 12.97 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.21 1.386 . . . . 44.119999999999997 113.217 -171.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -99.9 -85.58 0.4 Allowed 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 119.895 1.848 . . . . 73.25 109.004 -172.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -88.93 -14.17 37.31 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.656 1.116 . . . . 62.439999999999998 111.509 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -138.24 170.77 15.44 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.766 0.826 . . . . 65.439999999999998 109.587 169.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.4 mm -128.4 154.24 38.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 105.771 -1.937 . . . . 74.549999999999997 105.771 170.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.0 m -108.88 140.22 42.65 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.711 1.605 . . . . 73.420000000000002 108.357 175.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 74.5 mt -79.38 142.07 36.33 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.176 -1.046 . . . . 74.420000000000002 108.176 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -70.72 -40.91 72.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 122.612 1.196 . . . . 71.450000000000003 109.17 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -125.73 83.82 61.71 Favored Pre-proline 0 N--CA 1.455 -0.193 0 C-N-CA 127.345 2.258 . . . . 65.239999999999995 107.12 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo . . . . . 0 N--CA 1.444 -1.408 0 C-N-CA 123.923 3.082 . . . . 74.510000000000005 108.579 170.245 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 CA--C 1.535 0.4 0 N-CA-C 107.337 -1.356 . . . . 70.219999999999999 107.337 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.449 HD23 ' CE2' ' A' ' 25' ' ' PHE . 2.8 tp -166.53 160.56 15.4 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 120.036 1.289 . . . . 73.530000000000001 112.456 172.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' H ' ' HG ' ' A' ' 23' ' ' LEU . 16.4 mt-10 -141.36 136.04 31.07 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.045 1.338 . . . . 73.329999999999998 108.237 -171.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.449 ' CE2' HD23 ' A' ' 23' ' ' LEU . 83.3 m-85 -128.63 140.98 51.5 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.981 2.112 . . . . 61.219999999999999 109.874 -176.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -151.39 177.55 10.17 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 128.54 2.736 . . . . 74.25 107.97 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.3 t -139.29 -177.07 4.75 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.474 -0.766 . . . . 72.209999999999994 109.852 155.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -84.11 -51.79 6.79 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.626 1.57 . . . . 63.210000000000001 109.473 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -80.44 -13.83 58.8 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.265 0.839 . . . . 71.129999999999995 113.265 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.7 p -69.51 145.0 94.96 Favored Pre-proline 0 C--O 1.237 0.409 0 CA-C-N 119.743 1.156 . . . . 53.43 110.867 -175.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -70.7 175.61 8.64 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 121.251 1.301 . . . . 72.549999999999997 109.682 164.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 68.85 -55.08 0.55 Allowed 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 127.495 2.318 . . . . 71.409999999999997 111.218 -175.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 32.4 m -44.67 -41.03 6.37 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.133 2.173 . . . . 75.329999999999998 110.741 174.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -53.52 -68.4 0.18 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.303 1.841 . . . . 74.209999999999994 111.036 174.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -54.14 -44.28 71.27 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.726 -0.842 . . . . 75.530000000000001 108.726 -175.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -64.86 -13.11 55.19 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 116.532 -1.699 . . . . 74.530000000000001 113.046 -175.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -139.79 19.46 2.5 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 121.022 1.737 . . . . 73.430000000000007 112.62 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -136.58 -46.56 0.61 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.412 1.485 . . . . 73.040000000000006 111.685 171.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.5 t -101.16 -69.29 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.124 0 N-CA-C 107.753 -1.203 . . . . 62.109999999999999 107.753 -168.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 73.5 mt -71.01 -33.83 70.75 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.435 1.094 . . . . 74.129999999999995 111.813 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 44.36 54.18 6.39 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.313 1.445 . . . . 73.129999999999995 111.326 -169.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.48 ' O ' HG23 ' A' ' 46' ' ' VAL . 81.9 t -52.26 -47.28 45.43 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 C-N-CA 125.285 1.434 . . . . 75.329999999999998 109.554 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.4 t -49.47 -43.74 45.35 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.33 2.252 . . . . 63.420000000000002 112.122 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -87.02 -17.6 32.58 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.156 -1.59 . . . . 62.439999999999998 112.952 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -74.3 -46.34 41.74 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.058 -0.719 . . . . 70.540000000000006 109.058 169.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 42' ' ' VAL . 95.0 t -57.66 -44.31 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 124.789 1.235 . . . . 71.129999999999995 109.61 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -46.59 -43.97 17.73 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.833 0.853 . . . . 74.549999999999997 112.305 177.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -67.6 -12.65 60.89 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.281 1.586 . . . . 41.240000000000002 115.281 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -111.36 -7.65 14.37 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.044 1.338 . . . . 71.140000000000001 113.312 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.7 mt -68.89 144.87 96.29 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 118.996 0.816 . . . . 64.519999999999996 112.057 -168.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.0 160.0 37.23 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.096 2.531 . . . . 73.140000000000001 111.019 168.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.98 27.7 0.07 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.264 1.426 . . . . 65.439999999999998 114.312 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -144.72 25.4 1.96 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 126.292 1.901 . . . . 73.209999999999994 112.262 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.2 m -146.16 73.19 1.32 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.683 -1.228 . . . . 72.510000000000005 107.683 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.6 mttm -59.92 145.95 44.05 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 122.043 0.925 . . . . 54.450000000000003 112.014 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -76.3 114.33 14.88 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.387 -1.338 . . . . 72.420000000000002 107.387 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.7 m -124.27 163.72 21.06 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.065 -1.087 . . . . 72.049999999999997 108.065 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -161.68 100.11 1.15 Allowed 'General case' 0 C--N 1.332 -0.165 0 O-C-N 120.022 -1.674 . . . . 63.310000000000002 107.306 -165.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -98.7 160.83 14.0 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.03 -1.044 . . . . 72.340000000000003 109.769 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.644 ' CE1' HG23 ' A' ' 72' ' ' THR . 0.1 OUTLIER -102.93 165.36 11.08 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.612 1.565 . . . . 70.150000000000006 109.321 174.524 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.6 m -132.96 153.03 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 122.229 1.014 . . . . 43.25 110.217 156.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.425 ' HG3' HG21 ' A' ' 72' ' ' THR . 0.0 OUTLIER -90.68 2.78 55.64 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 130.244 3.418 . . . . 62.439999999999998 113.765 176.824 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -69.14 -8.99 50.55 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 115.41 1.633 . . . . 74.25 115.41 -168.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 mp -137.92 153.37 49.52 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 120.614 1.552 . . . . 51.420000000000002 110.543 -171.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.65 170.99 29.69 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 123.93 0.776 . . . . 55.539999999999999 113.751 173.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.52 -44.69 4.23 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.928 3.085 . . . . 74.319999999999993 111.851 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.9 mt -97.0 27.41 4.05 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 125.258 1.423 . . . . 53.109999999999999 110.868 -167.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -44.83 -56.77 5.65 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.01 1.291 . . . . 75.099999999999994 111.595 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.8 tptt -63.34 -40.0 96.1 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 118.024 0.912 . . . . 55.310000000000002 111.841 -177.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -65.21 -44.82 87.09 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.423 1.089 . . . . 72.109999999999999 109.731 -176.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.3 mt -62.17 -33.35 74.36 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.974 0.91 . . . . 73.310000000000002 110.824 174.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.644 HG23 ' CE1' ' A' ' 60' ' ' HIS . 27.3 m -77.88 3.52 14.23 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 127.689 2.396 . . . . 64.129999999999995 111.429 175.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -116.75 -24.61 7.64 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 119.181 -2.2 . . . . 73.430000000000007 110.747 169.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.65 -28.31 61.71 Favored 'General case' 0 N--CA 1.457 -0.112 0 O-C-N 120.758 -1.213 . . . . 34.009999999999998 114.053 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 39.2 t-105 -65.87 -40.01 91.24 Favored 'General case' 0 C--N 1.331 -0.201 0 O-C-N 121.386 -0.821 . . . . 73.200000000000003 110.377 -173.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.422 ' HB3' HG13 ' A' ' 130' ' ' VAL . . . -61.13 -37.98 84.76 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.707 1.203 . . . . 32.119999999999997 111.969 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.4 t -51.44 -51.57 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 119.277 0.944 . . . . 74.129999999999995 109.412 171.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.43 -32.17 62.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 117.152 -1.404 . . . . 70.200000000000003 112.091 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.1 mt -63.56 -38.91 83.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 120.903 1.683 . . . . 71.219999999999999 110.406 170.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.09 -49.69 76.3 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 119.043 0.838 . . . . 73.200000000000003 110.057 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.21 -9.76 59.73 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 112.137 0.421 . . . . 65.230000000000004 112.137 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.61 57.9 13.08 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 126.872 2.177 . . . . 72.239999999999995 111.757 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.3 m -129.46 18.64 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 125.507 1.523 . . . . 65.140000000000001 111.071 -175.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -51.88 -48.06 64.26 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.42 1.009 . . . . 74.349999999999994 110.072 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -61.81 -15.25 40.15 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 128.041 2.536 . . . . 74.25 114.997 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -98.13 -16.02 19.7 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.857 0.863 . . . . 73.109999999999999 109.514 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp -126.72 21.34 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 125.282 1.433 . . . . 72.109999999999999 110.646 -175.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 93.6 m -80.31 -59.85 2.55 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 109.143 -0.688 . . . . 73.030000000000001 109.143 173.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.52 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -57.71 -61.78 6.66 Favored Pre-proline 0 N--CA 1.453 -0.321 0 C-N-CA 125.384 1.474 . . . . 62.340000000000003 110.272 -166.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.52 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 38.6 Cg_endo -66.14 -22.31 54.44 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 120.645 0.897 . . . . 64.329999999999998 112.505 -174.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 5.2 tpp -59.61 -49.81 76.31 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.981 0.513 . . . . 75.030000000000001 110.702 170.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -64.23 -39.5 94.1 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.127 -0.983 . . . . 61.350000000000001 111.558 176.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.91 -27.82 68.46 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 120.491 -0.483 . . . . 64.430000000000007 111.497 171.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.19 -11.23 33.21 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 120.952 -1.092 . . . . 72.430000000000007 112.748 -173.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.5 t -117.39 -27.47 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 C-N-CA 124.633 1.173 . . . . 73.200000000000003 110.629 -173.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -115.44 -48.71 2.78 Favored 'General case' 0 C--N 1.336 -0.02 0 CA-C-N 118.87 0.759 . . . . 52.200000000000003 110.789 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -73.8 -65.51 0.82 Allowed 'General case' 0 C--O 1.23 0.06 0 CA-C-N 118.692 0.678 . . . . 73.430000000000007 111.015 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.4 p -83.43 -31.99 26.32 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.713 -0.617 . . . . 64.329999999999998 110.29 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 56.53 23.72 7.89 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.198 1.799 . . . . 75.420000000000002 112.558 -171.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -71.27 -12.22 61.34 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.588 1.155 . . . . 75.209999999999994 112.601 -171.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.519 HG13 HG12 ' A' ' 107' ' ' ILE . 26.7 t -63.97 109.3 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 O-C-N 120.808 -1.182 . . . . 63.030000000000001 109.329 168.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -132.04 -22.22 2.32 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.751 0.82 . . . . 71.439999999999998 112.624 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.26 165.77 26.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.68 1.992 . . . . 63.119999999999997 107.413 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 91.7 t -51.78 -44.96 37.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.393 1.077 . . . . 75.040000000000006 108.971 172.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.51 1.39 0.56 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.016 2.126 . . . . 55.329999999999998 115.422 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -106.91 -29.52 9.42 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 119.653 1.115 . . . . 60.200000000000003 109.321 170.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.519 HG12 HG13 ' A' ' 101' ' ' VAL . 0.5 OUTLIER -81.81 -24.1 9.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 O-C-N 121.057 -1.027 . . . . 53.509999999999998 111.01 -172.773 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -40.5 97.43 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.345 -0.983 . . . . 75.310000000000002 108.345 172.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -55.41 -49.46 72.31 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 123.929 0.768 . . . . 72.319999999999993 109.703 -164.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 47.0 t -54.47 -48.31 69.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.286 1.434 . . . . 61.43 111.511 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -56.41 -55.54 32.3 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 109.175 -0.676 . . . . 73.420000000000002 109.175 176.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 93.3 t -59.01 -44.53 91.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 122.917 0.487 . . . . 74.420000000000002 109.868 -172.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -62.02 -45.79 92.03 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.176 1.391 . . . . 73.319999999999993 108.526 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.22 -0.11 11.23 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.965 1.306 . . . . 71.0 112.723 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 109.86 36.12 2.08 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 119.879 1.218 . . . . 25.25 114.154 173.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.1 t -107.55 130.47 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 118.556 1.178 . . . . 73.420000000000002 109.536 173.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt -62.15 118.92 8.01 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.321 -0.992 . . . . 72.420000000000002 108.321 166.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.69 -22.51 68.17 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 119.063 -0.854 . . . . 74.209999999999994 111.138 173.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -65.52 -35.14 79.99 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.151 0.975 . . . . 73.219999999999999 111.25 175.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -83.25 -34.18 25.88 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.872 -1.159 . . . . 65.319999999999993 107.872 -172.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -51.01 -67.64 0.24 Allowed 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.995 1.318 . . . . 74.299999999999997 110.3 165.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -66.39 -11.55 52.05 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.248 0.547 . . . . 62.140000000000001 111.656 -170.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.38 -74.85 0.35 Allowed 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.315 1.046 . . . . 74.299999999999997 109.484 169.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.459 ' HA ' ' HB3' ' A' ' 127' ' ' SER . . . -58.4 -32.28 68.48 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 118.966 -0.54 . . . . 73.230000000000004 111.758 -169.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 60.6 t-105 -47.76 -34.81 8.96 Favored 'General case' 0 CA--C 1.523 -0.069 0 C-N-CA 124.718 1.207 . . . . 74.200000000000003 112.199 174.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -109.28 1.31 20.06 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.999 1.319 . . . . 73.019999999999996 111.728 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.459 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 5.7 t -105.98 151.64 24.35 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 124.197 1.951 . . . . 73.400000000000006 110.492 -174.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . 0.268 0.1 OUTLIER -57.12 -26.04 59.84 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 117.781 2.511 . . . . 64.430000000000007 117.781 -171.66 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 86.4 t -44.37 -56.82 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 C-N-CA 127.667 2.387 . . . . 71.230000000000004 108.159 167.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 76' ' ' ALA . 25.2 t -73.35 -42.72 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 124.169 0.988 . . . . 72.219999999999999 109.277 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -56.11 -49.04 74.98 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.683 1.129 . . . . 70.319999999999993 111.45 -173.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 72.3 m -77.48 -25.36 50.36 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 117.999 -1.0 . . . . 71.329999999999998 112.89 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.6 mt -65.02 -52.38 56.33 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 120.335 1.425 . . . . 73.040000000000006 110.25 170.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 40.9 t -45.81 -43.44 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.757 2.023 . . . . 71.329999999999998 110.937 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.57 -41.67 70.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.165 0.586 . . . . 34.020000000000003 111.877 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -53.13 -49.82 65.77 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 123.723 0.809 . . . . 44.530000000000001 112.737 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.461 ' HB2' ' CE1' ' A' ' 60' ' ' HIS . 0.6 OUTLIER -98.08 -20.26 17.46 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 118.883 -0.58 . . . . 61.210000000000001 110.967 -171.686 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -62.5 -50.48 71.24 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 107.855 -1.165 . . . . 71.420000000000002 107.855 167.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -55.83 -57.27 12.73 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.956 0.903 . . . . 73.450000000000003 110.94 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.76 6.36 2.58 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.424 1.268 . . . . 63.520000000000003 114.424 -175.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -106.25 -40.9 5.48 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.884 1.274 . . . . 51.009999999999998 110.601 160.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.03 -32.6 74.21 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.418 1.087 . . . . 75.549999999999997 112.889 -171.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -71.15 3.99 3.11 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.045 1.338 . . . . 60.539999999999999 113.125 -175.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.6 mt 74.78 1.94 3.91 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.746 2.018 . . . . 75.150000000000006 112.159 170.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.54 HE21 ' N ' ' A' ' 146' ' ' LEU . 0.0 OUTLIER -61.25 -16.9 50.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 129.851 3.26 . . . . 74.340000000000003 113.729 -179.133 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.54 ' N ' HE21 ' A' ' 145' ' ' GLN . 0.6 OUTLIER -155.55 126.27 6.92 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 128.773 2.829 . . . . 75.140000000000001 103.52 -172.068 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -139.29 5.08 2.26 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.142 0.577 . . . . 73.239999999999995 111.591 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -133.91 163.08 24.53 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.951 1.262 . . . . 73.129999999999995 109.957 171.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.26 164.69 33.86 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.095 0.958 . . . . 73.140000000000001 109.34 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.71 162.33 81.15 Favored 'Cis proline' 0 N--CA 1.455 -0.747 0 CA-C-N 119.313 0.79 . . . . 61.43 111.506 -13.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -146.41 127.19 14.37 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.076 -0.965 . . . . 72.209999999999994 109.026 175.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 42.7 ttm -112.78 109.99 19.82 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 105.587 -2.005 . . . . 54.210000000000001 105.587 169.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -77.94 165.7 23.76 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.678 -1.23 . . . . 62.450000000000003 107.678 166.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.4 t -125.46 -86.37 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 N-CA-C 107.635 -1.246 . . . . 52.439999999999998 107.635 167.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -88.96 35.94 0.8 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 120.565 1.53 . . . . 73.109999999999999 111.256 -171.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 68.13 -73.57 0.29 Allowed Glycine 0 C--N 1.338 0.646 0 N-CA-C 109.265 -1.534 . . . . 61.329999999999998 109.265 -160.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 12.7 ptmt -55.47 -4.92 0.11 Allowed 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 128.533 2.733 . . . . 65.340000000000003 116.641 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -124.34 143.94 50.3 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 120.2 1.364 . . . . 74.450000000000003 109.106 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -128.32 138.45 52.39 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.075 -1.454 . . . . 63.32 107.075 171.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -65.42 133.19 50.79 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.108 -1.441 . . . . 75.25 107.108 175.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -104.52 86.08 1.31 Allowed Pre-proline 0 C--O 1.236 0.355 0 C-N-CA 124.171 0.988 . . . . 72.530000000000001 112.035 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.02 -20.93 43.9 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 CA-C-N 119.931 1.011 . . . . 73.25 113.479 -177.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -72.61 -38.45 67.79 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 120.838 1.654 . . . . 63.539999999999999 109.406 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -78.48 3.78 62.02 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 118.762 0.71 . . . . 71.420000000000002 113.051 -177.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 55.3 mtt -90.29 168.14 12.13 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 118.746 1.273 . . . . 63.329999999999998 109.367 174.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -81.04 114.54 19.97 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 105.999 -1.852 . . . . 62.329999999999998 105.999 167.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.433 HG22 ' CD1' ' A' ' 173' ' ' PHE . 11.1 p -107.6 6.73 28.17 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 127.298 2.239 . . . . 52.450000000000003 109.983 -175.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.5 m -92.84 3.56 55.46 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 113.616 0.969 . . . . 61.450000000000003 113.616 -166.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.0 -4.71 1.52 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.499 1.12 . . . . 73.439999999999998 111.657 -176.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 7.6 mmt 67.64 -61.89 0.35 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.416 1.886 . . . . 75.510000000000005 112.926 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.28 -42.53 88.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 119.978 1.263 . . . . 75.219999999999999 109.229 -176.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 66.5 t -61.92 -28.34 44.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 123.713 0.805 . . . . 63.25 110.951 174.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.433 ' CD1' HG22 ' A' ' 167' ' ' THR . 59.5 t80 -64.27 -61.28 2.34 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 107.974 -1.121 . . . . 55.409999999999997 107.974 177.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.3 t -67.89 -32.2 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 119.289 -0.386 . . . . 73.439999999999998 111.086 -174.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.06 -47.12 68.72 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.76 1.224 . . . . 71.109999999999999 110.86 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -81.46 -38.27 26.66 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 118.252 -0.88 . . . . 64.540000000000006 111.658 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -54.82 -60.2 3.69 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.593 1.088 . . . . 75.409999999999997 110.209 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.41 ' HA ' HG22 ' A' ' 46' ' ' VAL . . . -59.14 -26.09 64.43 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.825 0.85 . . . . 54.409999999999997 112.249 -173.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -77.29 -54.42 6.5 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.101 0.56 . . . . 70.150000000000006 109.815 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.2 t -58.94 -25.57 63.61 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-O 117.741 -1.123 . . . . 74.209999999999994 111.516 -176.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 59.3 t -54.55 -57.64 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 118.944 0.793 . . . . 63.509999999999998 109.046 171.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? -62.89 -36.95 85.0 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.993 -0.442 . . . . 71.329999999999998 110.222 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -66.6 -30.73 71.08 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 123.859 0.864 . . . . 42.009999999999998 110.821 -173.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 47.1 mt -71.01 -31.84 68.46 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.027 -1.046 . . . . 73.420000000000002 111.375 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 85.4 t -66.1 -24.21 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 O-C-N 121.756 -0.59 . . . . 72.409999999999997 110.876 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -97.07 -5.77 36.72 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.332 1.053 . . . . 73.150000000000006 110.253 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -120.79 87.14 2.7 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 125.925 1.69 . . . . 72.549999999999997 107.871 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 37.5 mttm . . . . . 0 C--O 1.251 1.158 0 C-N-CA 127.069 2.147 . . . . 71.239999999999995 110.917 175.51 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.327 0 N-CA-C 112.871 0.693 . . . . 70.230000000000004 112.871 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -141.97 110.77 6.19 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.873 -1.899 . . . . 45.420000000000002 105.873 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.409 HD12 ' CD1' ' A' ' 9' ' ' TYR . 4.8 pt -143.09 164.97 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 130.966 3.706 . . . . 72.219999999999999 107.721 -178.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.9 m -139.17 148.86 43.74 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.876 1.67 . . . . 72.420000000000002 108.247 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -57.76 148.72 24.08 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.174 1.79 . . . . 64.010000000000005 111.065 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.63 -23.38 0.81 Allowed Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.832 1.206 . . . . 74.239999999999995 112.878 -171.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.2 tttp -90.23 -85.21 0.22 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 118.831 1.316 . . . . 74.120000000000005 108.539 -160.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -98.88 -7.13 27.73 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.021 0.929 . . . . 65.209999999999994 111.337 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.409 ' CD1' HD12 ' A' ' 3' ' ' ILE . 25.4 p90 -144.6 163.55 33.59 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.81 -1.182 . . . . 71.439999999999998 107.81 169.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.6 mm -124.8 157.09 33.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 106.264 -1.754 . . . . 53.109999999999999 106.264 169.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.45 171.53 14.61 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 127.295 2.238 . . . . 74.230000000000004 109.3 165.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.9 mt -108.24 159.6 16.5 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.359 1.064 . . . . 70.319999999999993 111.02 173.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -62.73 -44.6 95.79 Favored 'General case' 0 C--O 1.227 -0.096 0 N-CA-C 108.9 -0.778 . . . . 73.230000000000004 108.9 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -131.24 81.55 65.47 Favored Pre-proline 0 C--N 1.339 0.112 0 C-N-CA 127.015 2.126 . . . . 63.109999999999999 107.547 -173.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo . . . . . 0 N--CA 1.455 -0.761 0 C-N-CA 122.662 2.242 . . . . 70.310000000000002 110.812 -178.561 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.0 t . . . . . 0 N--CA 1.447 -0.602 0 N-CA-C 105.929 -1.878 . . . . 53.200000000000003 105.929 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 tt -147.15 157.82 43.73 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.221 -1.029 . . . . 64.129999999999995 108.221 -172.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -125.44 149.58 48.09 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.92 1.288 . . . . 62.299999999999997 107.958 170.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.421 ' CD2' HD13 ' A' ' 146' ' ' LEU . 95.3 m-85 -127.38 145.55 50.77 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.16 0.984 . . . . 73.409999999999997 108.95 169.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -153.72 -177.8 6.62 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 128.326 2.651 . . . . 74.530000000000001 106.98 168.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.422 ' CB ' HD12 ' A' ' 64' ' ' LEU . 10.6 t -133.4 179.85 5.95 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 121.351 -0.843 . . . . 71.319999999999993 108.745 170.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -82.43 -28.8 31.12 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.995 2.518 . . . . 74.209999999999994 110.583 -176.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -109.66 1.89 19.85 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.56 1.144 . . . . 74.540000000000006 112.231 -169.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.1 p -87.26 143.48 34.59 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 120.111 1.323 . . . . 71.310000000000002 110.453 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -83.66 -38.63 0.13 Allowed 'Trans proline' 0 CA--C 1.533 0.437 0 CA-C-N 119.901 1.0 . . . . 64.5 112.481 -166.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -52.31 -47.68 65.84 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 118.798 0.726 . . . . 53.409999999999997 109.661 172.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 14.2 m -54.77 -37.86 66.51 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.74 1.616 . . . . 65.319999999999993 111.482 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -62.49 -51.32 67.93 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.679 0.391 . . . . 73.530000000000001 110.861 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -59.61 -45.45 91.88 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 119.67 -0.812 . . . . 63.200000000000003 109.054 176.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -66.13 -10.39 40.46 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 116.919 -1.515 . . . . 64.129999999999995 112.015 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -140.26 10.47 2.33 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 121.86 2.118 . . . . 50.109999999999999 113.086 -174.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -134.13 -45.0 0.78 Allowed 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 123.903 0.881 . . . . 61.100000000000001 110.41 170.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.8 t -88.9 -69.81 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 108.255 -1.017 . . . . 74.409999999999997 108.255 -175.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.6 mt -77.81 -25.53 48.97 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.732 1.613 . . . . 74.519999999999996 113.333 -174.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 44.67 59.31 3.42 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.538 1.535 . . . . 72.430000000000007 112.911 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.4 t -55.48 -50.35 66.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 124.061 0.944 . . . . 70.299999999999997 109.302 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.2 t -47.17 -52.36 15.83 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.143 1.377 . . . . 73.430000000000007 112.308 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -79.37 -23.39 43.38 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 110.588 -0.152 . . . . 74.430000000000007 110.588 -169.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -69.93 -48.8 57.02 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.639 -1.245 . . . . 73.430000000000007 107.639 169.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 37.8 t -55.69 -49.83 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 125.162 1.385 . . . . 74.040000000000006 110.914 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -56.94 -28.02 61.67 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 119.87 -1.769 . . . . 72.510000000000005 113.297 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -71.14 -8.62 54.73 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.202 0.91 . . . . 72.319999999999993 113.192 177.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -119.83 -14.71 8.95 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 126.321 1.848 . . . . 72.409999999999997 111.968 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.495 HD13 HG21 ' A' ' 54' ' ' THR . 13.3 mt -69.53 151.11 96.78 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 119.222 0.919 . . . . 72.040000000000006 112.496 -169.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -85.95 159.19 10.22 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.625 2.883 . . . . 64.019999999999996 113.078 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -83.62 59.34 5.08 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.307 1.843 . . . . 62.100000000000001 111.031 -172.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.71 -23.98 0.02 OUTLIER Glycine 0 CA--C 1.527 0.802 0 CA-C-N 113.592 -1.64 . . . . 62.439999999999998 112.1 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.495 HG21 HD13 ' A' ' 50' ' ' LEU . 10.3 t -47.85 -57.1 6.09 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.561 1.544 . . . . 73.109999999999999 112.632 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.405 ' N ' HG23 ' A' ' 54' ' ' THR . 4.7 tmmm? 56.84 123.55 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.779 2.032 . . . . 70.129999999999995 111.04 -157.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.7 ttm -68.27 108.18 3.09 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 125.881 1.672 . . . . 74.099999999999994 108.253 172.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.18 115.03 21.69 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 107.127 -1.434 . . . . 72.319999999999993 107.127 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.27 122.04 35.78 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.18 -1.415 . . . . 74.200000000000003 107.18 -178.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.1 m-30 -113.35 145.85 40.42 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.488 -1.301 . . . . 72.430000000000007 107.488 172.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.0 117.85 32.47 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.258 1.423 . . . . 74.140000000000001 107.669 -167.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.8 m -93.88 157.78 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 O-C-N 121.472 -0.768 . . . . 72.200000000000003 110.747 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.43 -8.46 13.89 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.748 1.219 . . . . 72.129999999999995 113.448 -161.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -63.17 5.16 0.16 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.815 2.046 . . . . 62.32 115.346 -170.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.422 HD12 ' CB ' ' A' ' 27' ' ' SER . 11.1 mt -138.11 132.39 31.96 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 119.955 -1.715 . . . . 70.430000000000007 107.593 -165.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.76 174.76 30.25 Favored Glycine 0 CA--C 1.541 1.672 0 O-C-N 123.493 0.496 . . . . 52.100000000000001 111.877 -172.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.92 -55.33 0.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.92 3.08 . . . . 73.340000000000003 112.692 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.4 mt -87.34 24.85 1.52 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.958 1.303 . . . . 51.350000000000001 112.201 -167.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.04 -42.77 98.05 Favored Glycine 0 C--O 1.228 -0.247 0 N-CA-C 110.174 -1.17 . . . . 74.230000000000004 110.174 -167.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -61.42 -44.55 96.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.499 0.32 . . . . 73.340000000000003 110.689 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.43 -46.77 87.79 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.446 1.898 . . . . 74.430000000000007 109.012 177.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.9 mt -64.64 -40.53 95.62 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.751 0.82 . . . . 64.299999999999997 111.623 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.8 m -60.7 -40.45 92.27 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 120.272 1.396 . . . . 71.510000000000005 110.388 171.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -64.62 -39.28 93.43 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.26 -0.9 . . . . 70.150000000000006 108.876 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.61 -36.43 78.57 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 120.964 -1.085 . . . . 72.540000000000006 111.913 173.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 25.3 t-105 -58.42 -35.74 72.53 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 118.882 0.764 . . . . 71.5 111.996 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.36 -40.55 82.53 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 118.695 -0.669 . . . . 63.310000000000002 111.912 175.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 69.7 t -59.54 -44.89 94.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 119.657 1.117 . . . . 51.130000000000003 109.544 170.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.51 -42.04 98.21 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 118.364 -0.827 . . . . 74.530000000000001 111.6 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 76.3 mt -69.45 -38.51 77.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.899 0.88 . . . . 74.439999999999998 110.52 176.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.8 -40.21 91.81 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.488 1.04 . . . . 64.430000000000007 110.582 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.8 mt -93.0 -8.02 44.21 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.75 0.648 . . . . 74.109999999999999 112.75 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 53.83 62.91 5.61 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 125.485 1.517 . . . . 52.130000000000003 111.378 -172.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.1 m -125.54 18.97 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.49 1.116 . . . . 65.5 112.046 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -51.3 -49.54 61.1 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.341 1.456 . . . . 53.109999999999999 111.504 -174.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -63.36 -31.47 72.63 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 125.167 1.387 . . . . 74.109999999999999 113.807 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -75.24 -34.38 61.4 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.258 -0.645 . . . . 74.540000000000006 109.258 -176.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.1 pp -103.52 -16.37 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.967 0.729 . . . . 74.439999999999998 112.967 -166.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.7 m -58.93 -49.47 77.72 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 119.17 0.895 . . . . 70.420000000000002 111.116 -172.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.468 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -62.47 -58.76 15.36 Favored Pre-proline 0 N--CA 1.45 -0.458 0 C-N-CA 123.712 0.805 . . . . 53.0 110.181 -164.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.468 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 39.5 Cg_endo -66.25 -26.0 49.48 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 121.095 1.197 . . . . 62.140000000000001 112.222 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 10.8 tpp -61.7 -44.64 96.55 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.577 0.626 . . . . 63.229999999999997 111.051 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -69.69 -35.69 75.32 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.243 -0.911 . . . . 71.5 109.047 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -54.85 -48.34 73.01 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.388 0.54 . . . . 61.210000000000001 110.242 166.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.55 -16.09 60.83 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 121.73 -0.606 . . . . 73.109999999999999 111.154 -165.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 63.8 t -112.15 -33.86 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.368 1.467 . . . . 74.230000000000004 110.799 -173.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -109.73 -55.96 2.37 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.522 1.056 . . . . 72.420000000000002 110.744 -174.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -64.35 -63.93 1.01 Allowed 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.907 0.883 . . . . 74.299999999999997 110.784 -176.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.4 t -99.44 -27.6 13.66 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.672 1.189 . . . . 70.5 110.761 -173.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 59.43 29.4 18.96 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.811 1.244 . . . . 63.5 112.889 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.4 t -69.38 -12.63 61.82 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.782 1.633 . . . . 65.150000000000006 112.815 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.6 t -67.52 108.49 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.647 -1.242 . . . . 74.450000000000003 107.647 171.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -132.88 -28.09 1.6 Allowed 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 124.471 1.108 . . . . 65.439999999999998 111.623 -174.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.85 169.65 17.18 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.553 -1.277 . . . . 70.120000000000005 107.553 169.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.6 t -57.18 -25.69 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.138 0.975 . . . . 73.340000000000003 111.23 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.69 -29.57 70.18 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 126.316 1.847 . . . . 50.25 111.205 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.72 -22.26 22.29 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.111 0.481 . . . . 73.450000000000003 110.232 -176.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.0 mt -76.63 -49.11 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 126.314 1.846 . . . . 42.420000000000002 108.158 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -56.78 -30.69 63.9 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-O 118.205 -0.902 . . . . 70.439999999999998 112.719 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -57.47 -57.99 10.26 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 123.586 0.755 . . . . 62.350000000000001 109.578 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.1 t -48.43 -47.33 14.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 O-C-N 124.457 1.098 . . . . 72.340000000000003 109.804 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -55.21 -51.9 65.08 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.864 0.466 . . . . 70.519999999999996 110.741 177.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.2 t -62.42 -44.05 98.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 118.61 0.641 . . . . 72.340000000000003 111.114 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -64.74 -42.17 95.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 122.147 0.975 . . . . 72.209999999999994 108.758 -172.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -82.14 7.33 13.8 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.579 1.552 . . . . 74.219999999999999 112.572 176.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.93 29.04 4.22 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-N 119.751 1.16 . . . . 74.329999999999998 115.976 160.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.7 t -106.55 143.97 16.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 122.571 1.176 . . . . 61.549999999999997 111.026 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -62.4 126.89 28.88 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.268 1.427 . . . . 63.240000000000002 110.383 170.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.31 -23.96 74.91 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 118.483 -1.176 . . . . 53.219999999999999 111.896 169.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -69.13 -40.87 78.02 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 119.131 1.465 . . . . 61.310000000000002 109.249 170.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -79.36 -37.66 36.9 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 107.597 -1.26 . . . . 65.430000000000007 107.597 -166.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -56.65 -60.65 3.23 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.619 -0.512 . . . . 74.150000000000006 109.619 171.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.69 -13.84 61.05 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.454 0.538 . . . . 71.329999999999998 112.454 -170.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.19 -65.97 0.95 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.332 1.053 . . . . 34.32 109.202 168.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -50.4 -39.81 48.13 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.543 1.537 . . . . 73.25 110.848 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -46.19 -37.65 7.35 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.555 1.542 . . . . 73.540000000000006 112.801 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -114.35 4.3 15.33 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.917 1.287 . . . . 71.439999999999998 112.889 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.7 t -80.22 151.99 29.36 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.724 1.61 . . . . 74.530000000000001 111.492 175.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -51.99 -28.89 18.47 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.022 2.529 . . . . 64.230000000000004 113.081 175.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 93.3 t -52.75 -54.52 15.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 124.748 1.219 . . . . 51.219999999999999 109.836 174.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.3 t -69.66 -34.78 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 114.816 -1.083 . . . . 72.109999999999999 109.851 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -52.63 -47.88 66.75 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.914 1.233 . . . . 74.409999999999997 111.186 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.1 t -59.71 -55.54 33.09 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.605 0.762 . . . . 74.439999999999998 109.222 176.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 32.3 mt -64.47 -32.71 74.45 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.004 0.922 . . . . 71.310000000000002 113.483 -173.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.31 -64.45 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 C-N-CA 126.022 1.729 . . . . 70.430000000000007 107.451 166.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.42 -29.3 67.66 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 120.286 1.403 . . . . 73.430000000000007 113.744 -172.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -61.4 -51.95 66.65 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.401 0.68 . . . . 64.140000000000001 109.991 170.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -70.07 -34.08 72.74 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.41 1.084 . . . . 63.43 112.633 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -60.08 -59.04 6.05 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 107.39 -1.337 . . . . 63.119999999999997 107.39 174.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.7 ttpt -53.3 -52.03 60.41 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.318 0.647 . . . . 63.509999999999998 110.452 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.68 -2.2 4.65 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.07 1.137 . . . . 73.400000000000006 114.07 -174.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -116.65 -20.87 9.38 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.881 1.218 . . . . 53.229999999999997 112.025 164.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.54 -22.55 47.11 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 126.202 1.801 . . . . 73.519999999999996 112.434 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.05 4.13 13.1 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.104 -0.998 . . . . 72.319999999999993 112.386 -175.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.0 mt 71.43 -0.23 3.21 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.522 1.929 . . . . 65.109999999999999 111.437 171.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.23 -9.96 59.74 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.728 1.611 . . . . 73.329999999999998 112.567 -173.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.421 HD13 ' CD2' ' A' ' 25' ' ' PHE . 2.4 tp -142.15 105.44 4.62 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.606 1.562 . . . . 74.129999999999995 108.193 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -130.94 17.81 5.09 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.217 0.607 . . . . 65.340000000000003 110.605 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -134.47 160.21 24.12 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 109.621 -1.392 . . . . 72.129999999999995 109.621 163.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.4 m -144.45 167.08 15.93 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 125.658 1.583 . . . . 43.109999999999999 109.348 169.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -72.24 150.4 94.74 Favored 'Cis proline' 0 N--CA 1.46 -0.472 0 N-CA-C 110.057 -0.786 . . . . 72.430000000000007 110.057 -14.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -136.7 126.9 26.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 117.435 -1.269 . . . . 71.340000000000003 108.64 -172.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 47.5 ttm -124.12 124.74 43.15 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 119.205 0.911 . . . . 63.310000000000002 108.675 173.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -100.37 155.58 17.73 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 125.117 1.367 . . . . 71.340000000000003 110.086 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.8 t -140.54 144.71 26.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 124.259 1.024 . . . . 73.120000000000005 108.975 175.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 50.11 23.21 1.08 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.905 2.082 . . . . 72.409999999999997 113.91 169.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 61.58 17.2 53.11 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 118.681 -1.066 . . . . 61.039999999999999 113.777 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -149.2 -7.37 0.36 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.078 1.439 . . . . 65.200000000000003 114.571 -174.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -128.95 152.38 48.63 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 119.151 0.887 . . . . 70.230000000000004 110.401 -176.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -119.4 141.58 48.97 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.715 2.006 . . . . 73.099999999999994 107.819 168.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.89 132.54 45.41 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 107.772 -1.196 . . . . 74.200000000000003 107.772 170.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -106.39 86.95 2.35 Favored Pre-proline 0 C--O 1.235 0.291 0 C-N-CA 123.51 0.724 . . . . 71.519999999999996 111.954 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -65.77 -21.39 58.31 Favored 'Trans proline' 0 N--CA 1.444 -1.417 0 CA-C-O 117.911 -0.954 . . . . 72.299999999999997 112.32 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -64.79 -44.37 90.19 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 120.097 1.317 . . . . 74.530000000000001 110.942 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -82.0 1.68 86.01 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 118.87 -0.961 . . . . 44.240000000000002 112.876 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 46.6 mtt -79.3 168.05 20.07 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.958 1.879 . . . . 61.0 108.719 170.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -79.58 120.93 24.61 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 106.028 -1.841 . . . . 70.030000000000001 106.028 167.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.434 HG22 ' CD1' ' A' ' 173' ' ' PHE . 28.2 p -124.69 45.71 2.47 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.672 1.989 . . . . 74.219999999999999 106.76 -171.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 16.1 m -135.66 0.23 2.69 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 114.229 -1.351 . . . . 73.5 111.963 -164.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -133.74 -4.99 2.85 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.298 1.439 . . . . 72.040000000000006 110.899 174.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 1.7 mmt 66.83 -59.3 0.38 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.908 2.083 . . . . 72.340000000000003 112.897 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.39 -48.75 80.41 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 122.397 1.094 . . . . 64.329999999999998 109.121 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 99.3 t -64.04 -27.5 42.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 126.638 1.975 . . . . 73.439999999999998 111.674 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.434 ' CD1' HG22 ' A' ' 167' ' ' THR . 21.6 t80 -61.44 -59.22 5.59 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.065 -1.087 . . . . 70.140000000000001 108.065 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.92 -27.73 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 O-C-N 123.496 0.498 . . . . 72.200000000000003 110.906 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.45 -47.61 63.02 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.901 0.881 . . . . 70.040000000000006 111.022 171.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -79.6 -41.74 26.46 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 118.694 -0.67 . . . . 73.099999999999994 111.053 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -53.13 -59.26 4.77 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.274 0.943 . . . . 71.299999999999997 110.291 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.03 -29.07 68.26 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.521 1.128 . . . . 74.319999999999993 112.344 -175.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -65.54 -62.68 1.38 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.149 -0.686 . . . . 65.040000000000006 109.149 171.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 12.4 t -60.6 -28.43 68.5 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 118.837 -0.602 . . . . 73.219999999999999 112.186 -170.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 94.8 t -53.62 -47.08 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.821 0.737 . . . . 72.329999999999998 109.725 173.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 3.0 tmmt? -80.14 -32.75 38.92 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.152 -0.928 . . . . 61.409999999999997 110.778 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -57.25 -36.75 71.34 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.226 1.376 . . . . 65.019999999999996 110.661 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 59.1 mt -70.84 -27.09 63.6 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.037 -1.039 . . . . 70.230000000000004 112.776 -176.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 75.7 t -63.68 -30.89 51.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 122.8 0.44 . . . . 71.120000000000005 110.374 -178.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -87.84 -29.37 20.99 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.097 -0.705 . . . . 62.310000000000002 109.097 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 31.7 mttp -93.41 48.88 1.33 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.075 1.35 . . . . 74.310000000000002 110.04 -175.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 20.6 pttm . . . . . 0 C--O 1.245 0.836 0 N-CA-C 106.856 -1.535 . . . . 65.439999999999998 106.856 155.432 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.264 0 N-CA-C 112.053 0.39 . . . . 73.120000000000005 112.053 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.55 125.03 3.67 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 105.464 -2.05 . . . . 73.209999999999994 105.464 173.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.8 pt -131.3 147.15 32.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 127.974 2.51 . . . . 64.329999999999998 108.398 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.7 m -115.55 126.42 54.23 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.66 -1.237 . . . . 61.329999999999998 107.66 -176.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.45 121.41 3.42 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 127.77 2.428 . . . . 64.200000000000003 108.641 162.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.01 -11.77 71.25 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-O 117.834 -1.537 . . . . 65.310000000000002 113.707 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -102.7 -85.52 0.44 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 119.828 1.814 . . . . 74.5 108.972 -177.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -87.95 -16.68 33.13 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.552 1.141 . . . . 72.109999999999999 110.768 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.534 ' O ' HD13 ' A' ' 10' ' ' ILE . 28.3 p90 -136.69 163.09 31.39 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.309 1.044 . . . . 73.510000000000005 109.801 172.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.534 HD13 ' O ' ' A' ' 9' ' ' TYR . 6.4 mm -129.78 158.54 42.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 105.265 -2.124 . . . . 72.530000000000001 105.265 171.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.9 m -108.91 168.82 9.08 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.693 -1.225 . . . . 72.319999999999993 107.693 173.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.1 mt -92.03 161.08 14.93 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.518 -1.29 . . . . 50.439999999999998 107.518 166.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -79.1 -29.31 43.22 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 122.549 1.166 . . . . 74.129999999999995 108.201 174.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -133.68 71.67 74.66 Favored Pre-proline 0 N--CA 1.446 -0.626 0 O-C-N 120.187 -1.57 . . . . 63.140000000000001 110.757 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo . . . . . 0 N--CA 1.456 -0.727 0 C-N-CA 123.523 2.816 . . . . 42.340000000000003 110.571 176.983 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.514 HG22 ' H ' ' A' ' 23' ' ' LEU 0.277 2.9 p . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 112.942 0.719 . . . . 53.409999999999997 112.942 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.514 ' H ' HG22 ' A' ' 22' ' ' VAL . 6.0 tp -165.44 169.45 15.6 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 121.216 -0.928 . . . . 74.120000000000005 112.356 -172.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -145.5 125.35 13.48 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 127.915 2.486 . . . . 61.439999999999998 104.591 170.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.435 ' CE2' HD23 ' A' ' 23' ' ' LEU . 9.5 m-85 -115.41 131.75 56.83 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 119.808 1.185 . . . . 72.120000000000005 110.428 177.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.85 176.55 11.33 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.109 0.564 . . . . 73.519999999999996 110.812 178.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.9 t -129.46 172.61 11.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.598 -1.63 . . . . 70.200000000000003 106.598 169.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.862 ' CZ ' HD21 ' A' ' 71' ' ' LEU 0.253 0.0 OUTLIER -86.45 -18.76 30.86 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.288 0.635 . . . . 71.120000000000005 111.545 164.952 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -91.31 -6.37 53.22 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 119.742 -1.849 . . . . 73.519999999999996 113.335 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.1 p -77.83 141.36 63.87 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 121.2 1.818 . . . . 63.240000000000002 108.031 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -84.08 -40.3 0.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.86 1.707 . . . . 64.209999999999994 111.776 -174.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -56.08 -40.19 73.25 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 120.096 1.316 . . . . 74.299999999999997 110.105 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.2 m -51.36 -30.28 18.26 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.082 1.353 . . . . 74.209999999999994 112.719 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -62.11 -56.85 14.7 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 118.668 0.667 . . . . 71.299999999999997 111.698 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -57.6 -42.68 83.73 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.856 -0.794 . . . . 74.530000000000001 108.856 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -62.46 -18.15 61.1 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 115.294 -2.289 . . . . 71.200000000000003 112.173 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -139.69 9.14 2.4 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-N 122.122 2.237 . . . . 71.430000000000007 114.959 -170.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -136.44 -11.78 1.85 Allowed 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.86 1.264 . . . . 72.299999999999997 111.371 172.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.3 t -123.92 -81.39 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 107.401 -1.333 . . . . 75.140000000000001 107.401 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 49.8 mt -59.67 -31.09 69.23 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.771 2.028 . . . . 63.509999999999998 112.005 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 43.99 60.09 2.88 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.299 1.84 . . . . 71.040000000000006 110.536 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 86.7 t -63.02 -36.92 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.181 -0.918 . . . . 73.400000000000006 109.895 -174.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 t -51.07 -55.6 16.77 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.994 1.317 . . . . 31.309999999999999 110.39 173.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.34 -29.51 65.08 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 121.043 -1.036 . . . . 75.400000000000006 111.395 -174.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.57 -33.73 74.59 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.042 0.537 . . . . 71.400000000000006 112.05 175.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.6 t -70.97 -50.19 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.572 1.549 . . . . 74.129999999999995 109.158 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.6 ptm85 -61.72 -21.17 64.26 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 120.63 1.559 . . . . 72.099999999999994 113.883 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -68.04 -11.08 58.29 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.006 1.113 . . . . 72.010000000000005 114.006 172.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp -136.03 2.42 2.82 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.578 1.551 . . . . 43.43 112.117 -171.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.7 mt -72.35 145.71 88.33 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 119.725 1.148 . . . . 75.439999999999998 109.584 -176.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.94 150.16 29.78 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.427 2.085 . . . . 62.530000000000001 110.131 169.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -76.65 80.81 3.3 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 122.759 1.266 . . . . 75.430000000000007 111.029 -168.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.01 -49.53 0.23 Allowed Glycine 0 C--O 1.233 0.092 0 N-CA-C 109.595 -1.402 . . . . 74.030000000000001 109.595 -175.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.3 m -69.29 90.68 0.51 Allowed 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 107.767 -1.197 . . . . 74.519999999999996 107.767 173.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -80.12 129.92 34.86 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.469 -1.678 . . . . 71.430000000000007 106.469 173.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.4 mtm -66.26 161.93 21.15 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.258 -0.645 . . . . 64.239999999999995 109.258 173.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.39 -173.71 3.49 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.339 1.056 . . . . 65.439999999999998 108.155 178.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.41 91.89 0.46 Allowed 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.221 -1.029 . . . . 72.099999999999994 108.221 -173.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.499 ' CD2' ' HG3' ' A' ' 137' ' ' GLN . 6.4 m-30 -104.42 163.53 12.38 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.549 -0.908 . . . . 74.120000000000005 108.549 177.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.45 ' C ' ' CD2' ' A' ' 60' ' ' HIS . 2.0 p-80 -104.67 171.5 7.29 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 126.527 1.931 . . . . 72.200000000000003 108.071 -175.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.6 m -137.96 146.96 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.1 -1.074 . . . . 70.219999999999999 108.1 167.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -94.18 -0.47 55.19 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.076 0.853 . . . . 74.319999999999993 111.994 -175.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -73.99 167.64 21.1 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.575 1.15 . . . . 73.219999999999999 108.364 165.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 74.69 131.85 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 128.328 2.651 . . . . 65.430000000000007 111.093 177.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.6 173.59 3.51 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 122.472 1.04 . . . . 32.409999999999997 113.037 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -72.43 -45.27 0.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.473 2.115 . . . . 30.100000000000001 111.757 175.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.7 mt -80.85 19.65 0.84 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.537 1.535 . . . . 61.420000000000002 113.65 -171.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.07 -32.43 49.83 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-O 118.156 -1.358 . . . . 73.120000000000005 112.311 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.3 tmtp? -85.11 -7.46 59.08 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.16 1.48 . . . . 65.450000000000003 113.728 178.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -46.81 18.25 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-N 121.001 1.728 . . . . 72.140000000000001 107.893 162.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.862 HD21 ' CZ ' ' A' ' 28' ' ' PHE . 26.8 mt -57.75 -39.14 76.7 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 124.58 1.175 . . . . 65.230000000000004 111.145 -165.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -50.38 -51.7 43.74 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 128.542 2.737 . . . . 73.349999999999994 109.738 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -69.62 -58.96 3.29 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 114.149 -1.387 . . . . 72.420000000000002 107.308 -176.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.65 -28.65 68.64 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 121.264 1.847 . . . . 43.530000000000001 114.226 -171.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 36.4 t-105 -58.6 -36.68 74.4 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.79 0.723 . . . . 73.200000000000003 110.921 177.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.89 -41.29 97.71 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 118.055 -0.974 . . . . 62.119999999999997 111.032 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.505 HG22 ' HB3' ' A' ' 124' ' ' ALA . 41.4 t -54.62 -45.58 72.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 119.354 0.979 . . . . 63.020000000000003 110.1 171.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.96 -47.14 87.82 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.603 0.638 . . . . 33.310000000000002 111.306 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.8 mt -60.22 -44.73 96.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.736 1.214 . . . . 71.420000000000002 109.698 176.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.3 -31.76 72.4 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 123.945 0.898 . . . . 74.439999999999998 111.095 -175.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 75.2 mt -94.22 -12.41 28.28 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 119.008 -0.52 . . . . 62.439999999999998 111.819 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.67 54.87 32.18 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 126.907 2.194 . . . . 44.100000000000001 110.943 -172.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.71 11.62 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 124.141 0.976 . . . . 71.200000000000003 112.133 -176.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -56.24 -53.53 56.13 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 120.071 1.305 . . . . 75.109999999999999 110.491 -172.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -63.13 -8.09 7.12 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.755 1.622 . . . . 75.010000000000005 112.333 176.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -100.06 -18.03 17.19 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.434 1.494 . . . . 62.109999999999999 112.023 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.6 pp -127.51 33.3 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.036 1.335 . . . . 60.119999999999997 109.443 -175.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 76.1 m -107.23 -43.83 4.5 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 117.973 -1.013 . . . . 72.409999999999997 109.651 171.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.495 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -60.31 -63.36 4.36 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 120.736 1.607 . . . . 73.200000000000003 111.775 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 57.2 Cg_endo -65.27 -26.37 56.5 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 121.518 1.479 . . . . 74.209999999999994 111.81 -176.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 34.8 tpp -63.51 -49.61 72.85 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.584 0.754 . . . . 74.140000000000001 109.416 176.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -68.1 -35.14 77.67 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.874 0.87 . . . . 64.030000000000001 108.913 -176.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -60.97 -40.05 91.93 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.656 0.662 . . . . 62.299999999999997 110.423 171.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.18 -5.01 58.65 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 120.074 -1.642 . . . . 63.020000000000003 113.584 -174.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.681 HG21 ' CD2' ' A' ' 28' ' ' PHE . 50.2 t -111.01 -41.35 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 124.499 1.119 . . . . 74.219999999999999 109.709 -176.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -106.07 -53.77 2.58 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.42 0.688 . . . . 74.420000000000002 109.337 -172.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt -70.39 -54.12 13.74 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-O 118.675 -0.679 . . . . 72.329999999999998 110.61 -171.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.4 p -100.86 -18.49 16.37 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.176 0.99 . . . . 74.219999999999999 113.382 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 45.75 40.62 6.53 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.475 2.31 . . . . 72.219999999999999 114.228 -175.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.9 t -79.88 -8.0 59.05 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.288 -0.883 . . . . 63.420000000000002 112.557 178.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.487 HG11 ' CZ ' ' A' ' 28' ' ' PHE . 29.6 t -74.54 122.46 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 O-C-N 120.858 -1.151 . . . . 73.109999999999999 109.785 168.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -140.68 -23.41 0.79 Allowed 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.084 0.954 . . . . 73.340000000000003 112.303 175.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.21 175.4 11.09 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.307 0.643 . . . . 74.329999999999998 109.56 174.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 104' ' ' VAL . 18.0 t -55.55 -44.09 75.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 126.182 1.793 . . . . 70.049999999999997 109.941 -172.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.5 -14.34 40.43 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.212 0.605 . . . . 45.409999999999997 112.628 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -94.36 -27.65 15.96 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 119.421 1.01 . . . . 71.409999999999997 110.034 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.462 HG12 HG13 ' A' ' 101' ' ' VAL . 3.2 mt -81.52 -41.77 19.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 123.286 0.634 . . . . 65.239999999999995 109.378 -178.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -55.32 -25.08 32.42 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.441 -0.787 . . . . 74.450000000000003 113.055 176.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -62.23 -56.51 17.91 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.803 1.241 . . . . 70.310000000000002 110.78 -177.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 54.3 t -57.15 -43.1 80.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 119.165 -0.445 . . . . 51.219999999999999 110.369 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -50.68 -56.77 10.38 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.707 0.803 . . . . 74.239999999999995 109.482 175.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.74 -46.86 95.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 123.132 0.573 . . . . 71.450000000000003 109.811 -174.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.05 -43.57 91.7 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 123.652 0.595 . . . . 74.25 109.475 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.95 -17.32 62.08 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.425 1.09 . . . . 72.140000000000001 112.612 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 113.61 64.24 0.44 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.393 -1.083 . . . . 60.009999999999998 110.393 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.7 t -127.69 141.1 47.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 123.819 0.848 . . . . 74.129999999999995 109.976 163.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -66.04 148.2 52.17 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.905 -0.497 . . . . 53.210000000000001 112.027 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -73.5 1.84 41.71 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 124.775 1.179 . . . . 53.240000000000002 114.904 165.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -100.98 -39.98 7.47 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 117.367 0.584 . . . . 64.129999999999995 111.158 174.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.9 -35.04 62.27 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.014 -1.106 . . . . 62.420000000000002 108.014 -167.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -61.45 -59.93 4.5 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 116.067 -0.515 . . . . 72.030000000000001 109.857 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -59.64 -36.98 77.44 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.622 0.769 . . . . 74.450000000000003 110.969 -176.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.55 -65.49 0.71 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.916 0.886 . . . . 70.010000000000005 110.186 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.505 ' HB3' HG22 ' A' ' 77' ' ' VAL . . . -54.53 -37.08 64.96 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.175 0.99 . . . . 72.109999999999999 110.347 -173.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -45.08 -41.59 7.86 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.051 1.341 . . . . 65.209999999999994 112.904 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -112.83 19.78 17.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.703 1.201 . . . . 72.230000000000004 112.338 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.9 t -115.85 149.19 39.02 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 123.721 1.724 . . . . 62.049999999999997 110.783 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.84 -27.0 49.32 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 119.754 3.242 . . . . 72.150000000000006 119.754 -171.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 29.3 t -45.22 -56.31 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 C-N-CA 127.064 2.145 . . . . 74.310000000000002 107.996 168.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.25 -43.34 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 125.644 1.578 . . . . 70.150000000000006 109.398 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp -52.84 -46.31 67.72 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.544 -0.723 . . . . 64.120000000000005 112.089 177.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -49.11 71.89 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 118.724 -0.655 . . . . 71.340000000000003 110.055 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 13.5 mt -59.29 -42.17 90.65 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.777 -0.63 . . . . 74.150000000000006 111.469 -176.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 52.9 t -55.73 -48.96 77.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.672 -0.862 . . . . 72.230000000000004 108.672 176.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.59 -40.11 95.86 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 113.394 0.887 . . . . 52.229999999999997 113.394 -177.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -56.26 -50.93 69.94 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.934 0.894 . . . . 65.140000000000001 109.427 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.499 ' HG3' ' CD2' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -70.31 -38.12 74.88 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 117.454 -1.26 . . . . 74.329999999999998 111.148 -176.958 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -58.76 -44.41 90.56 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 120.535 1.516 . . . . 43.32 109.54 170.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.8 ttmm -67.12 -10.57 51.53 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.081 -1.012 . . . . 70.230000000000004 113.273 175.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.8 2.7 11.1 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 117.416 -1.278 . . . . 61.5 114.239 178.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -134.77 -12.28 2.29 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.154 1.343 . . . . 61.240000000000002 112.995 174.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -121.21 6.43 10.23 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.378 1.071 . . . . 73.120000000000005 111.121 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -70.83 -85.38 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.358 0.663 . . . . 70.209999999999994 112.364 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.1 pp -164.59 33.24 0.07 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.08 0.952 . . . . 61.420000000000002 113.438 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.555 ' NE2' ' H ' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -126.69 -69.41 0.76 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.298 0.954 . . . . 74.510000000000005 112.391 -163.368 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.555 ' H ' ' NE2' ' A' ' 145' ' ' GLN . 0.7 OUTLIER -133.91 142.22 47.66 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.556 2.742 . . . . 64.109999999999999 107.046 -171.208 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -143.68 13.11 1.71 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.222 1.009 . . . . 45.100000000000001 111.981 -178.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -141.02 176.89 21.32 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 109.36 -1.496 . . . . 70.239999999999995 109.36 173.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 19.2 m -147.7 171.15 6.66 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 124.417 1.087 . . . . 71.329999999999998 111.202 -169.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.432 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 44.2 Cg_endo -64.37 162.86 60.4 Favored 'Cis proline' 0 C--N 1.349 0.605 0 CA-C-N 120.376 1.17 . . . . 73.120000000000005 110.585 -14.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -146.78 147.31 30.77 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 122.89 0.476 . . . . 73.530000000000001 110.268 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 50.9 tpp -142.6 118.45 10.55 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.122 -2.177 . . . . 73.329999999999998 105.122 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -100.91 167.72 10.09 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.088 -0.708 . . . . 74.409999999999997 109.088 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.6 t -139.49 143.16 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.473 1.109 . . . . 71.099999999999994 108.393 170.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 49.45 18.17 0.27 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 128.108 2.563 . . . . 71.430000000000007 115.106 176.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 62.5 34.31 89.06 Favored Glycine 0 CA--C 1.534 1.232 0 O-C-N 120.765 -1.209 . . . . 65.129999999999995 111.687 -176.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -155.88 -22.0 0.11 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.346 1.61 . . . . 65.299999999999997 115.346 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -119.08 154.51 33.06 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 119.234 0.925 . . . . 72.510000000000005 109.044 -175.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.0 125.75 44.37 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.988 2.515 . . . . 72.420000000000002 107.833 176.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.425 HD11 ' CG2' ' A' ' 181' ' ' VAL . 1.0 OUTLIER -64.78 147.19 53.66 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 106.685 -1.598 . . . . 51.100000000000001 106.685 176.278 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.416 ' CG ' HD11 ' A' ' 10' ' ' ILE . 36.3 t30 -123.78 76.67 56.92 Favored Pre-proline 0 C--O 1.233 0.223 0 O-C-N 122.091 -0.38 . . . . 61.210000000000001 111.436 -176.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.58 -17.19 58.75 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.501 1.468 . . . . 74.400000000000006 112.198 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -70.96 -12.21 61.41 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.136 1.774 . . . . 51.140000000000001 113.087 177.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -121.28 35.47 3.62 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.854 1.216 . . . . 45.299999999999997 110.113 175.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 46.0 mtt -122.37 165.04 16.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 122.278 1.037 . . . . 72.319999999999993 109.596 176.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -82.83 76.4 9.68 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.562 -1.199 . . . . 65.209999999999994 110.771 -176.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 21.4 p -73.22 -1.06 16.23 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.256 2.222 . . . . 70.310000000000002 112.8 177.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 39.7 m -72.83 -6.34 44.24 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 113.851 1.056 . . . . 54.200000000000003 113.851 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.59 -9.6 1.42 Allowed 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 117.772 -1.109 . . . . 45.43 113.311 -167.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 3.0 mmt 66.36 -56.85 0.38 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.272 1.829 . . . . 72.5 114.998 174.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.76 -51.37 62.65 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 106.987 -1.486 . . . . 71.239999999999995 106.987 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 48.6 t -57.93 -36.43 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.881 1.272 . . . . 75.219999999999999 110.121 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -58.77 -60.98 2.98 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 118.214 -0.898 . . . . 74.200000000000003 109.771 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.5 t -70.73 -33.97 54.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 118.476 0.58 . . . . 74.400000000000006 110.931 -175.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -49.94 -46.5 52.25 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.76 1.224 . . . . 71.319999999999993 110.155 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -87.43 -28.74 21.94 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 113.349 0.87 . . . . 72.5 113.349 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -56.61 -60.54 3.39 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.054 1.297 . . . . 65.299999999999997 110.513 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.77 -32.22 70.39 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.039 0.536 . . . . 72.129999999999995 111.951 -177.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -60.12 -50.93 71.76 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.773 1.229 . . . . 74.230000000000004 110.275 175.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.0 t -68.44 -30.17 68.98 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 116.73 -1.605 . . . . 63.119999999999997 110.912 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.425 ' CG2' HD11 ' A' ' 160' ' ' LEU . 58.7 t -56.44 -52.06 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 120.512 1.506 . . . . 62.219999999999999 108.578 173.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -59.38 -53.54 56.98 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-O 118.39 -0.815 . . . . 74.5 110.682 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -53.03 -40.94 64.26 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.74 0.7 . . . . 65.230000000000004 111.796 -171.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.85 -20.59 63.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.739 1.014 . . . . 71.530000000000001 113.739 -176.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.08 -33.74 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 109.109 -0.7 . . . . 64.299999999999997 109.109 171.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -80.1 -41.64 25.14 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.877 -1.157 . . . . 42.210000000000001 107.877 -171.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -85.86 51.38 2.19 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.802 2.041 . . . . 73.099999999999994 110.24 -178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 20.4 pttt . . . . . 0 C--O 1.246 0.893 0 CA-C-O 117.264 -1.35 . . . . 65.120000000000005 110.158 172.094 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.484 0 N-CA-C 113.105 0.779 . . . . 45.219999999999999 113.105 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.52 122.47 3.58 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 105.613 -1.995 . . . . 71.140000000000001 105.613 170.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -126.68 158.35 37.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 126.318 1.847 . . . . 62.310000000000002 106.636 171.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.6 m -136.08 135.43 39.33 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.767 -1.197 . . . . 70.120000000000005 107.767 -176.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -51.74 104.15 0.08 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 131.52 3.928 . . . . 74.340000000000003 108.796 167.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 110.0 -22.17 23.74 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 126.998 2.237 . . . . 65.340000000000003 112.501 -177.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -90.7 -85.49 0.22 Allowed 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 119.776 1.788 . . . . 70.230000000000004 108.433 -172.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -89.4 -15.56 32.96 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.896 1.279 . . . . 72.150000000000006 109.915 -176.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -137.2 162.85 32.35 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.599 0.76 . . . . 71.310000000000002 110.709 172.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.401 ' HB ' ' HG3' ' A' ' 159' ' ' GLN . 3.0 mm -128.66 166.81 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 127.542 2.337 . . . . 74.25 105.97 171.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.1 174.22 5.98 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 127.605 2.362 . . . . 72.549999999999997 109.68 176.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 57.9 mt -116.4 148.63 40.48 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.524 1.13 . . . . 70.109999999999999 110.013 171.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -73.06 -35.81 66.76 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.474 1.11 . . . . 70.140000000000001 110.152 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.6 mmtm -122.05 77.99 41.85 Favored Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 126.522 1.929 . . . . 64.150000000000006 109.354 177.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo . . . . . 0 N--CA 1.458 -0.597 0 C-N-CA 124.553 3.502 . . . . 62.530000000000001 112.858 172.049 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 C--O 1.238 0.46 0 CA-C-O 121.917 0.865 . . . . 73.319999999999993 111.148 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.3 154.2 37.46 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.614 1.566 . . . . 65.120000000000005 107.015 -173.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -120.53 141.77 49.94 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.369 -1.345 . . . . 64.230000000000004 107.369 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -130.69 134.98 47.38 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.787 1.635 . . . . 72.200000000000003 109.339 176.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.3 179.27 7.5 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.784 1.234 . . . . 72.430000000000007 108.434 167.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.0 t -134.4 153.43 51.91 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.379 -0.971 . . . . 71.209999999999994 108.379 168.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.541 ' CE2' ' HG2' ' A' ' 91' ' ' MET . 12.2 m-30 -64.94 -24.39 67.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 118.483 -0.77 . . . . 74.209999999999994 111.705 172.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.407 ' CE2' ' HA3' ' A' ' 65' ' ' GLY . 47.7 m-85 -89.26 -5.2 57.8 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 120.283 1.401 . . . . 65.129999999999995 113.667 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.9 p -90.4 144.42 30.81 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 122.059 2.209 . . . . 73.310000000000002 111.298 -174.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -81.84 -43.19 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 121.935 1.756 . . . . 63.329999999999998 112.394 -166.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -54.48 -45.67 73.24 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 109.136 -0.69 . . . . 73.109999999999999 109.136 173.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 15.3 m -55.44 -35.86 65.91 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.503 1.921 . . . . 71.25 112.048 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -64.79 -48.53 74.12 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.822 0.737 . . . . 73.549999999999997 110.674 176.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -59.37 -44.5 92.71 Favored 'General case' 0 C--O 1.223 -0.302 0 O-C-N 121.091 -1.005 . . . . 74.150000000000006 108.908 172.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -60.3 -16.55 35.57 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 115.735 -2.079 . . . . 71.540000000000006 112.41 -178.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -142.83 12.21 1.85 Allowed 'General case' 0 C--N 1.347 0.461 0 CA-C-N 122.111 2.232 . . . . 74.430000000000007 114.438 -172.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -131.7 -13.04 3.34 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.15 0.98 . . . . 64.219999999999999 112.282 165.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.1 t -128.26 -77.12 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 108.353 -0.98 . . . . 72.510000000000005 108.353 -170.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.8 mt -67.18 -26.8 66.81 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.787 1.635 . . . . 74.450000000000003 111.838 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 44.03 56.25 4.85 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.128 1.371 . . . . 70.239999999999995 110.915 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.628 ' O ' HG23 ' A' ' 46' ' ' VAL . 61.1 t -61.64 -46.53 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 117.506 -1.235 . . . . 53.340000000000003 107.967 -169.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.5 t -56.86 -37.99 72.09 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 120.318 1.417 . . . . 64.219999999999999 112.283 -177.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.22 -49.07 63.18 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.103 0.961 . . . . 71.129999999999995 109.745 177.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -62.23 -41.28 98.26 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.625 1.17 . . . . 43.310000000000002 112.088 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 42' ' ' VAL . 2.5 t -62.97 -51.01 77.31 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 N-CA-C 107.553 -1.277 . . . . 71.120000000000005 107.553 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -50.01 -47.83 52.84 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.285 0.948 . . . . 72.239999999999995 111.578 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -66.5 -1.45 3.6 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 115.284 1.587 . . . . 71.120000000000005 115.284 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -130.01 -4.23 4.52 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.94 2.096 . . . . 63.420000000000002 112.891 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.695 HD13 HG21 ' A' ' 54' ' ' THR . 13.6 mt -69.33 151.28 96.95 Favored Pre-proline 0 N--CA 1.466 0.35 0 CA-C-N 120.065 1.302 . . . . 53.450000000000003 110.769 -172.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -81.07 146.3 15.93 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 122.275 1.984 . . . . 74.409999999999997 110.036 172.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -71.93 105.38 3.82 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.015 -1.448 . . . . 72.519999999999996 109.211 -175.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 131.79 -9.54 5.48 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.728 -1.04 . . . . 71.140000000000001 113.337 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.695 HG21 HD13 ' A' ' 50' ' ' LEU . 5.9 t -52.81 -46.79 67.85 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.705 1.253 . . . . 72.439999999999998 112.228 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? 46.5 83.54 0.03 OUTLIER 'General case' 0 C--N 1.346 0.417 0 C-N-CA 127.305 2.242 . . . . 62.310000000000002 110.3 -174.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 19.9 ptp -65.53 -175.74 0.29 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 112.317 -2.219 . . . . 70.450000000000003 111.89 176.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 m -154.75 174.98 14.29 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.278 1.831 . . . . 64.349999999999994 108.482 165.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -140.3 126.14 19.41 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.994 -1.113 . . . . 74.230000000000004 107.994 152.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.402 ' CD2' ' HG3' ' A' ' 137' ' ' GLN . 11.4 m-30 -106.09 -176.98 3.23 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.499 -0.926 . . . . 45.109999999999999 108.499 162.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.429 ' CE1' HD13 ' A' ' 71' ' ' LEU . 41.3 t-80 -134.75 135.12 41.65 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.015 1.726 . . . . 70.329999999999998 106.656 176.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.0 m -81.6 151.89 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.813 0.845 . . . . 62.100000000000001 110.399 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.65 -5.56 22.49 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.675 1.19 . . . . 72.319999999999993 112.314 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -68.49 -45.63 71.84 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.576 -0.702 . . . . 73.540000000000006 112.583 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.0 mt -78.18 132.17 37.49 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 121.838 -0.539 . . . . 73.120000000000005 109.689 -171.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.407 ' HA3' ' CE2' ' A' ' 29' ' ' TYR . . . 97.64 160.85 31.05 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 124.924 1.25 . . . . 64.109999999999999 112.39 169.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.71 -39.47 6.57 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.449 2.099 . . . . 74.239999999999995 110.276 173.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.5 mt -84.59 24.4 1.02 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.507 1.923 . . . . 74.310000000000002 110.661 172.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.39 -52.22 51.28 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 120.972 -1.08 . . . . 33.450000000000003 112.162 -175.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -56.17 -44.91 79.77 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.964 0.882 . . . . 72.219999999999999 110.994 174.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -63.44 -35.7 81.31 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 124.756 1.222 . . . . 73.140000000000001 111.396 -178.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.429 HD13 ' CE1' ' A' ' 60' ' ' HIS . 21.8 mt -60.02 -52.13 66.68 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 123.803 0.841 . . . . 43.240000000000002 110.76 176.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.9 m -62.96 -37.49 87.3 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.403 0.547 . . . . 73.219999999999999 110.339 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -58.51 -44.18 89.4 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.812 -0.555 . . . . 74.329999999999998 109.775 172.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.32 96.39 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.355 -1.466 . . . . 65.5 112.897 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 49.3 t-105 -57.93 -37.96 75.06 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.837 0.855 . . . . 71.109999999999999 109.786 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.09 -43.98 87.34 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 117.55 -1.214 . . . . 62.299999999999997 112.513 175.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.1 t -54.01 -46.35 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 120.632 1.56 . . . . 64.109999999999999 110.714 170.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.71 -45.04 94.58 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-O 118.951 -0.547 . . . . 71.439999999999998 110.864 -175.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 91.6 mt -57.69 -46.82 86.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.956 0.902 . . . . 72.519999999999996 109.43 174.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.45 -3.69 44.67 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.515 1.302 . . . . 65.5 114.515 -169.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 88.5 mt -106.23 -21.48 13.1 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.597 1.089 . . . . 65.329999999999998 111.696 156.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.11 64.08 2.77 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 125.573 1.559 . . . . 34.130000000000003 109.218 -169.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.22 13.76 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.745 1.218 . . . . 70.510000000000005 112.16 -176.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -51.13 -60.2 3.36 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.541 1.137 . . . . 73.420000000000002 109.766 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.12 -8.59 3.59 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.002 1.721 . . . . 72.150000000000006 113.291 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -102.56 -10.78 19.01 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 120.379 -1.45 . . . . 73.439999999999998 112.043 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.2 pp -126.77 -14.12 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 116.96 -1.495 . . . . 74.140000000000001 112.102 -174.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 34.3 m -55.18 -54.96 36.7 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 119.652 1.115 . . . . 53.009999999999998 109.503 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.533 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -54.45 -62.43 4.03 Favored Pre-proline 0 N--CA 1.449 -0.507 0 C-N-CA 124.866 1.266 . . . . 73.409999999999997 111.296 -170.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.533 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 38.0 Cg_endo -64.05 -26.01 66.03 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.112 1.208 . . . . 72.230000000000004 112.357 -177.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.541 ' HG2' ' CE2' ' A' ' 28' ' ' PHE . 8.5 tpp -62.44 -48.03 81.45 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-O 118.193 -0.908 . . . . 74.239999999999995 111.215 172.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -66.71 -35.96 81.37 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 120.412 1.46 . . . . 72.209999999999994 109.139 -178.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -62.39 -33.56 74.99 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.422 0.556 . . . . 74.129999999999995 111.324 170.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.93 -11.12 45.37 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.894 -1.129 . . . . 64.310000000000002 113.388 -176.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.3 t -109.52 -42.87 5.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 125.338 1.455 . . . . 74.239999999999995 110.61 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -103.52 -46.37 4.58 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.179 0.592 . . . . 72.549999999999997 110.133 -174.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt -77.13 -68.65 0.59 Allowed 'General case' 0 N--CA 1.457 -0.088 0 CA-C-O 119.03 -0.509 . . . . 74.25 109.897 -172.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.5 p -79.85 -30.91 40.43 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.296 0.953 . . . . 72.409999999999997 110.548 177.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 60.43 20.97 10.62 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.228 1.811 . . . . 62.219999999999999 113.317 -174.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -69.23 -12.77 61.96 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.324 1.05 . . . . 53.039999999999999 112.812 -174.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.455 HG13 HG12 ' A' ' 107' ' ' ILE . 29.6 t -65.41 115.07 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 O-C-N 120.998 -1.064 . . . . 74.430000000000007 109.189 170.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -136.68 -31.14 0.87 Allowed 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.762 1.225 . . . . 74.540000000000006 112.083 -173.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.67 170.1 16.64 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.904 0.882 . . . . 62.299999999999997 109.355 167.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 67.3 t -54.23 -37.52 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.016 1.326 . . . . 64.140000000000001 111.205 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.28 -31.18 42.5 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.385 1.074 . . . . 45.200000000000003 112.709 176.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -82.4 -27.73 31.84 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 123.242 0.617 . . . . 54.399999999999999 110.504 -177.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.455 HG12 HG13 ' A' ' 101' ' ' VAL . 3.2 mt -76.22 -50.43 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.808 1.643 . . . . 70.200000000000003 108.014 -177.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.412 ' HB3' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -64.82 -21.35 66.77 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.525 -0.734 . . . . 73.319999999999993 111.792 -177.284 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -56.45 21.75 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 124.552 1.141 . . . . 50.43 110.217 168.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.8 t -51.51 -45.53 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 123.654 0.781 . . . . 74.319999999999993 110.002 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -53.1 -55.71 21.89 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.808 0.443 . . . . 62.43 109.859 176.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 64.6 t -57.29 -42.91 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 O-C-N 121.7 -0.625 . . . . 73.319999999999993 110.232 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -61.6 -41.77 97.91 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 124.283 0.989 . . . . 65.530000000000001 109.534 -171.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.34 -2.21 30.58 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.008 1.723 . . . . 62.119999999999997 113.199 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 99.61 55.78 1.0 Allowed Glycine 0 CA--C 1.524 0.618 0 CA-C-N 119.257 0.935 . . . . 71.510000000000005 112.587 177.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 66.8 t -119.84 142.31 35.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 117.687 0.743 . . . . 63.32 109.668 170.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.84 126.32 29.05 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.048 0.939 . . . . 72.129999999999995 109.769 170.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.94 -24.04 69.82 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-O 118.017 -1.435 . . . . 71.420000000000002 112.413 175.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.54 -38.25 89.07 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.941 1.37 . . . . 74.430000000000007 109.752 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -73.4 -44.99 57.34 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 105.794 -1.928 . . . . 71.420000000000002 105.794 -171.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.412 ' CE1' ' HB3' ' A' ' 108' ' ' ARG . 5.1 t80 -60.32 -40.2 89.74 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.452 0.644 . . . . 71.239999999999995 110.045 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -79.61 -11.2 59.88 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.395 0.887 . . . . 72.409999999999997 113.395 -177.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -103.44 -63.55 1.17 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.985 1.314 . . . . 62.520000000000003 109.251 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -44.89 -45.07 10.13 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 128.001 2.521 . . . . 63.200000000000003 110.752 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 44.5 t-105 -50.9 -29.7 12.68 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.279 1.032 . . . . 73.530000000000001 113.563 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -119.33 5.78 11.18 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.895 1.678 . . . . 74.230000000000004 112.434 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.1 t -88.77 149.85 23.23 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.814 1.645 . . . . 65.5 109.466 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -49.2 -33.68 12.99 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.963 1.705 . . . . 73.129999999999995 112.121 177.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.0 t -46.09 -56.53 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 125.338 1.455 . . . . 73.430000000000007 110.426 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.1 t -67.4 -47.45 80.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 C-N-CA 125.016 1.326 . . . . 71.430000000000007 109.454 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -54.39 -44.54 72.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.213 0.53 . . . . 72.299999999999997 110.314 -172.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.05 -45.77 84.01 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.68 1.192 . . . . 73.319999999999993 111.534 176.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 16.3 mt -60.42 -48.62 80.95 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.86 0.864 . . . . 74.530000000000001 111.203 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.9 t -49.96 -45.26 22.37 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 C-N-CA 124.819 1.248 . . . . 73.420000000000002 109.3 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.5 -32.5 74.16 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.693 0.627 . . . . 52.229999999999997 112.693 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -62.85 -51.8 65.62 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.059 0.845 . . . . 73.510000000000005 110.588 171.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.402 ' HG3' ' CD2' ' A' ' 59' ' ' TYR . 7.4 mp0 -63.44 -47.14 83.1 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.793 0.27 . . . . 52.299999999999997 111.235 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -58.73 -47.16 85.57 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.938 1.295 . . . . 70.109999999999999 110.553 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -57.23 -45.06 84.24 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 118.492 0.587 . . . . 73.230000000000004 110.172 175.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.95 1.37 10.96 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.653 0.983 . . . . 74.299999999999997 113.653 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -86.37 -59.36 2.3 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.132 -1.605 . . . . 71.140000000000001 110.36 149.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.2 -7.87 40.51 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.028 2.131 . . . . 53.399999999999999 114.28 -163.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.08 -6.26 48.55 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.064 1.346 . . . . 71.099999999999994 112.343 172.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.0 mt 67.71 63.17 0.41 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 122.727 1.251 . . . . 61.409999999999997 109.494 167.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -144.58 -48.11 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.505 -1.225 . . . . 74.340000000000003 111.435 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 9.4 tp -78.69 -85.76 0.07 Allowed 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.76 0.709 . . . . 65.230000000000004 110.654 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 57.82 24.7 11.09 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.475 1.11 . . . . 71.510000000000005 112.515 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -169.39 162.47 36.06 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.682 1.61 . . . . 53.420000000000002 109.835 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 18.9 m -150.69 165.19 17.93 Favored Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 118.47 1.135 . . . . 72.510000000000005 109.852 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -65.31 157.31 76.63 Favored 'Cis proline' 0 C--N 1.351 0.665 0 CA-C-N 119.902 1.001 . . . . 64.450000000000003 110.592 -13.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -144.59 141.8 29.69 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.973 -0.558 . . . . 53.210000000000001 110.058 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 34.7 mtp -148.94 95.31 2.38 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 105.855 -1.905 . . . . 53.340000000000003 105.855 -169.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -82.13 169.31 16.79 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.996 -0.372 . . . . 73.140000000000001 109.996 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.2 t -147.38 150.31 14.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 O-C-N 121.128 -0.982 . . . . 62.530000000000001 109.602 169.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 60.31 6.1 0.97 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 128.431 2.692 . . . . 73.329999999999998 114.241 166.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.4 -1.47 84.25 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.298 -1.279 . . . . 72.340000000000003 112.455 -173.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -147.05 -7.12 0.48 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 116.252 1.945 . . . . 74.340000000000003 116.252 -164.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -121.48 155.6 34.57 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 118.517 0.599 . . . . 73.510000000000005 109.898 -175.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.401 ' HG3' ' HB ' ' A' ' 10' ' ' ILE . 0.5 OUTLIER -125.67 130.02 50.74 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 128.159 2.584 . . . . 74.439999999999998 107.302 172.199 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.61 153.74 38.43 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.67 -1.233 . . . . 63.329999999999998 107.67 174.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -126.48 85.59 59.97 Favored Pre-proline 0 C--O 1.234 0.272 0 O-C-N 122.241 -0.287 . . . . 63.210000000000001 110.93 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -63.11 -22.81 73.33 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 CA-C-N 118.948 0.66 . . . . 70.209999999999994 111.794 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.5 -2.59 23.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.875 1.27 . . . . 72.209999999999994 111.955 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -131.93 30.92 3.14 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.596 1.569 . . . . 72.530000000000001 111.021 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 20.8 mtm -127.15 165.18 20.05 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.439 1.496 . . . . 73.140000000000001 108.74 172.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -83.18 67.73 9.31 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 124.978 2.323 . . . . 70.310000000000002 110.762 -166.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.5 p -66.53 6.09 0.5 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 131.55 3.94 . . . . 72.129999999999995 112.204 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 23.0 m -91.74 -5.47 53.55 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 124.112 0.965 . . . . 73.319999999999993 113.458 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.44 -10.69 2.48 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 118.376 -0.821 . . . . 73.340000000000003 112.626 -172.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 10.1 mmt 70.25 -59.1 0.53 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 126.33 1.852 . . . . 53.140000000000001 112.978 177.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -67.4 -43.07 82.19 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.84 1.2 . . . . 73.319999999999993 108.774 -174.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 40.0 t -65.33 -30.56 50.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 124.516 1.127 . . . . 71.349999999999994 110.925 176.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -61.96 -62.53 1.72 Allowed 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.791 -0.818 . . . . 65.310000000000002 108.791 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 12.7 t -63.55 -39.01 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 119.079 -0.486 . . . . 73.540000000000006 110.271 -172.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -50.6 -49.52 56.36 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.627 1.171 . . . . 74.319999999999993 110.612 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -78.62 -40.36 34.57 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 118.342 -0.837 . . . . 73.310000000000002 112.005 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -54.1 -56.48 17.67 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.953 0.901 . . . . 74.519999999999996 110.289 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -53.86 -35.89 62.0 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.438 1.095 . . . . 72.530000000000001 112.326 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -73.29 -51.77 16.36 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.363 0.665 . . . . 72.530000000000001 109.829 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.0 t -62.15 -25.34 67.7 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 117.483 -1.246 . . . . 72.219999999999999 111.374 -176.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 57.8 t -56.62 -56.28 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 119.369 0.986 . . . . 72.549999999999997 108.896 168.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 13.6 tttm -55.8 -46.23 78.07 Favored 'General case' 0 N--CA 1.461 0.088 0 C-N-CA 123.512 0.725 . . . . 70.310000000000002 111.518 177.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -58.25 -29.18 65.56 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.442 0.697 . . . . 73.219999999999999 111.361 -175.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 50.9 mt -82.04 -25.77 34.35 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 120.964 -1.085 . . . . 73.150000000000006 113.222 -176.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 89.3 t -59.74 -36.14 64.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.732 -0.84 . . . . 53.030000000000001 108.732 175.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -91.43 -19.65 22.63 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 122.218 -0.301 . . . . 74.239999999999995 111.094 -173.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -95.17 65.78 2.87 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.947 1.299 . . . . 72.109999999999999 108.932 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt . . . . . 0 C--O 1.242 0.706 0 N-CA-C 108.47 -0.937 . . . . 62.509999999999998 108.47 165.337 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.387 0 N-CA-C 115.232 1.568 . . . . 72.239999999999995 115.232 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -165.37 113.74 1.01 Allowed 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.238 1.015 . . . . 73.230000000000004 110.398 169.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.0 pt -112.93 172.02 3.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 127.593 2.357 . . . . 70.430000000000007 109.612 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.9 m -142.68 141.52 31.86 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.138 -0.976 . . . . 62.240000000000002 108.86 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -53.21 135.55 37.93 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 126.174 1.79 . . . . 71.310000000000002 110.155 172.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.48 -18.02 7.51 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.376 1.465 . . . . 74.239999999999995 113.889 -175.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -93.41 -85.12 0.28 Allowed 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.569 1.684 . . . . 63.109999999999999 108.904 -167.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -89.43 -12.05 41.34 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.948 0.899 . . . . 64.239999999999995 111.381 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -141.69 160.83 39.36 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.494 0.718 . . . . 74.25 109.658 171.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.6 mm -121.74 162.77 20.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 107.407 -1.331 . . . . 73.209999999999994 107.407 170.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.4 m -119.57 127.46 53.0 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 127.137 2.175 . . . . 74.219999999999999 106.126 -178.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.4 mt -70.5 159.36 34.42 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.236 -0.653 . . . . 51.329999999999998 109.236 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -83.07 -30.1 28.28 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.847 0.459 . . . . 71.439999999999998 111.608 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -138.13 73.06 45.43 Favored Pre-proline 0 C--O 1.232 0.149 0 C-N-CA 124.903 1.281 . . . . 75.129999999999995 108.58 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo . . . . . 0 N--CA 1.451 -0.973 0 C-N-CA 123.161 2.574 . . . . 55.509999999999998 106.953 173.688 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.471 0.62 0 CA-C-O 122.165 0.983 . . . . 70.319999999999993 111.639 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.7 160.17 41.64 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.48 -0.933 . . . . 64.25 108.48 -173.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -126.77 161.36 28.37 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 125.083 1.353 . . . . 73.019999999999996 107.458 167.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -121.09 174.04 6.9 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.982 -1.488 . . . . 75.310000000000002 106.982 167.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -166.01 -179.03 4.97 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.669 2.388 . . . . 72.420000000000002 109.264 168.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.07 -168.63 2.4 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 106.729 -1.582 . . . . 44.100000000000001 106.729 158.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -104.47 -45.9 4.52 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.587 0.708 . . . . 74.319999999999993 109.256 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.499 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 69.4 m-85 -83.39 -4.09 58.15 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.544 -0.723 . . . . 73.310000000000002 111.814 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.2 p -62.36 144.09 95.36 Favored Pre-proline 0 C--N 1.343 0.283 0 CA-C-N 119.782 1.174 . . . . 72.200000000000003 109.841 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.0 173.93 13.66 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 121.461 1.441 . . . . 65.400000000000006 109.365 163.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 66.17 -40.63 0.35 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 128.936 2.895 . . . . 61.420000000000002 112.762 -174.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 60.2 m -54.84 -41.09 70.32 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.834 1.654 . . . . 73.099999999999994 112.128 -177.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -54.5 -63.69 1.07 Allowed 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 128.199 2.6 . . . . 73.219999999999999 108.854 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -57.16 -39.97 76.3 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 108.434 -0.95 . . . . 72.439999999999998 108.434 -179.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -57.09 -26.46 60.45 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 115.292 -2.289 . . . . 74.439999999999998 113.282 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.64 -24.57 4.5 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 122.158 2.254 . . . . 72.099999999999994 109.552 -174.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -105.76 -17.06 14.5 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.512 1.505 . . . . 74.310000000000002 113.757 -170.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.6 t -121.68 -63.73 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 108.187 -1.042 . . . . 70.439999999999998 108.187 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 42.6 mt -70.88 -18.39 62.69 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 118.147 -0.93 . . . . 74.019999999999996 111.966 175.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 44.89 39.59 3.71 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 121.139 1.79 . . . . 74.099999999999994 112.899 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 69.4 t -61.23 -45.41 98.65 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 O-C-N 121.091 -1.006 . . . . 71.230000000000004 109.864 -175.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.4 t -47.1 -53.27 13.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.86 1.264 . . . . 63.119999999999997 109.942 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.95 -31.89 69.85 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 113.558 0.948 . . . . 52.530000000000001 113.558 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -73.88 -51.69 15.39 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.702 0.683 . . . . 74.340000000000003 109.297 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 50.4 t -52.66 -52.68 25.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 126.055 1.742 . . . . 73.450000000000003 109.609 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.4 ptt85 -64.85 -14.01 58.03 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 116.795 -1.574 . . . . 74.349999999999994 114.015 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -75.75 -17.64 59.83 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 120.667 1.576 . . . . 73.409999999999997 112.55 170.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -123.34 -9.18 8.07 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.445 1.098 . . . . 64.109999999999999 113.34 -171.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.448 HD12 ' HE1' ' A' ' 56' ' ' MET . 10.8 mt -61.64 146.16 90.62 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 123.929 0.892 . . . . 73.239999999999995 112.184 -179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -83.47 162.1 14.79 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.879 3.053 . . . . 70.129999999999995 114.081 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -79.51 64.83 4.5 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 127.094 2.158 . . . . 65.310000000000002 110.257 -171.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -176.25 -30.41 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 125.174 1.368 . . . . 51.450000000000003 111.615 -169.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.445 HG21 HD13 ' A' ' 50' ' ' LEU . 3.8 t -58.04 -29.61 65.49 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 115.233 1.568 . . . . 74.430000000000007 115.233 -176.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.3 tptp 44.37 88.62 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.43 1.892 . . . . 74.329999999999998 112.185 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.448 ' HE1' HD12 ' A' ' 50' ' ' LEU . 4.5 ttm -49.77 100.71 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 129.388 3.075 . . . . 64.329999999999998 110.692 -175.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.4 m -139.84 121.31 15.1 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 107.337 -1.357 . . . . 62.299999999999997 107.337 -172.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -130.46 120.01 23.51 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 106.986 -1.487 . . . . 54.420000000000002 106.986 -176.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -95.52 157.11 16.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 123.13 1.443 . . . . 74.430000000000007 110.056 174.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.646 ' CE1' ' HG2' ' A' ' 137' ' ' GLN . 22.4 p-80 -98.0 167.06 11.13 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 129.176 2.99 . . . . 61.43 108.901 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.2 m -131.92 165.83 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.032 0.933 . . . . 51.439999999999998 108.507 176.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -100.68 16.65 24.21 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.53 1.132 . . . . 62.310000000000002 111.675 -169.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -115.73 162.6 17.04 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 126.436 1.895 . . . . 52.520000000000003 109.322 -169.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 75.3 124.34 0.04 OUTLIER 'General case' 0 C--O 1.232 0.153 0 C-N-CA 128.676 2.79 . . . . 63.039999999999999 110.519 174.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.499 ' HA3' ' CD2' ' A' ' 29' ' ' TYR . . . 90.19 173.47 44.93 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 124.302 0.953 . . . . 75.420000000000002 112.098 175.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -65.52 -55.15 0.47 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.348 2.699 . . . . 74.209999999999994 109.737 173.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.5 mt -86.54 17.0 4.1 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 125.174 1.39 . . . . 72.129999999999995 112.862 -167.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -48.16 -45.12 27.21 Favored Glycine 0 CA--C 1.542 1.739 0 CA-C-N 120.005 1.275 . . . . 72.129999999999995 113.715 -174.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.1 tptt -59.85 -46.37 89.5 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.887 1.275 . . . . 74.109999999999999 111.541 174.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -71.03 -38.18 72.58 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.749 -1.219 . . . . 71.019999999999996 109.026 -176.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.1 mt -62.46 -34.1 76.14 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.091 1.756 . . . . 71.209999999999994 111.915 173.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.468 ' HA ' ' HD2' ' A' ' 60' ' ' HIS . 18.7 m -54.04 -58.19 8.24 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 106.934 -1.506 . . . . 74.319999999999993 106.934 170.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -57.25 -50.56 72.51 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.968 0.907 . . . . 72.400000000000006 111.595 -169.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.5 -24.4 67.46 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.883 1.068 . . . . 61.020000000000003 113.883 -171.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 -57.7 -35.04 70.09 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.453 -0.779 . . . . 74.219999999999999 111.168 175.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.05 95.04 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.34 -0.838 . . . . 72.340000000000003 111.915 178.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.2 t -53.38 -43.73 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 119.177 0.898 . . . . 32.420000000000002 110.159 175.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.93 -26.24 40.2 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 117.362 -1.304 . . . . 32.119999999999997 113.088 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 76.8 mt -67.14 -41.75 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 120.835 1.652 . . . . 70.040000000000006 108.343 166.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.01 -44.36 94.63 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.623 0.647 . . . . 74.040000000000006 110.464 -172.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.4 mt -81.04 -18.07 48.01 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 112.902 0.705 . . . . 64.409999999999997 112.902 174.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.29 70.16 1.13 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.907 1.717 . . . . 54.219999999999999 110.789 -171.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.469 HG21 HG22 ' A' ' 116' ' ' VAL . 15.9 m -138.11 19.18 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 125.735 1.614 . . . . 72.400000000000006 111.432 -175.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -52.43 -51.52 58.78 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 126.03 1.732 . . . . 72.140000000000001 110.151 -178.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -68.36 -0.86 5.33 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.562 1.945 . . . . 65.0 113.393 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -104.42 -26.07 12.57 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 120.835 -1.165 . . . . 71.040000000000006 109.66 176.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.433 HG22 ' HB3' ' A' ' 114' ' ' ALA . 1.1 pt -112.04 9.93 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 C-N-CA 125.013 1.325 . . . . 70.420000000000002 111.698 -174.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 56.0 m -80.92 -44.71 17.84 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 120.931 1.696 . . . . 63.32 109.22 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.48 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -69.07 -63.5 2.1 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 124.081 0.952 . . . . 62.409999999999997 111.686 -165.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 31.2 Cg_endo -63.01 -21.41 73.16 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 121.355 1.37 . . . . 62.240000000000002 112.08 -176.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.441 ' HE3' ' HB2' ' A' ' 91' ' ' MET . 15.0 ttm -74.26 -37.69 63.67 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 125.875 1.67 . . . . 65.209999999999994 110.52 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -64.08 -42.29 97.01 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 119.047 -0.502 . . . . 74.010000000000005 110.304 164.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -64.75 -13.79 56.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 118.321 -0.847 . . . . 65.010000000000005 113.189 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.99 -14.12 15.28 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.782 1.173 . . . . 41.409999999999997 112.36 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 78.9 t -105.86 -45.04 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.251 1.02 . . . . 63.119999999999997 112.371 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -103.88 -48.54 3.88 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 114.587 1.329 . . . . 71.019999999999996 114.587 -174.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -70.31 -59.18 3.02 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.875 1.27 . . . . 74.109999999999999 113.587 -177.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 48.5 p -94.05 -30.26 14.78 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.779 1.232 . . . . 52.119999999999997 113.435 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 60.95 27.11 16.99 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.001 2.921 . . . . 71.430000000000007 113.569 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.5 t -59.78 -25.75 65.16 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.398 1.479 . . . . 62.32 112.438 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 42.7 t -62.58 109.91 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 108.528 -0.916 . . . . 72.219999999999999 108.528 175.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -141.66 -20.41 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.945 1.298 . . . . 72.129999999999995 110.841 -175.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.93 167.4 22.21 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.679 -1.6 . . . . 72.439999999999998 106.679 167.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.5 t -55.74 -28.8 24.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.11 0.564 . . . . 72.129999999999995 109.698 172.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.86 -15.04 57.96 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.972 1.709 . . . . 41.399999999999999 112.191 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.84 -23.67 13.37 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 118.635 0.652 . . . . 71.209999999999994 111.086 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.5 mt -71.52 -51.41 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 C-N-CA 125.4 1.48 . . . . 65.420000000000002 108.236 174.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.76 -22.36 62.0 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.269 1.028 . . . . 72.219999999999999 112.22 -175.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -62.06 -59.35 5.21 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 126.682 1.993 . . . . 74.439999999999998 111.076 170.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 71.1 t -54.53 -40.49 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.523 1.129 . . . . 70.200000000000003 110.354 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -54.06 -53.27 55.36 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 119.05 -0.5 . . . . 62.109999999999999 110.644 173.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.4 t -61.98 -46.72 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 119.617 1.098 . . . . 62.020000000000003 110.645 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -54.39 -44.2 72.1 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.164 0.986 . . . . 72.109999999999999 109.772 -176.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.433 ' HB3' HG22 ' A' ' 87' ' ' ILE . . . -75.1 -13.19 60.45 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.522 1.529 . . . . 34.420000000000002 114.907 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 126.42 6.47 5.67 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 117.402 1.721 . . . . 43.43 117.402 176.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.469 HG22 HG21 ' A' ' 83' ' ' VAL . 93.7 t -93.71 120.04 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-N 119.958 1.879 . . . . 73.209999999999994 110.051 -175.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.596 ' HG3' ' CB ' ' A' ' 120' ' ' ASP . 3.6 pttp -52.2 125.92 17.24 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.593 -0.73 . . . . 63.299999999999997 109.927 172.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.21 -30.6 61.24 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 109.41 -1.476 . . . . 52.329999999999998 109.41 166.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -30.38 66.56 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 119.371 1.585 . . . . 74.340000000000003 110.653 -175.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.596 ' CB ' ' HG3' ' A' ' 117' ' ' LYS . 23.3 t0 -83.31 -43.31 16.14 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.842 -0.799 . . . . 74.040000000000006 108.842 175.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -50.81 -54.62 22.13 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 123.58 0.752 . . . . 74.299999999999997 111.047 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -73.66 -9.95 59.2 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.619 1.568 . . . . 45.439999999999998 111.413 -173.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.29 -63.3 1.14 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.431 1.892 . . . . 72.030000000000001 109.501 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.49 -36.08 68.72 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.681 1.592 . . . . 72.329999999999998 112.893 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 65.3 t-105 -44.64 -39.26 4.9 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.562 1.145 . . . . 63.100000000000001 111.065 174.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.28 0.97 41.22 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.881 1.672 . . . . 74.420000000000002 113.657 -177.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.4 t -97.66 165.72 11.83 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.593 1.557 . . . . 43.530000000000001 112.676 -173.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -62.97 -36.64 84.16 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.001 1.72 . . . . 74.030000000000001 111.445 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.4 t -50.58 -47.75 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 122.342 1.068 . . . . 72.140000000000001 109.064 -178.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.6 t -68.84 -42.89 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-N 114.818 -1.083 . . . . 62.329999999999998 111.476 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -50.98 -53.87 29.42 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 118.98 0.809 . . . . 74.129999999999995 110.451 175.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.84 -42.96 99.95 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.214 0.606 . . . . 55.539999999999999 110.091 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.5 mt -64.4 -40.08 95.1 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 119.326 0.966 . . . . 64.420000000000002 112.823 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 74.2 t -59.23 -53.79 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 107.406 -1.331 . . . . 55.420000000000002 107.406 171.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.42 -34.35 68.82 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.385 0.883 . . . . 73.140000000000001 113.385 -174.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -53.28 -46.03 69.15 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 124.523 1.129 . . . . 63.140000000000001 111.565 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.646 ' HG2' ' CE1' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -94.18 -31.19 14.24 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 113.102 0.778 . . . . 74.319999999999993 113.102 -170.556 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -64.87 -38.08 89.78 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.796 0.726 . . . . 75.140000000000001 109.169 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -54.56 -48.83 71.58 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 126.404 1.882 . . . . 74.120000000000005 111.386 165.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.66 -17.0 60.75 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 118.513 -0.756 . . . . 51.130000000000003 112.596 -175.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.25 -44.91 35.26 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 120.839 1.654 . . . . 74.099999999999994 109.819 164.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.5 -5.11 21.93 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.428 1.491 . . . . 72.030000000000001 114.236 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.0 -2.46 51.66 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.67 1.123 . . . . 61.439999999999998 112.355 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 10.2 mt 74.56 54.84 0.08 Allowed 'General case' 0 C--N 1.342 0.245 0 C-N-CA 126.353 1.861 . . . . 75.150000000000006 110.454 164.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.405 HE21 ' HB3' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -132.41 -23.39 2.13 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.611 0.967 . . . . 73.150000000000006 113.611 -173.165 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.405 ' HB3' HE21 ' A' ' 145' ' ' GLN . 0.5 OUTLIER -131.91 -80.85 0.51 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.613 1.097 . . . . 63.039999999999999 111.382 -168.619 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 62.77 -3.58 0.3 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.707 2.003 . . . . 71.450000000000003 115.534 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -137.83 162.19 25.53 Favored Glycine 0 CA--C 1.526 0.727 0 O-C-N 120.395 -1.441 . . . . 33.43 110.858 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.471 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 5.1 m -142.39 166.93 18.15 Favored Pre-proline 0 C--O 1.239 0.504 0 N-CA-C 107.976 -1.12 . . . . 71.400000000000006 107.976 -177.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.471 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 98.1 Cg_endo -73.59 155.7 99.73 Favored 'Cis proline' 0 CA--C 1.536 0.625 0 CA-C-N 119.79 0.961 . . . . 74.439999999999998 113.532 -9.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -152.17 142.47 22.45 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 126.062 1.745 . . . . 73.040000000000006 110.079 -177.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 32.4 ttm -140.67 133.81 29.47 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 126.505 1.922 . . . . 62.039999999999999 106.43 172.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -117.42 159.58 22.56 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.836 0.854 . . . . 74.140000000000001 111.216 -177.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.5 t -141.23 145.74 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.407 1.083 . . . . 53.450000000000003 108.549 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 48.28 11.91 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.317 2.647 . . . . 71.030000000000001 116.124 177.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 62.56 41.93 99.75 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 119.705 1.138 . . . . 64.25 110.59 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -165.71 -21.93 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.778 1.231 . . . . 73.049999999999997 112.488 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -112.89 146.44 38.94 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 118.756 0.707 . . . . 72.450000000000003 109.362 177.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -117.78 139.36 51.19 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 104.933 -2.247 . . . . 60.130000000000003 104.933 167.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.418 ' CD1' HG23 ' A' ' 180' ' ' THR . 4.1 mm? -66.38 142.91 57.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.777 -1.564 . . . . 72.340000000000003 106.777 173.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -115.75 85.58 14.48 Favored Pre-proline 0 CA--C 1.516 -0.344 0 CA-C-N 117.84 0.291 . . . . 73.049999999999997 110.97 177.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -64.87 -27.13 59.11 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 CA-C-N 118.652 0.554 . . . . 62.32 111.139 174.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.93 -0.56 16.5 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.397 1.479 . . . . 74.450000000000003 112.825 -173.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -133.22 12.49 4.98 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.66 1.6 . . . . 64.019999999999996 111.699 175.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 17.5 mtt -87.73 172.32 9.77 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 120.129 1.965 . . . . 74.319999999999993 109.264 165.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.16 106.68 7.91 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.055 -1.461 . . . . 71.349999999999994 107.055 169.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.546 HG22 ' CD1' ' A' ' 173' ' ' PHE . 54.5 p -112.59 18.39 18.4 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.107 2.163 . . . . 70.109999999999999 110.368 -178.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 40.0 m -99.52 5.56 46.06 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.451 1.101 . . . . 74.409999999999997 112.77 -172.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -137.43 -15.22 1.45 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.554 1.142 . . . . 70.349999999999994 111.825 -177.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 2.2 mmt 69.17 -62.99 0.39 Allowed 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 126.246 1.819 . . . . 65.420000000000002 110.454 -175.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.99 -38.55 86.4 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.17 -0.956 . . . . 74.129999999999995 111.657 -172.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 65.5 t -75.29 -27.49 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 123.809 0.844 . . . . 54.130000000000003 111.161 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.546 ' CD1' HG22 ' A' ' 167' ' ' THR . 42.0 t80 -59.32 -52.03 67.4 Favored 'General case' 0 C--O 1.226 -0.158 0 N-CA-C 108.655 -0.868 . . . . 73.450000000000003 108.655 -177.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.7 t -77.28 -25.04 15.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 117.518 0.145 . . . . 74.209999999999994 111.11 -175.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.53 -31.25 67.76 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.3 0.482 . . . . 70.109999999999999 112.3 168.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -86.32 -44.94 11.69 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.25 1.02 . . . . 73.109999999999999 110.985 172.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -58.44 -56.74 18.21 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.519 0.728 . . . . 73.409999999999997 110.569 -167.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.15 -21.23 59.04 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 113.683 0.994 . . . . 71.040000000000006 113.683 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -77.96 -52.58 8.59 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 123.346 0.658 . . . . 70.430000000000007 110.321 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.418 HG23 ' CD1' ' A' ' 160' ' ' LEU . 9.0 t -62.16 -30.71 71.24 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 117.832 -1.08 . . . . 72.049999999999997 110.653 178.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 85.5 t -60.63 -54.57 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 119.987 1.267 . . . . 74.310000000000002 108.483 177.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -59.51 -48.17 82.67 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-O 118.777 -0.63 . . . . 72.319999999999993 110.255 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -60.13 -29.46 68.64 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 112.481 0.549 . . . . 74.450000000000003 112.481 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 60.2 mt -74.79 -23.13 58.45 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 120.826 -1.171 . . . . 72.409999999999997 112.309 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 92.9 t -66.05 -29.5 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 118.34 0.518 . . . . 70.120000000000005 109.671 174.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -95.46 -9.36 32.83 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.816 0.846 . . . . 65.450000000000003 110.428 -175.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 21.0 mttp -108.61 61.91 0.6 Allowed 'General case' 0 C--O 1.225 -0.186 0 O-C-N 120.661 -1.274 . . . . 72.439999999999998 109.664 -177.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.6 mmtm . . . . . 0 C--O 1.254 1.317 0 C-N-CA 127.179 2.191 . . . . 71.049999999999997 112.223 171.253 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 -0.069 0 CA-C-O 121.561 0.696 . . . . 74.420000000000002 112.691 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -156.35 105.95 2.32 Favored 'General case' 0 N--CA 1.425 -1.711 0 C-N-CA 125.563 1.545 . . . . 65.049999999999997 107.791 -175.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.512 HG21 HG23 ' A' ' 180' ' ' THR . 9.9 pt -106.16 167.0 3.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 127.185 2.194 . . . . 71.450000000000003 109.119 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.7 m -143.89 145.8 32.55 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 106.598 -1.63 . . . . 71.219999999999999 106.598 175.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -58.56 150.06 23.94 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 127.566 2.347 . . . . 44.119999999999997 109.758 167.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.56 -29.37 0.36 Allowed Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.546 1.07 . . . . 64.319999999999993 113.826 -168.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -94.85 -84.44 0.33 Allowed 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 118.951 1.375 . . . . 73.209999999999994 108.551 -165.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -92.7 -14.92 27.35 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.459 0.703 . . . . 73.129999999999995 110.852 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -143.48 165.31 27.9 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.544 0.611 . . . . 74.010000000000005 110.705 167.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.3 mm -122.17 162.61 21.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 126.827 2.051 . . . . 74.040000000000006 106.605 175.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.0 m -126.66 136.45 52.5 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 106.004 -1.85 . . . . 63.219999999999999 106.004 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.0 mt -81.07 156.4 25.84 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 118.541 0.61 . . . . 53.25 109.606 -178.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -71.7 -34.94 70.05 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.303 1.441 . . . . 53.409999999999997 110.509 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.4 mmtm -137.01 78.82 39.94 Favored Pre-proline 0 N--CA 1.453 -0.279 0 C-N-CA 125.112 1.365 . . . . 74.329999999999998 108.403 -175.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.448 -1.174 0 C-N-CA 123.391 2.728 . . . . 55.43 108.763 174.18 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.501 HG22 ' H ' ' A' ' 55' ' ' LYS . 14.8 m . . . . . 0 CA--C 1.543 0.697 0 N-CA-C 105.442 -2.058 . . . . 65.030000000000001 105.442 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.457 ' HG ' ' H ' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -169.61 171.06 7.75 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.573 1.549 . . . . 54.140000000000001 108.46 169.414 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.457 ' H ' ' HG ' ' A' ' 23' ' ' LEU . 19.4 tt0 -130.45 145.14 51.78 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 128.509 2.723 . . . . 65.420000000000002 108.875 176.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -132.52 125.44 30.6 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.833 1.253 . . . . 74.010000000000005 108.291 174.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -135.82 178.63 6.9 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.947 1.699 . . . . 74.439999999999998 109.527 174.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.499 ' HA ' ' CE1' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -146.59 -174.89 4.59 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.155 0.982 . . . . 64.310000000000002 110.5 164.435 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.551 ' CZ ' ' HG3' ' A' ' 91' ' ' MET . 50.9 m-85 -93.93 -41.39 9.62 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.654 -0.654 . . . . 74.120000000000005 112.73 176.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -80.72 -7.53 59.38 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.808 0.67 . . . . 74.109999999999999 112.808 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.0 p -74.7 149.2 85.78 Favored Pre-proline 0 CA--C 1.532 0.269 0 O-C-N 120.744 -1.223 . . . . 73.140000000000001 111.979 173.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.25 167.87 25.69 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.618 2.212 . . . . 73.310000000000002 109.184 164.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.2 m80 68.98 -51.32 0.59 Allowed 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 127.114 2.165 . . . . 70.019999999999996 110.738 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 61.0 m -44.42 -40.45 5.48 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 126.555 1.942 . . . . 45.210000000000001 112.046 177.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.95 -70.91 0.08 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.291 1.037 . . . . 74.230000000000004 108.229 175.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -65.98 -37.47 86.05 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.084 -1.01 . . . . 73.349999999999994 110.141 -169.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -61.58 -20.64 63.53 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 116.878 -1.534 . . . . 72.129999999999995 112.483 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -120.68 -11.25 9.06 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 119.395 0.998 . . . . 72.109999999999999 110.928 -170.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.5 ' HA ' ' CE1' ' A' ' 41' ' ' HIS . 0.0 OUTLIER -134.56 -16.54 2.05 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 114.666 1.358 . . . . 62.130000000000003 114.666 -173.765 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 77.7 t -117.64 -68.23 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.272 0.558 . . . . 74.040000000000006 110.368 174.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.4 mt -69.08 -21.76 64.05 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.247 1.419 . . . . 51.340000000000003 111.314 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.5 ' CE1' ' HA ' ' A' ' 38' ' ' GLU . 39.7 m-70 44.08 56.24 4.89 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 126.0 1.72 . . . . 74.219999999999999 111.074 171.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.614 ' O ' HG23 ' A' ' 46' ' ' VAL . 68.2 t -59.18 -49.13 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 117.184 -1.389 . . . . 72.120000000000005 107.754 -172.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.3 t -45.61 -53.47 9.1 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-N 119.685 1.13 . . . . 74.140000000000001 112.111 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.423 ' CG ' HH12 ' A' ' 47' ' ' ARG . 1.5 t70 -88.5 5.66 41.5 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.921 0.712 . . . . 72.420000000000002 112.921 -174.009 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -92.01 -49.06 6.42 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.733 0.813 . . . . 72.140000000000001 109.992 157.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 42' ' ' VAL . 2.4 t -63.49 -40.12 87.88 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-N 119.632 1.106 . . . . 74.109999999999999 110.392 -170.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.423 HH12 ' CG ' ' A' ' 44' ' ' ASP . 0.7 OUTLIER -51.58 -38.43 54.41 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 118.049 -0.977 . . . . 62.450000000000003 111.709 -179.045 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -64.76 -2.96 2.82 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 115.207 1.558 . . . . 73.25 115.207 176.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -129.05 -5.62 4.97 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.107 1.763 . . . . 73.310000000000002 111.603 -178.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.541 ' HG ' HG12 ' A' ' 46' ' ' VAL . 5.6 mt -87.67 152.7 52.05 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 127.334 2.254 . . . . 71.450000000000003 111.119 -165.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.425 ' O ' HG22 ' A' ' 54' ' ' THR . 26.1 Cg_endo -81.21 175.6 9.59 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.209 2.606 . . . . 61.340000000000003 112.015 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -84.63 23.03 1.2 Allowed 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.478 -1.389 . . . . 61.219999999999999 114.524 -169.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -143.19 -15.08 0.29 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.308 1.432 . . . . 63.240000000000002 113.724 -172.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.53 HG21 ' HB3' ' A' ' 50' ' ' LEU . 14.6 t -60.04 128.12 35.25 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 107.388 -1.338 . . . . 71.129999999999995 107.388 175.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.501 ' H ' HG22 ' A' ' 22' ' ' VAL . 48.0 tptt -118.61 72.78 0.89 Allowed 'General case' 0 C--N 1.341 0.196 0 CA-C-O 123.279 1.514 . . . . 71.109999999999999 109.535 173.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 18.4 ptp -52.96 -31.85 42.71 Favored 'General case' 0 CA--C 1.496 -1.1 0 C-N-CA 125.331 1.452 . . . . 70.120000000000005 114.339 -173.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.598 HG22 ' H ' ' A' ' 58' ' ' LYS . 7.5 m 46.82 -167.33 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 126.101 1.761 . . . . 74.209999999999994 113.063 -176.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.598 ' H ' HG22 ' A' ' 57' ' ' THR . 0.4 OUTLIER -159.09 104.72 1.71 Allowed 'General case' 0 CA--C 1.54 0.563 0 O-C-N 119.977 -1.702 . . . . 71.230000000000004 107.65 167.411 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.7 m-30 -102.63 174.81 5.73 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.635 1.561 . . . . 74.099999999999994 111.013 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.499 ' CE1' ' HA ' ' A' ' 27' ' ' SER . 6.2 t60 -135.02 118.5 16.86 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 118.722 0.692 . . . . 73.310000000000002 111.417 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.423 HG12 ' CB ' ' A' ' 141' ' ' ALA . 12.8 m -81.93 172.07 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 123.252 0.621 . . . . 75.430000000000007 110.042 178.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.27 3.39 6.36 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.625 1.57 . . . . 74.030000000000001 113.096 -169.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -81.32 1.23 33.55 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.414 1.265 . . . . 75.010000000000005 114.414 -172.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 mt -125.59 132.09 52.59 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.655 1.116 . . . . 52.420000000000002 110.44 -164.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.76 177.37 35.33 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.666 0.65 . . . . 73.010000000000005 111.66 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.77 -55.13 0.92 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.186 2.591 . . . . 62.329999999999998 110.453 173.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.439 HD11 ' C ' ' A' ' 102' ' ' GLN . 38.1 mt -91.84 22.37 4.25 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.375 -0.828 . . . . 70.409999999999997 112.875 -166.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -48.65 -48.43 29.03 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 119.101 0.864 . . . . 42.109999999999999 112.206 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -56.52 -42.53 78.58 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.482 1.513 . . . . 75.140000000000001 113.307 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -78.71 -33.37 46.86 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.332 0.653 . . . . 72.140000000000001 110.259 -176.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.426 HD22 ' CD2' ' A' ' 28' ' ' PHE . 25.6 mt -62.4 -41.03 98.35 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.886 -0.783 . . . . 64.099999999999994 108.886 171.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.9 m -55.65 -50.11 71.07 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.594 1.088 . . . . 53.439999999999998 110.171 168.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -61.71 -35.16 77.24 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 120.621 1.555 . . . . 65.099999999999994 113.012 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.27 -35.06 79.87 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.668 0.667 . . . . 54.420000000000002 111.914 174.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.508 ' CD1' HD11 ' A' ' 79' ' ' ILE . 11.3 t-105 -57.46 -42.71 83.09 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 118.619 0.645 . . . . 74.430000000000007 111.026 -176.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.96 -36.38 74.72 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 117.517 -1.23 . . . . 65.209999999999994 112.872 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.0 t -59.7 -47.12 92.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 120.065 1.302 . . . . 70.109999999999999 108.626 172.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.55 -47.21 86.58 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 121.806 -0.559 . . . . 72.140000000000001 111.142 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.508 HD11 ' CD1' ' A' ' 75' ' ' TRP . 92.7 mt -62.39 -42.54 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.137 0.975 . . . . 71.5 110.509 177.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.62 -47.25 86.34 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.576 0.625 . . . . 73.120000000000005 109.441 -174.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 87.3 mt -80.2 -20.34 44.95 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 119.195 -0.431 . . . . 71.5 112.065 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.69 66.68 2.4 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 125.9 1.715 . . . . 72.319999999999993 110.261 -167.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.1 m -134.85 18.29 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.742 1.617 . . . . 71.519999999999996 111.048 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -51.07 -53.57 32.77 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 124.466 1.107 . . . . 53.200000000000003 110.09 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -77.0 -5.79 50.08 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.066 0.946 . . . . 61.409999999999997 111.29 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -90.21 -8.49 50.97 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.224 1.01 . . . . 73.310000000000002 111.216 166.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.7 pp -133.19 38.12 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 124.901 1.28 . . . . 64.519999999999996 111.715 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.0 m -92.39 -52.33 4.72 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.748 -0.595 . . . . 72.329999999999998 110.753 171.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.49 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -59.83 -64.05 3.49 Favored Pre-proline 0 CA--C 1.532 0.276 0 C-N-CA 123.318 0.647 . . . . 74.540000000000006 112.295 -163.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.49 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 73.3 Cg_endo -70.33 -20.77 31.74 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 CA-C-N 119.575 0.884 . . . . 63.549999999999997 112.602 -173.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.551 ' HG3' ' CZ ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -54.47 -58.8 6.04 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 127.481 2.312 . . . . 65.109999999999999 108.116 170.705 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -59.09 -41.69 88.67 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 124.105 0.962 . . . . 70.129999999999995 111.817 177.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -56.62 -36.68 69.73 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.076 -0.511 . . . . 74.140000000000001 110.676 172.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.39 -17.03 43.65 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 121.4 -0.812 . . . . 65.310000000000002 112.541 -169.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.0 t -114.3 -23.17 4.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 C-N-CA 124.613 1.165 . . . . 74.040000000000006 111.064 -172.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -120.48 -52.36 2.15 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.678 0.791 . . . . 74.25 112.289 -178.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -69.27 -52.85 23.49 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 121.583 -0.698 . . . . 74.329999999999998 111.244 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 37.2 p -98.62 -31.69 11.81 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.14 0.976 . . . . 72.519999999999996 110.489 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 52.59 34.78 16.45 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.882 2.073 . . . . 61.039999999999999 111.534 -173.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 t -75.91 -12.76 60.21 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.648 1.179 . . . . 70.329999999999998 112.67 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.428 HG13 HG12 ' A' ' 107' ' ' ILE . 25.9 t -67.31 118.17 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 O-C-N 120.913 -1.117 . . . . 54.43 108.963 172.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.439 ' C ' HD11 ' A' ' 67' ' ' LEU . 10.3 mt-30 -141.93 -25.13 0.68 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.463 1.105 . . . . 72.109999999999999 111.799 -178.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.13 160.78 38.49 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.584 1.553 . . . . 70.439999999999998 107.166 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 63.9 t -58.59 -32.34 45.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.566 1.146 . . . . 74.409999999999997 110.221 177.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.32 -29.06 57.54 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.287 1.435 . . . . 70.239999999999995 112.743 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -88.33 -25.41 22.77 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.598 0.635 . . . . 71.299999999999997 109.293 -176.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.428 HG12 HG13 ' A' ' 101' ' ' VAL . 3.2 mt -78.39 -47.74 23.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 124.963 1.305 . . . . 71.540000000000006 109.582 -178.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -56.11 -28.08 56.37 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-O 118.342 -0.837 . . . . 74.519999999999996 111.406 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -58.88 -53.61 56.46 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 123.86 0.864 . . . . 64.510000000000005 110.113 -176.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 17.4 t -56.07 -41.44 68.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.164 0.586 . . . . 61.509999999999998 110.716 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -60.47 -49.32 78.04 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.127 0.971 . . . . 74.439999999999998 110.009 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 83.5 t -63.41 -35.87 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 121.581 -0.699 . . . . 61.200000000000003 110.194 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.67 -44.05 97.25 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.466 0.706 . . . . 44.439999999999998 109.3 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.52 -21.42 62.73 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.612 1.165 . . . . 45.140000000000001 112.497 175.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 131.62 2.29 4.46 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 115.908 1.123 . . . . 64.409999999999997 115.908 167.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 65.1 t -66.26 143.73 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 123.363 1.554 . . . . 64.299999999999997 108.354 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.65 145.53 50.57 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.626 -1.17 . . . . 72.530000000000001 110.446 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -78.47 -0.2 78.0 Favored Glycine 0 N--CA 1.467 0.708 0 C-N-CA 124.035 0.826 . . . . 74.439999999999998 114.241 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -94.88 -36.97 11.42 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 123.198 0.599 . . . . 73.329999999999998 111.449 172.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -86.79 -41.1 14.36 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 107.348 -1.353 . . . . 73.230000000000004 107.348 -160.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -60.61 -53.2 60.37 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.957 -0.757 . . . . 70.310000000000002 108.957 172.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -73.14 -20.47 60.91 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 118.77 -0.634 . . . . 72.310000000000002 111.48 -170.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.56 -65.24 1.01 Allowed 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.138 -1.06 . . . . 42.130000000000003 108.138 171.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.53 -35.19 65.39 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.106 0.962 . . . . 44.399999999999999 111.626 -171.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -44.86 -36.97 3.55 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 125.08 1.352 . . . . 74.299999999999997 111.83 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -114.35 8.42 16.65 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.744 1.618 . . . . 62.210000000000001 113.484 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.6 t -79.09 148.8 32.28 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.06 1.744 . . . . 52.119999999999997 110.53 169.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -54.92 -33.36 62.06 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.232 1.813 . . . . 64.530000000000001 112.532 -177.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 22.3 t -54.63 -48.22 71.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 124.14 0.976 . . . . 73.200000000000003 109.742 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 32.7 t -69.98 -44.41 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-O 117.956 -1.021 . . . . 61.299999999999997 108.667 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -49.21 -49.92 40.66 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.267 1.394 . . . . 74.129999999999995 111.373 175.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.1 t -61.59 -49.05 78.18 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 123.481 0.713 . . . . 71.430000000000007 109.897 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 13.6 mt -65.04 -38.71 91.73 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 118.606 0.639 . . . . 62.409999999999997 111.988 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 49.1 t -58.31 -60.8 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 125.797 1.639 . . . . 74.209999999999994 107.695 173.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.65 -42.06 70.84 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 119.007 -0.521 . . . . 33.439999999999998 110.856 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -57.28 -53.11 61.87 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 123.435 0.694 . . . . 74.200000000000003 111.654 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -67.03 -48.67 67.64 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 119.158 0.89 . . . . 70.400000000000006 110.774 -175.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -63.29 -27.76 69.56 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.362 0.665 . . . . 74.430000000000007 112.043 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -82.24 -54.75 5.0 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.512 0.725 . . . . 74.239999999999995 109.647 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.08 0.74 1.77 Allowed 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 125.574 1.549 . . . . 54.340000000000003 113.399 -175.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.423 ' CB ' HG12 ' A' ' 61' ' ' VAL . . . -123.58 -0.16 8.69 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 114.216 1.191 . . . . 75.239999999999995 114.216 169.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.38 -13.01 7.24 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.99 0.814 . . . . 52.539999999999999 113.167 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -51.75 -66.7 0.34 Allowed 'General case' 0 C--O 1.231 0.086 0 C-N-CA 125.893 1.677 . . . . 61.240000000000002 110.773 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.9 pp 174.19 -4.66 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 129.117 2.967 . . . . 74.140000000000001 112.154 169.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.63 -27.23 45.38 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.519 1.128 . . . . 75.439999999999998 111.735 -158.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -159.57 140.91 12.82 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 128.641 2.776 . . . . 74.0 106.759 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -145.4 12.27 1.34 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.202 1.401 . . . . 55.210000000000001 110.502 -172.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -151.53 147.89 18.3 Favored Glycine 0 C--N 1.342 0.862 0 O-C-N 120.255 -1.528 . . . . 15.109999999999999 110.901 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.409 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 35.5 m -133.83 165.46 36.54 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 118.45 1.125 . . . . 74.019999999999996 111.102 -168.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.409 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 45.6 Cg_endo -71.0 157.91 95.16 Favored 'Cis proline' 0 C--N 1.35 0.631 0 CA-C-N 119.233 0.762 . . . . 73.040000000000006 112.263 -11.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -138.59 146.63 42.04 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.639 -0.709 . . . . 73.430000000000007 111.472 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 7.8 ttm -145.14 119.22 9.42 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.667 -1.605 . . . . 70.109999999999999 106.667 174.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -88.21 164.74 15.49 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.367 0.667 . . . . 74.219999999999999 109.825 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.702 HG12 ' HB2' ' A' ' 158' ' ' TYR . 0.5 OUTLIER -149.55 150.31 13.93 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 O-C-N 121.067 -1.021 . . . . 73.230000000000004 108.719 175.291 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 48.3 15.21 0.07 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.328 1.603 . . . . 73.219999999999999 115.328 -175.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 50.79 38.33 36.88 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 120.039 1.291 . . . . 73.329999999999998 112.425 -167.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.422 ' HE3' ' CZ ' ' A' ' 158' ' ' TYR . 42.7 pttt -162.27 -14.21 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.946 1.299 . . . . 72.129999999999995 114.038 173.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.702 ' HB2' HG12 ' A' ' 154' ' ' VAL 0.276 14.3 m-85 -106.42 158.86 16.59 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 127.041 2.136 . . . . 65.439999999999998 110.834 178.918 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -139.24 130.62 26.96 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 105.063 -2.199 . . . . 65.129999999999995 105.063 174.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.92 142.49 56.02 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.518 -1.29 . . . . 70.409999999999997 107.518 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -114.26 85.28 10.31 Favored Pre-proline 0 C--O 1.236 0.376 0 N-CA-C 110.339 -0.245 . . . . 74.439999999999998 110.339 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.11 -16.02 43.99 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 N-CA-C 110.342 -0.676 . . . . 71.030000000000001 110.342 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -77.65 2.49 16.53 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.283 1.833 . . . . 62.329999999999998 112.477 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -135.3 35.5 2.17 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 119.422 1.01 . . . . 70.209999999999994 111.12 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 62.5 mtt -120.84 167.38 12.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.446 1.098 . . . . 74.150000000000006 110.403 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -62.21 112.42 2.38 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.237 1.015 . . . . 71.329999999999998 108.937 169.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 82.3 p -119.57 22.08 11.81 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.434 1.094 . . . . 32.100000000000001 110.186 175.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.23 -48.22 36.8 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 118.664 0.665 . . . . 71.319999999999993 109.934 172.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -107.82 -10.85 15.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 118.07 -0.966 . . . . 74.430000000000007 111.608 -156.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 16.6 mmm 73.47 -44.85 0.59 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 127.748 2.419 . . . . 64.150000000000006 111.935 169.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -55.54 23.17 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 127.179 2.191 . . . . 74.439999999999998 107.941 173.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 61.5 t -67.81 -26.47 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 127.057 2.143 . . . . 65.439999999999998 110.538 -174.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.68 -59.12 5.95 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.189 -1.041 . . . . 74.25 108.189 173.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 10.8 t -66.58 -32.03 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.101 0.56 . . . . 64.140000000000001 110.521 -177.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.66 -41.86 82.36 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.645 0.778 . . . . 73.230000000000004 111.607 176.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -85.35 -32.35 22.49 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.587 1.155 . . . . 73.049999999999997 112.69 177.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -56.8 -63.29 1.25 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.376 -0.972 . . . . 74.439999999999998 108.376 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.86 -26.95 69.02 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.562 0.578 . . . . 45.210000000000001 112.562 -170.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -71.24 -52.23 20.17 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.222 1.409 . . . . 71.420000000000002 109.878 177.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.512 HG23 HG21 ' A' ' 3' ' ' ILE . 92.4 m -53.78 -40.11 66.0 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.248 1.019 . . . . 72.409999999999997 110.155 176.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 46.1 t -57.75 -53.27 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 108.934 -0.765 . . . . 71.230000000000004 108.934 178.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.3 tttt -59.95 -43.47 95.0 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 124.065 0.946 . . . . 71.420000000000002 110.543 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -63.33 -32.62 74.09 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 123.14 0.576 . . . . 71.040000000000006 111.202 -171.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 19.5 mt -68.79 -25.97 64.97 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 112.756 0.65 . . . . 71.040000000000006 112.756 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 61.1 t -65.72 -25.91 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 O-C-N 121.188 -0.945 . . . . 63.450000000000003 109.442 173.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -92.02 -9.56 42.37 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.152 1.381 . . . . 62.009999999999998 110.967 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -129.56 70.52 1.42 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.78 2.032 . . . . 64.329999999999998 108.79 -174.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 21.6 pttp . . . . . 0 C--O 1.257 1.481 0 CA-C-O 117.064 -1.446 . . . . 72.019999999999996 109.814 -176.234 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.293 0 N-CA-C 115.786 1.772 . . . . 51.32 115.786 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.52 115.06 4.51 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 104.755 -2.313 . . . . 65.099999999999994 104.755 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.511 HG21 HG23 ' A' ' 180' ' ' THR . 6.9 pt -127.37 142.13 44.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 126.111 1.764 . . . . 74.129999999999995 107.861 175.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.8 m -129.53 145.54 51.45 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.977 -1.12 . . . . 71.409999999999997 107.977 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -47.33 146.32 2.02 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 127.38 2.272 . . . . 73.019999999999996 111.395 165.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.22 -19.15 0.25 Allowed Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.365 1.46 . . . . 74.230000000000004 114.428 -172.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -100.43 -86.26 0.4 Allowed 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 106.736 -1.579 . . . . 70.120000000000005 106.736 -165.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -92.15 -14.21 29.47 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.379 1.071 . . . . 51.310000000000002 110.522 -175.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -144.81 159.7 42.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.728 0.811 . . . . 71.030000000000001 111.04 172.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.3 mm -125.07 164.44 23.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 124.615 1.166 . . . . 72.209999999999994 108.323 178.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 m -109.97 152.56 25.71 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.624 1.97 . . . . 71.340000000000003 108.236 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 35.5 mt -84.33 160.84 20.61 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 108.008 -1.108 . . . . 70.400000000000006 108.008 164.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.95 -35.39 64.53 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 122.404 1.097 . . . . 73.510000000000005 110.088 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -123.49 78.29 54.68 Favored Pre-proline 0 N--CA 1.455 -0.211 0 C-N-CA 125.458 1.503 . . . . 74.219999999999999 108.032 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo . . . . . 0 N--CA 1.444 -1.395 0 N-CA-C 106.348 -2.212 . . . . 61.240000000000002 106.348 164.25 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 66.7 t . . . . . 0 C--O 1.234 0.252 0 CA-C-O 120.823 0.344 . . . . 45.340000000000003 110.699 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.417 HD12 HG21 ' A' ' 57' ' ' THR . 2.9 tp -136.57 153.82 50.86 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 126.664 1.986 . . . . 70.430000000000007 106.108 177.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 2.6 mp0 -143.91 149.43 36.85 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.363 1.865 . . . . 61.340000000000003 109.893 -169.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.561 ' HD1' ' HB3' ' A' ' 151' ' ' ALA . 0.5 OUTLIER -145.6 161.99 38.52 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.197 1.362 . . . . 74.430000000000007 108.457 174.551 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -163.63 -175.0 3.94 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.949 2.899 . . . . 62.109999999999999 107.144 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.1 t -138.94 173.11 11.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 123.101 1.429 . . . . 72.129999999999995 109.407 163.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -79.81 -34.93 39.14 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 126.902 2.081 . . . . 71.299999999999997 110.11 -175.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -90.8 -1.97 57.81 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.104 1.362 . . . . 73.409999999999997 112.578 -176.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 p -90.03 144.22 31.04 Favored Pre-proline 0 N--CA 1.471 0.622 0 CA-C-N 120.928 1.694 . . . . 72.530000000000001 112.112 -173.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -84.71 -40.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.047 1.831 . . . . 50.409999999999997 114.339 -170.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -59.07 -43.32 91.77 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.489 1.041 . . . . 62.329999999999998 108.437 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 32.1 m -48.35 -45.88 35.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.393 1.877 . . . . 74.219999999999999 111.233 175.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -51.16 -62.06 1.85 Allowed 'General case' 0 C--N 1.346 0.438 0 C-N-CA 123.628 0.771 . . . . 63.520000000000003 109.631 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -55.1 -41.63 71.86 Favored 'General case' 0 C--O 1.222 -0.345 0 O-C-N 121.08 -1.013 . . . . 72.230000000000004 110.587 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -68.18 -20.15 64.84 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 117.986 -1.007 . . . . 63.100000000000001 111.928 -172.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.79 -4.91 7.56 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.275 0.943 . . . . 73.439999999999998 112.756 -167.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -133.95 -26.93 1.49 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.629 1.572 . . . . 65.319999999999993 111.548 -168.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 83.0 t -119.81 -76.45 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 107.009 -1.478 . . . . 64.340000000000003 107.009 -175.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.1 mt -68.27 -17.54 64.31 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.56 1.544 . . . . 41.240000000000002 112.95 -176.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 44.08 60.38 2.78 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.437 1.895 . . . . 71.219999999999999 112.185 172.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 46' ' ' VAL . 33.2 t -66.76 -52.13 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 116.519 -1.705 . . . . 72.099999999999994 108.909 -173.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.0 t -53.99 -45.76 71.52 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 121.044 1.747 . . . . 25.140000000000001 110.501 -175.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -61.85 -40.56 95.75 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.761 0.825 . . . . 63.0 111.468 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -68.2 -36.88 80.25 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 124.488 1.115 . . . . 62.219999999999999 112.102 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 42' ' ' VAL . 3.1 t -66.54 -46.84 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.455 -1.313 . . . . 71.319999999999993 107.455 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 66.8 ttt-85 -48.0 -47.05 33.38 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-O 118.231 -0.89 . . . . 62.340000000000003 111.204 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -56.14 -10.74 0.91 Allowed 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 115.726 1.75 . . . . 71.0 115.726 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -130.31 7.25 4.96 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.653 1.981 . . . . 73.230000000000004 112.848 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.0 mt -79.82 161.65 65.48 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 120.194 1.361 . . . . 62.32 111.352 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -72.61 -161.92 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.75 1 C-N-CA 127.355 5.37 . . . . 54.100000000000001 110.739 172.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.431 ' CD ' ' H ' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -102.32 24.05 10.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 114.489 1.292 . . . . 74.219999999999999 114.489 176.513 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -143.08 -40.78 0.06 OUTLIER Glycine 0 CA--C 1.52 0.406 0 O-C-N 121.607 -0.683 . . . . 74.439999999999998 113.567 -172.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.0 m -71.55 95.19 1.38 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.597 1.559 . . . . 70.230000000000004 108.056 175.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.03 162.5 24.82 Favored 'General case' 0 CA--C 1.519 -0.25 0 O-C-N 120.478 -1.389 . . . . 72.430000000000007 109.014 169.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.89 109.04 21.83 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 106.805 -1.554 . . . . 63.009999999999998 106.805 175.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.56 HG22 ' H ' ' A' ' 58' ' ' LYS . 1.0 OUTLIER -87.36 -176.91 5.8 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 124.076 0.86 . . . . 65.239999999999995 109.237 171.06 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.56 ' H ' HG22 ' A' ' 57' ' ' THR . 0.1 OUTLIER -174.23 109.31 0.14 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 128.288 2.635 . . . . 74.209999999999994 105.612 174.275 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -74.76 -166.53 0.47 Allowed 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.006 -1.059 . . . . 72.329999999999998 109.532 163.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.568 ' CD2' ' HB3' ' A' ' 75' ' ' TRP 0.262 2.7 p-80 -136.77 156.88 47.93 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 129.709 3.204 . . . . 74.120000000000005 108.347 170.58 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.461 HG23 ' HB2' ' A' ' 63' ' ' PHE . 28.5 m -146.7 170.35 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 119.614 1.097 . . . . 73.340000000000003 108.398 169.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.99 -80.88 0.08 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 107.026 -1.472 . . . . 74.340000000000003 107.026 171.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.461 ' HB2' HG23 ' A' ' 61' ' ' VAL . 0.5 OUTLIER 68.13 -44.15 0.49 Allowed 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 130.136 3.375 . . . . 73.109999999999999 115.011 175.002 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.36 171.01 16.13 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 119.842 1.201 . . . . 61.340000000000003 110.65 -175.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.16 175.55 33.18 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 115.717 -0.674 . . . . 71.099999999999994 112.54 175.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -73.67 -55.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.673 2.915 . . . . 62.350000000000001 111.219 175.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.4 mt -89.38 30.18 1.02 Allowed 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.295 0.638 . . . . 52.32 111.844 -164.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -45.6 -56.3 6.53 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.929 1.252 . . . . 42.109999999999999 110.581 176.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -56.13 -46.46 79.18 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.601 1.161 . . . . 70.450000000000003 110.736 -174.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.49 -45.8 91.37 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 127.106 2.163 . . . . 65.109999999999999 109.329 -174.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 mt -64.98 -43.84 91.28 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.855 0.862 . . . . 74.450000000000003 109.431 176.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.495 ' HA ' ' HD2' ' A' ' 60' ' ' HIS . 44.5 m -66.37 -1.31 3.31 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 126.653 1.981 . . . . 73.519999999999996 110.582 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -111.9 -22.12 11.24 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 118.971 -2.33 . . . . 65.310000000000002 111.599 171.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.09 -35.8 48.94 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.698 0.999 . . . . 63.340000000000003 113.698 176.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.568 ' HB3' ' CD2' ' A' ' 60' ' ' HIS . 40.8 t-105 -58.23 -35.42 71.67 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.265 0.939 . . . . 73.510000000000005 110.949 -175.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.53 -34.33 77.56 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 118.206 -0.902 . . . . 50.439999999999998 110.814 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.1 t -60.98 -47.02 95.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 119.467 1.03 . . . . 73.239999999999995 108.964 167.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.16 -45.97 89.59 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 119.056 -0.497 . . . . 71.549999999999997 111.467 -177.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.5 mt -65.84 -42.84 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 124.602 1.161 . . . . 73.120000000000005 110.557 176.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.1 -32.44 70.98 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.054 0.843 . . . . 70.310000000000002 110.909 -177.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 43.2 mt -95.37 -15.24 23.2 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.261 0.837 . . . . 54.219999999999999 113.261 173.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 65.12 63.3 4.25 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.231 1.396 . . . . 71.530000000000001 111.667 -173.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.3 m -129.48 16.42 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.586 1.154 . . . . 63.420000000000002 111.852 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -52.86 -54.53 33.19 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.133 0.879 . . . . 71.209999999999994 111.016 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.56 -9.09 11.59 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.604 0.762 . . . . 74.120000000000005 112.648 -179.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -96.34 -13.92 22.92 Favored 'General case' 0 CA--C 1.519 -0.233 0 O-C-N 120.585 -1.322 . . . . 71.5 111.284 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.2 pt -121.21 -1.14 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 116.712 -1.613 . . . . 72.329999999999998 113.347 -175.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.2 m -64.38 -54.5 31.83 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 120.632 1.56 . . . . 54.310000000000002 109.096 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.43 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -52.54 -56.24 24.62 Favored Pre-proline 0 C--O 1.241 0.623 0 C-N-CA 124.614 1.166 . . . . 74.200000000000003 112.633 -169.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.43 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 54.1 Cg_endo -72.08 -26.97 17.6 Favored 'Trans proline' 0 N--CA 1.443 -1.443 0 C-N-CA 120.714 0.943 . . . . 71.209999999999994 112.653 -177.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 17.1 tpp -54.42 -51.34 65.22 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.09 0.956 . . . . 71.200000000000003 109.288 174.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -68.99 -33.57 73.88 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 121.872 -0.518 . . . . 53.399999999999999 111.191 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.45 ' HA ' ' HB2' ' A' ' 97' ' ' LYS . 0.9 OUTLIER -60.39 -38.82 85.15 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 118.964 -1.094 . . . . 70.5 109.594 171.056 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.99 -11.41 58.15 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.275 -0.891 . . . . 54.119999999999997 112.05 -167.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.3 t -119.93 -35.44 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.184 1.393 . . . . 73.540000000000006 110.36 -171.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -122.39 -38.38 2.68 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.098 0.959 . . . . 65.530000000000001 111.974 -164.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 93' ' ' GLU . 3.9 mmmt -76.01 -58.72 3.11 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 118.619 0.645 . . . . 71.400000000000006 110.733 174.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . 0.261 5.6 t -114.45 -18.23 11.56 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.095 0.776 . . . . 51.299999999999997 113.095 -176.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 65.87 19.73 11.32 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.521 0.934 . . . . 71.420000000000002 113.521 169.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 t -62.52 -16.48 56.05 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.247 2.219 . . . . 63.130000000000003 113.717 -173.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.452 HG13 HG12 ' A' ' 107' ' ' ILE . 26.9 t -64.46 115.05 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 124.434 1.094 . . . . 61.130000000000003 109.391 173.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -132.52 -23.12 2.12 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.502 1.121 . . . . 74.109999999999999 112.078 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.97 161.44 41.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.734 1.614 . . . . 62.210000000000001 107.291 -177.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.3 t -54.36 -36.15 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 118.973 0.806 . . . . 74.540000000000006 110.236 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.66 -34.17 57.75 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.378 1.471 . . . . 51.25 112.676 176.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -78.46 -34.75 47.5 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.518 -0.919 . . . . 73.349999999999994 108.518 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.452 HG12 HG13 ' A' ' 101' ' ' VAL . 2.9 mt -72.35 -49.27 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 124.085 0.954 . . . . 70.420000000000002 108.732 -174.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -17.28 64.53 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.569 0.748 . . . . 71.329999999999998 112.62 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -58.4 -54.18 49.93 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.24 1.016 . . . . 62.32 109.908 168.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.41 HG13 ' HB2' ' A' ' 90' ' ' PRO . 35.0 t -55.11 -36.78 40.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.519 1.128 . . . . 71.519999999999996 110.82 -175.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -57.36 -57.27 13.37 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.319 0.648 . . . . 73.219999999999999 109.536 173.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 89.2 t -60.88 -41.36 88.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 O-C-N 121.454 -0.779 . . . . 74.540000000000006 111.005 -175.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -55.44 -51.05 68.2 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.193 0.997 . . . . 70.329999999999998 109.237 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.36 -11.32 60.84 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.073 1.349 . . . . 52.310000000000002 112.506 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 112.02 48.06 0.68 Allowed Glycine 0 C--N 1.336 0.528 0 CA-C-N 118.84 0.745 . . . . 34.219999999999999 112.729 175.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.6 t -116.37 141.66 33.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 117.91 0.855 . . . . 71.230000000000004 109.741 177.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -70.27 118.43 13.08 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.188 0.995 . . . . 72.310000000000002 109.27 169.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.85 -9.28 52.28 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 117.347 -1.807 . . . . 70.219999999999999 112.479 167.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -74.98 -41.42 59.57 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 120.607 2.204 . . . . 71.129999999999995 108.67 168.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.71 -25.65 44.69 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.441 -0.948 . . . . 63.229999999999997 108.441 -171.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -70.31 -62.21 1.47 Allowed 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 107.59 -1.263 . . . . 63.409999999999997 107.59 175.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -64.41 -24.77 67.75 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.787 -0.625 . . . . 74.230000000000004 111.69 -173.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.78 -68.11 0.6 Allowed 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.667 1.187 . . . . 65.150000000000006 111.259 168.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.11 -27.71 67.25 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 118.223 -0.894 . . . . 53.32 111.517 -167.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -44.14 -39.4 4.29 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.851 1.66 . . . . 74.120000000000005 112.047 176.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -112.53 3.62 16.88 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.83 1.252 . . . . 53.009999999999998 113.147 -177.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 13.2 t -74.68 152.84 39.11 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.841 1.256 . . . . 73.349999999999994 111.252 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -52.61 -33.2 45.42 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.202 1.801 . . . . 65.310000000000002 112.581 170.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 46.8 t -53.16 -48.53 53.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 O-C-N 121.201 -0.937 . . . . 71.239999999999995 109.772 177.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.3 t -72.59 -38.16 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-O 118.311 -0.852 . . . . 72.540000000000006 109.868 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -52.46 -49.83 63.88 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.78 1.173 . . . . 73.329999999999998 111.234 174.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.3 t -58.06 -51.07 71.22 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.122 -0.696 . . . . 25.219999999999999 109.122 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 14.8 mt -66.26 -37.93 86.64 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.271 0.629 . . . . 73.140000000000001 112.658 -174.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.1 t -56.31 -59.21 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 125.16 1.384 . . . . 74.530000000000001 108.66 168.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.05 -40.35 60.98 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.799 0.839 . . . . 54.020000000000003 112.27 -174.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -51.9 -60.92 2.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 117.668 -1.158 . . . . 70.129999999999995 110.291 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.438 ' H ' ' HG3' ' A' ' 137' ' ' GLN . 0.9 OUTLIER -78.34 -32.95 49.38 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 120.576 1.534 . . . . 73.519999999999996 113.659 -179.621 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.92 -24.21 65.17 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.502 1.046 . . . . 65.5 109.766 -169.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 24.1 ttpt -82.2 -57.38 3.41 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 125.262 1.425 . . . . 73.430000000000007 109.305 160.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.86 -17.69 61.82 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.931 1.456 . . . . 51.409999999999997 114.931 -164.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -117.4 2.35 12.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 119.965 1.257 . . . . 64.400000000000006 113.257 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.98 6.42 3.38 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.628 0.771 . . . . 73.530000000000001 111.727 -178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -68.1 -85.88 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.874 0.87 . . . . 74.239999999999995 109.678 172.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 175.58 48.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.658 2.383 . . . . 65.310000000000002 109.244 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -139.47 -50.47 0.51 Allowed 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.782 -1.199 . . . . 74.530000000000001 109.493 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.13 109.05 14.98 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 127.029 2.132 . . . . 54.299999999999997 106.827 -171.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -149.84 28.62 0.76 Allowed 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 126.636 1.974 . . . . 65.5 111.144 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -138.38 91.2 0.2 Allowed Glycine 0 C--N 1.341 0.811 0 O-C-N 120.876 -1.14 . . . . 65.120000000000005 112.44 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.424 HG13 ' CZ ' ' A' ' 25' ' ' PHE . 34.1 m -73.38 163.55 67.63 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 113.331 0.863 . . . . 74.120000000000005 113.331 174.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -77.94 118.07 5.52 Favored 'Cis proline' 0 N--CA 1.446 -1.286 0 N-CA-C 108.666 -1.321 . . . . 71.200000000000003 108.666 -21.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.561 ' HB3' ' HD1' ' A' ' 25' ' ' PHE . . . -88.49 129.18 35.51 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 106.203 -1.777 . . . . 74.109999999999999 106.203 -174.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 80.0 mmm -138.19 89.26 2.38 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 104.245 -2.502 . . . . 62.140000000000001 104.245 -172.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -73.74 170.23 15.7 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 120.853 -1.155 . . . . 74.040000000000006 109.974 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.515 HG11 ' HB2' ' A' ' 184' ' ' LEU . 56.8 t -131.07 -41.41 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 113.252 0.834 . . . . 72.409999999999997 113.252 178.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.36 24.22 1.13 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.76 -0.588 . . . . 71.439999999999998 109.728 -171.081 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 77.44 -28.37 1.76 Allowed Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.237 1.875 . . . . 64.140000000000001 113.055 -174.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.55 -7.48 19.7 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.966 1.469 . . . . 65.439999999999998 114.966 -174.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -126.95 142.15 51.62 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.947 0.899 . . . . 70.120000000000005 109.531 -174.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -117.9 137.54 52.74 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 106.392 -1.707 . . . . 74.420000000000002 106.392 169.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.02 144.04 55.29 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.21 -0.663 . . . . 71.099999999999994 109.21 171.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -111.55 86.95 7.36 Favored Pre-proline 0 C--O 1.232 0.149 0 N-CA-C 113.519 0.933 . . . . 45.340000000000003 113.519 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -63.13 0.04 1.91 Allowed 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 121.041 1.161 . . . . 70.319999999999993 114.253 172.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -111.74 18.65 18.76 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.117 1.367 . . . . 74.420000000000002 112.287 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -146.06 52.24 0.57 Allowed Glycine 0 C--N 1.334 0.42 0 N-CA-C 108.681 -1.768 . . . . 54.409999999999997 108.681 171.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 35.6 mtt -144.58 176.02 9.71 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.931 1.292 . . . . 65.329999999999998 109.399 -176.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -85.24 44.52 1.1 Allowed 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 123.527 0.731 . . . . 71.209999999999994 112.269 -164.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.437 ' HB ' ' CD2' ' A' ' 173' ' ' PHE 0.257 10.7 t -67.79 30.91 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 129.102 2.961 . . . . 65.200000000000003 113.169 -177.163 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.19 -20.43 30.2 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 127.536 2.334 . . . . 72.019999999999996 112.4 169.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.18 -8.68 2.63 Favored 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 113.386 0.884 . . . . 72.019999999999996 113.386 -166.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 6.0 mmt 69.19 -61.88 0.42 Allowed 'General case' 0 C--O 1.231 0.129 0 C-N-CA 127.654 2.382 . . . . 33.539999999999999 113.003 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -63.66 -46.11 87.12 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.375 1.083 . . . . 65.310000000000002 109.682 -172.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.02 -26.48 40.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.386 1.474 . . . . 64.129999999999995 110.853 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' PHE . . . . . 0.437 ' CD2' ' HB ' ' A' ' 167' ' ' THR . 15.9 t80 -68.51 -57.72 5.38 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.267 -1.383 . . . . 74.430000000000007 107.267 -177.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.3 t -67.23 -33.85 65.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 117.899 0.318 . . . . 71.239999999999995 110.152 -174.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.42 -51.07 61.05 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.49 0.716 . . . . 72.319999999999993 110.987 174.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -73.3 -32.73 64.79 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.715 0.806 . . . . 54.530000000000001 112.559 177.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -59.06 -60.82 3.26 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.239 1.016 . . . . 73.140000000000001 108.429 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.7 -27.65 66.63 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.575 0.75 . . . . 73.120000000000005 111.981 -174.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.67 -47.96 28.85 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 121.75 -0.594 . . . . 65.219999999999999 111.248 176.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.511 HG23 HG21 ' A' ' 3' ' ' ILE . 90.9 m -53.63 -37.5 63.13 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.439 0.696 . . . . 72.109999999999999 109.697 173.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 93.4 t -58.22 -54.43 32.68 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 N-CA-C 109.206 -0.664 . . . . 45.200000000000003 109.206 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 13.3 pttp -64.71 -34.99 79.61 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 118.989 -1.085 . . . . 65.030000000000001 111.305 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -62.98 -31.11 72.16 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-N 118.739 0.7 . . . . 70.109999999999999 111.451 -172.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.515 ' HB2' HG11 ' A' ' 154' ' ' VAL . 75.4 mt -76.0 -18.98 59.06 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.075 -1.05 . . . . 63.340000000000003 112.636 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 76.8 t -67.5 -22.51 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 O-C-N 120.951 -1.093 . . . . 62.420000000000002 110.383 176.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -103.61 -12.23 17.2 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.325 1.05 . . . . 54.509999999999998 110.869 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 42.2 mttp -115.33 82.41 1.74 Allowed 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 126.125 1.77 . . . . 52.219999999999999 107.958 -173.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-N 114.208 -1.36 . . . . 71.230000000000004 109.111 164.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.464 0 N-CA-C 112.162 0.43 . . . . 71.439999999999998 112.162 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -148.52 118.33 7.11 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 106.105 -1.813 . . . . 64.439999999999998 106.105 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.42 HG21 ' OG1' ' A' ' 180' ' ' THR . 15.3 pt -122.51 149.12 25.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 C-N-CA 126.753 2.021 . . . . 64.129999999999995 108.676 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.1 m -119.05 130.91 55.88 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.792 -0.818 . . . . 62.340000000000003 108.792 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -46.65 111.47 0.39 Allowed 'General case' 0 C--O 1.232 0.183 0 C-N-CA 126.812 2.045 . . . . 54.43 109.638 162.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 102.97 -5.9 50.83 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.263 -1.298 . . . . 75.109999999999999 112.939 176.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -104.57 -86.33 0.46 Allowed 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 118.916 1.358 . . . . 50.130000000000003 107.773 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -92.87 -11.65 33.01 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.441 1.496 . . . . 73.329999999999998 112.287 -172.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -144.97 157.36 44.16 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 122.984 0.514 . . . . 74.239999999999995 110.499 170.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.0 mm -124.57 157.91 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 124.572 1.149 . . . . 61.039999999999999 108.071 177.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.24 143.55 41.84 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.69 1.596 . . . . 71.150000000000006 107.134 177.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.0 mt -81.91 147.36 29.32 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.885 -0.783 . . . . 74.019999999999996 108.885 170.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -73.49 -36.14 65.76 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.356 1.462 . . . . 53.130000000000003 109.885 173.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -131.03 84.1 58.88 Favored Pre-proline 0 CA--C 1.519 -0.227 0 C-N-CA 126.296 1.838 . . . . 75.409999999999997 108.173 177.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo . . . . . 0 N--CA 1.445 -1.333 0 C-N-CA 123.159 2.573 . . . . 75.150000000000006 110.029 173.285 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.241 0.634 0 N-CA-C 106.92 -1.511 . . . . 50.350000000000001 106.92 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.466 HD23 ' CE2' ' A' ' 25' ' ' PHE . 5.4 tp -159.77 154.8 24.82 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.501 1.046 . . . . 71.049999999999997 112.053 171.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -134.92 143.4 46.9 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 127.24 2.216 . . . . 70.549999999999997 107.272 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.643 ' CE1' ' HB2' ' A' ' 141' ' ' ALA . 45.8 m-85 -133.64 137.11 45.21 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.069 0.947 . . . . 65.230000000000004 110.768 174.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -162.34 165.85 26.01 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.75 1.62 . . . . 71.299999999999997 109.491 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.8 t -124.43 169.14 12.14 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.653 0.781 . . . . 72.219999999999999 109.842 167.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.674 ' CZ ' HD21 ' A' ' 71' ' ' LEU 0.275 0.0 OUTLIER -76.58 -18.77 58.47 Favored 'General case' 0 N--CA 1.435 -1.196 0 C-N-CA 124.081 0.953 . . . . 71.329999999999998 112.597 175.726 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -96.06 0.34 51.39 Favored 'General case' 0 C--N 1.346 0.446 0 O-C-N 120.232 -1.543 . . . . 72.540000000000006 111.655 -175.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.7 p -97.97 142.09 24.01 Favored Pre-proline 0 CA--C 1.534 0.341 0 O-C-N 121.121 -0.987 . . . . 53.100000000000001 108.773 -168.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -91.44 -28.25 0.19 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 120.314 0.676 . . . . 42.329999999999998 111.503 -162.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -59.9 -49.63 76.93 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.409 -0.96 . . . . 75.25 108.409 165.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.9 m -55.33 -36.7 66.53 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 124.609 1.164 . . . . 53.310000000000002 111.953 -178.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -58.82 -56.69 18.97 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 122.994 0.518 . . . . 72.200000000000003 109.694 175.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -59.89 -30.22 68.86 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-O 116.171 -1.871 . . . . 73.120000000000005 110.193 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -75.03 -6.01 47.12 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 121.245 1.839 . . . . 61.25 113.037 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -146.24 8.56 1.06 Allowed 'General case' 0 C--N 1.345 0.375 0 CA-C-N 120.51 1.505 . . . . 72.129999999999995 112.824 -175.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -139.97 -12.48 1.1 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.948 1.299 . . . . 64.329999999999998 111.341 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 80.9 t -129.27 -81.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 105.911 -1.885 . . . . 51.420000000000002 105.911 173.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.616 ' O ' HG23 ' A' ' 42' ' ' VAL . 3.4 mt -76.55 61.77 1.82 Allowed 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 128.335 2.654 . . . . 72.409999999999997 109.474 173.208 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -50.98 77.38 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 129.628 3.171 . . . . 61.439999999999998 110.444 172.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 40' ' ' LEU . 83.2 t -67.2 -48.31 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 114.709 -1.132 . . . . 63.329999999999998 108.111 -172.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.1 t -71.6 15.45 0.14 Allowed 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.076 1.139 . . . . 71.109999999999999 114.076 -172.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -129.36 -20.81 3.28 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 119.404 -2.06 . . . . 72.239999999999995 111.863 170.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.469 ' HB3' ' HB2' ' A' ' 178' ' ' ALA . 2.1 m-80 -62.28 -30.83 71.41 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 121.95 -0.469 . . . . 74.010000000000005 111.243 164.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.688 HG12 ' HG ' ' A' ' 50' ' ' LEU . 1.7 t -75.69 -52.14 18.92 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.649 0 N-CA-C 107.123 -1.436 . . . . 61.030000000000001 107.123 -162.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -52.95 -39.38 62.88 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.043 1.337 . . . . 73.030000000000001 109.915 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -56.35 -21.63 25.81 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.039 1.496 . . . . 72.010000000000005 115.039 174.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.6 mmtt -127.37 -5.17 6.0 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.618 2.767 . . . . 70.109999999999999 112.526 -176.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.688 ' HG ' HG12 ' A' ' 46' ' ' VAL . 12.7 mt -75.88 151.98 84.54 Favored Pre-proline 0 CA--C 1.518 -0.252 0 CA-C-N 120.43 1.468 . . . . 65.340000000000003 108.236 -174.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -78.24 148.54 24.19 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 122.098 1.865 . . . . 74.120000000000005 109.646 165.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -67.63 91.89 0.31 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.131 1.772 . . . . 72.209999999999994 112.12 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 137.17 -25.19 3.05 Favored Glycine 0 C--N 1.334 0.428 0 O-C-N 120.602 -1.311 . . . . 50.409999999999997 113.603 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 73.0 m -71.27 86.94 0.81 Allowed 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 104.075 -2.565 . . . . 71.230000000000004 104.075 151.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -82.68 157.31 23.4 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.574 -1.639 . . . . 72.329999999999998 106.574 169.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.07 169.24 8.86 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.92 -0.77 . . . . 73.129999999999995 108.92 -177.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.485 HG22 ' H ' ' A' ' 58' ' ' LYS . 1.3 m -140.48 -171.63 3.26 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.247 1.419 . . . . 72.510000000000005 108.105 -167.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.485 ' H ' HG22 ' A' ' 57' ' ' THR . 0.1 OUTLIER -173.62 85.45 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.291 1.436 . . . . 70.120000000000005 108.237 -178.091 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.405 ' CG ' ' HG2' ' A' ' 137' ' ' GLN . 8.2 m-30 -89.61 163.72 15.04 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 120.902 -1.124 . . . . 73.230000000000004 108.77 173.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.513 ' HD2' ' O ' ' A' ' 60' ' ' HIS . 1.2 p-80 -102.26 174.7 5.8 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 127.83 2.452 . . . . 75.430000000000007 110.133 -174.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.428 HG12 ' HB1' ' A' ' 141' ' ' ALA . 16.0 m -144.06 150.44 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 CA-C-N 122.407 2.367 . . . . 51.420000000000002 112.765 168.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . 0.304 0.0 OUTLIER -103.29 1.11 32.41 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.19 1.796 . . . . 73.200000000000003 114.776 176.87 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -70.8 9.06 0.73 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.199 1.399 . . . . 61.299999999999997 113.984 173.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.1 mt -141.77 148.44 38.95 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 119.68 -1.888 . . . . 75.109999999999999 109.221 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.54 166.41 12.03 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 115.082 -0.963 . . . . 62.520000000000003 111.725 171.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.44 -39.66 1.01 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.471 2.114 . . . . 52.240000000000002 110.119 170.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.474 HD13 HD11 ' A' ' 107' ' ' ILE . 57.3 mt -82.72 23.89 0.77 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.811 1.245 . . . . 54.43 112.032 -177.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -43.91 -63.52 2.24 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 117.222 -1.876 . . . . 74.319999999999993 109.863 169.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.8 tptp -59.82 -26.23 65.61 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 121.399 2.6 . . . . 72.299999999999997 114.126 -172.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -54.71 30.61 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 117.995 -1.002 . . . . 61.329999999999998 111.412 168.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.674 HD21 ' CZ ' ' A' ' 28' ' ' PHE . 34.6 mt -60.26 -40.95 92.15 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.252 0.933 . . . . 74.340000000000003 109.269 -164.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.462 HG22 ' CE1' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -49.61 -37.84 29.44 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 126.735 2.014 . . . . 60.509999999999998 109.682 -179.499 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.471 ' OE1' HG11 ' A' ' 130' ' ' VAL . 0.6 OUTLIER -86.04 -51.48 6.31 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 126.62 1.968 . . . . 55.0 110.895 -176.979 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.44 -31.13 72.06 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.513 1.051 . . . . 74.530000000000001 112.1 -177.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.458 ' CH2' ' HB3' ' A' ' 84' ' ' GLU . 43.3 t-105 -56.59 -36.39 69.31 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 119.139 0.881 . . . . 72.400000000000006 111.328 173.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.639 ' HB3' HG13 ' A' ' 130' ' ' VAL . . . -64.87 -42.46 94.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.624 -0.673 . . . . 65.299999999999997 110.125 -177.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 82.6 t -52.8 -43.5 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 122.953 0.501 . . . . 74.219999999999999 109.83 170.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.37 -50.14 66.66 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 121.239 -0.913 . . . . 43.240000000000002 111.13 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 86.6 mt -59.31 -37.28 68.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.344 1.058 . . . . 73.209999999999994 109.877 178.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.26 -50.13 74.27 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.505 0.593 . . . . 71.239999999999995 110.17 -174.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.0 mt -81.66 -12.2 58.78 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 118.32 -0.848 . . . . 72.209999999999994 112.791 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.03 63.87 3.58 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 126.14 1.828 . . . . 65.400000000000006 110.681 -175.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.2 m -130.14 11.9 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 117.67 -1.157 . . . . 74.319999999999993 112.838 -177.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.458 ' HB3' ' CH2' ' A' ' 75' ' ' TRP . 2.4 mp0 -51.58 -51.7 53.4 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.912 1.233 . . . . 62.240000000000002 111.629 -166.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -49.31 -47.67 46.86 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.681 1.592 . . . . 72.200000000000003 111.506 177.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -65.46 -26.73 68.08 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 124.342 1.057 . . . . 73.209999999999994 109.472 -170.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.5 pp -114.42 29.66 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 126.914 2.086 . . . . 65.540000000000006 109.322 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.504 HG23 ' CE1' ' A' ' 92' ' ' PHE . 18.6 m -108.97 -53.46 2.64 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 118.029 -0.986 . . . . 63.109999999999999 108.439 168.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.426 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -52.86 -54.55 42.5 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 113.602 0.964 . . . . 21.530000000000001 113.602 -174.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.426 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 48.9 Cg_endo -73.45 -29.37 11.16 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.363 1.375 . . . . 72.5 112.032 178.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 34.0 tpp -60.45 -50.11 74.89 Favored 'General case' 0 CA--C 1.515 -0.404 0 C-N-CA 125.225 1.41 . . . . 74.510000000000005 110.936 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.504 ' CE1' HG23 ' A' ' 88' ' ' THR . 6.2 m-85 -70.13 -33.15 71.46 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.938 -0.553 . . . . 74.209999999999994 109.56 -176.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -58.17 -37.27 74.4 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.353 0.979 . . . . 71.439999999999998 109.607 168.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.31 -0.9 57.66 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.062 -1.649 . . . . 74.140000000000001 113.578 -176.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.492 HG11 ' CD1' ' A' ' 28' ' ' PHE . 54.2 t -116.76 -33.77 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.531 1.533 . . . . 71.329999999999998 109.688 -177.069 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -116.06 -48.38 2.74 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 124.696 1.199 . . . . 73.400000000000006 111.577 -173.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -72.66 -62.26 1.51 Allowed 'General case' 0 C--N 1.334 -0.082 0 O-C-N 121.695 -0.628 . . . . 54.200000000000003 109.49 -176.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 28.2 p -86.43 -35.83 19.47 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.318 0.508 . . . . 74.510000000000005 110.659 -178.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 66.48 23.83 10.44 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.701 2.401 . . . . 73.219999999999999 113.174 -175.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -70.33 -19.51 63.06 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.503 0.592 . . . . 74.329999999999998 112.487 -173.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.443 HG13 HG12 ' A' ' 107' ' ' ILE . 26.8 t -64.3 124.63 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 O-C-N 121.354 -0.841 . . . . 64.530000000000001 109.046 171.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -147.04 -24.77 0.4 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.499 1.52 . . . . 64.540000000000006 111.44 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.6 162.56 32.36 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.802 0.728 . . . . 63.520000000000003 109.546 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.2 t -55.45 -38.74 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.309 1.044 . . . . 44.310000000000002 110.006 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.17 -11.77 23.1 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 114.064 1.135 . . . . 64.120000000000005 114.064 178.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -94.72 -33.73 12.82 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 124.979 1.311 . . . . 63.130000000000003 110.311 175.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.474 HD11 HD13 ' A' ' 67' ' ' LEU . 2.7 mt -71.62 -37.96 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.013 -0.736 . . . . 54.109999999999999 109.013 -177.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . 33.2 ptt180 -68.62 -23.37 64.43 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.342 -0.849 . . . . 73.430000000000007 111.474 -174.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -55.4 -54.52 42.68 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.469 -0.938 . . . . 73.400000000000006 108.469 176.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 29.0 t -58.52 -38.14 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 123.853 0.861 . . . . 72.319999999999993 110.625 -174.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -53.25 -57.75 9.45 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.463 -0.569 . . . . 74.140000000000001 109.463 172.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -63.92 -41.23 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 O-C-N 121.452 -0.78 . . . . 62.539999999999999 111.142 -175.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.25 -41.38 88.63 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.127 1.371 . . . . 72.200000000000003 109.746 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.64 0.18 18.46 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.795 1.238 . . . . 62.43 112.504 175.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.04 62.46 1.43 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 124.81 1.195 . . . . 63.539999999999999 111.118 175.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.5 t -121.66 149.47 24.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 124.181 0.992 . . . . 65.530000000000001 109.28 170.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -68.48 135.88 52.32 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.196 0.522 . . . . 72.530000000000001 110.106 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.22 -30.54 71.69 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 114.868 -1.06 . . . . 63.210000000000001 110.556 171.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -74.76 -17.8 60.58 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 123.447 0.699 . . . . 70.299999999999997 111.905 -172.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.74 -51.81 5.46 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.105 -1.072 . . . . 63.530000000000001 108.105 176.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.403 ' CZ ' ' HB3' ' A' ' 108' ' ' ARG . 36.4 t80 -50.89 -53.22 34.48 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.227 1.411 . . . . 72.329999999999998 109.978 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -76.61 -10.76 59.62 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 114.239 -1.346 . . . . 74.510000000000005 113.14 -172.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.65 -57.06 2.18 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 125.408 1.483 . . . . 63.509999999999998 110.407 176.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -50.23 -40.37 47.3 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.898 2.079 . . . . 72.329999999999998 110.89 -178.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 61.3 t-105 -45.97 -42.87 13.58 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.29 1.036 . . . . 73.239999999999995 111.972 173.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -102.41 8.04 40.25 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.367 -1.458 . . . . 72.420000000000002 112.901 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 8.8 t -89.3 151.38 22.13 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 127.019 2.128 . . . . 52.399999999999999 111.773 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -60.13 -28.71 68.1 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 125.493 1.517 . . . . 74.109999999999999 111.854 174.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 66.4 t -49.33 -54.3 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 119.363 0.983 . . . . 72.510000000000005 109.777 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.639 HG13 ' HB3' ' A' ' 76' ' ' ALA . 40.0 t -69.1 -39.28 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-N 115.22 -0.9 . . . . 64.239999999999995 108.668 -176.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.4 mmpt? -55.77 -48.58 75.04 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.059 0.845 . . . . 74.439999999999998 111.078 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.42 -36.96 85.47 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.068 0.947 . . . . 51.409999999999997 110.76 -178.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 13.9 mt -71.06 -58.72 3.29 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 124.882 1.273 . . . . 70.439999999999998 110.754 178.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 53.9 t -45.47 -49.38 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 C-N-CA 125.133 1.373 . . . . 75.230000000000004 108.595 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.1 -45.19 87.63 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 117.292 -1.337 . . . . 54.409999999999997 112.708 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -51.06 -46.57 61.76 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 120.409 1.459 . . . . 63.329999999999998 111.305 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.405 ' HG2' ' CG ' ' A' ' 59' ' ' TYR . 8.8 mt-30 -88.54 -36.51 16.34 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.926 -1.034 . . . . 73.200000000000003 109.801 -162.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -63.56 -47.99 79.3 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.276 -1.009 . . . . 73.340000000000003 108.276 171.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 54.7 tttt -60.87 -7.7 2.57 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.675 1.19 . . . . 52.409999999999997 113.88 171.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -112.09 -18.05 12.68 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-O 117.189 -1.386 . . . . 61.329999999999998 113.728 173.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.643 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . . . -113.86 -11.68 12.81 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 121.956 2.162 . . . . 55.210000000000001 112.688 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -117.36 -8.03 11.11 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.954 1.302 . . . . 44.100000000000001 111.751 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.25 8.81 3.0 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 114.239 1.199 . . . . 64.510000000000005 114.239 -178.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 12.3 mt 76.54 57.29 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.431 2.692 . . . . 73.120000000000005 111.828 174.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.27 -84.27 0.63 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.045 -1.094 . . . . 60.409999999999997 108.045 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.502 ' HG ' ' H ' ' A' ' 148' ' ' GLY . 11.4 tp -74.68 -73.12 0.25 Allowed 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 124.63 1.172 . . . . 73.109999999999999 112.931 -171.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 70.11 2.34 3.9 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.856 2.062 . . . . 75.329999999999998 115.217 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.502 ' H ' ' HG ' ' A' ' 146' ' ' LEU . . . -145.38 134.64 5.6 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 120.737 1.608 . . . . 72.420000000000002 111.327 176.09 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 35.5 m -126.42 164.33 34.84 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 119.183 1.492 . . . . 72.430000000000007 111.722 -173.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.48 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 30.0 Cg_endo -66.07 156.06 80.38 Favored 'Cis proline' 0 C--N 1.352 0.723 0 CA-C-N 119.712 0.933 . . . . 64.329999999999998 112.841 -6.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.424 ' HB2' HD11 ' A' ' 146' ' ' LEU . . . -141.36 156.94 45.78 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.454 0.702 . . . . 72.340000000000003 110.473 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 43.8 tpp -156.6 110.13 2.66 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.169 -1.789 . . . . 74.420000000000002 106.169 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -100.6 155.81 17.66 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.458 0.703 . . . . 63.039999999999999 109.54 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.1 t -137.76 139.53 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.612 -1.255 . . . . 74.120000000000005 107.612 177.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 64.67 -2.63 0.64 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.806 2.043 . . . . 72.25 114.874 171.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.48 -28.1 15.7 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.752 1.644 . . . . 63.119999999999997 112.169 -173.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.418 ' HG3' ' CD2' ' A' ' 158' ' ' TYR . 0.1 OUTLIER -115.34 -6.67 12.35 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.925 1.863 . . . . 74.420000000000002 115.81 -169.501 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.418 ' CD2' ' HG3' ' A' ' 157' ' ' LYS . 72.5 m-85 -121.81 148.82 44.19 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 108.901 -0.777 . . . . 72.329999999999998 108.901 -171.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -126.88 143.5 51.25 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.402 -0.962 . . . . 64.019999999999996 108.402 169.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -66.77 138.62 57.5 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 106.585 -1.635 . . . . 72.120000000000005 106.585 172.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -119.18 85.05 29.23 Favored Pre-proline 0 N--CA 1.452 -0.336 0 N-CA-C 111.7 0.259 . . . . 63.039999999999999 111.7 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.32 -21.77 71.78 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 121.27 1.313 . . . . 52.140000000000001 112.604 173.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -67.25 -10.61 52.39 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.147 0.979 . . . . 74.450000000000003 112.011 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -129.05 37.02 2.28 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 126.186 1.851 . . . . 75.019999999999996 109.752 171.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 40.4 mtt -114.12 162.37 16.57 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 119.128 1.464 . . . . 71.239999999999995 108.122 164.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -77.02 119.85 21.31 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 113.817 -1.538 . . . . 73.420000000000002 107.406 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.6 p -125.15 35.33 4.79 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.242 2.217 . . . . 72.010000000000005 108.795 -172.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 8.6 t -99.28 -12.09 20.67 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.761 -0.587 . . . . 53.229999999999997 112.195 178.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.4 -17.15 3.0 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 118.917 -0.564 . . . . 74.430000000000007 111.375 -167.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 5.5 mmt 70.78 -50.2 0.67 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.339 1.856 . . . . 72.140000000000001 112.076 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.66 -47.73 71.6 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 120.785 -1.197 . . . . 72.25 107.922 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 78.6 t -60.18 -32.85 51.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 124.792 1.237 . . . . 74.120000000000005 110.672 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -63.29 -62.69 1.52 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 118.769 -0.634 . . . . 74.209999999999994 109.487 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.4 t -71.69 -25.18 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 119.241 0.928 . . . . 73.340000000000003 111.685 -175.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.82 -40.04 82.99 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 111.865 0.32 . . . . 74.319999999999993 111.865 172.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -75.82 -21.21 57.53 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 118.042 -0.98 . . . . 72.439999999999998 113.147 171.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -67.95 -81.05 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 117.008 -1.472 . . . . 73.349999999999994 114.642 174.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' A' ' 45' ' ' ASN 0.359 . . -44.85 -18.4 0.02 OUTLIER 'General case' 0 CA--C 1.598 2.799 0 C-N-CA 126.672 1.989 . . . . 52.539999999999999 109.241 176.491 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -79.27 -63.98 1.29 Allowed 'General case' 0 C--N 1.382 1.98 0 C-N-CA 128.073 2.549 . . . . 65.450000000000003 113.533 169.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.42 ' OG1' HG21 ' A' ' 3' ' ' ILE . 13.2 t -59.01 -30.31 67.9 Favored 'General case' 0 C--N 1.347 0.488 0 CA-C-O 116.915 -1.517 . . . . 72.310000000000002 110.047 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 39.9 t -56.72 -44.23 81.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 120.462 1.483 . . . . 63.439999999999998 109.139 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 6.3 ptmt -75.15 -33.32 61.5 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-O 118.268 -0.872 . . . . 61.210000000000001 112.208 -177.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -62.36 -37.58 86.23 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 120.404 1.456 . . . . 54.509999999999998 112.035 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 77.1 mt -67.41 -20.61 65.55 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 119.069 -1.052 . . . . 72.230000000000004 111.808 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.03 -23.79 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 O-C-N 121.694 -0.629 . . . . 74.439999999999998 110.521 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -106.37 -2.49 22.14 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.364 0.983 . . . . 73.319999999999993 111.146 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -123.45 78.09 1.56 Allowed 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.862 1.265 . . . . 73.219999999999999 109.971 -176.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.95 0 CA-C-O 115.702 -2.094 . . . . 74.129999999999995 107.176 166.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 113.131 0.789 . . . . 74.129999999999995 113.131 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -161.84 119.53 2.22 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 127.16 2.184 . . . . 73.129999999999995 105.302 166.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.2 pt -124.45 143.15 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 126.108 1.763 . . . . 73.420000000000002 106.546 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.6 m -118.07 139.1 51.71 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.416 -1.328 . . . . 73.340000000000003 107.416 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -53.13 118.04 3.46 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.31 2.244 . . . . 70.200000000000003 108.724 164.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.27 -6.17 65.85 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 118.22 -1.322 . . . . 73.420000000000002 113.346 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.7 tptp -103.66 -85.33 0.46 Allowed 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 119.253 1.527 . . . . 65.129999999999995 107.304 177.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -89.45 -20.55 23.76 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 124.219 1.008 . . . . 71.010000000000005 110.777 -170.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -140.66 163.81 31.87 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.93 -0.767 . . . . 73.040000000000006 108.93 175.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.619 HD11 ' CG ' ' A' ' 161' ' ' ASN . 5.4 mm -127.84 159.72 38.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 106.006 -1.85 . . . . 70.019999999999996 106.006 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.6 m -90.53 154.25 19.75 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.498 -1.668 . . . . 74.099999999999994 106.498 168.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.8 mt -67.22 152.8 45.08 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.117 -1.068 . . . . 54.530000000000001 108.117 163.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -73.64 -28.13 61.62 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.67 -0.493 . . . . 65.340000000000003 109.67 171.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -126.37 72.98 72.97 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 126.13 1.772 . . . . 73.030000000000001 109.756 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo . . . . . 0 N--CA 1.454 -0.851 0 C-N-CA 124.287 3.325 . . . . 70.120000000000005 110.869 177.647 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.434 HG22 ' OG1' ' A' ' 57' ' ' THR . 1.8 p . . . . . 0 N--CA 1.448 -0.564 0 N-CA-C 108.129 -1.063 . . . . 70.329999999999998 108.129 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.1 tp -161.19 159.04 28.37 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.588 0.708 . . . . 44.119999999999997 112.462 172.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -139.83 150.38 44.61 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 127.567 2.347 . . . . 71.230000000000004 106.48 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -135.42 133.07 38.25 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.644 1.578 . . . . 72.030000000000001 108.536 173.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -156.6 -176.78 6.16 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.477 1.511 . . . . 65.019999999999996 110.858 177.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.1 t -135.38 176.43 8.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.665 1.586 . . . . 53.130000000000003 109.032 174.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.843 ' CD1' HD11 ' A' ' 71' ' ' LEU 0.278 0.0 OUTLIER -89.46 -7.5 54.92 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.976 1.102 . . . . 73.420000000000002 113.976 164.729 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.424 ' CE2' ' HA3' ' A' ' 65' ' ' GLY . 51.4 m-85 -103.24 0.72 32.0 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 120.146 1.339 . . . . 73.230000000000004 112.728 173.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.2 p -78.04 140.57 62.09 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 121.437 1.926 . . . . 74.120000000000005 108.857 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -91.45 -25.77 0.3 Allowed 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 120.869 1.046 . . . . 70.099999999999994 112.668 -176.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -57.77 -57.39 12.96 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 119.022 0.828 . . . . 73.040000000000006 109.813 166.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 24.9 p -65.02 -23.73 67.29 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.448 -0.796 . . . . 73.430000000000007 111.648 -170.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -58.07 -54.47 46.54 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 118.883 0.765 . . . . 72.319999999999993 110.534 169.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -55.71 -45.81 77.81 Favored 'General case' 0 C--O 1.221 -0.423 0 N-CA-C 107.894 -1.15 . . . . 52.310000000000002 107.894 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.421 ' CD2' HG21 ' A' ' 42' ' ' VAL . 4.3 m-85 -66.26 -10.45 42.34 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 115.647 -2.121 . . . . 63.130000000000003 113.858 -176.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -132.19 -2.45 3.55 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 122.044 2.202 . . . . 72.040000000000006 112.445 -173.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -133.04 -20.23 2.19 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.432 1.093 . . . . 54.409999999999997 112.426 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.0 t -121.35 -76.2 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 107.183 -1.414 . . . . 72.099999999999994 107.183 -173.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.1 mt -73.99 -18.2 60.9 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.116 2.166 . . . . 70.010000000000005 113.022 -177.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 54.5 m-70 43.75 53.87 5.86 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.291 1.836 . . . . 73.409999999999997 112.818 172.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 46' ' ' VAL . 86.1 t -62.68 -51.23 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 116.997 -1.478 . . . . 74.219999999999999 109.895 -172.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.1 t -45.41 -52.35 10.16 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.061 1.345 . . . . 65.430000000000007 110.143 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -63.77 -40.1 95.86 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.246 1.018 . . . . 61.310000000000002 110.691 -177.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.81 -35.33 74.74 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.542 1.137 . . . . 63.329999999999998 113.156 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 42' ' ' VAL . 1.9 t -67.53 -50.33 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 106.682 -1.599 . . . . 70.409999999999997 106.682 174.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 38.3 ttt-85 -47.47 -46.9 27.31 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.413 1.085 . . . . 63.130000000000003 111.608 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -60.31 -13.57 13.63 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.185 1.18 . . . . 74.0 114.185 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -118.37 -8.83 10.49 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.548 1.939 . . . . 64.230000000000004 111.507 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.61 ' HB3' HG21 ' A' ' 54' ' ' THR . 11.8 mt -76.16 143.83 74.17 Favored Pre-proline 0 C--O 1.237 0.401 0 CA-C-N 119.41 1.005 . . . . 62.030000000000001 109.579 -169.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.42 ' O ' HG22 ' A' ' 54' ' ' THR . 83.6 Cg_endo -80.01 167.35 20.13 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.043 1.829 . . . . 73.140000000000001 111.142 -176.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -73.14 68.4 0.98 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.375 1.07 . . . . 64.310000000000002 112.176 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.46 -7.06 0.05 OUTLIER Glycine 0 CA--C 1.524 0.635 0 O-C-N 119.748 -1.845 . . . . 65.200000000000003 114.773 176.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.61 HG21 ' HB3' ' A' ' 50' ' ' LEU . 0.7 OUTLIER -58.47 -45.08 89.34 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.042 1.421 . . . . 72.019999999999996 110.998 175.841 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . 0.294 19.0 ttpt 56.91 151.4 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.79 2.036 . . . . 73.040000000000006 111.725 -162.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.42 113.09 16.4 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 120.037 -1.664 . . . . 63.039999999999999 107.773 -167.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.434 ' OG1' HG22 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -115.92 -177.69 3.22 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.882 1.673 . . . . 65.200000000000003 109.347 -174.986 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -179.23 87.04 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 106.737 -1.579 . . . . 64.310000000000002 106.737 -170.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 -95.22 162.74 13.57 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.41 -0.806 . . . . 73.430000000000007 109.967 174.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.467 ' CE1' ' HB2' ' A' ' 137' ' ' GLN . 0.1 OUTLIER -100.15 174.39 6.18 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.779 2.031 . . . . 64.310000000000002 110.615 -176.724 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.5 m -135.07 145.86 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 120.418 1.463 . . . . 54.509999999999998 110.534 164.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -82.42 29.6 0.43 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.468 1.107 . . . . 70.299999999999997 111.396 -178.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -134.68 165.91 24.15 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.851 1.66 . . . . 61.130000000000003 107.652 -172.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.6 mt 75.79 128.61 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 127.007 2.123 . . . . 65.030000000000001 109.766 -172.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.424 ' HA3' ' CE2' ' A' ' 29' ' ' TYR . . . 66.72 171.31 4.46 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 121.944 0.747 . . . . 54.539999999999999 112.55 175.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.02 -40.99 1.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 123.069 2.513 . . . . 74.219999999999999 112.62 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.4 mt -81.88 16.6 1.79 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.248 1.419 . . . . 74.299999999999997 112.356 -174.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.19 -34.64 58.97 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 117.742 -1.588 . . . . 52.32 113.607 -173.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.2 -35.7 55.45 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 120.473 2.136 . . . . 71.329999999999998 110.28 176.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.37 -37.96 86.47 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 120.976 -1.078 . . . . 64.219999999999999 108.703 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.843 HD11 ' CD1' ' A' ' 28' ' ' PHE . 22.4 mt -53.91 -45.04 71.04 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 123.82 0.848 . . . . 73.5 111.093 169.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.464 HG23 ' CE1' ' A' ' 60' ' ' HIS . 2.6 m -57.12 -51.07 70.76 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 124.348 1.03 . . . . 73.219999999999999 109.314 -177.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -63.22 -49.11 75.46 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 118.587 -0.721 . . . . 72.319999999999993 109.919 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.22 -37.87 75.68 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 120.416 1.462 . . . . 65.439999999999998 114.363 -177.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.454 ' CD1' HD11 ' A' ' 79' ' ' ILE . 10.6 t-105 -61.09 -37.77 83.88 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.633 0.652 . . . . 65.109999999999999 111.371 -172.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.72 -34.68 71.62 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 117.832 -1.08 . . . . 71.219999999999999 112.373 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.09 -46.76 84.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 120.198 1.363 . . . . 72.209999999999994 109.779 171.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.23 -43.28 82.37 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 118.81 -0.614 . . . . 72.120000000000005 111.068 -177.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.454 HD11 ' CD1' ' A' ' 75' ' ' TRP . 75.0 mt -60.23 -41.9 88.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.145 0.978 . . . . 74.239999999999995 109.784 176.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.94 -48.23 81.33 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.885 0.474 . . . . 70.420000000000002 110.175 -173.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 81' ' ' LEU . 71.7 mt -76.66 -20.89 56.16 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 121.825 -0.547 . . . . 54.219999999999999 112.347 174.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.57 70.55 1.13 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 126.937 2.208 . . . . 41.130000000000003 110.097 -173.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.6 m -134.18 15.64 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 125.157 1.383 . . . . 70.239999999999995 112.804 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -52.43 -48.65 65.65 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.316 1.046 . . . . 74.200000000000003 110.66 -178.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.48 -7.93 16.75 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.948 1.699 . . . . 70.510000000000005 113.304 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -104.21 -19.92 13.97 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 125.124 1.37 . . . . 72.219999999999999 111.283 176.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.6 pp -124.04 28.53 2.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 C-N-CA 125.838 1.655 . . . . 70.400000000000006 110.416 -172.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 43.1 m -93.96 -51.15 4.99 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.742 -0.836 . . . . 65.099999999999994 108.742 165.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.504 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -57.66 -65.81 1.62 Allowed Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 124.007 0.923 . . . . 71.439999999999998 112.006 -171.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 52.3 Cg_endo -66.13 -26.28 50.16 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 121.161 1.241 . . . . 72.209999999999994 111.556 -174.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 24.0 tpp -61.76 -50.21 73.29 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.691 -0.855 . . . . 74.530000000000001 108.691 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -67.88 -35.13 77.98 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 123.974 0.91 . . . . 70.209999999999994 109.685 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -56.47 -45.31 80.97 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.599 0.636 . . . . 65.5 109.615 171.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.28 -1.76 42.24 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 120.727 -1.233 . . . . 64.099999999999994 112.993 -174.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.756 HG21 ' CD2' ' A' ' 28' ' ' PHE . 61.2 t -119.26 -33.74 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 C-N-CA 124.614 1.165 . . . . 73.030000000000001 110.949 -174.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -113.79 -52.92 2.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.105 1.362 . . . . 74.129999999999995 108.725 -173.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -71.99 -51.97 19.33 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 118.027 0.376 . . . . 74.319999999999993 110.338 -173.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.8 p -100.89 -27.04 13.53 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.056 0.942 . . . . 63.130000000000003 112.531 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 52.28 32.98 11.76 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.646 2.379 . . . . 71.040000000000006 114.979 -177.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 t -74.26 -21.02 59.95 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.749 0.82 . . . . 74.120000000000005 112.199 178.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.402 HG13 HG12 ' A' ' 107' ' ' ILE . 25.4 t -65.28 122.97 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 O-C-N 121.568 -0.708 . . . . 72.230000000000004 109.197 170.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -149.4 -19.99 0.28 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 114.068 -1.424 . . . . 74.430000000000007 111.63 -178.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.04 165.88 24.66 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.152 0.981 . . . . 71.340000000000003 109.64 173.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 39.1 t -57.57 -42.18 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.744 1.217 . . . . 43.43 108.388 175.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.02 13.89 0.05 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 128.809 2.843 . . . . 73.540000000000006 113.155 174.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -115.47 -48.68 2.78 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.42 1.488 . . . . 63.539999999999999 109.196 163.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.402 HG12 HG13 ' A' ' 101' ' ' VAL . 2.4 mt -52.66 -45.2 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.99 1.316 . . . . 64.129999999999995 110.907 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -22.36 65.72 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.651 0.982 . . . . 74.200000000000003 113.651 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -56.05 -56.02 25.9 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.981 1.264 . . . . 73.540000000000006 110.11 171.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 39.7 t -62.45 -34.55 65.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.83 -0.623 . . . . 71.129999999999995 110.789 -171.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -53.19 -58.6 6.5 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.716 -0.846 . . . . 73.239999999999995 108.716 171.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.1 t -65.71 -37.51 80.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 119.364 -0.35 . . . . 70.219999999999999 111.124 -173.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -60.84 -48.4 82.0 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.679 -0.86 . . . . 73.099999999999994 108.679 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.82 -0.39 7.11 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.612 1.565 . . . . 53.200000000000003 112.565 177.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.27 58.58 1.14 Allowed Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 124.428 1.013 . . . . 22.440000000000001 111.846 172.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.3 t -118.54 149.27 21.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 124.143 0.977 . . . . 70.230000000000004 109.832 169.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt -67.34 120.5 13.95 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.413 1.085 . . . . 74.439999999999998 110.49 168.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.68 -31.04 78.67 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-O 118.37 -1.239 . . . . 72.420000000000002 111.239 170.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -66.72 -36.58 82.82 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.846 1.323 . . . . 74.420000000000002 110.194 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -73.32 -42.49 62.28 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 106.766 -1.568 . . . . 65.340000000000003 106.766 -174.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -58.45 -55.43 35.07 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.996 0.903 . . . . 74.530000000000001 109.202 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -70.27 -12.61 61.71 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.004 0.922 . . . . 45.299999999999997 112.856 -173.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.98 -64.91 1.01 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.23 1.412 . . . . 34.240000000000002 109.946 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.64 -36.56 64.68 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.652 1.581 . . . . 45.020000000000003 111.491 -170.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 44.0 t-105 -45.14 -45.9 11.64 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.998 1.319 . . . . 73.5 112.067 176.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -102.35 11.22 38.4 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.206 1.402 . . . . 72.409999999999997 112.144 -177.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 7.0 t -99.27 163.79 12.4 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.281 1.832 . . . . 75.299999999999997 111.527 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -60.72 -28.31 68.58 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 128.177 2.591 . . . . 71.400000000000006 112.553 173.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 23.6 t -50.99 -53.28 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 122.78 1.276 . . . . 53.219999999999999 109.256 177.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.3 t -70.04 -32.51 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 114.923 -1.035 . . . . 74.219999999999999 110.624 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -56.47 -59.35 5.11 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.896 1.225 . . . . 74.5 110.045 176.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.0 m -68.45 -20.3 64.62 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.995 0.739 . . . . 63.210000000000001 112.995 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 26.2 mt -87.98 -33.48 18.39 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 113.642 0.979 . . . . 73.299999999999997 113.642 177.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 41.4 t -59.13 -52.77 56.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 107.064 -1.458 . . . . 65.519999999999996 107.064 165.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -46.67 -51.41 16.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.679 1.592 . . . . 61.119999999999997 112.893 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -58.04 -28.94 64.94 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.129 0.49 . . . . 75.120000000000005 112.017 -169.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.467 ' HB2' ' CE1' ' A' ' 60' ' ' HIS . 49.9 mt-30 -97.09 -47.56 5.73 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 128.095 2.558 . . . . 65.430000000000007 111.753 -176.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -62.89 -38.7 91.93 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 118.537 0.608 . . . . 74.0 109.653 -177.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -51.36 -45.7 62.48 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.486 1.114 . . . . 54.340000000000003 110.272 172.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.11 -52.97 35.29 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 124.392 1.058 . . . . 54.520000000000003 109.677 -175.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.29 -43.16 70.84 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.913 0.485 . . . . 34.43 111.42 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.16 7.51 9.15 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.218 1.807 . . . . 64.200000000000003 112.686 -177.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -86.18 -8.75 57.59 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.175 -0.953 . . . . 70.299999999999997 111.431 169.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 11.9 mt 68.43 58.53 0.42 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.921 1.344 . . . . 72.400000000000006 110.908 160.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.38 -34.86 0.36 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.646 1.178 . . . . 51.520000000000003 112.094 -173.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.3 tp -79.12 -85.09 0.08 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 125.437 1.495 . . . . 72.230000000000004 109.244 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 51.03 37.49 17.97 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.445 1.098 . . . . 73.109999999999999 111.852 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.63 132.77 3.29 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 107.803 -2.119 . . . . 65.129999999999995 107.803 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.465 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 1.4 m -138.13 160.45 64.17 Favored Pre-proline 0 C--O 1.241 0.632 0 N-CA-C 108.509 -0.923 . . . . 63.219999999999999 108.509 171.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.465 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 63.8 Cg_endo -74.21 142.52 75.0 Favored 'Cis proline' 0 N--CA 1.46 -0.494 0 C-N-CA 125.356 -0.685 . . . . 52.420000000000002 111.975 -10.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -126.25 138.7 53.64 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 125.516 1.526 . . . . 44.310000000000002 108.621 -175.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 34.5 mtp -140.12 108.61 5.87 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 106.471 -1.677 . . . . 73.140000000000001 106.471 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -81.36 173.04 12.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.857 -0.61 . . . . 72.340000000000003 110.232 -175.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.528 HG11 ' HB2' ' A' ' 184' ' ' LEU . 59.3 t -133.36 -86.05 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 CA-C-O 119.034 -0.508 . . . . 73.400000000000006 110.47 160.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -84.57 30.86 0.54 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.859 1.209 . . . . 72.299999999999997 110.379 -167.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 68.53 -68.0 0.4 Allowed Glycine 0 C--O 1.22 -0.74 0 C-N-CA 127.882 2.658 . . . . 43.100000000000001 109.201 -164.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.433 ' HE2' ' CZ ' ' A' ' 158' ' ' TYR . 36.5 pttt -60.44 -0.7 0.27 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 115.432 1.641 . . . . 70.219999999999999 115.432 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.433 ' CZ ' ' HE2' ' A' ' 157' ' ' LYS . 18.0 m-85 -121.68 139.31 53.72 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 120.473 1.488 . . . . 65.120000000000005 111.972 -177.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -118.86 132.36 56.1 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.471 2.308 . . . . 71.200000000000003 106.378 174.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -67.95 143.76 55.49 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.598 -0.89 . . . . 70.420000000000002 108.598 175.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ASN . . . . . 0.619 ' CG ' HD11 ' A' ' 10' ' ' ILE . 17.5 t30 -117.56 83.92 18.14 Favored Pre-proline 0 C--O 1.236 0.385 0 N-CA-C 112.406 0.521 . . . . 63.340000000000003 112.406 -174.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -62.92 -28.87 75.55 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 120.297 0.665 . . . . 71.019999999999996 112.102 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -64.16 -7.25 8.43 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 116.756 2.132 . . . . 64.209999999999994 116.756 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -107.69 -3.88 34.52 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-N 119.733 1.151 . . . . 44.439999999999998 113.776 170.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.1 mtt -85.82 166.37 16.09 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 119.952 1.876 . . . . 63.439999999999998 109.399 -174.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -79.32 65.83 4.61 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 122.674 1.226 . . . . 62.420000000000002 111.25 -172.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 41.6 p -67.04 3.57 1.09 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.59 1.956 . . . . 64.0 112.654 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 6.1 t -73.22 -18.63 61.22 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 119.799 1.182 . . . . 72.0 111.827 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.85 -11.74 8.11 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 117.557 -1.211 . . . . 72.200000000000003 114.043 -170.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 3.6 mmt 68.98 -63.36 0.37 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.483 1.913 . . . . 73.409999999999997 111.809 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.27 -31.07 71.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.767 1.27 . . . . 73.200000000000003 110.389 -170.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 76.0 t -75.71 -33.47 26.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 124.546 1.138 . . . . 53.439999999999998 111.133 173.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -60.27 -56.88 16.13 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.614 -0.884 . . . . 72.400000000000006 108.614 -176.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.0 t -65.01 -35.47 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 109.981 -0.377 . . . . 43.520000000000003 109.981 -175.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.09 -27.34 68.29 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.2 1.0 . . . . 74.010000000000005 112.301 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -93.92 -33.34 13.53 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.148 0.885 . . . . 72.200000000000003 112.105 171.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -56.34 -58.05 9.67 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 124.214 1.006 . . . . 72.219999999999999 110.277 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.01 -22.27 62.37 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.162 0.585 . . . . 72.040000000000006 112.433 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -70.97 -61.65 1.69 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.446 1.098 . . . . 71.219999999999999 109.54 178.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.1 t -61.71 -21.11 64.21 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 118.026 -0.988 . . . . 73.219999999999999 112.262 -174.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 57.3 t -56.58 -57.14 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 119.364 0.984 . . . . 74.120000000000005 108.667 169.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -56.8 -43.93 81.43 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.771 0.828 . . . . 71.129999999999995 109.578 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -61.55 -34.03 74.87 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 123.3 0.64 . . . . 65.109999999999999 111.318 -171.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.528 ' HB2' HG11 ' A' ' 154' ' ' VAL . 58.4 mt -79.78 -21.89 43.82 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 121.322 -0.861 . . . . 74.200000000000003 112.687 -178.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 72.3 t -61.46 -31.38 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 108.78 -0.822 . . . . 44.329999999999998 108.78 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -98.04 -14.53 20.47 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.14 0.976 . . . . 70.439999999999998 111.149 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -112.52 63.75 0.63 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.695 1.198 . . . . 73.109999999999999 111.198 -174.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt . . . . . 0 C--O 1.248 0.987 0 CA-C-O 119.094 -0.479 . . . . 72.040000000000006 110.098 160.605 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.394 0 N-CA-C 115.161 1.541 . . . . 51.43 115.161 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -161.57 117.32 2.09 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 107.097 -1.446 . . . . 73.25 107.097 -173.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.4 pt -126.41 150.84 32.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 126.174 1.79 . . . . 65.140000000000001 109.671 -172.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.9 m -132.14 133.93 44.84 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 105.965 -1.865 . . . . 74.25 105.965 176.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -59.85 144.14 49.45 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.49 1.516 . . . . 73.25 108.913 169.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.9 4.89 73.27 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 118.363 -1.243 . . . . 51.210000000000001 112.662 -174.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -129.28 -70.07 0.67 Allowed 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 119.308 1.554 . . . . 71.230000000000004 113.497 -176.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -101.17 -27.52 13.18 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.161 -0.681 . . . . 71.239999999999995 109.161 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -132.46 170.89 14.49 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 122.563 0.345 . . . . 75.25 110.505 171.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.72 147.82 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 105.535 -2.024 . . . . 61.140000000000001 105.535 177.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.09 169.89 17.2 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.733 -1.21 . . . . 73.030000000000001 107.733 163.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 36.2 mt -110.26 150.15 29.13 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.795 -1.557 . . . . 63.350000000000001 106.795 168.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -75.83 -30.96 59.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.101 0.477 . . . . 75.340000000000003 111.216 -174.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.5 mmmt -126.84 76.51 75.25 Favored Pre-proline 0 N--CA 1.464 0.245 0 C-N-CA 124.298 1.039 . . . . 74.049999999999997 108.535 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo . . . . . 0 N--CA 1.453 -0.867 0 C-N-CA 124.14 3.227 . . . . 64.329999999999998 111.157 -175.997 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.274 1.4 p . . . . . 0 CA--C 1.539 0.544 0 N-CA-C 115.387 1.625 . . . . 74.120000000000005 115.387 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.447 HD11 ' CE2' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -160.17 165.37 31.73 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 120.625 -1.297 . . . . 65.120000000000005 110.738 -172.542 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.419 ' H ' ' HG ' ' A' ' 23' ' ' LEU . 2.2 mp0 -137.14 132.85 34.58 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 126.007 1.723 . . . . 73.230000000000004 107.48 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.427 ' CD2' HD13 ' A' ' 146' ' ' LEU . 3.4 m-85 -127.41 139.02 53.11 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.466 1.506 . . . . 73.329999999999998 109.393 -176.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.67 173.13 11.82 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.354 1.462 . . . . 63.0 109.283 -174.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.75 179.47 6.4 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.404 -0.591 . . . . 63.119999999999997 109.404 161.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.503 ' HB2' HD13 ' A' ' 71' ' ' LEU . 32.4 m-85 -100.69 -17.15 17.12 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 123.733 0.813 . . . . 75.230000000000004 111.714 -173.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.433 ' CD1' ' HA3' ' A' ' 65' ' ' GLY . 64.3 m-85 -111.87 8.12 20.31 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 127.547 2.339 . . . . 75.120000000000005 111.854 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.9 p -88.47 144.5 33.85 Favored Pre-proline 0 N--CA 1.468 0.455 0 O-C-N 120.237 -1.54 . . . . 64.219999999999999 111.561 -176.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -73.38 -50.2 0.19 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.708 2.272 . . . . 75.109999999999999 112.371 -168.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -56.11 -35.52 67.16 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.239 0.616 . . . . 71.030000000000001 110.4 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.9 m -63.26 -32.72 74.2 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 124.184 0.994 . . . . 73.409999999999997 111.557 -174.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -57.27 -61.96 2.1 Favored 'General case' 0 C--O 1.216 -0.701 0 C-N-CA 123.535 0.734 . . . . 75.030000000000001 110.784 172.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.661 ' HB3' HD13 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -47.45 -53.12 14.99 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 120.263 -1.523 . . . . 73.409999999999997 110.633 173.198 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -65.5 -13.74 59.51 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 116.015 -1.945 . . . . 62.210000000000001 110.908 -163.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.425 ' HG2' HG21 ' A' ' 88' ' ' THR . 1.4 tp10 -141.11 20.21 2.27 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.667 1.576 . . . . 63.229999999999997 113.53 -177.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.425 ' OE2' ' HA ' ' A' ' 89' ' ' ALA . 26.0 mm-40 -142.26 -28.86 0.6 Allowed 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.222 1.009 . . . . 71.040000000000006 113.163 177.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.0 t -116.18 -44.02 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 105.796 -1.927 . . . . 73.209999999999994 105.796 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.661 HD13 ' HB3' ' A' ' 35' ' ' GLN . 4.4 mp -96.1 -32.89 12.3 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.431 1.892 . . . . 62.200000000000003 112.326 -170.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 27.8 m80 44.11 60.65 2.67 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.49 1.116 . . . . 72.310000000000002 112.272 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.71 -35.52 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 124.651 1.18 . . . . 64.420000000000002 109.163 -175.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.4 t -57.82 -51.25 70.35 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.8 1.182 . . . . 74.439999999999998 108.794 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -66.1 -47.28 74.72 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 124.494 1.117 . . . . 73.430000000000007 110.53 -177.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -58.26 -56.19 25.32 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 125.157 1.383 . . . . 72.129999999999995 111.579 -178.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.545 HG12 ' HG ' ' A' ' 50' ' ' LEU . 19.7 t -67.45 -42.14 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.529 -1.286 . . . . 51.229999999999997 107.529 -175.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 61.9 ttt-85 -51.27 -43.26 61.54 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.008 1.276 . . . . 65.400000000000006 111.865 174.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -61.71 -13.17 20.64 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.689 1.596 . . . . 74.340000000000003 114.778 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -120.58 -11.48 9.06 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.035 1.334 . . . . 71.200000000000003 112.912 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.545 ' HG ' HG12 ' A' ' 46' ' ' VAL . 7.7 mt -69.25 143.91 94.34 Favored Pre-proline 0 C--O 1.239 0.529 0 CA-C-N 119.224 0.92 . . . . 73.219999999999999 108.921 -163.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.69 145.98 33.44 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.937 2.424 . . . . 62.32 110.565 176.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.58 76.1 6.21 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.489 -1.232 . . . . 65.450000000000003 109.346 -168.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 166.49 -17.41 0.09 OUTLIER Glycine 0 CA--C 1.525 0.676 0 CA-C-O 117.769 -1.573 . . . . 65.420000000000002 112.255 -172.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.473 HG21 HD13 ' A' ' 50' ' ' LEU . 8.0 t -45.18 -46.06 11.9 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.372 1.586 . . . . 73.430000000000007 113.742 174.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.8 tptt 66.23 147.15 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.942 2.897 . . . . 62.149999999999999 112.964 -149.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 3.2 mtm -135.08 137.61 43.04 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 127.159 2.184 . . . . 64.129999999999995 108.378 175.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.8 m -146.82 168.15 22.12 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.006 1.323 . . . . 71.040000000000006 108.714 -177.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.93 106.74 3.07 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.289 -1.507 . . . . 74.439999999999998 109.366 -177.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.447 ' CE2' HD11 ' A' ' 23' ' ' LEU . 9.9 m-30 -112.23 169.48 8.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.194 1.398 . . . . 73.310000000000002 111.886 -176.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.691 ' CE1' HG23 ' A' ' 72' ' ' THR . 0.5 OUTLIER -114.82 173.29 6.55 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.04 1.736 . . . . 75.329999999999998 109.686 -177.099 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.3 m -136.78 169.77 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 119.692 1.133 . . . . 62.0 109.591 163.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -125.37 65.0 1.16 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.794 1.637 . . . . 71.040000000000006 109.806 -174.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -146.7 -13.29 0.44 Allowed 'General case' 0 C--N 1.328 -0.362 0 O-C-N 120.733 -1.23 . . . . 74.040000000000006 113.168 -168.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mt -128.24 125.45 38.96 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 119.972 1.26 . . . . 75.430000000000007 108.904 -176.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' A' ' 29' ' ' TYR . . . 89.06 158.08 33.72 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.442 1.496 . . . . 60.119999999999997 110.647 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -64.69 -48.57 3.98 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.415 2.077 . . . . 54.329999999999998 110.274 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.715 HD13 HD11 ' A' ' 107' ' ' ILE . 5.1 mt -74.36 10.39 1.31 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.471 1.285 . . . . 75.340000000000003 114.471 -175.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.23 -2.46 0.41 Allowed Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.176 1.369 . . . . 73.409999999999997 115.751 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -90.87 -42.33 10.68 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 120.172 1.986 . . . . 64.299999999999997 112.383 169.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -60.92 -54.73 41.45 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 118.595 0.634 . . . . 72.230000000000004 109.826 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.503 HD13 ' HB2' ' A' ' 28' ' ' PHE . 86.3 mt -55.63 -37.68 68.51 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 124.989 1.43 . . . . 62.030000000000001 111.682 -164.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.691 HG23 ' CE1' ' A' ' 60' ' ' HIS . 52.3 m -55.74 -49.58 72.68 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 129.506 3.122 . . . . 71.310000000000002 110.716 174.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -65.42 -54.73 24.32 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.466 -0.771 . . . . 70.319999999999993 109.248 174.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.8 -36.6 48.36 Favored 'General case' 0 C--O 1.227 -0.097 0 N-CA-C 114.042 1.127 . . . . 64.409999999999997 114.042 -177.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.469 ' CD1' HD11 ' A' ' 79' ' ' ILE . 35.7 t-105 -50.3 -41.43 50.91 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.058 1.343 . . . . 73.420000000000002 110.394 176.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.66 -36.57 83.3 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 117.628 -1.177 . . . . 72.230000000000004 113.314 179.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.1 t -54.69 -49.28 69.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 120.324 1.42 . . . . 62.210000000000001 109.475 169.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.55 -46.2 89.46 Favored 'General case' 0 C--N 1.342 0.242 0 O-C-N 122.007 -0.433 . . . . 65.010000000000005 110.495 -175.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.469 HD11 ' CD1' ' A' ' 75' ' ' TRP . 79.4 mt -62.43 -39.52 84.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 123.603 0.761 . . . . 65.439999999999998 110.153 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.62 -45.03 85.9 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.076 0.853 . . . . 64.120000000000005 110.135 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 89.5 mt -86.96 -11.6 50.09 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 112.945 0.72 . . . . 70.310000000000002 112.945 -177.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.77 60.89 6.73 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 126.326 1.917 . . . . 62.119999999999997 112.184 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.8 m -134.84 11.74 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.134 0 C-N-CA 125.045 1.338 . . . . 62.439999999999998 113.097 -174.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -44.42 -60.71 1.82 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.751 1.62 . . . . 73.030000000000001 109.911 175.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.8 -8.06 0.54 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.934 2.093 . . . . 72.230000000000004 114.183 176.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -108.2 -29.03 9.14 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.536 1.516 . . . . 74.439999999999998 112.311 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.9 pp -100.31 -14.07 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 C-N-CA 123.884 0.874 . . . . 72.230000000000004 111.619 -175.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.482 HG23 ' HE2' ' A' ' 92' ' ' PHE 0.25 3.2 m -63.31 -41.82 98.98 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 116.868 -1.539 . . . . 74.019999999999996 112.319 -179.474 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.585 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -50.76 -64.47 1.31 Allowed Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.477 1.111 . . . . 72.030000000000001 112.09 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 48.2 Cg_endo -68.07 -20.46 44.18 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 120.508 0.805 . . . . 73.0 112.387 -177.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 6.1 tpp -59.98 -55.17 37.37 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 126.539 1.935 . . . . 72.230000000000004 110.576 174.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.482 ' HE2' HG23 ' A' ' 88' ' ' THR . 41.8 m-85 -69.84 -32.02 70.2 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 121.348 -0.845 . . . . 74.420000000000002 110.96 -177.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.493 ' HA ' ' HB2' ' A' ' 97' ' ' LYS . 1.8 tt0 -60.97 -36.97 80.8 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 117.915 -1.514 . . . . 74.120000000000005 108.887 169.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.455 ' HB1' HG23 ' A' ' 101' ' ' VAL . . . -81.17 -15.12 56.68 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 120.376 -1.453 . . . . 61.210000000000001 112.408 -171.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 99.1 t -116.91 -22.73 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 125.232 1.413 . . . . 60.409999999999997 111.635 -171.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -120.55 -50.89 2.19 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.772 1.169 . . . . 74.010000000000005 110.582 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.519 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 1.7 mmpt? -72.44 -40.89 66.72 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 113.696 0.999 . . . . 74.310000000000002 113.696 -171.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.4 p -112.3 -34.98 5.74 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 124.809 1.318 . . . . 64.430000000000007 111.221 178.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 57.62 23.65 9.59 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.662 1.985 . . . . 74.219999999999999 113.308 -171.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -66.79 -13.42 61.46 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.927 0.785 . . . . 63.219999999999999 112.22 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.509 HG13 HG12 ' A' ' 107' ' ' ILE . 27.7 t -64.47 108.73 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 108.44 -0.948 . . . . 74.329999999999998 108.44 169.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -135.11 -26.96 1.26 Allowed 'General case' 0 C--O 1.237 0.399 0 CA-C-O 118.558 -0.734 . . . . 73.230000000000004 112.618 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.5 m -131.63 169.94 15.46 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 108.63 -0.878 . . . . 41.130000000000003 108.63 169.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 87.8 t -55.92 -36.1 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.019 0.928 . . . . 75.129999999999995 110.411 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.81 -16.38 16.81 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.504 1.522 . . . . 74.230000000000004 114.053 175.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -91.21 -35.12 14.69 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 119.335 0.97 . . . . 42.43 110.142 175.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.715 HD11 HD13 ' A' ' 67' ' ' LEU . 1.2 mt -78.84 -36.79 19.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 121.256 -0.902 . . . . 64.0 109.394 -169.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -54.39 -36.13 63.58 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-O 117.96 -1.019 . . . . 72.420000000000002 111.598 169.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -58.43 -51.63 69.01 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 118.853 0.752 . . . . 73.310000000000002 109.475 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 18.8 t -49.69 -48.12 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.427 1.091 . . . . 65.400000000000006 110.901 -177.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -55.07 -51.85 65.06 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.442 0.697 . . . . 73.099999999999994 110.369 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.2 t -69.94 -32.0 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 CA-C-O 119.098 -0.477 . . . . 74.200000000000003 110.205 -175.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -65.91 -41.57 91.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 118.593 0.633 . . . . 70.040000000000006 110.712 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.33 -43.86 92.67 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.538 -0.542 . . . . 73.420000000000002 109.538 171.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 144.35 3.94 0.7 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.519 1.057 . . . . 53.240000000000002 114.869 168.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 65.9 t -62.66 136.6 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 118.763 1.282 . . . . 54.509999999999998 108.836 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.4 mtmt -62.32 125.0 22.39 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.443 -0.947 . . . . 73.129999999999995 108.443 176.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.71 -27.08 69.34 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-O 118.83 -0.983 . . . . 73.439999999999998 111.301 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -70.65 -26.46 63.47 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 118.134 0.967 . . . . 71.230000000000004 112.373 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -87.42 -38.65 15.94 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.667 1.987 . . . . 73.129999999999995 107.565 -168.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -60.05 -56.05 26.39 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.482 1.513 . . . . 74.219999999999999 109.148 166.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -72.04 -8.01 52.11 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.139 0.792 . . . . 45.420000000000002 113.139 -173.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -85.89 -61.83 1.66 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.529 1.132 . . . . 71.329999999999998 109.598 164.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.09 -37.83 67.31 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 123.435 0.694 . . . . 63.109999999999999 112.636 -172.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -49.64 -38.66 33.17 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.097 0.959 . . . . 72.340000000000003 111.658 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.56 -11.15 40.91 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 120.487 -1.383 . . . . 73.230000000000004 113.965 177.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.7 t -77.07 155.22 32.63 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 126.835 2.054 . . . . 63.200000000000003 112.263 -169.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -66.29 -26.17 67.2 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.582 1.553 . . . . 72.340000000000003 111.274 175.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 68.0 t -50.04 -52.78 13.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 124.142 0.977 . . . . 63.399999999999999 109.19 172.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.2 t -69.45 -42.75 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 C-N-CA 123.383 0.673 . . . . 65.340000000000003 110.084 -177.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -51.44 -52.53 45.51 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.172 0.896 . . . . 54.409999999999997 111.256 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 36.1 t -63.22 -42.68 99.3 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 123.337 0.655 . . . . 43.100000000000001 109.714 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.0 mt -60.35 -52.07 66.84 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-O 118.256 -0.878 . . . . 54.299999999999997 109.957 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 95.1 t -51.13 -44.18 28.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 118.964 0.802 . . . . 71.0 108.953 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.41 -28.97 70.34 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 114.282 1.216 . . . . 64.019999999999996 114.282 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -63.42 -47.67 81.0 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 121.146 -0.971 . . . . 74.299999999999997 110.352 177.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.409 ' HG3' ' CD2' ' A' ' 59' ' ' TYR . 3.0 mp0 -78.52 -41.11 33.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 124.189 0.931 . . . . 73.120000000000005 110.95 -178.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -54.43 -46.78 73.3 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.385 0.993 . . . . 74.109999999999999 108.603 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -63.0 -45.87 90.37 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.517 0.727 . . . . 73.129999999999995 112.565 175.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.7 -49.92 74.53 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.707 0.685 . . . . 41.119999999999997 109.52 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.73 -30.17 71.22 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.136 -1.603 . . . . 52.539999999999999 110.895 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -76.57 -8.04 56.4 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.263 0.938 . . . . 71.420000000000002 113.405 173.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.68 -18.49 62.17 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 120.728 -1.232 . . . . 73.219999999999999 109.743 162.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 11.6 mt 75.42 -8.36 1.6 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 128.154 2.582 . . . . 73.120000000000005 112.394 171.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.13 -0.61 1.24 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.126 2.57 . . . . 75.040000000000006 115.008 -176.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.427 HD13 ' CD2' ' A' ' 25' ' ' PHE . 1.2 tt -152.06 119.67 6.07 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 124.323 1.049 . . . . 75.010000000000005 108.692 -172.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -146.23 16.91 1.36 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.491 1.116 . . . . 72.329999999999998 110.671 -174.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -152.97 97.55 0.17 Allowed Glycine 0 C--N 1.34 0.798 0 O-C-N 121.084 -1.01 . . . . 55.409999999999997 111.611 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.437 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 2.4 m -91.03 174.77 4.15 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.153 0.981 . . . . 64.430000000000007 110.161 176.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.437 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 43.9 Cg_endo -64.25 140.94 42.42 Favored 'Cis proline' 0 N--CA 1.456 -0.728 0 N-CA-C 109.218 -1.109 . . . . 62.310000000000002 109.218 -19.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -133.8 124.71 27.04 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.264 1.026 . . . . 73.439999999999998 108.62 -169.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 28.3 mtp -132.7 107.76 8.6 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.222 1.809 . . . . 74.319999999999993 106.471 -168.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -97.56 168.48 10.34 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.302 1.041 . . . . 72.140000000000001 109.859 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.0 t -125.35 -37.52 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 118.567 -0.73 . . . . 65.019999999999996 112.91 171.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.66 13.85 0.35 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.166 1.543 . . . . 73.150000000000006 115.166 -175.107 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 77.22 2.26 78.09 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 121.621 -0.674 . . . . 50.420000000000002 112.617 -175.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -128.11 -4.83 5.59 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 121.333 -1.098 . . . . 75.129999999999995 113.803 170.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -133.95 140.29 46.66 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.925 0.89 . . . . 74.450000000000003 108.688 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -122.11 154.86 36.81 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.934 1.693 . . . . 75.25 106.546 168.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -76.16 157.4 32.79 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.144 -0.973 . . . . 75.230000000000004 108.764 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.25 66.36 1.55 Allowed Pre-proline 0 N--CA 1.468 0.434 0 C-N-CA 123.371 0.668 . . . . 75.140000000000001 110.176 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -55.47 -36.62 94.54 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.707 1.605 . . . . 71.140000000000001 111.302 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -79.17 24.73 0.32 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.99 0.916 . . . . 62.020000000000003 112.921 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -136.13 7.55 4.08 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 121.12 -0.987 . . . . 54.409999999999997 113.043 161.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 12.6 mtt -92.25 158.84 15.91 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 119.161 1.48 . . . . 55.399999999999999 110.628 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -62.72 106.01 0.73 Allowed 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.735 1.214 . . . . 72.439999999999998 109.935 176.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 24.2 p -106.48 28.84 7.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.008 1.323 . . . . 74.340000000000003 110.247 174.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.3 m -72.49 -29.15 63.38 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 120.988 -1.07 . . . . 71.400000000000006 111.496 175.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -133.37 -20.45 2.1 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 112.876 0.695 . . . . 75.439999999999998 112.876 -171.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' MET . . . . . 0.442 ' O ' HG23 ' A' ' 174' ' ' VAL . 39.5 mmm 74.2 -31.26 0.21 Allowed 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 126.423 1.889 . . . . 52.439999999999998 112.118 173.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -70.59 -48.16 56.58 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 120.188 1.358 . . . . 72.319999999999993 108.322 174.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 59.5 t -65.04 -29.82 48.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 114.825 -1.08 . . . . 60.030000000000001 111.172 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -56.56 -51.56 68.13 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.533 -0.914 . . . . 75.219999999999999 108.533 174.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 170' ' ' MET . 1.8 t -68.45 -34.53 66.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 118.477 0.58 . . . . 73.409999999999997 111.014 -175.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.79 -28.1 68.51 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.103 0.561 . . . . 74.0 112.06 177.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -91.47 -31.16 16.09 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.376 1.07 . . . . 73.140000000000001 111.988 174.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -63.51 -58.63 6.39 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.925 -1.109 . . . . 73.319999999999993 109.778 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -55.55 -27.84 51.31 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.483 1.113 . . . . 64.319999999999993 113.808 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -70.7 -57.76 4.35 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.879 -0.513 . . . . 72.010000000000005 110.373 173.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 t -66.9 -30.12 70.19 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.43 -0.582 . . . . 71.219999999999999 109.43 -169.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 78.1 t -55.74 -56.54 11.84 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 N-CA-C 108.948 -0.76 . . . . 72.040000000000006 108.948 170.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -64.14 -39.23 93.59 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-O 119.015 -0.517 . . . . 51.530000000000001 111.315 -172.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -52.53 -33.0 43.38 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 122.75 0.42 . . . . 62.149999999999999 112.091 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 80.5 mt -81.19 -16.57 52.45 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 120.756 -1.215 . . . . 65.409999999999997 113.065 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 91.6 t -69.44 -20.31 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 120.997 -1.064 . . . . 70.209999999999994 110.288 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -105.96 -21.17 13.21 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.273 -0.892 . . . . 74.319999999999993 109.566 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 35.2 mttt -105.05 74.42 1.11 Allowed 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 125.954 1.702 . . . . 74.129999999999995 109.884 -171.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 33.4 tttt . . . . . 0 N--CA 1.432 -1.372 0 C-N-CA 126.879 2.072 . . . . 33.340000000000003 107.665 176.261 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.293 0 CA-C-O 121.723 0.773 . . . . 72.219999999999999 112.799 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -157.23 122.53 4.59 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 104.884 -2.265 . . . . 73.0 104.884 -178.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.633 HG21 HG23 ' A' ' 180' ' ' THR . 12.5 pt -127.14 152.29 34.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 128.303 2.641 . . . . 75.340000000000003 107.203 175.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.2 m -121.3 137.31 54.75 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.081 1.352 . . . . 64.230000000000004 107.399 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -57.59 152.09 15.72 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.267 1.427 . . . . 62.299999999999997 110.224 166.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.48 -31.56 0.84 Allowed Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.415 1.007 . . . . 73.129999999999995 112.693 -171.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -87.33 -71.39 0.56 Allowed 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 106.725 -1.583 . . . . 72.319999999999993 106.725 -164.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -123.67 -14.03 7.36 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.081 1.752 . . . . 72.430000000000007 110.016 -165.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -138.74 168.72 19.19 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.948 -0.47 . . . . 73.219999999999999 110.512 155.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.1 mm -125.79 158.35 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 127.955 2.502 . . . . 74.030000000000001 106.046 172.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.53 172.81 8.04 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.476 1.51 . . . . 64.239999999999995 108.813 178.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.9 mt -124.11 135.1 53.29 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 119.603 1.092 . . . . 72.019999999999996 108.784 162.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -66.33 -38.42 87.63 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 129.377 3.071 . . . . 64.310000000000002 110.343 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.22 64.81 7.5 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 125.483 1.513 . . . . 55.299999999999997 110.362 -177.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo . . . . . 0 N--CA 1.446 -1.271 0 C-N-CA 123.335 2.69 . . . . 71.409999999999997 113.626 -175.777 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.237 0.425 0 N-CA-C 107.129 -1.434 . . . . 74.209999999999994 107.129 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -165.28 161.28 19.07 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.812 0.845 . . . . 74.030000000000001 110.467 171.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -139.26 147.02 41.14 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.756 1.222 . . . . 64.010000000000005 110.013 174.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -127.22 145.94 50.59 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.397 1.079 . . . . 64.099999999999994 109.788 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -161.16 174.82 13.11 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.167 1.387 . . . . 74.329999999999998 109.314 177.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.3 t -129.79 179.62 5.74 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.998 1.319 . . . . 72.329999999999998 109.22 173.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -94.28 -21.66 18.87 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 128.007 2.523 . . . . 74.420000000000002 111.377 176.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.512 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 49.7 m-85 -104.35 9.72 35.71 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.697 1.599 . . . . 70.540000000000006 114.642 177.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.5 p -88.42 143.24 32.09 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 121.047 1.749 . . . . 74.219999999999999 111.014 175.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -80.44 -43.51 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 120.936 1.091 . . . . 74.510000000000005 112.352 -171.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -53.84 -44.81 70.62 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 118.447 0.567 . . . . 73.140000000000001 109.708 175.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.5 m -52.54 -42.47 64.43 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 125.092 1.357 . . . . 54.340000000000003 111.557 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -61.24 -52.09 66.21 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 110.114 -0.328 . . . . 75.230000000000004 110.114 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -58.22 -45.68 87.25 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.515 -0.92 . . . . 70.109999999999999 108.515 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -67.77 -6.26 20.29 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 116.319 -1.8 . . . . 73.329999999999998 113.691 -177.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -134.44 -1.02 2.88 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 121.901 2.137 . . . . 43.140000000000001 113.219 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -136.14 -12.51 1.9 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.854 1.262 . . . . 72.209999999999994 112.746 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.8 t -126.96 -79.89 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.089 0 N-CA-C 107.052 -1.462 . . . . 61.100000000000001 107.052 -176.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.6 mt -65.63 -24.78 67.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.287 2.235 . . . . 73.299999999999997 111.993 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 44.36 48.13 8.06 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.99 1.716 . . . . 61.399999999999999 111.817 176.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.601 ' O ' HG23 ' A' ' 46' ' ' VAL . 97.7 t -54.44 -49.56 64.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.361 0 C-N-CA 125.01 1.324 . . . . 74.209999999999994 110.184 -174.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.1 t -48.95 -49.95 37.92 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.4 1.48 . . . . 72.439999999999998 110.839 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -73.29 -36.45 66.3 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.654 0.782 . . . . 60.340000000000003 112.078 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -57.87 -49.61 76.11 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.486 0.715 . . . . 71.239999999999995 109.65 172.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 42' ' ' VAL . 2.1 t -59.02 -49.06 84.6 Favored 'Isoleucine or valine' 0 C--N 1.343 0.313 0 CA-C-N 119.024 0.829 . . . . 73.140000000000001 108.874 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.1 ptt180 -61.3 -26.67 67.94 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 121.741 -0.6 . . . . 74.310000000000002 112.443 -169.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -64.28 -15.57 60.45 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.391 0.886 . . . . 71.329999999999998 113.391 174.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -126.51 -6.13 6.41 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.956 1.702 . . . . 72.439999999999998 112.17 -170.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.508 ' HB3' HG21 ' A' ' 54' ' ' THR . 10.5 mt -70.08 144.27 92.5 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-O 118.904 -0.57 . . . . 63.439999999999998 110.988 -169.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.599 ' O ' HG22 ' A' ' 54' ' ' THR . 72.9 Cg_endo -74.88 153.25 42.25 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.043 2.495 . . . . 71.400000000000006 111.295 178.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -79.24 81.59 5.49 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.834 0.826 . . . . 61.340000000000003 109.072 -172.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 166.64 -23.62 0.13 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.11 1.338 . . . . 31.050000000000001 113.891 -177.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 51' ' ' PRO . 1.8 t -48.35 -46.79 37.17 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 118.926 1.363 . . . . 75.120000000000005 113.991 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? 60.01 124.47 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.407 2.283 . . . . 60.219999999999999 111.867 -170.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.6 ttm -75.48 102.06 5.07 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 106.286 -1.746 . . . . 53.43 106.286 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.1 m -129.66 101.39 5.89 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 107.649 -1.241 . . . . 54.5 107.649 -167.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.64 105.63 9.88 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.821 1.248 . . . . 72.099999999999994 108.151 -162.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -94.86 152.69 18.18 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.185 0.517 . . . . 75.219999999999999 109.974 175.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.582 ' NE2' HG23 ' A' ' 72' ' ' THR . 1.6 p-80 -81.62 176.09 9.94 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.513 1.525 . . . . 62.43 108.761 172.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.5 m -145.18 152.09 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 107.659 -1.237 . . . . 73.310000000000002 107.659 158.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.4 ' C ' ' H ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER -101.0 -14.7 17.74 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.23 1.012 . . . . 73.140000000000001 112.755 -172.09 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -57.8 5.66 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 129.144 2.978 . . . . 74.310000000000002 114.719 -177.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.4 ' H ' ' C ' ' A' ' 62' ' ' GLU . 30.5 mt -145.47 110.16 5.08 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 126.763 2.025 . . . . 65.209999999999994 106.963 -164.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.512 ' HA3' ' CD2' ' A' ' 29' ' ' TYR . . . 100.85 154.62 26.98 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 126.692 2.091 . . . . 41.310000000000002 110.75 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.56 -44.4 0.52 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 121.788 1.658 . . . . 65.310000000000002 110.093 173.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.1 mt -83.26 24.28 0.82 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.782 0.833 . . . . 74.109999999999999 111.151 174.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -50.78 -46.46 48.26 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.427 1.013 . . . . 62.25 111.191 176.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -58.75 -47.74 83.59 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.923 0.889 . . . . 64.319999999999993 111.689 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.68 -44.12 97.08 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.696 1.598 . . . . 44.32 108.509 -174.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.6 mt -61.86 -44.45 96.8 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.464 1.106 . . . . 73.010000000000005 111.019 174.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.582 HG23 ' NE2' ' A' ' 60' ' ' HIS . 82.6 m -58.14 -48.89 78.86 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.71 1.604 . . . . 72.319999999999993 110.937 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -62.59 -42.86 99.82 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 120.906 -1.121 . . . . 74.349999999999994 109.877 175.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.83 -35.74 75.36 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 120.663 -1.273 . . . . 72.049999999999997 112.569 178.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 52.9 t-105 -55.09 -34.62 63.8 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.228 1.011 . . . . 71.409999999999997 111.08 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.12 -36.73 83.93 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 118.382 -0.818 . . . . 62.039999999999999 111.481 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.7 t -56.92 -47.31 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 119.445 1.02 . . . . 75.439999999999998 109.309 172.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.51 -26.75 61.02 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 117.238 -1.363 . . . . 55.149999999999999 112.748 -175.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.12 -42.46 79.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 120.952 1.706 . . . . 75.430000000000007 108.937 167.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.04 -40.26 84.52 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.423 1.01 . . . . 75.420000000000002 110.771 -176.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.2 mt -87.56 -14.59 39.79 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.127 0.417 . . . . 73.230000000000004 112.127 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.98 67.03 2.25 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 126.563 2.03 . . . . 75.209999999999994 111.089 -176.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.5 m -136.86 17.07 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.628 1.171 . . . . 72.109999999999999 112.51 -176.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -49.29 -50.46 39.12 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.026 1.73 . . . . 73.420000000000002 111.772 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -80.09 5.77 13.36 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.677 1.591 . . . . 64.099999999999994 111.037 -176.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.8 mtpp -104.5 -20.29 13.74 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.604 1.562 . . . . 74.430000000000007 110.527 170.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.1 pp -119.25 13.08 6.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 C-N-CA 124.245 1.018 . . . . 74.450000000000003 111.487 -170.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.2 m -86.97 -42.22 13.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 119.542 1.065 . . . . 74.439999999999998 111.087 175.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.496 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -55.14 -64.25 2.26 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 118.906 0.776 . . . . 42.530000000000001 111.581 -177.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.496 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 90.6 Cg_endo -69.61 -27.75 26.81 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.428 1.419 . . . . 71.109999999999999 111.467 -171.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 23.0 tpp -56.16 -49.26 74.48 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.169 0.988 . . . . 71.299999999999997 109.038 175.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -73.7 -31.7 63.55 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 118.43 -0.795 . . . . 75.319999999999993 110.008 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -60.15 -33.73 72.57 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 119.143 0.883 . . . . 62.219999999999999 110.977 170.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -99.45 -12.4 20.25 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.871 1.214 . . . . 62.100000000000001 113.438 -174.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.7 t -97.52 -45.52 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.308 1.043 . . . . 72.230000000000004 109.216 177.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -98.07 -63.78 1.1 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.886 0.875 . . . . 70.340000000000003 109.576 -176.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -63.62 -59.18 4.94 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 119.188 0.904 . . . . 74.099999999999994 111.116 -166.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.5 p -95.6 -16.43 22.1 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.884 0.698 . . . . 73.140000000000001 112.884 -176.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 55.31 22.57 4.93 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.151 1.381 . . . . 72.400000000000006 113.806 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.1 t -68.39 -14.54 63.07 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.4 1.48 . . . . 52.210000000000001 112.143 -178.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 38.6 t -66.79 110.84 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 O-C-N 120.52 -1.362 . . . . 64.25 109.094 171.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -139.28 -23.21 0.9 Allowed 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.914 1.686 . . . . 71.420000000000002 111.616 -172.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 t -151.44 179.95 7.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.007 -1.058 . . . . 63.509999999999998 109.394 159.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.3 t -54.58 -34.34 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 124.664 1.185 . . . . 72.219999999999999 110.064 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.38 -23.86 17.31 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.867 1.667 . . . . 51.229999999999997 113.04 176.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -94.08 -37.66 11.51 Favored 'General case' 0 CA--C 1.518 -0.266 0 O-C-N 121.33 -0.856 . . . . 75.049999999999997 108.998 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.8 mt -65.4 -47.23 87.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 125.152 1.381 . . . . 71.019999999999996 108.096 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -62.51 -26.16 68.4 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.019 0.748 . . . . 74.239999999999995 113.019 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -65.08 -51.81 59.27 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 109.577 -0.527 . . . . 71.450000000000003 109.577 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.2 t -55.83 -41.7 67.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 123.549 0.53 . . . . 71.25 111.062 -176.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -54.11 -54.4 40.03 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.496 -0.557 . . . . 61.149999999999999 109.496 175.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 54.4 t -58.67 -47.34 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 C-N-CA 123.036 0.534 . . . . 63.25 110.436 -177.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -70.25 -37.91 75.02 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.437 -0.949 . . . . 74.319999999999993 108.437 -166.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.89 -9.9 59.21 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.607 1.163 . . . . 73.019999999999996 112.354 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 118.4 36.37 0.93 Allowed Glycine 0 C--N 1.336 0.577 0 CA-C-O 117.793 -1.56 . . . . 74.239999999999995 115.08 168.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 99.5 t -102.61 144.81 13.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 119.648 1.724 . . . . 44.109999999999999 109.204 172.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.555 ' HG3' ' H ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -67.53 133.14 48.92 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.53 -0.759 . . . . 74.040000000000006 110.23 171.964 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.42 -21.91 69.01 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-O 118.903 -0.943 . . . . 71.25 111.736 172.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -73.22 -49.8 25.93 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 118.147 -0.93 . . . . 73.019999999999996 111.917 175.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.555 ' H ' ' HG3' ' A' ' 117' ' ' LYS . 33.3 t70 -66.07 -40.67 91.05 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.181 -1.414 . . . . 64.430000000000007 107.181 -178.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -59.29 -51.38 70.19 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 123.907 0.754 . . . . 72.25 110.105 -174.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -77.88 -12.83 60.02 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 113.002 0.741 . . . . 64.239999999999995 113.002 -175.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.43 -61.7 1.46 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.979 1.312 . . . . 73.349999999999994 110.387 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.79 -34.22 58.41 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.57 1.548 . . . . 64.409999999999997 110.934 -177.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 61.7 t-105 -45.54 -37.02 5.0 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.017 1.727 . . . . 73.010000000000005 112.934 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -113.21 2.54 15.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.935 1.294 . . . . 63.439999999999998 113.162 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 10.0 t -77.34 156.0 31.58 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.441 1.097 . . . . 73.109999999999999 109.887 173.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -58.88 -30.86 68.07 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.448 1.499 . . . . 74.319999999999993 111.941 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 84.9 t -54.33 -48.54 67.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 O-C-N 121.606 -0.683 . . . . 64.049999999999997 109.391 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.4 t -65.32 -43.47 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-O 119.08 -0.486 . . . . 74.409999999999997 110.504 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -53.4 -51.55 62.19 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.68 0.673 . . . . 74.349999999999994 111.51 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.0 t -69.63 -38.15 77.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 117.863 -1.065 . . . . 60.039999999999999 110.285 -177.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.1 mt -58.92 -56.4 22.78 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 117.453 -1.26 . . . . 75.420000000000002 110.429 176.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 37.6 t -45.41 -46.72 4.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.245 0 C-N-CA 124.533 1.133 . . . . 63.009999999999998 109.98 174.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.02 -35.13 70.83 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 113.038 0.755 . . . . 51.350000000000001 113.038 -176.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -61.53 -38.37 87.16 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.048 0.539 . . . . 75.340000000000003 110.755 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 10.0 mp0 -85.9 -50.28 7.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.254 1.022 . . . . 72.349999999999994 110.746 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -52.72 -44.94 66.71 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.057 0.844 . . . . 75.040000000000006 109.69 -176.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -60.89 -61.89 2.26 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.092 0.472 . . . . 72.329999999999998 109.878 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.55 1.55 3.04 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.792 1.405 . . . . 71.010000000000005 114.792 -173.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -129.88 6.12 5.05 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.282 1.433 . . . . 74.230000000000004 112.279 174.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -120.81 -6.25 9.62 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 124.714 1.206 . . . . 70.150000000000006 113.085 168.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.97 5.06 0.25 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.317 2.247 . . . . 70.430000000000007 112.781 175.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 73.25 -5.68 1.9 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 131.682 3.993 . . . . 63.119999999999997 114.126 -178.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.415 ' HG3' ' H ' ' A' ' 145' ' ' GLN . 0.0 OUTLIER -71.76 -15.92 62.19 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 127.964 2.505 . . . . 73.010000000000005 113.468 -164.43 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.4 tp -164.17 125.01 2.17 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 128.16 2.584 . . . . 74.400000000000006 105.545 -176.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -142.13 21.95 2.08 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.475 0.655 . . . . 72.439999999999998 111.265 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -136.43 158.97 24.28 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 107.498 -2.241 . . . . 73.319999999999993 107.498 164.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.486 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 3.7 m -140.46 171.67 7.39 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 107.993 -1.114 . . . . 53.32 107.993 174.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.486 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 68.0 Cg_endo -63.21 156.16 69.21 Favored 'Cis proline' 0 N--CA 1.457 -0.639 0 CA-C-N 120.453 1.197 . . . . 45.299999999999997 111.27 -8.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -141.22 144.73 34.9 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.107 0.963 . . . . 71.340000000000003 108.766 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 29.2 ttm -151.08 109.94 3.87 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.001 -1.481 . . . . 75.400000000000006 107.001 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -93.15 156.23 16.98 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.595 -0.73 . . . . 74.120000000000005 109.31 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.6 t -139.48 140.0 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.614 -0.884 . . . . 74.209999999999994 108.614 175.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 45.78 28.84 0.61 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.967 2.507 . . . . 74.409999999999997 114.562 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 63.53 7.39 20.13 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.88 1.705 . . . . 74.409999999999997 113.488 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -141.5 -5.39 1.07 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 119.044 1.422 . . . . 75.299999999999997 113.648 -165.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -129.45 150.13 50.93 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.38 -0.97 . . . . 74.019999999999996 108.38 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.31 123.99 37.65 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 128.401 2.68 . . . . 75.209999999999994 107.998 177.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.5 139.73 57.61 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.513 -1.662 . . . . 73.299999999999997 106.513 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -114.66 86.09 12.3 Favored Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 123.256 0.622 . . . . 65.239999999999995 110.969 174.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.78 -17.9 47.39 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 120.706 0.937 . . . . 72.109999999999999 111.705 177.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -78.66 -6.02 54.6 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.09 1.756 . . . . 74.299999999999997 112.773 -172.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -130.35 13.46 5.68 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.573 1.082 . . . . 72.439999999999998 111.366 177.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 45.3 mtt -85.5 163.19 18.57 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.33 1.065 . . . . 61.420000000000002 109.192 170.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.57 108.73 6.59 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.705 -1.591 . . . . 71.420000000000002 106.705 170.257 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 31.9 p -102.1 -6.74 22.95 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 127.016 2.127 . . . . 73.200000000000003 110.94 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 46.5 m -61.74 -17.9 57.64 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 125.683 1.593 . . . . 64.299999999999997 114.491 -170.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -128.78 -6.3 5.09 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 117.76 -1.114 . . . . 75.329999999999998 111.197 -164.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 65.92 -63.73 0.22 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.348 1.859 . . . . 74.209999999999994 111.865 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.55 -44.49 94.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 119.114 0.87 . . . . 74.329999999999998 108.954 -171.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 91.9 t -62.12 -30.0 47.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 125.084 1.354 . . . . 71.109999999999999 111.587 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -66.78 -60.11 2.97 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 107.624 -1.25 . . . . 75.439999999999998 107.624 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.2 t -68.04 -35.4 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 O-C-N 123.72 0.637 . . . . 61.310000000000002 110.664 -174.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.02 -52.18 63.95 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.491 0.716 . . . . 34.439999999999998 109.799 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -72.64 -38.32 67.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.245 -0.883 . . . . 71.239999999999995 111.598 177.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -55.46 -58.41 7.88 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.745 1.157 . . . . 71.230000000000004 109.714 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.58 -42.07 61.62 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 125.989 1.716 . . . . 71.329999999999998 111.514 -176.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -71.44 -51.0 26.29 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.955 0.902 . . . . 63.210000000000001 108.935 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.633 HG23 HG21 ' A' ' 3' ' ' ILE . 31.1 m -59.81 -26.45 65.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.461 1.105 . . . . 64.099999999999994 112.229 -177.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 97.2 t -60.05 -51.43 73.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 108.912 -0.773 . . . . 75.019999999999996 108.912 169.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 31.1 tttm -61.35 -44.29 97.42 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 118.008 -0.996 . . . . 75.310000000000002 110.986 174.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -57.15 -28.98 63.23 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 119.599 1.091 . . . . 60.219999999999999 111.426 -169.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 58.5 mt -81.12 -24.61 37.56 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.874 0.694 . . . . 75.030000000000001 112.874 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.47 -28.22 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 O-C-N 121.027 -1.045 . . . . 75.230000000000004 110.508 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -89.28 -29.61 19.07 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 122.048 0.928 . . . . 73.040000000000006 109.45 178.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 45.6 mttp -95.64 66.42 2.73 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 125.094 1.358 . . . . 72.439999999999998 109.051 -176.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.507 ' H ' ' HD3' ' A' ' 188' ' ' LYS . 1.2 mppt? . . . . . 0 C--O 1.247 0.968 0 N-CA-C 107.427 -1.323 . . . . 62.399999999999999 107.427 154.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 114.023 1.12 . . . . 71.319999999999993 114.023 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -157.58 122.98 4.55 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 129.153 2.981 . . . . 71.299999999999997 103.533 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.711 HG21 HG23 ' A' ' 180' ' ' THR . 9.3 pt -127.85 149.59 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 126.735 2.014 . . . . 64.230000000000004 108.152 175.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.0 m -132.03 143.33 49.98 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.054 -1.091 . . . . 60.200000000000003 108.054 174.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -59.11 151.91 21.45 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.919 1.287 . . . . 64.129999999999995 110.151 170.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.86 -25.82 0.78 Allowed Glycine 0 CA--C 1.532 1.125 0 CA-C-O 118.873 -0.96 . . . . 60.329999999999998 112.783 -169.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -98.04 -85.61 0.37 Allowed 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 119.246 1.523 . . . . 75.319999999999993 107.565 -170.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -90.05 -17.92 26.89 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.505 0.722 . . . . 71.430000000000007 111.751 -176.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -140.76 164.91 28.95 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 118.208 0.458 . . . . 74.219999999999999 110.245 173.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.2 mm -127.87 163.12 32.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 105.761 -1.941 . . . . 71.140000000000001 105.761 173.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.21 164.26 11.74 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 124.998 1.319 . . . . 71.230000000000004 110.058 171.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 27.2 mt -79.67 154.53 28.57 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.929 -1.137 . . . . 74.239999999999995 107.929 161.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.62 -27.12 51.06 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.809 -0.812 . . . . 73.400000000000006 108.809 171.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -121.81 71.34 29.6 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.774 1.629 . . . . 74.239999999999995 108.987 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo . . . . . 0 CA--C 1.538 0.69 0 C-N-CA 124.079 3.186 . . . . 74.209999999999994 111.579 -177.565 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 N--CA 1.463 0.189 0 CA-C-O 121.653 0.739 . . . . 63.310000000000002 109.655 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 tp -150.64 161.83 41.84 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.374 -0.973 . . . . 74.0 108.374 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -146.15 136.58 23.95 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.496 -1.298 . . . . 75.109999999999999 107.496 -169.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -137.22 136.27 37.99 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 123.889 0.876 . . . . 73.109999999999999 110.505 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.03 171.64 18.75 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.606 1.962 . . . . 60.200000000000003 108.177 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.02 153.78 50.56 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 119.031 -0.509 . . . . 73.019999999999996 109.898 169.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.795 ' CD1' HD11 ' A' ' 71' ' ' LEU 0.296 0.0 OUTLIER -67.19 -15.61 63.8 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 113.306 0.854 . . . . 73.329999999999998 113.306 177.911 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.466 ' CE2' ' HA3' ' A' ' 65' ' ' GLY . 41.6 m-85 -93.45 -0.52 56.4 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.277 0.944 . . . . 60.240000000000002 112.248 176.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.9 t -82.05 141.04 46.52 Favored Pre-proline 0 CA--C 1.534 0.36 0 O-C-N 120.592 -1.317 . . . . 63.340000000000003 110.446 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -88.78 -37.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 121.769 1.646 . . . . 74.040000000000006 112.542 -175.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -62.95 -48.09 80.4 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 124.702 1.201 . . . . 75.129999999999995 108.778 176.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 21.0 m -57.44 -30.54 65.09 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.204 -0.907 . . . . 74.030000000000001 111.089 -178.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -59.81 -56.94 15.54 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 119.612 1.096 . . . . 63.420000000000002 110.109 173.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -53.93 -42.14 68.49 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.065 -0.717 . . . . 64.099999999999994 109.065 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -69.49 -16.18 63.41 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 116.641 -1.647 . . . . 71.239999999999995 112.67 -176.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -124.17 -10.44 7.57 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 121.245 1.839 . . . . 74.310000000000002 111.9 -172.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -136.97 -11.8 1.72 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.986 1.715 . . . . 74.129999999999995 112.972 -170.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.6 t -127.24 -81.76 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 O-C-N 120.315 -1.49 . . . . 75.340000000000003 107.718 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.2 mt -56.9 -28.18 61.59 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.498 1.919 . . . . 74.209999999999994 111.67 175.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 67.9 m80 44.57 46.51 8.26 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.942 1.697 . . . . 63.329999999999998 110.918 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 46' ' ' VAL . 98.7 t -51.0 -53.78 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 C-N-CA 126.614 1.966 . . . . 61.409999999999997 108.631 -175.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.5 t -45.44 -47.95 13.78 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.644 1.978 . . . . 72.040000000000006 111.587 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.64 -18.45 27.94 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.011 -1.055 . . . . 74.420000000000002 111.835 -176.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.5 -40.94 93.64 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.208 -0.932 . . . . 54.520000000000003 109.582 167.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 42' ' ' VAL . 1.9 t -59.61 -46.39 93.23 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 N-CA-C 109.437 -0.579 . . . . 62.299999999999997 109.437 178.01 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -47.93 -44.48 30.07 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.229 1.012 . . . . 71.019999999999996 112.033 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -62.57 -10.62 12.71 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.001 1.482 . . . . 72.209999999999994 115.001 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -125.44 -9.03 6.9 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 126.925 2.09 . . . . 73.340000000000003 113.199 -174.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.597 HD13 HG21 ' A' ' 54' ' ' THR . 14.5 mt -72.33 150.43 91.83 Favored Pre-proline 0 C--O 1.234 0.269 0 CA-C-N 119.328 0.967 . . . . 63.009999999999998 111.246 -167.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -71.82 156.63 56.59 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.146 1.898 . . . . 72.329999999999998 109.402 169.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.28 28.57 0.06 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 126.007 1.723 . . . . 73.200000000000003 114.974 -174.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -154.19 21.08 0.66 Allowed Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 124.708 1.147 . . . . 21.050000000000001 112.979 -168.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.597 HG21 HD13 ' A' ' 50' ' ' LEU . 2.9 t -89.72 -45.3 9.41 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 117.887 0.843 . . . . 51.420000000000002 110.908 -177.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? 55.52 95.55 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 124.155 1.931 . . . . 74.140000000000001 110.704 -162.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.8 mtm -62.29 122.84 16.65 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 113.84 -1.527 . . . . 44.329999999999998 108.765 169.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 58' ' ' LYS . 1.3 m -123.24 179.87 4.55 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.317 -0.994 . . . . 74.019999999999996 108.317 174.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.461 ' H ' HG22 ' A' ' 57' ' ' THR . 9.8 mtpt -172.35 88.1 0.09 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 106.78 -1.563 . . . . 72.409999999999997 106.78 -171.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.516 ' CD2' ' HG3' ' A' ' 137' ' ' GLN . 4.1 m-30 -89.02 176.02 7.17 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.992 1.317 . . . . 74.120000000000005 109.299 175.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.608 ' HD1' ' HB3' ' A' ' 75' ' ' TRP . 2.1 p-80 -117.04 175.42 5.6 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.154 1.381 . . . . 75.120000000000005 110.081 174.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.8 m -131.24 175.97 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.255 1.422 . . . . 74.230000000000004 109.036 169.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.71 59.74 1.72 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.693 2.397 . . . . 72.140000000000001 111.134 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -148.33 -163.71 1.84 Allowed 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.237 1.415 . . . . 75.129999999999995 109.82 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.8 mt 75.54 -85.03 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 128.616 2.767 . . . . 61.329999999999998 109.175 -176.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.466 ' HA3' ' CE2' ' A' ' 29' ' ' TYR . . . -95.32 174.46 32.36 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 125.43 1.491 . . . . 74.049999999999997 111.452 -178.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.88 -36.63 30.39 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 124.945 3.763 . . . . 63.329999999999998 113.124 -169.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.2 mt -83.68 24.82 0.83 Allowed 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 124.332 1.053 . . . . 72.129999999999995 112.721 -174.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -46.28 -51.6 11.53 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-N 118.72 0.691 . . . . 33.340000000000003 111.81 179.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -70.76 -6.38 37.13 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.49 1.116 . . . . 64.109999999999999 113.596 -177.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -111.44 -24.57 10.09 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.257 1.423 . . . . 61.310000000000002 109.389 -177.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.795 HD11 ' CD1' ' A' ' 28' ' ' PHE . 9.5 mt -63.67 -46.97 83.12 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.912 0.885 . . . . 72.430000000000007 109.368 165.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.531 HG22 ' CD2' ' A' ' 60' ' ' HIS . 0.5 OUTLIER -50.86 -52.11 44.82 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.414 1.486 . . . . 71.150000000000006 108.75 171.879 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -62.03 -54.47 41.03 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.551 -0.718 . . . . 72.239999999999995 110.5 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.24 -33.38 73.18 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.631 1.105 . . . . 74.450000000000003 113.435 -167.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.608 ' HB3' ' HD1' ' A' ' 60' ' ' HIS . 40.5 t-105 -56.73 -38.13 71.95 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 123.1 0.56 . . . . 75.140000000000001 110.367 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.27 84.7 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 117.505 -1.236 . . . . 73.450000000000003 112.055 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.453 HG22 ' HB3' ' A' ' 124' ' ' ALA . 93.9 t -56.35 -45.22 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 121.072 1.76 . . . . 64.349999999999994 110.986 167.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.37 -45.55 90.65 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 118.094 -0.955 . . . . 74.25 111.073 -177.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 60.2 mt -62.54 -40.44 88.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 124.263 1.025 . . . . 72.310000000000002 110.207 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.85 -42.17 83.9 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.758 0.708 . . . . 71.349999999999994 110.362 -175.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.5 mt -85.18 -29.92 24.34 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 111.732 0.271 . . . . 54.439999999999998 111.732 174.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.74 52.08 3.43 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 126.183 1.849 . . . . 74.239999999999995 111.853 -175.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -127.25 21.16 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.761 1.224 . . . . 64.319999999999993 111.403 -173.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -53.05 -53.2 53.74 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 123.757 0.823 . . . . 72.019999999999996 111.074 -175.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.18 -42.7 77.54 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.224 1.409 . . . . 74.150000000000006 109.687 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.7 mtpm? -72.64 -5.23 35.95 Favored 'General case' 0 N--CA 1.46 0.066 0 C-N-CA 125.012 1.325 . . . . 60.409999999999997 112.171 -176.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.6 pp -134.1 23.3 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 C-N-CA 125.669 1.587 . . . . 74.310000000000002 109.386 173.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 99.5 m -87.53 -57.56 2.9 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.222 -1.399 . . . . 71.409999999999997 107.222 168.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.477 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -58.89 -60.15 11.44 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 112.88 0.696 . . . . 53.439999999999998 112.88 -164.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 37.5 Cg_endo -66.92 -26.61 43.94 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.288 1.325 . . . . 75.310000000000002 111.579 -177.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 5.0 ttm -64.92 -43.5 92.59 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.56 0.744 . . . . 55.549999999999997 109.258 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -69.69 -40.19 76.5 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.496 1.118 . . . . 72.109999999999999 109.473 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.12 -27.25 66.88 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.223 0.465 . . . . 61.240000000000002 111.196 172.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -97.59 3.98 50.35 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 120.361 -1.462 . . . . 71.219999999999999 113.304 -177.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.69 HG21 ' CD2' ' A' ' 28' ' ' PHE . 65.6 t -119.73 -41.23 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 124.073 0.949 . . . . 73.150000000000006 110.067 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -101.4 -51.66 3.43 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 109.404 -0.591 . . . . 41.350000000000001 109.404 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -75.35 -60.02 2.49 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.88 -0.6 . . . . 71.349999999999994 109.432 -168.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.3 p -98.1 -19.13 18.13 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.775 0.83 . . . . 62.240000000000002 112.491 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 64.95 18.51 11.53 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.869 1.668 . . . . 51.420000000000002 114.163 166.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.1 t -74.78 -17.39 60.63 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.991 1.317 . . . . 74.150000000000006 113.486 -172.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.6 t -66.84 126.58 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.555 -0.716 . . . . 64.450000000000003 109.13 167.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -146.1 -25.71 0.44 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.239 1.415 . . . . 75.049999999999997 111.075 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.1 t -143.38 175.81 9.63 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.899 0.772 . . . . 75.049999999999997 110.25 171.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.4 t -52.39 -44.82 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.932 1.693 . . . . 72.319999999999993 110.028 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -52.77 -23.72 7.39 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.712 1.605 . . . . 75.030000000000001 112.862 177.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -94.38 -24.72 17.25 Favored 'General case' 0 CA--C 1.523 -0.078 0 CA-C-N 118.972 0.806 . . . . 73.040000000000006 111.123 -178.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.4 mt -82.45 -43.28 19.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.594 -0.891 . . . . 75.349999999999994 108.594 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -55.15 -31.79 61.59 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 118.534 -0.746 . . . . 44.420000000000002 111.479 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -57.51 -61.76 2.26 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.287 1.435 . . . . 73.219999999999999 109.85 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.7 t -55.33 -40.07 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 122.767 0.427 . . . . 64.019999999999996 110.756 -175.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -53.79 -53.48 51.8 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.472 0.578 . . . . 73.239999999999995 110.65 173.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.24 -41.36 91.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 123.876 0.87 . . . . 63.130000000000003 109.99 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -67.27 -37.71 83.9 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.678 -0.86 . . . . 73.439999999999998 108.678 -170.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.3 -24.71 61.36 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.443 1.097 . . . . 62.420000000000002 112.428 175.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.57 56.47 0.35 Allowed Glycine 0 C--N 1.332 0.315 0 N-CA-C 111.242 -0.743 . . . . 64.420000000000002 111.242 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.3 t -118.98 126.36 75.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 109.087 -0.708 . . . . 72.409999999999997 109.087 166.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -54.13 128.03 29.19 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.212 -0.662 . . . . 74.450000000000003 109.212 176.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.41 -21.19 66.34 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-O 117.6 -1.667 . . . . 60.229999999999997 110.434 170.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -68.83 -37.57 79.25 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 119.875 1.838 . . . . 75.409999999999997 108.826 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.74 -45.51 28.95 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 126.08 1.752 . . . . 72.120000000000005 107.164 -171.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -55.93 -57.4 12.27 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 109.501 -0.555 . . . . 72.439999999999998 109.501 174.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -66.23 -28.8 69.01 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 119.314 -0.374 . . . . 72.040000000000006 111.145 -172.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.27 -64.05 1.1 Allowed 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.859 0.864 . . . . 71.129999999999995 110.587 174.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.453 ' HB3' HG22 ' A' ' 77' ' ' VAL . . . -54.99 -36.37 65.33 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.585 1.154 . . . . 64.150000000000006 110.572 -171.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 59.9 t-105 -45.62 -42.83 11.78 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.744 1.218 . . . . 75.120000000000005 112.57 177.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -105.71 1.25 26.98 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.639 1.176 . . . . 64.049999999999997 112.872 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.2 t -77.97 150.24 33.99 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.51 1.524 . . . . 62.25 109.805 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -56.45 -35.27 67.7 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 124.429 1.092 . . . . 63.439999999999998 111.0 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.9 t -51.53 -52.51 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 CA-C-N 118.847 0.749 . . . . 51.350000000000001 109.581 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.13 -45.61 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-N 115.942 -0.572 . . . . 72.230000000000004 110.269 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -46.22 81.98 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.342 0.657 . . . . 73.349999999999994 111.109 -176.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.4 t -67.07 -48.39 68.39 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.638 1.175 . . . . 62.210000000000001 110.371 175.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.7 mt -53.8 -50.38 66.24 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-O 117.321 -1.324 . . . . 64.019999999999996 110.029 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.8 t -48.27 -51.74 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 120.573 1.533 . . . . 62.350000000000001 109.986 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.57 -27.45 64.62 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.514 0.931 . . . . 71.319999999999993 113.514 -177.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -63.99 -32.95 74.67 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 113.774 1.027 . . . . 74.129999999999995 113.774 172.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.516 ' HG3' ' CD2' ' A' ' 59' ' ' TYR . 11.3 mp0 -89.72 -35.94 15.48 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 117.652 -1.166 . . . . 75.140000000000001 111.85 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -56.64 -51.6 68.07 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 108.041 -1.096 . . . . 63.119999999999997 108.041 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 23.9 ttpt -59.66 -16.43 26.4 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 113.765 1.024 . . . . 43.210000000000001 113.765 174.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -117.26 -1.86 11.73 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 120.486 1.494 . . . . 54.420000000000002 114.828 -174.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.07 -29.86 4.16 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 119.145 0.884 . . . . 73.209999999999994 111.038 172.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -107.67 2.04 23.56 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.789 0.836 . . . . 63.43 112.034 -170.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -63.62 -85.82 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.504 1.121 . . . . 74.299999999999997 111.255 176.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -175.56 50.0 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.032 1.733 . . . . 74.019999999999996 109.216 177.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.276 0.6 OUTLIER -143.7 -50.0 0.31 Allowed 'General case' 0 C--N 1.344 0.332 0 N-CA-C 114.071 1.138 . . . . 71.109999999999999 114.071 -178.262 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 40.5 tp -70.07 -83.1 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 119.572 1.078 . . . . 72.140000000000001 110.071 -176.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 55.15 33.52 20.67 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.618 0.767 . . . . 64.420000000000002 112.477 173.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 176.35 159.44 21.93 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.681 1.61 . . . . 74.030000000000001 109.587 170.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.407 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 9.9 m -141.69 159.03 61.49 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 119.61 1.705 . . . . 71.030000000000001 110.582 173.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.407 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 73.7 Cg_endo -74.29 161.57 94.22 Favored 'Cis proline' 0 C--N 1.349 0.572 0 CA-C-N 118.987 0.674 . . . . 63.009999999999998 112.897 -4.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -144.36 146.07 32.33 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.858 -1.065 . . . . 64.129999999999995 110.055 175.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 38.8 tpp -135.96 105.43 6.07 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 105.006 -2.22 . . . . 74.239999999999995 105.006 175.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -82.81 149.51 27.14 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.084 0.953 . . . . 75.129999999999995 109.444 175.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.8 t -140.08 145.93 25.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 108.195 -1.039 . . . . 73.340000000000003 108.195 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 50.67 24.16 1.59 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.992 2.117 . . . . 60.43 113.765 173.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 68.36 4.29 36.58 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 120.336 -1.478 . . . . 54.32 113.612 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.436 ' HE2' ' CE2' ' A' ' 158' ' ' TYR . 11.1 pttt -147.26 -6.48 0.48 Allowed 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.442 1.621 . . . . 71.209999999999994 115.183 -166.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.436 ' CE2' ' HE2' ' A' ' 157' ' ' LYS . 63.0 m-85 -124.04 162.38 23.59 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.332 0.969 . . . . 72.019999999999996 110.288 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -129.63 139.94 51.29 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.815 1.646 . . . . 64.219999999999999 106.895 165.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.89 142.34 57.94 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 107.946 -1.131 . . . . 72.299999999999997 107.946 167.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -118.67 85.52 27.41 Favored Pre-proline 0 C--O 1.235 0.333 0 C-N-CA 123.603 0.761 . . . . 74.409999999999997 111.651 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.01 -24.87 52.23 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 CA-C-N 119.544 0.873 . . . . 75.030000000000001 111.493 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.99 -8.65 39.13 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.876 1.27 . . . . 75.239999999999995 112.642 -178.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -112.9 7.9 25.57 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-O 118.519 -1.156 . . . . 75.030000000000001 112.202 176.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 59.1 mtt -98.13 158.91 15.27 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 119.351 1.576 . . . . 54.119999999999997 110.528 -176.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -66.94 109.37 2.93 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 106.524 -1.658 . . . . 60.140000000000001 106.524 170.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.16 11.91 15.34 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 128.156 2.582 . . . . 75.400000000000006 108.632 -171.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.67 -4.33 56.84 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 125.693 1.597 . . . . 54.520000000000003 113.189 -169.084 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.06 -7.28 1.38 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.783 0.833 . . . . 75.099999999999994 111.491 -168.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 8.1 mmt 65.94 -62.78 0.24 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 127.142 2.177 . . . . 75.209999999999994 112.23 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.44 -36.65 74.09 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 120.371 1.441 . . . . 61.210000000000001 109.803 -171.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 79.9 t -58.68 -37.32 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.687 1.195 . . . . 73.030000000000001 110.162 172.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -60.16 -56.52 20.56 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.674 -0.861 . . . . 75.319999999999993 108.674 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.2 t -64.93 -37.82 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 123.314 0.384 . . . . 71.030000000000001 110.536 -178.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.42 -47.67 69.39 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.542 1.137 . . . . 63.210000000000001 110.657 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -80.75 -40.25 25.54 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 118.504 -0.76 . . . . 73.409999999999997 111.882 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -50.38 -59.69 3.74 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.486 1.039 . . . . 75.030000000000001 110.2 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.27 -37.48 75.07 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.229 1.012 . . . . 75.230000000000004 111.74 -172.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -67.39 -50.4 59.78 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.912 0.885 . . . . 74.530000000000001 109.994 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.711 HG23 HG21 ' A' ' 3' ' ' ILE . 22.0 m -57.03 -29.73 63.62 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.647 1.179 . . . . 74.420000000000002 111.964 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 3.7 t -60.38 -52.79 57.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 119.396 0.998 . . . . 73.230000000000004 109.354 172.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -62.55 -27.88 69.47 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 121.499 -0.751 . . . . 71.230000000000004 112.089 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -68.92 -33.62 74.04 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 119.214 0.915 . . . . 74.409999999999997 112.528 176.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 66.1 mt -71.21 -32.86 69.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 120.159 1.345 . . . . 71.430000000000007 110.98 -177.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 99.3 t -62.36 -23.68 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.163 0.985 . . . . 60.130000000000003 112.144 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -99.0 -19.42 17.28 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.453 -0.78 . . . . 74.299999999999997 110.203 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -98.89 77.54 2.22 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 125.197 1.399 . . . . 73.530000000000001 107.398 -168.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.967 0 C-N-CA 126.923 2.089 . . . . 63.219999999999999 111.563 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.469 0.502 0 CA-C-O 117.582 -1.199 . . . . 65.040000000000006 109.512 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 70.22 166.01 0.28 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 128.388 2.675 . . . . 74.450000000000003 112.96 172.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 50.94 37.58 17.9 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.176 1.39 . . . . 74.329999999999998 112.758 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.2 116.77 0.99 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 127.004 2.121 . . . . 74.019999999999996 105.799 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.8 pt -130.72 168.66 23.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 126.51 1.924 . . . . 73.109999999999999 108.514 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.9 m -139.58 135.15 33.08 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.549 1.139 . . . . 73.049999999999997 108.954 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -60.25 111.54 1.58 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.542 2.337 . . . . 54.439999999999998 108.263 169.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 107.69 -16.1 37.34 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 126.12 1.819 . . . . 72.209999999999994 112.921 -173.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -100.63 -86.48 0.4 Allowed 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 119.411 1.606 . . . . 71.430000000000007 108.056 -174.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -87.89 -18.01 30.14 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.435 1.094 . . . . 71.140000000000001 111.303 -176.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -138.83 161.13 38.01 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.144 0.978 . . . . 72.140000000000001 109.024 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mm -127.85 160.42 37.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 105.874 -1.898 . . . . 53.420000000000002 105.874 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.6 m -81.29 152.08 27.76 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.637 -1.246 . . . . 71.219999999999999 107.637 167.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 32.8 mt -62.01 163.83 7.39 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.751 -0.463 . . . . 62.240000000000002 109.751 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -71.64 -37.4 70.85 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.648 0.779 . . . . 71.040000000000006 109.313 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.4 mmtp -140.83 78.72 19.83 Favored Pre-proline 0 CA--C 1.529 0.166 0 C-N-CA 126.005 1.722 . . . . 72.439999999999998 108.073 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.4 108.03 2.53 Favored 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.171 1.914 . . . . 75.329999999999998 107.646 172.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.7 tt -154.48 170.39 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 118.955 0.798 . . . . 62.329999999999998 109.43 173.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 65.51 -176.93 0.18 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.114 2.166 . . . . 64.049999999999997 113.827 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.2 -83.15 0.15 Allowed Glycine 0 C--N 1.34 0.795 0 N-CA-C 108.22 -1.952 . . . . 75.25 108.22 170.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.23 166.5 0.1 OUTLIER Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 125.262 1.425 . . . . 42.509999999999998 113.15 174.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -64.44 120.39 7.69 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.558 1.505 . . . . 44.240000000000002 109.558 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -61.81 -25.75 67.69 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.368 1.467 . . . . 72.049999999999997 112.268 -174.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.829 HG21 HG23 ' A' ' 54' ' ' THR . 75.1 t -145.12 140.88 22.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 126.73 2.012 . . . . 44.549999999999997 106.15 173.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 tp -156.66 161.65 39.86 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.99 1.316 . . . . 73.25 107.94 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -139.74 126.43 20.57 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 106.511 -1.662 . . . . 63.32 106.511 -163.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -128.79 127.7 42.48 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.191 0.996 . . . . 74.150000000000006 112.174 -173.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -169.67 173.96 6.04 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.371 2.269 . . . . 63.219999999999999 112.233 176.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.8 t -135.84 151.11 49.71 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.078 -1.013 . . . . 74.25 109.073 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.722 ' CD1' HD11 ' A' ' 71' ' ' LEU 0.307 0.0 OUTLIER -62.12 -19.67 63.25 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 120.599 1.545 . . . . 63.420000000000002 113.44 -175.158 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.401 ' CE2' ' HA3' ' A' ' 65' ' ' GLY . 59.3 m-85 -92.26 1.45 57.21 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 120.928 1.695 . . . . 75.049999999999997 112.506 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.4 p -75.85 141.68 72.14 Favored Pre-proline 0 C--N 1.354 0.762 0 CA-C-N 122.162 2.256 . . . . 40.420000000000002 108.547 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -89.07 -31.27 0.16 Allowed 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 121.319 1.346 . . . . 60.130000000000003 111.338 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -62.03 -40.81 96.99 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.156 -0.965 . . . . 72.450000000000003 110.957 174.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.9 p -70.43 -28.46 65.06 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-O 118.146 -0.93 . . . . 61.049999999999997 110.971 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -54.85 -56.06 23.57 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.767 1.167 . . . . 73.239999999999995 110.263 175.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -56.16 -46.88 79.13 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-O 118.514 -0.755 . . . . 74.409999999999997 109.022 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -66.64 -10.35 45.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 117.005 -1.474 . . . . 53.32 113.386 -175.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -134.25 0.46 3.1 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 120.616 1.553 . . . . 72.420000000000002 112.67 -163.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -139.58 -36.37 0.52 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 126.687 1.995 . . . . 72.129999999999995 110.765 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.3 t -102.56 -76.84 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 107.284 -1.376 . . . . 52.109999999999999 107.284 -173.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 71.7 mt -68.19 -21.73 64.86 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.432 1.493 . . . . 71.310000000000002 113.614 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 13.8 m80 44.66 58.96 3.59 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.92 1.688 . . . . 73.329999999999998 113.062 176.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 96.4 t -63.74 -41.3 92.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.976 1.311 . . . . 55.310000000000002 110.861 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.5 t -56.42 -45.03 80.9 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.477 1.49 . . . . 74.010000000000005 110.696 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.18 -37.97 78.45 Favored 'General case' 0 C--O 1.233 0.189 0 O-C-N 121.253 -0.905 . . . . 64.109999999999999 110.2 -176.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.47 -39.7 85.3 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.461 1.105 . . . . 74.349999999999994 112.299 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.1 t -60.86 -49.17 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.283 1.433 . . . . 71.140000000000001 109.254 171.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -52.57 -42.49 64.52 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 119.546 1.066 . . . . 64.329999999999998 113.66 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -57.17 -13.31 2.92 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.614 1.339 . . . . 71.230000000000004 114.614 173.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -120.74 -4.2 9.73 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.585 1.954 . . . . 54.229999999999997 112.457 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.619 HD22 HG21 ' A' ' 54' ' ' THR . 14.6 mt -70.8 144.24 90.49 Favored Pre-proline 0 C--O 1.239 0.538 0 CA-C-N 119.947 1.249 . . . . 72.319999999999993 109.791 -171.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -84.38 161.27 12.99 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 123.74 2.96 . . . . 73.340000000000003 109.825 169.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.75 40.85 0.82 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.262 1.208 . . . . 74.040000000000006 114.262 -165.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.93 -37.64 0.65 Allowed Glycine 0 CA--C 1.524 0.633 0 O-C-N 121.052 -1.03 . . . . 24.02 111.419 167.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.829 HG23 HG21 ' A' ' 22' ' ' VAL . 58.2 m -44.79 -59.09 2.69 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.404 2.282 . . . . 32.210000000000001 114.534 -163.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.2 tptt 57.87 126.72 0.01 OUTLIER 'General case' 0 C--N 1.344 0.351 0 C-N-CA 126.547 1.939 . . . . 60.130000000000003 111.469 -168.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -75.82 128.67 35.63 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.713 -0.847 . . . . 72.120000000000005 108.713 175.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.41 -177.35 3.11 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 124.171 0.988 . . . . 75.420000000000002 110.104 173.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.7 104.8 0.59 Allowed 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 106.008 -1.849 . . . . 63.229999999999997 106.008 166.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.439 ' CD2' ' HG3' ' A' ' 137' ' ' GLN . 9.5 m-30 -85.69 170.86 12.1 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.956 -1.127 . . . . 74.049999999999997 107.956 161.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.558 ' NE2' HG22 ' A' ' 72' ' ' THR . 2.1 p-80 -108.76 171.48 7.4 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.239 1.416 . . . . 72.010000000000005 108.1 176.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 60' ' ' HIS . 2.2 m -148.29 157.73 8.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 119.832 1.196 . . . . 61.329999999999998 108.99 162.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.6 -8.98 14.19 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 129.345 3.058 . . . . 72.310000000000002 111.897 -166.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -60.92 1.09 0.16 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.792 1.637 . . . . 55.509999999999998 113.528 173.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 35.6 mt -129.4 119.36 23.71 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 119.879 -1.763 . . . . 75.150000000000006 108.282 -170.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.401 ' HA3' ' CE2' ' A' ' 29' ' ' TYR . . . 76.85 166.89 25.81 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 125.508 1.528 . . . . 61.340000000000003 112.816 175.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.58 -40.42 5.62 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.754 2.303 . . . . 75.430000000000007 111.132 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 58.7 mt -72.54 16.23 0.15 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.907 0.883 . . . . 52.149999999999999 112.012 174.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -45.31 -64.33 2.32 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.369 1.461 . . . . 72.239999999999995 110.999 172.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -59.74 -33.41 71.62 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.385 1.092 . . . . 62.020000000000003 112.472 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.58 -44.53 86.38 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.873 0.869 . . . . 75.019999999999996 109.779 176.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.722 HD11 ' CD1' ' A' ' 28' ' ' PHE . 16.2 mt -58.32 -46.06 86.89 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.668 1.187 . . . . 73.319999999999993 111.476 -176.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.558 HG22 ' NE2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -46.08 -46.36 16.81 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.346 1.858 . . . . 64.329999999999998 109.477 174.542 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -76.5 -50.98 12.63 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 118.412 -0.804 . . . . 75.319999999999993 110.715 -172.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.69 -35.05 75.32 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.705 1.593 . . . . 71.040000000000006 112.662 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 28.8 t-105 -59.3 -36.9 76.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.002 0.365 . . . . 73.319999999999993 111.147 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.31 -29.0 69.12 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 112.708 0.633 . . . . 54.530000000000001 112.708 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.2 t -57.23 -52.62 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 120.244 1.384 . . . . 51.530000000000001 109.495 162.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.89 -56.94 15.44 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 118.216 -0.897 . . . . 72.319999999999993 110.753 -174.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.4 mt -52.61 -41.27 36.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.497 1.119 . . . . 71.420000000000002 110.489 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.87 -33.75 76.55 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 120.017 -0.673 . . . . 74.409999999999997 110.933 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.9 mt -86.41 -23.9 25.92 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.253 0.464 . . . . 72.310000000000002 112.253 175.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.1 69.72 1.34 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.946 1.736 . . . . 75.209999999999994 110.116 -171.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.7 m -133.52 8.3 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.464 1.105 . . . . 60.32 112.563 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -53.56 -51.84 61.65 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 125.069 1.348 . . . . 75.439999999999998 112.055 -169.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -55.31 -45.29 76.3 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.037 0.935 . . . . 71.329999999999998 109.257 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.402 ' H ' ' HG3' ' A' ' 86' ' ' LYS . 17.5 mtpt -66.17 -21.83 66.34 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.825 1.65 . . . . 60.119999999999997 111.44 -176.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.5 pp -121.6 26.77 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.579 1.551 . . . . 73.030000000000001 110.014 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 96.6 m -95.2 -48.76 5.79 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.131 0.878 . . . . 61.43 108.963 166.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.486 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -61.35 -62.31 6.18 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 119.267 0.94 . . . . 42.350000000000001 112.211 -175.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.486 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 56.6 Cg_endo -67.32 -23.69 44.34 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 121.633 1.556 . . . . 74.25 111.624 -174.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 32.8 tpp -64.16 -52.63 58.09 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.539 1.136 . . . . 75.319999999999993 109.101 174.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -69.43 -32.7 71.82 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 124.163 0.914 . . . . 65.120000000000005 110.469 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -63.2 -33.21 74.99 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 118.272 0.487 . . . . 72.010000000000005 110.39 171.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.47 -12.89 33.33 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.87 1.214 . . . . 64.340000000000003 113.403 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.667 HG21 ' CD2' ' A' ' 28' ' ' PHE . 41.4 t -100.08 -39.59 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 C-N-CA 124.184 0.994 . . . . 74.430000000000007 109.746 -178.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -111.53 -53.58 2.69 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.72 0.808 . . . . 63.439999999999998 110.044 -171.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -67.77 -60.16 2.74 Favored 'General case' 0 C--N 1.339 0.142 0 O-C-N 121.453 -0.779 . . . . 73.109999999999999 109.909 -173.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.4 p -90.56 -25.71 20.08 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.547 0.573 . . . . 71.129999999999995 112.547 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 49.44 61.46 3.13 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 128.521 2.728 . . . . 73.430000000000007 112.393 -174.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.3 t -101.7 -14.52 17.33 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.762 1.225 . . . . 72.019999999999996 113.171 174.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.499 HG13 HG12 ' A' ' 107' ' ' ILE . 25.6 t -69.96 123.46 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 119.875 1.216 . . . . 51.310000000000002 108.834 171.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -144.35 -26.61 0.52 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.42 1.088 . . . . 53.439999999999998 111.714 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.82 167.32 21.98 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.308 0.958 . . . . 74.019999999999996 108.747 174.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 43.8 t -56.2 -40.28 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 123.709 0.804 . . . . 60.119999999999997 110.68 -175.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.26 -24.99 61.22 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.674 0.79 . . . . 75.329999999999998 112.617 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -79.83 -34.09 39.73 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.16 0.891 . . . . 74.140000000000001 110.807 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.499 HG12 HG13 ' A' ' 101' ' ' VAL . 1.8 mt -75.01 -48.23 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 108.716 -0.846 . . . . 61.32 108.716 -176.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -17.14 63.75 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.289 -0.862 . . . . 72.319999999999993 111.428 -176.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -58.87 -58.12 10.03 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.61 0.764 . . . . 73.120000000000005 110.012 168.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.3 t -57.24 -38.81 63.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 123.445 0.698 . . . . 74.25 111.565 -174.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -54.51 -53.03 59.84 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.839 -0.538 . . . . 75.450000000000003 109.765 173.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 97.5 t -60.62 -46.05 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 123.717 0.807 . . . . 72.439999999999998 110.186 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -55.39 -45.67 76.59 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.832 1.253 . . . . 64.030000000000001 109.425 -176.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.91 -15.05 60.25 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.703 1.201 . . . . 72.140000000000001 113.102 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 114.18 51.5 0.47 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.487 1.042 . . . . 65.319999999999993 113.213 172.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.8 t -111.6 142.78 22.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 124.374 1.07 . . . . 73.409999999999997 108.513 168.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.7 mmtm -61.57 148.67 41.51 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.831 0.824 . . . . 72.439999999999998 110.804 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.0 -18.17 74.29 Favored Glycine 0 CA--C 1.518 0.235 0 CA-C-N 114.985 -1.007 . . . . 61.310000000000002 113.15 167.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -87.57 -36.04 17.78 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 109.326 -0.62 . . . . 63.439999999999998 109.326 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.72 -43.3 72.64 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 106.25 -1.759 . . . . 63.039999999999999 106.25 -169.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -63.18 -52.93 60.39 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 123.693 0.621 . . . . 73.030000000000001 110.202 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -71.7 -17.05 62.25 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.963 0.505 . . . . 73.030000000000001 112.297 -174.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -87.15 -63.96 1.22 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.61 1.164 . . . . 51.509999999999998 109.597 172.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.32 -34.56 66.65 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.196 0.998 . . . . 73.430000000000007 111.463 -170.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -49.47 -33.53 14.54 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.862 0.865 . . . . 73.319999999999993 112.658 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -111.27 6.51 20.6 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.584 1.553 . . . . 75.25 112.848 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 43.3 t -82.73 157.21 23.37 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.283 1.433 . . . . 72.430000000000007 111.048 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -62.21 -34.53 76.65 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.373 1.469 . . . . 74.140000000000001 111.469 172.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 72.2 t -50.41 -50.98 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 108.843 -0.799 . . . . 73.310000000000002 108.843 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 22.1 t -65.91 -44.31 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 124.369 1.067 . . . . 64.219999999999999 111.723 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.538 ' HA ' ' HE2' ' A' ' 131' ' ' LYS . 10.8 mmpt? -51.55 -52.69 45.02 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.041 0.837 . . . . 75.140000000000001 110.921 176.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.6 -34.48 77.98 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.359 1.064 . . . . 63.240000000000002 110.955 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.0 mt -63.21 -54.99 28.81 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 117.141 -1.409 . . . . 63.420000000000002 110.848 175.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 87.4 t -54.07 -39.11 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 119.819 1.191 . . . . 61.229999999999997 109.601 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.68 -22.81 66.76 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 118.188 -0.91 . . . . 73.450000000000003 113.067 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -58.1 -53.1 62.02 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 119.638 1.108 . . . . 71.439999999999998 109.35 172.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.439 ' HG3' ' CD2' ' A' ' 59' ' ' TYR . 20.9 mp0 -78.88 -30.43 45.0 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.229 -0.919 . . . . 73.25 110.113 -175.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -68.87 11.67 0.18 Allowed 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.143 -1.598 . . . . 73.439999999999998 112.81 163.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -125.24 -19.93 4.98 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 124.775 1.23 . . . . 73.150000000000006 111.925 162.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -115.07 -10.41 12.22 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 114.557 1.317 . . . . 75.010000000000005 114.557 -172.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -96.66 -38.79 9.79 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.524 1.057 . . . . 74.310000000000002 108.343 157.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.9 -28.05 69.78 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.908 1.077 . . . . 63.43 113.908 -170.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -80.71 26.87 0.39 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.656 0.984 . . . . 63.219999999999999 113.656 -169.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.5 mt 65.16 28.3 12.2 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.815 -1.178 . . . . 62.219999999999999 111.504 165.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -104.68 -20.9 13.49 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.451 1.501 . . . . 74.019999999999996 112.216 -171.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.44 HD11 ' CB ' ' A' ' 151' ' ' ALA . 1.3 tt -168.15 137.03 2.4 Favored 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 128.738 2.815 . . . . 64.319999999999993 106.864 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -140.94 5.83 1.96 Allowed 'General case' 0 CA--C 1.546 0.802 0 O-C-N 124.017 0.823 . . . . 53.32 111.121 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -143.55 152.22 23.94 Favored Glycine 0 C--N 1.343 0.966 0 CA-C-N 119.624 1.102 . . . . 72.349999999999994 110.903 172.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.524 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 35.7 m -132.83 174.84 4.24 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 125.818 1.647 . . . . 75.019999999999996 110.717 -170.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.524 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 15.8 Cg_endo -61.98 152.04 61.76 Favored 'Cis proline' 0 C--N 1.352 0.746 0 CA-C-N 121.475 1.562 . . . . 73.049999999999997 112.165 -10.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.44 ' CB ' HD11 ' A' ' 146' ' ' LEU . . . -152.65 152.66 32.02 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.587 0.554 . . . . 63.140000000000001 111.111 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 77.1 mmm -151.78 121.51 6.99 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.673 1.189 . . . . 64.340000000000003 107.813 -167.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 12.0 m-30 -100.02 152.8 19.79 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.005 0.922 . . . . 54.409999999999997 110.361 -172.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.4 t -139.87 151.76 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.566 0.746 . . . . 72.25 110.202 174.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 44.88 24.12 0.1 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 129.273 3.029 . . . . 52.520000000000003 114.494 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 53.03 24.67 21.5 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.194 -0.941 . . . . 74.409999999999997 112.996 -173.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.584 ' HE2' ' CE2' ' A' ' 158' ' ' TYR . 9.3 pttt -150.24 -3.55 0.36 Allowed 'General case' 0 C--N 1.344 0.335 0 N-CA-C 114.527 1.306 . . . . 74.120000000000005 114.527 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.584 ' CE2' ' HE2' ' A' ' 157' ' ' LYS . 49.8 m-85 -126.59 159.93 32.1 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 124.73 1.212 . . . . 64.420000000000002 110.953 -176.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -126.22 149.2 49.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.654 1.982 . . . . 43.219999999999999 107.044 170.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.568 HD11 HG23 ' A' ' 180' ' ' THR . 2.2 mm? -74.47 154.26 38.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.995 -0.742 . . . . 63.039999999999999 108.995 167.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -125.18 80.61 64.41 Favored Pre-proline 0 C--O 1.232 0.18 0 C-N-CA 123.353 0.661 . . . . 63.439999999999998 110.808 177.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.36 -4.84 10.09 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 121.986 1.791 . . . . 72.040000000000006 113.212 175.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -86.82 -2.66 58.74 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.16 1.384 . . . . 71.430000000000007 113.127 173.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -132.47 46.16 1.08 Allowed Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 109.584 -1.406 . . . . 63.149999999999999 109.584 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 36.6 mtt -130.97 174.97 9.47 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 118.172 0.986 . . . . 72.319999999999993 111.851 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.32 90.35 4.97 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.945 -1.131 . . . . 73.129999999999995 107.945 174.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.344 6.4 t -118.53 48.13 1.5 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.78 1.232 . . . . 73.120000000000005 107.965 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.6 m -84.16 -47.79 10.49 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.074 -0.966 . . . . 74.109999999999999 110.338 159.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.05 -9.9 13.52 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 117.962 -1.018 . . . . 70.239999999999995 113.065 -162.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 33.6 mmm 75.47 -53.94 0.64 Allowed 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 126.451 1.901 . . . . 72.319999999999993 112.705 170.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.22 -31.35 72.48 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.656 1.116 . . . . 72.150000000000006 109.512 176.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 89.0 t -80.68 -25.04 11.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.65 1.58 . . . . 64.040000000000006 111.8 175.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -63.54 -58.06 8.2 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.014 -1.476 . . . . 73.049999999999997 107.014 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 14.3 t -61.83 -38.88 81.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 122.999 0.52 . . . . 73.019999999999996 110.195 -174.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.71 -46.06 70.65 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.437 1.095 . . . . 51.32 110.754 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -83.75 -31.29 26.06 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.165 0.986 . . . . 65.150000000000006 112.493 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -54.61 -54.8 36.67 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.227 -0.921 . . . . 64.239999999999995 109.242 175.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.96 -27.63 66.97 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.084 0.772 . . . . 62.109999999999999 113.084 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.2 -54.85 14.93 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.632 1.173 . . . . 64.239999999999995 110.614 177.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.568 HG23 HD11 ' A' ' 160' ' ' LEU . 13.6 t -62.21 -30.91 71.41 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 118.553 -0.737 . . . . 73.25 110.615 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 94.8 t -59.66 -51.81 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.519 -0.919 . . . . 54.240000000000002 108.519 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -62.0 -47.63 83.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.181 0.593 . . . . 75.25 109.8 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -58.29 -37.23 74.62 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 118.638 0.654 . . . . 75.439999999999998 111.932 -172.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 72.0 mt -65.51 -28.72 69.39 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.45 -0.781 . . . . 72.319999999999993 112.192 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.21 -22.55 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.403 0.681 . . . . 72.230000000000004 111.646 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -98.87 -16.47 18.82 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.652 0.66 . . . . 75.129999999999995 110.509 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -93.15 13.66 20.36 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.708 1.373 . . . . 75.409999999999997 114.708 -170.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 35.1 mttt . . . . . 0 C--O 1.246 0.898 0 C-N-CA 127.933 2.493 . . . . 64.310000000000002 113.886 -175.611 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.467 0.383 0 N-CA-C 109.408 -0.59 . . . . 61.240000000000002 109.408 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 75.79 -10.18 1.31 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 128.865 2.866 . . . . 53.32 113.697 165.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -76.31 48.74 0.54 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.86 2.064 . . . . 64.409999999999997 112.195 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -156.24 118.22 3.98 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.902 -1.148 . . . . 62.210000000000001 107.902 164.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.4 pt -115.63 164.62 11.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 126.217 1.807 . . . . 71.549999999999997 108.604 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.2 m -137.55 139.41 40.44 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.079 -1.823 . . . . 63.329999999999998 106.079 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -55.08 138.66 43.71 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.149 1.78 . . . . 72.340000000000003 109.739 167.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.45 -25.71 3.23 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.445 1.498 . . . . 41.340000000000003 113.41 -171.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -91.8 -77.35 0.43 Allowed 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 119.211 1.506 . . . . 65.420000000000002 107.227 -165.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -97.4 -15.38 20.7 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.543 0.737 . . . . 54.25 111.166 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -142.95 160.69 39.86 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.34 0.656 . . . . 75.319999999999993 110.246 173.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.3 mm -123.8 157.2 30.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 106.818 -1.549 . . . . 65.430000000000007 106.818 172.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.9 m -101.79 152.9 20.33 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.199 1.4 . . . . 75.519999999999996 107.633 174.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.3 mt -91.27 148.83 22.07 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 106.705 -1.591 . . . . 73.549999999999997 106.705 169.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -72.58 -34.43 67.45 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.128 1.371 . . . . 71.129999999999995 109.765 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.9 mmtm -125.68 82.31 63.91 Favored Pre-proline 0 C--O 1.232 0.136 0 C-N-CA 126.7 2.0 . . . . 73.120000000000005 108.166 175.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.51 86.63 1.45 Allowed 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 123.645 2.897 . . . . 71.519999999999996 107.844 168.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 15.7 tt -157.86 141.16 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 O-C-N 121.055 -1.028 . . . . 51.439999999999998 109.1 173.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 50.65 -173.69 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.657 1.983 . . . . 61.530000000000001 114.026 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.89 121.93 1.71 Allowed Glycine 0 CA--C 1.52 0.399 0 N-CA-C 109.997 -1.241 . . . . 54.130000000000003 109.997 -175.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 60.74 166.39 0.09 OUTLIER Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 126.147 1.779 . . . . 61.140000000000001 115.527 166.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -67.61 64.68 0.83 Allowed 'Trans proline' 0 CA--C 1.55 1.311 0 C-N-CA 123.768 2.979 . . . . 45.530000000000001 113.696 175.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 54.06 -28.64 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.799 1 C-N-CA 132.85 4.46 . . . . 62.340000000000003 118.442 174.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.7 p -151.91 147.72 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 122.3 2.318 . . . . 65.430000000000007 110.008 165.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.416 HD21 ' CD2' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -172.14 164.53 6.06 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.274 1.03 . . . . 64.430000000000007 110.536 -167.454 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -123.46 158.94 30.09 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.903 1.281 . . . . 54.130000000000003 109.435 173.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -142.04 134.18 27.59 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.731 1.613 . . . . 73.519999999999996 113.221 174.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -139.69 177.77 7.71 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.352 1.461 . . . . 52.509999999999998 111.125 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.9 t -136.61 162.33 33.42 Favored 'General case' 0 CA--C 1.527 0.09 0 N-CA-C 109.457 -0.571 . . . . 62.43 109.457 157.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.784 ' CD1' HD11 ' A' ' 71' ' ' LEU 0.257 0.0 OUTLIER -71.59 -20.14 62.04 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.502 -0.749 . . . . 63.119999999999997 112.834 171.232 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -89.03 -9.21 52.12 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 117.724 -1.131 . . . . 75.409999999999997 112.725 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.7 p -84.63 142.27 39.63 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 121.416 1.916 . . . . 40.219999999999999 110.284 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -91.72 -31.23 0.1 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 121.384 1.389 . . . . 75.109999999999999 112.395 -170.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -58.54 -44.02 89.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.143 -0.688 . . . . 74.409999999999997 109.143 169.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 25.7 m -55.62 -39.95 71.49 Favored 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 123.979 0.912 . . . . 74.519999999999996 110.742 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -52.47 -60.83 2.76 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 119.523 1.056 . . . . 64.239999999999995 109.813 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -54.54 -41.8 70.16 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 119.026 -0.511 . . . . 62.329999999999998 109.755 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -68.89 -24.41 64.31 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 118.347 -0.835 . . . . 71.519999999999996 112.526 -174.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -116.24 -3.82 11.95 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.689 0.677 . . . . 72.310000000000002 111.635 -167.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -138.38 -35.07 0.61 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.879 1.672 . . . . 60.119999999999997 114.016 -168.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 86.8 t -111.05 -78.79 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 N-CA-C 105.458 -2.053 . . . . 75.519999999999996 105.458 -172.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.6 mt -57.4 -29.15 63.87 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.48 1.912 . . . . 75.120000000000005 111.159 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 44.1 54.89 5.72 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.005 1.722 . . . . 72.430000000000007 110.23 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.543 ' O ' HG23 ' A' ' 46' ' ' VAL . 97.4 t -53.38 -51.47 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 126.099 1.76 . . . . 43.240000000000002 107.898 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.9 t -44.09 -53.2 6.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.669 1.987 . . . . 54.119999999999997 111.404 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -76.64 -30.29 56.78 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.462 0.649 . . . . 74.519999999999996 111.332 -173.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -72.86 -37.39 67.39 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.318 -0.864 . . . . 60.229999999999997 111.78 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 42' ' ' VAL . 1.9 t -60.68 -49.97 82.33 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 N-CA-C 107.93 -1.137 . . . . 72.450000000000003 107.93 173.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -47.62 -45.49 27.72 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 124.588 1.155 . . . . 73.239999999999995 112.335 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -63.6 -5.14 3.53 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 115.468 1.655 . . . . 75.310000000000002 115.468 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -123.4 -10.26 7.98 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.351 2.26 . . . . 60.43 113.03 174.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.453 HD13 HG21 ' A' ' 54' ' ' THR . 13.6 mt -73.17 145.39 85.81 Favored Pre-proline 0 C--O 1.238 0.478 0 CA-C-N 120.109 1.322 . . . . 44.530000000000001 112.306 -163.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.76 160.49 31.04 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 124.49 3.46 . . . . 63.130000000000003 112.348 175.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -76.97 45.44 0.43 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.541 1.936 . . . . 62.130000000000003 112.451 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -155.54 -6.59 0.08 OUTLIER Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.329 1.443 . . . . 73.310000000000002 113.523 175.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.453 HG21 HD13 ' A' ' 50' ' ' LEU . 14.2 t -56.4 -43.63 79.49 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.496 1.648 . . . . 74.150000000000006 112.092 174.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.8 tptt 44.66 90.94 0.01 OUTLIER 'General case' 0 C--N 1.346 0.417 0 C-N-CA 126.305 1.842 . . . . 73.219999999999999 110.196 -165.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.33 105.57 0.3 Allowed 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 127.342 2.257 . . . . 73.209999999999994 108.945 -175.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.0 m -143.36 115.3 8.29 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 107.138 -1.43 . . . . 72.129999999999995 107.138 -172.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.72 137.55 54.34 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.857 1.263 . . . . 61.109999999999999 108.459 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.462 ' CG ' ' HG2' ' A' ' 137' ' ' GLN . 17.1 m-30 -104.86 -174.94 2.65 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.936 1.694 . . . . 73.430000000000007 108.744 173.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -139.99 133.34 29.92 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.073 1.349 . . . . 63.329999999999998 107.644 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.3 m -85.99 170.77 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 119.096 0.862 . . . . 74.510000000000005 112.254 -172.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.11 0.77 9.11 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.888 2.075 . . . . 73.120000000000005 112.558 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -71.32 -34.26 70.4 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.253 1.021 . . . . 52.119999999999997 112.638 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 mt -91.91 126.44 36.99 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.372 -0.973 . . . . 73.540000000000006 108.372 -171.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.25 167.52 33.85 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 115.336 -0.847 . . . . 61.329999999999998 112.829 168.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -66.66 -48.19 2.33 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 124.424 3.416 . . . . 65.319999999999993 109.604 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.5 mt -73.22 13.62 0.41 Allowed 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 127.2 2.2 . . . . 73.519999999999996 112.514 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -50.48 -46.99 45.44 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 119.823 1.192 . . . . 55.030000000000001 111.697 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.1 tptp -71.42 -36.52 71.33 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.401 1.101 . . . . 75.310000000000002 111.414 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -63.83 -33.41 75.61 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.58 0.627 . . . . 72.120000000000005 110.189 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.784 HD11 ' CD1' ' A' ' 28' ' ' PHE . 15.1 mt -62.13 -49.66 74.99 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 118.416 -0.802 . . . . 51.140000000000001 113.038 175.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.5 m -57.2 -45.29 83.9 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.795 -1.187 . . . . 33.310000000000002 107.795 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -57.36 -47.3 82.0 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.189 0.904 . . . . 65.219999999999999 110.527 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.09 -41.11 82.77 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.949 1.249 . . . . 75.340000000000003 112.862 176.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 35.6 t-105 -57.93 -38.89 76.76 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.654 0.782 . . . . 74.239999999999995 110.681 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.69 -40.78 80.23 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 117.504 -1.236 . . . . 52.329999999999998 113.487 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.0 -43.47 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 120.532 1.514 . . . . 75.109999999999999 108.783 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.12 -43.31 87.54 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 118.255 -0.878 . . . . 72.519999999999996 111.545 -175.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 59.2 mt -63.02 -46.34 96.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.03 0.932 . . . . 71.219999999999999 109.634 172.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.21 -24.4 63.1 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.691 0.678 . . . . 71.129999999999995 111.477 -174.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.1 mt -107.17 -16.65 14.36 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 113.916 1.08 . . . . 53.439999999999998 113.916 176.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.56 69.96 1.16 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.285 0.945 . . . . 32.310000000000002 110.792 -166.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.4 m -135.61 13.5 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.753 1.221 . . . . 62.530000000000001 112.285 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -50.06 -50.78 46.75 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 125.563 1.545 . . . . 73.209999999999994 111.77 -173.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.78 -37.93 89.26 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.319 0.647 . . . . 64.230000000000004 110.221 -178.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -65.23 -43.68 90.68 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.17 0.509 . . . . 64.219999999999999 110.0 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.8 pp -92.44 17.33 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 C-N-CA 124.803 1.241 . . . . 62.350000000000001 111.633 -175.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 38.9 m -88.36 -48.12 7.88 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.032 0.833 . . . . 74.409999999999997 110.019 169.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.509 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -56.79 -60.85 8.18 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 113.907 1.077 . . . . 60.119999999999997 113.907 -169.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 30.2 Cg_endo -68.43 -25.74 35.32 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.299 1.332 . . . . 73.109999999999999 111.643 -178.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 20.2 tpp -65.25 -50.63 65.05 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 124.89 1.276 . . . . 72.540000000000006 110.826 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -69.64 -30.57 68.31 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.852 -0.796 . . . . 71.319999999999993 108.852 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -57.8 -46.97 83.87 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 118.648 0.658 . . . . 75.329999999999998 110.332 167.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.41 2.81 23.54 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 120.538 -1.351 . . . . 65.120000000000005 113.014 -174.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.739 HG21 ' CD2' ' A' ' 28' ' ' PHE . 38.8 t -123.59 -39.44 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 125.026 1.331 . . . . 62.32 110.826 -173.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -107.75 -47.59 3.57 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.12 -0.696 . . . . 71.25 109.12 -175.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -77.3 -52.42 9.21 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.24 0.616 . . . . 71.120000000000005 110.703 -171.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.5 p -103.86 -24.59 13.27 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.536 1.134 . . . . 53.409999999999997 112.18 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 57.31 26.12 12.0 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.58 2.352 . . . . 64.239999999999995 114.552 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.3 t -68.36 -20.58 64.72 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.937 0.718 . . . . 51.329999999999998 112.937 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.427 HG11 ' CZ ' ' A' ' 28' ' ' PHE . 25.1 t -67.43 123.71 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 O-C-N 120.87 -1.144 . . . . 54.509999999999998 109.444 173.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -145.84 -25.06 0.46 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.712 1.605 . . . . 75.510000000000005 111.326 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.17 164.93 26.56 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.793 -0.817 . . . . 74.450000000000003 108.793 176.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 25.3 t -55.07 -40.89 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.227 1.011 . . . . 73.25 109.432 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.16 8.48 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.539 1.935 . . . . 63.43 114.885 173.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -113.69 -46.9 3.01 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 125.045 1.338 . . . . 61.530000000000001 109.117 168.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.3 mt -59.01 -37.56 68.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 123.55 0.74 . . . . 64.420000000000002 110.356 -177.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.0 -19.59 64.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 117.54 -1.219 . . . . 72.540000000000006 112.845 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -57.6 -58.37 8.62 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 119.703 1.138 . . . . 74.310000000000002 110.024 164.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 55.2 t -57.13 -37.31 54.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 122.564 0.345 . . . . 60.310000000000002 111.732 -167.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -50.98 -56.81 10.61 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.417 -0.586 . . . . 65.25 109.417 171.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 39.8 t -64.57 -38.06 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 123.952 0.901 . . . . 74.120000000000005 110.699 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.66 -42.96 98.09 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.499 0.719 . . . . 73.209999999999994 109.511 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.48 2.89 12.49 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.353 1.461 . . . . 43.329999999999998 112.478 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.58 61.95 1.66 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 125.06 1.314 . . . . 53.049999999999997 111.468 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 77.7 t -119.57 145.43 25.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 123.273 0.629 . . . . 54.409999999999997 109.935 169.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -62.02 118.61 7.52 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.671 1.189 . . . . 74.25 108.661 169.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.61 -28.71 70.24 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-O 118.3 -1.278 . . . . 73.329999999999998 111.677 166.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -73.05 -25.64 61.0 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 118.93 1.365 . . . . 52.450000000000003 109.59 -177.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.03 -39.55 29.66 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.075 0.95 . . . . 73.310000000000002 109.393 176.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -64.5 -59.61 4.12 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.266 -1.383 . . . . 74.329999999999998 107.266 -177.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -60.68 -28.54 68.69 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.661 1.184 . . . . 42.350000000000001 110.302 -175.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -80.56 -64.43 1.19 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.473 -0.565 . . . . 73.450000000000003 109.473 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.91 -40.05 69.45 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 117.494 -1.241 . . . . 74.519999999999996 110.325 -172.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 46.0 t-105 -47.54 -37.6 12.47 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 124.503 1.121 . . . . 75.230000000000004 112.76 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -105.16 -5.03 21.1 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.579 1.152 . . . . 73.329999999999998 111.219 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 10.9 t -88.59 149.69 23.44 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.29 1.836 . . . . 55.030000000000001 109.753 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -50.24 -34.02 21.59 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.138 1.775 . . . . 73.150000000000006 111.622 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 76.7 t -45.49 -59.64 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 125.838 1.655 . . . . 44.219999999999999 109.461 176.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 134' ' ' VAL . 18.3 t -64.69 -46.04 93.46 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.682 0 CA-C-O 117.788 -1.101 . . . . 62.32 109.164 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -50.27 -50.33 50.64 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 120.247 1.385 . . . . 73.439999999999998 110.719 -177.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.4 t -69.73 -35.62 75.17 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 118.184 -0.912 . . . . 55.130000000000003 109.94 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.497 ' HA ' ' HG2' ' A' ' 136' ' ' GLN . 66.0 mt -64.51 -37.23 86.83 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 119.453 1.024 . . . . 73.239999999999995 112.225 177.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 130' ' ' VAL . 42.7 t -56.06 -49.18 77.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 N-CA-C 107.908 -1.145 . . . . 63.25 107.908 173.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.92 -49.89 70.18 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.308 0.503 . . . . 42.530000000000001 111.641 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.497 ' HG2' ' HA ' ' A' ' 133' ' ' LEU . 1.4 pt20 -58.76 -34.32 71.28 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 123.498 0.499 . . . . 75.239999999999995 111.82 -173.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.462 ' HG2' ' CG ' ' A' ' 59' ' ' TYR . 23.6 mt-30 -89.9 -48.12 7.43 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 126.391 1.877 . . . . 45.340000000000003 111.129 -173.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -62.66 -46.36 88.56 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.2 1.0 . . . . 74.430000000000007 109.159 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -58.72 -46.18 87.94 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.796 -0.816 . . . . 74.150000000000006 108.796 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.63 -9.06 16.88 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.586 0.958 . . . . 51.32 113.586 -174.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.67 5.44 10.55 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 120.755 1.616 . . . . 73.510000000000005 112.942 174.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.5 -3.41 5.45 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.01 0.924 . . . . 75.230000000000004 112.489 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -56.05 -85.68 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.922 2.489 . . . . 72.340000000000003 109.978 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.1 pp 179.18 41.49 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.062 1.745 . . . . 75.310000000000002 110.873 176.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -133.56 -45.27 0.82 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.254 1.205 . . . . 72.530000000000001 114.254 -172.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 16.1 tp -85.11 -85.3 0.14 Allowed 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 125.347 1.459 . . . . 72.530000000000001 109.746 -166.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 56.72 33.51 23.03 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.202 0.601 . . . . 73.329999999999998 111.628 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 178.31 155.81 15.27 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.856 1.693 . . . . 60.549999999999997 110.965 174.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 16.2 m -149.06 161.78 31.24 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 124.693 1.197 . . . . 74.209999999999994 108.931 175.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -65.14 141.12 46.56 Favored 'Cis proline' 0 C--N 1.35 0.626 0 CA-C-N 120.227 1.117 . . . . 64.230000000000004 112.504 -8.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -131.2 142.8 50.24 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.764 -1.107 . . . . 65.319999999999993 109.625 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 50.8 mtp -148.23 113.99 5.72 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 102.469 -3.16 . . . . 74.540000000000006 102.469 -176.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -100.95 165.66 11.22 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.4 0.68 . . . . 52.409999999999997 109.387 -175.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.6 t -138.07 133.44 44.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.667 0.746 . . . . 71.420000000000002 110.668 172.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 44.9 30.84 0.6 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 130.754 3.621 . . . . 60.340000000000003 115.417 171.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 64.59 34.41 89.82 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 124.823 1.202 . . . . 54.119999999999997 111.395 177.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.444 ' HG3' ' CE2' ' A' ' 158' ' ' TYR . 9.7 ptmt -160.52 -10.4 0.05 OUTLIER 'General case' 0 C--N 1.345 0.389 0 N-CA-C 116.742 2.126 . . . . 74.420000000000002 116.742 177.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.444 ' CE2' ' HG3' ' A' ' 157' ' ' LYS . 60.2 m-85 -128.89 160.88 31.24 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 120.376 1.444 . . . . 73.430000000000007 110.598 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -136.01 131.77 35.42 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 105.694 -1.965 . . . . 43.219999999999999 105.694 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.57 145.89 55.52 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.718 -1.216 . . . . 52.409999999999997 107.718 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -115.13 85.58 12.66 Favored Pre-proline 0 CA--C 1.522 -0.134 0 N-CA-C 113.034 0.753 . . . . 51.140000000000001 113.034 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -61.92 -24.19 76.74 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 CA-C-N 119.659 0.914 . . . . 72.349999999999994 112.059 173.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.28 2.58 27.44 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.139 1.376 . . . . 72.140000000000001 112.398 -170.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -130.24 22.02 4.8 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.229 1.395 . . . . 74.129999999999995 110.423 175.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 63.3 mtt -106.42 169.82 8.29 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 117.932 0.866 . . . . 73.409999999999997 110.335 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.2 63.82 7.39 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 124.626 2.155 . . . . 72.530000000000001 109.98 -174.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.6 p -73.65 32.51 0.08 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 129.376 3.07 . . . . 65.209999999999994 111.393 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.8 m -117.04 -3.02 11.61 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.031 1.732 . . . . 73.219999999999999 112.053 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.43 -9.67 2.87 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-O 117.678 -1.153 . . . . 53.109999999999999 111.744 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 13.2 mmt 65.49 -52.53 0.36 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 127.671 2.388 . . . . 61.530000000000001 115.282 172.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.38 -44.35 62.67 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.153 -1.425 . . . . 63.140000000000001 107.153 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 97.1 t -59.05 -39.14 77.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 124.02 0.928 . . . . 60.420000000000002 110.423 174.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -56.44 -59.78 4.48 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.838 -0.601 . . . . 73.25 109.736 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 20.2 t -66.54 -38.18 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 118.793 0.724 . . . . 72.349999999999994 110.807 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.46 -40.22 62.01 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.104 0.562 . . . . 75.530000000000001 110.903 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -86.37 -35.96 19.48 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 117.95 -1.024 . . . . 53.149999999999999 112.548 174.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -52.01 -60.85 2.71 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 121.039 1.745 . . . . 74.349999999999994 110.233 176.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -53.8 -35.27 61.19 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.459 1.104 . . . . 33.439999999999998 111.803 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -71.73 -48.52 46.51 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.505 1.122 . . . . 74.140000000000001 111.376 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.9 t -62.08 -31.09 71.48 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 117.071 -1.442 . . . . 52.43 109.782 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 30.7 t -58.56 -58.42 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 120.105 1.32 . . . . 71.329999999999998 108.929 171.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.96 -11.85 61.2 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 114.135 1.161 . . . . 74.25 114.135 -172.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -87.75 -33.11 18.8 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 123.972 0.909 . . . . 73.140000000000001 112.625 166.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 28.7 mt -66.51 -30.78 71.18 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 119.816 -1.803 . . . . 31.23 111.408 -177.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 69.3 t -61.89 -23.46 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.377 0.671 . . . . 73.239999999999995 112.549 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -101.25 -14.05 17.83 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 120.983 -1.073 . . . . 73.150000000000006 110.47 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -104.8 70.76 0.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 105.237 -2.134 . . . . 64.230000000000004 105.237 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? . . . . . 0 CA--C 1.508 -0.672 0 N-CA-C 103.162 -2.903 . . . . 75.439999999999998 103.162 170.466 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.468 0.43 0 N-CA-C 109.058 -0.719 . . . . 72.120000000000005 109.058 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -127.17 178.54 5.96 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.655 1.982 . . . . 64.140000000000001 107.032 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 56.57 25.07 9.44 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.415 1.886 . . . . 64.0 115.703 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -161.1 107.36 1.42 Allowed 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.693 1.597 . . . . 72.099999999999994 108.917 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.504 HD12 ' CE1' ' A' ' 9' ' ' TYR . 10.1 pt -111.68 170.87 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.604 1.562 . . . . 73.230000000000004 109.609 177.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.9 m -140.52 139.3 35.04 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 106.606 -1.627 . . . . 65.209999999999994 106.606 177.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -61.55 118.64 7.3 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.508 2.323 . . . . 72.019999999999996 109.102 172.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.01 -18.66 56.48 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.328 1.918 . . . . 71.420000000000002 112.404 -174.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -89.72 -84.8 0.22 Allowed 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.822 1.311 . . . . 63.020000000000003 108.725 -171.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -92.14 -10.91 37.12 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.449 1.1 . . . . 72.430000000000007 111.469 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.504 ' CE1' HD12 ' A' ' 3' ' ' ILE . 22.8 p90 -140.08 164.37 30.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.413 -0.803 . . . . 71.340000000000003 109.424 171.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.6 mm -125.12 161.22 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.383 1.473 . . . . 71.319999999999993 107.032 169.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -94.74 171.61 8.68 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.562 1.545 . . . . 54.420000000000002 108.737 174.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 50.5 mt -117.2 148.63 41.45 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.543 1.137 . . . . 63.229999999999997 109.902 162.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -75.21 -43.02 54.22 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.836 2.054 . . . . 70.239999999999995 109.062 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.4 mmtm -119.0 84.51 26.6 Favored Pre-proline 0 N--CA 1.454 -0.246 0 C-N-CA 126.76 2.024 . . . . 71.239999999999995 107.237 175.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -81.76 -6.73 12.47 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 124.717 3.611 . . . . 74.129999999999995 113.424 174.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.1 tt -150.94 116.4 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.455 0 O-C-N 121.063 -1.023 . . . . 72.230000000000004 108.552 -166.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -151.68 -43.28 0.11 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.666 1.186 . . . . 52.119999999999997 110.414 170.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.11 -21.67 0.02 OUTLIER Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.677 -1.068 . . . . 64.239999999999995 115.015 175.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -71.74 162.23 74.32 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-N 119.065 1.432 . . . . 54.340000000000003 112.864 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -78.36 -174.99 2.48 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.476 2.784 . . . . 72.329999999999998 111.113 175.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -114.44 158.48 21.51 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.616 1.166 . . . . 72.409999999999997 109.978 -175.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.31 3.5 p 51.41 91.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 129.896 3.278 . . . . 45.409999999999997 111.533 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.0 tp -140.96 142.3 34.35 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 113.61 -1.632 . . . . 72.120000000000005 108.224 -169.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -125.65 167.83 14.56 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 126.357 1.863 . . . . 65.200000000000003 108.448 -175.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.867 ' CE1' HG13 ' A' ' 149' ' ' VAL . 1.4 t80 -164.69 128.27 2.43 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 113.882 -1.508 . . . . 62.020000000000003 110.13 -167.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.6 ' HA ' HG11 ' A' ' 149' ' ' VAL . 27.8 m-85 -149.82 160.34 43.64 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 129.396 3.079 . . . . 65.120000000000005 109.719 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 t -124.0 159.1 30.56 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.8 -0.815 . . . . 73.099999999999994 108.8 164.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -77.17 -23.05 51.62 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.363 -0.836 . . . . 74.230000000000004 111.255 176.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.462 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 49.8 m-85 -102.06 5.29 40.44 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.076 1.35 . . . . 72.25 114.225 -178.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 11.2 p -91.51 145.0 30.46 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 120.683 1.583 . . . . 50.219999999999999 112.646 -173.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.08 165.76 31.22 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.375 2.05 . . . . 74.439999999999998 109.191 172.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.0 m80 69.04 -48.28 0.58 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 127.057 2.143 . . . . 73.420000000000002 110.243 -169.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 39.2 m -50.63 -43.2 56.89 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.969 1.708 . . . . 73.0 111.845 -176.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -51.12 -58.05 7.12 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.624 0.77 . . . . 70.409999999999997 111.29 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -56.74 -45.3 82.05 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.193 -1.04 . . . . 62.399999999999999 108.193 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -62.55 -22.54 66.41 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 117.27 -1.348 . . . . 70.310000000000002 113.009 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -120.67 -0.45 10.22 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 121.259 1.845 . . . . 72.019999999999996 112.87 -169.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -142.71 -26.4 0.61 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.031 0.933 . . . . 74.230000000000004 112.909 -173.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 54.2 t -115.23 -69.81 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 108.035 -1.098 . . . . 74.200000000000003 108.035 -173.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.6 mt -66.07 -26.4 67.47 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.233 1.013 . . . . 73.030000000000001 110.622 173.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 44.35 53.21 6.96 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.725 1.61 . . . . 74.019999999999996 111.924 173.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 46' ' ' VAL . 77.2 t -58.13 -52.0 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 114.876 -1.057 . . . . 65.120000000000005 110.743 -166.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 p -58.5 -38.49 77.76 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 119.359 0.981 . . . . 65.420000000000002 111.681 -167.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -74.34 -36.95 63.67 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.215 0.606 . . . . 63.229999999999997 110.665 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -60.36 -45.04 94.9 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.841 -0.537 . . . . 44.299999999999997 110.182 169.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 42' ' ' VAL . 2.2 t -61.8 -50.39 80.4 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 CA-C-N 118.651 0.659 . . . . 73.209999999999994 109.32 175.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -51.11 -43.61 61.14 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 126.606 1.962 . . . . 75.030000000000001 111.201 -176.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -59.62 -20.05 53.29 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 114.156 1.169 . . . . 75.129999999999995 114.156 175.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -115.77 -6.52 12.11 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.35 1.46 . . . . 74.0 112.038 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.61 HD13 HG21 ' A' ' 54' ' ' THR . 11.2 mt -70.62 144.11 90.82 Favored Pre-proline 0 C--O 1.239 0.522 0 CA-C-N 119.385 0.993 . . . . 72.0 109.792 -168.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.25 152.46 30.82 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.155 2.57 . . . . 73.019999999999996 109.668 174.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.268 1.6 pt-20 -81.22 87.43 6.1 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 123.859 1.79 . . . . 73.239999999999995 109.715 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.37 -7.58 0.36 Allowed Glycine 0 C--O 1.221 -0.66 0 CA-C-N 114.792 -1.094 . . . . 61.420000000000002 111.606 -174.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.61 HG21 HD13 ' A' ' 50' ' ' LEU . 15.2 t -58.52 -59.66 5.02 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.515 1.657 . . . . 72.230000000000004 109.48 166.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.421 ' N ' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER 50.14 86.64 0.03 OUTLIER 'General case' 0 C--N 1.346 0.448 0 C-N-CA 126.175 1.79 . . . . 74.340000000000003 109.685 -169.611 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 13.7 ptp -64.18 173.28 2.02 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 112.248 -2.251 . . . . 61.420000000000002 111.039 175.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.525 HG22 ' H ' ' A' ' 58' ' ' LYS . 1.5 m -144.57 -170.33 3.36 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.118 1.767 . . . . 71.099999999999994 108.95 177.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.525 ' H ' HG22 ' A' ' 57' ' ' THR . 25.3 tttt -176.81 103.51 0.06 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.759 2.023 . . . . 71.109999999999999 108.77 -172.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -114.76 111.0 20.57 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 121.008 1.731 . . . . 70.319999999999993 108.982 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.526 ' HB2' ' CG ' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -80.7 150.39 29.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 118.813 -0.613 . . . . 73.019999999999996 110.494 176.423 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.731 HG21 ' CE2' ' A' ' 25' ' ' PHE . 19.1 m -132.99 152.45 36.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 124.508 1.123 . . . . 64.450000000000003 111.298 -171.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.18 10.59 40.67 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.987 1.315 . . . . 73.340000000000003 114.231 -171.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -62.68 -8.26 6.31 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.414 1.635 . . . . 74.25 115.414 -170.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.52 165.35 29.72 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 120.044 -1.66 . . . . 71.019999999999996 111.017 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.462 ' HA3' ' CD2' ' A' ' 29' ' ' TYR . . . 71.98 159.61 4.22 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.474 1.512 . . . . 74.120000000000005 112.373 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.1 -55.56 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.737 2.291 . . . . 61.229999999999997 109.79 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.4 mt -75.37 22.38 0.12 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.657 1.583 . . . . 65.450000000000003 112.968 -178.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -52.06 -56.84 14.76 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 124.865 1.221 . . . . 72.209999999999994 111.002 -176.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -62.04 -42.03 98.74 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 117.871 0.835 . . . . 65.340000000000003 109.776 -173.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -67.79 -38.84 83.87 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.992 1.717 . . . . 61.439999999999998 108.908 -174.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.7 mt -64.75 -40.58 95.53 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.469 1.108 . . . . 72.25 112.016 172.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.7 m -61.41 -41.38 97.05 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.732 0.696 . . . . 65.329999999999998 109.694 172.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.63 -39.91 95.54 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.459 1.027 . . . . 63.219999999999999 110.624 176.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.03 -36.26 81.05 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.586 0.754 . . . . 64.219999999999999 112.317 176.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.526 ' CG ' ' HB2' ' A' ' 60' ' ' HIS . 59.6 t-105 -59.58 -40.56 87.81 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.022 0.439 . . . . 70.019999999999996 111.658 -176.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.35 -29.89 71.12 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 118.745 -0.645 . . . . 70.430000000000007 112.388 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.3 t -59.91 -44.02 93.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 119.642 1.11 . . . . 72.349999999999994 109.312 169.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.1 84.92 Favored 'General case' 0 C--N 1.34 0.176 0 O-C-N 121.665 -0.647 . . . . 73.230000000000004 111.229 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 79.3 mt -71.49 -39.87 71.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 119.136 -0.459 . . . . 73.129999999999995 109.944 176.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.87 -34.63 71.83 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.079 0.854 . . . . 72.450000000000003 111.31 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.689 HD12 HG13 ' A' ' 116' ' ' VAL . 15.8 mt -102.49 -3.06 27.46 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.181 0.808 . . . . 74.319999999999993 113.181 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 58.45 57.22 21.01 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.426 1.489 . . . . 62.420000000000002 111.814 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.501 HG21 HG22 ' A' ' 116' ' ' VAL . 22.6 m -131.15 13.65 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 126.216 1.806 . . . . 74.049999999999997 111.719 -175.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -46.92 -48.24 21.38 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 126.604 1.961 . . . . 74.409999999999997 111.682 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -68.07 -28.68 67.57 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.048 1.339 . . . . 63.0 111.196 -174.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -82.3 -27.12 32.51 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.882 1.273 . . . . 71.019999999999996 110.69 -172.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.4 pp -112.07 -2.19 10.21 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-O 117.805 -1.093 . . . . 71.430000000000007 112.347 -171.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.4 m -64.82 -56.55 12.81 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 119.784 1.175 . . . . 64.239999999999995 109.346 176.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.529 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -55.8 -62.03 5.31 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 123.523 0.729 . . . . 52.420000000000002 111.885 -165.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 34.6 Cg_endo -65.69 -22.46 57.5 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.456 1.438 . . . . 63.210000000000001 113.045 -173.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 6.0 tpp -64.79 -47.41 78.19 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 124.148 0.979 . . . . 74.129999999999995 110.919 171.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -65.05 -35.12 80.14 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.197 0.908 . . . . 73.340000000000003 108.891 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -60.05 -38.3 82.4 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.451 0.569 . . . . 73.140000000000001 110.393 169.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.75 -16.58 47.44 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.04 -1.037 . . . . 70.109999999999999 112.751 -172.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.3 t -111.89 -33.94 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 124.966 1.306 . . . . 73.230000000000004 110.495 -171.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -108.57 -54.03 2.56 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.534 1.134 . . . . 63.109999999999999 110.93 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt -69.2 -55.79 9.56 Favored 'General case' 0 N--CA 1.462 0.17 0 O-C-N 121.096 -1.002 . . . . 65.25 110.66 -171.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.4 p -104.5 -23.79 13.1 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.726 0.811 . . . . 74.230000000000004 112.551 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 55.93 30.86 16.78 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.89 2.076 . . . . 71.239999999999995 112.775 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.0 t -62.69 -25.8 68.34 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.602 1.561 . . . . 65.439999999999998 112.362 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.508 HG13 HG12 ' A' ' 107' ' ' ILE . 45.1 t -63.01 109.8 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 122.387 1.089 . . . . 70.310000000000002 108.22 -177.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.97 -26.4 0.79 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.121 1.769 . . . . 73.310000000000002 110.804 -171.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 m -136.99 163.95 29.5 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.577 -1.268 . . . . 74.140000000000001 107.577 168.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 85.7 t -53.75 -33.47 23.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 125.961 1.704 . . . . 64.540000000000006 109.408 173.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.8 -20.04 65.86 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.067 1.747 . . . . 61.539999999999999 112.361 -177.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.29 -49.0 8.01 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.986 0.914 . . . . 45.32 108.9 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.508 HG12 HG13 ' A' ' 101' ' ' VAL . 0.8 OUTLIER -55.57 -48.59 77.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 125.654 1.582 . . . . 63.130000000000003 109.122 178.935 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -20.9 66.72 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.519 -0.753 . . . . 64.120000000000005 112.381 -175.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -64.32 -52.77 56.83 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 118.898 0.772 . . . . 74.209999999999994 109.594 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.4 t -55.87 -44.15 76.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 123.753 0.658 . . . . 62.350000000000001 109.571 -174.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -51.12 -55.68 16.55 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.751 0.42 . . . . 65.310000000000002 110.428 175.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 82.6 t -59.32 -47.16 91.47 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-N 118.454 0.57 . . . . 72.340000000000003 111.332 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -73.86 -30.84 62.88 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 124.068 0.855 . . . . 74.230000000000004 110.369 -168.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.0 -32.41 67.17 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.528 0.731 . . . . 65.209999999999994 110.268 170.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 145.09 23.11 0.13 Allowed Glycine 0 CA--C 1.531 1.068 0 N-CA-C 116.768 1.467 . . . . 63.450000000000003 116.768 165.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.689 HG13 HD12 ' A' ' 81' ' ' LEU . 48.7 t -94.2 127.42 46.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 119.245 1.522 . . . . 61.229999999999997 110.595 -177.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -53.89 116.57 2.62 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.777 0.831 . . . . 74.230000000000004 108.78 172.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.36 -24.91 64.21 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-O 118.663 -1.076 . . . . 64.519999999999996 111.243 171.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -74.75 -23.31 58.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.168 1.484 . . . . 55.329999999999998 112.27 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.528 ' HB3' HD11 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -92.86 -43.73 8.84 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 108.656 -0.868 . . . . 64.129999999999995 108.656 -178.806 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -51.77 -60.65 2.92 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.271 1.428 . . . . 74.349999999999994 109.584 172.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -69.84 -14.59 62.82 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 119.718 -0.182 . . . . 72.349999999999994 111.091 -168.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -88.42 -58.72 2.45 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.72 1.208 . . . . 54.25 109.873 172.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.5 -36.82 67.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.962 1.705 . . . . 65.340000000000003 111.298 -176.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -45.11 -37.68 4.52 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 125.346 1.458 . . . . 70.230000000000004 112.189 176.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -108.43 -3.5 18.16 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.823 1.649 . . . . 64.439999999999998 113.498 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 32.6 t -81.41 155.38 25.93 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 127.563 2.345 . . . . 74.409999999999997 111.706 173.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.85 -21.52 64.28 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 112.599 -2.091 . . . . 65.030000000000001 115.778 -171.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.9 t -47.68 -55.42 2.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 C-N-CA 127.42 2.288 . . . . 73.329999999999998 106.83 167.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.1 t -71.81 -42.21 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.532 -0.758 . . . . 64.040000000000006 109.415 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -54.82 -51.08 66.96 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.448 1.022 . . . . 73.120000000000005 112.462 -177.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 67.7 m -69.83 -34.15 73.27 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.144 0.978 . . . . 71.049999999999997 111.563 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 11.9 mt -68.62 -46.46 69.19 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.647 1.112 . . . . 72.140000000000001 112.113 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 24.7 t -48.67 -53.67 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 C-N-CA 124.399 1.08 . . . . 62.450000000000003 109.681 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.35 -40.53 93.72 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 116.351 -1.785 . . . . 72.049999999999997 110.87 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -56.39 -45.91 80.37 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 122.235 2.289 . . . . 64.239999999999995 112.918 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -53.95 -57.25 11.68 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.184 -1.043 . . . . 74.209999999999994 108.184 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 77.6 mm-40 -79.82 -9.91 59.72 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.862 1.265 . . . . 70.049999999999997 113.983 -171.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.1 tptt -86.21 -55.23 4.02 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 107.716 -1.216 . . . . 74.049999999999997 107.716 176.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.93 -62.23 2.01 Favored 'General case' 0 N--CA 1.444 -0.733 0 O-C-N 124.646 1.216 . . . . 50.240000000000002 108.66 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -82.84 0.59 43.32 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.699 1.0 . . . . 64.430000000000007 113.699 -162.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -122.06 2.29 9.85 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 117.733 -1.127 . . . . 73.420000000000002 112.936 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -57.31 -85.77 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.066 0.848 . . . . 44.210000000000001 110.651 174.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 174.74 43.03 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.926 2.49 . . . . 71.120000000000005 110.705 174.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.69 -26.54 6.53 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 120.55 -1.344 . . . . 71.209999999999994 112.019 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.661 HD23 ' H ' ' A' ' 147' ' ' GLN . 0.1 OUTLIER -127.73 -85.96 0.58 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.571 -1.27 . . . . 74.319999999999993 107.571 -167.128 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.661 ' H ' HD23 ' A' ' 146' ' ' LEU . 7.9 mt-30 48.22 29.24 1.8 Allowed 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.428 1.091 . . . . 74.219999999999999 112.565 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -154.98 95.62 0.15 Allowed Glycine 0 C--N 1.347 1.152 0 O-C-N 120.337 -1.477 . . . . 62.020000000000003 114.826 -164.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.867 HG13 ' CE1' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -95.91 162.38 24.22 Favored Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 113.589 0.959 . . . . 64.230000000000004 113.589 -170.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.669 ' HA ' HG12 ' A' ' 149' ' ' VAL . 72.7 Cg_endo -81.51 123.08 8.76 Favored 'Cis proline' 0 C--N 1.352 0.729 0 CA-C-N 119.025 0.687 . . . . 70.099999999999994 112.841 -5.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -103.23 141.21 36.29 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 114.6 -1.182 . . . . 62.43 112.471 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 44.5 tpp -146.44 108.63 4.42 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 127.143 2.177 . . . . 61.0 106.355 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -96.71 158.42 15.44 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 123.006 0.191 . . . . 63.32 111.502 172.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.9 t -140.75 146.93 23.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 124.352 1.061 . . . . 72.430000000000007 108.56 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 46.71 19.18 0.08 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 128.686 2.794 . . . . 54.399999999999999 114.689 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.88 -2.92 58.47 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 120.783 -1.198 . . . . 64.140000000000001 113.328 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -140.57 -7.01 1.14 Allowed 'General case' 0 C--O 1.233 0.229 0 N-CA-C 114.434 1.272 . . . . 74.200000000000003 114.434 -159.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -124.3 146.08 49.01 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.161 -1.052 . . . . 73.040000000000006 108.161 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -113.91 147.71 38.02 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.32 -1.363 . . . . 61.299999999999997 107.32 162.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -68.84 140.09 55.22 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.128 -1.064 . . . . 74.109999999999999 108.128 170.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -113.81 86.13 10.51 Favored Pre-proline 0 C--O 1.234 0.262 0 C-N-CA 123.254 0.622 . . . . 73.019999999999996 111.216 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -61.61 -24.08 77.37 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.111 1.207 . . . . 71.329999999999998 112.565 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -66.23 -31.3 72.05 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.786 1.176 . . . . 50.310000000000002 110.416 -168.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -90.52 -4.77 70.1 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.737 -1.035 . . . . 51.509999999999998 111.823 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 43.8 mtt -78.99 166.18 22.63 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 119.58 1.69 . . . . 73.109999999999999 108.69 175.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -79.4 108.96 13.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 104.663 -2.347 . . . . 53.310000000000002 104.663 171.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.446 HG22 ' CD1' ' A' ' 173' ' ' PHE . 40.8 p -112.96 50.23 0.89 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.948 2.099 . . . . 74.200000000000003 107.019 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 13.9 m -131.31 3.39 4.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.095 -1.412 . . . . 72.319999999999993 111.098 -167.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.03 -20.67 1.11 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 126.751 2.02 . . . . 73.239999999999995 110.645 174.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 7.9 mmt 73.09 -54.96 0.69 Allowed 'General case' 0 C--N 1.347 0.484 0 C-N-CA 126.063 1.745 . . . . 72.0 110.568 -174.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.79 -50.22 69.03 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.142 1.377 . . . . 61.210000000000001 110.531 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 79.1 t -72.18 -24.07 22.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 125.53 1.532 . . . . 64.120000000000005 111.574 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.446 ' CD1' HG22 ' A' ' 167' ' ' THR . 35.2 t80 -60.16 -61.85 2.3 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.331 -0.989 . . . . 73.030000000000001 108.331 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.9 t -64.92 -33.47 63.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 O-C-N 123.367 0.417 . . . . 52.43 110.474 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.98 -42.91 69.51 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.368 0.667 . . . . 73.329999999999998 112.329 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -81.63 -40.41 22.98 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 118.492 -0.766 . . . . 65.010000000000005 110.874 176.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -54.85 -57.8 10.13 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.479 1.112 . . . . 74.310000000000002 110.154 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -55.69 -32.03 62.94 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.925 0.89 . . . . 65.439999999999998 111.571 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -65.88 -58.4 5.68 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.936 -0.394 . . . . 62.109999999999999 109.936 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.4 t -63.1 -29.96 71.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 116.93 -1.51 . . . . 65.120000000000005 110.771 -173.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 47.5 t -56.49 -56.95 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 120.138 1.335 . . . . 45.340000000000003 108.189 173.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.31 -43.46 83.28 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 124.649 1.18 . . . . 61.039999999999999 111.093 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -64.65 -30.1 71.11 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 119.001 0.819 . . . . 75.040000000000006 112.244 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 52.6 mt -74.27 -23.68 59.15 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 120.44 -1.412 . . . . 74.230000000000004 111.833 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 84.7 t -62.71 -30.21 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.646 -0.501 . . . . 72.239999999999995 109.646 174.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -99.17 -8.11 25.59 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.885 0.874 . . . . 74.040000000000006 110.872 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -110.82 77.26 1.03 Allowed 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 120.668 -1.27 . . . . 71.319999999999993 109.406 -174.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.043 0 C-N-CA 127.52 2.328 . . . . 75.219999999999999 112.634 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.468 0.44 0 N-CA-C 108.712 -0.848 . . . . 61.109999999999999 108.712 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -118.5 179.3 4.16 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 127.479 2.312 . . . . 71.349999999999994 108.383 -170.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 50.51 30.84 5.0 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.925 2.09 . . . . 71.150000000000006 113.996 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -166.25 109.74 0.77 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.12 1.768 . . . . 71.310000000000002 106.894 -177.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.458 HD12 ' CD2' ' A' ' 9' ' ' TYR . 6.4 pt -117.24 166.32 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.499 1.119 . . . . 72.430000000000007 110.349 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.6 m -149.28 141.85 24.41 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.297 -1.372 . . . . 73.329999999999998 107.297 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -59.41 149.27 29.8 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.744 0.783 . . . . 71.230000000000004 109.399 174.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.81 -21.34 2.08 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-O 117.587 -1.674 . . . . 71.450000000000003 112.629 -172.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -99.56 -69.5 0.76 Allowed 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 120.966 2.383 . . . . 74.439999999999998 110.224 -165.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -107.95 -15.91 14.42 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 123.684 0.794 . . . . 64.140000000000001 110.637 -177.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.458 ' CD2' HD12 ' A' ' 3' ' ' ILE . 38.0 p90 -141.86 167.99 20.83 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 108.49 -0.93 . . . . 72.150000000000006 108.49 171.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 mm -131.26 142.29 43.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 104.652 -2.351 . . . . 72.140000000000001 104.652 168.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.1 m -78.4 171.13 15.54 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 125.144 1.378 . . . . 62.329999999999998 108.354 170.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 32.9 mt -113.14 161.65 16.88 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.99 0.916 . . . . 73.150000000000006 110.467 171.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -80.37 -37.75 31.72 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.287 1.035 . . . . 75.450000000000003 108.716 -174.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -133.26 71.33 76.91 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 125.42 1.488 . . . . 74.299999999999997 110.807 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.08 74.95 5.07 Favored 'Trans proline' 0 CA--C 1.535 0.551 1 C-N-CA 125.547 4.165 . . . . 74.349999999999994 111.033 176.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.8 tt -155.0 112.5 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 O-C-N 120.656 -1.278 . . . . 63.039999999999999 109.981 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 53.38 -153.59 0.26 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.992 0.917 . . . . 65.439999999999998 109.706 -168.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.49 -61.99 0.63 Allowed Glycine 0 C--N 1.333 0.389 0 N-CA-C 108.362 -1.895 . . . . 74.129999999999995 108.362 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -121.56 162.78 34.55 Favored Pre-proline 0 C--N 1.325 -0.473 0 C-N-CA 125.987 1.715 . . . . 62.229999999999997 111.451 -173.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -72.14 -7.29 20.73 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.947 3.098 . . . . 71.409999999999997 114.262 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 63.24 179.61 0.15 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.867 1.667 . . . . 73.329999999999998 112.077 -175.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.5 m 46.36 33.87 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 127.555 2.342 . . . . 63.009999999999998 112.776 -173.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.519 HD22 ' CZ ' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -122.92 154.77 37.92 Favored 'General case' 0 CA--C 1.518 -0.287 0 O-C-N 121.352 -0.843 . . . . 65.430000000000007 113.249 -163.01 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -135.83 141.19 44.65 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 125.244 1.418 . . . . 71.219999999999999 108.101 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.519 ' CZ ' HD22 ' A' ' 23' ' ' LEU . 98.0 m-85 -127.75 137.77 52.54 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.738 1.215 . . . . 73.230000000000004 109.62 -176.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -165.38 -178.48 5.01 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.988 1.715 . . . . 74.420000000000002 109.749 -177.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.7 t -143.94 -174.48 4.28 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.776 1.23 . . . . 72.030000000000001 108.142 171.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.868 ' CD1' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -92.23 -7.66 47.58 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.507 1.299 . . . . 74.439999999999998 114.507 175.273 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -100.29 -4.92 28.31 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.922 0.889 . . . . 73.200000000000003 112.826 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.7 p -80.07 140.83 53.75 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 120.681 1.582 . . . . 71.040000000000006 108.764 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -92.07 -30.74 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 CA-C-N 120.133 1.083 . . . . 63.130000000000003 111.055 -168.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -64.25 -50.08 69.38 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.952 1.701 . . . . 75.219999999999999 109.517 171.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.5 p -67.0 -22.93 65.88 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 117.582 -1.199 . . . . 70.439999999999998 111.706 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -57.21 -55.08 39.39 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 120.338 1.427 . . . . 62.32 109.312 170.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -55.05 -46.46 75.36 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 108.804 -0.813 . . . . 71.049999999999997 108.804 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -65.58 -16.45 63.72 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 116.796 -1.574 . . . . 73.209999999999994 113.324 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -116.29 -8.13 11.71 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 121.105 1.775 . . . . 73.109999999999999 111.762 -173.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -141.38 -30.15 0.62 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.75 0.82 . . . . 72.049999999999997 112.907 -163.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.2 t -115.4 -68.02 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 N-CA-C 107.466 -1.309 . . . . 65.219999999999999 107.466 -172.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.8 mt -66.44 -28.41 68.58 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.843 -1.071 . . . . 72.150000000000006 111.075 171.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 45.14 41.6 5.94 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.438 1.495 . . . . 52.420000000000002 111.833 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.2 t -50.88 -48.2 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 C-N-CA 125.79 1.636 . . . . 73.120000000000005 108.696 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.3 p -46.08 -55.71 6.58 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 124.791 1.307 . . . . 65.140000000000001 112.293 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -75.36 -34.86 61.19 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 119.913 -1.742 . . . . 64.430000000000007 110.665 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.45 -54.58 45.22 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 123.035 0.534 . . . . 64.239999999999995 110.474 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.602 HG12 ' HG ' ' A' ' 50' ' ' LEU . 23.5 t -60.82 -43.02 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 109.253 -0.647 . . . . 74.010000000000005 109.253 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.685 ' HA ' HD12 ' A' ' 50' ' ' LEU . 40.7 ttt-85 -53.72 -29.5 39.6 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.391 1.256 . . . . 74.430000000000007 114.391 176.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -89.78 -3.56 58.1 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.186 1.18 . . . . 65.209999999999994 114.186 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -128.12 0.03 5.83 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.929 2.092 . . . . 70.219999999999999 113.032 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.693 HD13 ' O ' ' A' ' 54' ' ' THR . 6.3 mt -63.11 154.37 77.79 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.378 1.471 . . . . 63.109999999999999 108.988 -177.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.12 151.33 26.9 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.32 2.68 . . . . 70.049999999999997 108.837 172.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 45.46 24.01 0.16 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.236 2.615 . . . . 50.119999999999997 115.645 174.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.27 33.34 75.0 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-O 117.851 -1.527 . . . . 72.349999999999994 113.659 -172.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.693 ' O ' HD13 ' A' ' 50' ' ' LEU . 26.0 m -61.59 69.62 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.775 1.63 . . . . 73.340000000000003 111.191 172.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -63.63 132.19 50.37 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 120.385 -1.447 . . . . 74.200000000000003 108.357 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -75.57 173.56 10.85 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.037 0.935 . . . . 73.109999999999999 112.178 -174.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.84 154.01 26.97 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.557 0.743 . . . . 65.040000000000006 109.368 170.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.78 102.0 6.36 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.306 1.042 . . . . 54.210000000000001 108.488 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.421 ' HB2' HD21 ' A' ' 23' ' ' LEU . 10.6 m-30 -97.0 168.22 10.6 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.348 1.059 . . . . 74.299999999999997 110.336 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.515 ' CE1' HG22 ' A' ' 72' ' ' THR . 1.4 p-80 -101.18 172.05 7.24 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.986 1.314 . . . . 65.400000000000006 108.569 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.666 HG12 ' HB1' ' A' ' 141' ' ' ALA . 11.9 m -140.42 145.8 25.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 107.445 -1.317 . . . . 73.209999999999994 107.445 162.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . 0.293 0.0 OUTLIER -102.37 17.97 22.21 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 129.084 2.953 . . . . 71.230000000000004 113.54 -177.876 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -84.18 -4.33 58.74 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.294 1.438 . . . . 54.32 114.367 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.59 145.48 51.13 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 119.827 -1.796 . . . . 74.420000000000002 110.29 -166.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.87 -178.69 7.2 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 121.375 0.431 . . . . 55.539999999999999 112.517 174.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -78.36 -46.63 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.316 2.677 . . . . 62.130000000000003 113.308 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.8 mt -79.17 31.69 0.22 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.655 1.116 . . . . 72.439999999999998 112.518 -174.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -43.24 -63.71 1.99 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 126.053 1.787 . . . . 75.200000000000003 110.689 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -63.02 -40.06 96.62 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 117.548 0.674 . . . . 73.099999999999994 110.647 -172.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.51 -42.43 92.18 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.263 1.425 . . . . 73.409999999999997 110.458 -175.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.868 HD11 ' CD1' ' A' ' 28' ' ' PHE . 18.6 mt -65.33 -45.17 85.33 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 118.533 -0.746 . . . . 73.219999999999999 111.392 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.515 HG22 ' CE1' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -46.78 -53.73 11.3 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.057 -1.09 . . . . 65.040000000000006 108.057 175.697 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -58.17 -55.89 29.09 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.945 0.898 . . . . 73.430000000000007 110.418 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.88 -43.18 72.95 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 120.186 1.357 . . . . 61.420000000000002 113.838 -176.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 14.0 t-105 -59.8 -38.0 80.71 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.341 -0.85 . . . . 74.120000000000005 111.355 -174.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.39 -38.57 71.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 118.062 -0.971 . . . . 73.200000000000003 112.557 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.6 t -57.03 -47.77 82.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 120.031 1.287 . . . . 65.109999999999999 109.933 171.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.22 -40.53 94.24 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.868 -0.52 . . . . 65.329999999999998 111.237 -176.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 85.8 mt -67.01 -38.2 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.736 0.815 . . . . 42.210000000000001 109.68 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.86 -50.61 72.73 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.858 0.863 . . . . 74.5 110.111 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 77.4 mt -76.2 -27.75 56.99 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.805 -0.559 . . . . 73.530000000000001 112.098 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.51 62.4 2.72 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 126.566 2.032 . . . . 44.329999999999998 110.603 -173.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.0 m -129.81 14.07 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 125.226 1.41 . . . . 72.200000000000003 112.303 -174.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -49.99 -51.87 38.26 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 125.064 1.346 . . . . 72.019999999999996 112.307 -169.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.62 -43.02 79.78 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.37 1.468 . . . . 71.340000000000003 110.373 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -64.05 -27.12 68.89 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 124.456 1.102 . . . . 74.099999999999994 110.609 -176.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.3 pp -116.48 27.19 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 126.847 2.059 . . . . 42.130000000000003 109.876 -176.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 89.9 m -97.67 -54.58 3.07 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.755 -1.202 . . . . 64.0 107.755 164.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.501 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -52.52 -62.09 3.74 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 113.721 1.008 . . . . 53.200000000000003 113.721 -172.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 56.8 Cg_endo -70.37 -27.29 23.75 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.194 1.263 . . . . 72.340000000000003 111.557 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 32.6 tpp -65.07 -49.9 68.25 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.557 1.143 . . . . 73.120000000000005 109.635 -177.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -69.34 -35.63 76.09 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.49 -0.93 . . . . 63.020000000000003 108.49 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.494 ' CG ' ' HE3' ' A' ' 97' ' ' LYS . 2.6 mt-10 -65.68 -11.19 42.96 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 114.367 1.247 . . . . 70.400000000000006 114.367 169.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -109.15 1.52 20.41 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.576 1.08 . . . . 71.010000000000005 113.488 172.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.859 HG21 ' CD2' ' A' ' 28' ' ' PHE . 95.8 t -115.38 -34.66 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 117.392 -1.289 . . . . 33.409999999999997 114.04 175.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -108.84 -53.0 2.7 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 120.547 1.521 . . . . 65.439999999999998 113.401 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.494 ' HE3' ' CG ' ' A' ' 93' ' ' GLU . 2.9 mmmt -62.08 -64.54 0.9 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.479 1.911 . . . . 63.229999999999997 112.713 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.9 p -87.88 -30.66 19.97 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.736 1.384 . . . . 64.209999999999994 114.736 174.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 56.1 35.73 26.16 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 128.348 2.659 . . . . 72.0 114.432 -173.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.5 t -71.31 -22.36 61.94 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.342 0.867 . . . . 73.340000000000003 113.342 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.486 HG13 HG12 ' A' ' 107' ' ' ILE . 25.4 t -66.71 120.33 13.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 O-C-N 120.625 -1.297 . . . . 74.439999999999998 110.217 172.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -140.63 -28.8 0.7 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.063 -0.971 . . . . 74.310000000000002 111.633 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.83 174.39 10.58 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.539 1.063 . . . . 63.119999999999997 110.178 168.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.5 t -57.68 -41.32 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.139 0.975 . . . . 72.400000000000006 111.267 -169.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.28 -23.77 62.7 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 119.204 -0.427 . . . . 73.099999999999994 111.679 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -78.19 -30.54 49.06 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 119.044 0.838 . . . . 73.040000000000006 111.207 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.486 HG12 HG13 ' A' ' 101' ' ' VAL . 1.4 mt -81.8 -48.26 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 108.293 -1.003 . . . . 72.019999999999996 108.293 -174.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -62.18 -18.23 60.41 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.577 0.751 . . . . 73.0 112.356 179.336 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -62.5 -56.85 14.14 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 125.43 1.492 . . . . 61.439999999999998 109.837 169.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.7 t -61.77 -34.47 62.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 118.645 -0.693 . . . . 62.100000000000001 110.804 -175.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -49.62 -60.46 2.85 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.016 -0.735 . . . . 73.310000000000002 109.016 169.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.1 t -57.09 -49.03 80.82 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-O 118.922 -0.561 . . . . 71.409999999999997 109.814 -176.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.23 -43.22 96.23 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 124.062 0.851 . . . . 73.099999999999994 110.159 -170.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.87 0.25 7.66 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.73 1.612 . . . . 71.310000000000002 112.852 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.49 44.76 1.41 Allowed Glycine 0 CA--C 1.523 0.566 0 C-N-CA 124.973 1.273 . . . . 71.5 112.917 171.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.0 t -112.38 140.8 30.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 118.977 1.388 . . . . 65.099999999999994 110.765 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -64.28 110.12 2.12 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.307 1.443 . . . . 74.5 109.134 165.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.92 -23.37 65.64 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-O 118.162 -1.354 . . . . 74.439999999999998 110.931 168.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -70.95 -23.05 62.15 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.621 1.211 . . . . 74.239999999999995 110.977 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -87.79 -46.34 9.54 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.701 -1.222 . . . . 72.409999999999997 107.701 176.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 108' ' ' ARG . 14.9 t80 -51.97 -57.31 9.83 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.622 0.769 . . . . 65.400000000000006 109.603 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -74.7 -9.48 58.61 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.88 0.872 . . . . 62.399999999999999 112.43 -171.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -87.78 -66.15 0.94 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.909 1.283 . . . . 50.399999999999999 109.355 166.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -49.34 -43.06 43.44 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.397 2.279 . . . . 71.140000000000001 111.45 -174.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -45.55 -35.69 4.1 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 126.303 1.841 . . . . 72.030000000000001 113.507 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -116.91 8.45 13.51 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.713 1.205 . . . . 64.030000000000001 111.828 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 21.3 t -95.69 159.85 14.78 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 127.16 2.184 . . . . 72.230000000000004 110.226 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -57.14 -33.03 66.98 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.301 1.44 . . . . 63.340000000000003 111.892 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.8 t -49.57 -54.27 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 124.107 0.963 . . . . 61.109999999999999 109.912 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.5 t -63.87 -49.54 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 123.803 0.841 . . . . 61.229999999999997 110.694 176.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -49.61 -54.35 18.86 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.926 0.784 . . . . 72.040000000000006 111.549 -177.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.12 -40.0 93.89 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.102 0.561 . . . . 74.299999999999997 111.998 177.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.8 mt -60.6 -49.36 77.84 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-O 116.61 -1.662 . . . . 53.409999999999997 110.891 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 99.1 t -56.78 -37.26 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 120.199 1.363 . . . . 70.430000000000007 110.428 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.65 -28.83 70.18 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 117.763 -1.113 . . . . 72.209999999999994 112.329 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -53.47 -49.48 67.36 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 119.803 1.183 . . . . 64.0 112.097 175.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -103.77 -18.96 14.46 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 118.54 -0.743 . . . . 64.109999999999999 110.636 -166.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -60.07 -52.82 63.73 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.922 -1.14 . . . . 64.420000000000002 107.922 158.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 32.1 tttp -61.15 -18.7 59.46 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.268 0.94 . . . . 72.299999999999997 113.181 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -114.9 1.19 13.97 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 115.816 1.784 . . . . 65.329999999999998 115.816 -176.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.666 ' HB1' HG12 ' A' ' 61' ' ' VAL . . . -139.18 -19.1 0.99 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 119.462 1.028 . . . . 62.340000000000003 111.609 177.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -104.7 -4.77 22.02 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 117.942 -1.027 . . . . 63.229999999999997 110.94 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -59.81 -83.03 0.02 OUTLIER 'General case' 0 C--N 1.345 0.401 0 C-N-CA 125.929 1.692 . . . . 75.319999999999993 109.934 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.2 pp -172.92 -11.18 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.106 1.521 . . . . 64.019999999999996 115.106 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.2 -44.27 76.23 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.321 1.418 . . . . 73.219999999999999 112.556 -162.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.24 -70.05 0.79 Allowed 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 125.736 1.614 . . . . 75.019999999999996 109.561 -157.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 68.26 -3.75 1.22 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.676 1.991 . . . . 75.310000000000002 115.367 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -146.16 160.39 28.15 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 122.731 2.514 . . . . 51.100000000000001 112.709 174.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.446 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 19.3 m -142.23 167.01 17.8 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-N 118.532 1.166 . . . . 72.209999999999994 112.61 -174.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.446 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 36.5 Cg_endo -61.35 165.21 33.51 Favored 'Cis proline' 0 C--N 1.353 0.812 0 CA-C-N 119.743 0.944 . . . . 53.43 111.911 -11.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -149.67 151.49 33.8 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.563 -0.903 . . . . 65.409999999999997 108.563 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 6.6 ttm -149.25 117.97 6.61 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.531 -1.285 . . . . 74.140000000000001 107.531 -172.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -124.22 107.04 10.78 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 125.038 1.335 . . . . 73.319999999999993 110.015 -169.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 81.5 t -64.06 -65.16 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.177 0.591 . . . . 52.219999999999999 111.672 -170.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -132.96 25.02 4.28 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.793 2.037 . . . . 74.409999999999997 108.136 -171.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 68.0 20.2 72.51 Favored Glycine 0 C--N 1.343 0.951 0 C-N-CA 124.774 1.178 . . . . 51.439999999999998 113.988 -177.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.52 ' HE2' ' CZ ' ' A' ' 158' ' ' TYR . 18.7 ptmt -138.43 -7.65 1.51 Allowed 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 115.089 1.514 . . . . 44.229999999999997 115.089 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.52 ' CZ ' ' HE2' ' A' ' 157' ' ' LYS . 22.9 m-85 -133.94 122.09 22.61 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.457 -1.683 . . . . 72.239999999999995 106.457 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.12 143.87 27.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 105.518 -2.03 . . . . 70.439999999999998 105.518 161.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.442 ' CD1' HG23 ' A' ' 180' ' ' THR . 3.5 mm? -69.9 142.73 52.93 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.88 -1.155 . . . . 73.129999999999995 107.88 166.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -112.57 85.76 7.69 Favored Pre-proline 0 N--CA 1.453 -0.292 0 N-CA-C 113.024 0.75 . . . . 53.549999999999997 113.024 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.39 -19.74 37.52 Favored 'Trans proline' 0 N--CA 1.443 -1.486 0 C-N-CA 120.454 0.769 . . . . 74.230000000000004 111.1 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -61.86 -20.48 63.75 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 119.626 1.103 . . . . 75.409999999999997 112.821 -175.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -108.75 3.72 32.25 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 117.641 -1.644 . . . . 72.420000000000002 113.326 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 56.3 mtt -93.01 173.57 7.67 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.91 2.355 . . . . 70.040000000000006 111.794 -168.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.57 58.54 3.75 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 123.568 1.651 . . . . 73.409999999999997 111.764 -171.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 72.2 p -72.96 16.07 0.17 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.474 2.31 . . . . 65.340000000000003 112.851 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.4 m -94.43 -8.79 37.58 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.945 1.698 . . . . 65.230000000000004 112.707 173.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.0 -14.08 4.47 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 119.5 1.045 . . . . 73.340000000000003 113.181 -174.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 4.5 mmt 70.6 -57.66 0.58 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.591 1.957 . . . . 74.340000000000003 113.926 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.22 -48.95 68.93 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.694 -1.225 . . . . 70.329999999999998 107.694 -178.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 21.2 t -65.05 -36.81 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 124.928 1.291 . . . . 70.329999999999998 109.567 -177.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -52.14 -60.73 2.86 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 118.262 -0.875 . . . . 74.319999999999993 110.135 172.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 8.9 t -66.76 -39.26 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 119.198 0.908 . . . . 61.109999999999999 111.392 -175.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.42 -33.97 64.01 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.617 0.767 . . . . 63.009999999999998 111.419 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -88.94 -31.4 18.19 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.393 1.077 . . . . 71.129999999999995 112.159 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -58.68 -59.64 5.09 Favored 'General case' 0 CA--C 1.528 0.099 0 O-C-N 120.8 -1.187 . . . . 73.340000000000003 108.965 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.27 -32.7 72.52 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.873 -0.517 . . . . 72.040000000000006 111.795 -175.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.96 -52.01 67.23 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.879 1.272 . . . . 74.439999999999998 111.835 174.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.442 HG23 ' CD1' ' A' ' 160' ' ' LEU . 9.0 t -64.88 -30.22 71.21 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 117.403 -1.284 . . . . 72.439999999999998 110.491 177.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 99.9 t -60.07 -55.89 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 120.455 1.479 . . . . 74.049999999999997 108.302 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -62.42 -33.93 75.76 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-O 118.903 -0.57 . . . . 74.420000000000002 111.979 -177.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -68.92 -33.8 74.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.645 0.657 . . . . 71.140000000000001 111.342 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 34.4 mt -67.99 -29.36 68.36 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 120.957 -1.09 . . . . 73.129999999999995 111.936 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 62.2 t -62.06 -26.03 38.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.437 0.695 . . . . 72.430000000000007 111.506 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -98.34 -18.35 18.38 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.508 0.595 . . . . 54.229999999999997 110.531 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -96.32 76.56 2.98 Favored 'General case' 0 CA--C 1.516 -0.349 0 O-C-N 121.035 -1.041 . . . . 70.129999999999995 108.851 -172.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.246 0.896 0 C-N-CA 127.832 2.453 . . . . 73.239999999999995 112.023 -174.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 16.7 m . . . . . 0 N--CA 1.464 0.273 0 CA-C-O 121.929 0.871 . . . . 62.109999999999999 109.499 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -72.47 162.57 29.3 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.788 -0.819 . . . . 64.299999999999997 108.788 164.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 49.55 34.8 7.38 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.075 1.75 . . . . 72.209999999999994 114.207 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -163.78 120.75 1.75 Allowed 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.344 -1.724 . . . . 72.129999999999995 106.344 174.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.71 HG21 HG23 ' A' ' 180' ' ' THR . 9.8 pt -133.14 160.7 42.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 126.444 1.898 . . . . 51.409999999999997 109.592 177.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.5 m -140.4 144.51 36.23 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 121.607 -0.683 . . . . 61.329999999999998 109.551 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -51.37 142.04 14.18 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 127.238 2.215 . . . . 71.150000000000006 111.117 168.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.09 -22.79 2.32 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.415 1.007 . . . . 53.530000000000001 112.582 -176.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -102.38 -77.79 0.55 Allowed 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 124.129 0.971 . . . . 62.130000000000003 108.672 -165.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -100.24 -15.84 17.94 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.413 1.085 . . . . 71.140000000000001 110.719 -174.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -140.95 159.34 42.42 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.217 -0.66 . . . . 71.129999999999995 109.217 165.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.4 mm -113.55 162.55 11.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 124.762 1.225 . . . . 71.019999999999996 107.695 173.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 m -117.24 147.9 42.12 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.426 1.49 . . . . 65.120000000000005 107.603 176.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.2 mt -86.18 154.66 21.16 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.52 -0.548 . . . . 73.349999999999994 109.52 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -72.28 -37.33 69.06 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.878 1.671 . . . . 73.439999999999998 109.693 176.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -127.59 85.12 61.56 Favored Pre-proline 0 C--N 1.34 0.178 0 C-N-CA 127.479 2.312 . . . . 73.540000000000006 108.331 173.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -79.55 85.41 1.85 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.732 2.954 . . . . 74.040000000000006 109.583 168.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.4 tt -160.26 111.58 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 119.292 0.951 . . . . 62.25 109.796 170.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -157.38 -7.85 0.09 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.361 1.245 . . . . 70.120000000000005 114.361 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.69 -101.85 0.57 Allowed Glycine 0 C--N 1.338 0.645 0 O-C-N 120.524 -1.36 . . . . 70.019999999999996 109.877 -165.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 64.73 166.53 0.11 Allowed Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 125.006 1.322 . . . . 61.420000000000002 112.008 -175.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.55 178.98 6.87 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.651 2.234 . . . . 70.140000000000001 111.051 -169.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -66.86 92.4 0.23 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.38 1.072 . . . . 65.439999999999998 109.773 174.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.8 t 75.04 145.12 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 128.672 2.789 . . . . 72.239999999999995 111.206 170.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.3 tp -157.24 148.22 21.64 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.724 0.81 . . . . 73.040000000000006 109.747 -174.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -140.52 153.12 46.05 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.946 1.698 . . . . 73.430000000000007 109.262 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -133.35 139.32 46.76 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.727 1.211 . . . . 74.310000000000002 108.527 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.81 -179.71 7.81 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.285 1.834 . . . . 70.239999999999995 108.512 -177.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -158.68 161.87 37.16 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.872 0.76 . . . . 53.539999999999999 111.366 174.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -70.47 -39.83 74.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.461 1.504 . . . . 70.239999999999995 112.111 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.456 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 80.3 m-85 -93.6 18.09 10.6 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.567 1.147 . . . . 74.200000000000003 111.793 177.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 33.8 t -88.73 141.68 30.18 Favored Pre-proline 0 CA--C 1.538 0.503 0 O-C-N 120.136 -1.603 . . . . 72.109999999999999 110.042 171.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -83.68 -46.56 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 121.73 1.62 . . . . 71.409999999999997 112.165 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -61.45 -44.06 97.77 Favored 'General case' 0 CA--C 1.528 0.115 0 O-C-N 121.56 -0.712 . . . . 73.439999999999998 109.537 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.7 m -57.02 -33.34 67.08 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.566 0.746 . . . . 72.239999999999995 112.097 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -58.93 -53.55 57.17 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.438 0.695 . . . . 64.120000000000005 110.105 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -56.54 -47.73 78.79 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 118.431 -0.795 . . . . 72.530000000000001 109.432 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.434 ' CD2' HG21 ' A' ' 42' ' ' VAL . 10.4 m-85 -62.13 -19.83 63.43 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 116.83 -1.557 . . . . 74.120000000000005 112.341 -174.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -134.84 10.12 3.61 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 120.925 1.693 . . . . 62.32 112.11 -164.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -135.7 -41.21 0.69 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.868 2.067 . . . . 71.329999999999998 111.209 169.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 83.7 t -98.47 -74.57 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.11 0 N-CA-C 107.89 -1.152 . . . . 64.019999999999996 107.89 -168.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 65.7 mt -62.0 -28.19 69.4 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.985 1.314 . . . . 63.329999999999998 111.663 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 1.2 m170 44.36 56.76 4.76 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.669 1.988 . . . . 65.430000000000007 111.783 177.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.509 ' O ' HG23 ' A' ' 46' ' ' VAL . 63.6 t -62.06 -44.59 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 125.293 1.437 . . . . 74.129999999999995 109.752 -174.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.9 t -53.05 -44.77 67.68 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.333 0.97 . . . . 62.140000000000001 111.99 -175.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -76.89 -29.71 55.88 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 121.194 -0.941 . . . . 72.329999999999998 111.447 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -63.23 -46.99 84.38 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.492 0.717 . . . . 53.409999999999997 110.607 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 42' ' ' VAL . 1.9 t -59.53 -51.24 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 108.238 -1.023 . . . . 61.020000000000003 108.238 177.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 37.8 ttt-85 -47.36 -46.32 25.63 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.378 1.071 . . . . 72.400000000000006 111.948 177.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -64.89 -2.8 2.82 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.155 1.169 . . . . 73.120000000000005 114.155 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.6 mmtt -132.01 -9.9 3.42 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 127.466 2.306 . . . . 65.099999999999994 113.724 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.535 HD13 HG21 ' A' ' 54' ' ' THR . 7.7 mt -66.95 144.81 98.73 Favored Pre-proline 0 C--O 1.237 0.4 0 CA-C-N 119.306 0.957 . . . . 74.150000000000006 110.882 -164.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.69 165.38 32.89 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.988 2.459 . . . . 50.310000000000002 109.78 167.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.88 23.29 0.7 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.774 1.027 . . . . 65.219999999999999 113.774 -173.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.67 18.21 22.56 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 127.139 2.304 . . . . 71.340000000000003 112.057 -173.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.535 HG21 HD13 ' A' ' 50' ' ' LEU . 1.3 t -130.08 129.39 43.53 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.462 -1.31 . . . . 72.140000000000001 107.462 -163.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -96.29 121.1 37.71 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 104.8 -2.296 . . . . 65.409999999999997 104.8 166.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 6.2 ttm -66.39 102.49 0.88 Allowed 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 125.074 1.35 . . . . 74.349999999999994 108.02 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 58' ' ' LYS . 1.5 m -120.0 -171.73 2.21 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.215 -1.032 . . . . 73.310000000000002 108.215 -173.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.452 ' H ' HG22 ' A' ' 57' ' ' THR . 0.0 OUTLIER 174.58 108.99 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.423 1.489 . . . . 71.239999999999995 108.102 -173.053 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -108.59 146.67 32.96 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.795 1.18 . . . . 74.150000000000006 109.855 174.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.41 ' CE1' ' HB3' ' A' ' 137' ' ' GLN . 0.2 OUTLIER -82.01 168.54 17.72 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.242 1.017 . . . . 74.019999999999996 109.543 -174.482 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.508 HG12 ' HB1' ' A' ' 141' ' ' ALA . 6.6 m -139.03 111.12 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 119.528 1.058 . . . . 74.450000000000003 108.521 158.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.89 4.68 13.44 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 124.719 1.208 . . . . 44.25 113.183 176.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -55.77 -8.48 0.41 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.173 1.789 . . . . 72.150000000000006 113.376 169.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.8 132.07 34.19 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 125.425 1.49 . . . . 70.340000000000003 109.996 -176.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.456 ' HA3' ' CD2' ' A' ' 29' ' ' TYR . . . 116.59 156.54 10.7 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 126.443 1.973 . . . . 62.32 112.014 168.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -62.99 -56.12 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.47 2.113 . . . . 61.539999999999999 109.544 167.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.6 mt -91.21 34.99 0.92 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.652 1.581 . . . . 61.32 109.912 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.95 -51.89 50.41 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.508 -1.037 . . . . 70.540000000000006 110.508 175.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.9 tppm? -57.14 -40.2 76.72 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.291 1.036 . . . . 72.409999999999997 112.181 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.88 -38.63 89.29 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.852 1.661 . . . . 72.329999999999998 110.31 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.7 mt -67.36 -41.05 85.73 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 117.808 -1.092 . . . . 53.310000000000002 111.641 174.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.03 -56.65 14.49 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.922 1.289 . . . . 72.310000000000002 108.975 -177.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -62.4 -41.93 99.05 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.409 0.684 . . . . 61.25 109.477 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.14 -30.96 69.64 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 113.443 0.905 . . . . 72.420000000000002 113.443 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 33.7 t-105 -61.56 -41.04 96.8 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 118.507 0.594 . . . . 71.129999999999995 111.518 -176.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.89 -36.31 76.67 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 117.665 -1.16 . . . . 65.230000000000004 112.492 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.2 t -55.72 -46.69 79.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 120.711 1.596 . . . . 73.120000000000005 110.796 171.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.01 -43.16 88.49 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-O 119.137 -0.459 . . . . 61.140000000000001 110.628 -175.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.2 mt -63.65 -39.87 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 118.758 -0.639 . . . . 71.340000000000003 109.965 176.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.74 -22.84 66.04 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.622 0.646 . . . . 32.420000000000002 112.279 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.2 mt -99.49 -11.78 20.76 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.214 0.916 . . . . 73.140000000000001 112.631 169.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 64.11 56.06 20.41 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 124.346 0.974 . . . . 74.030000000000001 111.372 -173.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.7 m -133.88 14.46 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 124.174 0.99 . . . . 73.340000000000003 112.107 -176.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -45.36 -56.82 4.54 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.664 1.186 . . . . 74.349999999999994 109.386 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.31 -10.33 59.64 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 125.438 1.495 . . . . 74.450000000000003 111.886 -172.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -87.32 -30.73 20.62 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 120.827 -1.17 . . . . 52.340000000000003 110.715 171.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.447 HG22 ' HB3' ' A' ' 114' ' ' ALA . 2.5 pp -100.55 -14.58 7.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 CA-C-O 117.374 -1.298 . . . . 33.43 111.463 -171.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.1 m -59.09 -51.62 69.24 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 119.967 1.258 . . . . 73.120000000000005 110.583 -175.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.563 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -57.15 -62.14 5.77 Favored Pre-proline 0 N--CA 1.452 -0.357 0 C-N-CA 124.569 1.147 . . . . 33.25 110.734 -168.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 57.0 Cg_endo -67.05 -26.83 42.86 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 120.911 1.074 . . . . 72.200000000000003 112.397 -176.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 4.5 tpp -60.5 -49.55 77.09 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.221 0.464 . . . . 70.430000000000007 110.185 170.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -64.58 -37.13 86.51 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.029 0.831 . . . . 74.010000000000005 109.077 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.33 -32.83 72.71 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.68 0.673 . . . . 73.239999999999995 111.666 171.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.13 -17.17 29.75 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.355 -1.466 . . . . 65.109999999999999 112.817 -176.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.4 t -100.54 -43.4 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 124.9 1.28 . . . . 51.409999999999997 109.488 -176.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -98.59 -60.62 1.51 Allowed 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.161 0.984 . . . . 53.100000000000001 110.215 -177.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.5 mmmt -65.94 -58.45 5.51 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 118.902 -0.57 . . . . 65.120000000000005 110.581 -167.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.2 p -97.18 -16.51 20.39 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.672 0.619 . . . . 64.409999999999997 112.672 -176.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 48.12 25.62 0.86 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.659 2.384 . . . . 74.140000000000001 113.885 -175.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.9 t -62.76 -16.0 55.9 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.62 1.968 . . . . 73.109999999999999 112.013 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.411 HG13 HG12 ' A' ' 107' ' ' ILE . 70.1 t -68.5 111.87 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 O-C-N 121.182 -0.949 . . . . 64.200000000000003 109.236 175.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -136.81 -30.12 0.9 Allowed 'General case' 0 C--O 1.239 0.524 0 C-N-CA 125.058 1.343 . . . . 70.25 110.275 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.26 162.28 33.44 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.15 -0.685 . . . . 71.549999999999997 109.15 174.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.82 -30.27 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.819 0.847 . . . . 53.450000000000003 110.138 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -47.4 -39.94 16.53 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.442 2.297 . . . . 71.549999999999997 113.31 168.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -77.55 -38.93 47.53 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.691 -0.855 . . . . 74.239999999999995 108.691 -175.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.411 HG12 HG13 ' A' ' 101' ' ' VAL . 2.7 mt -66.76 -48.33 80.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 125.103 1.361 . . . . 71.109999999999999 107.864 -174.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -57.76 -31.74 66.8 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-O 117.341 -1.314 . . . . 63.340000000000003 112.765 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -57.33 -57.12 14.04 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 119.601 1.091 . . . . 73.349999999999994 109.153 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.19 -37.73 78.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 123.371 0.419 . . . . 53.130000000000003 110.678 -173.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -53.92 -51.7 62.9 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 118.373 0.533 . . . . 70.150000000000006 110.659 172.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 90.2 t -64.18 -44.91 97.6 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-N 118.37 0.532 . . . . 71.340000000000003 110.631 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -63.14 -41.54 99.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.808 0.813 . . . . 74.239999999999995 108.939 -170.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.447 ' HB3' HG22 ' A' ' 87' ' ' ILE . . . -79.29 -4.31 50.17 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.144 1.378 . . . . 72.329999999999998 112.866 176.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 123.21 22.66 2.31 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 117.163 1.625 . . . . 64.019999999999996 117.163 160.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.5 t -97.61 134.23 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 119.551 1.675 . . . . 70.420000000000002 109.667 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.422 ' HE2' ' OE2' ' A' ' 119' ' ' GLU . 0.8 OUTLIER -63.51 143.59 57.7 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 121.635 -0.666 . . . . 63.149999999999999 110.138 176.31 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.54 -10.89 76.36 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 119.565 -0.575 . . . . 71.340000000000003 112.749 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.422 ' OE2' ' HE2' ' A' ' 117' ' ' LYS . 6.9 pt-20 -92.3 -32.22 15.09 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 123.903 0.881 . . . . 63.030000000000001 110.326 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -70.09 -46.59 64.55 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 107.375 -1.343 . . . . 74.409999999999997 107.375 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -54.08 -60.12 3.75 Favored 'General case' 0 N--CA 1.438 -1.046 0 O-C-N 123.876 0.735 . . . . 73.439999999999998 109.437 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -75.22 -19.47 59.76 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 118.183 -0.913 . . . . 74.349999999999994 112.145 -171.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.64 -63.91 1.24 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.374 0.988 . . . . 73.430000000000007 108.876 172.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.77 -37.86 63.88 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.359 1.064 . . . . 70.040000000000006 110.581 -173.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -45.33 -36.72 4.33 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.675 1.59 . . . . 61.340000000000003 113.308 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -114.69 1.04 14.08 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.535 1.134 . . . . 72.319999999999993 112.976 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.8 t -77.36 147.18 36.24 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 126.215 1.806 . . . . 73.420000000000002 111.097 171.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.42 -27.79 26.36 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 118.703 2.853 . . . . 72.040000000000006 118.703 174.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 46.1 t -45.48 -57.15 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 C-N-CA 126.186 1.794 . . . . 74.349999999999994 107.924 167.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.3 t -68.65 -45.45 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 123.81 0.844 . . . . 70.209999999999994 109.576 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 58.3 mttt -54.41 -48.7 71.3 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.453 1.024 . . . . 74.129999999999995 112.428 -174.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 66.0 m -79.09 -22.0 45.88 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 113.183 0.809 . . . . 71.439999999999998 113.183 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 13.4 mt -69.15 -51.41 38.53 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 119.668 1.122 . . . . 63.119999999999997 110.172 167.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 52.9 t -49.84 -51.54 15.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.162 0 C-N-CA 125.209 1.404 . . . . 70.439999999999998 108.298 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.55 -39.09 75.89 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 118.067 -0.968 . . . . 65.150000000000006 113.101 -176.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -57.9 -46.56 84.76 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 119.399 0.999 . . . . 72.049999999999997 111.169 172.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.41 ' HB3' ' CE1' ' A' ' 60' ' ' HIS . 56.2 mt-30 -82.22 -31.61 30.18 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.901 -1.045 . . . . 71.010000000000005 109.226 -163.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -66.12 -52.74 45.74 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.635 -0.876 . . . . 73.519999999999996 108.635 167.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.9 ttmm -61.6 -7.77 3.68 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.132 -0.98 . . . . 63.350000000000001 113.449 177.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.4 -12.07 9.42 Favored 'General case' 0 CA--C 1.515 -0.394 0 O-C-N 120.27 -1.519 . . . . 72.209999999999994 114.545 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.508 ' HB1' HG12 ' A' ' 61' ' ' VAL . . . -134.17 1.01 3.18 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 119.038 0.835 . . . . 63.340000000000003 112.633 -175.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.32 0.85 4.6 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.835 1.654 . . . . 63.450000000000003 111.248 171.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -65.12 -86.56 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.878 0.871 . . . . 73.510000000000005 111.676 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.5 pp -175.81 23.95 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.351 0.978 . . . . 74.430000000000007 112.003 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -103.75 -71.91 0.72 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 120.151 1.341 . . . . 73.120000000000005 109.539 -168.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.53 -74.12 0.4 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 126.512 1.925 . . . . 61.43 110.431 -169.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 60.27 7.62 1.32 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 128.239 2.616 . . . . 71.450000000000003 115.304 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -147.18 146.42 16.22 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 109.034 -1.627 . . . . 63.310000000000002 109.034 176.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 5.2 m -137.14 169.15 13.99 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 118.271 1.035 . . . . 45.049999999999997 111.005 -172.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.426 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 69.3 Cg_endo -71.86 162.45 89.31 Favored 'Cis proline' 0 C--N 1.348 0.522 0 CA-C-N 119.596 0.892 . . . . 71.150000000000006 112.719 -10.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -150.56 156.53 41.57 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 124.252 0.97 . . . . 52.130000000000003 111.457 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 43.1 ttm -143.55 119.06 10.34 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.04 1.336 . . . . 63.030000000000001 107.749 169.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -97.36 132.02 43.48 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.927 1.291 . . . . 72.420000000000002 107.629 175.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 184' ' ' LEU . 95.8 t -96.23 -35.8 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 113.549 0.944 . . . . 65.030000000000001 113.549 -173.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -150.9 31.61 0.62 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.819 0.819 . . . . 64.010000000000005 109.571 -177.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 69.35 -64.73 0.57 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 126.194 1.854 . . . . 30.41 110.147 -162.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -58.95 -18.46 33.87 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 116.767 2.136 . . . . 71.230000000000004 116.767 -170.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -128.57 133.94 48.5 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 119.154 0.888 . . . . 74.349999999999994 111.252 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.79 137.15 52.28 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 105.773 -1.936 . . . . 63.009999999999998 105.773 175.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.07 143.11 58.07 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.744 -1.206 . . . . 72.010000000000005 107.744 176.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -124.66 75.55 64.03 Favored Pre-proline 0 C--O 1.234 0.275 0 C-N-CA 122.851 0.46 . . . . 61.039999999999999 110.22 -175.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -68.32 -22.56 39.62 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 120.831 1.021 . . . . 65.329999999999998 111.346 -172.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.55 -32.43 28.15 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 114.029 1.122 . . . . 50.240000000000002 114.029 171.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -103.13 4.78 48.98 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-O 118.325 -1.264 . . . . 70.040000000000006 112.687 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 62.1 mtt -80.3 174.49 11.55 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 119.814 1.807 . . . . 71.299999999999997 109.241 172.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -75.06 106.89 6.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.703 -1.592 . . . . 70.040000000000006 106.703 166.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.455 HG22 ' CD1' ' A' ' 173' ' ' PHE . 80.7 p -114.99 28.8 8.47 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.927 1.691 . . . . 72.439999999999998 109.444 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 75.2 m -108.95 -1.09 19.28 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 114.224 1.194 . . . . 31.140000000000001 114.224 -175.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -129.26 -9.93 4.7 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 124.386 1.074 . . . . 63.0 110.999 177.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 5.5 mmt 70.67 -58.97 0.54 Allowed 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.304 2.242 . . . . 74.400000000000006 112.262 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -58.52 -49.29 77.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 122.836 1.303 . . . . 72.099999999999994 109.699 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 93.3 t -63.56 -27.77 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 125.935 1.694 . . . . 52.420000000000002 111.433 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.455 ' CD1' HG22 ' A' ' 167' ' ' THR . 30.5 t80 -64.12 -59.24 4.69 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 107.8 -1.185 . . . . 71.109999999999999 107.8 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 5.9 t -69.19 -33.0 56.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 117.626 0.194 . . . . 74.040000000000006 110.913 -172.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.13 77.87 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.036 0.534 . . . . 73.239999999999995 111.23 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -82.6 -34.35 27.66 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 118.544 -0.741 . . . . 63.340000000000003 112.218 172.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -55.9 -57.64 11.25 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 120.208 1.367 . . . . 72.040000000000006 110.471 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.67 -30.46 67.38 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.411 0.684 . . . . 44.439999999999998 111.979 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -72.38 -50.83 23.68 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.44 1.496 . . . . 71.319999999999993 109.956 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.71 HG23 HG21 ' A' ' 3' ' ' ILE . 96.2 m -55.39 -39.16 69.8 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.165 1.386 . . . . 74.219999999999999 110.731 174.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 91.3 t -59.48 -58.41 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 108.101 -1.074 . . . . 64.299999999999997 108.101 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -59.99 -35.06 74.21 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.278 -0.868 . . . . 72.439999999999998 111.309 -177.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -59.96 -44.21 94.57 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 119.523 1.056 . . . . 70.219999999999999 110.78 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.443 ' HB2' HG11 ' A' ' 154' ' ' VAL . 77.9 mt -67.9 -25.5 65.53 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 121.047 -1.033 . . . . 65.109999999999999 111.835 -176.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 93.1 t -66.19 -22.08 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 O-C-N 121.253 -0.904 . . . . 64.129999999999995 111.177 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -102.96 -7.34 21.55 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.622 0.769 . . . . 72.209999999999994 110.401 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -125.94 75.72 1.53 Allowed 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.574 1.549 . . . . 74.030000000000001 109.24 -172.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.245 0.86 0 N-CA-C 106.019 -1.845 . . . . 62.140000000000001 106.019 167.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 44.8 m . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 110.511 -0.181 . . . . 65.140000000000001 110.511 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -79.65 -12.19 59.83 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.225 1.195 . . . . 74.099999999999994 114.225 -173.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -73.27 33.91 0.08 Allowed 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.377 1.471 . . . . 72.329999999999998 114.182 -166.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -159.89 120.74 3.09 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.588 -1.634 . . . . 62.43 106.588 171.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.2 pt -122.47 154.04 27.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 127.54 2.336 . . . . 72.430000000000007 106.869 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.0 m -129.21 134.77 48.14 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.075 -1.454 . . . . 71.319999999999993 107.075 -175.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -57.31 140.29 50.47 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 123.723 0.639 . . . . 54.5 109.667 170.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 84.61 -23.14 7.79 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.275 1.417 . . . . 73.340000000000003 112.587 -172.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.7 tptp -95.05 -85.53 0.31 Allowed 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 119.472 1.636 . . . . 72.310000000000002 109.092 -169.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -90.17 -19.13 24.59 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.983 0.913 . . . . 74.409999999999997 110.899 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -135.18 163.74 29.26 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.937 0.895 . . . . 73.0 109.53 171.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.5 mm -124.97 161.25 29.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 127.337 2.255 . . . . 61.329999999999998 105.525 174.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.6 m -119.68 147.61 44.36 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.804 1.242 . . . . 54.439999999999998 108.362 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 31.3 mt -76.35 155.74 33.88 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.022 -0.732 . . . . 70.0 109.022 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -71.81 -37.41 70.38 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 122.308 1.051 . . . . 74.140000000000001 109.681 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -132.91 74.76 73.6 Favored Pre-proline 0 C--N 1.339 0.129 0 C-N-CA 126.463 1.905 . . . . 74.120000000000005 109.356 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.2 137.05 39.32 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.113 1.875 . . . . 53.420000000000002 107.588 171.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.7 tp -149.71 164.85 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 108.355 -0.98 . . . . 72.129999999999995 108.355 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.01 158.04 33.89 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.991 -0.744 . . . . 65.310000000000002 108.991 167.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 122.53 -10.03 9.23 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-O 119.12 -0.822 . . . . 53.509999999999998 113.835 176.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -105.79 165.18 13.54 Favored Pre-proline 0 C--O 1.241 0.64 0 C-N-CA 125.546 1.539 . . . . 64.219999999999999 108.531 172.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -72.31 -179.71 4.27 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.46 2.107 . . . . 65.219999999999999 112.988 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.57 -46.34 90.32 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.523 1.529 . . . . 65.349999999999994 111.634 -174.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.6 m -151.06 173.14 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 127.781 2.433 . . . . 65.299999999999997 106.683 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.436 HD23 ' CE2' ' A' ' 25' ' ' PHE . 5.7 tp -162.05 169.69 20.55 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.165 -0.679 . . . . 65.319999999999993 109.165 163.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -136.72 131.02 32.91 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 106.715 -1.587 . . . . 74.019999999999996 106.715 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.436 ' CE2' HD23 ' A' ' 23' ' ' LEU . 96.0 m-85 -119.14 128.13 53.98 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 118.57 0.623 . . . . 71.209999999999994 109.82 171.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -141.18 173.32 11.6 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.503 1.121 . . . . 70.120000000000005 108.821 164.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.5 t -128.37 179.7 5.49 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.509 -0.552 . . . . 45.329999999999998 109.509 168.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -87.5 -35.17 18.36 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 118.241 -0.885 . . . . 74.329999999999998 111.845 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.411 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 96.9 m-85 -83.84 -3.12 57.64 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 121.157 1.799 . . . . 61.329999999999998 112.891 -177.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.7 p -80.04 141.01 53.98 Favored Pre-proline 0 CA--C 1.541 0.615 0 O-C-N 119.97 -1.706 . . . . 52.240000000000002 110.143 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -83.65 -35.3 0.24 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 121.866 1.711 . . . . 70.140000000000001 113.071 -170.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.82 -48.96 72.15 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 109.464 -0.569 . . . . 70.340000000000003 109.464 172.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.6 m -52.36 -33.88 45.13 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.065 1.346 . . . . 65.140000000000001 111.556 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -63.49 -55.73 21.73 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.819 0.736 . . . . 74.109999999999999 110.863 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -55.79 -44.29 77.63 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 121.185 -0.947 . . . . 65.299999999999997 109.024 175.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -64.71 -15.69 61.8 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 116.057 -1.925 . . . . 54.509999999999998 111.071 -174.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -141.54 12.79 2.13 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 121.457 1.935 . . . . 73.420000000000002 114.333 -171.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -135.69 -14.63 1.88 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.653 1.581 . . . . 72.120000000000005 112.115 167.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.2 t -124.34 -82.12 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.079 0 N-CA-C 107.795 -1.187 . . . . 65.310000000000002 107.795 -175.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.03 -29.36 67.22 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.714 2.006 . . . . 73.230000000000004 111.973 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 44.34 62.48 1.99 Allowed 'General case' 0 C--O 1.241 0.621 0 C-N-CA 126.005 1.722 . . . . 65.040000000000006 110.837 178.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.549 ' O ' HG23 ' A' ' 46' ' ' VAL . 99.7 t -63.05 -46.83 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 113.983 -1.462 . . . . 62.229999999999997 108.026 -173.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 95.2 p -49.72 -52.61 30.13 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.824 0.849 . . . . 54.340000000000003 111.014 -177.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.85 -31.8 65.01 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.132 0.573 . . . . 72.329999999999998 109.965 -171.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -64.73 -43.18 94.2 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 118.774 -0.632 . . . . 70.200000000000003 110.965 171.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 42' ' ' VAL . 1.9 t -59.57 -46.89 92.65 Favored 'Isoleucine or valine' 0 C--N 1.342 0.258 0 CA-C-N 119.251 0.932 . . . . 71.010000000000005 108.993 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -50.99 -42.13 60.09 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.193 0.997 . . . . 74.129999999999995 112.262 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -61.66 -5.43 1.91 Allowed 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.998 1.481 . . . . 63.409999999999997 114.998 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -127.08 -15.63 5.25 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.969 1.708 . . . . 71.329999999999998 113.219 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.553 HD13 HG21 ' A' ' 54' ' ' THR . 14.1 mt -67.71 149.68 98.17 Favored Pre-proline 0 N--CA 1.469 0.511 0 CA-C-N 119.964 1.256 . . . . 54.219999999999999 112.497 -164.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.19 151.83 27.04 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.449 2.766 . . . . 73.200000000000003 111.17 171.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -82.11 81.68 7.95 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 122.636 1.208 . . . . 73.129999999999995 109.091 -176.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 175.44 -30.42 0.08 OUTLIER Glycine 0 CA--C 1.521 0.439 0 C-N-CA 125.131 1.348 . . . . 52.329999999999998 110.665 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.553 HG21 HD13 ' A' ' 50' ' ' LEU . 10.7 t -44.02 -45.21 7.81 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.911 1.684 . . . . 74.439999999999998 113.398 -173.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? 59.48 99.63 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.626 1.97 . . . . 62.149999999999999 110.045 -169.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.79 125.67 25.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.361 -1.29 . . . . 43.450000000000003 107.65 172.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 m -137.32 161.71 35.51 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.075 -1.454 . . . . 74.030000000000001 107.075 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -151.51 110.45 3.87 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 104.335 -2.468 . . . . 71.25 104.335 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -104.36 136.68 43.48 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.836 -1.913 . . . . 73.129999999999995 105.836 168.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.54 ' H ' ' NE2' ' A' ' 137' ' ' GLN . 16.5 t-80 -82.86 169.68 15.81 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.043 -1.095 . . . . 71.450000000000003 108.043 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.3 m -131.22 136.22 58.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 108.698 -0.853 . . . . 74.040000000000006 108.698 170.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.47 5.18 11.29 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.626 1.17 . . . . 33.119999999999997 113.015 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -72.15 -177.43 2.09 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 122.71 1.243 . . . . 73.049999999999997 112.421 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 mp 63.8 -86.37 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 130.199 3.4 . . . . 71.219999999999999 112.588 177.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.411 ' HA3' ' CD2' ' A' ' 29' ' ' TYR . . . -72.7 160.87 54.23 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 124.03 0.824 . . . . 72.409999999999997 111.323 -176.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -65.27 -54.04 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.895 3.064 . . . . 45.310000000000002 110.052 -175.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.5 mt -73.62 8.78 1.68 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 117.777 -1.106 . . . . 73.010000000000005 113.425 -176.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -47.7 -33.19 8.87 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 120.135 1.334 . . . . 52.450000000000003 113.446 -177.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -58.61 -39.97 81.98 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.768 1.025 . . . . 74.109999999999999 113.768 175.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -62.21 -47.44 84.41 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.391 -0.966 . . . . 74.030000000000001 108.391 171.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.0 mt -54.18 -50.12 67.76 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 123.893 0.746 . . . . 52.549999999999997 110.191 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.7 m -57.29 -39.48 75.82 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.277 1.431 . . . . 72.439999999999998 112.955 173.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -68.04 -50.84 52.81 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.663 0.665 . . . . 74.030000000000001 110.375 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.78 -40.26 75.57 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 126.166 1.786 . . . . 52.310000000000002 111.678 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 46.2 t-105 -56.27 -35.21 67.19 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.041 0.536 . . . . 73.140000000000001 111.821 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.45 -40.36 94.2 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.246 -0.883 . . . . 65.340000000000003 111.798 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.5 t -57.46 -46.85 85.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 119.362 0.983 . . . . 72.349999999999994 108.896 172.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.16 -41.1 97.28 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-O 118.416 -0.802 . . . . 74.140000000000001 111.701 -176.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.7 mt -66.82 -43.36 89.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 118.107 -0.949 . . . . 65.219999999999999 109.765 175.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.29 93.81 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 119.185 0.902 . . . . 61.109999999999999 110.949 -174.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.8 mt -87.62 -12.52 45.32 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 119.038 -0.506 . . . . 73.019999999999996 112.265 175.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.44 61.83 6.66 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 126.148 1.832 . . . . 53.43 111.709 -174.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.9 m -134.18 20.23 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 125.361 1.464 . . . . 70.329999999999998 111.205 -177.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -50.38 -50.47 51.44 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.225 1.01 . . . . 71.25 110.0 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.18 -28.44 69.75 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.13 1.772 . . . . 52.329999999999998 110.623 -176.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -84.72 -25.24 28.48 Favored 'General case' 0 C--O 1.227 -0.11 0 C-N-CA 123.783 0.833 . . . . 74.349999999999994 111.671 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.1 pp -99.22 -15.4 7.44 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 CA-C-O 117.315 -1.326 . . . . 63.229999999999997 112.637 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.0 m -62.68 -45.7 91.57 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 119.863 1.21 . . . . 61.450000000000003 110.264 -170.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.526 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -56.8 -61.37 7.04 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 123.266 0.627 . . . . 61.420000000000002 111.385 -173.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 41.6 Cg_endo -66.72 -21.84 50.96 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.603 1.535 . . . . 72.140000000000001 112.735 -177.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.98 -53.77 53.98 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.08 0.952 . . . . 74.25 110.556 173.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -66.35 -33.32 75.47 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 118.083 0.401 . . . . 73.010000000000005 111.103 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.86 -38.25 81.59 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 120.15 -0.62 . . . . 64.409999999999997 110.925 169.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -86.52 -18.4 31.66 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 121.265 -0.897 . . . . 41.329999999999998 112.214 -168.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.7 t -107.93 -28.46 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 124.758 1.223 . . . . 73.049999999999997 109.822 -173.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -118.96 -53.5 2.27 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 118.887 0.767 . . . . 74.439999999999998 111.536 -173.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -64.99 -65.48 0.67 Allowed 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 118.62 0.645 . . . . 74.129999999999995 109.27 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.6 p -94.85 -18.29 21.31 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.04 0.536 . . . . 72.340000000000003 111.733 -170.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 45.34 39.79 4.71 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.503 2.321 . . . . 74.239999999999995 112.165 -175.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.0 t -73.77 -20.16 60.57 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.588 1.155 . . . . 72.420000000000002 111.466 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.417 HG13 HG12 ' A' ' 107' ' ' ILE . 31.9 t -69.38 117.87 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 108.29 -1.004 . . . . 65.420000000000002 108.29 172.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -137.6 -24.0 1.06 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.407 1.083 . . . . 74.109999999999999 111.575 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.43 177.34 11.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.079 2.152 . . . . 65.439999999999998 109.411 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.8 t -53.47 -46.0 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.264 1.826 . . . . 70.239999999999995 109.42 -173.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.04 -23.79 35.46 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.283 1.433 . . . . 65.019999999999996 112.713 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -91.83 -28.88 17.05 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 118.261 0.482 . . . . 54.240000000000002 110.091 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.417 HG12 HG13 ' A' ' 101' ' ' VAL . 0.5 OUTLIER -79.95 -46.34 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 123.205 0.602 . . . . 72.25 109.433 -175.093 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -25.35 61.83 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 112.932 0.715 . . . . 73.450000000000003 112.932 175.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -58.83 -52.46 65.62 Favored 'General case' 0 C--O 1.222 -0.342 0 N-CA-C 109.323 -0.621 . . . . 74.010000000000005 109.323 175.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.7 t -52.94 -43.69 47.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 123.862 0.865 . . . . 62.450000000000003 110.734 -176.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -55.1 -52.91 61.76 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.405 0.682 . . . . 73.430000000000007 110.392 175.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 96.7 t -65.64 -42.15 92.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 124.126 0.97 . . . . 72.150000000000006 111.242 -177.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.39 -51.26 65.4 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.673 1.589 . . . . 73.310000000000002 108.259 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.02 -13.64 60.89 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.408 1.083 . . . . 41.509999999999998 112.913 -178.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 118.08 32.89 1.32 Allowed Glycine 0 CA--C 1.524 0.612 0 C-N-CA 124.456 1.027 . . . . 64.150000000000006 114.92 165.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.9 t -97.96 134.96 34.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 119.452 1.626 . . . . 62.149999999999999 109.372 174.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.421 ' HG3' ' CB ' ' A' ' 120' ' ' ASP . 1.2 pttm -62.42 133.23 54.75 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.54 -1.209 . . . . 74.239999999999995 110.384 176.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.85 -20.73 66.81 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.061 -0.815 . . . . 70.129999999999995 111.061 168.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -76.84 -41.05 45.67 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.817 0.809 . . . . 74.439999999999998 111.163 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.421 ' CB ' ' HG3' ' A' ' 117' ' ' LYS . 36.8 t70 -69.84 -47.09 64.05 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 107.343 -1.354 . . . . 62.240000000000002 107.343 175.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -54.94 -52.48 62.87 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 123.778 0.673 . . . . 65.329999999999998 109.652 -172.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -72.24 -17.35 61.91 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.083 -1.011 . . . . 65.209999999999994 113.503 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.17 -71.56 0.47 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.074 -0.713 . . . . 74.450000000000003 109.074 172.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -46.46 -47.33 19.19 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 127.352 2.261 . . . . 61.310000000000002 109.886 -175.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 30.7 t-105 -48.77 -31.64 7.33 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.581 1.152 . . . . 64.209999999999994 113.288 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -113.05 3.18 16.01 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.277 2.231 . . . . 64.209999999999994 111.928 -176.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 21.8 m -93.93 159.11 15.32 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 126.266 1.827 . . . . 72.150000000000006 112.356 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -55.02 -34.11 63.21 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.259 1.823 . . . . 72.150000000000006 112.709 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.411 ' H ' HG23 ' A' ' 129' ' ' VAL . 14.5 t -51.71 -47.6 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.259 1.024 . . . . 72.340000000000003 110.166 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.3 t -72.77 -39.87 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 117.826 -1.083 . . . . 53.340000000000003 109.547 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.502 ' HA ' ' HE2' ' A' ' 131' ' ' LYS . 8.6 mmpt? -50.86 -48.78 60.07 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 120.713 1.597 . . . . 63.310000000000002 111.697 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 64.8 m -64.01 -49.87 70.75 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 122.217 -0.302 . . . . 70.010000000000005 111.546 175.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.4 mt -65.72 -32.06 73.41 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.202 0.816 . . . . 64.109999999999999 113.202 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 37.9 t -65.51 -62.58 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 126.169 1.788 . . . . 73.140000000000001 107.765 170.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.44 -39.89 58.29 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.649 0.78 . . . . 61.25 111.39 -175.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -47.62 -62.72 1.31 Allowed 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 117.383 -1.294 . . . . 71.150000000000006 110.574 175.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.54 ' NE2' ' H ' ' A' ' 60' ' ' HIS . 3.8 pt20 -81.41 -28.39 34.32 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 120.115 1.325 . . . . 74.120000000000005 113.997 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -59.19 -38.67 80.42 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 120.189 1.359 . . . . 74.140000000000001 108.736 176.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 8.4 tttt -79.46 -53.71 6.62 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.534 -0.729 . . . . 72.239999999999995 111.427 171.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.73 -6.95 6.35 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 117.255 -1.355 . . . . 73.239999999999995 113.704 -171.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.97 16.71 10.89 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.053 1.341 . . . . 54.329999999999998 113.457 172.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.13 4.61 1.08 Allowed 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.468 -0.77 . . . . 62.009999999999998 112.71 174.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.13 -79.04 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.535 1.134 . . . . 70.239999999999995 110.891 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -174.86 50.73 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.146 2.179 . . . . 34.43 110.359 175.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.479 ' NE2' ' H ' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -127.65 -55.2 1.32 Allowed 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.199 -0.938 . . . . 70.239999999999995 112.898 -175.24 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.479 ' H ' ' NE2' ' A' ' 145' ' ' GLN . 0.9 OUTLIER -147.18 143.69 28.39 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 128.08 2.552 . . . . 71.319999999999993 105.915 -172.435 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -137.33 14.91 3.0 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.11 0.964 . . . . 74.420000000000002 111.664 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -155.84 168.83 33.46 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.795 -1.322 . . . . 62.049999999999997 109.795 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.9 m -147.6 168.88 10.28 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.469 1.108 . . . . 73.420000000000002 111.102 -166.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.18 160.87 88.55 Favored 'Cis proline' 0 C--N 1.35 0.648 0 CA-C-N 119.953 1.019 . . . . 73.140000000000001 112.696 -9.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -149.61 154.51 38.77 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.611 0.764 . . . . 71.010000000000005 111.262 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 29.8 ttm -142.24 121.92 13.41 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.301 1.44 . . . . 70.319999999999993 107.258 172.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -94.28 152.62 18.54 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.737 1.615 . . . . 74.239999999999995 109.271 177.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.1 t -140.26 140.72 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.181 0.592 . . . . 65.430000000000007 109.948 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 44.67 30.34 0.51 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 129.17 2.988 . . . . 73.340000000000003 114.017 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 64.91 9.36 39.74 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.937 -0.924 . . . . 50.439999999999998 114.684 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -148.3 -2.8 0.51 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.431 1.615 . . . . 64.129999999999995 114.982 -165.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -131.07 161.84 31.15 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.931 1.292 . . . . 72.420000000000002 108.682 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -136.86 141.39 42.81 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.418 -1.697 . . . . 65.0 106.418 171.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.17 151.44 46.98 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 107.318 -1.364 . . . . 70.299999999999997 107.318 176.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -120.37 82.97 32.4 Favored Pre-proline 0 N--CA 1.462 0.138 0 CA-C-N 118.497 0.59 . . . . 72.030000000000001 111.474 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.48 -15.02 45.94 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 121.602 1.534 . . . . 74.219999999999999 113.608 175.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -90.21 -5.63 56.16 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 125.686 1.594 . . . . 74.409999999999997 111.225 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -117.67 18.01 11.91 Favored Glycine 0 CA--C 1.526 0.724 0 O-C-N 121.081 -1.012 . . . . 62.0 112.518 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 64.0 mtt -101.37 170.01 8.51 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.711 1.256 . . . . 63.030000000000001 110.398 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -66.05 120.92 13.99 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 105.893 -1.892 . . . . 74.129999999999995 105.893 158.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.432 1.1 t -136.38 63.01 1.6 Allowed 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 105.652 -1.981 . . . . 70.219999999999999 105.652 175.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.2 t -129.91 -15.77 3.79 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.171 1.788 . . . . 63.020000000000003 113.258 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -127.28 -3.32 6.24 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.0 1.273 . . . . 71.409999999999997 112.334 -174.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 7.9 mmt 62.81 -43.04 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 131.543 3.937 . . . . 53.140000000000001 114.618 -177.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.98 -48.84 33.0 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.281 -1.007 . . . . 50.409999999999997 108.281 -176.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 71.5 t -61.32 -28.57 44.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 125.342 1.457 . . . . 74.129999999999995 111.769 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -63.39 -57.69 9.51 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.167 -1.049 . . . . 74.099999999999994 108.167 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.9 t -74.67 -28.62 22.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 119.472 -0.299 . . . . 73.299999999999997 110.947 -175.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.97 -40.82 73.82 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.123 0.969 . . . . 65.010000000000005 110.761 175.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -83.87 -42.55 16.26 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 117.803 -1.094 . . . . 73.019999999999996 111.413 174.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -50.48 -55.65 15.04 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 120.202 1.365 . . . . 70.439999999999998 110.224 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -54.27 -34.51 60.98 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.902 0.881 . . . . 70.340000000000003 112.401 -177.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -78.47 -52.27 8.78 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.208 0.603 . . . . 74.319999999999993 109.852 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.2 t -58.03 -28.77 64.78 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-O 117.74 -1.124 . . . . 54.520000000000003 110.861 -176.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 61.0 t -54.95 -57.4 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 118.777 0.717 . . . . 74.219999999999999 109.463 170.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -32.2 71.84 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 119.1 0.864 . . . . 70.439999999999998 111.96 -178.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -60.11 -31.88 70.46 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 119.045 0.839 . . . . 72.409999999999997 110.527 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 29.0 mt -73.39 -28.41 62.0 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.342 -0.849 . . . . 65.230000000000004 111.793 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 74.9 t -65.53 -23.25 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.901 0.88 . . . . 73.0 111.306 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -99.15 -17.9 17.95 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.127 0.571 . . . . 74.430000000000007 109.962 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -102.77 77.74 1.62 Allowed 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 125.232 1.413 . . . . 65.400000000000006 108.526 -171.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? . . . . . 0 C--O 1.249 1.046 0 CA-C-O 114.502 -2.666 . . . . 65.109999999999999 112.962 -178.715 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.826 0.346 . . . . 73.040000000000006 110.87 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 58.47 178.42 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 53.439999999999998 110.889 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 51.75 42.58 29.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 71.040000000000006 111.112 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -175.17 110.45 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 71.439999999999998 110.933 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.746 HD12 ' CE2' ' A' ' 9' ' ' TYR . 5.0 pt -122.12 164.08 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 72.109999999999999 111.115 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.7 m -138.24 142.74 39.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 74.200000000000003 111.101 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -65.1 132.9 50.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 70.010000000000005 110.873 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.15 6.22 81.97 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.753 . . . . 72.519999999999996 112.518 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -117.47 -74.59 0.6 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.717 0.294 . . . . 33.109999999999999 110.839 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -101.19 -19.36 15.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.433 . . . . 65.439999999999998 110.918 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.746 ' CE2' HD12 ' A' ' 3' ' ' ILE . 20.3 p90 -144.66 157.9 44.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 70.439999999999998 110.942 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.738 HD13 ' O ' ' A' ' 9' ' ' TYR . 7.8 mm -129.69 160.76 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 64.549999999999997 111.149 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.408 ' N ' HG22 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -118.54 138.21 52.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 70.530000000000001 111.154 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' A' ' 157' ' ' LYS . 19.7 mt -67.84 151.67 46.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 51.25 110.827 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.14 -27.03 48.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 44.219999999999999 110.858 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -140.11 66.58 31.94 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.597 0.713 . . . . 75.549999999999997 110.913 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 77.07 1.08 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.652 2.234 . . . . 75.439999999999998 112.419 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.406 HG23 ' O ' ' A' ' 16' ' ' ILE . 5.6 tt -158.29 122.1 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 71.340000000000003 111.123 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -179.29 -67.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 63.450000000000003 111.077 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -141.01 -60.53 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.861 -0.685 . . . . 75.019999999999996 112.541 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 51.44 66.65 5.04 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.665 0.745 . . . . 71.409999999999997 110.875 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -54.55 0.22 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.619 2.213 . . . . 51.409999999999997 112.35 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.837 ' O ' HG22 ' A' ' 22' ' ' VAL . 1.9 tt0 177.38 79.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 71.030000000000001 110.858 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.837 HG22 ' O ' ' A' ' 21' ' ' GLN . 2.9 m 51.8 167.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.426 . . . . 71.049999999999997 111.154 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.77 HD11 ' CD1' ' A' ' 59' ' ' TYR . 15.7 tp -178.03 151.99 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 44.409999999999997 110.898 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -128.55 166.42 18.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 70.25 110.902 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.43 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 47.6 m-85 -144.45 136.69 26.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 73.530000000000001 110.866 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -173.14 147.63 1.6 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 64.409999999999997 110.931 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.3 t -101.1 -168.28 1.54 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 52.039999999999999 110.863 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.412 ' CD1' HD13 ' A' ' 71' ' ' LEU . 18.0 m-85 -115.8 -8.45 11.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 74.099999999999994 110.884 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.562 ' HE1' HD11 ' A' ' 71' ' ' LEU . 54.8 m-85 -113.76 18.59 17.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 74.430000000000007 110.911 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.8 p -103.38 138.61 19.59 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.567 0.698 . . . . 72.519999999999996 110.892 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.91 -41.84 3.75 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.707 2.271 . . . . 74.519999999999996 112.268 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -59.42 -64.22 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 72.219999999999999 110.789 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.6 p -49.78 -32.55 14.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.464 . . . . 74.510000000000005 110.885 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -63.75 -53.07 56.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 63.140000000000001 110.896 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -67.61 -11.01 57.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 74.409999999999997 110.864 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -104.08 0.94 30.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.31 -0.404 . . . . 73.099999999999994 110.924 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -141.53 13.1 2.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 74.140000000000001 110.913 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -141.99 -52.39 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 65.200000000000003 110.921 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 67.6 t -92.8 -78.42 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 64.340000000000003 111.114 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.8 mt -59.33 -41.44 89.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 44.439999999999998 110.841 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 2.2 m80 53.8 72.43 0.44 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 70.040000000000006 110.856 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.489 HG22 HG13 ' A' ' 174' ' ' VAL . 80.0 t -72.51 -33.89 46.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 61.229999999999997 111.124 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.5 t -52.74 -42.59 65.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 70.219999999999999 110.796 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -82.72 2.29 34.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.119 -0.492 . . . . 72.439999999999998 110.939 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -102.7 -21.36 14.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 73.329999999999998 110.867 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.67 HG12 ' HG ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -85.14 -53.92 9.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 65.219999999999999 110.929 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -46.59 -33.57 4.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 74.109999999999999 110.922 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -71.16 -30.95 67.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.481 . . . . 62.32 110.947 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 46' ' ' VAL . 4.2 mmmt -121.17 28.13 8.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 74.230000000000004 110.915 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.67 ' HG ' HG12 ' A' ' 46' ' ' VAL . 12.5 mt -104.42 144.24 28.31 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.59 0.709 . . . . 63.409999999999997 110.885 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.82 159.12 54.54 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.713 2.275 . . . . 74.340000000000003 112.23 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.94 59.35 2.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 73.25 110.848 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.45 35.68 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.779 -0.724 . . . . 62.219999999999999 112.438 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.666 HG21 HD13 ' A' ' 50' ' ' LEU . 10.9 t -103.07 -30.71 10.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.811 0.339 . . . . 60.030000000000001 111.129 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 62.89 107.65 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 63.119999999999997 110.928 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.75 102.03 8.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 63.049999999999997 110.93 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -105.36 -178.94 3.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 72.340000000000003 111.185 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.422 ' H ' HG22 ' A' ' 57' ' ' THR . 5.7 mttm 178.33 110.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 71.439999999999998 110.888 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.77 ' CD1' HD11 ' A' ' 23' ' ' LEU . 2.7 m-30 -101.14 124.49 46.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 74.219999999999999 110.939 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.853 ' CE1' HG22 ' A' ' 72' ' ' THR . 0.7 OUTLIER -60.84 175.14 0.52 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 61.530000000000001 110.862 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 60' ' ' HIS . 3.6 m -154.97 129.72 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 74.219999999999999 111.115 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.24 75.46 0.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 73.150000000000006 110.91 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -135.94 3.81 2.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 64.519999999999996 110.908 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.05 163.65 32.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.481 . . . . 54.229999999999997 110.906 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.84 155.25 0.12 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 42.32 112.465 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -42.83 3.09 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.642 2.228 . . . . 70.219999999999999 112.418 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.744 HD11 ' O ' ' A' ' 102' ' ' GLN . 92.7 mt -93.83 38.7 1.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.457 . . . . 63.210000000000001 110.968 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.32 -20.32 75.08 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.804 -0.713 . . . . 63.509999999999998 112.498 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -85.38 -33.94 21.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.801 0.334 . . . . 73.349999999999994 110.903 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.38 -46.82 72.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 65.519999999999996 110.849 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.594 HD23 HG21 ' A' ' 107' ' ' ILE . 3.6 mt -60.74 -37.49 81.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 71.439999999999998 110.918 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.853 HG22 ' CE1' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -50.14 -65.41 0.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 71.349999999999994 111.156 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -51.16 -44.33 61.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 74.239999999999995 110.837 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.413 ' HB1' ' CZ ' ' A' ' 111' ' ' PHE . . . -54.91 -35.92 64.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.406 . . . . 63.149999999999999 111.138 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 13.0 t-105 -53.66 -48.55 69.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 72.540000000000006 110.949 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.664 ' HB3' HG13 ' A' ' 130' ' ' VAL . . . -49.44 -41.83 41.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 72.049999999999997 111.1 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.509 HG11 ' CD2' ' A' ' 121' ' ' TYR . 74.7 t -61.33 -34.35 60.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.263 -0.426 . . . . 62.450000000000003 111.122 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.92 -35.59 64.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 44.549999999999997 111.103 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -79.12 -33.13 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 74.340000000000003 111.092 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.77 -34.34 77.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 74.340000000000003 111.064 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.629 HD21 ' CG ' ' A' ' 120' ' ' ASP . 91.5 mt -98.86 -21.66 16.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 55.140000000000001 110.915 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.98 57.05 3.12 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.806 -0.711 . . . . 75.209999999999994 112.512 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.708 HG12 ' HD2' ' A' ' 86' ' ' LYS . 13.5 m -143.97 39.87 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.735 0.303 . . . . 64.150000000000006 111.115 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.04 -54.07 30.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 73.430000000000007 110.839 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.73 -17.82 57.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 51.420000000000002 110.827 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.708 ' HD2' HG12 ' A' ' 83' ' ' VAL . 14.8 mtpt -83.62 -27.18 29.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 71.040000000000006 110.891 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.712 HD13 ' CZ ' ' A' ' 111' ' ' PHE . 1.5 pp -114.08 41.32 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 73.310000000000002 111.122 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 66.8 m -118.46 -26.82 6.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 65.319999999999993 111.147 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.788 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -69.9 -60.99 3.22 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.593 0.711 . . . . 50.439999999999998 111.033 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 53.4 Cg_endo -69.72 -30.59 22.24 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.721 2.281 . . . . 70.420000000000002 112.309 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 33.4 tpp -60.39 -29.73 69.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.439 . . . . 52.009999999999998 110.869 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -90.41 -33.94 15.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.288 -0.414 . . . . 74.439999999999998 110.883 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -76.8 -8.69 57.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 73.430000000000007 110.881 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.604 ' HB1' HG22 ' A' ' 100' ' ' THR . . . -111.69 0.83 16.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 53.310000000000002 111.088 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.441 ' CG2' HG21 ' A' ' 101' ' ' VAL . 65.7 t -121.15 -30.65 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 65.299999999999997 111.149 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -110.5 -57.99 2.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 74.5 110.853 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -58.54 -76.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 64.420000000000002 110.838 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.4 p -83.49 -33.49 25.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 74.400000000000006 111.089 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 62.11 34.52 16.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 71.120000000000005 110.948 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.604 HG22 ' HB1' ' A' ' 94' ' ' ALA . 12.3 t -66.35 -19.79 65.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 72.540000000000006 111.142 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.697 HG13 HG12 ' A' ' 107' ' ' ILE . 53.5 t -64.36 115.29 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.32 -0.4 . . . . 62.329999999999998 111.07 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.744 ' O ' HD11 ' A' ' 67' ' ' LEU . 11.7 mt-30 -131.4 -39.68 1.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 65.230000000000004 110.937 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.49 166.04 22.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 62.130000000000003 110.817 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.0 t -57.87 -21.69 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.112 -0.495 . . . . 53.310000000000002 111.129 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.78 -5.29 52.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 32.32 111.128 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -108.42 -24.37 11.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 74.540000000000006 110.864 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.697 HG12 HG13 ' A' ' 101' ' ' VAL . 2.3 mt -84.37 -25.17 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 73.430000000000007 111.111 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.83 -26.61 49.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 74.340000000000003 110.811 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -62.5 -53.99 46.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.42 . . . . 71.150000000000006 110.883 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.475 HG13 ' HB2' ' A' ' 90' ' ' PRO . 99.8 t -50.62 -45.02 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.255 -0.429 . . . . 73.129999999999995 111.114 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.712 ' CZ ' HD13 ' A' ' 87' ' ' ILE . 7.9 m-85 -54.38 -48.28 71.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 74.450000000000003 110.905 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 89.7 t -69.37 -42.15 81.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 52.229999999999997 111.156 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.81 -22.33 35.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 72.5 110.877 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -86.09 -27.82 24.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 63.340000000000003 111.096 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.8 -20.54 1.63 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.787 -0.72 . . . . 65.129999999999995 112.523 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 93.9 t -51.46 133.79 12.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.896 0.379 . . . . 71.439999999999998 111.123 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.554 ' HE2' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -79.59 139.56 37.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 60.049999999999997 110.878 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.69 -8.18 59.87 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.693 -0.765 . . . . 44.240000000000002 112.481 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -90.0 -30.14 17.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.829 0.347 . . . . 74.450000000000003 110.908 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.629 ' CG ' HD21 ' A' ' 81' ' ' LEU . 17.6 t70 -88.69 -34.56 17.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 75.230000000000004 110.855 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.509 ' CD2' HG11 ' A' ' 77' ' ' VAL . 24.7 t80 -75.73 -30.63 59.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.472 . . . . 75.540000000000006 110.931 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -88.55 -10.84 47.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 73.319999999999993 110.834 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -106.12 -60.29 1.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 13.4 111.058 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.17 -38.33 57.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 61.140000000000001 111.141 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 21.7 t-105 -48.45 -39.68 23.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.43 . . . . 65.150000000000006 110.956 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -110.84 39.13 2.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 73.310000000000002 110.932 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 75.2 m -123.87 166.17 16.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 71.349999999999994 110.913 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -64.38 -34.63 78.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 75.409999999999997 110.862 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 38.6 t -50.15 -50.81 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 71.109999999999999 111.108 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.718 ' O ' HG23 ' A' ' 134' ' ' VAL . 41.0 t -72.8 -33.78 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.125 -0.488 . . . . 71.340000000000003 111.103 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.4 -59.01 6.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 52.049999999999997 110.895 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.19 -42.45 63.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 75.549999999999997 110.869 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.493 HD13 ' HA ' ' A' ' 76' ' ' ALA . 5.5 mt -58.66 -59.99 4.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 75.510000000000005 110.888 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 130' ' ' VAL . 39.9 t -48.4 -36.46 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 71.239999999999995 111.046 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.81 -49.3 71.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 64.219999999999999 111.093 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 47.4 mm-40 -54.15 -51.17 65.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 75.109999999999999 110.977 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -67.19 -50.39 61.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 74.140000000000001 110.957 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.492 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 20.0 mm-40 -59.16 -20.09 50.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 61.32 110.877 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -101.96 -15.36 16.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 63.350000000000001 110.893 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -100.5 -6.16 25.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 43.340000000000003 111.1 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.65 -4.45 8.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 74.319999999999993 111.143 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -120.47 0.11 10.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 52.009999999999998 111.138 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -69.98 -84.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 62.530000000000001 110.838 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 174.63 36.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.405 . . . . 74.549999999999997 110.896 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.457 ' NE2' ' H ' ' A' ' 145' ' ' GLN . 0.1 OUTLIER -120.7 -15.37 8.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 72.140000000000001 110.945 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.637 HD11 ' CB ' ' A' ' 151' ' ' ALA . 0.6 OUTLIER -164.15 146.87 9.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 65.420000000000002 110.837 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -152.56 20.05 0.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 74.109999999999999 110.906 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -144.9 167.1 27.3 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.793 -0.718 . . . . 65.540000000000006 112.467 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.492 ' HA ' ' C ' ' A' ' 150' ' ' PRO . 2.3 m -154.28 158.48 32.38 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.579 0.704 . . . . 65.129999999999995 111.187 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 149' ' ' VAL . 54.4 Cg_endo -69.64 167.74 69.62 Favored 'Cis proline' 0 C--N 1.341 0.153 0 C-N-CA 122.644 -1.815 . . . . 62.229999999999997 112.4 -0.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.637 ' CB ' HD11 ' A' ' 146' ' ' LEU . . . -157.27 109.26 2.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 42.329999999999998 111.04 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 2.5 ttm -106.11 114.93 29.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.419 . . . . 74.409999999999997 110.888 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.603 ' HE2' HD13 ' A' ' 146' ' ' LEU . 35.1 m-85 -94.33 129.21 41.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 70.25 110.898 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.706 HG11 ' HB2' ' A' ' 184' ' ' LEU . 31.9 t -108.9 121.86 62.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.49 . . . . 60.329999999999998 111.09 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.487 ' H ' HG12 ' A' ' 22' ' ' VAL . 0.7 OUTLIER 74.39 -60.16 0.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 75.25 110.88 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 151.02 -15.9 0.9 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.841 -0.695 . . . . 73.430000000000007 112.476 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.475 ' HA ' HD12 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -125.75 39.18 4.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.756 0.312 . . . . 74.109999999999999 110.904 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.421 ' CG ' HD22 ' A' ' 184' ' ' LEU . 78.3 m-85 -153.29 155.93 37.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 71.450000000000003 110.926 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -144.68 115.43 7.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 64.329999999999998 110.89 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.635 HD11 HG23 ' A' ' 180' ' ' THR . 3.4 mm? -51.34 140.36 17.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 63.509999999999998 110.903 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -122.33 76.62 43.68 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.607 0.718 . . . . 70.209999999999994 110.873 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -7.52 21.26 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.656 2.237 . . . . 63.509999999999998 112.393 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.27 -25.33 54.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 72.510000000000005 110.896 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -95.36 -8.95 58.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.777 -0.725 . . . . 50.219999999999999 112.503 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 6.9 mtt -77.6 173.35 12.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.784 0.326 . . . . 62.409999999999997 110.858 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -85.16 87.35 7.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 70.299999999999997 110.897 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.639 HG22 ' CD1' ' A' ' 173' ' ' PHE . 19.4 p -93.05 39.44 1.04 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 74.329999999999998 111.162 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.8 m -109.37 -14.16 14.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 73.200000000000003 110.864 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.38 -16.51 9.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 73.340000000000003 110.851 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.439 ' HE2' ' HA ' ' A' ' 170' ' ' MET . 7.4 mmt 71.94 -64.85 0.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 73.430000000000007 110.882 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.42 -45.68 69.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 53.539999999999999 110.849 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 63.6 t -69.83 -36.35 69.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 71.230000000000004 111.105 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.639 ' CD1' HG22 ' A' ' 167' ' ' THR . 30.2 t80 -55.53 -70.06 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 63.420000000000002 110.822 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.489 HG13 HG22 ' A' ' 42' ' ' VAL . 21.7 t -54.59 -37.95 40.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 64.230000000000004 111.13 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.2 -43.67 61.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 62.240000000000002 111.129 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -80.62 -33.48 35.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 70.299999999999997 110.884 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.626 ' O ' HG23 ' A' ' 181' ' ' VAL . 49.1 t80 -51.35 -65.94 0.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 74.340000000000003 110.923 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.85 -25.12 10.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 61.409999999999997 111.056 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -70.55 -55.12 9.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 72.239999999999995 110.86 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.635 HG23 HD11 ' A' ' 160' ' ' LEU . 7.1 t -65.36 -29.06 69.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 73.230000000000004 111.13 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 177' ' ' TYR . 84.1 t -68.39 -39.28 80.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 71.120000000000005 111.073 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.54 -21.89 41.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 75.439999999999998 110.907 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -81.3 -20.87 39.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.422 . . . . 70.120000000000005 110.853 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.706 ' HB2' HG11 ' A' ' 154' ' ' VAL . 20.0 mt -79.74 -35.56 38.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.302 -0.408 . . . . 74.129999999999995 110.889 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 87.0 t -59.77 -23.25 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 72.209999999999994 111.15 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -109.69 -5.24 15.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 73.219999999999999 110.846 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -105.7 28.96 6.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 75.019999999999996 110.921 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 74.049999999999997 110.832 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 14.6 t . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 118.683 -0.675 . . . . 74.310000000000002 109.968 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -138.96 21.01 2.64 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.793 1.179 . . . . 62.140000000000001 112.89 -164.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -68.17 38.52 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.931 1.693 . . . . 74.310000000000002 114.781 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -155.51 106.47 2.53 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 127.979 2.512 . . . . 65.010000000000005 107.255 -161.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.7 pt -129.44 149.45 33.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 127.219 2.208 . . . . 71.209999999999994 106.884 178.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.4 m -109.35 130.48 55.49 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.209 -1.034 . . . . 63.329999999999998 108.209 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -44.3 124.31 3.95 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 126.505 1.922 . . . . 70.349999999999994 110.155 159.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.67 -15.06 53.92 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 126.945 2.212 . . . . 74.409999999999997 113.653 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -95.02 -85.88 0.3 Allowed 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 119.98 1.89 . . . . 74.140000000000001 108.154 -174.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -85.75 -16.64 38.24 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.971 0.805 . . . . 71.230000000000004 111.394 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -139.64 163.1 33.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.637 0.375 . . . . 73.439999999999998 110.601 172.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.8 mm -120.64 158.18 23.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.651 -1.611 . . . . 74.019999999999996 106.651 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.4 m -109.56 134.47 51.88 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 126.001 1.72 . . . . 71.349999999999994 107.606 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.2 mt -84.04 144.9 28.78 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 108.031 -1.1 . . . . 64.219999999999999 108.031 172.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -76.08 -31.61 58.84 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.191 1.396 . . . . 74.439999999999998 111.397 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm -127.84 74.29 78.63 Favored Pre-proline 0 N--CA 1.455 -0.19 0 C-N-CA 125.439 1.496 . . . . 74.420000000000002 109.026 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -79.71 63.14 8.7 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.319 2.679 . . . . 62.450000000000003 109.511 174.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.6 tt -162.26 99.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 O-C-N 120.935 -1.103 . . . . 64.219999999999999 109.436 172.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.29 -169.33 2.93 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.035 2.134 . . . . 64.209999999999994 107.133 166.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.27 22.59 37.82 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 124.615 1.102 . . . . 54.140000000000001 112.725 -177.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -69.74 158.98 85.72 Favored Pre-proline 0 N--CA 1.451 -0.396 0 CA-C-N 117.649 0.724 . . . . 72.439999999999998 110.497 170.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.88 154.85 66.79 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 121.145 1.23 . . . . 72.049999999999997 110.47 173.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -66.69 -19.09 65.68 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 118.114 -0.946 . . . . 63.140000000000001 112.705 -175.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.614 HG11 ' H ' ' A' ' 55' ' ' LYS . 14.3 p -154.85 141.91 12.26 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 CA-C-N 120.194 1.361 . . . . 55.520000000000003 109.67 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -169.2 172.17 7.53 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.394 1.078 . . . . 74.030000000000001 110.953 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -130.75 148.55 52.55 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.585 1.954 . . . . 74.239999999999995 107.632 154.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -115.24 143.0 45.91 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.502 1.521 . . . . 73.430000000000007 107.658 164.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -153.77 165.63 35.41 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.326 1.451 . . . . 73.340000000000003 108.607 175.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.86 179.15 4.05 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.918 1.287 . . . . 74.310000000000002 108.249 175.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -97.54 -23.71 15.89 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.913 -0.492 . . . . 72.329999999999998 110.638 171.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -105.82 12.64 30.57 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.748 1.619 . . . . 74.450000000000003 111.876 -177.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.7 p -84.11 143.76 43.11 Favored Pre-proline 0 CA--C 1.541 0.602 0 O-C-N 120.274 -1.516 . . . . 72.519999999999996 109.562 167.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -83.11 -33.69 0.39 Allowed 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 121.832 1.688 . . . . 74.329999999999998 110.005 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -49.48 -60.57 2.73 Favored 'General case' 0 C--N 1.337 0.062 0 C-N-CA 125.881 1.673 . . . . 74.109999999999999 110.155 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 23.6 p -62.74 -34.72 77.78 Favored 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 123.227 0.611 . . . . 73.409999999999997 111.088 -176.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -56.45 -52.27 65.31 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.886 -0.783 . . . . 74.439999999999998 108.886 173.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -57.66 -44.78 85.96 Favored 'General case' 0 C--O 1.224 -0.248 0 O-C-N 121.081 -1.012 . . . . 71.200000000000003 109.174 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -68.05 -12.99 61.85 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.411 1.084 . . . . 74.109999999999999 113.231 -174.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -130.76 2.77 4.46 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.181 1.355 . . . . 73.430000000000007 110.747 -166.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -144.44 -48.01 0.26 Allowed 'General case' 0 C--N 1.345 0.408 0 C-N-CA 125.574 1.549 . . . . 72.439999999999998 112.527 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.1 t -91.87 -72.63 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 105.898 -1.89 . . . . 52.439999999999998 105.898 -173.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.8 mt -73.1 -26.08 61.12 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.043 1.737 . . . . 73.200000000000003 111.981 -175.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 29.2 m80 44.72 60.07 3.08 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 122.752 1.263 . . . . 71.239999999999995 112.118 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 46' ' ' VAL . 93.4 t -57.92 -54.8 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.437 1.495 . . . . 65.019999999999996 107.334 170.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.71 -43.18 36.96 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.338 1.055 . . . . 70.219999999999999 113.329 -178.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -73.61 -42.55 61.35 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.256 -0.903 . . . . 74.239999999999995 110.836 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -56.77 -51.99 66.78 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 123.507 0.723 . . . . 72.409999999999997 110.098 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.679 HG12 ' HG ' ' A' ' 50' ' ' LEU . 15.6 t -61.64 -43.88 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 108.364 -0.976 . . . . 73.230000000000004 108.364 -175.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -49.93 -46.03 51.71 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.717 1.598 . . . . 74.219999999999999 112.553 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -61.4 -20.97 63.66 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.751 1.019 . . . . 74.400000000000006 113.751 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -114.01 -7.17 13.12 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.089 0.956 . . . . 71.319999999999993 111.816 -175.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.679 ' HG ' HG12 ' A' ' 46' ' ' VAL . 13.1 mt -70.65 143.75 90.25 Favored Pre-proline 0 C--O 1.239 0.501 0 O-C-N 120.881 -1.137 . . . . 73.319999999999993 109.416 -173.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -76.31 169.57 21.71 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.777 2.318 . . . . 71.230000000000004 108.905 167.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.531 ' CD ' ' H ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -82.82 23.09 0.85 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 124.774 1.229 . . . . 73.019999999999996 113.44 -176.11 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -119.81 -19.04 4.17 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 126.61 2.052 . . . . 60.109999999999999 111.725 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 77.6 m -121.09 101.55 7.74 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 106.838 -1.541 . . . . 72.150000000000006 106.838 -164.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.614 ' H ' HG11 ' A' ' 22' ' ' VAL . 3.2 tppt? -87.68 126.62 35.07 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.55 0.74 . . . . 74.329999999999998 109.913 -177.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.02 45.75 0.28 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.415 1.886 . . . . 73.030000000000001 112.426 171.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.4 m -53.99 145.04 17.49 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.926 1.291 . . . . 74.239999999999995 108.651 173.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -131.55 99.46 4.81 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.152 -1.055 . . . . 73.120000000000005 108.152 -166.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -95.37 150.61 20.09 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.319 1.048 . . . . 73.219999999999999 110.066 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.586 ' CE1' HG22 ' A' ' 72' ' ' THR . 0.3 OUTLIER -88.0 175.58 7.7 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.451 -0.944 . . . . 65.129999999999995 108.451 -176.153 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -145.0 163.28 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 107.563 -1.273 . . . . 70.430000000000007 107.563 156.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.61 -5.42 10.72 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.654 1.182 . . . . 71.109999999999999 113.607 -174.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -58.15 -11.23 2.41 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.489 1.915 . . . . 74.109999999999999 115.244 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 mp -127.81 137.61 52.44 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 120.916 1.689 . . . . 73.439999999999998 110.702 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.96 170.44 45.27 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.746 2.117 . . . . 50.030000000000001 112.291 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.72 -53.21 0.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 124.514 3.476 . . . . 64.239999999999995 111.675 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.473 HD13 HD11 ' A' ' 107' ' ' ILE . 5.2 mt -84.4 14.32 4.57 Favored 'General case' 0 CA--C 1.528 0.104 0 N-CA-C 113.887 1.069 . . . . 73.450000000000003 113.887 -165.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.639 ' HA2' HD12 ' A' ' 71' ' ' LEU . . . -53.57 -38.9 59.33 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-O 118.873 -0.96 . . . . 33.229999999999997 112.846 -163.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp -53.6 -38.1 63.65 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.937 1.695 . . . . 61.25 113.327 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.435 ' OD1' HG22 ' A' ' 104' ' ' VAL . 9.8 t70 -76.3 -45.35 32.81 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 118.614 -0.707 . . . . 72.129999999999995 109.154 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.639 HD12 ' HA2' ' A' ' 68' ' ' GLY . 15.4 mt -54.98 -37.32 66.38 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 118.789 -0.624 . . . . 73.25 110.646 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.586 HG22 ' CE1' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -57.49 -52.9 63.52 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.987 0.915 . . . . 74.329999999999998 109.086 177.292 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -69.18 -50.44 47.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.294 -0.632 . . . . 74.430000000000007 109.294 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.0 -37.17 63.73 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.553 1.07 . . . . 71.310000000000002 113.607 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 29.8 t-105 -59.85 -38.37 81.89 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 119.759 1.163 . . . . 74.549999999999997 112.016 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.94 -39.66 74.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 118.633 -0.698 . . . . 73.430000000000007 111.31 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' A' ' 124' ' ' ALA . 56.3 t -56.41 -49.22 78.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 118.817 0.735 . . . . 74.530000000000001 109.543 174.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.97 -40.27 97.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 118.677 -0.678 . . . . 74.450000000000003 111.018 -175.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.0 mt -69.24 -40.27 80.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 118.157 -0.925 . . . . 65.230000000000004 110.417 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.36 -30.83 69.8 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.097 0.862 . . . . 74.049999999999997 110.818 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.7 mt -94.29 -14.99 24.86 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.824 0.85 . . . . 74.439999999999998 112.532 175.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 59.94 64.32 4.29 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 126.306 1.908 . . . . 71.430000000000007 112.3 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.9 m -137.42 19.9 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 124.362 1.065 . . . . 61.420000000000002 112.217 -177.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -50.69 -52.34 40.95 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.563 1.074 . . . . 73.030000000000001 111.251 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -60.07 -17.08 36.93 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.866 1.666 . . . . 72.109999999999999 114.219 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -94.85 -9.16 35.19 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.275 1.03 . . . . 72.439999999999998 110.748 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.5 pp -136.1 33.53 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 125.033 1.333 . . . . 65.319999999999993 110.875 -173.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 52.5 m -111.47 -41.62 4.07 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 118.8 -0.619 . . . . 71.109999999999999 110.382 177.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.44 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -66.85 -60.64 5.98 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 119.183 0.901 . . . . 70.409999999999997 110.958 -175.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 33.2 Cg_endo -62.53 -28.1 77.23 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 120.541 0.828 . . . . 72.510000000000005 111.286 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 29.4 tpp -59.41 -50.55 73.53 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.374 1.07 . . . . 71.510000000000005 110.846 176.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -72.34 -31.21 65.45 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.949 0.9 . . . . 50.439999999999998 109.786 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.65 -36.8 81.85 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.726 0.694 . . . . 74.409999999999997 109.626 171.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -85.91 -13.1 48.82 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.322 -0.861 . . . . 70.120000000000005 112.239 -176.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.7 t -101.5 -39.29 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 125.382 1.473 . . . . 72.230000000000004 111.722 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -109.78 -59.35 1.93 Allowed 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.544 1.137 . . . . 61.409999999999997 109.296 -172.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -67.0 -50.96 60.61 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 118.45 -0.786 . . . . 72.329999999999998 111.164 -169.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.9 p -104.86 -19.68 13.81 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 123.691 0.619 . . . . 64.400000000000006 112.658 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 53.72 23.76 3.9 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.51 1.924 . . . . 71.310000000000002 113.903 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -66.14 -18.16 65.17 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.361 1.064 . . . . 73.400000000000006 111.539 -173.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.405 HG13 HG12 ' A' ' 107' ' ' ILE . 53.0 t -62.13 119.56 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 121.141 -0.975 . . . . 53.109999999999999 108.479 171.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -141.54 -26.52 0.69 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.899 1.28 . . . . 71.420000000000002 111.377 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.37 160.92 39.11 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.179 -1.415 . . . . 72.239999999999995 107.179 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.435 HG22 ' OD1' ' A' ' 70' ' ' ASP . 24.2 t -57.65 -28.05 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.722 0.809 . . . . 71.310000000000002 110.718 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.9 -29.91 71.04 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.365 1.466 . . . . 74.430000000000007 110.185 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.92 -19.36 24.64 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.266 0.626 . . . . 65.510000000000005 111.385 -175.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.473 HD11 HD13 ' A' ' 67' ' ' LEU . 1.4 mt -82.57 -45.03 19.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 123.855 0.862 . . . . 72.209999999999994 108.958 174.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -59.57 -26.49 65.45 Favored 'General case' 0 C--N 1.346 0.441 0 O-C-N 121.557 -0.715 . . . . 72.129999999999995 112.299 -176.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -54.93 -55.24 32.86 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.301 1.04 . . . . 74.430000000000007 110.442 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.9 t -52.84 -45.64 50.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 124.933 1.293 . . . . 73.319999999999993 109.975 -175.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -55.8 -54.07 48.91 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.659 0.784 . . . . 74.150000000000006 110.149 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 17.5 t -66.59 -38.51 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 118.024 0.375 . . . . 50.130000000000003 110.27 -174.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -63.5 -32.01 73.34 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.126 0.971 . . . . 74.230000000000004 111.068 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -83.8 -3.38 57.81 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.673 1.189 . . . . 64.329999999999998 113.838 173.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.2 14.48 16.55 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-N 119.558 1.072 . . . . 53.530000000000001 115.332 171.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.9 t -77.66 128.28 38.15 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.055 0 CA-C-N 119.593 1.696 . . . . 43.219999999999999 108.545 172.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -57.26 129.38 41.5 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.686 -0.857 . . . . 70.349999999999994 108.686 170.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -59.55 -22.82 57.41 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 118.173 -1.349 . . . . 51.340000000000003 112.341 173.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.4 -23.41 21.07 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.876 1.338 . . . . 75.25 110.764 -177.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -70.59 -42.49 70.96 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 107.457 -1.312 . . . . 64.549999999999997 107.457 177.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.417 ' CD1' HG21 ' A' ' 77' ' ' VAL . 53.7 t80 -61.54 -59.47 5.17 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 124.181 0.926 . . . . 73.209999999999994 110.028 177.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -66.55 -16.73 64.37 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.276 0.489 . . . . 61.420000000000002 111.336 -176.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.43 -64.98 0.95 Allowed 'General case' 0 C--N 1.341 0.21 0 O-C-N 121.092 -1.005 . . . . 73.540000000000006 109.023 169.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.565 ' HB3' HG22 ' A' ' 77' ' ' VAL . . . -52.28 -43.35 64.4 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.272 1.029 . . . . 71.319999999999993 110.246 -175.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -46.07 -41.54 12.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.675 1.59 . . . . 73.25 112.23 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -103.94 -2.47 26.08 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.995 1.318 . . . . 63.140000000000001 111.553 -173.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.8 t -84.91 157.05 20.96 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 127.017 2.127 . . . . 72.209999999999994 111.495 -175.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -57.76 -31.15 66.22 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 125.505 1.522 . . . . 73.530000000000001 111.552 169.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 42.3 t -52.68 -50.1 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 119.248 0.931 . . . . 75.150000000000006 108.933 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.4 t -68.99 -39.89 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-O 118.923 -0.561 . . . . 74.129999999999995 110.42 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -53.71 -51.48 63.14 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.187 0.903 . . . . 74.439999999999998 110.685 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 t -67.34 -37.07 82.68 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.346 1.059 . . . . 64.510000000000005 111.207 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.88 -53.24 49.78 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-O 117.493 -1.241 . . . . 75.109999999999999 110.753 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 53.4 t -52.19 -38.74 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.178 1.391 . . . . 72.140000000000001 110.405 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.7 -34.77 76.34 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 118.361 -0.828 . . . . 75.140000000000001 112.777 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -55.32 -58.52 7.39 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.795 0.725 . . . . 71.319999999999993 110.655 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.485 ' HB2' ' CE1' ' A' ' 60' ' ' HIS . 0.9 OUTLIER -84.68 -33.3 23.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.182 -0.913 . . . . 62.310000000000002 110.951 -168.344 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -57.43 -52.92 63.41 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 119.145 0.884 . . . . 74.129999999999995 109.11 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -55.06 -48.49 73.4 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 110.144 -0.317 . . . . 75.129999999999995 110.144 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.9 -12.04 15.99 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 113.763 1.023 . . . . 75.25 113.763 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -130.14 18.65 5.46 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.809 1.244 . . . . 75.329999999999998 111.724 176.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -132.23 2.39 3.9 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.424 1.89 . . . . 72.530000000000001 111.651 173.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -83.51 22.77 1.01 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.036 1.734 . . . . 71.510000000000005 111.276 169.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 62.92 -16.89 0.05 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 130.375 3.47 . . . . 73.120000000000005 117.342 -175.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.56 -26.22 50.69 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 119.997 1.271 . . . . 61.549999999999997 111.942 -167.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 tt -134.56 111.98 10.49 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 126.2 1.8 . . . . 73.239999999999995 106.414 -173.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -140.63 22.09 2.33 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 127.306 2.242 . . . . 73.120000000000005 108.619 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -162.86 114.21 0.59 Allowed Glycine 0 C--N 1.337 0.595 0 N-CA-C 109.943 -1.263 . . . . 45.109999999999999 109.943 -171.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.521 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 2.7 m -120.91 171.01 6.37 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 118.239 1.02 . . . . 73.209999999999994 110.386 -176.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.521 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 91.2 Cg_endo -68.97 153.65 90.99 Favored 'Cis proline' 0 N--CA 1.456 -0.679 0 CA-C-N 120.342 1.158 . . . . 61.450000000000003 111.237 -4.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -146.81 108.6 4.36 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.564 -0.902 . . . . 54.329999999999998 108.564 -173.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 39.0 ttm -101.57 135.02 43.79 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.963 -1.125 . . . . 73.420000000000002 107.963 173.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -123.18 154.23 38.98 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.534 1.534 . . . . 74.230000000000004 107.982 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 96.6 t -115.23 -48.09 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 112.9 0.704 . . . . 72.310000000000002 112.9 -163.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -144.55 33.2 1.17 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 128.16 2.584 . . . . 74.439999999999998 107.609 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 65.63 5.33 23.27 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.469 1.509 . . . . 72.150000000000006 115.759 -175.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.416 ' HE2' ' CZ ' ' A' ' 158' ' ' TYR . 9.9 ptmt -124.57 -16.3 6.32 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 120.357 2.079 . . . . 71.439999999999998 114.725 -172.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.416 ' CZ ' ' HE2' ' A' ' 157' ' ' LYS . 23.3 m-85 -126.79 124.28 39.32 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.701 -1.592 . . . . 73.010000000000005 106.701 -176.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -98.69 135.47 40.14 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 105.706 -1.961 . . . . 53.310000000000002 105.706 172.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -74.91 146.0 42.2 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.936 -0.765 . . . . 73.329999999999998 108.936 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -119.6 85.24 32.16 Favored Pre-proline 0 C--O 1.233 0.211 0 N-CA-C 112.864 0.691 . . . . 72.329999999999998 112.864 -175.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -67.11 -22.13 47.79 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 121.282 1.321 . . . . 73.299999999999997 113.614 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.7 tp60 -68.68 -34.29 75.42 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 119.79 1.177 . . . . 73.0 110.093 176.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -92.02 30.76 6.4 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-O 118.966 -0.908 . . . . 64.439999999999998 111.177 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.6 mtt -122.04 176.35 5.85 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 118.681 1.241 . . . . 72.109999999999999 109.567 173.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.64 64.89 8.76 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 123.279 1.514 . . . . 73.299999999999997 111.075 -172.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 21.0 p -74.9 40.53 0.15 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 129.217 3.007 . . . . 70.420000000000002 110.901 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 3.8 m -124.06 -3.5 8.07 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.34 1.456 . . . . 71.040000000000006 111.646 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.78 -10.31 2.08 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.484 1.114 . . . . 70.030000000000001 112.029 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 8.7 mmt 70.81 -56.69 0.61 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.625 1.97 . . . . 74.0 114.315 174.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.34 -45.61 75.87 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.782 -1.192 . . . . 74.230000000000004 107.782 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 82.5 t -63.15 -31.37 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.488 1.515 . . . . 74.140000000000001 111.577 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -60.21 -56.01 26.84 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.014 -0.736 . . . . 73.010000000000005 109.014 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 t -70.74 -34.43 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 119.145 -0.455 . . . . 74.340000000000003 110.775 -176.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.72 -35.31 63.54 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.507 0.723 . . . . 74.310000000000002 110.77 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -78.87 -44.67 22.34 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.699 1.199 . . . . 74.340000000000003 112.741 168.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -56.97 -58.04 9.9 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.716 1.144 . . . . 73.099999999999994 111.349 -173.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -55.68 -31.84 62.74 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.561 -0.733 . . . . 54.200000000000003 112.149 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -68.34 -58.15 4.82 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.8 0.727 . . . . 74.420000000000002 109.869 177.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.9 t -60.53 -29.26 69.01 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 119.064 -0.493 . . . . 74.109999999999999 110.554 -172.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 98.0 t -55.42 -57.23 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.318 -0.993 . . . . 71.349999999999994 108.318 171.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.63 -46.3 90.39 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.129 0.972 . . . . 73.0 111.16 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -60.26 -18.49 49.39 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.267 1.427 . . . . 73.400000000000006 113.383 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.622 HD23 ' HD3' ' A' ' 187' ' ' LYS . 69.1 mt -92.56 -23.33 19.09 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 121.508 -0.745 . . . . 75.430000000000007 112.927 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 66.8 t -63.14 -35.81 73.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.068 -0.716 . . . . 62.130000000000003 109.068 174.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -83.58 -18.41 38.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.417 -0.81 . . . . 65.319999999999993 110.142 -172.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.622 ' HD3' HD23 ' A' ' 184' ' ' LEU 0.305 0.0 OUTLIER -77.75 15.78 0.79 Allowed 'General case' 0 CA--C 1.545 0.759 0 O-C-N 120.751 -1.218 . . . . 74.319999999999993 113.776 -168.101 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.433 -1.279 0 C-N-CA 129.4 3.08 . . . . 64.209999999999994 109.422 -152.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.468 0.453 0 N-CA-C 109.05 -0.722 . . . . 74.230000000000004 109.05 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -112.58 7.73 18.94 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.351 1.461 . . . . 73.439999999999998 112.096 -171.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -72.24 43.44 0.1 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.301 1.84 . . . . 70.140000000000001 112.815 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.22 122.2 4.98 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 104.205 -2.517 . . . . 71.519999999999996 104.205 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.1 pt -126.77 156.89 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 126.519 1.927 . . . . 72.120000000000005 107.33 170.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 99.4 m -135.08 130.34 35.39 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.639 1.575 . . . . 72.430000000000007 106.76 -171.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -57.35 137.43 56.1 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.315 -0.624 . . . . 72.239999999999995 109.315 171.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.74 -21.97 12.97 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.21 1.386 . . . . 44.119999999999997 113.217 -171.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -99.9 -85.58 0.4 Allowed 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 119.895 1.848 . . . . 73.25 109.004 -172.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -88.93 -14.17 37.31 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.656 1.116 . . . . 62.439999999999998 111.509 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -138.24 170.77 15.44 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.766 0.826 . . . . 65.439999999999998 109.587 169.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.4 mm -128.4 154.24 38.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 105.771 -1.937 . . . . 74.549999999999997 105.771 170.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.0 m -108.88 140.22 42.65 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.711 1.605 . . . . 73.420000000000002 108.357 175.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 74.5 mt -79.38 142.07 36.33 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.176 -1.046 . . . . 74.420000000000002 108.176 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -70.72 -40.91 72.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 122.612 1.196 . . . . 71.450000000000003 109.17 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -125.73 83.82 61.71 Favored Pre-proline 0 N--CA 1.455 -0.193 0 C-N-CA 127.345 2.258 . . . . 65.239999999999995 107.12 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -77.46 69.45 7.22 Favored 'Trans proline' 0 N--CA 1.444 -1.408 0 C-N-CA 123.923 3.082 . . . . 74.510000000000005 108.579 170.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.6 mt -134.08 148.48 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 107.118 -1.438 . . . . 72.129999999999995 107.118 172.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 174.46 -80.13 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.925 2.49 . . . . 52.329999999999998 108.679 147.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 159.04 37.76 0.02 OUTLIER Glycine 0 C--N 1.333 0.416 0 CA-C-O 118.575 -1.125 . . . . 43.130000000000003 113.826 -174.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -113.73 161.61 26.75 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 107.184 -1.413 . . . . 65.510000000000005 107.184 168.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.11 169.81 21.76 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 CA-C-N 120.128 1.081 . . . . 65.109999999999999 113.514 -157.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -68.49 16.64 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 127.699 2.4 . . . . 71.340000000000003 114.47 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.5 p -171.88 125.62 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 127.402 2.281 . . . . 70.219999999999999 107.337 177.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.449 HD23 ' CE2' ' A' ' 25' ' ' PHE . 2.8 tp -166.53 160.56 15.4 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 120.036 1.289 . . . . 73.530000000000001 112.456 172.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' H ' ' HG ' ' A' ' 23' ' ' LEU . 16.4 mt-10 -141.36 136.04 31.07 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.045 1.338 . . . . 73.329999999999998 108.237 -171.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.449 ' CE2' HD23 ' A' ' 23' ' ' LEU . 83.3 m-85 -128.63 140.98 51.5 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.981 2.112 . . . . 61.219999999999999 109.874 -176.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -151.39 177.55 10.17 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 128.54 2.736 . . . . 74.25 107.97 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.3 t -139.29 -177.07 4.75 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.474 -0.766 . . . . 72.209999999999994 109.852 155.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -84.11 -51.79 6.79 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.626 1.57 . . . . 63.210000000000001 109.473 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -80.44 -13.83 58.8 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.265 0.839 . . . . 71.129999999999995 113.265 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.7 p -69.51 145.0 94.96 Favored Pre-proline 0 C--O 1.237 0.409 0 CA-C-N 119.743 1.156 . . . . 53.43 110.867 -175.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -70.7 175.61 8.64 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 121.251 1.301 . . . . 72.549999999999997 109.682 164.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 68.85 -55.08 0.55 Allowed 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 127.495 2.318 . . . . 71.409999999999997 111.218 -175.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 32.4 m -44.67 -41.03 6.37 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.133 2.173 . . . . 75.329999999999998 110.741 174.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -53.52 -68.4 0.18 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.303 1.841 . . . . 74.209999999999994 111.036 174.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -54.14 -44.28 71.27 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.726 -0.842 . . . . 75.530000000000001 108.726 -175.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -64.86 -13.11 55.19 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 116.532 -1.699 . . . . 74.530000000000001 113.046 -175.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -139.79 19.46 2.5 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 121.022 1.737 . . . . 73.430000000000007 112.62 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -136.58 -46.56 0.61 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.412 1.485 . . . . 73.040000000000006 111.685 171.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.5 t -101.16 -69.29 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.124 0 N-CA-C 107.753 -1.203 . . . . 62.109999999999999 107.753 -168.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 73.5 mt -71.01 -33.83 70.75 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.435 1.094 . . . . 74.129999999999995 111.813 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 44.36 54.18 6.39 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.313 1.445 . . . . 73.129999999999995 111.326 -169.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.48 ' O ' HG23 ' A' ' 46' ' ' VAL . 81.9 t -52.26 -47.28 45.43 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 C-N-CA 125.285 1.434 . . . . 75.329999999999998 109.554 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.4 t -49.47 -43.74 45.35 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.33 2.252 . . . . 63.420000000000002 112.122 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -87.02 -17.6 32.58 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.156 -1.59 . . . . 62.439999999999998 112.952 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -74.3 -46.34 41.74 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.058 -0.719 . . . . 70.540000000000006 109.058 169.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 42' ' ' VAL . 95.0 t -57.66 -44.31 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 124.789 1.235 . . . . 71.129999999999995 109.61 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -46.59 -43.97 17.73 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.833 0.853 . . . . 74.549999999999997 112.305 177.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -67.6 -12.65 60.89 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.281 1.586 . . . . 41.240000000000002 115.281 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -111.36 -7.65 14.37 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.044 1.338 . . . . 71.140000000000001 113.312 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.7 mt -68.89 144.87 96.29 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 118.996 0.816 . . . . 64.519999999999996 112.057 -168.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.0 160.0 37.23 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.096 2.531 . . . . 73.140000000000001 111.019 168.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.98 27.7 0.07 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.264 1.426 . . . . 65.439999999999998 114.312 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -144.72 25.4 1.96 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 126.292 1.901 . . . . 73.209999999999994 112.262 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.2 m -146.16 73.19 1.32 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.683 -1.228 . . . . 72.510000000000005 107.683 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.6 mttm -59.92 145.95 44.05 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 122.043 0.925 . . . . 54.450000000000003 112.014 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -76.3 114.33 14.88 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.387 -1.338 . . . . 72.420000000000002 107.387 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.7 m -124.27 163.72 21.06 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.065 -1.087 . . . . 72.049999999999997 108.065 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -161.68 100.11 1.15 Allowed 'General case' 0 C--N 1.332 -0.165 0 O-C-N 120.022 -1.674 . . . . 63.310000000000002 107.306 -165.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -98.7 160.83 14.0 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.03 -1.044 . . . . 72.340000000000003 109.769 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.644 ' CE1' HG23 ' A' ' 72' ' ' THR . 0.1 OUTLIER -102.93 165.36 11.08 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.612 1.565 . . . . 70.150000000000006 109.321 174.524 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.6 m -132.96 153.03 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 122.229 1.014 . . . . 43.25 110.217 156.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.425 ' HG3' HG21 ' A' ' 72' ' ' THR . 0.0 OUTLIER -90.68 2.78 55.64 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 130.244 3.418 . . . . 62.439999999999998 113.765 176.824 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -69.14 -8.99 50.55 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 115.41 1.633 . . . . 74.25 115.41 -168.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 mp -137.92 153.37 49.52 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 120.614 1.552 . . . . 51.420000000000002 110.543 -171.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.65 170.99 29.69 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 123.93 0.776 . . . . 55.539999999999999 113.751 173.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.52 -44.69 4.23 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.928 3.085 . . . . 74.319999999999993 111.851 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.9 mt -97.0 27.41 4.05 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 125.258 1.423 . . . . 53.109999999999999 110.868 -167.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -44.83 -56.77 5.65 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.01 1.291 . . . . 75.099999999999994 111.595 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.8 tptt -63.34 -40.0 96.1 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 118.024 0.912 . . . . 55.310000000000002 111.841 -177.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -65.21 -44.82 87.09 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.423 1.089 . . . . 72.109999999999999 109.731 -176.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.3 mt -62.17 -33.35 74.36 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.974 0.91 . . . . 73.310000000000002 110.824 174.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.644 HG23 ' CE1' ' A' ' 60' ' ' HIS . 27.3 m -77.88 3.52 14.23 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 127.689 2.396 . . . . 64.129999999999995 111.429 175.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -116.75 -24.61 7.64 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 119.181 -2.2 . . . . 73.430000000000007 110.747 169.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.65 -28.31 61.71 Favored 'General case' 0 N--CA 1.457 -0.112 0 O-C-N 120.758 -1.213 . . . . 34.009999999999998 114.053 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 39.2 t-105 -65.87 -40.01 91.24 Favored 'General case' 0 C--N 1.331 -0.201 0 O-C-N 121.386 -0.821 . . . . 73.200000000000003 110.377 -173.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.422 ' HB3' HG13 ' A' ' 130' ' ' VAL . . . -61.13 -37.98 84.76 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.707 1.203 . . . . 32.119999999999997 111.969 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.4 t -51.44 -51.57 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 119.277 0.944 . . . . 74.129999999999995 109.412 171.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.43 -32.17 62.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 117.152 -1.404 . . . . 70.200000000000003 112.091 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.1 mt -63.56 -38.91 83.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 120.903 1.683 . . . . 71.219999999999999 110.406 170.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.09 -49.69 76.3 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 119.043 0.838 . . . . 73.200000000000003 110.057 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.21 -9.76 59.73 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 112.137 0.421 . . . . 65.230000000000004 112.137 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.61 57.9 13.08 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 126.872 2.177 . . . . 72.239999999999995 111.757 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.3 m -129.46 18.64 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 125.507 1.523 . . . . 65.140000000000001 111.071 -175.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -51.88 -48.06 64.26 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.42 1.009 . . . . 74.349999999999994 110.072 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -61.81 -15.25 40.15 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 128.041 2.536 . . . . 74.25 114.997 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -98.13 -16.02 19.7 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.857 0.863 . . . . 73.109999999999999 109.514 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp -126.72 21.34 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 125.282 1.433 . . . . 72.109999999999999 110.646 -175.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 93.6 m -80.31 -59.85 2.55 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 109.143 -0.688 . . . . 73.030000000000001 109.143 173.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.52 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -57.71 -61.78 6.66 Favored Pre-proline 0 N--CA 1.453 -0.321 0 C-N-CA 125.384 1.474 . . . . 62.340000000000003 110.272 -166.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.52 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 38.6 Cg_endo -66.14 -22.31 54.44 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 120.645 0.897 . . . . 64.329999999999998 112.505 -174.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 5.2 tpp -59.61 -49.81 76.31 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.981 0.513 . . . . 75.030000000000001 110.702 170.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -64.23 -39.5 94.1 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.127 -0.983 . . . . 61.350000000000001 111.558 176.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.91 -27.82 68.46 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 120.491 -0.483 . . . . 64.430000000000007 111.497 171.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.19 -11.23 33.21 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 120.952 -1.092 . . . . 72.430000000000007 112.748 -173.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.5 t -117.39 -27.47 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 C-N-CA 124.633 1.173 . . . . 73.200000000000003 110.629 -173.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -115.44 -48.71 2.78 Favored 'General case' 0 C--N 1.336 -0.02 0 CA-C-N 118.87 0.759 . . . . 52.200000000000003 110.789 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -73.8 -65.51 0.82 Allowed 'General case' 0 C--O 1.23 0.06 0 CA-C-N 118.692 0.678 . . . . 73.430000000000007 111.015 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.4 p -83.43 -31.99 26.32 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.713 -0.617 . . . . 64.329999999999998 110.29 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 56.53 23.72 7.89 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.198 1.799 . . . . 75.420000000000002 112.558 -171.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -71.27 -12.22 61.34 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.588 1.155 . . . . 75.209999999999994 112.601 -171.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.519 HG13 HG12 ' A' ' 107' ' ' ILE . 26.7 t -63.97 109.3 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 O-C-N 120.808 -1.182 . . . . 63.030000000000001 109.329 168.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -132.04 -22.22 2.32 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.751 0.82 . . . . 71.439999999999998 112.624 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.26 165.77 26.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.68 1.992 . . . . 63.119999999999997 107.413 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 91.7 t -51.78 -44.96 37.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.393 1.077 . . . . 75.040000000000006 108.971 172.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.51 1.39 0.56 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.016 2.126 . . . . 55.329999999999998 115.422 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -106.91 -29.52 9.42 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 119.653 1.115 . . . . 60.200000000000003 109.321 170.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.519 HG12 HG13 ' A' ' 101' ' ' VAL . 0.5 OUTLIER -81.81 -24.1 9.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 O-C-N 121.057 -1.027 . . . . 53.509999999999998 111.01 -172.773 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -40.5 97.43 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.345 -0.983 . . . . 75.310000000000002 108.345 172.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -55.41 -49.46 72.31 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 123.929 0.768 . . . . 72.319999999999993 109.703 -164.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 47.0 t -54.47 -48.31 69.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.286 1.434 . . . . 61.43 111.511 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -56.41 -55.54 32.3 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 109.175 -0.676 . . . . 73.420000000000002 109.175 176.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 93.3 t -59.01 -44.53 91.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 122.917 0.487 . . . . 74.420000000000002 109.868 -172.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -62.02 -45.79 92.03 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.176 1.391 . . . . 73.319999999999993 108.526 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.22 -0.11 11.23 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.965 1.306 . . . . 71.0 112.723 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 109.86 36.12 2.08 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 119.879 1.218 . . . . 25.25 114.154 173.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.1 t -107.55 130.47 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 118.556 1.178 . . . . 73.420000000000002 109.536 173.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt -62.15 118.92 8.01 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.321 -0.992 . . . . 72.420000000000002 108.321 166.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.69 -22.51 68.17 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 119.063 -0.854 . . . . 74.209999999999994 111.138 173.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -65.52 -35.14 79.99 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.151 0.975 . . . . 73.219999999999999 111.25 175.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -83.25 -34.18 25.88 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.872 -1.159 . . . . 65.319999999999993 107.872 -172.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -51.01 -67.64 0.24 Allowed 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.995 1.318 . . . . 74.299999999999997 110.3 165.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -66.39 -11.55 52.05 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.248 0.547 . . . . 62.140000000000001 111.656 -170.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.38 -74.85 0.35 Allowed 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.315 1.046 . . . . 74.299999999999997 109.484 169.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.459 ' HA ' ' HB3' ' A' ' 127' ' ' SER . . . -58.4 -32.28 68.48 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 118.966 -0.54 . . . . 73.230000000000004 111.758 -169.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 60.6 t-105 -47.76 -34.81 8.96 Favored 'General case' 0 CA--C 1.523 -0.069 0 C-N-CA 124.718 1.207 . . . . 74.200000000000003 112.199 174.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -109.28 1.31 20.06 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.999 1.319 . . . . 73.019999999999996 111.728 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.459 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 5.7 t -105.98 151.64 24.35 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 124.197 1.951 . . . . 73.400000000000006 110.492 -174.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . 0.268 0.1 OUTLIER -57.12 -26.04 59.84 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 117.781 2.511 . . . . 64.430000000000007 117.781 -171.66 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 86.4 t -44.37 -56.82 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 C-N-CA 127.667 2.387 . . . . 71.230000000000004 108.159 167.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 76' ' ' ALA . 25.2 t -73.35 -42.72 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 124.169 0.988 . . . . 72.219999999999999 109.277 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -56.11 -49.04 74.98 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.683 1.129 . . . . 70.319999999999993 111.45 -173.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 72.3 m -77.48 -25.36 50.36 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 117.999 -1.0 . . . . 71.329999999999998 112.89 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.6 mt -65.02 -52.38 56.33 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 120.335 1.425 . . . . 73.040000000000006 110.25 170.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 40.9 t -45.81 -43.44 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.757 2.023 . . . . 71.329999999999998 110.937 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.57 -41.67 70.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.165 0.586 . . . . 34.020000000000003 111.877 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -53.13 -49.82 65.77 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 123.723 0.809 . . . . 44.530000000000001 112.737 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.461 ' HB2' ' CE1' ' A' ' 60' ' ' HIS . 0.6 OUTLIER -98.08 -20.26 17.46 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 118.883 -0.58 . . . . 61.210000000000001 110.967 -171.686 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -62.5 -50.48 71.24 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 107.855 -1.165 . . . . 71.420000000000002 107.855 167.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -55.83 -57.27 12.73 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.956 0.903 . . . . 73.450000000000003 110.94 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.76 6.36 2.58 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.424 1.268 . . . . 63.520000000000003 114.424 -175.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -106.25 -40.9 5.48 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.884 1.274 . . . . 51.009999999999998 110.601 160.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.03 -32.6 74.21 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.418 1.087 . . . . 75.549999999999997 112.889 -171.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -71.15 3.99 3.11 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.045 1.338 . . . . 60.539999999999999 113.125 -175.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.6 mt 74.78 1.94 3.91 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.746 2.018 . . . . 75.150000000000006 112.159 170.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.54 HE21 ' N ' ' A' ' 146' ' ' LEU . 0.0 OUTLIER -61.25 -16.9 50.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 129.851 3.26 . . . . 74.340000000000003 113.729 -179.133 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.54 ' N ' HE21 ' A' ' 145' ' ' GLN . 0.6 OUTLIER -155.55 126.27 6.92 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 128.773 2.829 . . . . 75.140000000000001 103.52 -172.068 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -139.29 5.08 2.26 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.142 0.577 . . . . 73.239999999999995 111.591 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -133.91 163.08 24.53 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.951 1.262 . . . . 73.129999999999995 109.957 171.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.26 164.69 33.86 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.095 0.958 . . . . 73.140000000000001 109.34 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.71 162.33 81.15 Favored 'Cis proline' 0 N--CA 1.455 -0.747 0 CA-C-N 119.313 0.79 . . . . 61.43 111.506 -13.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -146.41 127.19 14.37 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.076 -0.965 . . . . 72.209999999999994 109.026 175.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 42.7 ttm -112.78 109.99 19.82 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 105.587 -2.005 . . . . 54.210000000000001 105.587 169.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -77.94 165.7 23.76 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.678 -1.23 . . . . 62.450000000000003 107.678 166.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.4 t -125.46 -86.37 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 N-CA-C 107.635 -1.246 . . . . 52.439999999999998 107.635 167.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -88.96 35.94 0.8 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 120.565 1.53 . . . . 73.109999999999999 111.256 -171.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 68.13 -73.57 0.29 Allowed Glycine 0 C--N 1.338 0.646 0 N-CA-C 109.265 -1.534 . . . . 61.329999999999998 109.265 -160.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 12.7 ptmt -55.47 -4.92 0.11 Allowed 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 128.533 2.733 . . . . 65.340000000000003 116.641 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -124.34 143.94 50.3 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 120.2 1.364 . . . . 74.450000000000003 109.106 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -128.32 138.45 52.39 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.075 -1.454 . . . . 63.32 107.075 171.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -65.42 133.19 50.79 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.108 -1.441 . . . . 75.25 107.108 175.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -104.52 86.08 1.31 Allowed Pre-proline 0 C--O 1.236 0.355 0 C-N-CA 124.171 0.988 . . . . 72.530000000000001 112.035 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.02 -20.93 43.9 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 CA-C-N 119.931 1.011 . . . . 73.25 113.479 -177.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -72.61 -38.45 67.79 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 120.838 1.654 . . . . 63.539999999999999 109.406 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -78.48 3.78 62.02 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 118.762 0.71 . . . . 71.420000000000002 113.051 -177.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 55.3 mtt -90.29 168.14 12.13 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 118.746 1.273 . . . . 63.329999999999998 109.367 174.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -81.04 114.54 19.97 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 105.999 -1.852 . . . . 62.329999999999998 105.999 167.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.433 HG22 ' CD1' ' A' ' 173' ' ' PHE . 11.1 p -107.6 6.73 28.17 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 127.298 2.239 . . . . 52.450000000000003 109.983 -175.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.5 m -92.84 3.56 55.46 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 113.616 0.969 . . . . 61.450000000000003 113.616 -166.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.0 -4.71 1.52 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.499 1.12 . . . . 73.439999999999998 111.657 -176.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 7.6 mmt 67.64 -61.89 0.35 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.416 1.886 . . . . 75.510000000000005 112.926 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.28 -42.53 88.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 119.978 1.263 . . . . 75.219999999999999 109.229 -176.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 66.5 t -61.92 -28.34 44.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 123.713 0.805 . . . . 63.25 110.951 174.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.433 ' CD1' HG22 ' A' ' 167' ' ' THR . 59.5 t80 -64.27 -61.28 2.34 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 107.974 -1.121 . . . . 55.409999999999997 107.974 177.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.3 t -67.89 -32.2 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 119.289 -0.386 . . . . 73.439999999999998 111.086 -174.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.06 -47.12 68.72 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.76 1.224 . . . . 71.109999999999999 110.86 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -81.46 -38.27 26.66 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 118.252 -0.88 . . . . 64.540000000000006 111.658 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -54.82 -60.2 3.69 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.593 1.088 . . . . 75.409999999999997 110.209 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.41 ' HA ' HG22 ' A' ' 46' ' ' VAL . . . -59.14 -26.09 64.43 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.825 0.85 . . . . 54.409999999999997 112.249 -173.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -77.29 -54.42 6.5 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.101 0.56 . . . . 70.150000000000006 109.815 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.2 t -58.94 -25.57 63.61 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-O 117.741 -1.123 . . . . 74.209999999999994 111.516 -176.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 59.3 t -54.55 -57.64 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 118.944 0.793 . . . . 63.509999999999998 109.046 171.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? -62.89 -36.95 85.0 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.993 -0.442 . . . . 71.329999999999998 110.222 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -66.6 -30.73 71.08 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 123.859 0.864 . . . . 42.009999999999998 110.821 -173.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 47.1 mt -71.01 -31.84 68.46 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.027 -1.046 . . . . 73.420000000000002 111.375 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 85.4 t -66.1 -24.21 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 O-C-N 121.756 -0.59 . . . . 72.409999999999997 110.876 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -97.07 -5.77 36.72 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.332 1.053 . . . . 73.150000000000006 110.253 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -120.79 87.14 2.7 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 125.925 1.69 . . . . 72.549999999999997 107.871 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 37.5 mttm . . . . . 0 C--O 1.251 1.158 0 C-N-CA 127.069 2.147 . . . . 71.239999999999995 110.917 175.51 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.465 0.325 0 N-CA-C 107.265 -1.383 . . . . 72.430000000000007 107.265 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -68.67 170.7 8.86 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 118.313 0.506 . . . . 71.299999999999997 109.67 -174.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 56.88 38.18 29.26 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.051 0.94 . . . . 70.230000000000004 112.871 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -141.97 110.77 6.19 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.873 -1.899 . . . . 45.420000000000002 105.873 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.409 HD12 ' CD1' ' A' ' 9' ' ' TYR . 4.8 pt -143.09 164.97 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 130.966 3.706 . . . . 72.219999999999999 107.721 -178.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.9 m -139.17 148.86 43.74 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.876 1.67 . . . . 72.420000000000002 108.247 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -57.76 148.72 24.08 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.174 1.79 . . . . 64.010000000000005 111.065 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.63 -23.38 0.81 Allowed Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.832 1.206 . . . . 74.239999999999995 112.878 -171.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.2 tttp -90.23 -85.21 0.22 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 118.831 1.316 . . . . 74.120000000000005 108.539 -160.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -98.88 -7.13 27.73 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.021 0.929 . . . . 65.209999999999994 111.337 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.409 ' CD1' HD12 ' A' ' 3' ' ' ILE . 25.4 p90 -144.6 163.55 33.59 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.81 -1.182 . . . . 71.439999999999998 107.81 169.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.6 mm -124.8 157.09 33.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 106.264 -1.754 . . . . 53.109999999999999 106.264 169.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.45 171.53 14.61 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 127.295 2.238 . . . . 74.230000000000004 109.3 165.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.9 mt -108.24 159.6 16.5 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.359 1.064 . . . . 70.319999999999993 111.02 173.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -62.73 -44.6 95.79 Favored 'General case' 0 C--O 1.227 -0.096 0 N-CA-C 108.9 -0.778 . . . . 73.230000000000004 108.9 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -131.24 81.55 65.47 Favored Pre-proline 0 C--N 1.339 0.112 0 C-N-CA 127.015 2.126 . . . . 63.109999999999999 107.547 -173.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -80.16 63.82 8.8 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.662 2.242 . . . . 70.310000000000002 110.812 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.9 mp -96.18 152.79 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 O-C-N 120.55 -1.344 . . . . 64.129999999999995 109.899 -174.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.08 113.99 3.45 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.986 1.314 . . . . 64.030000000000001 109.281 175.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.52 -171.44 39.2 Favored Glycine 0 C--O 1.226 -0.406 0 N-CA-C 108.527 -1.829 . . . . 70.120000000000005 108.527 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . 0.308 0.8 OUTLIER 59.05 166.67 0.08 OUTLIER Pre-proline 0 C--O 1.241 0.638 0 N-CA-C 114.986 1.476 . . . . 72.540000000000006 114.986 176.02 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -66.86 78.81 0.38 Allowed 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.305 2.003 . . . . 70.340000000000003 109.717 167.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -51.62 -21.24 2.45 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 127.414 2.286 . . . . 65.099999999999994 115.509 -169.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.0 t -134.51 87.64 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 105.929 -1.878 . . . . 53.200000000000003 105.929 -175.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 tt -147.15 157.82 43.73 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.221 -1.029 . . . . 64.129999999999995 108.221 -172.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -125.44 149.58 48.09 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.92 1.288 . . . . 62.299999999999997 107.958 170.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.421 ' CD2' HD13 ' A' ' 146' ' ' LEU . 95.3 m-85 -127.38 145.55 50.77 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.16 0.984 . . . . 73.409999999999997 108.95 169.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -153.72 -177.8 6.62 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 128.326 2.651 . . . . 74.530000000000001 106.98 168.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.422 ' CB ' HD12 ' A' ' 64' ' ' LEU . 10.6 t -133.4 179.85 5.95 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 121.351 -0.843 . . . . 71.319999999999993 108.745 170.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -82.43 -28.8 31.12 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.995 2.518 . . . . 74.209999999999994 110.583 -176.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -109.66 1.89 19.85 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.56 1.144 . . . . 74.540000000000006 112.231 -169.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.1 p -87.26 143.48 34.59 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 120.111 1.323 . . . . 71.310000000000002 110.453 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -83.66 -38.63 0.13 Allowed 'Trans proline' 0 CA--C 1.533 0.437 0 CA-C-N 119.901 1.0 . . . . 64.5 112.481 -166.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -52.31 -47.68 65.84 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 118.798 0.726 . . . . 53.409999999999997 109.661 172.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 14.2 m -54.77 -37.86 66.51 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.74 1.616 . . . . 65.319999999999993 111.482 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -62.49 -51.32 67.93 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.679 0.391 . . . . 73.530000000000001 110.861 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -59.61 -45.45 91.88 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 119.67 -0.812 . . . . 63.200000000000003 109.054 176.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -66.13 -10.39 40.46 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 116.919 -1.515 . . . . 64.129999999999995 112.015 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -140.26 10.47 2.33 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 121.86 2.118 . . . . 50.109999999999999 113.086 -174.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -134.13 -45.0 0.78 Allowed 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 123.903 0.881 . . . . 61.100000000000001 110.41 170.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.8 t -88.9 -69.81 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 108.255 -1.017 . . . . 74.409999999999997 108.255 -175.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.6 mt -77.81 -25.53 48.97 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.732 1.613 . . . . 74.519999999999996 113.333 -174.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 44.67 59.31 3.42 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.538 1.535 . . . . 72.430000000000007 112.911 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.4 t -55.48 -50.35 66.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 124.061 0.944 . . . . 70.299999999999997 109.302 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.2 t -47.17 -52.36 15.83 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.143 1.377 . . . . 73.430000000000007 112.308 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -79.37 -23.39 43.38 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 110.588 -0.152 . . . . 74.430000000000007 110.588 -169.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -69.93 -48.8 57.02 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.639 -1.245 . . . . 73.430000000000007 107.639 169.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 37.8 t -55.69 -49.83 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 125.162 1.385 . . . . 74.040000000000006 110.914 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -56.94 -28.02 61.67 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 119.87 -1.769 . . . . 72.510000000000005 113.297 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -71.14 -8.62 54.73 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.202 0.91 . . . . 72.319999999999993 113.192 177.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -119.83 -14.71 8.95 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 126.321 1.848 . . . . 72.409999999999997 111.968 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.495 HD13 HG21 ' A' ' 54' ' ' THR . 13.3 mt -69.53 151.11 96.78 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 119.222 0.919 . . . . 72.040000000000006 112.496 -169.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -85.95 159.19 10.22 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.625 2.883 . . . . 64.019999999999996 113.078 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -83.62 59.34 5.08 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.307 1.843 . . . . 62.100000000000001 111.031 -172.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.71 -23.98 0.02 OUTLIER Glycine 0 CA--C 1.527 0.802 0 CA-C-N 113.592 -1.64 . . . . 62.439999999999998 112.1 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.495 HG21 HD13 ' A' ' 50' ' ' LEU . 10.3 t -47.85 -57.1 6.09 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.561 1.544 . . . . 73.109999999999999 112.632 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.405 ' N ' HG23 ' A' ' 54' ' ' THR . 4.7 tmmm? 56.84 123.55 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.779 2.032 . . . . 70.129999999999995 111.04 -157.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.7 ttm -68.27 108.18 3.09 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 125.881 1.672 . . . . 74.099999999999994 108.253 172.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.18 115.03 21.69 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 107.127 -1.434 . . . . 72.319999999999993 107.127 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.27 122.04 35.78 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.18 -1.415 . . . . 74.200000000000003 107.18 -178.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.1 m-30 -113.35 145.85 40.42 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.488 -1.301 . . . . 72.430000000000007 107.488 172.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.0 117.85 32.47 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.258 1.423 . . . . 74.140000000000001 107.669 -167.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.8 m -93.88 157.78 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 O-C-N 121.472 -0.768 . . . . 72.200000000000003 110.747 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.43 -8.46 13.89 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.748 1.219 . . . . 72.129999999999995 113.448 -161.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -63.17 5.16 0.16 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.815 2.046 . . . . 62.32 115.346 -170.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.422 HD12 ' CB ' ' A' ' 27' ' ' SER . 11.1 mt -138.11 132.39 31.96 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 119.955 -1.715 . . . . 70.430000000000007 107.593 -165.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.76 174.76 30.25 Favored Glycine 0 CA--C 1.541 1.672 0 O-C-N 123.493 0.496 . . . . 52.100000000000001 111.877 -172.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.92 -55.33 0.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.92 3.08 . . . . 73.340000000000003 112.692 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.4 mt -87.34 24.85 1.52 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.958 1.303 . . . . 51.350000000000001 112.201 -167.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.04 -42.77 98.05 Favored Glycine 0 C--O 1.228 -0.247 0 N-CA-C 110.174 -1.17 . . . . 74.230000000000004 110.174 -167.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -61.42 -44.55 96.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.499 0.32 . . . . 73.340000000000003 110.689 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.43 -46.77 87.79 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.446 1.898 . . . . 74.430000000000007 109.012 177.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.9 mt -64.64 -40.53 95.62 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.751 0.82 . . . . 64.299999999999997 111.623 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.8 m -60.7 -40.45 92.27 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 120.272 1.396 . . . . 71.510000000000005 110.388 171.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -64.62 -39.28 93.43 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.26 -0.9 . . . . 70.150000000000006 108.876 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.61 -36.43 78.57 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 120.964 -1.085 . . . . 72.540000000000006 111.913 173.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 25.3 t-105 -58.42 -35.74 72.53 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 118.882 0.764 . . . . 71.5 111.996 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.36 -40.55 82.53 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 118.695 -0.669 . . . . 63.310000000000002 111.912 175.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 69.7 t -59.54 -44.89 94.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 119.657 1.117 . . . . 51.130000000000003 109.544 170.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.51 -42.04 98.21 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 118.364 -0.827 . . . . 74.530000000000001 111.6 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 76.3 mt -69.45 -38.51 77.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.899 0.88 . . . . 74.439999999999998 110.52 176.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.8 -40.21 91.81 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.488 1.04 . . . . 64.430000000000007 110.582 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.8 mt -93.0 -8.02 44.21 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.75 0.648 . . . . 74.109999999999999 112.75 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 53.83 62.91 5.61 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 125.485 1.517 . . . . 52.130000000000003 111.378 -172.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.1 m -125.54 18.97 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.49 1.116 . . . . 65.5 112.046 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -51.3 -49.54 61.1 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.341 1.456 . . . . 53.109999999999999 111.504 -174.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -63.36 -31.47 72.63 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 125.167 1.387 . . . . 74.109999999999999 113.807 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -75.24 -34.38 61.4 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.258 -0.645 . . . . 74.540000000000006 109.258 -176.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.1 pp -103.52 -16.37 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.967 0.729 . . . . 74.439999999999998 112.967 -166.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.7 m -58.93 -49.47 77.72 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 119.17 0.895 . . . . 70.420000000000002 111.116 -172.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.468 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -62.47 -58.76 15.36 Favored Pre-proline 0 N--CA 1.45 -0.458 0 C-N-CA 123.712 0.805 . . . . 53.0 110.181 -164.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.468 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 39.5 Cg_endo -66.25 -26.0 49.48 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 121.095 1.197 . . . . 62.140000000000001 112.222 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 10.8 tpp -61.7 -44.64 96.55 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.577 0.626 . . . . 63.229999999999997 111.051 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -69.69 -35.69 75.32 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.243 -0.911 . . . . 71.5 109.047 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -54.85 -48.34 73.01 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.388 0.54 . . . . 61.210000000000001 110.242 166.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.55 -16.09 60.83 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 121.73 -0.606 . . . . 73.109999999999999 111.154 -165.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 63.8 t -112.15 -33.86 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.368 1.467 . . . . 74.230000000000004 110.799 -173.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -109.73 -55.96 2.37 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.522 1.056 . . . . 72.420000000000002 110.744 -174.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -64.35 -63.93 1.01 Allowed 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.907 0.883 . . . . 74.299999999999997 110.784 -176.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.4 t -99.44 -27.6 13.66 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.672 1.189 . . . . 70.5 110.761 -173.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 59.43 29.4 18.96 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.811 1.244 . . . . 63.5 112.889 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.4 t -69.38 -12.63 61.82 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.782 1.633 . . . . 65.150000000000006 112.815 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.6 t -67.52 108.49 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.647 -1.242 . . . . 74.450000000000003 107.647 171.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -132.88 -28.09 1.6 Allowed 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 124.471 1.108 . . . . 65.439999999999998 111.623 -174.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.85 169.65 17.18 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.553 -1.277 . . . . 70.120000000000005 107.553 169.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.6 t -57.18 -25.69 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.138 0.975 . . . . 73.340000000000003 111.23 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.69 -29.57 70.18 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 126.316 1.847 . . . . 50.25 111.205 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.72 -22.26 22.29 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.111 0.481 . . . . 73.450000000000003 110.232 -176.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.0 mt -76.63 -49.11 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 126.314 1.846 . . . . 42.420000000000002 108.158 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -56.78 -30.69 63.9 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-O 118.205 -0.902 . . . . 70.439999999999998 112.719 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -57.47 -57.99 10.26 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 123.586 0.755 . . . . 62.350000000000001 109.578 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.1 t -48.43 -47.33 14.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 O-C-N 124.457 1.098 . . . . 72.340000000000003 109.804 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -55.21 -51.9 65.08 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.864 0.466 . . . . 70.519999999999996 110.741 177.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.2 t -62.42 -44.05 98.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 118.61 0.641 . . . . 72.340000000000003 111.114 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -64.74 -42.17 95.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 122.147 0.975 . . . . 72.209999999999994 108.758 -172.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -82.14 7.33 13.8 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.579 1.552 . . . . 74.219999999999999 112.572 176.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.93 29.04 4.22 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-N 119.751 1.16 . . . . 74.329999999999998 115.976 160.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.7 t -106.55 143.97 16.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 122.571 1.176 . . . . 61.549999999999997 111.026 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -62.4 126.89 28.88 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.268 1.427 . . . . 63.240000000000002 110.383 170.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.31 -23.96 74.91 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 118.483 -1.176 . . . . 53.219999999999999 111.896 169.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -69.13 -40.87 78.02 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 119.131 1.465 . . . . 61.310000000000002 109.249 170.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -79.36 -37.66 36.9 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 107.597 -1.26 . . . . 65.430000000000007 107.597 -166.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -56.65 -60.65 3.23 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.619 -0.512 . . . . 74.150000000000006 109.619 171.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.69 -13.84 61.05 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.454 0.538 . . . . 71.329999999999998 112.454 -170.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.19 -65.97 0.95 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.332 1.053 . . . . 34.32 109.202 168.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -50.4 -39.81 48.13 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.543 1.537 . . . . 73.25 110.848 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -46.19 -37.65 7.35 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.555 1.542 . . . . 73.540000000000006 112.801 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -114.35 4.3 15.33 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.917 1.287 . . . . 71.439999999999998 112.889 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.7 t -80.22 151.99 29.36 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.724 1.61 . . . . 74.530000000000001 111.492 175.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -51.99 -28.89 18.47 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.022 2.529 . . . . 64.230000000000004 113.081 175.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 93.3 t -52.75 -54.52 15.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 124.748 1.219 . . . . 51.219999999999999 109.836 174.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.3 t -69.66 -34.78 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 114.816 -1.083 . . . . 72.109999999999999 109.851 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -52.63 -47.88 66.75 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.914 1.233 . . . . 74.409999999999997 111.186 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.1 t -59.71 -55.54 33.09 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.605 0.762 . . . . 74.439999999999998 109.222 176.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 32.3 mt -64.47 -32.71 74.45 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.004 0.922 . . . . 71.310000000000002 113.483 -173.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.31 -64.45 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 C-N-CA 126.022 1.729 . . . . 70.430000000000007 107.451 166.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.42 -29.3 67.66 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 120.286 1.403 . . . . 73.430000000000007 113.744 -172.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -61.4 -51.95 66.65 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.401 0.68 . . . . 64.140000000000001 109.991 170.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -70.07 -34.08 72.74 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.41 1.084 . . . . 63.43 112.633 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -60.08 -59.04 6.05 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 107.39 -1.337 . . . . 63.119999999999997 107.39 174.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.7 ttpt -53.3 -52.03 60.41 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.318 0.647 . . . . 63.509999999999998 110.452 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.68 -2.2 4.65 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.07 1.137 . . . . 73.400000000000006 114.07 -174.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -116.65 -20.87 9.38 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.881 1.218 . . . . 53.229999999999997 112.025 164.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.54 -22.55 47.11 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 126.202 1.801 . . . . 73.519999999999996 112.434 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.05 4.13 13.1 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.104 -0.998 . . . . 72.319999999999993 112.386 -175.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.0 mt 71.43 -0.23 3.21 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.522 1.929 . . . . 65.109999999999999 111.437 171.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.23 -9.96 59.74 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.728 1.611 . . . . 73.329999999999998 112.567 -173.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.421 HD13 ' CD2' ' A' ' 25' ' ' PHE . 2.4 tp -142.15 105.44 4.62 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.606 1.562 . . . . 74.129999999999995 108.193 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -130.94 17.81 5.09 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.217 0.607 . . . . 65.340000000000003 110.605 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -134.47 160.21 24.12 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 109.621 -1.392 . . . . 72.129999999999995 109.621 163.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.4 m -144.45 167.08 15.93 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 125.658 1.583 . . . . 43.109999999999999 109.348 169.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -72.24 150.4 94.74 Favored 'Cis proline' 0 N--CA 1.46 -0.472 0 N-CA-C 110.057 -0.786 . . . . 72.430000000000007 110.057 -14.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -136.7 126.9 26.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 117.435 -1.269 . . . . 71.340000000000003 108.64 -172.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 47.5 ttm -124.12 124.74 43.15 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 119.205 0.911 . . . . 63.310000000000002 108.675 173.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -100.37 155.58 17.73 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 125.117 1.367 . . . . 71.340000000000003 110.086 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.8 t -140.54 144.71 26.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 124.259 1.024 . . . . 73.120000000000005 108.975 175.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 50.11 23.21 1.08 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.905 2.082 . . . . 72.409999999999997 113.91 169.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 61.58 17.2 53.11 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 118.681 -1.066 . . . . 61.039999999999999 113.777 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -149.2 -7.37 0.36 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.078 1.439 . . . . 65.200000000000003 114.571 -174.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -128.95 152.38 48.63 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 119.151 0.887 . . . . 70.230000000000004 110.401 -176.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -119.4 141.58 48.97 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.715 2.006 . . . . 73.099999999999994 107.819 168.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.89 132.54 45.41 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 107.772 -1.196 . . . . 74.200000000000003 107.772 170.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -106.39 86.95 2.35 Favored Pre-proline 0 C--O 1.235 0.291 0 C-N-CA 123.51 0.724 . . . . 71.519999999999996 111.954 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -65.77 -21.39 58.31 Favored 'Trans proline' 0 N--CA 1.444 -1.417 0 CA-C-O 117.911 -0.954 . . . . 72.299999999999997 112.32 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -64.79 -44.37 90.19 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 120.097 1.317 . . . . 74.530000000000001 110.942 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -82.0 1.68 86.01 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 118.87 -0.961 . . . . 44.240000000000002 112.876 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 46.6 mtt -79.3 168.05 20.07 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.958 1.879 . . . . 61.0 108.719 170.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -79.58 120.93 24.61 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 106.028 -1.841 . . . . 70.030000000000001 106.028 167.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.434 HG22 ' CD1' ' A' ' 173' ' ' PHE . 28.2 p -124.69 45.71 2.47 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.672 1.989 . . . . 74.219999999999999 106.76 -171.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 16.1 m -135.66 0.23 2.69 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 114.229 -1.351 . . . . 73.5 111.963 -164.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -133.74 -4.99 2.85 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.298 1.439 . . . . 72.040000000000006 110.899 174.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 1.7 mmt 66.83 -59.3 0.38 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.908 2.083 . . . . 72.340000000000003 112.897 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.39 -48.75 80.41 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 122.397 1.094 . . . . 64.329999999999998 109.121 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 99.3 t -64.04 -27.5 42.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 126.638 1.975 . . . . 73.439999999999998 111.674 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.434 ' CD1' HG22 ' A' ' 167' ' ' THR . 21.6 t80 -61.44 -59.22 5.59 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.065 -1.087 . . . . 70.140000000000001 108.065 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.92 -27.73 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 O-C-N 123.496 0.498 . . . . 72.200000000000003 110.906 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.45 -47.61 63.02 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.901 0.881 . . . . 70.040000000000006 111.022 171.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -79.6 -41.74 26.46 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 118.694 -0.67 . . . . 73.099999999999994 111.053 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -53.13 -59.26 4.77 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.274 0.943 . . . . 71.299999999999997 110.291 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.03 -29.07 68.26 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.521 1.128 . . . . 74.319999999999993 112.344 -175.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -65.54 -62.68 1.38 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.149 -0.686 . . . . 65.040000000000006 109.149 171.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 12.4 t -60.6 -28.43 68.5 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 118.837 -0.602 . . . . 73.219999999999999 112.186 -170.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 94.8 t -53.62 -47.08 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.821 0.737 . . . . 72.329999999999998 109.725 173.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 3.0 tmmt? -80.14 -32.75 38.92 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.152 -0.928 . . . . 61.409999999999997 110.778 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -57.25 -36.75 71.34 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.226 1.376 . . . . 65.019999999999996 110.661 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 59.1 mt -70.84 -27.09 63.6 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.037 -1.039 . . . . 70.230000000000004 112.776 -176.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 75.7 t -63.68 -30.89 51.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 122.8 0.44 . . . . 71.120000000000005 110.374 -178.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -87.84 -29.37 20.99 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.097 -0.705 . . . . 62.310000000000002 109.097 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 31.7 mttp -93.41 48.88 1.33 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.075 1.35 . . . . 74.310000000000002 110.04 -175.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 20.6 pttm . . . . . 0 C--O 1.245 0.836 0 N-CA-C 106.856 -1.535 . . . . 65.439999999999998 106.856 155.432 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 8.6 m . . . . . 0 N--CA 1.467 0.425 0 CA-C-O 119.02 -0.514 . . . . 73.400000000000006 111.682 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -67.59 177.41 2.0 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.41 1.484 . . . . 60.399999999999999 111.926 173.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 52.29 33.71 13.27 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 126.638 1.975 . . . . 73.120000000000005 112.053 174.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.55 125.03 3.67 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 105.464 -2.05 . . . . 73.209999999999994 105.464 173.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.8 pt -131.3 147.15 32.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 127.974 2.51 . . . . 64.329999999999998 108.398 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.7 m -115.55 126.42 54.23 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.66 -1.237 . . . . 61.329999999999998 107.66 -176.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.45 121.41 3.42 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 127.77 2.428 . . . . 64.200000000000003 108.641 162.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.01 -11.77 71.25 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-O 117.834 -1.537 . . . . 65.310000000000002 113.707 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -102.7 -85.52 0.44 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 119.828 1.814 . . . . 74.5 108.972 -177.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -87.95 -16.68 33.13 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.552 1.141 . . . . 72.109999999999999 110.768 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.534 ' O ' HD13 ' A' ' 10' ' ' ILE . 28.3 p90 -136.69 163.09 31.39 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.309 1.044 . . . . 73.510000000000005 109.801 172.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.534 HD13 ' O ' ' A' ' 9' ' ' TYR . 6.4 mm -129.78 158.54 42.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 105.265 -2.124 . . . . 72.530000000000001 105.265 171.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.9 m -108.91 168.82 9.08 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.693 -1.225 . . . . 72.319999999999993 107.693 173.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.1 mt -92.03 161.08 14.93 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.518 -1.29 . . . . 50.439999999999998 107.518 166.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -79.1 -29.31 43.22 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 122.549 1.166 . . . . 74.129999999999995 108.201 174.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -133.68 71.67 74.66 Favored Pre-proline 0 N--CA 1.446 -0.626 0 O-C-N 120.187 -1.57 . . . . 63.140000000000001 110.757 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.66 63.45 7.36 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.523 2.816 . . . . 42.340000000000003 110.571 176.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.4 mt -136.42 144.15 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 O-C-N 120.696 -1.253 . . . . 62.5 107.708 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 47.48 12.23 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 128.898 2.879 . . . . 71.400000000000006 116.781 171.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -89.29 -110.79 1.24 Allowed Glycine 0 C--N 1.333 0.398 0 CA-C-N 119.493 1.042 . . . . 74.239999999999995 110.679 -169.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -67.18 162.99 49.76 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 114.133 1.161 . . . . 65.209999999999994 114.133 -171.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.12 -164.92 0.12 Allowed 'Trans proline' 0 CA--C 1.545 1.055 1 C-N-CA 125.47 4.114 . . . . 62.420000000000002 114.069 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -66.59 77.74 0.11 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.295 1.838 . . . . 74.319999999999993 110.884 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.514 HG22 ' H ' ' A' ' 23' ' ' LEU 0.277 2.9 p 56.15 169.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 128.926 2.89 . . . . 53.409999999999997 112.942 -174.377 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.514 ' H ' HG22 ' A' ' 22' ' ' VAL . 6.0 tp -165.44 169.45 15.6 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 121.216 -0.928 . . . . 74.120000000000005 112.356 -172.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -145.5 125.35 13.48 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 127.915 2.486 . . . . 61.439999999999998 104.591 170.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.435 ' CE2' HD23 ' A' ' 23' ' ' LEU . 9.5 m-85 -115.41 131.75 56.83 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 119.808 1.185 . . . . 72.120000000000005 110.428 177.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.85 176.55 11.33 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.109 0.564 . . . . 73.519999999999996 110.812 178.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.9 t -129.46 172.61 11.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.598 -1.63 . . . . 70.200000000000003 106.598 169.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.862 ' CZ ' HD21 ' A' ' 71' ' ' LEU 0.253 0.0 OUTLIER -86.45 -18.76 30.86 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.288 0.635 . . . . 71.120000000000005 111.545 164.952 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -91.31 -6.37 53.22 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 119.742 -1.849 . . . . 73.519999999999996 113.335 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.1 p -77.83 141.36 63.87 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 121.2 1.818 . . . . 63.240000000000002 108.031 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -84.08 -40.3 0.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.86 1.707 . . . . 64.209999999999994 111.776 -174.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -56.08 -40.19 73.25 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 120.096 1.316 . . . . 74.299999999999997 110.105 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.2 m -51.36 -30.28 18.26 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.082 1.353 . . . . 74.209999999999994 112.719 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -62.11 -56.85 14.7 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 118.668 0.667 . . . . 71.299999999999997 111.698 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -57.6 -42.68 83.73 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.856 -0.794 . . . . 74.530000000000001 108.856 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -62.46 -18.15 61.1 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 115.294 -2.289 . . . . 71.200000000000003 112.173 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -139.69 9.14 2.4 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-N 122.122 2.237 . . . . 71.430000000000007 114.959 -170.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -136.44 -11.78 1.85 Allowed 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.86 1.264 . . . . 72.299999999999997 111.371 172.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.3 t -123.92 -81.39 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 107.401 -1.333 . . . . 75.140000000000001 107.401 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 49.8 mt -59.67 -31.09 69.23 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.771 2.028 . . . . 63.509999999999998 112.005 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 43.99 60.09 2.88 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.299 1.84 . . . . 71.040000000000006 110.536 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 86.7 t -63.02 -36.92 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.181 -0.918 . . . . 73.400000000000006 109.895 -174.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 t -51.07 -55.6 16.77 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.994 1.317 . . . . 31.309999999999999 110.39 173.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.34 -29.51 65.08 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 121.043 -1.036 . . . . 75.400000000000006 111.395 -174.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.57 -33.73 74.59 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.042 0.537 . . . . 71.400000000000006 112.05 175.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.6 t -70.97 -50.19 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.572 1.549 . . . . 74.129999999999995 109.158 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.6 ptm85 -61.72 -21.17 64.26 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 120.63 1.559 . . . . 72.099999999999994 113.883 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -68.04 -11.08 58.29 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.006 1.113 . . . . 72.010000000000005 114.006 172.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp -136.03 2.42 2.82 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.578 1.551 . . . . 43.43 112.117 -171.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.7 mt -72.35 145.71 88.33 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 119.725 1.148 . . . . 75.439999999999998 109.584 -176.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.94 150.16 29.78 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.427 2.085 . . . . 62.530000000000001 110.131 169.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -76.65 80.81 3.3 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 122.759 1.266 . . . . 75.430000000000007 111.029 -168.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.01 -49.53 0.23 Allowed Glycine 0 C--O 1.233 0.092 0 N-CA-C 109.595 -1.402 . . . . 74.030000000000001 109.595 -175.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.3 m -69.29 90.68 0.51 Allowed 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 107.767 -1.197 . . . . 74.519999999999996 107.767 173.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -80.12 129.92 34.86 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.469 -1.678 . . . . 71.430000000000007 106.469 173.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.4 mtm -66.26 161.93 21.15 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.258 -0.645 . . . . 64.239999999999995 109.258 173.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.39 -173.71 3.49 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.339 1.056 . . . . 65.439999999999998 108.155 178.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.41 91.89 0.46 Allowed 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.221 -1.029 . . . . 72.099999999999994 108.221 -173.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.499 ' CD2' ' HG3' ' A' ' 137' ' ' GLN . 6.4 m-30 -104.42 163.53 12.38 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.549 -0.908 . . . . 74.120000000000005 108.549 177.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.45 ' C ' ' CD2' ' A' ' 60' ' ' HIS . 2.0 p-80 -104.67 171.5 7.29 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 126.527 1.931 . . . . 72.200000000000003 108.071 -175.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.6 m -137.96 146.96 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.1 -1.074 . . . . 70.219999999999999 108.1 167.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -94.18 -0.47 55.19 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.076 0.853 . . . . 74.319999999999993 111.994 -175.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -73.99 167.64 21.1 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.575 1.15 . . . . 73.219999999999999 108.364 165.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 74.69 131.85 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 128.328 2.651 . . . . 65.430000000000007 111.093 177.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.6 173.59 3.51 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 122.472 1.04 . . . . 32.409999999999997 113.037 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -72.43 -45.27 0.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.473 2.115 . . . . 30.100000000000001 111.757 175.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.7 mt -80.85 19.65 0.84 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.537 1.535 . . . . 61.420000000000002 113.65 -171.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.07 -32.43 49.83 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-O 118.156 -1.358 . . . . 73.120000000000005 112.311 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.3 tmtp? -85.11 -7.46 59.08 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.16 1.48 . . . . 65.450000000000003 113.728 178.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -46.81 18.25 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-N 121.001 1.728 . . . . 72.140000000000001 107.893 162.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.862 HD21 ' CZ ' ' A' ' 28' ' ' PHE . 26.8 mt -57.75 -39.14 76.7 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 124.58 1.175 . . . . 65.230000000000004 111.145 -165.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -50.38 -51.7 43.74 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 128.542 2.737 . . . . 73.349999999999994 109.738 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -69.62 -58.96 3.29 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 114.149 -1.387 . . . . 72.420000000000002 107.308 -176.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.65 -28.65 68.64 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 121.264 1.847 . . . . 43.530000000000001 114.226 -171.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 36.4 t-105 -58.6 -36.68 74.4 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.79 0.723 . . . . 73.200000000000003 110.921 177.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.89 -41.29 97.71 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 118.055 -0.974 . . . . 62.119999999999997 111.032 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.505 HG22 ' HB3' ' A' ' 124' ' ' ALA . 41.4 t -54.62 -45.58 72.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 119.354 0.979 . . . . 63.020000000000003 110.1 171.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.96 -47.14 87.82 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.603 0.638 . . . . 33.310000000000002 111.306 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.8 mt -60.22 -44.73 96.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.736 1.214 . . . . 71.420000000000002 109.698 176.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.3 -31.76 72.4 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 123.945 0.898 . . . . 74.439999999999998 111.095 -175.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 75.2 mt -94.22 -12.41 28.28 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 119.008 -0.52 . . . . 62.439999999999998 111.819 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.67 54.87 32.18 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 126.907 2.194 . . . . 44.100000000000001 110.943 -172.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.71 11.62 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 124.141 0.976 . . . . 71.200000000000003 112.133 -176.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -56.24 -53.53 56.13 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 120.071 1.305 . . . . 75.109999999999999 110.491 -172.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -63.13 -8.09 7.12 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.755 1.622 . . . . 75.010000000000005 112.333 176.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -100.06 -18.03 17.19 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.434 1.494 . . . . 62.109999999999999 112.023 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.6 pp -127.51 33.3 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.036 1.335 . . . . 60.119999999999997 109.443 -175.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 76.1 m -107.23 -43.83 4.5 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 117.973 -1.013 . . . . 72.409999999999997 109.651 171.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.495 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -60.31 -63.36 4.36 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 120.736 1.607 . . . . 73.200000000000003 111.775 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 57.2 Cg_endo -65.27 -26.37 56.5 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 121.518 1.479 . . . . 74.209999999999994 111.81 -176.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 34.8 tpp -63.51 -49.61 72.85 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.584 0.754 . . . . 74.140000000000001 109.416 176.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -68.1 -35.14 77.67 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.874 0.87 . . . . 64.030000000000001 108.913 -176.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -60.97 -40.05 91.93 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.656 0.662 . . . . 62.299999999999997 110.423 171.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.18 -5.01 58.65 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 120.074 -1.642 . . . . 63.020000000000003 113.584 -174.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.681 HG21 ' CD2' ' A' ' 28' ' ' PHE . 50.2 t -111.01 -41.35 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 124.499 1.119 . . . . 74.219999999999999 109.709 -176.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -106.07 -53.77 2.58 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.42 0.688 . . . . 74.420000000000002 109.337 -172.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt -70.39 -54.12 13.74 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-O 118.675 -0.679 . . . . 72.329999999999998 110.61 -171.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.4 p -100.86 -18.49 16.37 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.176 0.99 . . . . 74.219999999999999 113.382 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 45.75 40.62 6.53 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.475 2.31 . . . . 72.219999999999999 114.228 -175.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.9 t -79.88 -8.0 59.05 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.288 -0.883 . . . . 63.420000000000002 112.557 178.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.487 HG11 ' CZ ' ' A' ' 28' ' ' PHE . 29.6 t -74.54 122.46 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 O-C-N 120.858 -1.151 . . . . 73.109999999999999 109.785 168.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -140.68 -23.41 0.79 Allowed 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.084 0.954 . . . . 73.340000000000003 112.303 175.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.21 175.4 11.09 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.307 0.643 . . . . 74.329999999999998 109.56 174.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 104' ' ' VAL . 18.0 t -55.55 -44.09 75.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 126.182 1.793 . . . . 70.049999999999997 109.941 -172.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.5 -14.34 40.43 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.212 0.605 . . . . 45.409999999999997 112.628 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -94.36 -27.65 15.96 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 119.421 1.01 . . . . 71.409999999999997 110.034 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.462 HG12 HG13 ' A' ' 101' ' ' VAL . 3.2 mt -81.52 -41.77 19.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 123.286 0.634 . . . . 65.239999999999995 109.378 -178.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -55.32 -25.08 32.42 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.441 -0.787 . . . . 74.450000000000003 113.055 176.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -62.23 -56.51 17.91 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.803 1.241 . . . . 70.310000000000002 110.78 -177.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 54.3 t -57.15 -43.1 80.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 119.165 -0.445 . . . . 51.219999999999999 110.369 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -50.68 -56.77 10.38 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.707 0.803 . . . . 74.239999999999995 109.482 175.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.74 -46.86 95.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 123.132 0.573 . . . . 71.450000000000003 109.811 -174.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.05 -43.57 91.7 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 123.652 0.595 . . . . 74.25 109.475 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.95 -17.32 62.08 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.425 1.09 . . . . 72.140000000000001 112.612 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 113.61 64.24 0.44 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.393 -1.083 . . . . 60.009999999999998 110.393 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.7 t -127.69 141.1 47.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 123.819 0.848 . . . . 74.129999999999995 109.976 163.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -66.04 148.2 52.17 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.905 -0.497 . . . . 53.210000000000001 112.027 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -73.5 1.84 41.71 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 124.775 1.179 . . . . 53.240000000000002 114.904 165.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -100.98 -39.98 7.47 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 117.367 0.584 . . . . 64.129999999999995 111.158 174.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.9 -35.04 62.27 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.014 -1.106 . . . . 62.420000000000002 108.014 -167.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -61.45 -59.93 4.5 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 116.067 -0.515 . . . . 72.030000000000001 109.857 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -59.64 -36.98 77.44 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.622 0.769 . . . . 74.450000000000003 110.969 -176.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.55 -65.49 0.71 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.916 0.886 . . . . 70.010000000000005 110.186 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.505 ' HB3' HG22 ' A' ' 77' ' ' VAL . . . -54.53 -37.08 64.96 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.175 0.99 . . . . 72.109999999999999 110.347 -173.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -45.08 -41.59 7.86 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.051 1.341 . . . . 65.209999999999994 112.904 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -112.83 19.78 17.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.703 1.201 . . . . 72.230000000000004 112.338 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.9 t -115.85 149.19 39.02 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 123.721 1.724 . . . . 62.049999999999997 110.783 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.84 -27.0 49.32 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 119.754 3.242 . . . . 72.150000000000006 119.754 -171.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 29.3 t -45.22 -56.31 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 C-N-CA 127.064 2.145 . . . . 74.310000000000002 107.996 168.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.25 -43.34 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 125.644 1.578 . . . . 70.150000000000006 109.398 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp -52.84 -46.31 67.72 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.544 -0.723 . . . . 64.120000000000005 112.089 177.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -49.11 71.89 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 118.724 -0.655 . . . . 71.340000000000003 110.055 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 13.5 mt -59.29 -42.17 90.65 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.777 -0.63 . . . . 74.150000000000006 111.469 -176.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 52.9 t -55.73 -48.96 77.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.672 -0.862 . . . . 72.230000000000004 108.672 176.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.59 -40.11 95.86 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 113.394 0.887 . . . . 52.229999999999997 113.394 -177.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -56.26 -50.93 69.94 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.934 0.894 . . . . 65.140000000000001 109.427 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.499 ' HG3' ' CD2' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -70.31 -38.12 74.88 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 117.454 -1.26 . . . . 74.329999999999998 111.148 -176.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -58.76 -44.41 90.56 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 120.535 1.516 . . . . 43.32 109.54 170.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.8 ttmm -67.12 -10.57 51.53 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.081 -1.012 . . . . 70.230000000000004 113.273 175.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.8 2.7 11.1 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 117.416 -1.278 . . . . 61.5 114.239 178.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -134.77 -12.28 2.29 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.154 1.343 . . . . 61.240000000000002 112.995 174.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -121.21 6.43 10.23 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.378 1.071 . . . . 73.120000000000005 111.121 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -70.83 -85.38 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.358 0.663 . . . . 70.209999999999994 112.364 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.1 pp -164.59 33.24 0.07 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.08 0.952 . . . . 61.420000000000002 113.438 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.555 ' NE2' ' H ' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -126.69 -69.41 0.76 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.298 0.954 . . . . 74.510000000000005 112.391 -163.368 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.555 ' H ' ' NE2' ' A' ' 145' ' ' GLN . 0.7 OUTLIER -133.91 142.22 47.66 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.556 2.742 . . . . 64.109999999999999 107.046 -171.208 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -143.68 13.11 1.71 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.222 1.009 . . . . 45.100000000000001 111.981 -178.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -141.02 176.89 21.32 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 109.36 -1.496 . . . . 70.239999999999995 109.36 173.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 19.2 m -147.7 171.15 6.66 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 124.417 1.087 . . . . 71.329999999999998 111.202 -169.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.432 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 44.2 Cg_endo -64.37 162.86 60.4 Favored 'Cis proline' 0 C--N 1.349 0.605 0 CA-C-N 120.376 1.17 . . . . 73.120000000000005 110.585 -14.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -146.78 147.31 30.77 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 122.89 0.476 . . . . 73.530000000000001 110.268 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 50.9 tpp -142.6 118.45 10.55 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.122 -2.177 . . . . 73.329999999999998 105.122 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -100.91 167.72 10.09 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.088 -0.708 . . . . 74.409999999999997 109.088 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.6 t -139.49 143.16 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.473 1.109 . . . . 71.099999999999994 108.393 170.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 49.45 18.17 0.27 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 128.108 2.563 . . . . 71.430000000000007 115.106 176.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 62.5 34.31 89.06 Favored Glycine 0 CA--C 1.534 1.232 0 O-C-N 120.765 -1.209 . . . . 65.129999999999995 111.687 -176.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -155.88 -22.0 0.11 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.346 1.61 . . . . 65.299999999999997 115.346 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -119.08 154.51 33.06 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 119.234 0.925 . . . . 72.510000000000005 109.044 -175.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.0 125.75 44.37 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.988 2.515 . . . . 72.420000000000002 107.833 176.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.425 HD11 ' CG2' ' A' ' 181' ' ' VAL . 1.0 OUTLIER -64.78 147.19 53.66 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 106.685 -1.598 . . . . 51.100000000000001 106.685 176.278 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.416 ' CG ' HD11 ' A' ' 10' ' ' ILE . 36.3 t30 -123.78 76.67 56.92 Favored Pre-proline 0 C--O 1.233 0.223 0 O-C-N 122.091 -0.38 . . . . 61.210000000000001 111.436 -176.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.58 -17.19 58.75 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.501 1.468 . . . . 74.400000000000006 112.198 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -70.96 -12.21 61.41 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.136 1.774 . . . . 51.140000000000001 113.087 177.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -121.28 35.47 3.62 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.854 1.216 . . . . 45.299999999999997 110.113 175.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 46.0 mtt -122.37 165.04 16.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 122.278 1.037 . . . . 72.319999999999993 109.596 176.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -82.83 76.4 9.68 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.562 -1.199 . . . . 65.209999999999994 110.771 -176.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 21.4 p -73.22 -1.06 16.23 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.256 2.222 . . . . 70.310000000000002 112.8 177.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 39.7 m -72.83 -6.34 44.24 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 113.851 1.056 . . . . 54.200000000000003 113.851 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.59 -9.6 1.42 Allowed 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 117.772 -1.109 . . . . 45.43 113.311 -167.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 3.0 mmt 66.36 -56.85 0.38 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.272 1.829 . . . . 72.5 114.998 174.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.76 -51.37 62.65 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 106.987 -1.486 . . . . 71.239999999999995 106.987 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 48.6 t -57.93 -36.43 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.881 1.272 . . . . 75.219999999999999 110.121 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -58.77 -60.98 2.98 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 118.214 -0.898 . . . . 74.200000000000003 109.771 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.5 t -70.73 -33.97 54.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 118.476 0.58 . . . . 74.400000000000006 110.931 -175.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -49.94 -46.5 52.25 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.76 1.224 . . . . 71.319999999999993 110.155 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -87.43 -28.74 21.94 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 113.349 0.87 . . . . 72.5 113.349 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -56.61 -60.54 3.39 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.054 1.297 . . . . 65.299999999999997 110.513 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.77 -32.22 70.39 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.039 0.536 . . . . 72.129999999999995 111.951 -177.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -60.12 -50.93 71.76 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.773 1.229 . . . . 74.230000000000004 110.275 175.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.0 t -68.44 -30.17 68.98 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 116.73 -1.605 . . . . 63.119999999999997 110.912 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.425 ' CG2' HD11 ' A' ' 160' ' ' LEU . 58.7 t -56.44 -52.06 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 120.512 1.506 . . . . 62.219999999999999 108.578 173.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -59.38 -53.54 56.98 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-O 118.39 -0.815 . . . . 74.5 110.682 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -53.03 -40.94 64.26 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.74 0.7 . . . . 65.230000000000004 111.796 -171.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.85 -20.59 63.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.739 1.014 . . . . 71.530000000000001 113.739 -176.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.08 -33.74 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 109.109 -0.7 . . . . 64.299999999999997 109.109 171.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -80.1 -41.64 25.14 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.877 -1.157 . . . . 42.210000000000001 107.877 -171.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -85.86 51.38 2.19 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.802 2.041 . . . . 73.099999999999994 110.24 -178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 20.4 pttt . . . . . 0 C--O 1.246 0.893 0 CA-C-O 117.264 -1.35 . . . . 65.120000000000005 110.158 172.094 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 119.774 -0.155 . . . . 74.140000000000001 110.676 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -98.02 1.92 48.3 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.814 -1.179 . . . . 73.340000000000003 112.753 -175.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -72.15 46.31 0.14 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.676 1.19 . . . . 45.219999999999999 113.105 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.52 122.47 3.58 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 105.613 -1.995 . . . . 71.140000000000001 105.613 170.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -126.68 158.35 37.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 126.318 1.847 . . . . 62.310000000000002 106.636 171.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.6 m -136.08 135.43 39.33 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.767 -1.197 . . . . 70.120000000000005 107.767 -176.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -51.74 104.15 0.08 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 131.52 3.928 . . . . 74.340000000000003 108.796 167.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 110.0 -22.17 23.74 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 126.998 2.237 . . . . 65.340000000000003 112.501 -177.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -90.7 -85.49 0.22 Allowed 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 119.776 1.788 . . . . 70.230000000000004 108.433 -172.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -89.4 -15.56 32.96 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.896 1.279 . . . . 72.150000000000006 109.915 -176.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -137.2 162.85 32.35 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.599 0.76 . . . . 71.310000000000002 110.709 172.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.401 ' HB ' ' HG3' ' A' ' 159' ' ' GLN . 3.0 mm -128.66 166.81 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 127.542 2.337 . . . . 74.25 105.97 171.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.1 174.22 5.98 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 127.605 2.362 . . . . 72.549999999999997 109.68 176.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 57.9 mt -116.4 148.63 40.48 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.524 1.13 . . . . 70.109999999999999 110.013 171.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -73.06 -35.81 66.76 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.474 1.11 . . . . 70.140000000000001 110.152 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.6 mmtm -122.05 77.99 41.85 Favored Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 126.522 1.929 . . . . 64.150000000000006 109.354 177.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -80.25 1.65 9.09 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 124.553 3.502 . . . . 62.530000000000001 112.858 172.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 15.8 tt -141.12 154.53 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 O-C-N 120.334 -1.479 . . . . 70.549999999999997 107.936 -171.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 64.69 -9.24 0.19 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.343 2.257 . . . . 63.350000000000001 113.545 -166.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -105.32 154.11 17.19 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 124.687 1.137 . . . . 50.039999999999999 110.739 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 52.13 165.36 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 130.395 3.478 . . . . 73.140000000000001 116.868 175.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -71.99 -54.49 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.125 1.883 . . . . 64.439999999999998 110.878 172.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -174.66 -171.88 0.6 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.808 2.043 . . . . 73.25 107.336 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 p -44.24 130.25 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 126.262 1.825 . . . . 73.319999999999993 111.148 173.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.3 154.2 37.46 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.614 1.566 . . . . 65.120000000000005 107.015 -173.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -120.53 141.77 49.94 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.369 -1.345 . . . . 64.230000000000004 107.369 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -130.69 134.98 47.38 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.787 1.635 . . . . 72.200000000000003 109.339 176.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.3 179.27 7.5 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.784 1.234 . . . . 72.430000000000007 108.434 167.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.0 t -134.4 153.43 51.91 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.379 -0.971 . . . . 71.209999999999994 108.379 168.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.541 ' CE2' ' HG2' ' A' ' 91' ' ' MET . 12.2 m-30 -64.94 -24.39 67.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 118.483 -0.77 . . . . 74.209999999999994 111.705 172.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.407 ' CE2' ' HA3' ' A' ' 65' ' ' GLY . 47.7 m-85 -89.26 -5.2 57.8 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 120.283 1.401 . . . . 65.129999999999995 113.667 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.9 p -90.4 144.42 30.81 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 122.059 2.209 . . . . 73.310000000000002 111.298 -174.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -81.84 -43.19 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 121.935 1.756 . . . . 63.329999999999998 112.394 -166.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -54.48 -45.67 73.24 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 109.136 -0.69 . . . . 73.109999999999999 109.136 173.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 15.3 m -55.44 -35.86 65.91 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.503 1.921 . . . . 71.25 112.048 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -64.79 -48.53 74.12 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.822 0.737 . . . . 73.549999999999997 110.674 176.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -59.37 -44.5 92.71 Favored 'General case' 0 C--O 1.223 -0.302 0 O-C-N 121.091 -1.005 . . . . 74.150000000000006 108.908 172.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -60.3 -16.55 35.57 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 115.735 -2.079 . . . . 71.540000000000006 112.41 -178.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -142.83 12.21 1.85 Allowed 'General case' 0 C--N 1.347 0.461 0 CA-C-N 122.111 2.232 . . . . 74.430000000000007 114.438 -172.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -131.7 -13.04 3.34 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.15 0.98 . . . . 64.219999999999999 112.282 165.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.1 t -128.26 -77.12 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 108.353 -0.98 . . . . 72.510000000000005 108.353 -170.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.8 mt -67.18 -26.8 66.81 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.787 1.635 . . . . 74.450000000000003 111.838 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 44.03 56.25 4.85 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.128 1.371 . . . . 70.239999999999995 110.915 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.628 ' O ' HG23 ' A' ' 46' ' ' VAL . 61.1 t -61.64 -46.53 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 117.506 -1.235 . . . . 53.340000000000003 107.967 -169.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.5 t -56.86 -37.99 72.09 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 120.318 1.417 . . . . 64.219999999999999 112.283 -177.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.22 -49.07 63.18 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.103 0.961 . . . . 71.129999999999995 109.745 177.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -62.23 -41.28 98.26 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.625 1.17 . . . . 43.310000000000002 112.088 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 42' ' ' VAL . 2.5 t -62.97 -51.01 77.31 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 N-CA-C 107.553 -1.277 . . . . 71.120000000000005 107.553 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -50.01 -47.83 52.84 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.285 0.948 . . . . 72.239999999999995 111.578 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -66.5 -1.45 3.6 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 115.284 1.587 . . . . 71.120000000000005 115.284 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -130.01 -4.23 4.52 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.94 2.096 . . . . 63.420000000000002 112.891 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.695 HD13 HG21 ' A' ' 54' ' ' THR . 13.6 mt -69.33 151.28 96.95 Favored Pre-proline 0 N--CA 1.466 0.35 0 CA-C-N 120.065 1.302 . . . . 53.450000000000003 110.769 -172.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -81.07 146.3 15.93 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 122.275 1.984 . . . . 74.409999999999997 110.036 172.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -71.93 105.38 3.82 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.015 -1.448 . . . . 72.519999999999996 109.211 -175.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 131.79 -9.54 5.48 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.728 -1.04 . . . . 71.140000000000001 113.337 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.695 HG21 HD13 ' A' ' 50' ' ' LEU . 5.9 t -52.81 -46.79 67.85 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.705 1.253 . . . . 72.439999999999998 112.228 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? 46.5 83.54 0.03 OUTLIER 'General case' 0 C--N 1.346 0.417 0 C-N-CA 127.305 2.242 . . . . 62.310000000000002 110.3 -174.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 19.9 ptp -65.53 -175.74 0.29 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 112.317 -2.219 . . . . 70.450000000000003 111.89 176.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 m -154.75 174.98 14.29 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.278 1.831 . . . . 64.349999999999994 108.482 165.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -140.3 126.14 19.41 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.994 -1.113 . . . . 74.230000000000004 107.994 152.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.402 ' CD2' ' HG3' ' A' ' 137' ' ' GLN . 11.4 m-30 -106.09 -176.98 3.23 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.499 -0.926 . . . . 45.109999999999999 108.499 162.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.429 ' CE1' HD13 ' A' ' 71' ' ' LEU . 41.3 t-80 -134.75 135.12 41.65 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.015 1.726 . . . . 70.329999999999998 106.656 176.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.0 m -81.6 151.89 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.813 0.845 . . . . 62.100000000000001 110.399 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.65 -5.56 22.49 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.675 1.19 . . . . 72.319999999999993 112.314 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -68.49 -45.63 71.84 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.576 -0.702 . . . . 73.540000000000006 112.583 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.0 mt -78.18 132.17 37.49 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 121.838 -0.539 . . . . 73.120000000000005 109.689 -171.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.407 ' HA3' ' CE2' ' A' ' 29' ' ' TYR . . . 97.64 160.85 31.05 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 124.924 1.25 . . . . 64.109999999999999 112.39 169.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.71 -39.47 6.57 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.449 2.099 . . . . 74.239999999999995 110.276 173.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.5 mt -84.59 24.4 1.02 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.507 1.923 . . . . 74.310000000000002 110.661 172.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.39 -52.22 51.28 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 120.972 -1.08 . . . . 33.450000000000003 112.162 -175.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -56.17 -44.91 79.77 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.964 0.882 . . . . 72.219999999999999 110.994 174.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -63.44 -35.7 81.31 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 124.756 1.222 . . . . 73.140000000000001 111.396 -178.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.429 HD13 ' CE1' ' A' ' 60' ' ' HIS . 21.8 mt -60.02 -52.13 66.68 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 123.803 0.841 . . . . 43.240000000000002 110.76 176.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.9 m -62.96 -37.49 87.3 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.403 0.547 . . . . 73.219999999999999 110.339 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -58.51 -44.18 89.4 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.812 -0.555 . . . . 74.329999999999998 109.775 172.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.32 96.39 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.355 -1.466 . . . . 65.5 112.897 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 49.3 t-105 -57.93 -37.96 75.06 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.837 0.855 . . . . 71.109999999999999 109.786 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.09 -43.98 87.34 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 117.55 -1.214 . . . . 62.299999999999997 112.513 175.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.1 t -54.01 -46.35 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 120.632 1.56 . . . . 64.109999999999999 110.714 170.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.71 -45.04 94.58 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-O 118.951 -0.547 . . . . 71.439999999999998 110.864 -175.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 91.6 mt -57.69 -46.82 86.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.956 0.902 . . . . 72.519999999999996 109.43 174.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.45 -3.69 44.67 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.515 1.302 . . . . 65.5 114.515 -169.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 88.5 mt -106.23 -21.48 13.1 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.597 1.089 . . . . 65.329999999999998 111.696 156.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.11 64.08 2.77 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 125.573 1.559 . . . . 34.130000000000003 109.218 -169.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.22 13.76 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.745 1.218 . . . . 70.510000000000005 112.16 -176.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -51.13 -60.2 3.36 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.541 1.137 . . . . 73.420000000000002 109.766 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.12 -8.59 3.59 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.002 1.721 . . . . 72.150000000000006 113.291 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -102.56 -10.78 19.01 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 120.379 -1.45 . . . . 73.439999999999998 112.043 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.2 pp -126.77 -14.12 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 116.96 -1.495 . . . . 74.140000000000001 112.102 -174.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 34.3 m -55.18 -54.96 36.7 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 119.652 1.115 . . . . 53.009999999999998 109.503 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.533 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -54.45 -62.43 4.03 Favored Pre-proline 0 N--CA 1.449 -0.507 0 C-N-CA 124.866 1.266 . . . . 73.409999999999997 111.296 -170.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.533 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 38.0 Cg_endo -64.05 -26.01 66.03 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.112 1.208 . . . . 72.230000000000004 112.357 -177.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.541 ' HG2' ' CE2' ' A' ' 28' ' ' PHE . 8.5 tpp -62.44 -48.03 81.45 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-O 118.193 -0.908 . . . . 74.239999999999995 111.215 172.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -66.71 -35.96 81.37 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 120.412 1.46 . . . . 72.209999999999994 109.139 -178.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -62.39 -33.56 74.99 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.422 0.556 . . . . 74.129999999999995 111.324 170.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.93 -11.12 45.37 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.894 -1.129 . . . . 64.310000000000002 113.388 -176.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.3 t -109.52 -42.87 5.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 125.338 1.455 . . . . 74.239999999999995 110.61 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -103.52 -46.37 4.58 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.179 0.592 . . . . 72.549999999999997 110.133 -174.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt -77.13 -68.65 0.59 Allowed 'General case' 0 N--CA 1.457 -0.088 0 CA-C-O 119.03 -0.509 . . . . 74.25 109.897 -172.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.5 p -79.85 -30.91 40.43 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.296 0.953 . . . . 72.409999999999997 110.548 177.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 60.43 20.97 10.62 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.228 1.811 . . . . 62.219999999999999 113.317 -174.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -69.23 -12.77 61.96 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.324 1.05 . . . . 53.039999999999999 112.812 -174.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.455 HG13 HG12 ' A' ' 107' ' ' ILE . 29.6 t -65.41 115.07 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 O-C-N 120.998 -1.064 . . . . 74.430000000000007 109.189 170.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -136.68 -31.14 0.87 Allowed 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.762 1.225 . . . . 74.540000000000006 112.083 -173.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.67 170.1 16.64 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.904 0.882 . . . . 62.299999999999997 109.355 167.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 67.3 t -54.23 -37.52 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.016 1.326 . . . . 64.140000000000001 111.205 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.28 -31.18 42.5 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.385 1.074 . . . . 45.200000000000003 112.709 176.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -82.4 -27.73 31.84 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 123.242 0.617 . . . . 54.399999999999999 110.504 -177.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.455 HG12 HG13 ' A' ' 101' ' ' VAL . 3.2 mt -76.22 -50.43 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.808 1.643 . . . . 70.200000000000003 108.014 -177.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.412 ' HB3' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -64.82 -21.35 66.77 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.525 -0.734 . . . . 73.319999999999993 111.792 -177.284 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -56.45 21.75 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 124.552 1.141 . . . . 50.43 110.217 168.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.8 t -51.51 -45.53 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 123.654 0.781 . . . . 74.319999999999993 110.002 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -53.1 -55.71 21.89 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.808 0.443 . . . . 62.43 109.859 176.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 64.6 t -57.29 -42.91 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 O-C-N 121.7 -0.625 . . . . 73.319999999999993 110.232 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -61.6 -41.77 97.91 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 124.283 0.989 . . . . 65.530000000000001 109.534 -171.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.34 -2.21 30.58 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.008 1.723 . . . . 62.119999999999997 113.199 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 99.61 55.78 1.0 Allowed Glycine 0 CA--C 1.524 0.618 0 CA-C-N 119.257 0.935 . . . . 71.510000000000005 112.587 177.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 66.8 t -119.84 142.31 35.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 117.687 0.743 . . . . 63.32 109.668 170.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.84 126.32 29.05 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.048 0.939 . . . . 72.129999999999995 109.769 170.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.94 -24.04 69.82 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-O 118.017 -1.435 . . . . 71.420000000000002 112.413 175.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.54 -38.25 89.07 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.941 1.37 . . . . 74.430000000000007 109.752 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -73.4 -44.99 57.34 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 105.794 -1.928 . . . . 71.420000000000002 105.794 -171.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.412 ' CE1' ' HB3' ' A' ' 108' ' ' ARG . 5.1 t80 -60.32 -40.2 89.74 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.452 0.644 . . . . 71.239999999999995 110.045 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -79.61 -11.2 59.88 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.395 0.887 . . . . 72.409999999999997 113.395 -177.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -103.44 -63.55 1.17 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.985 1.314 . . . . 62.520000000000003 109.251 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -44.89 -45.07 10.13 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 128.001 2.521 . . . . 63.200000000000003 110.752 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 44.5 t-105 -50.9 -29.7 12.68 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.279 1.032 . . . . 73.530000000000001 113.563 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -119.33 5.78 11.18 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.895 1.678 . . . . 74.230000000000004 112.434 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.1 t -88.77 149.85 23.23 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.814 1.645 . . . . 65.5 109.466 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -49.2 -33.68 12.99 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.963 1.705 . . . . 73.129999999999995 112.121 177.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.0 t -46.09 -56.53 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 125.338 1.455 . . . . 73.430000000000007 110.426 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.1 t -67.4 -47.45 80.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 C-N-CA 125.016 1.326 . . . . 71.430000000000007 109.454 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -54.39 -44.54 72.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.213 0.53 . . . . 72.299999999999997 110.314 -172.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.05 -45.77 84.01 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.68 1.192 . . . . 73.319999999999993 111.534 176.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 16.3 mt -60.42 -48.62 80.95 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.86 0.864 . . . . 74.530000000000001 111.203 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.9 t -49.96 -45.26 22.37 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 C-N-CA 124.819 1.248 . . . . 73.420000000000002 109.3 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.5 -32.5 74.16 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.693 0.627 . . . . 52.229999999999997 112.693 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -62.85 -51.8 65.62 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.059 0.845 . . . . 73.510000000000005 110.588 171.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.402 ' HG3' ' CD2' ' A' ' 59' ' ' TYR . 7.4 mp0 -63.44 -47.14 83.1 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.793 0.27 . . . . 52.299999999999997 111.235 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -58.73 -47.16 85.57 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.938 1.295 . . . . 70.109999999999999 110.553 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -57.23 -45.06 84.24 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 118.492 0.587 . . . . 73.230000000000004 110.172 175.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.95 1.37 10.96 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.653 0.983 . . . . 74.299999999999997 113.653 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -86.37 -59.36 2.3 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.132 -1.605 . . . . 71.140000000000001 110.36 149.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.2 -7.87 40.51 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.028 2.131 . . . . 53.399999999999999 114.28 -163.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.08 -6.26 48.55 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.064 1.346 . . . . 71.099999999999994 112.343 172.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.0 mt 67.71 63.17 0.41 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 122.727 1.251 . . . . 61.409999999999997 109.494 167.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -144.58 -48.11 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.505 -1.225 . . . . 74.340000000000003 111.435 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 9.4 tp -78.69 -85.76 0.07 Allowed 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.76 0.709 . . . . 65.230000000000004 110.654 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 57.82 24.7 11.09 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.475 1.11 . . . . 71.510000000000005 112.515 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -169.39 162.47 36.06 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.682 1.61 . . . . 53.420000000000002 109.835 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 18.9 m -150.69 165.19 17.93 Favored Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 118.47 1.135 . . . . 72.510000000000005 109.852 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -65.31 157.31 76.63 Favored 'Cis proline' 0 C--N 1.351 0.665 0 CA-C-N 119.902 1.001 . . . . 64.450000000000003 110.592 -13.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -144.59 141.8 29.69 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.973 -0.558 . . . . 53.210000000000001 110.058 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 34.7 mtp -148.94 95.31 2.38 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 105.855 -1.905 . . . . 53.340000000000003 105.855 -169.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -82.13 169.31 16.79 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.996 -0.372 . . . . 73.140000000000001 109.996 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.2 t -147.38 150.31 14.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 O-C-N 121.128 -0.982 . . . . 62.530000000000001 109.602 169.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 60.31 6.1 0.97 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 128.431 2.692 . . . . 73.329999999999998 114.241 166.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.4 -1.47 84.25 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.298 -1.279 . . . . 72.340000000000003 112.455 -173.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -147.05 -7.12 0.48 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 116.252 1.945 . . . . 74.340000000000003 116.252 -164.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -121.48 155.6 34.57 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 118.517 0.599 . . . . 73.510000000000005 109.898 -175.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.401 ' HG3' ' HB ' ' A' ' 10' ' ' ILE . 0.5 OUTLIER -125.67 130.02 50.74 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 128.159 2.584 . . . . 74.439999999999998 107.302 172.199 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.61 153.74 38.43 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.67 -1.233 . . . . 63.329999999999998 107.67 174.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -126.48 85.59 59.97 Favored Pre-proline 0 C--O 1.234 0.272 0 O-C-N 122.241 -0.287 . . . . 63.210000000000001 110.93 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -63.11 -22.81 73.33 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 CA-C-N 118.948 0.66 . . . . 70.209999999999994 111.794 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.5 -2.59 23.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.875 1.27 . . . . 72.209999999999994 111.955 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -131.93 30.92 3.14 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.596 1.569 . . . . 72.530000000000001 111.021 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 20.8 mtm -127.15 165.18 20.05 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.439 1.496 . . . . 73.140000000000001 108.74 172.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -83.18 67.73 9.31 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 124.978 2.323 . . . . 70.310000000000002 110.762 -166.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.5 p -66.53 6.09 0.5 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 131.55 3.94 . . . . 72.129999999999995 112.204 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 23.0 m -91.74 -5.47 53.55 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 124.112 0.965 . . . . 73.319999999999993 113.458 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.44 -10.69 2.48 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 118.376 -0.821 . . . . 73.340000000000003 112.626 -172.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 10.1 mmt 70.25 -59.1 0.53 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 126.33 1.852 . . . . 53.140000000000001 112.978 177.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -67.4 -43.07 82.19 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.84 1.2 . . . . 73.319999999999993 108.774 -174.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 40.0 t -65.33 -30.56 50.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 124.516 1.127 . . . . 71.349999999999994 110.925 176.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -61.96 -62.53 1.72 Allowed 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.791 -0.818 . . . . 65.310000000000002 108.791 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 12.7 t -63.55 -39.01 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 119.079 -0.486 . . . . 73.540000000000006 110.271 -172.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -50.6 -49.52 56.36 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.627 1.171 . . . . 74.319999999999993 110.612 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -78.62 -40.36 34.57 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 118.342 -0.837 . . . . 73.310000000000002 112.005 178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -54.1 -56.48 17.67 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.953 0.901 . . . . 74.519999999999996 110.289 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -53.86 -35.89 62.0 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.438 1.095 . . . . 72.530000000000001 112.326 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -73.29 -51.77 16.36 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.363 0.665 . . . . 72.530000000000001 109.829 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.0 t -62.15 -25.34 67.7 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 117.483 -1.246 . . . . 72.219999999999999 111.374 -176.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 57.8 t -56.62 -56.28 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 119.369 0.986 . . . . 72.549999999999997 108.896 168.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 13.6 tttm -55.8 -46.23 78.07 Favored 'General case' 0 N--CA 1.461 0.088 0 C-N-CA 123.512 0.725 . . . . 70.310000000000002 111.518 177.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -58.25 -29.18 65.56 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.442 0.697 . . . . 73.219999999999999 111.361 -175.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 50.9 mt -82.04 -25.77 34.35 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 120.964 -1.085 . . . . 73.150000000000006 113.222 -176.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 89.3 t -59.74 -36.14 64.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.732 -0.84 . . . . 53.030000000000001 108.732 175.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -91.43 -19.65 22.63 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 122.218 -0.301 . . . . 74.239999999999995 111.094 -173.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -95.17 65.78 2.87 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.947 1.299 . . . . 72.109999999999999 108.932 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt . . . . . 0 C--O 1.242 0.706 0 N-CA-C 108.47 -0.937 . . . . 62.509999999999998 108.47 165.337 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 56.0 p . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 111.489 0.181 . . . . 71.329999999999998 111.489 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -65.62 175.65 1.77 Allowed 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.464 -0.773 . . . . 53.340000000000003 109.07 170.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 50.15 28.55 3.11 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.388 1.875 . . . . 72.239999999999995 115.232 -176.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -165.37 113.74 1.01 Allowed 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.238 1.015 . . . . 73.230000000000004 110.398 169.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.0 pt -112.93 172.02 3.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 127.593 2.357 . . . . 70.430000000000007 109.612 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.9 m -142.68 141.52 31.86 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.138 -0.976 . . . . 62.240000000000002 108.86 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -53.21 135.55 37.93 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 126.174 1.79 . . . . 71.310000000000002 110.155 172.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.48 -18.02 7.51 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.376 1.465 . . . . 74.239999999999995 113.889 -175.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -93.41 -85.12 0.28 Allowed 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.569 1.684 . . . . 63.109999999999999 108.904 -167.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -89.43 -12.05 41.34 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.948 0.899 . . . . 64.239999999999995 111.381 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -141.69 160.83 39.36 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.494 0.718 . . . . 74.25 109.658 171.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.6 mm -121.74 162.77 20.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 107.407 -1.331 . . . . 73.209999999999994 107.407 170.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.4 m -119.57 127.46 53.0 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 127.137 2.175 . . . . 74.219999999999999 106.126 -178.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.4 mt -70.5 159.36 34.42 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.236 -0.653 . . . . 51.329999999999998 109.236 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -83.07 -30.1 28.28 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.847 0.459 . . . . 71.439999999999998 111.608 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -138.13 73.06 45.43 Favored Pre-proline 0 C--O 1.232 0.149 0 C-N-CA 124.903 1.281 . . . . 75.129999999999995 108.58 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -69.5 107.31 1.78 Allowed 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.161 2.574 . . . . 55.509999999999998 106.953 173.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.8 tt -137.34 149.24 25.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 O-C-N 121.1 -1.0 . . . . 73.420000000000002 110.189 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.68 148.46 24.49 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.572 -0.899 . . . . 74.239999999999995 108.572 173.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 124.74 -17.83 7.22 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-O 118.809 -0.995 . . . . 62.009999999999998 111.537 -170.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -84.69 159.53 57.89 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 119.21 1.505 . . . . 72.420000000000002 109.185 161.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.33 -22.26 46.27 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.616 2.211 . . . . 61.030000000000001 112.55 173.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 65.66 152.58 0.06 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 128.05 2.54 . . . . 63.340000000000003 111.991 -171.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.4 m 44.59 72.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 127.514 2.326 . . . . 70.319999999999993 111.639 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.7 160.17 41.64 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.48 -0.933 . . . . 64.25 108.48 -173.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -126.77 161.36 28.37 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 125.083 1.353 . . . . 73.019999999999996 107.458 167.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -121.09 174.04 6.9 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.982 -1.488 . . . . 75.310000000000002 106.982 167.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -166.01 -179.03 4.97 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.669 2.388 . . . . 72.420000000000002 109.264 168.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.07 -168.63 2.4 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 106.729 -1.582 . . . . 44.100000000000001 106.729 158.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -104.47 -45.9 4.52 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.587 0.708 . . . . 74.319999999999993 109.256 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.499 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 69.4 m-85 -83.39 -4.09 58.15 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.544 -0.723 . . . . 73.310000000000002 111.814 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.2 p -62.36 144.09 95.36 Favored Pre-proline 0 C--N 1.343 0.283 0 CA-C-N 119.782 1.174 . . . . 72.200000000000003 109.841 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.0 173.93 13.66 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 121.461 1.441 . . . . 65.400000000000006 109.365 163.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 66.17 -40.63 0.35 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 128.936 2.895 . . . . 61.420000000000002 112.762 -174.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 60.2 m -54.84 -41.09 70.32 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.834 1.654 . . . . 73.099999999999994 112.128 -177.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -54.5 -63.69 1.07 Allowed 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 128.199 2.6 . . . . 73.219999999999999 108.854 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -57.16 -39.97 76.3 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 108.434 -0.95 . . . . 72.439999999999998 108.434 -179.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -57.09 -26.46 60.45 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 115.292 -2.289 . . . . 74.439999999999998 113.282 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.64 -24.57 4.5 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 122.158 2.254 . . . . 72.099999999999994 109.552 -174.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -105.76 -17.06 14.5 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.512 1.505 . . . . 74.310000000000002 113.757 -170.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.6 t -121.68 -63.73 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 108.187 -1.042 . . . . 70.439999999999998 108.187 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 42.6 mt -70.88 -18.39 62.69 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 118.147 -0.93 . . . . 74.019999999999996 111.966 175.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 44.89 39.59 3.71 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 121.139 1.79 . . . . 74.099999999999994 112.899 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 69.4 t -61.23 -45.41 98.65 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 O-C-N 121.091 -1.006 . . . . 71.230000000000004 109.864 -175.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.4 t -47.1 -53.27 13.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.86 1.264 . . . . 63.119999999999997 109.942 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.95 -31.89 69.85 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 113.558 0.948 . . . . 52.530000000000001 113.558 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -73.88 -51.69 15.39 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.702 0.683 . . . . 74.340000000000003 109.297 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 50.4 t -52.66 -52.68 25.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 126.055 1.742 . . . . 73.450000000000003 109.609 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.4 ptt85 -64.85 -14.01 58.03 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 116.795 -1.574 . . . . 74.349999999999994 114.015 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -75.75 -17.64 59.83 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 120.667 1.576 . . . . 73.409999999999997 112.55 170.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -123.34 -9.18 8.07 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.445 1.098 . . . . 64.109999999999999 113.34 -171.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.448 HD12 ' HE1' ' A' ' 56' ' ' MET . 10.8 mt -61.64 146.16 90.62 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 123.929 0.892 . . . . 73.239999999999995 112.184 -179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -83.47 162.1 14.79 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.879 3.053 . . . . 70.129999999999995 114.081 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -79.51 64.83 4.5 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 127.094 2.158 . . . . 65.310000000000002 110.257 -171.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -176.25 -30.41 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 125.174 1.368 . . . . 51.450000000000003 111.615 -169.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.445 HG21 HD13 ' A' ' 50' ' ' LEU . 3.8 t -58.04 -29.61 65.49 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 115.233 1.568 . . . . 74.430000000000007 115.233 -176.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.3 tptp 44.37 88.62 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.43 1.892 . . . . 74.329999999999998 112.185 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.448 ' HE1' HD12 ' A' ' 50' ' ' LEU . 4.5 ttm -49.77 100.71 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 129.388 3.075 . . . . 64.329999999999998 110.692 -175.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.4 m -139.84 121.31 15.1 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 107.337 -1.357 . . . . 62.299999999999997 107.337 -172.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -130.46 120.01 23.51 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 106.986 -1.487 . . . . 54.420000000000002 106.986 -176.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -95.52 157.11 16.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 123.13 1.443 . . . . 74.430000000000007 110.056 174.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.646 ' CE1' ' HG2' ' A' ' 137' ' ' GLN . 22.4 p-80 -98.0 167.06 11.13 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 129.176 2.99 . . . . 61.43 108.901 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.2 m -131.92 165.83 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.032 0.933 . . . . 51.439999999999998 108.507 176.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -100.68 16.65 24.21 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.53 1.132 . . . . 62.310000000000002 111.675 -169.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -115.73 162.6 17.04 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 126.436 1.895 . . . . 52.520000000000003 109.322 -169.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 75.3 124.34 0.04 OUTLIER 'General case' 0 C--O 1.232 0.153 0 C-N-CA 128.676 2.79 . . . . 63.039999999999999 110.519 174.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.499 ' HA3' ' CD2' ' A' ' 29' ' ' TYR . . . 90.19 173.47 44.93 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 124.302 0.953 . . . . 75.420000000000002 112.098 175.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -65.52 -55.15 0.47 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.348 2.699 . . . . 74.209999999999994 109.737 173.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.5 mt -86.54 17.0 4.1 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 125.174 1.39 . . . . 72.129999999999995 112.862 -167.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -48.16 -45.12 27.21 Favored Glycine 0 CA--C 1.542 1.739 0 CA-C-N 120.005 1.275 . . . . 72.129999999999995 113.715 -174.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.1 tptt -59.85 -46.37 89.5 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.887 1.275 . . . . 74.109999999999999 111.541 174.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -71.03 -38.18 72.58 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.749 -1.219 . . . . 71.019999999999996 109.026 -176.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.1 mt -62.46 -34.1 76.14 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.091 1.756 . . . . 71.209999999999994 111.915 173.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.468 ' HA ' ' HD2' ' A' ' 60' ' ' HIS . 18.7 m -54.04 -58.19 8.24 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 106.934 -1.506 . . . . 74.319999999999993 106.934 170.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -57.25 -50.56 72.51 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.968 0.907 . . . . 72.400000000000006 111.595 -169.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.5 -24.4 67.46 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.883 1.068 . . . . 61.020000000000003 113.883 -171.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 -57.7 -35.04 70.09 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.453 -0.779 . . . . 74.219999999999999 111.168 175.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.05 95.04 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.34 -0.838 . . . . 72.340000000000003 111.915 178.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.2 t -53.38 -43.73 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 119.177 0.898 . . . . 32.420000000000002 110.159 175.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.93 -26.24 40.2 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 117.362 -1.304 . . . . 32.119999999999997 113.088 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 76.8 mt -67.14 -41.75 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 120.835 1.652 . . . . 70.040000000000006 108.343 166.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.01 -44.36 94.63 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.623 0.647 . . . . 74.040000000000006 110.464 -172.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.4 mt -81.04 -18.07 48.01 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 112.902 0.705 . . . . 64.409999999999997 112.902 174.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.29 70.16 1.13 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.907 1.717 . . . . 54.219999999999999 110.789 -171.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.469 HG21 HG22 ' A' ' 116' ' ' VAL . 15.9 m -138.11 19.18 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 125.735 1.614 . . . . 72.400000000000006 111.432 -175.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -52.43 -51.52 58.78 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 126.03 1.732 . . . . 72.140000000000001 110.151 -178.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -68.36 -0.86 5.33 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.562 1.945 . . . . 65.0 113.393 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -104.42 -26.07 12.57 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 120.835 -1.165 . . . . 71.040000000000006 109.66 176.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.433 HG22 ' HB3' ' A' ' 114' ' ' ALA . 1.1 pt -112.04 9.93 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 C-N-CA 125.013 1.325 . . . . 70.420000000000002 111.698 -174.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 56.0 m -80.92 -44.71 17.84 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 120.931 1.696 . . . . 63.32 109.22 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.48 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -69.07 -63.5 2.1 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 124.081 0.952 . . . . 62.409999999999997 111.686 -165.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 31.2 Cg_endo -63.01 -21.41 73.16 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 121.355 1.37 . . . . 62.240000000000002 112.08 -176.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.441 ' HE3' ' HB2' ' A' ' 91' ' ' MET . 15.0 ttm -74.26 -37.69 63.67 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 125.875 1.67 . . . . 65.209999999999994 110.52 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -64.08 -42.29 97.01 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 119.047 -0.502 . . . . 74.010000000000005 110.304 164.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -64.75 -13.79 56.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 118.321 -0.847 . . . . 65.010000000000005 113.189 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.99 -14.12 15.28 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.782 1.173 . . . . 41.409999999999997 112.36 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 78.9 t -105.86 -45.04 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.251 1.02 . . . . 63.119999999999997 112.371 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -103.88 -48.54 3.88 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 114.587 1.329 . . . . 71.019999999999996 114.587 -174.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -70.31 -59.18 3.02 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.875 1.27 . . . . 74.109999999999999 113.587 -177.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 48.5 p -94.05 -30.26 14.78 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.779 1.232 . . . . 52.119999999999997 113.435 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 60.95 27.11 16.99 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.001 2.921 . . . . 71.430000000000007 113.569 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.5 t -59.78 -25.75 65.16 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.398 1.479 . . . . 62.32 112.438 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 42.7 t -62.58 109.91 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 108.528 -0.916 . . . . 72.219999999999999 108.528 175.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -141.66 -20.41 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.945 1.298 . . . . 72.129999999999995 110.841 -175.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.93 167.4 22.21 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.679 -1.6 . . . . 72.439999999999998 106.679 167.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.5 t -55.74 -28.8 24.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.11 0.564 . . . . 72.129999999999995 109.698 172.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.86 -15.04 57.96 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.972 1.709 . . . . 41.399999999999999 112.191 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.84 -23.67 13.37 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 118.635 0.652 . . . . 71.209999999999994 111.086 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.5 mt -71.52 -51.41 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 C-N-CA 125.4 1.48 . . . . 65.420000000000002 108.236 174.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.76 -22.36 62.0 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.269 1.028 . . . . 72.219999999999999 112.22 -175.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -62.06 -59.35 5.21 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 126.682 1.993 . . . . 74.439999999999998 111.076 170.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 71.1 t -54.53 -40.49 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.523 1.129 . . . . 70.200000000000003 110.354 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -54.06 -53.27 55.36 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 119.05 -0.5 . . . . 62.109999999999999 110.644 173.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.4 t -61.98 -46.72 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 119.617 1.098 . . . . 62.020000000000003 110.645 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -54.39 -44.2 72.1 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.164 0.986 . . . . 72.109999999999999 109.772 -176.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.433 ' HB3' HG22 ' A' ' 87' ' ' ILE . . . -75.1 -13.19 60.45 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.522 1.529 . . . . 34.420000000000002 114.907 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 126.42 6.47 5.67 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 117.402 1.721 . . . . 43.43 117.402 176.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.469 HG22 HG21 ' A' ' 83' ' ' VAL . 93.7 t -93.71 120.04 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-N 119.958 1.879 . . . . 73.209999999999994 110.051 -175.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.596 ' HG3' ' CB ' ' A' ' 120' ' ' ASP . 3.6 pttp -52.2 125.92 17.24 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.593 -0.73 . . . . 63.299999999999997 109.927 172.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.21 -30.6 61.24 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 109.41 -1.476 . . . . 52.329999999999998 109.41 166.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -30.38 66.56 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 119.371 1.585 . . . . 74.340000000000003 110.653 -175.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.596 ' CB ' ' HG3' ' A' ' 117' ' ' LYS . 23.3 t0 -83.31 -43.31 16.14 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.842 -0.799 . . . . 74.040000000000006 108.842 175.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -50.81 -54.62 22.13 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 123.58 0.752 . . . . 74.299999999999997 111.047 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -73.66 -9.95 59.2 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.619 1.568 . . . . 45.439999999999998 111.413 -173.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.29 -63.3 1.14 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.431 1.892 . . . . 72.030000000000001 109.501 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.49 -36.08 68.72 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.681 1.592 . . . . 72.329999999999998 112.893 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 65.3 t-105 -44.64 -39.26 4.9 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.562 1.145 . . . . 63.100000000000001 111.065 174.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.28 0.97 41.22 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.881 1.672 . . . . 74.420000000000002 113.657 -177.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.4 t -97.66 165.72 11.83 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.593 1.557 . . . . 43.530000000000001 112.676 -173.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -62.97 -36.64 84.16 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.001 1.72 . . . . 74.030000000000001 111.445 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.4 t -50.58 -47.75 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 122.342 1.068 . . . . 72.140000000000001 109.064 -178.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.6 t -68.84 -42.89 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-N 114.818 -1.083 . . . . 62.329999999999998 111.476 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -50.98 -53.87 29.42 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 118.98 0.809 . . . . 74.129999999999995 110.451 175.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.84 -42.96 99.95 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.214 0.606 . . . . 55.539999999999999 110.091 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.5 mt -64.4 -40.08 95.1 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 119.326 0.966 . . . . 64.420000000000002 112.823 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 74.2 t -59.23 -53.79 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 107.406 -1.331 . . . . 55.420000000000002 107.406 171.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.42 -34.35 68.82 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.385 0.883 . . . . 73.140000000000001 113.385 -174.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -53.28 -46.03 69.15 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 124.523 1.129 . . . . 63.140000000000001 111.565 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.646 ' HG2' ' CE1' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -94.18 -31.19 14.24 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 113.102 0.778 . . . . 74.319999999999993 113.102 -170.556 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -64.87 -38.08 89.78 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.796 0.726 . . . . 75.140000000000001 109.169 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -54.56 -48.83 71.58 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 126.404 1.882 . . . . 74.120000000000005 111.386 165.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.66 -17.0 60.75 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 118.513 -0.756 . . . . 51.130000000000003 112.596 -175.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.25 -44.91 35.26 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 120.839 1.654 . . . . 74.099999999999994 109.819 164.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.5 -5.11 21.93 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.428 1.491 . . . . 72.030000000000001 114.236 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.0 -2.46 51.66 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.67 1.123 . . . . 61.439999999999998 112.355 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 10.2 mt 74.56 54.84 0.08 Allowed 'General case' 0 C--N 1.342 0.245 0 C-N-CA 126.353 1.861 . . . . 75.150000000000006 110.454 164.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.405 HE21 ' HB3' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -132.41 -23.39 2.13 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.611 0.967 . . . . 73.150000000000006 113.611 -173.165 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.405 ' HB3' HE21 ' A' ' 145' ' ' GLN . 0.5 OUTLIER -131.91 -80.85 0.51 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.613 1.097 . . . . 63.039999999999999 111.382 -168.619 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 62.77 -3.58 0.3 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.707 2.003 . . . . 71.450000000000003 115.534 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -137.83 162.19 25.53 Favored Glycine 0 CA--C 1.526 0.727 0 O-C-N 120.395 -1.441 . . . . 33.43 110.858 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.471 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 5.1 m -142.39 166.93 18.15 Favored Pre-proline 0 C--O 1.239 0.504 0 N-CA-C 107.976 -1.12 . . . . 71.400000000000006 107.976 -177.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.471 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 98.1 Cg_endo -73.59 155.7 99.73 Favored 'Cis proline' 0 CA--C 1.536 0.625 0 CA-C-N 119.79 0.961 . . . . 74.439999999999998 113.532 -9.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -152.17 142.47 22.45 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 126.062 1.745 . . . . 73.040000000000006 110.079 -177.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 32.4 ttm -140.67 133.81 29.47 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 126.505 1.922 . . . . 62.039999999999999 106.43 172.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -117.42 159.58 22.56 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.836 0.854 . . . . 74.140000000000001 111.216 -177.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.5 t -141.23 145.74 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.407 1.083 . . . . 53.450000000000003 108.549 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 48.28 11.91 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.317 2.647 . . . . 71.030000000000001 116.124 177.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 62.56 41.93 99.75 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 119.705 1.138 . . . . 64.25 110.59 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -165.71 -21.93 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.778 1.231 . . . . 73.049999999999997 112.488 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -112.89 146.44 38.94 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 118.756 0.707 . . . . 72.450000000000003 109.362 177.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -117.78 139.36 51.19 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 104.933 -2.247 . . . . 60.130000000000003 104.933 167.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.418 ' CD1' HG23 ' A' ' 180' ' ' THR . 4.1 mm? -66.38 142.91 57.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.777 -1.564 . . . . 72.340000000000003 106.777 173.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -115.75 85.58 14.48 Favored Pre-proline 0 CA--C 1.516 -0.344 0 CA-C-N 117.84 0.291 . . . . 73.049999999999997 110.97 177.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -64.87 -27.13 59.11 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 CA-C-N 118.652 0.554 . . . . 62.32 111.139 174.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.93 -0.56 16.5 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.397 1.479 . . . . 74.450000000000003 112.825 -173.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -133.22 12.49 4.98 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.66 1.6 . . . . 64.019999999999996 111.699 175.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 17.5 mtt -87.73 172.32 9.77 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 120.129 1.965 . . . . 74.319999999999993 109.264 165.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.16 106.68 7.91 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.055 -1.461 . . . . 71.349999999999994 107.055 169.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.546 HG22 ' CD1' ' A' ' 173' ' ' PHE . 54.5 p -112.59 18.39 18.4 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.107 2.163 . . . . 70.109999999999999 110.368 -178.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 40.0 m -99.52 5.56 46.06 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.451 1.101 . . . . 74.409999999999997 112.77 -172.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -137.43 -15.22 1.45 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.554 1.142 . . . . 70.349999999999994 111.825 -177.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 2.2 mmt 69.17 -62.99 0.39 Allowed 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 126.246 1.819 . . . . 65.420000000000002 110.454 -175.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.99 -38.55 86.4 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.17 -0.956 . . . . 74.129999999999995 111.657 -172.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 65.5 t -75.29 -27.49 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 123.809 0.844 . . . . 54.130000000000003 111.161 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.546 ' CD1' HG22 ' A' ' 167' ' ' THR . 42.0 t80 -59.32 -52.03 67.4 Favored 'General case' 0 C--O 1.226 -0.158 0 N-CA-C 108.655 -0.868 . . . . 73.450000000000003 108.655 -177.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.7 t -77.28 -25.04 15.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 117.518 0.145 . . . . 74.209999999999994 111.11 -175.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.53 -31.25 67.76 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.3 0.482 . . . . 70.109999999999999 112.3 168.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -86.32 -44.94 11.69 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.25 1.02 . . . . 73.109999999999999 110.985 172.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -58.44 -56.74 18.21 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.519 0.728 . . . . 73.409999999999997 110.569 -167.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.15 -21.23 59.04 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 113.683 0.994 . . . . 71.040000000000006 113.683 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -77.96 -52.58 8.59 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 123.346 0.658 . . . . 70.430000000000007 110.321 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.418 HG23 ' CD1' ' A' ' 160' ' ' LEU . 9.0 t -62.16 -30.71 71.24 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 117.832 -1.08 . . . . 72.049999999999997 110.653 178.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 85.5 t -60.63 -54.57 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 119.987 1.267 . . . . 74.310000000000002 108.483 177.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -59.51 -48.17 82.67 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-O 118.777 -0.63 . . . . 72.319999999999993 110.255 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -60.13 -29.46 68.64 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 112.481 0.549 . . . . 74.450000000000003 112.481 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 60.2 mt -74.79 -23.13 58.45 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 120.826 -1.171 . . . . 72.409999999999997 112.309 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 92.9 t -66.05 -29.5 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 118.34 0.518 . . . . 70.120000000000005 109.671 174.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -95.46 -9.36 32.83 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.816 0.846 . . . . 65.450000000000003 110.428 -175.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 21.0 mttp -108.61 61.91 0.6 Allowed 'General case' 0 C--O 1.225 -0.186 0 O-C-N 120.661 -1.274 . . . . 72.439999999999998 109.664 -177.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.6 mmtm . . . . . 0 C--O 1.254 1.317 0 C-N-CA 127.179 2.191 . . . . 71.049999999999997 112.223 171.253 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 44.0 t . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 109.548 -0.538 . . . . 71.239999999999995 109.548 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -143.85 -175.52 4.62 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.662 1.585 . . . . 72.329999999999998 107.146 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 61.72 32.57 18.28 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 125.918 1.687 . . . . 74.420000000000002 112.691 -177.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -156.35 105.95 2.32 Favored 'General case' 0 N--CA 1.425 -1.711 0 C-N-CA 125.563 1.545 . . . . 65.049999999999997 107.791 -175.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.512 HG21 HG23 ' A' ' 180' ' ' THR . 9.9 pt -106.16 167.0 3.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 127.185 2.194 . . . . 71.450000000000003 109.119 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.7 m -143.89 145.8 32.55 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 106.598 -1.63 . . . . 71.219999999999999 106.598 175.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -58.56 150.06 23.94 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 127.566 2.347 . . . . 44.119999999999997 109.758 167.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.56 -29.37 0.36 Allowed Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.546 1.07 . . . . 64.319999999999993 113.826 -168.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -94.85 -84.44 0.33 Allowed 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 118.951 1.375 . . . . 73.209999999999994 108.551 -165.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -92.7 -14.92 27.35 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.459 0.703 . . . . 73.129999999999995 110.852 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -143.48 165.31 27.9 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.544 0.611 . . . . 74.010000000000005 110.705 167.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.3 mm -122.17 162.61 21.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 126.827 2.051 . . . . 74.040000000000006 106.605 175.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.0 m -126.66 136.45 52.5 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 106.004 -1.85 . . . . 63.219999999999999 106.004 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.0 mt -81.07 156.4 25.84 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 118.541 0.61 . . . . 53.25 109.606 -178.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -71.7 -34.94 70.05 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.303 1.441 . . . . 53.409999999999997 110.509 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.4 mmtm -137.01 78.82 39.94 Favored Pre-proline 0 N--CA 1.453 -0.279 0 C-N-CA 125.112 1.365 . . . . 74.329999999999998 108.403 -175.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -77.45 73.96 5.34 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 123.391 2.728 . . . . 55.43 108.763 174.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.1 tt -157.21 95.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 107.969 -1.123 . . . . 63.210000000000001 107.969 165.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.77 -176.68 4.86 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.732 2.013 . . . . 51.229999999999997 106.918 169.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.34 -108.62 0.79 Allowed Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 108.953 -1.659 . . . . 74.010000000000005 108.953 172.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 60.57 165.85 0.09 OUTLIER Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.812 1.245 . . . . 73.140000000000001 112.993 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.41 164.7 24.95 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 120.914 1.076 . . . . 74.219999999999999 109.922 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.78 -32.06 59.63 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.696 1.198 . . . . 74.129999999999995 113.268 -170.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.501 HG22 ' H ' ' A' ' 55' ' ' LYS . 14.8 m -150.51 -176.41 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 128.769 2.828 . . . . 65.030000000000001 105.442 166.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.457 ' HG ' ' H ' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -169.61 171.06 7.75 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.573 1.549 . . . . 54.140000000000001 108.46 169.414 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.457 ' H ' ' HG ' ' A' ' 23' ' ' LEU . 19.4 tt0 -130.45 145.14 51.78 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 128.509 2.723 . . . . 65.420000000000002 108.875 176.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -132.52 125.44 30.6 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.833 1.253 . . . . 74.010000000000005 108.291 174.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -135.82 178.63 6.9 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.947 1.699 . . . . 74.439999999999998 109.527 174.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.499 ' HA ' ' CE1' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -146.59 -174.89 4.59 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.155 0.982 . . . . 64.310000000000002 110.5 164.435 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.551 ' CZ ' ' HG3' ' A' ' 91' ' ' MET . 50.9 m-85 -93.93 -41.39 9.62 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.654 -0.654 . . . . 74.120000000000005 112.73 176.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -80.72 -7.53 59.38 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.808 0.67 . . . . 74.109999999999999 112.808 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.0 p -74.7 149.2 85.78 Favored Pre-proline 0 CA--C 1.532 0.269 0 O-C-N 120.744 -1.223 . . . . 73.140000000000001 111.979 173.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.25 167.87 25.69 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.618 2.212 . . . . 73.310000000000002 109.184 164.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.2 m80 68.98 -51.32 0.59 Allowed 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 127.114 2.165 . . . . 70.019999999999996 110.738 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 61.0 m -44.42 -40.45 5.48 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 126.555 1.942 . . . . 45.210000000000001 112.046 177.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.95 -70.91 0.08 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.291 1.037 . . . . 74.230000000000004 108.229 175.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -65.98 -37.47 86.05 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.084 -1.01 . . . . 73.349999999999994 110.141 -169.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -61.58 -20.64 63.53 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 116.878 -1.534 . . . . 72.129999999999995 112.483 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -120.68 -11.25 9.06 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 119.395 0.998 . . . . 72.109999999999999 110.928 -170.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.5 ' HA ' ' CE1' ' A' ' 41' ' ' HIS . 0.0 OUTLIER -134.56 -16.54 2.05 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 114.666 1.358 . . . . 62.130000000000003 114.666 -173.765 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 77.7 t -117.64 -68.23 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.272 0.558 . . . . 74.040000000000006 110.368 174.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.4 mt -69.08 -21.76 64.05 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.247 1.419 . . . . 51.340000000000003 111.314 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.5 ' CE1' ' HA ' ' A' ' 38' ' ' GLU . 39.7 m-70 44.08 56.24 4.89 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 126.0 1.72 . . . . 74.219999999999999 111.074 171.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.614 ' O ' HG23 ' A' ' 46' ' ' VAL . 68.2 t -59.18 -49.13 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 117.184 -1.389 . . . . 72.120000000000005 107.754 -172.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.3 t -45.61 -53.47 9.1 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-N 119.685 1.13 . . . . 74.140000000000001 112.111 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.423 ' CG ' HH12 ' A' ' 47' ' ' ARG . 1.5 t70 -88.5 5.66 41.5 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.921 0.712 . . . . 72.420000000000002 112.921 -174.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -92.01 -49.06 6.42 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.733 0.813 . . . . 72.140000000000001 109.992 157.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 42' ' ' VAL . 2.4 t -63.49 -40.12 87.88 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-N 119.632 1.106 . . . . 74.109999999999999 110.392 -170.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.423 HH12 ' CG ' ' A' ' 44' ' ' ASP . 0.7 OUTLIER -51.58 -38.43 54.41 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 118.049 -0.977 . . . . 62.450000000000003 111.709 -179.045 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -64.76 -2.96 2.82 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 115.207 1.558 . . . . 73.25 115.207 176.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -129.05 -5.62 4.97 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.107 1.763 . . . . 73.310000000000002 111.603 -178.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.541 ' HG ' HG12 ' A' ' 46' ' ' VAL . 5.6 mt -87.67 152.7 52.05 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 127.334 2.254 . . . . 71.450000000000003 111.119 -165.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.425 ' O ' HG22 ' A' ' 54' ' ' THR . 26.1 Cg_endo -81.21 175.6 9.59 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.209 2.606 . . . . 61.340000000000003 112.015 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -84.63 23.03 1.2 Allowed 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.478 -1.389 . . . . 61.219999999999999 114.524 -169.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -143.19 -15.08 0.29 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.308 1.432 . . . . 63.240000000000002 113.724 -172.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.53 HG21 ' HB3' ' A' ' 50' ' ' LEU . 14.6 t -60.04 128.12 35.25 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 107.388 -1.338 . . . . 71.129999999999995 107.388 175.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.501 ' H ' HG22 ' A' ' 22' ' ' VAL . 48.0 tptt -118.61 72.78 0.89 Allowed 'General case' 0 C--N 1.341 0.196 0 CA-C-O 123.279 1.514 . . . . 71.109999999999999 109.535 173.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 18.4 ptp -52.96 -31.85 42.71 Favored 'General case' 0 CA--C 1.496 -1.1 0 C-N-CA 125.331 1.452 . . . . 70.120000000000005 114.339 -173.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.598 HG22 ' H ' ' A' ' 58' ' ' LYS . 7.5 m 46.82 -167.33 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 126.101 1.761 . . . . 74.209999999999994 113.063 -176.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.598 ' H ' HG22 ' A' ' 57' ' ' THR . 0.4 OUTLIER -159.09 104.72 1.71 Allowed 'General case' 0 CA--C 1.54 0.563 0 O-C-N 119.977 -1.702 . . . . 71.230000000000004 107.65 167.411 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.7 m-30 -102.63 174.81 5.73 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.635 1.561 . . . . 74.099999999999994 111.013 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.499 ' CE1' ' HA ' ' A' ' 27' ' ' SER . 6.2 t60 -135.02 118.5 16.86 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 118.722 0.692 . . . . 73.310000000000002 111.417 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.423 HG12 ' CB ' ' A' ' 141' ' ' ALA . 12.8 m -81.93 172.07 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 123.252 0.621 . . . . 75.430000000000007 110.042 178.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.27 3.39 6.36 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.625 1.57 . . . . 74.030000000000001 113.096 -169.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -81.32 1.23 33.55 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.414 1.265 . . . . 75.010000000000005 114.414 -172.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 mt -125.59 132.09 52.59 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.655 1.116 . . . . 52.420000000000002 110.44 -164.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.76 177.37 35.33 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.666 0.65 . . . . 73.010000000000005 111.66 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.77 -55.13 0.92 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.186 2.591 . . . . 62.329999999999998 110.453 173.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.439 HD11 ' C ' ' A' ' 102' ' ' GLN . 38.1 mt -91.84 22.37 4.25 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.375 -0.828 . . . . 70.409999999999997 112.875 -166.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -48.65 -48.43 29.03 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 119.101 0.864 . . . . 42.109999999999999 112.206 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -56.52 -42.53 78.58 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.482 1.513 . . . . 75.140000000000001 113.307 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -78.71 -33.37 46.86 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.332 0.653 . . . . 72.140000000000001 110.259 -176.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.426 HD22 ' CD2' ' A' ' 28' ' ' PHE . 25.6 mt -62.4 -41.03 98.35 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.886 -0.783 . . . . 64.099999999999994 108.886 171.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.9 m -55.65 -50.11 71.07 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.594 1.088 . . . . 53.439999999999998 110.171 168.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -61.71 -35.16 77.24 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 120.621 1.555 . . . . 65.099999999999994 113.012 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.27 -35.06 79.87 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.668 0.667 . . . . 54.420000000000002 111.914 174.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.508 ' CD1' HD11 ' A' ' 79' ' ' ILE . 11.3 t-105 -57.46 -42.71 83.09 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 118.619 0.645 . . . . 74.430000000000007 111.026 -176.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.96 -36.38 74.72 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 117.517 -1.23 . . . . 65.209999999999994 112.872 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.0 t -59.7 -47.12 92.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 120.065 1.302 . . . . 70.109999999999999 108.626 172.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.55 -47.21 86.58 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 121.806 -0.559 . . . . 72.140000000000001 111.142 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.508 HD11 ' CD1' ' A' ' 75' ' ' TRP . 92.7 mt -62.39 -42.54 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.137 0.975 . . . . 71.5 110.509 177.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.62 -47.25 86.34 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.576 0.625 . . . . 73.120000000000005 109.441 -174.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 87.3 mt -80.2 -20.34 44.95 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 119.195 -0.431 . . . . 71.5 112.065 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.69 66.68 2.4 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 125.9 1.715 . . . . 72.319999999999993 110.261 -167.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.1 m -134.85 18.29 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.742 1.617 . . . . 71.519999999999996 111.048 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -51.07 -53.57 32.77 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 124.466 1.107 . . . . 53.200000000000003 110.09 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -77.0 -5.79 50.08 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.066 0.946 . . . . 61.409999999999997 111.29 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -90.21 -8.49 50.97 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.224 1.01 . . . . 73.310000000000002 111.216 166.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.7 pp -133.19 38.12 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 124.901 1.28 . . . . 64.519999999999996 111.715 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.0 m -92.39 -52.33 4.72 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.748 -0.595 . . . . 72.329999999999998 110.753 171.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.49 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -59.83 -64.05 3.49 Favored Pre-proline 0 CA--C 1.532 0.276 0 C-N-CA 123.318 0.647 . . . . 74.540000000000006 112.295 -163.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.49 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 73.3 Cg_endo -70.33 -20.77 31.74 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 CA-C-N 119.575 0.884 . . . . 63.549999999999997 112.602 -173.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.551 ' HG3' ' CZ ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -54.47 -58.8 6.04 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 127.481 2.312 . . . . 65.109999999999999 108.116 170.705 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -59.09 -41.69 88.67 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 124.105 0.962 . . . . 70.129999999999995 111.817 177.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -56.62 -36.68 69.73 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.076 -0.511 . . . . 74.140000000000001 110.676 172.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.39 -17.03 43.65 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 121.4 -0.812 . . . . 65.310000000000002 112.541 -169.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.0 t -114.3 -23.17 4.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 C-N-CA 124.613 1.165 . . . . 74.040000000000006 111.064 -172.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -120.48 -52.36 2.15 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.678 0.791 . . . . 74.25 112.289 -178.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -69.27 -52.85 23.49 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 121.583 -0.698 . . . . 74.329999999999998 111.244 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 37.2 p -98.62 -31.69 11.81 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.14 0.976 . . . . 72.519999999999996 110.489 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 52.59 34.78 16.45 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.882 2.073 . . . . 61.039999999999999 111.534 -173.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 t -75.91 -12.76 60.21 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.648 1.179 . . . . 70.329999999999998 112.67 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.428 HG13 HG12 ' A' ' 107' ' ' ILE . 25.9 t -67.31 118.17 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 O-C-N 120.913 -1.117 . . . . 54.43 108.963 172.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.439 ' C ' HD11 ' A' ' 67' ' ' LEU . 10.3 mt-30 -141.93 -25.13 0.68 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.463 1.105 . . . . 72.109999999999999 111.799 -178.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.13 160.78 38.49 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.584 1.553 . . . . 70.439999999999998 107.166 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 63.9 t -58.59 -32.34 45.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.566 1.146 . . . . 74.409999999999997 110.221 177.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.32 -29.06 57.54 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.287 1.435 . . . . 70.239999999999995 112.743 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -88.33 -25.41 22.77 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.598 0.635 . . . . 71.299999999999997 109.293 -176.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.428 HG12 HG13 ' A' ' 101' ' ' VAL . 3.2 mt -78.39 -47.74 23.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 124.963 1.305 . . . . 71.540000000000006 109.582 -178.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -56.11 -28.08 56.37 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-O 118.342 -0.837 . . . . 74.519999999999996 111.406 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -58.88 -53.61 56.46 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 123.86 0.864 . . . . 64.510000000000005 110.113 -176.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 17.4 t -56.07 -41.44 68.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.164 0.586 . . . . 61.509999999999998 110.716 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -60.47 -49.32 78.04 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.127 0.971 . . . . 74.439999999999998 110.009 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 83.5 t -63.41 -35.87 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 121.581 -0.699 . . . . 61.200000000000003 110.194 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.67 -44.05 97.25 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.466 0.706 . . . . 44.439999999999998 109.3 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.52 -21.42 62.73 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.612 1.165 . . . . 45.140000000000001 112.497 175.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 131.62 2.29 4.46 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 115.908 1.123 . . . . 64.409999999999997 115.908 167.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 65.1 t -66.26 143.73 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 123.363 1.554 . . . . 64.299999999999997 108.354 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.65 145.53 50.57 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.626 -1.17 . . . . 72.530000000000001 110.446 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -78.47 -0.2 78.0 Favored Glycine 0 N--CA 1.467 0.708 0 C-N-CA 124.035 0.826 . . . . 74.439999999999998 114.241 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -94.88 -36.97 11.42 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 123.198 0.599 . . . . 73.329999999999998 111.449 172.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -86.79 -41.1 14.36 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 107.348 -1.353 . . . . 73.230000000000004 107.348 -160.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -60.61 -53.2 60.37 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.957 -0.757 . . . . 70.310000000000002 108.957 172.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -73.14 -20.47 60.91 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 118.77 -0.634 . . . . 72.310000000000002 111.48 -170.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.56 -65.24 1.01 Allowed 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.138 -1.06 . . . . 42.130000000000003 108.138 171.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.53 -35.19 65.39 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.106 0.962 . . . . 44.399999999999999 111.626 -171.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -44.86 -36.97 3.55 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 125.08 1.352 . . . . 74.299999999999997 111.83 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -114.35 8.42 16.65 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.744 1.618 . . . . 62.210000000000001 113.484 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.6 t -79.09 148.8 32.28 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.06 1.744 . . . . 52.119999999999997 110.53 169.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -54.92 -33.36 62.06 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.232 1.813 . . . . 64.530000000000001 112.532 -177.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 22.3 t -54.63 -48.22 71.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 124.14 0.976 . . . . 73.200000000000003 109.742 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 32.7 t -69.98 -44.41 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-O 117.956 -1.021 . . . . 61.299999999999997 108.667 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -49.21 -49.92 40.66 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.267 1.394 . . . . 74.129999999999995 111.373 175.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.1 t -61.59 -49.05 78.18 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 123.481 0.713 . . . . 71.430000000000007 109.897 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 13.6 mt -65.04 -38.71 91.73 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 118.606 0.639 . . . . 62.409999999999997 111.988 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 49.1 t -58.31 -60.8 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 125.797 1.639 . . . . 74.209999999999994 107.695 173.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.65 -42.06 70.84 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 119.007 -0.521 . . . . 33.439999999999998 110.856 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -57.28 -53.11 61.87 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 123.435 0.694 . . . . 74.200000000000003 111.654 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -67.03 -48.67 67.64 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 119.158 0.89 . . . . 70.400000000000006 110.774 -175.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -63.29 -27.76 69.56 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.362 0.665 . . . . 74.430000000000007 112.043 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -82.24 -54.75 5.0 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.512 0.725 . . . . 74.239999999999995 109.647 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.08 0.74 1.77 Allowed 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 125.574 1.549 . . . . 54.340000000000003 113.399 -175.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.423 ' CB ' HG12 ' A' ' 61' ' ' VAL . . . -123.58 -0.16 8.69 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 114.216 1.191 . . . . 75.239999999999995 114.216 169.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.38 -13.01 7.24 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.99 0.814 . . . . 52.539999999999999 113.167 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -51.75 -66.7 0.34 Allowed 'General case' 0 C--O 1.231 0.086 0 C-N-CA 125.893 1.677 . . . . 61.240000000000002 110.773 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.9 pp 174.19 -4.66 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 129.117 2.967 . . . . 74.140000000000001 112.154 169.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.63 -27.23 45.38 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.519 1.128 . . . . 75.439999999999998 111.735 -158.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -159.57 140.91 12.82 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 128.641 2.776 . . . . 74.0 106.759 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -145.4 12.27 1.34 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.202 1.401 . . . . 55.210000000000001 110.502 -172.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -151.53 147.89 18.3 Favored Glycine 0 C--N 1.342 0.862 0 O-C-N 120.255 -1.528 . . . . 15.109999999999999 110.901 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.409 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 35.5 m -133.83 165.46 36.54 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 118.45 1.125 . . . . 74.019999999999996 111.102 -168.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.409 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 45.6 Cg_endo -71.0 157.91 95.16 Favored 'Cis proline' 0 C--N 1.35 0.631 0 CA-C-N 119.233 0.762 . . . . 73.040000000000006 112.263 -11.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -138.59 146.63 42.04 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.639 -0.709 . . . . 73.430000000000007 111.472 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 7.8 ttm -145.14 119.22 9.42 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.667 -1.605 . . . . 70.109999999999999 106.667 174.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -88.21 164.74 15.49 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.367 0.667 . . . . 74.219999999999999 109.825 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.702 HG12 ' HB2' ' A' ' 158' ' ' TYR . 0.5 OUTLIER -149.55 150.31 13.93 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 O-C-N 121.067 -1.021 . . . . 73.230000000000004 108.719 175.291 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 48.3 15.21 0.07 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.328 1.603 . . . . 73.219999999999999 115.328 -175.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 50.79 38.33 36.88 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 120.039 1.291 . . . . 73.329999999999998 112.425 -167.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.422 ' HE3' ' CZ ' ' A' ' 158' ' ' TYR . 42.7 pttt -162.27 -14.21 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.946 1.299 . . . . 72.129999999999995 114.038 173.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.702 ' HB2' HG12 ' A' ' 154' ' ' VAL 0.276 14.3 m-85 -106.42 158.86 16.59 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 127.041 2.136 . . . . 65.439999999999998 110.834 178.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -139.24 130.62 26.96 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 105.063 -2.199 . . . . 65.129999999999995 105.063 174.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.92 142.49 56.02 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.518 -1.29 . . . . 70.409999999999997 107.518 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -114.26 85.28 10.31 Favored Pre-proline 0 C--O 1.236 0.376 0 N-CA-C 110.339 -0.245 . . . . 74.439999999999998 110.339 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.11 -16.02 43.99 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 N-CA-C 110.342 -0.676 . . . . 71.030000000000001 110.342 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -77.65 2.49 16.53 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.283 1.833 . . . . 62.329999999999998 112.477 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -135.3 35.5 2.17 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 119.422 1.01 . . . . 70.209999999999994 111.12 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 62.5 mtt -120.84 167.38 12.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.446 1.098 . . . . 74.150000000000006 110.403 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -62.21 112.42 2.38 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.237 1.015 . . . . 71.329999999999998 108.937 169.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 82.3 p -119.57 22.08 11.81 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.434 1.094 . . . . 32.100000000000001 110.186 175.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.23 -48.22 36.8 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 118.664 0.665 . . . . 71.319999999999993 109.934 172.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -107.82 -10.85 15.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 118.07 -0.966 . . . . 74.430000000000007 111.608 -156.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 16.6 mmm 73.47 -44.85 0.59 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 127.748 2.419 . . . . 64.150000000000006 111.935 169.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -55.54 23.17 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 127.179 2.191 . . . . 74.439999999999998 107.941 173.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 61.5 t -67.81 -26.47 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 127.057 2.143 . . . . 65.439999999999998 110.538 -174.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.68 -59.12 5.95 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.189 -1.041 . . . . 74.25 108.189 173.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 10.8 t -66.58 -32.03 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.101 0.56 . . . . 64.140000000000001 110.521 -177.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.66 -41.86 82.36 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.645 0.778 . . . . 73.230000000000004 111.607 176.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -85.35 -32.35 22.49 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.587 1.155 . . . . 73.049999999999997 112.69 177.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -56.8 -63.29 1.25 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.376 -0.972 . . . . 74.439999999999998 108.376 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.86 -26.95 69.02 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.562 0.578 . . . . 45.210000000000001 112.562 -170.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -71.24 -52.23 20.17 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.222 1.409 . . . . 71.420000000000002 109.878 177.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.512 HG23 HG21 ' A' ' 3' ' ' ILE . 92.4 m -53.78 -40.11 66.0 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.248 1.019 . . . . 72.409999999999997 110.155 176.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 46.1 t -57.75 -53.27 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 108.934 -0.765 . . . . 71.230000000000004 108.934 178.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.3 tttt -59.95 -43.47 95.0 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 124.065 0.946 . . . . 71.420000000000002 110.543 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -63.33 -32.62 74.09 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 123.14 0.576 . . . . 71.040000000000006 111.202 -171.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 19.5 mt -68.79 -25.97 64.97 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 112.756 0.65 . . . . 71.040000000000006 112.756 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 61.1 t -65.72 -25.91 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 O-C-N 121.188 -0.945 . . . . 63.450000000000003 109.442 173.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -92.02 -9.56 42.37 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.152 1.381 . . . . 62.009999999999998 110.967 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -129.56 70.52 1.42 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.78 2.032 . . . . 64.329999999999998 108.79 -174.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 21.6 pttp . . . . . 0 C--O 1.257 1.481 0 CA-C-O 117.064 -1.446 . . . . 72.019999999999996 109.814 -176.234 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 C--O 1.236 0.372 0 N-CA-C 109.105 -0.702 . . . . 72.420000000000002 109.105 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -168.12 -178.21 3.6 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.177 2.191 . . . . 63.109999999999999 108.633 172.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 50.9 25.88 2.4 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 127.45 2.3 . . . . 51.32 115.786 173.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.52 115.06 4.51 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 104.755 -2.313 . . . . 65.099999999999994 104.755 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.511 HG21 HG23 ' A' ' 180' ' ' THR . 6.9 pt -127.37 142.13 44.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 126.111 1.764 . . . . 74.129999999999995 107.861 175.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.8 m -129.53 145.54 51.45 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.977 -1.12 . . . . 71.409999999999997 107.977 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -47.33 146.32 2.02 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 127.38 2.272 . . . . 73.019999999999996 111.395 165.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.22 -19.15 0.25 Allowed Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.365 1.46 . . . . 74.230000000000004 114.428 -172.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -100.43 -86.26 0.4 Allowed 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 106.736 -1.579 . . . . 70.120000000000005 106.736 -165.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -92.15 -14.21 29.47 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.379 1.071 . . . . 51.310000000000002 110.522 -175.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -144.81 159.7 42.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.728 0.811 . . . . 71.030000000000001 111.04 172.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.3 mm -125.07 164.44 23.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 124.615 1.166 . . . . 72.209999999999994 108.323 178.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 m -109.97 152.56 25.71 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.624 1.97 . . . . 71.340000000000003 108.236 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 35.5 mt -84.33 160.84 20.61 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 108.008 -1.108 . . . . 70.400000000000006 108.008 164.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.95 -35.39 64.53 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 122.404 1.097 . . . . 73.510000000000005 110.088 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -123.49 78.29 54.68 Favored Pre-proline 0 N--CA 1.455 -0.211 0 C-N-CA 125.458 1.503 . . . . 74.219999999999999 108.032 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -72.37 117.18 5.01 Favored 'Trans proline' 0 N--CA 1.444 -1.395 0 N-CA-C 106.348 -2.212 . . . . 61.240000000000002 106.348 164.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.0 tt -145.85 158.14 12.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 106.734 -1.58 . . . . 65.019999999999996 106.734 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.42 103.98 1.14 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.318 0.508 . . . . 65.010000000000005 110.451 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.02 -170.06 18.88 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 108.347 -1.901 . . . . 72.109999999999999 108.347 173.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 61.08 164.58 0.1 Allowed Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 127.637 2.375 . . . . 64.099999999999994 113.824 176.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -68.66 -165.76 0.14 Allowed 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.472 2.781 . . . . 74.510000000000005 110.06 158.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -69.97 -164.63 0.08 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.965 1.306 . . . . 74.340000000000003 110.53 176.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 66.7 t -47.52 130.61 4.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 125.055 1.342 . . . . 45.340000000000003 110.699 -177.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.417 HD12 HG21 ' A' ' 57' ' ' THR . 2.9 tp -136.57 153.82 50.86 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 126.664 1.986 . . . . 70.430000000000007 106.108 177.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 2.6 mp0 -143.91 149.43 36.85 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.363 1.865 . . . . 61.340000000000003 109.893 -169.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.561 ' HD1' ' HB3' ' A' ' 151' ' ' ALA . 0.5 OUTLIER -145.6 161.99 38.52 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.197 1.362 . . . . 74.430000000000007 108.457 174.551 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -163.63 -175.0 3.94 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.949 2.899 . . . . 62.109999999999999 107.144 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.1 t -138.94 173.11 11.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 123.101 1.429 . . . . 72.129999999999995 109.407 163.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -79.81 -34.93 39.14 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 126.902 2.081 . . . . 71.299999999999997 110.11 -175.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -90.8 -1.97 57.81 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.104 1.362 . . . . 73.409999999999997 112.578 -176.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 p -90.03 144.22 31.04 Favored Pre-proline 0 N--CA 1.471 0.622 0 CA-C-N 120.928 1.694 . . . . 72.530000000000001 112.112 -173.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -84.71 -40.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.047 1.831 . . . . 50.409999999999997 114.339 -170.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -59.07 -43.32 91.77 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.489 1.041 . . . . 62.329999999999998 108.437 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 32.1 m -48.35 -45.88 35.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.393 1.877 . . . . 74.219999999999999 111.233 175.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -51.16 -62.06 1.85 Allowed 'General case' 0 C--N 1.346 0.438 0 C-N-CA 123.628 0.771 . . . . 63.520000000000003 109.631 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -55.1 -41.63 71.86 Favored 'General case' 0 C--O 1.222 -0.345 0 O-C-N 121.08 -1.013 . . . . 72.230000000000004 110.587 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -68.18 -20.15 64.84 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 117.986 -1.007 . . . . 63.100000000000001 111.928 -172.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.79 -4.91 7.56 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.275 0.943 . . . . 73.439999999999998 112.756 -167.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -133.95 -26.93 1.49 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.629 1.572 . . . . 65.319999999999993 111.548 -168.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 83.0 t -119.81 -76.45 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 107.009 -1.478 . . . . 64.340000000000003 107.009 -175.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.1 mt -68.27 -17.54 64.31 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.56 1.544 . . . . 41.240000000000002 112.95 -176.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 44.08 60.38 2.78 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.437 1.895 . . . . 71.219999999999999 112.185 172.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 46' ' ' VAL . 33.2 t -66.76 -52.13 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 116.519 -1.705 . . . . 72.099999999999994 108.909 -173.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.0 t -53.99 -45.76 71.52 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 121.044 1.747 . . . . 25.140000000000001 110.501 -175.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -61.85 -40.56 95.75 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.761 0.825 . . . . 63.0 111.468 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -68.2 -36.88 80.25 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 124.488 1.115 . . . . 62.219999999999999 112.102 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 42' ' ' VAL . 3.1 t -66.54 -46.84 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.455 -1.313 . . . . 71.319999999999993 107.455 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 66.8 ttt-85 -48.0 -47.05 33.38 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-O 118.231 -0.89 . . . . 62.340000000000003 111.204 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -56.14 -10.74 0.91 Allowed 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 115.726 1.75 . . . . 71.0 115.726 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -130.31 7.25 4.96 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.653 1.981 . . . . 73.230000000000004 112.848 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.0 mt -79.82 161.65 65.48 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 120.194 1.361 . . . . 62.32 111.352 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -72.61 -161.92 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.75 1 C-N-CA 127.355 5.37 . . . . 54.100000000000001 110.739 172.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.431 ' CD ' ' H ' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -102.32 24.05 10.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 114.489 1.292 . . . . 74.219999999999999 114.489 176.513 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -143.08 -40.78 0.06 OUTLIER Glycine 0 CA--C 1.52 0.406 0 O-C-N 121.607 -0.683 . . . . 74.439999999999998 113.567 -172.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.0 m -71.55 95.19 1.38 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.597 1.559 . . . . 70.230000000000004 108.056 175.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.03 162.5 24.82 Favored 'General case' 0 CA--C 1.519 -0.25 0 O-C-N 120.478 -1.389 . . . . 72.430000000000007 109.014 169.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.89 109.04 21.83 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 106.805 -1.554 . . . . 63.009999999999998 106.805 175.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.56 HG22 ' H ' ' A' ' 58' ' ' LYS . 1.0 OUTLIER -87.36 -176.91 5.8 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 124.076 0.86 . . . . 65.239999999999995 109.237 171.06 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.56 ' H ' HG22 ' A' ' 57' ' ' THR . 0.1 OUTLIER -174.23 109.31 0.14 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 128.288 2.635 . . . . 74.209999999999994 105.612 174.275 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -74.76 -166.53 0.47 Allowed 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.006 -1.059 . . . . 72.329999999999998 109.532 163.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.568 ' CD2' ' HB3' ' A' ' 75' ' ' TRP 0.262 2.7 p-80 -136.77 156.88 47.93 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 129.709 3.204 . . . . 74.120000000000005 108.347 170.58 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.461 HG23 ' HB2' ' A' ' 63' ' ' PHE . 28.5 m -146.7 170.35 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 119.614 1.097 . . . . 73.340000000000003 108.398 169.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.99 -80.88 0.08 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 107.026 -1.472 . . . . 74.340000000000003 107.026 171.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.461 ' HB2' HG23 ' A' ' 61' ' ' VAL . 0.5 OUTLIER 68.13 -44.15 0.49 Allowed 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 130.136 3.375 . . . . 73.109999999999999 115.011 175.002 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.36 171.01 16.13 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 119.842 1.201 . . . . 61.340000000000003 110.65 -175.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.16 175.55 33.18 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 115.717 -0.674 . . . . 71.099999999999994 112.54 175.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -73.67 -55.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.673 2.915 . . . . 62.350000000000001 111.219 175.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.4 mt -89.38 30.18 1.02 Allowed 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.295 0.638 . . . . 52.32 111.844 -164.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -45.6 -56.3 6.53 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.929 1.252 . . . . 42.109999999999999 110.581 176.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -56.13 -46.46 79.18 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.601 1.161 . . . . 70.450000000000003 110.736 -174.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.49 -45.8 91.37 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 127.106 2.163 . . . . 65.109999999999999 109.329 -174.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 mt -64.98 -43.84 91.28 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.855 0.862 . . . . 74.450000000000003 109.431 176.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.495 ' HA ' ' HD2' ' A' ' 60' ' ' HIS . 44.5 m -66.37 -1.31 3.31 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 126.653 1.981 . . . . 73.519999999999996 110.582 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -111.9 -22.12 11.24 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 118.971 -2.33 . . . . 65.310000000000002 111.599 171.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.09 -35.8 48.94 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.698 0.999 . . . . 63.340000000000003 113.698 176.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.568 ' HB3' ' CD2' ' A' ' 60' ' ' HIS . 40.8 t-105 -58.23 -35.42 71.67 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.265 0.939 . . . . 73.510000000000005 110.949 -175.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.53 -34.33 77.56 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 118.206 -0.902 . . . . 50.439999999999998 110.814 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.1 t -60.98 -47.02 95.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 119.467 1.03 . . . . 73.239999999999995 108.964 167.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.16 -45.97 89.59 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 119.056 -0.497 . . . . 71.549999999999997 111.467 -177.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.5 mt -65.84 -42.84 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 124.602 1.161 . . . . 73.120000000000005 110.557 176.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.1 -32.44 70.98 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.054 0.843 . . . . 70.310000000000002 110.909 -177.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 43.2 mt -95.37 -15.24 23.2 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.261 0.837 . . . . 54.219999999999999 113.261 173.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 65.12 63.3 4.25 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.231 1.396 . . . . 71.530000000000001 111.667 -173.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.3 m -129.48 16.42 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.586 1.154 . . . . 63.420000000000002 111.852 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -52.86 -54.53 33.19 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.133 0.879 . . . . 71.209999999999994 111.016 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.56 -9.09 11.59 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.604 0.762 . . . . 74.120000000000005 112.648 -179.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -96.34 -13.92 22.92 Favored 'General case' 0 CA--C 1.519 -0.233 0 O-C-N 120.585 -1.322 . . . . 71.5 111.284 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.2 pt -121.21 -1.14 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 116.712 -1.613 . . . . 72.329999999999998 113.347 -175.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.2 m -64.38 -54.5 31.83 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 120.632 1.56 . . . . 54.310000000000002 109.096 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.43 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -52.54 -56.24 24.62 Favored Pre-proline 0 C--O 1.241 0.623 0 C-N-CA 124.614 1.166 . . . . 74.200000000000003 112.633 -169.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.43 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 54.1 Cg_endo -72.08 -26.97 17.6 Favored 'Trans proline' 0 N--CA 1.443 -1.443 0 C-N-CA 120.714 0.943 . . . . 71.209999999999994 112.653 -177.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 17.1 tpp -54.42 -51.34 65.22 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.09 0.956 . . . . 71.200000000000003 109.288 174.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -68.99 -33.57 73.88 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 121.872 -0.518 . . . . 53.399999999999999 111.191 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.45 ' HA ' ' HB2' ' A' ' 97' ' ' LYS . 0.9 OUTLIER -60.39 -38.82 85.15 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 118.964 -1.094 . . . . 70.5 109.594 171.056 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.99 -11.41 58.15 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.275 -0.891 . . . . 54.119999999999997 112.05 -167.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.3 t -119.93 -35.44 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.184 1.393 . . . . 73.540000000000006 110.36 -171.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -122.39 -38.38 2.68 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.098 0.959 . . . . 65.530000000000001 111.974 -164.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 93' ' ' GLU . 3.9 mmmt -76.01 -58.72 3.11 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 118.619 0.645 . . . . 71.400000000000006 110.733 174.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . 0.261 5.6 t -114.45 -18.23 11.56 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.095 0.776 . . . . 51.299999999999997 113.095 -176.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 65.87 19.73 11.32 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.521 0.934 . . . . 71.420000000000002 113.521 169.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 t -62.52 -16.48 56.05 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.247 2.219 . . . . 63.130000000000003 113.717 -173.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.452 HG13 HG12 ' A' ' 107' ' ' ILE . 26.9 t -64.46 115.05 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 124.434 1.094 . . . . 61.130000000000003 109.391 173.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -132.52 -23.12 2.12 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.502 1.121 . . . . 74.109999999999999 112.078 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.97 161.44 41.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.734 1.614 . . . . 62.210000000000001 107.291 -177.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.3 t -54.36 -36.15 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 118.973 0.806 . . . . 74.540000000000006 110.236 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.66 -34.17 57.75 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.378 1.471 . . . . 51.25 112.676 176.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -78.46 -34.75 47.5 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.518 -0.919 . . . . 73.349999999999994 108.518 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.452 HG12 HG13 ' A' ' 101' ' ' VAL . 2.9 mt -72.35 -49.27 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 124.085 0.954 . . . . 70.420000000000002 108.732 -174.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -17.28 64.53 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.569 0.748 . . . . 71.329999999999998 112.62 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -58.4 -54.18 49.93 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.24 1.016 . . . . 62.32 109.908 168.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.41 HG13 ' HB2' ' A' ' 90' ' ' PRO . 35.0 t -55.11 -36.78 40.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.519 1.128 . . . . 71.519999999999996 110.82 -175.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -57.36 -57.27 13.37 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.319 0.648 . . . . 73.219999999999999 109.536 173.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 89.2 t -60.88 -41.36 88.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 O-C-N 121.454 -0.779 . . . . 74.540000000000006 111.005 -175.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -55.44 -51.05 68.2 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.193 0.997 . . . . 70.329999999999998 109.237 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.36 -11.32 60.84 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.073 1.349 . . . . 52.310000000000002 112.506 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 112.02 48.06 0.68 Allowed Glycine 0 C--N 1.336 0.528 0 CA-C-N 118.84 0.745 . . . . 34.219999999999999 112.729 175.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.6 t -116.37 141.66 33.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 117.91 0.855 . . . . 71.230000000000004 109.741 177.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -70.27 118.43 13.08 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.188 0.995 . . . . 72.310000000000002 109.27 169.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.85 -9.28 52.28 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 117.347 -1.807 . . . . 70.219999999999999 112.479 167.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -74.98 -41.42 59.57 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 120.607 2.204 . . . . 71.129999999999995 108.67 168.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.71 -25.65 44.69 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.441 -0.948 . . . . 63.229999999999997 108.441 -171.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -70.31 -62.21 1.47 Allowed 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 107.59 -1.263 . . . . 63.409999999999997 107.59 175.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -64.41 -24.77 67.75 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.787 -0.625 . . . . 74.230000000000004 111.69 -173.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.78 -68.11 0.6 Allowed 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.667 1.187 . . . . 65.150000000000006 111.259 168.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.11 -27.71 67.25 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 118.223 -0.894 . . . . 53.32 111.517 -167.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -44.14 -39.4 4.29 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.851 1.66 . . . . 74.120000000000005 112.047 176.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -112.53 3.62 16.88 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.83 1.252 . . . . 53.009999999999998 113.147 -177.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 13.2 t -74.68 152.84 39.11 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.841 1.256 . . . . 73.349999999999994 111.252 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -52.61 -33.2 45.42 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.202 1.801 . . . . 65.310000000000002 112.581 170.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 46.8 t -53.16 -48.53 53.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 O-C-N 121.201 -0.937 . . . . 71.239999999999995 109.772 177.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.3 t -72.59 -38.16 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-O 118.311 -0.852 . . . . 72.540000000000006 109.868 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -52.46 -49.83 63.88 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.78 1.173 . . . . 73.329999999999998 111.234 174.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.3 t -58.06 -51.07 71.22 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.122 -0.696 . . . . 25.219999999999999 109.122 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 14.8 mt -66.26 -37.93 86.64 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.271 0.629 . . . . 73.140000000000001 112.658 -174.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.1 t -56.31 -59.21 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 125.16 1.384 . . . . 74.530000000000001 108.66 168.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.05 -40.35 60.98 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.799 0.839 . . . . 54.020000000000003 112.27 -174.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -51.9 -60.92 2.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 117.668 -1.158 . . . . 70.129999999999995 110.291 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.438 ' H ' ' HG3' ' A' ' 137' ' ' GLN . 0.9 OUTLIER -78.34 -32.95 49.38 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 120.576 1.534 . . . . 73.519999999999996 113.659 -179.621 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.92 -24.21 65.17 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.502 1.046 . . . . 65.5 109.766 -169.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 24.1 ttpt -82.2 -57.38 3.41 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 125.262 1.425 . . . . 73.430000000000007 109.305 160.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.86 -17.69 61.82 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.931 1.456 . . . . 51.409999999999997 114.931 -164.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -117.4 2.35 12.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 119.965 1.257 . . . . 64.400000000000006 113.257 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.98 6.42 3.38 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.628 0.771 . . . . 73.530000000000001 111.727 -178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -68.1 -85.88 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.874 0.87 . . . . 74.239999999999995 109.678 172.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 175.58 48.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.658 2.383 . . . . 65.310000000000002 109.244 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -139.47 -50.47 0.51 Allowed 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.782 -1.199 . . . . 74.530000000000001 109.493 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.13 109.05 14.98 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 127.029 2.132 . . . . 54.299999999999997 106.827 -171.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -149.84 28.62 0.76 Allowed 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 126.636 1.974 . . . . 65.5 111.144 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -138.38 91.2 0.2 Allowed Glycine 0 C--N 1.341 0.811 0 O-C-N 120.876 -1.14 . . . . 65.120000000000005 112.44 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.424 HG13 ' CZ ' ' A' ' 25' ' ' PHE . 34.1 m -73.38 163.55 67.63 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 113.331 0.863 . . . . 74.120000000000005 113.331 174.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -77.94 118.07 5.52 Favored 'Cis proline' 0 N--CA 1.446 -1.286 0 N-CA-C 108.666 -1.321 . . . . 71.200000000000003 108.666 -21.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.561 ' HB3' ' HD1' ' A' ' 25' ' ' PHE . . . -88.49 129.18 35.51 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 106.203 -1.777 . . . . 74.109999999999999 106.203 -174.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 80.0 mmm -138.19 89.26 2.38 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 104.245 -2.502 . . . . 62.140000000000001 104.245 -172.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -73.74 170.23 15.7 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 120.853 -1.155 . . . . 74.040000000000006 109.974 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.515 HG11 ' HB2' ' A' ' 184' ' ' LEU . 56.8 t -131.07 -41.41 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 113.252 0.834 . . . . 72.409999999999997 113.252 178.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.36 24.22 1.13 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.76 -0.588 . . . . 71.439999999999998 109.728 -171.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 77.44 -28.37 1.76 Allowed Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.237 1.875 . . . . 64.140000000000001 113.055 -174.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.55 -7.48 19.7 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.966 1.469 . . . . 65.439999999999998 114.966 -174.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -126.95 142.15 51.62 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.947 0.899 . . . . 70.120000000000005 109.531 -174.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -117.9 137.54 52.74 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 106.392 -1.707 . . . . 74.420000000000002 106.392 169.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.02 144.04 55.29 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.21 -0.663 . . . . 71.099999999999994 109.21 171.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -111.55 86.95 7.36 Favored Pre-proline 0 C--O 1.232 0.149 0 N-CA-C 113.519 0.933 . . . . 45.340000000000003 113.519 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -63.13 0.04 1.91 Allowed 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 121.041 1.161 . . . . 70.319999999999993 114.253 172.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -111.74 18.65 18.76 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.117 1.367 . . . . 74.420000000000002 112.287 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -146.06 52.24 0.57 Allowed Glycine 0 C--N 1.334 0.42 0 N-CA-C 108.681 -1.768 . . . . 54.409999999999997 108.681 171.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 35.6 mtt -144.58 176.02 9.71 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.931 1.292 . . . . 65.329999999999998 109.399 -176.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -85.24 44.52 1.1 Allowed 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 123.527 0.731 . . . . 71.209999999999994 112.269 -164.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.437 ' HB ' ' CD2' ' A' ' 173' ' ' PHE 0.257 10.7 t -67.79 30.91 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 129.102 2.961 . . . . 65.200000000000003 113.169 -177.163 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.19 -20.43 30.2 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 127.536 2.334 . . . . 72.019999999999996 112.4 169.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.18 -8.68 2.63 Favored 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 113.386 0.884 . . . . 72.019999999999996 113.386 -166.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 6.0 mmt 69.19 -61.88 0.42 Allowed 'General case' 0 C--O 1.231 0.129 0 C-N-CA 127.654 2.382 . . . . 33.539999999999999 113.003 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -63.66 -46.11 87.12 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.375 1.083 . . . . 65.310000000000002 109.682 -172.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.02 -26.48 40.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.386 1.474 . . . . 64.129999999999995 110.853 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.437 ' CD2' ' HB ' ' A' ' 167' ' ' THR . 15.9 t80 -68.51 -57.72 5.38 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.267 -1.383 . . . . 74.430000000000007 107.267 -177.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.3 t -67.23 -33.85 65.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 117.899 0.318 . . . . 71.239999999999995 110.152 -174.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.42 -51.07 61.05 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.49 0.716 . . . . 72.319999999999993 110.987 174.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -73.3 -32.73 64.79 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.715 0.806 . . . . 54.530000000000001 112.559 177.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -59.06 -60.82 3.26 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.239 1.016 . . . . 73.140000000000001 108.429 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.7 -27.65 66.63 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.575 0.75 . . . . 73.120000000000005 111.981 -174.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.67 -47.96 28.85 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 121.75 -0.594 . . . . 65.219999999999999 111.248 176.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.511 HG23 HG21 ' A' ' 3' ' ' ILE . 90.9 m -53.63 -37.5 63.13 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.439 0.696 . . . . 72.109999999999999 109.697 173.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 93.4 t -58.22 -54.43 32.68 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 N-CA-C 109.206 -0.664 . . . . 45.200000000000003 109.206 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 13.3 pttp -64.71 -34.99 79.61 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 118.989 -1.085 . . . . 65.030000000000001 111.305 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -62.98 -31.11 72.16 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-N 118.739 0.7 . . . . 70.109999999999999 111.451 -172.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.515 ' HB2' HG11 ' A' ' 154' ' ' VAL . 75.4 mt -76.0 -18.98 59.06 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.075 -1.05 . . . . 63.340000000000003 112.636 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 76.8 t -67.5 -22.51 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 O-C-N 120.951 -1.093 . . . . 62.420000000000002 110.383 176.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -103.61 -12.23 17.2 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.325 1.05 . . . . 54.509999999999998 110.869 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 42.2 mttp -115.33 82.41 1.74 Allowed 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 126.125 1.77 . . . . 52.219999999999999 107.958 -173.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-N 114.208 -1.36 . . . . 71.230000000000004 109.111 164.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 117.311 -1.328 . . . . 65.329999999999998 109.981 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 45.73 -156.46 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 120.152 1.342 . . . . 70.420000000000002 111.842 -176.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 44.8 50.11 8.8 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.225 2.21 . . . . 71.439999999999998 112.162 -175.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -148.52 118.33 7.11 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 106.105 -1.813 . . . . 64.439999999999998 106.105 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.42 HG21 ' OG1' ' A' ' 180' ' ' THR . 15.3 pt -122.51 149.12 25.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 C-N-CA 126.753 2.021 . . . . 64.129999999999995 108.676 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.1 m -119.05 130.91 55.88 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.792 -0.818 . . . . 62.340000000000003 108.792 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -46.65 111.47 0.39 Allowed 'General case' 0 C--O 1.232 0.183 0 C-N-CA 126.812 2.045 . . . . 54.43 109.638 162.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 102.97 -5.9 50.83 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.263 -1.298 . . . . 75.109999999999999 112.939 176.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -104.57 -86.33 0.46 Allowed 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 118.916 1.358 . . . . 50.130000000000003 107.773 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -92.87 -11.65 33.01 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.441 1.496 . . . . 73.329999999999998 112.287 -172.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -144.97 157.36 44.16 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 122.984 0.514 . . . . 74.239999999999995 110.499 170.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.0 mm -124.57 157.91 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 124.572 1.149 . . . . 61.039999999999999 108.071 177.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.24 143.55 41.84 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.69 1.596 . . . . 71.150000000000006 107.134 177.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.0 mt -81.91 147.36 29.32 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.885 -0.783 . . . . 74.019999999999996 108.885 170.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -73.49 -36.14 65.76 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.356 1.462 . . . . 53.130000000000003 109.885 173.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -131.03 84.1 58.88 Favored Pre-proline 0 CA--C 1.519 -0.227 0 C-N-CA 126.296 1.838 . . . . 75.409999999999997 108.173 177.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.41 74.68 4.61 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 123.159 2.573 . . . . 75.150000000000006 110.029 173.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -160.06 101.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 107.247 -1.39 . . . . 71.420000000000002 107.247 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -171.39 -86.5 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.238 1.015 . . . . 75.230000000000004 110.947 164.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -122.8 32.2 4.51 Favored Glycine 0 C--N 1.336 0.559 0 C-N-CA 124.366 0.984 . . . . 75.439999999999998 111.98 -163.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -126.9 85.32 61.21 Favored Pre-proline 0 C--O 1.241 0.606 0 C-N-CA 123.963 0.905 . . . . 75.439999999999998 109.242 -150.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -79.34 -164.03 0.26 Allowed 'Trans proline' 0 CA--C 1.541 0.872 1 C-N-CA 126.168 4.579 . . . . 63.340000000000003 111.703 -171.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -44.65 -56.6 4.26 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.554 1.942 . . . . 61.130000000000003 113.098 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.8 t -150.99 148.08 15.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 127.124 2.17 . . . . 50.350000000000001 106.92 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.466 HD23 ' CE2' ' A' ' 25' ' ' PHE . 5.4 tp -159.77 154.8 24.82 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.501 1.046 . . . . 71.049999999999997 112.053 171.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -134.92 143.4 46.9 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 127.24 2.216 . . . . 70.549999999999997 107.272 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.643 ' CE1' ' HB2' ' A' ' 141' ' ' ALA . 45.8 m-85 -133.64 137.11 45.21 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.069 0.947 . . . . 65.230000000000004 110.768 174.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -162.34 165.85 26.01 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.75 1.62 . . . . 71.299999999999997 109.491 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.8 t -124.43 169.14 12.14 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.653 0.781 . . . . 72.219999999999999 109.842 167.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.674 ' CZ ' HD21 ' A' ' 71' ' ' LEU 0.275 0.0 OUTLIER -76.58 -18.77 58.47 Favored 'General case' 0 N--CA 1.435 -1.196 0 C-N-CA 124.081 0.953 . . . . 71.329999999999998 112.597 175.726 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -96.06 0.34 51.39 Favored 'General case' 0 C--N 1.346 0.446 0 O-C-N 120.232 -1.543 . . . . 72.540000000000006 111.655 -175.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.7 p -97.97 142.09 24.01 Favored Pre-proline 0 CA--C 1.534 0.341 0 O-C-N 121.121 -0.987 . . . . 53.100000000000001 108.773 -168.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -91.44 -28.25 0.19 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 120.314 0.676 . . . . 42.329999999999998 111.503 -162.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -59.9 -49.63 76.93 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.409 -0.96 . . . . 75.25 108.409 165.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.9 m -55.33 -36.7 66.53 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 124.609 1.164 . . . . 53.310000000000002 111.953 -178.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -58.82 -56.69 18.97 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 122.994 0.518 . . . . 72.200000000000003 109.694 175.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -59.89 -30.22 68.86 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-O 116.171 -1.871 . . . . 73.120000000000005 110.193 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -75.03 -6.01 47.12 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 121.245 1.839 . . . . 61.25 113.037 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -146.24 8.56 1.06 Allowed 'General case' 0 C--N 1.345 0.375 0 CA-C-N 120.51 1.505 . . . . 72.129999999999995 112.824 -175.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -139.97 -12.48 1.1 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.948 1.299 . . . . 64.329999999999998 111.341 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 80.9 t -129.27 -81.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 105.911 -1.885 . . . . 51.420000000000002 105.911 173.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.616 ' O ' HG23 ' A' ' 42' ' ' VAL . 3.4 mt -76.55 61.77 1.82 Allowed 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 128.335 2.654 . . . . 72.409999999999997 109.474 173.208 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -50.98 77.38 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 129.628 3.171 . . . . 61.439999999999998 110.444 172.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 40' ' ' LEU . 83.2 t -67.2 -48.31 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 114.709 -1.132 . . . . 63.329999999999998 108.111 -172.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.1 t -71.6 15.45 0.14 Allowed 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.076 1.139 . . . . 71.109999999999999 114.076 -172.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -129.36 -20.81 3.28 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 119.404 -2.06 . . . . 72.239999999999995 111.863 170.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.469 ' HB3' ' HB2' ' A' ' 178' ' ' ALA . 2.1 m-80 -62.28 -30.83 71.41 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 121.95 -0.469 . . . . 74.010000000000005 111.243 164.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.688 HG12 ' HG ' ' A' ' 50' ' ' LEU . 1.7 t -75.69 -52.14 18.92 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.649 0 N-CA-C 107.123 -1.436 . . . . 61.030000000000001 107.123 -162.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -52.95 -39.38 62.88 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.043 1.337 . . . . 73.030000000000001 109.915 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -56.35 -21.63 25.81 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.039 1.496 . . . . 72.010000000000005 115.039 174.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.6 mmtt -127.37 -5.17 6.0 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.618 2.767 . . . . 70.109999999999999 112.526 -176.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.688 ' HG ' HG12 ' A' ' 46' ' ' VAL . 12.7 mt -75.88 151.98 84.54 Favored Pre-proline 0 CA--C 1.518 -0.252 0 CA-C-N 120.43 1.468 . . . . 65.340000000000003 108.236 -174.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -78.24 148.54 24.19 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 122.098 1.865 . . . . 74.120000000000005 109.646 165.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -67.63 91.89 0.31 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.131 1.772 . . . . 72.209999999999994 112.12 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 137.17 -25.19 3.05 Favored Glycine 0 C--N 1.334 0.428 0 O-C-N 120.602 -1.311 . . . . 50.409999999999997 113.603 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 73.0 m -71.27 86.94 0.81 Allowed 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 104.075 -2.565 . . . . 71.230000000000004 104.075 151.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -82.68 157.31 23.4 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.574 -1.639 . . . . 72.329999999999998 106.574 169.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.07 169.24 8.86 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.92 -0.77 . . . . 73.129999999999995 108.92 -177.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.485 HG22 ' H ' ' A' ' 58' ' ' LYS . 1.3 m -140.48 -171.63 3.26 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.247 1.419 . . . . 72.510000000000005 108.105 -167.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.485 ' H ' HG22 ' A' ' 57' ' ' THR . 0.1 OUTLIER -173.62 85.45 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.291 1.436 . . . . 70.120000000000005 108.237 -178.091 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.405 ' CG ' ' HG2' ' A' ' 137' ' ' GLN . 8.2 m-30 -89.61 163.72 15.04 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 120.902 -1.124 . . . . 73.230000000000004 108.77 173.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.513 ' HD2' ' O ' ' A' ' 60' ' ' HIS . 1.2 p-80 -102.26 174.7 5.8 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 127.83 2.452 . . . . 75.430000000000007 110.133 -174.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.428 HG12 ' HB1' ' A' ' 141' ' ' ALA . 16.0 m -144.06 150.44 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 CA-C-N 122.407 2.367 . . . . 51.420000000000002 112.765 168.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . 0.304 0.0 OUTLIER -103.29 1.11 32.41 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.19 1.796 . . . . 73.200000000000003 114.776 176.87 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -70.8 9.06 0.73 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.199 1.399 . . . . 61.299999999999997 113.984 173.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.1 mt -141.77 148.44 38.95 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 119.68 -1.888 . . . . 75.109999999999999 109.221 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.54 166.41 12.03 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 115.082 -0.963 . . . . 62.520000000000003 111.725 171.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.44 -39.66 1.01 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.471 2.114 . . . . 52.240000000000002 110.119 170.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.474 HD13 HD11 ' A' ' 107' ' ' ILE . 57.3 mt -82.72 23.89 0.77 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.811 1.245 . . . . 54.43 112.032 -177.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -43.91 -63.52 2.24 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 117.222 -1.876 . . . . 74.319999999999993 109.863 169.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.8 tptp -59.82 -26.23 65.61 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 121.399 2.6 . . . . 72.299999999999997 114.126 -172.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -54.71 30.61 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 117.995 -1.002 . . . . 61.329999999999998 111.412 168.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.674 HD21 ' CZ ' ' A' ' 28' ' ' PHE . 34.6 mt -60.26 -40.95 92.15 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.252 0.933 . . . . 74.340000000000003 109.269 -164.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.462 HG22 ' CE1' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -49.61 -37.84 29.44 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 126.735 2.014 . . . . 60.509999999999998 109.682 -179.499 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.471 ' OE1' HG11 ' A' ' 130' ' ' VAL . 0.6 OUTLIER -86.04 -51.48 6.31 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 126.62 1.968 . . . . 55.0 110.895 -176.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.44 -31.13 72.06 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.513 1.051 . . . . 74.530000000000001 112.1 -177.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.458 ' CH2' ' HB3' ' A' ' 84' ' ' GLU . 43.3 t-105 -56.59 -36.39 69.31 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 119.139 0.881 . . . . 72.400000000000006 111.328 173.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.639 ' HB3' HG13 ' A' ' 130' ' ' VAL . . . -64.87 -42.46 94.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.624 -0.673 . . . . 65.299999999999997 110.125 -177.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 82.6 t -52.8 -43.5 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 122.953 0.501 . . . . 74.219999999999999 109.83 170.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.37 -50.14 66.66 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 121.239 -0.913 . . . . 43.240000000000002 111.13 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 86.6 mt -59.31 -37.28 68.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.344 1.058 . . . . 73.209999999999994 109.877 178.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.26 -50.13 74.27 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.505 0.593 . . . . 71.239999999999995 110.17 -174.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.0 mt -81.66 -12.2 58.78 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 118.32 -0.848 . . . . 72.209999999999994 112.791 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.03 63.87 3.58 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 126.14 1.828 . . . . 65.400000000000006 110.681 -175.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.2 m -130.14 11.9 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 117.67 -1.157 . . . . 74.319999999999993 112.838 -177.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.458 ' HB3' ' CH2' ' A' ' 75' ' ' TRP . 2.4 mp0 -51.58 -51.7 53.4 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.912 1.233 . . . . 62.240000000000002 111.629 -166.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -49.31 -47.67 46.86 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.681 1.592 . . . . 72.200000000000003 111.506 177.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -65.46 -26.73 68.08 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 124.342 1.057 . . . . 73.209999999999994 109.472 -170.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.5 pp -114.42 29.66 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 126.914 2.086 . . . . 65.540000000000006 109.322 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.504 HG23 ' CE1' ' A' ' 92' ' ' PHE . 18.6 m -108.97 -53.46 2.64 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 118.029 -0.986 . . . . 63.109999999999999 108.439 168.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.426 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -52.86 -54.55 42.5 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 113.602 0.964 . . . . 21.530000000000001 113.602 -174.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.426 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 48.9 Cg_endo -73.45 -29.37 11.16 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.363 1.375 . . . . 72.5 112.032 178.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 34.0 tpp -60.45 -50.11 74.89 Favored 'General case' 0 CA--C 1.515 -0.404 0 C-N-CA 125.225 1.41 . . . . 74.510000000000005 110.936 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.504 ' CE1' HG23 ' A' ' 88' ' ' THR . 6.2 m-85 -70.13 -33.15 71.46 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.938 -0.553 . . . . 74.209999999999994 109.56 -176.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -58.17 -37.27 74.4 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.353 0.979 . . . . 71.439999999999998 109.607 168.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.31 -0.9 57.66 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.062 -1.649 . . . . 74.140000000000001 113.578 -176.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.492 HG11 ' CD1' ' A' ' 28' ' ' PHE . 54.2 t -116.76 -33.77 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.531 1.533 . . . . 71.329999999999998 109.688 -177.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -116.06 -48.38 2.74 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 124.696 1.199 . . . . 73.400000000000006 111.577 -173.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -72.66 -62.26 1.51 Allowed 'General case' 0 C--N 1.334 -0.082 0 O-C-N 121.695 -0.628 . . . . 54.200000000000003 109.49 -176.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 28.2 p -86.43 -35.83 19.47 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.318 0.508 . . . . 74.510000000000005 110.659 -178.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 66.48 23.83 10.44 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.701 2.401 . . . . 73.219999999999999 113.174 -175.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -70.33 -19.51 63.06 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.503 0.592 . . . . 74.329999999999998 112.487 -173.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.443 HG13 HG12 ' A' ' 107' ' ' ILE . 26.8 t -64.3 124.63 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 O-C-N 121.354 -0.841 . . . . 64.530000000000001 109.046 171.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -147.04 -24.77 0.4 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.499 1.52 . . . . 64.540000000000006 111.44 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.6 162.56 32.36 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.802 0.728 . . . . 63.520000000000003 109.546 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.2 t -55.45 -38.74 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.309 1.044 . . . . 44.310000000000002 110.006 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.17 -11.77 23.1 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 114.064 1.135 . . . . 64.120000000000005 114.064 178.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -94.72 -33.73 12.82 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 124.979 1.311 . . . . 63.130000000000003 110.311 175.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.474 HD11 HD13 ' A' ' 67' ' ' LEU . 2.7 mt -71.62 -37.96 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.013 -0.736 . . . . 54.109999999999999 109.013 -177.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . 33.2 ptt180 -68.62 -23.37 64.43 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.342 -0.849 . . . . 73.430000000000007 111.474 -174.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -55.4 -54.52 42.68 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.469 -0.938 . . . . 73.400000000000006 108.469 176.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 29.0 t -58.52 -38.14 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 123.853 0.861 . . . . 72.319999999999993 110.625 -174.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -53.25 -57.75 9.45 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.463 -0.569 . . . . 74.140000000000001 109.463 172.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -63.92 -41.23 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 O-C-N 121.452 -0.78 . . . . 62.539999999999999 111.142 -175.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.25 -41.38 88.63 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.127 1.371 . . . . 72.200000000000003 109.746 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.64 0.18 18.46 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.795 1.238 . . . . 62.43 112.504 175.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.04 62.46 1.43 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 124.81 1.195 . . . . 63.539999999999999 111.118 175.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.5 t -121.66 149.47 24.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 124.181 0.992 . . . . 65.530000000000001 109.28 170.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -68.48 135.88 52.32 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.196 0.522 . . . . 72.530000000000001 110.106 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.22 -30.54 71.69 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 114.868 -1.06 . . . . 63.210000000000001 110.556 171.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -74.76 -17.8 60.58 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 123.447 0.699 . . . . 70.299999999999997 111.905 -172.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.74 -51.81 5.46 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.105 -1.072 . . . . 63.530000000000001 108.105 176.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.403 ' CZ ' ' HB3' ' A' ' 108' ' ' ARG . 36.4 t80 -50.89 -53.22 34.48 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.227 1.411 . . . . 72.329999999999998 109.978 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -76.61 -10.76 59.62 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 114.239 -1.346 . . . . 74.510000000000005 113.14 -172.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.65 -57.06 2.18 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 125.408 1.483 . . . . 63.509999999999998 110.407 176.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -50.23 -40.37 47.3 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.898 2.079 . . . . 72.329999999999998 110.89 -178.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 61.3 t-105 -45.97 -42.87 13.58 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.29 1.036 . . . . 73.239999999999995 111.972 173.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -102.41 8.04 40.25 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.367 -1.458 . . . . 72.420000000000002 112.901 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 8.8 t -89.3 151.38 22.13 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 127.019 2.128 . . . . 52.399999999999999 111.773 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -60.13 -28.71 68.1 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 125.493 1.517 . . . . 74.109999999999999 111.854 174.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 66.4 t -49.33 -54.3 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 119.363 0.983 . . . . 72.510000000000005 109.777 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.639 HG13 ' HB3' ' A' ' 76' ' ' ALA . 40.0 t -69.1 -39.28 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-N 115.22 -0.9 . . . . 64.239999999999995 108.668 -176.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.4 mmpt? -55.77 -48.58 75.04 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.059 0.845 . . . . 74.439999999999998 111.078 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.42 -36.96 85.47 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.068 0.947 . . . . 51.409999999999997 110.76 -178.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 13.9 mt -71.06 -58.72 3.29 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 124.882 1.273 . . . . 70.439999999999998 110.754 178.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 53.9 t -45.47 -49.38 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 C-N-CA 125.133 1.373 . . . . 75.230000000000004 108.595 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.1 -45.19 87.63 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 117.292 -1.337 . . . . 54.409999999999997 112.708 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -51.06 -46.57 61.76 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 120.409 1.459 . . . . 63.329999999999998 111.305 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.405 ' HG2' ' CG ' ' A' ' 59' ' ' TYR . 8.8 mt-30 -88.54 -36.51 16.34 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.926 -1.034 . . . . 73.200000000000003 109.801 -162.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -63.56 -47.99 79.3 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.276 -1.009 . . . . 73.340000000000003 108.276 171.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 54.7 tttt -60.87 -7.7 2.57 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.675 1.19 . . . . 52.409999999999997 113.88 171.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -112.09 -18.05 12.68 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-O 117.189 -1.386 . . . . 61.329999999999998 113.728 173.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.643 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . . . -113.86 -11.68 12.81 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 121.956 2.162 . . . . 55.210000000000001 112.688 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -117.36 -8.03 11.11 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.954 1.302 . . . . 44.100000000000001 111.751 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.25 8.81 3.0 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 114.239 1.199 . . . . 64.510000000000005 114.239 -178.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 12.3 mt 76.54 57.29 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.431 2.692 . . . . 73.120000000000005 111.828 174.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.27 -84.27 0.63 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.045 -1.094 . . . . 60.409999999999997 108.045 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.502 ' HG ' ' H ' ' A' ' 148' ' ' GLY . 11.4 tp -74.68 -73.12 0.25 Allowed 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 124.63 1.172 . . . . 73.109999999999999 112.931 -171.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 70.11 2.34 3.9 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.856 2.062 . . . . 75.329999999999998 115.217 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.502 ' H ' ' HG ' ' A' ' 146' ' ' LEU . . . -145.38 134.64 5.6 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 120.737 1.608 . . . . 72.420000000000002 111.327 176.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 35.5 m -126.42 164.33 34.84 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 119.183 1.492 . . . . 72.430000000000007 111.722 -173.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.48 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 30.0 Cg_endo -66.07 156.06 80.38 Favored 'Cis proline' 0 C--N 1.352 0.723 0 CA-C-N 119.712 0.933 . . . . 64.329999999999998 112.841 -6.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.424 ' HB2' HD11 ' A' ' 146' ' ' LEU . . . -141.36 156.94 45.78 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.454 0.702 . . . . 72.340000000000003 110.473 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 43.8 tpp -156.6 110.13 2.66 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.169 -1.789 . . . . 74.420000000000002 106.169 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -100.6 155.81 17.66 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.458 0.703 . . . . 63.039999999999999 109.54 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.1 t -137.76 139.53 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.612 -1.255 . . . . 74.120000000000005 107.612 177.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 64.67 -2.63 0.64 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.806 2.043 . . . . 72.25 114.874 171.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.48 -28.1 15.7 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.752 1.644 . . . . 63.119999999999997 112.169 -173.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.418 ' HG3' ' CD2' ' A' ' 158' ' ' TYR . 0.1 OUTLIER -115.34 -6.67 12.35 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.925 1.863 . . . . 74.420000000000002 115.81 -169.501 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.418 ' CD2' ' HG3' ' A' ' 157' ' ' LYS . 72.5 m-85 -121.81 148.82 44.19 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 108.901 -0.777 . . . . 72.329999999999998 108.901 -171.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -126.88 143.5 51.25 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.402 -0.962 . . . . 64.019999999999996 108.402 169.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -66.77 138.62 57.5 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 106.585 -1.635 . . . . 72.120000000000005 106.585 172.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -119.18 85.05 29.23 Favored Pre-proline 0 N--CA 1.452 -0.336 0 N-CA-C 111.7 0.259 . . . . 63.039999999999999 111.7 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.32 -21.77 71.78 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 121.27 1.313 . . . . 52.140000000000001 112.604 173.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -67.25 -10.61 52.39 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.147 0.979 . . . . 74.450000000000003 112.011 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -129.05 37.02 2.28 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 126.186 1.851 . . . . 75.019999999999996 109.752 171.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 40.4 mtt -114.12 162.37 16.57 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 119.128 1.464 . . . . 71.239999999999995 108.122 164.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -77.02 119.85 21.31 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 113.817 -1.538 . . . . 73.420000000000002 107.406 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.6 p -125.15 35.33 4.79 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.242 2.217 . . . . 72.010000000000005 108.795 -172.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 8.6 t -99.28 -12.09 20.67 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.761 -0.587 . . . . 53.229999999999997 112.195 178.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.4 -17.15 3.0 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 118.917 -0.564 . . . . 74.430000000000007 111.375 -167.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 5.5 mmt 70.78 -50.2 0.67 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.339 1.856 . . . . 72.140000000000001 112.076 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.66 -47.73 71.6 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 120.785 -1.197 . . . . 72.25 107.922 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 78.6 t -60.18 -32.85 51.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 124.792 1.237 . . . . 74.120000000000005 110.672 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -63.29 -62.69 1.52 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 118.769 -0.634 . . . . 74.209999999999994 109.487 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.4 t -71.69 -25.18 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 119.241 0.928 . . . . 73.340000000000003 111.685 -175.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.82 -40.04 82.99 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 111.865 0.32 . . . . 74.319999999999993 111.865 172.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -75.82 -21.21 57.53 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 118.042 -0.98 . . . . 72.439999999999998 113.147 171.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -67.95 -81.05 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 117.008 -1.472 . . . . 73.349999999999994 114.642 174.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' A' ' 45' ' ' ASN 0.359 . . -44.85 -18.4 0.02 OUTLIER 'General case' 0 CA--C 1.598 2.799 0 C-N-CA 126.672 1.989 . . . . 52.539999999999999 109.241 176.491 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -79.27 -63.98 1.29 Allowed 'General case' 0 C--N 1.382 1.98 0 C-N-CA 128.073 2.549 . . . . 65.450000000000003 113.533 169.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.42 ' OG1' HG21 ' A' ' 3' ' ' ILE . 13.2 t -59.01 -30.31 67.9 Favored 'General case' 0 C--N 1.347 0.488 0 CA-C-O 116.915 -1.517 . . . . 72.310000000000002 110.047 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 39.9 t -56.72 -44.23 81.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 120.462 1.483 . . . . 63.439999999999998 109.139 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 6.3 ptmt -75.15 -33.32 61.5 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-O 118.268 -0.872 . . . . 61.210000000000001 112.208 -177.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -62.36 -37.58 86.23 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 120.404 1.456 . . . . 54.509999999999998 112.035 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 77.1 mt -67.41 -20.61 65.55 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 119.069 -1.052 . . . . 72.230000000000004 111.808 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.03 -23.79 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 O-C-N 121.694 -0.629 . . . . 74.439999999999998 110.521 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -106.37 -2.49 22.14 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.364 0.983 . . . . 73.319999999999993 111.146 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -123.45 78.09 1.56 Allowed 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.862 1.265 . . . . 73.219999999999999 109.971 -176.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.95 0 CA-C-O 115.702 -2.094 . . . . 74.129999999999995 107.176 166.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 9.2 m . . . . . 0 C--O 1.236 0.35 0 N-CA-C 108.836 -0.802 . . . . 65.209999999999994 108.836 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 16.3 m-20 -106.79 1.68 25.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 118.908 -0.568 . . . . 73.010000000000005 111.547 -162.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -67.04 45.06 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.358 2.263 . . . . 74.129999999999995 113.131 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -161.84 119.53 2.22 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 127.16 2.184 . . . . 73.129999999999995 105.302 166.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.2 pt -124.45 143.15 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 126.108 1.763 . . . . 73.420000000000002 106.546 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.6 m -118.07 139.1 51.71 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.416 -1.328 . . . . 73.340000000000003 107.416 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -53.13 118.04 3.46 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.31 2.244 . . . . 70.200000000000003 108.724 164.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.27 -6.17 65.85 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 118.22 -1.322 . . . . 73.420000000000002 113.346 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.7 tptp -103.66 -85.33 0.46 Allowed 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 119.253 1.527 . . . . 65.129999999999995 107.304 177.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -89.45 -20.55 23.76 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 124.219 1.008 . . . . 71.010000000000005 110.777 -170.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -140.66 163.81 31.87 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.93 -0.767 . . . . 73.040000000000006 108.93 175.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.619 HD11 ' CG ' ' A' ' 161' ' ' ASN . 5.4 mm -127.84 159.72 38.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 106.006 -1.85 . . . . 70.019999999999996 106.006 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.6 m -90.53 154.25 19.75 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.498 -1.668 . . . . 74.099999999999994 106.498 168.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.8 mt -67.22 152.8 45.08 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.117 -1.068 . . . . 54.530000000000001 108.117 163.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -73.64 -28.13 61.62 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.67 -0.493 . . . . 65.340000000000003 109.67 171.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -126.37 72.98 72.97 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 126.13 1.772 . . . . 73.030000000000001 109.756 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.39 70.53 6.76 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 124.287 3.325 . . . . 70.120000000000005 110.869 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.1 mt -105.77 164.98 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 O-C-N 121.444 -0.785 . . . . 74.430000000000007 109.083 -175.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 57.81 4.15 0.25 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.103 2.161 . . . . 64.299999999999997 114.866 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.1 -9.0 3.28 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 116.48 -2.289 . . . . 51.399999999999999 113.725 -169.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 53.21 166.67 0.04 OUTLIER Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 127.704 2.402 . . . . 71.329999999999998 113.798 -168.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.18 -11.42 31.18 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 121.66 1.573 . . . . 74.099999999999994 113.271 -174.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 66.89 11.08 8.1 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 128.344 2.658 . . . . 74.129999999999995 113.868 -175.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.434 HG22 ' OG1' ' A' ' 57' ' ' THR . 1.8 p -156.54 97.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.129 -1.063 . . . . 70.329999999999998 108.129 -178.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.1 tp -161.19 159.04 28.37 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.588 0.708 . . . . 44.119999999999997 112.462 172.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -139.83 150.38 44.61 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 127.567 2.347 . . . . 71.230000000000004 106.48 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -135.42 133.07 38.25 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.644 1.578 . . . . 72.030000000000001 108.536 173.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -156.6 -176.78 6.16 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.477 1.511 . . . . 65.019999999999996 110.858 177.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.1 t -135.38 176.43 8.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.665 1.586 . . . . 53.130000000000003 109.032 174.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.843 ' CD1' HD11 ' A' ' 71' ' ' LEU 0.278 0.0 OUTLIER -89.46 -7.5 54.92 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.976 1.102 . . . . 73.420000000000002 113.976 164.729 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.424 ' CE2' ' HA3' ' A' ' 65' ' ' GLY . 51.4 m-85 -103.24 0.72 32.0 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 120.146 1.339 . . . . 73.230000000000004 112.728 173.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.2 p -78.04 140.57 62.09 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 121.437 1.926 . . . . 74.120000000000005 108.857 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -91.45 -25.77 0.3 Allowed 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 120.869 1.046 . . . . 70.099999999999994 112.668 -176.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -57.77 -57.39 12.96 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 119.022 0.828 . . . . 73.040000000000006 109.813 166.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 24.9 p -65.02 -23.73 67.29 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.448 -0.796 . . . . 73.430000000000007 111.648 -170.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -58.07 -54.47 46.54 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 118.883 0.765 . . . . 72.319999999999993 110.534 169.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -55.71 -45.81 77.81 Favored 'General case' 0 C--O 1.221 -0.423 0 N-CA-C 107.894 -1.15 . . . . 52.310000000000002 107.894 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.421 ' CD2' HG21 ' A' ' 42' ' ' VAL . 4.3 m-85 -66.26 -10.45 42.34 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 115.647 -2.121 . . . . 63.130000000000003 113.858 -176.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -132.19 -2.45 3.55 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 122.044 2.202 . . . . 72.040000000000006 112.445 -173.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -133.04 -20.23 2.19 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.432 1.093 . . . . 54.409999999999997 112.426 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.0 t -121.35 -76.2 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 107.183 -1.414 . . . . 72.099999999999994 107.183 -173.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.1 mt -73.99 -18.2 60.9 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.116 2.166 . . . . 70.010000000000005 113.022 -177.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 54.5 m-70 43.75 53.87 5.86 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.291 1.836 . . . . 73.409999999999997 112.818 172.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 46' ' ' VAL . 86.1 t -62.68 -51.23 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 116.997 -1.478 . . . . 74.219999999999999 109.895 -172.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.1 t -45.41 -52.35 10.16 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.061 1.345 . . . . 65.430000000000007 110.143 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -63.77 -40.1 95.86 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.246 1.018 . . . . 61.310000000000002 110.691 -177.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.81 -35.33 74.74 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.542 1.137 . . . . 63.329999999999998 113.156 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 42' ' ' VAL . 1.9 t -67.53 -50.33 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 106.682 -1.599 . . . . 70.409999999999997 106.682 174.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 38.3 ttt-85 -47.47 -46.9 27.31 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.413 1.085 . . . . 63.130000000000003 111.608 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -60.31 -13.57 13.63 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.185 1.18 . . . . 74.0 114.185 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -118.37 -8.83 10.49 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.548 1.939 . . . . 64.230000000000004 111.507 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.61 ' HB3' HG21 ' A' ' 54' ' ' THR . 11.8 mt -76.16 143.83 74.17 Favored Pre-proline 0 C--O 1.237 0.401 0 CA-C-N 119.41 1.005 . . . . 62.030000000000001 109.579 -169.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.42 ' O ' HG22 ' A' ' 54' ' ' THR . 83.6 Cg_endo -80.01 167.35 20.13 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.043 1.829 . . . . 73.140000000000001 111.142 -176.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -73.14 68.4 0.98 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.375 1.07 . . . . 64.310000000000002 112.176 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.46 -7.06 0.05 OUTLIER Glycine 0 CA--C 1.524 0.635 0 O-C-N 119.748 -1.845 . . . . 65.200000000000003 114.773 176.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.61 HG21 ' HB3' ' A' ' 50' ' ' LEU . 0.7 OUTLIER -58.47 -45.08 89.34 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.042 1.421 . . . . 72.019999999999996 110.998 175.841 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . 0.294 19.0 ttpt 56.91 151.4 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.79 2.036 . . . . 73.040000000000006 111.725 -162.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.42 113.09 16.4 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 120.037 -1.664 . . . . 63.039999999999999 107.773 -167.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.434 ' OG1' HG22 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -115.92 -177.69 3.22 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.882 1.673 . . . . 65.200000000000003 109.347 -174.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -179.23 87.04 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 106.737 -1.579 . . . . 64.310000000000002 106.737 -170.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 -95.22 162.74 13.57 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.41 -0.806 . . . . 73.430000000000007 109.967 174.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.467 ' CE1' ' HB2' ' A' ' 137' ' ' GLN . 0.1 OUTLIER -100.15 174.39 6.18 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.779 2.031 . . . . 64.310000000000002 110.615 -176.724 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.5 m -135.07 145.86 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 120.418 1.463 . . . . 54.509999999999998 110.534 164.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -82.42 29.6 0.43 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.468 1.107 . . . . 70.299999999999997 111.396 -178.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -134.68 165.91 24.15 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.851 1.66 . . . . 61.130000000000003 107.652 -172.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.6 mt 75.79 128.61 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 127.007 2.123 . . . . 65.030000000000001 109.766 -172.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.424 ' HA3' ' CE2' ' A' ' 29' ' ' TYR . . . 66.72 171.31 4.46 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 121.944 0.747 . . . . 54.539999999999999 112.55 175.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.02 -40.99 1.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 123.069 2.513 . . . . 74.219999999999999 112.62 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.4 mt -81.88 16.6 1.79 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.248 1.419 . . . . 74.299999999999997 112.356 -174.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.19 -34.64 58.97 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 117.742 -1.588 . . . . 52.32 113.607 -173.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.2 -35.7 55.45 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 120.473 2.136 . . . . 71.329999999999998 110.28 176.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.37 -37.96 86.47 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 120.976 -1.078 . . . . 64.219999999999999 108.703 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.843 HD11 ' CD1' ' A' ' 28' ' ' PHE . 22.4 mt -53.91 -45.04 71.04 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 123.82 0.848 . . . . 73.5 111.093 169.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.464 HG23 ' CE1' ' A' ' 60' ' ' HIS . 2.6 m -57.12 -51.07 70.76 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 124.348 1.03 . . . . 73.219999999999999 109.314 -177.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -63.22 -49.11 75.46 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 118.587 -0.721 . . . . 72.319999999999993 109.919 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.22 -37.87 75.68 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 120.416 1.462 . . . . 65.439999999999998 114.363 -177.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.454 ' CD1' HD11 ' A' ' 79' ' ' ILE . 10.6 t-105 -61.09 -37.77 83.88 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.633 0.652 . . . . 65.109999999999999 111.371 -172.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.72 -34.68 71.62 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 117.832 -1.08 . . . . 71.219999999999999 112.373 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.09 -46.76 84.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 120.198 1.363 . . . . 72.209999999999994 109.779 171.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.23 -43.28 82.37 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 118.81 -0.614 . . . . 72.120000000000005 111.068 -177.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.454 HD11 ' CD1' ' A' ' 75' ' ' TRP . 75.0 mt -60.23 -41.9 88.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.145 0.978 . . . . 74.239999999999995 109.784 176.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.94 -48.23 81.33 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.885 0.474 . . . . 70.420000000000002 110.175 -173.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 81' ' ' LEU . 71.7 mt -76.66 -20.89 56.16 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 121.825 -0.547 . . . . 54.219999999999999 112.347 174.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.57 70.55 1.13 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 126.937 2.208 . . . . 41.130000000000003 110.097 -173.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.6 m -134.18 15.64 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 125.157 1.383 . . . . 70.239999999999995 112.804 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -52.43 -48.65 65.65 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.316 1.046 . . . . 74.200000000000003 110.66 -178.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.48 -7.93 16.75 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.948 1.699 . . . . 70.510000000000005 113.304 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -104.21 -19.92 13.97 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 125.124 1.37 . . . . 72.219999999999999 111.283 176.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.6 pp -124.04 28.53 2.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 C-N-CA 125.838 1.655 . . . . 70.400000000000006 110.416 -172.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 43.1 m -93.96 -51.15 4.99 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.742 -0.836 . . . . 65.099999999999994 108.742 165.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.504 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -57.66 -65.81 1.62 Allowed Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 124.007 0.923 . . . . 71.439999999999998 112.006 -171.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 52.3 Cg_endo -66.13 -26.28 50.16 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 121.161 1.241 . . . . 72.209999999999994 111.556 -174.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 24.0 tpp -61.76 -50.21 73.29 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.691 -0.855 . . . . 74.530000000000001 108.691 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -67.88 -35.13 77.98 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 123.974 0.91 . . . . 70.209999999999994 109.685 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -56.47 -45.31 80.97 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.599 0.636 . . . . 65.5 109.615 171.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.28 -1.76 42.24 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 120.727 -1.233 . . . . 64.099999999999994 112.993 -174.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.756 HG21 ' CD2' ' A' ' 28' ' ' PHE . 61.2 t -119.26 -33.74 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 C-N-CA 124.614 1.165 . . . . 73.030000000000001 110.949 -174.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -113.79 -52.92 2.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.105 1.362 . . . . 74.129999999999995 108.725 -173.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -71.99 -51.97 19.33 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 118.027 0.376 . . . . 74.319999999999993 110.338 -173.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.8 p -100.89 -27.04 13.53 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.056 0.942 . . . . 63.130000000000003 112.531 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 52.28 32.98 11.76 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.646 2.379 . . . . 71.040000000000006 114.979 -177.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 t -74.26 -21.02 59.95 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.749 0.82 . . . . 74.120000000000005 112.199 178.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.402 HG13 HG12 ' A' ' 107' ' ' ILE . 25.4 t -65.28 122.97 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 O-C-N 121.568 -0.708 . . . . 72.230000000000004 109.197 170.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -149.4 -19.99 0.28 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 114.068 -1.424 . . . . 74.430000000000007 111.63 -178.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.04 165.88 24.66 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.152 0.981 . . . . 71.340000000000003 109.64 173.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 39.1 t -57.57 -42.18 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.744 1.217 . . . . 43.43 108.388 175.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.02 13.89 0.05 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 128.809 2.843 . . . . 73.540000000000006 113.155 174.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -115.47 -48.68 2.78 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.42 1.488 . . . . 63.539999999999999 109.196 163.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.402 HG12 HG13 ' A' ' 101' ' ' VAL . 2.4 mt -52.66 -45.2 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.99 1.316 . . . . 64.129999999999995 110.907 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -22.36 65.72 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.651 0.982 . . . . 74.200000000000003 113.651 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -56.05 -56.02 25.9 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.981 1.264 . . . . 73.540000000000006 110.11 171.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 39.7 t -62.45 -34.55 65.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.83 -0.623 . . . . 71.129999999999995 110.789 -171.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -53.19 -58.6 6.5 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.716 -0.846 . . . . 73.239999999999995 108.716 171.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.1 t -65.71 -37.51 80.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 119.364 -0.35 . . . . 70.219999999999999 111.124 -173.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -60.84 -48.4 82.0 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.679 -0.86 . . . . 73.099999999999994 108.679 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.82 -0.39 7.11 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.612 1.565 . . . . 53.200000000000003 112.565 177.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.27 58.58 1.14 Allowed Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 124.428 1.013 . . . . 22.440000000000001 111.846 172.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.3 t -118.54 149.27 21.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 124.143 0.977 . . . . 70.230000000000004 109.832 169.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt -67.34 120.5 13.95 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.413 1.085 . . . . 74.439999999999998 110.49 168.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.68 -31.04 78.67 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-O 118.37 -1.239 . . . . 72.420000000000002 111.239 170.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -66.72 -36.58 82.82 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.846 1.323 . . . . 74.420000000000002 110.194 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -73.32 -42.49 62.28 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 106.766 -1.568 . . . . 65.340000000000003 106.766 -174.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -58.45 -55.43 35.07 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.996 0.903 . . . . 74.530000000000001 109.202 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -70.27 -12.61 61.71 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.004 0.922 . . . . 45.299999999999997 112.856 -173.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.98 -64.91 1.01 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.23 1.412 . . . . 34.240000000000002 109.946 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.64 -36.56 64.68 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.652 1.581 . . . . 45.020000000000003 111.491 -170.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 44.0 t-105 -45.14 -45.9 11.64 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.998 1.319 . . . . 73.5 112.067 176.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -102.35 11.22 38.4 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.206 1.402 . . . . 72.409999999999997 112.144 -177.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 7.0 t -99.27 163.79 12.4 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.281 1.832 . . . . 75.299999999999997 111.527 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -60.72 -28.31 68.58 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 128.177 2.591 . . . . 71.400000000000006 112.553 173.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 23.6 t -50.99 -53.28 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 122.78 1.276 . . . . 53.219999999999999 109.256 177.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.3 t -70.04 -32.51 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 114.923 -1.035 . . . . 74.219999999999999 110.624 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -56.47 -59.35 5.11 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.896 1.225 . . . . 74.5 110.045 176.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.0 m -68.45 -20.3 64.62 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.995 0.739 . . . . 63.210000000000001 112.995 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 26.2 mt -87.98 -33.48 18.39 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 113.642 0.979 . . . . 73.299999999999997 113.642 177.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 41.4 t -59.13 -52.77 56.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 107.064 -1.458 . . . . 65.519999999999996 107.064 165.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -46.67 -51.41 16.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.679 1.592 . . . . 61.119999999999997 112.893 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -58.04 -28.94 64.94 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.129 0.49 . . . . 75.120000000000005 112.017 -169.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.467 ' HB2' ' CE1' ' A' ' 60' ' ' HIS . 49.9 mt-30 -97.09 -47.56 5.73 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 128.095 2.558 . . . . 65.430000000000007 111.753 -176.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -62.89 -38.7 91.93 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 118.537 0.608 . . . . 74.0 109.653 -177.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -51.36 -45.7 62.48 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.486 1.114 . . . . 54.340000000000003 110.272 172.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.11 -52.97 35.29 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 124.392 1.058 . . . . 54.520000000000003 109.677 -175.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.29 -43.16 70.84 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.913 0.485 . . . . 34.43 111.42 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.16 7.51 9.15 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.218 1.807 . . . . 64.200000000000003 112.686 -177.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -86.18 -8.75 57.59 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.175 -0.953 . . . . 70.299999999999997 111.431 169.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 11.9 mt 68.43 58.53 0.42 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.921 1.344 . . . . 72.400000000000006 110.908 160.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.38 -34.86 0.36 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.646 1.178 . . . . 51.520000000000003 112.094 -173.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.3 tp -79.12 -85.09 0.08 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 125.437 1.495 . . . . 72.230000000000004 109.244 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 51.03 37.49 17.97 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.445 1.098 . . . . 73.109999999999999 111.852 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.63 132.77 3.29 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 107.803 -2.119 . . . . 65.129999999999995 107.803 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.465 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 1.4 m -138.13 160.45 64.17 Favored Pre-proline 0 C--O 1.241 0.632 0 N-CA-C 108.509 -0.923 . . . . 63.219999999999999 108.509 171.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.465 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 63.8 Cg_endo -74.21 142.52 75.0 Favored 'Cis proline' 0 N--CA 1.46 -0.494 0 C-N-CA 125.356 -0.685 . . . . 52.420000000000002 111.975 -10.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -126.25 138.7 53.64 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 125.516 1.526 . . . . 44.310000000000002 108.621 -175.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 34.5 mtp -140.12 108.61 5.87 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 106.471 -1.677 . . . . 73.140000000000001 106.471 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -81.36 173.04 12.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.857 -0.61 . . . . 72.340000000000003 110.232 -175.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.528 HG11 ' HB2' ' A' ' 184' ' ' LEU . 59.3 t -133.36 -86.05 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 CA-C-O 119.034 -0.508 . . . . 73.400000000000006 110.47 160.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -84.57 30.86 0.54 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.859 1.209 . . . . 72.299999999999997 110.379 -167.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 68.53 -68.0 0.4 Allowed Glycine 0 C--O 1.22 -0.74 0 C-N-CA 127.882 2.658 . . . . 43.100000000000001 109.201 -164.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.433 ' HE2' ' CZ ' ' A' ' 158' ' ' TYR . 36.5 pttt -60.44 -0.7 0.27 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 115.432 1.641 . . . . 70.219999999999999 115.432 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.433 ' CZ ' ' HE2' ' A' ' 157' ' ' LYS . 18.0 m-85 -121.68 139.31 53.72 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 120.473 1.488 . . . . 65.120000000000005 111.972 -177.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -118.86 132.36 56.1 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.471 2.308 . . . . 71.200000000000003 106.378 174.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -67.95 143.76 55.49 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.598 -0.89 . . . . 70.420000000000002 108.598 175.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASN . . . . . 0.619 ' CG ' HD11 ' A' ' 10' ' ' ILE . 17.5 t30 -117.56 83.92 18.14 Favored Pre-proline 0 C--O 1.236 0.385 0 N-CA-C 112.406 0.521 . . . . 63.340000000000003 112.406 -174.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -62.92 -28.87 75.55 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 120.297 0.665 . . . . 71.019999999999996 112.102 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -64.16 -7.25 8.43 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 116.756 2.132 . . . . 64.209999999999994 116.756 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -107.69 -3.88 34.52 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-N 119.733 1.151 . . . . 44.439999999999998 113.776 170.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.1 mtt -85.82 166.37 16.09 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 119.952 1.876 . . . . 63.439999999999998 109.399 -174.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -79.32 65.83 4.61 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 122.674 1.226 . . . . 62.420000000000002 111.25 -172.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 41.6 p -67.04 3.57 1.09 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.59 1.956 . . . . 64.0 112.654 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 6.1 t -73.22 -18.63 61.22 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 119.799 1.182 . . . . 72.0 111.827 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.85 -11.74 8.11 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 117.557 -1.211 . . . . 72.200000000000003 114.043 -170.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 3.6 mmt 68.98 -63.36 0.37 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.483 1.913 . . . . 73.409999999999997 111.809 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.27 -31.07 71.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.767 1.27 . . . . 73.200000000000003 110.389 -170.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 76.0 t -75.71 -33.47 26.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 124.546 1.138 . . . . 53.439999999999998 111.133 173.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -60.27 -56.88 16.13 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.614 -0.884 . . . . 72.400000000000006 108.614 -176.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.0 t -65.01 -35.47 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 109.981 -0.377 . . . . 43.520000000000003 109.981 -175.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.09 -27.34 68.29 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.2 1.0 . . . . 74.010000000000005 112.301 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -93.92 -33.34 13.53 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.148 0.885 . . . . 72.200000000000003 112.105 171.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -56.34 -58.05 9.67 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 124.214 1.006 . . . . 72.219999999999999 110.277 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.01 -22.27 62.37 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.162 0.585 . . . . 72.040000000000006 112.433 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -70.97 -61.65 1.69 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.446 1.098 . . . . 71.219999999999999 109.54 178.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.1 t -61.71 -21.11 64.21 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 118.026 -0.988 . . . . 73.219999999999999 112.262 -174.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 57.3 t -56.58 -57.14 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 119.364 0.984 . . . . 74.120000000000005 108.667 169.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -56.8 -43.93 81.43 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.771 0.828 . . . . 71.129999999999995 109.578 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -61.55 -34.03 74.87 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 123.3 0.64 . . . . 65.109999999999999 111.318 -171.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.528 ' HB2' HG11 ' A' ' 154' ' ' VAL . 58.4 mt -79.78 -21.89 43.82 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 121.322 -0.861 . . . . 74.200000000000003 112.687 -178.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 72.3 t -61.46 -31.38 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 108.78 -0.822 . . . . 44.329999999999998 108.78 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -98.04 -14.53 20.47 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.14 0.976 . . . . 70.439999999999998 111.149 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -112.52 63.75 0.63 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.695 1.198 . . . . 73.109999999999999 111.198 -174.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt . . . . . 0 C--O 1.248 0.987 0 CA-C-O 119.094 -0.479 . . . . 72.040000000000006 110.098 160.605 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 106.965 -1.495 . . . . 74.140000000000001 106.965 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -117.95 173.03 7.0 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 123.467 0.48 . . . . 71.310000000000002 110.705 -154.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 46.8 25.23 0.42 Allowed 'General case' 0 C--O 1.236 0.394 0 C-N-CA 127.801 2.44 . . . . 51.43 115.161 171.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -161.57 117.32 2.09 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 107.097 -1.446 . . . . 73.25 107.097 -173.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.4 pt -126.41 150.84 32.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 126.174 1.79 . . . . 65.140000000000001 109.671 -172.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.9 m -132.14 133.93 44.84 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 105.965 -1.865 . . . . 74.25 105.965 176.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -59.85 144.14 49.45 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.49 1.516 . . . . 73.25 108.913 169.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.9 4.89 73.27 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 118.363 -1.243 . . . . 51.210000000000001 112.662 -174.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -129.28 -70.07 0.67 Allowed 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 119.308 1.554 . . . . 71.230000000000004 113.497 -176.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -101.17 -27.52 13.18 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.161 -0.681 . . . . 71.239999999999995 109.161 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -132.46 170.89 14.49 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 122.563 0.345 . . . . 75.25 110.505 171.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.72 147.82 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 105.535 -2.024 . . . . 61.140000000000001 105.535 177.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.09 169.89 17.2 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.733 -1.21 . . . . 73.030000000000001 107.733 163.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 36.2 mt -110.26 150.15 29.13 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.795 -1.557 . . . . 63.350000000000001 106.795 168.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -75.83 -30.96 59.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.101 0.477 . . . . 75.340000000000003 111.216 -174.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.5 mmmt -126.84 76.51 75.25 Favored Pre-proline 0 N--CA 1.464 0.245 0 C-N-CA 124.298 1.039 . . . . 74.049999999999997 108.535 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -79.38 71.54 6.98 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 124.14 3.227 . . . . 64.329999999999998 111.157 -175.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.7 tp -160.35 144.2 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 O-C-N 120.664 -1.272 . . . . 73.239999999999995 109.578 172.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 53.62 -161.45 0.12 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.385 1.874 . . . . 50.109999999999999 111.637 171.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.58 -24.97 2.12 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.221 1.391 . . . . 64.140000000000001 112.905 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -138.82 160.66 62.13 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 119.351 1.575 . . . . 65.450000000000003 111.705 -167.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -76.46 -165.15 0.29 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.865 3.043 . . . . 65.430000000000007 111.673 172.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -71.06 90.51 0.85 Allowed 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.579 -1.326 . . . . 65.329999999999998 108.467 164.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.274 1.4 p 52.07 151.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.544 1 C-N-CA 131.91 4.084 . . . . 74.120000000000005 115.387 174.477 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.447 HD11 ' CE2' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -160.17 165.37 31.73 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 120.625 -1.297 . . . . 65.120000000000005 110.738 -172.542 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.419 ' H ' ' HG ' ' A' ' 23' ' ' LEU . 2.2 mp0 -137.14 132.85 34.58 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 126.007 1.723 . . . . 73.230000000000004 107.48 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.427 ' CD2' HD13 ' A' ' 146' ' ' LEU . 3.4 m-85 -127.41 139.02 53.11 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.466 1.506 . . . . 73.329999999999998 109.393 -176.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.67 173.13 11.82 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.354 1.462 . . . . 63.0 109.283 -174.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.75 179.47 6.4 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.404 -0.591 . . . . 63.119999999999997 109.404 161.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.503 ' HB2' HD13 ' A' ' 71' ' ' LEU . 32.4 m-85 -100.69 -17.15 17.12 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 123.733 0.813 . . . . 75.230000000000004 111.714 -173.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.433 ' CD1' ' HA3' ' A' ' 65' ' ' GLY . 64.3 m-85 -111.87 8.12 20.31 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 127.547 2.339 . . . . 75.120000000000005 111.854 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.9 p -88.47 144.5 33.85 Favored Pre-proline 0 N--CA 1.468 0.455 0 O-C-N 120.237 -1.54 . . . . 64.219999999999999 111.561 -176.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -73.38 -50.2 0.19 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.708 2.272 . . . . 75.109999999999999 112.371 -168.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -56.11 -35.52 67.16 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.239 0.616 . . . . 71.030000000000001 110.4 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.9 m -63.26 -32.72 74.2 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 124.184 0.994 . . . . 73.409999999999997 111.557 -174.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -57.27 -61.96 2.1 Favored 'General case' 0 C--O 1.216 -0.701 0 C-N-CA 123.535 0.734 . . . . 75.030000000000001 110.784 172.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.661 ' HB3' HD13 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -47.45 -53.12 14.99 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 120.263 -1.523 . . . . 73.409999999999997 110.633 173.198 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -65.5 -13.74 59.51 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 116.015 -1.945 . . . . 62.210000000000001 110.908 -163.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.425 ' HG2' HG21 ' A' ' 88' ' ' THR . 1.4 tp10 -141.11 20.21 2.27 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.667 1.576 . . . . 63.229999999999997 113.53 -177.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.425 ' OE2' ' HA ' ' A' ' 89' ' ' ALA . 26.0 mm-40 -142.26 -28.86 0.6 Allowed 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.222 1.009 . . . . 71.040000000000006 113.163 177.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.0 t -116.18 -44.02 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 105.796 -1.927 . . . . 73.209999999999994 105.796 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.661 HD13 ' HB3' ' A' ' 35' ' ' GLN . 4.4 mp -96.1 -32.89 12.3 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.431 1.892 . . . . 62.200000000000003 112.326 -170.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 27.8 m80 44.11 60.65 2.67 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.49 1.116 . . . . 72.310000000000002 112.272 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.71 -35.52 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 124.651 1.18 . . . . 64.420000000000002 109.163 -175.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.4 t -57.82 -51.25 70.35 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.8 1.182 . . . . 74.439999999999998 108.794 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -66.1 -47.28 74.72 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 124.494 1.117 . . . . 73.430000000000007 110.53 -177.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -58.26 -56.19 25.32 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 125.157 1.383 . . . . 72.129999999999995 111.579 -178.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.545 HG12 ' HG ' ' A' ' 50' ' ' LEU . 19.7 t -67.45 -42.14 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.529 -1.286 . . . . 51.229999999999997 107.529 -175.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 61.9 ttt-85 -51.27 -43.26 61.54 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.008 1.276 . . . . 65.400000000000006 111.865 174.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -61.71 -13.17 20.64 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.689 1.596 . . . . 74.340000000000003 114.778 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -120.58 -11.48 9.06 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.035 1.334 . . . . 71.200000000000003 112.912 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.545 ' HG ' HG12 ' A' ' 46' ' ' VAL . 7.7 mt -69.25 143.91 94.34 Favored Pre-proline 0 C--O 1.239 0.529 0 CA-C-N 119.224 0.92 . . . . 73.219999999999999 108.921 -163.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.69 145.98 33.44 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.937 2.424 . . . . 62.32 110.565 176.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.58 76.1 6.21 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.489 -1.232 . . . . 65.450000000000003 109.346 -168.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 166.49 -17.41 0.09 OUTLIER Glycine 0 CA--C 1.525 0.676 0 CA-C-O 117.769 -1.573 . . . . 65.420000000000002 112.255 -172.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.473 HG21 HD13 ' A' ' 50' ' ' LEU . 8.0 t -45.18 -46.06 11.9 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.372 1.586 . . . . 73.430000000000007 113.742 174.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.8 tptt 66.23 147.15 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.942 2.897 . . . . 62.149999999999999 112.964 -149.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 3.2 mtm -135.08 137.61 43.04 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 127.159 2.184 . . . . 64.129999999999995 108.378 175.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.8 m -146.82 168.15 22.12 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.006 1.323 . . . . 71.040000000000006 108.714 -177.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.93 106.74 3.07 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.289 -1.507 . . . . 74.439999999999998 109.366 -177.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.447 ' CE2' HD11 ' A' ' 23' ' ' LEU . 9.9 m-30 -112.23 169.48 8.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.194 1.398 . . . . 73.310000000000002 111.886 -176.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.691 ' CE1' HG23 ' A' ' 72' ' ' THR . 0.5 OUTLIER -114.82 173.29 6.55 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.04 1.736 . . . . 75.329999999999998 109.686 -177.099 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.3 m -136.78 169.77 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 119.692 1.133 . . . . 62.0 109.591 163.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -125.37 65.0 1.16 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.794 1.637 . . . . 71.040000000000006 109.806 -174.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -146.7 -13.29 0.44 Allowed 'General case' 0 C--N 1.328 -0.362 0 O-C-N 120.733 -1.23 . . . . 74.040000000000006 113.168 -168.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mt -128.24 125.45 38.96 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 119.972 1.26 . . . . 75.430000000000007 108.904 -176.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' A' ' 29' ' ' TYR . . . 89.06 158.08 33.72 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.442 1.496 . . . . 60.119999999999997 110.647 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -64.69 -48.57 3.98 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.415 2.077 . . . . 54.329999999999998 110.274 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.715 HD13 HD11 ' A' ' 107' ' ' ILE . 5.1 mt -74.36 10.39 1.31 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.471 1.285 . . . . 75.340000000000003 114.471 -175.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.23 -2.46 0.41 Allowed Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.176 1.369 . . . . 73.409999999999997 115.751 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -90.87 -42.33 10.68 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 120.172 1.986 . . . . 64.299999999999997 112.383 169.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -60.92 -54.73 41.45 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 118.595 0.634 . . . . 72.230000000000004 109.826 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.503 HD13 ' HB2' ' A' ' 28' ' ' PHE . 86.3 mt -55.63 -37.68 68.51 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 124.989 1.43 . . . . 62.030000000000001 111.682 -164.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.691 HG23 ' CE1' ' A' ' 60' ' ' HIS . 52.3 m -55.74 -49.58 72.68 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 129.506 3.122 . . . . 71.310000000000002 110.716 174.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -65.42 -54.73 24.32 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.466 -0.771 . . . . 70.319999999999993 109.248 174.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.8 -36.6 48.36 Favored 'General case' 0 C--O 1.227 -0.097 0 N-CA-C 114.042 1.127 . . . . 64.409999999999997 114.042 -177.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.469 ' CD1' HD11 ' A' ' 79' ' ' ILE . 35.7 t-105 -50.3 -41.43 50.91 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.058 1.343 . . . . 73.420000000000002 110.394 176.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.66 -36.57 83.3 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 117.628 -1.177 . . . . 72.230000000000004 113.314 179.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.1 t -54.69 -49.28 69.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 120.324 1.42 . . . . 62.210000000000001 109.475 169.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.55 -46.2 89.46 Favored 'General case' 0 C--N 1.342 0.242 0 O-C-N 122.007 -0.433 . . . . 65.010000000000005 110.495 -175.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.469 HD11 ' CD1' ' A' ' 75' ' ' TRP . 79.4 mt -62.43 -39.52 84.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 123.603 0.761 . . . . 65.439999999999998 110.153 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.62 -45.03 85.9 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.076 0.853 . . . . 64.120000000000005 110.135 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 89.5 mt -86.96 -11.6 50.09 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 112.945 0.72 . . . . 70.310000000000002 112.945 -177.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.77 60.89 6.73 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 126.326 1.917 . . . . 62.119999999999997 112.184 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.8 m -134.84 11.74 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.134 0 C-N-CA 125.045 1.338 . . . . 62.439999999999998 113.097 -174.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -44.42 -60.71 1.82 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.751 1.62 . . . . 73.030000000000001 109.911 175.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.8 -8.06 0.54 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.934 2.093 . . . . 72.230000000000004 114.183 176.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -108.2 -29.03 9.14 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.536 1.516 . . . . 74.439999999999998 112.311 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.9 pp -100.31 -14.07 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 C-N-CA 123.884 0.874 . . . . 72.230000000000004 111.619 -175.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.482 HG23 ' HE2' ' A' ' 92' ' ' PHE 0.25 3.2 m -63.31 -41.82 98.98 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 116.868 -1.539 . . . . 74.019999999999996 112.319 -179.474 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.585 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -50.76 -64.47 1.31 Allowed Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.477 1.111 . . . . 72.030000000000001 112.09 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 48.2 Cg_endo -68.07 -20.46 44.18 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 120.508 0.805 . . . . 73.0 112.387 -177.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 6.1 tpp -59.98 -55.17 37.37 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 126.539 1.935 . . . . 72.230000000000004 110.576 174.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.482 ' HE2' HG23 ' A' ' 88' ' ' THR . 41.8 m-85 -69.84 -32.02 70.2 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 121.348 -0.845 . . . . 74.420000000000002 110.96 -177.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.493 ' HA ' ' HB2' ' A' ' 97' ' ' LYS . 1.8 tt0 -60.97 -36.97 80.8 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 117.915 -1.514 . . . . 74.120000000000005 108.887 169.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.455 ' HB1' HG23 ' A' ' 101' ' ' VAL . . . -81.17 -15.12 56.68 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 120.376 -1.453 . . . . 61.210000000000001 112.408 -171.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 99.1 t -116.91 -22.73 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 125.232 1.413 . . . . 60.409999999999997 111.635 -171.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -120.55 -50.89 2.19 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.772 1.169 . . . . 74.010000000000005 110.582 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.519 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 1.7 mmpt? -72.44 -40.89 66.72 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 113.696 0.999 . . . . 74.310000000000002 113.696 -171.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.4 p -112.3 -34.98 5.74 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 124.809 1.318 . . . . 64.430000000000007 111.221 178.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 57.62 23.65 9.59 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.662 1.985 . . . . 74.219999999999999 113.308 -171.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -66.79 -13.42 61.46 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.927 0.785 . . . . 63.219999999999999 112.22 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.509 HG13 HG12 ' A' ' 107' ' ' ILE . 27.7 t -64.47 108.73 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 108.44 -0.948 . . . . 74.329999999999998 108.44 169.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -135.11 -26.96 1.26 Allowed 'General case' 0 C--O 1.237 0.399 0 CA-C-O 118.558 -0.734 . . . . 73.230000000000004 112.618 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.5 m -131.63 169.94 15.46 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 108.63 -0.878 . . . . 41.130000000000003 108.63 169.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 87.8 t -55.92 -36.1 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.019 0.928 . . . . 75.129999999999995 110.411 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.81 -16.38 16.81 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.504 1.522 . . . . 74.230000000000004 114.053 175.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -91.21 -35.12 14.69 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 119.335 0.97 . . . . 42.43 110.142 175.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.715 HD11 HD13 ' A' ' 67' ' ' LEU . 1.2 mt -78.84 -36.79 19.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 121.256 -0.902 . . . . 64.0 109.394 -169.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -54.39 -36.13 63.58 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-O 117.96 -1.019 . . . . 72.420000000000002 111.598 169.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -58.43 -51.63 69.01 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 118.853 0.752 . . . . 73.310000000000002 109.475 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 18.8 t -49.69 -48.12 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.427 1.091 . . . . 65.400000000000006 110.901 -177.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -55.07 -51.85 65.06 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.442 0.697 . . . . 73.099999999999994 110.369 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.2 t -69.94 -32.0 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 CA-C-O 119.098 -0.477 . . . . 74.200000000000003 110.205 -175.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -65.91 -41.57 91.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 118.593 0.633 . . . . 70.040000000000006 110.712 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.33 -43.86 92.67 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.538 -0.542 . . . . 73.420000000000002 109.538 171.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 144.35 3.94 0.7 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.519 1.057 . . . . 53.240000000000002 114.869 168.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 65.9 t -62.66 136.6 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 118.763 1.282 . . . . 54.509999999999998 108.836 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.4 mtmt -62.32 125.0 22.39 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.443 -0.947 . . . . 73.129999999999995 108.443 176.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.71 -27.08 69.34 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-O 118.83 -0.983 . . . . 73.439999999999998 111.301 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -70.65 -26.46 63.47 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 118.134 0.967 . . . . 71.230000000000004 112.373 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -87.42 -38.65 15.94 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.667 1.987 . . . . 73.129999999999995 107.565 -168.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -60.05 -56.05 26.39 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.482 1.513 . . . . 74.219999999999999 109.148 166.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -72.04 -8.01 52.11 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.139 0.792 . . . . 45.420000000000002 113.139 -173.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -85.89 -61.83 1.66 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.529 1.132 . . . . 71.329999999999998 109.598 164.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.09 -37.83 67.31 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 123.435 0.694 . . . . 63.109999999999999 112.636 -172.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -49.64 -38.66 33.17 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.097 0.959 . . . . 72.340000000000003 111.658 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.56 -11.15 40.91 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 120.487 -1.383 . . . . 73.230000000000004 113.965 177.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.7 t -77.07 155.22 32.63 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 126.835 2.054 . . . . 63.200000000000003 112.263 -169.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -66.29 -26.17 67.2 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.582 1.553 . . . . 72.340000000000003 111.274 175.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 68.0 t -50.04 -52.78 13.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 124.142 0.977 . . . . 63.399999999999999 109.19 172.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.2 t -69.45 -42.75 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 C-N-CA 123.383 0.673 . . . . 65.340000000000003 110.084 -177.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -51.44 -52.53 45.51 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.172 0.896 . . . . 54.409999999999997 111.256 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 36.1 t -63.22 -42.68 99.3 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 123.337 0.655 . . . . 43.100000000000001 109.714 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.0 mt -60.35 -52.07 66.84 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-O 118.256 -0.878 . . . . 54.299999999999997 109.957 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 95.1 t -51.13 -44.18 28.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 118.964 0.802 . . . . 71.0 108.953 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.41 -28.97 70.34 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 114.282 1.216 . . . . 64.019999999999996 114.282 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -63.42 -47.67 81.0 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 121.146 -0.971 . . . . 74.299999999999997 110.352 177.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.409 ' HG3' ' CD2' ' A' ' 59' ' ' TYR . 3.0 mp0 -78.52 -41.11 33.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 124.189 0.931 . . . . 73.120000000000005 110.95 -178.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -54.43 -46.78 73.3 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.385 0.993 . . . . 74.109999999999999 108.603 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -63.0 -45.87 90.37 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.517 0.727 . . . . 73.129999999999995 112.565 175.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.7 -49.92 74.53 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.707 0.685 . . . . 41.119999999999997 109.52 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.73 -30.17 71.22 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.136 -1.603 . . . . 52.539999999999999 110.895 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -76.57 -8.04 56.4 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.263 0.938 . . . . 71.420000000000002 113.405 173.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.68 -18.49 62.17 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 120.728 -1.232 . . . . 73.219999999999999 109.743 162.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 11.6 mt 75.42 -8.36 1.6 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 128.154 2.582 . . . . 73.120000000000005 112.394 171.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.13 -0.61 1.24 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.126 2.57 . . . . 75.040000000000006 115.008 -176.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.427 HD13 ' CD2' ' A' ' 25' ' ' PHE . 1.2 tt -152.06 119.67 6.07 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 124.323 1.049 . . . . 75.010000000000005 108.692 -172.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -146.23 16.91 1.36 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.491 1.116 . . . . 72.329999999999998 110.671 -174.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -152.97 97.55 0.17 Allowed Glycine 0 C--N 1.34 0.798 0 O-C-N 121.084 -1.01 . . . . 55.409999999999997 111.611 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.437 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 2.4 m -91.03 174.77 4.15 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.153 0.981 . . . . 64.430000000000007 110.161 176.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.437 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 43.9 Cg_endo -64.25 140.94 42.42 Favored 'Cis proline' 0 N--CA 1.456 -0.728 0 N-CA-C 109.218 -1.109 . . . . 62.310000000000002 109.218 -19.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -133.8 124.71 27.04 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.264 1.026 . . . . 73.439999999999998 108.62 -169.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 28.3 mtp -132.7 107.76 8.6 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.222 1.809 . . . . 74.319999999999993 106.471 -168.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -97.56 168.48 10.34 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.302 1.041 . . . . 72.140000000000001 109.859 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.0 t -125.35 -37.52 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 118.567 -0.73 . . . . 65.019999999999996 112.91 171.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.66 13.85 0.35 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.166 1.543 . . . . 73.150000000000006 115.166 -175.107 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 77.22 2.26 78.09 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 121.621 -0.674 . . . . 50.420000000000002 112.617 -175.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -128.11 -4.83 5.59 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 121.333 -1.098 . . . . 75.129999999999995 113.803 170.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -133.95 140.29 46.66 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.925 0.89 . . . . 74.450000000000003 108.688 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -122.11 154.86 36.81 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.934 1.693 . . . . 75.25 106.546 168.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -76.16 157.4 32.79 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.144 -0.973 . . . . 75.230000000000004 108.764 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.25 66.36 1.55 Allowed Pre-proline 0 N--CA 1.468 0.434 0 C-N-CA 123.371 0.668 . . . . 75.140000000000001 110.176 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -55.47 -36.62 94.54 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.707 1.605 . . . . 71.140000000000001 111.302 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -79.17 24.73 0.32 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.99 0.916 . . . . 62.020000000000003 112.921 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -136.13 7.55 4.08 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 121.12 -0.987 . . . . 54.409999999999997 113.043 161.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 12.6 mtt -92.25 158.84 15.91 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 119.161 1.48 . . . . 55.399999999999999 110.628 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -62.72 106.01 0.73 Allowed 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.735 1.214 . . . . 72.439999999999998 109.935 176.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 24.2 p -106.48 28.84 7.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.008 1.323 . . . . 74.340000000000003 110.247 174.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.3 m -72.49 -29.15 63.38 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 120.988 -1.07 . . . . 71.400000000000006 111.496 175.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -133.37 -20.45 2.1 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 112.876 0.695 . . . . 75.439999999999998 112.876 -171.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' MET . . . . . 0.442 ' O ' HG23 ' A' ' 174' ' ' VAL . 39.5 mmm 74.2 -31.26 0.21 Allowed 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 126.423 1.889 . . . . 52.439999999999998 112.118 173.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -70.59 -48.16 56.58 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 120.188 1.358 . . . . 72.319999999999993 108.322 174.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 59.5 t -65.04 -29.82 48.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 114.825 -1.08 . . . . 60.030000000000001 111.172 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -56.56 -51.56 68.13 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.533 -0.914 . . . . 75.219999999999999 108.533 174.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 170' ' ' MET . 1.8 t -68.45 -34.53 66.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 118.477 0.58 . . . . 73.409999999999997 111.014 -175.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.79 -28.1 68.51 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.103 0.561 . . . . 74.0 112.06 177.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -91.47 -31.16 16.09 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.376 1.07 . . . . 73.140000000000001 111.988 174.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -63.51 -58.63 6.39 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.925 -1.109 . . . . 73.319999999999993 109.778 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -55.55 -27.84 51.31 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.483 1.113 . . . . 64.319999999999993 113.808 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -70.7 -57.76 4.35 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.879 -0.513 . . . . 72.010000000000005 110.373 173.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 t -66.9 -30.12 70.19 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.43 -0.582 . . . . 71.219999999999999 109.43 -169.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 78.1 t -55.74 -56.54 11.84 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 N-CA-C 108.948 -0.76 . . . . 72.040000000000006 108.948 170.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -64.14 -39.23 93.59 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-O 119.015 -0.517 . . . . 51.530000000000001 111.315 -172.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -52.53 -33.0 43.38 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 122.75 0.42 . . . . 62.149999999999999 112.091 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 80.5 mt -81.19 -16.57 52.45 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 120.756 -1.215 . . . . 65.409999999999997 113.065 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 91.6 t -69.44 -20.31 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 120.997 -1.064 . . . . 70.209999999999994 110.288 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -105.96 -21.17 13.21 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.273 -0.892 . . . . 74.319999999999993 109.566 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 35.2 mttt -105.05 74.42 1.11 Allowed 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 125.954 1.702 . . . . 74.129999999999995 109.884 -171.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 33.4 tttt . . . . . 0 N--CA 1.432 -1.372 0 C-N-CA 126.879 2.072 . . . . 33.340000000000003 107.665 176.261 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.468 0.443 0 CA-C-O 119.843 -0.122 . . . . 61.310000000000002 110.678 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 13.3 m-20 -104.82 94.66 5.39 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.661 -1.237 . . . . 63.109999999999999 107.661 -173.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -161.76 23.97 0.12 Allowed 'General case' 0 C--O 1.235 0.293 0 O-C-N 120.977 -1.077 . . . . 72.219999999999999 112.799 169.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -157.23 122.53 4.59 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 104.884 -2.265 . . . . 73.0 104.884 -178.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.633 HG21 HG23 ' A' ' 180' ' ' THR . 12.5 pt -127.14 152.29 34.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 128.303 2.641 . . . . 75.340000000000003 107.203 175.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.2 m -121.3 137.31 54.75 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.081 1.352 . . . . 64.230000000000004 107.399 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -57.59 152.09 15.72 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.267 1.427 . . . . 62.299999999999997 110.224 166.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.48 -31.56 0.84 Allowed Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.415 1.007 . . . . 73.129999999999995 112.693 -171.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -87.33 -71.39 0.56 Allowed 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 106.725 -1.583 . . . . 72.319999999999993 106.725 -164.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -123.67 -14.03 7.36 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.081 1.752 . . . . 72.430000000000007 110.016 -165.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -138.74 168.72 19.19 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.948 -0.47 . . . . 73.219999999999999 110.512 155.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.1 mm -125.79 158.35 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 127.955 2.502 . . . . 74.030000000000001 106.046 172.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.53 172.81 8.04 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.476 1.51 . . . . 64.239999999999995 108.813 178.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.9 mt -124.11 135.1 53.29 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 119.603 1.092 . . . . 72.019999999999996 108.784 162.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -66.33 -38.42 87.63 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 129.377 3.071 . . . . 64.310000000000002 110.343 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.22 64.81 7.5 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 125.483 1.513 . . . . 55.299999999999997 110.362 -177.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -73.15 -9.06 22.98 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 123.335 2.69 . . . . 71.409999999999997 113.626 -175.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.4 tt -141.8 105.41 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 121.171 -0.956 . . . . 74.040000000000006 110.035 -173.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.03 -53.22 0.29 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.149 1.38 . . . . 53.409999999999997 109.914 166.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -160.01 -6.2 0.05 OUTLIER Glycine 0 CA--C 1.526 0.72 0 C-N-CA 123.516 0.579 . . . . 74.129999999999995 114.196 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.6 mp0 -68.17 148.31 98.3 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 126.652 1.981 . . . . 74.349999999999994 109.676 -173.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.99 152.25 81.73 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.309 2.006 . . . . 64.219999999999999 109.042 174.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -78.66 -16.31 57.46 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.52 -0.737 . . . . 71.420000000000002 111.625 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.25 117.67 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.129 -1.434 . . . . 74.209999999999994 107.129 -175.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -165.28 161.28 19.07 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.812 0.845 . . . . 74.030000000000001 110.467 171.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -139.26 147.02 41.14 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.756 1.222 . . . . 64.010000000000005 110.013 174.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -127.22 145.94 50.59 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.397 1.079 . . . . 64.099999999999994 109.788 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -161.16 174.82 13.11 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.167 1.387 . . . . 74.329999999999998 109.314 177.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.3 t -129.79 179.62 5.74 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.998 1.319 . . . . 72.329999999999998 109.22 173.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -94.28 -21.66 18.87 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 128.007 2.523 . . . . 74.420000000000002 111.377 176.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.512 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 49.7 m-85 -104.35 9.72 35.71 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.697 1.599 . . . . 70.540000000000006 114.642 177.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.5 p -88.42 143.24 32.09 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 121.047 1.749 . . . . 74.219999999999999 111.014 175.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -80.44 -43.51 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 120.936 1.091 . . . . 74.510000000000005 112.352 -171.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -53.84 -44.81 70.62 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 118.447 0.567 . . . . 73.140000000000001 109.708 175.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.5 m -52.54 -42.47 64.43 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 125.092 1.357 . . . . 54.340000000000003 111.557 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -61.24 -52.09 66.21 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 110.114 -0.328 . . . . 75.230000000000004 110.114 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -58.22 -45.68 87.25 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.515 -0.92 . . . . 70.109999999999999 108.515 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -67.77 -6.26 20.29 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 116.319 -1.8 . . . . 73.329999999999998 113.691 -177.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -134.44 -1.02 2.88 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 121.901 2.137 . . . . 43.140000000000001 113.219 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -136.14 -12.51 1.9 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.854 1.262 . . . . 72.209999999999994 112.746 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.8 t -126.96 -79.89 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.089 0 N-CA-C 107.052 -1.462 . . . . 61.100000000000001 107.052 -176.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.6 mt -65.63 -24.78 67.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.287 2.235 . . . . 73.299999999999997 111.993 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 44.36 48.13 8.06 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.99 1.716 . . . . 61.399999999999999 111.817 176.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.601 ' O ' HG23 ' A' ' 46' ' ' VAL . 97.7 t -54.44 -49.56 64.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.361 0 C-N-CA 125.01 1.324 . . . . 74.209999999999994 110.184 -174.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.1 t -48.95 -49.95 37.92 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.4 1.48 . . . . 72.439999999999998 110.839 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -73.29 -36.45 66.3 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.654 0.782 . . . . 60.340000000000003 112.078 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -57.87 -49.61 76.11 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.486 0.715 . . . . 71.239999999999995 109.65 172.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 42' ' ' VAL . 2.1 t -59.02 -49.06 84.6 Favored 'Isoleucine or valine' 0 C--N 1.343 0.313 0 CA-C-N 119.024 0.829 . . . . 73.140000000000001 108.874 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.1 ptt180 -61.3 -26.67 67.94 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 121.741 -0.6 . . . . 74.310000000000002 112.443 -169.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -64.28 -15.57 60.45 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.391 0.886 . . . . 71.329999999999998 113.391 174.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -126.51 -6.13 6.41 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.956 1.702 . . . . 72.439999999999998 112.17 -170.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.508 ' HB3' HG21 ' A' ' 54' ' ' THR . 10.5 mt -70.08 144.27 92.5 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-O 118.904 -0.57 . . . . 63.439999999999998 110.988 -169.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.599 ' O ' HG22 ' A' ' 54' ' ' THR . 72.9 Cg_endo -74.88 153.25 42.25 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.043 2.495 . . . . 71.400000000000006 111.295 178.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -79.24 81.59 5.49 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.834 0.826 . . . . 61.340000000000003 109.072 -172.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 166.64 -23.62 0.13 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.11 1.338 . . . . 31.050000000000001 113.891 -177.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 51' ' ' PRO . 1.8 t -48.35 -46.79 37.17 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 118.926 1.363 . . . . 75.120000000000005 113.991 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? 60.01 124.47 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.407 2.283 . . . . 60.219999999999999 111.867 -170.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.6 ttm -75.48 102.06 5.07 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 106.286 -1.746 . . . . 53.43 106.286 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.1 m -129.66 101.39 5.89 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 107.649 -1.241 . . . . 54.5 107.649 -167.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.64 105.63 9.88 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.821 1.248 . . . . 72.099999999999994 108.151 -162.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -94.86 152.69 18.18 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.185 0.517 . . . . 75.219999999999999 109.974 175.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.582 ' NE2' HG23 ' A' ' 72' ' ' THR . 1.6 p-80 -81.62 176.09 9.94 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.513 1.525 . . . . 62.43 108.761 172.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.5 m -145.18 152.09 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 107.659 -1.237 . . . . 73.310000000000002 107.659 158.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.4 ' C ' ' H ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER -101.0 -14.7 17.74 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.23 1.012 . . . . 73.140000000000001 112.755 -172.09 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -57.8 5.66 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 129.144 2.978 . . . . 74.310000000000002 114.719 -177.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.4 ' H ' ' C ' ' A' ' 62' ' ' GLU . 30.5 mt -145.47 110.16 5.08 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 126.763 2.025 . . . . 65.209999999999994 106.963 -164.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.512 ' HA3' ' CD2' ' A' ' 29' ' ' TYR . . . 100.85 154.62 26.98 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 126.692 2.091 . . . . 41.310000000000002 110.75 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.56 -44.4 0.52 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 121.788 1.658 . . . . 65.310000000000002 110.093 173.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.1 mt -83.26 24.28 0.82 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.782 0.833 . . . . 74.109999999999999 111.151 174.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -50.78 -46.46 48.26 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.427 1.013 . . . . 62.25 111.191 176.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -58.75 -47.74 83.59 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.923 0.889 . . . . 64.319999999999993 111.689 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.68 -44.12 97.08 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.696 1.598 . . . . 44.32 108.509 -174.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.6 mt -61.86 -44.45 96.8 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.464 1.106 . . . . 73.010000000000005 111.019 174.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.582 HG23 ' NE2' ' A' ' 60' ' ' HIS . 82.6 m -58.14 -48.89 78.86 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.71 1.604 . . . . 72.319999999999993 110.937 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -62.59 -42.86 99.82 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 120.906 -1.121 . . . . 74.349999999999994 109.877 175.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.83 -35.74 75.36 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 120.663 -1.273 . . . . 72.049999999999997 112.569 178.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 52.9 t-105 -55.09 -34.62 63.8 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.228 1.011 . . . . 71.409999999999997 111.08 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.12 -36.73 83.93 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 118.382 -0.818 . . . . 62.039999999999999 111.481 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.7 t -56.92 -47.31 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 119.445 1.02 . . . . 75.439999999999998 109.309 172.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.51 -26.75 61.02 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 117.238 -1.363 . . . . 55.149999999999999 112.748 -175.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.12 -42.46 79.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 120.952 1.706 . . . . 75.430000000000007 108.937 167.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.04 -40.26 84.52 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.423 1.01 . . . . 75.420000000000002 110.771 -176.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.2 mt -87.56 -14.59 39.79 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.127 0.417 . . . . 73.230000000000004 112.127 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.98 67.03 2.25 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 126.563 2.03 . . . . 75.209999999999994 111.089 -176.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.5 m -136.86 17.07 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.628 1.171 . . . . 72.109999999999999 112.51 -176.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -49.29 -50.46 39.12 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.026 1.73 . . . . 73.420000000000002 111.772 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -80.09 5.77 13.36 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.677 1.591 . . . . 64.099999999999994 111.037 -176.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.8 mtpp -104.5 -20.29 13.74 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.604 1.562 . . . . 74.430000000000007 110.527 170.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.1 pp -119.25 13.08 6.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 C-N-CA 124.245 1.018 . . . . 74.450000000000003 111.487 -170.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.2 m -86.97 -42.22 13.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 119.542 1.065 . . . . 74.439999999999998 111.087 175.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.496 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -55.14 -64.25 2.26 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 118.906 0.776 . . . . 42.530000000000001 111.581 -177.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.496 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 90.6 Cg_endo -69.61 -27.75 26.81 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.428 1.419 . . . . 71.109999999999999 111.467 -171.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 23.0 tpp -56.16 -49.26 74.48 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.169 0.988 . . . . 71.299999999999997 109.038 175.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -73.7 -31.7 63.55 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 118.43 -0.795 . . . . 75.319999999999993 110.008 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -60.15 -33.73 72.57 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 119.143 0.883 . . . . 62.219999999999999 110.977 170.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -99.45 -12.4 20.25 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.871 1.214 . . . . 62.100000000000001 113.438 -174.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.7 t -97.52 -45.52 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.308 1.043 . . . . 72.230000000000004 109.216 177.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -98.07 -63.78 1.1 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.886 0.875 . . . . 70.340000000000003 109.576 -176.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -63.62 -59.18 4.94 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 119.188 0.904 . . . . 74.099999999999994 111.116 -166.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.5 p -95.6 -16.43 22.1 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.884 0.698 . . . . 73.140000000000001 112.884 -176.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 55.31 22.57 4.93 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.151 1.381 . . . . 72.400000000000006 113.806 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.1 t -68.39 -14.54 63.07 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.4 1.48 . . . . 52.210000000000001 112.143 -178.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 38.6 t -66.79 110.84 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 O-C-N 120.52 -1.362 . . . . 64.25 109.094 171.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -139.28 -23.21 0.9 Allowed 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.914 1.686 . . . . 71.420000000000002 111.616 -172.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 t -151.44 179.95 7.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.007 -1.058 . . . . 63.509999999999998 109.394 159.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.3 t -54.58 -34.34 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 124.664 1.185 . . . . 72.219999999999999 110.064 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.38 -23.86 17.31 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.867 1.667 . . . . 51.229999999999997 113.04 176.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -94.08 -37.66 11.51 Favored 'General case' 0 CA--C 1.518 -0.266 0 O-C-N 121.33 -0.856 . . . . 75.049999999999997 108.998 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.8 mt -65.4 -47.23 87.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 125.152 1.381 . . . . 71.019999999999996 108.096 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -62.51 -26.16 68.4 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.019 0.748 . . . . 74.239999999999995 113.019 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -65.08 -51.81 59.27 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 109.577 -0.527 . . . . 71.450000000000003 109.577 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.2 t -55.83 -41.7 67.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 123.549 0.53 . . . . 71.25 111.062 -176.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -54.11 -54.4 40.03 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.496 -0.557 . . . . 61.149999999999999 109.496 175.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 54.4 t -58.67 -47.34 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 C-N-CA 123.036 0.534 . . . . 63.25 110.436 -177.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -70.25 -37.91 75.02 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.437 -0.949 . . . . 74.319999999999993 108.437 -166.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.89 -9.9 59.21 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.607 1.163 . . . . 73.019999999999996 112.354 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 118.4 36.37 0.93 Allowed Glycine 0 C--N 1.336 0.577 0 CA-C-O 117.793 -1.56 . . . . 74.239999999999995 115.08 168.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 99.5 t -102.61 144.81 13.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 119.648 1.724 . . . . 44.109999999999999 109.204 172.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.555 ' HG3' ' H ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -67.53 133.14 48.92 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.53 -0.759 . . . . 74.040000000000006 110.23 171.964 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.42 -21.91 69.01 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-O 118.903 -0.943 . . . . 71.25 111.736 172.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -73.22 -49.8 25.93 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 118.147 -0.93 . . . . 73.019999999999996 111.917 175.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.555 ' H ' ' HG3' ' A' ' 117' ' ' LYS . 33.3 t70 -66.07 -40.67 91.05 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.181 -1.414 . . . . 64.430000000000007 107.181 -178.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -59.29 -51.38 70.19 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 123.907 0.754 . . . . 72.25 110.105 -174.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -77.88 -12.83 60.02 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 113.002 0.741 . . . . 64.239999999999995 113.002 -175.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.43 -61.7 1.46 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.979 1.312 . . . . 73.349999999999994 110.387 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.79 -34.22 58.41 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.57 1.548 . . . . 64.409999999999997 110.934 -177.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 61.7 t-105 -45.54 -37.02 5.0 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.017 1.727 . . . . 73.010000000000005 112.934 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -113.21 2.54 15.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.935 1.294 . . . . 63.439999999999998 113.162 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 10.0 t -77.34 156.0 31.58 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.441 1.097 . . . . 73.109999999999999 109.887 173.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -58.88 -30.86 68.07 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.448 1.499 . . . . 74.319999999999993 111.941 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 84.9 t -54.33 -48.54 67.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 O-C-N 121.606 -0.683 . . . . 64.049999999999997 109.391 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.4 t -65.32 -43.47 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-O 119.08 -0.486 . . . . 74.409999999999997 110.504 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -53.4 -51.55 62.19 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.68 0.673 . . . . 74.349999999999994 111.51 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.0 t -69.63 -38.15 77.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 117.863 -1.065 . . . . 60.039999999999999 110.285 -177.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.1 mt -58.92 -56.4 22.78 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 117.453 -1.26 . . . . 75.420000000000002 110.429 176.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 37.6 t -45.41 -46.72 4.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.245 0 C-N-CA 124.533 1.133 . . . . 63.009999999999998 109.98 174.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.02 -35.13 70.83 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 113.038 0.755 . . . . 51.350000000000001 113.038 -176.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -61.53 -38.37 87.16 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.048 0.539 . . . . 75.340000000000003 110.755 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 10.0 mp0 -85.9 -50.28 7.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.254 1.022 . . . . 72.349999999999994 110.746 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -52.72 -44.94 66.71 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.057 0.844 . . . . 75.040000000000006 109.69 -176.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -60.89 -61.89 2.26 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.092 0.472 . . . . 72.329999999999998 109.878 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.55 1.55 3.04 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.792 1.405 . . . . 71.010000000000005 114.792 -173.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -129.88 6.12 5.05 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.282 1.433 . . . . 74.230000000000004 112.279 174.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -120.81 -6.25 9.62 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 124.714 1.206 . . . . 70.150000000000006 113.085 168.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.97 5.06 0.25 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.317 2.247 . . . . 70.430000000000007 112.781 175.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 73.25 -5.68 1.9 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 131.682 3.993 . . . . 63.119999999999997 114.126 -178.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.415 ' HG3' ' H ' ' A' ' 145' ' ' GLN . 0.0 OUTLIER -71.76 -15.92 62.19 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 127.964 2.505 . . . . 73.010000000000005 113.468 -164.43 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.4 tp -164.17 125.01 2.17 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 128.16 2.584 . . . . 74.400000000000006 105.545 -176.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -142.13 21.95 2.08 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.475 0.655 . . . . 72.439999999999998 111.265 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -136.43 158.97 24.28 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 107.498 -2.241 . . . . 73.319999999999993 107.498 164.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.486 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 3.7 m -140.46 171.67 7.39 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 107.993 -1.114 . . . . 53.32 107.993 174.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.486 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 68.0 Cg_endo -63.21 156.16 69.21 Favored 'Cis proline' 0 N--CA 1.457 -0.639 0 CA-C-N 120.453 1.197 . . . . 45.299999999999997 111.27 -8.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -141.22 144.73 34.9 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.107 0.963 . . . . 71.340000000000003 108.766 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 29.2 ttm -151.08 109.94 3.87 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.001 -1.481 . . . . 75.400000000000006 107.001 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -93.15 156.23 16.98 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.595 -0.73 . . . . 74.120000000000005 109.31 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.6 t -139.48 140.0 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.614 -0.884 . . . . 74.209999999999994 108.614 175.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 45.78 28.84 0.61 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.967 2.507 . . . . 74.409999999999997 114.562 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 63.53 7.39 20.13 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.88 1.705 . . . . 74.409999999999997 113.488 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -141.5 -5.39 1.07 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 119.044 1.422 . . . . 75.299999999999997 113.648 -165.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -129.45 150.13 50.93 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.38 -0.97 . . . . 74.019999999999996 108.38 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.31 123.99 37.65 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 128.401 2.68 . . . . 75.209999999999994 107.998 177.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.5 139.73 57.61 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.513 -1.662 . . . . 73.299999999999997 106.513 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -114.66 86.09 12.3 Favored Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 123.256 0.622 . . . . 65.239999999999995 110.969 174.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.78 -17.9 47.39 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 120.706 0.937 . . . . 72.109999999999999 111.705 177.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -78.66 -6.02 54.6 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.09 1.756 . . . . 74.299999999999997 112.773 -172.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -130.35 13.46 5.68 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.573 1.082 . . . . 72.439999999999998 111.366 177.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 45.3 mtt -85.5 163.19 18.57 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.33 1.065 . . . . 61.420000000000002 109.192 170.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.57 108.73 6.59 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.705 -1.591 . . . . 71.420000000000002 106.705 170.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 31.9 p -102.1 -6.74 22.95 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 127.016 2.127 . . . . 73.200000000000003 110.94 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 46.5 m -61.74 -17.9 57.64 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 125.683 1.593 . . . . 64.299999999999997 114.491 -170.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -128.78 -6.3 5.09 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 117.76 -1.114 . . . . 75.329999999999998 111.197 -164.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 65.92 -63.73 0.22 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.348 1.859 . . . . 74.209999999999994 111.865 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.55 -44.49 94.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 119.114 0.87 . . . . 74.329999999999998 108.954 -171.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 91.9 t -62.12 -30.0 47.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 125.084 1.354 . . . . 71.109999999999999 111.587 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -66.78 -60.11 2.97 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 107.624 -1.25 . . . . 75.439999999999998 107.624 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.2 t -68.04 -35.4 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 O-C-N 123.72 0.637 . . . . 61.310000000000002 110.664 -174.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.02 -52.18 63.95 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.491 0.716 . . . . 34.439999999999998 109.799 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -72.64 -38.32 67.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.245 -0.883 . . . . 71.239999999999995 111.598 177.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -55.46 -58.41 7.88 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.745 1.157 . . . . 71.230000000000004 109.714 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.58 -42.07 61.62 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 125.989 1.716 . . . . 71.329999999999998 111.514 -176.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -71.44 -51.0 26.29 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.955 0.902 . . . . 63.210000000000001 108.935 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.633 HG23 HG21 ' A' ' 3' ' ' ILE . 31.1 m -59.81 -26.45 65.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.461 1.105 . . . . 64.099999999999994 112.229 -177.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 97.2 t -60.05 -51.43 73.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 108.912 -0.773 . . . . 75.019999999999996 108.912 169.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 31.1 tttm -61.35 -44.29 97.42 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 118.008 -0.996 . . . . 75.310000000000002 110.986 174.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -57.15 -28.98 63.23 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 119.599 1.091 . . . . 60.219999999999999 111.426 -169.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 58.5 mt -81.12 -24.61 37.56 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.874 0.694 . . . . 75.030000000000001 112.874 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.47 -28.22 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 O-C-N 121.027 -1.045 . . . . 75.230000000000004 110.508 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -89.28 -29.61 19.07 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 122.048 0.928 . . . . 73.040000000000006 109.45 178.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 45.6 mttp -95.64 66.42 2.73 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 125.094 1.358 . . . . 72.439999999999998 109.051 -176.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.507 ' H ' ' HD3' ' A' ' 188' ' ' LYS . 1.2 mppt? . . . . . 0 C--O 1.247 0.968 0 N-CA-C 107.427 -1.323 . . . . 62.399999999999999 107.427 154.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 31.4 m . . . . . 0 CA--C 1.514 -0.404 0 N-CA-C 108.931 -0.766 . . . . 74.329999999999998 108.931 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -140.51 -25.11 0.77 Allowed 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 114.821 1.415 . . . . 74.340000000000003 114.821 -174.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -76.32 28.71 0.12 Allowed 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 125.865 1.666 . . . . 71.319999999999993 114.023 -164.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -157.58 122.98 4.55 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 129.153 2.981 . . . . 71.299999999999997 103.533 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.711 HG21 HG23 ' A' ' 180' ' ' THR . 9.3 pt -127.85 149.59 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 126.735 2.014 . . . . 64.230000000000004 108.152 175.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.0 m -132.03 143.33 49.98 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.054 -1.091 . . . . 60.200000000000003 108.054 174.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -59.11 151.91 21.45 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.919 1.287 . . . . 64.129999999999995 110.151 170.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.86 -25.82 0.78 Allowed Glycine 0 CA--C 1.532 1.125 0 CA-C-O 118.873 -0.96 . . . . 60.329999999999998 112.783 -169.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -98.04 -85.61 0.37 Allowed 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 119.246 1.523 . . . . 75.319999999999993 107.565 -170.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -90.05 -17.92 26.89 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.505 0.722 . . . . 71.430000000000007 111.751 -176.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -140.76 164.91 28.95 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 118.208 0.458 . . . . 74.219999999999999 110.245 173.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.2 mm -127.87 163.12 32.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 105.761 -1.941 . . . . 71.140000000000001 105.761 173.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.21 164.26 11.74 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 124.998 1.319 . . . . 71.230000000000004 110.058 171.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 27.2 mt -79.67 154.53 28.57 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.929 -1.137 . . . . 74.239999999999995 107.929 161.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.62 -27.12 51.06 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.809 -0.812 . . . . 73.400000000000006 108.809 171.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -121.81 71.34 29.6 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.774 1.629 . . . . 74.239999999999995 108.987 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -84.19 63.56 6.89 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 124.079 3.186 . . . . 74.209999999999994 111.579 -177.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.5 mp -123.29 152.93 28.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 O-C-N 120.054 -1.654 . . . . 54.530000000000001 109.046 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.54 110.03 0.46 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.428 1.891 . . . . 71.030000000000001 109.111 175.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.65 -37.59 0.05 OUTLIER Glycine 0 CA--C 1.521 0.454 0 N-CA-C 111.02 -0.832 . . . . 75.439999999999998 111.02 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.76 165.85 39.35 Favored Pre-proline 0 C--O 1.242 0.674 0 C-N-CA 124.698 1.199 . . . . 71.329999999999998 110.332 166.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -58.72 172.37 1.58 Allowed 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.579 2.186 . . . . 73.329999999999998 110.671 161.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -120.17 119.15 32.43 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.661 -1.237 . . . . 74.120000000000005 107.661 -174.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t 69.19 113.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 127.936 2.494 . . . . 63.310000000000002 109.655 -170.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 tp -150.64 161.83 41.84 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.374 -0.973 . . . . 74.0 108.374 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -146.15 136.58 23.95 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.496 -1.298 . . . . 75.109999999999999 107.496 -169.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -137.22 136.27 37.99 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 123.889 0.876 . . . . 73.109999999999999 110.505 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.03 171.64 18.75 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.606 1.962 . . . . 60.200000000000003 108.177 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.02 153.78 50.56 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 119.031 -0.509 . . . . 73.019999999999996 109.898 169.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.795 ' CD1' HD11 ' A' ' 71' ' ' LEU 0.296 0.0 OUTLIER -67.19 -15.61 63.8 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 113.306 0.854 . . . . 73.329999999999998 113.306 177.911 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.466 ' CE2' ' HA3' ' A' ' 65' ' ' GLY . 41.6 m-85 -93.45 -0.52 56.4 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.277 0.944 . . . . 60.240000000000002 112.248 176.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.9 t -82.05 141.04 46.52 Favored Pre-proline 0 CA--C 1.534 0.36 0 O-C-N 120.592 -1.317 . . . . 63.340000000000003 110.446 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -88.78 -37.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 121.769 1.646 . . . . 74.040000000000006 112.542 -175.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -62.95 -48.09 80.4 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 124.702 1.201 . . . . 75.129999999999995 108.778 176.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 21.0 m -57.44 -30.54 65.09 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.204 -0.907 . . . . 74.030000000000001 111.089 -178.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -59.81 -56.94 15.54 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 119.612 1.096 . . . . 63.420000000000002 110.109 173.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -53.93 -42.14 68.49 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.065 -0.717 . . . . 64.099999999999994 109.065 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -69.49 -16.18 63.41 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 116.641 -1.647 . . . . 71.239999999999995 112.67 -176.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -124.17 -10.44 7.57 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 121.245 1.839 . . . . 74.310000000000002 111.9 -172.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -136.97 -11.8 1.72 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.986 1.715 . . . . 74.129999999999995 112.972 -170.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.6 t -127.24 -81.76 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 O-C-N 120.315 -1.49 . . . . 75.340000000000003 107.718 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.2 mt -56.9 -28.18 61.59 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.498 1.919 . . . . 74.209999999999994 111.67 175.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 67.9 m80 44.57 46.51 8.26 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.942 1.697 . . . . 63.329999999999998 110.918 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 46' ' ' VAL . 98.7 t -51.0 -53.78 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 C-N-CA 126.614 1.966 . . . . 61.409999999999997 108.631 -175.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.5 t -45.44 -47.95 13.78 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.644 1.978 . . . . 72.040000000000006 111.587 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.64 -18.45 27.94 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.011 -1.055 . . . . 74.420000000000002 111.835 -176.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.5 -40.94 93.64 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.208 -0.932 . . . . 54.520000000000003 109.582 167.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 42' ' ' VAL . 1.9 t -59.61 -46.39 93.23 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 N-CA-C 109.437 -0.579 . . . . 62.299999999999997 109.437 178.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -47.93 -44.48 30.07 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.229 1.012 . . . . 71.019999999999996 112.033 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -62.57 -10.62 12.71 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.001 1.482 . . . . 72.209999999999994 115.001 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -125.44 -9.03 6.9 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 126.925 2.09 . . . . 73.340000000000003 113.199 -174.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.597 HD13 HG21 ' A' ' 54' ' ' THR . 14.5 mt -72.33 150.43 91.83 Favored Pre-proline 0 C--O 1.234 0.269 0 CA-C-N 119.328 0.967 . . . . 63.009999999999998 111.246 -167.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -71.82 156.63 56.59 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.146 1.898 . . . . 72.329999999999998 109.402 169.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.28 28.57 0.06 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 126.007 1.723 . . . . 73.200000000000003 114.974 -174.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -154.19 21.08 0.66 Allowed Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 124.708 1.147 . . . . 21.050000000000001 112.979 -168.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.597 HG21 HD13 ' A' ' 50' ' ' LEU . 2.9 t -89.72 -45.3 9.41 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 117.887 0.843 . . . . 51.420000000000002 110.908 -177.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? 55.52 95.55 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 124.155 1.931 . . . . 74.140000000000001 110.704 -162.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.8 mtm -62.29 122.84 16.65 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 113.84 -1.527 . . . . 44.329999999999998 108.765 169.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 58' ' ' LYS . 1.3 m -123.24 179.87 4.55 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.317 -0.994 . . . . 74.019999999999996 108.317 174.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.461 ' H ' HG22 ' A' ' 57' ' ' THR . 9.8 mtpt -172.35 88.1 0.09 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 106.78 -1.563 . . . . 72.409999999999997 106.78 -171.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.516 ' CD2' ' HG3' ' A' ' 137' ' ' GLN . 4.1 m-30 -89.02 176.02 7.17 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.992 1.317 . . . . 74.120000000000005 109.299 175.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.608 ' HD1' ' HB3' ' A' ' 75' ' ' TRP . 2.1 p-80 -117.04 175.42 5.6 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.154 1.381 . . . . 75.120000000000005 110.081 174.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.8 m -131.24 175.97 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.255 1.422 . . . . 74.230000000000004 109.036 169.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.71 59.74 1.72 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.693 2.397 . . . . 72.140000000000001 111.134 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -148.33 -163.71 1.84 Allowed 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.237 1.415 . . . . 75.129999999999995 109.82 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.8 mt 75.54 -85.03 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 128.616 2.767 . . . . 61.329999999999998 109.175 -176.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.466 ' HA3' ' CE2' ' A' ' 29' ' ' TYR . . . -95.32 174.46 32.36 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 125.43 1.491 . . . . 74.049999999999997 111.452 -178.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.88 -36.63 30.39 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 124.945 3.763 . . . . 63.329999999999998 113.124 -169.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.2 mt -83.68 24.82 0.83 Allowed 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 124.332 1.053 . . . . 72.129999999999995 112.721 -174.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -46.28 -51.6 11.53 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-N 118.72 0.691 . . . . 33.340000000000003 111.81 179.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -70.76 -6.38 37.13 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.49 1.116 . . . . 64.109999999999999 113.596 -177.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -111.44 -24.57 10.09 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.257 1.423 . . . . 61.310000000000002 109.389 -177.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.795 HD11 ' CD1' ' A' ' 28' ' ' PHE . 9.5 mt -63.67 -46.97 83.12 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.912 0.885 . . . . 72.430000000000007 109.368 165.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.531 HG22 ' CD2' ' A' ' 60' ' ' HIS . 0.5 OUTLIER -50.86 -52.11 44.82 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.414 1.486 . . . . 71.150000000000006 108.75 171.879 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -62.03 -54.47 41.03 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.551 -0.718 . . . . 72.239999999999995 110.5 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.24 -33.38 73.18 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.631 1.105 . . . . 74.450000000000003 113.435 -167.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.608 ' HB3' ' HD1' ' A' ' 60' ' ' HIS . 40.5 t-105 -56.73 -38.13 71.95 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 123.1 0.56 . . . . 75.140000000000001 110.367 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.27 84.7 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 117.505 -1.236 . . . . 73.450000000000003 112.055 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.453 HG22 ' HB3' ' A' ' 124' ' ' ALA . 93.9 t -56.35 -45.22 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 121.072 1.76 . . . . 64.349999999999994 110.986 167.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.37 -45.55 90.65 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 118.094 -0.955 . . . . 74.25 111.073 -177.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 60.2 mt -62.54 -40.44 88.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 124.263 1.025 . . . . 72.310000000000002 110.207 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.85 -42.17 83.9 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.758 0.708 . . . . 71.349999999999994 110.362 -175.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.5 mt -85.18 -29.92 24.34 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 111.732 0.271 . . . . 54.439999999999998 111.732 174.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.74 52.08 3.43 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 126.183 1.849 . . . . 74.239999999999995 111.853 -175.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -127.25 21.16 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.761 1.224 . . . . 64.319999999999993 111.403 -173.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -53.05 -53.2 53.74 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 123.757 0.823 . . . . 72.019999999999996 111.074 -175.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.18 -42.7 77.54 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.224 1.409 . . . . 74.150000000000006 109.687 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.7 mtpm? -72.64 -5.23 35.95 Favored 'General case' 0 N--CA 1.46 0.066 0 C-N-CA 125.012 1.325 . . . . 60.409999999999997 112.171 -176.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.6 pp -134.1 23.3 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 C-N-CA 125.669 1.587 . . . . 74.310000000000002 109.386 173.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 99.5 m -87.53 -57.56 2.9 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.222 -1.399 . . . . 71.409999999999997 107.222 168.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.477 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -58.89 -60.15 11.44 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 112.88 0.696 . . . . 53.439999999999998 112.88 -164.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 37.5 Cg_endo -66.92 -26.61 43.94 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.288 1.325 . . . . 75.310000000000002 111.579 -177.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 5.0 ttm -64.92 -43.5 92.59 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.56 0.744 . . . . 55.549999999999997 109.258 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -69.69 -40.19 76.5 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.496 1.118 . . . . 72.109999999999999 109.473 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.12 -27.25 66.88 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.223 0.465 . . . . 61.240000000000002 111.196 172.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -97.59 3.98 50.35 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 120.361 -1.462 . . . . 71.219999999999999 113.304 -177.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.69 HG21 ' CD2' ' A' ' 28' ' ' PHE . 65.6 t -119.73 -41.23 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 124.073 0.949 . . . . 73.150000000000006 110.067 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -101.4 -51.66 3.43 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 109.404 -0.591 . . . . 41.350000000000001 109.404 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -75.35 -60.02 2.49 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.88 -0.6 . . . . 71.349999999999994 109.432 -168.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.3 p -98.1 -19.13 18.13 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.775 0.83 . . . . 62.240000000000002 112.491 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 64.95 18.51 11.53 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.869 1.668 . . . . 51.420000000000002 114.163 166.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.1 t -74.78 -17.39 60.63 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.991 1.317 . . . . 74.150000000000006 113.486 -172.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.6 t -66.84 126.58 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.555 -0.716 . . . . 64.450000000000003 109.13 167.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -146.1 -25.71 0.44 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.239 1.415 . . . . 75.049999999999997 111.075 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.1 t -143.38 175.81 9.63 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.899 0.772 . . . . 75.049999999999997 110.25 171.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.4 t -52.39 -44.82 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.932 1.693 . . . . 72.319999999999993 110.028 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -52.77 -23.72 7.39 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.712 1.605 . . . . 75.030000000000001 112.862 177.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -94.38 -24.72 17.25 Favored 'General case' 0 CA--C 1.523 -0.078 0 CA-C-N 118.972 0.806 . . . . 73.040000000000006 111.123 -178.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.4 mt -82.45 -43.28 19.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.594 -0.891 . . . . 75.349999999999994 108.594 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -55.15 -31.79 61.59 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 118.534 -0.746 . . . . 44.420000000000002 111.479 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -57.51 -61.76 2.26 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.287 1.435 . . . . 73.219999999999999 109.85 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.7 t -55.33 -40.07 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 122.767 0.427 . . . . 64.019999999999996 110.756 -175.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -53.79 -53.48 51.8 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.472 0.578 . . . . 73.239999999999995 110.65 173.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.24 -41.36 91.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 123.876 0.87 . . . . 63.130000000000003 109.99 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -67.27 -37.71 83.9 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.678 -0.86 . . . . 73.439999999999998 108.678 -170.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.3 -24.71 61.36 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.443 1.097 . . . . 62.420000000000002 112.428 175.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.57 56.47 0.35 Allowed Glycine 0 C--N 1.332 0.315 0 N-CA-C 111.242 -0.743 . . . . 64.420000000000002 111.242 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.3 t -118.98 126.36 75.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 109.087 -0.708 . . . . 72.409999999999997 109.087 166.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -54.13 128.03 29.19 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.212 -0.662 . . . . 74.450000000000003 109.212 176.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.41 -21.19 66.34 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-O 117.6 -1.667 . . . . 60.229999999999997 110.434 170.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -68.83 -37.57 79.25 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 119.875 1.838 . . . . 75.409999999999997 108.826 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.74 -45.51 28.95 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 126.08 1.752 . . . . 72.120000000000005 107.164 -171.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -55.93 -57.4 12.27 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 109.501 -0.555 . . . . 72.439999999999998 109.501 174.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -66.23 -28.8 69.01 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 119.314 -0.374 . . . . 72.040000000000006 111.145 -172.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.27 -64.05 1.1 Allowed 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.859 0.864 . . . . 71.129999999999995 110.587 174.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.453 ' HB3' HG22 ' A' ' 77' ' ' VAL . . . -54.99 -36.37 65.33 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.585 1.154 . . . . 64.150000000000006 110.572 -171.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 59.9 t-105 -45.62 -42.83 11.78 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.744 1.218 . . . . 75.120000000000005 112.57 177.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -105.71 1.25 26.98 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.639 1.176 . . . . 64.049999999999997 112.872 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.2 t -77.97 150.24 33.99 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.51 1.524 . . . . 62.25 109.805 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -56.45 -35.27 67.7 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 124.429 1.092 . . . . 63.439999999999998 111.0 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.9 t -51.53 -52.51 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 CA-C-N 118.847 0.749 . . . . 51.350000000000001 109.581 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.13 -45.61 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-N 115.942 -0.572 . . . . 72.230000000000004 110.269 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -46.22 81.98 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.342 0.657 . . . . 73.349999999999994 111.109 -176.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.4 t -67.07 -48.39 68.39 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.638 1.175 . . . . 62.210000000000001 110.371 175.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.7 mt -53.8 -50.38 66.24 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-O 117.321 -1.324 . . . . 64.019999999999996 110.029 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.8 t -48.27 -51.74 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 120.573 1.533 . . . . 62.350000000000001 109.986 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.57 -27.45 64.62 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.514 0.931 . . . . 71.319999999999993 113.514 -177.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -63.99 -32.95 74.67 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 113.774 1.027 . . . . 74.129999999999995 113.774 172.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.516 ' HG3' ' CD2' ' A' ' 59' ' ' TYR . 11.3 mp0 -89.72 -35.94 15.48 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 117.652 -1.166 . . . . 75.140000000000001 111.85 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -56.64 -51.6 68.07 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 108.041 -1.096 . . . . 63.119999999999997 108.041 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 23.9 ttpt -59.66 -16.43 26.4 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 113.765 1.024 . . . . 43.210000000000001 113.765 174.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -117.26 -1.86 11.73 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 120.486 1.494 . . . . 54.420000000000002 114.828 -174.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.07 -29.86 4.16 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 119.145 0.884 . . . . 73.209999999999994 111.038 172.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -107.67 2.04 23.56 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.789 0.836 . . . . 63.43 112.034 -170.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -63.62 -85.82 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.504 1.121 . . . . 74.299999999999997 111.255 176.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -175.56 50.0 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.032 1.733 . . . . 74.019999999999996 109.216 177.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.276 0.6 OUTLIER -143.7 -50.0 0.31 Allowed 'General case' 0 C--N 1.344 0.332 0 N-CA-C 114.071 1.138 . . . . 71.109999999999999 114.071 -178.262 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 40.5 tp -70.07 -83.1 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 119.572 1.078 . . . . 72.140000000000001 110.071 -176.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 55.15 33.52 20.67 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.618 0.767 . . . . 64.420000000000002 112.477 173.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 176.35 159.44 21.93 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.681 1.61 . . . . 74.030000000000001 109.587 170.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.407 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 9.9 m -141.69 159.03 61.49 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 119.61 1.705 . . . . 71.030000000000001 110.582 173.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.407 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 73.7 Cg_endo -74.29 161.57 94.22 Favored 'Cis proline' 0 C--N 1.349 0.572 0 CA-C-N 118.987 0.674 . . . . 63.009999999999998 112.897 -4.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -144.36 146.07 32.33 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.858 -1.065 . . . . 64.129999999999995 110.055 175.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 38.8 tpp -135.96 105.43 6.07 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 105.006 -2.22 . . . . 74.239999999999995 105.006 175.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -82.81 149.51 27.14 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.084 0.953 . . . . 75.129999999999995 109.444 175.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.8 t -140.08 145.93 25.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 108.195 -1.039 . . . . 73.340000000000003 108.195 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 50.67 24.16 1.59 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.992 2.117 . . . . 60.43 113.765 173.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 68.36 4.29 36.58 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 120.336 -1.478 . . . . 54.32 113.612 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.436 ' HE2' ' CE2' ' A' ' 158' ' ' TYR . 11.1 pttt -147.26 -6.48 0.48 Allowed 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.442 1.621 . . . . 71.209999999999994 115.183 -166.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.436 ' CE2' ' HE2' ' A' ' 157' ' ' LYS . 63.0 m-85 -124.04 162.38 23.59 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.332 0.969 . . . . 72.019999999999996 110.288 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -129.63 139.94 51.29 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.815 1.646 . . . . 64.219999999999999 106.895 165.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.89 142.34 57.94 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 107.946 -1.131 . . . . 72.299999999999997 107.946 167.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -118.67 85.52 27.41 Favored Pre-proline 0 C--O 1.235 0.333 0 C-N-CA 123.603 0.761 . . . . 74.409999999999997 111.651 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.01 -24.87 52.23 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 CA-C-N 119.544 0.873 . . . . 75.030000000000001 111.493 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.99 -8.65 39.13 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.876 1.27 . . . . 75.239999999999995 112.642 -178.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -112.9 7.9 25.57 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-O 118.519 -1.156 . . . . 75.030000000000001 112.202 176.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 59.1 mtt -98.13 158.91 15.27 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 119.351 1.576 . . . . 54.119999999999997 110.528 -176.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -66.94 109.37 2.93 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 106.524 -1.658 . . . . 60.140000000000001 106.524 170.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.16 11.91 15.34 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 128.156 2.582 . . . . 75.400000000000006 108.632 -171.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.67 -4.33 56.84 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 125.693 1.597 . . . . 54.520000000000003 113.189 -169.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.06 -7.28 1.38 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.783 0.833 . . . . 75.099999999999994 111.491 -168.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 8.1 mmt 65.94 -62.78 0.24 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 127.142 2.177 . . . . 75.209999999999994 112.23 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.44 -36.65 74.09 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 120.371 1.441 . . . . 61.210000000000001 109.803 -171.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 79.9 t -58.68 -37.32 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.687 1.195 . . . . 73.030000000000001 110.162 172.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -60.16 -56.52 20.56 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.674 -0.861 . . . . 75.319999999999993 108.674 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.2 t -64.93 -37.82 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 123.314 0.384 . . . . 71.030000000000001 110.536 -178.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.42 -47.67 69.39 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.542 1.137 . . . . 63.210000000000001 110.657 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -80.75 -40.25 25.54 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 118.504 -0.76 . . . . 73.409999999999997 111.882 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -50.38 -59.69 3.74 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.486 1.039 . . . . 75.030000000000001 110.2 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.27 -37.48 75.07 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.229 1.012 . . . . 75.230000000000004 111.74 -172.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -67.39 -50.4 59.78 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.912 0.885 . . . . 74.530000000000001 109.994 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.711 HG23 HG21 ' A' ' 3' ' ' ILE . 22.0 m -57.03 -29.73 63.62 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.647 1.179 . . . . 74.420000000000002 111.964 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 3.7 t -60.38 -52.79 57.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 119.396 0.998 . . . . 73.230000000000004 109.354 172.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -62.55 -27.88 69.47 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 121.499 -0.751 . . . . 71.230000000000004 112.089 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -68.92 -33.62 74.04 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 119.214 0.915 . . . . 74.409999999999997 112.528 176.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 66.1 mt -71.21 -32.86 69.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 120.159 1.345 . . . . 71.430000000000007 110.98 -177.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 99.3 t -62.36 -23.68 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.163 0.985 . . . . 60.130000000000003 112.144 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -99.0 -19.42 17.28 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.453 -0.78 . . . . 74.299999999999997 110.203 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -98.89 77.54 2.22 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 125.197 1.399 . . . . 73.530000000000001 107.398 -168.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.967 0 C-N-CA 126.923 2.089 . . . . 63.219999999999999 111.563 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.612 0 N-CA-C 112.758 0.651 . . . . 74.33 112.758 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.2 116.77 0.99 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 127.004 2.121 . . . . 74.02 105.799 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.8 pt -130.72 168.66 23.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 126.51 1.924 . . . . 73.11 108.514 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.9 m -139.58 135.15 33.08 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.549 1.139 . . . . 73.05 108.954 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -60.25 111.54 1.58 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.542 2.337 . . . . 54.44 108.263 169.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 107.69 -16.1 37.34 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 126.12 1.819 . . . . 72.21 112.921 -173.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -100.63 -86.48 0.4 Allowed 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 119.411 1.606 . . . . 71.43 108.056 -174.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -87.89 -18.01 30.14 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.435 1.094 . . . . 71.14 111.303 -176.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -138.83 161.13 38.01 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.144 0.978 . . . . 72.14 109.024 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mm -127.85 160.42 37.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 105.874 -1.898 . . . . 53.42 105.874 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.6 m -81.29 152.08 27.76 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.637 -1.246 . . . . 71.22 107.637 167.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 32.8 mt -62.01 163.83 7.39 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.751 -0.463 . . . . 62.24 109.751 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -71.64 -37.4 70.85 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.648 0.779 . . . . 71.04 109.313 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.4 mmtp -140.83 78.72 19.83 Favored Pre-proline 0 CA--C 1.529 0.166 0 C-N-CA 126.005 1.722 . . . . 72.44 108.073 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 N--CA 1.445 -1.328 0 C-N-CA 122.171 1.914 . . . . 75.33 107.646 172.726 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.829 HG21 HG23 ' A' ' 54' ' ' THR . 75.1 t . . . . . 0 C--O 1.233 0.209 0 N-CA-C 106.15 -1.796 . . . . 44.55 106.15 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 tp -156.66 161.65 39.86 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.99 1.316 . . . . 73.25 107.94 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -139.74 126.43 20.57 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 106.511 -1.662 . . . . 63.32 106.511 -163.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -128.79 127.7 42.48 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.191 0.996 . . . . 74.15 112.174 -173.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -169.67 173.96 6.04 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.371 2.269 . . . . 63.22 112.233 176.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.8 t -135.84 151.11 49.71 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.078 -1.013 . . . . 74.25 109.073 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.722 ' CD1' HD11 ' A' ' 71' ' ' LEU 0.307 0.0 OUTLIER -62.12 -19.67 63.25 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 120.599 1.545 . . . . 63.42 113.44 -175.158 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.401 ' CE2' ' HA3' ' A' ' 65' ' ' GLY . 59.3 m-85 -92.26 1.45 57.21 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 120.928 1.695 . . . . 75.05 112.506 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.4 p -75.85 141.68 72.14 Favored Pre-proline 0 C--N 1.354 0.762 0 CA-C-N 122.162 2.256 . . . . 40.42 108.547 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -89.07 -31.27 0.16 Allowed 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 121.319 1.346 . . . . 60.13 111.338 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -62.03 -40.81 96.99 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.156 -0.965 . . . . 72.45 110.957 174.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.9 p -70.43 -28.46 65.06 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-O 118.146 -0.93 . . . . 61.05 110.971 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -54.85 -56.06 23.57 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.767 1.167 . . . . 73.24 110.263 175.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.401 ' HA ' HE21 ' A' ' 35' ' ' GLN . 0.3 OUTLIER -56.16 -46.88 79.13 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-O 118.514 -0.755 . . . . 74.41 109.022 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -66.64 -10.35 45.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 117.005 -1.474 . . . . 53.32 113.386 -175.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -134.25 0.46 3.1 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 120.616 1.553 . . . . 72.42 112.67 -163.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -139.58 -36.37 0.52 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 126.687 1.995 . . . . 72.13 110.765 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.3 t -102.56 -76.84 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 107.284 -1.376 . . . . 52.11 107.284 -173.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 71.7 mt -68.19 -21.73 64.86 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.432 1.493 . . . . 71.31 113.614 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 13.8 m80 44.66 58.96 3.59 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.92 1.688 . . . . 73.33 113.062 176.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 96.4 t -63.74 -41.3 92.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.976 1.311 . . . . 55.31 110.861 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.5 t -56.42 -45.03 80.9 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.477 1.49 . . . . 74.01 110.696 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.18 -37.97 78.45 Favored 'General case' 0 C--O 1.233 0.189 0 O-C-N 121.253 -0.905 . . . . 64.11 110.2 -176.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.47 -39.7 85.3 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.461 1.105 . . . . 74.35 112.299 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.1 t -60.86 -49.17 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.283 1.433 . . . . 71.14 109.254 171.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -52.57 -42.49 64.52 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 119.546 1.066 . . . . 64.33 113.66 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -57.17 -13.31 2.92 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.614 1.339 . . . . 71.23 114.614 173.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -120.74 -4.2 9.73 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.585 1.954 . . . . 54.23 112.457 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.619 HD22 HG21 ' A' ' 54' ' ' THR . 14.6 mt -70.8 144.24 90.49 Favored Pre-proline 0 C--O 1.239 0.538 0 CA-C-N 119.947 1.249 . . . . 72.32 109.791 -171.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -84.38 161.27 12.99 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 123.74 2.96 . . . . 73.34 109.825 169.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.75 40.85 0.82 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.262 1.208 . . . . 74.04 114.262 -165.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.93 -37.64 0.65 Allowed Glycine 0 CA--C 1.524 0.633 0 O-C-N 121.052 -1.03 . . . . 24.02 111.419 167.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.829 HG23 HG21 ' A' ' 22' ' ' VAL . 58.2 m -44.79 -59.09 2.69 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.404 2.282 . . . . 32.21 114.534 -163.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.2 tptt 57.87 126.72 0.01 OUTLIER 'General case' 0 C--N 1.344 0.351 0 C-N-CA 126.547 1.939 . . . . 60.13 111.469 -168.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -75.82 128.67 35.63 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.713 -0.847 . . . . 72.12 108.713 175.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.41 -177.35 3.11 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 124.171 0.988 . . . . 75.42 110.104 173.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.7 104.8 0.59 Allowed 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 106.008 -1.849 . . . . 63.23 106.008 166.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.439 ' CD2' ' HG3' ' A' ' 137' ' ' GLN . 9.5 m-30 -85.69 170.86 12.1 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.956 -1.127 . . . . 74.05 107.956 161.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.757 ' CE1' HG22 ' A' ' 72' ' ' THR . 1.5 p80 -108.76 171.48 7.4 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.239 1.416 . . . . 72.01 108.1 176.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 60' ' ' HIS . 2.2 m -148.29 157.73 8.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 119.832 1.196 . . . . 61.33 108.99 162.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.6 -8.98 14.19 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 129.345 3.058 . . . . 72.31 111.897 -166.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -60.92 1.09 0.16 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.792 1.637 . . . . 55.51 113.528 173.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 35.6 mt -129.4 119.36 23.71 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 119.879 -1.763 . . . . 75.15 108.282 -170.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.401 ' HA3' ' CE2' ' A' ' 29' ' ' TYR . . . 76.85 166.89 25.81 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 125.508 1.528 . . . . 61.34 112.816 175.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.58 -40.42 5.62 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.754 2.303 . . . . 75.43 111.132 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 58.7 mt -72.54 16.23 0.15 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.907 0.883 . . . . 52.15 112.012 174.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -45.31 -64.33 2.32 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.369 1.461 . . . . 72.24 110.999 172.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -59.74 -33.41 71.62 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.385 1.092 . . . . 62.02 112.472 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.58 -44.53 86.38 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.873 0.869 . . . . 75.02 109.779 176.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.722 HD11 ' CD1' ' A' ' 28' ' ' PHE . 16.2 mt -58.32 -46.06 86.89 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.668 1.187 . . . . 73.32 111.476 -176.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.757 HG22 ' CE1' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -46.08 -46.36 16.81 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.346 1.858 . . . . 64.33 109.477 174.542 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -76.5 -50.98 12.63 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 118.412 -0.804 . . . . 75.32 110.715 -172.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.69 -35.05 75.32 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.705 1.593 . . . . 71.04 112.662 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.43 ' HB3' ' HD2' ' A' ' 60' ' ' HIS . 28.8 t-105 -59.3 -36.9 76.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.002 0.365 . . . . 73.32 111.147 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.31 -29.0 69.12 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 112.708 0.633 . . . . 54.53 112.708 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.2 t -57.23 -52.62 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 120.244 1.384 . . . . 51.53 109.495 162.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.89 -56.94 15.44 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 118.216 -0.897 . . . . 72.32 110.753 -174.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.4 mt -52.61 -41.27 36.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.497 1.119 . . . . 71.42 110.489 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.87 -33.75 76.55 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 120.017 -0.673 . . . . 74.41 110.933 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.9 mt -86.41 -23.9 25.92 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.253 0.464 . . . . 72.31 112.253 175.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.1 69.72 1.34 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.946 1.736 . . . . 75.21 110.116 -171.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.7 m -133.52 8.3 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.464 1.105 . . . . 60.32 112.563 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -53.56 -51.84 61.65 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 125.069 1.348 . . . . 75.44 112.055 -169.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -55.31 -45.29 76.3 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.037 0.935 . . . . 71.33 109.257 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.402 ' H ' ' HG3' ' A' ' 86' ' ' LYS . 17.5 mtpt -66.17 -21.83 66.34 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.825 1.65 . . . . 60.12 111.44 -176.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.5 pp -121.6 26.77 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.579 1.551 . . . . 73.03 110.014 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 96.6 m -95.2 -48.76 5.79 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.131 0.878 . . . . 61.43 108.963 166.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.486 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -61.35 -62.31 6.18 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 119.267 0.94 . . . . 42.35 112.211 -175.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.486 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 56.6 Cg_endo -67.32 -23.69 44.34 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 121.633 1.556 . . . . 74.25 111.624 -174.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 32.8 tpp -64.16 -52.63 58.09 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.539 1.136 . . . . 75.32 109.101 174.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -69.43 -32.7 71.82 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 124.163 0.914 . . . . 65.12 110.469 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -63.2 -33.21 74.99 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 118.272 0.487 . . . . 72.01 110.39 171.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.47 -12.89 33.33 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.87 1.214 . . . . 64.34 113.403 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.667 HG21 ' CD2' ' A' ' 28' ' ' PHE . 41.4 t -100.08 -39.59 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 C-N-CA 124.184 0.994 . . . . 74.43 109.746 -178.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -111.53 -53.58 2.69 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.72 0.808 . . . . 63.44 110.044 -171.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -67.77 -60.16 2.74 Favored 'General case' 0 C--N 1.339 0.142 0 O-C-N 121.453 -0.779 . . . . 73.11 109.909 -173.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.4 p -90.56 -25.71 20.08 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.547 0.573 . . . . 71.13 112.547 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 49.44 61.46 3.13 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 128.521 2.728 . . . . 73.43 112.393 -174.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.3 t -101.7 -14.52 17.33 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.762 1.225 . . . . 72.02 113.171 174.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.499 HG13 HG12 ' A' ' 107' ' ' ILE . 25.6 t -69.96 123.46 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 119.875 1.216 . . . . 51.31 108.834 171.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -144.35 -26.61 0.52 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.42 1.088 . . . . 53.44 111.714 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.82 167.32 21.98 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.308 0.958 . . . . 74.02 108.747 174.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 43.8 t -56.2 -40.28 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 123.709 0.804 . . . . 60.12 110.68 -175.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.26 -24.99 61.22 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.674 0.79 . . . . 75.33 112.617 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -79.83 -34.09 39.73 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.16 0.891 . . . . 74.14 110.807 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.499 HG12 HG13 ' A' ' 101' ' ' VAL . 1.8 mt -75.01 -48.23 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 108.716 -0.846 . . . . 61.32 108.716 -176.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -17.14 63.75 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.289 -0.862 . . . . 72.32 111.428 -176.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -58.87 -58.12 10.03 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.61 0.764 . . . . 73.12 110.012 168.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.3 t -57.24 -38.81 63.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 123.445 0.698 . . . . 74.25 111.565 -174.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -54.51 -53.03 59.84 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.839 -0.538 . . . . 75.45 109.765 173.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 97.5 t -60.62 -46.05 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 123.717 0.807 . . . . 72.44 110.186 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -55.39 -45.67 76.59 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.832 1.253 . . . . 64.03 109.425 -176.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.91 -15.05 60.25 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.703 1.201 . . . . 72.14 113.102 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 114.18 51.5 0.47 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.487 1.042 . . . . 65.32 113.213 172.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.8 t -111.6 142.78 22.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 124.374 1.07 . . . . 73.41 108.513 168.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.7 mmtm -61.57 148.67 41.51 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.831 0.824 . . . . 72.44 110.804 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.0 -18.17 74.29 Favored Glycine 0 CA--C 1.518 0.235 0 CA-C-N 114.985 -1.007 . . . . 61.31 113.15 167.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -87.57 -36.04 17.78 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 109.326 -0.62 . . . . 63.44 109.326 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.72 -43.3 72.64 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 106.25 -1.759 . . . . 63.04 106.25 -169.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -63.18 -52.93 60.39 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 123.693 0.621 . . . . 73.03 110.202 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -71.7 -17.05 62.25 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.963 0.505 . . . . 73.03 112.297 -174.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -87.15 -63.96 1.22 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.61 1.164 . . . . 51.51 109.597 172.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.32 -34.56 66.65 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.196 0.998 . . . . 73.43 111.463 -170.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -49.47 -33.53 14.54 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.862 0.865 . . . . 73.32 112.658 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -111.27 6.51 20.6 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.584 1.553 . . . . 75.25 112.848 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 43.3 t -82.73 157.21 23.37 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.283 1.433 . . . . 72.43 111.048 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -62.21 -34.53 76.65 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.373 1.469 . . . . 74.14 111.469 172.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 72.2 t -50.41 -50.98 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 108.843 -0.799 . . . . 73.31 108.843 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 22.1 t -65.91 -44.31 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 124.369 1.067 . . . . 64.22 111.723 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.538 ' HE2' ' HA ' ' A' ' 131' ' ' LYS . 10.8 mmpt? -51.55 -52.69 45.02 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.041 0.837 . . . . 75.14 110.921 176.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.6 -34.48 77.98 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.359 1.064 . . . . 63.24 110.955 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.0 mt -63.21 -54.99 28.81 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 117.141 -1.409 . . . . 63.42 110.848 175.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 87.4 t -54.07 -39.11 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 119.819 1.191 . . . . 61.23 109.601 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.68 -22.81 66.76 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 118.188 -0.91 . . . . 73.45 113.067 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -58.1 -53.1 62.02 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 119.638 1.108 . . . . 71.44 109.35 172.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.439 ' HG3' ' CD2' ' A' ' 59' ' ' TYR . 20.9 mp0 -78.88 -30.43 45.0 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.229 -0.919 . . . . 73.25 110.113 -175.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -68.87 11.67 0.18 Allowed 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.143 -1.598 . . . . 73.44 112.81 163.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -125.24 -19.93 4.98 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 124.775 1.23 . . . . 73.15 111.925 162.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -115.07 -10.41 12.22 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 114.557 1.317 . . . . 75.01 114.557 -172.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -96.66 -38.79 9.79 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.524 1.057 . . . . 74.31 108.343 157.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.9 -28.05 69.78 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.908 1.077 . . . . 63.43 113.908 -170.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -80.71 26.87 0.39 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.656 0.984 . . . . 63.22 113.656 -169.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.5 mt 65.16 28.3 12.2 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.815 -1.178 . . . . 62.22 111.504 165.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -104.68 -20.9 13.49 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.451 1.501 . . . . 74.02 112.216 -171.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.44 HD11 ' CB ' ' A' ' 151' ' ' ALA . 1.3 tt -168.15 137.03 2.4 Favored 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 128.738 2.815 . . . . 64.32 106.864 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -140.94 5.83 1.96 Allowed 'General case' 0 CA--C 1.546 0.802 0 O-C-N 124.017 0.823 . . . . 53.32 111.121 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -143.55 152.22 23.94 Favored Glycine 0 C--N 1.343 0.966 0 CA-C-N 119.624 1.102 . . . . 72.35 110.903 172.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.524 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 35.7 m -132.83 174.84 4.24 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 125.818 1.647 . . . . 75.02 110.717 -170.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.524 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 15.8 Cg_endo -61.98 152.04 61.76 Favored 'Cis proline' 0 C--N 1.352 0.746 0 CA-C-N 121.475 1.562 . . . . 73.05 112.165 -10.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.44 ' CB ' HD11 ' A' ' 146' ' ' LEU . . . -152.65 152.66 32.02 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.587 0.554 . . . . 63.14 111.111 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 77.1 mmm -151.78 121.51 6.99 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.673 1.189 . . . . 64.34 107.813 -167.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 12.0 m-30 -100.02 152.8 19.79 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.005 0.922 . . . . 54.41 110.361 -172.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.4 t -139.87 151.76 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.566 0.746 . . . . 72.25 110.202 174.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 44.88 24.12 0.1 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 129.273 3.029 . . . . 52.52 114.494 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 53.03 24.67 21.5 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.194 -0.941 . . . . 74.41 112.996 -173.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.584 ' HE2' ' CE2' ' A' ' 158' ' ' TYR . 9.3 pttt -150.24 -3.55 0.36 Allowed 'General case' 0 C--N 1.344 0.335 0 N-CA-C 114.527 1.306 . . . . 74.12 114.527 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.584 ' CE2' ' HE2' ' A' ' 157' ' ' LYS . 49.8 m-85 -126.59 159.93 32.1 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 124.73 1.212 . . . . 64.42 110.953 -176.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -126.22 149.2 49.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.654 1.982 . . . . 43.22 107.044 170.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.568 HD11 HG23 ' A' ' 180' ' ' THR . 2.2 mm? -74.47 154.26 38.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.995 -0.742 . . . . 63.04 108.995 167.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -125.18 80.61 64.41 Favored Pre-proline 0 C--O 1.232 0.18 0 C-N-CA 123.353 0.661 . . . . 63.44 110.808 177.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.36 -4.84 10.09 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 121.986 1.791 . . . . 72.04 113.212 175.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -86.82 -2.66 58.74 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.16 1.384 . . . . 71.43 113.127 173.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -132.47 46.16 1.08 Allowed Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 109.584 -1.406 . . . . 63.15 109.584 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 36.6 mtt -130.97 174.97 9.47 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 118.172 0.986 . . . . 72.32 111.851 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.32 90.35 4.97 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.945 -1.131 . . . . 73.13 107.945 174.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.344 6.4 t -118.53 48.13 1.5 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.78 1.232 . . . . 73.12 107.965 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.6 m -84.16 -47.79 10.49 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.074 -0.966 . . . . 74.11 110.338 159.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.519 HD22 ' CG2' ' A' ' 172' ' ' VAL . 0.0 OUTLIER -113.05 -9.9 13.52 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 117.962 -1.018 . . . . 70.24 113.065 -162.401 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 33.6 mmm 75.47 -53.94 0.64 Allowed 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 126.451 1.901 . . . . 72.32 112.705 170.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.22 -31.35 72.48 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.656 1.116 . . . . 72.15 109.512 176.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.519 ' CG2' HD22 ' A' ' 169' ' ' ASN . 89.0 t -80.68 -25.04 11.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.65 1.58 . . . . 64.04 111.8 175.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -63.54 -58.06 8.2 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.014 -1.476 . . . . 73.05 107.014 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 14.3 t -61.83 -38.88 81.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 122.999 0.52 . . . . 73.02 110.195 -174.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.71 -46.06 70.65 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.437 1.095 . . . . 51.32 110.754 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -83.75 -31.29 26.06 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.165 0.986 . . . . 65.15 112.493 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -54.61 -54.8 36.67 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.227 -0.921 . . . . 64.24 109.242 175.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.96 -27.63 66.97 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.084 0.772 . . . . 62.11 113.084 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.2 -54.85 14.93 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.632 1.173 . . . . 64.24 110.614 177.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.568 HG23 HD11 ' A' ' 160' ' ' LEU . 13.6 t -62.21 -30.91 71.41 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 118.553 -0.737 . . . . 73.25 110.615 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 94.8 t -59.66 -51.81 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.519 -0.919 . . . . 54.24 108.519 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -62.0 -47.63 83.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.181 0.593 . . . . 75.25 109.8 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -58.29 -37.23 74.62 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 118.638 0.654 . . . . 75.44 111.932 -172.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 72.0 mt -65.51 -28.72 69.39 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.45 -0.781 . . . . 72.32 112.192 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.21 -22.55 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.403 0.681 . . . . 72.23 111.646 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -98.87 -16.47 18.82 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.652 0.66 . . . . 75.13 110.509 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -93.15 13.66 20.36 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.708 1.373 . . . . 75.41 114.708 -170.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 35.1 mttt . . . . . 0 C--O 1.246 0.898 0 C-N-CA 127.933 2.493 . . . . 64.31 113.886 -175.611 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.573 0 N-CA-C 112.195 0.442 . . . . 64.41 112.195 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -156.24 118.22 3.98 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.902 -1.148 . . . . 62.21 107.902 164.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.4 pt -115.63 164.62 11.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 126.217 1.807 . . . . 71.55 108.604 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.2 m -137.55 139.41 40.44 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.079 -1.823 . . . . 63.33 106.079 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -55.08 138.66 43.71 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.149 1.78 . . . . 72.34 109.739 167.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.45 -25.71 3.23 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.445 1.498 . . . . 41.34 113.41 -171.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -91.8 -77.35 0.43 Allowed 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 119.211 1.506 . . . . 65.42 107.227 -165.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -97.4 -15.38 20.7 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.543 0.737 . . . . 54.25 111.166 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -142.95 160.69 39.86 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.34 0.656 . . . . 75.32 110.246 173.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.3 mm -123.8 157.2 30.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 106.818 -1.549 . . . . 65.43 106.818 172.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.9 m -101.79 152.9 20.33 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.199 1.4 . . . . 75.52 107.633 174.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.3 mt -91.27 148.83 22.07 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 106.705 -1.591 . . . . 73.55 106.705 169.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -72.58 -34.43 67.45 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.128 1.371 . . . . 71.13 109.765 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.9 mmtm -125.68 82.31 63.91 Favored Pre-proline 0 C--O 1.232 0.136 0 C-N-CA 126.7 2.0 . . . . 73.12 108.166 175.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 N--CA 1.451 -1.017 0 C-N-CA 123.645 2.897 . . . . 71.52 107.844 168.975 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.469 0.498 0 CA-C-O 119.279 -0.391 . . . . 65.43 110.008 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.416 HD21 ' CD2' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -172.14 164.53 6.06 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.274 1.03 . . . . 64.43 110.536 -167.454 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -123.46 158.94 30.09 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.903 1.281 . . . . 54.13 109.435 173.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -142.04 134.18 27.59 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.731 1.613 . . . . 73.52 113.221 174.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -139.69 177.77 7.71 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.352 1.461 . . . . 52.51 111.125 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.9 t -136.61 162.33 33.42 Favored 'General case' 0 CA--C 1.527 0.09 0 N-CA-C 109.457 -0.571 . . . . 62.43 109.457 157.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.784 ' CD1' HD11 ' A' ' 71' ' ' LEU 0.257 0.0 OUTLIER -71.59 -20.14 62.04 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.502 -0.749 . . . . 63.12 112.834 171.232 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -89.03 -9.21 52.12 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 117.724 -1.131 . . . . 75.41 112.725 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.7 p -84.63 142.27 39.63 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 121.416 1.916 . . . . 40.22 110.284 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -91.72 -31.23 0.1 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 121.384 1.389 . . . . 75.11 112.395 -170.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -58.54 -44.02 89.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.143 -0.688 . . . . 74.41 109.143 169.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 25.7 m -55.62 -39.95 71.49 Favored 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 123.979 0.912 . . . . 74.52 110.742 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -52.47 -60.83 2.76 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 119.523 1.056 . . . . 64.24 109.813 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -54.54 -41.8 70.16 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 119.026 -0.511 . . . . 62.33 109.755 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -68.89 -24.41 64.31 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 118.347 -0.835 . . . . 71.52 112.526 -174.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -116.24 -3.82 11.95 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.689 0.677 . . . . 72.31 111.635 -167.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -138.38 -35.07 0.61 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.879 1.672 . . . . 60.12 114.016 -168.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 86.8 t -111.05 -78.79 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 N-CA-C 105.458 -2.053 . . . . 75.52 105.458 -172.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.6 mt -57.4 -29.15 63.87 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.48 1.912 . . . . 75.12 111.159 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 44.1 54.89 5.72 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.005 1.722 . . . . 72.43 110.23 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.543 ' O ' HG23 ' A' ' 46' ' ' VAL . 97.4 t -53.38 -51.47 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 126.099 1.76 . . . . 43.24 107.898 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.9 t -44.09 -53.2 6.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.669 1.987 . . . . 54.12 111.404 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -76.64 -30.29 56.78 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.462 0.649 . . . . 74.52 111.332 -173.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -72.86 -37.39 67.39 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.318 -0.864 . . . . 60.23 111.78 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 42' ' ' VAL . 1.9 t -60.68 -49.97 82.33 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 N-CA-C 107.93 -1.137 . . . . 72.45 107.93 173.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -47.62 -45.49 27.72 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 124.588 1.155 . . . . 73.24 112.335 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -63.6 -5.14 3.53 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 115.468 1.655 . . . . 75.31 115.468 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -123.4 -10.26 7.98 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.351 2.26 . . . . 60.43 113.03 174.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.453 HD13 HG21 ' A' ' 54' ' ' THR . 13.6 mt -73.17 145.39 85.81 Favored Pre-proline 0 C--O 1.238 0.478 0 CA-C-N 120.109 1.322 . . . . 44.53 112.306 -163.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.76 160.49 31.04 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 124.49 3.46 . . . . 63.13 112.348 175.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -76.97 45.44 0.43 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.541 1.936 . . . . 62.13 112.451 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -155.54 -6.59 0.08 OUTLIER Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.329 1.443 . . . . 73.31 113.523 175.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.453 HG21 HD13 ' A' ' 50' ' ' LEU . 14.2 t -56.4 -43.63 79.49 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.496 1.648 . . . . 74.15 112.092 174.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.8 tptt 44.66 90.94 0.01 OUTLIER 'General case' 0 C--N 1.346 0.417 0 C-N-CA 126.305 1.842 . . . . 73.22 110.196 -165.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.33 105.57 0.3 Allowed 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 127.342 2.257 . . . . 73.21 108.945 -175.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.0 m -143.36 115.3 8.29 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 107.138 -1.43 . . . . 72.13 107.138 -172.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.72 137.55 54.34 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.857 1.263 . . . . 61.11 108.459 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.462 ' CG ' ' HG2' ' A' ' 137' ' ' GLN . 17.1 m-30 -104.86 -174.94 2.65 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.936 1.694 . . . . 73.43 108.744 173.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -139.99 133.34 29.92 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.073 1.349 . . . . 63.33 107.644 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.3 m -85.99 170.77 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 119.096 0.862 . . . . 74.51 112.254 -172.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.11 0.77 9.11 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.888 2.075 . . . . 73.12 112.558 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -71.32 -34.26 70.4 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.253 1.021 . . . . 52.12 112.638 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 mt -91.91 126.44 36.99 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.372 -0.973 . . . . 73.54 108.372 -171.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.25 167.52 33.85 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 115.336 -0.847 . . . . 61.33 112.829 168.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -66.66 -48.19 2.33 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 124.424 3.416 . . . . 65.32 109.604 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.5 mt -73.22 13.62 0.41 Allowed 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 127.2 2.2 . . . . 73.52 112.514 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -50.48 -46.99 45.44 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 119.823 1.192 . . . . 55.03 111.697 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.1 tptp -71.42 -36.52 71.33 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.401 1.101 . . . . 75.31 111.414 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -63.83 -33.41 75.61 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.58 0.627 . . . . 72.12 110.189 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.784 HD11 ' CD1' ' A' ' 28' ' ' PHE . 15.1 mt -62.13 -49.66 74.99 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 118.416 -0.802 . . . . 51.14 113.038 175.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.5 m -57.2 -45.29 83.9 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.795 -1.187 . . . . 33.31 107.795 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -57.36 -47.3 82.0 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.189 0.904 . . . . 65.22 110.527 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.09 -41.11 82.77 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.949 1.249 . . . . 75.34 112.862 176.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 35.6 t-105 -57.93 -38.89 76.76 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.654 0.782 . . . . 74.24 110.681 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.69 -40.78 80.23 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 117.504 -1.236 . . . . 52.33 113.487 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.0 -43.47 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 120.532 1.514 . . . . 75.11 108.783 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.12 -43.31 87.54 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 118.255 -0.878 . . . . 72.52 111.545 -175.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 59.2 mt -63.02 -46.34 96.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.03 0.932 . . . . 71.22 109.634 172.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.21 -24.4 63.1 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.691 0.678 . . . . 71.13 111.477 -174.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.1 mt -107.17 -16.65 14.36 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 113.916 1.08 . . . . 53.44 113.916 176.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.56 69.96 1.16 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.285 0.945 . . . . 32.31 110.792 -166.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.4 m -135.61 13.5 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.753 1.221 . . . . 62.53 112.285 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -50.06 -50.78 46.75 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 125.563 1.545 . . . . 73.21 111.77 -173.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.78 -37.93 89.26 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.319 0.647 . . . . 64.23 110.221 -178.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -65.23 -43.68 90.68 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.17 0.509 . . . . 64.22 110.0 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.8 pp -92.44 17.33 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 C-N-CA 124.803 1.241 . . . . 62.35 111.633 -175.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 38.9 m -88.36 -48.12 7.88 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.032 0.833 . . . . 74.41 110.019 169.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.509 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -56.79 -60.85 8.18 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 113.907 1.077 . . . . 60.12 113.907 -169.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 30.2 Cg_endo -68.43 -25.74 35.32 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.299 1.332 . . . . 73.11 111.643 -178.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 20.2 tpp -65.25 -50.63 65.05 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 124.89 1.276 . . . . 72.54 110.826 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -69.64 -30.57 68.31 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.852 -0.796 . . . . 71.32 108.852 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -57.8 -46.97 83.87 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 118.648 0.658 . . . . 75.33 110.332 167.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.41 2.81 23.54 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 120.538 -1.351 . . . . 65.12 113.014 -174.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.739 HG21 ' CD2' ' A' ' 28' ' ' PHE . 38.8 t -123.59 -39.44 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 125.026 1.331 . . . . 62.32 110.826 -173.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -107.75 -47.59 3.57 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.12 -0.696 . . . . 71.25 109.12 -175.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -77.3 -52.42 9.21 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.24 0.616 . . . . 71.12 110.703 -171.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.5 p -103.86 -24.59 13.27 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.536 1.134 . . . . 53.41 112.18 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 57.31 26.12 12.0 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.58 2.352 . . . . 64.24 114.552 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.3 t -68.36 -20.58 64.72 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.937 0.718 . . . . 51.33 112.937 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.427 HG11 ' CZ ' ' A' ' 28' ' ' PHE . 25.1 t -67.43 123.71 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 O-C-N 120.87 -1.144 . . . . 54.51 109.444 173.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -145.84 -25.06 0.46 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.712 1.605 . . . . 75.51 111.326 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.17 164.93 26.56 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.793 -0.817 . . . . 74.45 108.793 176.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 25.3 t -55.07 -40.89 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.227 1.011 . . . . 73.25 109.432 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.16 8.48 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.539 1.935 . . . . 63.43 114.885 173.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -113.69 -46.9 3.01 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 125.045 1.338 . . . . 61.53 109.117 168.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.3 mt -59.01 -37.56 68.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 123.55 0.74 . . . . 64.42 110.356 -177.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.0 -19.59 64.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 117.54 -1.219 . . . . 72.54 112.845 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -57.6 -58.37 8.62 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 119.703 1.138 . . . . 74.31 110.024 164.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 55.2 t -57.13 -37.31 54.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 122.564 0.345 . . . . 60.31 111.732 -167.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -50.98 -56.81 10.61 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.417 -0.586 . . . . 65.25 109.417 171.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 39.8 t -64.57 -38.06 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 123.952 0.901 . . . . 74.12 110.699 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.66 -42.96 98.09 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.499 0.719 . . . . 73.21 109.511 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.48 2.89 12.49 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.353 1.461 . . . . 43.33 112.478 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.58 61.95 1.66 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 125.06 1.314 . . . . 53.05 111.468 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 77.7 t -119.57 145.43 25.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 123.273 0.629 . . . . 54.41 109.935 169.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -62.02 118.61 7.52 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.671 1.189 . . . . 74.25 108.661 169.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.61 -28.71 70.24 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-O 118.3 -1.278 . . . . 73.33 111.677 166.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -73.05 -25.64 61.0 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 118.93 1.365 . . . . 52.45 109.59 -177.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.03 -39.55 29.66 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.075 0.95 . . . . 73.31 109.393 176.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -64.5 -59.61 4.12 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.266 -1.383 . . . . 74.33 107.266 -177.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -60.68 -28.54 68.69 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.661 1.184 . . . . 42.35 110.302 -175.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -80.56 -64.43 1.19 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.473 -0.565 . . . . 73.45 109.473 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.91 -40.05 69.45 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 117.494 -1.241 . . . . 74.52 110.325 -172.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 46.0 t-105 -47.54 -37.6 12.47 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 124.503 1.121 . . . . 75.23 112.76 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -105.16 -5.03 21.1 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.579 1.152 . . . . 73.33 111.219 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 10.9 t -88.59 149.69 23.44 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.29 1.836 . . . . 55.03 109.753 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -50.24 -34.02 21.59 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.138 1.775 . . . . 73.15 111.622 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 76.7 t -45.49 -59.64 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 125.838 1.655 . . . . 44.22 109.461 176.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 134' ' ' VAL . 18.3 t -64.69 -46.04 93.46 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.682 0 CA-C-O 117.788 -1.101 . . . . 62.32 109.164 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -50.27 -50.33 50.64 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 120.247 1.385 . . . . 73.44 110.719 -177.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.4 t -69.73 -35.62 75.17 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 118.184 -0.912 . . . . 55.13 109.94 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.497 ' HA ' ' HG2' ' A' ' 136' ' ' GLN . 66.0 mt -64.51 -37.23 86.83 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 119.453 1.024 . . . . 73.24 112.225 177.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 130' ' ' VAL . 42.7 t -56.06 -49.18 77.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 N-CA-C 107.908 -1.145 . . . . 63.25 107.908 173.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.92 -49.89 70.18 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.308 0.503 . . . . 42.53 111.641 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.497 ' HG2' ' HA ' ' A' ' 133' ' ' LEU . 1.4 pt20 -58.76 -34.32 71.28 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 123.498 0.499 . . . . 75.24 111.82 -173.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.462 ' HG2' ' CG ' ' A' ' 59' ' ' TYR . 23.6 mt-30 -89.9 -48.12 7.43 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 126.391 1.877 . . . . 45.34 111.129 -173.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -62.66 -46.36 88.56 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.2 1.0 . . . . 74.43 109.159 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -58.72 -46.18 87.94 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.796 -0.816 . . . . 74.15 108.796 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.63 -9.06 16.88 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.586 0.958 . . . . 51.32 113.586 -174.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.67 5.44 10.55 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 120.755 1.616 . . . . 73.51 112.942 174.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.5 -3.41 5.45 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.01 0.924 . . . . 75.23 112.489 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -56.05 -85.68 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.922 2.489 . . . . 72.34 109.978 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.1 pp 179.18 41.49 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.062 1.745 . . . . 75.31 110.873 176.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -133.56 -45.27 0.82 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.254 1.205 . . . . 72.53 114.254 -172.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 16.1 tp -85.11 -85.3 0.14 Allowed 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 125.347 1.459 . . . . 72.53 109.746 -166.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 56.72 33.51 23.03 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.202 0.601 . . . . 73.33 111.628 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 178.31 155.81 15.27 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.856 1.693 . . . . 60.55 110.965 174.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 16.2 m -149.06 161.78 31.24 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 124.693 1.197 . . . . 74.21 108.931 175.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -65.14 141.12 46.56 Favored 'Cis proline' 0 C--N 1.35 0.626 0 CA-C-N 120.227 1.117 . . . . 64.23 112.504 -8.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -131.2 142.8 50.24 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.764 -1.107 . . . . 65.32 109.625 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 50.8 mtp -148.23 113.99 5.72 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 102.469 -3.16 . . . . 74.54 102.469 -176.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -100.95 165.66 11.22 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.4 0.68 . . . . 52.41 109.387 -175.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.6 t -138.07 133.44 44.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.667 0.746 . . . . 71.42 110.668 172.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 44.9 30.84 0.6 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 130.754 3.621 . . . . 60.34 115.417 171.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 64.59 34.41 89.82 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 124.823 1.202 . . . . 54.12 111.395 177.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.444 ' HG3' ' CE2' ' A' ' 158' ' ' TYR . 9.7 ptmt -160.52 -10.4 0.05 OUTLIER 'General case' 0 C--N 1.345 0.389 0 N-CA-C 116.742 2.126 . . . . 74.42 116.742 177.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.444 ' CE2' ' HG3' ' A' ' 157' ' ' LYS . 60.2 m-85 -128.89 160.88 31.24 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 120.376 1.444 . . . . 73.43 110.598 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -136.01 131.77 35.42 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 105.694 -1.965 . . . . 43.22 105.694 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.57 145.89 55.52 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.718 -1.216 . . . . 52.41 107.718 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -115.13 85.58 12.66 Favored Pre-proline 0 CA--C 1.522 -0.134 0 N-CA-C 113.034 0.753 . . . . 51.14 113.034 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -61.92 -24.19 76.74 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 CA-C-N 119.659 0.914 . . . . 72.35 112.059 173.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.28 2.58 27.44 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.139 1.376 . . . . 72.14 112.398 -170.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -130.24 22.02 4.8 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.229 1.395 . . . . 74.13 110.423 175.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 63.3 mtt -106.42 169.82 8.29 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 117.932 0.866 . . . . 73.41 110.335 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.2 63.82 7.39 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 124.626 2.155 . . . . 72.53 109.98 -174.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.6 p -73.65 32.51 0.08 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 129.376 3.07 . . . . 65.21 111.393 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.8 m -117.04 -3.02 11.61 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.031 1.732 . . . . 73.22 112.053 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.43 -9.67 2.87 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-O 117.678 -1.153 . . . . 53.11 111.744 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 13.2 mmt 65.49 -52.53 0.36 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 127.671 2.388 . . . . 61.53 115.282 172.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.38 -44.35 62.67 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.153 -1.425 . . . . 63.14 107.153 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 97.1 t -59.05 -39.14 77.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 124.02 0.928 . . . . 60.42 110.423 174.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -56.44 -59.78 4.48 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.838 -0.601 . . . . 73.25 109.736 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 20.2 t -66.54 -38.18 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 118.793 0.724 . . . . 72.35 110.807 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.46 -40.22 62.01 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.104 0.562 . . . . 75.53 110.903 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -86.37 -35.96 19.48 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 117.95 -1.024 . . . . 53.15 112.548 174.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -52.01 -60.85 2.71 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 121.039 1.745 . . . . 74.35 110.233 176.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -53.8 -35.27 61.19 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.459 1.104 . . . . 33.44 111.803 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -71.73 -48.52 46.51 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.505 1.122 . . . . 74.14 111.376 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.9 t -62.08 -31.09 71.48 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 117.071 -1.442 . . . . 52.43 109.782 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 30.7 t -58.56 -58.42 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 120.105 1.32 . . . . 71.33 108.929 171.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.96 -11.85 61.2 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 114.135 1.161 . . . . 74.25 114.135 -172.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -87.75 -33.11 18.8 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 123.972 0.909 . . . . 73.14 112.625 166.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 28.7 mt -66.51 -30.78 71.18 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 119.816 -1.803 . . . . 31.23 111.408 -177.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 69.3 t -61.89 -23.46 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.377 0.671 . . . . 73.24 112.549 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -101.25 -14.05 17.83 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 120.983 -1.073 . . . . 73.15 110.47 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -104.8 70.76 0.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 105.237 -2.134 . . . . 64.23 105.237 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? . . . . . 0 CA--C 1.508 -0.672 0 N-CA-C 103.162 -2.903 . . . . 75.44 103.162 170.466 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.46 0 N-CA-C 115.703 1.742 . . . . 64.0 115.703 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -161.1 107.36 1.42 Allowed 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.693 1.597 . . . . 72.1 108.917 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.504 HD12 ' CE1' ' A' ' 9' ' ' TYR . 10.1 pt -111.68 170.87 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.604 1.562 . . . . 73.23 109.609 177.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.9 m -140.52 139.3 35.04 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 106.606 -1.627 . . . . 65.21 106.606 177.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -61.55 118.64 7.3 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.508 2.323 . . . . 72.02 109.102 172.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.01 -18.66 56.48 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.328 1.918 . . . . 71.42 112.404 -174.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -89.72 -84.8 0.22 Allowed 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.822 1.311 . . . . 63.02 108.725 -171.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -92.14 -10.91 37.12 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.449 1.1 . . . . 72.43 111.469 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.504 ' CE1' HD12 ' A' ' 3' ' ' ILE . 22.8 p90 -140.08 164.37 30.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.413 -0.803 . . . . 71.34 109.424 171.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.6 mm -125.12 161.22 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.383 1.473 . . . . 71.32 107.032 169.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -94.74 171.61 8.68 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.562 1.545 . . . . 54.42 108.737 174.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 50.5 mt -117.2 148.63 41.45 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.543 1.137 . . . . 63.23 109.902 162.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -75.21 -43.02 54.22 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.836 2.054 . . . . 70.24 109.062 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.4 mmtm -119.0 84.51 26.6 Favored Pre-proline 0 N--CA 1.454 -0.246 0 C-N-CA 126.76 2.024 . . . . 71.24 107.237 175.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo . . . . . 0 CA--C 1.538 0.7 0 C-N-CA 124.717 3.611 . . . . 74.13 113.424 174.826 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.31 3.5 p . . . . . 0 N--CA 1.467 0.409 0 CA-C-O 123.357 1.551 . . . . 45.41 111.533 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.0 tp -140.96 142.3 34.35 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 113.61 -1.632 . . . . 72.12 108.224 -169.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -125.65 167.83 14.56 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 126.357 1.863 . . . . 65.2 108.448 -175.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.867 ' CE1' HG13 ' A' ' 149' ' ' VAL . 1.4 t80 -164.69 128.27 2.43 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 113.882 -1.508 . . . . 62.02 110.13 -167.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.6 ' HA ' HG11 ' A' ' 149' ' ' VAL . 27.8 m-85 -149.82 160.34 43.64 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 129.396 3.079 . . . . 65.12 109.719 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 t -124.0 159.1 30.56 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.8 -0.815 . . . . 73.1 108.8 164.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -77.17 -23.05 51.62 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.363 -0.836 . . . . 74.23 111.255 176.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.462 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 49.8 m-85 -102.06 5.29 40.44 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.076 1.35 . . . . 72.25 114.225 -178.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 11.2 p -91.51 145.0 30.46 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 120.683 1.583 . . . . 50.22 112.646 -173.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.08 165.76 31.22 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.375 2.05 . . . . 74.44 109.191 172.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.0 m80 69.04 -48.28 0.58 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 127.057 2.143 . . . . 73.42 110.243 -169.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 39.2 m -50.63 -43.2 56.89 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.969 1.708 . . . . 73.0 111.845 -176.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -51.12 -58.05 7.12 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.624 0.77 . . . . 70.41 111.29 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -56.74 -45.3 82.05 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.193 -1.04 . . . . 62.4 108.193 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -62.55 -22.54 66.41 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 117.27 -1.348 . . . . 70.31 113.009 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -120.67 -0.45 10.22 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 121.259 1.845 . . . . 72.02 112.87 -169.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -142.71 -26.4 0.61 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.031 0.933 . . . . 74.23 112.909 -173.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 54.2 t -115.23 -69.81 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 108.035 -1.098 . . . . 74.2 108.035 -173.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.6 mt -66.07 -26.4 67.47 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.233 1.013 . . . . 73.03 110.622 173.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 44.35 53.21 6.96 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.725 1.61 . . . . 74.02 111.924 173.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 46' ' ' VAL . 77.2 t -58.13 -52.0 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 114.876 -1.057 . . . . 65.12 110.743 -166.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 p -58.5 -38.49 77.76 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 119.359 0.981 . . . . 65.42 111.681 -167.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -74.34 -36.95 63.67 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.215 0.606 . . . . 63.23 110.665 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -60.36 -45.04 94.9 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.841 -0.537 . . . . 44.3 110.182 169.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 42' ' ' VAL . 2.2 t -61.8 -50.39 80.4 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 CA-C-N 118.651 0.659 . . . . 73.21 109.32 175.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -51.11 -43.61 61.14 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 126.606 1.962 . . . . 75.03 111.201 -176.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -59.62 -20.05 53.29 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 114.156 1.169 . . . . 75.13 114.156 175.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -115.77 -6.52 12.11 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.35 1.46 . . . . 74.0 112.038 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.61 HD13 HG21 ' A' ' 54' ' ' THR . 11.2 mt -70.62 144.11 90.82 Favored Pre-proline 0 C--O 1.239 0.522 0 CA-C-N 119.385 0.993 . . . . 72.0 109.792 -168.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.25 152.46 30.82 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.155 2.57 . . . . 73.02 109.668 174.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.268 1.6 pt-20 -81.22 87.43 6.1 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 123.859 1.79 . . . . 73.24 109.715 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.37 -7.58 0.36 Allowed Glycine 0 C--O 1.221 -0.66 0 CA-C-N 114.792 -1.094 . . . . 61.42 111.606 -174.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.61 HG21 HD13 ' A' ' 50' ' ' LEU . 15.2 t -58.52 -59.66 5.02 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.515 1.657 . . . . 72.23 109.48 166.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.421 ' N ' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER 50.14 86.64 0.03 OUTLIER 'General case' 0 C--N 1.346 0.448 0 C-N-CA 126.175 1.79 . . . . 74.34 109.685 -169.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 13.7 ptp -64.18 173.28 2.02 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 112.248 -2.251 . . . . 61.42 111.039 175.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.525 HG22 ' H ' ' A' ' 58' ' ' LYS . 1.5 m -144.57 -170.33 3.36 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.118 1.767 . . . . 71.1 108.95 177.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.525 ' H ' HG22 ' A' ' 57' ' ' THR . 25.3 tttt -176.81 103.51 0.06 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.759 2.023 . . . . 71.11 108.77 -172.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -114.76 111.0 20.57 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 121.008 1.731 . . . . 70.32 108.982 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.526 ' HB2' ' CG ' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -80.7 150.39 29.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 118.813 -0.613 . . . . 73.02 110.494 176.423 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.731 HG21 ' CE2' ' A' ' 25' ' ' PHE . 19.1 m -132.99 152.45 36.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 124.508 1.123 . . . . 64.45 111.298 -171.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.18 10.59 40.67 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.987 1.315 . . . . 73.34 114.231 -171.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -62.68 -8.26 6.31 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.414 1.635 . . . . 74.25 115.414 -170.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.52 165.35 29.72 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 120.044 -1.66 . . . . 71.02 111.017 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.462 ' HA3' ' CD2' ' A' ' 29' ' ' TYR . . . 71.98 159.61 4.22 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.474 1.512 . . . . 74.12 112.373 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.1 -55.56 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.737 2.291 . . . . 61.23 109.79 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.4 mt -75.37 22.38 0.12 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.657 1.583 . . . . 65.45 112.968 -178.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -52.06 -56.84 14.76 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 124.865 1.221 . . . . 72.21 111.002 -176.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -62.04 -42.03 98.74 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 117.871 0.835 . . . . 65.34 109.776 -173.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -67.79 -38.84 83.87 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.992 1.717 . . . . 61.44 108.908 -174.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.7 mt -64.75 -40.58 95.53 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.469 1.108 . . . . 72.25 112.016 172.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.7 m -61.41 -41.38 97.05 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.732 0.696 . . . . 65.33 109.694 172.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.63 -39.91 95.54 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.459 1.027 . . . . 63.22 110.624 176.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.03 -36.26 81.05 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.586 0.754 . . . . 64.22 112.317 176.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.526 ' CG ' ' HB2' ' A' ' 60' ' ' HIS . 59.6 t-105 -59.58 -40.56 87.81 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.022 0.439 . . . . 70.02 111.658 -176.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.35 -29.89 71.12 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 118.745 -0.645 . . . . 70.43 112.388 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.3 t -59.91 -44.02 93.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 119.642 1.11 . . . . 72.35 109.312 169.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.1 84.92 Favored 'General case' 0 C--N 1.34 0.176 0 O-C-N 121.665 -0.647 . . . . 73.23 111.229 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 79.3 mt -71.49 -39.87 71.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 119.136 -0.459 . . . . 73.13 109.944 176.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.87 -34.63 71.83 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.079 0.854 . . . . 72.45 111.31 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.689 HD12 HG13 ' A' ' 116' ' ' VAL . 15.8 mt -102.49 -3.06 27.46 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.181 0.808 . . . . 74.32 113.181 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 58.45 57.22 21.01 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.426 1.489 . . . . 62.42 111.814 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.501 HG21 HG22 ' A' ' 116' ' ' VAL . 22.6 m -131.15 13.65 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 126.216 1.806 . . . . 74.05 111.719 -175.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -46.92 -48.24 21.38 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 126.604 1.961 . . . . 74.41 111.682 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -68.07 -28.68 67.57 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.048 1.339 . . . . 63.0 111.196 -174.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -82.3 -27.12 32.51 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.882 1.273 . . . . 71.02 110.69 -172.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.4 pp -112.07 -2.19 10.21 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-O 117.805 -1.093 . . . . 71.43 112.347 -171.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.4 m -64.82 -56.55 12.81 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 119.784 1.175 . . . . 64.24 109.346 176.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.529 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -55.8 -62.03 5.31 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 123.523 0.729 . . . . 52.42 111.885 -165.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 34.6 Cg_endo -65.69 -22.46 57.5 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.456 1.438 . . . . 63.21 113.045 -173.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 6.0 tpp -64.79 -47.41 78.19 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 124.148 0.979 . . . . 74.13 110.919 171.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -65.05 -35.12 80.14 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.197 0.908 . . . . 73.34 108.891 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -60.05 -38.3 82.4 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.451 0.569 . . . . 73.14 110.393 169.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.75 -16.58 47.44 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.04 -1.037 . . . . 70.11 112.751 -172.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.3 t -111.89 -33.94 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 124.966 1.306 . . . . 73.23 110.495 -171.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -108.57 -54.03 2.56 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.534 1.134 . . . . 63.11 110.93 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt -69.2 -55.79 9.56 Favored 'General case' 0 N--CA 1.462 0.17 0 O-C-N 121.096 -1.002 . . . . 65.25 110.66 -171.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.4 p -104.5 -23.79 13.1 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.726 0.811 . . . . 74.23 112.551 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 55.93 30.86 16.78 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.89 2.076 . . . . 71.24 112.775 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.0 t -62.69 -25.8 68.34 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.602 1.561 . . . . 65.44 112.362 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.508 HG13 HG12 ' A' ' 107' ' ' ILE . 45.1 t -63.01 109.8 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 122.387 1.089 . . . . 70.31 108.22 -177.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.97 -26.4 0.79 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.121 1.769 . . . . 73.31 110.804 -171.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 m -136.99 163.95 29.5 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.577 -1.268 . . . . 74.14 107.577 168.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 85.7 t -53.75 -33.47 23.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 125.961 1.704 . . . . 64.54 109.408 173.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.8 -20.04 65.86 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.067 1.747 . . . . 61.54 112.361 -177.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.29 -49.0 8.01 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.986 0.914 . . . . 45.32 108.9 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.508 HG12 HG13 ' A' ' 101' ' ' VAL . 0.8 OUTLIER -55.57 -48.59 77.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 125.654 1.582 . . . . 63.13 109.122 178.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -20.9 66.72 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.519 -0.753 . . . . 64.12 112.381 -175.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -64.32 -52.77 56.83 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 118.898 0.772 . . . . 74.21 109.594 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.4 t -55.87 -44.15 76.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 123.753 0.658 . . . . 62.35 109.571 -174.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -51.12 -55.68 16.55 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.751 0.42 . . . . 65.31 110.428 175.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 82.6 t -59.32 -47.16 91.47 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-N 118.454 0.57 . . . . 72.34 111.332 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -73.86 -30.84 62.88 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 124.068 0.855 . . . . 74.23 110.369 -168.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.0 -32.41 67.17 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.528 0.731 . . . . 65.21 110.268 170.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 145.09 23.11 0.13 Allowed Glycine 0 CA--C 1.531 1.068 0 N-CA-C 116.768 1.467 . . . . 63.45 116.768 165.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.689 HG13 HD12 ' A' ' 81' ' ' LEU . 48.7 t -94.2 127.42 46.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 119.245 1.522 . . . . 61.23 110.595 -177.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -53.89 116.57 2.62 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.777 0.831 . . . . 74.23 108.78 172.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.36 -24.91 64.21 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-O 118.663 -1.076 . . . . 64.52 111.243 171.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -74.75 -23.31 58.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.168 1.484 . . . . 55.33 112.27 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.528 ' HB3' HD11 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -92.86 -43.73 8.84 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 108.656 -0.868 . . . . 64.13 108.656 -178.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -51.77 -60.65 2.92 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.271 1.428 . . . . 74.35 109.584 172.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -69.84 -14.59 62.82 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 119.718 -0.182 . . . . 72.35 111.091 -168.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -88.42 -58.72 2.45 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.72 1.208 . . . . 54.25 109.873 172.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.5 -36.82 67.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.962 1.705 . . . . 65.34 111.298 -176.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -45.11 -37.68 4.52 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 125.346 1.458 . . . . 70.23 112.189 176.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -108.43 -3.5 18.16 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.823 1.649 . . . . 64.44 113.498 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 32.6 t -81.41 155.38 25.93 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 127.563 2.345 . . . . 74.41 111.706 173.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.85 -21.52 64.28 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 112.599 -2.091 . . . . 65.03 115.778 -171.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.9 t -47.68 -55.42 2.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 C-N-CA 127.42 2.288 . . . . 73.33 106.83 167.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.1 t -71.81 -42.21 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.532 -0.758 . . . . 64.04 109.415 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -54.82 -51.08 66.96 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.448 1.022 . . . . 73.12 112.462 -177.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 67.7 m -69.83 -34.15 73.27 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.144 0.978 . . . . 71.05 111.563 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 11.9 mt -68.62 -46.46 69.19 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.647 1.112 . . . . 72.14 112.113 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 24.7 t -48.67 -53.67 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 C-N-CA 124.399 1.08 . . . . 62.45 109.681 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.35 -40.53 93.72 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 116.351 -1.785 . . . . 72.05 110.87 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -56.39 -45.91 80.37 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 122.235 2.289 . . . . 64.24 112.918 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -53.95 -57.25 11.68 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.184 -1.043 . . . . 74.21 108.184 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 77.6 mm-40 -79.82 -9.91 59.72 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.862 1.265 . . . . 70.05 113.983 -171.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.1 tptt -86.21 -55.23 4.02 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 107.716 -1.216 . . . . 74.05 107.716 176.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.93 -62.23 2.01 Favored 'General case' 0 N--CA 1.444 -0.733 0 O-C-N 124.646 1.216 . . . . 50.24 108.66 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -82.84 0.59 43.32 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.699 1.0 . . . . 64.43 113.699 -162.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -122.06 2.29 9.85 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 117.733 -1.127 . . . . 73.42 112.936 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -57.31 -85.77 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.066 0.848 . . . . 44.21 110.651 174.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 174.74 43.03 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.926 2.49 . . . . 71.12 110.705 174.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.69 -26.54 6.53 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 120.55 -1.344 . . . . 71.21 112.019 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.661 HD23 ' H ' ' A' ' 147' ' ' GLN . 0.1 OUTLIER -127.73 -85.96 0.58 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.571 -1.27 . . . . 74.32 107.571 -167.128 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.661 ' H ' HD23 ' A' ' 146' ' ' LEU . 7.9 mt-30 48.22 29.24 1.8 Allowed 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.428 1.091 . . . . 74.22 112.565 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -154.98 95.62 0.15 Allowed Glycine 0 C--N 1.347 1.152 0 O-C-N 120.337 -1.477 . . . . 62.02 114.826 -164.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.867 HG13 ' CE1' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -95.91 162.38 24.22 Favored Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 113.589 0.959 . . . . 64.23 113.589 -170.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.669 ' HA ' HG12 ' A' ' 149' ' ' VAL . 72.7 Cg_endo -81.51 123.08 8.76 Favored 'Cis proline' 0 C--N 1.352 0.729 0 CA-C-N 119.025 0.687 . . . . 70.1 112.841 -5.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -103.23 141.21 36.29 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 114.6 -1.182 . . . . 62.43 112.471 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 44.5 tpp -146.44 108.63 4.42 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 127.143 2.177 . . . . 61.0 106.355 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -96.71 158.42 15.44 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 123.006 0.191 . . . . 63.32 111.502 172.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.9 t -140.75 146.93 23.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 124.352 1.061 . . . . 72.43 108.56 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 46.71 19.18 0.08 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 128.686 2.794 . . . . 54.4 114.689 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.88 -2.92 58.47 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 120.783 -1.198 . . . . 64.14 113.328 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -140.57 -7.01 1.14 Allowed 'General case' 0 C--O 1.233 0.229 0 N-CA-C 114.434 1.272 . . . . 74.2 114.434 -159.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -124.3 146.08 49.01 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.161 -1.052 . . . . 73.04 108.161 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -113.91 147.71 38.02 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.32 -1.363 . . . . 61.3 107.32 162.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -68.84 140.09 55.22 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.128 -1.064 . . . . 74.11 108.128 170.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -113.81 86.13 10.51 Favored Pre-proline 0 C--O 1.234 0.262 0 C-N-CA 123.254 0.622 . . . . 73.02 111.216 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -61.61 -24.08 77.37 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.111 1.207 . . . . 71.33 112.565 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -66.23 -31.3 72.05 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.786 1.176 . . . . 50.31 110.416 -168.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -90.52 -4.77 70.1 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.737 -1.035 . . . . 51.51 111.823 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 43.8 mtt -78.99 166.18 22.63 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 119.58 1.69 . . . . 73.11 108.69 175.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -79.4 108.96 13.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 104.663 -2.347 . . . . 53.31 104.663 171.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.446 HG22 ' CD1' ' A' ' 173' ' ' PHE . 40.8 p -112.96 50.23 0.89 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.948 2.099 . . . . 74.2 107.019 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 13.9 m -131.31 3.39 4.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.095 -1.412 . . . . 72.32 111.098 -167.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.03 -20.67 1.11 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 126.751 2.02 . . . . 73.24 110.645 174.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 7.9 mmt 73.09 -54.96 0.69 Allowed 'General case' 0 C--N 1.347 0.484 0 C-N-CA 126.063 1.745 . . . . 72.0 110.568 -174.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.79 -50.22 69.03 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.142 1.377 . . . . 61.21 110.531 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 79.1 t -72.18 -24.07 22.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 125.53 1.532 . . . . 64.12 111.574 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.446 ' CD1' HG22 ' A' ' 167' ' ' THR . 35.2 t80 -60.16 -61.85 2.3 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.331 -0.989 . . . . 73.03 108.331 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.9 t -64.92 -33.47 63.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 O-C-N 123.367 0.417 . . . . 52.43 110.474 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.98 -42.91 69.51 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.368 0.667 . . . . 73.33 112.329 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -81.63 -40.41 22.98 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 118.492 -0.766 . . . . 65.01 110.874 176.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -54.85 -57.8 10.13 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.479 1.112 . . . . 74.31 110.154 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -55.69 -32.03 62.94 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.925 0.89 . . . . 65.44 111.571 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -65.88 -58.4 5.68 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.936 -0.394 . . . . 62.11 109.936 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.4 t -63.1 -29.96 71.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 116.93 -1.51 . . . . 65.12 110.771 -173.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 47.5 t -56.49 -56.95 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 120.138 1.335 . . . . 45.34 108.189 173.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.31 -43.46 83.28 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 124.649 1.18 . . . . 61.04 111.093 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -64.65 -30.1 71.11 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 119.001 0.819 . . . . 75.04 112.244 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 52.6 mt -74.27 -23.68 59.15 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 120.44 -1.412 . . . . 74.23 111.833 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 84.7 t -62.71 -30.21 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.646 -0.501 . . . . 72.24 109.646 174.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -99.17 -8.11 25.59 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.885 0.874 . . . . 74.04 110.872 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -110.82 77.26 1.03 Allowed 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 120.668 -1.27 . . . . 71.32 109.406 -174.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.043 0 C-N-CA 127.52 2.328 . . . . 75.22 112.634 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 113.996 1.11 . . . . 71.15 113.996 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -166.25 109.74 0.77 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.12 1.768 . . . . 71.31 106.894 -177.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.458 HD12 ' CD2' ' A' ' 9' ' ' TYR . 6.4 pt -117.24 166.32 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.499 1.119 . . . . 72.43 110.349 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.6 m -149.28 141.85 24.41 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.297 -1.372 . . . . 73.33 107.297 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -59.41 149.27 29.8 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.744 0.783 . . . . 71.23 109.399 174.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.81 -21.34 2.08 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-O 117.587 -1.674 . . . . 71.45 112.629 -172.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -99.56 -69.5 0.76 Allowed 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 120.966 2.383 . . . . 74.44 110.224 -165.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -107.95 -15.91 14.42 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 123.684 0.794 . . . . 64.14 110.637 -177.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.458 ' CD2' HD12 ' A' ' 3' ' ' ILE . 38.0 p90 -141.86 167.99 20.83 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 108.49 -0.93 . . . . 72.15 108.49 171.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 mm -131.26 142.29 43.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 104.652 -2.351 . . . . 72.14 104.652 168.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.1 m -78.4 171.13 15.54 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 125.144 1.378 . . . . 62.33 108.354 170.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 32.9 mt -113.14 161.65 16.88 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.99 0.916 . . . . 73.15 110.467 171.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -80.37 -37.75 31.72 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.287 1.035 . . . . 75.45 108.716 -174.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -133.26 71.33 76.91 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 125.42 1.488 . . . . 74.3 110.807 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 CA--C 1.535 0.551 1 C-N-CA 125.547 4.165 . . . . 74.35 111.033 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 CA--C 1.542 0.66 0 N-CA-C 112.776 0.658 . . . . 63.01 112.776 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.519 HD22 ' CZ ' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -122.92 154.77 37.92 Favored 'General case' 0 CA--C 1.518 -0.287 0 O-C-N 121.352 -0.843 . . . . 65.43 113.249 -163.01 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -135.83 141.19 44.65 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 125.244 1.418 . . . . 71.22 108.101 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.519 ' CZ ' HD22 ' A' ' 23' ' ' LEU . 98.0 m-85 -127.75 137.77 52.54 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.738 1.215 . . . . 73.23 109.62 -176.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -165.38 -178.48 5.01 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.988 1.715 . . . . 74.42 109.749 -177.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.7 t -143.94 -174.48 4.28 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.776 1.23 . . . . 72.03 108.142 171.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.868 ' CD1' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -92.23 -7.66 47.58 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.507 1.299 . . . . 74.44 114.507 175.273 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -100.29 -4.92 28.31 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.922 0.889 . . . . 73.2 112.826 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.7 p -80.07 140.83 53.75 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 120.681 1.582 . . . . 71.04 108.764 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -92.07 -30.74 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 CA-C-N 120.133 1.083 . . . . 63.13 111.055 -168.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -64.25 -50.08 69.38 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.952 1.701 . . . . 75.22 109.517 171.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.5 p -67.0 -22.93 65.88 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 117.582 -1.199 . . . . 70.44 111.706 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -57.21 -55.08 39.39 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 120.338 1.427 . . . . 62.32 109.312 170.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -55.05 -46.46 75.36 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 108.804 -0.813 . . . . 71.05 108.804 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -65.58 -16.45 63.72 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 116.796 -1.574 . . . . 73.21 113.324 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -116.29 -8.13 11.71 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 121.105 1.775 . . . . 73.11 111.762 -173.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -141.38 -30.15 0.62 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.75 0.82 . . . . 72.05 112.907 -163.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.2 t -115.4 -68.02 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 N-CA-C 107.466 -1.309 . . . . 65.22 107.466 -172.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.8 mt -66.44 -28.41 68.58 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.843 -1.071 . . . . 72.15 111.075 171.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 45.14 41.6 5.94 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.438 1.495 . . . . 52.42 111.833 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.2 t -50.88 -48.2 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 C-N-CA 125.79 1.636 . . . . 73.12 108.696 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.3 p -46.08 -55.71 6.58 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 124.791 1.307 . . . . 65.14 112.293 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -75.36 -34.86 61.19 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 119.913 -1.742 . . . . 64.43 110.665 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.45 -54.58 45.22 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 123.035 0.534 . . . . 64.24 110.474 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.602 HG12 ' HG ' ' A' ' 50' ' ' LEU . 23.5 t -60.82 -43.02 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 109.253 -0.647 . . . . 74.01 109.253 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.685 ' HA ' HD12 ' A' ' 50' ' ' LEU . 40.7 ttt-85 -53.72 -29.5 39.6 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.391 1.256 . . . . 74.43 114.391 176.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -89.78 -3.56 58.1 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.186 1.18 . . . . 65.21 114.186 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -128.12 0.03 5.83 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.929 2.092 . . . . 70.22 113.032 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.693 HD13 ' O ' ' A' ' 54' ' ' THR . 6.3 mt -63.11 154.37 77.79 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.378 1.471 . . . . 63.11 108.988 -177.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.12 151.33 26.9 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.32 2.68 . . . . 70.05 108.837 172.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 45.46 24.01 0.16 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.236 2.615 . . . . 50.12 115.645 174.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.27 33.34 75.0 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-O 117.851 -1.527 . . . . 72.35 113.659 -172.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.693 ' O ' HD13 ' A' ' 50' ' ' LEU . 26.0 m -61.59 69.62 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.775 1.63 . . . . 73.34 111.191 172.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -63.63 132.19 50.37 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 120.385 -1.447 . . . . 74.2 108.357 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -75.57 173.56 10.85 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.037 0.935 . . . . 73.11 112.178 -174.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.84 154.01 26.97 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.557 0.743 . . . . 65.04 109.368 170.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.78 102.0 6.36 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.306 1.042 . . . . 54.21 108.488 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.421 ' HB2' HD21 ' A' ' 23' ' ' LEU . 10.6 m-30 -97.0 168.22 10.6 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.348 1.059 . . . . 74.3 110.336 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.593 ' CE1' ' HB2' ' A' ' 137' ' ' GLN . 0.3 OUTLIER -101.18 172.05 7.24 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.986 1.314 . . . . 65.4 108.569 -179.249 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.666 HG12 ' HB1' ' A' ' 141' ' ' ALA . 11.9 m -140.42 145.8 25.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 107.445 -1.317 . . . . 73.21 107.445 162.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . 0.293 0.0 OUTLIER -102.37 17.97 22.21 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 129.084 2.953 . . . . 71.23 113.54 -177.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -84.18 -4.33 58.74 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.294 1.438 . . . . 54.32 114.367 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.59 145.48 51.13 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 119.827 -1.796 . . . . 74.42 110.29 -166.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.87 -178.69 7.2 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 121.375 0.431 . . . . 55.54 112.517 174.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -78.36 -46.63 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.316 2.677 . . . . 62.13 113.308 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.8 mt -79.17 31.69 0.22 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.655 1.116 . . . . 72.44 112.518 -174.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -43.24 -63.71 1.99 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 126.053 1.787 . . . . 75.2 110.689 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -63.02 -40.06 96.62 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 117.548 0.674 . . . . 73.1 110.647 -172.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.51 -42.43 92.18 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.263 1.425 . . . . 73.41 110.458 -175.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.868 HD11 ' CD1' ' A' ' 28' ' ' PHE . 18.6 mt -65.33 -45.17 85.33 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 118.533 -0.746 . . . . 73.22 111.392 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.537 HG22 ' CE1' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -46.78 -53.73 11.3 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.057 -1.09 . . . . 65.04 108.057 175.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -58.17 -55.89 29.09 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.945 0.898 . . . . 73.43 110.418 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.88 -43.18 72.95 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 120.186 1.357 . . . . 61.42 113.838 -176.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 14.0 t-105 -59.8 -38.0 80.71 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.341 -0.85 . . . . 74.12 111.355 -174.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.39 -38.57 71.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 118.062 -0.971 . . . . 73.2 112.557 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.6 t -57.03 -47.77 82.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 120.031 1.287 . . . . 65.11 109.933 171.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.22 -40.53 94.24 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.868 -0.52 . . . . 65.33 111.237 -176.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 85.8 mt -67.01 -38.2 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.736 0.815 . . . . 42.21 109.68 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.86 -50.61 72.73 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.858 0.863 . . . . 74.5 110.111 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 77.4 mt -76.2 -27.75 56.99 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.805 -0.559 . . . . 73.53 112.098 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.51 62.4 2.72 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 126.566 2.032 . . . . 44.33 110.603 -173.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.0 m -129.81 14.07 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 125.226 1.41 . . . . 72.2 112.303 -174.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -49.99 -51.87 38.26 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 125.064 1.346 . . . . 72.02 112.307 -169.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.62 -43.02 79.78 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.37 1.468 . . . . 71.34 110.373 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -64.05 -27.12 68.89 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 124.456 1.102 . . . . 74.1 110.609 -176.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.3 pp -116.48 27.19 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 126.847 2.059 . . . . 42.13 109.876 -176.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 89.9 m -97.67 -54.58 3.07 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.755 -1.202 . . . . 64.0 107.755 164.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.501 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -52.52 -62.09 3.74 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 113.721 1.008 . . . . 53.2 113.721 -172.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 56.8 Cg_endo -70.37 -27.29 23.75 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.194 1.263 . . . . 72.34 111.557 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 32.6 tpp -65.07 -49.9 68.25 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.557 1.143 . . . . 73.12 109.635 -177.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -69.34 -35.63 76.09 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.49 -0.93 . . . . 63.02 108.49 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.494 ' CG ' ' HE3' ' A' ' 97' ' ' LYS . 2.6 mt-10 -65.68 -11.19 42.96 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 114.367 1.247 . . . . 70.4 114.367 169.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -109.15 1.52 20.41 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.576 1.08 . . . . 71.01 113.488 172.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.859 HG21 ' CD2' ' A' ' 28' ' ' PHE . 95.8 t -115.38 -34.66 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 117.392 -1.289 . . . . 33.41 114.04 175.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -108.84 -53.0 2.7 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 120.547 1.521 . . . . 65.44 113.401 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.494 ' HE3' ' CG ' ' A' ' 93' ' ' GLU . 2.9 mmmt -62.08 -64.54 0.9 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.479 1.911 . . . . 63.23 112.713 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.9 p -87.88 -30.66 19.97 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.736 1.384 . . . . 64.21 114.736 174.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 56.1 35.73 26.16 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 128.348 2.659 . . . . 72.0 114.432 -173.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.5 t -71.31 -22.36 61.94 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.342 0.867 . . . . 73.34 113.342 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.486 HG13 HG12 ' A' ' 107' ' ' ILE . 25.4 t -66.71 120.33 13.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 O-C-N 120.625 -1.297 . . . . 74.44 110.217 172.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -140.63 -28.8 0.7 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.063 -0.971 . . . . 74.31 111.633 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.83 174.39 10.58 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.539 1.063 . . . . 63.12 110.178 168.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.5 t -57.68 -41.32 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.139 0.975 . . . . 72.4 111.267 -169.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.28 -23.77 62.7 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 119.204 -0.427 . . . . 73.1 111.679 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -78.19 -30.54 49.06 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 119.044 0.838 . . . . 73.04 111.207 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.486 HG12 HG13 ' A' ' 101' ' ' VAL . 1.4 mt -81.8 -48.26 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 108.293 -1.003 . . . . 72.02 108.293 -174.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -62.18 -18.23 60.41 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.577 0.751 . . . . 73.0 112.356 179.336 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -62.5 -56.85 14.14 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 125.43 1.492 . . . . 61.44 109.837 169.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.7 t -61.77 -34.47 62.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 118.645 -0.693 . . . . 62.1 110.804 -175.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -49.62 -60.46 2.85 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.016 -0.735 . . . . 73.31 109.016 169.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.1 t -57.09 -49.03 80.82 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-O 118.922 -0.561 . . . . 71.41 109.814 -176.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.23 -43.22 96.23 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 124.062 0.851 . . . . 73.1 110.159 -170.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.87 0.25 7.66 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.73 1.612 . . . . 71.31 112.852 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.49 44.76 1.41 Allowed Glycine 0 CA--C 1.523 0.566 0 C-N-CA 124.973 1.273 . . . . 71.5 112.917 171.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.0 t -112.38 140.8 30.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 118.977 1.388 . . . . 65.1 110.765 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -64.28 110.12 2.12 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.307 1.443 . . . . 74.5 109.134 165.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.92 -23.37 65.64 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-O 118.162 -1.354 . . . . 74.44 110.931 168.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -70.95 -23.05 62.15 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.621 1.211 . . . . 74.24 110.977 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -87.79 -46.34 9.54 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.701 -1.222 . . . . 72.41 107.701 176.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 108' ' ' ARG . 14.9 t80 -51.97 -57.31 9.83 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.622 0.769 . . . . 65.4 109.603 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -74.7 -9.48 58.61 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.88 0.872 . . . . 62.4 112.43 -171.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -87.78 -66.15 0.94 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.909 1.283 . . . . 50.4 109.355 166.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -49.34 -43.06 43.44 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.397 2.279 . . . . 71.14 111.45 -174.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -45.55 -35.69 4.1 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 126.303 1.841 . . . . 72.03 113.507 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -116.91 8.45 13.51 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.713 1.205 . . . . 64.03 111.828 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 21.3 t -95.69 159.85 14.78 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 127.16 2.184 . . . . 72.23 110.226 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -57.14 -33.03 66.98 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.301 1.44 . . . . 63.34 111.892 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.8 t -49.57 -54.27 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 124.107 0.963 . . . . 61.11 109.912 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.5 t -63.87 -49.54 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 123.803 0.841 . . . . 61.23 110.694 176.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -49.61 -54.35 18.86 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.926 0.784 . . . . 72.04 111.549 -177.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.12 -40.0 93.89 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.102 0.561 . . . . 74.3 111.998 177.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.8 mt -60.6 -49.36 77.84 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-O 116.61 -1.662 . . . . 53.41 110.891 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 99.1 t -56.78 -37.26 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 120.199 1.363 . . . . 70.43 110.428 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.65 -28.83 70.18 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 117.763 -1.113 . . . . 72.21 112.329 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -53.47 -49.48 67.36 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 119.803 1.183 . . . . 64.0 112.097 175.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.593 ' HB2' ' CE1' ' A' ' 60' ' ' HIS . 0.5 OUTLIER -103.77 -18.96 14.46 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 118.54 -0.743 . . . . 64.11 110.636 -166.07 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -60.07 -52.82 63.73 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.922 -1.14 . . . . 64.42 107.922 158.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 32.1 tttp -61.15 -18.7 59.46 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.268 0.94 . . . . 72.3 113.181 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -114.9 1.19 13.97 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 115.816 1.784 . . . . 65.33 115.816 -176.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.666 ' HB1' HG12 ' A' ' 61' ' ' VAL . . . -139.18 -19.1 0.99 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 119.462 1.028 . . . . 62.34 111.609 177.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -104.7 -4.77 22.02 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 117.942 -1.027 . . . . 63.23 110.94 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -59.81 -83.03 0.02 OUTLIER 'General case' 0 C--N 1.345 0.401 0 C-N-CA 125.929 1.692 . . . . 75.32 109.934 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.2 pp -172.92 -11.18 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.106 1.521 . . . . 64.02 115.106 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.441 HE21 ' H ' ' A' ' 145' ' ' GLN . 0.0 OUTLIER -68.2 -44.27 76.23 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.321 1.418 . . . . 73.22 112.556 -162.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.24 -70.05 0.79 Allowed 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 125.736 1.614 . . . . 75.02 109.561 -157.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 68.26 -3.75 1.22 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.676 1.991 . . . . 75.31 115.367 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -146.16 160.39 28.15 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 122.731 2.514 . . . . 51.1 112.709 174.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.446 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 19.3 m -142.23 167.01 17.8 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-N 118.532 1.166 . . . . 72.21 112.61 -174.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.446 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 36.5 Cg_endo -61.35 165.21 33.51 Favored 'Cis proline' 0 C--N 1.353 0.812 0 CA-C-N 119.743 0.944 . . . . 53.43 111.911 -11.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -149.67 151.49 33.8 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.563 -0.903 . . . . 65.41 108.563 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 6.6 ttm -149.25 117.97 6.61 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.531 -1.285 . . . . 74.14 107.531 -172.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -124.22 107.04 10.78 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 125.038 1.335 . . . . 73.32 110.015 -169.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 81.5 t -64.06 -65.16 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.177 0.591 . . . . 52.22 111.672 -170.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -132.96 25.02 4.28 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.793 2.037 . . . . 74.41 108.136 -171.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 68.0 20.2 72.51 Favored Glycine 0 C--N 1.343 0.951 0 C-N-CA 124.774 1.178 . . . . 51.44 113.988 -177.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.52 ' HE2' ' CZ ' ' A' ' 158' ' ' TYR . 18.7 ptmt -138.43 -7.65 1.51 Allowed 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 115.089 1.514 . . . . 44.23 115.089 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.52 ' CZ ' ' HE2' ' A' ' 157' ' ' LYS . 22.9 m-85 -133.94 122.09 22.61 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.457 -1.683 . . . . 72.24 106.457 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.12 143.87 27.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 105.518 -2.03 . . . . 70.44 105.518 161.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.442 ' CD1' HG23 ' A' ' 180' ' ' THR . 3.5 mm? -69.9 142.73 52.93 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.88 -1.155 . . . . 73.13 107.88 166.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -112.57 85.76 7.69 Favored Pre-proline 0 N--CA 1.453 -0.292 0 N-CA-C 113.024 0.75 . . . . 53.55 113.024 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.39 -19.74 37.52 Favored 'Trans proline' 0 N--CA 1.443 -1.486 0 C-N-CA 120.454 0.769 . . . . 74.23 111.1 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -61.86 -20.48 63.75 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 119.626 1.103 . . . . 75.41 112.821 -175.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -108.75 3.72 32.25 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 117.641 -1.644 . . . . 72.42 113.326 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 56.3 mtt -93.01 173.57 7.67 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.91 2.355 . . . . 70.04 111.794 -168.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.57 58.54 3.75 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 123.568 1.651 . . . . 73.41 111.764 -171.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 72.2 p -72.96 16.07 0.17 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.474 2.31 . . . . 65.34 112.851 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.4 m -94.43 -8.79 37.58 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.945 1.698 . . . . 65.23 112.707 173.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.0 -14.08 4.47 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 119.5 1.045 . . . . 73.34 113.181 -174.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 4.5 mmt 70.6 -57.66 0.58 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.591 1.957 . . . . 74.34 113.926 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.22 -48.95 68.93 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.694 -1.225 . . . . 70.33 107.694 -178.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.423 HG12 ' NE2' ' A' ' 176' ' ' GLN . 21.2 t -65.05 -36.81 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 124.928 1.291 . . . . 70.33 109.567 -177.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -52.14 -60.73 2.86 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 118.262 -0.875 . . . . 74.32 110.135 172.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 8.9 t -66.76 -39.26 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 119.198 0.908 . . . . 61.11 111.392 -175.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.42 -33.97 64.01 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.617 0.767 . . . . 63.01 111.419 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.423 ' NE2' HG12 ' A' ' 172' ' ' VAL . 34.8 mt-30 -88.94 -31.4 18.19 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.393 1.077 . . . . 71.13 112.159 175.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -58.68 -59.64 5.09 Favored 'General case' 0 CA--C 1.528 0.099 0 O-C-N 120.8 -1.187 . . . . 73.34 108.965 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.27 -32.7 72.52 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.873 -0.517 . . . . 72.04 111.795 -175.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.96 -52.01 67.23 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.879 1.272 . . . . 74.44 111.835 174.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.442 HG23 ' CD1' ' A' ' 160' ' ' LEU . 9.0 t -64.88 -30.22 71.21 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 117.403 -1.284 . . . . 72.44 110.491 177.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 99.9 t -60.07 -55.89 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 120.455 1.479 . . . . 74.05 108.302 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -62.42 -33.93 75.76 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-O 118.903 -0.57 . . . . 74.42 111.979 -177.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -68.92 -33.8 74.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.645 0.657 . . . . 71.14 111.342 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 34.4 mt -67.99 -29.36 68.36 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 120.957 -1.09 . . . . 73.13 111.936 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 62.2 t -62.06 -26.03 38.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.437 0.695 . . . . 72.43 111.506 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -98.34 -18.35 18.38 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.508 0.595 . . . . 54.23 110.531 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -96.32 76.56 2.98 Favored 'General case' 0 CA--C 1.516 -0.349 0 O-C-N 121.035 -1.041 . . . . 70.13 108.851 -172.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.246 0.896 0 C-N-CA 127.832 2.453 . . . . 73.24 112.023 -174.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.524 0 N-CA-C 114.207 1.188 . . . . 72.21 114.207 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -163.78 120.75 1.75 Allowed 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.344 -1.724 . . . . 72.13 106.344 174.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.71 HG21 HG23 ' A' ' 180' ' ' THR . 9.8 pt -133.14 160.7 42.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 126.444 1.898 . . . . 51.41 109.592 177.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.5 m -140.4 144.51 36.23 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 121.607 -0.683 . . . . 61.33 109.551 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -51.37 142.04 14.18 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 127.238 2.215 . . . . 71.15 111.117 168.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.09 -22.79 2.32 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.415 1.007 . . . . 53.53 112.582 -176.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -102.38 -77.79 0.55 Allowed 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 124.129 0.971 . . . . 62.13 108.672 -165.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -100.24 -15.84 17.94 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.413 1.085 . . . . 71.14 110.719 -174.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -140.95 159.34 42.42 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.217 -0.66 . . . . 71.13 109.217 165.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.4 mm -113.55 162.55 11.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 124.762 1.225 . . . . 71.02 107.695 173.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 m -117.24 147.9 42.12 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.426 1.49 . . . . 65.12 107.603 176.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.2 mt -86.18 154.66 21.16 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.52 -0.548 . . . . 73.35 109.52 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -72.28 -37.33 69.06 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.878 1.671 . . . . 73.44 109.693 176.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -127.59 85.12 61.56 Favored Pre-proline 0 C--N 1.34 0.178 0 C-N-CA 127.479 2.312 . . . . 73.54 108.331 173.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo . . . . . 0 N--CA 1.45 -1.031 0 C-N-CA 123.732 2.954 . . . . 74.04 109.583 168.583 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.8 t . . . . . 0 CA--C 1.537 0.45 0 CA-C-O 121.395 0.617 . . . . 72.24 111.206 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.3 tp -157.24 148.22 21.64 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.724 0.81 . . . . 73.04 109.747 -174.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -140.52 153.12 46.05 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.946 1.698 . . . . 73.43 109.262 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -133.35 139.32 46.76 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.727 1.211 . . . . 74.31 108.527 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.81 -179.71 7.81 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.285 1.834 . . . . 70.24 108.512 -177.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -158.68 161.87 37.16 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.872 0.76 . . . . 53.54 111.366 174.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -70.47 -39.83 74.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.461 1.504 . . . . 70.24 112.111 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.456 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 80.3 m-85 -93.6 18.09 10.6 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.567 1.147 . . . . 74.2 111.793 177.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 33.8 t -88.73 141.68 30.18 Favored Pre-proline 0 CA--C 1.538 0.503 0 O-C-N 120.136 -1.603 . . . . 72.11 110.042 171.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -83.68 -46.56 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 121.73 1.62 . . . . 71.41 112.165 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -61.45 -44.06 97.77 Favored 'General case' 0 CA--C 1.528 0.115 0 O-C-N 121.56 -0.712 . . . . 73.44 109.537 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.7 m -57.02 -33.34 67.08 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.566 0.746 . . . . 72.24 112.097 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -58.93 -53.55 57.17 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.438 0.695 . . . . 64.12 110.105 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.401 HE21 ' HA ' ' A' ' 35' ' ' GLN . 0.8 OUTLIER -56.54 -47.73 78.79 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 118.431 -0.795 . . . . 72.53 109.432 177.049 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.434 ' CD2' HG21 ' A' ' 42' ' ' VAL . 10.4 m-85 -62.13 -19.83 63.43 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 116.83 -1.557 . . . . 74.12 112.341 -174.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -134.84 10.12 3.61 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 120.925 1.693 . . . . 62.32 112.11 -164.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -135.7 -41.21 0.69 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.868 2.067 . . . . 71.33 111.209 169.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 83.7 t -98.47 -74.57 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.11 0 N-CA-C 107.89 -1.152 . . . . 64.02 107.89 -168.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 65.7 mt -62.0 -28.19 69.4 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.985 1.314 . . . . 63.33 111.663 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 1.2 m170 44.36 56.76 4.76 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.669 1.988 . . . . 65.43 111.783 177.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.509 ' O ' HG23 ' A' ' 46' ' ' VAL . 63.6 t -62.06 -44.59 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 125.293 1.437 . . . . 74.13 109.752 -174.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.9 t -53.05 -44.77 67.68 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.333 0.97 . . . . 62.14 111.99 -175.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -76.89 -29.71 55.88 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 121.194 -0.941 . . . . 72.33 111.447 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -63.23 -46.99 84.38 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.492 0.717 . . . . 53.41 110.607 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 42' ' ' VAL . 1.9 t -59.53 -51.24 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 108.238 -1.023 . . . . 61.02 108.238 177.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 37.8 ttt-85 -47.36 -46.32 25.63 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.378 1.071 . . . . 72.4 111.948 177.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -64.89 -2.8 2.82 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.155 1.169 . . . . 73.12 114.155 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.6 mmtt -132.01 -9.9 3.42 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 127.466 2.306 . . . . 65.1 113.724 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.535 HD13 HG21 ' A' ' 54' ' ' THR . 7.7 mt -66.95 144.81 98.73 Favored Pre-proline 0 C--O 1.237 0.4 0 CA-C-N 119.306 0.957 . . . . 74.15 110.882 -164.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.69 165.38 32.89 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.988 2.459 . . . . 50.31 109.78 167.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.88 23.29 0.7 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.774 1.027 . . . . 65.22 113.774 -173.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.67 18.21 22.56 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 127.139 2.304 . . . . 71.34 112.057 -173.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.535 HG21 HD13 ' A' ' 50' ' ' LEU . 1.3 t -130.08 129.39 43.53 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.462 -1.31 . . . . 72.14 107.462 -163.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -96.29 121.1 37.71 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 104.8 -2.296 . . . . 65.41 104.8 166.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 6.2 ttm -66.39 102.49 0.88 Allowed 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 125.074 1.35 . . . . 74.35 108.02 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 58' ' ' LYS . 1.5 m -120.0 -171.73 2.21 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.215 -1.032 . . . . 73.31 108.215 -173.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.452 ' H ' HG22 ' A' ' 57' ' ' THR . 0.0 OUTLIER 174.58 108.99 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.423 1.489 . . . . 71.24 108.102 -173.053 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -108.59 146.67 32.96 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.795 1.18 . . . . 74.15 109.855 174.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.41 ' CE1' ' HB3' ' A' ' 137' ' ' GLN . 0.2 OUTLIER -82.01 168.54 17.72 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.242 1.017 . . . . 74.02 109.543 -174.482 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.508 HG12 ' HB1' ' A' ' 141' ' ' ALA . 6.6 m -139.03 111.12 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 119.528 1.058 . . . . 74.45 108.521 158.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.89 4.68 13.44 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 124.719 1.208 . . . . 44.25 113.183 176.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -55.77 -8.48 0.41 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.173 1.789 . . . . 72.15 113.376 169.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.8 132.07 34.19 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 125.425 1.49 . . . . 70.34 109.996 -176.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.456 ' HA3' ' CD2' ' A' ' 29' ' ' TYR . . . 116.59 156.54 10.7 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 126.443 1.973 . . . . 62.32 112.014 168.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -62.99 -56.12 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.47 2.113 . . . . 61.54 109.544 167.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.6 mt -91.21 34.99 0.92 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.652 1.581 . . . . 61.32 109.912 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.95 -51.89 50.41 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.508 -1.037 . . . . 70.54 110.508 175.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.9 tppm? -57.14 -40.2 76.72 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.291 1.036 . . . . 72.41 112.181 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.88 -38.63 89.29 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.852 1.661 . . . . 72.33 110.31 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.7 mt -67.36 -41.05 85.73 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 117.808 -1.092 . . . . 53.31 111.641 174.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.03 -56.65 14.49 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.922 1.289 . . . . 72.31 108.975 -177.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -62.4 -41.93 99.05 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.409 0.684 . . . . 61.25 109.477 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.14 -30.96 69.64 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 113.443 0.905 . . . . 72.42 113.443 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 33.7 t-105 -61.56 -41.04 96.8 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 118.507 0.594 . . . . 71.13 111.518 -176.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.89 -36.31 76.67 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 117.665 -1.16 . . . . 65.23 112.492 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.2 t -55.72 -46.69 79.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 120.711 1.596 . . . . 73.12 110.796 171.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.01 -43.16 88.49 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-O 119.137 -0.459 . . . . 61.14 110.628 -175.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.2 mt -63.65 -39.87 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 118.758 -0.639 . . . . 71.34 109.965 176.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.74 -22.84 66.04 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.622 0.646 . . . . 32.42 112.279 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.2 mt -99.49 -11.78 20.76 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.214 0.916 . . . . 73.14 112.631 169.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 64.11 56.06 20.41 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 124.346 0.974 . . . . 74.03 111.372 -173.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.7 m -133.88 14.46 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 124.174 0.99 . . . . 73.34 112.107 -176.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -45.36 -56.82 4.54 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.664 1.186 . . . . 74.35 109.386 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.31 -10.33 59.64 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 125.438 1.495 . . . . 74.45 111.886 -172.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -87.32 -30.73 20.62 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 120.827 -1.17 . . . . 52.34 110.715 171.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.447 HG22 ' HB3' ' A' ' 114' ' ' ALA . 2.5 pp -100.55 -14.58 7.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 CA-C-O 117.374 -1.298 . . . . 33.43 111.463 -171.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.1 m -59.09 -51.62 69.24 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 119.967 1.258 . . . . 73.12 110.583 -175.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.563 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -57.15 -62.14 5.77 Favored Pre-proline 0 N--CA 1.452 -0.357 0 C-N-CA 124.569 1.147 . . . . 33.25 110.734 -168.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 57.0 Cg_endo -67.05 -26.83 42.86 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 120.911 1.074 . . . . 72.2 112.397 -176.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 4.5 tpp -60.5 -49.55 77.09 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.221 0.464 . . . . 70.43 110.185 170.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -64.58 -37.13 86.51 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.029 0.831 . . . . 74.01 109.077 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.33 -32.83 72.71 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.68 0.673 . . . . 73.24 111.666 171.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.13 -17.17 29.75 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.355 -1.466 . . . . 65.11 112.817 -176.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.4 t -100.54 -43.4 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 124.9 1.28 . . . . 51.41 109.488 -176.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -98.59 -60.62 1.51 Allowed 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.161 0.984 . . . . 53.1 110.215 -177.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.5 mmmt -65.94 -58.45 5.51 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 118.902 -0.57 . . . . 65.12 110.581 -167.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.2 p -97.18 -16.51 20.39 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.672 0.619 . . . . 64.41 112.672 -176.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 48.12 25.62 0.86 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.659 2.384 . . . . 74.14 113.885 -175.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.9 t -62.76 -16.0 55.9 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.62 1.968 . . . . 73.11 112.013 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.411 HG13 HG12 ' A' ' 107' ' ' ILE . 70.1 t -68.5 111.87 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 O-C-N 121.182 -0.949 . . . . 64.2 109.236 175.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -136.81 -30.12 0.9 Allowed 'General case' 0 C--O 1.239 0.524 0 C-N-CA 125.058 1.343 . . . . 70.25 110.275 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.26 162.28 33.44 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.15 -0.685 . . . . 71.55 109.15 174.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.82 -30.27 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.819 0.847 . . . . 53.45 110.138 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -47.4 -39.94 16.53 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.442 2.297 . . . . 71.55 113.31 168.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -77.55 -38.93 47.53 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.691 -0.855 . . . . 74.24 108.691 -175.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.411 HG12 HG13 ' A' ' 101' ' ' VAL . 2.7 mt -66.76 -48.33 80.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 125.103 1.361 . . . . 71.11 107.864 -174.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -57.76 -31.74 66.8 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-O 117.341 -1.314 . . . . 63.34 112.765 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -57.33 -57.12 14.04 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 119.601 1.091 . . . . 73.35 109.153 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.19 -37.73 78.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 123.371 0.419 . . . . 53.13 110.678 -173.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -53.92 -51.7 62.9 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 118.373 0.533 . . . . 70.15 110.659 172.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 90.2 t -64.18 -44.91 97.6 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-N 118.37 0.532 . . . . 71.34 110.631 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -63.14 -41.54 99.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.808 0.813 . . . . 74.24 108.939 -170.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.447 ' HB3' HG22 ' A' ' 87' ' ' ILE . . . -79.29 -4.31 50.17 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.144 1.378 . . . . 72.33 112.866 176.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 123.21 22.66 2.31 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 117.163 1.625 . . . . 64.02 117.163 160.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.5 t -97.61 134.23 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 119.551 1.675 . . . . 70.42 109.667 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.422 ' HE2' ' OE2' ' A' ' 119' ' ' GLU . 0.8 OUTLIER -63.51 143.59 57.7 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 121.635 -0.666 . . . . 63.15 110.138 176.31 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.54 -10.89 76.36 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 119.565 -0.575 . . . . 71.34 112.749 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.422 ' OE2' ' HE2' ' A' ' 117' ' ' LYS . 6.9 pt-20 -92.3 -32.22 15.09 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 123.903 0.881 . . . . 63.03 110.326 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -70.09 -46.59 64.55 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 107.375 -1.343 . . . . 74.41 107.375 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -54.08 -60.12 3.75 Favored 'General case' 0 N--CA 1.438 -1.046 0 O-C-N 123.876 0.735 . . . . 73.44 109.437 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -75.22 -19.47 59.76 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 118.183 -0.913 . . . . 74.35 112.145 -171.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.64 -63.91 1.24 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.374 0.988 . . . . 73.43 108.876 172.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.77 -37.86 63.88 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.359 1.064 . . . . 70.04 110.581 -173.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -45.33 -36.72 4.33 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.675 1.59 . . . . 61.34 113.308 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -114.69 1.04 14.08 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.535 1.134 . . . . 72.32 112.976 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.8 t -77.36 147.18 36.24 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 126.215 1.806 . . . . 73.42 111.097 171.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.42 -27.79 26.36 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 118.703 2.853 . . . . 72.04 118.703 174.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 46.1 t -45.48 -57.15 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 C-N-CA 126.186 1.794 . . . . 74.35 107.924 167.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.3 t -68.65 -45.45 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 123.81 0.844 . . . . 70.21 109.576 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 58.3 mttt -54.41 -48.7 71.3 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.453 1.024 . . . . 74.13 112.428 -174.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 66.0 m -79.09 -22.0 45.88 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 113.183 0.809 . . . . 71.44 113.183 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 13.4 mt -69.15 -51.41 38.53 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 119.668 1.122 . . . . 63.12 110.172 167.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 52.9 t -49.84 -51.54 15.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.162 0 C-N-CA 125.209 1.404 . . . . 70.44 108.298 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.55 -39.09 75.89 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 118.067 -0.968 . . . . 65.15 113.101 -176.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -57.9 -46.56 84.76 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 119.399 0.999 . . . . 72.05 111.169 172.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.41 ' HB3' ' CE1' ' A' ' 60' ' ' HIS . 56.2 mt-30 -82.22 -31.61 30.18 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.901 -1.045 . . . . 71.01 109.226 -163.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -66.12 -52.74 45.74 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.635 -0.876 . . . . 73.52 108.635 167.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.9 ttmm -61.6 -7.77 3.68 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.132 -0.98 . . . . 63.35 113.449 177.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.4 -12.07 9.42 Favored 'General case' 0 CA--C 1.515 -0.394 0 O-C-N 120.27 -1.519 . . . . 72.21 114.545 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.508 ' HB1' HG12 ' A' ' 61' ' ' VAL . . . -134.17 1.01 3.18 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 119.038 0.835 . . . . 63.34 112.633 -175.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.32 0.85 4.6 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.835 1.654 . . . . 63.45 111.248 171.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -65.12 -86.56 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.878 0.871 . . . . 73.51 111.676 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.5 pp -175.81 23.95 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.351 0.978 . . . . 74.43 112.003 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -103.75 -71.91 0.72 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 120.151 1.341 . . . . 73.12 109.539 -168.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.53 -74.12 0.4 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 126.512 1.925 . . . . 61.43 110.431 -169.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 60.27 7.62 1.32 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 128.239 2.616 . . . . 71.45 115.304 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -147.18 146.42 16.22 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 109.034 -1.627 . . . . 63.31 109.034 176.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 5.2 m -137.14 169.15 13.99 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 118.271 1.035 . . . . 45.05 111.005 -172.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.426 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 69.3 Cg_endo -71.86 162.45 89.31 Favored 'Cis proline' 0 C--N 1.348 0.522 0 CA-C-N 119.596 0.892 . . . . 71.15 112.719 -10.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -150.56 156.53 41.57 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 124.252 0.97 . . . . 52.13 111.457 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 43.1 ttm -143.55 119.06 10.34 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.04 1.336 . . . . 63.03 107.749 169.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -97.36 132.02 43.48 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.927 1.291 . . . . 72.42 107.629 175.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 184' ' ' LEU . 95.8 t -96.23 -35.8 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 113.549 0.944 . . . . 65.03 113.549 -173.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -150.9 31.61 0.62 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.819 0.819 . . . . 64.01 109.571 -177.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 69.35 -64.73 0.57 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 126.194 1.854 . . . . 30.41 110.147 -162.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -58.95 -18.46 33.87 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 116.767 2.136 . . . . 71.23 116.767 -170.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -128.57 133.94 48.5 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 119.154 0.888 . . . . 74.35 111.252 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.79 137.15 52.28 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 105.773 -1.936 . . . . 63.01 105.773 175.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.07 143.11 58.07 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.744 -1.206 . . . . 72.01 107.744 176.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -124.66 75.55 64.03 Favored Pre-proline 0 C--O 1.234 0.275 0 C-N-CA 122.851 0.46 . . . . 61.04 110.22 -175.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -68.32 -22.56 39.62 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 120.831 1.021 . . . . 65.33 111.346 -172.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.55 -32.43 28.15 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 114.029 1.122 . . . . 50.24 114.029 171.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -103.13 4.78 48.98 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-O 118.325 -1.264 . . . . 70.04 112.687 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 62.1 mtt -80.3 174.49 11.55 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 119.814 1.807 . . . . 71.3 109.241 172.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -75.06 106.89 6.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.703 -1.592 . . . . 70.04 106.703 166.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.455 HG22 ' CD1' ' A' ' 173' ' ' PHE . 80.7 p -114.99 28.8 8.47 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.927 1.691 . . . . 72.44 109.444 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 75.2 m -108.95 -1.09 19.28 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 114.224 1.194 . . . . 31.14 114.224 -175.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.26 -9.93 4.7 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 124.386 1.074 . . . . 63.0 110.999 177.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 5.5 mmt 70.67 -58.97 0.54 Allowed 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.304 2.242 . . . . 74.4 112.262 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -58.52 -49.29 77.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 122.836 1.303 . . . . 72.1 109.699 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 93.3 t -63.56 -27.77 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 125.935 1.694 . . . . 52.42 111.433 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.455 ' CD1' HG22 ' A' ' 167' ' ' THR . 30.5 t80 -64.12 -59.24 4.69 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 107.8 -1.185 . . . . 71.11 107.8 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 5.9 t -69.19 -33.0 56.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 117.626 0.194 . . . . 74.04 110.913 -172.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.13 77.87 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.036 0.534 . . . . 73.24 111.23 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -82.6 -34.35 27.66 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 118.544 -0.741 . . . . 63.34 112.218 172.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -55.9 -57.64 11.25 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 120.208 1.367 . . . . 72.04 110.471 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.67 -30.46 67.38 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.411 0.684 . . . . 44.44 111.979 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -72.38 -50.83 23.68 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.44 1.496 . . . . 71.32 109.956 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.71 HG23 HG21 ' A' ' 3' ' ' ILE . 96.2 m -55.39 -39.16 69.8 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.165 1.386 . . . . 74.22 110.731 174.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 91.3 t -59.48 -58.41 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 108.101 -1.074 . . . . 64.3 108.101 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -59.99 -35.06 74.21 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.278 -0.868 . . . . 72.44 111.309 -177.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -59.96 -44.21 94.57 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 119.523 1.056 . . . . 70.22 110.78 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.443 ' HB2' HG11 ' A' ' 154' ' ' VAL . 77.9 mt -67.9 -25.5 65.53 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 121.047 -1.033 . . . . 65.11 111.835 -176.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 93.1 t -66.19 -22.08 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 O-C-N 121.253 -0.904 . . . . 64.13 111.177 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -102.96 -7.34 21.55 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.622 0.769 . . . . 72.21 110.401 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -125.94 75.72 1.53 Allowed 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.574 1.549 . . . . 74.03 109.24 -172.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.245 0.86 0 N-CA-C 106.019 -1.845 . . . . 62.14 106.019 167.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.407 0 N-CA-C 114.182 1.178 . . . . 72.33 114.182 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -159.89 120.74 3.09 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.588 -1.634 . . . . 62.43 106.588 171.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.2 pt -122.47 154.04 27.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 127.54 2.336 . . . . 72.43 106.869 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.0 m -129.21 134.77 48.14 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.075 -1.454 . . . . 71.32 107.075 -175.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -57.31 140.29 50.47 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 123.723 0.639 . . . . 54.5 109.667 170.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 84.61 -23.14 7.79 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.275 1.417 . . . . 73.34 112.587 -172.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.7 tptp -95.05 -85.53 0.31 Allowed 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 119.472 1.636 . . . . 72.31 109.092 -169.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -90.17 -19.13 24.59 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.983 0.913 . . . . 74.41 110.899 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -135.18 163.74 29.26 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.937 0.895 . . . . 73.0 109.53 171.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.5 mm -124.97 161.25 29.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 127.337 2.255 . . . . 61.33 105.525 174.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.6 m -119.68 147.61 44.36 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.804 1.242 . . . . 54.44 108.362 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 31.3 mt -76.35 155.74 33.88 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.022 -0.732 . . . . 70.0 109.022 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -71.81 -37.41 70.38 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 122.308 1.051 . . . . 74.14 109.681 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -132.91 74.76 73.6 Favored Pre-proline 0 C--N 1.339 0.129 0 C-N-CA 126.463 1.905 . . . . 74.12 109.356 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 N--CA 1.449 -1.094 0 C-N-CA 122.113 1.875 . . . . 53.42 107.588 171.068 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 C--O 1.239 0.515 0 N-CA-C 106.683 -1.599 . . . . 65.3 106.683 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.436 HD23 ' CE2' ' A' ' 25' ' ' PHE . 5.7 tp -162.05 169.69 20.55 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.165 -0.679 . . . . 65.32 109.165 163.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -136.72 131.02 32.91 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 106.715 -1.587 . . . . 74.02 106.715 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.436 ' CE2' HD23 ' A' ' 23' ' ' LEU . 96.0 m-85 -119.14 128.13 53.98 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 118.57 0.623 . . . . 71.21 109.82 171.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -141.18 173.32 11.6 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.503 1.121 . . . . 70.12 108.821 164.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.516 ' HA ' ' CE1' ' A' ' 60' ' ' HIS . 3.5 t -128.37 179.7 5.49 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.509 -0.552 . . . . 45.33 109.509 168.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.498 ' CD2' ' CE1' ' A' ' 60' ' ' HIS . 46.8 m-85 -87.5 -35.17 18.36 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 118.241 -0.885 . . . . 74.33 111.845 177.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.411 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 96.9 m-85 -83.84 -3.12 57.64 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 121.157 1.799 . . . . 61.33 112.891 -177.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.7 p -80.04 141.01 53.98 Favored Pre-proline 0 CA--C 1.541 0.615 0 O-C-N 119.97 -1.706 . . . . 52.24 110.143 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -83.65 -35.3 0.24 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 121.866 1.711 . . . . 70.14 113.071 -170.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.82 -48.96 72.15 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 109.464 -0.569 . . . . 70.34 109.464 172.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.6 m -52.36 -33.88 45.13 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.065 1.346 . . . . 65.14 111.556 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -63.49 -55.73 21.73 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.819 0.736 . . . . 74.11 110.863 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.79 -44.29 77.63 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 121.185 -0.947 . . . . 65.3 109.024 175.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -64.71 -15.69 61.8 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 116.057 -1.925 . . . . 54.51 111.071 -174.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -141.54 12.79 2.13 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 121.457 1.935 . . . . 73.42 114.333 -171.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -135.69 -14.63 1.88 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.653 1.581 . . . . 72.12 112.115 167.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.2 t -124.34 -82.12 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.079 0 N-CA-C 107.795 -1.187 . . . . 65.31 107.795 -175.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.03 -29.36 67.22 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.714 2.006 . . . . 73.23 111.973 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 44.34 62.48 1.99 Allowed 'General case' 0 C--O 1.241 0.621 0 C-N-CA 126.005 1.722 . . . . 65.04 110.837 178.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.549 ' O ' HG23 ' A' ' 46' ' ' VAL . 99.7 t -63.05 -46.83 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 113.983 -1.462 . . . . 62.23 108.026 -173.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 95.2 p -49.72 -52.61 30.13 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.824 0.849 . . . . 54.34 111.014 -177.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.85 -31.8 65.01 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.132 0.573 . . . . 72.33 109.965 -171.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -64.73 -43.18 94.2 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 118.774 -0.632 . . . . 70.2 110.965 171.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 42' ' ' VAL . 1.9 t -59.57 -46.89 92.65 Favored 'Isoleucine or valine' 0 C--N 1.342 0.258 0 CA-C-N 119.251 0.932 . . . . 71.01 108.993 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -50.99 -42.13 60.09 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.193 0.997 . . . . 74.13 112.262 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -61.66 -5.43 1.91 Allowed 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.998 1.481 . . . . 63.41 114.998 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -127.08 -15.63 5.25 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.969 1.708 . . . . 71.33 113.219 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.553 HD13 HG21 ' A' ' 54' ' ' THR . 14.1 mt -67.71 149.68 98.17 Favored Pre-proline 0 N--CA 1.469 0.511 0 CA-C-N 119.964 1.256 . . . . 54.22 112.497 -164.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.19 151.83 27.04 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.449 2.766 . . . . 73.2 111.17 171.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -82.11 81.68 7.95 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 122.636 1.208 . . . . 73.13 109.091 -176.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 175.44 -30.42 0.08 OUTLIER Glycine 0 CA--C 1.521 0.439 0 C-N-CA 125.131 1.348 . . . . 52.33 110.665 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.553 HG21 HD13 ' A' ' 50' ' ' LEU . 10.7 t -44.02 -45.21 7.81 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.911 1.684 . . . . 74.44 113.398 -173.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? 59.48 99.63 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.626 1.97 . . . . 62.15 110.045 -169.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.79 125.67 25.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.361 -1.29 . . . . 43.45 107.65 172.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 m -137.32 161.71 35.51 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.075 -1.454 . . . . 74.03 107.075 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -151.51 110.45 3.87 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 104.335 -2.468 . . . . 71.25 104.335 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -104.36 136.68 43.48 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.836 -1.913 . . . . 73.13 105.836 168.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.54 ' H ' ' NE2' ' A' ' 137' ' ' GLN . 15.3 t60 -82.86 169.68 15.81 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.043 -1.095 . . . . 71.45 108.043 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.3 m -131.22 136.22 58.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 108.698 -0.853 . . . . 74.04 108.698 170.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.47 5.18 11.29 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.626 1.17 . . . . 33.12 113.015 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -72.15 -177.43 2.09 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 122.71 1.243 . . . . 73.05 112.421 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 mp 63.8 -86.37 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 130.199 3.4 . . . . 71.22 112.588 177.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.411 ' HA3' ' CD2' ' A' ' 29' ' ' TYR . . . -72.7 160.87 54.23 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 124.03 0.824 . . . . 72.41 111.323 -176.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -65.27 -54.04 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.895 3.064 . . . . 45.31 110.052 -175.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.5 mt -73.62 8.78 1.68 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 117.777 -1.106 . . . . 73.01 113.425 -176.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -47.7 -33.19 8.87 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 120.135 1.334 . . . . 52.45 113.446 -177.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -58.61 -39.97 81.98 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.768 1.025 . . . . 74.11 113.768 175.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -62.21 -47.44 84.41 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.391 -0.966 . . . . 74.03 108.391 171.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.0 mt -54.18 -50.12 67.76 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 123.893 0.746 . . . . 52.55 110.191 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.7 m -57.29 -39.48 75.82 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.277 1.431 . . . . 72.44 112.955 173.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -68.04 -50.84 52.81 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.663 0.665 . . . . 74.03 110.375 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.78 -40.26 75.57 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 126.166 1.786 . . . . 52.31 111.678 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 46.2 t-105 -56.27 -35.21 67.19 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.041 0.536 . . . . 73.14 111.821 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.45 -40.36 94.2 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.246 -0.883 . . . . 65.34 111.798 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.5 t -57.46 -46.85 85.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 119.362 0.983 . . . . 72.35 108.896 172.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.16 -41.1 97.28 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-O 118.416 -0.802 . . . . 74.14 111.701 -176.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.7 mt -66.82 -43.36 89.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 118.107 -0.949 . . . . 65.22 109.765 175.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.29 93.81 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 119.185 0.902 . . . . 61.11 110.949 -174.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.8 mt -87.62 -12.52 45.32 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 119.038 -0.506 . . . . 73.02 112.265 175.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.44 61.83 6.66 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 126.148 1.832 . . . . 53.43 111.709 -174.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.9 m -134.18 20.23 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 125.361 1.464 . . . . 70.33 111.205 -177.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -50.38 -50.47 51.44 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.225 1.01 . . . . 71.25 110.0 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.18 -28.44 69.75 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.13 1.772 . . . . 52.33 110.623 -176.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -84.72 -25.24 28.48 Favored 'General case' 0 C--O 1.227 -0.11 0 C-N-CA 123.783 0.833 . . . . 74.35 111.671 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.1 pp -99.22 -15.4 7.44 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 CA-C-O 117.315 -1.326 . . . . 63.23 112.637 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.0 m -62.68 -45.7 91.57 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 119.863 1.21 . . . . 61.45 110.264 -170.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.526 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -56.8 -61.37 7.04 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 123.266 0.627 . . . . 61.42 111.385 -173.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 41.6 Cg_endo -66.72 -21.84 50.96 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.603 1.535 . . . . 72.14 112.735 -177.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.98 -53.77 53.98 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.08 0.952 . . . . 74.25 110.556 173.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -66.35 -33.32 75.47 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 118.083 0.401 . . . . 73.01 111.103 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.86 -38.25 81.59 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 120.15 -0.62 . . . . 64.41 110.925 169.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -86.52 -18.4 31.66 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 121.265 -0.897 . . . . 41.33 112.214 -168.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.7 t -107.93 -28.46 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 124.758 1.223 . . . . 73.05 109.822 -173.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -118.96 -53.5 2.27 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 118.887 0.767 . . . . 74.44 111.536 -173.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -64.99 -65.48 0.67 Allowed 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 118.62 0.645 . . . . 74.13 109.27 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.6 p -94.85 -18.29 21.31 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.04 0.536 . . . . 72.34 111.733 -170.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 45.34 39.79 4.71 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.503 2.321 . . . . 74.24 112.165 -175.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.0 t -73.77 -20.16 60.57 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.588 1.155 . . . . 72.42 111.466 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.417 HG13 HG12 ' A' ' 107' ' ' ILE . 31.9 t -69.38 117.87 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 108.29 -1.004 . . . . 65.42 108.29 172.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -137.6 -24.0 1.06 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.407 1.083 . . . . 74.11 111.575 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.43 177.34 11.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.079 2.152 . . . . 65.44 109.411 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.8 t -53.47 -46.0 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.264 1.826 . . . . 70.24 109.42 -173.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.04 -23.79 35.46 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.283 1.433 . . . . 65.02 112.713 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -91.83 -28.88 17.05 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 118.261 0.482 . . . . 54.24 110.091 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.417 HG12 HG13 ' A' ' 101' ' ' VAL . 0.5 OUTLIER -79.95 -46.34 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 123.205 0.602 . . . . 72.25 109.433 -175.093 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -25.35 61.83 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 112.932 0.715 . . . . 73.45 112.932 175.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -58.83 -52.46 65.62 Favored 'General case' 0 C--O 1.222 -0.342 0 N-CA-C 109.323 -0.621 . . . . 74.01 109.323 175.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.7 t -52.94 -43.69 47.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 123.862 0.865 . . . . 62.45 110.734 -176.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -55.1 -52.91 61.76 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.405 0.682 . . . . 73.43 110.392 175.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 96.7 t -65.64 -42.15 92.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 124.126 0.97 . . . . 72.15 111.242 -177.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.39 -51.26 65.4 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.673 1.589 . . . . 73.31 108.259 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.02 -13.64 60.89 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.408 1.083 . . . . 41.51 112.913 -178.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 118.08 32.89 1.32 Allowed Glycine 0 CA--C 1.524 0.612 0 C-N-CA 124.456 1.027 . . . . 64.15 114.92 165.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.9 t -97.96 134.96 34.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 119.452 1.626 . . . . 62.15 109.372 174.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.421 ' HG3' ' CB ' ' A' ' 120' ' ' ASP . 1.2 pttm -62.42 133.23 54.75 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.54 -1.209 . . . . 74.24 110.384 176.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.85 -20.73 66.81 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.061 -0.815 . . . . 70.13 111.061 168.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -76.84 -41.05 45.67 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.817 0.809 . . . . 74.44 111.163 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.421 ' CB ' ' HG3' ' A' ' 117' ' ' LYS . 36.8 t70 -69.84 -47.09 64.05 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 107.343 -1.354 . . . . 62.24 107.343 175.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -54.94 -52.48 62.87 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 123.778 0.673 . . . . 65.33 109.652 -172.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -72.24 -17.35 61.91 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.083 -1.011 . . . . 65.21 113.503 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.17 -71.56 0.47 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.074 -0.713 . . . . 74.45 109.074 172.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -46.46 -47.33 19.19 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 127.352 2.261 . . . . 61.31 109.886 -175.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 30.7 t-105 -48.77 -31.64 7.33 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.581 1.152 . . . . 64.21 113.288 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -113.05 3.18 16.01 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.277 2.231 . . . . 64.21 111.928 -176.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 21.8 m -93.93 159.11 15.32 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 126.266 1.827 . . . . 72.15 112.356 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -55.02 -34.11 63.21 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.259 1.823 . . . . 72.15 112.709 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 129' ' ' VAL . 14.5 t -51.71 -47.6 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.259 1.024 . . . . 72.34 110.166 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.3 t -72.77 -39.87 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 117.826 -1.083 . . . . 53.34 109.547 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.502 ' HA ' ' HE2' ' A' ' 131' ' ' LYS . 8.6 mmpt? -50.86 -48.78 60.07 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 120.713 1.597 . . . . 63.31 111.697 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 64.8 m -64.01 -49.87 70.75 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 122.217 -0.302 . . . . 70.01 111.546 175.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.4 mt -65.72 -32.06 73.41 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.202 0.816 . . . . 64.11 113.202 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 37.9 t -65.51 -62.58 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 126.169 1.788 . . . . 73.14 107.765 170.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.44 -39.89 58.29 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.649 0.78 . . . . 61.25 111.39 -175.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -47.62 -62.72 1.31 Allowed 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 117.383 -1.294 . . . . 71.15 110.574 175.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.54 ' NE2' ' H ' ' A' ' 60' ' ' HIS . 3.8 pt20 -81.41 -28.39 34.32 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 120.115 1.325 . . . . 74.12 113.997 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -59.19 -38.67 80.42 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 120.189 1.359 . . . . 74.14 108.736 176.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 8.4 tttt -79.46 -53.71 6.62 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.534 -0.729 . . . . 72.24 111.427 171.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.73 -6.95 6.35 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 117.255 -1.355 . . . . 73.24 113.704 -171.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.97 16.71 10.89 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.053 1.341 . . . . 54.33 113.457 172.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.13 4.61 1.08 Allowed 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.468 -0.77 . . . . 62.01 112.71 174.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.13 -79.04 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.535 1.134 . . . . 70.24 110.891 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -174.86 50.73 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.146 2.179 . . . . 34.43 110.359 175.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.479 ' NE2' ' H ' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -127.65 -55.2 1.32 Allowed 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.199 -0.938 . . . . 70.24 112.898 -175.24 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.479 ' H ' ' NE2' ' A' ' 145' ' ' GLN . 0.9 OUTLIER -147.18 143.69 28.39 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 128.08 2.552 . . . . 71.32 105.915 -172.435 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -137.33 14.91 3.0 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.11 0.964 . . . . 74.42 111.664 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -155.84 168.83 33.46 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.795 -1.322 . . . . 62.05 109.795 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.9 m -147.6 168.88 10.28 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.469 1.108 . . . . 73.42 111.102 -166.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.18 160.87 88.55 Favored 'Cis proline' 0 C--N 1.35 0.648 0 CA-C-N 119.953 1.019 . . . . 73.14 112.696 -9.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -149.61 154.51 38.77 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.611 0.764 . . . . 71.01 111.262 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 29.8 ttm -142.24 121.92 13.41 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.301 1.44 . . . . 70.32 107.258 172.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -94.28 152.62 18.54 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.737 1.615 . . . . 74.24 109.271 177.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.1 t -140.26 140.72 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.181 0.592 . . . . 65.43 109.948 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 44.67 30.34 0.51 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 129.17 2.988 . . . . 73.34 114.017 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 64.91 9.36 39.74 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.937 -0.924 . . . . 50.44 114.684 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -148.3 -2.8 0.51 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.431 1.615 . . . . 64.13 114.982 -165.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -131.07 161.84 31.15 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.931 1.292 . . . . 72.42 108.682 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -136.86 141.39 42.81 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.418 -1.697 . . . . 65.0 106.418 171.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.17 151.44 46.98 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 107.318 -1.364 . . . . 70.3 107.318 176.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -120.37 82.97 32.4 Favored Pre-proline 0 N--CA 1.462 0.138 0 CA-C-N 118.497 0.59 . . . . 72.03 111.474 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.48 -15.02 45.94 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 121.602 1.534 . . . . 74.22 113.608 175.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -90.21 -5.63 56.16 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 125.686 1.594 . . . . 74.41 111.225 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -117.67 18.01 11.91 Favored Glycine 0 CA--C 1.526 0.724 0 O-C-N 121.081 -1.012 . . . . 62.0 112.518 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 64.0 mtt -101.37 170.01 8.51 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.711 1.256 . . . . 63.03 110.398 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -66.05 120.92 13.99 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 105.893 -1.892 . . . . 74.13 105.893 158.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.432 1.1 t -136.38 63.01 1.6 Allowed 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 105.652 -1.981 . . . . 70.22 105.652 175.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.2 t -129.91 -15.77 3.79 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.171 1.788 . . . . 63.02 113.258 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -127.28 -3.32 6.24 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.0 1.273 . . . . 71.41 112.334 -174.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 7.9 mmt 62.81 -43.04 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 131.543 3.937 . . . . 53.14 114.618 -177.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.98 -48.84 33.0 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.281 -1.007 . . . . 50.41 108.281 -176.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 71.5 t -61.32 -28.57 44.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 125.342 1.457 . . . . 74.13 111.769 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -63.39 -57.69 9.51 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.167 -1.049 . . . . 74.1 108.167 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.9 t -74.67 -28.62 22.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 119.472 -0.299 . . . . 73.3 110.947 -175.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.97 -40.82 73.82 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.123 0.969 . . . . 65.01 110.761 175.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -83.87 -42.55 16.26 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 117.803 -1.094 . . . . 73.02 111.413 174.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -50.48 -55.65 15.04 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 120.202 1.365 . . . . 70.44 110.224 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -54.27 -34.51 60.98 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.902 0.881 . . . . 70.34 112.401 -177.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -78.47 -52.27 8.78 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.208 0.603 . . . . 74.32 109.852 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.2 t -58.03 -28.77 64.78 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-O 117.74 -1.124 . . . . 54.52 110.861 -176.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 61.0 t -54.95 -57.4 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 118.777 0.717 . . . . 74.22 109.463 170.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -32.2 71.84 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 119.1 0.864 . . . . 70.44 111.96 -178.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -60.11 -31.88 70.46 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 119.045 0.839 . . . . 72.41 110.527 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 29.0 mt -73.39 -28.41 62.0 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.342 -0.849 . . . . 65.23 111.793 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 74.9 t -65.53 -23.25 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.901 0.88 . . . . 73.0 111.306 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -99.15 -17.9 17.95 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.127 0.571 . . . . 74.43 109.962 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -102.77 77.74 1.62 Allowed 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 125.232 1.413 . . . . 65.4 108.526 -171.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? . . . . . 0 C--O 1.249 1.046 0 CA-C-O 114.502 -2.666 . . . . 65.11 112.962 -178.715 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.72 0.295 . . . . 71.04 111.112 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -175.17 110.45 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 71.44 110.933 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.746 HD12 ' CE2' ' A' ' 9' ' ' TYR . 5.0 pt -122.12 164.08 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 72.11 111.115 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.7 m -138.24 142.74 39.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 74.2 111.101 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -65.1 132.9 50.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 70.01 110.873 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.15 6.22 81.97 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.753 . . . . 72.52 112.518 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -117.47 -74.59 0.6 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.717 0.294 . . . . 33.11 110.839 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -101.19 -19.36 15.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.433 . . . . 65.44 110.918 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.746 ' CE2' HD12 ' A' ' 3' ' ' ILE . 20.3 p90 -144.66 157.9 44.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 70.44 110.942 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.738 HD13 ' O ' ' A' ' 9' ' ' TYR . 7.8 mm -129.69 160.76 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 64.55 111.149 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.408 ' N ' HG22 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -118.54 138.21 52.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 70.53 111.154 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' A' ' 157' ' ' LYS . 19.7 mt -67.84 151.67 46.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 51.25 110.827 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.14 -27.03 48.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 44.22 110.858 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -140.11 66.58 31.94 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.597 0.713 . . . . 75.55 110.913 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--N 1.341 0.183 0 C-N-CA 122.652 2.234 . . . . 75.44 112.419 179.864 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.487 HG12 ' H ' ' A' ' 155' ' ' ASN . 2.9 m . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.883 0.373 . . . . 71.05 111.154 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.77 HD11 ' CD1' ' A' ' 59' ' ' TYR . 15.7 tp -178.03 151.99 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 44.41 110.898 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -128.55 166.42 18.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 70.25 110.902 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.43 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 47.6 m-85 -144.45 136.69 26.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 73.53 110.866 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -173.14 147.63 1.6 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 64.41 110.931 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.3 t -101.1 -168.28 1.54 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 52.04 110.863 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.412 ' CD1' HD13 ' A' ' 71' ' ' LEU . 18.0 m-85 -115.8 -8.45 11.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 74.1 110.884 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.562 ' HE1' HD11 ' A' ' 71' ' ' LEU . 54.8 m-85 -113.76 18.59 17.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 74.43 110.911 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.8 p -103.38 138.61 19.59 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.567 0.698 . . . . 72.52 110.892 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.91 -41.84 3.75 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.707 2.271 . . . . 74.52 112.268 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -59.42 -64.22 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 72.22 110.789 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.6 p -49.78 -32.55 14.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.464 . . . . 74.51 110.885 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -63.75 -53.07 56.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 63.14 110.896 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -67.61 -11.01 57.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 74.41 110.864 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -104.08 0.94 30.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.31 -0.404 . . . . 73.1 110.924 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -141.53 13.1 2.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 74.14 110.913 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -141.99 -52.39 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 65.2 110.921 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 67.6 t -92.8 -78.42 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 64.34 111.114 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.8 mt -59.33 -41.44 89.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 44.44 110.841 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 53.8 72.43 0.44 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 70.04 110.856 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.489 HG22 HG13 ' A' ' 174' ' ' VAL . 80.0 t -72.51 -33.89 46.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 61.23 111.124 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.5 t -52.74 -42.59 65.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 70.22 110.796 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -82.72 2.29 34.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.119 -0.492 . . . . 72.44 110.939 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -102.7 -21.36 14.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 73.33 110.867 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.67 HG12 ' HG ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -85.14 -53.92 9.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 65.22 110.929 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -46.59 -33.57 4.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 74.11 110.922 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -71.16 -30.95 67.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.481 . . . . 62.32 110.947 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 46' ' ' VAL . 4.2 mmmt -121.17 28.13 8.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 74.23 110.915 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.67 ' HG ' HG12 ' A' ' 46' ' ' VAL . 12.5 mt -104.42 144.24 28.31 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.59 0.709 . . . . 63.41 110.885 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.82 159.12 54.54 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.713 2.275 . . . . 74.34 112.23 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.94 59.35 2.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 73.25 110.848 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.45 35.68 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.779 -0.724 . . . . 62.22 112.438 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.666 HG21 HD13 ' A' ' 50' ' ' LEU . 10.9 t -103.07 -30.71 10.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.811 0.339 . . . . 60.03 111.129 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 62.89 107.65 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 63.12 110.928 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.75 102.03 8.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 63.05 110.93 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -105.36 -178.94 3.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 72.34 111.185 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.422 ' H ' HG22 ' A' ' 57' ' ' THR . 5.7 mttm 178.33 110.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 71.44 110.888 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.77 ' CD1' HD11 ' A' ' 23' ' ' LEU . 2.7 m-30 -101.14 124.49 46.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 74.22 110.939 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.853 ' CE1' HG22 ' A' ' 72' ' ' THR . 0.7 OUTLIER -60.84 175.14 0.52 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 61.53 110.862 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 60' ' ' HIS . 3.6 m -154.97 129.72 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 74.22 111.115 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.24 75.46 0.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 73.15 110.91 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -135.94 3.81 2.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 64.52 110.908 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.05 163.65 32.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.481 . . . . 54.23 110.906 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.84 155.25 0.12 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 42.32 112.465 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -42.83 3.09 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.642 2.228 . . . . 70.22 112.418 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.744 HD11 ' O ' ' A' ' 102' ' ' GLN . 92.7 mt -93.83 38.7 1.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.457 . . . . 63.21 110.968 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.32 -20.32 75.08 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.804 -0.713 . . . . 63.51 112.498 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -85.38 -33.94 21.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.801 0.334 . . . . 73.35 110.903 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.38 -46.82 72.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 65.52 110.849 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.594 HD23 HG21 ' A' ' 107' ' ' ILE . 3.6 mt -60.74 -37.49 81.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 71.44 110.918 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.853 HG22 ' CE1' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -50.14 -65.41 0.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 71.35 111.156 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -51.16 -44.33 61.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 74.24 110.837 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.413 ' HB1' ' CZ ' ' A' ' 111' ' ' PHE . . . -54.91 -35.92 64.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.406 . . . . 63.15 111.138 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 13.0 t-105 -53.66 -48.55 69.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 72.54 110.949 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.664 ' HB3' HG13 ' A' ' 130' ' ' VAL . . . -49.44 -41.83 41.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 72.05 111.1 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.509 HG11 ' CD2' ' A' ' 121' ' ' TYR . 74.7 t -61.33 -34.35 60.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.263 -0.426 . . . . 62.45 111.122 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.92 -35.59 64.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 44.55 111.103 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -79.12 -33.13 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 74.34 111.092 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.77 -34.34 77.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 74.34 111.064 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.629 HD21 ' CG ' ' A' ' 120' ' ' ASP . 91.5 mt -98.86 -21.66 16.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 55.14 110.915 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.98 57.05 3.12 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.806 -0.711 . . . . 75.21 112.512 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.708 HG12 ' HD2' ' A' ' 86' ' ' LYS . 13.5 m -143.97 39.87 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.735 0.303 . . . . 64.15 111.115 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.04 -54.07 30.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 73.43 110.839 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.73 -17.82 57.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 51.42 110.827 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.708 ' HD2' HG12 ' A' ' 83' ' ' VAL . 14.8 mtpt -83.62 -27.18 29.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 71.04 110.891 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.712 HD13 ' CZ ' ' A' ' 111' ' ' PHE . 1.5 pp -114.08 41.32 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 73.31 111.122 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 66.8 m -118.46 -26.82 6.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 65.32 111.147 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.788 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -69.9 -60.99 3.22 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.593 0.711 . . . . 50.44 111.033 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 53.4 Cg_endo -69.72 -30.59 22.24 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.721 2.281 . . . . 70.42 112.309 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 33.4 tpp -60.39 -29.73 69.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.439 . . . . 52.01 110.869 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -90.41 -33.94 15.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.288 -0.414 . . . . 74.44 110.883 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -76.8 -8.69 57.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 73.43 110.881 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.604 ' HB1' HG22 ' A' ' 100' ' ' THR . . . -111.69 0.83 16.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 53.31 111.088 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.441 ' CG2' HG21 ' A' ' 101' ' ' VAL . 65.7 t -121.15 -30.65 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 65.3 111.149 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -110.5 -57.99 2.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 74.5 110.853 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -58.54 -76.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 64.42 110.838 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.4 p -83.49 -33.49 25.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 74.4 111.089 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 62.11 34.52 16.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 71.12 110.948 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.604 HG22 ' HB1' ' A' ' 94' ' ' ALA . 12.3 t -66.35 -19.79 65.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 72.54 111.142 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.697 HG13 HG12 ' A' ' 107' ' ' ILE . 53.5 t -64.36 115.29 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.32 -0.4 . . . . 62.33 111.07 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.744 ' O ' HD11 ' A' ' 67' ' ' LEU . 11.7 mt-30 -131.4 -39.68 1.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 65.23 110.937 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.49 166.04 22.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 62.13 110.817 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.0 t -57.87 -21.69 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.112 -0.495 . . . . 53.31 111.129 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.78 -5.29 52.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 32.32 111.128 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -108.42 -24.37 11.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 74.54 110.864 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.697 HG12 HG13 ' A' ' 101' ' ' VAL . 2.3 mt -84.37 -25.17 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 73.43 111.111 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.83 -26.61 49.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 74.34 110.811 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -62.5 -53.99 46.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.42 . . . . 71.15 110.883 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.475 HG13 ' HB2' ' A' ' 90' ' ' PRO . 99.8 t -50.62 -45.02 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.255 -0.429 . . . . 73.13 111.114 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.712 ' CZ ' HD13 ' A' ' 87' ' ' ILE . 7.9 m-85 -54.38 -48.28 71.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 74.45 110.905 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 89.7 t -69.37 -42.15 81.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 52.23 111.156 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.81 -22.33 35.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 72.5 110.877 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -86.09 -27.82 24.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 63.34 111.096 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.8 -20.54 1.63 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.787 -0.72 . . . . 65.13 112.523 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 93.9 t -51.46 133.79 12.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.896 0.379 . . . . 71.44 111.123 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.554 ' HE2' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -79.59 139.56 37.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 60.05 110.878 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.69 -8.18 59.87 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.693 -0.765 . . . . 44.24 112.481 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -90.0 -30.14 17.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.829 0.347 . . . . 74.45 110.908 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.629 ' CG ' HD21 ' A' ' 81' ' ' LEU . 17.6 t70 -88.69 -34.56 17.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 75.23 110.855 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.509 ' CD2' HG11 ' A' ' 77' ' ' VAL . 24.7 t80 -75.73 -30.63 59.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.472 . . . . 75.54 110.931 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -88.55 -10.84 47.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 73.32 110.834 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -106.12 -60.29 1.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 13.4 111.058 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.17 -38.33 57.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 61.14 111.141 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 21.7 t-105 -48.45 -39.68 23.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.43 . . . . 65.15 110.956 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -110.84 39.13 2.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 73.31 110.932 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 75.2 m -123.87 166.17 16.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 71.35 110.913 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -64.38 -34.63 78.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 75.41 110.862 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 38.6 t -50.15 -50.81 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 71.11 111.108 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.718 ' O ' HG23 ' A' ' 134' ' ' VAL . 41.0 t -72.8 -33.78 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.125 -0.488 . . . . 71.34 111.103 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.4 -59.01 6.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 52.05 110.895 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.19 -42.45 63.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 75.55 110.869 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.493 HD13 ' HA ' ' A' ' 76' ' ' ALA . 5.5 mt -58.66 -59.99 4.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 75.51 110.888 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 130' ' ' VAL . 39.9 t -48.4 -36.46 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 71.24 111.046 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.81 -49.3 71.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 64.22 111.093 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 47.4 mm-40 -54.15 -51.17 65.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 75.11 110.977 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -67.19 -50.39 61.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 74.14 110.957 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.492 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 20.0 mm-40 -59.16 -20.09 50.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 61.32 110.877 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -101.96 -15.36 16.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 63.35 110.893 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -100.5 -6.16 25.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 43.34 111.1 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.65 -4.45 8.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 74.32 111.143 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -120.47 0.11 10.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 52.01 111.138 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -69.98 -84.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 62.53 110.838 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 174.63 36.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.405 . . . . 74.55 110.896 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.457 ' H ' ' NE2' ' A' ' 145' ' ' GLN . 0.1 OUTLIER -120.7 -15.37 8.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 72.14 110.945 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.637 HD11 ' CB ' ' A' ' 151' ' ' ALA . 0.6 OUTLIER -164.15 146.87 9.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 65.42 110.837 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -152.56 20.05 0.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 74.11 110.906 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -144.9 167.1 27.3 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.793 -0.718 . . . . 65.54 112.467 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.492 ' HA ' ' C ' ' A' ' 150' ' ' PRO . 2.3 m -154.28 158.48 32.38 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.579 0.704 . . . . 65.13 111.187 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 149' ' ' VAL . 54.4 Cg_endo -69.64 167.74 69.62 Favored 'Cis proline' 0 C--N 1.341 0.153 0 C-N-CA 122.644 -1.815 . . . . 62.23 112.4 -0.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.637 ' CB ' HD11 ' A' ' 146' ' ' LEU . . . -157.27 109.26 2.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 42.33 111.04 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 2.5 ttm -106.11 114.93 29.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.419 . . . . 74.41 110.888 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.603 ' HE2' HD13 ' A' ' 146' ' ' LEU . 35.1 m-85 -94.33 129.21 41.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 70.25 110.898 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.706 HG11 ' HB2' ' A' ' 184' ' ' LEU . 31.9 t -108.9 121.86 62.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.49 . . . . 60.33 111.09 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.487 ' H ' HG12 ' A' ' 22' ' ' VAL . 0.7 OUTLIER 74.39 -60.16 0.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 75.25 110.88 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 151.02 -15.9 0.9 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.841 -0.695 . . . . 73.43 112.476 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.475 ' HA ' HD12 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -125.75 39.18 4.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.756 0.312 . . . . 74.11 110.904 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.421 ' CG ' HD22 ' A' ' 184' ' ' LEU . 78.3 m-85 -153.29 155.93 37.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 71.45 110.926 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -144.68 115.43 7.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 64.33 110.89 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.635 HD11 HG23 ' A' ' 180' ' ' THR . 3.4 mm? -51.34 140.36 17.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 63.51 110.903 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -122.33 76.62 43.68 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.607 0.718 . . . . 70.21 110.873 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -7.52 21.26 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.656 2.237 . . . . 63.51 112.393 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.27 -25.33 54.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 72.51 110.896 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -95.36 -8.95 58.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.777 -0.725 . . . . 50.22 112.503 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 6.9 mtt -77.6 173.35 12.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.784 0.326 . . . . 62.41 110.858 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -85.16 87.35 7.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 70.3 110.897 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.639 HG22 ' CD1' ' A' ' 173' ' ' PHE . 19.4 p -93.05 39.44 1.04 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 74.33 111.162 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.8 m -109.37 -14.16 14.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 73.2 110.864 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.38 -16.51 9.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 73.34 110.851 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.439 ' HA ' ' HE2' ' A' ' 170' ' ' MET . 7.4 mmt 71.94 -64.85 0.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 73.43 110.882 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.42 -45.68 69.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 53.54 110.849 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.608 HG12 HE21 ' A' ' 176' ' ' GLN . 63.6 t -69.83 -36.35 69.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 71.23 111.105 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.639 ' CD1' HG22 ' A' ' 167' ' ' THR . 30.2 t80 -55.53 -70.06 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 63.42 110.822 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.489 HG13 HG22 ' A' ' 42' ' ' VAL . 21.7 t -54.59 -37.95 40.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 64.23 111.13 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.2 -43.67 61.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 62.24 111.129 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.608 HE21 HG12 ' A' ' 172' ' ' VAL . 52.3 mt-30 -80.62 -33.48 35.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 70.3 110.884 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.626 ' O ' HG23 ' A' ' 181' ' ' VAL . 49.1 t80 -51.35 -65.94 0.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 74.34 110.923 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.85 -25.12 10.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 61.41 111.056 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -70.55 -55.12 9.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 72.24 110.86 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.635 HG23 HD11 ' A' ' 160' ' ' LEU . 7.1 t -65.36 -29.06 69.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 73.23 111.13 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 177' ' ' TYR . 84.1 t -68.39 -39.28 80.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 71.12 111.073 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.54 -21.89 41.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 75.44 110.907 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.3 -20.87 39.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.422 . . . . 70.12 110.853 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.706 ' HB2' HG11 ' A' ' 154' ' ' VAL . 20.0 mt -79.74 -35.56 38.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.302 -0.408 . . . . 74.13 110.889 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 87.0 t -59.77 -23.25 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 72.21 111.15 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -109.69 -5.24 15.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 73.22 110.846 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -105.7 28.96 6.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 75.02 110.921 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 74.05 110.832 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.593 0 N-CA-C 114.781 1.4 . . . . 74.31 114.781 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -155.51 106.47 2.53 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 127.979 2.512 . . . . 65.01 107.255 -161.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.7 pt -129.44 149.45 33.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 127.219 2.208 . . . . 71.21 106.884 178.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.4 m -109.35 130.48 55.49 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.209 -1.034 . . . . 63.33 108.209 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -44.3 124.31 3.95 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 126.505 1.922 . . . . 70.35 110.155 159.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.67 -15.06 53.92 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 126.945 2.212 . . . . 74.41 113.653 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -95.02 -85.88 0.3 Allowed 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 119.98 1.89 . . . . 74.14 108.154 -174.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -85.75 -16.64 38.24 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.971 0.805 . . . . 71.23 111.394 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -139.64 163.1 33.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.637 0.375 . . . . 73.44 110.601 172.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.8 mm -120.64 158.18 23.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.651 -1.611 . . . . 74.02 106.651 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.4 m -109.56 134.47 51.88 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 126.001 1.72 . . . . 71.35 107.606 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.2 mt -84.04 144.9 28.78 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 108.031 -1.1 . . . . 64.22 108.031 172.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -76.08 -31.61 58.84 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.191 1.396 . . . . 74.44 111.397 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm -127.84 74.29 78.63 Favored Pre-proline 0 N--CA 1.455 -0.19 0 C-N-CA 125.439 1.496 . . . . 74.42 109.026 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo . . . . . 0 N--CA 1.45 -1.035 0 C-N-CA 123.319 2.679 . . . . 62.45 109.511 174.102 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.614 HG11 ' H ' ' A' ' 55' ' ' LYS . 14.3 p . . . . . 0 C--O 1.242 0.68 0 N-CA-C 109.67 -0.493 . . . . 55.52 109.67 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -169.2 172.17 7.53 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.394 1.078 . . . . 74.03 110.953 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -130.75 148.55 52.55 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.585 1.954 . . . . 74.24 107.632 154.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -115.24 143.0 45.91 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.502 1.521 . . . . 73.43 107.658 164.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -153.77 165.63 35.41 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.326 1.451 . . . . 73.34 108.607 175.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.86 179.15 4.05 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.918 1.287 . . . . 74.31 108.249 175.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -97.54 -23.71 15.89 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.913 -0.492 . . . . 72.33 110.638 171.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -105.82 12.64 30.57 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.748 1.619 . . . . 74.45 111.876 -177.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.7 p -84.11 143.76 43.11 Favored Pre-proline 0 CA--C 1.541 0.602 0 O-C-N 120.274 -1.516 . . . . 72.52 109.562 167.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -83.11 -33.69 0.39 Allowed 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 121.832 1.688 . . . . 74.33 110.005 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -49.48 -60.57 2.73 Favored 'General case' 0 C--N 1.337 0.062 0 C-N-CA 125.881 1.673 . . . . 74.11 110.155 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 23.6 p -62.74 -34.72 77.78 Favored 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 123.227 0.611 . . . . 73.41 111.088 -176.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -56.45 -52.27 65.31 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.886 -0.783 . . . . 74.44 108.886 173.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -57.66 -44.78 85.96 Favored 'General case' 0 C--O 1.224 -0.248 0 O-C-N 121.081 -1.012 . . . . 71.2 109.174 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -68.05 -12.99 61.85 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.411 1.084 . . . . 74.11 113.231 -174.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -130.76 2.77 4.46 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.181 1.355 . . . . 73.43 110.747 -166.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -144.44 -48.01 0.26 Allowed 'General case' 0 C--N 1.345 0.408 0 C-N-CA 125.574 1.549 . . . . 72.44 112.527 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.1 t -91.87 -72.63 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 105.898 -1.89 . . . . 52.44 105.898 -173.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.8 mt -73.1 -26.08 61.12 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.043 1.737 . . . . 73.2 111.981 -175.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 29.2 m80 44.72 60.07 3.08 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 122.752 1.263 . . . . 71.24 112.118 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 46' ' ' VAL . 93.4 t -57.92 -54.8 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.437 1.495 . . . . 65.02 107.334 170.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.71 -43.18 36.96 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.338 1.055 . . . . 70.22 113.329 -178.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -73.61 -42.55 61.35 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.256 -0.903 . . . . 74.24 110.836 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -56.77 -51.99 66.78 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 123.507 0.723 . . . . 72.41 110.098 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.679 HG12 ' HG ' ' A' ' 50' ' ' LEU . 15.6 t -61.64 -43.88 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 108.364 -0.976 . . . . 73.23 108.364 -175.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -49.93 -46.03 51.71 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.717 1.598 . . . . 74.22 112.553 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -61.4 -20.97 63.66 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.751 1.019 . . . . 74.4 113.751 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -114.01 -7.17 13.12 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.089 0.956 . . . . 71.32 111.816 -175.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.679 ' HG ' HG12 ' A' ' 46' ' ' VAL . 13.1 mt -70.65 143.75 90.25 Favored Pre-proline 0 C--O 1.239 0.501 0 O-C-N 120.881 -1.137 . . . . 73.32 109.416 -173.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -76.31 169.57 21.71 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.777 2.318 . . . . 71.23 108.905 167.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.531 ' CD ' ' H ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -82.82 23.09 0.85 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 124.774 1.229 . . . . 73.02 113.44 -176.11 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -119.81 -19.04 4.17 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 126.61 2.052 . . . . 60.11 111.725 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 77.6 m -121.09 101.55 7.74 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 106.838 -1.541 . . . . 72.15 106.838 -164.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.614 ' H ' HG11 ' A' ' 22' ' ' VAL . 3.2 tppt? -87.68 126.62 35.07 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.55 0.74 . . . . 74.33 109.913 -177.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.02 45.75 0.28 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.415 1.886 . . . . 73.03 112.426 171.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.4 m -53.99 145.04 17.49 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.926 1.291 . . . . 74.24 108.651 173.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -131.55 99.46 4.81 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.152 -1.055 . . . . 73.12 108.152 -166.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -95.37 150.61 20.09 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.319 1.048 . . . . 73.22 110.066 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.586 ' CE1' HG22 ' A' ' 72' ' ' THR . 0.3 OUTLIER -88.0 175.58 7.7 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.451 -0.944 . . . . 65.13 108.451 -176.153 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -145.0 163.28 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 107.563 -1.273 . . . . 70.43 107.563 156.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.61 -5.42 10.72 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.654 1.182 . . . . 71.11 113.607 -174.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -58.15 -11.23 2.41 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.489 1.915 . . . . 74.11 115.244 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 mp -127.81 137.61 52.44 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 120.916 1.689 . . . . 73.44 110.702 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.96 170.44 45.27 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.746 2.117 . . . . 50.03 112.291 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.72 -53.21 0.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 124.514 3.476 . . . . 64.24 111.675 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.473 HD13 HD11 ' A' ' 107' ' ' ILE . 5.2 mt -84.4 14.32 4.57 Favored 'General case' 0 CA--C 1.528 0.104 0 N-CA-C 113.887 1.069 . . . . 73.45 113.887 -165.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.639 ' HA2' HD12 ' A' ' 71' ' ' LEU . . . -53.57 -38.9 59.33 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-O 118.873 -0.96 . . . . 33.23 112.846 -163.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp -53.6 -38.1 63.65 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.937 1.695 . . . . 61.25 113.327 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.435 ' OD1' HG22 ' A' ' 104' ' ' VAL . 9.8 t70 -76.3 -45.35 32.81 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 118.614 -0.707 . . . . 72.13 109.154 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.639 HD12 ' HA2' ' A' ' 68' ' ' GLY . 15.4 mt -54.98 -37.32 66.38 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 118.789 -0.624 . . . . 73.25 110.646 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.586 HG22 ' CE1' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -57.49 -52.9 63.52 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.987 0.915 . . . . 74.33 109.086 177.292 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -69.18 -50.44 47.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.294 -0.632 . . . . 74.43 109.294 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.0 -37.17 63.73 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.553 1.07 . . . . 71.31 113.607 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 29.8 t-105 -59.85 -38.37 81.89 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 119.759 1.163 . . . . 74.55 112.016 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.94 -39.66 74.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 118.633 -0.698 . . . . 73.43 111.31 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' A' ' 124' ' ' ALA . 56.3 t -56.41 -49.22 78.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 118.817 0.735 . . . . 74.53 109.543 174.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.97 -40.27 97.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 118.677 -0.678 . . . . 74.45 111.018 -175.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.0 mt -69.24 -40.27 80.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 118.157 -0.925 . . . . 65.23 110.417 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.36 -30.83 69.8 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.097 0.862 . . . . 74.05 110.818 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.7 mt -94.29 -14.99 24.86 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.824 0.85 . . . . 74.44 112.532 175.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 59.94 64.32 4.29 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 126.306 1.908 . . . . 71.43 112.3 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.9 m -137.42 19.9 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 124.362 1.065 . . . . 61.42 112.217 -177.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -50.69 -52.34 40.95 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.563 1.074 . . . . 73.03 111.251 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -60.07 -17.08 36.93 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.866 1.666 . . . . 72.11 114.219 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -94.85 -9.16 35.19 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.275 1.03 . . . . 72.44 110.748 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.5 pp -136.1 33.53 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 125.033 1.333 . . . . 65.32 110.875 -173.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 52.5 m -111.47 -41.62 4.07 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 118.8 -0.619 . . . . 71.11 110.382 177.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.44 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -66.85 -60.64 5.98 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 119.183 0.901 . . . . 70.41 110.958 -175.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 33.2 Cg_endo -62.53 -28.1 77.23 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 120.541 0.828 . . . . 72.51 111.286 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 29.4 tpp -59.41 -50.55 73.53 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.374 1.07 . . . . 71.51 110.846 176.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -72.34 -31.21 65.45 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.949 0.9 . . . . 50.44 109.786 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.65 -36.8 81.85 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.726 0.694 . . . . 74.41 109.626 171.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -85.91 -13.1 48.82 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.322 -0.861 . . . . 70.12 112.239 -176.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.7 t -101.5 -39.29 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 125.382 1.473 . . . . 72.23 111.722 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -109.78 -59.35 1.93 Allowed 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.544 1.137 . . . . 61.41 109.296 -172.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -67.0 -50.96 60.61 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 118.45 -0.786 . . . . 72.33 111.164 -169.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.9 p -104.86 -19.68 13.81 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 123.691 0.619 . . . . 64.4 112.658 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 53.72 23.76 3.9 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.51 1.924 . . . . 71.31 113.903 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -66.14 -18.16 65.17 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.361 1.064 . . . . 73.4 111.539 -173.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.405 HG13 HG12 ' A' ' 107' ' ' ILE . 53.0 t -62.13 119.56 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 121.141 -0.975 . . . . 53.11 108.479 171.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -141.54 -26.52 0.69 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.899 1.28 . . . . 71.42 111.377 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.37 160.92 39.11 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.179 -1.415 . . . . 72.24 107.179 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.435 HG22 ' OD1' ' A' ' 70' ' ' ASP . 24.2 t -57.65 -28.05 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.722 0.809 . . . . 71.31 110.718 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.9 -29.91 71.04 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.365 1.466 . . . . 74.43 110.185 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.92 -19.36 24.64 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.266 0.626 . . . . 65.51 111.385 -175.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.473 HD11 HD13 ' A' ' 67' ' ' LEU . 1.4 mt -82.57 -45.03 19.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 123.855 0.862 . . . . 72.21 108.958 174.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -59.57 -26.49 65.45 Favored 'General case' 0 C--N 1.346 0.441 0 O-C-N 121.557 -0.715 . . . . 72.13 112.299 -176.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -54.93 -55.24 32.86 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.301 1.04 . . . . 74.43 110.442 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.9 t -52.84 -45.64 50.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 124.933 1.293 . . . . 73.32 109.975 -175.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -55.8 -54.07 48.91 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.659 0.784 . . . . 74.15 110.149 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 17.5 t -66.59 -38.51 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 118.024 0.375 . . . . 50.13 110.27 -174.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -63.5 -32.01 73.34 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.126 0.971 . . . . 74.23 111.068 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -83.8 -3.38 57.81 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.673 1.189 . . . . 64.33 113.838 173.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.2 14.48 16.55 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-N 119.558 1.072 . . . . 53.53 115.332 171.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.9 t -77.66 128.28 38.15 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.055 0 CA-C-N 119.593 1.696 . . . . 43.22 108.545 172.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -57.26 129.38 41.5 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.686 -0.857 . . . . 70.35 108.686 170.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -59.55 -22.82 57.41 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 118.173 -1.349 . . . . 51.34 112.341 173.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.4 -23.41 21.07 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.876 1.338 . . . . 75.25 110.764 -177.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -70.59 -42.49 70.96 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 107.457 -1.312 . . . . 64.55 107.457 177.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.417 ' CD1' HG21 ' A' ' 77' ' ' VAL . 53.7 t80 -61.54 -59.47 5.17 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 124.181 0.926 . . . . 73.21 110.028 177.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -66.55 -16.73 64.37 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.276 0.489 . . . . 61.42 111.336 -176.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.43 -64.98 0.95 Allowed 'General case' 0 C--N 1.341 0.21 0 O-C-N 121.092 -1.005 . . . . 73.54 109.023 169.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.565 ' HB3' HG22 ' A' ' 77' ' ' VAL . . . -52.28 -43.35 64.4 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.272 1.029 . . . . 71.32 110.246 -175.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -46.07 -41.54 12.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.675 1.59 . . . . 73.25 112.23 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -103.94 -2.47 26.08 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.995 1.318 . . . . 63.14 111.553 -173.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.8 t -84.91 157.05 20.96 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 127.017 2.127 . . . . 72.21 111.495 -175.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -57.76 -31.15 66.22 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 125.505 1.522 . . . . 73.53 111.552 169.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 42.3 t -52.68 -50.1 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 119.248 0.931 . . . . 75.15 108.933 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.4 t -68.99 -39.89 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-O 118.923 -0.561 . . . . 74.13 110.42 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -53.71 -51.48 63.14 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.187 0.903 . . . . 74.44 110.685 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 t -67.34 -37.07 82.68 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.346 1.059 . . . . 64.51 111.207 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.88 -53.24 49.78 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-O 117.493 -1.241 . . . . 75.11 110.753 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 53.4 t -52.19 -38.74 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.178 1.391 . . . . 72.14 110.405 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.7 -34.77 76.34 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 118.361 -0.828 . . . . 75.14 112.777 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -55.32 -58.52 7.39 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.795 0.725 . . . . 71.32 110.655 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.485 ' HB2' ' CE1' ' A' ' 60' ' ' HIS . 0.9 OUTLIER -84.68 -33.3 23.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.182 -0.913 . . . . 62.31 110.951 -168.344 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -57.43 -52.92 63.41 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 119.145 0.884 . . . . 74.13 109.11 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -55.06 -48.49 73.4 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 110.144 -0.317 . . . . 75.13 110.144 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.9 -12.04 15.99 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 113.763 1.023 . . . . 75.25 113.763 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -130.14 18.65 5.46 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.809 1.244 . . . . 75.33 111.724 176.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -132.23 2.39 3.9 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.424 1.89 . . . . 72.53 111.651 173.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -83.51 22.77 1.01 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.036 1.734 . . . . 71.51 111.276 169.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 62.92 -16.89 0.05 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 130.375 3.47 . . . . 73.12 117.342 -175.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.56 -26.22 50.69 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 119.997 1.271 . . . . 61.55 111.942 -167.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 tt -134.56 111.98 10.49 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 126.2 1.8 . . . . 73.24 106.414 -173.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -140.63 22.09 2.33 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 127.306 2.242 . . . . 73.12 108.619 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -162.86 114.21 0.59 Allowed Glycine 0 C--N 1.337 0.595 0 N-CA-C 109.943 -1.263 . . . . 45.11 109.943 -171.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.521 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 2.7 m -120.91 171.01 6.37 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 118.239 1.02 . . . . 73.21 110.386 -176.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.521 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 91.2 Cg_endo -68.97 153.65 90.99 Favored 'Cis proline' 0 N--CA 1.456 -0.679 0 CA-C-N 120.342 1.158 . . . . 61.45 111.237 -4.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -146.81 108.6 4.36 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.564 -0.902 . . . . 54.33 108.564 -173.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 39.0 ttm -101.57 135.02 43.79 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.963 -1.125 . . . . 73.42 107.963 173.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -123.18 154.23 38.98 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.534 1.534 . . . . 74.23 107.982 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 96.6 t -115.23 -48.09 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 112.9 0.704 . . . . 72.31 112.9 -163.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -144.55 33.2 1.17 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 128.16 2.584 . . . . 74.44 107.609 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 65.63 5.33 23.27 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.469 1.509 . . . . 72.15 115.759 -175.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.416 ' HE2' ' CZ ' ' A' ' 158' ' ' TYR . 9.9 ptmt -124.57 -16.3 6.32 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 120.357 2.079 . . . . 71.44 114.725 -172.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.416 ' CZ ' ' HE2' ' A' ' 157' ' ' LYS . 23.3 m-85 -126.79 124.28 39.32 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.701 -1.592 . . . . 73.01 106.701 -176.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -98.69 135.47 40.14 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 105.706 -1.961 . . . . 53.31 105.706 172.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -74.91 146.0 42.2 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.936 -0.765 . . . . 73.33 108.936 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -119.6 85.24 32.16 Favored Pre-proline 0 C--O 1.233 0.211 0 N-CA-C 112.864 0.691 . . . . 72.33 112.864 -175.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -67.11 -22.13 47.79 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 121.282 1.321 . . . . 73.3 113.614 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.7 tp60 -68.68 -34.29 75.42 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 119.79 1.177 . . . . 73.0 110.093 176.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -92.02 30.76 6.4 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-O 118.966 -0.908 . . . . 64.44 111.177 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.6 mtt -122.04 176.35 5.85 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 118.681 1.241 . . . . 72.11 109.567 173.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.503 ' HB2' HE22 ' A' ' 176' ' ' GLN . 0.4 OUTLIER -86.64 64.89 8.76 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 123.279 1.514 . . . . 73.3 111.075 -172.39 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 21.0 p -74.9 40.53 0.15 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 129.217 3.007 . . . . 70.42 110.901 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 3.8 m -124.06 -3.5 8.07 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.34 1.456 . . . . 71.04 111.646 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.78 -10.31 2.08 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.484 1.114 . . . . 70.03 112.029 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 8.7 mmt 70.81 -56.69 0.61 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.625 1.97 . . . . 74.0 114.315 174.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.34 -45.61 75.87 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.782 -1.192 . . . . 74.23 107.782 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 82.5 t -63.15 -31.37 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.488 1.515 . . . . 74.14 111.577 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -60.21 -56.01 26.84 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.014 -0.736 . . . . 73.01 109.014 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 t -70.74 -34.43 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 119.145 -0.455 . . . . 74.34 110.775 -176.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.72 -35.31 63.54 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.507 0.723 . . . . 74.31 110.77 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.503 HE22 ' HB2' ' A' ' 166' ' ' ASP . 39.7 mt-30 -78.87 -44.67 22.34 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.699 1.199 . . . . 74.34 112.741 168.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -56.97 -58.04 9.9 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.716 1.144 . . . . 73.1 111.349 -173.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -55.68 -31.84 62.74 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.561 -0.733 . . . . 54.2 112.149 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -68.34 -58.15 4.82 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.8 0.727 . . . . 74.42 109.869 177.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.9 t -60.53 -29.26 69.01 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 119.064 -0.493 . . . . 74.11 110.554 -172.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 98.0 t -55.42 -57.23 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.318 -0.993 . . . . 71.35 108.318 171.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.63 -46.3 90.39 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.129 0.972 . . . . 73.0 111.16 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -60.26 -18.49 49.39 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.267 1.427 . . . . 73.4 113.383 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.622 HD23 ' HD3' ' A' ' 187' ' ' LYS . 69.1 mt -92.56 -23.33 19.09 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 121.508 -0.745 . . . . 75.43 112.927 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 66.8 t -63.14 -35.81 73.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.068 -0.716 . . . . 62.13 109.068 174.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -83.58 -18.41 38.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.417 -0.81 . . . . 65.32 110.142 -172.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.622 ' HD3' HD23 ' A' ' 184' ' ' LEU 0.305 0.0 OUTLIER -77.75 15.78 0.79 Allowed 'General case' 0 CA--C 1.545 0.759 0 O-C-N 120.751 -1.218 . . . . 74.32 113.776 -168.101 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.433 -1.279 0 C-N-CA 129.4 3.08 . . . . 64.21 109.422 -152.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 112.815 0.672 . . . . 70.14 112.815 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.22 122.2 4.98 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 104.205 -2.517 . . . . 71.52 104.205 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.1 pt -126.77 156.89 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 126.519 1.927 . . . . 72.12 107.33 170.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 99.4 m -135.08 130.34 35.39 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.639 1.575 . . . . 72.43 106.76 -171.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -57.35 137.43 56.1 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.315 -0.624 . . . . 72.24 109.315 171.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.74 -21.97 12.97 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.21 1.386 . . . . 44.12 113.217 -171.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -99.9 -85.58 0.4 Allowed 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 119.895 1.848 . . . . 73.25 109.004 -172.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -88.93 -14.17 37.31 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.656 1.116 . . . . 62.44 111.509 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -138.24 170.77 15.44 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.766 0.826 . . . . 65.44 109.587 169.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.4 mm -128.4 154.24 38.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 105.771 -1.937 . . . . 74.55 105.771 170.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.0 m -108.88 140.22 42.65 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.711 1.605 . . . . 73.42 108.357 175.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 74.5 mt -79.38 142.07 36.33 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.176 -1.046 . . . . 74.42 108.176 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -70.72 -40.91 72.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 122.612 1.196 . . . . 71.45 109.17 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -125.73 83.82 61.71 Favored Pre-proline 0 N--CA 1.455 -0.193 0 C-N-CA 127.345 2.258 . . . . 65.24 107.12 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo . . . . . 0 N--CA 1.444 -1.408 0 C-N-CA 123.923 3.082 . . . . 74.51 108.579 170.245 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 CA--C 1.535 0.4 0 N-CA-C 107.337 -1.356 . . . . 70.22 107.337 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.449 HD23 ' CE2' ' A' ' 25' ' ' PHE . 2.8 tp -166.53 160.56 15.4 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 120.036 1.289 . . . . 73.53 112.456 172.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' H ' ' HG ' ' A' ' 23' ' ' LEU . 16.4 mt-10 -141.36 136.04 31.07 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.045 1.338 . . . . 73.33 108.237 -171.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.449 ' CE2' HD23 ' A' ' 23' ' ' LEU . 83.3 m-85 -128.63 140.98 51.5 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.981 2.112 . . . . 61.22 109.874 -176.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -151.39 177.55 10.17 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 128.54 2.736 . . . . 74.25 107.97 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.3 t -139.29 -177.07 4.75 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.474 -0.766 . . . . 72.21 109.852 155.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -84.11 -51.79 6.79 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.626 1.57 . . . . 63.21 109.473 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -80.44 -13.83 58.8 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.265 0.839 . . . . 71.13 113.265 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.7 p -69.51 145.0 94.96 Favored Pre-proline 0 C--O 1.237 0.409 0 CA-C-N 119.743 1.156 . . . . 53.43 110.867 -175.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -70.7 175.61 8.64 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 121.251 1.301 . . . . 72.55 109.682 164.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 68.85 -55.08 0.55 Allowed 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 127.495 2.318 . . . . 71.41 111.218 -175.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 32.4 m -44.67 -41.03 6.37 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.133 2.173 . . . . 75.33 110.741 174.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -53.52 -68.4 0.18 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.303 1.841 . . . . 74.21 111.036 174.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.14 -44.28 71.27 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.726 -0.842 . . . . 75.53 108.726 -175.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -64.86 -13.11 55.19 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 116.532 -1.699 . . . . 74.53 113.046 -175.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -139.79 19.46 2.5 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 121.022 1.737 . . . . 73.43 112.62 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -136.58 -46.56 0.61 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.412 1.485 . . . . 73.04 111.685 171.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.5 t -101.16 -69.29 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.124 0 N-CA-C 107.753 -1.203 . . . . 62.11 107.753 -168.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 73.5 mt -71.01 -33.83 70.75 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.435 1.094 . . . . 74.13 111.813 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 44.36 54.18 6.39 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.313 1.445 . . . . 73.13 111.326 -169.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.48 ' O ' HG23 ' A' ' 46' ' ' VAL . 81.9 t -52.26 -47.28 45.43 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 C-N-CA 125.285 1.434 . . . . 75.33 109.554 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.4 t -49.47 -43.74 45.35 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.33 2.252 . . . . 63.42 112.122 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -87.02 -17.6 32.58 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.156 -1.59 . . . . 62.44 112.952 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -74.3 -46.34 41.74 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.058 -0.719 . . . . 70.54 109.058 169.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 42' ' ' VAL . 95.0 t -57.66 -44.31 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 124.789 1.235 . . . . 71.13 109.61 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -46.59 -43.97 17.73 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.833 0.853 . . . . 74.55 112.305 177.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -67.6 -12.65 60.89 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.281 1.586 . . . . 41.24 115.281 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -111.36 -7.65 14.37 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.044 1.338 . . . . 71.14 113.312 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.7 mt -68.89 144.87 96.29 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 118.996 0.816 . . . . 64.52 112.057 -168.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.0 160.0 37.23 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.096 2.531 . . . . 73.14 111.019 168.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.98 27.7 0.07 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.264 1.426 . . . . 65.44 114.312 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -144.72 25.4 1.96 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 126.292 1.901 . . . . 73.21 112.262 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.2 m -146.16 73.19 1.32 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.683 -1.228 . . . . 72.51 107.683 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.6 mttm -59.92 145.95 44.05 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 122.043 0.925 . . . . 54.45 112.014 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -76.3 114.33 14.88 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.387 -1.338 . . . . 72.42 107.387 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.7 m -124.27 163.72 21.06 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.065 -1.087 . . . . 72.05 108.065 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -161.68 100.11 1.15 Allowed 'General case' 0 C--N 1.332 -0.165 0 O-C-N 120.022 -1.674 . . . . 63.31 107.306 -165.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -98.7 160.83 14.0 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.03 -1.044 . . . . 72.34 109.769 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.644 ' CE1' HG23 ' A' ' 72' ' ' THR . 0.1 OUTLIER -102.93 165.36 11.08 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.612 1.565 . . . . 70.15 109.321 174.524 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.6 m -132.96 153.03 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 122.229 1.014 . . . . 43.25 110.217 156.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.425 ' HG3' HG21 ' A' ' 72' ' ' THR . 0.0 OUTLIER -90.68 2.78 55.64 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 130.244 3.418 . . . . 62.44 113.765 176.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -69.14 -8.99 50.55 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 115.41 1.633 . . . . 74.25 115.41 -168.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 mp -137.92 153.37 49.52 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 120.614 1.552 . . . . 51.42 110.543 -171.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.65 170.99 29.69 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 123.93 0.776 . . . . 55.54 113.751 173.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.52 -44.69 4.23 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.928 3.085 . . . . 74.32 111.851 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.9 mt -97.0 27.41 4.05 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 125.258 1.423 . . . . 53.11 110.868 -167.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -44.83 -56.77 5.65 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.01 1.291 . . . . 75.1 111.595 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.8 tptt -63.34 -40.0 96.1 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 118.024 0.912 . . . . 55.31 111.841 -177.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -65.21 -44.82 87.09 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.423 1.089 . . . . 72.11 109.731 -176.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.3 mt -62.17 -33.35 74.36 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.974 0.91 . . . . 73.31 110.824 174.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.644 HG23 ' CE1' ' A' ' 60' ' ' HIS . 27.3 m -77.88 3.52 14.23 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 127.689 2.396 . . . . 64.13 111.429 175.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -116.75 -24.61 7.64 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 119.181 -2.2 . . . . 73.43 110.747 169.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.65 -28.31 61.71 Favored 'General case' 0 N--CA 1.457 -0.112 0 O-C-N 120.758 -1.213 . . . . 34.01 114.053 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 39.2 t-105 -65.87 -40.01 91.24 Favored 'General case' 0 C--N 1.331 -0.201 0 O-C-N 121.386 -0.821 . . . . 73.2 110.377 -173.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.422 ' HB3' HG13 ' A' ' 130' ' ' VAL . . . -61.13 -37.98 84.76 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.707 1.203 . . . . 32.12 111.969 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.4 t -51.44 -51.57 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 119.277 0.944 . . . . 74.13 109.412 171.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.43 -32.17 62.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 117.152 -1.404 . . . . 70.2 112.091 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.1 mt -63.56 -38.91 83.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 120.903 1.683 . . . . 71.22 110.406 170.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.09 -49.69 76.3 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 119.043 0.838 . . . . 73.2 110.057 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.21 -9.76 59.73 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 112.137 0.421 . . . . 65.23 112.137 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.61 57.9 13.08 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 126.872 2.177 . . . . 72.24 111.757 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.3 m -129.46 18.64 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 125.507 1.523 . . . . 65.14 111.071 -175.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -51.88 -48.06 64.26 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.42 1.009 . . . . 74.35 110.072 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -61.81 -15.25 40.15 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 128.041 2.536 . . . . 74.25 114.997 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -98.13 -16.02 19.7 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.857 0.863 . . . . 73.11 109.514 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp -126.72 21.34 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 125.282 1.433 . . . . 72.11 110.646 -175.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 93.6 m -80.31 -59.85 2.55 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 109.143 -0.688 . . . . 73.03 109.143 173.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.52 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -57.71 -61.78 6.66 Favored Pre-proline 0 N--CA 1.453 -0.321 0 C-N-CA 125.384 1.474 . . . . 62.34 110.272 -166.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.52 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 38.6 Cg_endo -66.14 -22.31 54.44 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 120.645 0.897 . . . . 64.33 112.505 -174.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 5.2 tpp -59.61 -49.81 76.31 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.981 0.513 . . . . 75.03 110.702 170.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -64.23 -39.5 94.1 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.127 -0.983 . . . . 61.35 111.558 176.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.91 -27.82 68.46 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 120.491 -0.483 . . . . 64.43 111.497 171.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.19 -11.23 33.21 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 120.952 -1.092 . . . . 72.43 112.748 -173.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.5 t -117.39 -27.47 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 C-N-CA 124.633 1.173 . . . . 73.2 110.629 -173.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -115.44 -48.71 2.78 Favored 'General case' 0 C--N 1.336 -0.02 0 CA-C-N 118.87 0.759 . . . . 52.2 110.789 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -73.8 -65.51 0.82 Allowed 'General case' 0 C--O 1.23 0.06 0 CA-C-N 118.692 0.678 . . . . 73.43 111.015 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.4 p -83.43 -31.99 26.32 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.713 -0.617 . . . . 64.33 110.29 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 56.53 23.72 7.89 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.198 1.799 . . . . 75.42 112.558 -171.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -71.27 -12.22 61.34 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.588 1.155 . . . . 75.21 112.601 -171.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.519 HG13 HG12 ' A' ' 107' ' ' ILE . 26.7 t -63.97 109.3 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 O-C-N 120.808 -1.182 . . . . 63.03 109.329 168.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -132.04 -22.22 2.32 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.751 0.82 . . . . 71.44 112.624 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.26 165.77 26.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.68 1.992 . . . . 63.12 107.413 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 91.7 t -51.78 -44.96 37.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.393 1.077 . . . . 75.04 108.971 172.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.51 1.39 0.56 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.016 2.126 . . . . 55.33 115.422 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -106.91 -29.52 9.42 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 119.653 1.115 . . . . 60.2 109.321 170.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.519 HG12 HG13 ' A' ' 101' ' ' VAL . 0.5 OUTLIER -81.81 -24.1 9.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 O-C-N 121.057 -1.027 . . . . 53.51 111.01 -172.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -40.5 97.43 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.345 -0.983 . . . . 75.31 108.345 172.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -55.41 -49.46 72.31 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 123.929 0.768 . . . . 72.32 109.703 -164.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 47.0 t -54.47 -48.31 69.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.286 1.434 . . . . 61.43 111.511 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -56.41 -55.54 32.3 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 109.175 -0.676 . . . . 73.42 109.175 176.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 93.3 t -59.01 -44.53 91.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 122.917 0.487 . . . . 74.42 109.868 -172.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -62.02 -45.79 92.03 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.176 1.391 . . . . 73.32 108.526 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.22 -0.11 11.23 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.965 1.306 . . . . 71.0 112.723 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 109.86 36.12 2.08 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 119.879 1.218 . . . . 25.25 114.154 173.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.1 t -107.55 130.47 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 118.556 1.178 . . . . 73.42 109.536 173.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt -62.15 118.92 8.01 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.321 -0.992 . . . . 72.42 108.321 166.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.69 -22.51 68.17 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 119.063 -0.854 . . . . 74.21 111.138 173.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -65.52 -35.14 79.99 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.151 0.975 . . . . 73.22 111.25 175.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -83.25 -34.18 25.88 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.872 -1.159 . . . . 65.32 107.872 -172.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -51.01 -67.64 0.24 Allowed 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.995 1.318 . . . . 74.3 110.3 165.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -66.39 -11.55 52.05 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.248 0.547 . . . . 62.14 111.656 -170.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.38 -74.85 0.35 Allowed 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.315 1.046 . . . . 74.3 109.484 169.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.459 ' HA ' ' HB3' ' A' ' 127' ' ' SER . . . -58.4 -32.28 68.48 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 118.966 -0.54 . . . . 73.23 111.758 -169.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 60.6 t-105 -47.76 -34.81 8.96 Favored 'General case' 0 CA--C 1.523 -0.069 0 C-N-CA 124.718 1.207 . . . . 74.2 112.199 174.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -109.28 1.31 20.06 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.999 1.319 . . . . 73.02 111.728 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.459 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 5.7 t -105.98 151.64 24.35 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 124.197 1.951 . . . . 73.4 110.492 -174.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . 0.268 0.1 OUTLIER -57.12 -26.04 59.84 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 117.781 2.511 . . . . 64.43 117.781 -171.66 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 86.4 t -44.37 -56.82 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 C-N-CA 127.667 2.387 . . . . 71.23 108.159 167.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 76' ' ' ALA . 25.2 t -73.35 -42.72 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 124.169 0.988 . . . . 72.22 109.277 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -56.11 -49.04 74.98 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.683 1.129 . . . . 70.32 111.45 -173.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 72.3 m -77.48 -25.36 50.36 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 117.999 -1.0 . . . . 71.33 112.89 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.6 mt -65.02 -52.38 56.33 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 120.335 1.425 . . . . 73.04 110.25 170.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 40.9 t -45.81 -43.44 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.757 2.023 . . . . 71.33 110.937 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.57 -41.67 70.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.165 0.586 . . . . 34.02 111.877 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -53.13 -49.82 65.77 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 123.723 0.809 . . . . 44.53 112.737 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.461 ' HB2' ' CE1' ' A' ' 60' ' ' HIS . 0.6 OUTLIER -98.08 -20.26 17.46 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 118.883 -0.58 . . . . 61.21 110.967 -171.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -62.5 -50.48 71.24 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 107.855 -1.165 . . . . 71.42 107.855 167.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -55.83 -57.27 12.73 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.956 0.903 . . . . 73.45 110.94 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.76 6.36 2.58 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.424 1.268 . . . . 63.52 114.424 -175.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -106.25 -40.9 5.48 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.884 1.274 . . . . 51.01 110.601 160.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.03 -32.6 74.21 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.418 1.087 . . . . 75.55 112.889 -171.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -71.15 3.99 3.11 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.045 1.338 . . . . 60.54 113.125 -175.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.6 mt 74.78 1.94 3.91 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.746 2.018 . . . . 75.15 112.159 170.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.54 HE21 ' N ' ' A' ' 146' ' ' LEU . 0.0 OUTLIER -61.25 -16.9 50.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 129.851 3.26 . . . . 74.34 113.729 -179.133 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.54 ' N ' HE21 ' A' ' 145' ' ' GLN . 0.6 OUTLIER -155.55 126.27 6.92 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 128.773 2.829 . . . . 75.14 103.52 -172.068 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -139.29 5.08 2.26 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.142 0.577 . . . . 73.24 111.591 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -133.91 163.08 24.53 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.951 1.262 . . . . 73.13 109.957 171.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.26 164.69 33.86 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.095 0.958 . . . . 73.14 109.34 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.71 162.33 81.15 Favored 'Cis proline' 0 N--CA 1.455 -0.747 0 CA-C-N 119.313 0.79 . . . . 61.43 111.506 -13.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -146.41 127.19 14.37 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.076 -0.965 . . . . 72.21 109.026 175.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 42.7 ttm -112.78 109.99 19.82 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 105.587 -2.005 . . . . 54.21 105.587 169.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -77.94 165.7 23.76 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.678 -1.23 . . . . 62.45 107.678 166.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.4 t -125.46 -86.37 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 N-CA-C 107.635 -1.246 . . . . 52.44 107.635 167.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -88.96 35.94 0.8 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 120.565 1.53 . . . . 73.11 111.256 -171.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 68.13 -73.57 0.29 Allowed Glycine 0 C--N 1.338 0.646 0 N-CA-C 109.265 -1.534 . . . . 61.33 109.265 -160.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 12.7 ptmt -55.47 -4.92 0.11 Allowed 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 128.533 2.733 . . . . 65.34 116.641 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -124.34 143.94 50.3 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 120.2 1.364 . . . . 74.45 109.106 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -128.32 138.45 52.39 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.075 -1.454 . . . . 63.32 107.075 171.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -65.42 133.19 50.79 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.108 -1.441 . . . . 75.25 107.108 175.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -104.52 86.08 1.31 Allowed Pre-proline 0 C--O 1.236 0.355 0 C-N-CA 124.171 0.988 . . . . 72.53 112.035 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.02 -20.93 43.9 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 CA-C-N 119.931 1.011 . . . . 73.25 113.479 -177.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -72.61 -38.45 67.79 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 120.838 1.654 . . . . 63.54 109.406 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -78.48 3.78 62.02 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 118.762 0.71 . . . . 71.42 113.051 -177.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 55.3 mtt -90.29 168.14 12.13 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 118.746 1.273 . . . . 63.33 109.367 174.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -81.04 114.54 19.97 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 105.999 -1.852 . . . . 62.33 105.999 167.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.433 HG22 ' CD1' ' A' ' 173' ' ' PHE . 11.1 p -107.6 6.73 28.17 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 127.298 2.239 . . . . 52.45 109.983 -175.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.5 m -92.84 3.56 55.46 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 113.616 0.969 . . . . 61.45 113.616 -166.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.0 -4.71 1.52 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.499 1.12 . . . . 73.44 111.657 -176.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 7.6 mmt 67.64 -61.89 0.35 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.416 1.886 . . . . 75.51 112.926 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.28 -42.53 88.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 119.978 1.263 . . . . 75.22 109.229 -176.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 66.5 t -61.92 -28.34 44.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 123.713 0.805 . . . . 63.25 110.951 174.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.433 ' CD1' HG22 ' A' ' 167' ' ' THR . 59.5 t80 -64.27 -61.28 2.34 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 107.974 -1.121 . . . . 55.41 107.974 177.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.3 t -67.89 -32.2 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 119.289 -0.386 . . . . 73.44 111.086 -174.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.06 -47.12 68.72 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.76 1.224 . . . . 71.11 110.86 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -81.46 -38.27 26.66 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 118.252 -0.88 . . . . 64.54 111.658 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -54.82 -60.2 3.69 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.593 1.088 . . . . 75.41 110.209 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.41 ' HA ' HG22 ' A' ' 46' ' ' VAL . . . -59.14 -26.09 64.43 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.825 0.85 . . . . 54.41 112.249 -173.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -77.29 -54.42 6.5 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.101 0.56 . . . . 70.15 109.815 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.2 t -58.94 -25.57 63.61 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-O 117.741 -1.123 . . . . 74.21 111.516 -176.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 59.3 t -54.55 -57.64 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 118.944 0.793 . . . . 63.51 109.046 171.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? -62.89 -36.95 85.0 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.993 -0.442 . . . . 71.33 110.222 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -66.6 -30.73 71.08 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 123.859 0.864 . . . . 42.01 110.821 -173.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 47.1 mt -71.01 -31.84 68.46 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.027 -1.046 . . . . 73.42 111.375 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 85.4 t -66.1 -24.21 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 O-C-N 121.756 -0.59 . . . . 72.41 110.876 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -97.07 -5.77 36.72 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.332 1.053 . . . . 73.15 110.253 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -120.79 87.14 2.7 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 125.925 1.69 . . . . 72.55 107.871 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 37.5 mttm . . . . . 0 C--O 1.251 1.158 0 C-N-CA 127.069 2.147 . . . . 71.24 110.917 175.51 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.327 0 N-CA-C 112.871 0.693 . . . . 70.23 112.871 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -141.97 110.77 6.19 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.873 -1.899 . . . . 45.42 105.873 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.585 HG23 HE22 ' A' ' 183' ' ' GLN . 4.8 pt -143.09 164.97 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 130.966 3.706 . . . . 72.22 107.721 -178.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.9 m -139.17 148.86 43.74 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.876 1.67 . . . . 72.42 108.247 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -57.76 148.72 24.08 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.174 1.79 . . . . 64.01 111.065 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.63 -23.38 0.81 Allowed Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.832 1.206 . . . . 74.24 112.878 -171.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.2 tttp -90.23 -85.21 0.22 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 118.831 1.316 . . . . 74.12 108.539 -160.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -98.88 -7.13 27.73 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.021 0.929 . . . . 65.21 111.337 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.409 ' CD1' HD12 ' A' ' 3' ' ' ILE . 25.4 p90 -144.6 163.55 33.59 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.81 -1.182 . . . . 71.44 107.81 169.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.6 mm -124.8 157.09 33.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 106.264 -1.754 . . . . 53.11 106.264 169.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.45 171.53 14.61 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 127.295 2.238 . . . . 74.23 109.3 165.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.9 mt -108.24 159.6 16.5 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.359 1.064 . . . . 70.32 111.02 173.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -62.73 -44.6 95.79 Favored 'General case' 0 C--O 1.227 -0.096 0 N-CA-C 108.9 -0.778 . . . . 73.23 108.9 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -131.24 81.55 65.47 Favored Pre-proline 0 C--N 1.339 0.112 0 C-N-CA 127.015 2.126 . . . . 63.11 107.547 -173.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo . . . . . 0 N--CA 1.455 -0.761 0 C-N-CA 122.662 2.242 . . . . 70.31 110.812 -178.561 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.0 t . . . . . 0 N--CA 1.447 -0.602 0 N-CA-C 105.929 -1.878 . . . . 53.2 105.929 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 tt -147.15 157.82 43.73 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.221 -1.029 . . . . 64.13 108.221 -172.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -125.44 149.58 48.09 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.92 1.288 . . . . 62.3 107.958 170.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.421 ' CD2' HD13 ' A' ' 146' ' ' LEU . 95.3 m-85 -127.38 145.55 50.77 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.16 0.984 . . . . 73.41 108.95 169.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -153.72 -177.8 6.62 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 128.326 2.651 . . . . 74.53 106.98 168.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.422 ' CB ' HD12 ' A' ' 64' ' ' LEU . 10.6 t -133.4 179.85 5.95 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 121.351 -0.843 . . . . 71.32 108.745 170.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -82.43 -28.8 31.12 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.995 2.518 . . . . 74.21 110.583 -176.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -109.66 1.89 19.85 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.56 1.144 . . . . 74.54 112.231 -169.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.1 p -87.26 143.48 34.59 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 120.111 1.323 . . . . 71.31 110.453 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -83.66 -38.63 0.13 Allowed 'Trans proline' 0 CA--C 1.533 0.437 0 CA-C-N 119.901 1.0 . . . . 64.5 112.481 -166.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -52.31 -47.68 65.84 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 118.798 0.726 . . . . 53.41 109.661 172.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 14.2 m -54.77 -37.86 66.51 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.74 1.616 . . . . 65.32 111.482 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -62.49 -51.32 67.93 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.679 0.391 . . . . 73.53 110.861 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.556 ' HA ' HE21 ' A' ' 35' ' ' GLN . 0.0 OUTLIER -59.61 -45.45 91.88 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 119.67 -0.812 . . . . 63.2 109.054 176.029 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -66.13 -10.39 40.46 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 116.919 -1.515 . . . . 64.13 112.015 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -140.26 10.47 2.33 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 121.86 2.118 . . . . 50.11 113.086 -174.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -134.13 -45.0 0.78 Allowed 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 123.903 0.881 . . . . 61.1 110.41 170.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.8 t -88.9 -69.81 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 108.255 -1.017 . . . . 74.41 108.255 -175.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.6 mt -77.81 -25.53 48.97 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.732 1.613 . . . . 74.52 113.333 -174.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 44.67 59.31 3.42 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.538 1.535 . . . . 72.43 112.911 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.4 t -55.48 -50.35 66.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 124.061 0.944 . . . . 70.3 109.302 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.2 t -47.17 -52.36 15.83 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.143 1.377 . . . . 73.43 112.308 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -79.37 -23.39 43.38 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 110.588 -0.152 . . . . 74.43 110.588 -169.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -69.93 -48.8 57.02 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.639 -1.245 . . . . 73.43 107.639 169.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 37.8 t -55.69 -49.83 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 125.162 1.385 . . . . 74.04 110.914 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -56.94 -28.02 61.67 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 119.87 -1.769 . . . . 72.51 113.297 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -71.14 -8.62 54.73 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.202 0.91 . . . . 72.32 113.192 177.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -119.83 -14.71 8.95 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 126.321 1.848 . . . . 72.41 111.968 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.495 HD13 HG21 ' A' ' 54' ' ' THR . 13.3 mt -69.53 151.11 96.78 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 119.222 0.919 . . . . 72.04 112.496 -169.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -85.95 159.19 10.22 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.625 2.883 . . . . 64.02 113.078 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -83.62 59.34 5.08 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.307 1.843 . . . . 62.1 111.031 -172.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.71 -23.98 0.02 OUTLIER Glycine 0 CA--C 1.527 0.802 0 CA-C-N 113.592 -1.64 . . . . 62.44 112.1 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.495 HG21 HD13 ' A' ' 50' ' ' LEU . 10.3 t -47.85 -57.1 6.09 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.561 1.544 . . . . 73.11 112.632 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.405 ' N ' HG23 ' A' ' 54' ' ' THR . 4.7 tmmm? 56.84 123.55 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.779 2.032 . . . . 70.13 111.04 -157.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.7 ttm -68.27 108.18 3.09 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 125.881 1.672 . . . . 74.1 108.253 172.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.18 115.03 21.69 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 107.127 -1.434 . . . . 72.32 107.127 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.27 122.04 35.78 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.18 -1.415 . . . . 74.2 107.18 -178.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.1 m-30 -113.35 145.85 40.42 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.488 -1.301 . . . . 72.43 107.488 172.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.0 117.85 32.47 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.258 1.423 . . . . 74.14 107.669 -167.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.8 m -93.88 157.78 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 O-C-N 121.472 -0.768 . . . . 72.2 110.747 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.43 -8.46 13.89 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.748 1.219 . . . . 72.13 113.448 -161.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -63.17 5.16 0.16 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.815 2.046 . . . . 62.32 115.346 -170.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.422 HD12 ' CB ' ' A' ' 27' ' ' SER . 11.1 mt -138.11 132.39 31.96 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 119.955 -1.715 . . . . 70.43 107.593 -165.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.76 174.76 30.25 Favored Glycine 0 CA--C 1.541 1.672 0 O-C-N 123.493 0.496 . . . . 52.1 111.877 -172.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.92 -55.33 0.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.92 3.08 . . . . 73.34 112.692 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.4 mt -87.34 24.85 1.52 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.958 1.303 . . . . 51.35 112.201 -167.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.04 -42.77 98.05 Favored Glycine 0 C--O 1.228 -0.247 0 N-CA-C 110.174 -1.17 . . . . 74.23 110.174 -167.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -61.42 -44.55 96.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.499 0.32 . . . . 73.34 110.689 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.43 -46.77 87.79 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.446 1.898 . . . . 74.43 109.012 177.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.9 mt -64.64 -40.53 95.62 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.751 0.82 . . . . 64.3 111.623 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.8 m -60.7 -40.45 92.27 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 120.272 1.396 . . . . 71.51 110.388 171.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -64.62 -39.28 93.43 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.26 -0.9 . . . . 70.15 108.876 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.61 -36.43 78.57 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 120.964 -1.085 . . . . 72.54 111.913 173.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 25.3 t-105 -58.42 -35.74 72.53 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 118.882 0.764 . . . . 71.5 111.996 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.36 -40.55 82.53 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 118.695 -0.669 . . . . 63.31 111.912 175.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 69.7 t -59.54 -44.89 94.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 119.657 1.117 . . . . 51.13 109.544 170.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.51 -42.04 98.21 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 118.364 -0.827 . . . . 74.53 111.6 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 76.3 mt -69.45 -38.51 77.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.899 0.88 . . . . 74.44 110.52 176.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.8 -40.21 91.81 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.488 1.04 . . . . 64.43 110.582 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.8 mt -93.0 -8.02 44.21 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.75 0.648 . . . . 74.11 112.75 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 53.83 62.91 5.61 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 125.485 1.517 . . . . 52.13 111.378 -172.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.1 m -125.54 18.97 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.49 1.116 . . . . 65.5 112.046 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -51.3 -49.54 61.1 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.341 1.456 . . . . 53.11 111.504 -174.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -63.36 -31.47 72.63 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 125.167 1.387 . . . . 74.11 113.807 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -75.24 -34.38 61.4 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.258 -0.645 . . . . 74.54 109.258 -176.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.1 pp -103.52 -16.37 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.967 0.729 . . . . 74.44 112.967 -166.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.7 m -58.93 -49.47 77.72 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 119.17 0.895 . . . . 70.42 111.116 -172.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.468 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -62.47 -58.76 15.36 Favored Pre-proline 0 N--CA 1.45 -0.458 0 C-N-CA 123.712 0.805 . . . . 53.0 110.181 -164.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.468 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 39.5 Cg_endo -66.25 -26.0 49.48 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 121.095 1.197 . . . . 62.14 112.222 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 10.8 tpp -61.7 -44.64 96.55 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.577 0.626 . . . . 63.23 111.051 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -69.69 -35.69 75.32 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.243 -0.911 . . . . 71.5 109.047 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -54.85 -48.34 73.01 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.388 0.54 . . . . 61.21 110.242 166.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.55 -16.09 60.83 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 121.73 -0.606 . . . . 73.11 111.154 -165.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 63.8 t -112.15 -33.86 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.368 1.467 . . . . 74.23 110.799 -173.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -109.73 -55.96 2.37 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.522 1.056 . . . . 72.42 110.744 -174.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -64.35 -63.93 1.01 Allowed 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.907 0.883 . . . . 74.3 110.784 -176.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.4 t -99.44 -27.6 13.66 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.672 1.189 . . . . 70.5 110.761 -173.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 59.43 29.4 18.96 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.811 1.244 . . . . 63.5 112.889 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.4 t -69.38 -12.63 61.82 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.782 1.633 . . . . 65.15 112.815 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.6 t -67.52 108.49 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.647 -1.242 . . . . 74.45 107.647 171.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -132.88 -28.09 1.6 Allowed 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 124.471 1.108 . . . . 65.44 111.623 -174.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.85 169.65 17.18 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.553 -1.277 . . . . 70.12 107.553 169.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.6 t -57.18 -25.69 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.138 0.975 . . . . 73.34 111.23 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.69 -29.57 70.18 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 126.316 1.847 . . . . 50.25 111.205 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.72 -22.26 22.29 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.111 0.481 . . . . 73.45 110.232 -176.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.0 mt -76.63 -49.11 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 126.314 1.846 . . . . 42.42 108.158 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -56.78 -30.69 63.9 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-O 118.205 -0.902 . . . . 70.44 112.719 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -57.47 -57.99 10.26 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 123.586 0.755 . . . . 62.35 109.578 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.1 t -48.43 -47.33 14.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 O-C-N 124.457 1.098 . . . . 72.34 109.804 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -55.21 -51.9 65.08 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.864 0.466 . . . . 70.52 110.741 177.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.2 t -62.42 -44.05 98.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 118.61 0.641 . . . . 72.34 111.114 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -64.74 -42.17 95.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 122.147 0.975 . . . . 72.21 108.758 -172.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -82.14 7.33 13.8 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.579 1.552 . . . . 74.22 112.572 176.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.93 29.04 4.22 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-N 119.751 1.16 . . . . 74.33 115.976 160.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.7 t -106.55 143.97 16.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 122.571 1.176 . . . . 61.55 111.026 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -62.4 126.89 28.88 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.268 1.427 . . . . 63.24 110.383 170.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.31 -23.96 74.91 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 118.483 -1.176 . . . . 53.22 111.896 169.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -69.13 -40.87 78.02 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 119.131 1.465 . . . . 61.31 109.249 170.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -79.36 -37.66 36.9 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 107.597 -1.26 . . . . 65.43 107.597 -166.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -56.65 -60.65 3.23 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.619 -0.512 . . . . 74.15 109.619 171.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.69 -13.84 61.05 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.454 0.538 . . . . 71.33 112.454 -170.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.19 -65.97 0.95 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.332 1.053 . . . . 34.32 109.202 168.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -50.4 -39.81 48.13 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.543 1.537 . . . . 73.25 110.848 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -46.19 -37.65 7.35 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.555 1.542 . . . . 73.54 112.801 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -114.35 4.3 15.33 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.917 1.287 . . . . 71.44 112.889 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.7 t -80.22 151.99 29.36 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.724 1.61 . . . . 74.53 111.492 175.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -51.99 -28.89 18.47 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.022 2.529 . . . . 64.23 113.081 175.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 93.3 t -52.75 -54.52 15.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 124.748 1.219 . . . . 51.22 109.836 174.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.3 t -69.66 -34.78 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 114.816 -1.083 . . . . 72.11 109.851 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -52.63 -47.88 66.75 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.914 1.233 . . . . 74.41 111.186 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.1 t -59.71 -55.54 33.09 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.605 0.762 . . . . 74.44 109.222 176.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 32.3 mt -64.47 -32.71 74.45 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.004 0.922 . . . . 71.31 113.483 -173.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.31 -64.45 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 C-N-CA 126.022 1.729 . . . . 70.43 107.451 166.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.42 -29.3 67.66 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 120.286 1.403 . . . . 73.43 113.744 -172.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -61.4 -51.95 66.65 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.401 0.68 . . . . 64.14 109.991 170.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -70.07 -34.08 72.74 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.41 1.084 . . . . 63.43 112.633 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -60.08 -59.04 6.05 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 107.39 -1.337 . . . . 63.12 107.39 174.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.7 ttpt -53.3 -52.03 60.41 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.318 0.647 . . . . 63.51 110.452 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.68 -2.2 4.65 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.07 1.137 . . . . 73.4 114.07 -174.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -116.65 -20.87 9.38 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.881 1.218 . . . . 53.23 112.025 164.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.54 -22.55 47.11 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 126.202 1.801 . . . . 73.52 112.434 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.05 4.13 13.1 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.104 -0.998 . . . . 72.32 112.386 -175.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.0 mt 71.43 -0.23 3.21 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.522 1.929 . . . . 65.11 111.437 171.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.23 -9.96 59.74 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.728 1.611 . . . . 73.33 112.567 -173.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.421 HD13 ' CD2' ' A' ' 25' ' ' PHE . 2.4 tp -142.15 105.44 4.62 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.606 1.562 . . . . 74.13 108.193 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -130.94 17.81 5.09 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.217 0.607 . . . . 65.34 110.605 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -134.47 160.21 24.12 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 109.621 -1.392 . . . . 72.13 109.621 163.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.4 m -144.45 167.08 15.93 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 125.658 1.583 . . . . 43.11 109.348 169.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -72.24 150.4 94.74 Favored 'Cis proline' 0 N--CA 1.46 -0.472 0 N-CA-C 110.057 -0.786 . . . . 72.43 110.057 -14.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -136.7 126.9 26.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 117.435 -1.269 . . . . 71.34 108.64 -172.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 47.5 ttm -124.12 124.74 43.15 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 119.205 0.911 . . . . 63.31 108.675 173.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -100.37 155.58 17.73 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 125.117 1.367 . . . . 71.34 110.086 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.8 t -140.54 144.71 26.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 124.259 1.024 . . . . 73.12 108.975 175.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 50.11 23.21 1.08 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.905 2.082 . . . . 72.41 113.91 169.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 61.58 17.2 53.11 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 118.681 -1.066 . . . . 61.04 113.777 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -149.2 -7.37 0.36 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.078 1.439 . . . . 65.2 114.571 -174.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -128.95 152.38 48.63 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 119.151 0.887 . . . . 70.23 110.401 -176.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -119.4 141.58 48.97 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.715 2.006 . . . . 73.1 107.819 168.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.89 132.54 45.41 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 107.772 -1.196 . . . . 74.2 107.772 170.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -106.39 86.95 2.35 Favored Pre-proline 0 C--O 1.235 0.291 0 C-N-CA 123.51 0.724 . . . . 71.52 111.954 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -65.77 -21.39 58.31 Favored 'Trans proline' 0 N--CA 1.444 -1.417 0 CA-C-O 117.911 -0.954 . . . . 72.3 112.32 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -64.79 -44.37 90.19 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 120.097 1.317 . . . . 74.53 110.942 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -82.0 1.68 86.01 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 118.87 -0.961 . . . . 44.24 112.876 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 46.6 mtt -79.3 168.05 20.07 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.958 1.879 . . . . 61.0 108.719 170.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -79.58 120.93 24.61 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 106.028 -1.841 . . . . 70.03 106.028 167.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.434 HG22 ' CD1' ' A' ' 173' ' ' PHE . 28.2 p -124.69 45.71 2.47 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.672 1.989 . . . . 74.22 106.76 -171.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 16.1 m -135.66 0.23 2.69 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 114.229 -1.351 . . . . 73.5 111.963 -164.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.471 HD22 ' HB ' ' A' ' 172' ' ' VAL . 0.5 OUTLIER -133.74 -4.99 2.85 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.298 1.439 . . . . 72.04 110.899 174.216 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 1.7 mmt 66.83 -59.3 0.38 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.908 2.083 . . . . 72.34 112.897 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.39 -48.75 80.41 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 122.397 1.094 . . . . 64.33 109.121 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.471 ' HB ' HD22 ' A' ' 169' ' ' ASN . 99.3 t -64.04 -27.5 42.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 126.638 1.975 . . . . 73.44 111.674 -178.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.434 ' CD1' HG22 ' A' ' 167' ' ' THR . 21.6 t80 -61.44 -59.22 5.59 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.065 -1.087 . . . . 70.14 108.065 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.92 -27.73 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 O-C-N 123.496 0.498 . . . . 72.2 110.906 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.45 -47.61 63.02 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.901 0.881 . . . . 70.04 111.022 171.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -79.6 -41.74 26.46 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 118.694 -0.67 . . . . 73.1 111.053 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -53.13 -59.26 4.77 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.274 0.943 . . . . 71.3 110.291 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.03 -29.07 68.26 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.521 1.128 . . . . 74.32 112.344 -175.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -65.54 -62.68 1.38 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.149 -0.686 . . . . 65.04 109.149 171.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 12.4 t -60.6 -28.43 68.5 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 118.837 -0.602 . . . . 73.22 112.186 -170.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 94.8 t -53.62 -47.08 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.821 0.737 . . . . 72.33 109.725 173.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 3.0 tmmt? -80.14 -32.75 38.92 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.152 -0.928 . . . . 61.41 110.778 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . 0.585 HE22 HG23 ' A' ' 3' ' ' ILE . 35.0 mt-30 -57.25 -36.75 71.34 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.226 1.376 . . . . 65.02 110.661 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 59.1 mt -70.84 -27.09 63.6 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.037 -1.039 . . . . 70.23 112.776 -176.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 75.7 t -63.68 -30.89 51.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 122.8 0.44 . . . . 71.12 110.374 -178.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -87.84 -29.37 20.99 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.097 -0.705 . . . . 62.31 109.097 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 31.7 mttp -93.41 48.88 1.33 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.075 1.35 . . . . 74.31 110.04 -175.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 20.6 pttm . . . . . 0 C--O 1.245 0.836 0 N-CA-C 106.856 -1.535 . . . . 65.44 106.856 155.432 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.264 0 N-CA-C 112.053 0.39 . . . . 73.12 112.053 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.55 125.03 3.67 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 105.464 -2.05 . . . . 73.21 105.464 173.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.8 pt -131.3 147.15 32.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 127.974 2.51 . . . . 64.33 108.398 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.7 m -115.55 126.42 54.23 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.66 -1.237 . . . . 61.33 107.66 -176.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.45 121.41 3.42 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 127.77 2.428 . . . . 64.2 108.641 162.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.01 -11.77 71.25 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-O 117.834 -1.537 . . . . 65.31 113.707 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -102.7 -85.52 0.44 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 119.828 1.814 . . . . 74.5 108.972 -177.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -87.95 -16.68 33.13 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.552 1.141 . . . . 72.11 110.768 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.534 ' O ' HD13 ' A' ' 10' ' ' ILE . 28.3 p90 -136.69 163.09 31.39 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.309 1.044 . . . . 73.51 109.801 172.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.534 HD13 ' O ' ' A' ' 9' ' ' TYR . 6.4 mm -129.78 158.54 42.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 105.265 -2.124 . . . . 72.53 105.265 171.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.9 m -108.91 168.82 9.08 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.693 -1.225 . . . . 72.32 107.693 173.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.1 mt -92.03 161.08 14.93 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.518 -1.29 . . . . 50.44 107.518 166.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -79.1 -29.31 43.22 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 122.549 1.166 . . . . 74.13 108.201 174.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -133.68 71.67 74.66 Favored Pre-proline 0 N--CA 1.446 -0.626 0 O-C-N 120.187 -1.57 . . . . 63.14 110.757 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo . . . . . 0 N--CA 1.456 -0.727 0 C-N-CA 123.523 2.816 . . . . 42.34 110.571 176.983 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.514 HG22 ' H ' ' A' ' 23' ' ' LEU 0.277 2.9 p . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 112.942 0.719 . . . . 53.41 112.942 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.514 ' H ' HG22 ' A' ' 22' ' ' VAL . 6.0 tp -165.44 169.45 15.6 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 121.216 -0.928 . . . . 74.12 112.356 -172.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -145.5 125.35 13.48 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 127.915 2.486 . . . . 61.44 104.591 170.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.435 ' CE2' HD23 ' A' ' 23' ' ' LEU . 9.5 m-85 -115.41 131.75 56.83 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 119.808 1.185 . . . . 72.12 110.428 177.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.85 176.55 11.33 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.109 0.564 . . . . 73.52 110.812 178.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.9 t -129.46 172.61 11.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.598 -1.63 . . . . 70.2 106.598 169.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.862 ' CZ ' HD21 ' A' ' 71' ' ' LEU 0.253 0.0 OUTLIER -86.45 -18.76 30.86 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.288 0.635 . . . . 71.12 111.545 164.952 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -91.31 -6.37 53.22 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 119.742 -1.849 . . . . 73.52 113.335 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.1 p -77.83 141.36 63.87 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 121.2 1.818 . . . . 63.24 108.031 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -84.08 -40.3 0.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.86 1.707 . . . . 64.21 111.776 -174.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -56.08 -40.19 73.25 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 120.096 1.316 . . . . 74.3 110.105 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.2 m -51.36 -30.28 18.26 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.082 1.353 . . . . 74.21 112.719 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -62.11 -56.85 14.7 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 118.668 0.667 . . . . 71.3 111.698 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -57.6 -42.68 83.73 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.856 -0.794 . . . . 74.53 108.856 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -62.46 -18.15 61.1 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 115.294 -2.289 . . . . 71.2 112.173 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -139.69 9.14 2.4 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-N 122.122 2.237 . . . . 71.43 114.959 -170.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -136.44 -11.78 1.85 Allowed 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.86 1.264 . . . . 72.3 111.371 172.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.3 t -123.92 -81.39 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 107.401 -1.333 . . . . 75.14 107.401 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 49.8 mt -59.67 -31.09 69.23 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.771 2.028 . . . . 63.51 112.005 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 43.99 60.09 2.88 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.299 1.84 . . . . 71.04 110.536 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 86.7 t -63.02 -36.92 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.181 -0.918 . . . . 73.4 109.895 -174.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 t -51.07 -55.6 16.77 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.994 1.317 . . . . 31.31 110.39 173.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.34 -29.51 65.08 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 121.043 -1.036 . . . . 75.4 111.395 -174.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.57 -33.73 74.59 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.042 0.537 . . . . 71.4 112.05 175.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.6 t -70.97 -50.19 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.572 1.549 . . . . 74.13 109.158 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.6 ptm85 -61.72 -21.17 64.26 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 120.63 1.559 . . . . 72.1 113.883 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -68.04 -11.08 58.29 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.006 1.113 . . . . 72.01 114.006 172.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp -136.03 2.42 2.82 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.578 1.551 . . . . 43.43 112.117 -171.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.7 mt -72.35 145.71 88.33 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 119.725 1.148 . . . . 75.44 109.584 -176.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.94 150.16 29.78 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.427 2.085 . . . . 62.53 110.131 169.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -76.65 80.81 3.3 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 122.759 1.266 . . . . 75.43 111.029 -168.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.01 -49.53 0.23 Allowed Glycine 0 C--O 1.233 0.092 0 N-CA-C 109.595 -1.402 . . . . 74.03 109.595 -175.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.3 m -69.29 90.68 0.51 Allowed 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 107.767 -1.197 . . . . 74.52 107.767 173.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -80.12 129.92 34.86 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.469 -1.678 . . . . 71.43 106.469 173.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.4 mtm -66.26 161.93 21.15 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.258 -0.645 . . . . 64.24 109.258 173.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.39 -173.71 3.49 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.339 1.056 . . . . 65.44 108.155 178.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.41 91.89 0.46 Allowed 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.221 -1.029 . . . . 72.1 108.221 -173.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.499 ' CD2' ' HG3' ' A' ' 137' ' ' GLN . 6.4 m-30 -104.42 163.53 12.38 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.549 -0.908 . . . . 74.12 108.549 177.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.552 ' CE1' ' CG2' ' A' ' 72' ' ' THR . 2.0 p80 -104.67 171.5 7.29 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 126.527 1.931 . . . . 72.2 108.071 -175.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.6 m -137.96 146.96 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.1 -1.074 . . . . 70.22 108.1 167.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -94.18 -0.47 55.19 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.076 0.853 . . . . 74.32 111.994 -175.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -73.99 167.64 21.1 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.575 1.15 . . . . 73.22 108.364 165.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 74.69 131.85 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 128.328 2.651 . . . . 65.43 111.093 177.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.6 173.59 3.51 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 122.472 1.04 . . . . 32.41 113.037 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -72.43 -45.27 0.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.473 2.115 . . . . 30.1 111.757 175.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.7 mt -80.85 19.65 0.84 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.537 1.535 . . . . 61.42 113.65 -171.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.07 -32.43 49.83 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-O 118.156 -1.358 . . . . 73.12 112.311 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.3 tmtp? -85.11 -7.46 59.08 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.16 1.48 . . . . 65.45 113.728 178.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -46.81 18.25 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-N 121.001 1.728 . . . . 72.14 107.893 162.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.862 HD21 ' CZ ' ' A' ' 28' ' ' PHE . 26.8 mt -57.75 -39.14 76.7 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 124.58 1.175 . . . . 65.23 111.145 -165.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.552 ' CG2' ' CE1' ' A' ' 60' ' ' HIS . 0.3 OUTLIER -50.38 -51.7 43.74 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 128.542 2.737 . . . . 73.35 109.738 177.168 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -69.62 -58.96 3.29 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 114.149 -1.387 . . . . 72.42 107.308 -176.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.65 -28.65 68.64 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 121.264 1.847 . . . . 43.53 114.226 -171.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 36.4 t-105 -58.6 -36.68 74.4 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.79 0.723 . . . . 73.2 110.921 177.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.89 -41.29 97.71 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 118.055 -0.974 . . . . 62.12 111.032 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.505 HG22 ' HB3' ' A' ' 124' ' ' ALA . 41.4 t -54.62 -45.58 72.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 119.354 0.979 . . . . 63.02 110.1 171.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.96 -47.14 87.82 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.603 0.638 . . . . 33.31 111.306 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.8 mt -60.22 -44.73 96.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.736 1.214 . . . . 71.42 109.698 176.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.3 -31.76 72.4 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 123.945 0.898 . . . . 74.44 111.095 -175.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 75.2 mt -94.22 -12.41 28.28 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 119.008 -0.52 . . . . 62.44 111.819 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.67 54.87 32.18 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 126.907 2.194 . . . . 44.1 110.943 -172.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.71 11.62 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 124.141 0.976 . . . . 71.2 112.133 -176.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -56.24 -53.53 56.13 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 120.071 1.305 . . . . 75.11 110.491 -172.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -63.13 -8.09 7.12 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.755 1.622 . . . . 75.01 112.333 176.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -100.06 -18.03 17.19 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.434 1.494 . . . . 62.11 112.023 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.6 pp -127.51 33.3 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.036 1.335 . . . . 60.12 109.443 -175.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 76.1 m -107.23 -43.83 4.5 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 117.973 -1.013 . . . . 72.41 109.651 171.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.495 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -60.31 -63.36 4.36 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 120.736 1.607 . . . . 73.2 111.775 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 57.2 Cg_endo -65.27 -26.37 56.5 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 121.518 1.479 . . . . 74.21 111.81 -176.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 34.8 tpp -63.51 -49.61 72.85 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.584 0.754 . . . . 74.14 109.416 176.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -68.1 -35.14 77.67 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.874 0.87 . . . . 64.03 108.913 -176.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -60.97 -40.05 91.93 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.656 0.662 . . . . 62.3 110.423 171.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.18 -5.01 58.65 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 120.074 -1.642 . . . . 63.02 113.584 -174.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.681 HG21 ' CD2' ' A' ' 28' ' ' PHE . 50.2 t -111.01 -41.35 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 124.499 1.119 . . . . 74.22 109.709 -176.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -106.07 -53.77 2.58 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.42 0.688 . . . . 74.42 109.337 -172.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt -70.39 -54.12 13.74 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-O 118.675 -0.679 . . . . 72.33 110.61 -171.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.4 p -100.86 -18.49 16.37 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.176 0.99 . . . . 74.22 113.382 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 45.75 40.62 6.53 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.475 2.31 . . . . 72.22 114.228 -175.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.9 t -79.88 -8.0 59.05 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.288 -0.883 . . . . 63.42 112.557 178.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.487 HG11 ' CZ ' ' A' ' 28' ' ' PHE . 29.6 t -74.54 122.46 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 O-C-N 120.858 -1.151 . . . . 73.11 109.785 168.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -140.68 -23.41 0.79 Allowed 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.084 0.954 . . . . 73.34 112.303 175.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.21 175.4 11.09 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.307 0.643 . . . . 74.33 109.56 174.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 104' ' ' VAL . 18.0 t -55.55 -44.09 75.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 126.182 1.793 . . . . 70.05 109.941 -172.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.5 -14.34 40.43 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.212 0.605 . . . . 45.41 112.628 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -94.36 -27.65 15.96 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 119.421 1.01 . . . . 71.41 110.034 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.462 HG12 HG13 ' A' ' 101' ' ' VAL . 3.2 mt -81.52 -41.77 19.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 123.286 0.634 . . . . 65.24 109.378 -178.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -55.32 -25.08 32.42 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.441 -0.787 . . . . 74.45 113.055 176.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -62.23 -56.51 17.91 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.803 1.241 . . . . 70.31 110.78 -177.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 54.3 t -57.15 -43.1 80.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 119.165 -0.445 . . . . 51.22 110.369 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -50.68 -56.77 10.38 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.707 0.803 . . . . 74.24 109.482 175.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.74 -46.86 95.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 123.132 0.573 . . . . 71.45 109.811 -174.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.05 -43.57 91.7 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 123.652 0.595 . . . . 74.25 109.475 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.95 -17.32 62.08 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.425 1.09 . . . . 72.14 112.612 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 113.61 64.24 0.44 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.393 -1.083 . . . . 60.01 110.393 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.7 t -127.69 141.1 47.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 123.819 0.848 . . . . 74.13 109.976 163.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -66.04 148.2 52.17 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.905 -0.497 . . . . 53.21 112.027 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -73.5 1.84 41.71 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 124.775 1.179 . . . . 53.24 114.904 165.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -100.98 -39.98 7.47 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 117.367 0.584 . . . . 64.13 111.158 174.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.9 -35.04 62.27 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.014 -1.106 . . . . 62.42 108.014 -167.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -61.45 -59.93 4.5 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 116.067 -0.515 . . . . 72.03 109.857 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -59.64 -36.98 77.44 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.622 0.769 . . . . 74.45 110.969 -176.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.55 -65.49 0.71 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.916 0.886 . . . . 70.01 110.186 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.505 ' HB3' HG22 ' A' ' 77' ' ' VAL . . . -54.53 -37.08 64.96 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.175 0.99 . . . . 72.11 110.347 -173.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -45.08 -41.59 7.86 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.051 1.341 . . . . 65.21 112.904 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -112.83 19.78 17.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.703 1.201 . . . . 72.23 112.338 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.9 t -115.85 149.19 39.02 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 123.721 1.724 . . . . 62.05 110.783 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.84 -27.0 49.32 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 119.754 3.242 . . . . 72.15 119.754 -171.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 29.3 t -45.22 -56.31 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 C-N-CA 127.064 2.145 . . . . 74.31 107.996 168.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.25 -43.34 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 125.644 1.578 . . . . 70.15 109.398 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp -52.84 -46.31 67.72 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.544 -0.723 . . . . 64.12 112.089 177.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -49.11 71.89 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 118.724 -0.655 . . . . 71.34 110.055 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 13.5 mt -59.29 -42.17 90.65 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.777 -0.63 . . . . 74.15 111.469 -176.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 52.9 t -55.73 -48.96 77.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.672 -0.862 . . . . 72.23 108.672 176.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.59 -40.11 95.86 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 113.394 0.887 . . . . 52.23 113.394 -177.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -56.26 -50.93 69.94 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.934 0.894 . . . . 65.14 109.427 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.512 ' CB ' ' CE1' ' A' ' 60' ' ' HIS . 0.5 OUTLIER -70.31 -38.12 74.88 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 117.454 -1.26 . . . . 74.33 111.148 -176.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -58.76 -44.41 90.56 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 120.535 1.516 . . . . 43.32 109.54 170.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.8 ttmm -67.12 -10.57 51.53 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.081 -1.012 . . . . 70.23 113.273 175.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.8 2.7 11.1 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 117.416 -1.278 . . . . 61.5 114.239 178.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -134.77 -12.28 2.29 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.154 1.343 . . . . 61.24 112.995 174.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -121.21 6.43 10.23 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.378 1.071 . . . . 73.12 111.121 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -70.83 -85.38 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.358 0.663 . . . . 70.21 112.364 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.1 pp -164.59 33.24 0.07 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.08 0.952 . . . . 61.42 113.438 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.555 ' NE2' ' H ' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -126.69 -69.41 0.76 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.298 0.954 . . . . 74.51 112.391 -163.368 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.555 ' H ' ' NE2' ' A' ' 145' ' ' GLN . 0.7 OUTLIER -133.91 142.22 47.66 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.556 2.742 . . . . 64.11 107.046 -171.208 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -143.68 13.11 1.71 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.222 1.009 . . . . 45.1 111.981 -178.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -141.02 176.89 21.32 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 109.36 -1.496 . . . . 70.24 109.36 173.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 19.2 m -147.7 171.15 6.66 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 124.417 1.087 . . . . 71.33 111.202 -169.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.432 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 44.2 Cg_endo -64.37 162.86 60.4 Favored 'Cis proline' 0 C--N 1.349 0.605 0 CA-C-N 120.376 1.17 . . . . 73.12 110.585 -14.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -146.78 147.31 30.77 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 122.89 0.476 . . . . 73.53 110.268 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 50.9 tpp -142.6 118.45 10.55 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.122 -2.177 . . . . 73.33 105.122 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -100.91 167.72 10.09 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.088 -0.708 . . . . 74.41 109.088 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.6 t -139.49 143.16 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.473 1.109 . . . . 71.1 108.393 170.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 49.45 18.17 0.27 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 128.108 2.563 . . . . 71.43 115.106 176.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 62.5 34.31 89.06 Favored Glycine 0 CA--C 1.534 1.232 0 O-C-N 120.765 -1.209 . . . . 65.13 111.687 -176.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -155.88 -22.0 0.11 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.346 1.61 . . . . 65.3 115.346 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -119.08 154.51 33.06 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 119.234 0.925 . . . . 72.51 109.044 -175.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.0 125.75 44.37 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.988 2.515 . . . . 72.42 107.833 176.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.425 HD11 ' CG2' ' A' ' 181' ' ' VAL . 1.0 OUTLIER -64.78 147.19 53.66 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 106.685 -1.598 . . . . 51.1 106.685 176.278 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.416 ' CG ' HD11 ' A' ' 10' ' ' ILE . 36.3 t30 -123.78 76.67 56.92 Favored Pre-proline 0 C--O 1.233 0.223 0 O-C-N 122.091 -0.38 . . . . 61.21 111.436 -176.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.58 -17.19 58.75 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.501 1.468 . . . . 74.4 112.198 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.96 -12.21 61.41 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.136 1.774 . . . . 51.14 113.087 177.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -121.28 35.47 3.62 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.854 1.216 . . . . 45.3 110.113 175.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 46.0 mtt -122.37 165.04 16.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 122.278 1.037 . . . . 72.32 109.596 176.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -82.83 76.4 9.68 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.562 -1.199 . . . . 65.21 110.771 -176.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 21.4 p -73.22 -1.06 16.23 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.256 2.222 . . . . 70.31 112.8 177.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 39.7 m -72.83 -6.34 44.24 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 113.851 1.056 . . . . 54.2 113.851 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.59 -9.6 1.42 Allowed 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 117.772 -1.109 . . . . 45.43 113.311 -167.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 3.0 mmt 66.36 -56.85 0.38 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.272 1.829 . . . . 72.5 114.998 174.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.76 -51.37 62.65 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 106.987 -1.486 . . . . 71.24 106.987 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 48.6 t -57.93 -36.43 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.881 1.272 . . . . 75.22 110.121 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -58.77 -60.98 2.98 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 118.214 -0.898 . . . . 74.2 109.771 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.5 t -70.73 -33.97 54.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 118.476 0.58 . . . . 74.4 110.931 -175.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -49.94 -46.5 52.25 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.76 1.224 . . . . 71.32 110.155 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -87.43 -28.74 21.94 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 113.349 0.87 . . . . 72.5 113.349 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -56.61 -60.54 3.39 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.054 1.297 . . . . 65.3 110.513 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.77 -32.22 70.39 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.039 0.536 . . . . 72.13 111.951 -177.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -60.12 -50.93 71.76 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.773 1.229 . . . . 74.23 110.275 175.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.0 t -68.44 -30.17 68.98 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 116.73 -1.605 . . . . 63.12 110.912 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.425 ' CG2' HD11 ' A' ' 160' ' ' LEU . 58.7 t -56.44 -52.06 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 120.512 1.506 . . . . 62.22 108.578 173.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -59.38 -53.54 56.98 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-O 118.39 -0.815 . . . . 74.5 110.682 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -53.03 -40.94 64.26 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.74 0.7 . . . . 65.23 111.796 -171.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.85 -20.59 63.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.739 1.014 . . . . 71.53 113.739 -176.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.08 -33.74 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 109.109 -0.7 . . . . 64.3 109.109 171.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -80.1 -41.64 25.14 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.877 -1.157 . . . . 42.21 107.877 -171.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -85.86 51.38 2.19 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.802 2.041 . . . . 73.1 110.24 -178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 20.4 pttt . . . . . 0 C--O 1.246 0.893 0 CA-C-O 117.264 -1.35 . . . . 65.12 110.158 172.094 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.484 0 N-CA-C 113.105 0.779 . . . . 45.22 113.105 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.52 122.47 3.58 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 105.613 -1.995 . . . . 71.14 105.613 170.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -126.68 158.35 37.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 126.318 1.847 . . . . 62.31 106.636 171.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.6 m -136.08 135.43 39.33 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.767 -1.197 . . . . 70.12 107.767 -176.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -51.74 104.15 0.08 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 131.52 3.928 . . . . 74.34 108.796 167.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 110.0 -22.17 23.74 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 126.998 2.237 . . . . 65.34 112.501 -177.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -90.7 -85.49 0.22 Allowed 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 119.776 1.788 . . . . 70.23 108.433 -172.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -89.4 -15.56 32.96 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.896 1.279 . . . . 72.15 109.915 -176.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -137.2 162.85 32.35 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.599 0.76 . . . . 71.31 110.709 172.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.401 ' HB ' ' HG3' ' A' ' 159' ' ' GLN . 3.0 mm -128.66 166.81 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 127.542 2.337 . . . . 74.25 105.97 171.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.1 174.22 5.98 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 127.605 2.362 . . . . 72.55 109.68 176.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 57.9 mt -116.4 148.63 40.48 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.524 1.13 . . . . 70.11 110.013 171.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -73.06 -35.81 66.76 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.474 1.11 . . . . 70.14 110.152 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.6 mmtm -122.05 77.99 41.85 Favored Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 126.522 1.929 . . . . 64.15 109.354 177.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo . . . . . 0 N--CA 1.458 -0.597 0 C-N-CA 124.553 3.502 . . . . 62.53 112.858 172.049 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 C--O 1.238 0.46 0 CA-C-O 121.917 0.865 . . . . 73.32 111.148 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.3 154.2 37.46 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.614 1.566 . . . . 65.12 107.015 -173.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -120.53 141.77 49.94 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.369 -1.345 . . . . 64.23 107.369 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -130.69 134.98 47.38 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.787 1.635 . . . . 72.2 109.339 176.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.3 179.27 7.5 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.784 1.234 . . . . 72.43 108.434 167.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.0 t -134.4 153.43 51.91 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.379 -0.971 . . . . 71.21 108.379 168.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.541 ' CE2' ' HG2' ' A' ' 91' ' ' MET . 12.2 m-30 -64.94 -24.39 67.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 118.483 -0.77 . . . . 74.21 111.705 172.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.407 ' CE2' ' HA3' ' A' ' 65' ' ' GLY . 47.7 m-85 -89.26 -5.2 57.8 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 120.283 1.401 . . . . 65.13 113.667 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.9 p -90.4 144.42 30.81 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 122.059 2.209 . . . . 73.31 111.298 -174.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -81.84 -43.19 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 121.935 1.756 . . . . 63.33 112.394 -166.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -54.48 -45.67 73.24 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 109.136 -0.69 . . . . 73.11 109.136 173.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 15.3 m -55.44 -35.86 65.91 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.503 1.921 . . . . 71.25 112.048 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -64.79 -48.53 74.12 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.822 0.737 . . . . 73.55 110.674 176.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.537 ' HA ' HE21 ' A' ' 35' ' ' GLN . 0.0 OUTLIER -59.37 -44.5 92.71 Favored 'General case' 0 C--O 1.223 -0.302 0 O-C-N 121.091 -1.005 . . . . 74.15 108.908 172.673 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -60.3 -16.55 35.57 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 115.735 -2.079 . . . . 71.54 112.41 -178.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -142.83 12.21 1.85 Allowed 'General case' 0 C--N 1.347 0.461 0 CA-C-N 122.111 2.232 . . . . 74.43 114.438 -172.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -131.7 -13.04 3.34 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.15 0.98 . . . . 64.22 112.282 165.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.1 t -128.26 -77.12 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 108.353 -0.98 . . . . 72.51 108.353 -170.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.8 mt -67.18 -26.8 66.81 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.787 1.635 . . . . 74.45 111.838 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 44.03 56.25 4.85 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.128 1.371 . . . . 70.24 110.915 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.628 ' O ' HG23 ' A' ' 46' ' ' VAL . 61.1 t -61.64 -46.53 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 117.506 -1.235 . . . . 53.34 107.967 -169.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.5 t -56.86 -37.99 72.09 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 120.318 1.417 . . . . 64.22 112.283 -177.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.22 -49.07 63.18 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.103 0.961 . . . . 71.13 109.745 177.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -62.23 -41.28 98.26 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.625 1.17 . . . . 43.31 112.088 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 42' ' ' VAL . 2.5 t -62.97 -51.01 77.31 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 N-CA-C 107.553 -1.277 . . . . 71.12 107.553 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -50.01 -47.83 52.84 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.285 0.948 . . . . 72.24 111.578 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -66.5 -1.45 3.6 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 115.284 1.587 . . . . 71.12 115.284 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -130.01 -4.23 4.52 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.94 2.096 . . . . 63.42 112.891 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.695 HD13 HG21 ' A' ' 54' ' ' THR . 13.6 mt -69.33 151.28 96.95 Favored Pre-proline 0 N--CA 1.466 0.35 0 CA-C-N 120.065 1.302 . . . . 53.45 110.769 -172.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -81.07 146.3 15.93 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 122.275 1.984 . . . . 74.41 110.036 172.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -71.93 105.38 3.82 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.015 -1.448 . . . . 72.52 109.211 -175.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 131.79 -9.54 5.48 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.728 -1.04 . . . . 71.14 113.337 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.695 HG21 HD13 ' A' ' 50' ' ' LEU . 5.9 t -52.81 -46.79 67.85 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.705 1.253 . . . . 72.44 112.228 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? 46.5 83.54 0.03 OUTLIER 'General case' 0 C--N 1.346 0.417 0 C-N-CA 127.305 2.242 . . . . 62.31 110.3 -174.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 19.9 ptp -65.53 -175.74 0.29 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 112.317 -2.219 . . . . 70.45 111.89 176.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 m -154.75 174.98 14.29 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.278 1.831 . . . . 64.35 108.482 165.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -140.3 126.14 19.41 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.994 -1.113 . . . . 74.23 107.994 152.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.402 ' CD2' ' HG3' ' A' ' 137' ' ' GLN . 11.4 m-30 -106.09 -176.98 3.23 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.499 -0.926 . . . . 45.11 108.499 162.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.429 ' CE1' HD13 ' A' ' 71' ' ' LEU . 41.3 t-80 -134.75 135.12 41.65 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.015 1.726 . . . . 70.33 106.656 176.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.0 m -81.6 151.89 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.813 0.845 . . . . 62.1 110.399 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.65 -5.56 22.49 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.675 1.19 . . . . 72.32 112.314 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -68.49 -45.63 71.84 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.576 -0.702 . . . . 73.54 112.583 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.0 mt -78.18 132.17 37.49 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 121.838 -0.539 . . . . 73.12 109.689 -171.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.407 ' HA3' ' CE2' ' A' ' 29' ' ' TYR . . . 97.64 160.85 31.05 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 124.924 1.25 . . . . 64.11 112.39 169.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.71 -39.47 6.57 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.449 2.099 . . . . 74.24 110.276 173.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.5 mt -84.59 24.4 1.02 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.507 1.923 . . . . 74.31 110.661 172.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.39 -52.22 51.28 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 120.972 -1.08 . . . . 33.45 112.162 -175.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -56.17 -44.91 79.77 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.964 0.882 . . . . 72.22 110.994 174.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -63.44 -35.7 81.31 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 124.756 1.222 . . . . 73.14 111.396 -178.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.429 HD13 ' CE1' ' A' ' 60' ' ' HIS . 21.8 mt -60.02 -52.13 66.68 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 123.803 0.841 . . . . 43.24 110.76 176.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.9 m -62.96 -37.49 87.3 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.403 0.547 . . . . 73.22 110.339 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -58.51 -44.18 89.4 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.812 -0.555 . . . . 74.33 109.775 172.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.32 96.39 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.355 -1.466 . . . . 65.5 112.897 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 49.3 t-105 -57.93 -37.96 75.06 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.837 0.855 . . . . 71.11 109.786 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.09 -43.98 87.34 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 117.55 -1.214 . . . . 62.3 112.513 175.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.1 t -54.01 -46.35 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 120.632 1.56 . . . . 64.11 110.714 170.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.71 -45.04 94.58 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-O 118.951 -0.547 . . . . 71.44 110.864 -175.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 91.6 mt -57.69 -46.82 86.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.956 0.902 . . . . 72.52 109.43 174.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.45 -3.69 44.67 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.515 1.302 . . . . 65.5 114.515 -169.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 88.5 mt -106.23 -21.48 13.1 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.597 1.089 . . . . 65.33 111.696 156.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.11 64.08 2.77 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 125.573 1.559 . . . . 34.13 109.218 -169.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.22 13.76 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.745 1.218 . . . . 70.51 112.16 -176.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -51.13 -60.2 3.36 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.541 1.137 . . . . 73.42 109.766 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.12 -8.59 3.59 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.002 1.721 . . . . 72.15 113.291 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -102.56 -10.78 19.01 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 120.379 -1.45 . . . . 73.44 112.043 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.2 pp -126.77 -14.12 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 116.96 -1.495 . . . . 74.14 112.102 -174.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 34.3 m -55.18 -54.96 36.7 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 119.652 1.115 . . . . 53.01 109.503 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.533 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -54.45 -62.43 4.03 Favored Pre-proline 0 N--CA 1.449 -0.507 0 C-N-CA 124.866 1.266 . . . . 73.41 111.296 -170.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.533 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 38.0 Cg_endo -64.05 -26.01 66.03 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.112 1.208 . . . . 72.23 112.357 -177.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.541 ' HG2' ' CE2' ' A' ' 28' ' ' PHE . 8.5 tpp -62.44 -48.03 81.45 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-O 118.193 -0.908 . . . . 74.24 111.215 172.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -66.71 -35.96 81.37 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 120.412 1.46 . . . . 72.21 109.139 -178.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -62.39 -33.56 74.99 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.422 0.556 . . . . 74.13 111.324 170.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.93 -11.12 45.37 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.894 -1.129 . . . . 64.31 113.388 -176.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.3 t -109.52 -42.87 5.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 125.338 1.455 . . . . 74.24 110.61 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -103.52 -46.37 4.58 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.179 0.592 . . . . 72.55 110.133 -174.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt -77.13 -68.65 0.59 Allowed 'General case' 0 N--CA 1.457 -0.088 0 CA-C-O 119.03 -0.509 . . . . 74.25 109.897 -172.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.5 p -79.85 -30.91 40.43 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.296 0.953 . . . . 72.41 110.548 177.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 60.43 20.97 10.62 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.228 1.811 . . . . 62.22 113.317 -174.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -69.23 -12.77 61.96 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.324 1.05 . . . . 53.04 112.812 -174.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.455 HG13 HG12 ' A' ' 107' ' ' ILE . 29.6 t -65.41 115.07 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 O-C-N 120.998 -1.064 . . . . 74.43 109.189 170.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -136.68 -31.14 0.87 Allowed 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.762 1.225 . . . . 74.54 112.083 -173.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.67 170.1 16.64 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.904 0.882 . . . . 62.3 109.355 167.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 67.3 t -54.23 -37.52 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.016 1.326 . . . . 64.14 111.205 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.28 -31.18 42.5 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.385 1.074 . . . . 45.2 112.709 176.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -82.4 -27.73 31.84 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 123.242 0.617 . . . . 54.4 110.504 -177.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.455 HG12 HG13 ' A' ' 101' ' ' VAL . 3.2 mt -76.22 -50.43 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.808 1.643 . . . . 70.2 108.014 -177.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.412 ' HB3' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -64.82 -21.35 66.77 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.525 -0.734 . . . . 73.32 111.792 -177.284 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -56.45 21.75 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 124.552 1.141 . . . . 50.43 110.217 168.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.8 t -51.51 -45.53 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 123.654 0.781 . . . . 74.32 110.002 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -53.1 -55.71 21.89 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.808 0.443 . . . . 62.43 109.859 176.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 64.6 t -57.29 -42.91 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 O-C-N 121.7 -0.625 . . . . 73.32 110.232 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -61.6 -41.77 97.91 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 124.283 0.989 . . . . 65.53 109.534 -171.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.34 -2.21 30.58 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.008 1.723 . . . . 62.12 113.199 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 99.61 55.78 1.0 Allowed Glycine 0 CA--C 1.524 0.618 0 CA-C-N 119.257 0.935 . . . . 71.51 112.587 177.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 66.8 t -119.84 142.31 35.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 117.687 0.743 . . . . 63.32 109.668 170.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.84 126.32 29.05 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.048 0.939 . . . . 72.13 109.769 170.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.94 -24.04 69.82 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-O 118.017 -1.435 . . . . 71.42 112.413 175.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.54 -38.25 89.07 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.941 1.37 . . . . 74.43 109.752 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -73.4 -44.99 57.34 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 105.794 -1.928 . . . . 71.42 105.794 -171.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.412 ' CE1' ' HB3' ' A' ' 108' ' ' ARG . 5.1 t80 -60.32 -40.2 89.74 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.452 0.644 . . . . 71.24 110.045 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -79.61 -11.2 59.88 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.395 0.887 . . . . 72.41 113.395 -177.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -103.44 -63.55 1.17 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.985 1.314 . . . . 62.52 109.251 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -44.89 -45.07 10.13 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 128.001 2.521 . . . . 63.2 110.752 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 44.5 t-105 -50.9 -29.7 12.68 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.279 1.032 . . . . 73.53 113.563 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -119.33 5.78 11.18 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.895 1.678 . . . . 74.23 112.434 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.1 t -88.77 149.85 23.23 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.814 1.645 . . . . 65.5 109.466 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -49.2 -33.68 12.99 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.963 1.705 . . . . 73.13 112.121 177.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.0 t -46.09 -56.53 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 125.338 1.455 . . . . 73.43 110.426 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.1 t -67.4 -47.45 80.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 C-N-CA 125.016 1.326 . . . . 71.43 109.454 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -54.39 -44.54 72.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.213 0.53 . . . . 72.3 110.314 -172.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.05 -45.77 84.01 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.68 1.192 . . . . 73.32 111.534 176.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 16.3 mt -60.42 -48.62 80.95 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.86 0.864 . . . . 74.53 111.203 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.9 t -49.96 -45.26 22.37 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 C-N-CA 124.819 1.248 . . . . 73.42 109.3 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.5 -32.5 74.16 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.693 0.627 . . . . 52.23 112.693 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -62.85 -51.8 65.62 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.059 0.845 . . . . 73.51 110.588 171.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.402 ' HG3' ' CD2' ' A' ' 59' ' ' TYR . 7.4 mp0 -63.44 -47.14 83.1 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.793 0.27 . . . . 52.3 111.235 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -58.73 -47.16 85.57 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.938 1.295 . . . . 70.11 110.553 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -57.23 -45.06 84.24 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 118.492 0.587 . . . . 73.23 110.172 175.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.95 1.37 10.96 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.653 0.983 . . . . 74.3 113.653 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -86.37 -59.36 2.3 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.132 -1.605 . . . . 71.14 110.36 149.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.2 -7.87 40.51 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.028 2.131 . . . . 53.4 114.28 -163.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.08 -6.26 48.55 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.064 1.346 . . . . 71.1 112.343 172.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.0 mt 67.71 63.17 0.41 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 122.727 1.251 . . . . 61.41 109.494 167.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -144.58 -48.11 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.505 -1.225 . . . . 74.34 111.435 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 9.4 tp -78.69 -85.76 0.07 Allowed 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.76 0.709 . . . . 65.23 110.654 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 57.82 24.7 11.09 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.475 1.11 . . . . 71.51 112.515 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -169.39 162.47 36.06 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.682 1.61 . . . . 53.42 109.835 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 18.9 m -150.69 165.19 17.93 Favored Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 118.47 1.135 . . . . 72.51 109.852 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -65.31 157.31 76.63 Favored 'Cis proline' 0 C--N 1.351 0.665 0 CA-C-N 119.902 1.001 . . . . 64.45 110.592 -13.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -144.59 141.8 29.69 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.973 -0.558 . . . . 53.21 110.058 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 34.7 mtp -148.94 95.31 2.38 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 105.855 -1.905 . . . . 53.34 105.855 -169.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -82.13 169.31 16.79 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.996 -0.372 . . . . 73.14 109.996 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.2 t -147.38 150.31 14.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 O-C-N 121.128 -0.982 . . . . 62.53 109.602 169.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 60.31 6.1 0.97 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 128.431 2.692 . . . . 73.33 114.241 166.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.4 -1.47 84.25 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.298 -1.279 . . . . 72.34 112.455 -173.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -147.05 -7.12 0.48 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 116.252 1.945 . . . . 74.34 116.252 -164.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -121.48 155.6 34.57 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 118.517 0.599 . . . . 73.51 109.898 -175.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.401 ' HG3' ' HB ' ' A' ' 10' ' ' ILE . 0.5 OUTLIER -125.67 130.02 50.74 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 128.159 2.584 . . . . 74.44 107.302 172.199 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.61 153.74 38.43 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.67 -1.233 . . . . 63.33 107.67 174.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -126.48 85.59 59.97 Favored Pre-proline 0 C--O 1.234 0.272 0 O-C-N 122.241 -0.287 . . . . 63.21 110.93 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -63.11 -22.81 73.33 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 CA-C-N 118.948 0.66 . . . . 70.21 111.794 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.5 -2.59 23.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.875 1.27 . . . . 72.21 111.955 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -131.93 30.92 3.14 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.596 1.569 . . . . 72.53 111.021 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 20.8 mtm -127.15 165.18 20.05 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.439 1.496 . . . . 73.14 108.74 172.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -83.18 67.73 9.31 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 124.978 2.323 . . . . 70.31 110.762 -166.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.5 p -66.53 6.09 0.5 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 131.55 3.94 . . . . 72.13 112.204 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 23.0 m -91.74 -5.47 53.55 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 124.112 0.965 . . . . 73.32 113.458 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.44 -10.69 2.48 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 118.376 -0.821 . . . . 73.34 112.626 -172.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 10.1 mmt 70.25 -59.1 0.53 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 126.33 1.852 . . . . 53.14 112.978 177.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -67.4 -43.07 82.19 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.84 1.2 . . . . 73.32 108.774 -174.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.404 HG12 HE21 ' A' ' 176' ' ' GLN . 40.0 t -65.33 -30.56 50.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 124.516 1.127 . . . . 71.35 110.925 176.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -61.96 -62.53 1.72 Allowed 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.791 -0.818 . . . . 65.31 108.791 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 12.7 t -63.55 -39.01 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 119.079 -0.486 . . . . 73.54 110.271 -172.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -50.6 -49.52 56.36 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.627 1.171 . . . . 74.32 110.612 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.404 HE21 HG12 ' A' ' 172' ' ' VAL . 50.1 mt-30 -78.62 -40.36 34.57 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 118.342 -0.837 . . . . 73.31 112.005 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -54.1 -56.48 17.67 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.953 0.901 . . . . 74.52 110.289 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -53.86 -35.89 62.0 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.438 1.095 . . . . 72.53 112.326 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -73.29 -51.77 16.36 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.363 0.665 . . . . 72.53 109.829 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.0 t -62.15 -25.34 67.7 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 117.483 -1.246 . . . . 72.22 111.374 -176.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 57.8 t -56.62 -56.28 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 119.369 0.986 . . . . 72.55 108.896 168.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 13.6 tttm -55.8 -46.23 78.07 Favored 'General case' 0 N--CA 1.461 0.088 0 C-N-CA 123.512 0.725 . . . . 70.31 111.518 177.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -58.25 -29.18 65.56 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.442 0.697 . . . . 73.22 111.361 -175.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 50.9 mt -82.04 -25.77 34.35 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 120.964 -1.085 . . . . 73.15 113.222 -176.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 89.3 t -59.74 -36.14 64.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.732 -0.84 . . . . 53.03 108.732 175.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -91.43 -19.65 22.63 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 122.218 -0.301 . . . . 74.24 111.094 -173.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -95.17 65.78 2.87 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.947 1.299 . . . . 72.11 108.932 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt . . . . . 0 C--O 1.242 0.706 0 N-CA-C 108.47 -0.937 . . . . 62.51 108.47 165.337 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.387 0 N-CA-C 115.232 1.568 . . . . 72.24 115.232 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -165.37 113.74 1.01 Allowed 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.238 1.015 . . . . 73.23 110.398 169.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.0 pt -112.93 172.02 3.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 127.593 2.357 . . . . 70.43 109.612 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.9 m -142.68 141.52 31.86 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.138 -0.976 . . . . 62.24 108.86 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -53.21 135.55 37.93 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 126.174 1.79 . . . . 71.31 110.155 172.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.48 -18.02 7.51 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.376 1.465 . . . . 74.24 113.889 -175.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -93.41 -85.12 0.28 Allowed 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.569 1.684 . . . . 63.11 108.904 -167.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -89.43 -12.05 41.34 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.948 0.899 . . . . 64.24 111.381 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -141.69 160.83 39.36 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.494 0.718 . . . . 74.25 109.658 171.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.6 mm -121.74 162.77 20.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 107.407 -1.331 . . . . 73.21 107.407 170.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.4 m -119.57 127.46 53.0 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 127.137 2.175 . . . . 74.22 106.126 -178.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.4 mt -70.5 159.36 34.42 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.236 -0.653 . . . . 51.33 109.236 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -83.07 -30.1 28.28 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.847 0.459 . . . . 71.44 111.608 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -138.13 73.06 45.43 Favored Pre-proline 0 C--O 1.232 0.149 0 C-N-CA 124.903 1.281 . . . . 75.13 108.58 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo . . . . . 0 N--CA 1.451 -0.973 0 C-N-CA 123.161 2.574 . . . . 55.51 106.953 173.688 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.471 0.62 0 CA-C-O 122.165 0.983 . . . . 70.32 111.639 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.7 160.17 41.64 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.48 -0.933 . . . . 64.25 108.48 -173.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -126.77 161.36 28.37 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 125.083 1.353 . . . . 73.02 107.458 167.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -121.09 174.04 6.9 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.982 -1.488 . . . . 75.31 106.982 167.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -166.01 -179.03 4.97 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.669 2.388 . . . . 72.42 109.264 168.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.07 -168.63 2.4 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 106.729 -1.582 . . . . 44.1 106.729 158.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -104.47 -45.9 4.52 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.587 0.708 . . . . 74.32 109.256 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.499 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 69.4 m-85 -83.39 -4.09 58.15 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.544 -0.723 . . . . 73.31 111.814 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.2 p -62.36 144.09 95.36 Favored Pre-proline 0 C--N 1.343 0.283 0 CA-C-N 119.782 1.174 . . . . 72.2 109.841 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.0 173.93 13.66 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 121.461 1.441 . . . . 65.4 109.365 163.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 66.17 -40.63 0.35 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 128.936 2.895 . . . . 61.42 112.762 -174.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 60.2 m -54.84 -41.09 70.32 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.834 1.654 . . . . 73.1 112.128 -177.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -54.5 -63.69 1.07 Allowed 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 128.199 2.6 . . . . 73.22 108.854 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.16 -39.97 76.3 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 108.434 -0.95 . . . . 72.44 108.434 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -57.09 -26.46 60.45 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 115.292 -2.289 . . . . 74.44 113.282 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.64 -24.57 4.5 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 122.158 2.254 . . . . 72.1 109.552 -174.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -105.76 -17.06 14.5 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.512 1.505 . . . . 74.31 113.757 -170.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.6 t -121.68 -63.73 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 108.187 -1.042 . . . . 70.44 108.187 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 42.6 mt -70.88 -18.39 62.69 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 118.147 -0.93 . . . . 74.02 111.966 175.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 44.89 39.59 3.71 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 121.139 1.79 . . . . 74.1 112.899 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 69.4 t -61.23 -45.41 98.65 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 O-C-N 121.091 -1.006 . . . . 71.23 109.864 -175.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.4 t -47.1 -53.27 13.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.86 1.264 . . . . 63.12 109.942 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.95 -31.89 69.85 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 113.558 0.948 . . . . 52.53 113.558 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -73.88 -51.69 15.39 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.702 0.683 . . . . 74.34 109.297 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 50.4 t -52.66 -52.68 25.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 126.055 1.742 . . . . 73.45 109.609 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.4 ptt85 -64.85 -14.01 58.03 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 116.795 -1.574 . . . . 74.35 114.015 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -75.75 -17.64 59.83 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 120.667 1.576 . . . . 73.41 112.55 170.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -123.34 -9.18 8.07 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.445 1.098 . . . . 64.11 113.34 -171.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.448 HD12 ' HE1' ' A' ' 56' ' ' MET . 10.8 mt -61.64 146.16 90.62 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 123.929 0.892 . . . . 73.24 112.184 -179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -83.47 162.1 14.79 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.879 3.053 . . . . 70.13 114.081 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -79.51 64.83 4.5 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 127.094 2.158 . . . . 65.31 110.257 -171.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -176.25 -30.41 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 125.174 1.368 . . . . 51.45 111.615 -169.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.445 HG21 HD13 ' A' ' 50' ' ' LEU . 3.8 t -58.04 -29.61 65.49 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 115.233 1.568 . . . . 74.43 115.233 -176.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.3 tptp 44.37 88.62 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.43 1.892 . . . . 74.33 112.185 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.448 ' HE1' HD12 ' A' ' 50' ' ' LEU . 4.5 ttm -49.77 100.71 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 129.388 3.075 . . . . 64.33 110.692 -175.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.4 m -139.84 121.31 15.1 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 107.337 -1.357 . . . . 62.3 107.337 -172.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -130.46 120.01 23.51 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 106.986 -1.487 . . . . 54.42 106.986 -176.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -95.52 157.11 16.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 123.13 1.443 . . . . 74.43 110.056 174.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.712 ' CD2' ' H ' ' A' ' 60' ' ' HIS . 5.4 p80 -98.0 167.06 11.13 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 129.176 2.99 . . . . 61.43 108.901 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.2 m -131.92 165.83 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.032 0.933 . . . . 51.44 108.507 176.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -100.68 16.65 24.21 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.53 1.132 . . . . 62.31 111.675 -169.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -115.73 162.6 17.04 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 126.436 1.895 . . . . 52.52 109.322 -169.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 75.3 124.34 0.04 OUTLIER 'General case' 0 C--O 1.232 0.153 0 C-N-CA 128.676 2.79 . . . . 63.04 110.519 174.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.499 ' HA3' ' CD2' ' A' ' 29' ' ' TYR . . . 90.19 173.47 44.93 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 124.302 0.953 . . . . 75.42 112.098 175.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -65.52 -55.15 0.47 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.348 2.699 . . . . 74.21 109.737 173.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.5 mt -86.54 17.0 4.1 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 125.174 1.39 . . . . 72.13 112.862 -167.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -48.16 -45.12 27.21 Favored Glycine 0 CA--C 1.542 1.739 0 CA-C-N 120.005 1.275 . . . . 72.13 113.715 -174.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.1 tptt -59.85 -46.37 89.5 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.887 1.275 . . . . 74.11 111.541 174.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -71.03 -38.18 72.58 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.749 -1.219 . . . . 71.02 109.026 -176.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.1 mt -62.46 -34.1 76.14 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.091 1.756 . . . . 71.21 111.915 173.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.7 m -54.04 -58.19 8.24 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 106.934 -1.506 . . . . 74.32 106.934 170.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -57.25 -50.56 72.51 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.968 0.907 . . . . 72.4 111.595 -169.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.5 -24.4 67.46 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.883 1.068 . . . . 61.02 113.883 -171.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.571 ' CD1' ' CD2' ' A' ' 60' ' ' HIS . 52.0 t-105 -57.7 -35.04 70.09 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.453 -0.779 . . . . 74.22 111.168 175.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.05 95.04 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.34 -0.838 . . . . 72.34 111.915 178.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.2 t -53.38 -43.73 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 119.177 0.898 . . . . 32.42 110.159 175.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.93 -26.24 40.2 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 117.362 -1.304 . . . . 32.12 113.088 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 76.8 mt -67.14 -41.75 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 120.835 1.652 . . . . 70.04 108.343 166.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.01 -44.36 94.63 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.623 0.647 . . . . 74.04 110.464 -172.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.4 mt -81.04 -18.07 48.01 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 112.902 0.705 . . . . 64.41 112.902 174.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.29 70.16 1.13 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.907 1.717 . . . . 54.22 110.789 -171.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.469 HG21 HG22 ' A' ' 116' ' ' VAL . 15.9 m -138.11 19.18 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 125.735 1.614 . . . . 72.4 111.432 -175.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -52.43 -51.52 58.78 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 126.03 1.732 . . . . 72.14 110.151 -178.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -68.36 -0.86 5.33 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.562 1.945 . . . . 65.0 113.393 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -104.42 -26.07 12.57 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 120.835 -1.165 . . . . 71.04 109.66 176.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.433 HG22 ' HB3' ' A' ' 114' ' ' ALA . 1.1 pt -112.04 9.93 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 C-N-CA 125.013 1.325 . . . . 70.42 111.698 -174.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 56.0 m -80.92 -44.71 17.84 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 120.931 1.696 . . . . 63.32 109.22 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.48 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -69.07 -63.5 2.1 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 124.081 0.952 . . . . 62.41 111.686 -165.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 31.2 Cg_endo -63.01 -21.41 73.16 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 121.355 1.37 . . . . 62.24 112.08 -176.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.441 ' HE3' ' HB2' ' A' ' 91' ' ' MET . 15.0 ttm -74.26 -37.69 63.67 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 125.875 1.67 . . . . 65.21 110.52 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -64.08 -42.29 97.01 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 119.047 -0.502 . . . . 74.01 110.304 164.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -64.75 -13.79 56.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 118.321 -0.847 . . . . 65.01 113.189 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.99 -14.12 15.28 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.782 1.173 . . . . 41.41 112.36 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 78.9 t -105.86 -45.04 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.251 1.02 . . . . 63.12 112.371 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -103.88 -48.54 3.88 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 114.587 1.329 . . . . 71.02 114.587 -174.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -70.31 -59.18 3.02 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.875 1.27 . . . . 74.11 113.587 -177.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 48.5 p -94.05 -30.26 14.78 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.779 1.232 . . . . 52.12 113.435 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 60.95 27.11 16.99 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.001 2.921 . . . . 71.43 113.569 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.5 t -59.78 -25.75 65.16 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.398 1.479 . . . . 62.32 112.438 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 42.7 t -62.58 109.91 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 108.528 -0.916 . . . . 72.22 108.528 175.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -141.66 -20.41 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.945 1.298 . . . . 72.13 110.841 -175.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.93 167.4 22.21 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.679 -1.6 . . . . 72.44 106.679 167.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.5 t -55.74 -28.8 24.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.11 0.564 . . . . 72.13 109.698 172.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.86 -15.04 57.96 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.972 1.709 . . . . 41.4 112.191 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.84 -23.67 13.37 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 118.635 0.652 . . . . 71.21 111.086 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.5 mt -71.52 -51.41 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 C-N-CA 125.4 1.48 . . . . 65.42 108.236 174.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.76 -22.36 62.0 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.269 1.028 . . . . 72.22 112.22 -175.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -62.06 -59.35 5.21 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 126.682 1.993 . . . . 74.44 111.076 170.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 71.1 t -54.53 -40.49 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.523 1.129 . . . . 70.2 110.354 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -54.06 -53.27 55.36 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 119.05 -0.5 . . . . 62.11 110.644 173.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.4 t -61.98 -46.72 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 119.617 1.098 . . . . 62.02 110.645 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -54.39 -44.2 72.1 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.164 0.986 . . . . 72.11 109.772 -176.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.433 ' HB3' HG22 ' A' ' 87' ' ' ILE . . . -75.1 -13.19 60.45 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.522 1.529 . . . . 34.42 114.907 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 126.42 6.47 5.67 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 117.402 1.721 . . . . 43.43 117.402 176.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.469 HG22 HG21 ' A' ' 83' ' ' VAL . 93.7 t -93.71 120.04 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-N 119.958 1.879 . . . . 73.21 110.051 -175.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.596 ' HG3' ' CB ' ' A' ' 120' ' ' ASP . 3.6 pttp -52.2 125.92 17.24 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.593 -0.73 . . . . 63.3 109.927 172.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.21 -30.6 61.24 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 109.41 -1.476 . . . . 52.33 109.41 166.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -30.38 66.56 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 119.371 1.585 . . . . 74.34 110.653 -175.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.596 ' CB ' ' HG3' ' A' ' 117' ' ' LYS . 23.3 t0 -83.31 -43.31 16.14 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.842 -0.799 . . . . 74.04 108.842 175.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -50.81 -54.62 22.13 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 123.58 0.752 . . . . 74.3 111.047 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -73.66 -9.95 59.2 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.619 1.568 . . . . 45.44 111.413 -173.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.29 -63.3 1.14 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.431 1.892 . . . . 72.03 109.501 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.49 -36.08 68.72 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.681 1.592 . . . . 72.33 112.893 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 65.3 t-105 -44.64 -39.26 4.9 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.562 1.145 . . . . 63.1 111.065 174.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.28 0.97 41.22 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.881 1.672 . . . . 74.42 113.657 -177.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.4 t -97.66 165.72 11.83 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.593 1.557 . . . . 43.53 112.676 -173.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -62.97 -36.64 84.16 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.001 1.72 . . . . 74.03 111.445 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.4 t -50.58 -47.75 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 122.342 1.068 . . . . 72.14 109.064 -178.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.6 t -68.84 -42.89 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-N 114.818 -1.083 . . . . 62.33 111.476 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -50.98 -53.87 29.42 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 118.98 0.809 . . . . 74.13 110.451 175.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.84 -42.96 99.95 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.214 0.606 . . . . 55.54 110.091 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.5 mt -64.4 -40.08 95.1 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 119.326 0.966 . . . . 64.42 112.823 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 74.2 t -59.23 -53.79 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 107.406 -1.331 . . . . 55.42 107.406 171.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.42 -34.35 68.82 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.385 0.883 . . . . 73.14 113.385 -174.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -53.28 -46.03 69.15 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 124.523 1.129 . . . . 63.14 111.565 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.521 ' HG2' ' CD2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -94.18 -31.19 14.24 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 113.102 0.778 . . . . 74.32 113.102 -170.556 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -64.87 -38.08 89.78 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.796 0.726 . . . . 75.14 109.169 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -54.56 -48.83 71.58 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 126.404 1.882 . . . . 74.12 111.386 165.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.66 -17.0 60.75 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 118.513 -0.756 . . . . 51.13 112.596 -175.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.25 -44.91 35.26 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 120.839 1.654 . . . . 74.1 109.819 164.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.5 -5.11 21.93 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.428 1.491 . . . . 72.03 114.236 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.0 -2.46 51.66 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.67 1.123 . . . . 61.44 112.355 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 10.2 mt 74.56 54.84 0.08 Allowed 'General case' 0 C--N 1.342 0.245 0 C-N-CA 126.353 1.861 . . . . 75.15 110.454 164.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.405 HE21 ' HB3' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -132.41 -23.39 2.13 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.611 0.967 . . . . 73.15 113.611 -173.165 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.405 ' HB3' HE21 ' A' ' 145' ' ' GLN . 0.5 OUTLIER -131.91 -80.85 0.51 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.613 1.097 . . . . 63.04 111.382 -168.619 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 62.77 -3.58 0.3 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.707 2.003 . . . . 71.45 115.534 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -137.83 162.19 25.53 Favored Glycine 0 CA--C 1.526 0.727 0 O-C-N 120.395 -1.441 . . . . 33.43 110.858 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.471 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 5.1 m -142.39 166.93 18.15 Favored Pre-proline 0 C--O 1.239 0.504 0 N-CA-C 107.976 -1.12 . . . . 71.4 107.976 -177.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.471 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 98.1 Cg_endo -73.59 155.7 99.73 Favored 'Cis proline' 0 CA--C 1.536 0.625 0 CA-C-N 119.79 0.961 . . . . 74.44 113.532 -9.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -152.17 142.47 22.45 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 126.062 1.745 . . . . 73.04 110.079 -177.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 32.4 ttm -140.67 133.81 29.47 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 126.505 1.922 . . . . 62.04 106.43 172.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -117.42 159.58 22.56 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.836 0.854 . . . . 74.14 111.216 -177.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.5 t -141.23 145.74 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.407 1.083 . . . . 53.45 108.549 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 48.28 11.91 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.317 2.647 . . . . 71.03 116.124 177.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 62.56 41.93 99.75 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 119.705 1.138 . . . . 64.25 110.59 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -165.71 -21.93 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.778 1.231 . . . . 73.05 112.488 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -112.89 146.44 38.94 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 118.756 0.707 . . . . 72.45 109.362 177.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -117.78 139.36 51.19 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 104.933 -2.247 . . . . 60.13 104.933 167.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.418 ' CD1' HG23 ' A' ' 180' ' ' THR . 4.1 mm? -66.38 142.91 57.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.777 -1.564 . . . . 72.34 106.777 173.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -115.75 85.58 14.48 Favored Pre-proline 0 CA--C 1.516 -0.344 0 CA-C-N 117.84 0.291 . . . . 73.05 110.97 177.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -64.87 -27.13 59.11 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 CA-C-N 118.652 0.554 . . . . 62.32 111.139 174.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.93 -0.56 16.5 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.397 1.479 . . . . 74.45 112.825 -173.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -133.22 12.49 4.98 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.66 1.6 . . . . 64.02 111.699 175.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 17.5 mtt -87.73 172.32 9.77 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 120.129 1.965 . . . . 74.32 109.264 165.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.16 106.68 7.91 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.055 -1.461 . . . . 71.35 107.055 169.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.546 HG22 ' CD1' ' A' ' 173' ' ' PHE . 54.5 p -112.59 18.39 18.4 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.107 2.163 . . . . 70.11 110.368 -178.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 40.0 m -99.52 5.56 46.06 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.451 1.101 . . . . 74.41 112.77 -172.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -137.43 -15.22 1.45 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.554 1.142 . . . . 70.35 111.825 -177.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 2.2 mmt 69.17 -62.99 0.39 Allowed 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 126.246 1.819 . . . . 65.42 110.454 -175.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.99 -38.55 86.4 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.17 -0.956 . . . . 74.13 111.657 -172.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 65.5 t -75.29 -27.49 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 123.809 0.844 . . . . 54.13 111.161 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.546 ' CD1' HG22 ' A' ' 167' ' ' THR . 42.0 t80 -59.32 -52.03 67.4 Favored 'General case' 0 C--O 1.226 -0.158 0 N-CA-C 108.655 -0.868 . . . . 73.45 108.655 -177.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.7 t -77.28 -25.04 15.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 117.518 0.145 . . . . 74.21 111.11 -175.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.53 -31.25 67.76 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.3 0.482 . . . . 70.11 112.3 168.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -86.32 -44.94 11.69 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.25 1.02 . . . . 73.11 110.985 172.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -58.44 -56.74 18.21 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.519 0.728 . . . . 73.41 110.569 -167.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.15 -21.23 59.04 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 113.683 0.994 . . . . 71.04 113.683 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -77.96 -52.58 8.59 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 123.346 0.658 . . . . 70.43 110.321 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.418 HG23 ' CD1' ' A' ' 160' ' ' LEU . 9.0 t -62.16 -30.71 71.24 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 117.832 -1.08 . . . . 72.05 110.653 178.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 85.5 t -60.63 -54.57 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 119.987 1.267 . . . . 74.31 108.483 177.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -59.51 -48.17 82.67 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-O 118.777 -0.63 . . . . 72.32 110.255 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -60.13 -29.46 68.64 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 112.481 0.549 . . . . 74.45 112.481 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 60.2 mt -74.79 -23.13 58.45 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 120.826 -1.171 . . . . 72.41 112.309 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 92.9 t -66.05 -29.5 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 118.34 0.518 . . . . 70.12 109.671 174.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -95.46 -9.36 32.83 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.816 0.846 . . . . 65.45 110.428 -175.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 21.0 mttp -108.61 61.91 0.6 Allowed 'General case' 0 C--O 1.225 -0.186 0 O-C-N 120.661 -1.274 . . . . 72.44 109.664 -177.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.6 mmtm . . . . . 0 C--O 1.254 1.317 0 C-N-CA 127.179 2.191 . . . . 71.05 112.223 171.253 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 -0.069 0 CA-C-O 121.561 0.696 . . . . 74.42 112.691 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -156.35 105.95 2.32 Favored 'General case' 0 N--CA 1.425 -1.711 0 C-N-CA 125.563 1.545 . . . . 65.05 107.791 -175.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.512 HG21 HG23 ' A' ' 180' ' ' THR . 9.9 pt -106.16 167.0 3.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 127.185 2.194 . . . . 71.45 109.119 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.7 m -143.89 145.8 32.55 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 106.598 -1.63 . . . . 71.22 106.598 175.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -58.56 150.06 23.94 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 127.566 2.347 . . . . 44.12 109.758 167.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.56 -29.37 0.36 Allowed Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.546 1.07 . . . . 64.32 113.826 -168.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -94.85 -84.44 0.33 Allowed 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 118.951 1.375 . . . . 73.21 108.551 -165.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -92.7 -14.92 27.35 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.459 0.703 . . . . 73.13 110.852 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -143.48 165.31 27.9 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.544 0.611 . . . . 74.01 110.705 167.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.3 mm -122.17 162.61 21.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 126.827 2.051 . . . . 74.04 106.605 175.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.0 m -126.66 136.45 52.5 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 106.004 -1.85 . . . . 63.22 106.004 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.0 mt -81.07 156.4 25.84 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 118.541 0.61 . . . . 53.25 109.606 -178.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -71.7 -34.94 70.05 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.303 1.441 . . . . 53.41 110.509 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.4 mmtm -137.01 78.82 39.94 Favored Pre-proline 0 N--CA 1.453 -0.279 0 C-N-CA 125.112 1.365 . . . . 74.33 108.403 -175.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 N--CA 1.448 -1.174 0 C-N-CA 123.391 2.728 . . . . 55.43 108.763 174.18 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.501 HG22 ' H ' ' A' ' 55' ' ' LYS . 14.8 m . . . . . 0 CA--C 1.543 0.697 0 N-CA-C 105.442 -2.058 . . . . 65.03 105.442 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.457 ' HG ' ' H ' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -169.61 171.06 7.75 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.573 1.549 . . . . 54.14 108.46 169.414 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.457 ' H ' ' HG ' ' A' ' 23' ' ' LEU . 19.4 tt0 -130.45 145.14 51.78 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 128.509 2.723 . . . . 65.42 108.875 176.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -132.52 125.44 30.6 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.833 1.253 . . . . 74.01 108.291 174.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -135.82 178.63 6.9 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.947 1.699 . . . . 74.44 109.527 174.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.499 ' HA ' ' CE1' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -146.59 -174.89 4.59 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.155 0.982 . . . . 64.31 110.5 164.435 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.551 ' CZ ' ' HG3' ' A' ' 91' ' ' MET . 50.9 m-85 -93.93 -41.39 9.62 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.654 -0.654 . . . . 74.12 112.73 176.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -80.72 -7.53 59.38 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.808 0.67 . . . . 74.11 112.808 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.0 p -74.7 149.2 85.78 Favored Pre-proline 0 CA--C 1.532 0.269 0 O-C-N 120.744 -1.223 . . . . 73.14 111.979 173.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.25 167.87 25.69 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.618 2.212 . . . . 73.31 109.184 164.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.2 m80 68.98 -51.32 0.59 Allowed 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 127.114 2.165 . . . . 70.02 110.738 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 61.0 m -44.42 -40.45 5.48 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 126.555 1.942 . . . . 45.21 112.046 177.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.95 -70.91 0.08 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.291 1.037 . . . . 74.23 108.229 175.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.64 ' HA ' HE21 ' A' ' 35' ' ' GLN . 0.0 OUTLIER -65.98 -37.47 86.05 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.084 -1.01 . . . . 73.35 110.141 -169.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -61.58 -20.64 63.53 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 116.878 -1.534 . . . . 72.13 112.483 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -120.68 -11.25 9.06 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 119.395 0.998 . . . . 72.11 110.928 -170.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.5 ' HA ' ' CE1' ' A' ' 41' ' ' HIS . 0.0 OUTLIER -134.56 -16.54 2.05 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 114.666 1.358 . . . . 62.13 114.666 -173.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 77.7 t -117.64 -68.23 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.272 0.558 . . . . 74.04 110.368 174.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.4 mt -69.08 -21.76 64.05 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.247 1.419 . . . . 51.34 111.314 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.5 ' CE1' ' HA ' ' A' ' 38' ' ' GLU . 39.7 m-70 44.08 56.24 4.89 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 126.0 1.72 . . . . 74.22 111.074 171.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.614 ' O ' HG23 ' A' ' 46' ' ' VAL . 68.2 t -59.18 -49.13 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 117.184 -1.389 . . . . 72.12 107.754 -172.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.3 t -45.61 -53.47 9.1 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-N 119.685 1.13 . . . . 74.14 112.111 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.423 ' CG ' HH12 ' A' ' 47' ' ' ARG . 1.5 t70 -88.5 5.66 41.5 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.921 0.712 . . . . 72.42 112.921 -174.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -92.01 -49.06 6.42 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.733 0.813 . . . . 72.14 109.992 157.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 42' ' ' VAL . 2.4 t -63.49 -40.12 87.88 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-N 119.632 1.106 . . . . 74.11 110.392 -170.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.423 HH12 ' CG ' ' A' ' 44' ' ' ASP . 0.7 OUTLIER -51.58 -38.43 54.41 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 118.049 -0.977 . . . . 62.45 111.709 -179.045 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -64.76 -2.96 2.82 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 115.207 1.558 . . . . 73.25 115.207 176.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -129.05 -5.62 4.97 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.107 1.763 . . . . 73.31 111.603 -178.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.541 ' HG ' HG12 ' A' ' 46' ' ' VAL . 5.6 mt -87.67 152.7 52.05 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 127.334 2.254 . . . . 71.45 111.119 -165.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.425 ' O ' HG22 ' A' ' 54' ' ' THR . 26.1 Cg_endo -81.21 175.6 9.59 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.209 2.606 . . . . 61.34 112.015 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -84.63 23.03 1.2 Allowed 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.478 -1.389 . . . . 61.22 114.524 -169.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -143.19 -15.08 0.29 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.308 1.432 . . . . 63.24 113.724 -172.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.53 HG21 ' HB3' ' A' ' 50' ' ' LEU . 14.6 t -60.04 128.12 35.25 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 107.388 -1.338 . . . . 71.13 107.388 175.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.501 ' H ' HG22 ' A' ' 22' ' ' VAL . 48.0 tptt -118.61 72.78 0.89 Allowed 'General case' 0 C--N 1.341 0.196 0 CA-C-O 123.279 1.514 . . . . 71.11 109.535 173.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 18.4 ptp -52.96 -31.85 42.71 Favored 'General case' 0 CA--C 1.496 -1.1 0 C-N-CA 125.331 1.452 . . . . 70.12 114.339 -173.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.598 HG22 ' H ' ' A' ' 58' ' ' LYS . 7.5 m 46.82 -167.33 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 126.101 1.761 . . . . 74.21 113.063 -176.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.598 ' H ' HG22 ' A' ' 57' ' ' THR . 0.4 OUTLIER -159.09 104.72 1.71 Allowed 'General case' 0 CA--C 1.54 0.563 0 O-C-N 119.977 -1.702 . . . . 71.23 107.65 167.411 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.7 m-30 -102.63 174.81 5.73 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.635 1.561 . . . . 74.1 111.013 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.499 ' CE1' ' HA ' ' A' ' 27' ' ' SER . 6.2 t60 -135.02 118.5 16.86 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 118.722 0.692 . . . . 73.31 111.417 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.423 HG12 ' CB ' ' A' ' 141' ' ' ALA . 12.8 m -81.93 172.07 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 123.252 0.621 . . . . 75.43 110.042 178.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.27 3.39 6.36 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.625 1.57 . . . . 74.03 113.096 -169.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -81.32 1.23 33.55 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.414 1.265 . . . . 75.01 114.414 -172.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 mt -125.59 132.09 52.59 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.655 1.116 . . . . 52.42 110.44 -164.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.76 177.37 35.33 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.666 0.65 . . . . 73.01 111.66 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.77 -55.13 0.92 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.186 2.591 . . . . 62.33 110.453 173.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.439 HD11 ' C ' ' A' ' 102' ' ' GLN . 38.1 mt -91.84 22.37 4.25 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.375 -0.828 . . . . 70.41 112.875 -166.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -48.65 -48.43 29.03 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 119.101 0.864 . . . . 42.11 112.206 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -56.52 -42.53 78.58 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.482 1.513 . . . . 75.14 113.307 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -78.71 -33.37 46.86 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.332 0.653 . . . . 72.14 110.259 -176.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.426 HD22 ' CD2' ' A' ' 28' ' ' PHE . 25.6 mt -62.4 -41.03 98.35 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.886 -0.783 . . . . 64.1 108.886 171.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.9 m -55.65 -50.11 71.07 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.594 1.088 . . . . 53.44 110.171 168.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -61.71 -35.16 77.24 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 120.621 1.555 . . . . 65.1 113.012 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.27 -35.06 79.87 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.668 0.667 . . . . 54.42 111.914 174.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.508 ' CD1' HD11 ' A' ' 79' ' ' ILE . 11.3 t-105 -57.46 -42.71 83.09 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 118.619 0.645 . . . . 74.43 111.026 -176.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.96 -36.38 74.72 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 117.517 -1.23 . . . . 65.21 112.872 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.0 t -59.7 -47.12 92.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 120.065 1.302 . . . . 70.11 108.626 172.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.55 -47.21 86.58 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 121.806 -0.559 . . . . 72.14 111.142 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.508 HD11 ' CD1' ' A' ' 75' ' ' TRP . 92.7 mt -62.39 -42.54 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.137 0.975 . . . . 71.5 110.509 177.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.62 -47.25 86.34 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.576 0.625 . . . . 73.12 109.441 -174.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 87.3 mt -80.2 -20.34 44.95 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 119.195 -0.431 . . . . 71.5 112.065 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.69 66.68 2.4 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 125.9 1.715 . . . . 72.32 110.261 -167.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.1 m -134.85 18.29 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.742 1.617 . . . . 71.52 111.048 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -51.07 -53.57 32.77 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 124.466 1.107 . . . . 53.2 110.09 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -77.0 -5.79 50.08 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.066 0.946 . . . . 61.41 111.29 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -90.21 -8.49 50.97 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.224 1.01 . . . . 73.31 111.216 166.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.7 pp -133.19 38.12 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 124.901 1.28 . . . . 64.52 111.715 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.0 m -92.39 -52.33 4.72 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.748 -0.595 . . . . 72.33 110.753 171.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.49 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -59.83 -64.05 3.49 Favored Pre-proline 0 CA--C 1.532 0.276 0 C-N-CA 123.318 0.647 . . . . 74.54 112.295 -163.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.49 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 73.3 Cg_endo -70.33 -20.77 31.74 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 CA-C-N 119.575 0.884 . . . . 63.55 112.602 -173.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.551 ' HG3' ' CZ ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -54.47 -58.8 6.04 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 127.481 2.312 . . . . 65.11 108.116 170.705 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -59.09 -41.69 88.67 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 124.105 0.962 . . . . 70.13 111.817 177.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -56.62 -36.68 69.73 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.076 -0.511 . . . . 74.14 110.676 172.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.39 -17.03 43.65 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 121.4 -0.812 . . . . 65.31 112.541 -169.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.0 t -114.3 -23.17 4.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 C-N-CA 124.613 1.165 . . . . 74.04 111.064 -172.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -120.48 -52.36 2.15 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.678 0.791 . . . . 74.25 112.289 -178.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -69.27 -52.85 23.49 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 121.583 -0.698 . . . . 74.33 111.244 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 37.2 p -98.62 -31.69 11.81 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.14 0.976 . . . . 72.52 110.489 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 52.59 34.78 16.45 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.882 2.073 . . . . 61.04 111.534 -173.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 t -75.91 -12.76 60.21 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.648 1.179 . . . . 70.33 112.67 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.428 HG13 HG12 ' A' ' 107' ' ' ILE . 25.9 t -67.31 118.17 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 O-C-N 120.913 -1.117 . . . . 54.43 108.963 172.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.439 ' C ' HD11 ' A' ' 67' ' ' LEU . 10.3 mt-30 -141.93 -25.13 0.68 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.463 1.105 . . . . 72.11 111.799 -178.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.13 160.78 38.49 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.584 1.553 . . . . 70.44 107.166 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 63.9 t -58.59 -32.34 45.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.566 1.146 . . . . 74.41 110.221 177.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.32 -29.06 57.54 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.287 1.435 . . . . 70.24 112.743 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -88.33 -25.41 22.77 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.598 0.635 . . . . 71.3 109.293 -176.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.428 HG12 HG13 ' A' ' 101' ' ' VAL . 3.2 mt -78.39 -47.74 23.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 124.963 1.305 . . . . 71.54 109.582 -178.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -56.11 -28.08 56.37 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-O 118.342 -0.837 . . . . 74.52 111.406 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -58.88 -53.61 56.46 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 123.86 0.864 . . . . 64.51 110.113 -176.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 17.4 t -56.07 -41.44 68.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.164 0.586 . . . . 61.51 110.716 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -60.47 -49.32 78.04 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.127 0.971 . . . . 74.44 110.009 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 83.5 t -63.41 -35.87 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 121.581 -0.699 . . . . 61.2 110.194 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.67 -44.05 97.25 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.466 0.706 . . . . 44.44 109.3 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.52 -21.42 62.73 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.612 1.165 . . . . 45.14 112.497 175.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 131.62 2.29 4.46 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 115.908 1.123 . . . . 64.41 115.908 167.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 65.1 t -66.26 143.73 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 123.363 1.554 . . . . 64.3 108.354 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.65 145.53 50.57 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.626 -1.17 . . . . 72.53 110.446 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -78.47 -0.2 78.0 Favored Glycine 0 N--CA 1.467 0.708 0 C-N-CA 124.035 0.826 . . . . 74.44 114.241 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -94.88 -36.97 11.42 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 123.198 0.599 . . . . 73.33 111.449 172.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -86.79 -41.1 14.36 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 107.348 -1.353 . . . . 73.23 107.348 -160.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -60.61 -53.2 60.37 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.957 -0.757 . . . . 70.31 108.957 172.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -73.14 -20.47 60.91 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 118.77 -0.634 . . . . 72.31 111.48 -170.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.56 -65.24 1.01 Allowed 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.138 -1.06 . . . . 42.13 108.138 171.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.53 -35.19 65.39 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.106 0.962 . . . . 44.4 111.626 -171.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -44.86 -36.97 3.55 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 125.08 1.352 . . . . 74.3 111.83 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -114.35 8.42 16.65 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.744 1.618 . . . . 62.21 113.484 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.6 t -79.09 148.8 32.28 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.06 1.744 . . . . 52.12 110.53 169.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -54.92 -33.36 62.06 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.232 1.813 . . . . 64.53 112.532 -177.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 22.3 t -54.63 -48.22 71.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 124.14 0.976 . . . . 73.2 109.742 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 32.7 t -69.98 -44.41 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-O 117.956 -1.021 . . . . 61.3 108.667 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -49.21 -49.92 40.66 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.267 1.394 . . . . 74.13 111.373 175.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.1 t -61.59 -49.05 78.18 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 123.481 0.713 . . . . 71.43 109.897 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 13.6 mt -65.04 -38.71 91.73 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 118.606 0.639 . . . . 62.41 111.988 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 49.1 t -58.31 -60.8 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 125.797 1.639 . . . . 74.21 107.695 173.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.65 -42.06 70.84 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 119.007 -0.521 . . . . 33.44 110.856 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -57.28 -53.11 61.87 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 123.435 0.694 . . . . 74.2 111.654 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -67.03 -48.67 67.64 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 119.158 0.89 . . . . 70.4 110.774 -175.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -63.29 -27.76 69.56 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.362 0.665 . . . . 74.43 112.043 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -82.24 -54.75 5.0 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.512 0.725 . . . . 74.24 109.647 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.08 0.74 1.77 Allowed 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 125.574 1.549 . . . . 54.34 113.399 -175.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.423 ' CB ' HG12 ' A' ' 61' ' ' VAL . . . -123.58 -0.16 8.69 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 114.216 1.191 . . . . 75.24 114.216 169.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.38 -13.01 7.24 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.99 0.814 . . . . 52.54 113.167 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -51.75 -66.7 0.34 Allowed 'General case' 0 C--O 1.231 0.086 0 C-N-CA 125.893 1.677 . . . . 61.24 110.773 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.9 pp 174.19 -4.66 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 129.117 2.967 . . . . 74.14 112.154 169.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.63 -27.23 45.38 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.519 1.128 . . . . 75.44 111.735 -158.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -159.57 140.91 12.82 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 128.641 2.776 . . . . 74.0 106.759 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -145.4 12.27 1.34 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.202 1.401 . . . . 55.21 110.502 -172.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -151.53 147.89 18.3 Favored Glycine 0 C--N 1.342 0.862 0 O-C-N 120.255 -1.528 . . . . 15.11 110.901 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.409 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 35.5 m -133.83 165.46 36.54 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 118.45 1.125 . . . . 74.02 111.102 -168.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.409 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 45.6 Cg_endo -71.0 157.91 95.16 Favored 'Cis proline' 0 C--N 1.35 0.631 0 CA-C-N 119.233 0.762 . . . . 73.04 112.263 -11.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -138.59 146.63 42.04 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.639 -0.709 . . . . 73.43 111.472 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 7.8 ttm -145.14 119.22 9.42 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.667 -1.605 . . . . 70.11 106.667 174.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -88.21 164.74 15.49 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.367 0.667 . . . . 74.22 109.825 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.702 HG12 ' HB2' ' A' ' 158' ' ' TYR . 0.5 OUTLIER -149.55 150.31 13.93 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 O-C-N 121.067 -1.021 . . . . 73.23 108.719 175.291 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 48.3 15.21 0.07 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.328 1.603 . . . . 73.22 115.328 -175.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 50.79 38.33 36.88 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 120.039 1.291 . . . . 73.33 112.425 -167.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.422 ' HE3' ' CZ ' ' A' ' 158' ' ' TYR . 42.7 pttt -162.27 -14.21 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.946 1.299 . . . . 72.13 114.038 173.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.702 ' HB2' HG12 ' A' ' 154' ' ' VAL 0.276 14.3 m-85 -106.42 158.86 16.59 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 127.041 2.136 . . . . 65.44 110.834 178.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -139.24 130.62 26.96 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 105.063 -2.199 . . . . 65.13 105.063 174.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.92 142.49 56.02 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.518 -1.29 . . . . 70.41 107.518 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -114.26 85.28 10.31 Favored Pre-proline 0 C--O 1.236 0.376 0 N-CA-C 110.339 -0.245 . . . . 74.44 110.339 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.11 -16.02 43.99 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 N-CA-C 110.342 -0.676 . . . . 71.03 110.342 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -77.65 2.49 16.53 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.283 1.833 . . . . 62.33 112.477 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -135.3 35.5 2.17 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 119.422 1.01 . . . . 70.21 111.12 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 62.5 mtt -120.84 167.38 12.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.446 1.098 . . . . 74.15 110.403 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -62.21 112.42 2.38 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.237 1.015 . . . . 71.33 108.937 169.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 82.3 p -119.57 22.08 11.81 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.434 1.094 . . . . 32.1 110.186 175.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.23 -48.22 36.8 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 118.664 0.665 . . . . 71.32 109.934 172.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.483 HD22 ' HB ' ' A' ' 172' ' ' VAL . 0.4 OUTLIER -107.82 -10.85 15.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 118.07 -0.966 . . . . 74.43 111.608 -156.172 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 16.6 mmm 73.47 -44.85 0.59 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 127.748 2.419 . . . . 64.15 111.935 169.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -55.54 23.17 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 127.179 2.191 . . . . 74.44 107.941 173.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.483 ' HB ' HD22 ' A' ' 169' ' ' ASN . 61.5 t -67.81 -26.47 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 127.057 2.143 . . . . 65.44 110.538 -174.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.68 -59.12 5.95 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.189 -1.041 . . . . 74.25 108.189 173.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 10.8 t -66.58 -32.03 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.101 0.56 . . . . 64.14 110.521 -177.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.66 -41.86 82.36 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.645 0.778 . . . . 73.23 111.607 176.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -85.35 -32.35 22.49 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.587 1.155 . . . . 73.05 112.69 177.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -56.8 -63.29 1.25 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.376 -0.972 . . . . 74.44 108.376 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.86 -26.95 69.02 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.562 0.578 . . . . 45.21 112.562 -170.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -71.24 -52.23 20.17 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.222 1.409 . . . . 71.42 109.878 177.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.512 HG23 HG21 ' A' ' 3' ' ' ILE . 92.4 m -53.78 -40.11 66.0 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.248 1.019 . . . . 72.41 110.155 176.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 46.1 t -57.75 -53.27 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 108.934 -0.765 . . . . 71.23 108.934 178.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.3 tttt -59.95 -43.47 95.0 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 124.065 0.946 . . . . 71.42 110.543 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -63.33 -32.62 74.09 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 123.14 0.576 . . . . 71.04 111.202 -171.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 19.5 mt -68.79 -25.97 64.97 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 112.756 0.65 . . . . 71.04 112.756 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 61.1 t -65.72 -25.91 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 O-C-N 121.188 -0.945 . . . . 63.45 109.442 173.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -92.02 -9.56 42.37 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.152 1.381 . . . . 62.01 110.967 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -129.56 70.52 1.42 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.78 2.032 . . . . 64.33 108.79 -174.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 21.6 pttp . . . . . 0 C--O 1.257 1.481 0 CA-C-O 117.064 -1.446 . . . . 72.02 109.814 -176.234 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.293 0 N-CA-C 115.786 1.772 . . . . 51.32 115.786 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.52 115.06 4.51 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 104.755 -2.313 . . . . 65.1 104.755 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.511 HG21 HG23 ' A' ' 180' ' ' THR . 6.9 pt -127.37 142.13 44.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 126.111 1.764 . . . . 74.13 107.861 175.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.8 m -129.53 145.54 51.45 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.977 -1.12 . . . . 71.41 107.977 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -47.33 146.32 2.02 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 127.38 2.272 . . . . 73.02 111.395 165.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.22 -19.15 0.25 Allowed Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.365 1.46 . . . . 74.23 114.428 -172.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -100.43 -86.26 0.4 Allowed 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 106.736 -1.579 . . . . 70.12 106.736 -165.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -92.15 -14.21 29.47 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.379 1.071 . . . . 51.31 110.522 -175.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -144.81 159.7 42.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.728 0.811 . . . . 71.03 111.04 172.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.3 mm -125.07 164.44 23.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 124.615 1.166 . . . . 72.21 108.323 178.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 m -109.97 152.56 25.71 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.624 1.97 . . . . 71.34 108.236 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 35.5 mt -84.33 160.84 20.61 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 108.008 -1.108 . . . . 70.4 108.008 164.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.95 -35.39 64.53 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 122.404 1.097 . . . . 73.51 110.088 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -123.49 78.29 54.68 Favored Pre-proline 0 N--CA 1.455 -0.211 0 C-N-CA 125.458 1.503 . . . . 74.22 108.032 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo . . . . . 0 N--CA 1.444 -1.395 0 N-CA-C 106.348 -2.212 . . . . 61.24 106.348 164.25 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 66.7 t . . . . . 0 C--O 1.234 0.252 0 CA-C-O 120.823 0.344 . . . . 45.34 110.699 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.417 HD12 HG21 ' A' ' 57' ' ' THR . 2.9 tp -136.57 153.82 50.86 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 126.664 1.986 . . . . 70.43 106.108 177.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 2.6 mp0 -143.91 149.43 36.85 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.363 1.865 . . . . 61.34 109.893 -169.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.561 ' HD1' ' HB3' ' A' ' 151' ' ' ALA . 0.5 OUTLIER -145.6 161.99 38.52 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.197 1.362 . . . . 74.43 108.457 174.551 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -163.63 -175.0 3.94 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.949 2.899 . . . . 62.11 107.144 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.1 t -138.94 173.11 11.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 123.101 1.429 . . . . 72.13 109.407 163.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -79.81 -34.93 39.14 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 126.902 2.081 . . . . 71.3 110.11 -175.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -90.8 -1.97 57.81 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.104 1.362 . . . . 73.41 112.578 -176.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 p -90.03 144.22 31.04 Favored Pre-proline 0 N--CA 1.471 0.622 0 CA-C-N 120.928 1.694 . . . . 72.53 112.112 -173.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -84.71 -40.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.047 1.831 . . . . 50.41 114.339 -170.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -59.07 -43.32 91.77 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.489 1.041 . . . . 62.33 108.437 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 32.1 m -48.35 -45.88 35.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.393 1.877 . . . . 74.22 111.233 175.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -51.16 -62.06 1.85 Allowed 'General case' 0 C--N 1.346 0.438 0 C-N-CA 123.628 0.771 . . . . 63.52 109.631 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -55.1 -41.63 71.86 Favored 'General case' 0 C--O 1.222 -0.345 0 O-C-N 121.08 -1.013 . . . . 72.23 110.587 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -68.18 -20.15 64.84 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 117.986 -1.007 . . . . 63.1 111.928 -172.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.79 -4.91 7.56 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.275 0.943 . . . . 73.44 112.756 -167.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -133.95 -26.93 1.49 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.629 1.572 . . . . 65.32 111.548 -168.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 83.0 t -119.81 -76.45 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 107.009 -1.478 . . . . 64.34 107.009 -175.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.1 mt -68.27 -17.54 64.31 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.56 1.544 . . . . 41.24 112.95 -176.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 44.08 60.38 2.78 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.437 1.895 . . . . 71.22 112.185 172.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 46' ' ' VAL . 33.2 t -66.76 -52.13 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 116.519 -1.705 . . . . 72.1 108.909 -173.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.0 t -53.99 -45.76 71.52 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 121.044 1.747 . . . . 25.14 110.501 -175.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -61.85 -40.56 95.75 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.761 0.825 . . . . 63.0 111.468 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -68.2 -36.88 80.25 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 124.488 1.115 . . . . 62.22 112.102 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 42' ' ' VAL . 3.1 t -66.54 -46.84 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.455 -1.313 . . . . 71.32 107.455 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 66.8 ttt-85 -48.0 -47.05 33.38 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-O 118.231 -0.89 . . . . 62.34 111.204 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -56.14 -10.74 0.91 Allowed 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 115.726 1.75 . . . . 71.0 115.726 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -130.31 7.25 4.96 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.653 1.981 . . . . 73.23 112.848 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.0 mt -79.82 161.65 65.48 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 120.194 1.361 . . . . 62.32 111.352 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -72.61 -161.92 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.75 1 C-N-CA 127.355 5.37 . . . . 54.1 110.739 172.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.431 ' CD ' ' H ' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -102.32 24.05 10.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 114.489 1.292 . . . . 74.22 114.489 176.513 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -143.08 -40.78 0.06 OUTLIER Glycine 0 CA--C 1.52 0.406 0 O-C-N 121.607 -0.683 . . . . 74.44 113.567 -172.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.0 m -71.55 95.19 1.38 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.597 1.559 . . . . 70.23 108.056 175.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.03 162.5 24.82 Favored 'General case' 0 CA--C 1.519 -0.25 0 O-C-N 120.478 -1.389 . . . . 72.43 109.014 169.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.89 109.04 21.83 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 106.805 -1.554 . . . . 63.01 106.805 175.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.56 HG22 ' H ' ' A' ' 58' ' ' LYS . 1.0 OUTLIER -87.36 -176.91 5.8 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 124.076 0.86 . . . . 65.24 109.237 171.06 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.56 ' H ' HG22 ' A' ' 57' ' ' THR . 0.1 OUTLIER -174.23 109.31 0.14 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 128.288 2.635 . . . . 74.21 105.612 174.275 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -74.76 -166.53 0.47 Allowed 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.006 -1.059 . . . . 72.33 109.532 163.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.568 ' CD2' ' HB3' ' A' ' 75' ' ' TRP 0.262 2.7 p-80 -136.77 156.88 47.93 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 129.709 3.204 . . . . 74.12 108.347 170.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.461 HG23 ' HB2' ' A' ' 63' ' ' PHE . 28.5 m -146.7 170.35 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 119.614 1.097 . . . . 73.34 108.398 169.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.99 -80.88 0.08 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 107.026 -1.472 . . . . 74.34 107.026 171.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.461 ' HB2' HG23 ' A' ' 61' ' ' VAL . 0.5 OUTLIER 68.13 -44.15 0.49 Allowed 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 130.136 3.375 . . . . 73.11 115.011 175.002 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.36 171.01 16.13 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 119.842 1.201 . . . . 61.34 110.65 -175.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.16 175.55 33.18 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 115.717 -0.674 . . . . 71.1 112.54 175.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -73.67 -55.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.673 2.915 . . . . 62.35 111.219 175.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.4 mt -89.38 30.18 1.02 Allowed 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.295 0.638 . . . . 52.32 111.844 -164.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -45.6 -56.3 6.53 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.929 1.252 . . . . 42.11 110.581 176.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -56.13 -46.46 79.18 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.601 1.161 . . . . 70.45 110.736 -174.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.49 -45.8 91.37 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 127.106 2.163 . . . . 65.11 109.329 -174.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 mt -64.98 -43.84 91.28 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.855 0.862 . . . . 74.45 109.431 176.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.495 ' HA ' ' HD2' ' A' ' 60' ' ' HIS . 44.5 m -66.37 -1.31 3.31 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 126.653 1.981 . . . . 73.52 110.582 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -111.9 -22.12 11.24 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 118.971 -2.33 . . . . 65.31 111.599 171.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.09 -35.8 48.94 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.698 0.999 . . . . 63.34 113.698 176.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.568 ' HB3' ' CD2' ' A' ' 60' ' ' HIS . 40.8 t-105 -58.23 -35.42 71.67 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.265 0.939 . . . . 73.51 110.949 -175.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.53 -34.33 77.56 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 118.206 -0.902 . . . . 50.44 110.814 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.1 t -60.98 -47.02 95.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 119.467 1.03 . . . . 73.24 108.964 167.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.16 -45.97 89.59 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 119.056 -0.497 . . . . 71.55 111.467 -177.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.5 mt -65.84 -42.84 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 124.602 1.161 . . . . 73.12 110.557 176.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.1 -32.44 70.98 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.054 0.843 . . . . 70.31 110.909 -177.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 43.2 mt -95.37 -15.24 23.2 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.261 0.837 . . . . 54.22 113.261 173.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 65.12 63.3 4.25 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.231 1.396 . . . . 71.53 111.667 -173.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.3 m -129.48 16.42 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.586 1.154 . . . . 63.42 111.852 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -52.86 -54.53 33.19 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.133 0.879 . . . . 71.21 111.016 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.56 -9.09 11.59 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.604 0.762 . . . . 74.12 112.648 -179.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -96.34 -13.92 22.92 Favored 'General case' 0 CA--C 1.519 -0.233 0 O-C-N 120.585 -1.322 . . . . 71.5 111.284 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.2 pt -121.21 -1.14 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 116.712 -1.613 . . . . 72.33 113.347 -175.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.2 m -64.38 -54.5 31.83 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 120.632 1.56 . . . . 54.31 109.096 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.43 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -52.54 -56.24 24.62 Favored Pre-proline 0 C--O 1.241 0.623 0 C-N-CA 124.614 1.166 . . . . 74.2 112.633 -169.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.43 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 54.1 Cg_endo -72.08 -26.97 17.6 Favored 'Trans proline' 0 N--CA 1.443 -1.443 0 C-N-CA 120.714 0.943 . . . . 71.21 112.653 -177.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 17.1 tpp -54.42 -51.34 65.22 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.09 0.956 . . . . 71.2 109.288 174.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -68.99 -33.57 73.88 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 121.872 -0.518 . . . . 53.4 111.191 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.45 ' HA ' ' HB2' ' A' ' 97' ' ' LYS . 0.9 OUTLIER -60.39 -38.82 85.15 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 118.964 -1.094 . . . . 70.5 109.594 171.056 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.99 -11.41 58.15 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.275 -0.891 . . . . 54.12 112.05 -167.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.3 t -119.93 -35.44 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.184 1.393 . . . . 73.54 110.36 -171.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -122.39 -38.38 2.68 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.098 0.959 . . . . 65.53 111.974 -164.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 93' ' ' GLU . 3.9 mmmt -76.01 -58.72 3.11 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 118.619 0.645 . . . . 71.4 110.733 174.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . 0.261 5.6 t -114.45 -18.23 11.56 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.095 0.776 . . . . 51.3 113.095 -176.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 65.87 19.73 11.32 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.521 0.934 . . . . 71.42 113.521 169.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 t -62.52 -16.48 56.05 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.247 2.219 . . . . 63.13 113.717 -173.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.452 HG13 HG12 ' A' ' 107' ' ' ILE . 26.9 t -64.46 115.05 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 124.434 1.094 . . . . 61.13 109.391 173.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -132.52 -23.12 2.12 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.502 1.121 . . . . 74.11 112.078 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.97 161.44 41.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.734 1.614 . . . . 62.21 107.291 -177.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.3 t -54.36 -36.15 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 118.973 0.806 . . . . 74.54 110.236 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.66 -34.17 57.75 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.378 1.471 . . . . 51.25 112.676 176.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -78.46 -34.75 47.5 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.518 -0.919 . . . . 73.35 108.518 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.452 HG12 HG13 ' A' ' 101' ' ' VAL . 2.9 mt -72.35 -49.27 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 124.085 0.954 . . . . 70.42 108.732 -174.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -17.28 64.53 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.569 0.748 . . . . 71.33 112.62 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -58.4 -54.18 49.93 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.24 1.016 . . . . 62.32 109.908 168.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.41 HG13 ' HB2' ' A' ' 90' ' ' PRO . 35.0 t -55.11 -36.78 40.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.519 1.128 . . . . 71.52 110.82 -175.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -57.36 -57.27 13.37 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.319 0.648 . . . . 73.22 109.536 173.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 89.2 t -60.88 -41.36 88.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 O-C-N 121.454 -0.779 . . . . 74.54 111.005 -175.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -55.44 -51.05 68.2 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.193 0.997 . . . . 70.33 109.237 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.36 -11.32 60.84 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.073 1.349 . . . . 52.31 112.506 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 112.02 48.06 0.68 Allowed Glycine 0 C--N 1.336 0.528 0 CA-C-N 118.84 0.745 . . . . 34.22 112.729 175.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.6 t -116.37 141.66 33.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 117.91 0.855 . . . . 71.23 109.741 177.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -70.27 118.43 13.08 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.188 0.995 . . . . 72.31 109.27 169.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.85 -9.28 52.28 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 117.347 -1.807 . . . . 70.22 112.479 167.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -74.98 -41.42 59.57 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 120.607 2.204 . . . . 71.13 108.67 168.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.71 -25.65 44.69 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.441 -0.948 . . . . 63.23 108.441 -171.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -70.31 -62.21 1.47 Allowed 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 107.59 -1.263 . . . . 63.41 107.59 175.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -64.41 -24.77 67.75 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.787 -0.625 . . . . 74.23 111.69 -173.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.78 -68.11 0.6 Allowed 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.667 1.187 . . . . 65.15 111.259 168.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.11 -27.71 67.25 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 118.223 -0.894 . . . . 53.32 111.517 -167.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -44.14 -39.4 4.29 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.851 1.66 . . . . 74.12 112.047 176.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -112.53 3.62 16.88 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.83 1.252 . . . . 53.01 113.147 -177.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 13.2 t -74.68 152.84 39.11 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.841 1.256 . . . . 73.35 111.252 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -52.61 -33.2 45.42 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.202 1.801 . . . . 65.31 112.581 170.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 46.8 t -53.16 -48.53 53.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 O-C-N 121.201 -0.937 . . . . 71.24 109.772 177.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.3 t -72.59 -38.16 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-O 118.311 -0.852 . . . . 72.54 109.868 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -52.46 -49.83 63.88 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.78 1.173 . . . . 73.33 111.234 174.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.3 t -58.06 -51.07 71.22 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.122 -0.696 . . . . 25.22 109.122 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 14.8 mt -66.26 -37.93 86.64 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.271 0.629 . . . . 73.14 112.658 -174.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.1 t -56.31 -59.21 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 125.16 1.384 . . . . 74.53 108.66 168.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.05 -40.35 60.98 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.799 0.839 . . . . 54.02 112.27 -174.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -51.9 -60.92 2.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 117.668 -1.158 . . . . 70.13 110.291 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.438 ' H ' ' HG3' ' A' ' 137' ' ' GLN . 0.9 OUTLIER -78.34 -32.95 49.38 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 120.576 1.534 . . . . 73.52 113.659 -179.621 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.92 -24.21 65.17 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.502 1.046 . . . . 65.5 109.766 -169.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 24.1 ttpt -82.2 -57.38 3.41 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 125.262 1.425 . . . . 73.43 109.305 160.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.86 -17.69 61.82 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.931 1.456 . . . . 51.41 114.931 -164.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -117.4 2.35 12.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 119.965 1.257 . . . . 64.4 113.257 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.98 6.42 3.38 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.628 0.771 . . . . 73.53 111.727 -178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -68.1 -85.88 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.874 0.87 . . . . 74.24 109.678 172.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 175.58 48.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.658 2.383 . . . . 65.31 109.244 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.47 -50.47 0.51 Allowed 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.782 -1.199 . . . . 74.53 109.493 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.13 109.05 14.98 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 127.029 2.132 . . . . 54.3 106.827 -171.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -149.84 28.62 0.76 Allowed 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 126.636 1.974 . . . . 65.5 111.144 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -138.38 91.2 0.2 Allowed Glycine 0 C--N 1.341 0.811 0 O-C-N 120.876 -1.14 . . . . 65.12 112.44 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.424 HG13 ' CZ ' ' A' ' 25' ' ' PHE . 34.1 m -73.38 163.55 67.63 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 113.331 0.863 . . . . 74.12 113.331 174.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -77.94 118.07 5.52 Favored 'Cis proline' 0 N--CA 1.446 -1.286 0 N-CA-C 108.666 -1.321 . . . . 71.2 108.666 -21.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.561 ' HB3' ' HD1' ' A' ' 25' ' ' PHE . . . -88.49 129.18 35.51 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 106.203 -1.777 . . . . 74.11 106.203 -174.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 80.0 mmm -138.19 89.26 2.38 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 104.245 -2.502 . . . . 62.14 104.245 -172.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -73.74 170.23 15.7 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 120.853 -1.155 . . . . 74.04 109.974 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.515 HG11 ' HB2' ' A' ' 184' ' ' LEU . 56.8 t -131.07 -41.41 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 113.252 0.834 . . . . 72.41 113.252 178.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.36 24.22 1.13 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.76 -0.588 . . . . 71.44 109.728 -171.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 77.44 -28.37 1.76 Allowed Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.237 1.875 . . . . 64.14 113.055 -174.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.55 -7.48 19.7 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.966 1.469 . . . . 65.44 114.966 -174.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -126.95 142.15 51.62 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.947 0.899 . . . . 70.12 109.531 -174.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -117.9 137.54 52.74 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 106.392 -1.707 . . . . 74.42 106.392 169.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.02 144.04 55.29 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.21 -0.663 . . . . 71.1 109.21 171.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -111.55 86.95 7.36 Favored Pre-proline 0 C--O 1.232 0.149 0 N-CA-C 113.519 0.933 . . . . 45.34 113.519 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -63.13 0.04 1.91 Allowed 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 121.041 1.161 . . . . 70.32 114.253 172.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -111.74 18.65 18.76 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.117 1.367 . . . . 74.42 112.287 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -146.06 52.24 0.57 Allowed Glycine 0 C--N 1.334 0.42 0 N-CA-C 108.681 -1.768 . . . . 54.41 108.681 171.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 35.6 mtt -144.58 176.02 9.71 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.931 1.292 . . . . 65.33 109.399 -176.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -85.24 44.52 1.1 Allowed 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 123.527 0.731 . . . . 71.21 112.269 -164.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.437 ' HB ' ' CD2' ' A' ' 173' ' ' PHE 0.257 10.7 t -67.79 30.91 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 129.102 2.961 . . . . 65.2 113.169 -177.163 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.19 -20.43 30.2 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 127.536 2.334 . . . . 72.02 112.4 169.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.18 -8.68 2.63 Favored 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 113.386 0.884 . . . . 72.02 113.386 -166.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 6.0 mmt 69.19 -61.88 0.42 Allowed 'General case' 0 C--O 1.231 0.129 0 C-N-CA 127.654 2.382 . . . . 33.54 113.003 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -63.66 -46.11 87.12 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.375 1.083 . . . . 65.31 109.682 -172.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.02 -26.48 40.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.386 1.474 . . . . 64.13 110.853 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . 0.437 ' CD2' ' HB ' ' A' ' 167' ' ' THR . 15.9 t80 -68.51 -57.72 5.38 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.267 -1.383 . . . . 74.43 107.267 -177.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.3 t -67.23 -33.85 65.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 117.899 0.318 . . . . 71.24 110.152 -174.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.42 -51.07 61.05 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.49 0.716 . . . . 72.32 110.987 174.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -73.3 -32.73 64.79 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.715 0.806 . . . . 54.53 112.559 177.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -59.06 -60.82 3.26 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.239 1.016 . . . . 73.14 108.429 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.7 -27.65 66.63 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.575 0.75 . . . . 73.12 111.981 -174.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.67 -47.96 28.85 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 121.75 -0.594 . . . . 65.22 111.248 176.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.511 HG23 HG21 ' A' ' 3' ' ' ILE . 90.9 m -53.63 -37.5 63.13 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.439 0.696 . . . . 72.11 109.697 173.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 93.4 t -58.22 -54.43 32.68 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 N-CA-C 109.206 -0.664 . . . . 45.2 109.206 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 13.3 pttp -64.71 -34.99 79.61 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 118.989 -1.085 . . . . 65.03 111.305 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -62.98 -31.11 72.16 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-N 118.739 0.7 . . . . 70.11 111.451 -172.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.515 ' HB2' HG11 ' A' ' 154' ' ' VAL . 75.4 mt -76.0 -18.98 59.06 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.075 -1.05 . . . . 63.34 112.636 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 76.8 t -67.5 -22.51 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 O-C-N 120.951 -1.093 . . . . 62.42 110.383 176.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -103.61 -12.23 17.2 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.325 1.05 . . . . 54.51 110.869 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 42.2 mttp -115.33 82.41 1.74 Allowed 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 126.125 1.77 . . . . 52.22 107.958 -173.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-N 114.208 -1.36 . . . . 71.23 109.111 164.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.464 0 N-CA-C 112.162 0.43 . . . . 71.44 112.162 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -148.52 118.33 7.11 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 106.105 -1.813 . . . . 64.44 106.105 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.42 HG21 ' OG1' ' A' ' 180' ' ' THR . 15.3 pt -122.51 149.12 25.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 C-N-CA 126.753 2.021 . . . . 64.13 108.676 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.1 m -119.05 130.91 55.88 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.792 -0.818 . . . . 62.34 108.792 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -46.65 111.47 0.39 Allowed 'General case' 0 C--O 1.232 0.183 0 C-N-CA 126.812 2.045 . . . . 54.43 109.638 162.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 102.97 -5.9 50.83 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.263 -1.298 . . . . 75.11 112.939 176.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -104.57 -86.33 0.46 Allowed 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 118.916 1.358 . . . . 50.13 107.773 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -92.87 -11.65 33.01 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.441 1.496 . . . . 73.33 112.287 -172.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -144.97 157.36 44.16 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 122.984 0.514 . . . . 74.24 110.499 170.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.0 mm -124.57 157.91 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 124.572 1.149 . . . . 61.04 108.071 177.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.24 143.55 41.84 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.69 1.596 . . . . 71.15 107.134 177.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.0 mt -81.91 147.36 29.32 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.885 -0.783 . . . . 74.02 108.885 170.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -73.49 -36.14 65.76 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.356 1.462 . . . . 53.13 109.885 173.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -131.03 84.1 58.88 Favored Pre-proline 0 CA--C 1.519 -0.227 0 C-N-CA 126.296 1.838 . . . . 75.41 108.173 177.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo . . . . . 0 N--CA 1.445 -1.333 0 C-N-CA 123.159 2.573 . . . . 75.15 110.029 173.285 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.241 0.634 0 N-CA-C 106.92 -1.511 . . . . 50.35 106.92 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.466 HD23 ' CE2' ' A' ' 25' ' ' PHE . 5.4 tp -159.77 154.8 24.82 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.501 1.046 . . . . 71.05 112.053 171.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -134.92 143.4 46.9 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 127.24 2.216 . . . . 70.55 107.272 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.643 ' CE1' ' HB2' ' A' ' 141' ' ' ALA . 45.8 m-85 -133.64 137.11 45.21 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.069 0.947 . . . . 65.23 110.768 174.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -162.34 165.85 26.01 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.75 1.62 . . . . 71.3 109.491 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.8 t -124.43 169.14 12.14 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.653 0.781 . . . . 72.22 109.842 167.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.674 ' CZ ' HD21 ' A' ' 71' ' ' LEU 0.275 0.0 OUTLIER -76.58 -18.77 58.47 Favored 'General case' 0 N--CA 1.435 -1.196 0 C-N-CA 124.081 0.953 . . . . 71.33 112.597 175.726 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -96.06 0.34 51.39 Favored 'General case' 0 C--N 1.346 0.446 0 O-C-N 120.232 -1.543 . . . . 72.54 111.655 -175.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.7 p -97.97 142.09 24.01 Favored Pre-proline 0 CA--C 1.534 0.341 0 O-C-N 121.121 -0.987 . . . . 53.1 108.773 -168.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -91.44 -28.25 0.19 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 120.314 0.676 . . . . 42.33 111.503 -162.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -59.9 -49.63 76.93 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.409 -0.96 . . . . 75.25 108.409 165.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.9 m -55.33 -36.7 66.53 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 124.609 1.164 . . . . 53.31 111.953 -178.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -58.82 -56.69 18.97 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 122.994 0.518 . . . . 72.2 109.694 175.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.89 -30.22 68.86 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-O 116.171 -1.871 . . . . 73.12 110.193 177.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -75.03 -6.01 47.12 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 121.245 1.839 . . . . 61.25 113.037 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -146.24 8.56 1.06 Allowed 'General case' 0 C--N 1.345 0.375 0 CA-C-N 120.51 1.505 . . . . 72.13 112.824 -175.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -139.97 -12.48 1.1 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.948 1.299 . . . . 64.33 111.341 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 80.9 t -129.27 -81.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 105.911 -1.885 . . . . 51.42 105.911 173.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.616 ' O ' HG23 ' A' ' 42' ' ' VAL . 3.4 mt -76.55 61.77 1.82 Allowed 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 128.335 2.654 . . . . 72.41 109.474 173.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -50.98 77.38 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 129.628 3.171 . . . . 61.44 110.444 172.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 40' ' ' LEU . 83.2 t -67.2 -48.31 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 114.709 -1.132 . . . . 63.33 108.111 -172.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.1 t -71.6 15.45 0.14 Allowed 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.076 1.139 . . . . 71.11 114.076 -172.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -129.36 -20.81 3.28 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 119.404 -2.06 . . . . 72.24 111.863 170.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.469 ' HB3' ' HB2' ' A' ' 178' ' ' ALA . 2.1 m-80 -62.28 -30.83 71.41 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 121.95 -0.469 . . . . 74.01 111.243 164.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.688 HG12 ' HG ' ' A' ' 50' ' ' LEU . 1.7 t -75.69 -52.14 18.92 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.649 0 N-CA-C 107.123 -1.436 . . . . 61.03 107.123 -162.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -52.95 -39.38 62.88 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.043 1.337 . . . . 73.03 109.915 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -56.35 -21.63 25.81 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.039 1.496 . . . . 72.01 115.039 174.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.6 mmtt -127.37 -5.17 6.0 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.618 2.767 . . . . 70.11 112.526 -176.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.688 ' HG ' HG12 ' A' ' 46' ' ' VAL . 12.7 mt -75.88 151.98 84.54 Favored Pre-proline 0 CA--C 1.518 -0.252 0 CA-C-N 120.43 1.468 . . . . 65.34 108.236 -174.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -78.24 148.54 24.19 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 122.098 1.865 . . . . 74.12 109.646 165.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -67.63 91.89 0.31 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.131 1.772 . . . . 72.21 112.12 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 137.17 -25.19 3.05 Favored Glycine 0 C--N 1.334 0.428 0 O-C-N 120.602 -1.311 . . . . 50.41 113.603 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 73.0 m -71.27 86.94 0.81 Allowed 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 104.075 -2.565 . . . . 71.23 104.075 151.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -82.68 157.31 23.4 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.574 -1.639 . . . . 72.33 106.574 169.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.07 169.24 8.86 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.92 -0.77 . . . . 73.13 108.92 -177.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.485 HG22 ' H ' ' A' ' 58' ' ' LYS . 1.3 m -140.48 -171.63 3.26 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.247 1.419 . . . . 72.51 108.105 -167.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.485 ' H ' HG22 ' A' ' 57' ' ' THR . 0.1 OUTLIER -173.62 85.45 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.291 1.436 . . . . 70.12 108.237 -178.091 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.405 ' CG ' ' HG2' ' A' ' 137' ' ' GLN . 8.2 m-30 -89.61 163.72 15.04 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 120.902 -1.124 . . . . 73.23 108.77 173.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.566 ' CE1' HG22 ' A' ' 72' ' ' THR . 0.1 OUTLIER -102.26 174.7 5.8 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 127.83 2.452 . . . . 75.43 110.133 -174.198 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.428 HG12 ' HB1' ' A' ' 141' ' ' ALA . 16.0 m -144.06 150.44 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 CA-C-N 122.407 2.367 . . . . 51.42 112.765 168.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . 0.304 0.0 OUTLIER -103.29 1.11 32.41 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.19 1.796 . . . . 73.2 114.776 176.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -70.8 9.06 0.73 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.199 1.399 . . . . 61.3 113.984 173.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.1 mt -141.77 148.44 38.95 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 119.68 -1.888 . . . . 75.11 109.221 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.54 166.41 12.03 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 115.082 -0.963 . . . . 62.52 111.725 171.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.44 -39.66 1.01 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.471 2.114 . . . . 52.24 110.119 170.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.474 HD13 HD11 ' A' ' 107' ' ' ILE . 57.3 mt -82.72 23.89 0.77 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.811 1.245 . . . . 54.43 112.032 -177.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -43.91 -63.52 2.24 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 117.222 -1.876 . . . . 74.32 109.863 169.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.8 tptp -59.82 -26.23 65.61 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 121.399 2.6 . . . . 72.3 114.126 -172.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -54.71 30.61 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 117.995 -1.002 . . . . 61.33 111.412 168.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.674 HD21 ' CZ ' ' A' ' 28' ' ' PHE . 34.6 mt -60.26 -40.95 92.15 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.252 0.933 . . . . 74.34 109.269 -164.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.566 HG22 ' CE1' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -49.61 -37.84 29.44 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 126.735 2.014 . . . . 60.51 109.682 -179.499 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.471 ' OE1' HG11 ' A' ' 130' ' ' VAL . 0.6 OUTLIER -86.04 -51.48 6.31 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 126.62 1.968 . . . . 55.0 110.895 -176.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.44 -31.13 72.06 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.513 1.051 . . . . 74.53 112.1 -177.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.458 ' CH2' ' HB3' ' A' ' 84' ' ' GLU . 43.3 t-105 -56.59 -36.39 69.31 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 119.139 0.881 . . . . 72.4 111.328 173.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.639 ' HB3' HG13 ' A' ' 130' ' ' VAL . . . -64.87 -42.46 94.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.624 -0.673 . . . . 65.3 110.125 -177.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 82.6 t -52.8 -43.5 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 122.953 0.501 . . . . 74.22 109.83 170.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.37 -50.14 66.66 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 121.239 -0.913 . . . . 43.24 111.13 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.501 ' CD1' HE22 ' A' ' 137' ' ' GLN . 86.6 mt -59.31 -37.28 68.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.344 1.058 . . . . 73.21 109.877 178.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.26 -50.13 74.27 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.505 0.593 . . . . 71.24 110.17 -174.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.0 mt -81.66 -12.2 58.78 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 118.32 -0.848 . . . . 72.21 112.791 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.03 63.87 3.58 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 126.14 1.828 . . . . 65.4 110.681 -175.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.2 m -130.14 11.9 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 117.67 -1.157 . . . . 74.32 112.838 -177.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.458 ' HB3' ' CH2' ' A' ' 75' ' ' TRP . 2.4 mp0 -51.58 -51.7 53.4 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.912 1.233 . . . . 62.24 111.629 -166.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -49.31 -47.67 46.86 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.681 1.592 . . . . 72.2 111.506 177.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -65.46 -26.73 68.08 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 124.342 1.057 . . . . 73.21 109.472 -170.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.5 pp -114.42 29.66 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 126.914 2.086 . . . . 65.54 109.322 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.504 HG23 ' CE1' ' A' ' 92' ' ' PHE . 18.6 m -108.97 -53.46 2.64 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 118.029 -0.986 . . . . 63.11 108.439 168.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.426 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -52.86 -54.55 42.5 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 113.602 0.964 . . . . 21.53 113.602 -174.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.426 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 48.9 Cg_endo -73.45 -29.37 11.16 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.363 1.375 . . . . 72.5 112.032 178.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 34.0 tpp -60.45 -50.11 74.89 Favored 'General case' 0 CA--C 1.515 -0.404 0 C-N-CA 125.225 1.41 . . . . 74.51 110.936 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.504 ' CE1' HG23 ' A' ' 88' ' ' THR . 6.2 m-85 -70.13 -33.15 71.46 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.938 -0.553 . . . . 74.21 109.56 -176.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -58.17 -37.27 74.4 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.353 0.979 . . . . 71.44 109.607 168.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.31 -0.9 57.66 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.062 -1.649 . . . . 74.14 113.578 -176.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.492 HG11 ' CD1' ' A' ' 28' ' ' PHE . 54.2 t -116.76 -33.77 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.531 1.533 . . . . 71.33 109.688 -177.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -116.06 -48.38 2.74 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 124.696 1.199 . . . . 73.4 111.577 -173.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -72.66 -62.26 1.51 Allowed 'General case' 0 C--N 1.334 -0.082 0 O-C-N 121.695 -0.628 . . . . 54.2 109.49 -176.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 28.2 p -86.43 -35.83 19.47 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.318 0.508 . . . . 74.51 110.659 -178.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 66.48 23.83 10.44 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.701 2.401 . . . . 73.22 113.174 -175.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -70.33 -19.51 63.06 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.503 0.592 . . . . 74.33 112.487 -173.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.443 HG13 HG12 ' A' ' 107' ' ' ILE . 26.8 t -64.3 124.63 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 O-C-N 121.354 -0.841 . . . . 64.53 109.046 171.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -147.04 -24.77 0.4 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.499 1.52 . . . . 64.54 111.44 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.6 162.56 32.36 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.802 0.728 . . . . 63.52 109.546 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.2 t -55.45 -38.74 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.309 1.044 . . . . 44.31 110.006 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.17 -11.77 23.1 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 114.064 1.135 . . . . 64.12 114.064 178.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -94.72 -33.73 12.82 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 124.979 1.311 . . . . 63.13 110.311 175.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.474 HD11 HD13 ' A' ' 67' ' ' LEU . 2.7 mt -71.62 -37.96 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.013 -0.736 . . . . 54.11 109.013 -177.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . 33.2 ptt180 -68.62 -23.37 64.43 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.342 -0.849 . . . . 73.43 111.474 -174.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -55.4 -54.52 42.68 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.469 -0.938 . . . . 73.4 108.469 176.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 29.0 t -58.52 -38.14 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 123.853 0.861 . . . . 72.32 110.625 -174.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -53.25 -57.75 9.45 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.463 -0.569 . . . . 74.14 109.463 172.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -63.92 -41.23 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 O-C-N 121.452 -0.78 . . . . 62.54 111.142 -175.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.25 -41.38 88.63 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.127 1.371 . . . . 72.2 109.746 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.64 0.18 18.46 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.795 1.238 . . . . 62.43 112.504 175.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.04 62.46 1.43 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 124.81 1.195 . . . . 63.54 111.118 175.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.5 t -121.66 149.47 24.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 124.181 0.992 . . . . 65.53 109.28 170.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -68.48 135.88 52.32 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.196 0.522 . . . . 72.53 110.106 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.22 -30.54 71.69 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 114.868 -1.06 . . . . 63.21 110.556 171.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -74.76 -17.8 60.58 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 123.447 0.699 . . . . 70.3 111.905 -172.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.74 -51.81 5.46 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.105 -1.072 . . . . 63.53 108.105 176.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.403 ' CZ ' ' HB3' ' A' ' 108' ' ' ARG . 36.4 t80 -50.89 -53.22 34.48 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.227 1.411 . . . . 72.33 109.978 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -76.61 -10.76 59.62 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 114.239 -1.346 . . . . 74.51 113.14 -172.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.65 -57.06 2.18 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 125.408 1.483 . . . . 63.51 110.407 176.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -50.23 -40.37 47.3 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.898 2.079 . . . . 72.33 110.89 -178.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 61.3 t-105 -45.97 -42.87 13.58 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.29 1.036 . . . . 73.24 111.972 173.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -102.41 8.04 40.25 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.367 -1.458 . . . . 72.42 112.901 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 8.8 t -89.3 151.38 22.13 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 127.019 2.128 . . . . 52.4 111.773 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -60.13 -28.71 68.1 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 125.493 1.517 . . . . 74.11 111.854 174.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 66.4 t -49.33 -54.3 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 119.363 0.983 . . . . 72.51 109.777 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.639 HG13 ' HB3' ' A' ' 76' ' ' ALA . 40.0 t -69.1 -39.28 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-N 115.22 -0.9 . . . . 64.24 108.668 -176.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.4 mmpt? -55.77 -48.58 75.04 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.059 0.845 . . . . 74.44 111.078 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.42 -36.96 85.47 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.068 0.947 . . . . 51.41 110.76 -178.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 13.9 mt -71.06 -58.72 3.29 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 124.882 1.273 . . . . 70.44 110.754 178.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 53.9 t -45.47 -49.38 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 C-N-CA 125.133 1.373 . . . . 75.23 108.595 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.1 -45.19 87.63 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 117.292 -1.337 . . . . 54.41 112.708 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -51.06 -46.57 61.76 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 120.409 1.459 . . . . 63.33 111.305 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.501 HE22 ' CD1' ' A' ' 79' ' ' ILE . 43.0 mt-30 -88.54 -36.51 16.34 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.926 -1.034 . . . . 73.2 109.801 -162.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -63.56 -47.99 79.3 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.276 -1.009 . . . . 73.34 108.276 171.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 54.7 tttt -60.87 -7.7 2.57 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.675 1.19 . . . . 52.41 113.88 171.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -112.09 -18.05 12.68 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-O 117.189 -1.386 . . . . 61.33 113.728 173.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.643 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . . . -113.86 -11.68 12.81 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 121.956 2.162 . . . . 55.21 112.688 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -117.36 -8.03 11.11 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.954 1.302 . . . . 44.1 111.751 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.25 8.81 3.0 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 114.239 1.199 . . . . 64.51 114.239 -178.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 12.3 mt 76.54 57.29 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.431 2.692 . . . . 73.12 111.828 174.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.27 -84.27 0.63 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.045 -1.094 . . . . 60.41 108.045 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.502 ' HG ' ' H ' ' A' ' 148' ' ' GLY . 11.4 tp -74.68 -73.12 0.25 Allowed 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 124.63 1.172 . . . . 73.11 112.931 -171.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 70.11 2.34 3.9 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.856 2.062 . . . . 75.33 115.217 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.502 ' H ' ' HG ' ' A' ' 146' ' ' LEU . . . -145.38 134.64 5.6 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 120.737 1.608 . . . . 72.42 111.327 176.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 35.5 m -126.42 164.33 34.84 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 119.183 1.492 . . . . 72.43 111.722 -173.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.48 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 30.0 Cg_endo -66.07 156.06 80.38 Favored 'Cis proline' 0 C--N 1.352 0.723 0 CA-C-N 119.712 0.933 . . . . 64.33 112.841 -6.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.424 ' HB2' HD11 ' A' ' 146' ' ' LEU . . . -141.36 156.94 45.78 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.454 0.702 . . . . 72.34 110.473 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 43.8 tpp -156.6 110.13 2.66 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.169 -1.789 . . . . 74.42 106.169 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -100.6 155.81 17.66 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.458 0.703 . . . . 63.04 109.54 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.1 t -137.76 139.53 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.612 -1.255 . . . . 74.12 107.612 177.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 64.67 -2.63 0.64 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.806 2.043 . . . . 72.25 114.874 171.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.48 -28.1 15.7 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.752 1.644 . . . . 63.12 112.169 -173.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.418 ' HG3' ' CD2' ' A' ' 158' ' ' TYR . 0.1 OUTLIER -115.34 -6.67 12.35 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.925 1.863 . . . . 74.42 115.81 -169.501 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.418 ' CD2' ' HG3' ' A' ' 157' ' ' LYS . 72.5 m-85 -121.81 148.82 44.19 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 108.901 -0.777 . . . . 72.33 108.901 -171.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -126.88 143.5 51.25 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.402 -0.962 . . . . 64.02 108.402 169.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -66.77 138.62 57.5 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 106.585 -1.635 . . . . 72.12 106.585 172.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -119.18 85.05 29.23 Favored Pre-proline 0 N--CA 1.452 -0.336 0 N-CA-C 111.7 0.259 . . . . 63.04 111.7 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.32 -21.77 71.78 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 121.27 1.313 . . . . 52.14 112.604 173.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -67.25 -10.61 52.39 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.147 0.979 . . . . 74.45 112.011 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -129.05 37.02 2.28 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 126.186 1.851 . . . . 75.02 109.752 171.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 40.4 mtt -114.12 162.37 16.57 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 119.128 1.464 . . . . 71.24 108.122 164.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -77.02 119.85 21.31 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 113.817 -1.538 . . . . 73.42 107.406 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.6 p -125.15 35.33 4.79 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.242 2.217 . . . . 72.01 108.795 -172.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 8.6 t -99.28 -12.09 20.67 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.761 -0.587 . . . . 53.23 112.195 178.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.4 -17.15 3.0 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 118.917 -0.564 . . . . 74.43 111.375 -167.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 5.5 mmt 70.78 -50.2 0.67 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.339 1.856 . . . . 72.14 112.076 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.66 -47.73 71.6 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 120.785 -1.197 . . . . 72.25 107.922 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 78.6 t -60.18 -32.85 51.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 124.792 1.237 . . . . 74.12 110.672 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -63.29 -62.69 1.52 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 118.769 -0.634 . . . . 74.21 109.487 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.4 t -71.69 -25.18 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 119.241 0.928 . . . . 73.34 111.685 -175.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.82 -40.04 82.99 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 111.865 0.32 . . . . 74.32 111.865 172.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -75.82 -21.21 57.53 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 118.042 -0.98 . . . . 72.44 113.147 171.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -67.95 -81.05 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 117.008 -1.472 . . . . 73.35 114.642 174.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' A' ' 45' ' ' ASN 0.359 . . -44.85 -18.4 0.02 OUTLIER 'General case' 0 CA--C 1.598 2.799 0 C-N-CA 126.672 1.989 . . . . 52.54 109.241 176.491 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -79.27 -63.98 1.29 Allowed 'General case' 0 C--N 1.382 1.98 0 C-N-CA 128.073 2.549 . . . . 65.45 113.533 169.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.42 ' OG1' HG21 ' A' ' 3' ' ' ILE . 13.2 t -59.01 -30.31 67.9 Favored 'General case' 0 C--N 1.347 0.488 0 CA-C-O 116.915 -1.517 . . . . 72.31 110.047 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 39.9 t -56.72 -44.23 81.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 120.462 1.483 . . . . 63.44 109.139 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 6.3 ptmt -75.15 -33.32 61.5 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-O 118.268 -0.872 . . . . 61.21 112.208 -177.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -62.36 -37.58 86.23 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 120.404 1.456 . . . . 54.51 112.035 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 77.1 mt -67.41 -20.61 65.55 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 119.069 -1.052 . . . . 72.23 111.808 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.03 -23.79 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 O-C-N 121.694 -0.629 . . . . 74.44 110.521 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -106.37 -2.49 22.14 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.364 0.983 . . . . 73.32 111.146 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -123.45 78.09 1.56 Allowed 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.862 1.265 . . . . 73.22 109.971 -176.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.95 0 CA-C-O 115.702 -2.094 . . . . 74.13 107.176 166.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 113.131 0.789 . . . . 74.13 113.131 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -161.84 119.53 2.22 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 127.16 2.184 . . . . 73.13 105.302 166.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.2 pt -124.45 143.15 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 126.108 1.763 . . . . 73.42 106.546 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.6 m -118.07 139.1 51.71 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.416 -1.328 . . . . 73.34 107.416 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -53.13 118.04 3.46 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.31 2.244 . . . . 70.2 108.724 164.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.27 -6.17 65.85 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 118.22 -1.322 . . . . 73.42 113.346 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.7 tptp -103.66 -85.33 0.46 Allowed 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 119.253 1.527 . . . . 65.13 107.304 177.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -89.45 -20.55 23.76 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 124.219 1.008 . . . . 71.01 110.777 -170.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -140.66 163.81 31.87 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.93 -0.767 . . . . 73.04 108.93 175.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.619 HD11 ' CG ' ' A' ' 161' ' ' ASN . 5.4 mm -127.84 159.72 38.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 106.006 -1.85 . . . . 70.02 106.006 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.6 m -90.53 154.25 19.75 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.498 -1.668 . . . . 74.1 106.498 168.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.8 mt -67.22 152.8 45.08 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.117 -1.068 . . . . 54.53 108.117 163.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -73.64 -28.13 61.62 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.67 -0.493 . . . . 65.34 109.67 171.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -126.37 72.98 72.97 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 126.13 1.772 . . . . 73.03 109.756 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo . . . . . 0 N--CA 1.454 -0.851 0 C-N-CA 124.287 3.325 . . . . 70.12 110.869 177.647 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.434 HG22 ' OG1' ' A' ' 57' ' ' THR . 1.8 p . . . . . 0 N--CA 1.448 -0.564 0 N-CA-C 108.129 -1.063 . . . . 70.33 108.129 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.1 tp -161.19 159.04 28.37 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.588 0.708 . . . . 44.12 112.462 172.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -139.83 150.38 44.61 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 127.567 2.347 . . . . 71.23 106.48 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -135.42 133.07 38.25 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.644 1.578 . . . . 72.03 108.536 173.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -156.6 -176.78 6.16 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.477 1.511 . . . . 65.02 110.858 177.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.1 t -135.38 176.43 8.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.665 1.586 . . . . 53.13 109.032 174.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.843 ' CD1' HD11 ' A' ' 71' ' ' LEU 0.278 0.0 OUTLIER -89.46 -7.5 54.92 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.976 1.102 . . . . 73.42 113.976 164.729 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.424 ' CE2' ' HA3' ' A' ' 65' ' ' GLY . 51.4 m-85 -103.24 0.72 32.0 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 120.146 1.339 . . . . 73.23 112.728 173.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.2 p -78.04 140.57 62.09 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 121.437 1.926 . . . . 74.12 108.857 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -91.45 -25.77 0.3 Allowed 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 120.869 1.046 . . . . 70.1 112.668 -176.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -57.77 -57.39 12.96 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 119.022 0.828 . . . . 73.04 109.813 166.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 24.9 p -65.02 -23.73 67.29 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.448 -0.796 . . . . 73.43 111.648 -170.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -58.07 -54.47 46.54 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 118.883 0.765 . . . . 72.32 110.534 169.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.71 -45.81 77.81 Favored 'General case' 0 C--O 1.221 -0.423 0 N-CA-C 107.894 -1.15 . . . . 52.31 107.894 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.421 ' CD2' HG21 ' A' ' 42' ' ' VAL . 4.3 m-85 -66.26 -10.45 42.34 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 115.647 -2.121 . . . . 63.13 113.858 -176.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -132.19 -2.45 3.55 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 122.044 2.202 . . . . 72.04 112.445 -173.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -133.04 -20.23 2.19 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.432 1.093 . . . . 54.41 112.426 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.0 t -121.35 -76.2 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 107.183 -1.414 . . . . 72.1 107.183 -173.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.1 mt -73.99 -18.2 60.9 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.116 2.166 . . . . 70.01 113.022 -177.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 54.5 m-70 43.75 53.87 5.86 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.291 1.836 . . . . 73.41 112.818 172.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 46' ' ' VAL . 86.1 t -62.68 -51.23 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 116.997 -1.478 . . . . 74.22 109.895 -172.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.1 t -45.41 -52.35 10.16 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.061 1.345 . . . . 65.43 110.143 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -63.77 -40.1 95.86 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.246 1.018 . . . . 61.31 110.691 -177.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.81 -35.33 74.74 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.542 1.137 . . . . 63.33 113.156 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 42' ' ' VAL . 1.9 t -67.53 -50.33 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 106.682 -1.599 . . . . 70.41 106.682 174.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 38.3 ttt-85 -47.47 -46.9 27.31 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.413 1.085 . . . . 63.13 111.608 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -60.31 -13.57 13.63 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.185 1.18 . . . . 74.0 114.185 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -118.37 -8.83 10.49 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.548 1.939 . . . . 64.23 111.507 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.61 ' HB3' HG21 ' A' ' 54' ' ' THR . 11.8 mt -76.16 143.83 74.17 Favored Pre-proline 0 C--O 1.237 0.401 0 CA-C-N 119.41 1.005 . . . . 62.03 109.579 -169.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.42 ' O ' HG22 ' A' ' 54' ' ' THR . 83.6 Cg_endo -80.01 167.35 20.13 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.043 1.829 . . . . 73.14 111.142 -176.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -73.14 68.4 0.98 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.375 1.07 . . . . 64.31 112.176 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.46 -7.06 0.05 OUTLIER Glycine 0 CA--C 1.524 0.635 0 O-C-N 119.748 -1.845 . . . . 65.2 114.773 176.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.61 HG21 ' HB3' ' A' ' 50' ' ' LEU . 0.7 OUTLIER -58.47 -45.08 89.34 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.042 1.421 . . . . 72.02 110.998 175.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . 0.294 19.0 ttpt 56.91 151.4 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.79 2.036 . . . . 73.04 111.725 -162.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.42 113.09 16.4 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 120.037 -1.664 . . . . 63.04 107.773 -167.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.434 ' OG1' HG22 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -115.92 -177.69 3.22 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.882 1.673 . . . . 65.2 109.347 -174.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -179.23 87.04 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 106.737 -1.579 . . . . 64.31 106.737 -170.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 -95.22 162.74 13.57 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.41 -0.806 . . . . 73.43 109.967 174.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.467 ' CE1' ' HB2' ' A' ' 137' ' ' GLN . 0.1 OUTLIER -100.15 174.39 6.18 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.779 2.031 . . . . 64.31 110.615 -176.724 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.5 m -135.07 145.86 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 120.418 1.463 . . . . 54.51 110.534 164.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -82.42 29.6 0.43 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.468 1.107 . . . . 70.3 111.396 -178.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -134.68 165.91 24.15 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.851 1.66 . . . . 61.13 107.652 -172.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.6 mt 75.79 128.61 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 127.007 2.123 . . . . 65.03 109.766 -172.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.424 ' HA3' ' CE2' ' A' ' 29' ' ' TYR . . . 66.72 171.31 4.46 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 121.944 0.747 . . . . 54.54 112.55 175.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.02 -40.99 1.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 123.069 2.513 . . . . 74.22 112.62 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.4 mt -81.88 16.6 1.79 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.248 1.419 . . . . 74.3 112.356 -174.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.19 -34.64 58.97 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 117.742 -1.588 . . . . 52.32 113.607 -173.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.2 -35.7 55.45 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 120.473 2.136 . . . . 71.33 110.28 176.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.37 -37.96 86.47 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 120.976 -1.078 . . . . 64.22 108.703 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.843 HD11 ' CD1' ' A' ' 28' ' ' PHE . 22.4 mt -53.91 -45.04 71.04 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 123.82 0.848 . . . . 73.5 111.093 169.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.464 HG23 ' CE1' ' A' ' 60' ' ' HIS . 2.6 m -57.12 -51.07 70.76 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 124.348 1.03 . . . . 73.22 109.314 -177.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -63.22 -49.11 75.46 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 118.587 -0.721 . . . . 72.32 109.919 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.22 -37.87 75.68 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 120.416 1.462 . . . . 65.44 114.363 -177.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.454 ' CD1' HD11 ' A' ' 79' ' ' ILE . 10.6 t-105 -61.09 -37.77 83.88 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.633 0.652 . . . . 65.11 111.371 -172.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.72 -34.68 71.62 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 117.832 -1.08 . . . . 71.22 112.373 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.09 -46.76 84.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 120.198 1.363 . . . . 72.21 109.779 171.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.23 -43.28 82.37 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 118.81 -0.614 . . . . 72.12 111.068 -177.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.454 HD11 ' CD1' ' A' ' 75' ' ' TRP . 75.0 mt -60.23 -41.9 88.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.145 0.978 . . . . 74.24 109.784 176.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.94 -48.23 81.33 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.885 0.474 . . . . 70.42 110.175 -173.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 81' ' ' LEU . 71.7 mt -76.66 -20.89 56.16 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 121.825 -0.547 . . . . 54.22 112.347 174.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.57 70.55 1.13 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 126.937 2.208 . . . . 41.13 110.097 -173.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.6 m -134.18 15.64 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 125.157 1.383 . . . . 70.24 112.804 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -52.43 -48.65 65.65 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.316 1.046 . . . . 74.2 110.66 -178.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.48 -7.93 16.75 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.948 1.699 . . . . 70.51 113.304 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -104.21 -19.92 13.97 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 125.124 1.37 . . . . 72.22 111.283 176.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.6 pp -124.04 28.53 2.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 C-N-CA 125.838 1.655 . . . . 70.4 110.416 -172.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 43.1 m -93.96 -51.15 4.99 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.742 -0.836 . . . . 65.1 108.742 165.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.504 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -57.66 -65.81 1.62 Allowed Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 124.007 0.923 . . . . 71.44 112.006 -171.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 52.3 Cg_endo -66.13 -26.28 50.16 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 121.161 1.241 . . . . 72.21 111.556 -174.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 24.0 tpp -61.76 -50.21 73.29 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.691 -0.855 . . . . 74.53 108.691 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -67.88 -35.13 77.98 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 123.974 0.91 . . . . 70.21 109.685 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -56.47 -45.31 80.97 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.599 0.636 . . . . 65.5 109.615 171.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.28 -1.76 42.24 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 120.727 -1.233 . . . . 64.1 112.993 -174.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.756 HG21 ' CD2' ' A' ' 28' ' ' PHE . 61.2 t -119.26 -33.74 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 C-N-CA 124.614 1.165 . . . . 73.03 110.949 -174.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -113.79 -52.92 2.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.105 1.362 . . . . 74.13 108.725 -173.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -71.99 -51.97 19.33 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 118.027 0.376 . . . . 74.32 110.338 -173.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.8 p -100.89 -27.04 13.53 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.056 0.942 . . . . 63.13 112.531 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 52.28 32.98 11.76 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.646 2.379 . . . . 71.04 114.979 -177.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 t -74.26 -21.02 59.95 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.749 0.82 . . . . 74.12 112.199 178.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.402 HG13 HG12 ' A' ' 107' ' ' ILE . 25.4 t -65.28 122.97 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 O-C-N 121.568 -0.708 . . . . 72.23 109.197 170.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -149.4 -19.99 0.28 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 114.068 -1.424 . . . . 74.43 111.63 -178.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.04 165.88 24.66 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.152 0.981 . . . . 71.34 109.64 173.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 39.1 t -57.57 -42.18 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.744 1.217 . . . . 43.43 108.388 175.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.02 13.89 0.05 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 128.809 2.843 . . . . 73.54 113.155 174.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -115.47 -48.68 2.78 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.42 1.488 . . . . 63.54 109.196 163.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.402 HG12 HG13 ' A' ' 101' ' ' VAL . 2.4 mt -52.66 -45.2 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.99 1.316 . . . . 64.13 110.907 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -22.36 65.72 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.651 0.982 . . . . 74.2 113.651 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -56.05 -56.02 25.9 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.981 1.264 . . . . 73.54 110.11 171.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 39.7 t -62.45 -34.55 65.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.83 -0.623 . . . . 71.13 110.789 -171.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -53.19 -58.6 6.5 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.716 -0.846 . . . . 73.24 108.716 171.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.1 t -65.71 -37.51 80.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 119.364 -0.35 . . . . 70.22 111.124 -173.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -60.84 -48.4 82.0 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.679 -0.86 . . . . 73.1 108.679 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.82 -0.39 7.11 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.612 1.565 . . . . 53.2 112.565 177.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.27 58.58 1.14 Allowed Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 124.428 1.013 . . . . 22.44 111.846 172.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.3 t -118.54 149.27 21.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 124.143 0.977 . . . . 70.23 109.832 169.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt -67.34 120.5 13.95 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.413 1.085 . . . . 74.44 110.49 168.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.68 -31.04 78.67 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-O 118.37 -1.239 . . . . 72.42 111.239 170.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -66.72 -36.58 82.82 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.846 1.323 . . . . 74.42 110.194 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -73.32 -42.49 62.28 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 106.766 -1.568 . . . . 65.34 106.766 -174.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -58.45 -55.43 35.07 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.996 0.903 . . . . 74.53 109.202 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -70.27 -12.61 61.71 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.004 0.922 . . . . 45.3 112.856 -173.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.98 -64.91 1.01 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.23 1.412 . . . . 34.24 109.946 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.64 -36.56 64.68 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.652 1.581 . . . . 45.02 111.491 -170.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 44.0 t-105 -45.14 -45.9 11.64 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.998 1.319 . . . . 73.5 112.067 176.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -102.35 11.22 38.4 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.206 1.402 . . . . 72.41 112.144 -177.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 7.0 t -99.27 163.79 12.4 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.281 1.832 . . . . 75.3 111.527 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -60.72 -28.31 68.58 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 128.177 2.591 . . . . 71.4 112.553 173.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 23.6 t -50.99 -53.28 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 122.78 1.276 . . . . 53.22 109.256 177.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.3 t -70.04 -32.51 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 114.923 -1.035 . . . . 74.22 110.624 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -56.47 -59.35 5.11 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.896 1.225 . . . . 74.5 110.045 176.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.0 m -68.45 -20.3 64.62 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.995 0.739 . . . . 63.21 112.995 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 26.2 mt -87.98 -33.48 18.39 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 113.642 0.979 . . . . 73.3 113.642 177.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 41.4 t -59.13 -52.77 56.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 107.064 -1.458 . . . . 65.52 107.064 165.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -46.67 -51.41 16.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.679 1.592 . . . . 61.12 112.893 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -58.04 -28.94 64.94 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.129 0.49 . . . . 75.12 112.017 -169.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.467 ' HB2' ' CE1' ' A' ' 60' ' ' HIS . 49.9 mt-30 -97.09 -47.56 5.73 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 128.095 2.558 . . . . 65.43 111.753 -176.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -62.89 -38.7 91.93 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 118.537 0.608 . . . . 74.0 109.653 -177.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -51.36 -45.7 62.48 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.486 1.114 . . . . 54.34 110.272 172.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.11 -52.97 35.29 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 124.392 1.058 . . . . 54.52 109.677 -175.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.29 -43.16 70.84 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.913 0.485 . . . . 34.43 111.42 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.16 7.51 9.15 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.218 1.807 . . . . 64.2 112.686 -177.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -86.18 -8.75 57.59 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.175 -0.953 . . . . 70.3 111.431 169.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 11.9 mt 68.43 58.53 0.42 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.921 1.344 . . . . 72.4 110.908 160.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.448 ' NE2' ' H ' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -144.38 -34.86 0.36 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.646 1.178 . . . . 51.52 112.094 -173.337 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.448 ' H ' ' NE2' ' A' ' 145' ' ' GLN . 2.3 tp -79.12 -85.09 0.08 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 125.437 1.495 . . . . 72.23 109.244 178.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 51.03 37.49 17.97 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.445 1.098 . . . . 73.11 111.852 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.63 132.77 3.29 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 107.803 -2.119 . . . . 65.13 107.803 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.465 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 1.4 m -138.13 160.45 64.17 Favored Pre-proline 0 C--O 1.241 0.632 0 N-CA-C 108.509 -0.923 . . . . 63.22 108.509 171.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.465 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 63.8 Cg_endo -74.21 142.52 75.0 Favored 'Cis proline' 0 N--CA 1.46 -0.494 0 C-N-CA 125.356 -0.685 . . . . 52.42 111.975 -10.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -126.25 138.7 53.64 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 125.516 1.526 . . . . 44.31 108.621 -175.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 34.5 mtp -140.12 108.61 5.87 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 106.471 -1.677 . . . . 73.14 106.471 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -81.36 173.04 12.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.857 -0.61 . . . . 72.34 110.232 -175.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.528 HG11 ' HB2' ' A' ' 184' ' ' LEU . 59.3 t -133.36 -86.05 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 CA-C-O 119.034 -0.508 . . . . 73.4 110.47 160.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -84.57 30.86 0.54 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.859 1.209 . . . . 72.3 110.379 -167.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 68.53 -68.0 0.4 Allowed Glycine 0 C--O 1.22 -0.74 0 C-N-CA 127.882 2.658 . . . . 43.1 109.201 -164.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.433 ' HE2' ' CZ ' ' A' ' 158' ' ' TYR . 36.5 pttt -60.44 -0.7 0.27 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 115.432 1.641 . . . . 70.22 115.432 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.433 ' CZ ' ' HE2' ' A' ' 157' ' ' LYS . 18.0 m-85 -121.68 139.31 53.72 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 120.473 1.488 . . . . 65.12 111.972 -177.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -118.86 132.36 56.1 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.471 2.308 . . . . 71.2 106.378 174.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -67.95 143.76 55.49 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.598 -0.89 . . . . 70.42 108.598 175.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . 0.619 ' CG ' HD11 ' A' ' 10' ' ' ILE . 17.5 t30 -117.56 83.92 18.14 Favored Pre-proline 0 C--O 1.236 0.385 0 N-CA-C 112.406 0.521 . . . . 63.34 112.406 -174.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -62.92 -28.87 75.55 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 120.297 0.665 . . . . 71.02 112.102 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -64.16 -7.25 8.43 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 116.756 2.132 . . . . 64.21 116.756 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -107.69 -3.88 34.52 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-N 119.733 1.151 . . . . 44.44 113.776 170.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.1 mtt -85.82 166.37 16.09 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 119.952 1.876 . . . . 63.44 109.399 -174.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -79.32 65.83 4.61 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 122.674 1.226 . . . . 62.42 111.25 -172.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 41.6 p -67.04 3.57 1.09 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.59 1.956 . . . . 64.0 112.654 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 6.1 t -73.22 -18.63 61.22 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 119.799 1.182 . . . . 72.0 111.827 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.85 -11.74 8.11 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 117.557 -1.211 . . . . 72.2 114.043 -170.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 3.6 mmt 68.98 -63.36 0.37 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.483 1.913 . . . . 73.41 111.809 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.27 -31.07 71.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.767 1.27 . . . . 73.2 110.389 -170.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.424 HG12 HE21 ' A' ' 176' ' ' GLN . 76.0 t -75.71 -33.47 26.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 124.546 1.138 . . . . 53.44 111.133 173.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -60.27 -56.88 16.13 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.614 -0.884 . . . . 72.4 108.614 -176.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.0 t -65.01 -35.47 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 109.981 -0.377 . . . . 43.52 109.981 -175.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.09 -27.34 68.29 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.2 1.0 . . . . 74.01 112.301 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.424 HE21 HG12 ' A' ' 172' ' ' VAL . 66.6 mt-30 -93.92 -33.34 13.53 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.148 0.885 . . . . 72.2 112.105 171.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -56.34 -58.05 9.67 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 124.214 1.006 . . . . 72.22 110.277 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.01 -22.27 62.37 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.162 0.585 . . . . 72.04 112.433 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -70.97 -61.65 1.69 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.446 1.098 . . . . 71.22 109.54 178.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.1 t -61.71 -21.11 64.21 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 118.026 -0.988 . . . . 73.22 112.262 -174.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 57.3 t -56.58 -57.14 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 119.364 0.984 . . . . 74.12 108.667 169.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -56.8 -43.93 81.43 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.771 0.828 . . . . 71.13 109.578 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -61.55 -34.03 74.87 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 123.3 0.64 . . . . 65.11 111.318 -171.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.528 ' HB2' HG11 ' A' ' 154' ' ' VAL . 58.4 mt -79.78 -21.89 43.82 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 121.322 -0.861 . . . . 74.2 112.687 -178.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 72.3 t -61.46 -31.38 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 108.78 -0.822 . . . . 44.33 108.78 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -98.04 -14.53 20.47 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.14 0.976 . . . . 70.44 111.149 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -112.52 63.75 0.63 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.695 1.198 . . . . 73.11 111.198 -174.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt . . . . . 0 C--O 1.248 0.987 0 CA-C-O 119.094 -0.479 . . . . 72.04 110.098 160.605 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.394 0 N-CA-C 115.161 1.541 . . . . 51.43 115.161 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -161.57 117.32 2.09 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 107.097 -1.446 . . . . 73.25 107.097 -173.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.4 pt -126.41 150.84 32.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 126.174 1.79 . . . . 65.14 109.671 -172.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.9 m -132.14 133.93 44.84 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 105.965 -1.865 . . . . 74.25 105.965 176.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -59.85 144.14 49.45 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.49 1.516 . . . . 73.25 108.913 169.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.9 4.89 73.27 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 118.363 -1.243 . . . . 51.21 112.662 -174.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -129.28 -70.07 0.67 Allowed 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 119.308 1.554 . . . . 71.23 113.497 -176.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -101.17 -27.52 13.18 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.161 -0.681 . . . . 71.24 109.161 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -132.46 170.89 14.49 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 122.563 0.345 . . . . 75.25 110.505 171.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.72 147.82 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 105.535 -2.024 . . . . 61.14 105.535 177.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.09 169.89 17.2 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.733 -1.21 . . . . 73.03 107.733 163.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 36.2 mt -110.26 150.15 29.13 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.795 -1.557 . . . . 63.35 106.795 168.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -75.83 -30.96 59.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.101 0.477 . . . . 75.34 111.216 -174.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.5 mmmt -126.84 76.51 75.25 Favored Pre-proline 0 N--CA 1.464 0.245 0 C-N-CA 124.298 1.039 . . . . 74.05 108.535 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo . . . . . 0 N--CA 1.453 -0.867 0 C-N-CA 124.14 3.227 . . . . 64.33 111.157 -175.997 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.274 1.4 p . . . . . 0 CA--C 1.539 0.544 0 N-CA-C 115.387 1.625 . . . . 74.12 115.387 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.447 HD11 ' CE2' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -160.17 165.37 31.73 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 120.625 -1.297 . . . . 65.12 110.738 -172.542 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.419 ' H ' ' HG ' ' A' ' 23' ' ' LEU . 2.2 mp0 -137.14 132.85 34.58 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 126.007 1.723 . . . . 73.23 107.48 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.427 ' CD2' HD13 ' A' ' 146' ' ' LEU . 3.4 m-85 -127.41 139.02 53.11 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.466 1.506 . . . . 73.33 109.393 -176.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.67 173.13 11.82 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.354 1.462 . . . . 63.0 109.283 -174.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.75 179.47 6.4 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.404 -0.591 . . . . 63.12 109.404 161.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.503 ' HB2' HD13 ' A' ' 71' ' ' LEU . 32.4 m-85 -100.69 -17.15 17.12 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 123.733 0.813 . . . . 75.23 111.714 -173.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.433 ' CD1' ' HA3' ' A' ' 65' ' ' GLY . 64.3 m-85 -111.87 8.12 20.31 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 127.547 2.339 . . . . 75.12 111.854 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.9 p -88.47 144.5 33.85 Favored Pre-proline 0 N--CA 1.468 0.455 0 O-C-N 120.237 -1.54 . . . . 64.22 111.561 -176.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -73.38 -50.2 0.19 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.708 2.272 . . . . 75.11 112.371 -168.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -56.11 -35.52 67.16 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.239 0.616 . . . . 71.03 110.4 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.9 m -63.26 -32.72 74.2 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 124.184 0.994 . . . . 73.41 111.557 -174.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -57.27 -61.96 2.1 Favored 'General case' 0 C--O 1.216 -0.701 0 C-N-CA 123.535 0.734 . . . . 75.03 110.784 172.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.75 ' HA ' HE21 ' A' ' 35' ' ' GLN . 0.0 OUTLIER -47.45 -53.12 14.99 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 120.263 -1.523 . . . . 73.41 110.633 173.198 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -65.5 -13.74 59.51 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 116.015 -1.945 . . . . 62.21 110.908 -163.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.425 ' HG2' HG21 ' A' ' 88' ' ' THR . 1.4 tp10 -141.11 20.21 2.27 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.667 1.576 . . . . 63.23 113.53 -177.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.425 ' OE2' ' HA ' ' A' ' 89' ' ' ALA . 26.0 mm-40 -142.26 -28.86 0.6 Allowed 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.222 1.009 . . . . 71.04 113.163 177.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.0 t -116.18 -44.02 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 105.796 -1.927 . . . . 73.21 105.796 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.661 HD13 ' HB3' ' A' ' 35' ' ' GLN . 4.4 mp -96.1 -32.89 12.3 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.431 1.892 . . . . 62.2 112.326 -170.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 44.11 60.65 2.67 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.49 1.116 . . . . 72.31 112.272 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.71 -35.52 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 124.651 1.18 . . . . 64.42 109.163 -175.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.4 t -57.82 -51.25 70.35 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.8 1.182 . . . . 74.44 108.794 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -66.1 -47.28 74.72 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 124.494 1.117 . . . . 73.43 110.53 -177.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -58.26 -56.19 25.32 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 125.157 1.383 . . . . 72.13 111.579 -178.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.545 HG12 ' HG ' ' A' ' 50' ' ' LEU . 19.7 t -67.45 -42.14 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.529 -1.286 . . . . 51.23 107.529 -175.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 61.9 ttt-85 -51.27 -43.26 61.54 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.008 1.276 . . . . 65.4 111.865 174.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -61.71 -13.17 20.64 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.689 1.596 . . . . 74.34 114.778 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -120.58 -11.48 9.06 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.035 1.334 . . . . 71.2 112.912 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.545 ' HG ' HG12 ' A' ' 46' ' ' VAL . 7.7 mt -69.25 143.91 94.34 Favored Pre-proline 0 C--O 1.239 0.529 0 CA-C-N 119.224 0.92 . . . . 73.22 108.921 -163.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.69 145.98 33.44 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.937 2.424 . . . . 62.32 110.565 176.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.58 76.1 6.21 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.489 -1.232 . . . . 65.45 109.346 -168.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 166.49 -17.41 0.09 OUTLIER Glycine 0 CA--C 1.525 0.676 0 CA-C-O 117.769 -1.573 . . . . 65.42 112.255 -172.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.473 HG21 HD13 ' A' ' 50' ' ' LEU . 8.0 t -45.18 -46.06 11.9 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.372 1.586 . . . . 73.43 113.742 174.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.8 tptt 66.23 147.15 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.942 2.897 . . . . 62.15 112.964 -149.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 3.2 mtm -135.08 137.61 43.04 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 127.159 2.184 . . . . 64.13 108.378 175.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.8 m -146.82 168.15 22.12 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.006 1.323 . . . . 71.04 108.714 -177.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.93 106.74 3.07 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.289 -1.507 . . . . 74.44 109.366 -177.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.447 ' CE2' HD11 ' A' ' 23' ' ' LEU . 9.9 m-30 -112.23 169.48 8.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.194 1.398 . . . . 73.31 111.886 -176.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.691 ' CE1' HG23 ' A' ' 72' ' ' THR . 0.5 OUTLIER -114.82 173.29 6.55 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.04 1.736 . . . . 75.33 109.686 -177.099 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.3 m -136.78 169.77 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 119.692 1.133 . . . . 62.0 109.591 163.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -125.37 65.0 1.16 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.794 1.637 . . . . 71.04 109.806 -174.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -146.7 -13.29 0.44 Allowed 'General case' 0 C--N 1.328 -0.362 0 O-C-N 120.733 -1.23 . . . . 74.04 113.168 -168.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mt -128.24 125.45 38.96 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 119.972 1.26 . . . . 75.43 108.904 -176.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' A' ' 29' ' ' TYR . . . 89.06 158.08 33.72 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.442 1.496 . . . . 60.12 110.647 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -64.69 -48.57 3.98 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.415 2.077 . . . . 54.33 110.274 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.715 HD13 HD11 ' A' ' 107' ' ' ILE . 5.1 mt -74.36 10.39 1.31 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.471 1.285 . . . . 75.34 114.471 -175.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.23 -2.46 0.41 Allowed Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.176 1.369 . . . . 73.41 115.751 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -90.87 -42.33 10.68 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 120.172 1.986 . . . . 64.3 112.383 169.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -60.92 -54.73 41.45 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 118.595 0.634 . . . . 72.23 109.826 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.503 HD13 ' HB2' ' A' ' 28' ' ' PHE . 86.3 mt -55.63 -37.68 68.51 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 124.989 1.43 . . . . 62.03 111.682 -164.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.691 HG23 ' CE1' ' A' ' 60' ' ' HIS . 52.3 m -55.74 -49.58 72.68 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 129.506 3.122 . . . . 71.31 110.716 174.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -65.42 -54.73 24.32 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.466 -0.771 . . . . 70.32 109.248 174.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.8 -36.6 48.36 Favored 'General case' 0 C--O 1.227 -0.097 0 N-CA-C 114.042 1.127 . . . . 64.41 114.042 -177.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.469 ' CD1' HD11 ' A' ' 79' ' ' ILE . 35.7 t-105 -50.3 -41.43 50.91 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.058 1.343 . . . . 73.42 110.394 176.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.66 -36.57 83.3 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 117.628 -1.177 . . . . 72.23 113.314 179.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.1 t -54.69 -49.28 69.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 120.324 1.42 . . . . 62.21 109.475 169.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.55 -46.2 89.46 Favored 'General case' 0 C--N 1.342 0.242 0 O-C-N 122.007 -0.433 . . . . 65.01 110.495 -175.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.469 HD11 ' CD1' ' A' ' 75' ' ' TRP . 79.4 mt -62.43 -39.52 84.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 123.603 0.761 . . . . 65.44 110.153 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.62 -45.03 85.9 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.076 0.853 . . . . 64.12 110.135 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 89.5 mt -86.96 -11.6 50.09 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 112.945 0.72 . . . . 70.31 112.945 -177.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.77 60.89 6.73 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 126.326 1.917 . . . . 62.12 112.184 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.8 m -134.84 11.74 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.134 0 C-N-CA 125.045 1.338 . . . . 62.44 113.097 -174.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -44.42 -60.71 1.82 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.751 1.62 . . . . 73.03 109.911 175.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.8 -8.06 0.54 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.934 2.093 . . . . 72.23 114.183 176.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -108.2 -29.03 9.14 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.536 1.516 . . . . 74.44 112.311 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.9 pp -100.31 -14.07 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 C-N-CA 123.884 0.874 . . . . 72.23 111.619 -175.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.482 HG23 ' HE2' ' A' ' 92' ' ' PHE 0.25 3.2 m -63.31 -41.82 98.98 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 116.868 -1.539 . . . . 74.02 112.319 -179.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.585 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -50.76 -64.47 1.31 Allowed Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.477 1.111 . . . . 72.03 112.09 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 48.2 Cg_endo -68.07 -20.46 44.18 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 120.508 0.805 . . . . 73.0 112.387 -177.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 6.1 tpp -59.98 -55.17 37.37 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 126.539 1.935 . . . . 72.23 110.576 174.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.482 ' HE2' HG23 ' A' ' 88' ' ' THR . 41.8 m-85 -69.84 -32.02 70.2 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 121.348 -0.845 . . . . 74.42 110.96 -177.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.493 ' HA ' ' HB2' ' A' ' 97' ' ' LYS . 1.8 tt0 -60.97 -36.97 80.8 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 117.915 -1.514 . . . . 74.12 108.887 169.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.455 ' HB1' HG23 ' A' ' 101' ' ' VAL . . . -81.17 -15.12 56.68 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 120.376 -1.453 . . . . 61.21 112.408 -171.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 99.1 t -116.91 -22.73 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 125.232 1.413 . . . . 60.41 111.635 -171.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -120.55 -50.89 2.19 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.772 1.169 . . . . 74.01 110.582 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.519 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 1.7 mmpt? -72.44 -40.89 66.72 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 113.696 0.999 . . . . 74.31 113.696 -171.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.4 p -112.3 -34.98 5.74 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 124.809 1.318 . . . . 64.43 111.221 178.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 57.62 23.65 9.59 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.662 1.985 . . . . 74.22 113.308 -171.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -66.79 -13.42 61.46 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.927 0.785 . . . . 63.22 112.22 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.509 HG13 HG12 ' A' ' 107' ' ' ILE . 27.7 t -64.47 108.73 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 108.44 -0.948 . . . . 74.33 108.44 169.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -135.11 -26.96 1.26 Allowed 'General case' 0 C--O 1.237 0.399 0 CA-C-O 118.558 -0.734 . . . . 73.23 112.618 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.5 m -131.63 169.94 15.46 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 108.63 -0.878 . . . . 41.13 108.63 169.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 87.8 t -55.92 -36.1 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.019 0.928 . . . . 75.13 110.411 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.81 -16.38 16.81 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.504 1.522 . . . . 74.23 114.053 175.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -91.21 -35.12 14.69 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 119.335 0.97 . . . . 42.43 110.142 175.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.715 HD11 HD13 ' A' ' 67' ' ' LEU . 1.2 mt -78.84 -36.79 19.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 121.256 -0.902 . . . . 64.0 109.394 -169.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -54.39 -36.13 63.58 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-O 117.96 -1.019 . . . . 72.42 111.598 169.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -58.43 -51.63 69.01 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 118.853 0.752 . . . . 73.31 109.475 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 18.8 t -49.69 -48.12 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.427 1.091 . . . . 65.4 110.901 -177.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -55.07 -51.85 65.06 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.442 0.697 . . . . 73.1 110.369 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.2 t -69.94 -32.0 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 CA-C-O 119.098 -0.477 . . . . 74.2 110.205 -175.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -65.91 -41.57 91.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 118.593 0.633 . . . . 70.04 110.712 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.33 -43.86 92.67 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.538 -0.542 . . . . 73.42 109.538 171.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 144.35 3.94 0.7 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.519 1.057 . . . . 53.24 114.869 168.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 65.9 t -62.66 136.6 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 118.763 1.282 . . . . 54.51 108.836 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.4 mtmt -62.32 125.0 22.39 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.443 -0.947 . . . . 73.13 108.443 176.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.71 -27.08 69.34 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-O 118.83 -0.983 . . . . 73.44 111.301 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -70.65 -26.46 63.47 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 118.134 0.967 . . . . 71.23 112.373 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -87.42 -38.65 15.94 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.667 1.987 . . . . 73.13 107.565 -168.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -60.05 -56.05 26.39 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.482 1.513 . . . . 74.22 109.148 166.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -72.04 -8.01 52.11 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.139 0.792 . . . . 45.42 113.139 -173.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -85.89 -61.83 1.66 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.529 1.132 . . . . 71.33 109.598 164.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.09 -37.83 67.31 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 123.435 0.694 . . . . 63.11 112.636 -172.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -49.64 -38.66 33.17 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.097 0.959 . . . . 72.34 111.658 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.56 -11.15 40.91 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 120.487 -1.383 . . . . 73.23 113.965 177.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.7 t -77.07 155.22 32.63 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 126.835 2.054 . . . . 63.2 112.263 -169.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -66.29 -26.17 67.2 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.582 1.553 . . . . 72.34 111.274 175.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 68.0 t -50.04 -52.78 13.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 124.142 0.977 . . . . 63.4 109.19 172.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.2 t -69.45 -42.75 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 C-N-CA 123.383 0.673 . . . . 65.34 110.084 -177.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -51.44 -52.53 45.51 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.172 0.896 . . . . 54.41 111.256 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 36.1 t -63.22 -42.68 99.3 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 123.337 0.655 . . . . 43.1 109.714 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.0 mt -60.35 -52.07 66.84 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-O 118.256 -0.878 . . . . 54.3 109.957 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 95.1 t -51.13 -44.18 28.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 118.964 0.802 . . . . 71.0 108.953 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.41 -28.97 70.34 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 114.282 1.216 . . . . 64.02 114.282 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -63.42 -47.67 81.0 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 121.146 -0.971 . . . . 74.3 110.352 177.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.409 ' HG3' ' CD2' ' A' ' 59' ' ' TYR . 3.0 mp0 -78.52 -41.11 33.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 124.189 0.931 . . . . 73.12 110.95 -178.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -54.43 -46.78 73.3 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.385 0.993 . . . . 74.11 108.603 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -63.0 -45.87 90.37 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.517 0.727 . . . . 73.13 112.565 175.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.7 -49.92 74.53 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.707 0.685 . . . . 41.12 109.52 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.73 -30.17 71.22 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.136 -1.603 . . . . 52.54 110.895 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -76.57 -8.04 56.4 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.263 0.938 . . . . 71.42 113.405 173.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.68 -18.49 62.17 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 120.728 -1.232 . . . . 73.22 109.743 162.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 11.6 mt 75.42 -8.36 1.6 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 128.154 2.582 . . . . 73.12 112.394 171.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.456 HE21 ' N ' ' A' ' 146' ' ' LEU . 0.0 OUTLIER -64.13 -0.61 1.24 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.126 2.57 . . . . 75.04 115.008 -176.438 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.456 ' N ' HE21 ' A' ' 145' ' ' GLN . 1.2 tt -152.06 119.67 6.07 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 124.323 1.049 . . . . 75.01 108.692 -172.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -146.23 16.91 1.36 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.491 1.116 . . . . 72.33 110.671 -174.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -152.97 97.55 0.17 Allowed Glycine 0 C--N 1.34 0.798 0 O-C-N 121.084 -1.01 . . . . 55.41 111.611 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.437 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 2.4 m -91.03 174.77 4.15 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.153 0.981 . . . . 64.43 110.161 176.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.437 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 43.9 Cg_endo -64.25 140.94 42.42 Favored 'Cis proline' 0 N--CA 1.456 -0.728 0 N-CA-C 109.218 -1.109 . . . . 62.31 109.218 -19.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -133.8 124.71 27.04 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.264 1.026 . . . . 73.44 108.62 -169.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 28.3 mtp -132.7 107.76 8.6 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.222 1.809 . . . . 74.32 106.471 -168.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -97.56 168.48 10.34 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.302 1.041 . . . . 72.14 109.859 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.0 t -125.35 -37.52 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 118.567 -0.73 . . . . 65.02 112.91 171.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.66 13.85 0.35 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.166 1.543 . . . . 73.15 115.166 -175.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 77.22 2.26 78.09 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 121.621 -0.674 . . . . 50.42 112.617 -175.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -128.11 -4.83 5.59 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 121.333 -1.098 . . . . 75.13 113.803 170.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -133.95 140.29 46.66 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.925 0.89 . . . . 74.45 108.688 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -122.11 154.86 36.81 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.934 1.693 . . . . 75.25 106.546 168.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -76.16 157.4 32.79 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.144 -0.973 . . . . 75.23 108.764 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.25 66.36 1.55 Allowed Pre-proline 0 N--CA 1.468 0.434 0 C-N-CA 123.371 0.668 . . . . 75.14 110.176 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -55.47 -36.62 94.54 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.707 1.605 . . . . 71.14 111.302 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -79.17 24.73 0.32 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.99 0.916 . . . . 62.02 112.921 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -136.13 7.55 4.08 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 121.12 -0.987 . . . . 54.41 113.043 161.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 12.6 mtt -92.25 158.84 15.91 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 119.161 1.48 . . . . 55.4 110.628 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.461 ' HB3' HE22 ' A' ' 176' ' ' GLN . 10.4 t0 -62.72 106.01 0.73 Allowed 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.735 1.214 . . . . 72.44 109.935 176.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 24.2 p -106.48 28.84 7.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.008 1.323 . . . . 74.34 110.247 174.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.3 m -72.49 -29.15 63.38 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 120.988 -1.07 . . . . 71.4 111.496 175.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -133.37 -20.45 2.1 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 112.876 0.695 . . . . 75.44 112.876 -171.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . 0.442 ' O ' HG23 ' A' ' 174' ' ' VAL . 39.5 mmm 74.2 -31.26 0.21 Allowed 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 126.423 1.889 . . . . 52.44 112.118 173.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -70.59 -48.16 56.58 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 120.188 1.358 . . . . 72.32 108.322 174.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 59.5 t -65.04 -29.82 48.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 114.825 -1.08 . . . . 60.03 111.172 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -56.56 -51.56 68.13 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.533 -0.914 . . . . 75.22 108.533 174.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 170' ' ' MET . 1.8 t -68.45 -34.53 66.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 118.477 0.58 . . . . 73.41 111.014 -175.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.79 -28.1 68.51 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.103 0.561 . . . . 74.0 112.06 177.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.461 HE22 ' HB3' ' A' ' 166' ' ' ASP . 31.1 mt-30 -91.47 -31.16 16.09 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.376 1.07 . . . . 73.14 111.988 174.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -63.51 -58.63 6.39 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.925 -1.109 . . . . 73.32 109.778 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -55.55 -27.84 51.31 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.483 1.113 . . . . 64.32 113.808 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -70.7 -57.76 4.35 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.879 -0.513 . . . . 72.01 110.373 173.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 t -66.9 -30.12 70.19 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.43 -0.582 . . . . 71.22 109.43 -169.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 78.1 t -55.74 -56.54 11.84 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 N-CA-C 108.948 -0.76 . . . . 72.04 108.948 170.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -64.14 -39.23 93.59 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-O 119.015 -0.517 . . . . 51.53 111.315 -172.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -52.53 -33.0 43.38 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 122.75 0.42 . . . . 62.15 112.091 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 80.5 mt -81.19 -16.57 52.45 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 120.756 -1.215 . . . . 65.41 113.065 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 91.6 t -69.44 -20.31 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 120.997 -1.064 . . . . 70.21 110.288 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -105.96 -21.17 13.21 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.273 -0.892 . . . . 74.32 109.566 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 35.2 mttt -105.05 74.42 1.11 Allowed 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 125.954 1.702 . . . . 74.13 109.884 -171.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 33.4 tttt . . . . . 0 N--CA 1.432 -1.372 0 C-N-CA 126.879 2.072 . . . . 33.34 107.665 176.261 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.293 0 CA-C-O 121.723 0.773 . . . . 72.22 112.799 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -157.23 122.53 4.59 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 104.884 -2.265 . . . . 73.0 104.884 -178.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.633 HG21 HG23 ' A' ' 180' ' ' THR . 12.5 pt -127.14 152.29 34.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 128.303 2.641 . . . . 75.34 107.203 175.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.2 m -121.3 137.31 54.75 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.081 1.352 . . . . 64.23 107.399 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -57.59 152.09 15.72 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.267 1.427 . . . . 62.3 110.224 166.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.48 -31.56 0.84 Allowed Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.415 1.007 . . . . 73.13 112.693 -171.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -87.33 -71.39 0.56 Allowed 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 106.725 -1.583 . . . . 72.32 106.725 -164.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -123.67 -14.03 7.36 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.081 1.752 . . . . 72.43 110.016 -165.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -138.74 168.72 19.19 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.948 -0.47 . . . . 73.22 110.512 155.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.1 mm -125.79 158.35 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 127.955 2.502 . . . . 74.03 106.046 172.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.53 172.81 8.04 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.476 1.51 . . . . 64.24 108.813 178.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.9 mt -124.11 135.1 53.29 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 119.603 1.092 . . . . 72.02 108.784 162.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -66.33 -38.42 87.63 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 129.377 3.071 . . . . 64.31 110.343 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.22 64.81 7.5 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 125.483 1.513 . . . . 55.3 110.362 -177.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo . . . . . 0 N--CA 1.446 -1.271 0 C-N-CA 123.335 2.69 . . . . 71.41 113.626 -175.777 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.237 0.425 0 N-CA-C 107.129 -1.434 . . . . 74.21 107.129 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -165.28 161.28 19.07 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.812 0.845 . . . . 74.03 110.467 171.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -139.26 147.02 41.14 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.756 1.222 . . . . 64.01 110.013 174.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -127.22 145.94 50.59 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.397 1.079 . . . . 64.1 109.788 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -161.16 174.82 13.11 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.167 1.387 . . . . 74.33 109.314 177.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.3 t -129.79 179.62 5.74 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.998 1.319 . . . . 72.33 109.22 173.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -94.28 -21.66 18.87 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 128.007 2.523 . . . . 74.42 111.377 176.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.512 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 49.7 m-85 -104.35 9.72 35.71 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.697 1.599 . . . . 70.54 114.642 177.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.5 p -88.42 143.24 32.09 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 121.047 1.749 . . . . 74.22 111.014 175.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -80.44 -43.51 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 120.936 1.091 . . . . 74.51 112.352 -171.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -53.84 -44.81 70.62 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 118.447 0.567 . . . . 73.14 109.708 175.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.5 m -52.54 -42.47 64.43 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 125.092 1.357 . . . . 54.34 111.557 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -61.24 -52.09 66.21 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 110.114 -0.328 . . . . 75.23 110.114 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.22 -45.68 87.25 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.515 -0.92 . . . . 70.11 108.515 177.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -67.77 -6.26 20.29 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 116.319 -1.8 . . . . 73.33 113.691 -177.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -134.44 -1.02 2.88 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 121.901 2.137 . . . . 43.14 113.219 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -136.14 -12.51 1.9 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.854 1.262 . . . . 72.21 112.746 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.8 t -126.96 -79.89 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.089 0 N-CA-C 107.052 -1.462 . . . . 61.1 107.052 -176.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.6 mt -65.63 -24.78 67.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.287 2.235 . . . . 73.3 111.993 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 44.36 48.13 8.06 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.99 1.716 . . . . 61.4 111.817 176.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.601 ' O ' HG23 ' A' ' 46' ' ' VAL . 97.7 t -54.44 -49.56 64.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.361 0 C-N-CA 125.01 1.324 . . . . 74.21 110.184 -174.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.1 t -48.95 -49.95 37.92 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.4 1.48 . . . . 72.44 110.839 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -73.29 -36.45 66.3 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.654 0.782 . . . . 60.34 112.078 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -57.87 -49.61 76.11 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.486 0.715 . . . . 71.24 109.65 172.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 42' ' ' VAL . 2.1 t -59.02 -49.06 84.6 Favored 'Isoleucine or valine' 0 C--N 1.343 0.313 0 CA-C-N 119.024 0.829 . . . . 73.14 108.874 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.1 ptt180 -61.3 -26.67 67.94 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 121.741 -0.6 . . . . 74.31 112.443 -169.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -64.28 -15.57 60.45 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.391 0.886 . . . . 71.33 113.391 174.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -126.51 -6.13 6.41 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.956 1.702 . . . . 72.44 112.17 -170.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.508 ' HB3' HG21 ' A' ' 54' ' ' THR . 10.5 mt -70.08 144.27 92.5 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-O 118.904 -0.57 . . . . 63.44 110.988 -169.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.599 ' O ' HG22 ' A' ' 54' ' ' THR . 72.9 Cg_endo -74.88 153.25 42.25 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.043 2.495 . . . . 71.4 111.295 178.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -79.24 81.59 5.49 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.834 0.826 . . . . 61.34 109.072 -172.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 166.64 -23.62 0.13 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.11 1.338 . . . . 31.05 113.891 -177.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 51' ' ' PRO . 1.8 t -48.35 -46.79 37.17 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 118.926 1.363 . . . . 75.12 113.991 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? 60.01 124.47 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.407 2.283 . . . . 60.22 111.867 -170.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.6 ttm -75.48 102.06 5.07 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 106.286 -1.746 . . . . 53.43 106.286 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.1 m -129.66 101.39 5.89 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 107.649 -1.241 . . . . 54.5 107.649 -167.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.64 105.63 9.88 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.821 1.248 . . . . 72.1 108.151 -162.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -94.86 152.69 18.18 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.185 0.517 . . . . 75.22 109.974 175.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.582 ' NE2' HG23 ' A' ' 72' ' ' THR . 1.6 p-80 -81.62 176.09 9.94 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.513 1.525 . . . . 62.43 108.761 172.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.5 m -145.18 152.09 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 107.659 -1.237 . . . . 73.31 107.659 158.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.4 ' C ' ' H ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER -101.0 -14.7 17.74 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.23 1.012 . . . . 73.14 112.755 -172.09 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -57.8 5.66 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 129.144 2.978 . . . . 74.31 114.719 -177.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.4 ' H ' ' C ' ' A' ' 62' ' ' GLU . 30.5 mt -145.47 110.16 5.08 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 126.763 2.025 . . . . 65.21 106.963 -164.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.512 ' HA3' ' CD2' ' A' ' 29' ' ' TYR . . . 100.85 154.62 26.98 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 126.692 2.091 . . . . 41.31 110.75 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.56 -44.4 0.52 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 121.788 1.658 . . . . 65.31 110.093 173.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.1 mt -83.26 24.28 0.82 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.782 0.833 . . . . 74.11 111.151 174.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -50.78 -46.46 48.26 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.427 1.013 . . . . 62.25 111.191 176.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -58.75 -47.74 83.59 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.923 0.889 . . . . 64.32 111.689 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.68 -44.12 97.08 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.696 1.598 . . . . 44.32 108.509 -174.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.6 mt -61.86 -44.45 96.8 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.464 1.106 . . . . 73.01 111.019 174.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.582 HG23 ' NE2' ' A' ' 60' ' ' HIS . 82.6 m -58.14 -48.89 78.86 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.71 1.604 . . . . 72.32 110.937 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -62.59 -42.86 99.82 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 120.906 -1.121 . . . . 74.35 109.877 175.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.83 -35.74 75.36 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 120.663 -1.273 . . . . 72.05 112.569 178.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 52.9 t-105 -55.09 -34.62 63.8 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.228 1.011 . . . . 71.41 111.08 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.12 -36.73 83.93 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 118.382 -0.818 . . . . 62.04 111.481 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.7 t -56.92 -47.31 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 119.445 1.02 . . . . 75.44 109.309 172.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.51 -26.75 61.02 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 117.238 -1.363 . . . . 55.15 112.748 -175.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.12 -42.46 79.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 120.952 1.706 . . . . 75.43 108.937 167.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.04 -40.26 84.52 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.423 1.01 . . . . 75.42 110.771 -176.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.2 mt -87.56 -14.59 39.79 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.127 0.417 . . . . 73.23 112.127 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.98 67.03 2.25 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 126.563 2.03 . . . . 75.21 111.089 -176.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.5 m -136.86 17.07 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.628 1.171 . . . . 72.11 112.51 -176.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -49.29 -50.46 39.12 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.026 1.73 . . . . 73.42 111.772 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -80.09 5.77 13.36 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.677 1.591 . . . . 64.1 111.037 -176.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.8 mtpp -104.5 -20.29 13.74 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.604 1.562 . . . . 74.43 110.527 170.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.1 pp -119.25 13.08 6.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 C-N-CA 124.245 1.018 . . . . 74.45 111.487 -170.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.2 m -86.97 -42.22 13.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 119.542 1.065 . . . . 74.44 111.087 175.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.496 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -55.14 -64.25 2.26 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 118.906 0.776 . . . . 42.53 111.581 -177.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.496 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 90.6 Cg_endo -69.61 -27.75 26.81 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.428 1.419 . . . . 71.11 111.467 -171.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 23.0 tpp -56.16 -49.26 74.48 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.169 0.988 . . . . 71.3 109.038 175.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -73.7 -31.7 63.55 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 118.43 -0.795 . . . . 75.32 110.008 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -60.15 -33.73 72.57 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 119.143 0.883 . . . . 62.22 110.977 170.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -99.45 -12.4 20.25 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.871 1.214 . . . . 62.1 113.438 -174.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.7 t -97.52 -45.52 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.308 1.043 . . . . 72.23 109.216 177.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -98.07 -63.78 1.1 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.886 0.875 . . . . 70.34 109.576 -176.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -63.62 -59.18 4.94 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 119.188 0.904 . . . . 74.1 111.116 -166.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.5 p -95.6 -16.43 22.1 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.884 0.698 . . . . 73.14 112.884 -176.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 55.31 22.57 4.93 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.151 1.381 . . . . 72.4 113.806 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.1 t -68.39 -14.54 63.07 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.4 1.48 . . . . 52.21 112.143 -178.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 38.6 t -66.79 110.84 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 O-C-N 120.52 -1.362 . . . . 64.25 109.094 171.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -139.28 -23.21 0.9 Allowed 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.914 1.686 . . . . 71.42 111.616 -172.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 t -151.44 179.95 7.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.007 -1.058 . . . . 63.51 109.394 159.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.3 t -54.58 -34.34 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 124.664 1.185 . . . . 72.22 110.064 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.38 -23.86 17.31 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.867 1.667 . . . . 51.23 113.04 176.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -94.08 -37.66 11.51 Favored 'General case' 0 CA--C 1.518 -0.266 0 O-C-N 121.33 -0.856 . . . . 75.05 108.998 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.8 mt -65.4 -47.23 87.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 125.152 1.381 . . . . 71.02 108.096 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -62.51 -26.16 68.4 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.019 0.748 . . . . 74.24 113.019 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -65.08 -51.81 59.27 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 109.577 -0.527 . . . . 71.45 109.577 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.2 t -55.83 -41.7 67.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 123.549 0.53 . . . . 71.25 111.062 -176.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -54.11 -54.4 40.03 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.496 -0.557 . . . . 61.15 109.496 175.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 54.4 t -58.67 -47.34 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 C-N-CA 123.036 0.534 . . . . 63.25 110.436 -177.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -70.25 -37.91 75.02 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.437 -0.949 . . . . 74.32 108.437 -166.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.89 -9.9 59.21 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.607 1.163 . . . . 73.02 112.354 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 118.4 36.37 0.93 Allowed Glycine 0 C--N 1.336 0.577 0 CA-C-O 117.793 -1.56 . . . . 74.24 115.08 168.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 99.5 t -102.61 144.81 13.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 119.648 1.724 . . . . 44.11 109.204 172.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.555 ' HG3' ' H ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -67.53 133.14 48.92 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.53 -0.759 . . . . 74.04 110.23 171.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.42 -21.91 69.01 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-O 118.903 -0.943 . . . . 71.25 111.736 172.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -73.22 -49.8 25.93 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 118.147 -0.93 . . . . 73.02 111.917 175.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.555 ' H ' ' HG3' ' A' ' 117' ' ' LYS . 33.3 t70 -66.07 -40.67 91.05 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.181 -1.414 . . . . 64.43 107.181 -178.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -59.29 -51.38 70.19 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 123.907 0.754 . . . . 72.25 110.105 -174.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -77.88 -12.83 60.02 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 113.002 0.741 . . . . 64.24 113.002 -175.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.43 -61.7 1.46 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.979 1.312 . . . . 73.35 110.387 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.79 -34.22 58.41 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.57 1.548 . . . . 64.41 110.934 -177.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 61.7 t-105 -45.54 -37.02 5.0 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.017 1.727 . . . . 73.01 112.934 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -113.21 2.54 15.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.935 1.294 . . . . 63.44 113.162 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 10.0 t -77.34 156.0 31.58 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.441 1.097 . . . . 73.11 109.887 173.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -58.88 -30.86 68.07 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.448 1.499 . . . . 74.32 111.941 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 84.9 t -54.33 -48.54 67.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 O-C-N 121.606 -0.683 . . . . 64.05 109.391 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.4 t -65.32 -43.47 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-O 119.08 -0.486 . . . . 74.41 110.504 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -53.4 -51.55 62.19 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.68 0.673 . . . . 74.35 111.51 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.0 t -69.63 -38.15 77.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 117.863 -1.065 . . . . 60.04 110.285 -177.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.1 mt -58.92 -56.4 22.78 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 117.453 -1.26 . . . . 75.42 110.429 176.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 37.6 t -45.41 -46.72 4.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.245 0 C-N-CA 124.533 1.133 . . . . 63.01 109.98 174.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.02 -35.13 70.83 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 113.038 0.755 . . . . 51.35 113.038 -176.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -61.53 -38.37 87.16 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.048 0.539 . . . . 75.34 110.755 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 10.0 mp0 -85.9 -50.28 7.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.254 1.022 . . . . 72.35 110.746 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -52.72 -44.94 66.71 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.057 0.844 . . . . 75.04 109.69 -176.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -60.89 -61.89 2.26 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.092 0.472 . . . . 72.33 109.878 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.55 1.55 3.04 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.792 1.405 . . . . 71.01 114.792 -173.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -129.88 6.12 5.05 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.282 1.433 . . . . 74.23 112.279 174.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -120.81 -6.25 9.62 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 124.714 1.206 . . . . 70.15 113.085 168.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.97 5.06 0.25 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.317 2.247 . . . . 70.43 112.781 175.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 73.25 -5.68 1.9 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 131.682 3.993 . . . . 63.12 114.126 -178.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.415 ' HG3' ' H ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -71.76 -15.92 62.19 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 127.964 2.505 . . . . 73.01 113.468 -164.43 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.4 tp -164.17 125.01 2.17 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 128.16 2.584 . . . . 74.4 105.545 -176.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -142.13 21.95 2.08 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.475 0.655 . . . . 72.44 111.265 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -136.43 158.97 24.28 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 107.498 -2.241 . . . . 73.32 107.498 164.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.486 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 3.7 m -140.46 171.67 7.39 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 107.993 -1.114 . . . . 53.32 107.993 174.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.486 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 68.0 Cg_endo -63.21 156.16 69.21 Favored 'Cis proline' 0 N--CA 1.457 -0.639 0 CA-C-N 120.453 1.197 . . . . 45.3 111.27 -8.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -141.22 144.73 34.9 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.107 0.963 . . . . 71.34 108.766 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 29.2 ttm -151.08 109.94 3.87 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.001 -1.481 . . . . 75.4 107.001 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -93.15 156.23 16.98 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.595 -0.73 . . . . 74.12 109.31 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.6 t -139.48 140.0 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.614 -0.884 . . . . 74.21 108.614 175.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 45.78 28.84 0.61 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.967 2.507 . . . . 74.41 114.562 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 63.53 7.39 20.13 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.88 1.705 . . . . 74.41 113.488 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -141.5 -5.39 1.07 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 119.044 1.422 . . . . 75.3 113.648 -165.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -129.45 150.13 50.93 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.38 -0.97 . . . . 74.02 108.38 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.31 123.99 37.65 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 128.401 2.68 . . . . 75.21 107.998 177.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.5 139.73 57.61 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.513 -1.662 . . . . 73.3 106.513 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -114.66 86.09 12.3 Favored Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 123.256 0.622 . . . . 65.24 110.969 174.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.78 -17.9 47.39 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 120.706 0.937 . . . . 72.11 111.705 177.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -78.66 -6.02 54.6 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.09 1.756 . . . . 74.3 112.773 -172.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -130.35 13.46 5.68 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.573 1.082 . . . . 72.44 111.366 177.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 45.3 mtt -85.5 163.19 18.57 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.33 1.065 . . . . 61.42 109.192 170.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.57 108.73 6.59 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.705 -1.591 . . . . 71.42 106.705 170.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 31.9 p -102.1 -6.74 22.95 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 127.016 2.127 . . . . 73.2 110.94 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 46.5 m -61.74 -17.9 57.64 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 125.683 1.593 . . . . 64.3 114.491 -170.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -128.78 -6.3 5.09 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 117.76 -1.114 . . . . 75.33 111.197 -164.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 65.92 -63.73 0.22 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.348 1.859 . . . . 74.21 111.865 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.55 -44.49 94.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 119.114 0.87 . . . . 74.33 108.954 -171.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 91.9 t -62.12 -30.0 47.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 125.084 1.354 . . . . 71.11 111.587 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -66.78 -60.11 2.97 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 107.624 -1.25 . . . . 75.44 107.624 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.2 t -68.04 -35.4 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 O-C-N 123.72 0.637 . . . . 61.31 110.664 -174.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.02 -52.18 63.95 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.491 0.716 . . . . 34.44 109.799 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -72.64 -38.32 67.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.245 -0.883 . . . . 71.24 111.598 177.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -55.46 -58.41 7.88 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.745 1.157 . . . . 71.23 109.714 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.58 -42.07 61.62 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 125.989 1.716 . . . . 71.33 111.514 -176.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -71.44 -51.0 26.29 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.955 0.902 . . . . 63.21 108.935 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.633 HG23 HG21 ' A' ' 3' ' ' ILE . 31.1 m -59.81 -26.45 65.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.461 1.105 . . . . 64.1 112.229 -177.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 97.2 t -60.05 -51.43 73.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 108.912 -0.773 . . . . 75.02 108.912 169.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 31.1 tttm -61.35 -44.29 97.42 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 118.008 -0.996 . . . . 75.31 110.986 174.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -57.15 -28.98 63.23 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 119.599 1.091 . . . . 60.22 111.426 -169.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 58.5 mt -81.12 -24.61 37.56 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.874 0.694 . . . . 75.03 112.874 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.47 -28.22 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 O-C-N 121.027 -1.045 . . . . 75.23 110.508 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -89.28 -29.61 19.07 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 122.048 0.928 . . . . 73.04 109.45 178.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 45.6 mttp -95.64 66.42 2.73 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 125.094 1.358 . . . . 72.44 109.051 -176.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.507 ' H ' ' HD3' ' A' ' 188' ' ' LYS . 1.2 mppt? . . . . . 0 C--O 1.247 0.968 0 N-CA-C 107.427 -1.323 . . . . 62.4 107.427 154.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 114.023 1.12 . . . . 71.32 114.023 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -157.58 122.98 4.55 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 129.153 2.981 . . . . 71.3 103.533 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.711 HG21 HG23 ' A' ' 180' ' ' THR . 9.3 pt -127.85 149.59 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 126.735 2.014 . . . . 64.23 108.152 175.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.0 m -132.03 143.33 49.98 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.054 -1.091 . . . . 60.2 108.054 174.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -59.11 151.91 21.45 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.919 1.287 . . . . 64.13 110.151 170.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.86 -25.82 0.78 Allowed Glycine 0 CA--C 1.532 1.125 0 CA-C-O 118.873 -0.96 . . . . 60.33 112.783 -169.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -98.04 -85.61 0.37 Allowed 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 119.246 1.523 . . . . 75.32 107.565 -170.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -90.05 -17.92 26.89 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.505 0.722 . . . . 71.43 111.751 -176.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -140.76 164.91 28.95 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 118.208 0.458 . . . . 74.22 110.245 173.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.2 mm -127.87 163.12 32.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 105.761 -1.941 . . . . 71.14 105.761 173.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.21 164.26 11.74 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 124.998 1.319 . . . . 71.23 110.058 171.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 27.2 mt -79.67 154.53 28.57 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.929 -1.137 . . . . 74.24 107.929 161.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.62 -27.12 51.06 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.809 -0.812 . . . . 73.4 108.809 171.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -121.81 71.34 29.6 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.774 1.629 . . . . 74.24 108.987 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo . . . . . 0 CA--C 1.538 0.69 0 C-N-CA 124.079 3.186 . . . . 74.21 111.579 -177.565 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 N--CA 1.463 0.189 0 CA-C-O 121.653 0.739 . . . . 63.31 109.655 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 tp -150.64 161.83 41.84 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.374 -0.973 . . . . 74.0 108.374 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -146.15 136.58 23.95 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.496 -1.298 . . . . 75.11 107.496 -169.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -137.22 136.27 37.99 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 123.889 0.876 . . . . 73.11 110.505 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.03 171.64 18.75 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.606 1.962 . . . . 60.2 108.177 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.02 153.78 50.56 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 119.031 -0.509 . . . . 73.02 109.898 169.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.795 ' CD1' HD11 ' A' ' 71' ' ' LEU 0.296 0.0 OUTLIER -67.19 -15.61 63.8 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 113.306 0.854 . . . . 73.33 113.306 177.911 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.466 ' CE2' ' HA3' ' A' ' 65' ' ' GLY . 41.6 m-85 -93.45 -0.52 56.4 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.277 0.944 . . . . 60.24 112.248 176.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.9 t -82.05 141.04 46.52 Favored Pre-proline 0 CA--C 1.534 0.36 0 O-C-N 120.592 -1.317 . . . . 63.34 110.446 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -88.78 -37.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 121.769 1.646 . . . . 74.04 112.542 -175.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -62.95 -48.09 80.4 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 124.702 1.201 . . . . 75.13 108.778 176.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 21.0 m -57.44 -30.54 65.09 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.204 -0.907 . . . . 74.03 111.089 -178.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -59.81 -56.94 15.54 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 119.612 1.096 . . . . 63.42 110.109 173.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.487 ' HA ' HE21 ' A' ' 35' ' ' GLN . 0.0 OUTLIER -53.93 -42.14 68.49 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.065 -0.717 . . . . 64.1 109.065 -179.491 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -69.49 -16.18 63.41 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 116.641 -1.647 . . . . 71.24 112.67 -176.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -124.17 -10.44 7.57 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 121.245 1.839 . . . . 74.31 111.9 -172.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -136.97 -11.8 1.72 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.986 1.715 . . . . 74.13 112.972 -170.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.6 t -127.24 -81.76 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 O-C-N 120.315 -1.49 . . . . 75.34 107.718 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.2 mt -56.9 -28.18 61.59 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.498 1.919 . . . . 74.21 111.67 175.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 67.9 m80 44.57 46.51 8.26 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.942 1.697 . . . . 63.33 110.918 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 46' ' ' VAL . 98.7 t -51.0 -53.78 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 C-N-CA 126.614 1.966 . . . . 61.41 108.631 -175.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.5 t -45.44 -47.95 13.78 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.644 1.978 . . . . 72.04 111.587 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.64 -18.45 27.94 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.011 -1.055 . . . . 74.42 111.835 -176.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.5 -40.94 93.64 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.208 -0.932 . . . . 54.52 109.582 167.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 42' ' ' VAL . 1.9 t -59.61 -46.39 93.23 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 N-CA-C 109.437 -0.579 . . . . 62.3 109.437 178.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -47.93 -44.48 30.07 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.229 1.012 . . . . 71.02 112.033 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -62.57 -10.62 12.71 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.001 1.482 . . . . 72.21 115.001 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -125.44 -9.03 6.9 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 126.925 2.09 . . . . 73.34 113.199 -174.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.597 HD13 HG21 ' A' ' 54' ' ' THR . 14.5 mt -72.33 150.43 91.83 Favored Pre-proline 0 C--O 1.234 0.269 0 CA-C-N 119.328 0.967 . . . . 63.01 111.246 -167.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -71.82 156.63 56.59 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.146 1.898 . . . . 72.33 109.402 169.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.28 28.57 0.06 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 126.007 1.723 . . . . 73.2 114.974 -174.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -154.19 21.08 0.66 Allowed Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 124.708 1.147 . . . . 21.05 112.979 -168.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.597 HG21 HD13 ' A' ' 50' ' ' LEU . 2.9 t -89.72 -45.3 9.41 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 117.887 0.843 . . . . 51.42 110.908 -177.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? 55.52 95.55 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 124.155 1.931 . . . . 74.14 110.704 -162.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.8 mtm -62.29 122.84 16.65 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 113.84 -1.527 . . . . 44.33 108.765 169.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 58' ' ' LYS . 1.3 m -123.24 179.87 4.55 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.317 -0.994 . . . . 74.02 108.317 174.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.461 ' H ' HG22 ' A' ' 57' ' ' THR . 9.8 mtpt -172.35 88.1 0.09 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 106.78 -1.563 . . . . 72.41 106.78 -171.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.516 ' CD2' ' HG3' ' A' ' 137' ' ' GLN . 4.1 m-30 -89.02 176.02 7.17 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.992 1.317 . . . . 74.12 109.299 175.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.623 ' CE1' HE21 ' A' ' 137' ' ' GLN . 2.1 p-80 -117.04 175.42 5.6 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.154 1.381 . . . . 75.12 110.081 174.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.8 m -131.24 175.97 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.255 1.422 . . . . 74.23 109.036 169.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.71 59.74 1.72 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.693 2.397 . . . . 72.14 111.134 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -148.33 -163.71 1.84 Allowed 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.237 1.415 . . . . 75.13 109.82 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.8 mt 75.54 -85.03 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 128.616 2.767 . . . . 61.33 109.175 -176.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.466 ' HA3' ' CE2' ' A' ' 29' ' ' TYR . . . -95.32 174.46 32.36 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 125.43 1.491 . . . . 74.05 111.452 -178.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.88 -36.63 30.39 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 124.945 3.763 . . . . 63.33 113.124 -169.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.2 mt -83.68 24.82 0.83 Allowed 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 124.332 1.053 . . . . 72.13 112.721 -174.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -46.28 -51.6 11.53 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-N 118.72 0.691 . . . . 33.34 111.81 179.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -70.76 -6.38 37.13 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.49 1.116 . . . . 64.11 113.596 -177.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -111.44 -24.57 10.09 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.257 1.423 . . . . 61.31 109.389 -177.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.795 HD11 ' CD1' ' A' ' 28' ' ' PHE . 9.5 mt -63.67 -46.97 83.12 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.912 0.885 . . . . 72.43 109.368 165.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.531 HG22 ' CD2' ' A' ' 60' ' ' HIS . 0.5 OUTLIER -50.86 -52.11 44.82 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.414 1.486 . . . . 71.15 108.75 171.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -62.03 -54.47 41.03 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.551 -0.718 . . . . 72.24 110.5 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.24 -33.38 73.18 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.631 1.105 . . . . 74.45 113.435 -167.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.608 ' HB3' ' HD1' ' A' ' 60' ' ' HIS . 40.5 t-105 -56.73 -38.13 71.95 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 123.1 0.56 . . . . 75.14 110.367 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.27 84.7 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 117.505 -1.236 . . . . 73.45 112.055 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.453 HG22 ' HB3' ' A' ' 124' ' ' ALA . 93.9 t -56.35 -45.22 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 121.072 1.76 . . . . 64.35 110.986 167.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.37 -45.55 90.65 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 118.094 -0.955 . . . . 74.25 111.073 -177.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 60.2 mt -62.54 -40.44 88.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 124.263 1.025 . . . . 72.31 110.207 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.85 -42.17 83.9 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.758 0.708 . . . . 71.35 110.362 -175.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.5 mt -85.18 -29.92 24.34 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 111.732 0.271 . . . . 54.44 111.732 174.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.74 52.08 3.43 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 126.183 1.849 . . . . 74.24 111.853 -175.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -127.25 21.16 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.761 1.224 . . . . 64.32 111.403 -173.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -53.05 -53.2 53.74 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 123.757 0.823 . . . . 72.02 111.074 -175.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.18 -42.7 77.54 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.224 1.409 . . . . 74.15 109.687 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.7 mtpm? -72.64 -5.23 35.95 Favored 'General case' 0 N--CA 1.46 0.066 0 C-N-CA 125.012 1.325 . . . . 60.41 112.171 -176.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.6 pp -134.1 23.3 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 C-N-CA 125.669 1.587 . . . . 74.31 109.386 173.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 99.5 m -87.53 -57.56 2.9 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.222 -1.399 . . . . 71.41 107.222 168.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.477 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -58.89 -60.15 11.44 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 112.88 0.696 . . . . 53.44 112.88 -164.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 37.5 Cg_endo -66.92 -26.61 43.94 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.288 1.325 . . . . 75.31 111.579 -177.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 5.0 ttm -64.92 -43.5 92.59 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.56 0.744 . . . . 55.55 109.258 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -69.69 -40.19 76.5 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.496 1.118 . . . . 72.11 109.473 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.12 -27.25 66.88 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.223 0.465 . . . . 61.24 111.196 172.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -97.59 3.98 50.35 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 120.361 -1.462 . . . . 71.22 113.304 -177.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.69 HG21 ' CD2' ' A' ' 28' ' ' PHE . 65.6 t -119.73 -41.23 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 124.073 0.949 . . . . 73.15 110.067 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -101.4 -51.66 3.43 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 109.404 -0.591 . . . . 41.35 109.404 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -75.35 -60.02 2.49 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.88 -0.6 . . . . 71.35 109.432 -168.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.3 p -98.1 -19.13 18.13 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.775 0.83 . . . . 62.24 112.491 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 64.95 18.51 11.53 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.869 1.668 . . . . 51.42 114.163 166.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.1 t -74.78 -17.39 60.63 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.991 1.317 . . . . 74.15 113.486 -172.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.6 t -66.84 126.58 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.555 -0.716 . . . . 64.45 109.13 167.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -146.1 -25.71 0.44 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.239 1.415 . . . . 75.05 111.075 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.1 t -143.38 175.81 9.63 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.899 0.772 . . . . 75.05 110.25 171.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.4 t -52.39 -44.82 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.932 1.693 . . . . 72.32 110.028 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -52.77 -23.72 7.39 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.712 1.605 . . . . 75.03 112.862 177.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -94.38 -24.72 17.25 Favored 'General case' 0 CA--C 1.523 -0.078 0 CA-C-N 118.972 0.806 . . . . 73.04 111.123 -178.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.4 mt -82.45 -43.28 19.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.594 -0.891 . . . . 75.35 108.594 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -55.15 -31.79 61.59 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 118.534 -0.746 . . . . 44.42 111.479 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -57.51 -61.76 2.26 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.287 1.435 . . . . 73.22 109.85 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.7 t -55.33 -40.07 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 122.767 0.427 . . . . 64.02 110.756 -175.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -53.79 -53.48 51.8 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.472 0.578 . . . . 73.24 110.65 173.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.24 -41.36 91.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 123.876 0.87 . . . . 63.13 109.99 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -67.27 -37.71 83.9 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.678 -0.86 . . . . 73.44 108.678 -170.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.3 -24.71 61.36 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.443 1.097 . . . . 62.42 112.428 175.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.57 56.47 0.35 Allowed Glycine 0 C--N 1.332 0.315 0 N-CA-C 111.242 -0.743 . . . . 64.42 111.242 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.3 t -118.98 126.36 75.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 109.087 -0.708 . . . . 72.41 109.087 166.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -54.13 128.03 29.19 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.212 -0.662 . . . . 74.45 109.212 176.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.41 -21.19 66.34 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-O 117.6 -1.667 . . . . 60.23 110.434 170.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -68.83 -37.57 79.25 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 119.875 1.838 . . . . 75.41 108.826 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.74 -45.51 28.95 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 126.08 1.752 . . . . 72.12 107.164 -171.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -55.93 -57.4 12.27 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 109.501 -0.555 . . . . 72.44 109.501 174.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -66.23 -28.8 69.01 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 119.314 -0.374 . . . . 72.04 111.145 -172.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.27 -64.05 1.1 Allowed 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.859 0.864 . . . . 71.13 110.587 174.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.453 ' HB3' HG22 ' A' ' 77' ' ' VAL . . . -54.99 -36.37 65.33 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.585 1.154 . . . . 64.15 110.572 -171.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 59.9 t-105 -45.62 -42.83 11.78 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.744 1.218 . . . . 75.12 112.57 177.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -105.71 1.25 26.98 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.639 1.176 . . . . 64.05 112.872 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.2 t -77.97 150.24 33.99 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.51 1.524 . . . . 62.25 109.805 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -56.45 -35.27 67.7 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 124.429 1.092 . . . . 63.44 111.0 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.9 t -51.53 -52.51 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 CA-C-N 118.847 0.749 . . . . 51.35 109.581 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.13 -45.61 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-N 115.942 -0.572 . . . . 72.23 110.269 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -46.22 81.98 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.342 0.657 . . . . 73.35 111.109 -176.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.4 t -67.07 -48.39 68.39 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.638 1.175 . . . . 62.21 110.371 175.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.7 mt -53.8 -50.38 66.24 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-O 117.321 -1.324 . . . . 64.02 110.029 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.8 t -48.27 -51.74 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 120.573 1.533 . . . . 62.35 109.986 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.57 -27.45 64.62 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.514 0.931 . . . . 71.32 113.514 -177.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -63.99 -32.95 74.67 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 113.774 1.027 . . . . 74.13 113.774 172.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.623 HE21 ' CE1' ' A' ' 60' ' ' HIS . 4.1 mp0 -89.72 -35.94 15.48 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 117.652 -1.166 . . . . 75.14 111.85 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -56.64 -51.6 68.07 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 108.041 -1.096 . . . . 63.12 108.041 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 23.9 ttpt -59.66 -16.43 26.4 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 113.765 1.024 . . . . 43.21 113.765 174.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -117.26 -1.86 11.73 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 120.486 1.494 . . . . 54.42 114.828 -174.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.07 -29.86 4.16 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 119.145 0.884 . . . . 73.21 111.038 172.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -107.67 2.04 23.56 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.789 0.836 . . . . 63.43 112.034 -170.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -63.62 -85.82 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.504 1.121 . . . . 74.3 111.255 176.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -175.56 50.0 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.032 1.733 . . . . 74.02 109.216 177.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.276 0.6 OUTLIER -143.7 -50.0 0.31 Allowed 'General case' 0 C--N 1.344 0.332 0 N-CA-C 114.071 1.138 . . . . 71.11 114.071 -178.262 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 40.5 tp -70.07 -83.1 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 119.572 1.078 . . . . 72.14 110.071 -176.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 55.15 33.52 20.67 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.618 0.767 . . . . 64.42 112.477 173.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 176.35 159.44 21.93 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.681 1.61 . . . . 74.03 109.587 170.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.407 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 9.9 m -141.69 159.03 61.49 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 119.61 1.705 . . . . 71.03 110.582 173.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.407 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 73.7 Cg_endo -74.29 161.57 94.22 Favored 'Cis proline' 0 C--N 1.349 0.572 0 CA-C-N 118.987 0.674 . . . . 63.01 112.897 -4.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -144.36 146.07 32.33 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.858 -1.065 . . . . 64.13 110.055 175.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 38.8 tpp -135.96 105.43 6.07 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 105.006 -2.22 . . . . 74.24 105.006 175.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -82.81 149.51 27.14 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.084 0.953 . . . . 75.13 109.444 175.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.8 t -140.08 145.93 25.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 108.195 -1.039 . . . . 73.34 108.195 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 50.67 24.16 1.59 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.992 2.117 . . . . 60.43 113.765 173.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 68.36 4.29 36.58 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 120.336 -1.478 . . . . 54.32 113.612 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.436 ' HE2' ' CE2' ' A' ' 158' ' ' TYR . 11.1 pttt -147.26 -6.48 0.48 Allowed 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.442 1.621 . . . . 71.21 115.183 -166.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.436 ' CE2' ' HE2' ' A' ' 157' ' ' LYS . 63.0 m-85 -124.04 162.38 23.59 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.332 0.969 . . . . 72.02 110.288 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -129.63 139.94 51.29 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.815 1.646 . . . . 64.22 106.895 165.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.89 142.34 57.94 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 107.946 -1.131 . . . . 72.3 107.946 167.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -118.67 85.52 27.41 Favored Pre-proline 0 C--O 1.235 0.333 0 C-N-CA 123.603 0.761 . . . . 74.41 111.651 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.01 -24.87 52.23 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 CA-C-N 119.544 0.873 . . . . 75.03 111.493 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.99 -8.65 39.13 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.876 1.27 . . . . 75.24 112.642 -178.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -112.9 7.9 25.57 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-O 118.519 -1.156 . . . . 75.03 112.202 176.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 59.1 mtt -98.13 158.91 15.27 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 119.351 1.576 . . . . 54.12 110.528 -176.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -66.94 109.37 2.93 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 106.524 -1.658 . . . . 60.14 106.524 170.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.16 11.91 15.34 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 128.156 2.582 . . . . 75.4 108.632 -171.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.67 -4.33 56.84 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 125.693 1.597 . . . . 54.52 113.189 -169.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.06 -7.28 1.38 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.783 0.833 . . . . 75.1 111.491 -168.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 8.1 mmt 65.94 -62.78 0.24 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 127.142 2.177 . . . . 75.21 112.23 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.44 -36.65 74.09 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 120.371 1.441 . . . . 61.21 109.803 -171.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 79.9 t -58.68 -37.32 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.687 1.195 . . . . 73.03 110.162 172.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -60.16 -56.52 20.56 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.674 -0.861 . . . . 75.32 108.674 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.2 t -64.93 -37.82 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 123.314 0.384 . . . . 71.03 110.536 -178.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.42 -47.67 69.39 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.542 1.137 . . . . 63.21 110.657 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -80.75 -40.25 25.54 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 118.504 -0.76 . . . . 73.41 111.882 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -50.38 -59.69 3.74 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.486 1.039 . . . . 75.03 110.2 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.27 -37.48 75.07 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.229 1.012 . . . . 75.23 111.74 -172.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -67.39 -50.4 59.78 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.912 0.885 . . . . 74.53 109.994 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.711 HG23 HG21 ' A' ' 3' ' ' ILE . 22.0 m -57.03 -29.73 63.62 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.647 1.179 . . . . 74.42 111.964 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 3.7 t -60.38 -52.79 57.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 119.396 0.998 . . . . 73.23 109.354 172.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -62.55 -27.88 69.47 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 121.499 -0.751 . . . . 71.23 112.089 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -68.92 -33.62 74.04 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 119.214 0.915 . . . . 74.41 112.528 176.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 66.1 mt -71.21 -32.86 69.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 120.159 1.345 . . . . 71.43 110.98 -177.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 99.3 t -62.36 -23.68 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.163 0.985 . . . . 60.13 112.144 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -99.0 -19.42 17.28 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.453 -0.78 . . . . 74.3 110.203 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -98.89 77.54 2.22 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 125.197 1.399 . . . . 73.53 107.398 -168.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.967 0 C-N-CA 126.923 2.089 . . . . 63.22 111.563 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.469 0.502 0 CA-C-O 117.582 -1.199 . . . . 65.04 109.512 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 70.22 166.01 0.28 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 128.388 2.675 . . . . 74.45 112.96 172.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 50.94 37.58 17.9 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.176 1.39 . . . . 74.33 112.758 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.2 116.77 0.99 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 127.004 2.121 . . . . 74.02 105.799 178.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.8 pt -130.72 168.66 23.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 126.51 1.924 . . . . 73.11 108.514 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.9 m -139.58 135.15 33.08 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.549 1.139 . . . . 73.05 108.954 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -60.25 111.54 1.58 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.542 2.337 . . . . 54.44 108.263 169.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 107.69 -16.1 37.34 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 126.12 1.819 . . . . 72.21 112.921 -173.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.5 tppt? -100.63 -86.48 0.4 Allowed 'General case' 0 C--O 1.227 -0.095 0 CA-C-N 119.411 1.606 . . . . 71.43 108.056 -174.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -87.89 -18.01 30.14 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.435 1.094 . . . . 71.14 111.303 -176.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -138.83 161.13 38.01 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.144 0.978 . . . . 72.14 109.024 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mm -127.85 160.42 37.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 105.874 -1.898 . . . . 53.42 105.874 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.6 m -81.29 152.08 27.76 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.637 -1.246 . . . . 71.22 107.637 167.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 32.8 mt -62.01 163.83 7.39 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.751 -0.463 . . . . 62.24 109.751 173.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -71.64 -37.4 70.85 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.648 0.779 . . . . 71.04 109.313 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.4 mmtp -140.83 78.72 19.83 Favored Pre-proline 0 CA--C 1.529 0.166 0 C-N-CA 126.005 1.722 . . . . 72.44 108.073 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.4 108.03 2.53 Favored 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.171 1.914 . . . . 75.33 107.646 172.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.7 tt -154.48 170.39 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 118.955 0.798 . . . . 62.33 109.43 173.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 65.51 -176.93 0.18 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.114 2.166 . . . . 64.05 113.827 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.2 -83.15 0.15 Allowed Glycine 0 C--N 1.34 0.795 0 N-CA-C 108.22 -1.952 . . . . 75.25 108.22 170.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.23 166.5 0.1 OUTLIER Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 125.262 1.425 . . . . 42.51 113.15 174.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -64.44 120.39 7.69 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.558 1.505 . . . . 44.24 109.558 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -61.81 -25.75 67.69 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.368 1.467 . . . . 72.05 112.268 -174.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.829 HG21 HG23 ' A' ' 54' ' ' THR . 75.1 t -145.12 140.88 22.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 126.73 2.012 . . . . 44.55 106.15 173.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 tp -156.66 161.65 39.86 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.99 1.316 . . . . 73.25 107.94 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -139.74 126.43 20.57 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 106.511 -1.662 . . . . 63.32 106.511 -163.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -128.79 127.7 42.48 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.191 0.996 . . . . 74.15 112.174 -173.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -169.67 173.96 6.04 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.371 2.269 . . . . 63.22 112.233 176.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.8 t -135.84 151.11 49.71 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.078 -1.013 . . . . 74.25 109.073 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.722 ' CD1' HD11 ' A' ' 71' ' ' LEU 0.307 0.0 OUTLIER -62.12 -19.67 63.25 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 120.599 1.545 . . . . 63.42 113.44 -175.158 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.401 ' CE2' ' HA3' ' A' ' 65' ' ' GLY . 59.3 m-85 -92.26 1.45 57.21 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 120.928 1.695 . . . . 75.05 112.506 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.4 p -75.85 141.68 72.14 Favored Pre-proline 0 C--N 1.354 0.762 0 CA-C-N 122.162 2.256 . . . . 40.42 108.547 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -89.07 -31.27 0.16 Allowed 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 121.319 1.346 . . . . 60.13 111.338 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -62.03 -40.81 96.99 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.156 -0.965 . . . . 72.45 110.957 174.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.9 p -70.43 -28.46 65.06 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-O 118.146 -0.93 . . . . 61.05 110.971 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -54.85 -56.06 23.57 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.767 1.167 . . . . 73.24 110.263 175.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.401 ' HA ' HE21 ' A' ' 35' ' ' GLN . 0.3 OUTLIER -56.16 -46.88 79.13 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-O 118.514 -0.755 . . . . 74.41 109.022 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -66.64 -10.35 45.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 117.005 -1.474 . . . . 53.32 113.386 -175.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -134.25 0.46 3.1 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 120.616 1.553 . . . . 72.42 112.67 -163.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -139.58 -36.37 0.52 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 126.687 1.995 . . . . 72.13 110.765 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.3 t -102.56 -76.84 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 107.284 -1.376 . . . . 52.11 107.284 -173.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 71.7 mt -68.19 -21.73 64.86 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.432 1.493 . . . . 71.31 113.614 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 13.8 m80 44.66 58.96 3.59 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.92 1.688 . . . . 73.33 113.062 176.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 96.4 t -63.74 -41.3 92.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.976 1.311 . . . . 55.31 110.861 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.5 t -56.42 -45.03 80.9 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.477 1.49 . . . . 74.01 110.696 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -69.18 -37.97 78.45 Favored 'General case' 0 C--O 1.233 0.189 0 O-C-N 121.253 -0.905 . . . . 64.11 110.2 -176.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.47 -39.7 85.3 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.461 1.105 . . . . 74.35 112.299 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.1 t -60.86 -49.17 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.283 1.433 . . . . 71.14 109.254 171.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -52.57 -42.49 64.52 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 119.546 1.066 . . . . 64.33 113.66 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -57.17 -13.31 2.92 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.614 1.339 . . . . 71.23 114.614 173.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -120.74 -4.2 9.73 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.585 1.954 . . . . 54.23 112.457 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.619 HD22 HG21 ' A' ' 54' ' ' THR . 14.6 mt -70.8 144.24 90.49 Favored Pre-proline 0 C--O 1.239 0.538 0 CA-C-N 119.947 1.249 . . . . 72.32 109.791 -171.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -84.38 161.27 12.99 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 123.74 2.96 . . . . 73.34 109.825 169.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.75 40.85 0.82 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 114.262 1.208 . . . . 74.04 114.262 -165.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.93 -37.64 0.65 Allowed Glycine 0 CA--C 1.524 0.633 0 O-C-N 121.052 -1.03 . . . . 24.02 111.419 167.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.829 HG23 HG21 ' A' ' 22' ' ' VAL . 58.2 m -44.79 -59.09 2.69 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.404 2.282 . . . . 32.21 114.534 -163.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.2 tptt 57.87 126.72 0.01 OUTLIER 'General case' 0 C--N 1.344 0.351 0 C-N-CA 126.547 1.939 . . . . 60.13 111.469 -168.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -75.82 128.67 35.63 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.713 -0.847 . . . . 72.12 108.713 175.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.41 -177.35 3.11 Favored 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 124.171 0.988 . . . . 75.42 110.104 173.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -166.7 104.8 0.59 Allowed 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 106.008 -1.849 . . . . 63.23 106.008 166.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.439 ' CD2' ' HG3' ' A' ' 137' ' ' GLN . 9.5 m-30 -85.69 170.86 12.1 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.956 -1.127 . . . . 74.05 107.956 161.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.757 ' CE1' HG22 ' A' ' 72' ' ' THR . 1.5 p80 -108.76 171.48 7.4 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.239 1.416 . . . . 72.01 108.1 176.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 60' ' ' HIS . 2.2 m -148.29 157.73 8.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 119.832 1.196 . . . . 61.33 108.99 162.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.6 -8.98 14.19 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 129.345 3.058 . . . . 72.31 111.897 -166.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -60.92 1.09 0.16 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.792 1.637 . . . . 55.51 113.528 173.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 35.6 mt -129.4 119.36 23.71 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 119.879 -1.763 . . . . 75.15 108.282 -170.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.401 ' HA3' ' CE2' ' A' ' 29' ' ' TYR . . . 76.85 166.89 25.81 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 125.508 1.528 . . . . 61.34 112.816 175.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.58 -40.42 5.62 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.754 2.303 . . . . 75.43 111.132 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 58.7 mt -72.54 16.23 0.15 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.907 0.883 . . . . 52.15 112.012 174.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -45.31 -64.33 2.32 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.369 1.461 . . . . 72.24 110.999 172.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -59.74 -33.41 71.62 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.385 1.092 . . . . 62.02 112.472 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.58 -44.53 86.38 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.873 0.869 . . . . 75.02 109.779 176.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.722 HD11 ' CD1' ' A' ' 28' ' ' PHE . 16.2 mt -58.32 -46.06 86.89 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.668 1.187 . . . . 73.32 111.476 -176.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.757 HG22 ' CE1' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -46.08 -46.36 16.81 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.346 1.858 . . . . 64.33 109.477 174.542 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -76.5 -50.98 12.63 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 118.412 -0.804 . . . . 75.32 110.715 -172.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.69 -35.05 75.32 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.705 1.593 . . . . 71.04 112.662 -176.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.43 ' HB3' ' HD2' ' A' ' 60' ' ' HIS . 28.8 t-105 -59.3 -36.9 76.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.002 0.365 . . . . 73.32 111.147 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.31 -29.0 69.12 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 112.708 0.633 . . . . 54.53 112.708 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.2 t -57.23 -52.62 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 120.244 1.384 . . . . 51.53 109.495 162.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.89 -56.94 15.44 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 118.216 -0.897 . . . . 72.32 110.753 -174.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.4 mt -52.61 -41.27 36.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.497 1.119 . . . . 71.42 110.489 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.87 -33.75 76.55 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 120.017 -0.673 . . . . 74.41 110.933 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.9 mt -86.41 -23.9 25.92 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.253 0.464 . . . . 72.31 112.253 175.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 71.1 69.72 1.34 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.946 1.736 . . . . 75.21 110.116 -171.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.7 m -133.52 8.3 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.464 1.105 . . . . 60.32 112.563 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -53.56 -51.84 61.65 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 125.069 1.348 . . . . 75.44 112.055 -169.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -55.31 -45.29 76.3 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.037 0.935 . . . . 71.33 109.257 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.402 ' H ' ' HG3' ' A' ' 86' ' ' LYS . 17.5 mtpt -66.17 -21.83 66.34 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.825 1.65 . . . . 60.12 111.44 -176.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.5 pp -121.6 26.77 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 125.579 1.551 . . . . 73.03 110.014 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 96.6 m -95.2 -48.76 5.79 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 119.131 0.878 . . . . 61.43 108.963 166.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.486 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -61.35 -62.31 6.18 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 119.267 0.94 . . . . 42.35 112.211 -175.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.486 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 56.6 Cg_endo -67.32 -23.69 44.34 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 121.633 1.556 . . . . 74.25 111.624 -174.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 32.8 tpp -64.16 -52.63 58.09 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.539 1.136 . . . . 75.32 109.101 174.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -69.43 -32.7 71.82 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 124.163 0.914 . . . . 65.12 110.469 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -63.2 -33.21 74.99 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 118.272 0.487 . . . . 72.01 110.39 171.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.47 -12.89 33.33 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.87 1.214 . . . . 64.34 113.403 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.667 HG21 ' CD2' ' A' ' 28' ' ' PHE . 41.4 t -100.08 -39.59 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 C-N-CA 124.184 0.994 . . . . 74.43 109.746 -178.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -111.53 -53.58 2.69 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.72 0.808 . . . . 63.44 110.044 -171.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -67.77 -60.16 2.74 Favored 'General case' 0 C--N 1.339 0.142 0 O-C-N 121.453 -0.779 . . . . 73.11 109.909 -173.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.4 p -90.56 -25.71 20.08 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.547 0.573 . . . . 71.13 112.547 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 49.44 61.46 3.13 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 128.521 2.728 . . . . 73.43 112.393 -174.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.3 t -101.7 -14.52 17.33 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.762 1.225 . . . . 72.02 113.171 174.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.499 HG13 HG12 ' A' ' 107' ' ' ILE . 25.6 t -69.96 123.46 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 119.875 1.216 . . . . 51.31 108.834 171.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -144.35 -26.61 0.52 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.42 1.088 . . . . 53.44 111.714 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.82 167.32 21.98 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.308 0.958 . . . . 74.02 108.747 174.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 43.8 t -56.2 -40.28 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 123.709 0.804 . . . . 60.12 110.68 -175.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.26 -24.99 61.22 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.674 0.79 . . . . 75.33 112.617 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -79.83 -34.09 39.73 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.16 0.891 . . . . 74.14 110.807 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.499 HG12 HG13 ' A' ' 101' ' ' VAL . 1.8 mt -75.01 -48.23 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 108.716 -0.846 . . . . 61.32 108.716 -176.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -17.14 63.75 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 118.289 -0.862 . . . . 72.32 111.428 -176.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -58.87 -58.12 10.03 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.61 0.764 . . . . 73.12 110.012 168.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.3 t -57.24 -38.81 63.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 123.445 0.698 . . . . 74.25 111.565 -174.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -54.51 -53.03 59.84 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.839 -0.538 . . . . 75.45 109.765 173.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 97.5 t -60.62 -46.05 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 123.717 0.807 . . . . 72.44 110.186 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -55.39 -45.67 76.59 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.832 1.253 . . . . 64.03 109.425 -176.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.91 -15.05 60.25 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.703 1.201 . . . . 72.14 113.102 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 114.18 51.5 0.47 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.487 1.042 . . . . 65.32 113.213 172.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.8 t -111.6 142.78 22.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 124.374 1.07 . . . . 73.41 108.513 168.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.7 mmtm -61.57 148.67 41.51 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.831 0.824 . . . . 72.44 110.804 176.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.0 -18.17 74.29 Favored Glycine 0 CA--C 1.518 0.235 0 CA-C-N 114.985 -1.007 . . . . 61.31 113.15 167.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -87.57 -36.04 17.78 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 109.326 -0.62 . . . . 63.44 109.326 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.72 -43.3 72.64 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 106.25 -1.759 . . . . 63.04 106.25 -169.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -63.18 -52.93 60.39 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 123.693 0.621 . . . . 73.03 110.202 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -71.7 -17.05 62.25 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.963 0.505 . . . . 73.03 112.297 -174.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -87.15 -63.96 1.22 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.61 1.164 . . . . 51.51 109.597 172.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.32 -34.56 66.65 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.196 0.998 . . . . 73.43 111.463 -170.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -49.47 -33.53 14.54 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.862 0.865 . . . . 73.32 112.658 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -111.27 6.51 20.6 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.584 1.553 . . . . 75.25 112.848 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 43.3 t -82.73 157.21 23.37 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.283 1.433 . . . . 72.43 111.048 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -62.21 -34.53 76.65 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.373 1.469 . . . . 74.14 111.469 172.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 72.2 t -50.41 -50.98 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 108.843 -0.799 . . . . 73.31 108.843 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 22.1 t -65.91 -44.31 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 124.369 1.067 . . . . 64.22 111.723 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.538 ' HE2' ' HA ' ' A' ' 131' ' ' LYS . 10.8 mmpt? -51.55 -52.69 45.02 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.041 0.837 . . . . 75.14 110.921 176.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.6 -34.48 77.98 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.359 1.064 . . . . 63.24 110.955 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.0 mt -63.21 -54.99 28.81 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 117.141 -1.409 . . . . 63.42 110.848 175.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 87.4 t -54.07 -39.11 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 119.819 1.191 . . . . 61.23 109.601 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.68 -22.81 66.76 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 118.188 -0.91 . . . . 73.45 113.067 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -58.1 -53.1 62.02 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 119.638 1.108 . . . . 71.44 109.35 172.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.439 ' HG3' ' CD2' ' A' ' 59' ' ' TYR . 20.9 mp0 -78.88 -30.43 45.0 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.229 -0.919 . . . . 73.25 110.113 -175.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -68.87 11.67 0.18 Allowed 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.143 -1.598 . . . . 73.44 112.81 163.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -125.24 -19.93 4.98 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 124.775 1.23 . . . . 73.15 111.925 162.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -115.07 -10.41 12.22 Favored 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 114.557 1.317 . . . . 75.01 114.557 -172.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -96.66 -38.79 9.79 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.524 1.057 . . . . 74.31 108.343 157.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.9 -28.05 69.78 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 113.908 1.077 . . . . 63.43 113.908 -170.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -80.71 26.87 0.39 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.656 0.984 . . . . 63.22 113.656 -169.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.5 mt 65.16 28.3 12.2 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.815 -1.178 . . . . 62.22 111.504 165.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -104.68 -20.9 13.49 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.451 1.501 . . . . 74.02 112.216 -171.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.44 HD11 ' CB ' ' A' ' 151' ' ' ALA . 1.3 tt -168.15 137.03 2.4 Favored 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 128.738 2.815 . . . . 64.32 106.864 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -140.94 5.83 1.96 Allowed 'General case' 0 CA--C 1.546 0.802 0 O-C-N 124.017 0.823 . . . . 53.32 111.121 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -143.55 152.22 23.94 Favored Glycine 0 C--N 1.343 0.966 0 CA-C-N 119.624 1.102 . . . . 72.35 110.903 172.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.524 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 35.7 m -132.83 174.84 4.24 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 125.818 1.647 . . . . 75.02 110.717 -170.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.524 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 15.8 Cg_endo -61.98 152.04 61.76 Favored 'Cis proline' 0 C--N 1.352 0.746 0 CA-C-N 121.475 1.562 . . . . 73.05 112.165 -10.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.44 ' CB ' HD11 ' A' ' 146' ' ' LEU . . . -152.65 152.66 32.02 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.587 0.554 . . . . 63.14 111.111 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 77.1 mmm -151.78 121.51 6.99 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.673 1.189 . . . . 64.34 107.813 -167.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 12.0 m-30 -100.02 152.8 19.79 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.005 0.922 . . . . 54.41 110.361 -172.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.4 t -139.87 151.76 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.566 0.746 . . . . 72.25 110.202 174.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 44.88 24.12 0.1 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 129.273 3.029 . . . . 52.52 114.494 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 53.03 24.67 21.5 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 121.194 -0.941 . . . . 74.41 112.996 -173.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.584 ' HE2' ' CE2' ' A' ' 158' ' ' TYR . 9.3 pttt -150.24 -3.55 0.36 Allowed 'General case' 0 C--N 1.344 0.335 0 N-CA-C 114.527 1.306 . . . . 74.12 114.527 177.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.584 ' CE2' ' HE2' ' A' ' 157' ' ' LYS . 49.8 m-85 -126.59 159.93 32.1 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 124.73 1.212 . . . . 64.42 110.953 -176.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -126.22 149.2 49.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.654 1.982 . . . . 43.22 107.044 170.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.568 HD11 HG23 ' A' ' 180' ' ' THR . 2.2 mm? -74.47 154.26 38.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.995 -0.742 . . . . 63.04 108.995 167.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -125.18 80.61 64.41 Favored Pre-proline 0 C--O 1.232 0.18 0 C-N-CA 123.353 0.661 . . . . 63.44 110.808 177.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.36 -4.84 10.09 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 121.986 1.791 . . . . 72.04 113.212 175.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -86.82 -2.66 58.74 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.16 1.384 . . . . 71.43 113.127 173.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -132.47 46.16 1.08 Allowed Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 109.584 -1.406 . . . . 63.15 109.584 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 36.6 mtt -130.97 174.97 9.47 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 118.172 0.986 . . . . 72.32 111.851 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.32 90.35 4.97 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.945 -1.131 . . . . 73.13 107.945 174.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.344 6.4 t -118.53 48.13 1.5 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.78 1.232 . . . . 73.12 107.965 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.6 m -84.16 -47.79 10.49 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.074 -0.966 . . . . 74.11 110.338 159.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.519 HD22 ' CG2' ' A' ' 172' ' ' VAL . 0.0 OUTLIER -113.05 -9.9 13.52 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 117.962 -1.018 . . . . 70.24 113.065 -162.401 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 33.6 mmm 75.47 -53.94 0.64 Allowed 'General case' 0 C--O 1.227 -0.103 0 C-N-CA 126.451 1.901 . . . . 72.32 112.705 170.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.22 -31.35 72.48 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.656 1.116 . . . . 72.15 109.512 176.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.519 ' CG2' HD22 ' A' ' 169' ' ' ASN . 89.0 t -80.68 -25.04 11.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.65 1.58 . . . . 64.04 111.8 175.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -63.54 -58.06 8.2 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.014 -1.476 . . . . 73.05 107.014 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 14.3 t -61.83 -38.88 81.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 122.999 0.52 . . . . 73.02 110.195 -174.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.71 -46.06 70.65 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.437 1.095 . . . . 51.32 110.754 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -83.75 -31.29 26.06 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.165 0.986 . . . . 65.15 112.493 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -54.61 -54.8 36.67 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.227 -0.921 . . . . 64.24 109.242 175.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.96 -27.63 66.97 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.084 0.772 . . . . 62.11 113.084 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.2 -54.85 14.93 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.632 1.173 . . . . 64.24 110.614 177.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.568 HG23 HD11 ' A' ' 160' ' ' LEU . 13.6 t -62.21 -30.91 71.41 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 118.553 -0.737 . . . . 73.25 110.615 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 94.8 t -59.66 -51.81 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.519 -0.919 . . . . 54.24 108.519 177.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -62.0 -47.63 83.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.181 0.593 . . . . 75.25 109.8 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -58.29 -37.23 74.62 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 118.638 0.654 . . . . 75.44 111.932 -172.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 72.0 mt -65.51 -28.72 69.39 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.45 -0.781 . . . . 72.32 112.192 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.21 -22.55 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.403 0.681 . . . . 72.23 111.646 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -98.87 -16.47 18.82 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 118.652 0.66 . . . . 75.13 110.509 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -93.15 13.66 20.36 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.708 1.373 . . . . 75.41 114.708 -170.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 35.1 mttt . . . . . 0 C--O 1.246 0.898 0 C-N-CA 127.933 2.493 . . . . 64.31 113.886 -175.611 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.467 0.383 0 N-CA-C 109.408 -0.59 . . . . 61.24 109.408 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 75.79 -10.18 1.31 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 128.865 2.866 . . . . 53.32 113.697 165.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -76.31 48.74 0.54 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.86 2.064 . . . . 64.41 112.195 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -156.24 118.22 3.98 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.902 -1.148 . . . . 62.21 107.902 164.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.4 pt -115.63 164.62 11.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 126.217 1.807 . . . . 71.55 108.604 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.2 m -137.55 139.41 40.44 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.079 -1.823 . . . . 63.33 106.079 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -55.08 138.66 43.71 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.149 1.78 . . . . 72.34 109.739 167.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.45 -25.71 3.23 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.445 1.498 . . . . 41.34 113.41 -171.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -91.8 -77.35 0.43 Allowed 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 119.211 1.506 . . . . 65.42 107.227 -165.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -97.4 -15.38 20.7 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.543 0.737 . . . . 54.25 111.166 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -142.95 160.69 39.86 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.34 0.656 . . . . 75.32 110.246 173.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.3 mm -123.8 157.2 30.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 106.818 -1.549 . . . . 65.43 106.818 172.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.9 m -101.79 152.9 20.33 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.199 1.4 . . . . 75.52 107.633 174.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 12.3 mt -91.27 148.83 22.07 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 106.705 -1.591 . . . . 73.55 106.705 169.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -72.58 -34.43 67.45 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.128 1.371 . . . . 71.13 109.765 177.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.9 mmtm -125.68 82.31 63.91 Favored Pre-proline 0 C--O 1.232 0.136 0 C-N-CA 126.7 2.0 . . . . 73.12 108.166 175.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.51 86.63 1.45 Allowed 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 123.645 2.897 . . . . 71.52 107.844 168.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 15.7 tt -157.86 141.16 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 O-C-N 121.055 -1.028 . . . . 51.44 109.1 173.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 50.65 -173.69 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.657 1.983 . . . . 61.53 114.026 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.89 121.93 1.71 Allowed Glycine 0 CA--C 1.52 0.399 0 N-CA-C 109.997 -1.241 . . . . 54.13 109.997 -175.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 60.74 166.39 0.09 OUTLIER Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 126.147 1.779 . . . . 61.14 115.527 166.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -67.61 64.68 0.83 Allowed 'Trans proline' 0 CA--C 1.55 1.311 0 C-N-CA 123.768 2.979 . . . . 45.53 113.696 175.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 54.06 -28.64 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.799 1 C-N-CA 132.85 4.46 . . . . 62.34 118.442 174.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.7 p -151.91 147.72 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 122.3 2.318 . . . . 65.43 110.008 165.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.416 HD21 ' CD2' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -172.14 164.53 6.06 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.274 1.03 . . . . 64.43 110.536 -167.454 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -123.46 158.94 30.09 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.903 1.281 . . . . 54.13 109.435 173.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -142.04 134.18 27.59 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.731 1.613 . . . . 73.52 113.221 174.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -139.69 177.77 7.71 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.352 1.461 . . . . 52.51 111.125 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.9 t -136.61 162.33 33.42 Favored 'General case' 0 CA--C 1.527 0.09 0 N-CA-C 109.457 -0.571 . . . . 62.43 109.457 157.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.784 ' CD1' HD11 ' A' ' 71' ' ' LEU 0.257 0.0 OUTLIER -71.59 -20.14 62.04 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.502 -0.749 . . . . 63.12 112.834 171.232 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -89.03 -9.21 52.12 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 117.724 -1.131 . . . . 75.41 112.725 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.7 p -84.63 142.27 39.63 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 121.416 1.916 . . . . 40.22 110.284 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -91.72 -31.23 0.1 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 121.384 1.389 . . . . 75.11 112.395 -170.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -58.54 -44.02 89.46 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.143 -0.688 . . . . 74.41 109.143 169.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 25.7 m -55.62 -39.95 71.49 Favored 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 123.979 0.912 . . . . 74.52 110.742 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -52.47 -60.83 2.76 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 119.523 1.056 . . . . 64.24 109.813 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -54.54 -41.8 70.16 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 119.026 -0.511 . . . . 62.33 109.755 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -68.89 -24.41 64.31 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 118.347 -0.835 . . . . 71.52 112.526 -174.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -116.24 -3.82 11.95 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.689 0.677 . . . . 72.31 111.635 -167.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -138.38 -35.07 0.61 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.879 1.672 . . . . 60.12 114.016 -168.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 86.8 t -111.05 -78.79 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 N-CA-C 105.458 -2.053 . . . . 75.52 105.458 -172.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.6 mt -57.4 -29.15 63.87 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.48 1.912 . . . . 75.12 111.159 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 44.1 54.89 5.72 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.005 1.722 . . . . 72.43 110.23 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.543 ' O ' HG23 ' A' ' 46' ' ' VAL . 97.4 t -53.38 -51.47 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 126.099 1.76 . . . . 43.24 107.898 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.9 t -44.09 -53.2 6.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.669 1.987 . . . . 54.12 111.404 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -76.64 -30.29 56.78 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.462 0.649 . . . . 74.52 111.332 -173.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -72.86 -37.39 67.39 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.318 -0.864 . . . . 60.23 111.78 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 42' ' ' VAL . 1.9 t -60.68 -49.97 82.33 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 N-CA-C 107.93 -1.137 . . . . 72.45 107.93 173.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -47.62 -45.49 27.72 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 124.588 1.155 . . . . 73.24 112.335 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -63.6 -5.14 3.53 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 115.468 1.655 . . . . 75.31 115.468 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -123.4 -10.26 7.98 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.351 2.26 . . . . 60.43 113.03 174.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.453 HD13 HG21 ' A' ' 54' ' ' THR . 13.6 mt -73.17 145.39 85.81 Favored Pre-proline 0 C--O 1.238 0.478 0 CA-C-N 120.109 1.322 . . . . 44.53 112.306 -163.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.76 160.49 31.04 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 124.49 3.46 . . . . 63.13 112.348 175.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -76.97 45.44 0.43 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.541 1.936 . . . . 62.13 112.451 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -155.54 -6.59 0.08 OUTLIER Glycine 0 CA--C 1.528 0.896 0 C-N-CA 125.329 1.443 . . . . 73.31 113.523 175.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.453 HG21 HD13 ' A' ' 50' ' ' LEU . 14.2 t -56.4 -43.63 79.49 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.496 1.648 . . . . 74.15 112.092 174.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 33.8 tptt 44.66 90.94 0.01 OUTLIER 'General case' 0 C--N 1.346 0.417 0 C-N-CA 126.305 1.842 . . . . 73.22 110.196 -165.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.33 105.57 0.3 Allowed 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 127.342 2.257 . . . . 73.21 108.945 -175.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.0 m -143.36 115.3 8.29 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 107.138 -1.43 . . . . 72.13 107.138 -172.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.72 137.55 54.34 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.857 1.263 . . . . 61.11 108.459 178.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.462 ' CG ' ' HG2' ' A' ' 137' ' ' GLN . 17.1 m-30 -104.86 -174.94 2.65 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.936 1.694 . . . . 73.43 108.744 173.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -139.99 133.34 29.92 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.073 1.349 . . . . 63.33 107.644 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.3 m -85.99 170.77 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 119.096 0.862 . . . . 74.51 112.254 -172.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.11 0.77 9.11 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.888 2.075 . . . . 73.12 112.558 -178.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -71.32 -34.26 70.4 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.253 1.021 . . . . 52.12 112.638 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 mt -91.91 126.44 36.99 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 108.372 -0.973 . . . . 73.54 108.372 -171.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.25 167.52 33.85 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 115.336 -0.847 . . . . 61.33 112.829 168.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -66.66 -48.19 2.33 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 124.424 3.416 . . . . 65.32 109.604 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.5 mt -73.22 13.62 0.41 Allowed 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 127.2 2.2 . . . . 73.52 112.514 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -50.48 -46.99 45.44 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 119.823 1.192 . . . . 55.03 111.697 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.1 tptp -71.42 -36.52 71.33 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.401 1.101 . . . . 75.31 111.414 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -63.83 -33.41 75.61 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 118.58 0.627 . . . . 72.12 110.189 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.784 HD11 ' CD1' ' A' ' 28' ' ' PHE . 15.1 mt -62.13 -49.66 74.99 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 118.416 -0.802 . . . . 51.14 113.038 175.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.5 m -57.2 -45.29 83.9 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.795 -1.187 . . . . 33.31 107.795 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -57.36 -47.3 82.0 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.189 0.904 . . . . 65.22 110.527 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.09 -41.11 82.77 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.949 1.249 . . . . 75.34 112.862 176.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 35.6 t-105 -57.93 -38.89 76.76 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.654 0.782 . . . . 74.24 110.681 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.69 -40.78 80.23 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 117.504 -1.236 . . . . 52.33 113.487 175.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.0 -43.47 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 120.532 1.514 . . . . 75.11 108.783 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.12 -43.31 87.54 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 118.255 -0.878 . . . . 72.52 111.545 -175.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 59.2 mt -63.02 -46.34 96.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.03 0.932 . . . . 71.22 109.634 172.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.21 -24.4 63.1 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.691 0.678 . . . . 71.13 111.477 -174.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.1 mt -107.17 -16.65 14.36 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 113.916 1.08 . . . . 53.44 113.916 176.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.56 69.96 1.16 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.285 0.945 . . . . 32.31 110.792 -166.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.4 m -135.61 13.5 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 124.753 1.221 . . . . 62.53 112.285 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -50.06 -50.78 46.75 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 125.563 1.545 . . . . 73.21 111.77 -173.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.78 -37.93 89.26 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.319 0.647 . . . . 64.23 110.221 -178.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -65.23 -43.68 90.68 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.17 0.509 . . . . 64.22 110.0 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.8 pp -92.44 17.33 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.18 0 C-N-CA 124.803 1.241 . . . . 62.35 111.633 -175.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 38.9 m -88.36 -48.12 7.88 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.032 0.833 . . . . 74.41 110.019 169.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.509 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -56.79 -60.85 8.18 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 113.907 1.077 . . . . 60.12 113.907 -169.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 30.2 Cg_endo -68.43 -25.74 35.32 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.299 1.332 . . . . 73.11 111.643 -178.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 20.2 tpp -65.25 -50.63 65.05 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 124.89 1.276 . . . . 72.54 110.826 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -69.64 -30.57 68.31 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.852 -0.796 . . . . 71.32 108.852 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -57.8 -46.97 83.87 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 118.648 0.658 . . . . 75.33 110.332 167.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.41 2.81 23.54 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 120.538 -1.351 . . . . 65.12 113.014 -174.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.739 HG21 ' CD2' ' A' ' 28' ' ' PHE . 38.8 t -123.59 -39.44 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 C-N-CA 125.026 1.331 . . . . 62.32 110.826 -173.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -107.75 -47.59 3.57 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.12 -0.696 . . . . 71.25 109.12 -175.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -77.3 -52.42 9.21 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.24 0.616 . . . . 71.12 110.703 -171.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.5 p -103.86 -24.59 13.27 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.536 1.134 . . . . 53.41 112.18 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 57.31 26.12 12.0 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 127.58 2.352 . . . . 64.24 114.552 177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.3 t -68.36 -20.58 64.72 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.937 0.718 . . . . 51.33 112.937 -178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.427 HG11 ' CZ ' ' A' ' 28' ' ' PHE . 25.1 t -67.43 123.71 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 O-C-N 120.87 -1.144 . . . . 54.51 109.444 173.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -145.84 -25.06 0.46 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.712 1.605 . . . . 75.51 111.326 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.17 164.93 26.56 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.793 -0.817 . . . . 74.45 108.793 176.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 25.3 t -55.07 -40.89 56.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.227 1.011 . . . . 73.25 109.432 173.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.16 8.48 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.539 1.935 . . . . 63.43 114.885 173.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -113.69 -46.9 3.01 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 125.045 1.338 . . . . 61.53 109.117 168.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.3 mt -59.01 -37.56 68.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 123.55 0.74 . . . . 64.42 110.356 -177.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.0 -19.59 64.14 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 117.54 -1.219 . . . . 72.54 112.845 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -57.6 -58.37 8.62 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 119.703 1.138 . . . . 74.31 110.024 164.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 55.2 t -57.13 -37.31 54.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 122.564 0.345 . . . . 60.31 111.732 -167.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -50.98 -56.81 10.61 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.417 -0.586 . . . . 65.25 109.417 171.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 39.8 t -64.57 -38.06 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 123.952 0.901 . . . . 74.12 110.699 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.66 -42.96 98.09 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.499 0.719 . . . . 73.21 109.511 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.48 2.89 12.49 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.353 1.461 . . . . 43.33 112.478 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.58 61.95 1.66 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 125.06 1.314 . . . . 53.05 111.468 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 77.7 t -119.57 145.43 25.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 123.273 0.629 . . . . 54.41 109.935 169.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -62.02 118.61 7.52 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.671 1.189 . . . . 74.25 108.661 169.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.61 -28.71 70.24 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-O 118.3 -1.278 . . . . 73.33 111.677 166.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -73.05 -25.64 61.0 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 118.93 1.365 . . . . 52.45 109.59 -177.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.03 -39.55 29.66 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.075 0.95 . . . . 73.31 109.393 176.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -64.5 -59.61 4.12 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 107.266 -1.383 . . . . 74.33 107.266 -177.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -60.68 -28.54 68.69 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.661 1.184 . . . . 42.35 110.302 -175.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -80.56 -64.43 1.19 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.473 -0.565 . . . . 73.45 109.473 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.91 -40.05 69.45 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 117.494 -1.241 . . . . 74.52 110.325 -172.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 46.0 t-105 -47.54 -37.6 12.47 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 124.503 1.121 . . . . 75.23 112.76 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -105.16 -5.03 21.1 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.579 1.152 . . . . 73.33 111.219 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 10.9 t -88.59 149.69 23.44 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.29 1.836 . . . . 55.03 109.753 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -50.24 -34.02 21.59 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.138 1.775 . . . . 73.15 111.622 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 76.7 t -45.49 -59.64 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 125.838 1.655 . . . . 44.22 109.461 176.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 134' ' ' VAL . 18.3 t -64.69 -46.04 93.46 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.682 0 CA-C-O 117.788 -1.101 . . . . 62.32 109.164 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -50.27 -50.33 50.64 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 120.247 1.385 . . . . 73.44 110.719 -177.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.4 t -69.73 -35.62 75.17 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 118.184 -0.912 . . . . 55.13 109.94 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.497 ' HA ' ' HG2' ' A' ' 136' ' ' GLN . 66.0 mt -64.51 -37.23 86.83 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 119.453 1.024 . . . . 73.24 112.225 177.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 130' ' ' VAL . 42.7 t -56.06 -49.18 77.12 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 N-CA-C 107.908 -1.145 . . . . 63.25 107.908 173.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.92 -49.89 70.18 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.308 0.503 . . . . 42.53 111.641 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.497 ' HG2' ' HA ' ' A' ' 133' ' ' LEU . 1.4 pt20 -58.76 -34.32 71.28 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 123.498 0.499 . . . . 75.24 111.82 -173.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.462 ' HG2' ' CG ' ' A' ' 59' ' ' TYR . 23.6 mt-30 -89.9 -48.12 7.43 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 126.391 1.877 . . . . 45.34 111.129 -173.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -62.66 -46.36 88.56 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.2 1.0 . . . . 74.43 109.159 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -58.72 -46.18 87.94 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.796 -0.816 . . . . 74.15 108.796 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.63 -9.06 16.88 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.586 0.958 . . . . 51.32 113.586 -174.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.67 5.44 10.55 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 120.755 1.616 . . . . 73.51 112.942 174.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.5 -3.41 5.45 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.01 0.924 . . . . 75.23 112.489 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -56.05 -85.68 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.922 2.489 . . . . 72.34 109.978 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.1 pp 179.18 41.49 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.062 1.745 . . . . 75.31 110.873 176.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -133.56 -45.27 0.82 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.254 1.205 . . . . 72.53 114.254 -172.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 16.1 tp -85.11 -85.3 0.14 Allowed 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 125.347 1.459 . . . . 72.53 109.746 -166.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 56.72 33.51 23.03 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.202 0.601 . . . . 73.33 111.628 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 178.31 155.81 15.27 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.856 1.693 . . . . 60.55 110.965 174.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 16.2 m -149.06 161.78 31.24 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 124.693 1.197 . . . . 74.21 108.931 175.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -65.14 141.12 46.56 Favored 'Cis proline' 0 C--N 1.35 0.626 0 CA-C-N 120.227 1.117 . . . . 64.23 112.504 -8.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -131.2 142.8 50.24 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 114.764 -1.107 . . . . 65.32 109.625 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 50.8 mtp -148.23 113.99 5.72 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 102.469 -3.16 . . . . 74.54 102.469 -176.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -100.95 165.66 11.22 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.4 0.68 . . . . 52.41 109.387 -175.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.6 t -138.07 133.44 44.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.667 0.746 . . . . 71.42 110.668 172.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 44.9 30.84 0.6 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 130.754 3.621 . . . . 60.34 115.417 171.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 64.59 34.41 89.82 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 124.823 1.202 . . . . 54.12 111.395 177.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.444 ' HG3' ' CE2' ' A' ' 158' ' ' TYR . 9.7 ptmt -160.52 -10.4 0.05 OUTLIER 'General case' 0 C--N 1.345 0.389 0 N-CA-C 116.742 2.126 . . . . 74.42 116.742 177.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.444 ' CE2' ' HG3' ' A' ' 157' ' ' LYS . 60.2 m-85 -128.89 160.88 31.24 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 120.376 1.444 . . . . 73.43 110.598 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -136.01 131.77 35.42 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 105.694 -1.965 . . . . 43.22 105.694 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.57 145.89 55.52 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.718 -1.216 . . . . 52.41 107.718 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -115.13 85.58 12.66 Favored Pre-proline 0 CA--C 1.522 -0.134 0 N-CA-C 113.034 0.753 . . . . 51.14 113.034 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -61.92 -24.19 76.74 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 CA-C-N 119.659 0.914 . . . . 72.35 112.059 173.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.28 2.58 27.44 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.139 1.376 . . . . 72.14 112.398 -170.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -130.24 22.02 4.8 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.229 1.395 . . . . 74.13 110.423 175.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 63.3 mtt -106.42 169.82 8.29 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 117.932 0.866 . . . . 73.41 110.335 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.2 63.82 7.39 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 124.626 2.155 . . . . 72.53 109.98 -174.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.6 p -73.65 32.51 0.08 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 129.376 3.07 . . . . 65.21 111.393 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.8 m -117.04 -3.02 11.61 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.031 1.732 . . . . 73.22 112.053 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.43 -9.67 2.87 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-O 117.678 -1.153 . . . . 53.11 111.744 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 13.2 mmt 65.49 -52.53 0.36 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 127.671 2.388 . . . . 61.53 115.282 172.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.38 -44.35 62.67 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.153 -1.425 . . . . 63.14 107.153 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 97.1 t -59.05 -39.14 77.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 124.02 0.928 . . . . 60.42 110.423 174.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -56.44 -59.78 4.48 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.838 -0.601 . . . . 73.25 109.736 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 20.2 t -66.54 -38.18 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 118.793 0.724 . . . . 72.35 110.807 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.46 -40.22 62.01 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.104 0.562 . . . . 75.53 110.903 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -86.37 -35.96 19.48 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 117.95 -1.024 . . . . 53.15 112.548 174.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -52.01 -60.85 2.71 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 121.039 1.745 . . . . 74.35 110.233 176.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -53.8 -35.27 61.19 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.459 1.104 . . . . 33.44 111.803 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -71.73 -48.52 46.51 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.505 1.122 . . . . 74.14 111.376 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.9 t -62.08 -31.09 71.48 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 117.071 -1.442 . . . . 52.43 109.782 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 30.7 t -58.56 -58.42 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-N 120.105 1.32 . . . . 71.33 108.929 171.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.96 -11.85 61.2 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 114.135 1.161 . . . . 74.25 114.135 -172.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -87.75 -33.11 18.8 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 123.972 0.909 . . . . 73.14 112.625 166.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 28.7 mt -66.51 -30.78 71.18 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 119.816 -1.803 . . . . 31.23 111.408 -177.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 69.3 t -61.89 -23.46 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.377 0.671 . . . . 73.24 112.549 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -101.25 -14.05 17.83 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 120.983 -1.073 . . . . 73.15 110.47 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -104.8 70.76 0.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 105.237 -2.134 . . . . 64.23 105.237 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? . . . . . 0 CA--C 1.508 -0.672 0 N-CA-C 103.162 -2.903 . . . . 75.44 103.162 170.466 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.468 0.43 0 N-CA-C 109.058 -0.719 . . . . 72.12 109.058 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -127.17 178.54 5.96 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.655 1.982 . . . . 64.14 107.032 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 56.57 25.07 9.44 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.415 1.886 . . . . 64.0 115.703 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -161.1 107.36 1.42 Allowed 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 125.693 1.597 . . . . 72.1 108.917 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.504 HD12 ' CE1' ' A' ' 9' ' ' TYR . 10.1 pt -111.68 170.87 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 125.604 1.562 . . . . 73.23 109.609 177.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.9 m -140.52 139.3 35.04 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 106.606 -1.627 . . . . 65.21 106.606 177.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -61.55 118.64 7.3 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.508 2.323 . . . . 72.02 109.102 172.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.01 -18.66 56.48 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.328 1.918 . . . . 71.42 112.404 -174.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -89.72 -84.8 0.22 Allowed 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.822 1.311 . . . . 63.02 108.725 -171.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -92.14 -10.91 37.12 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.449 1.1 . . . . 72.43 111.469 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.504 ' CE1' HD12 ' A' ' 3' ' ' ILE . 22.8 p90 -140.08 164.37 30.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.413 -0.803 . . . . 71.34 109.424 171.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.6 mm -125.12 161.22 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.383 1.473 . . . . 71.32 107.032 169.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -94.74 171.61 8.68 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.562 1.545 . . . . 54.42 108.737 174.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 50.5 mt -117.2 148.63 41.45 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.543 1.137 . . . . 63.23 109.902 162.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -75.21 -43.02 54.22 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.836 2.054 . . . . 70.24 109.062 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.4 mmtm -119.0 84.51 26.6 Favored Pre-proline 0 N--CA 1.454 -0.246 0 C-N-CA 126.76 2.024 . . . . 71.24 107.237 175.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -81.76 -6.73 12.47 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 124.717 3.611 . . . . 74.13 113.424 174.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 11.1 tt -150.94 116.4 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.455 0 O-C-N 121.063 -1.023 . . . . 72.23 108.552 -166.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -151.68 -43.28 0.11 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.666 1.186 . . . . 52.12 110.414 170.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.11 -21.67 0.02 OUTLIER Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.677 -1.068 . . . . 64.24 115.015 175.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -71.74 162.23 74.32 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-N 119.065 1.432 . . . . 54.34 112.864 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -78.36 -174.99 2.48 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.476 2.784 . . . . 72.33 111.113 175.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -114.44 158.48 21.51 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.616 1.166 . . . . 72.41 109.978 -175.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.31 3.5 p 51.41 91.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 129.896 3.278 . . . . 45.41 111.533 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.0 tp -140.96 142.3 34.35 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 113.61 -1.632 . . . . 72.12 108.224 -169.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -125.65 167.83 14.56 Favored 'General case' 0 CA--C 1.508 -0.645 0 C-N-CA 126.357 1.863 . . . . 65.2 108.448 -175.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.867 ' CE1' HG13 ' A' ' 149' ' ' VAL . 1.4 t80 -164.69 128.27 2.43 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 113.882 -1.508 . . . . 62.02 110.13 -167.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.6 ' HA ' HG11 ' A' ' 149' ' ' VAL . 27.8 m-85 -149.82 160.34 43.64 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 129.396 3.079 . . . . 65.12 109.719 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.5 t -124.0 159.1 30.56 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.8 -0.815 . . . . 73.1 108.8 164.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -77.17 -23.05 51.62 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.363 -0.836 . . . . 74.23 111.255 176.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.462 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 49.8 m-85 -102.06 5.29 40.44 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.076 1.35 . . . . 72.25 114.225 -178.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 11.2 p -91.51 145.0 30.46 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 120.683 1.583 . . . . 50.22 112.646 -173.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.08 165.76 31.22 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.375 2.05 . . . . 74.44 109.191 172.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.0 m80 69.04 -48.28 0.58 Allowed 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 127.057 2.143 . . . . 73.42 110.243 -169.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 39.2 m -50.63 -43.2 56.89 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.969 1.708 . . . . 73.0 111.845 -176.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -51.12 -58.05 7.12 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.624 0.77 . . . . 70.41 111.29 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -56.74 -45.3 82.05 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.193 -1.04 . . . . 62.4 108.193 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -62.55 -22.54 66.41 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 117.27 -1.348 . . . . 70.31 113.009 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -120.67 -0.45 10.22 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 121.259 1.845 . . . . 72.02 112.87 -169.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -142.71 -26.4 0.61 Allowed 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.031 0.933 . . . . 74.23 112.909 -173.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 54.2 t -115.23 -69.81 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 108.035 -1.098 . . . . 74.2 108.035 -173.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.6 mt -66.07 -26.4 67.47 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.233 1.013 . . . . 73.03 110.622 173.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 44.35 53.21 6.96 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.725 1.61 . . . . 74.02 111.924 173.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 46' ' ' VAL . 77.2 t -58.13 -52.0 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 114.876 -1.057 . . . . 65.12 110.743 -166.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 p -58.5 -38.49 77.76 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 119.359 0.981 . . . . 65.42 111.681 -167.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -74.34 -36.95 63.67 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.215 0.606 . . . . 63.23 110.665 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -60.36 -45.04 94.9 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.841 -0.537 . . . . 44.3 110.182 169.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 42' ' ' VAL . 2.2 t -61.8 -50.39 80.4 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 CA-C-N 118.651 0.659 . . . . 73.21 109.32 175.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -51.11 -43.61 61.14 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 126.606 1.962 . . . . 75.03 111.201 -176.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -59.62 -20.05 53.29 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 114.156 1.169 . . . . 75.13 114.156 175.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -115.77 -6.52 12.11 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.35 1.46 . . . . 74.0 112.038 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.61 HD13 HG21 ' A' ' 54' ' ' THR . 11.2 mt -70.62 144.11 90.82 Favored Pre-proline 0 C--O 1.239 0.522 0 CA-C-N 119.385 0.993 . . . . 72.0 109.792 -168.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.25 152.46 30.82 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.155 2.57 . . . . 73.02 109.668 174.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.268 1.6 pt-20 -81.22 87.43 6.1 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 123.859 1.79 . . . . 73.24 109.715 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.37 -7.58 0.36 Allowed Glycine 0 C--O 1.221 -0.66 0 CA-C-N 114.792 -1.094 . . . . 61.42 111.606 -174.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.61 HG21 HD13 ' A' ' 50' ' ' LEU . 15.2 t -58.52 -59.66 5.02 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.515 1.657 . . . . 72.23 109.48 166.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.421 ' N ' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER 50.14 86.64 0.03 OUTLIER 'General case' 0 C--N 1.346 0.448 0 C-N-CA 126.175 1.79 . . . . 74.34 109.685 -169.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 13.7 ptp -64.18 173.28 2.02 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 112.248 -2.251 . . . . 61.42 111.039 175.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.525 HG22 ' H ' ' A' ' 58' ' ' LYS . 1.5 m -144.57 -170.33 3.36 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.118 1.767 . . . . 71.1 108.95 177.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.525 ' H ' HG22 ' A' ' 57' ' ' THR . 25.3 tttt -176.81 103.51 0.06 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.759 2.023 . . . . 71.11 108.77 -172.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.3 m-30 -114.76 111.0 20.57 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 121.008 1.731 . . . . 70.32 108.982 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.526 ' HB2' ' CG ' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -80.7 150.39 29.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 118.813 -0.613 . . . . 73.02 110.494 176.423 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.731 HG21 ' CE2' ' A' ' 25' ' ' PHE . 19.1 m -132.99 152.45 36.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 C-N-CA 124.508 1.123 . . . . 64.45 111.298 -171.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.18 10.59 40.67 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.987 1.315 . . . . 73.34 114.231 -171.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -62.68 -8.26 6.31 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.414 1.635 . . . . 74.25 115.414 -170.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.52 165.35 29.72 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 120.044 -1.66 . . . . 71.02 111.017 -179.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.462 ' HA3' ' CD2' ' A' ' 29' ' ' TYR . . . 71.98 159.61 4.22 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.474 1.512 . . . . 74.12 112.373 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.1 -55.56 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.737 2.291 . . . . 61.23 109.79 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.4 mt -75.37 22.38 0.12 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.657 1.583 . . . . 65.45 112.968 -178.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -52.06 -56.84 14.76 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 124.865 1.221 . . . . 72.21 111.002 -176.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -62.04 -42.03 98.74 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 117.871 0.835 . . . . 65.34 109.776 -173.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -67.79 -38.84 83.87 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.992 1.717 . . . . 61.44 108.908 -174.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.7 mt -64.75 -40.58 95.53 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.469 1.108 . . . . 72.25 112.016 172.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.7 m -61.41 -41.38 97.05 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.732 0.696 . . . . 65.33 109.694 172.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.63 -39.91 95.54 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.459 1.027 . . . . 63.22 110.624 176.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.03 -36.26 81.05 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.586 0.754 . . . . 64.22 112.317 176.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.526 ' CG ' ' HB2' ' A' ' 60' ' ' HIS . 59.6 t-105 -59.58 -40.56 87.81 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.022 0.439 . . . . 70.02 111.658 -176.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.35 -29.89 71.12 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 118.745 -0.645 . . . . 70.43 112.388 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.3 t -59.91 -44.02 93.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 119.642 1.11 . . . . 72.35 109.312 169.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.1 84.92 Favored 'General case' 0 C--N 1.34 0.176 0 O-C-N 121.665 -0.647 . . . . 73.23 111.229 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 79.3 mt -71.49 -39.87 71.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 119.136 -0.459 . . . . 73.13 109.944 176.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.87 -34.63 71.83 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.079 0.854 . . . . 72.45 111.31 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.689 HD12 HG13 ' A' ' 116' ' ' VAL . 15.8 mt -102.49 -3.06 27.46 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.181 0.808 . . . . 74.32 113.181 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 58.45 57.22 21.01 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.426 1.489 . . . . 62.42 111.814 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.501 HG21 HG22 ' A' ' 116' ' ' VAL . 22.6 m -131.15 13.65 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 126.216 1.806 . . . . 74.05 111.719 -175.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -46.92 -48.24 21.38 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 126.604 1.961 . . . . 74.41 111.682 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -68.07 -28.68 67.57 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.048 1.339 . . . . 63.0 111.196 -174.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -82.3 -27.12 32.51 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.882 1.273 . . . . 71.02 110.69 -172.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.4 pp -112.07 -2.19 10.21 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-O 117.805 -1.093 . . . . 71.43 112.347 -171.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.4 m -64.82 -56.55 12.81 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 119.784 1.175 . . . . 64.24 109.346 176.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.529 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -55.8 -62.03 5.31 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 123.523 0.729 . . . . 52.42 111.885 -165.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 34.6 Cg_endo -65.69 -22.46 57.5 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.456 1.438 . . . . 63.21 113.045 -173.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 6.0 tpp -64.79 -47.41 78.19 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 124.148 0.979 . . . . 74.13 110.919 171.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -65.05 -35.12 80.14 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.197 0.908 . . . . 73.34 108.891 177.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -60.05 -38.3 82.4 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.451 0.569 . . . . 73.14 110.393 169.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.75 -16.58 47.44 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.04 -1.037 . . . . 70.11 112.751 -172.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.3 t -111.89 -33.94 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 124.966 1.306 . . . . 73.23 110.495 -171.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -108.57 -54.03 2.56 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.534 1.134 . . . . 63.11 110.93 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt -69.2 -55.79 9.56 Favored 'General case' 0 N--CA 1.462 0.17 0 O-C-N 121.096 -1.002 . . . . 65.25 110.66 -171.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.4 p -104.5 -23.79 13.1 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.726 0.811 . . . . 74.23 112.551 -174.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 55.93 30.86 16.78 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.89 2.076 . . . . 71.24 112.775 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.0 t -62.69 -25.8 68.34 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.602 1.561 . . . . 65.44 112.362 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.508 HG13 HG12 ' A' ' 107' ' ' ILE . 45.1 t -63.01 109.8 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 122.387 1.089 . . . . 70.31 108.22 -177.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -139.97 -26.4 0.79 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.121 1.769 . . . . 73.31 110.804 -171.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 m -136.99 163.95 29.5 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.577 -1.268 . . . . 74.14 107.577 168.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 85.7 t -53.75 -33.47 23.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 125.961 1.704 . . . . 64.54 109.408 173.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.8 -20.04 65.86 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 126.067 1.747 . . . . 61.54 112.361 -177.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.29 -49.0 8.01 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.986 0.914 . . . . 45.32 108.9 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.508 HG12 HG13 ' A' ' 101' ' ' VAL . 0.8 OUTLIER -55.57 -48.59 77.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 125.654 1.582 . . . . 63.13 109.122 178.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -20.9 66.72 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.519 -0.753 . . . . 64.12 112.381 -175.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -64.32 -52.77 56.83 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 118.898 0.772 . . . . 74.21 109.594 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.4 t -55.87 -44.15 76.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 123.753 0.658 . . . . 62.35 109.571 -174.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -51.12 -55.68 16.55 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.751 0.42 . . . . 65.31 110.428 175.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 82.6 t -59.32 -47.16 91.47 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 CA-C-N 118.454 0.57 . . . . 72.34 111.332 -177.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -73.86 -30.84 62.88 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 124.068 0.855 . . . . 74.23 110.369 -168.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.0 -32.41 67.17 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.528 0.731 . . . . 65.21 110.268 170.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 145.09 23.11 0.13 Allowed Glycine 0 CA--C 1.531 1.068 0 N-CA-C 116.768 1.467 . . . . 63.45 116.768 165.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.689 HG13 HD12 ' A' ' 81' ' ' LEU . 48.7 t -94.2 127.42 46.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 119.245 1.522 . . . . 61.23 110.595 -177.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -53.89 116.57 2.62 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.777 0.831 . . . . 74.23 108.78 172.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -61.36 -24.91 64.21 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-O 118.663 -1.076 . . . . 64.52 111.243 171.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -74.75 -23.31 58.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.168 1.484 . . . . 55.33 112.27 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.528 ' HB3' HD11 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -92.86 -43.73 8.84 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 108.656 -0.868 . . . . 64.13 108.656 -178.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -51.77 -60.65 2.92 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.271 1.428 . . . . 74.35 109.584 172.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -69.84 -14.59 62.82 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 119.718 -0.182 . . . . 72.35 111.091 -168.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -88.42 -58.72 2.45 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.72 1.208 . . . . 54.25 109.873 172.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.5 -36.82 67.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.962 1.705 . . . . 65.34 111.298 -176.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -45.11 -37.68 4.52 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 125.346 1.458 . . . . 70.23 112.189 176.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -108.43 -3.5 18.16 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.823 1.649 . . . . 64.44 113.498 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 32.6 t -81.41 155.38 25.93 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 127.563 2.345 . . . . 74.41 111.706 173.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.85 -21.52 64.28 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 112.599 -2.091 . . . . 65.03 115.778 -171.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.9 t -47.68 -55.42 2.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 C-N-CA 127.42 2.288 . . . . 73.33 106.83 167.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.1 t -71.81 -42.21 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.532 -0.758 . . . . 64.04 109.415 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -54.82 -51.08 66.96 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.448 1.022 . . . . 73.12 112.462 -177.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 67.7 m -69.83 -34.15 73.27 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.144 0.978 . . . . 71.05 111.563 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 11.9 mt -68.62 -46.46 69.19 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.647 1.112 . . . . 72.14 112.113 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 24.7 t -48.67 -53.67 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 C-N-CA 124.399 1.08 . . . . 62.45 109.681 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.35 -40.53 93.72 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-O 116.351 -1.785 . . . . 72.05 110.87 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -56.39 -45.91 80.37 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 122.235 2.289 . . . . 64.24 112.918 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -53.95 -57.25 11.68 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.184 -1.043 . . . . 74.21 108.184 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 77.6 mm-40 -79.82 -9.91 59.72 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.862 1.265 . . . . 70.05 113.983 -171.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 17.1 tptt -86.21 -55.23 4.02 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 107.716 -1.216 . . . . 74.05 107.716 176.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.93 -62.23 2.01 Favored 'General case' 0 N--CA 1.444 -0.733 0 O-C-N 124.646 1.216 . . . . 50.24 108.66 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -82.84 0.59 43.32 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.699 1.0 . . . . 64.43 113.699 -162.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -122.06 2.29 9.85 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 117.733 -1.127 . . . . 73.42 112.936 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -57.31 -85.77 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.066 0.848 . . . . 44.21 110.651 174.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 174.74 43.03 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.926 2.49 . . . . 71.12 110.705 174.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.69 -26.54 6.53 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 120.55 -1.344 . . . . 71.21 112.019 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.661 HD23 ' H ' ' A' ' 147' ' ' GLN . 0.1 OUTLIER -127.73 -85.96 0.58 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.571 -1.27 . . . . 74.32 107.571 -167.128 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.661 ' H ' HD23 ' A' ' 146' ' ' LEU . 7.9 mt-30 48.22 29.24 1.8 Allowed 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.428 1.091 . . . . 74.22 112.565 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -154.98 95.62 0.15 Allowed Glycine 0 C--N 1.347 1.152 0 O-C-N 120.337 -1.477 . . . . 62.02 114.826 -164.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.867 HG13 ' CE1' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -95.91 162.38 24.22 Favored Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 113.589 0.959 . . . . 64.23 113.589 -170.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.669 ' HA ' HG12 ' A' ' 149' ' ' VAL . 72.7 Cg_endo -81.51 123.08 8.76 Favored 'Cis proline' 0 C--N 1.352 0.729 0 CA-C-N 119.025 0.687 . . . . 70.1 112.841 -5.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -103.23 141.21 36.29 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 114.6 -1.182 . . . . 62.43 112.471 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 44.5 tpp -146.44 108.63 4.42 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 127.143 2.177 . . . . 61.0 106.355 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -96.71 158.42 15.44 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 123.006 0.191 . . . . 63.32 111.502 172.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.9 t -140.75 146.93 23.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 124.352 1.061 . . . . 72.43 108.56 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 46.71 19.18 0.08 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 128.686 2.794 . . . . 54.4 114.689 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.88 -2.92 58.47 Favored Glycine 0 CA--C 1.528 0.876 0 O-C-N 120.783 -1.198 . . . . 64.14 113.328 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -140.57 -7.01 1.14 Allowed 'General case' 0 C--O 1.233 0.229 0 N-CA-C 114.434 1.272 . . . . 74.2 114.434 -159.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -124.3 146.08 49.01 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.161 -1.052 . . . . 73.04 108.161 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -113.91 147.71 38.02 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.32 -1.363 . . . . 61.3 107.32 162.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -68.84 140.09 55.22 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.128 -1.064 . . . . 74.11 108.128 170.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -113.81 86.13 10.51 Favored Pre-proline 0 C--O 1.234 0.262 0 C-N-CA 123.254 0.622 . . . . 73.02 111.216 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -61.61 -24.08 77.37 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.111 1.207 . . . . 71.33 112.565 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -66.23 -31.3 72.05 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.786 1.176 . . . . 50.31 110.416 -168.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -90.52 -4.77 70.1 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.737 -1.035 . . . . 51.51 111.823 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 43.8 mtt -78.99 166.18 22.63 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 119.58 1.69 . . . . 73.11 108.69 175.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -79.4 108.96 13.32 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 104.663 -2.347 . . . . 53.31 104.663 171.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.446 HG22 ' CD1' ' A' ' 173' ' ' PHE . 40.8 p -112.96 50.23 0.89 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.948 2.099 . . . . 74.2 107.019 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 13.9 m -131.31 3.39 4.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.095 -1.412 . . . . 72.32 111.098 -167.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.03 -20.67 1.11 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 126.751 2.02 . . . . 73.24 110.645 174.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 7.9 mmt 73.09 -54.96 0.69 Allowed 'General case' 0 C--N 1.347 0.484 0 C-N-CA 126.063 1.745 . . . . 72.0 110.568 -174.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.79 -50.22 69.03 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.142 1.377 . . . . 61.21 110.531 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 79.1 t -72.18 -24.07 22.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 125.53 1.532 . . . . 64.12 111.574 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.446 ' CD1' HG22 ' A' ' 167' ' ' THR . 35.2 t80 -60.16 -61.85 2.3 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.331 -0.989 . . . . 73.03 108.331 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.9 t -64.92 -33.47 63.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 O-C-N 123.367 0.417 . . . . 52.43 110.474 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.98 -42.91 69.51 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.368 0.667 . . . . 73.33 112.329 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -81.63 -40.41 22.98 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 118.492 -0.766 . . . . 65.01 110.874 176.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -54.85 -57.8 10.13 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.479 1.112 . . . . 74.31 110.154 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -55.69 -32.03 62.94 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.925 0.89 . . . . 65.44 111.571 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -65.88 -58.4 5.68 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.936 -0.394 . . . . 62.11 109.936 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.4 t -63.1 -29.96 71.22 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 116.93 -1.51 . . . . 65.12 110.771 -173.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 47.5 t -56.49 -56.95 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 120.138 1.335 . . . . 45.34 108.189 173.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.31 -43.46 83.28 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 124.649 1.18 . . . . 61.04 111.093 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -64.65 -30.1 71.11 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 119.001 0.819 . . . . 75.04 112.244 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 52.6 mt -74.27 -23.68 59.15 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 120.44 -1.412 . . . . 74.23 111.833 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 84.7 t -62.71 -30.21 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.646 -0.501 . . . . 72.24 109.646 174.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -99.17 -8.11 25.59 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.885 0.874 . . . . 74.04 110.872 -174.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -110.82 77.26 1.03 Allowed 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 120.668 -1.27 . . . . 71.32 109.406 -174.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.043 0 C-N-CA 127.52 2.328 . . . . 75.22 112.634 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.468 0.44 0 N-CA-C 108.712 -0.848 . . . . 61.11 108.712 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -118.5 179.3 4.16 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 127.479 2.312 . . . . 71.35 108.383 -170.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 50.51 30.84 5.0 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.925 2.09 . . . . 71.15 113.996 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -166.25 109.74 0.77 Allowed 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.12 1.768 . . . . 71.31 106.894 -177.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.458 HD12 ' CD2' ' A' ' 9' ' ' TYR . 6.4 pt -117.24 166.32 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.499 1.119 . . . . 72.43 110.349 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.6 m -149.28 141.85 24.41 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.297 -1.372 . . . . 73.33 107.297 -177.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -59.41 149.27 29.8 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.744 0.783 . . . . 71.23 109.399 174.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 75.81 -21.34 2.08 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-O 117.587 -1.674 . . . . 71.45 112.629 -172.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -99.56 -69.5 0.76 Allowed 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 120.966 2.383 . . . . 74.44 110.224 -165.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -107.95 -15.91 14.42 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 123.684 0.794 . . . . 64.14 110.637 -177.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.458 ' CD2' HD12 ' A' ' 3' ' ' ILE . 38.0 p90 -141.86 167.99 20.83 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 108.49 -0.93 . . . . 72.15 108.49 171.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 mm -131.26 142.29 43.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 104.652 -2.351 . . . . 72.14 104.652 168.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.1 m -78.4 171.13 15.54 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 125.144 1.378 . . . . 62.33 108.354 170.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 32.9 mt -113.14 161.65 16.88 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.99 0.916 . . . . 73.15 110.467 171.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -80.37 -37.75 31.72 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.287 1.035 . . . . 75.45 108.716 -174.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -133.26 71.33 76.91 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 125.42 1.488 . . . . 74.3 110.807 178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.08 74.95 5.07 Favored 'Trans proline' 0 CA--C 1.535 0.551 1 C-N-CA 125.547 4.165 . . . . 74.35 111.033 176.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.8 tt -155.0 112.5 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 O-C-N 120.656 -1.278 . . . . 63.04 109.981 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 53.38 -153.59 0.26 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.992 0.917 . . . . 65.44 109.706 -168.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 100.49 -61.99 0.63 Allowed Glycine 0 C--N 1.333 0.389 0 N-CA-C 108.362 -1.895 . . . . 74.13 108.362 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -121.56 162.78 34.55 Favored Pre-proline 0 C--N 1.325 -0.473 0 C-N-CA 125.987 1.715 . . . . 62.23 111.451 -173.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -72.14 -7.29 20.73 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.947 3.098 . . . . 71.41 114.262 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 63.24 179.61 0.15 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.867 1.667 . . . . 73.33 112.077 -175.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.5 m 46.36 33.87 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 127.555 2.342 . . . . 63.01 112.776 -173.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.519 HD22 ' CZ ' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -122.92 154.77 37.92 Favored 'General case' 0 CA--C 1.518 -0.287 0 O-C-N 121.352 -0.843 . . . . 65.43 113.249 -163.01 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -135.83 141.19 44.65 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 125.244 1.418 . . . . 71.22 108.101 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.519 ' CZ ' HD22 ' A' ' 23' ' ' LEU . 98.0 m-85 -127.75 137.77 52.54 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.738 1.215 . . . . 73.23 109.62 -176.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -165.38 -178.48 5.01 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.988 1.715 . . . . 74.42 109.749 -177.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.7 t -143.94 -174.48 4.28 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.776 1.23 . . . . 72.03 108.142 171.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.868 ' CD1' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -92.23 -7.66 47.58 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.507 1.299 . . . . 74.44 114.507 175.273 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -100.29 -4.92 28.31 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.922 0.889 . . . . 73.2 112.826 175.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.7 p -80.07 140.83 53.75 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 120.681 1.582 . . . . 71.04 108.764 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -92.07 -30.74 0.1 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 CA-C-N 120.133 1.083 . . . . 63.13 111.055 -168.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -64.25 -50.08 69.38 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.952 1.701 . . . . 75.22 109.517 171.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.5 p -67.0 -22.93 65.88 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 117.582 -1.199 . . . . 70.44 111.706 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -57.21 -55.08 39.39 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 120.338 1.427 . . . . 62.32 109.312 170.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -55.05 -46.46 75.36 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 108.804 -0.813 . . . . 71.05 108.804 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -65.58 -16.45 63.72 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 116.796 -1.574 . . . . 73.21 113.324 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -116.29 -8.13 11.71 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 121.105 1.775 . . . . 73.11 111.762 -173.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -141.38 -30.15 0.62 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.75 0.82 . . . . 72.05 112.907 -163.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.2 t -115.4 -68.02 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 N-CA-C 107.466 -1.309 . . . . 65.22 107.466 -172.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.8 mt -66.44 -28.41 68.58 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 114.843 -1.071 . . . . 72.15 111.075 171.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 45.14 41.6 5.94 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.438 1.495 . . . . 52.42 111.833 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.2 t -50.88 -48.2 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 0 C-N-CA 125.79 1.636 . . . . 73.12 108.696 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.3 p -46.08 -55.71 6.58 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 124.791 1.307 . . . . 65.14 112.293 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -75.36 -34.86 61.19 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 119.913 -1.742 . . . . 64.43 110.665 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.45 -54.58 45.22 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 123.035 0.534 . . . . 64.24 110.474 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.602 HG12 ' HG ' ' A' ' 50' ' ' LEU . 23.5 t -60.82 -43.02 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 109.253 -0.647 . . . . 74.01 109.253 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.685 ' HA ' HD12 ' A' ' 50' ' ' LEU . 40.7 ttt-85 -53.72 -29.5 39.6 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.391 1.256 . . . . 74.43 114.391 176.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -89.78 -3.56 58.1 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.186 1.18 . . . . 65.21 114.186 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -128.12 0.03 5.83 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.929 2.092 . . . . 70.22 113.032 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.693 HD13 ' O ' ' A' ' 54' ' ' THR . 6.3 mt -63.11 154.37 77.79 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.378 1.471 . . . . 63.11 108.988 -177.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.12 151.33 26.9 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.32 2.68 . . . . 70.05 108.837 172.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 45.46 24.01 0.16 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.236 2.615 . . . . 50.12 115.645 174.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.27 33.34 75.0 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-O 117.851 -1.527 . . . . 72.35 113.659 -172.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.693 ' O ' HD13 ' A' ' 50' ' ' LEU . 26.0 m -61.59 69.62 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.775 1.63 . . . . 73.34 111.191 172.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -63.63 132.19 50.37 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 120.385 -1.447 . . . . 74.2 108.357 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -75.57 173.56 10.85 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.037 0.935 . . . . 73.11 112.178 -174.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.84 154.01 26.97 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.557 0.743 . . . . 65.04 109.368 170.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.78 102.0 6.36 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.306 1.042 . . . . 54.21 108.488 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.421 ' HB2' HD21 ' A' ' 23' ' ' LEU . 10.6 m-30 -97.0 168.22 10.6 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.348 1.059 . . . . 74.3 110.336 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.593 ' CE1' ' HB2' ' A' ' 137' ' ' GLN . 0.3 OUTLIER -101.18 172.05 7.24 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.986 1.314 . . . . 65.4 108.569 -179.249 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.666 HG12 ' HB1' ' A' ' 141' ' ' ALA . 11.9 m -140.42 145.8 25.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 107.445 -1.317 . . . . 73.21 107.445 162.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . 0.293 0.0 OUTLIER -102.37 17.97 22.21 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 129.084 2.953 . . . . 71.23 113.54 -177.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -84.18 -4.33 58.74 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.294 1.438 . . . . 54.32 114.367 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.59 145.48 51.13 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 119.827 -1.796 . . . . 74.42 110.29 -166.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.87 -178.69 7.2 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 121.375 0.431 . . . . 55.54 112.517 174.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -78.36 -46.63 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 123.316 2.677 . . . . 62.13 113.308 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.8 mt -79.17 31.69 0.22 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.655 1.116 . . . . 72.44 112.518 -174.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -43.24 -63.71 1.99 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 126.053 1.787 . . . . 75.2 110.689 174.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -63.02 -40.06 96.62 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 117.548 0.674 . . . . 73.1 110.647 -172.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.51 -42.43 92.18 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.263 1.425 . . . . 73.41 110.458 -175.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.868 HD11 ' CD1' ' A' ' 28' ' ' PHE . 18.6 mt -65.33 -45.17 85.33 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 118.533 -0.746 . . . . 73.22 111.392 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.537 HG22 ' CE1' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -46.78 -53.73 11.3 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.057 -1.09 . . . . 65.04 108.057 175.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -58.17 -55.89 29.09 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 123.945 0.898 . . . . 73.43 110.418 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.88 -43.18 72.95 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 120.186 1.357 . . . . 61.42 113.838 -176.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 14.0 t-105 -59.8 -38.0 80.71 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.341 -0.85 . . . . 74.12 111.355 -174.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.39 -38.57 71.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 118.062 -0.971 . . . . 73.2 112.557 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.6 t -57.03 -47.77 82.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 120.031 1.287 . . . . 65.11 109.933 171.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.22 -40.53 94.24 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.868 -0.52 . . . . 65.33 111.237 -176.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 85.8 mt -67.01 -38.2 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.736 0.815 . . . . 42.21 109.68 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.86 -50.61 72.73 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 123.858 0.863 . . . . 74.5 110.111 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 77.4 mt -76.2 -27.75 56.99 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.805 -0.559 . . . . 73.53 112.098 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.51 62.4 2.72 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 126.566 2.032 . . . . 44.33 110.603 -173.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.0 m -129.81 14.07 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 125.226 1.41 . . . . 72.2 112.303 -174.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -49.99 -51.87 38.26 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 125.064 1.346 . . . . 72.02 112.307 -169.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.62 -43.02 79.78 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.37 1.468 . . . . 71.34 110.373 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -64.05 -27.12 68.89 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 124.456 1.102 . . . . 74.1 110.609 -176.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.3 pp -116.48 27.19 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 126.847 2.059 . . . . 42.13 109.876 -176.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 89.9 m -97.67 -54.58 3.07 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.755 -1.202 . . . . 64.0 107.755 164.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.501 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -52.52 -62.09 3.74 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 113.721 1.008 . . . . 53.2 113.721 -172.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 56.8 Cg_endo -70.37 -27.29 23.75 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.194 1.263 . . . . 72.34 111.557 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 32.6 tpp -65.07 -49.9 68.25 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.557 1.143 . . . . 73.12 109.635 -177.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -69.34 -35.63 76.09 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.49 -0.93 . . . . 63.02 108.49 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.494 ' CG ' ' HE3' ' A' ' 97' ' ' LYS . 2.6 mt-10 -65.68 -11.19 42.96 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 114.367 1.247 . . . . 70.4 114.367 169.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -109.15 1.52 20.41 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.576 1.08 . . . . 71.01 113.488 172.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.859 HG21 ' CD2' ' A' ' 28' ' ' PHE . 95.8 t -115.38 -34.66 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-O 117.392 -1.289 . . . . 33.41 114.04 175.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -108.84 -53.0 2.7 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 120.547 1.521 . . . . 65.44 113.401 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.494 ' HE3' ' CG ' ' A' ' 93' ' ' GLU . 2.9 mmmt -62.08 -64.54 0.9 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.479 1.911 . . . . 63.23 112.713 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.9 p -87.88 -30.66 19.97 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.736 1.384 . . . . 64.21 114.736 174.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 56.1 35.73 26.16 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 128.348 2.659 . . . . 72.0 114.432 -173.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.5 t -71.31 -22.36 61.94 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.342 0.867 . . . . 73.34 113.342 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.486 HG13 HG12 ' A' ' 107' ' ' ILE . 25.4 t -66.71 120.33 13.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 O-C-N 120.625 -1.297 . . . . 74.44 110.217 172.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -140.63 -28.8 0.7 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.063 -0.971 . . . . 74.31 111.633 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.83 174.39 10.58 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.539 1.063 . . . . 63.12 110.178 168.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.5 t -57.68 -41.32 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.139 0.975 . . . . 72.4 111.267 -169.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.28 -23.77 62.7 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 119.204 -0.427 . . . . 73.1 111.679 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -78.19 -30.54 49.06 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 119.044 0.838 . . . . 73.04 111.207 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.486 HG12 HG13 ' A' ' 101' ' ' VAL . 1.4 mt -81.8 -48.26 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 108.293 -1.003 . . . . 72.02 108.293 -174.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -62.18 -18.23 60.41 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.577 0.751 . . . . 73.0 112.356 179.336 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -62.5 -56.85 14.14 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 125.43 1.492 . . . . 61.44 109.837 169.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.7 t -61.77 -34.47 62.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 118.645 -0.693 . . . . 62.1 110.804 -175.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -49.62 -60.46 2.85 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.016 -0.735 . . . . 73.31 109.016 169.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.1 t -57.09 -49.03 80.82 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-O 118.922 -0.561 . . . . 71.41 109.814 -176.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.23 -43.22 96.23 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 124.062 0.851 . . . . 73.1 110.159 -170.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.87 0.25 7.66 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.73 1.612 . . . . 71.31 112.852 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.49 44.76 1.41 Allowed Glycine 0 CA--C 1.523 0.566 0 C-N-CA 124.973 1.273 . . . . 71.5 112.917 171.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.0 t -112.38 140.8 30.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 118.977 1.388 . . . . 65.1 110.765 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -64.28 110.12 2.12 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.307 1.443 . . . . 74.5 109.134 165.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.92 -23.37 65.64 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-O 118.162 -1.354 . . . . 74.44 110.931 168.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -70.95 -23.05 62.15 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.621 1.211 . . . . 74.24 110.977 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -87.79 -46.34 9.54 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.701 -1.222 . . . . 72.41 107.701 176.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 108' ' ' ARG . 14.9 t80 -51.97 -57.31 9.83 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.622 0.769 . . . . 65.4 109.603 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -74.7 -9.48 58.61 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.88 0.872 . . . . 62.4 112.43 -171.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -87.78 -66.15 0.94 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.909 1.283 . . . . 50.4 109.355 166.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -49.34 -43.06 43.44 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.397 2.279 . . . . 71.14 111.45 -174.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 55.1 t-105 -45.55 -35.69 4.1 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 126.303 1.841 . . . . 72.03 113.507 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -116.91 8.45 13.51 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.713 1.205 . . . . 64.03 111.828 -175.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 21.3 t -95.69 159.85 14.78 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 127.16 2.184 . . . . 72.23 110.226 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -57.14 -33.03 66.98 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.301 1.44 . . . . 63.34 111.892 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 59.8 t -49.57 -54.27 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 124.107 0.963 . . . . 61.11 109.912 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.5 t -63.87 -49.54 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 123.803 0.841 . . . . 61.23 110.694 176.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -49.61 -54.35 18.86 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.926 0.784 . . . . 72.04 111.549 -177.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.12 -40.0 93.89 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.102 0.561 . . . . 74.3 111.998 177.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.8 mt -60.6 -49.36 77.84 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-O 116.61 -1.662 . . . . 53.41 110.891 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 99.1 t -56.78 -37.26 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 120.199 1.363 . . . . 70.43 110.428 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.65 -28.83 70.18 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 117.763 -1.113 . . . . 72.21 112.329 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -53.47 -49.48 67.36 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-N 119.803 1.183 . . . . 64.0 112.097 175.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.593 ' HB2' ' CE1' ' A' ' 60' ' ' HIS . 0.5 OUTLIER -103.77 -18.96 14.46 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 118.54 -0.743 . . . . 64.11 110.636 -166.07 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -60.07 -52.82 63.73 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.922 -1.14 . . . . 64.42 107.922 158.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 32.1 tttp -61.15 -18.7 59.46 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.268 0.94 . . . . 72.3 113.181 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -114.9 1.19 13.97 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 115.816 1.784 . . . . 65.33 115.816 -176.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.666 ' HB1' HG12 ' A' ' 61' ' ' VAL . . . -139.18 -19.1 0.99 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 119.462 1.028 . . . . 62.34 111.609 177.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -104.7 -4.77 22.02 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 117.942 -1.027 . . . . 63.23 110.94 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -59.81 -83.03 0.02 OUTLIER 'General case' 0 C--N 1.345 0.401 0 C-N-CA 125.929 1.692 . . . . 75.32 109.934 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.2 pp -172.92 -11.18 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.106 1.521 . . . . 64.02 115.106 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.441 HE21 ' H ' ' A' ' 145' ' ' GLN . 0.0 OUTLIER -68.2 -44.27 76.23 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.321 1.418 . . . . 73.22 112.556 -162.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.24 -70.05 0.79 Allowed 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 125.736 1.614 . . . . 75.02 109.561 -157.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 68.26 -3.75 1.22 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.676 1.991 . . . . 75.31 115.367 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -146.16 160.39 28.15 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-N 122.731 2.514 . . . . 51.1 112.709 174.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.446 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 19.3 m -142.23 167.01 17.8 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-N 118.532 1.166 . . . . 72.21 112.61 -174.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.446 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 36.5 Cg_endo -61.35 165.21 33.51 Favored 'Cis proline' 0 C--N 1.353 0.812 0 CA-C-N 119.743 0.944 . . . . 53.43 111.911 -11.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -149.67 151.49 33.8 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.563 -0.903 . . . . 65.41 108.563 175.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 6.6 ttm -149.25 117.97 6.61 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.531 -1.285 . . . . 74.14 107.531 -172.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -124.22 107.04 10.78 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 125.038 1.335 . . . . 73.32 110.015 -169.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 81.5 t -64.06 -65.16 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.177 0.591 . . . . 52.22 111.672 -170.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -132.96 25.02 4.28 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.793 2.037 . . . . 74.41 108.136 -171.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 68.0 20.2 72.51 Favored Glycine 0 C--N 1.343 0.951 0 C-N-CA 124.774 1.178 . . . . 51.44 113.988 -177.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.52 ' HE2' ' CZ ' ' A' ' 158' ' ' TYR . 18.7 ptmt -138.43 -7.65 1.51 Allowed 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 115.089 1.514 . . . . 44.23 115.089 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.52 ' CZ ' ' HE2' ' A' ' 157' ' ' LYS . 22.9 m-85 -133.94 122.09 22.61 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 106.457 -1.683 . . . . 72.24 106.457 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.12 143.87 27.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 105.518 -2.03 . . . . 70.44 105.518 161.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.442 ' CD1' HG23 ' A' ' 180' ' ' THR . 3.5 mm? -69.9 142.73 52.93 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.88 -1.155 . . . . 73.13 107.88 166.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -112.57 85.76 7.69 Favored Pre-proline 0 N--CA 1.453 -0.292 0 N-CA-C 113.024 0.75 . . . . 53.55 113.024 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.39 -19.74 37.52 Favored 'Trans proline' 0 N--CA 1.443 -1.486 0 C-N-CA 120.454 0.769 . . . . 74.23 111.1 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -61.86 -20.48 63.75 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 119.626 1.103 . . . . 75.41 112.821 -175.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -108.75 3.72 32.25 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 117.641 -1.644 . . . . 72.42 113.326 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 56.3 mtt -93.01 173.57 7.67 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.91 2.355 . . . . 70.04 111.794 -168.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.57 58.54 3.75 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 123.568 1.651 . . . . 73.41 111.764 -171.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 72.2 p -72.96 16.07 0.17 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 127.474 2.31 . . . . 65.34 112.851 -176.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 19.4 m -94.43 -8.79 37.58 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 125.945 1.698 . . . . 65.23 112.707 173.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.0 -14.08 4.47 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 119.5 1.045 . . . . 73.34 113.181 -174.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 4.5 mmt 70.6 -57.66 0.58 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.591 1.957 . . . . 74.34 113.926 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.22 -48.95 68.93 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.694 -1.225 . . . . 70.33 107.694 -178.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.423 HG12 ' NE2' ' A' ' 176' ' ' GLN . 21.2 t -65.05 -36.81 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 124.928 1.291 . . . . 70.33 109.567 -177.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -52.14 -60.73 2.86 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 118.262 -0.875 . . . . 74.32 110.135 172.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 8.9 t -66.76 -39.26 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 119.198 0.908 . . . . 61.11 111.392 -175.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.42 -33.97 64.01 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.617 0.767 . . . . 63.01 111.419 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.423 ' NE2' HG12 ' A' ' 172' ' ' VAL . 34.8 mt-30 -88.94 -31.4 18.19 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.393 1.077 . . . . 71.13 112.159 175.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -58.68 -59.64 5.09 Favored 'General case' 0 CA--C 1.528 0.099 0 O-C-N 120.8 -1.187 . . . . 73.34 108.965 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.27 -32.7 72.52 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.873 -0.517 . . . . 72.04 111.795 -175.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -59.96 -52.01 67.23 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.879 1.272 . . . . 74.44 111.835 174.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.442 HG23 ' CD1' ' A' ' 160' ' ' LEU . 9.0 t -64.88 -30.22 71.21 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 117.403 -1.284 . . . . 72.44 110.491 177.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 99.9 t -60.07 -55.89 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 120.455 1.479 . . . . 74.05 108.302 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -62.42 -33.93 75.76 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-O 118.903 -0.57 . . . . 74.42 111.979 -177.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -68.92 -33.8 74.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.645 0.657 . . . . 71.14 111.342 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 34.4 mt -67.99 -29.36 68.36 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 120.957 -1.09 . . . . 73.13 111.936 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 62.2 t -62.06 -26.03 38.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.437 0.695 . . . . 72.43 111.506 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -98.34 -18.35 18.38 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.508 0.595 . . . . 54.23 110.531 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -96.32 76.56 2.98 Favored 'General case' 0 CA--C 1.516 -0.349 0 O-C-N 121.035 -1.041 . . . . 70.13 108.851 -172.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.246 0.896 0 C-N-CA 127.832 2.453 . . . . 73.24 112.023 -174.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 16.7 m . . . . . 0 N--CA 1.464 0.273 0 CA-C-O 121.929 0.871 . . . . 62.11 109.499 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -72.47 162.57 29.3 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.788 -0.819 . . . . 64.3 108.788 164.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 49.55 34.8 7.38 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.075 1.75 . . . . 72.21 114.207 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -163.78 120.75 1.75 Allowed 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.344 -1.724 . . . . 72.13 106.344 174.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.71 HG21 HG23 ' A' ' 180' ' ' THR . 9.8 pt -133.14 160.7 42.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 126.444 1.898 . . . . 51.41 109.592 177.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.5 m -140.4 144.51 36.23 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 121.607 -0.683 . . . . 61.33 109.551 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -51.37 142.04 14.18 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 127.238 2.215 . . . . 71.15 111.117 168.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 77.09 -22.79 2.32 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.415 1.007 . . . . 53.53 112.582 -176.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -102.38 -77.79 0.55 Allowed 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 124.129 0.971 . . . . 62.13 108.672 -165.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -100.24 -15.84 17.94 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.413 1.085 . . . . 71.14 110.719 -174.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -140.95 159.34 42.42 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.217 -0.66 . . . . 71.13 109.217 165.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.4 mm -113.55 162.55 11.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 124.762 1.225 . . . . 71.02 107.695 173.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.5 m -117.24 147.9 42.12 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.426 1.49 . . . . 65.12 107.603 176.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.2 mt -86.18 154.66 21.16 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.52 -0.548 . . . . 73.35 109.52 174.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -72.28 -37.33 69.06 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.878 1.671 . . . . 73.44 109.693 176.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -127.59 85.12 61.56 Favored Pre-proline 0 C--N 1.34 0.178 0 C-N-CA 127.479 2.312 . . . . 73.54 108.331 173.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -79.55 85.41 1.85 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.732 2.954 . . . . 74.04 109.583 168.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.4 tt -160.26 111.58 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 119.292 0.951 . . . . 62.25 109.796 170.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -157.38 -7.85 0.09 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 114.361 1.245 . . . . 70.12 114.361 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.69 -101.85 0.57 Allowed Glycine 0 C--N 1.338 0.645 0 O-C-N 120.524 -1.36 . . . . 70.02 109.877 -165.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 64.73 166.53 0.11 Allowed Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 125.006 1.322 . . . . 61.42 112.008 -175.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.55 178.98 6.87 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.651 2.234 . . . . 70.14 111.051 -169.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -66.86 92.4 0.23 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.38 1.072 . . . . 65.44 109.773 174.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.8 t 75.04 145.12 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 128.672 2.789 . . . . 72.24 111.206 170.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.3 tp -157.24 148.22 21.64 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.724 0.81 . . . . 73.04 109.747 -174.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -140.52 153.12 46.05 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.946 1.698 . . . . 73.43 109.262 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -133.35 139.32 46.76 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.727 1.211 . . . . 74.31 108.527 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.81 -179.71 7.81 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.285 1.834 . . . . 70.24 108.512 -177.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -158.68 161.87 37.16 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.872 0.76 . . . . 53.54 111.366 174.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -70.47 -39.83 74.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.461 1.504 . . . . 70.24 112.111 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.456 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 80.3 m-85 -93.6 18.09 10.6 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.567 1.147 . . . . 74.2 111.793 177.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 33.8 t -88.73 141.68 30.18 Favored Pre-proline 0 CA--C 1.538 0.503 0 O-C-N 120.136 -1.603 . . . . 72.11 110.042 171.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -83.68 -46.56 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 121.73 1.62 . . . . 71.41 112.165 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -61.45 -44.06 97.77 Favored 'General case' 0 CA--C 1.528 0.115 0 O-C-N 121.56 -0.712 . . . . 73.44 109.537 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.7 m -57.02 -33.34 67.08 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.566 0.746 . . . . 72.24 112.097 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -58.93 -53.55 57.17 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.438 0.695 . . . . 64.12 110.105 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.401 HE21 ' HA ' ' A' ' 35' ' ' GLN . 0.8 OUTLIER -56.54 -47.73 78.79 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 118.431 -0.795 . . . . 72.53 109.432 177.049 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.434 ' CD2' HG21 ' A' ' 42' ' ' VAL . 10.4 m-85 -62.13 -19.83 63.43 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 116.83 -1.557 . . . . 74.12 112.341 -174.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -134.84 10.12 3.61 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 120.925 1.693 . . . . 62.32 112.11 -164.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -135.7 -41.21 0.69 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.868 2.067 . . . . 71.33 111.209 169.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 83.7 t -98.47 -74.57 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.11 0 N-CA-C 107.89 -1.152 . . . . 64.02 107.89 -168.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 65.7 mt -62.0 -28.19 69.4 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.985 1.314 . . . . 63.33 111.663 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 1.2 m170 44.36 56.76 4.76 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 126.669 1.988 . . . . 65.43 111.783 177.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.509 ' O ' HG23 ' A' ' 46' ' ' VAL . 63.6 t -62.06 -44.59 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 125.293 1.437 . . . . 74.13 109.752 -174.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.9 t -53.05 -44.77 67.68 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.333 0.97 . . . . 62.14 111.99 -175.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -76.89 -29.71 55.88 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 121.194 -0.941 . . . . 72.33 111.447 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -63.23 -46.99 84.38 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.492 0.717 . . . . 53.41 110.607 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 42' ' ' VAL . 1.9 t -59.53 -51.24 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 108.238 -1.023 . . . . 61.02 108.238 177.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 37.8 ttt-85 -47.36 -46.32 25.63 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.378 1.071 . . . . 72.4 111.948 177.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -64.89 -2.8 2.82 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.155 1.169 . . . . 73.12 114.155 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.6 mmtt -132.01 -9.9 3.42 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 127.466 2.306 . . . . 65.1 113.724 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.535 HD13 HG21 ' A' ' 54' ' ' THR . 7.7 mt -66.95 144.81 98.73 Favored Pre-proline 0 C--O 1.237 0.4 0 CA-C-N 119.306 0.957 . . . . 74.15 110.882 -164.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.69 165.38 32.89 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.988 2.459 . . . . 50.31 109.78 167.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.88 23.29 0.7 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.774 1.027 . . . . 65.22 113.774 -173.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.67 18.21 22.56 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 127.139 2.304 . . . . 71.34 112.057 -173.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.535 HG21 HD13 ' A' ' 50' ' ' LEU . 1.3 t -130.08 129.39 43.53 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.462 -1.31 . . . . 72.14 107.462 -163.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -96.29 121.1 37.71 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 104.8 -2.296 . . . . 65.41 104.8 166.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 6.2 ttm -66.39 102.49 0.88 Allowed 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 125.074 1.35 . . . . 74.35 108.02 173.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 58' ' ' LYS . 1.5 m -120.0 -171.73 2.21 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.215 -1.032 . . . . 73.31 108.215 -173.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.452 ' H ' HG22 ' A' ' 57' ' ' THR . 0.0 OUTLIER 174.58 108.99 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.423 1.489 . . . . 71.24 108.102 -173.053 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -108.59 146.67 32.96 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.795 1.18 . . . . 74.15 109.855 174.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.41 ' CE1' ' HB3' ' A' ' 137' ' ' GLN . 0.2 OUTLIER -82.01 168.54 17.72 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.242 1.017 . . . . 74.02 109.543 -174.482 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.508 HG12 ' HB1' ' A' ' 141' ' ' ALA . 6.6 m -139.03 111.12 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 119.528 1.058 . . . . 74.45 108.521 158.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.89 4.68 13.44 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 124.719 1.208 . . . . 44.25 113.183 176.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -55.77 -8.48 0.41 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 126.173 1.789 . . . . 72.15 113.376 169.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.8 132.07 34.19 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 125.425 1.49 . . . . 70.34 109.996 -176.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.456 ' HA3' ' CD2' ' A' ' 29' ' ' TYR . . . 116.59 156.54 10.7 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 126.443 1.973 . . . . 62.32 112.014 168.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -62.99 -56.12 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.47 2.113 . . . . 61.54 109.544 167.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.6 mt -91.21 34.99 0.92 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.652 1.581 . . . . 61.32 109.912 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.95 -51.89 50.41 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.508 -1.037 . . . . 70.54 110.508 175.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.9 tppm? -57.14 -40.2 76.72 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.291 1.036 . . . . 72.41 112.181 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.88 -38.63 89.29 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.852 1.661 . . . . 72.33 110.31 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.7 mt -67.36 -41.05 85.73 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 117.808 -1.092 . . . . 53.31 111.641 174.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.03 -56.65 14.49 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.922 1.289 . . . . 72.31 108.975 -177.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -62.4 -41.93 99.05 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.409 0.684 . . . . 61.25 109.477 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.14 -30.96 69.64 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 113.443 0.905 . . . . 72.42 113.443 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 33.7 t-105 -61.56 -41.04 96.8 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 118.507 0.594 . . . . 71.13 111.518 -176.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.89 -36.31 76.67 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 117.665 -1.16 . . . . 65.23 112.492 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.2 t -55.72 -46.69 79.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 120.711 1.596 . . . . 73.12 110.796 171.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.01 -43.16 88.49 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-O 119.137 -0.459 . . . . 61.14 110.628 -175.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.2 mt -63.65 -39.87 86.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 118.758 -0.639 . . . . 71.34 109.965 176.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.74 -22.84 66.04 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.622 0.646 . . . . 32.42 112.279 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.2 mt -99.49 -11.78 20.76 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.214 0.916 . . . . 73.14 112.631 169.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 64.11 56.06 20.41 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 124.346 0.974 . . . . 74.03 111.372 -173.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.7 m -133.88 14.46 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 124.174 0.99 . . . . 73.34 112.107 -176.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -45.36 -56.82 4.54 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.664 1.186 . . . . 74.35 109.386 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.31 -10.33 59.64 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 125.438 1.495 . . . . 74.45 111.886 -172.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -87.32 -30.73 20.62 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 120.827 -1.17 . . . . 52.34 110.715 171.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.447 HG22 ' HB3' ' A' ' 114' ' ' ALA . 2.5 pp -100.55 -14.58 7.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 CA-C-O 117.374 -1.298 . . . . 33.43 111.463 -171.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.1 m -59.09 -51.62 69.24 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 119.967 1.258 . . . . 73.12 110.583 -175.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.563 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -57.15 -62.14 5.77 Favored Pre-proline 0 N--CA 1.452 -0.357 0 C-N-CA 124.569 1.147 . . . . 33.25 110.734 -168.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 57.0 Cg_endo -67.05 -26.83 42.86 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 120.911 1.074 . . . . 72.2 112.397 -176.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 4.5 tpp -60.5 -49.55 77.09 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.221 0.464 . . . . 70.43 110.185 170.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -64.58 -37.13 86.51 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.029 0.831 . . . . 74.01 109.077 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.33 -32.83 72.71 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.68 0.673 . . . . 73.24 111.666 171.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.13 -17.17 29.75 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.355 -1.466 . . . . 65.11 112.817 -176.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.4 t -100.54 -43.4 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 124.9 1.28 . . . . 51.41 109.488 -176.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -98.59 -60.62 1.51 Allowed 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.161 0.984 . . . . 53.1 110.215 -177.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.5 mmmt -65.94 -58.45 5.51 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 118.902 -0.57 . . . . 65.12 110.581 -167.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.2 p -97.18 -16.51 20.39 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.672 0.619 . . . . 64.41 112.672 -176.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 48.12 25.62 0.86 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.659 2.384 . . . . 74.14 113.885 -175.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.9 t -62.76 -16.0 55.9 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.62 1.968 . . . . 73.11 112.013 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.411 HG13 HG12 ' A' ' 107' ' ' ILE . 70.1 t -68.5 111.87 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 O-C-N 121.182 -0.949 . . . . 64.2 109.236 175.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -136.81 -30.12 0.9 Allowed 'General case' 0 C--O 1.239 0.524 0 C-N-CA 125.058 1.343 . . . . 70.25 110.275 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.26 162.28 33.44 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.15 -0.685 . . . . 71.55 109.15 174.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.82 -30.27 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.819 0.847 . . . . 53.45 110.138 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -47.4 -39.94 16.53 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.442 2.297 . . . . 71.55 113.31 168.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -77.55 -38.93 47.53 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.691 -0.855 . . . . 74.24 108.691 -175.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.411 HG12 HG13 ' A' ' 101' ' ' VAL . 2.7 mt -66.76 -48.33 80.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 125.103 1.361 . . . . 71.11 107.864 -174.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -57.76 -31.74 66.8 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-O 117.341 -1.314 . . . . 63.34 112.765 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -57.33 -57.12 14.04 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 119.601 1.091 . . . . 73.35 109.153 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.19 -37.73 78.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 123.371 0.419 . . . . 53.13 110.678 -173.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -53.92 -51.7 62.9 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 118.373 0.533 . . . . 70.15 110.659 172.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 90.2 t -64.18 -44.91 97.6 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 CA-C-N 118.37 0.532 . . . . 71.34 110.631 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -63.14 -41.54 99.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.808 0.813 . . . . 74.24 108.939 -170.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.447 ' HB3' HG22 ' A' ' 87' ' ' ILE . . . -79.29 -4.31 50.17 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.144 1.378 . . . . 72.33 112.866 176.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 123.21 22.66 2.31 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 117.163 1.625 . . . . 64.02 117.163 160.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 78.5 t -97.61 134.23 36.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 119.551 1.675 . . . . 70.42 109.667 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.422 ' HE2' ' OE2' ' A' ' 119' ' ' GLU . 0.8 OUTLIER -63.51 143.59 57.7 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 121.635 -0.666 . . . . 63.15 110.138 176.31 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.54 -10.89 76.36 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 119.565 -0.575 . . . . 71.34 112.749 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.422 ' OE2' ' HE2' ' A' ' 117' ' ' LYS . 6.9 pt-20 -92.3 -32.22 15.09 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 123.903 0.881 . . . . 63.03 110.326 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -70.09 -46.59 64.55 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 107.375 -1.343 . . . . 74.41 107.375 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -54.08 -60.12 3.75 Favored 'General case' 0 N--CA 1.438 -1.046 0 O-C-N 123.876 0.735 . . . . 73.44 109.437 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -75.22 -19.47 59.76 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 118.183 -0.913 . . . . 74.35 112.145 -171.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.64 -63.91 1.24 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.374 0.988 . . . . 73.43 108.876 172.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.77 -37.86 63.88 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.359 1.064 . . . . 70.04 110.581 -173.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -45.33 -36.72 4.33 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.675 1.59 . . . . 61.34 113.308 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -114.69 1.04 14.08 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.535 1.134 . . . . 72.32 112.976 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 47.8 t -77.36 147.18 36.24 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 126.215 1.806 . . . . 73.42 111.097 171.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -53.42 -27.79 26.36 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 118.703 2.853 . . . . 72.04 118.703 174.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 46.1 t -45.48 -57.15 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 C-N-CA 126.186 1.794 . . . . 74.35 107.924 167.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.3 t -68.65 -45.45 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 123.81 0.844 . . . . 70.21 109.576 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 58.3 mttt -54.41 -48.7 71.3 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.453 1.024 . . . . 74.13 112.428 -174.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 66.0 m -79.09 -22.0 45.88 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 113.183 0.809 . . . . 71.44 113.183 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 13.4 mt -69.15 -51.41 38.53 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 119.668 1.122 . . . . 63.12 110.172 167.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 52.9 t -49.84 -51.54 15.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.162 0 C-N-CA 125.209 1.404 . . . . 70.44 108.298 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.55 -39.09 75.89 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 118.067 -0.968 . . . . 65.15 113.101 -176.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -57.9 -46.56 84.76 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 119.399 0.999 . . . . 72.05 111.169 172.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.41 ' HB3' ' CE1' ' A' ' 60' ' ' HIS . 56.2 mt-30 -82.22 -31.61 30.18 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.901 -1.045 . . . . 71.01 109.226 -163.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -66.12 -52.74 45.74 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.635 -0.876 . . . . 73.52 108.635 167.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.9 ttmm -61.6 -7.77 3.68 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.132 -0.98 . . . . 63.35 113.449 177.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.4 -12.07 9.42 Favored 'General case' 0 CA--C 1.515 -0.394 0 O-C-N 120.27 -1.519 . . . . 72.21 114.545 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.508 ' HB1' HG12 ' A' ' 61' ' ' VAL . . . -134.17 1.01 3.18 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 119.038 0.835 . . . . 63.34 112.633 -175.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.32 0.85 4.6 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.835 1.654 . . . . 63.45 111.248 171.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -65.12 -86.56 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.878 0.871 . . . . 73.51 111.676 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.5 pp -175.81 23.95 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.351 0.978 . . . . 74.43 112.003 -177.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -103.75 -71.91 0.72 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 120.151 1.341 . . . . 73.12 109.539 -168.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.53 -74.12 0.4 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 126.512 1.925 . . . . 61.43 110.431 -169.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 60.27 7.62 1.32 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 128.239 2.616 . . . . 71.45 115.304 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -147.18 146.42 16.22 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 109.034 -1.627 . . . . 63.31 109.034 176.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 5.2 m -137.14 169.15 13.99 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 118.271 1.035 . . . . 45.05 111.005 -172.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.426 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 69.3 Cg_endo -71.86 162.45 89.31 Favored 'Cis proline' 0 C--N 1.348 0.522 0 CA-C-N 119.596 0.892 . . . . 71.15 112.719 -10.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -150.56 156.53 41.57 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 124.252 0.97 . . . . 52.13 111.457 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 43.1 ttm -143.55 119.06 10.34 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.04 1.336 . . . . 63.03 107.749 169.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -97.36 132.02 43.48 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.927 1.291 . . . . 72.42 107.629 175.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 184' ' ' LEU . 95.8 t -96.23 -35.8 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 113.549 0.944 . . . . 65.03 113.549 -173.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -150.9 31.61 0.62 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.819 0.819 . . . . 64.01 109.571 -177.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 69.35 -64.73 0.57 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 126.194 1.854 . . . . 30.41 110.147 -162.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -58.95 -18.46 33.87 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 116.767 2.136 . . . . 71.23 116.767 -170.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -128.57 133.94 48.5 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 119.154 0.888 . . . . 74.35 111.252 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.79 137.15 52.28 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 105.773 -1.936 . . . . 63.01 105.773 175.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.07 143.11 58.07 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.744 -1.206 . . . . 72.01 107.744 176.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -124.66 75.55 64.03 Favored Pre-proline 0 C--O 1.234 0.275 0 C-N-CA 122.851 0.46 . . . . 61.04 110.22 -175.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -68.32 -22.56 39.62 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 120.831 1.021 . . . . 65.33 111.346 -172.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -51.55 -32.43 28.15 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 114.029 1.122 . . . . 50.24 114.029 171.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -103.13 4.78 48.98 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-O 118.325 -1.264 . . . . 70.04 112.687 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 62.1 mtt -80.3 174.49 11.55 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 119.814 1.807 . . . . 71.3 109.241 172.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -75.06 106.89 6.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.703 -1.592 . . . . 70.04 106.703 166.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.455 HG22 ' CD1' ' A' ' 173' ' ' PHE . 80.7 p -114.99 28.8 8.47 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.927 1.691 . . . . 72.44 109.444 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 75.2 m -108.95 -1.09 19.28 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 114.224 1.194 . . . . 31.14 114.224 -175.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.26 -9.93 4.7 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 124.386 1.074 . . . . 63.0 110.999 177.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 5.5 mmt 70.67 -58.97 0.54 Allowed 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 127.304 2.242 . . . . 74.4 112.262 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -58.52 -49.29 77.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 122.836 1.303 . . . . 72.1 109.699 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 93.3 t -63.56 -27.77 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 125.935 1.694 . . . . 52.42 111.433 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.455 ' CD1' HG22 ' A' ' 167' ' ' THR . 30.5 t80 -64.12 -59.24 4.69 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 107.8 -1.185 . . . . 71.11 107.8 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 5.9 t -69.19 -33.0 56.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 117.626 0.194 . . . . 74.04 110.913 -172.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.79 -38.13 77.87 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.036 0.534 . . . . 73.24 111.23 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -82.6 -34.35 27.66 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 118.544 -0.741 . . . . 63.34 112.218 172.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -55.9 -57.64 11.25 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 120.208 1.367 . . . . 72.04 110.471 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.67 -30.46 67.38 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.411 0.684 . . . . 44.44 111.979 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -72.38 -50.83 23.68 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.44 1.496 . . . . 71.32 109.956 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.71 HG23 HG21 ' A' ' 3' ' ' ILE . 96.2 m -55.39 -39.16 69.8 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.165 1.386 . . . . 74.22 110.731 174.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 91.3 t -59.48 -58.41 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 108.101 -1.074 . . . . 64.3 108.101 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -59.99 -35.06 74.21 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.278 -0.868 . . . . 72.44 111.309 -177.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -59.96 -44.21 94.57 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 119.523 1.056 . . . . 70.22 110.78 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.443 ' HB2' HG11 ' A' ' 154' ' ' VAL . 77.9 mt -67.9 -25.5 65.53 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 121.047 -1.033 . . . . 65.11 111.835 -176.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 93.1 t -66.19 -22.08 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 O-C-N 121.253 -0.904 . . . . 64.13 111.177 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -102.96 -7.34 21.55 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.622 0.769 . . . . 72.21 110.401 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -125.94 75.72 1.53 Allowed 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.574 1.549 . . . . 74.03 109.24 -172.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.245 0.86 0 N-CA-C 106.019 -1.845 . . . . 62.14 106.019 167.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 44.8 m . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 110.511 -0.181 . . . . 65.14 110.511 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -79.65 -12.19 59.83 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.225 1.195 . . . . 74.1 114.225 -173.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -73.27 33.91 0.08 Allowed 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.377 1.471 . . . . 72.33 114.182 -166.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -159.89 120.74 3.09 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.588 -1.634 . . . . 62.43 106.588 171.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.2 pt -122.47 154.04 27.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 127.54 2.336 . . . . 72.43 106.869 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.0 m -129.21 134.77 48.14 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.075 -1.454 . . . . 71.32 107.075 -175.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -57.31 140.29 50.47 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 123.723 0.639 . . . . 54.5 109.667 170.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 84.61 -23.14 7.79 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.275 1.417 . . . . 73.34 112.587 -172.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.7 tptp -95.05 -85.53 0.31 Allowed 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 119.472 1.636 . . . . 72.31 109.092 -169.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -90.17 -19.13 24.59 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.983 0.913 . . . . 74.41 110.899 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -135.18 163.74 29.26 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.937 0.895 . . . . 73.0 109.53 171.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.5 mm -124.97 161.25 29.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 C-N-CA 127.337 2.255 . . . . 61.33 105.525 174.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.6 m -119.68 147.61 44.36 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.804 1.242 . . . . 54.44 108.362 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 31.3 mt -76.35 155.74 33.88 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.022 -0.732 . . . . 70.0 109.022 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -71.81 -37.41 70.38 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 122.308 1.051 . . . . 74.14 109.681 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -132.91 74.76 73.6 Favored Pre-proline 0 C--N 1.339 0.129 0 C-N-CA 126.463 1.905 . . . . 74.12 109.356 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.2 137.05 39.32 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.113 1.875 . . . . 53.42 107.588 171.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.7 tp -149.71 164.85 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 108.355 -0.98 . . . . 72.13 108.355 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.01 158.04 33.89 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.991 -0.744 . . . . 65.31 108.991 167.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 122.53 -10.03 9.23 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-O 119.12 -0.822 . . . . 53.51 113.835 176.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -105.79 165.18 13.54 Favored Pre-proline 0 C--O 1.241 0.64 0 C-N-CA 125.546 1.539 . . . . 64.22 108.531 172.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -72.31 -179.71 4.27 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.46 2.107 . . . . 65.22 112.988 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.57 -46.34 90.32 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.523 1.529 . . . . 65.35 111.634 -174.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.6 m -151.06 173.14 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 127.781 2.433 . . . . 65.3 106.683 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.436 HD23 ' CE2' ' A' ' 25' ' ' PHE . 5.7 tp -162.05 169.69 20.55 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.165 -0.679 . . . . 65.32 109.165 163.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -136.72 131.02 32.91 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 106.715 -1.587 . . . . 74.02 106.715 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.436 ' CE2' HD23 ' A' ' 23' ' ' LEU . 96.0 m-85 -119.14 128.13 53.98 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 118.57 0.623 . . . . 71.21 109.82 171.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -141.18 173.32 11.6 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.503 1.121 . . . . 70.12 108.821 164.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.516 ' HA ' ' CE1' ' A' ' 60' ' ' HIS . 3.5 t -128.37 179.7 5.49 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.509 -0.552 . . . . 45.33 109.509 168.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.498 ' CD2' ' CE1' ' A' ' 60' ' ' HIS . 46.8 m-85 -87.5 -35.17 18.36 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 118.241 -0.885 . . . . 74.33 111.845 177.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.411 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 96.9 m-85 -83.84 -3.12 57.64 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 121.157 1.799 . . . . 61.33 112.891 -177.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.7 p -80.04 141.01 53.98 Favored Pre-proline 0 CA--C 1.541 0.615 0 O-C-N 119.97 -1.706 . . . . 52.24 110.143 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -83.65 -35.3 0.24 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 121.866 1.711 . . . . 70.14 113.071 -170.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.82 -48.96 72.15 Favored 'General case' 0 C--O 1.227 -0.121 0 N-CA-C 109.464 -0.569 . . . . 70.34 109.464 172.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.6 m -52.36 -33.88 45.13 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.065 1.346 . . . . 65.14 111.556 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -63.49 -55.73 21.73 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 118.819 0.736 . . . . 74.11 110.863 176.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.79 -44.29 77.63 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 121.185 -0.947 . . . . 65.3 109.024 175.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -64.71 -15.69 61.8 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 116.057 -1.925 . . . . 54.51 111.071 -174.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -141.54 12.79 2.13 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-N 121.457 1.935 . . . . 73.42 114.333 -171.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -135.69 -14.63 1.88 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.653 1.581 . . . . 72.12 112.115 167.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.2 t -124.34 -82.12 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.079 0 N-CA-C 107.795 -1.187 . . . . 65.31 107.795 -175.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.5 mt -59.03 -29.36 67.22 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.714 2.006 . . . . 73.23 111.973 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 44.34 62.48 1.99 Allowed 'General case' 0 C--O 1.241 0.621 0 C-N-CA 126.005 1.722 . . . . 65.04 110.837 178.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.549 ' O ' HG23 ' A' ' 46' ' ' VAL . 99.7 t -63.05 -46.83 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 113.983 -1.462 . . . . 62.23 108.026 -173.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 95.2 p -49.72 -52.61 30.13 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.824 0.849 . . . . 54.34 111.014 -177.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.85 -31.8 65.01 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.132 0.573 . . . . 72.33 109.965 -171.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -64.73 -43.18 94.2 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 118.774 -0.632 . . . . 70.2 110.965 171.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 42' ' ' VAL . 1.9 t -59.57 -46.89 92.65 Favored 'Isoleucine or valine' 0 C--N 1.342 0.258 0 CA-C-N 119.251 0.932 . . . . 71.01 108.993 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -50.99 -42.13 60.09 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.193 0.997 . . . . 74.13 112.262 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -61.66 -5.43 1.91 Allowed 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.998 1.481 . . . . 63.41 114.998 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -127.08 -15.63 5.25 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.969 1.708 . . . . 71.33 113.219 177.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.553 HD13 HG21 ' A' ' 54' ' ' THR . 14.1 mt -67.71 149.68 98.17 Favored Pre-proline 0 N--CA 1.469 0.511 0 CA-C-N 119.964 1.256 . . . . 54.22 112.497 -164.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.19 151.83 27.04 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.449 2.766 . . . . 73.2 111.17 171.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -82.11 81.68 7.95 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 122.636 1.208 . . . . 73.13 109.091 -176.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 175.44 -30.42 0.08 OUTLIER Glycine 0 CA--C 1.521 0.439 0 C-N-CA 125.131 1.348 . . . . 52.33 110.665 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.553 HG21 HD13 ' A' ' 50' ' ' LEU . 10.7 t -44.02 -45.21 7.81 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.911 1.684 . . . . 74.44 113.398 -173.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? 59.48 99.63 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.626 1.97 . . . . 62.15 110.045 -169.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.79 125.67 25.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.361 -1.29 . . . . 43.45 107.65 172.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 m -137.32 161.71 35.51 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.075 -1.454 . . . . 74.03 107.075 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -151.51 110.45 3.87 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 104.335 -2.468 . . . . 71.25 104.335 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -104.36 136.68 43.48 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 105.836 -1.913 . . . . 73.13 105.836 168.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.54 ' H ' ' NE2' ' A' ' 137' ' ' GLN . 15.3 t60 -82.86 169.68 15.81 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.043 -1.095 . . . . 71.45 108.043 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.3 m -131.22 136.22 58.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 108.698 -0.853 . . . . 74.04 108.698 170.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.47 5.18 11.29 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.626 1.17 . . . . 33.12 113.015 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -72.15 -177.43 2.09 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 122.71 1.243 . . . . 73.05 112.421 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 mp 63.8 -86.37 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 130.199 3.4 . . . . 71.22 112.588 177.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.411 ' HA3' ' CD2' ' A' ' 29' ' ' TYR . . . -72.7 160.87 54.23 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 124.03 0.824 . . . . 72.41 111.323 -176.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -65.27 -54.04 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.895 3.064 . . . . 45.31 110.052 -175.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.5 mt -73.62 8.78 1.68 Allowed 'General case' 0 N--CA 1.456 -0.145 0 CA-C-O 117.777 -1.106 . . . . 73.01 113.425 -176.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -47.7 -33.19 8.87 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 120.135 1.334 . . . . 52.45 113.446 -177.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -58.61 -39.97 81.98 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.768 1.025 . . . . 74.11 113.768 175.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -62.21 -47.44 84.41 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.391 -0.966 . . . . 74.03 108.391 171.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.0 mt -54.18 -50.12 67.76 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 123.893 0.746 . . . . 52.55 110.191 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.7 m -57.29 -39.48 75.82 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.277 1.431 . . . . 72.44 112.955 173.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -68.04 -50.84 52.81 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.663 0.665 . . . . 74.03 110.375 176.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.78 -40.26 75.57 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 126.166 1.786 . . . . 52.31 111.678 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 46.2 t-105 -56.27 -35.21 67.19 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.041 0.536 . . . . 73.14 111.821 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.45 -40.36 94.2 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.246 -0.883 . . . . 65.34 111.798 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.5 t -57.46 -46.85 85.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 119.362 0.983 . . . . 72.35 108.896 172.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.16 -41.1 97.28 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-O 118.416 -0.802 . . . . 74.14 111.701 -176.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.7 mt -66.82 -43.36 89.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-O 118.107 -0.949 . . . . 65.22 109.765 175.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.39 -40.29 93.81 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 119.185 0.902 . . . . 61.11 110.949 -174.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 85.8 mt -87.62 -12.52 45.32 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 119.038 -0.506 . . . . 73.02 112.265 175.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 60.44 61.83 6.66 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 126.148 1.832 . . . . 53.43 111.709 -174.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.9 m -134.18 20.23 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 125.361 1.464 . . . . 70.33 111.205 -177.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -50.38 -50.47 51.44 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.225 1.01 . . . . 71.25 110.0 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.18 -28.44 69.75 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.13 1.772 . . . . 52.33 110.623 -176.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -84.72 -25.24 28.48 Favored 'General case' 0 C--O 1.227 -0.11 0 C-N-CA 123.783 0.833 . . . . 74.35 111.671 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.1 pp -99.22 -15.4 7.44 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 CA-C-O 117.315 -1.326 . . . . 63.23 112.637 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.0 m -62.68 -45.7 91.57 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 119.863 1.21 . . . . 61.45 110.264 -170.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.526 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -56.8 -61.37 7.04 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 123.266 0.627 . . . . 61.42 111.385 -173.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 41.6 Cg_endo -66.72 -21.84 50.96 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.603 1.535 . . . . 72.14 112.735 -177.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.98 -53.77 53.98 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.08 0.952 . . . . 74.25 110.556 173.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -66.35 -33.32 75.47 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 118.083 0.401 . . . . 73.01 111.103 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.86 -38.25 81.59 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 120.15 -0.62 . . . . 64.41 110.925 169.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -86.52 -18.4 31.66 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 121.265 -0.897 . . . . 41.33 112.214 -168.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.7 t -107.93 -28.46 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 124.758 1.223 . . . . 73.05 109.822 -173.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -118.96 -53.5 2.27 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 118.887 0.767 . . . . 74.44 111.536 -173.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -64.99 -65.48 0.67 Allowed 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 118.62 0.645 . . . . 74.13 109.27 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.6 p -94.85 -18.29 21.31 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.04 0.536 . . . . 72.34 111.733 -170.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 45.34 39.79 4.71 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.503 2.321 . . . . 74.24 112.165 -175.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.0 t -73.77 -20.16 60.57 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.588 1.155 . . . . 72.42 111.466 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.417 HG13 HG12 ' A' ' 107' ' ' ILE . 31.9 t -69.38 117.87 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 108.29 -1.004 . . . . 65.42 108.29 172.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -137.6 -24.0 1.06 Allowed 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 124.407 1.083 . . . . 74.11 111.575 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.43 177.34 11.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.079 2.152 . . . . 65.44 109.411 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.8 t -53.47 -46.0 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.264 1.826 . . . . 70.24 109.42 -173.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.04 -23.79 35.46 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.283 1.433 . . . . 65.02 112.713 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -91.83 -28.88 17.05 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 118.261 0.482 . . . . 54.24 110.091 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.417 HG12 HG13 ' A' ' 101' ' ' VAL . 0.5 OUTLIER -79.95 -46.34 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 123.205 0.602 . . . . 72.25 109.433 -175.093 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.33 -25.35 61.83 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 112.932 0.715 . . . . 73.45 112.932 175.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -58.83 -52.46 65.62 Favored 'General case' 0 C--O 1.222 -0.342 0 N-CA-C 109.323 -0.621 . . . . 74.01 109.323 175.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 21.7 t -52.94 -43.69 47.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 123.862 0.865 . . . . 62.45 110.734 -176.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -55.1 -52.91 61.76 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.405 0.682 . . . . 73.43 110.392 175.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 96.7 t -65.64 -42.15 92.14 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 124.126 0.97 . . . . 72.15 111.242 -177.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.39 -51.26 65.4 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.673 1.589 . . . . 73.31 108.259 178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.02 -13.64 60.89 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.408 1.083 . . . . 41.51 112.913 -178.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 118.08 32.89 1.32 Allowed Glycine 0 CA--C 1.524 0.612 0 C-N-CA 124.456 1.027 . . . . 64.15 114.92 165.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.9 t -97.96 134.96 34.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 119.452 1.626 . . . . 62.15 109.372 174.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.421 ' HG3' ' CB ' ' A' ' 120' ' ' ASP . 1.2 pttm -62.42 133.23 54.75 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.54 -1.209 . . . . 74.24 110.384 176.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.85 -20.73 66.81 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.061 -0.815 . . . . 70.13 111.061 168.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -76.84 -41.05 45.67 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 117.817 0.809 . . . . 74.44 111.163 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.421 ' CB ' ' HG3' ' A' ' 117' ' ' LYS . 36.8 t70 -69.84 -47.09 64.05 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 107.343 -1.354 . . . . 62.24 107.343 175.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -54.94 -52.48 62.87 Favored 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 123.778 0.673 . . . . 65.33 109.652 -172.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -72.24 -17.35 61.91 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.083 -1.011 . . . . 65.21 113.503 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.17 -71.56 0.47 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.074 -0.713 . . . . 74.45 109.074 172.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -46.46 -47.33 19.19 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 127.352 2.261 . . . . 61.31 109.886 -175.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 30.7 t-105 -48.77 -31.64 7.33 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.581 1.152 . . . . 64.21 113.288 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -113.05 3.18 16.01 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.277 2.231 . . . . 64.21 111.928 -176.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 21.8 m -93.93 159.11 15.32 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 126.266 1.827 . . . . 72.15 112.356 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -55.02 -34.11 63.21 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.259 1.823 . . . . 72.15 112.709 174.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 129' ' ' VAL . 14.5 t -51.71 -47.6 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.259 1.024 . . . . 72.34 110.166 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.3 t -72.77 -39.87 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 117.826 -1.083 . . . . 53.34 109.547 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.502 ' HA ' ' HE2' ' A' ' 131' ' ' LYS . 8.6 mmpt? -50.86 -48.78 60.07 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 120.713 1.597 . . . . 63.31 111.697 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 64.8 m -64.01 -49.87 70.75 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 122.217 -0.302 . . . . 70.01 111.546 175.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 18.4 mt -65.72 -32.06 73.41 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.202 0.816 . . . . 64.11 113.202 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 37.9 t -65.51 -62.58 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 126.169 1.788 . . . . 73.14 107.765 170.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.44 -39.89 58.29 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.649 0.78 . . . . 61.25 111.39 -175.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -47.62 -62.72 1.31 Allowed 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 117.383 -1.294 . . . . 71.15 110.574 175.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.54 ' NE2' ' H ' ' A' ' 60' ' ' HIS . 3.8 pt20 -81.41 -28.39 34.32 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 120.115 1.325 . . . . 74.12 113.997 -178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -59.19 -38.67 80.42 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 120.189 1.359 . . . . 74.14 108.736 176.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 8.4 tttt -79.46 -53.71 6.62 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.534 -0.729 . . . . 72.24 111.427 171.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.73 -6.95 6.35 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-O 117.255 -1.355 . . . . 73.24 113.704 -171.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.97 16.71 10.89 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.053 1.341 . . . . 54.33 113.457 172.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.13 4.61 1.08 Allowed 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.468 -0.77 . . . . 62.01 112.71 174.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.13 -79.04 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.535 1.134 . . . . 70.24 110.891 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -174.86 50.73 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.146 2.179 . . . . 34.43 110.359 175.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.479 ' NE2' ' H ' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -127.65 -55.2 1.32 Allowed 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.199 -0.938 . . . . 70.24 112.898 -175.24 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.479 ' H ' ' NE2' ' A' ' 145' ' ' GLN . 0.9 OUTLIER -147.18 143.69 28.39 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 128.08 2.552 . . . . 71.32 105.915 -172.435 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -137.33 14.91 3.0 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.11 0.964 . . . . 74.42 111.664 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -155.84 168.83 33.46 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.795 -1.322 . . . . 62.05 109.795 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.9 m -147.6 168.88 10.28 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.469 1.108 . . . . 73.42 111.102 -166.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.18 160.87 88.55 Favored 'Cis proline' 0 C--N 1.35 0.648 0 CA-C-N 119.953 1.019 . . . . 73.14 112.696 -9.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -149.61 154.51 38.77 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.611 0.764 . . . . 71.01 111.262 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 29.8 ttm -142.24 121.92 13.41 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.301 1.44 . . . . 70.32 107.258 172.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -94.28 152.62 18.54 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.737 1.615 . . . . 74.24 109.271 177.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.1 t -140.26 140.72 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 123.181 0.592 . . . . 65.43 109.948 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 44.67 30.34 0.51 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 129.17 2.988 . . . . 73.34 114.017 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 64.91 9.36 39.74 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.937 -0.924 . . . . 50.44 114.684 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -148.3 -2.8 0.51 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.431 1.615 . . . . 64.13 114.982 -165.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -131.07 161.84 31.15 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.931 1.292 . . . . 72.42 108.682 176.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -136.86 141.39 42.81 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.418 -1.697 . . . . 65.0 106.418 171.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.17 151.44 46.98 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 107.318 -1.364 . . . . 70.3 107.318 176.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -120.37 82.97 32.4 Favored Pre-proline 0 N--CA 1.462 0.138 0 CA-C-N 118.497 0.59 . . . . 72.03 111.474 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.48 -15.02 45.94 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 121.602 1.534 . . . . 74.22 113.608 175.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -90.21 -5.63 56.16 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 125.686 1.594 . . . . 74.41 111.225 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -117.67 18.01 11.91 Favored Glycine 0 CA--C 1.526 0.724 0 O-C-N 121.081 -1.012 . . . . 62.0 112.518 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 64.0 mtt -101.37 170.01 8.51 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.711 1.256 . . . . 63.03 110.398 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -66.05 120.92 13.99 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 105.893 -1.892 . . . . 74.13 105.893 158.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . 0.432 1.1 t -136.38 63.01 1.6 Allowed 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 105.652 -1.981 . . . . 70.22 105.652 175.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 35.2 t -129.91 -15.77 3.79 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.171 1.788 . . . . 63.02 113.258 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -127.28 -3.32 6.24 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.0 1.273 . . . . 71.41 112.334 -174.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 7.9 mmt 62.81 -43.04 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 131.543 3.937 . . . . 53.14 114.618 -177.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.98 -48.84 33.0 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.281 -1.007 . . . . 50.41 108.281 -176.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 71.5 t -61.32 -28.57 44.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 125.342 1.457 . . . . 74.13 111.769 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -63.39 -57.69 9.51 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.167 -1.049 . . . . 74.1 108.167 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.9 t -74.67 -28.62 22.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 119.472 -0.299 . . . . 73.3 110.947 -175.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.97 -40.82 73.82 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.123 0.969 . . . . 65.01 110.761 175.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -83.87 -42.55 16.26 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 117.803 -1.094 . . . . 73.02 111.413 174.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -50.48 -55.65 15.04 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 120.202 1.365 . . . . 70.44 110.224 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -54.27 -34.51 60.98 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.902 0.881 . . . . 70.34 112.401 -177.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -78.47 -52.27 8.78 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.208 0.603 . . . . 74.32 109.852 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 8.2 t -58.03 -28.77 64.78 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-O 117.74 -1.124 . . . . 54.52 110.861 -176.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 61.0 t -54.95 -57.4 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 118.777 0.717 . . . . 74.22 109.463 170.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -32.2 71.84 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 119.1 0.864 . . . . 70.44 111.96 -178.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -60.11 -31.88 70.46 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 119.045 0.839 . . . . 72.41 110.527 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 29.0 mt -73.39 -28.41 62.0 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.342 -0.849 . . . . 65.23 111.793 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 74.9 t -65.53 -23.25 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.901 0.88 . . . . 73.0 111.306 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -99.15 -17.9 17.95 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.127 0.571 . . . . 74.43 109.962 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -102.77 77.74 1.62 Allowed 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 125.232 1.413 . . . . 65.4 108.526 -171.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? . . . . . 0 C--O 1.249 1.046 0 CA-C-O 114.502 -2.666 . . . . 65.11 112.962 -178.715 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.826 0.346 . . . . 73.04 110.87 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 58.47 178.42 0.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 53.44 110.889 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 51.75 42.58 29.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 71.04 111.112 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -175.17 110.45 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 71.44 110.933 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.746 HD12 ' CE2' ' A' ' 9' ' ' TYR . 5.0 pt -122.12 164.08 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 72.11 111.115 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.7 m -138.24 142.74 39.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 74.2 111.101 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -65.1 132.9 50.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.183 -0.462 . . . . 70.01 110.873 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.15 6.22 81.97 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.753 . . . . 72.52 112.518 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -117.47 -74.59 0.6 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.717 0.294 . . . . 33.11 110.839 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -101.19 -19.36 15.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.433 . . . . 65.44 110.918 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.746 ' CE2' HD12 ' A' ' 3' ' ' ILE . 20.3 p90 -144.66 157.9 44.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.226 -0.443 . . . . 70.44 110.942 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.738 HD13 ' O ' ' A' ' 9' ' ' TYR . 7.8 mm -129.69 160.76 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 64.55 111.149 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.408 ' N ' HG22 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -118.54 138.21 52.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 70.53 111.154 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' A' ' 157' ' ' LYS . 19.7 mt -67.84 151.67 46.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 51.25 110.827 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.14 -27.03 48.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 44.22 110.858 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -140.11 66.58 31.94 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.597 0.713 . . . . 75.55 110.913 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 77.07 1.08 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.652 2.234 . . . . 75.44 112.419 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.406 HG23 ' O ' ' A' ' 16' ' ' ILE . 5.6 tt -158.29 122.1 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 71.34 111.123 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -179.29 -67.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 63.45 111.077 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -141.01 -60.53 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.861 -0.685 . . . . 75.02 112.541 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 51.44 66.65 5.04 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.665 0.745 . . . . 71.41 110.875 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -54.55 0.22 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.619 2.213 . . . . 51.41 112.35 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.837 ' O ' HG22 ' A' ' 22' ' ' VAL . 1.9 tt0 177.38 79.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 71.03 110.858 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.837 HG22 ' O ' ' A' ' 21' ' ' GLN . 2.9 m 51.8 167.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.426 . . . . 71.05 111.154 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.77 HD11 ' CD1' ' A' ' 59' ' ' TYR . 15.7 tp -178.03 151.99 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.26 -0.427 . . . . 44.41 110.898 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -128.55 166.42 18.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 70.25 110.902 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.43 ' HB2' ' HB3' ' A' ' 151' ' ' ALA . 47.6 m-85 -144.45 136.69 26.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 73.53 110.866 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -173.14 147.63 1.6 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 64.41 110.931 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.3 t -101.1 -168.28 1.54 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 52.04 110.863 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.412 ' CD1' HD13 ' A' ' 71' ' ' LEU . 18.0 m-85 -115.8 -8.45 11.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 74.1 110.884 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.562 ' HE1' HD11 ' A' ' 71' ' ' LEU . 54.8 m-85 -113.76 18.59 17.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 74.43 110.911 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.8 p -103.38 138.61 19.59 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.567 0.698 . . . . 72.52 110.892 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.91 -41.84 3.75 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.707 2.271 . . . . 74.52 112.268 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -59.42 -64.22 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 72.22 110.789 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 29.6 p -49.78 -32.55 14.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.464 . . . . 74.51 110.885 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -63.75 -53.07 56.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 63.14 110.896 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -67.61 -11.01 57.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 74.41 110.864 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -104.08 0.94 30.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.31 -0.404 . . . . 73.1 110.924 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -141.53 13.1 2.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 74.14 110.913 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -141.99 -52.39 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 65.2 110.921 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 67.6 t -92.8 -78.42 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 64.34 111.114 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.8 mt -59.33 -41.44 89.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 44.44 110.841 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 53.8 72.43 0.44 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 70.04 110.856 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.489 HG22 HG13 ' A' ' 174' ' ' VAL . 80.0 t -72.51 -33.89 46.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 61.23 111.124 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.5 t -52.74 -42.59 65.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 70.22 110.796 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -82.72 2.29 34.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.119 -0.492 . . . . 72.44 110.939 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -102.7 -21.36 14.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 73.33 110.867 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.67 HG12 ' HG ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -85.14 -53.92 9.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 65.22 110.929 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -46.59 -33.57 4.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 74.11 110.922 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -71.16 -30.95 67.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.481 . . . . 62.32 110.947 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 46' ' ' VAL . 4.2 mmmt -121.17 28.13 8.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 74.23 110.915 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.67 ' HG ' HG12 ' A' ' 46' ' ' VAL . 12.5 mt -104.42 144.24 28.31 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.59 0.709 . . . . 63.41 110.885 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.82 159.12 54.54 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.713 2.275 . . . . 74.34 112.23 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.94 59.35 2.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 73.25 110.848 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.45 35.68 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.779 -0.724 . . . . 62.22 112.438 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.666 HG21 HD13 ' A' ' 50' ' ' LEU . 10.9 t -103.07 -30.71 10.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.811 0.339 . . . . 60.03 111.129 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 62.89 107.65 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 63.12 110.928 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.75 102.03 8.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 63.05 110.93 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -105.36 -178.94 3.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 72.34 111.185 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.422 ' H ' HG22 ' A' ' 57' ' ' THR . 5.7 mttm 178.33 110.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 71.44 110.888 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.77 ' CD1' HD11 ' A' ' 23' ' ' LEU . 2.7 m-30 -101.14 124.49 46.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.218 -0.446 . . . . 74.22 110.939 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.853 ' CE1' HG22 ' A' ' 72' ' ' THR . 0.7 OUTLIER -60.84 175.14 0.52 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 61.53 110.862 179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 60' ' ' HIS . 3.6 m -154.97 129.72 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 74.22 111.115 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.24 75.46 0.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 73.15 110.91 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -135.94 3.81 2.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 64.52 110.908 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.05 163.65 32.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.481 . . . . 54.23 110.906 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 63.84 155.25 0.12 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 42.32 112.465 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -42.83 3.09 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.642 2.228 . . . . 70.22 112.418 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.744 HD11 ' O ' ' A' ' 102' ' ' GLN . 92.7 mt -93.83 38.7 1.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.457 . . . . 63.21 110.968 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.32 -20.32 75.08 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.804 -0.713 . . . . 63.51 112.498 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -85.38 -33.94 21.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.801 0.334 . . . . 73.35 110.903 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.38 -46.82 72.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 65.52 110.849 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.594 HD23 HG21 ' A' ' 107' ' ' ILE . 3.6 mt -60.74 -37.49 81.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 71.44 110.918 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.853 HG22 ' CE1' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -50.14 -65.41 0.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 71.35 111.156 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -51.16 -44.33 61.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 74.24 110.837 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.413 ' HB1' ' CZ ' ' A' ' 111' ' ' PHE . . . -54.91 -35.92 64.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.406 . . . . 63.15 111.138 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 13.0 t-105 -53.66 -48.55 69.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 72.54 110.949 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.664 ' HB3' HG13 ' A' ' 130' ' ' VAL . . . -49.44 -41.83 41.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 72.05 111.1 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.509 HG11 ' CD2' ' A' ' 121' ' ' TYR . 74.7 t -61.33 -34.35 60.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.263 -0.426 . . . . 62.45 111.122 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.92 -35.59 64.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 44.55 111.103 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -79.12 -33.13 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 74.34 111.092 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.77 -34.34 77.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 74.34 111.064 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.629 HD21 ' CG ' ' A' ' 120' ' ' ASP . 91.5 mt -98.86 -21.66 16.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 55.14 110.915 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.98 57.05 3.12 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.806 -0.711 . . . . 75.21 112.512 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.708 HG12 ' HD2' ' A' ' 86' ' ' LYS . 13.5 m -143.97 39.87 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.735 0.303 . . . . 64.15 111.115 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.04 -54.07 30.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 73.43 110.839 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.73 -17.82 57.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 51.42 110.827 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.708 ' HD2' HG12 ' A' ' 83' ' ' VAL . 14.8 mtpt -83.62 -27.18 29.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 71.04 110.891 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.712 HD13 ' CZ ' ' A' ' 111' ' ' PHE . 1.5 pp -114.08 41.32 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 73.31 111.122 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 66.8 m -118.46 -26.82 6.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 65.32 111.147 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.788 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -69.9 -60.99 3.22 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.593 0.711 . . . . 50.44 111.033 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 53.4 Cg_endo -69.72 -30.59 22.24 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.721 2.281 . . . . 70.42 112.309 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 33.4 tpp -60.39 -29.73 69.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.439 . . . . 52.01 110.869 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -90.41 -33.94 15.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.288 -0.414 . . . . 74.44 110.883 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -76.8 -8.69 57.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 73.43 110.881 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.604 ' HB1' HG22 ' A' ' 100' ' ' THR . . . -111.69 0.83 16.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 53.31 111.088 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.441 ' CG2' HG21 ' A' ' 101' ' ' VAL . 65.7 t -121.15 -30.65 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.259 -0.428 . . . . 65.3 111.149 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -110.5 -57.99 2.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 74.5 110.853 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -58.54 -76.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 64.42 110.838 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.4 p -83.49 -33.49 25.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 74.4 111.089 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 62.11 34.52 16.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.237 -0.438 . . . . 71.12 110.948 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.604 HG22 ' HB1' ' A' ' 94' ' ' ALA . 12.3 t -66.35 -19.79 65.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 72.54 111.142 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.697 HG13 HG12 ' A' ' 107' ' ' ILE . 53.5 t -64.36 115.29 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.32 -0.4 . . . . 62.33 111.07 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.744 ' O ' HD11 ' A' ' 67' ' ' LEU . 11.7 mt-30 -131.4 -39.68 1.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.112 -0.495 . . . . 65.23 110.937 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.49 166.04 22.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 62.13 110.817 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.0 t -57.87 -21.69 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.112 -0.495 . . . . 53.31 111.129 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.78 -5.29 52.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 32.32 111.128 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -108.42 -24.37 11.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 74.54 110.864 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.697 HG12 HG13 ' A' ' 101' ' ' VAL . 2.3 mt -84.37 -25.17 7.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 73.43 111.111 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.83 -26.61 49.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 74.34 110.811 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -62.5 -53.99 46.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.42 . . . . 71.15 110.883 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.475 HG13 ' HB2' ' A' ' 90' ' ' PRO . 99.8 t -50.62 -45.02 26.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.255 -0.429 . . . . 73.13 111.114 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.712 ' CZ ' HD13 ' A' ' 87' ' ' ILE . 7.9 m-85 -54.38 -48.28 71.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 74.45 110.905 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 89.7 t -69.37 -42.15 81.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 52.23 111.156 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.81 -22.33 35.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 72.5 110.877 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -86.09 -27.82 24.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 63.34 111.096 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.8 -20.54 1.63 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.787 -0.72 . . . . 65.13 112.523 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 93.9 t -51.46 133.79 12.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.896 0.379 . . . . 71.44 111.123 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.554 ' HE2' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -79.59 139.56 37.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 60.05 110.878 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.69 -8.18 59.87 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.693 -0.765 . . . . 44.24 112.481 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -90.0 -30.14 17.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.829 0.347 . . . . 74.45 110.908 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.629 ' CG ' HD21 ' A' ' 81' ' ' LEU . 17.6 t70 -88.69 -34.56 17.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 75.23 110.855 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.509 ' CD2' HG11 ' A' ' 77' ' ' VAL . 24.7 t80 -75.73 -30.63 59.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.472 . . . . 75.54 110.931 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -88.55 -10.84 47.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 73.32 110.834 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -106.12 -60.29 1.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 13.4 111.058 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -52.17 -38.33 57.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 61.14 111.141 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 21.7 t-105 -48.45 -39.68 23.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.43 . . . . 65.15 110.956 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -110.84 39.13 2.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 73.31 110.932 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 75.2 m -123.87 166.17 16.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 71.35 110.913 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -64.38 -34.63 78.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 75.41 110.862 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 38.6 t -50.15 -50.81 19.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 71.11 111.108 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.718 ' O ' HG23 ' A' ' 134' ' ' VAL . 41.0 t -72.8 -33.78 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.125 -0.488 . . . . 71.34 111.103 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.4 -59.01 6.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 52.05 110.895 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.19 -42.45 63.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 75.55 110.869 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.493 HD13 ' HA ' ' A' ' 76' ' ' ALA . 5.5 mt -58.66 -59.99 4.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 75.51 110.888 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 130' ' ' VAL . 39.9 t -48.4 -36.46 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 71.24 111.046 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.81 -49.3 71.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 64.22 111.093 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 47.4 mm-40 -54.15 -51.17 65.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 75.11 110.977 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -67.19 -50.39 61.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 74.14 110.957 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.492 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 20.0 mm-40 -59.16 -20.09 50.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 61.32 110.877 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -101.96 -15.36 16.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 63.35 110.893 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -100.5 -6.16 25.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.278 -0.419 . . . . 43.34 111.1 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.65 -4.45 8.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 74.32 111.143 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.492 ' HB3' ' O ' ' A' ' 138' ' ' GLU . . . -120.47 0.11 10.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 52.01 111.138 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -69.98 -84.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 62.53 110.838 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 174.63 36.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.405 . . . . 74.55 110.896 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.457 ' H ' ' NE2' ' A' ' 145' ' ' GLN . 0.1 OUTLIER -120.7 -15.37 8.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 72.14 110.945 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.637 HD11 ' CB ' ' A' ' 151' ' ' ALA . 0.6 OUTLIER -164.15 146.87 9.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 65.42 110.837 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -152.56 20.05 0.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 74.11 110.906 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -144.9 167.1 27.3 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.793 -0.718 . . . . 65.54 112.467 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.492 ' HA ' ' C ' ' A' ' 150' ' ' PRO . 2.3 m -154.28 158.48 32.38 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.579 0.704 . . . . 65.13 111.187 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 149' ' ' VAL . 54.4 Cg_endo -69.64 167.74 69.62 Favored 'Cis proline' 0 C--N 1.341 0.153 0 C-N-CA 122.644 -1.815 . . . . 62.23 112.4 -0.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.637 ' CB ' HD11 ' A' ' 146' ' ' LEU . . . -157.27 109.26 2.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 42.33 111.04 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 2.5 ttm -106.11 114.93 29.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.277 -0.419 . . . . 74.41 110.888 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.603 ' HE2' HD13 ' A' ' 146' ' ' LEU . 35.1 m-85 -94.33 129.21 41.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.45 . . . . 70.25 110.898 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.706 HG11 ' HB2' ' A' ' 184' ' ' LEU . 31.9 t -108.9 121.86 62.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.49 . . . . 60.33 111.09 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.487 ' H ' HG12 ' A' ' 22' ' ' VAL . 0.7 OUTLIER 74.39 -60.16 0.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 75.25 110.88 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 151.02 -15.9 0.9 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.841 -0.695 . . . . 73.43 112.476 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.475 ' HA ' HD12 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -125.75 39.18 4.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.756 0.312 . . . . 74.11 110.904 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.421 ' CG ' HD22 ' A' ' 184' ' ' LEU . 78.3 m-85 -153.29 155.93 37.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 71.45 110.926 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -144.68 115.43 7.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 64.33 110.89 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.635 HD11 HG23 ' A' ' 180' ' ' THR . 3.4 mm? -51.34 140.36 17.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 63.51 110.903 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -122.33 76.62 43.68 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.607 0.718 . . . . 70.21 110.873 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -7.52 21.26 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.656 2.237 . . . . 63.51 112.393 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.27 -25.33 54.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 72.51 110.896 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -95.36 -8.95 58.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.777 -0.725 . . . . 50.22 112.503 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 6.9 mtt -77.6 173.35 12.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.784 0.326 . . . . 62.41 110.858 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -85.16 87.35 7.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 70.3 110.897 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.639 HG22 ' CD1' ' A' ' 173' ' ' PHE . 19.4 p -93.05 39.44 1.04 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 74.33 111.162 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 47.8 m -109.37 -14.16 14.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 73.2 110.864 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.38 -16.51 9.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 73.34 110.851 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.439 ' HA ' ' HE2' ' A' ' 170' ' ' MET . 7.4 mmt 71.94 -64.85 0.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 73.43 110.882 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.42 -45.68 69.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 53.54 110.849 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.608 HG12 HE21 ' A' ' 176' ' ' GLN . 63.6 t -69.83 -36.35 69.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 71.23 111.105 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.639 ' CD1' HG22 ' A' ' 167' ' ' THR . 30.2 t80 -55.53 -70.06 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 63.42 110.822 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.489 HG13 HG22 ' A' ' 42' ' ' VAL . 21.7 t -54.59 -37.95 40.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 64.23 111.13 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.2 -43.67 61.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 62.24 111.129 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.608 HE21 HG12 ' A' ' 172' ' ' VAL . 52.3 mt-30 -80.62 -33.48 35.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 70.3 110.884 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.626 ' O ' HG23 ' A' ' 181' ' ' VAL . 49.1 t80 -51.35 -65.94 0.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 74.34 110.923 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.85 -25.12 10.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 61.41 111.056 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -70.55 -55.12 9.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 72.24 110.86 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.635 HG23 HD11 ' A' ' 160' ' ' LEU . 7.1 t -65.36 -29.06 69.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 73.23 111.13 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 177' ' ' TYR . 84.1 t -68.39 -39.28 80.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 71.12 111.073 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.54 -21.89 41.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 75.44 110.907 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.3 -20.87 39.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.422 . . . . 70.12 110.853 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.706 ' HB2' HG11 ' A' ' 154' ' ' VAL . 20.0 mt -79.74 -35.56 38.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.302 -0.408 . . . . 74.13 110.889 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 87.0 t -59.77 -23.25 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 72.21 111.15 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -109.69 -5.24 15.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 73.22 110.846 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -105.7 28.96 6.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 75.02 110.921 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 74.05 110.832 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 14.6 t . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 118.683 -0.675 . . . . 74.31 109.968 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -138.96 21.01 2.64 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.793 1.179 . . . . 62.14 112.89 -164.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -68.17 38.52 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.931 1.693 . . . . 74.31 114.781 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -155.51 106.47 2.53 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 127.979 2.512 . . . . 65.01 107.255 -161.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.7 pt -129.44 149.45 33.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 127.219 2.208 . . . . 71.21 106.884 178.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.4 m -109.35 130.48 55.49 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.209 -1.034 . . . . 63.33 108.209 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -44.3 124.31 3.95 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 126.505 1.922 . . . . 70.35 110.155 159.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.67 -15.06 53.92 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 126.945 2.212 . . . . 74.41 113.653 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -95.02 -85.88 0.3 Allowed 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 119.98 1.89 . . . . 74.14 108.154 -174.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.4 mp0 -85.75 -16.64 38.24 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.971 0.805 . . . . 71.23 111.394 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -139.64 163.1 33.48 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 122.637 0.375 . . . . 73.44 110.601 172.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.8 mm -120.64 158.18 23.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.651 -1.611 . . . . 74.02 106.651 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.4 m -109.56 134.47 51.88 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 126.001 1.72 . . . . 71.35 107.606 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.2 mt -84.04 144.9 28.78 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 108.031 -1.1 . . . . 64.22 108.031 172.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -76.08 -31.61 58.84 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.191 1.396 . . . . 74.44 111.397 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm -127.84 74.29 78.63 Favored Pre-proline 0 N--CA 1.455 -0.19 0 C-N-CA 125.439 1.496 . . . . 74.42 109.026 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -79.71 63.14 8.7 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.319 2.679 . . . . 62.45 109.511 174.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.6 tt -162.26 99.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 O-C-N 120.935 -1.103 . . . . 64.22 109.436 172.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.29 -169.33 2.93 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.035 2.134 . . . . 64.21 107.133 166.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -95.27 22.59 37.82 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 124.615 1.102 . . . . 54.14 112.725 -177.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -69.74 158.98 85.72 Favored Pre-proline 0 N--CA 1.451 -0.396 0 CA-C-N 117.649 0.724 . . . . 72.44 110.497 170.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.88 154.85 66.79 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 121.145 1.23 . . . . 72.05 110.47 173.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -66.69 -19.09 65.68 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 118.114 -0.946 . . . . 63.14 112.705 -175.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.614 HG11 ' H ' ' A' ' 55' ' ' LYS . 14.3 p -154.85 141.91 12.26 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 CA-C-N 120.194 1.361 . . . . 55.52 109.67 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -169.2 172.17 7.53 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.394 1.078 . . . . 74.03 110.953 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -130.75 148.55 52.55 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.585 1.954 . . . . 74.24 107.632 154.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -115.24 143.0 45.91 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.502 1.521 . . . . 73.43 107.658 164.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -153.77 165.63 35.41 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.326 1.451 . . . . 73.34 108.607 175.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.86 179.15 4.05 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.918 1.287 . . . . 74.31 108.249 175.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -97.54 -23.71 15.89 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.913 -0.492 . . . . 72.33 110.638 171.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -105.82 12.64 30.57 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.748 1.619 . . . . 74.45 111.876 -177.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.7 p -84.11 143.76 43.11 Favored Pre-proline 0 CA--C 1.541 0.602 0 O-C-N 120.274 -1.516 . . . . 72.52 109.562 167.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -83.11 -33.69 0.39 Allowed 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 121.832 1.688 . . . . 74.33 110.005 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -49.48 -60.57 2.73 Favored 'General case' 0 C--N 1.337 0.062 0 C-N-CA 125.881 1.673 . . . . 74.11 110.155 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 23.6 p -62.74 -34.72 77.78 Favored 'General case' 0 C--O 1.221 -0.439 0 C-N-CA 123.227 0.611 . . . . 73.41 111.088 -176.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -56.45 -52.27 65.31 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.886 -0.783 . . . . 74.44 108.886 173.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -57.66 -44.78 85.96 Favored 'General case' 0 C--O 1.224 -0.248 0 O-C-N 121.081 -1.012 . . . . 71.2 109.174 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -68.05 -12.99 61.85 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.411 1.084 . . . . 74.11 113.231 -174.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -130.76 2.77 4.46 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 120.181 1.355 . . . . 73.43 110.747 -166.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -144.44 -48.01 0.26 Allowed 'General case' 0 C--N 1.345 0.408 0 C-N-CA 125.574 1.549 . . . . 72.44 112.527 -174.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.1 t -91.87 -72.63 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 105.898 -1.89 . . . . 52.44 105.898 -173.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.8 mt -73.1 -26.08 61.12 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.043 1.737 . . . . 73.2 111.981 -175.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 29.2 m80 44.72 60.07 3.08 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 122.752 1.263 . . . . 71.24 112.118 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 46' ' ' VAL . 93.4 t -57.92 -54.8 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.437 1.495 . . . . 65.02 107.334 170.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.71 -43.18 36.96 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.338 1.055 . . . . 70.22 113.329 -178.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -73.61 -42.55 61.35 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.256 -0.903 . . . . 74.24 110.836 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -56.77 -51.99 66.78 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 123.507 0.723 . . . . 72.41 110.098 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.679 HG12 ' HG ' ' A' ' 50' ' ' LEU . 15.6 t -61.64 -43.88 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 108.364 -0.976 . . . . 73.23 108.364 -175.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -49.93 -46.03 51.71 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.717 1.598 . . . . 74.22 112.553 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -61.4 -20.97 63.66 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.751 1.019 . . . . 74.4 113.751 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -114.01 -7.17 13.12 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.089 0.956 . . . . 71.32 111.816 -175.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.679 ' HG ' HG12 ' A' ' 46' ' ' VAL . 13.1 mt -70.65 143.75 90.25 Favored Pre-proline 0 C--O 1.239 0.501 0 O-C-N 120.881 -1.137 . . . . 73.32 109.416 -173.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -76.31 169.57 21.71 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.777 2.318 . . . . 71.23 108.905 167.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.531 ' CD ' ' H ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -82.82 23.09 0.85 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 124.774 1.229 . . . . 73.02 113.44 -176.11 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -119.81 -19.04 4.17 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 126.61 2.052 . . . . 60.11 111.725 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 77.6 m -121.09 101.55 7.74 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 106.838 -1.541 . . . . 72.15 106.838 -164.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.614 ' H ' HG11 ' A' ' 22' ' ' VAL . 3.2 tppt? -87.68 126.62 35.07 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.55 0.74 . . . . 74.33 109.913 -177.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.02 45.75 0.28 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.415 1.886 . . . . 73.03 112.426 171.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.4 m -53.99 145.04 17.49 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.926 1.291 . . . . 74.24 108.651 173.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -131.55 99.46 4.81 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.152 -1.055 . . . . 73.12 108.152 -166.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -95.37 150.61 20.09 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.319 1.048 . . . . 73.22 110.066 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.586 ' CE1' HG22 ' A' ' 72' ' ' THR . 0.3 OUTLIER -88.0 175.58 7.7 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.451 -0.944 . . . . 65.13 108.451 -176.153 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -145.0 163.28 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 107.563 -1.273 . . . . 70.43 107.563 156.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.61 -5.42 10.72 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.654 1.182 . . . . 71.11 113.607 -174.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -58.15 -11.23 2.41 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.489 1.915 . . . . 74.11 115.244 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 mp -127.81 137.61 52.44 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 120.916 1.689 . . . . 73.44 110.702 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.96 170.44 45.27 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 126.746 2.117 . . . . 50.03 112.291 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.72 -53.21 0.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 124.514 3.476 . . . . 64.24 111.675 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.473 HD13 HD11 ' A' ' 107' ' ' ILE . 5.2 mt -84.4 14.32 4.57 Favored 'General case' 0 CA--C 1.528 0.104 0 N-CA-C 113.887 1.069 . . . . 73.45 113.887 -165.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.639 ' HA2' HD12 ' A' ' 71' ' ' LEU . . . -53.57 -38.9 59.33 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-O 118.873 -0.96 . . . . 33.23 112.846 -163.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp -53.6 -38.1 63.65 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.937 1.695 . . . . 61.25 113.327 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.435 ' OD1' HG22 ' A' ' 104' ' ' VAL . 9.8 t70 -76.3 -45.35 32.81 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 118.614 -0.707 . . . . 72.13 109.154 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.639 HD12 ' HA2' ' A' ' 68' ' ' GLY . 15.4 mt -54.98 -37.32 66.38 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 118.789 -0.624 . . . . 73.25 110.646 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.586 HG22 ' CE1' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -57.49 -52.9 63.52 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.987 0.915 . . . . 74.33 109.086 177.292 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -69.18 -50.44 47.54 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.294 -0.632 . . . . 74.43 109.294 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.0 -37.17 63.73 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.553 1.07 . . . . 71.31 113.607 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 29.8 t-105 -59.85 -38.37 81.89 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 119.759 1.163 . . . . 74.55 112.016 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.94 -39.66 74.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 118.633 -0.698 . . . . 73.43 111.31 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' A' ' 124' ' ' ALA . 56.3 t -56.41 -49.22 78.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 118.817 0.735 . . . . 74.53 109.543 174.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.97 -40.27 97.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 118.677 -0.678 . . . . 74.45 111.018 -175.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.0 mt -69.24 -40.27 80.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 118.157 -0.925 . . . . 65.23 110.417 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.36 -30.83 69.8 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.097 0.862 . . . . 74.05 110.818 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.7 mt -94.29 -14.99 24.86 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.824 0.85 . . . . 74.44 112.532 175.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 59.94 64.32 4.29 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 126.306 1.908 . . . . 71.43 112.3 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.9 m -137.42 19.9 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 124.362 1.065 . . . . 61.42 112.217 -177.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -50.69 -52.34 40.95 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.563 1.074 . . . . 73.03 111.251 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -60.07 -17.08 36.93 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.866 1.666 . . . . 72.11 114.219 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.3 mttt -94.85 -9.16 35.19 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.275 1.03 . . . . 72.44 110.748 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.5 pp -136.1 33.53 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 125.033 1.333 . . . . 65.32 110.875 -173.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 52.5 m -111.47 -41.62 4.07 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 118.8 -0.619 . . . . 71.11 110.382 177.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.44 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -66.85 -60.64 5.98 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 119.183 0.901 . . . . 70.41 110.958 -175.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 33.2 Cg_endo -62.53 -28.1 77.23 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 120.541 0.828 . . . . 72.51 111.286 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 29.4 tpp -59.41 -50.55 73.53 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.374 1.07 . . . . 71.51 110.846 176.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -72.34 -31.21 65.45 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.949 0.9 . . . . 50.44 109.786 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.65 -36.8 81.85 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.726 0.694 . . . . 74.41 109.626 171.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -85.91 -13.1 48.82 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.322 -0.861 . . . . 70.12 112.239 -176.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.7 t -101.5 -39.29 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 125.382 1.473 . . . . 72.23 111.722 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -109.78 -59.35 1.93 Allowed 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.544 1.137 . . . . 61.41 109.296 -172.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -67.0 -50.96 60.61 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 118.45 -0.786 . . . . 72.33 111.164 -169.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.9 p -104.86 -19.68 13.81 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 123.691 0.619 . . . . 64.4 112.658 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 53.72 23.76 3.9 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.51 1.924 . . . . 71.31 113.903 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -66.14 -18.16 65.17 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.361 1.064 . . . . 73.4 111.539 -173.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.405 HG13 HG12 ' A' ' 107' ' ' ILE . 53.0 t -62.13 119.56 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 121.141 -0.975 . . . . 53.11 108.479 171.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -141.54 -26.52 0.69 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.899 1.28 . . . . 71.42 111.377 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.37 160.92 39.11 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.179 -1.415 . . . . 72.24 107.179 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.435 HG22 ' OD1' ' A' ' 70' ' ' ASP . 24.2 t -57.65 -28.05 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.722 0.809 . . . . 71.31 110.718 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.9 -29.91 71.04 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.365 1.466 . . . . 74.43 110.185 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.92 -19.36 24.64 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.266 0.626 . . . . 65.51 111.385 -175.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.473 HD11 HD13 ' A' ' 67' ' ' LEU . 1.4 mt -82.57 -45.03 19.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 123.855 0.862 . . . . 72.21 108.958 174.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -59.57 -26.49 65.45 Favored 'General case' 0 C--N 1.346 0.441 0 O-C-N 121.557 -0.715 . . . . 72.13 112.299 -176.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -54.93 -55.24 32.86 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.301 1.04 . . . . 74.43 110.442 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 26.9 t -52.84 -45.64 50.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 124.933 1.293 . . . . 73.32 109.975 -175.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -55.8 -54.07 48.91 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.659 0.784 . . . . 74.15 110.149 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 17.5 t -66.59 -38.51 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 118.024 0.375 . . . . 50.13 110.27 -174.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -63.5 -32.01 73.34 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.126 0.971 . . . . 74.23 111.068 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -83.8 -3.38 57.81 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.673 1.189 . . . . 64.33 113.838 173.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.2 14.48 16.55 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-N 119.558 1.072 . . . . 53.53 115.332 171.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.9 t -77.66 128.28 38.15 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.055 0 CA-C-N 119.593 1.696 . . . . 43.22 108.545 172.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -57.26 129.38 41.5 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.686 -0.857 . . . . 70.35 108.686 170.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -59.55 -22.82 57.41 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 118.173 -1.349 . . . . 51.34 112.341 173.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.4 -23.41 21.07 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.876 1.338 . . . . 75.25 110.764 -177.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -70.59 -42.49 70.96 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 107.457 -1.312 . . . . 64.55 107.457 177.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.417 ' CD1' HG21 ' A' ' 77' ' ' VAL . 53.7 t80 -61.54 -59.47 5.17 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 124.181 0.926 . . . . 73.21 110.028 177.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -66.55 -16.73 64.37 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.276 0.489 . . . . 61.42 111.336 -176.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.43 -64.98 0.95 Allowed 'General case' 0 C--N 1.341 0.21 0 O-C-N 121.092 -1.005 . . . . 73.54 109.023 169.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.565 ' HB3' HG22 ' A' ' 77' ' ' VAL . . . -52.28 -43.35 64.4 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.272 1.029 . . . . 71.32 110.246 -175.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -46.07 -41.54 12.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.675 1.59 . . . . 73.25 112.23 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -103.94 -2.47 26.08 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.995 1.318 . . . . 63.14 111.553 -173.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 41.8 t -84.91 157.05 20.96 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 127.017 2.127 . . . . 72.21 111.495 -175.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -57.76 -31.15 66.22 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 125.505 1.522 . . . . 73.53 111.552 169.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 42.3 t -52.68 -50.1 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 119.248 0.931 . . . . 75.15 108.933 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.4 t -68.99 -39.89 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-O 118.923 -0.561 . . . . 74.13 110.42 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -53.71 -51.48 63.14 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.187 0.903 . . . . 74.44 110.685 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 t -67.34 -37.07 82.68 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.346 1.059 . . . . 64.51 111.207 -178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.88 -53.24 49.78 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-O 117.493 -1.241 . . . . 75.11 110.753 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 53.4 t -52.19 -38.74 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.178 1.391 . . . . 72.14 110.405 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.7 -34.77 76.34 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 118.361 -0.828 . . . . 75.14 112.777 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -55.32 -58.52 7.39 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 118.795 0.725 . . . . 71.32 110.655 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.485 ' HB2' ' CE1' ' A' ' 60' ' ' HIS . 0.9 OUTLIER -84.68 -33.3 23.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 118.182 -0.913 . . . . 62.31 110.951 -168.344 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -57.43 -52.92 63.41 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 119.145 0.884 . . . . 74.13 109.11 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -55.06 -48.49 73.4 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 110.144 -0.317 . . . . 75.13 110.144 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.9 -12.04 15.99 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 113.763 1.023 . . . . 75.25 113.763 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -130.14 18.65 5.46 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.809 1.244 . . . . 75.33 111.724 176.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -132.23 2.39 3.9 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.424 1.89 . . . . 72.53 111.651 173.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -83.51 22.77 1.01 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.036 1.734 . . . . 71.51 111.276 169.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 62.92 -16.89 0.05 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 130.375 3.47 . . . . 73.12 117.342 -175.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.56 -26.22 50.69 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 119.997 1.271 . . . . 61.55 111.942 -167.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.2 tt -134.56 111.98 10.49 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 126.2 1.8 . . . . 73.24 106.414 -173.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -140.63 22.09 2.33 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 127.306 2.242 . . . . 73.12 108.619 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -162.86 114.21 0.59 Allowed Glycine 0 C--N 1.337 0.595 0 N-CA-C 109.943 -1.263 . . . . 45.11 109.943 -171.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.521 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 2.7 m -120.91 171.01 6.37 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 118.239 1.02 . . . . 73.21 110.386 -176.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.521 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 91.2 Cg_endo -68.97 153.65 90.99 Favored 'Cis proline' 0 N--CA 1.456 -0.679 0 CA-C-N 120.342 1.158 . . . . 61.45 111.237 -4.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -146.81 108.6 4.36 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.564 -0.902 . . . . 54.33 108.564 -173.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 39.0 ttm -101.57 135.02 43.79 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.963 -1.125 . . . . 73.42 107.963 173.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -123.18 154.23 38.98 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.534 1.534 . . . . 74.23 107.982 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 96.6 t -115.23 -48.09 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 N-CA-C 112.9 0.704 . . . . 72.31 112.9 -163.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -144.55 33.2 1.17 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 128.16 2.584 . . . . 74.44 107.609 178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 65.63 5.33 23.27 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.469 1.509 . . . . 72.15 115.759 -175.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.416 ' HE2' ' CZ ' ' A' ' 158' ' ' TYR . 9.9 ptmt -124.57 -16.3 6.32 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 120.357 2.079 . . . . 71.44 114.725 -172.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.416 ' CZ ' ' HE2' ' A' ' 157' ' ' LYS . 23.3 m-85 -126.79 124.28 39.32 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.701 -1.592 . . . . 73.01 106.701 -176.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -98.69 135.47 40.14 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 105.706 -1.961 . . . . 53.31 105.706 172.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -74.91 146.0 42.2 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.936 -0.765 . . . . 73.33 108.936 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -119.6 85.24 32.16 Favored Pre-proline 0 C--O 1.233 0.211 0 N-CA-C 112.864 0.691 . . . . 72.33 112.864 -175.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -67.11 -22.13 47.79 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 121.282 1.321 . . . . 73.3 113.614 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.7 tp60 -68.68 -34.29 75.42 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 119.79 1.177 . . . . 73.0 110.093 176.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -92.02 30.76 6.4 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-O 118.966 -0.908 . . . . 64.44 111.177 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.6 mtt -122.04 176.35 5.85 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 118.681 1.241 . . . . 72.11 109.567 173.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.503 ' HB2' HE22 ' A' ' 176' ' ' GLN . 0.4 OUTLIER -86.64 64.89 8.76 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 123.279 1.514 . . . . 73.3 111.075 -172.39 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 21.0 p -74.9 40.53 0.15 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 129.217 3.007 . . . . 70.42 110.901 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 3.8 m -124.06 -3.5 8.07 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.34 1.456 . . . . 71.04 111.646 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.78 -10.31 2.08 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.484 1.114 . . . . 70.03 112.029 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 8.7 mmt 70.81 -56.69 0.61 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.625 1.97 . . . . 74.0 114.315 174.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.34 -45.61 75.87 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.782 -1.192 . . . . 74.23 107.782 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 82.5 t -63.15 -31.37 52.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.488 1.515 . . . . 74.14 111.577 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -60.21 -56.01 26.84 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.014 -0.736 . . . . 73.01 109.014 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 15.5 t -70.74 -34.43 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 119.145 -0.455 . . . . 74.34 110.775 -176.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -54.72 -35.31 63.54 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.507 0.723 . . . . 74.31 110.77 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.503 HE22 ' HB2' ' A' ' 166' ' ' ASP . 39.7 mt-30 -78.87 -44.67 22.34 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.699 1.199 . . . . 74.34 112.741 168.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -56.97 -58.04 9.9 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.716 1.144 . . . . 73.1 111.349 -173.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -55.68 -31.84 62.74 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.561 -0.733 . . . . 54.2 112.149 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -68.34 -58.15 4.82 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 118.8 0.727 . . . . 74.42 109.869 177.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.9 t -60.53 -29.26 69.01 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 119.064 -0.493 . . . . 74.11 110.554 -172.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 98.0 t -55.42 -57.23 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.318 -0.993 . . . . 71.35 108.318 171.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.63 -46.3 90.39 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.129 0.972 . . . . 73.0 111.16 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -60.26 -18.49 49.39 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.267 1.427 . . . . 73.4 113.383 -178.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.622 HD23 ' HD3' ' A' ' 187' ' ' LYS . 69.1 mt -92.56 -23.33 19.09 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 121.508 -0.745 . . . . 75.43 112.927 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 66.8 t -63.14 -35.81 73.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.068 -0.716 . . . . 62.13 109.068 174.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -83.58 -18.41 38.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.417 -0.81 . . . . 65.32 110.142 -172.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.622 ' HD3' HD23 ' A' ' 184' ' ' LEU 0.305 0.0 OUTLIER -77.75 15.78 0.79 Allowed 'General case' 0 CA--C 1.545 0.759 0 O-C-N 120.751 -1.218 . . . . 74.32 113.776 -168.101 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.433 -1.279 0 C-N-CA 129.4 3.08 . . . . 64.21 109.422 -152.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.468 0.453 0 N-CA-C 109.05 -0.722 . . . . 74.23 109.05 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -112.58 7.73 18.94 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.351 1.461 . . . . 73.44 112.096 -171.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -72.24 43.44 0.1 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.301 1.84 . . . . 70.14 112.815 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.22 122.2 4.98 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 104.205 -2.517 . . . . 71.52 104.205 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.1 pt -126.77 156.89 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 C-N-CA 126.519 1.927 . . . . 72.12 107.33 170.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 99.4 m -135.08 130.34 35.39 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.639 1.575 . . . . 72.43 106.76 -171.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -57.35 137.43 56.1 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.315 -0.624 . . . . 72.24 109.315 171.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.74 -21.97 12.97 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.21 1.386 . . . . 44.12 113.217 -171.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -99.9 -85.58 0.4 Allowed 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 119.895 1.848 . . . . 73.25 109.004 -172.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -88.93 -14.17 37.31 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 119.656 1.116 . . . . 62.44 111.509 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -138.24 170.77 15.44 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.766 0.826 . . . . 65.44 109.587 169.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.4 mm -128.4 154.24 38.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 105.771 -1.937 . . . . 74.55 105.771 170.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.0 m -108.88 140.22 42.65 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 125.711 1.605 . . . . 73.42 108.357 175.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 74.5 mt -79.38 142.07 36.33 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.176 -1.046 . . . . 74.42 108.176 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -70.72 -40.91 72.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 122.612 1.196 . . . . 71.45 109.17 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -125.73 83.82 61.71 Favored Pre-proline 0 N--CA 1.455 -0.193 0 C-N-CA 127.345 2.258 . . . . 65.24 107.12 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -77.46 69.45 7.22 Favored 'Trans proline' 0 N--CA 1.444 -1.408 0 C-N-CA 123.923 3.082 . . . . 74.51 108.579 170.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.6 mt -134.08 148.48 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 107.118 -1.438 . . . . 72.13 107.118 172.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 174.46 -80.13 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.925 2.49 . . . . 52.33 108.679 147.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 159.04 37.76 0.02 OUTLIER Glycine 0 C--N 1.333 0.416 0 CA-C-O 118.575 -1.125 . . . . 43.13 113.826 -174.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -113.73 161.61 26.75 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 107.184 -1.413 . . . . 65.51 107.184 168.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.11 169.81 21.76 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 CA-C-N 120.128 1.081 . . . . 65.11 113.514 -157.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -68.49 16.64 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 127.699 2.4 . . . . 71.34 114.47 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.5 p -171.88 125.62 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 127.402 2.281 . . . . 70.22 107.337 177.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.449 HD23 ' CE2' ' A' ' 25' ' ' PHE . 2.8 tp -166.53 160.56 15.4 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 120.036 1.289 . . . . 73.53 112.456 172.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' H ' ' HG ' ' A' ' 23' ' ' LEU . 16.4 mt-10 -141.36 136.04 31.07 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.045 1.338 . . . . 73.33 108.237 -171.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.449 ' CE2' HD23 ' A' ' 23' ' ' LEU . 83.3 m-85 -128.63 140.98 51.5 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.981 2.112 . . . . 61.22 109.874 -176.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -151.39 177.55 10.17 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 128.54 2.736 . . . . 74.25 107.97 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.3 t -139.29 -177.07 4.75 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.474 -0.766 . . . . 72.21 109.852 155.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -84.11 -51.79 6.79 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.626 1.57 . . . . 63.21 109.473 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -80.44 -13.83 58.8 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.265 0.839 . . . . 71.13 113.265 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.7 p -69.51 145.0 94.96 Favored Pre-proline 0 C--O 1.237 0.409 0 CA-C-N 119.743 1.156 . . . . 53.43 110.867 -175.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -70.7 175.61 8.64 Favored 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 121.251 1.301 . . . . 72.55 109.682 164.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 68.85 -55.08 0.55 Allowed 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 127.495 2.318 . . . . 71.41 111.218 -175.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 32.4 m -44.67 -41.03 6.37 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.133 2.173 . . . . 75.33 110.741 174.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -53.52 -68.4 0.18 Allowed 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.303 1.841 . . . . 74.21 111.036 174.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.14 -44.28 71.27 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.726 -0.842 . . . . 75.53 108.726 -175.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -64.86 -13.11 55.19 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 116.532 -1.699 . . . . 74.53 113.046 -175.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -139.79 19.46 2.5 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 121.022 1.737 . . . . 73.43 112.62 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -136.58 -46.56 0.61 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.412 1.485 . . . . 73.04 111.685 171.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.5 t -101.16 -69.29 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.124 0 N-CA-C 107.753 -1.203 . . . . 62.11 107.753 -168.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 73.5 mt -71.01 -33.83 70.75 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.435 1.094 . . . . 74.13 111.813 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 44.36 54.18 6.39 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.313 1.445 . . . . 73.13 111.326 -169.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.48 ' O ' HG23 ' A' ' 46' ' ' VAL . 81.9 t -52.26 -47.28 45.43 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 C-N-CA 125.285 1.434 . . . . 75.33 109.554 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.4 t -49.47 -43.74 45.35 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.33 2.252 . . . . 63.42 112.122 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -87.02 -17.6 32.58 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.156 -1.59 . . . . 62.44 112.952 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -74.3 -46.34 41.74 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.058 -0.719 . . . . 70.54 109.058 169.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 42' ' ' VAL . 95.0 t -57.66 -44.31 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 C-N-CA 124.789 1.235 . . . . 71.13 109.61 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 46.6 ttt180 -46.59 -43.97 17.73 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.833 0.853 . . . . 74.55 112.305 177.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -67.6 -12.65 60.89 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.281 1.586 . . . . 41.24 115.281 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -111.36 -7.65 14.37 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.044 1.338 . . . . 71.14 113.312 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.7 mt -68.89 144.87 96.29 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 118.996 0.816 . . . . 64.52 112.057 -168.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.0 160.0 37.23 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.096 2.531 . . . . 73.14 111.019 168.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.98 27.7 0.07 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.264 1.426 . . . . 65.44 114.312 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -144.72 25.4 1.96 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 126.292 1.901 . . . . 73.21 112.262 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.2 m -146.16 73.19 1.32 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.683 -1.228 . . . . 72.51 107.683 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.6 mttm -59.92 145.95 44.05 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 122.043 0.925 . . . . 54.45 112.014 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -76.3 114.33 14.88 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.387 -1.338 . . . . 72.42 107.387 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.7 m -124.27 163.72 21.06 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.065 -1.087 . . . . 72.05 108.065 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -161.68 100.11 1.15 Allowed 'General case' 0 C--N 1.332 -0.165 0 O-C-N 120.022 -1.674 . . . . 63.31 107.306 -165.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -98.7 160.83 14.0 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.03 -1.044 . . . . 72.34 109.769 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.644 ' CE1' HG23 ' A' ' 72' ' ' THR . 0.1 OUTLIER -102.93 165.36 11.08 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.612 1.565 . . . . 70.15 109.321 174.524 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.6 m -132.96 153.03 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 122.229 1.014 . . . . 43.25 110.217 156.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.425 ' HG3' HG21 ' A' ' 72' ' ' THR . 0.0 OUTLIER -90.68 2.78 55.64 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 130.244 3.418 . . . . 62.44 113.765 176.824 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -69.14 -8.99 50.55 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 115.41 1.633 . . . . 74.25 115.41 -168.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 mp -137.92 153.37 49.52 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 120.614 1.552 . . . . 51.42 110.543 -171.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.65 170.99 29.69 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 123.93 0.776 . . . . 55.54 113.751 173.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.52 -44.69 4.23 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.928 3.085 . . . . 74.32 111.851 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.9 mt -97.0 27.41 4.05 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 125.258 1.423 . . . . 53.11 110.868 -167.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -44.83 -56.77 5.65 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.01 1.291 . . . . 75.1 111.595 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.8 tptt -63.34 -40.0 96.1 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 118.024 0.912 . . . . 55.31 111.841 -177.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -65.21 -44.82 87.09 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.423 1.089 . . . . 72.11 109.731 -176.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.3 mt -62.17 -33.35 74.36 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.974 0.91 . . . . 73.31 110.824 174.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.644 HG23 ' CE1' ' A' ' 60' ' ' HIS . 27.3 m -77.88 3.52 14.23 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 127.689 2.396 . . . . 64.13 111.429 175.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -116.75 -24.61 7.64 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 119.181 -2.2 . . . . 73.43 110.747 169.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.65 -28.31 61.71 Favored 'General case' 0 N--CA 1.457 -0.112 0 O-C-N 120.758 -1.213 . . . . 34.01 114.053 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 39.2 t-105 -65.87 -40.01 91.24 Favored 'General case' 0 C--N 1.331 -0.201 0 O-C-N 121.386 -0.821 . . . . 73.2 110.377 -173.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.422 ' HB3' HG13 ' A' ' 130' ' ' VAL . . . -61.13 -37.98 84.76 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.707 1.203 . . . . 32.12 111.969 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.4 t -51.44 -51.57 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 119.277 0.944 . . . . 74.13 109.412 171.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.43 -32.17 62.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 117.152 -1.404 . . . . 70.2 112.091 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.1 mt -63.56 -38.91 83.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 120.903 1.683 . . . . 71.22 110.406 170.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.09 -49.69 76.3 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 119.043 0.838 . . . . 73.2 110.057 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.21 -9.76 59.73 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 112.137 0.421 . . . . 65.23 112.137 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.61 57.9 13.08 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 126.872 2.177 . . . . 72.24 111.757 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.3 m -129.46 18.64 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 125.507 1.523 . . . . 65.14 111.071 -175.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -51.88 -48.06 64.26 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.42 1.009 . . . . 74.35 110.072 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -61.81 -15.25 40.15 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 128.041 2.536 . . . . 74.25 114.997 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -98.13 -16.02 19.7 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.857 0.863 . . . . 73.11 109.514 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp -126.72 21.34 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 125.282 1.433 . . . . 72.11 110.646 -175.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 93.6 m -80.31 -59.85 2.55 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 109.143 -0.688 . . . . 73.03 109.143 173.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.52 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -57.71 -61.78 6.66 Favored Pre-proline 0 N--CA 1.453 -0.321 0 C-N-CA 125.384 1.474 . . . . 62.34 110.272 -166.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.52 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 38.6 Cg_endo -66.14 -22.31 54.44 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 120.645 0.897 . . . . 64.33 112.505 -174.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 5.2 tpp -59.61 -49.81 76.31 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.981 0.513 . . . . 75.03 110.702 170.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -64.23 -39.5 94.1 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.127 -0.983 . . . . 61.35 111.558 176.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.91 -27.82 68.46 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 120.491 -0.483 . . . . 64.43 111.497 171.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.19 -11.23 33.21 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 120.952 -1.092 . . . . 72.43 112.748 -173.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.5 t -117.39 -27.47 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 C-N-CA 124.633 1.173 . . . . 73.2 110.629 -173.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -115.44 -48.71 2.78 Favored 'General case' 0 C--N 1.336 -0.02 0 CA-C-N 118.87 0.759 . . . . 52.2 110.789 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -73.8 -65.51 0.82 Allowed 'General case' 0 C--O 1.23 0.06 0 CA-C-N 118.692 0.678 . . . . 73.43 111.015 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.4 p -83.43 -31.99 26.32 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.713 -0.617 . . . . 64.33 110.29 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 56.53 23.72 7.89 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.198 1.799 . . . . 75.42 112.558 -171.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -71.27 -12.22 61.34 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.588 1.155 . . . . 75.21 112.601 -171.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.519 HG13 HG12 ' A' ' 107' ' ' ILE . 26.7 t -63.97 109.3 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 O-C-N 120.808 -1.182 . . . . 63.03 109.329 168.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -132.04 -22.22 2.32 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.751 0.82 . . . . 71.44 112.624 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.26 165.77 26.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.68 1.992 . . . . 63.12 107.413 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 91.7 t -51.78 -44.96 37.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 124.393 1.077 . . . . 75.04 108.971 172.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.51 1.39 0.56 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.016 2.126 . . . . 55.33 115.422 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -106.91 -29.52 9.42 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 119.653 1.115 . . . . 60.2 109.321 170.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.519 HG12 HG13 ' A' ' 101' ' ' VAL . 0.5 OUTLIER -81.81 -24.1 9.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 O-C-N 121.057 -1.027 . . . . 53.51 111.01 -172.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -40.5 97.43 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 108.345 -0.983 . . . . 75.31 108.345 172.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -55.41 -49.46 72.31 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 123.929 0.768 . . . . 72.32 109.703 -164.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 47.0 t -54.47 -48.31 69.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.286 1.434 . . . . 61.43 111.511 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -56.41 -55.54 32.3 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 109.175 -0.676 . . . . 73.42 109.175 176.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 93.3 t -59.01 -44.53 91.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 122.917 0.487 . . . . 74.42 109.868 -172.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -62.02 -45.79 92.03 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.176 1.391 . . . . 73.32 108.526 -175.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.22 -0.11 11.23 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.965 1.306 . . . . 71.0 112.723 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 109.86 36.12 2.08 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 119.879 1.218 . . . . 25.25 114.154 173.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.1 t -107.55 130.47 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 118.556 1.178 . . . . 73.42 109.536 173.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt -62.15 118.92 8.01 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.321 -0.992 . . . . 72.42 108.321 166.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.69 -22.51 68.17 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 119.063 -0.854 . . . . 74.21 111.138 173.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -65.52 -35.14 79.99 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.151 0.975 . . . . 73.22 111.25 175.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -83.25 -34.18 25.88 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 107.872 -1.159 . . . . 65.32 107.872 -172.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -51.01 -67.64 0.24 Allowed 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.995 1.318 . . . . 74.3 110.3 165.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -66.39 -11.55 52.05 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.248 0.547 . . . . 62.14 111.656 -170.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.38 -74.85 0.35 Allowed 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.315 1.046 . . . . 74.3 109.484 169.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.459 ' HA ' ' HB3' ' A' ' 127' ' ' SER . . . -58.4 -32.28 68.48 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 118.966 -0.54 . . . . 73.23 111.758 -169.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 60.6 t-105 -47.76 -34.81 8.96 Favored 'General case' 0 CA--C 1.523 -0.069 0 C-N-CA 124.718 1.207 . . . . 74.2 112.199 174.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -109.28 1.31 20.06 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.999 1.319 . . . . 73.02 111.728 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.459 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 5.7 t -105.98 151.64 24.35 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 124.197 1.951 . . . . 73.4 110.492 -174.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . 0.268 0.1 OUTLIER -57.12 -26.04 59.84 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 117.781 2.511 . . . . 64.43 117.781 -171.66 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 86.4 t -44.37 -56.82 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 C-N-CA 127.667 2.387 . . . . 71.23 108.159 167.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 76' ' ' ALA . 25.2 t -73.35 -42.72 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 124.169 0.988 . . . . 72.22 109.277 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -56.11 -49.04 74.98 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.683 1.129 . . . . 70.32 111.45 -173.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 72.3 m -77.48 -25.36 50.36 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 117.999 -1.0 . . . . 71.33 112.89 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.6 mt -65.02 -52.38 56.33 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 120.335 1.425 . . . . 73.04 110.25 170.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 40.9 t -45.81 -43.44 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.757 2.023 . . . . 71.33 110.937 176.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.57 -41.67 70.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.165 0.586 . . . . 34.02 111.877 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -53.13 -49.82 65.77 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 123.723 0.809 . . . . 44.53 112.737 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.461 ' HB2' ' CE1' ' A' ' 60' ' ' HIS . 0.6 OUTLIER -98.08 -20.26 17.46 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 118.883 -0.58 . . . . 61.21 110.967 -171.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -62.5 -50.48 71.24 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 107.855 -1.165 . . . . 71.42 107.855 167.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -55.83 -57.27 12.73 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.956 0.903 . . . . 73.45 110.94 173.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.76 6.36 2.58 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.424 1.268 . . . . 63.52 114.424 -175.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -106.25 -40.9 5.48 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.884 1.274 . . . . 51.01 110.601 160.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -64.03 -32.6 74.21 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.418 1.087 . . . . 75.55 112.889 -171.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -71.15 3.99 3.11 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.045 1.338 . . . . 60.54 113.125 -175.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.6 mt 74.78 1.94 3.91 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.746 2.018 . . . . 75.15 112.159 170.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.54 HE21 ' N ' ' A' ' 146' ' ' LEU . 0.0 OUTLIER -61.25 -16.9 50.19 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 129.851 3.26 . . . . 74.34 113.729 -179.133 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.54 ' N ' HE21 ' A' ' 145' ' ' GLN . 0.6 OUTLIER -155.55 126.27 6.92 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 128.773 2.829 . . . . 75.14 103.52 -172.068 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -139.29 5.08 2.26 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.142 0.577 . . . . 73.24 111.591 177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -133.91 163.08 24.53 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.951 1.262 . . . . 73.13 109.957 171.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.26 164.69 33.86 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.095 0.958 . . . . 73.14 109.34 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.71 162.33 81.15 Favored 'Cis proline' 0 N--CA 1.455 -0.747 0 CA-C-N 119.313 0.79 . . . . 61.43 111.506 -13.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -146.41 127.19 14.37 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 115.076 -0.965 . . . . 72.21 109.026 175.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 42.7 ttm -112.78 109.99 19.82 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 105.587 -2.005 . . . . 54.21 105.587 169.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -77.94 165.7 23.76 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.678 -1.23 . . . . 62.45 107.678 166.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.4 t -125.46 -86.37 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.4 0 N-CA-C 107.635 -1.246 . . . . 52.44 107.635 167.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -88.96 35.94 0.8 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 120.565 1.53 . . . . 73.11 111.256 -171.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 68.13 -73.57 0.29 Allowed Glycine 0 C--N 1.338 0.646 0 N-CA-C 109.265 -1.534 . . . . 61.33 109.265 -160.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 12.7 ptmt -55.47 -4.92 0.11 Allowed 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 128.533 2.733 . . . . 65.34 116.641 -177.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -124.34 143.94 50.3 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 120.2 1.364 . . . . 74.45 109.106 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -128.32 138.45 52.39 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.075 -1.454 . . . . 63.32 107.075 171.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -65.42 133.19 50.79 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.108 -1.441 . . . . 75.25 107.108 175.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -104.52 86.08 1.31 Allowed Pre-proline 0 C--O 1.236 0.355 0 C-N-CA 124.171 0.988 . . . . 72.53 112.035 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.02 -20.93 43.9 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 CA-C-N 119.931 1.011 . . . . 73.25 113.479 -177.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -72.61 -38.45 67.79 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 120.838 1.654 . . . . 63.54 109.406 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -78.48 3.78 62.02 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 118.762 0.71 . . . . 71.42 113.051 -177.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 55.3 mtt -90.29 168.14 12.13 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 118.746 1.273 . . . . 63.33 109.367 174.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -81.04 114.54 19.97 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 105.999 -1.852 . . . . 62.33 105.999 167.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.433 HG22 ' CD1' ' A' ' 173' ' ' PHE . 11.1 p -107.6 6.73 28.17 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 127.298 2.239 . . . . 52.45 109.983 -175.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 17.5 m -92.84 3.56 55.46 Favored 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 113.616 0.969 . . . . 61.45 113.616 -166.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.0 -4.71 1.52 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.499 1.12 . . . . 73.44 111.657 -176.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 7.6 mmt 67.64 -61.89 0.35 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.416 1.886 . . . . 75.51 112.926 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.28 -42.53 88.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 119.978 1.263 . . . . 75.22 109.229 -176.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 66.5 t -61.92 -28.34 44.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 123.713 0.805 . . . . 63.25 110.951 174.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.433 ' CD1' HG22 ' A' ' 167' ' ' THR . 59.5 t80 -64.27 -61.28 2.34 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 107.974 -1.121 . . . . 55.41 107.974 177.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.3 t -67.89 -32.2 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 119.289 -0.386 . . . . 73.44 111.086 -174.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.06 -47.12 68.72 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.76 1.224 . . . . 71.11 110.86 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -81.46 -38.27 26.66 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 118.252 -0.88 . . . . 64.54 111.658 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -54.82 -60.2 3.69 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.593 1.088 . . . . 75.41 110.209 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.41 ' HA ' HG22 ' A' ' 46' ' ' VAL . . . -59.14 -26.09 64.43 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.825 0.85 . . . . 54.41 112.249 -173.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -77.29 -54.42 6.5 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.101 0.56 . . . . 70.15 109.815 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.2 t -58.94 -25.57 63.61 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-O 117.741 -1.123 . . . . 74.21 111.516 -176.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 59.3 t -54.55 -57.64 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 118.944 0.793 . . . . 63.51 109.046 171.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? -62.89 -36.95 85.0 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.993 -0.442 . . . . 71.33 110.222 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -66.6 -30.73 71.08 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 123.859 0.864 . . . . 42.01 110.821 -173.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 47.1 mt -71.01 -31.84 68.46 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.027 -1.046 . . . . 73.42 111.375 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 85.4 t -66.1 -24.21 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 O-C-N 121.756 -0.59 . . . . 72.41 110.876 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -97.07 -5.77 36.72 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.332 1.053 . . . . 73.15 110.253 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -120.79 87.14 2.7 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 125.925 1.69 . . . . 72.55 107.871 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 37.5 mttm . . . . . 0 C--O 1.251 1.158 0 C-N-CA 127.069 2.147 . . . . 71.24 110.917 175.51 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.465 0.325 0 N-CA-C 107.265 -1.383 . . . . 72.43 107.265 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -68.67 170.7 8.86 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 118.313 0.506 . . . . 71.3 109.67 -174.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 56.88 38.18 29.26 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.051 0.94 . . . . 70.23 112.871 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -141.97 110.77 6.19 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.873 -1.899 . . . . 45.42 105.873 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.585 HG23 HE22 ' A' ' 183' ' ' GLN . 4.8 pt -143.09 164.97 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 130.966 3.706 . . . . 72.22 107.721 -178.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.9 m -139.17 148.86 43.74 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.876 1.67 . . . . 72.42 108.247 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -57.76 148.72 24.08 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.174 1.79 . . . . 64.01 111.065 172.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.63 -23.38 0.81 Allowed Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.832 1.206 . . . . 74.24 112.878 -171.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.2 tttp -90.23 -85.21 0.22 Allowed 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 118.831 1.316 . . . . 74.12 108.539 -160.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -98.88 -7.13 27.73 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.021 0.929 . . . . 65.21 111.337 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.409 ' CD1' HD12 ' A' ' 3' ' ' ILE . 25.4 p90 -144.6 163.55 33.59 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.81 -1.182 . . . . 71.44 107.81 169.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.6 mm -124.8 157.09 33.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 106.264 -1.754 . . . . 53.11 106.264 169.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.45 171.53 14.61 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 127.295 2.238 . . . . 74.23 109.3 165.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.9 mt -108.24 159.6 16.5 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 124.359 1.064 . . . . 70.32 111.02 173.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -62.73 -44.6 95.79 Favored 'General case' 0 C--O 1.227 -0.096 0 N-CA-C 108.9 -0.778 . . . . 73.23 108.9 -179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -131.24 81.55 65.47 Favored Pre-proline 0 C--N 1.339 0.112 0 C-N-CA 127.015 2.126 . . . . 63.11 107.547 -173.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -80.16 63.82 8.8 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.662 2.242 . . . . 70.31 110.812 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.9 mp -96.18 152.79 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 O-C-N 120.55 -1.344 . . . . 64.13 109.899 -174.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.08 113.99 3.45 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.986 1.314 . . . . 64.03 109.281 175.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.52 -171.44 39.2 Favored Glycine 0 C--O 1.226 -0.406 0 N-CA-C 108.527 -1.829 . . . . 70.12 108.527 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . 0.308 0.8 OUTLIER 59.05 166.67 0.08 OUTLIER Pre-proline 0 C--O 1.241 0.638 0 N-CA-C 114.986 1.476 . . . . 72.54 114.986 176.02 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -66.86 78.81 0.38 Allowed 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.305 2.003 . . . . 70.34 109.717 167.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -51.62 -21.24 2.45 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 127.414 2.286 . . . . 65.1 115.509 -169.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 17.0 t -134.51 87.64 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 105.929 -1.878 . . . . 53.2 105.929 -175.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 tt -147.15 157.82 43.73 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.221 -1.029 . . . . 64.13 108.221 -172.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -125.44 149.58 48.09 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.92 1.288 . . . . 62.3 107.958 170.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.421 ' CD2' HD13 ' A' ' 146' ' ' LEU . 95.3 m-85 -127.38 145.55 50.77 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.16 0.984 . . . . 73.41 108.95 169.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -153.72 -177.8 6.62 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 128.326 2.651 . . . . 74.53 106.98 168.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.422 ' CB ' HD12 ' A' ' 64' ' ' LEU . 10.6 t -133.4 179.85 5.95 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 121.351 -0.843 . . . . 71.32 108.745 170.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -82.43 -28.8 31.12 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.995 2.518 . . . . 74.21 110.583 -176.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -109.66 1.89 19.85 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.56 1.144 . . . . 74.54 112.231 -169.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.1 p -87.26 143.48 34.59 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 120.111 1.323 . . . . 71.31 110.453 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -83.66 -38.63 0.13 Allowed 'Trans proline' 0 CA--C 1.533 0.437 0 CA-C-N 119.901 1.0 . . . . 64.5 112.481 -166.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -52.31 -47.68 65.84 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 118.798 0.726 . . . . 53.41 109.661 172.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 14.2 m -54.77 -37.86 66.51 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.74 1.616 . . . . 65.32 111.482 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -62.49 -51.32 67.93 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.679 0.391 . . . . 73.53 110.861 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.556 ' HA ' HE21 ' A' ' 35' ' ' GLN . 0.0 OUTLIER -59.61 -45.45 91.88 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 119.67 -0.812 . . . . 63.2 109.054 176.029 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -66.13 -10.39 40.46 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 116.919 -1.515 . . . . 64.13 112.015 -173.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -140.26 10.47 2.33 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 121.86 2.118 . . . . 50.11 113.086 -174.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -134.13 -45.0 0.78 Allowed 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 123.903 0.881 . . . . 61.1 110.41 170.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.8 t -88.9 -69.81 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 108.255 -1.017 . . . . 74.41 108.255 -175.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.6 mt -77.81 -25.53 48.97 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.732 1.613 . . . . 74.52 113.333 -174.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 44.67 59.31 3.42 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.538 1.535 . . . . 72.43 112.911 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.4 t -55.48 -50.35 66.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 124.061 0.944 . . . . 70.3 109.302 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.2 t -47.17 -52.36 15.83 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.143 1.377 . . . . 73.43 112.308 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -79.37 -23.39 43.38 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 110.588 -0.152 . . . . 74.43 110.588 -169.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -69.93 -48.8 57.02 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.639 -1.245 . . . . 73.43 107.639 169.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 37.8 t -55.69 -49.83 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 125.162 1.385 . . . . 74.04 110.914 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -56.94 -28.02 61.67 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 119.87 -1.769 . . . . 72.51 113.297 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -71.14 -8.62 54.73 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.202 0.91 . . . . 72.32 113.192 177.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -119.83 -14.71 8.95 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 126.321 1.848 . . . . 72.41 111.968 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.495 HD13 HG21 ' A' ' 54' ' ' THR . 13.3 mt -69.53 151.11 96.78 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 119.222 0.919 . . . . 72.04 112.496 -169.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -85.95 159.19 10.22 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.625 2.883 . . . . 64.02 113.078 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -83.62 59.34 5.08 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.307 1.843 . . . . 62.1 111.031 -172.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.71 -23.98 0.02 OUTLIER Glycine 0 CA--C 1.527 0.802 0 CA-C-N 113.592 -1.64 . . . . 62.44 112.1 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.495 HG21 HD13 ' A' ' 50' ' ' LEU . 10.3 t -47.85 -57.1 6.09 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.561 1.544 . . . . 73.11 112.632 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.405 ' N ' HG23 ' A' ' 54' ' ' THR . 4.7 tmmm? 56.84 123.55 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.779 2.032 . . . . 70.13 111.04 -157.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.7 ttm -68.27 108.18 3.09 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 125.881 1.672 . . . . 74.1 108.253 172.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.18 115.03 21.69 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 107.127 -1.434 . . . . 72.32 107.127 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.27 122.04 35.78 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.18 -1.415 . . . . 74.2 107.18 -178.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.1 m-30 -113.35 145.85 40.42 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.488 -1.301 . . . . 72.43 107.488 172.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.0 117.85 32.47 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.258 1.423 . . . . 74.14 107.669 -167.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.8 m -93.88 157.78 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 O-C-N 121.472 -0.768 . . . . 72.2 110.747 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.43 -8.46 13.89 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.748 1.219 . . . . 72.13 113.448 -161.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -63.17 5.16 0.16 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.815 2.046 . . . . 62.32 115.346 -170.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.422 HD12 ' CB ' ' A' ' 27' ' ' SER . 11.1 mt -138.11 132.39 31.96 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 119.955 -1.715 . . . . 70.43 107.593 -165.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.76 174.76 30.25 Favored Glycine 0 CA--C 1.541 1.672 0 O-C-N 123.493 0.496 . . . . 52.1 111.877 -172.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.92 -55.33 0.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.92 3.08 . . . . 73.34 112.692 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.4 mt -87.34 24.85 1.52 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.958 1.303 . . . . 51.35 112.201 -167.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.04 -42.77 98.05 Favored Glycine 0 C--O 1.228 -0.247 0 N-CA-C 110.174 -1.17 . . . . 74.23 110.174 -167.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -61.42 -44.55 96.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.499 0.32 . . . . 73.34 110.689 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.43 -46.77 87.79 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.446 1.898 . . . . 74.43 109.012 177.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.9 mt -64.64 -40.53 95.62 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.751 0.82 . . . . 64.3 111.623 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.8 m -60.7 -40.45 92.27 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 120.272 1.396 . . . . 71.51 110.388 171.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -64.62 -39.28 93.43 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.26 -0.9 . . . . 70.15 108.876 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.61 -36.43 78.57 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 120.964 -1.085 . . . . 72.54 111.913 173.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 25.3 t-105 -58.42 -35.74 72.53 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 118.882 0.764 . . . . 71.5 111.996 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.36 -40.55 82.53 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 118.695 -0.669 . . . . 63.31 111.912 175.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 69.7 t -59.54 -44.89 94.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 119.657 1.117 . . . . 51.13 109.544 170.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.51 -42.04 98.21 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 118.364 -0.827 . . . . 74.53 111.6 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 76.3 mt -69.45 -38.51 77.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 123.899 0.88 . . . . 74.44 110.52 176.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.8 -40.21 91.81 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.488 1.04 . . . . 64.43 110.582 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.8 mt -93.0 -8.02 44.21 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.75 0.648 . . . . 74.11 112.75 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 53.83 62.91 5.61 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 125.485 1.517 . . . . 52.13 111.378 -172.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.1 m -125.54 18.97 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.49 1.116 . . . . 65.5 112.046 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -51.3 -49.54 61.1 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.341 1.456 . . . . 53.11 111.504 -174.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -63.36 -31.47 72.63 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 125.167 1.387 . . . . 74.11 113.807 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -75.24 -34.38 61.4 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.258 -0.645 . . . . 74.54 109.258 -176.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.1 pp -103.52 -16.37 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.967 0.729 . . . . 74.44 112.967 -166.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.7 m -58.93 -49.47 77.72 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 119.17 0.895 . . . . 70.42 111.116 -172.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.468 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -62.47 -58.76 15.36 Favored Pre-proline 0 N--CA 1.45 -0.458 0 C-N-CA 123.712 0.805 . . . . 53.0 110.181 -164.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.468 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 39.5 Cg_endo -66.25 -26.0 49.48 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 121.095 1.197 . . . . 62.14 112.222 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 10.8 tpp -61.7 -44.64 96.55 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.577 0.626 . . . . 63.23 111.051 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -69.69 -35.69 75.32 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.243 -0.911 . . . . 71.5 109.047 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -54.85 -48.34 73.01 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.388 0.54 . . . . 61.21 110.242 166.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.55 -16.09 60.83 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 121.73 -0.606 . . . . 73.11 111.154 -165.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 63.8 t -112.15 -33.86 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 125.368 1.467 . . . . 74.23 110.799 -173.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -109.73 -55.96 2.37 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.522 1.056 . . . . 72.42 110.744 -174.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -64.35 -63.93 1.01 Allowed 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.907 0.883 . . . . 74.3 110.784 -176.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.4 t -99.44 -27.6 13.66 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.672 1.189 . . . . 70.5 110.761 -173.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 59.43 29.4 18.96 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.811 1.244 . . . . 63.5 112.889 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.4 t -69.38 -12.63 61.82 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.782 1.633 . . . . 65.15 112.815 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.6 t -67.52 108.49 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.647 -1.242 . . . . 74.45 107.647 171.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -132.88 -28.09 1.6 Allowed 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 124.471 1.108 . . . . 65.44 111.623 -174.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.85 169.65 17.18 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.553 -1.277 . . . . 70.12 107.553 169.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 33.6 t -57.18 -25.69 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.138 0.975 . . . . 73.34 111.23 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.69 -29.57 70.18 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 126.316 1.847 . . . . 50.25 111.205 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.72 -22.26 22.29 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.111 0.481 . . . . 73.45 110.232 -176.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.0 mt -76.63 -49.11 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 126.314 1.846 . . . . 42.42 108.158 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -56.78 -30.69 63.9 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-O 118.205 -0.902 . . . . 70.44 112.719 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -57.47 -57.99 10.26 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 123.586 0.755 . . . . 62.35 109.578 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.1 t -48.43 -47.33 14.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 O-C-N 124.457 1.098 . . . . 72.34 109.804 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -55.21 -51.9 65.08 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.864 0.466 . . . . 70.52 110.741 177.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.2 t -62.42 -44.05 98.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 118.61 0.641 . . . . 72.34 111.114 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -64.74 -42.17 95.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 122.147 0.975 . . . . 72.21 108.758 -172.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -82.14 7.33 13.8 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.579 1.552 . . . . 74.22 112.572 176.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 108.93 29.04 4.22 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-N 119.751 1.16 . . . . 74.33 115.976 160.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.7 t -106.55 143.97 16.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 122.571 1.176 . . . . 61.55 111.026 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 13.8 mttp -62.4 126.89 28.88 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.268 1.427 . . . . 63.24 110.383 170.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -68.31 -23.96 74.91 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 118.483 -1.176 . . . . 53.22 111.896 169.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -69.13 -40.87 78.02 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 119.131 1.465 . . . . 61.31 109.249 170.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -79.36 -37.66 36.9 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 107.597 -1.26 . . . . 65.43 107.597 -166.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -56.65 -60.65 3.23 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.619 -0.512 . . . . 74.15 109.619 171.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.69 -13.84 61.05 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.454 0.538 . . . . 71.33 112.454 -170.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.19 -65.97 0.95 Allowed 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.332 1.053 . . . . 34.32 109.202 168.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -50.4 -39.81 48.13 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.543 1.537 . . . . 73.25 110.848 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -46.19 -37.65 7.35 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.555 1.542 . . . . 73.54 112.801 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -114.35 4.3 15.33 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.917 1.287 . . . . 71.44 112.889 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.7 t -80.22 151.99 29.36 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.724 1.61 . . . . 74.53 111.492 175.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -51.99 -28.89 18.47 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.022 2.529 . . . . 64.23 113.081 175.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 93.3 t -52.75 -54.52 15.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 124.748 1.219 . . . . 51.22 109.836 174.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.3 t -69.66 -34.78 62.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 114.816 -1.083 . . . . 72.11 109.851 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -52.63 -47.88 66.75 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.914 1.233 . . . . 74.41 111.186 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.1 t -59.71 -55.54 33.09 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.605 0.762 . . . . 74.44 109.222 176.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 32.3 mt -64.47 -32.71 74.45 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.004 0.922 . . . . 71.31 113.483 -173.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.31 -64.45 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 C-N-CA 126.022 1.729 . . . . 70.43 107.451 166.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.42 -29.3 67.66 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 120.286 1.403 . . . . 73.43 113.744 -172.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -61.4 -51.95 66.65 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.401 0.68 . . . . 64.14 109.991 170.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -70.07 -34.08 72.74 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.41 1.084 . . . . 63.43 112.633 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -60.08 -59.04 6.05 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 107.39 -1.337 . . . . 63.12 107.39 174.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.7 ttpt -53.3 -52.03 60.41 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.318 0.647 . . . . 63.51 110.452 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.68 -2.2 4.65 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.07 1.137 . . . . 73.4 114.07 -174.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -116.65 -20.87 9.38 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.881 1.218 . . . . 53.23 112.025 164.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -78.54 -22.55 47.11 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 126.202 1.801 . . . . 73.52 112.434 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.05 4.13 13.1 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.104 -0.998 . . . . 72.32 112.386 -175.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.0 mt 71.43 -0.23 3.21 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.522 1.929 . . . . 65.11 111.437 171.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.23 -9.96 59.74 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.728 1.611 . . . . 73.33 112.567 -173.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.421 HD13 ' CD2' ' A' ' 25' ' ' PHE . 2.4 tp -142.15 105.44 4.62 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.606 1.562 . . . . 74.13 108.193 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -130.94 17.81 5.09 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.217 0.607 . . . . 65.34 110.605 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -134.47 160.21 24.12 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 109.621 -1.392 . . . . 72.13 109.621 163.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.4 m -144.45 167.08 15.93 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 125.658 1.583 . . . . 43.11 109.348 169.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -72.24 150.4 94.74 Favored 'Cis proline' 0 N--CA 1.46 -0.472 0 N-CA-C 110.057 -0.786 . . . . 72.43 110.057 -14.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -136.7 126.9 26.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 117.435 -1.269 . . . . 71.34 108.64 -172.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 47.5 ttm -124.12 124.74 43.15 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 119.205 0.911 . . . . 63.31 108.675 173.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -100.37 155.58 17.73 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 125.117 1.367 . . . . 71.34 110.086 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.8 t -140.54 144.71 26.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 124.259 1.024 . . . . 73.12 108.975 175.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 50.11 23.21 1.08 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.905 2.082 . . . . 72.41 113.91 169.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 61.58 17.2 53.11 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 118.681 -1.066 . . . . 61.04 113.777 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -149.2 -7.37 0.36 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.078 1.439 . . . . 65.2 114.571 -174.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -128.95 152.38 48.63 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 119.151 0.887 . . . . 70.23 110.401 -176.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -119.4 141.58 48.97 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.715 2.006 . . . . 73.1 107.819 168.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.89 132.54 45.41 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 107.772 -1.196 . . . . 74.2 107.772 170.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -106.39 86.95 2.35 Favored Pre-proline 0 C--O 1.235 0.291 0 C-N-CA 123.51 0.724 . . . . 71.52 111.954 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -65.77 -21.39 58.31 Favored 'Trans proline' 0 N--CA 1.444 -1.417 0 CA-C-O 117.911 -0.954 . . . . 72.3 112.32 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -64.79 -44.37 90.19 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 120.097 1.317 . . . . 74.53 110.942 -177.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -82.0 1.68 86.01 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-O 118.87 -0.961 . . . . 44.24 112.876 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 46.6 mtt -79.3 168.05 20.07 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 119.958 1.879 . . . . 61.0 108.719 170.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -79.58 120.93 24.61 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 106.028 -1.841 . . . . 70.03 106.028 167.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.434 HG22 ' CD1' ' A' ' 173' ' ' PHE . 28.2 p -124.69 45.71 2.47 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.672 1.989 . . . . 74.22 106.76 -171.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 16.1 m -135.66 0.23 2.69 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 114.229 -1.351 . . . . 73.5 111.963 -164.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.471 HD22 ' HB ' ' A' ' 172' ' ' VAL . 0.5 OUTLIER -133.74 -4.99 2.85 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.298 1.439 . . . . 72.04 110.899 174.216 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 1.7 mmt 66.83 -59.3 0.38 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.908 2.083 . . . . 72.34 112.897 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.39 -48.75 80.41 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 122.397 1.094 . . . . 64.33 109.121 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.471 ' HB ' HD22 ' A' ' 169' ' ' ASN . 99.3 t -64.04 -27.5 42.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 126.638 1.975 . . . . 73.44 111.674 -178.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.434 ' CD1' HG22 ' A' ' 167' ' ' THR . 21.6 t80 -61.44 -59.22 5.59 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.065 -1.087 . . . . 70.14 108.065 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.92 -27.73 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 O-C-N 123.496 0.498 . . . . 72.2 110.906 -174.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -51.45 -47.61 63.02 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.901 0.881 . . . . 70.04 111.022 171.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -79.6 -41.74 26.46 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 118.694 -0.67 . . . . 73.1 111.053 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -53.13 -59.26 4.77 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.274 0.943 . . . . 71.3 110.291 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.03 -29.07 68.26 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.521 1.128 . . . . 74.32 112.344 -175.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -65.54 -62.68 1.38 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.149 -0.686 . . . . 65.04 109.149 171.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 12.4 t -60.6 -28.43 68.5 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 118.837 -0.602 . . . . 73.22 112.186 -170.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 94.8 t -53.62 -47.08 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.821 0.737 . . . . 72.33 109.725 173.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 3.0 tmmt? -80.14 -32.75 38.92 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.152 -0.928 . . . . 61.41 110.778 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.585 HE22 HG23 ' A' ' 3' ' ' ILE . 35.0 mt-30 -57.25 -36.75 71.34 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.226 1.376 . . . . 65.02 110.661 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 59.1 mt -70.84 -27.09 63.6 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.037 -1.039 . . . . 70.23 112.776 -176.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 75.7 t -63.68 -30.89 51.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 122.8 0.44 . . . . 71.12 110.374 -178.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -87.84 -29.37 20.99 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.097 -0.705 . . . . 62.31 109.097 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 31.7 mttp -93.41 48.88 1.33 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.075 1.35 . . . . 74.31 110.04 -175.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 20.6 pttm . . . . . 0 C--O 1.245 0.836 0 N-CA-C 106.856 -1.535 . . . . 65.44 106.856 155.432 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 8.6 m . . . . . 0 N--CA 1.467 0.425 0 CA-C-O 119.02 -0.514 . . . . 73.4 111.682 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -67.59 177.41 2.0 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.41 1.484 . . . . 60.4 111.926 173.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 52.29 33.71 13.27 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 126.638 1.975 . . . . 73.12 112.053 174.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.55 125.03 3.67 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 105.464 -2.05 . . . . 73.21 105.464 173.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.8 pt -131.3 147.15 32.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 127.974 2.51 . . . . 64.33 108.398 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.7 m -115.55 126.42 54.23 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.66 -1.237 . . . . 61.33 107.66 -176.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.45 121.41 3.42 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 127.77 2.428 . . . . 64.2 108.641 162.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.01 -11.77 71.25 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-O 117.834 -1.537 . . . . 65.31 113.707 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -102.7 -85.52 0.44 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 119.828 1.814 . . . . 74.5 108.972 -177.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -87.95 -16.68 33.13 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.552 1.141 . . . . 72.11 110.768 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.534 ' O ' HD13 ' A' ' 10' ' ' ILE . 28.3 p90 -136.69 163.09 31.39 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.309 1.044 . . . . 73.51 109.801 172.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.534 HD13 ' O ' ' A' ' 9' ' ' TYR . 6.4 mm -129.78 158.54 42.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 105.265 -2.124 . . . . 72.53 105.265 171.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.9 m -108.91 168.82 9.08 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.693 -1.225 . . . . 72.32 107.693 173.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.1 mt -92.03 161.08 14.93 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.518 -1.29 . . . . 50.44 107.518 166.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -79.1 -29.31 43.22 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 122.549 1.166 . . . . 74.13 108.201 174.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -133.68 71.67 74.66 Favored Pre-proline 0 N--CA 1.446 -0.626 0 O-C-N 120.187 -1.57 . . . . 63.14 110.757 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.66 63.45 7.36 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.523 2.816 . . . . 42.34 110.571 176.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.4 mt -136.42 144.15 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 O-C-N 120.696 -1.253 . . . . 62.5 107.708 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 47.48 12.23 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 128.898 2.879 . . . . 71.4 116.781 171.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -89.29 -110.79 1.24 Allowed Glycine 0 C--N 1.333 0.398 0 CA-C-N 119.493 1.042 . . . . 74.24 110.679 -169.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -67.18 162.99 49.76 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 114.133 1.161 . . . . 65.21 114.133 -171.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.12 -164.92 0.12 Allowed 'Trans proline' 0 CA--C 1.545 1.055 1 C-N-CA 125.47 4.114 . . . . 62.42 114.069 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -66.59 77.74 0.11 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.295 1.838 . . . . 74.32 110.884 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.514 HG22 ' H ' ' A' ' 23' ' ' LEU 0.277 2.9 p 56.15 169.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 128.926 2.89 . . . . 53.41 112.942 -174.377 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.514 ' H ' HG22 ' A' ' 22' ' ' VAL . 6.0 tp -165.44 169.45 15.6 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 121.216 -0.928 . . . . 74.12 112.356 -172.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -145.5 125.35 13.48 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 127.915 2.486 . . . . 61.44 104.591 170.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.435 ' CE2' HD23 ' A' ' 23' ' ' LEU . 9.5 m-85 -115.41 131.75 56.83 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 119.808 1.185 . . . . 72.12 110.428 177.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.85 176.55 11.33 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.109 0.564 . . . . 73.52 110.812 178.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.9 t -129.46 172.61 11.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.598 -1.63 . . . . 70.2 106.598 169.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.862 ' CZ ' HD21 ' A' ' 71' ' ' LEU 0.253 0.0 OUTLIER -86.45 -18.76 30.86 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.288 0.635 . . . . 71.12 111.545 164.952 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -91.31 -6.37 53.22 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 119.742 -1.849 . . . . 73.52 113.335 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.1 p -77.83 141.36 63.87 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 121.2 1.818 . . . . 63.24 108.031 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -84.08 -40.3 0.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.86 1.707 . . . . 64.21 111.776 -174.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -56.08 -40.19 73.25 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 120.096 1.316 . . . . 74.3 110.105 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.2 m -51.36 -30.28 18.26 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.082 1.353 . . . . 74.21 112.719 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -62.11 -56.85 14.7 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 118.668 0.667 . . . . 71.3 111.698 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -57.6 -42.68 83.73 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 108.856 -0.794 . . . . 74.53 108.856 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -62.46 -18.15 61.1 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 115.294 -2.289 . . . . 71.2 112.173 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -139.69 9.14 2.4 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-N 122.122 2.237 . . . . 71.43 114.959 -170.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -136.44 -11.78 1.85 Allowed 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.86 1.264 . . . . 72.3 111.371 172.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.3 t -123.92 -81.39 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 107.401 -1.333 . . . . 75.14 107.401 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 49.8 mt -59.67 -31.09 69.23 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.771 2.028 . . . . 63.51 112.005 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 43.99 60.09 2.88 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.299 1.84 . . . . 71.04 110.536 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 86.7 t -63.02 -36.92 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 115.181 -0.918 . . . . 73.4 109.895 -174.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.9 t -51.07 -55.6 16.77 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.994 1.317 . . . . 31.31 110.39 173.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.34 -29.51 65.08 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 121.043 -1.036 . . . . 75.4 111.395 -174.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.57 -33.73 74.59 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.042 0.537 . . . . 71.4 112.05 175.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.6 t -70.97 -50.19 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.572 1.549 . . . . 74.13 109.158 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.6 ptm85 -61.72 -21.17 64.26 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 120.63 1.559 . . . . 72.1 113.883 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -68.04 -11.08 58.29 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.006 1.113 . . . . 72.01 114.006 172.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp -136.03 2.42 2.82 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.578 1.551 . . . . 43.43 112.117 -171.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.7 mt -72.35 145.71 88.33 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 119.725 1.148 . . . . 75.44 109.584 -176.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.94 150.16 29.78 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.427 2.085 . . . . 62.53 110.131 169.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -76.65 80.81 3.3 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 122.759 1.266 . . . . 75.43 111.029 -168.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.01 -49.53 0.23 Allowed Glycine 0 C--O 1.233 0.092 0 N-CA-C 109.595 -1.402 . . . . 74.03 109.595 -175.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.3 m -69.29 90.68 0.51 Allowed 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 107.767 -1.197 . . . . 74.52 107.767 173.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -80.12 129.92 34.86 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.469 -1.678 . . . . 71.43 106.469 173.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.4 mtm -66.26 161.93 21.15 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.258 -0.645 . . . . 64.24 109.258 173.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.39 -173.71 3.49 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.339 1.056 . . . . 65.44 108.155 178.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.41 91.89 0.46 Allowed 'General case' 0 C--O 1.234 0.241 0 N-CA-C 108.221 -1.029 . . . . 72.1 108.221 -173.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.499 ' CD2' ' HG3' ' A' ' 137' ' ' GLN . 6.4 m-30 -104.42 163.53 12.38 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.549 -0.908 . . . . 74.12 108.549 177.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.552 ' CE1' ' CG2' ' A' ' 72' ' ' THR . 2.0 p80 -104.67 171.5 7.29 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 126.527 1.931 . . . . 72.2 108.071 -175.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.6 m -137.96 146.96 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.1 -1.074 . . . . 70.22 108.1 167.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -94.18 -0.47 55.19 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.076 0.853 . . . . 74.32 111.994 -175.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -73.99 167.64 21.1 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.575 1.15 . . . . 73.22 108.364 165.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 74.69 131.85 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 128.328 2.651 . . . . 65.43 111.093 177.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 64.6 173.59 3.51 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-O 122.472 1.04 . . . . 32.41 113.037 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -72.43 -45.27 0.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.473 2.115 . . . . 30.1 111.757 175.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.7 mt -80.85 19.65 0.84 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.537 1.535 . . . . 61.42 113.65 -171.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.07 -32.43 49.83 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-O 118.156 -1.358 . . . . 73.12 112.311 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.3 tmtp? -85.11 -7.46 59.08 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.16 1.48 . . . . 65.45 113.728 178.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -46.81 18.25 Favored 'General case' 0 CA--C 1.505 -0.75 0 CA-C-N 121.001 1.728 . . . . 72.14 107.893 162.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.862 HD21 ' CZ ' ' A' ' 28' ' ' PHE . 26.8 mt -57.75 -39.14 76.7 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 124.58 1.175 . . . . 65.23 111.145 -165.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.552 ' CG2' ' CE1' ' A' ' 60' ' ' HIS . 0.3 OUTLIER -50.38 -51.7 43.74 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 128.542 2.737 . . . . 73.35 109.738 177.168 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -69.62 -58.96 3.29 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 114.149 -1.387 . . . . 72.42 107.308 -176.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.65 -28.65 68.64 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 121.264 1.847 . . . . 43.53 114.226 -171.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 36.4 t-105 -58.6 -36.68 74.4 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 118.79 0.723 . . . . 73.2 110.921 177.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.89 -41.29 97.71 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 118.055 -0.974 . . . . 62.12 111.032 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.505 HG22 ' HB3' ' A' ' 124' ' ' ALA . 41.4 t -54.62 -45.58 72.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 119.354 0.979 . . . . 63.02 110.1 171.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.96 -47.14 87.82 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.603 0.638 . . . . 33.31 111.306 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.8 mt -60.22 -44.73 96.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.736 1.214 . . . . 71.42 109.698 176.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.3 -31.76 72.4 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 123.945 0.898 . . . . 74.44 111.095 -175.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 75.2 mt -94.22 -12.41 28.28 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 119.008 -0.52 . . . . 62.44 111.819 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 61.67 54.87 32.18 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 126.907 2.194 . . . . 44.1 110.943 -172.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.71 11.62 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 124.141 0.976 . . . . 71.2 112.133 -176.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -56.24 -53.53 56.13 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 120.071 1.305 . . . . 75.11 110.491 -172.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -63.13 -8.09 7.12 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.755 1.622 . . . . 75.01 112.333 176.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -100.06 -18.03 17.19 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.434 1.494 . . . . 62.11 112.023 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.6 pp -127.51 33.3 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.036 1.335 . . . . 60.12 109.443 -175.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 76.1 m -107.23 -43.83 4.5 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 117.973 -1.013 . . . . 72.41 109.651 171.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.495 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -60.31 -63.36 4.36 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 120.736 1.607 . . . . 73.2 111.775 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 57.2 Cg_endo -65.27 -26.37 56.5 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 121.518 1.479 . . . . 74.21 111.81 -176.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 34.8 tpp -63.51 -49.61 72.85 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.584 0.754 . . . . 74.14 109.416 176.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -68.1 -35.14 77.67 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.874 0.87 . . . . 64.03 108.913 -176.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -60.97 -40.05 91.93 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.656 0.662 . . . . 62.3 110.423 171.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.18 -5.01 58.65 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 120.074 -1.642 . . . . 63.02 113.584 -174.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.681 HG21 ' CD2' ' A' ' 28' ' ' PHE . 50.2 t -111.01 -41.35 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 124.499 1.119 . . . . 74.22 109.709 -176.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -106.07 -53.77 2.58 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.42 0.688 . . . . 74.42 109.337 -172.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt -70.39 -54.12 13.74 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-O 118.675 -0.679 . . . . 72.33 110.61 -171.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.4 p -100.86 -18.49 16.37 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.176 0.99 . . . . 74.22 113.382 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 45.75 40.62 6.53 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.475 2.31 . . . . 72.22 114.228 -175.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.9 t -79.88 -8.0 59.05 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.288 -0.883 . . . . 63.42 112.557 178.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.487 HG11 ' CZ ' ' A' ' 28' ' ' PHE . 29.6 t -74.54 122.46 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 O-C-N 120.858 -1.151 . . . . 73.11 109.785 168.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -140.68 -23.41 0.79 Allowed 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.084 0.954 . . . . 73.34 112.303 175.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.21 175.4 11.09 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.307 0.643 . . . . 74.33 109.56 174.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 104' ' ' VAL . 18.0 t -55.55 -44.09 75.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 126.182 1.793 . . . . 70.05 109.941 -172.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.5 -14.34 40.43 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.212 0.605 . . . . 45.41 112.628 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -94.36 -27.65 15.96 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 119.421 1.01 . . . . 71.41 110.034 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.462 HG12 HG13 ' A' ' 101' ' ' VAL . 3.2 mt -81.52 -41.77 19.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 123.286 0.634 . . . . 65.24 109.378 -178.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -55.32 -25.08 32.42 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.441 -0.787 . . . . 74.45 113.055 176.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -62.23 -56.51 17.91 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.803 1.241 . . . . 70.31 110.78 -177.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 54.3 t -57.15 -43.1 80.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 119.165 -0.445 . . . . 51.22 110.369 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -50.68 -56.77 10.38 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.707 0.803 . . . . 74.24 109.482 175.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.74 -46.86 95.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 123.132 0.573 . . . . 71.45 109.811 -174.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.05 -43.57 91.7 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 123.652 0.595 . . . . 74.25 109.475 -176.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.95 -17.32 62.08 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.425 1.09 . . . . 72.14 112.612 -177.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 113.61 64.24 0.44 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 110.393 -1.083 . . . . 60.01 110.393 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.7 t -127.69 141.1 47.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 123.819 0.848 . . . . 74.13 109.976 163.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -66.04 148.2 52.17 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.905 -0.497 . . . . 53.21 112.027 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -73.5 1.84 41.71 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 124.775 1.179 . . . . 53.24 114.904 165.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -100.98 -39.98 7.47 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 117.367 0.584 . . . . 64.13 111.158 174.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.9 -35.04 62.27 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.014 -1.106 . . . . 62.42 108.014 -167.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -61.45 -59.93 4.5 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 116.067 -0.515 . . . . 72.03 109.857 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -59.64 -36.98 77.44 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.622 0.769 . . . . 74.45 110.969 -176.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.55 -65.49 0.71 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.916 0.886 . . . . 70.01 110.186 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.505 ' HB3' HG22 ' A' ' 77' ' ' VAL . . . -54.53 -37.08 64.96 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.175 0.99 . . . . 72.11 110.347 -173.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -45.08 -41.59 7.86 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.051 1.341 . . . . 65.21 112.904 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -112.83 19.78 17.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.703 1.201 . . . . 72.23 112.338 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 11.9 t -115.85 149.19 39.02 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 123.721 1.724 . . . . 62.05 110.783 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.84 -27.0 49.32 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 119.754 3.242 . . . . 72.15 119.754 -171.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 29.3 t -45.22 -56.31 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 C-N-CA 127.064 2.145 . . . . 74.31 107.996 168.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.25 -43.34 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 125.644 1.578 . . . . 70.15 109.398 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp -52.84 -46.31 67.72 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.544 -0.723 . . . . 64.12 112.089 177.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.83 -49.11 71.89 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 118.724 -0.655 . . . . 71.34 110.055 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 13.5 mt -59.29 -42.17 90.65 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.777 -0.63 . . . . 74.15 111.469 -176.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 52.9 t -55.73 -48.96 77.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.672 -0.862 . . . . 72.23 108.672 176.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.59 -40.11 95.86 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 113.394 0.887 . . . . 52.23 113.394 -177.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -56.26 -50.93 69.94 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.934 0.894 . . . . 65.14 109.427 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.512 ' CB ' ' CE1' ' A' ' 60' ' ' HIS . 0.5 OUTLIER -70.31 -38.12 74.88 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 117.454 -1.26 . . . . 74.33 111.148 -176.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -58.76 -44.41 90.56 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 120.535 1.516 . . . . 43.32 109.54 170.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.8 ttmm -67.12 -10.57 51.53 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.081 -1.012 . . . . 70.23 113.273 175.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.8 2.7 11.1 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 117.416 -1.278 . . . . 61.5 114.239 178.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -134.77 -12.28 2.29 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.154 1.343 . . . . 61.24 112.995 174.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -121.21 6.43 10.23 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.378 1.071 . . . . 73.12 111.121 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -70.83 -85.38 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.358 0.663 . . . . 70.21 112.364 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.1 pp -164.59 33.24 0.07 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.08 0.952 . . . . 61.42 113.438 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.555 ' NE2' ' H ' ' A' ' 146' ' ' LEU . 0.8 OUTLIER -126.69 -69.41 0.76 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.298 0.954 . . . . 74.51 112.391 -163.368 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.555 ' H ' ' NE2' ' A' ' 145' ' ' GLN . 0.7 OUTLIER -133.91 142.22 47.66 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.556 2.742 . . . . 64.11 107.046 -171.208 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -143.68 13.11 1.71 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.222 1.009 . . . . 45.1 111.981 -178.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -141.02 176.89 21.32 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 109.36 -1.496 . . . . 70.24 109.36 173.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 19.2 m -147.7 171.15 6.66 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 124.417 1.087 . . . . 71.33 111.202 -169.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.432 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 44.2 Cg_endo -64.37 162.86 60.4 Favored 'Cis proline' 0 C--N 1.349 0.605 0 CA-C-N 120.376 1.17 . . . . 73.12 110.585 -14.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -146.78 147.31 30.77 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 122.89 0.476 . . . . 73.53 110.268 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 50.9 tpp -142.6 118.45 10.55 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.122 -2.177 . . . . 73.33 105.122 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -100.91 167.72 10.09 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.088 -0.708 . . . . 74.41 109.088 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.6 t -139.49 143.16 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.473 1.109 . . . . 71.1 108.393 170.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 49.45 18.17 0.27 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 128.108 2.563 . . . . 71.43 115.106 176.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 62.5 34.31 89.06 Favored Glycine 0 CA--C 1.534 1.232 0 O-C-N 120.765 -1.209 . . . . 65.13 111.687 -176.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -155.88 -22.0 0.11 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.346 1.61 . . . . 65.3 115.346 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -119.08 154.51 33.06 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 119.234 0.925 . . . . 72.51 109.044 -175.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.0 125.75 44.37 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.988 2.515 . . . . 72.42 107.833 176.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.425 HD11 ' CG2' ' A' ' 181' ' ' VAL . 1.0 OUTLIER -64.78 147.19 53.66 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 106.685 -1.598 . . . . 51.1 106.685 176.278 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.416 ' CG ' HD11 ' A' ' 10' ' ' ILE . 36.3 t30 -123.78 76.67 56.92 Favored Pre-proline 0 C--O 1.233 0.223 0 O-C-N 122.091 -0.38 . . . . 61.21 111.436 -176.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.58 -17.19 58.75 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.501 1.468 . . . . 74.4 112.198 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.96 -12.21 61.41 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.136 1.774 . . . . 51.14 113.087 177.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -121.28 35.47 3.62 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.854 1.216 . . . . 45.3 110.113 175.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 46.0 mtt -122.37 165.04 16.91 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 122.278 1.037 . . . . 72.32 109.596 176.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -82.83 76.4 9.68 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.562 -1.199 . . . . 65.21 110.771 -176.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 21.4 p -73.22 -1.06 16.23 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.256 2.222 . . . . 70.31 112.8 177.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 39.7 m -72.83 -6.34 44.24 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 113.851 1.056 . . . . 54.2 113.851 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.59 -9.6 1.42 Allowed 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 117.772 -1.109 . . . . 45.43 113.311 -167.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 3.0 mmt 66.36 -56.85 0.38 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.272 1.829 . . . . 72.5 114.998 174.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.76 -51.37 62.65 Favored 'General case' 0 C--O 1.224 -0.284 0 N-CA-C 106.987 -1.486 . . . . 71.24 106.987 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 48.6 t -57.93 -36.43 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.881 1.272 . . . . 75.22 110.121 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -58.77 -60.98 2.98 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 118.214 -0.898 . . . . 74.2 109.771 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.5 t -70.73 -33.97 54.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 118.476 0.58 . . . . 74.4 110.931 -175.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -49.94 -46.5 52.25 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.76 1.224 . . . . 71.32 110.155 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -87.43 -28.74 21.94 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 113.349 0.87 . . . . 72.5 113.349 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -56.61 -60.54 3.39 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.054 1.297 . . . . 65.3 110.513 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.77 -32.22 70.39 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.039 0.536 . . . . 72.13 111.951 -177.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -60.12 -50.93 71.76 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.773 1.229 . . . . 74.23 110.275 175.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.0 t -68.44 -30.17 68.98 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 116.73 -1.605 . . . . 63.12 110.912 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.425 ' CG2' HD11 ' A' ' 160' ' ' LEU . 58.7 t -56.44 -52.06 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 120.512 1.506 . . . . 62.22 108.578 173.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -59.38 -53.54 56.98 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-O 118.39 -0.815 . . . . 74.5 110.682 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -53.03 -40.94 64.26 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.74 0.7 . . . . 65.23 111.796 -171.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.85 -20.59 63.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.739 1.014 . . . . 71.53 113.739 -176.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.08 -33.74 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 109.109 -0.7 . . . . 64.3 109.109 171.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -80.1 -41.64 25.14 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.877 -1.157 . . . . 42.21 107.877 -171.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -85.86 51.38 2.19 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.802 2.041 . . . . 73.1 110.24 -178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 20.4 pttt . . . . . 0 C--O 1.246 0.893 0 CA-C-O 117.264 -1.35 . . . . 65.12 110.158 172.094 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 34.8 m . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 119.774 -0.155 . . . . 74.14 110.676 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -98.02 1.92 48.3 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.814 -1.179 . . . . 73.34 112.753 -175.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -72.15 46.31 0.14 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.676 1.19 . . . . 45.22 113.105 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.52 122.47 3.58 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 105.613 -1.995 . . . . 71.14 105.613 170.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -126.68 158.35 37.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 126.318 1.847 . . . . 62.31 106.636 171.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.6 m -136.08 135.43 39.33 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.767 -1.197 . . . . 70.12 107.767 -176.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -51.74 104.15 0.08 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 131.52 3.928 . . . . 74.34 108.796 167.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 110.0 -22.17 23.74 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 126.998 2.237 . . . . 65.34 112.501 -177.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -90.7 -85.49 0.22 Allowed 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 119.776 1.788 . . . . 70.23 108.433 -172.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -89.4 -15.56 32.96 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.896 1.279 . . . . 72.15 109.915 -176.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -137.2 162.85 32.35 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.599 0.76 . . . . 71.31 110.709 172.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.401 ' HB ' ' HG3' ' A' ' 159' ' ' GLN . 3.0 mm -128.66 166.81 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 127.542 2.337 . . . . 74.25 105.97 171.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.1 174.22 5.98 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 127.605 2.362 . . . . 72.55 109.68 176.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 57.9 mt -116.4 148.63 40.48 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.524 1.13 . . . . 70.11 110.013 171.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -73.06 -35.81 66.76 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.474 1.11 . . . . 70.14 110.152 176.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.6 mmtm -122.05 77.99 41.85 Favored Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 126.522 1.929 . . . . 64.15 109.354 177.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -80.25 1.65 9.09 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 124.553 3.502 . . . . 62.53 112.858 172.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 15.8 tt -141.12 154.53 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 O-C-N 120.334 -1.479 . . . . 70.55 107.936 -171.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 64.69 -9.24 0.19 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.343 2.257 . . . . 63.35 113.545 -166.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -105.32 154.11 17.19 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 124.687 1.137 . . . . 50.04 110.739 176.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 52.13 165.36 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 130.395 3.478 . . . . 73.14 116.868 175.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -71.99 -54.49 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.125 1.883 . . . . 64.44 110.878 172.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -174.66 -171.88 0.6 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.808 2.043 . . . . 73.25 107.336 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.9 p -44.24 130.25 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 126.262 1.825 . . . . 73.32 111.148 173.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.3 154.2 37.46 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.614 1.566 . . . . 65.12 107.015 -173.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -120.53 141.77 49.94 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.369 -1.345 . . . . 64.23 107.369 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -130.69 134.98 47.38 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.787 1.635 . . . . 72.2 109.339 176.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.3 179.27 7.5 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.784 1.234 . . . . 72.43 108.434 167.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.0 t -134.4 153.43 51.91 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.379 -0.971 . . . . 71.21 108.379 168.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.541 ' CE2' ' HG2' ' A' ' 91' ' ' MET . 12.2 m-30 -64.94 -24.39 67.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 118.483 -0.77 . . . . 74.21 111.705 172.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.407 ' CE2' ' HA3' ' A' ' 65' ' ' GLY . 47.7 m-85 -89.26 -5.2 57.8 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 120.283 1.401 . . . . 65.13 113.667 178.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.9 p -90.4 144.42 30.81 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 122.059 2.209 . . . . 73.31 111.298 -174.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -81.84 -43.19 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 121.935 1.756 . . . . 63.33 112.394 -166.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -54.48 -45.67 73.24 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 109.136 -0.69 . . . . 73.11 109.136 173.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 15.3 m -55.44 -35.86 65.91 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.503 1.921 . . . . 71.25 112.048 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -64.79 -48.53 74.12 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.822 0.737 . . . . 73.55 110.674 176.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.537 ' HA ' HE21 ' A' ' 35' ' ' GLN . 0.0 OUTLIER -59.37 -44.5 92.71 Favored 'General case' 0 C--O 1.223 -0.302 0 O-C-N 121.091 -1.005 . . . . 74.15 108.908 172.673 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -60.3 -16.55 35.57 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 115.735 -2.079 . . . . 71.54 112.41 -178.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -142.83 12.21 1.85 Allowed 'General case' 0 C--N 1.347 0.461 0 CA-C-N 122.111 2.232 . . . . 74.43 114.438 -172.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -131.7 -13.04 3.34 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.15 0.98 . . . . 64.22 112.282 165.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.1 t -128.26 -77.12 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 108.353 -0.98 . . . . 72.51 108.353 -170.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.8 mt -67.18 -26.8 66.81 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.787 1.635 . . . . 74.45 111.838 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 44.03 56.25 4.85 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.128 1.371 . . . . 70.24 110.915 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.628 ' O ' HG23 ' A' ' 46' ' ' VAL . 61.1 t -61.64 -46.53 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 117.506 -1.235 . . . . 53.34 107.967 -169.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.5 t -56.86 -37.99 72.09 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 120.318 1.417 . . . . 64.22 112.283 -177.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.22 -49.07 63.18 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.103 0.961 . . . . 71.13 109.745 177.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -62.23 -41.28 98.26 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.625 1.17 . . . . 43.31 112.088 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 42' ' ' VAL . 2.5 t -62.97 -51.01 77.31 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 N-CA-C 107.553 -1.277 . . . . 71.12 107.553 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -50.01 -47.83 52.84 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.285 0.948 . . . . 72.24 111.578 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -66.5 -1.45 3.6 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 115.284 1.587 . . . . 71.12 115.284 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -130.01 -4.23 4.52 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.94 2.096 . . . . 63.42 112.891 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.695 HD13 HG21 ' A' ' 54' ' ' THR . 13.6 mt -69.33 151.28 96.95 Favored Pre-proline 0 N--CA 1.466 0.35 0 CA-C-N 120.065 1.302 . . . . 53.45 110.769 -172.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -81.07 146.3 15.93 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 122.275 1.984 . . . . 74.41 110.036 172.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -71.93 105.38 3.82 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.015 -1.448 . . . . 72.52 109.211 -175.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 131.79 -9.54 5.48 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.728 -1.04 . . . . 71.14 113.337 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.695 HG21 HD13 ' A' ' 50' ' ' LEU . 5.9 t -52.81 -46.79 67.85 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.705 1.253 . . . . 72.44 112.228 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? 46.5 83.54 0.03 OUTLIER 'General case' 0 C--N 1.346 0.417 0 C-N-CA 127.305 2.242 . . . . 62.31 110.3 -174.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 19.9 ptp -65.53 -175.74 0.29 Allowed 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 112.317 -2.219 . . . . 70.45 111.89 176.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 m -154.75 174.98 14.29 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.278 1.831 . . . . 64.35 108.482 165.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -140.3 126.14 19.41 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.994 -1.113 . . . . 74.23 107.994 152.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.402 ' CD2' ' HG3' ' A' ' 137' ' ' GLN . 11.4 m-30 -106.09 -176.98 3.23 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.499 -0.926 . . . . 45.11 108.499 162.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.429 ' CE1' HD13 ' A' ' 71' ' ' LEU . 41.3 t-80 -134.75 135.12 41.65 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.015 1.726 . . . . 70.33 106.656 176.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.0 m -81.6 151.89 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.813 0.845 . . . . 62.1 110.399 178.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.65 -5.56 22.49 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.675 1.19 . . . . 72.32 112.314 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -68.49 -45.63 71.84 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.576 -0.702 . . . . 73.54 112.583 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.0 mt -78.18 132.17 37.49 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 121.838 -0.539 . . . . 73.12 109.689 -171.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.407 ' HA3' ' CE2' ' A' ' 29' ' ' TYR . . . 97.64 160.85 31.05 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 124.924 1.25 . . . . 64.11 112.39 169.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.71 -39.47 6.57 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.449 2.099 . . . . 74.24 110.276 173.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.5 mt -84.59 24.4 1.02 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.507 1.923 . . . . 74.31 110.661 172.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.39 -52.22 51.28 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 120.972 -1.08 . . . . 33.45 112.162 -175.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -56.17 -44.91 79.77 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.964 0.882 . . . . 72.22 110.994 174.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -63.44 -35.7 81.31 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 124.756 1.222 . . . . 73.14 111.396 -178.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.429 HD13 ' CE1' ' A' ' 60' ' ' HIS . 21.8 mt -60.02 -52.13 66.68 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 123.803 0.841 . . . . 43.24 110.76 176.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.9 m -62.96 -37.49 87.3 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.403 0.547 . . . . 73.22 110.339 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -58.51 -44.18 89.4 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.812 -0.555 . . . . 74.33 109.775 172.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.56 -41.32 96.39 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.355 -1.466 . . . . 65.5 112.897 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 49.3 t-105 -57.93 -37.96 75.06 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.837 0.855 . . . . 71.11 109.786 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.09 -43.98 87.34 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 117.55 -1.214 . . . . 62.3 112.513 175.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 98.1 t -54.01 -46.35 65.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 120.632 1.56 . . . . 64.11 110.714 170.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.71 -45.04 94.58 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-O 118.951 -0.547 . . . . 71.44 110.864 -175.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 91.6 mt -57.69 -46.82 86.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 123.956 0.902 . . . . 72.52 109.43 174.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.45 -3.69 44.67 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.515 1.302 . . . . 65.5 114.515 -169.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 88.5 mt -106.23 -21.48 13.1 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 119.597 1.089 . . . . 65.33 111.696 156.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.11 64.08 2.77 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 125.573 1.559 . . . . 34.13 109.218 -169.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -133.22 13.76 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.745 1.218 . . . . 70.51 112.16 -176.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -51.13 -60.2 3.36 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.541 1.137 . . . . 73.42 109.766 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.12 -8.59 3.59 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.002 1.721 . . . . 72.15 113.291 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.9 mtpt -102.56 -10.78 19.01 Favored 'General case' 0 CA--C 1.518 -0.271 0 O-C-N 120.379 -1.45 . . . . 73.44 112.043 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.2 pp -126.77 -14.12 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 116.96 -1.495 . . . . 74.14 112.102 -174.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 34.3 m -55.18 -54.96 36.7 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 119.652 1.115 . . . . 53.01 109.503 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.533 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -54.45 -62.43 4.03 Favored Pre-proline 0 N--CA 1.449 -0.507 0 C-N-CA 124.866 1.266 . . . . 73.41 111.296 -170.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.533 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 38.0 Cg_endo -64.05 -26.01 66.03 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.112 1.208 . . . . 72.23 112.357 -177.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.541 ' HG2' ' CE2' ' A' ' 28' ' ' PHE . 8.5 tpp -62.44 -48.03 81.45 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-O 118.193 -0.908 . . . . 74.24 111.215 172.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -66.71 -35.96 81.37 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 120.412 1.46 . . . . 72.21 109.139 -178.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -62.39 -33.56 74.99 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.422 0.556 . . . . 74.13 111.324 170.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.93 -11.12 45.37 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.894 -1.129 . . . . 64.31 113.388 -176.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.3 t -109.52 -42.87 5.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 125.338 1.455 . . . . 74.24 110.61 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -103.52 -46.37 4.58 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.179 0.592 . . . . 72.55 110.133 -174.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt -77.13 -68.65 0.59 Allowed 'General case' 0 N--CA 1.457 -0.088 0 CA-C-O 119.03 -0.509 . . . . 74.25 109.897 -172.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.5 p -79.85 -30.91 40.43 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 119.296 0.953 . . . . 72.41 110.548 177.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 60.43 20.97 10.62 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.228 1.811 . . . . 62.22 113.317 -174.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -69.23 -12.77 61.96 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.324 1.05 . . . . 53.04 112.812 -174.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.455 HG13 HG12 ' A' ' 107' ' ' ILE . 29.6 t -65.41 115.07 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 O-C-N 120.998 -1.064 . . . . 74.43 109.189 170.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -136.68 -31.14 0.87 Allowed 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.762 1.225 . . . . 74.54 112.083 -173.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.67 170.1 16.64 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.904 0.882 . . . . 62.3 109.355 167.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 67.3 t -54.23 -37.52 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.016 1.326 . . . . 64.14 111.205 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.28 -31.18 42.5 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.385 1.074 . . . . 45.2 112.709 176.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -82.4 -27.73 31.84 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 123.242 0.617 . . . . 54.4 110.504 -177.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.455 HG12 HG13 ' A' ' 101' ' ' VAL . 3.2 mt -76.22 -50.43 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.808 1.643 . . . . 70.2 108.014 -177.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.412 ' HB3' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -64.82 -21.35 66.77 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.525 -0.734 . . . . 73.32 111.792 -177.284 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -56.45 21.75 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 124.552 1.141 . . . . 50.43 110.217 168.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.8 t -51.51 -45.53 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 123.654 0.781 . . . . 74.32 110.002 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -53.1 -55.71 21.89 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.808 0.443 . . . . 62.43 109.859 176.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 64.6 t -57.29 -42.91 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 O-C-N 121.7 -0.625 . . . . 73.32 110.232 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -61.6 -41.77 97.91 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 124.283 0.989 . . . . 65.53 109.534 -171.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.34 -2.21 30.58 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.008 1.723 . . . . 62.12 113.199 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 99.61 55.78 1.0 Allowed Glycine 0 CA--C 1.524 0.618 0 CA-C-N 119.257 0.935 . . . . 71.51 112.587 177.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 66.8 t -119.84 142.31 35.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 117.687 0.743 . . . . 63.32 109.668 170.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.84 126.32 29.05 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.048 0.939 . . . . 72.13 109.769 170.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.94 -24.04 69.82 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-O 118.017 -1.435 . . . . 71.42 112.413 175.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.54 -38.25 89.07 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.941 1.37 . . . . 74.43 109.752 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -73.4 -44.99 57.34 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 105.794 -1.928 . . . . 71.42 105.794 -171.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.412 ' CE1' ' HB3' ' A' ' 108' ' ' ARG . 5.1 t80 -60.32 -40.2 89.74 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.452 0.644 . . . . 71.24 110.045 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -79.61 -11.2 59.88 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 113.395 0.887 . . . . 72.41 113.395 -177.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -103.44 -63.55 1.17 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.985 1.314 . . . . 62.52 109.251 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -44.89 -45.07 10.13 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 128.001 2.521 . . . . 63.2 110.752 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 44.5 t-105 -50.9 -29.7 12.68 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.279 1.032 . . . . 73.53 113.563 -178.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -119.33 5.78 11.18 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.895 1.678 . . . . 74.23 112.434 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.1 t -88.77 149.85 23.23 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 125.814 1.645 . . . . 65.5 109.466 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -49.2 -33.68 12.99 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.963 1.705 . . . . 73.13 112.121 177.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.0 t -46.09 -56.53 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 125.338 1.455 . . . . 73.43 110.426 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.1 t -67.4 -47.45 80.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 C-N-CA 125.016 1.326 . . . . 71.43 109.454 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -54.39 -44.54 72.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.213 0.53 . . . . 72.3 110.314 -172.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.05 -45.77 84.01 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.68 1.192 . . . . 73.32 111.534 176.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 16.3 mt -60.42 -48.62 80.95 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.86 0.864 . . . . 74.53 111.203 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.9 t -49.96 -45.26 22.37 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 C-N-CA 124.819 1.248 . . . . 73.42 109.3 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.5 -32.5 74.16 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.693 0.627 . . . . 52.23 112.693 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -62.85 -51.8 65.62 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.059 0.845 . . . . 73.51 110.588 171.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.402 ' HG3' ' CD2' ' A' ' 59' ' ' TYR . 7.4 mp0 -63.44 -47.14 83.1 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.793 0.27 . . . . 52.3 111.235 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -58.73 -47.16 85.57 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.938 1.295 . . . . 70.11 110.553 178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -57.23 -45.06 84.24 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-N 118.492 0.587 . . . . 73.23 110.172 175.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.95 1.37 10.96 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.653 0.983 . . . . 74.3 113.653 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -86.37 -59.36 2.3 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.132 -1.605 . . . . 71.14 110.36 149.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.2 -7.87 40.51 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.028 2.131 . . . . 53.4 114.28 -163.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.08 -6.26 48.55 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.064 1.346 . . . . 71.1 112.343 172.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.0 mt 67.71 63.17 0.41 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 122.727 1.251 . . . . 61.41 109.494 167.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -144.58 -48.11 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.505 -1.225 . . . . 74.34 111.435 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 9.4 tp -78.69 -85.76 0.07 Allowed 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.76 0.709 . . . . 65.23 110.654 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 57.82 24.7 11.09 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.475 1.11 . . . . 71.51 112.515 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -169.39 162.47 36.06 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.682 1.61 . . . . 53.42 109.835 178.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 18.9 m -150.69 165.19 17.93 Favored Pre-proline 0 CA--C 1.546 0.801 0 CA-C-N 118.47 1.135 . . . . 72.51 109.852 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -65.31 157.31 76.63 Favored 'Cis proline' 0 C--N 1.351 0.665 0 CA-C-N 119.902 1.001 . . . . 64.45 110.592 -13.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -144.59 141.8 29.69 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.973 -0.558 . . . . 53.21 110.058 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 34.7 mtp -148.94 95.31 2.38 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 105.855 -1.905 . . . . 53.34 105.855 -169.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -82.13 169.31 16.79 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.996 -0.372 . . . . 73.14 109.996 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.2 t -147.38 150.31 14.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 O-C-N 121.128 -0.982 . . . . 62.53 109.602 169.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 60.31 6.1 0.97 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 128.431 2.692 . . . . 73.33 114.241 166.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.4 -1.47 84.25 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.298 -1.279 . . . . 72.34 112.455 -173.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -147.05 -7.12 0.48 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 116.252 1.945 . . . . 74.34 116.252 -164.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -121.48 155.6 34.57 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 118.517 0.599 . . . . 73.51 109.898 -175.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.401 ' HG3' ' HB ' ' A' ' 10' ' ' ILE . 0.5 OUTLIER -125.67 130.02 50.74 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 128.159 2.584 . . . . 74.44 107.302 172.199 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.61 153.74 38.43 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 107.67 -1.233 . . . . 63.33 107.67 174.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -126.48 85.59 59.97 Favored Pre-proline 0 C--O 1.234 0.272 0 O-C-N 122.241 -0.287 . . . . 63.21 110.93 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -63.11 -22.81 73.33 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 CA-C-N 118.948 0.66 . . . . 70.21 111.794 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.5 -2.59 23.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.875 1.27 . . . . 72.21 111.955 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -131.93 30.92 3.14 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.596 1.569 . . . . 72.53 111.021 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 20.8 mtm -127.15 165.18 20.05 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.439 1.496 . . . . 73.14 108.74 172.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -83.18 67.73 9.31 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 124.978 2.323 . . . . 70.31 110.762 -166.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.5 p -66.53 6.09 0.5 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 131.55 3.94 . . . . 72.13 112.204 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 23.0 m -91.74 -5.47 53.55 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 124.112 0.965 . . . . 73.32 113.458 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.44 -10.69 2.48 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 118.376 -0.821 . . . . 73.34 112.626 -172.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 10.1 mmt 70.25 -59.1 0.53 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 126.33 1.852 . . . . 53.14 112.978 177.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -67.4 -43.07 82.19 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.84 1.2 . . . . 73.32 108.774 -174.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.404 HG12 HE21 ' A' ' 176' ' ' GLN . 40.0 t -65.33 -30.56 50.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 124.516 1.127 . . . . 71.35 110.925 176.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -61.96 -62.53 1.72 Allowed 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.791 -0.818 . . . . 65.31 108.791 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 12.7 t -63.55 -39.01 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 119.079 -0.486 . . . . 73.54 110.271 -172.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -50.6 -49.52 56.36 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.627 1.171 . . . . 74.32 110.612 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.404 HE21 HG12 ' A' ' 172' ' ' VAL . 50.1 mt-30 -78.62 -40.36 34.57 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 118.342 -0.837 . . . . 73.31 112.005 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -54.1 -56.48 17.67 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.953 0.901 . . . . 74.52 110.289 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -53.86 -35.89 62.0 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.438 1.095 . . . . 72.53 112.326 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -73.29 -51.77 16.36 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.363 0.665 . . . . 72.53 109.829 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.0 t -62.15 -25.34 67.7 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 117.483 -1.246 . . . . 72.22 111.374 -176.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 57.8 t -56.62 -56.28 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 119.369 0.986 . . . . 72.55 108.896 168.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 13.6 tttm -55.8 -46.23 78.07 Favored 'General case' 0 N--CA 1.461 0.088 0 C-N-CA 123.512 0.725 . . . . 70.31 111.518 177.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -58.25 -29.18 65.56 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.442 0.697 . . . . 73.22 111.361 -175.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 50.9 mt -82.04 -25.77 34.35 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 120.964 -1.085 . . . . 73.15 113.222 -176.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 89.3 t -59.74 -36.14 64.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.732 -0.84 . . . . 53.03 108.732 175.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -91.43 -19.65 22.63 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 122.218 -0.301 . . . . 74.24 111.094 -173.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -95.17 65.78 2.87 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.947 1.299 . . . . 72.11 108.932 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt . . . . . 0 C--O 1.242 0.706 0 N-CA-C 108.47 -0.937 . . . . 62.51 108.47 165.337 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 56.0 p . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 111.489 0.181 . . . . 71.33 111.489 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -65.62 175.65 1.77 Allowed 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.464 -0.773 . . . . 53.34 109.07 170.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 50.15 28.55 3.11 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.388 1.875 . . . . 72.24 115.232 -176.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -165.37 113.74 1.01 Allowed 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.238 1.015 . . . . 73.23 110.398 169.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.0 pt -112.93 172.02 3.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 127.593 2.357 . . . . 70.43 109.612 179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.9 m -142.68 141.52 31.86 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.138 -0.976 . . . . 62.24 108.86 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -53.21 135.55 37.93 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 126.174 1.79 . . . . 71.31 110.155 172.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 79.48 -18.02 7.51 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.376 1.465 . . . . 74.24 113.889 -175.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -93.41 -85.12 0.28 Allowed 'General case' 0 C--N 1.341 0.221 0 CA-C-N 119.569 1.684 . . . . 63.11 108.904 -167.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.8 mp0 -89.43 -12.05 41.34 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 123.948 0.899 . . . . 64.24 111.381 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -141.69 160.83 39.36 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.494 0.718 . . . . 74.25 109.658 171.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.6 mm -121.74 162.77 20.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 107.407 -1.331 . . . . 73.21 107.407 170.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.4 m -119.57 127.46 53.0 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 127.137 2.175 . . . . 74.22 106.126 -178.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.4 mt -70.5 159.36 34.42 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.236 -0.653 . . . . 51.33 109.236 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -83.07 -30.1 28.28 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.847 0.459 . . . . 71.44 111.608 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -138.13 73.06 45.43 Favored Pre-proline 0 C--O 1.232 0.149 0 C-N-CA 124.903 1.281 . . . . 75.13 108.58 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -69.5 107.31 1.78 Allowed 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.161 2.574 . . . . 55.51 106.953 173.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 13.8 tt -137.34 149.24 25.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 O-C-N 121.1 -1.0 . . . . 73.42 110.189 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.68 148.46 24.49 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.572 -0.899 . . . . 74.24 108.572 173.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 124.74 -17.83 7.22 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-O 118.809 -0.995 . . . . 62.01 111.537 -170.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -84.69 159.53 57.89 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 119.21 1.505 . . . . 72.42 109.185 161.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.33 -22.26 46.27 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.616 2.211 . . . . 61.03 112.55 173.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 65.66 152.58 0.06 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 128.05 2.54 . . . . 63.34 111.991 -171.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.4 m 44.59 72.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 127.514 2.326 . . . . 70.32 111.639 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.7 160.17 41.64 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.48 -0.933 . . . . 64.25 108.48 -173.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -126.77 161.36 28.37 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 125.083 1.353 . . . . 73.02 107.458 167.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -121.09 174.04 6.9 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.982 -1.488 . . . . 75.31 106.982 167.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -166.01 -179.03 4.97 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.669 2.388 . . . . 72.42 109.264 168.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.07 -168.63 2.4 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 106.729 -1.582 . . . . 44.1 106.729 158.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -104.47 -45.9 4.52 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.587 0.708 . . . . 74.32 109.256 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.499 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 69.4 m-85 -83.39 -4.09 58.15 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.544 -0.723 . . . . 73.31 111.814 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.2 p -62.36 144.09 95.36 Favored Pre-proline 0 C--N 1.343 0.283 0 CA-C-N 119.782 1.174 . . . . 72.2 109.841 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.0 173.93 13.66 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 121.461 1.441 . . . . 65.4 109.365 163.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 66.17 -40.63 0.35 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 128.936 2.895 . . . . 61.42 112.762 -174.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 60.2 m -54.84 -41.09 70.32 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.834 1.654 . . . . 73.1 112.128 -177.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -54.5 -63.69 1.07 Allowed 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 128.199 2.6 . . . . 73.22 108.854 177.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.16 -39.97 76.3 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 108.434 -0.95 . . . . 72.44 108.434 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -57.09 -26.46 60.45 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 115.292 -2.289 . . . . 74.44 113.282 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.64 -24.57 4.5 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 122.158 2.254 . . . . 72.1 109.552 -174.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -105.76 -17.06 14.5 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 120.512 1.505 . . . . 74.31 113.757 -170.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.6 t -121.68 -63.73 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 108.187 -1.042 . . . . 70.44 108.187 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 42.6 mt -70.88 -18.39 62.69 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 118.147 -0.93 . . . . 74.02 111.966 175.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 44.89 39.59 3.71 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 121.139 1.79 . . . . 74.1 112.899 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 69.4 t -61.23 -45.41 98.65 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.388 0 O-C-N 121.091 -1.006 . . . . 71.23 109.864 -175.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.4 t -47.1 -53.27 13.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.86 1.264 . . . . 63.12 109.942 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.95 -31.89 69.85 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 113.558 0.948 . . . . 52.53 113.558 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -73.88 -51.69 15.39 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.702 0.683 . . . . 74.34 109.297 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 50.4 t -52.66 -52.68 25.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 126.055 1.742 . . . . 73.45 109.609 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.4 ptt85 -64.85 -14.01 58.03 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 116.795 -1.574 . . . . 74.35 114.015 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -75.75 -17.64 59.83 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 120.667 1.576 . . . . 73.41 112.55 170.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -123.34 -9.18 8.07 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.445 1.098 . . . . 64.11 113.34 -171.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.448 HD12 ' HE1' ' A' ' 56' ' ' MET . 10.8 mt -61.64 146.16 90.62 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 123.929 0.892 . . . . 73.24 112.184 -179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -83.47 162.1 14.79 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.879 3.053 . . . . 70.13 114.081 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -79.51 64.83 4.5 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 127.094 2.158 . . . . 65.31 110.257 -171.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -176.25 -30.41 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 125.174 1.368 . . . . 51.45 111.615 -169.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.445 HG21 HD13 ' A' ' 50' ' ' LEU . 3.8 t -58.04 -29.61 65.49 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 115.233 1.568 . . . . 74.43 115.233 -176.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 11.3 tptp 44.37 88.62 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.43 1.892 . . . . 74.33 112.185 -177.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.448 ' HE1' HD12 ' A' ' 50' ' ' LEU . 4.5 ttm -49.77 100.71 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 129.388 3.075 . . . . 64.33 110.692 -175.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 18.4 m -139.84 121.31 15.1 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 107.337 -1.357 . . . . 62.3 107.337 -172.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -130.46 120.01 23.51 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 106.986 -1.487 . . . . 54.42 106.986 -176.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -95.52 157.11 16.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 123.13 1.443 . . . . 74.43 110.056 174.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.712 ' CD2' ' H ' ' A' ' 60' ' ' HIS . 5.4 p80 -98.0 167.06 11.13 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 129.176 2.99 . . . . 61.43 108.901 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.2 m -131.92 165.83 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 124.032 0.933 . . . . 51.44 108.507 176.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -100.68 16.65 24.21 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.53 1.132 . . . . 62.31 111.675 -169.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -115.73 162.6 17.04 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 126.436 1.895 . . . . 52.52 109.322 -169.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 75.3 124.34 0.04 OUTLIER 'General case' 0 C--O 1.232 0.153 0 C-N-CA 128.676 2.79 . . . . 63.04 110.519 174.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.499 ' HA3' ' CD2' ' A' ' 29' ' ' TYR . . . 90.19 173.47 44.93 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 124.302 0.953 . . . . 75.42 112.098 175.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -65.52 -55.15 0.47 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.348 2.699 . . . . 74.21 109.737 173.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.5 mt -86.54 17.0 4.1 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 125.174 1.39 . . . . 72.13 112.862 -167.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -48.16 -45.12 27.21 Favored Glycine 0 CA--C 1.542 1.739 0 CA-C-N 120.005 1.275 . . . . 72.13 113.715 -174.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.1 tptt -59.85 -46.37 89.5 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.887 1.275 . . . . 74.11 111.541 174.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -71.03 -38.18 72.58 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.749 -1.219 . . . . 71.02 109.026 -176.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.1 mt -62.46 -34.1 76.14 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.091 1.756 . . . . 71.21 111.915 173.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.7 m -54.04 -58.19 8.24 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 106.934 -1.506 . . . . 74.32 106.934 170.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -57.25 -50.56 72.51 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.968 0.907 . . . . 72.4 111.595 -169.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.5 -24.4 67.46 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.883 1.068 . . . . 61.02 113.883 -171.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.571 ' CD1' ' CD2' ' A' ' 60' ' ' HIS . 52.0 t-105 -57.7 -35.04 70.09 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.453 -0.779 . . . . 74.22 111.168 175.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.05 95.04 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.34 -0.838 . . . . 72.34 111.915 178.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.2 t -53.38 -43.73 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 119.177 0.898 . . . . 32.42 110.159 175.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.93 -26.24 40.2 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 117.362 -1.304 . . . . 32.12 113.088 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 76.8 mt -67.14 -41.75 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 120.835 1.652 . . . . 70.04 108.343 166.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.01 -44.36 94.63 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.623 0.647 . . . . 74.04 110.464 -172.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.4 mt -81.04 -18.07 48.01 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 112.902 0.705 . . . . 64.41 112.902 174.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.29 70.16 1.13 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.907 1.717 . . . . 54.22 110.789 -171.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.469 HG21 HG22 ' A' ' 116' ' ' VAL . 15.9 m -138.11 19.18 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 125.735 1.614 . . . . 72.4 111.432 -175.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -52.43 -51.52 58.78 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 126.03 1.732 . . . . 72.14 110.151 -178.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -68.36 -0.86 5.33 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.562 1.945 . . . . 65.0 113.393 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -104.42 -26.07 12.57 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 120.835 -1.165 . . . . 71.04 109.66 176.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.433 HG22 ' HB3' ' A' ' 114' ' ' ALA . 1.1 pt -112.04 9.93 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 C-N-CA 125.013 1.325 . . . . 70.42 111.698 -174.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 56.0 m -80.92 -44.71 17.84 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 120.931 1.696 . . . . 63.32 109.22 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.48 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -69.07 -63.5 2.1 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 124.081 0.952 . . . . 62.41 111.686 -165.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.48 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 31.2 Cg_endo -63.01 -21.41 73.16 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 121.355 1.37 . . . . 62.24 112.08 -176.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.441 ' HE3' ' HB2' ' A' ' 91' ' ' MET . 15.0 ttm -74.26 -37.69 63.67 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 125.875 1.67 . . . . 65.21 110.52 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -64.08 -42.29 97.01 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 119.047 -0.502 . . . . 74.01 110.304 164.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -64.75 -13.79 56.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 118.321 -0.847 . . . . 65.01 113.189 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.99 -14.12 15.28 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.782 1.173 . . . . 41.41 112.36 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 78.9 t -105.86 -45.04 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.251 1.02 . . . . 63.12 112.371 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -103.88 -48.54 3.88 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 114.587 1.329 . . . . 71.02 114.587 -174.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -70.31 -59.18 3.02 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.875 1.27 . . . . 74.11 113.587 -177.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 48.5 p -94.05 -30.26 14.78 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.779 1.232 . . . . 52.12 113.435 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 60.95 27.11 16.99 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.001 2.921 . . . . 71.43 113.569 -177.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.5 t -59.78 -25.75 65.16 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.398 1.479 . . . . 62.32 112.438 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 42.7 t -62.58 109.91 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 108.528 -0.916 . . . . 72.22 108.528 175.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -141.66 -20.41 0.74 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.945 1.298 . . . . 72.13 110.841 -175.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.93 167.4 22.21 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.679 -1.6 . . . . 72.44 106.679 167.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.5 t -55.74 -28.8 24.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.11 0.564 . . . . 72.13 109.698 172.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.86 -15.04 57.96 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.972 1.709 . . . . 41.4 112.191 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.84 -23.67 13.37 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 118.635 0.652 . . . . 71.21 111.086 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.5 mt -71.52 -51.41 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.118 0 C-N-CA 125.4 1.48 . . . . 65.42 108.236 174.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.76 -22.36 62.0 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.269 1.028 . . . . 72.22 112.22 -175.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -62.06 -59.35 5.21 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 126.682 1.993 . . . . 74.44 111.076 170.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 71.1 t -54.53 -40.49 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.523 1.129 . . . . 70.2 110.354 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -54.06 -53.27 55.36 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-O 119.05 -0.5 . . . . 62.11 110.644 173.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.4 t -61.98 -46.72 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 119.617 1.098 . . . . 62.02 110.645 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -54.39 -44.2 72.1 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.164 0.986 . . . . 72.11 109.772 -176.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.433 ' HB3' HG22 ' A' ' 87' ' ' ILE . . . -75.1 -13.19 60.45 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.522 1.529 . . . . 34.42 114.907 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 126.42 6.47 5.67 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 117.402 1.721 . . . . 43.43 117.402 176.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.469 HG22 HG21 ' A' ' 83' ' ' VAL . 93.7 t -93.71 120.04 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-N 119.958 1.879 . . . . 73.21 110.051 -175.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.596 ' HG3' ' CB ' ' A' ' 120' ' ' ASP . 3.6 pttp -52.2 125.92 17.24 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.593 -0.73 . . . . 63.3 109.927 172.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.21 -30.6 61.24 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 109.41 -1.476 . . . . 52.33 109.41 166.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.03 -30.38 66.56 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 119.371 1.585 . . . . 74.34 110.653 -175.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.596 ' CB ' ' HG3' ' A' ' 117' ' ' LYS . 23.3 t0 -83.31 -43.31 16.14 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.842 -0.799 . . . . 74.04 108.842 175.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -50.81 -54.62 22.13 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 123.58 0.752 . . . . 74.3 111.047 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -73.66 -9.95 59.2 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.619 1.568 . . . . 45.44 111.413 -173.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.29 -63.3 1.14 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.431 1.892 . . . . 72.03 109.501 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.49 -36.08 68.72 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.681 1.592 . . . . 72.33 112.893 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 65.3 t-105 -44.64 -39.26 4.9 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.562 1.145 . . . . 63.1 111.065 174.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.28 0.97 41.22 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.881 1.672 . . . . 74.42 113.657 -177.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 17.4 t -97.66 165.72 11.83 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.593 1.557 . . . . 43.53 112.676 -173.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -62.97 -36.64 84.16 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.001 1.72 . . . . 74.03 111.445 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.4 t -50.58 -47.75 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 122.342 1.068 . . . . 72.14 109.064 -178.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.6 t -68.84 -42.89 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-N 114.818 -1.083 . . . . 62.33 111.476 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -50.98 -53.87 29.42 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 118.98 0.809 . . . . 74.13 110.451 175.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.84 -42.96 99.95 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.214 0.606 . . . . 55.54 110.091 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.5 mt -64.4 -40.08 95.1 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 119.326 0.966 . . . . 64.42 112.823 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 74.2 t -59.23 -53.79 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 107.406 -1.331 . . . . 55.42 107.406 171.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.42 -34.35 68.82 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.385 0.883 . . . . 73.14 113.385 -174.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -53.28 -46.03 69.15 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 124.523 1.129 . . . . 63.14 111.565 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.521 ' HG2' ' CD2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -94.18 -31.19 14.24 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 113.102 0.778 . . . . 74.32 113.102 -170.556 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -64.87 -38.08 89.78 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.796 0.726 . . . . 75.14 109.169 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -54.56 -48.83 71.58 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 126.404 1.882 . . . . 74.12 111.386 165.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.66 -17.0 60.75 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 118.513 -0.756 . . . . 51.13 112.596 -175.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.25 -44.91 35.26 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 120.839 1.654 . . . . 74.1 109.819 164.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.5 -5.11 21.93 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.428 1.491 . . . . 72.03 114.236 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.0 -2.46 51.66 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.67 1.123 . . . . 61.44 112.355 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 10.2 mt 74.56 54.84 0.08 Allowed 'General case' 0 C--N 1.342 0.245 0 C-N-CA 126.353 1.861 . . . . 75.15 110.454 164.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.405 HE21 ' HB3' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -132.41 -23.39 2.13 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.611 0.967 . . . . 73.15 113.611 -173.165 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.405 ' HB3' HE21 ' A' ' 145' ' ' GLN . 0.5 OUTLIER -131.91 -80.85 0.51 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.613 1.097 . . . . 63.04 111.382 -168.619 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 62.77 -3.58 0.3 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.707 2.003 . . . . 71.45 115.534 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -137.83 162.19 25.53 Favored Glycine 0 CA--C 1.526 0.727 0 O-C-N 120.395 -1.441 . . . . 33.43 110.858 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.471 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 5.1 m -142.39 166.93 18.15 Favored Pre-proline 0 C--O 1.239 0.504 0 N-CA-C 107.976 -1.12 . . . . 71.4 107.976 -177.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.471 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 98.1 Cg_endo -73.59 155.7 99.73 Favored 'Cis proline' 0 CA--C 1.536 0.625 0 CA-C-N 119.79 0.961 . . . . 74.44 113.532 -9.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -152.17 142.47 22.45 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 126.062 1.745 . . . . 73.04 110.079 -177.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 32.4 ttm -140.67 133.81 29.47 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 126.505 1.922 . . . . 62.04 106.43 172.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -117.42 159.58 22.56 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.836 0.854 . . . . 74.14 111.216 -177.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.5 t -141.23 145.74 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.407 1.083 . . . . 53.45 108.549 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 48.28 11.91 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.317 2.647 . . . . 71.03 116.124 177.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 62.56 41.93 99.75 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 119.705 1.138 . . . . 64.25 110.59 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -165.71 -21.93 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 124.778 1.231 . . . . 73.05 112.488 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -112.89 146.44 38.94 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 118.756 0.707 . . . . 72.45 109.362 177.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -117.78 139.36 51.19 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 104.933 -2.247 . . . . 60.13 104.933 167.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.418 ' CD1' HG23 ' A' ' 180' ' ' THR . 4.1 mm? -66.38 142.91 57.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.777 -1.564 . . . . 72.34 106.777 173.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -115.75 85.58 14.48 Favored Pre-proline 0 CA--C 1.516 -0.344 0 CA-C-N 117.84 0.291 . . . . 73.05 110.97 177.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -64.87 -27.13 59.11 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 CA-C-N 118.652 0.554 . . . . 62.32 111.139 174.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.93 -0.56 16.5 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.397 1.479 . . . . 74.45 112.825 -173.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -133.22 12.49 4.98 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.66 1.6 . . . . 64.02 111.699 175.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 17.5 mtt -87.73 172.32 9.77 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 120.129 1.965 . . . . 74.32 109.264 165.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.16 106.68 7.91 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.055 -1.461 . . . . 71.35 107.055 169.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.546 HG22 ' CD1' ' A' ' 173' ' ' PHE . 54.5 p -112.59 18.39 18.4 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.107 2.163 . . . . 70.11 110.368 -178.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 40.0 m -99.52 5.56 46.06 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.451 1.101 . . . . 74.41 112.77 -172.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -137.43 -15.22 1.45 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.554 1.142 . . . . 70.35 111.825 -177.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 2.2 mmt 69.17 -62.99 0.39 Allowed 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 126.246 1.819 . . . . 65.42 110.454 -175.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.99 -38.55 86.4 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.17 -0.956 . . . . 74.13 111.657 -172.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 65.5 t -75.29 -27.49 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 123.809 0.844 . . . . 54.13 111.161 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.546 ' CD1' HG22 ' A' ' 167' ' ' THR . 42.0 t80 -59.32 -52.03 67.4 Favored 'General case' 0 C--O 1.226 -0.158 0 N-CA-C 108.655 -0.868 . . . . 73.45 108.655 -177.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.7 t -77.28 -25.04 15.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 117.518 0.145 . . . . 74.21 111.11 -175.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.53 -31.25 67.76 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.3 0.482 . . . . 70.11 112.3 168.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -86.32 -44.94 11.69 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.25 1.02 . . . . 73.11 110.985 172.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -58.44 -56.74 18.21 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.519 0.728 . . . . 73.41 110.569 -167.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.15 -21.23 59.04 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 113.683 0.994 . . . . 71.04 113.683 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -77.96 -52.58 8.59 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 123.346 0.658 . . . . 70.43 110.321 177.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.418 HG23 ' CD1' ' A' ' 160' ' ' LEU . 9.0 t -62.16 -30.71 71.24 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 117.832 -1.08 . . . . 72.05 110.653 178.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 85.5 t -60.63 -54.57 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 119.987 1.267 . . . . 74.31 108.483 177.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -59.51 -48.17 82.67 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-O 118.777 -0.63 . . . . 72.32 110.255 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -60.13 -29.46 68.64 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 112.481 0.549 . . . . 74.45 112.481 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 60.2 mt -74.79 -23.13 58.45 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 120.826 -1.171 . . . . 72.41 112.309 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 92.9 t -66.05 -29.5 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 118.34 0.518 . . . . 70.12 109.671 174.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -95.46 -9.36 32.83 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.816 0.846 . . . . 65.45 110.428 -175.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 21.0 mttp -108.61 61.91 0.6 Allowed 'General case' 0 C--O 1.225 -0.186 0 O-C-N 120.661 -1.274 . . . . 72.44 109.664 -177.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.6 mmtm . . . . . 0 C--O 1.254 1.317 0 C-N-CA 127.179 2.191 . . . . 71.05 112.223 171.253 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 44.0 t . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 109.548 -0.538 . . . . 71.24 109.548 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -143.85 -175.52 4.62 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.662 1.585 . . . . 72.33 107.146 -178.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 61.72 32.57 18.28 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 125.918 1.687 . . . . 74.42 112.691 -177.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -156.35 105.95 2.32 Favored 'General case' 0 N--CA 1.425 -1.711 0 C-N-CA 125.563 1.545 . . . . 65.05 107.791 -175.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.512 HG21 HG23 ' A' ' 180' ' ' THR . 9.9 pt -106.16 167.0 3.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 127.185 2.194 . . . . 71.45 109.119 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.7 m -143.89 145.8 32.55 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 106.598 -1.63 . . . . 71.22 106.598 175.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -58.56 150.06 23.94 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 127.566 2.347 . . . . 44.12 109.758 167.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.56 -29.37 0.36 Allowed Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.546 1.07 . . . . 64.32 113.826 -168.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -94.85 -84.44 0.33 Allowed 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 118.951 1.375 . . . . 73.21 108.551 -165.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -92.7 -14.92 27.35 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.459 0.703 . . . . 73.13 110.852 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -143.48 165.31 27.9 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.544 0.611 . . . . 74.01 110.705 167.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.3 mm -122.17 162.61 21.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 126.827 2.051 . . . . 74.04 106.605 175.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.0 m -126.66 136.45 52.5 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 106.004 -1.85 . . . . 63.22 106.004 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 51.0 mt -81.07 156.4 25.84 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 118.541 0.61 . . . . 53.25 109.606 -178.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -71.7 -34.94 70.05 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.303 1.441 . . . . 53.41 110.509 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.4 mmtm -137.01 78.82 39.94 Favored Pre-proline 0 N--CA 1.453 -0.279 0 C-N-CA 125.112 1.365 . . . . 74.33 108.403 -175.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -77.45 73.96 5.34 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 123.391 2.728 . . . . 55.43 108.763 174.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.1 tt -157.21 95.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 107.969 -1.123 . . . . 63.21 107.969 165.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.77 -176.68 4.86 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.732 2.013 . . . . 51.23 106.918 169.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.34 -108.62 0.79 Allowed Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 108.953 -1.659 . . . . 74.01 108.953 172.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 60.57 165.85 0.09 OUTLIER Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.812 1.245 . . . . 73.14 112.993 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.41 164.7 24.95 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 120.914 1.076 . . . . 74.22 109.922 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.78 -32.06 59.63 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.696 1.198 . . . . 74.13 113.268 -170.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.501 HG22 ' H ' ' A' ' 55' ' ' LYS . 14.8 m -150.51 -176.41 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 128.769 2.828 . . . . 65.03 105.442 166.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.457 ' HG ' ' H ' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -169.61 171.06 7.75 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.573 1.549 . . . . 54.14 108.46 169.414 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.457 ' H ' ' HG ' ' A' ' 23' ' ' LEU . 19.4 tt0 -130.45 145.14 51.78 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 128.509 2.723 . . . . 65.42 108.875 176.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -132.52 125.44 30.6 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.833 1.253 . . . . 74.01 108.291 174.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -135.82 178.63 6.9 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.947 1.699 . . . . 74.44 109.527 174.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.499 ' HA ' ' CE1' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -146.59 -174.89 4.59 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.155 0.982 . . . . 64.31 110.5 164.435 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.551 ' CZ ' ' HG3' ' A' ' 91' ' ' MET . 50.9 m-85 -93.93 -41.39 9.62 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 121.654 -0.654 . . . . 74.12 112.73 176.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -80.72 -7.53 59.38 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.808 0.67 . . . . 74.11 112.808 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.0 p -74.7 149.2 85.78 Favored Pre-proline 0 CA--C 1.532 0.269 0 O-C-N 120.744 -1.223 . . . . 73.14 111.979 173.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.25 167.87 25.69 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.618 2.212 . . . . 73.31 109.184 164.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.2 m80 68.98 -51.32 0.59 Allowed 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 127.114 2.165 . . . . 70.02 110.738 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 61.0 m -44.42 -40.45 5.48 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 126.555 1.942 . . . . 45.21 112.046 177.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.95 -70.91 0.08 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.291 1.037 . . . . 74.23 108.229 175.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.64 ' HA ' HE21 ' A' ' 35' ' ' GLN . 0.0 OUTLIER -65.98 -37.47 86.05 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 121.084 -1.01 . . . . 73.35 110.141 -169.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -61.58 -20.64 63.53 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 116.878 -1.534 . . . . 72.13 112.483 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -120.68 -11.25 9.06 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 119.395 0.998 . . . . 72.11 110.928 -170.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.5 ' HA ' ' CE1' ' A' ' 41' ' ' HIS . 0.0 OUTLIER -134.56 -16.54 2.05 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 114.666 1.358 . . . . 62.13 114.666 -173.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 77.7 t -117.64 -68.23 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.272 0.558 . . . . 74.04 110.368 174.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.4 mt -69.08 -21.76 64.05 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.247 1.419 . . . . 51.34 111.314 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.5 ' CE1' ' HA ' ' A' ' 38' ' ' GLU . 39.7 m-70 44.08 56.24 4.89 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 126.0 1.72 . . . . 74.22 111.074 171.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.614 ' O ' HG23 ' A' ' 46' ' ' VAL . 68.2 t -59.18 -49.13 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 117.184 -1.389 . . . . 72.12 107.754 -172.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.3 t -45.61 -53.47 9.1 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-N 119.685 1.13 . . . . 74.14 112.111 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.423 ' CG ' HH12 ' A' ' 47' ' ' ARG . 1.5 t70 -88.5 5.66 41.5 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.921 0.712 . . . . 72.42 112.921 -174.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -92.01 -49.06 6.42 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.733 0.813 . . . . 72.14 109.992 157.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 42' ' ' VAL . 2.4 t -63.49 -40.12 87.88 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-N 119.632 1.106 . . . . 74.11 110.392 -170.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.423 HH12 ' CG ' ' A' ' 44' ' ' ASP . 0.7 OUTLIER -51.58 -38.43 54.41 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 118.049 -0.977 . . . . 62.45 111.709 -179.045 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -64.76 -2.96 2.82 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 115.207 1.558 . . . . 73.25 115.207 176.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -129.05 -5.62 4.97 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.107 1.763 . . . . 73.31 111.603 -178.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.541 ' HG ' HG12 ' A' ' 46' ' ' VAL . 5.6 mt -87.67 152.7 52.05 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 127.334 2.254 . . . . 71.45 111.119 -165.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.425 ' O ' HG22 ' A' ' 54' ' ' THR . 26.1 Cg_endo -81.21 175.6 9.59 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.209 2.606 . . . . 61.34 112.015 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -84.63 23.03 1.2 Allowed 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.478 -1.389 . . . . 61.22 114.524 -169.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -143.19 -15.08 0.29 Allowed Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.308 1.432 . . . . 63.24 113.724 -172.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.53 HG21 ' HB3' ' A' ' 50' ' ' LEU . 14.6 t -60.04 128.12 35.25 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 107.388 -1.338 . . . . 71.13 107.388 175.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.501 ' H ' HG22 ' A' ' 22' ' ' VAL . 48.0 tptt -118.61 72.78 0.89 Allowed 'General case' 0 C--N 1.341 0.196 0 CA-C-O 123.279 1.514 . . . . 71.11 109.535 173.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 18.4 ptp -52.96 -31.85 42.71 Favored 'General case' 0 CA--C 1.496 -1.1 0 C-N-CA 125.331 1.452 . . . . 70.12 114.339 -173.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.598 HG22 ' H ' ' A' ' 58' ' ' LYS . 7.5 m 46.82 -167.33 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 126.101 1.761 . . . . 74.21 113.063 -176.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.598 ' H ' HG22 ' A' ' 57' ' ' THR . 0.4 OUTLIER -159.09 104.72 1.71 Allowed 'General case' 0 CA--C 1.54 0.563 0 O-C-N 119.977 -1.702 . . . . 71.23 107.65 167.411 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.7 m-30 -102.63 174.81 5.73 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 120.635 1.561 . . . . 74.1 111.013 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.499 ' CE1' ' HA ' ' A' ' 27' ' ' SER . 6.2 t60 -135.02 118.5 16.86 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 118.722 0.692 . . . . 73.31 111.417 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.423 HG12 ' CB ' ' A' ' 141' ' ' ALA . 12.8 m -81.93 172.07 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 123.252 0.621 . . . . 75.43 110.042 178.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.27 3.39 6.36 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.625 1.57 . . . . 74.03 113.096 -169.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -81.32 1.23 33.55 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.414 1.265 . . . . 75.01 114.414 -172.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 mt -125.59 132.09 52.59 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.655 1.116 . . . . 52.42 110.44 -164.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.76 177.37 35.33 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 123.666 0.65 . . . . 73.01 111.66 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.77 -55.13 0.92 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.186 2.591 . . . . 62.33 110.453 173.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.439 HD11 ' C ' ' A' ' 102' ' ' GLN . 38.1 mt -91.84 22.37 4.25 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.375 -0.828 . . . . 70.41 112.875 -166.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -48.65 -48.43 29.03 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-N 119.101 0.864 . . . . 42.11 112.206 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -56.52 -42.53 78.58 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.482 1.513 . . . . 75.14 113.307 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -78.71 -33.37 46.86 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.332 0.653 . . . . 72.14 110.259 -176.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.426 HD22 ' CD2' ' A' ' 28' ' ' PHE . 25.6 mt -62.4 -41.03 98.35 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.886 -0.783 . . . . 64.1 108.886 171.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.9 m -55.65 -50.11 71.07 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.594 1.088 . . . . 53.44 110.171 168.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -61.71 -35.16 77.24 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 120.621 1.555 . . . . 65.1 113.012 -178.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.27 -35.06 79.87 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.668 0.667 . . . . 54.42 111.914 174.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.508 ' CD1' HD11 ' A' ' 79' ' ' ILE . 11.3 t-105 -57.46 -42.71 83.09 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 118.619 0.645 . . . . 74.43 111.026 -176.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.96 -36.38 74.72 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 117.517 -1.23 . . . . 65.21 112.872 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 96.0 t -59.7 -47.12 92.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 120.065 1.302 . . . . 70.11 108.626 172.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.55 -47.21 86.58 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 121.806 -0.559 . . . . 72.14 111.142 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.508 HD11 ' CD1' ' A' ' 75' ' ' TRP . 92.7 mt -62.39 -42.54 95.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.137 0.975 . . . . 71.5 110.509 177.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.62 -47.25 86.34 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.576 0.625 . . . . 73.12 109.441 -174.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 87.3 mt -80.2 -20.34 44.95 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 119.195 -0.431 . . . . 71.5 112.065 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.69 66.68 2.4 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 125.9 1.715 . . . . 72.32 110.261 -167.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.1 m -134.85 18.29 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.742 1.617 . . . . 71.52 111.048 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -51.07 -53.57 32.77 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 124.466 1.107 . . . . 53.2 110.09 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -77.0 -5.79 50.08 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.066 0.946 . . . . 61.41 111.29 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -90.21 -8.49 50.97 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.224 1.01 . . . . 73.31 111.216 166.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.7 pp -133.19 38.12 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 124.901 1.28 . . . . 64.52 111.715 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.0 m -92.39 -52.33 4.72 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.748 -0.595 . . . . 72.33 110.753 171.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.49 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -59.83 -64.05 3.49 Favored Pre-proline 0 CA--C 1.532 0.276 0 C-N-CA 123.318 0.647 . . . . 74.54 112.295 -163.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.49 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 73.3 Cg_endo -70.33 -20.77 31.74 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 CA-C-N 119.575 0.884 . . . . 63.55 112.602 -173.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.551 ' HG3' ' CZ ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -54.47 -58.8 6.04 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 127.481 2.312 . . . . 65.11 108.116 170.705 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -59.09 -41.69 88.67 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 124.105 0.962 . . . . 70.13 111.817 177.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -56.62 -36.68 69.73 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 116.076 -0.511 . . . . 74.14 110.676 172.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.39 -17.03 43.65 Favored 'General case' 0 C--N 1.331 -0.231 0 O-C-N 121.4 -0.812 . . . . 65.31 112.541 -169.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.0 t -114.3 -23.17 4.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 C-N-CA 124.613 1.165 . . . . 74.04 111.064 -172.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -120.48 -52.36 2.15 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.678 0.791 . . . . 74.25 112.289 -178.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -69.27 -52.85 23.49 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 121.583 -0.698 . . . . 74.33 111.244 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 37.2 p -98.62 -31.69 11.81 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.14 0.976 . . . . 72.52 110.489 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 52.59 34.78 16.45 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.882 2.073 . . . . 61.04 111.534 -173.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 t -75.91 -12.76 60.21 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.648 1.179 . . . . 70.33 112.67 -177.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.428 HG13 HG12 ' A' ' 107' ' ' ILE . 25.9 t -67.31 118.17 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 O-C-N 120.913 -1.117 . . . . 54.43 108.963 172.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.439 ' C ' HD11 ' A' ' 67' ' ' LEU . 10.3 mt-30 -141.93 -25.13 0.68 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.463 1.105 . . . . 72.11 111.799 -178.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.13 160.78 38.49 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.584 1.553 . . . . 70.44 107.166 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 63.9 t -58.59 -32.34 45.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.566 1.146 . . . . 74.41 110.221 177.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.32 -29.06 57.54 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.287 1.435 . . . . 70.24 112.743 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -88.33 -25.41 22.77 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.598 0.635 . . . . 71.3 109.293 -176.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.428 HG12 HG13 ' A' ' 101' ' ' VAL . 3.2 mt -78.39 -47.74 23.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 124.963 1.305 . . . . 71.54 109.582 -178.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -56.11 -28.08 56.37 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-O 118.342 -0.837 . . . . 74.52 111.406 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -58.88 -53.61 56.46 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 123.86 0.864 . . . . 64.51 110.113 -176.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 17.4 t -56.07 -41.44 68.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.164 0.586 . . . . 61.51 110.716 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -60.47 -49.32 78.04 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.127 0.971 . . . . 74.44 110.009 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 83.5 t -63.41 -35.87 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 O-C-N 121.581 -0.699 . . . . 61.2 110.194 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.67 -44.05 97.25 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.466 0.706 . . . . 44.44 109.3 -178.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.52 -21.42 62.73 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.612 1.165 . . . . 45.14 112.497 175.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 131.62 2.29 4.46 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 115.908 1.123 . . . . 64.41 115.908 167.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 65.1 t -66.26 143.73 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 123.363 1.554 . . . . 64.3 108.354 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.65 145.53 50.57 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.626 -1.17 . . . . 72.53 110.446 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -78.47 -0.2 78.0 Favored Glycine 0 N--CA 1.467 0.708 0 C-N-CA 124.035 0.826 . . . . 74.44 114.241 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -94.88 -36.97 11.42 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 123.198 0.599 . . . . 73.33 111.449 172.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -86.79 -41.1 14.36 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 107.348 -1.353 . . . . 73.23 107.348 -160.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -60.61 -53.2 60.37 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 108.957 -0.757 . . . . 70.31 108.957 172.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -73.14 -20.47 60.91 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 118.77 -0.634 . . . . 72.31 111.48 -170.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.56 -65.24 1.01 Allowed 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.138 -1.06 . . . . 42.13 108.138 171.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.53 -35.19 65.39 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.106 0.962 . . . . 44.4 111.626 -171.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -44.86 -36.97 3.55 Favored 'General case' 0 N--CA 1.457 -0.076 0 C-N-CA 125.08 1.352 . . . . 74.3 111.83 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -114.35 8.42 16.65 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.744 1.618 . . . . 62.21 113.484 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 30.6 t -79.09 148.8 32.28 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.06 1.744 . . . . 52.12 110.53 169.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -54.92 -33.36 62.06 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.232 1.813 . . . . 64.53 112.532 -177.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 22.3 t -54.63 -48.22 71.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 124.14 0.976 . . . . 73.2 109.742 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 32.7 t -69.98 -44.41 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-O 117.956 -1.021 . . . . 61.3 108.667 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -49.21 -49.92 40.66 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.267 1.394 . . . . 74.13 111.373 175.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 21.1 t -61.59 -49.05 78.18 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 123.481 0.713 . . . . 71.43 109.897 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 13.6 mt -65.04 -38.71 91.73 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 118.606 0.639 . . . . 62.41 111.988 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 49.1 t -58.31 -60.8 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 125.797 1.639 . . . . 74.21 107.695 173.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.65 -42.06 70.84 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 119.007 -0.521 . . . . 33.44 110.856 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -57.28 -53.11 61.87 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 123.435 0.694 . . . . 74.2 111.654 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -67.03 -48.67 67.64 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 119.158 0.89 . . . . 70.4 110.774 -175.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -63.29 -27.76 69.56 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.362 0.665 . . . . 74.43 112.043 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -82.24 -54.75 5.0 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.512 0.725 . . . . 74.24 109.647 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.08 0.74 1.77 Allowed 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 125.574 1.549 . . . . 54.34 113.399 -175.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.423 ' CB ' HG12 ' A' ' 61' ' ' VAL . . . -123.58 -0.16 8.69 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 114.216 1.191 . . . . 75.24 114.216 169.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.38 -13.01 7.24 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.99 0.814 . . . . 52.54 113.167 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -51.75 -66.7 0.34 Allowed 'General case' 0 C--O 1.231 0.086 0 C-N-CA 125.893 1.677 . . . . 61.24 110.773 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.9 pp 174.19 -4.66 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 129.117 2.967 . . . . 74.14 112.154 169.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.63 -27.23 45.38 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.519 1.128 . . . . 75.44 111.735 -158.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -159.57 140.91 12.82 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 128.641 2.776 . . . . 74.0 106.759 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -145.4 12.27 1.34 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.202 1.401 . . . . 55.21 110.502 -172.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -151.53 147.89 18.3 Favored Glycine 0 C--N 1.342 0.862 0 O-C-N 120.255 -1.528 . . . . 15.11 110.901 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.409 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 35.5 m -133.83 165.46 36.54 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 118.45 1.125 . . . . 74.02 111.102 -168.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.409 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 45.6 Cg_endo -71.0 157.91 95.16 Favored 'Cis proline' 0 C--N 1.35 0.631 0 CA-C-N 119.233 0.762 . . . . 73.04 112.263 -11.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -138.59 146.63 42.04 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.639 -0.709 . . . . 73.43 111.472 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 7.8 ttm -145.14 119.22 9.42 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.667 -1.605 . . . . 70.11 106.667 174.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -88.21 164.74 15.49 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.367 0.667 . . . . 74.22 109.825 177.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.702 HG12 ' HB2' ' A' ' 158' ' ' TYR . 0.5 OUTLIER -149.55 150.31 13.93 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.386 0 O-C-N 121.067 -1.021 . . . . 73.23 108.719 175.291 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 48.3 15.21 0.07 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.328 1.603 . . . . 73.22 115.328 -175.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 50.79 38.33 36.88 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 120.039 1.291 . . . . 73.33 112.425 -167.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.422 ' HE3' ' CZ ' ' A' ' 158' ' ' TYR . 42.7 pttt -162.27 -14.21 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.946 1.299 . . . . 72.13 114.038 173.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.702 ' HB2' HG12 ' A' ' 154' ' ' VAL 0.276 14.3 m-85 -106.42 158.86 16.59 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 127.041 2.136 . . . . 65.44 110.834 178.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -139.24 130.62 26.96 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 105.063 -2.199 . . . . 65.13 105.063 174.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.92 142.49 56.02 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.518 -1.29 . . . . 70.41 107.518 177.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -114.26 85.28 10.31 Favored Pre-proline 0 C--O 1.236 0.376 0 N-CA-C 110.339 -0.245 . . . . 74.44 110.339 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -68.11 -16.02 43.99 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 N-CA-C 110.342 -0.676 . . . . 71.03 110.342 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -77.65 2.49 16.53 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.283 1.833 . . . . 62.33 112.477 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -135.3 35.5 2.17 Favored Glycine 0 C--N 1.335 0.515 0 CA-C-N 119.422 1.01 . . . . 70.21 111.12 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 62.5 mtt -120.84 167.38 12.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.446 1.098 . . . . 74.15 110.403 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -62.21 112.42 2.38 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.237 1.015 . . . . 71.33 108.937 169.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 82.3 p -119.57 22.08 11.81 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.434 1.094 . . . . 32.1 110.186 175.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.23 -48.22 36.8 Favored 'General case' 0 CA--C 1.522 -0.108 0 CA-C-N 118.664 0.665 . . . . 71.32 109.934 172.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.483 HD22 ' HB ' ' A' ' 172' ' ' VAL . 0.4 OUTLIER -107.82 -10.85 15.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 118.07 -0.966 . . . . 74.43 111.608 -156.172 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 16.6 mmm 73.47 -44.85 0.59 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 127.748 2.419 . . . . 64.15 111.935 169.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -55.54 23.17 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 127.179 2.191 . . . . 74.44 107.941 173.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.483 ' HB ' HD22 ' A' ' 169' ' ' ASN . 61.5 t -67.81 -26.47 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 127.057 2.143 . . . . 65.44 110.538 -174.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.68 -59.12 5.95 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.189 -1.041 . . . . 74.25 108.189 173.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 10.8 t -66.58 -32.03 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.101 0.56 . . . . 64.14 110.521 -177.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.66 -41.86 82.36 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.645 0.778 . . . . 73.23 111.607 176.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -85.35 -32.35 22.49 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.587 1.155 . . . . 73.05 112.69 177.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -56.8 -63.29 1.25 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.376 -0.972 . . . . 74.44 108.376 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.86 -26.95 69.02 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.562 0.578 . . . . 45.21 112.562 -170.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -71.24 -52.23 20.17 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.222 1.409 . . . . 71.42 109.878 177.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.512 HG23 HG21 ' A' ' 3' ' ' ILE . 92.4 m -53.78 -40.11 66.0 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.248 1.019 . . . . 72.41 110.155 176.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 46.1 t -57.75 -53.27 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 108.934 -0.765 . . . . 71.23 108.934 178.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 62.3 tttt -59.95 -43.47 95.0 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 124.065 0.946 . . . . 71.42 110.543 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -63.33 -32.62 74.09 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 123.14 0.576 . . . . 71.04 111.202 -171.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 19.5 mt -68.79 -25.97 64.97 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 112.756 0.65 . . . . 71.04 112.756 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 61.1 t -65.72 -25.91 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 O-C-N 121.188 -0.945 . . . . 63.45 109.442 173.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -92.02 -9.56 42.37 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.152 1.381 . . . . 62.01 110.967 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -129.56 70.52 1.42 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.78 2.032 . . . . 64.33 108.79 -174.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 21.6 pttp . . . . . 0 C--O 1.257 1.481 0 CA-C-O 117.064 -1.446 . . . . 72.02 109.814 -176.234 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 C--O 1.236 0.372 0 N-CA-C 109.105 -0.702 . . . . 72.42 109.105 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -168.12 -178.21 3.6 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.177 2.191 . . . . 63.11 108.633 172.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 50.9 25.88 2.4 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 127.45 2.3 . . . . 51.32 115.786 173.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -152.52 115.06 4.51 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 104.755 -2.313 . . . . 65.1 104.755 177.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.511 HG21 HG23 ' A' ' 180' ' ' THR . 6.9 pt -127.37 142.13 44.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 126.111 1.764 . . . . 74.13 107.861 175.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.8 m -129.53 145.54 51.45 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.977 -1.12 . . . . 71.41 107.977 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -47.33 146.32 2.02 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 127.38 2.272 . . . . 73.02 111.395 165.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.22 -19.15 0.25 Allowed Glycine 0 CA--C 1.53 1.011 0 C-N-CA 125.365 1.46 . . . . 74.23 114.428 -172.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -100.43 -86.26 0.4 Allowed 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 106.736 -1.579 . . . . 70.12 106.736 -165.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -92.15 -14.21 29.47 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.379 1.071 . . . . 51.31 110.522 -175.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -144.81 159.7 42.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.728 0.811 . . . . 71.03 111.04 172.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.3 mm -125.07 164.44 23.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 124.615 1.166 . . . . 72.21 108.323 178.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 m -109.97 152.56 25.71 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.624 1.97 . . . . 71.34 108.236 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 35.5 mt -84.33 160.84 20.61 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 108.008 -1.108 . . . . 70.4 108.008 164.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.95 -35.39 64.53 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 122.404 1.097 . . . . 73.51 110.088 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 mmmp? -123.49 78.29 54.68 Favored Pre-proline 0 N--CA 1.455 -0.211 0 C-N-CA 125.458 1.503 . . . . 74.22 108.032 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -72.37 117.18 5.01 Favored 'Trans proline' 0 N--CA 1.444 -1.395 0 N-CA-C 106.348 -2.212 . . . . 61.24 106.348 164.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.0 tt -145.85 158.14 12.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 106.734 -1.58 . . . . 65.02 106.734 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.42 103.98 1.14 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.318 0.508 . . . . 65.01 110.451 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.02 -170.06 18.88 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 108.347 -1.901 . . . . 72.11 108.347 173.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 61.08 164.58 0.1 Allowed Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 127.637 2.375 . . . . 64.1 113.824 176.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -68.66 -165.76 0.14 Allowed 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.472 2.781 . . . . 74.51 110.06 158.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -69.97 -164.63 0.08 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.965 1.306 . . . . 74.34 110.53 176.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 66.7 t -47.52 130.61 4.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 125.055 1.342 . . . . 45.34 110.699 -177.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.417 HD12 HG21 ' A' ' 57' ' ' THR . 2.9 tp -136.57 153.82 50.86 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 126.664 1.986 . . . . 70.43 106.108 177.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 151' ' ' ALA . 2.6 mp0 -143.91 149.43 36.85 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.363 1.865 . . . . 61.34 109.893 -169.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.561 ' HD1' ' HB3' ' A' ' 151' ' ' ALA . 0.5 OUTLIER -145.6 161.99 38.52 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.197 1.362 . . . . 74.43 108.457 174.551 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -163.63 -175.0 3.94 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.949 2.899 . . . . 62.11 107.144 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.1 t -138.94 173.11 11.91 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 123.101 1.429 . . . . 72.13 109.407 163.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -79.81 -34.93 39.14 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 126.902 2.081 . . . . 71.3 110.11 -175.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -90.8 -1.97 57.81 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.104 1.362 . . . . 73.41 112.578 -176.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 p -90.03 144.22 31.04 Favored Pre-proline 0 N--CA 1.471 0.622 0 CA-C-N 120.928 1.694 . . . . 72.53 112.112 -173.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -84.71 -40.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.047 1.831 . . . . 50.41 114.339 -170.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -59.07 -43.32 91.77 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.489 1.041 . . . . 62.33 108.437 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 32.1 m -48.35 -45.88 35.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.393 1.877 . . . . 74.22 111.233 175.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -51.16 -62.06 1.85 Allowed 'General case' 0 C--N 1.346 0.438 0 C-N-CA 123.628 0.771 . . . . 63.52 109.631 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -55.1 -41.63 71.86 Favored 'General case' 0 C--O 1.222 -0.345 0 O-C-N 121.08 -1.013 . . . . 72.23 110.587 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -68.18 -20.15 64.84 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 117.986 -1.007 . . . . 63.1 111.928 -172.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.79 -4.91 7.56 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.275 0.943 . . . . 73.44 112.756 -167.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -133.95 -26.93 1.49 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.629 1.572 . . . . 65.32 111.548 -168.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 83.0 t -119.81 -76.45 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 107.009 -1.478 . . . . 64.34 107.009 -175.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.1 mt -68.27 -17.54 64.31 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.56 1.544 . . . . 41.24 112.95 -176.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 44.08 60.38 2.78 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.437 1.895 . . . . 71.22 112.185 172.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 46' ' ' VAL . 33.2 t -66.76 -52.13 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 116.519 -1.705 . . . . 72.1 108.909 -173.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.0 t -53.99 -45.76 71.52 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 121.044 1.747 . . . . 25.14 110.501 -175.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -61.85 -40.56 95.75 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.761 0.825 . . . . 63.0 111.468 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -68.2 -36.88 80.25 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 124.488 1.115 . . . . 62.22 112.102 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 42' ' ' VAL . 3.1 t -66.54 -46.84 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.455 -1.313 . . . . 71.32 107.455 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 66.8 ttt-85 -48.0 -47.05 33.38 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-O 118.231 -0.89 . . . . 62.34 111.204 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -56.14 -10.74 0.91 Allowed 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 115.726 1.75 . . . . 71.0 115.726 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -130.31 7.25 4.96 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.653 1.981 . . . . 73.23 112.848 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.0 mt -79.82 161.65 65.48 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 120.194 1.361 . . . . 62.32 111.352 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -72.61 -161.92 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.75 1 C-N-CA 127.355 5.37 . . . . 54.1 110.739 172.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.431 ' CD ' ' H ' ' A' ' 52' ' ' GLU . 0.2 OUTLIER -102.32 24.05 10.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 114.489 1.292 . . . . 74.22 114.489 176.513 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -143.08 -40.78 0.06 OUTLIER Glycine 0 CA--C 1.52 0.406 0 O-C-N 121.607 -0.683 . . . . 74.44 113.567 -172.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.0 m -71.55 95.19 1.38 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.597 1.559 . . . . 70.23 108.056 175.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.03 162.5 24.82 Favored 'General case' 0 CA--C 1.519 -0.25 0 O-C-N 120.478 -1.389 . . . . 72.43 109.014 169.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.89 109.04 21.83 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 106.805 -1.554 . . . . 63.01 106.805 175.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.56 HG22 ' H ' ' A' ' 58' ' ' LYS . 1.0 OUTLIER -87.36 -176.91 5.8 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 124.076 0.86 . . . . 65.24 109.237 171.06 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.56 ' H ' HG22 ' A' ' 57' ' ' THR . 0.1 OUTLIER -174.23 109.31 0.14 Allowed 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 128.288 2.635 . . . . 74.21 105.612 174.275 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -74.76 -166.53 0.47 Allowed 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.006 -1.059 . . . . 72.33 109.532 163.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.568 ' CD2' ' HB3' ' A' ' 75' ' ' TRP 0.262 2.7 p-80 -136.77 156.88 47.93 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 129.709 3.204 . . . . 74.12 108.347 170.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.461 HG23 ' HB2' ' A' ' 63' ' ' PHE . 28.5 m -146.7 170.35 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-N 119.614 1.097 . . . . 73.34 108.398 169.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.99 -80.88 0.08 Allowed 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 107.026 -1.472 . . . . 74.34 107.026 171.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.461 ' HB2' HG23 ' A' ' 61' ' ' VAL . 0.5 OUTLIER 68.13 -44.15 0.49 Allowed 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 130.136 3.375 . . . . 73.11 115.011 175.002 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.36 171.01 16.13 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 119.842 1.201 . . . . 61.34 110.65 -175.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.16 175.55 33.18 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 115.717 -0.674 . . . . 71.1 112.54 175.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -73.67 -55.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.673 2.915 . . . . 62.35 111.219 175.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.4 mt -89.38 30.18 1.02 Allowed 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.295 0.638 . . . . 52.32 111.844 -164.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -45.6 -56.3 6.53 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.929 1.252 . . . . 42.11 110.581 176.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -56.13 -46.46 79.18 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.601 1.161 . . . . 70.45 110.736 -174.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.49 -45.8 91.37 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 127.106 2.163 . . . . 65.11 109.329 -174.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 mt -64.98 -43.84 91.28 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.855 0.862 . . . . 74.45 109.431 176.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.495 ' HA ' ' HD2' ' A' ' 60' ' ' HIS . 44.5 m -66.37 -1.31 3.31 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 126.653 1.981 . . . . 73.52 110.582 177.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -111.9 -22.12 11.24 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 118.971 -2.33 . . . . 65.31 111.599 171.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.09 -35.8 48.94 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.698 0.999 . . . . 63.34 113.698 176.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.568 ' HB3' ' CD2' ' A' ' 60' ' ' HIS . 40.8 t-105 -58.23 -35.42 71.67 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.265 0.939 . . . . 73.51 110.949 -175.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.53 -34.33 77.56 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 118.206 -0.902 . . . . 50.44 110.814 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 45.1 t -60.98 -47.02 95.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 119.467 1.03 . . . . 73.24 108.964 167.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.16 -45.97 89.59 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 119.056 -0.497 . . . . 71.55 111.467 -177.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.5 mt -65.84 -42.84 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 124.602 1.161 . . . . 73.12 110.557 176.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.1 -32.44 70.98 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.054 0.843 . . . . 70.31 110.909 -177.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 43.2 mt -95.37 -15.24 23.2 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.261 0.837 . . . . 54.22 113.261 173.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 65.12 63.3 4.25 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.231 1.396 . . . . 71.53 111.667 -173.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.3 m -129.48 16.42 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.586 1.154 . . . . 63.42 111.852 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -52.86 -54.53 33.19 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.133 0.879 . . . . 71.21 111.016 -177.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.56 -9.09 11.59 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.604 0.762 . . . . 74.12 112.648 -179.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -96.34 -13.92 22.92 Favored 'General case' 0 CA--C 1.519 -0.233 0 O-C-N 120.585 -1.322 . . . . 71.5 111.284 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.2 pt -121.21 -1.14 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 116.712 -1.613 . . . . 72.33 113.347 -175.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.2 m -64.38 -54.5 31.83 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 120.632 1.56 . . . . 54.31 109.096 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.43 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -52.54 -56.24 24.62 Favored Pre-proline 0 C--O 1.241 0.623 0 C-N-CA 124.614 1.166 . . . . 74.2 112.633 -169.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.43 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 54.1 Cg_endo -72.08 -26.97 17.6 Favored 'Trans proline' 0 N--CA 1.443 -1.443 0 C-N-CA 120.714 0.943 . . . . 71.21 112.653 -177.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 17.1 tpp -54.42 -51.34 65.22 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.09 0.956 . . . . 71.2 109.288 174.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -68.99 -33.57 73.88 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 121.872 -0.518 . . . . 53.4 111.191 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.45 ' HA ' ' HB2' ' A' ' 97' ' ' LYS . 0.9 OUTLIER -60.39 -38.82 85.15 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 118.964 -1.094 . . . . 70.5 109.594 171.056 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.99 -11.41 58.15 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.275 -0.891 . . . . 54.12 112.05 -167.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.3 t -119.93 -35.44 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.184 1.393 . . . . 73.54 110.36 -171.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -122.39 -38.38 2.68 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.098 0.959 . . . . 65.53 111.974 -164.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 93' ' ' GLU . 3.9 mmmt -76.01 -58.72 3.11 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 118.619 0.645 . . . . 71.4 110.733 174.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . 0.261 5.6 t -114.45 -18.23 11.56 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 113.095 0.776 . . . . 51.3 113.095 -176.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 65.87 19.73 11.32 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.521 0.934 . . . . 71.42 113.521 169.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 t -62.52 -16.48 56.05 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.247 2.219 . . . . 63.13 113.717 -173.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.452 HG13 HG12 ' A' ' 107' ' ' ILE . 26.9 t -64.46 115.05 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 124.434 1.094 . . . . 61.13 109.391 173.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -132.52 -23.12 2.12 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.502 1.121 . . . . 74.11 112.078 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.97 161.44 41.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.734 1.614 . . . . 62.21 107.291 -177.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.3 t -54.36 -36.15 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 118.973 0.806 . . . . 74.54 110.236 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.66 -34.17 57.75 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.378 1.471 . . . . 51.25 112.676 176.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -78.46 -34.75 47.5 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.518 -0.919 . . . . 73.35 108.518 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.452 HG12 HG13 ' A' ' 101' ' ' VAL . 2.9 mt -72.35 -49.27 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 124.085 0.954 . . . . 70.42 108.732 -174.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -17.28 64.53 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.569 0.748 . . . . 71.33 112.62 -178.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -58.4 -54.18 49.93 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.24 1.016 . . . . 62.32 109.908 168.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.41 HG13 ' HB2' ' A' ' 90' ' ' PRO . 35.0 t -55.11 -36.78 40.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.519 1.128 . . . . 71.52 110.82 -175.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -57.36 -57.27 13.37 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.319 0.648 . . . . 73.22 109.536 173.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 89.2 t -60.88 -41.36 88.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 O-C-N 121.454 -0.779 . . . . 74.54 111.005 -175.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -55.44 -51.05 68.2 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.193 0.997 . . . . 70.33 109.237 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.36 -11.32 60.84 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.073 1.349 . . . . 52.31 112.506 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 112.02 48.06 0.68 Allowed Glycine 0 C--N 1.336 0.528 0 CA-C-N 118.84 0.745 . . . . 34.22 112.729 175.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.6 t -116.37 141.66 33.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 117.91 0.855 . . . . 71.23 109.741 177.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 34.7 mttp -70.27 118.43 13.08 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.188 0.995 . . . . 72.31 109.27 169.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -66.85 -9.28 52.28 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 117.347 -1.807 . . . . 70.22 112.479 167.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -74.98 -41.42 59.57 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 120.607 2.204 . . . . 71.13 108.67 168.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.71 -25.65 44.69 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.441 -0.948 . . . . 63.23 108.441 -171.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -70.31 -62.21 1.47 Allowed 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 107.59 -1.263 . . . . 63.41 107.59 175.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -64.41 -24.77 67.75 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.787 -0.625 . . . . 74.23 111.69 -173.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.78 -68.11 0.6 Allowed 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.667 1.187 . . . . 65.15 111.259 168.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.11 -27.71 67.25 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 118.223 -0.894 . . . . 53.32 111.517 -167.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -44.14 -39.4 4.29 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.851 1.66 . . . . 74.12 112.047 176.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -112.53 3.62 16.88 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.83 1.252 . . . . 53.01 113.147 -177.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 13.2 t -74.68 152.84 39.11 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.841 1.256 . . . . 73.35 111.252 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -52.61 -33.2 45.42 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.202 1.801 . . . . 65.31 112.581 170.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 46.8 t -53.16 -48.53 53.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 O-C-N 121.201 -0.937 . . . . 71.24 109.772 177.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.3 t -72.59 -38.16 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-O 118.311 -0.852 . . . . 72.54 109.868 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -52.46 -49.83 63.88 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 119.78 1.173 . . . . 73.33 111.234 174.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.3 t -58.06 -51.07 71.22 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.122 -0.696 . . . . 25.22 109.122 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 14.8 mt -66.26 -37.93 86.64 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.271 0.629 . . . . 73.14 112.658 -174.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 55.1 t -56.31 -59.21 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 125.16 1.384 . . . . 74.53 108.66 168.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.05 -40.35 60.98 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 123.799 0.839 . . . . 54.02 112.27 -174.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -51.9 -60.92 2.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 117.668 -1.158 . . . . 70.13 110.291 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.438 ' H ' ' HG3' ' A' ' 137' ' ' GLN . 0.9 OUTLIER -78.34 -32.95 49.38 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 120.576 1.534 . . . . 73.52 113.659 -179.621 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -67.92 -24.21 65.17 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.502 1.046 . . . . 65.5 109.766 -169.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 24.1 ttpt -82.2 -57.38 3.41 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 125.262 1.425 . . . . 73.43 109.305 160.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -62.86 -17.69 61.82 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.931 1.456 . . . . 51.41 114.931 -164.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -117.4 2.35 12.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 119.965 1.257 . . . . 64.4 113.257 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.98 6.42 3.38 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.628 0.771 . . . . 73.53 111.727 -178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -68.1 -85.88 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.874 0.87 . . . . 74.24 109.678 172.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 175.58 48.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 127.658 2.383 . . . . 65.31 109.244 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.47 -50.47 0.51 Allowed 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.782 -1.199 . . . . 74.53 109.493 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.13 109.05 14.98 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 127.029 2.132 . . . . 54.3 106.827 -171.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -149.84 28.62 0.76 Allowed 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 126.636 1.974 . . . . 65.5 111.144 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -138.38 91.2 0.2 Allowed Glycine 0 C--N 1.341 0.811 0 O-C-N 120.876 -1.14 . . . . 65.12 112.44 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.424 HG13 ' CZ ' ' A' ' 25' ' ' PHE . 34.1 m -73.38 163.55 67.63 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 113.331 0.863 . . . . 74.12 113.331 174.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -77.94 118.07 5.52 Favored 'Cis proline' 0 N--CA 1.446 -1.286 0 N-CA-C 108.666 -1.321 . . . . 71.2 108.666 -21.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.561 ' HB3' ' HD1' ' A' ' 25' ' ' PHE . . . -88.49 129.18 35.51 Favored 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 106.203 -1.777 . . . . 74.11 106.203 -174.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 80.0 mmm -138.19 89.26 2.38 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 104.245 -2.502 . . . . 62.14 104.245 -172.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -73.74 170.23 15.7 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 120.853 -1.155 . . . . 74.04 109.974 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.515 HG11 ' HB2' ' A' ' 184' ' ' LEU . 56.8 t -131.07 -41.41 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 113.252 0.834 . . . . 72.41 113.252 178.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.36 24.22 1.13 Allowed 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.76 -0.588 . . . . 71.44 109.728 -171.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 77.44 -28.37 1.76 Allowed Glycine 0 CA--C 1.532 1.136 0 C-N-CA 126.237 1.875 . . . . 64.14 113.055 -174.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.55 -7.48 19.7 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.966 1.469 . . . . 65.44 114.966 -174.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -126.95 142.15 51.62 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.947 0.899 . . . . 70.12 109.531 -174.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -117.9 137.54 52.74 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 106.392 -1.707 . . . . 74.42 106.392 169.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.02 144.04 55.29 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.21 -0.663 . . . . 71.1 109.21 171.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -111.55 86.95 7.36 Favored Pre-proline 0 C--O 1.232 0.149 0 N-CA-C 113.519 0.933 . . . . 45.34 113.519 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -63.13 0.04 1.91 Allowed 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 121.041 1.161 . . . . 70.32 114.253 172.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -111.74 18.65 18.76 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.117 1.367 . . . . 74.42 112.287 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -146.06 52.24 0.57 Allowed Glycine 0 C--N 1.334 0.42 0 N-CA-C 108.681 -1.768 . . . . 54.41 108.681 171.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 35.6 mtt -144.58 176.02 9.71 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.931 1.292 . . . . 65.33 109.399 -176.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -85.24 44.52 1.1 Allowed 'General case' 0 C--O 1.219 -0.505 0 C-N-CA 123.527 0.731 . . . . 71.21 112.269 -164.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.437 ' HB ' ' CD2' ' A' ' 173' ' ' PHE 0.257 10.7 t -67.79 30.91 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 129.102 2.961 . . . . 65.2 113.169 -177.163 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.19 -20.43 30.2 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 127.536 2.334 . . . . 72.02 112.4 169.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.18 -8.68 2.63 Favored 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 113.386 0.884 . . . . 72.02 113.386 -166.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 6.0 mmt 69.19 -61.88 0.42 Allowed 'General case' 0 C--O 1.231 0.129 0 C-N-CA 127.654 2.382 . . . . 33.54 113.003 -178.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -63.66 -46.11 87.12 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 122.375 1.083 . . . . 65.31 109.682 -172.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.02 -26.48 40.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.386 1.474 . . . . 64.13 110.853 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.437 ' CD2' ' HB ' ' A' ' 167' ' ' THR . 15.9 t80 -68.51 -57.72 5.38 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.267 -1.383 . . . . 74.43 107.267 -177.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.3 t -67.23 -33.85 65.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 117.899 0.318 . . . . 71.24 110.152 -174.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -52.42 -51.07 61.05 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.49 0.716 . . . . 72.32 110.987 174.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -73.3 -32.73 64.79 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.715 0.806 . . . . 54.53 112.559 177.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -59.06 -60.82 3.26 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.239 1.016 . . . . 73.14 108.429 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.7 -27.65 66.63 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.575 0.75 . . . . 73.12 111.981 -174.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -74.67 -47.96 28.85 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 121.75 -0.594 . . . . 65.22 111.248 176.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.511 HG23 HG21 ' A' ' 3' ' ' ILE . 90.9 m -53.63 -37.5 63.13 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.439 0.696 . . . . 72.11 109.697 173.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 93.4 t -58.22 -54.43 32.68 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 N-CA-C 109.206 -0.664 . . . . 45.2 109.206 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 13.3 pttp -64.71 -34.99 79.61 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 118.989 -1.085 . . . . 65.03 111.305 -177.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -62.98 -31.11 72.16 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-N 118.739 0.7 . . . . 70.11 111.451 -172.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.515 ' HB2' HG11 ' A' ' 154' ' ' VAL . 75.4 mt -76.0 -18.98 59.06 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 119.075 -1.05 . . . . 63.34 112.636 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 76.8 t -67.5 -22.51 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 O-C-N 120.951 -1.093 . . . . 62.42 110.383 176.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -103.61 -12.23 17.2 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.325 1.05 . . . . 54.51 110.869 178.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 42.2 mttp -115.33 82.41 1.74 Allowed 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 126.125 1.77 . . . . 52.22 107.958 -173.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-N 114.208 -1.36 . . . . 71.23 109.111 164.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 117.311 -1.328 . . . . 65.33 109.981 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' ASN . . . . . 0.511 ' ND2' ' H ' ' A' ' 1' ' ' ALA . 4.0 t30 45.73 -156.46 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 120.152 1.342 . . . . 70.42 111.842 -176.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.511 ' H ' ' ND2' ' A' ' 0' ' ' ASN . . . 44.8 50.11 8.8 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 127.225 2.21 . . . . 71.44 112.162 -175.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -148.52 118.33 7.11 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 106.105 -1.813 . . . . 64.44 106.105 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.42 HG21 ' OG1' ' A' ' 180' ' ' THR . 15.3 pt -122.51 149.12 25.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 C-N-CA 126.753 2.021 . . . . 64.13 108.676 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 59.1 m -119.05 130.91 55.88 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.792 -0.818 . . . . 62.34 108.792 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -46.65 111.47 0.39 Allowed 'General case' 0 C--O 1.232 0.183 0 C-N-CA 126.812 2.045 . . . . 54.43 109.638 162.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 102.97 -5.9 50.83 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.263 -1.298 . . . . 75.11 112.939 176.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -104.57 -86.33 0.46 Allowed 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 118.916 1.358 . . . . 50.13 107.773 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -92.87 -11.65 33.01 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.441 1.496 . . . . 73.33 112.287 -172.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -144.97 157.36 44.16 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 122.984 0.514 . . . . 74.24 110.499 170.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.0 mm -124.57 157.91 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 124.572 1.149 . . . . 61.04 108.071 177.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.24 143.55 41.84 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.69 1.596 . . . . 71.15 107.134 177.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.0 mt -81.91 147.36 29.32 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.885 -0.783 . . . . 74.02 108.885 170.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -73.49 -36.14 65.76 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.356 1.462 . . . . 53.13 109.885 173.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -131.03 84.1 58.88 Favored Pre-proline 0 CA--C 1.519 -0.227 0 C-N-CA 126.296 1.838 . . . . 75.41 108.173 177.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -76.41 74.68 4.61 Favored 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 123.159 2.573 . . . . 75.15 110.029 173.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -160.06 101.18 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 107.247 -1.39 . . . . 71.42 107.247 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -171.39 -86.5 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.238 1.015 . . . . 75.23 110.947 164.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -122.8 32.2 4.51 Favored Glycine 0 C--N 1.336 0.559 0 C-N-CA 124.366 0.984 . . . . 75.44 111.98 -163.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -126.9 85.32 61.21 Favored Pre-proline 0 C--O 1.241 0.606 0 C-N-CA 123.963 0.905 . . . . 75.44 109.242 -150.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -79.34 -164.03 0.26 Allowed 'Trans proline' 0 CA--C 1.541 0.872 1 C-N-CA 126.168 4.579 . . . . 63.34 111.703 -171.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -44.65 -56.6 4.26 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.554 1.942 . . . . 61.13 113.098 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.8 t -150.99 148.08 15.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 127.124 2.17 . . . . 50.35 106.92 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.466 HD23 ' CE2' ' A' ' 25' ' ' PHE . 5.4 tp -159.77 154.8 24.82 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 119.501 1.046 . . . . 71.05 112.053 171.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -134.92 143.4 46.9 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 127.24 2.216 . . . . 70.55 107.272 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.643 ' CE1' ' HB2' ' A' ' 141' ' ' ALA . 45.8 m-85 -133.64 137.11 45.21 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.069 0.947 . . . . 65.23 110.768 174.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -162.34 165.85 26.01 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.75 1.62 . . . . 71.3 109.491 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.8 t -124.43 169.14 12.14 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.653 0.781 . . . . 72.22 109.842 167.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.674 ' CZ ' HD21 ' A' ' 71' ' ' LEU 0.275 0.0 OUTLIER -76.58 -18.77 58.47 Favored 'General case' 0 N--CA 1.435 -1.196 0 C-N-CA 124.081 0.953 . . . . 71.33 112.597 175.726 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -96.06 0.34 51.39 Favored 'General case' 0 C--N 1.346 0.446 0 O-C-N 120.232 -1.543 . . . . 72.54 111.655 -175.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.7 p -97.97 142.09 24.01 Favored Pre-proline 0 CA--C 1.534 0.341 0 O-C-N 121.121 -0.987 . . . . 53.1 108.773 -168.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -91.44 -28.25 0.19 Allowed 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 120.314 0.676 . . . . 42.33 111.503 -162.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -59.9 -49.63 76.93 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.409 -0.96 . . . . 75.25 108.409 165.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.9 m -55.33 -36.7 66.53 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 124.609 1.164 . . . . 53.31 111.953 -178.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -58.82 -56.69 18.97 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 122.994 0.518 . . . . 72.2 109.694 175.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.89 -30.22 68.86 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-O 116.171 -1.871 . . . . 73.12 110.193 177.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -75.03 -6.01 47.12 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 121.245 1.839 . . . . 61.25 113.037 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -146.24 8.56 1.06 Allowed 'General case' 0 C--N 1.345 0.375 0 CA-C-N 120.51 1.505 . . . . 72.13 112.824 -175.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -139.97 -12.48 1.1 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.948 1.299 . . . . 64.33 111.341 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 80.9 t -129.27 -81.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 105.911 -1.885 . . . . 51.42 105.911 173.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.616 ' O ' HG23 ' A' ' 42' ' ' VAL . 3.4 mt -76.55 61.77 1.82 Allowed 'General case' 0 C--O 1.216 -0.692 0 C-N-CA 128.335 2.654 . . . . 72.41 109.474 173.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -50.98 77.38 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 129.628 3.171 . . . . 61.44 110.444 172.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 40' ' ' LEU . 83.2 t -67.2 -48.31 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 114.709 -1.132 . . . . 63.33 108.111 -172.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.1 t -71.6 15.45 0.14 Allowed 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.076 1.139 . . . . 71.11 114.076 -172.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -129.36 -20.81 3.28 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 119.404 -2.06 . . . . 72.24 111.863 170.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.469 ' HB3' ' HB2' ' A' ' 178' ' ' ALA . 2.1 m-80 -62.28 -30.83 71.41 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 121.95 -0.469 . . . . 74.01 111.243 164.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.688 HG12 ' HG ' ' A' ' 50' ' ' LEU . 1.7 t -75.69 -52.14 18.92 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.649 0 N-CA-C 107.123 -1.436 . . . . 61.03 107.123 -162.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -52.95 -39.38 62.88 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.043 1.337 . . . . 73.03 109.915 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -56.35 -21.63 25.81 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.039 1.496 . . . . 72.01 115.039 174.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.6 mmtt -127.37 -5.17 6.0 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.618 2.767 . . . . 70.11 112.526 -176.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.688 ' HG ' HG12 ' A' ' 46' ' ' VAL . 12.7 mt -75.88 151.98 84.54 Favored Pre-proline 0 CA--C 1.518 -0.252 0 CA-C-N 120.43 1.468 . . . . 65.34 108.236 -174.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -78.24 148.54 24.19 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 122.098 1.865 . . . . 74.12 109.646 165.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -67.63 91.89 0.31 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.131 1.772 . . . . 72.21 112.12 -174.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 137.17 -25.19 3.05 Favored Glycine 0 C--N 1.334 0.428 0 O-C-N 120.602 -1.311 . . . . 50.41 113.603 177.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 73.0 m -71.27 86.94 0.81 Allowed 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 104.075 -2.565 . . . . 71.23 104.075 151.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -82.68 157.31 23.4 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.574 -1.639 . . . . 72.33 106.574 169.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.07 169.24 8.86 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.92 -0.77 . . . . 73.13 108.92 -177.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.485 HG22 ' H ' ' A' ' 58' ' ' LYS . 1.3 m -140.48 -171.63 3.26 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.247 1.419 . . . . 72.51 108.105 -167.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.485 ' H ' HG22 ' A' ' 57' ' ' THR . 0.1 OUTLIER -173.62 85.45 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.291 1.436 . . . . 70.12 108.237 -178.091 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.405 ' CG ' ' HG2' ' A' ' 137' ' ' GLN . 8.2 m-30 -89.61 163.72 15.04 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 120.902 -1.124 . . . . 73.23 108.77 173.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.566 ' CE1' HG22 ' A' ' 72' ' ' THR . 0.1 OUTLIER -102.26 174.7 5.8 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 127.83 2.452 . . . . 75.43 110.133 -174.198 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.428 HG12 ' HB1' ' A' ' 141' ' ' ALA . 16.0 m -144.06 150.44 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 CA-C-N 122.407 2.367 . . . . 51.42 112.765 168.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . 0.304 0.0 OUTLIER -103.29 1.11 32.41 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.19 1.796 . . . . 73.2 114.776 176.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -70.8 9.06 0.73 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.199 1.399 . . . . 61.3 113.984 173.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.1 mt -141.77 148.44 38.95 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 119.68 -1.888 . . . . 75.11 109.221 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.54 166.41 12.03 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-N 115.082 -0.963 . . . . 62.52 111.725 171.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -75.44 -39.66 1.01 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.471 2.114 . . . . 52.24 110.119 170.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.474 HD13 HD11 ' A' ' 107' ' ' ILE . 57.3 mt -82.72 23.89 0.77 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.811 1.245 . . . . 54.43 112.032 -177.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -43.91 -63.52 2.24 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 117.222 -1.876 . . . . 74.32 109.863 169.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 16.8 tptp -59.82 -26.23 65.61 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 121.399 2.6 . . . . 72.3 114.126 -172.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -54.71 30.61 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 117.995 -1.002 . . . . 61.33 111.412 168.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.674 HD21 ' CZ ' ' A' ' 28' ' ' PHE . 34.6 mt -60.26 -40.95 92.15 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.252 0.933 . . . . 74.34 109.269 -164.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.566 HG22 ' CE1' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -49.61 -37.84 29.44 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 126.735 2.014 . . . . 60.51 109.682 -179.499 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.471 ' OE1' HG11 ' A' ' 130' ' ' VAL . 0.6 OUTLIER -86.04 -51.48 6.31 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 126.62 1.968 . . . . 55.0 110.895 -176.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.44 -31.13 72.06 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.513 1.051 . . . . 74.53 112.1 -177.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.458 ' CH2' ' HB3' ' A' ' 84' ' ' GLU . 43.3 t-105 -56.59 -36.39 69.31 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 119.139 0.881 . . . . 72.4 111.328 173.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.639 ' HB3' HG13 ' A' ' 130' ' ' VAL . . . -64.87 -42.46 94.81 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 121.624 -0.673 . . . . 65.3 110.125 -177.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 82.6 t -52.8 -43.5 45.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 122.953 0.501 . . . . 74.22 109.83 170.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.37 -50.14 66.66 Favored 'General case' 0 N--CA 1.457 -0.098 0 O-C-N 121.239 -0.913 . . . . 43.24 111.13 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.501 ' CD1' HE22 ' A' ' 137' ' ' GLN . 86.6 mt -59.31 -37.28 68.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.344 1.058 . . . . 73.21 109.877 178.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.26 -50.13 74.27 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.505 0.593 . . . . 71.24 110.17 -174.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.0 mt -81.66 -12.2 58.78 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 118.32 -0.848 . . . . 72.21 112.791 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.03 63.87 3.58 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 126.14 1.828 . . . . 65.4 110.681 -175.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.2 m -130.14 11.9 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 117.67 -1.157 . . . . 74.32 112.838 -177.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.458 ' HB3' ' CH2' ' A' ' 75' ' ' TRP . 2.4 mp0 -51.58 -51.7 53.4 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.912 1.233 . . . . 62.24 111.629 -166.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -49.31 -47.67 46.86 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.681 1.592 . . . . 72.2 111.506 177.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -65.46 -26.73 68.08 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 124.342 1.057 . . . . 73.21 109.472 -170.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.5 pp -114.42 29.66 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 126.914 2.086 . . . . 65.54 109.322 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.504 HG23 ' CE1' ' A' ' 92' ' ' PHE . 18.6 m -108.97 -53.46 2.64 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 118.029 -0.986 . . . . 63.11 108.439 168.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.426 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -52.86 -54.55 42.5 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 113.602 0.964 . . . . 21.53 113.602 -174.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.426 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 48.9 Cg_endo -73.45 -29.37 11.16 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 121.363 1.375 . . . . 72.5 112.032 178.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 34.0 tpp -60.45 -50.11 74.89 Favored 'General case' 0 CA--C 1.515 -0.404 0 C-N-CA 125.225 1.41 . . . . 74.51 110.936 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.504 ' CE1' HG23 ' A' ' 88' ' ' THR . 6.2 m-85 -70.13 -33.15 71.46 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.938 -0.553 . . . . 74.21 109.56 -176.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -58.17 -37.27 74.4 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.353 0.979 . . . . 71.44 109.607 168.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -88.31 -0.9 57.66 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 120.062 -1.649 . . . . 74.14 113.578 -176.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.492 HG11 ' CD1' ' A' ' 28' ' ' PHE . 54.2 t -116.76 -33.77 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.531 1.533 . . . . 71.33 109.688 -177.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -116.06 -48.38 2.74 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 124.696 1.199 . . . . 73.4 111.577 -173.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -72.66 -62.26 1.51 Allowed 'General case' 0 C--N 1.334 -0.082 0 O-C-N 121.695 -0.628 . . . . 54.2 109.49 -176.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 28.2 p -86.43 -35.83 19.47 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.318 0.508 . . . . 74.51 110.659 -178.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 66.48 23.83 10.44 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.701 2.401 . . . . 73.22 113.174 -175.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -70.33 -19.51 63.06 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.503 0.592 . . . . 74.33 112.487 -173.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.443 HG13 HG12 ' A' ' 107' ' ' ILE . 26.8 t -64.3 124.63 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 O-C-N 121.354 -0.841 . . . . 64.53 109.046 171.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -147.04 -24.77 0.4 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.499 1.52 . . . . 64.54 111.44 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.6 162.56 32.36 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 118.802 0.728 . . . . 63.52 109.546 176.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.2 t -55.45 -38.74 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.309 1.044 . . . . 44.31 110.006 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.17 -11.77 23.1 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 114.064 1.135 . . . . 64.12 114.064 178.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -94.72 -33.73 12.82 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 124.979 1.311 . . . . 63.13 110.311 175.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.474 HD11 HD13 ' A' ' 67' ' ' LEU . 2.7 mt -71.62 -37.96 65.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.013 -0.736 . . . . 54.11 109.013 -177.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . 33.2 ptt180 -68.62 -23.37 64.43 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.342 -0.849 . . . . 73.43 111.474 -174.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -55.4 -54.52 42.68 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.469 -0.938 . . . . 73.4 108.469 176.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 29.0 t -58.52 -38.14 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 123.853 0.861 . . . . 72.32 110.625 -174.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -53.25 -57.75 9.45 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.463 -0.569 . . . . 74.14 109.463 172.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -63.92 -41.23 91.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 O-C-N 121.452 -0.78 . . . . 62.54 111.142 -175.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.25 -41.38 88.63 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.127 1.371 . . . . 72.2 109.746 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.64 0.18 18.46 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.795 1.238 . . . . 62.43 112.504 175.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.04 62.46 1.43 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 124.81 1.195 . . . . 63.54 111.118 175.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 73.5 t -121.66 149.47 24.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 124.181 0.992 . . . . 65.53 109.28 170.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -68.48 135.88 52.32 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.196 0.522 . . . . 72.53 110.106 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -69.22 -30.54 71.69 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 114.868 -1.06 . . . . 63.21 110.556 171.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -74.76 -17.8 60.58 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 123.447 0.699 . . . . 70.3 111.905 -172.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.74 -51.81 5.46 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.105 -1.072 . . . . 63.53 108.105 176.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.403 ' CZ ' ' HB3' ' A' ' 108' ' ' ARG . 36.4 t80 -50.89 -53.22 34.48 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.227 1.411 . . . . 72.33 109.978 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -76.61 -10.76 59.62 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 114.239 -1.346 . . . . 74.51 113.14 -172.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.65 -57.06 2.18 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 125.408 1.483 . . . . 63.51 110.407 176.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -50.23 -40.37 47.3 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.898 2.079 . . . . 72.33 110.89 -178.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 61.3 t-105 -45.97 -42.87 13.58 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.29 1.036 . . . . 73.24 111.972 173.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -102.41 8.04 40.25 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.367 -1.458 . . . . 72.42 112.901 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 8.8 t -89.3 151.38 22.13 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 127.019 2.128 . . . . 52.4 111.773 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -60.13 -28.71 68.1 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 125.493 1.517 . . . . 74.11 111.854 174.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 66.4 t -49.33 -54.3 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 119.363 0.983 . . . . 72.51 109.777 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.639 HG13 ' HB3' ' A' ' 76' ' ' ALA . 40.0 t -69.1 -39.28 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-N 115.22 -0.9 . . . . 64.24 108.668 -176.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.4 mmpt? -55.77 -48.58 75.04 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.059 0.845 . . . . 74.44 111.078 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.42 -36.96 85.47 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.068 0.947 . . . . 51.41 110.76 -178.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 13.9 mt -71.06 -58.72 3.29 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 124.882 1.273 . . . . 70.44 110.754 178.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 53.9 t -45.47 -49.38 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.163 0 C-N-CA 125.133 1.373 . . . . 75.23 108.595 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.1 -45.19 87.63 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 117.292 -1.337 . . . . 54.41 112.708 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -51.06 -46.57 61.76 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 120.409 1.459 . . . . 63.33 111.305 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.501 HE22 ' CD1' ' A' ' 79' ' ' ILE . 43.0 mt-30 -88.54 -36.51 16.34 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.926 -1.034 . . . . 73.2 109.801 -162.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -63.56 -47.99 79.3 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.276 -1.009 . . . . 73.34 108.276 171.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 54.7 tttt -60.87 -7.7 2.57 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.675 1.19 . . . . 52.41 113.88 171.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -112.09 -18.05 12.68 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-O 117.189 -1.386 . . . . 61.33 113.728 173.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.643 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . . . -113.86 -11.68 12.81 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 121.956 2.162 . . . . 55.21 112.688 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -117.36 -8.03 11.11 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.954 1.302 . . . . 44.1 111.751 -178.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.25 8.81 3.0 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 114.239 1.199 . . . . 64.51 114.239 -178.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 12.3 mt 76.54 57.29 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.431 2.692 . . . . 73.12 111.828 174.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.27 -84.27 0.63 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.045 -1.094 . . . . 60.41 108.045 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.502 ' HG ' ' H ' ' A' ' 148' ' ' GLY . 11.4 tp -74.68 -73.12 0.25 Allowed 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 124.63 1.172 . . . . 73.11 112.931 -171.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 70.11 2.34 3.9 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.856 2.062 . . . . 75.33 115.217 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.502 ' H ' ' HG ' ' A' ' 146' ' ' LEU . . . -145.38 134.64 5.6 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 120.737 1.608 . . . . 72.42 111.327 176.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 35.5 m -126.42 164.33 34.84 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 119.183 1.492 . . . . 72.43 111.722 -173.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.48 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 30.0 Cg_endo -66.07 156.06 80.38 Favored 'Cis proline' 0 C--N 1.352 0.723 0 CA-C-N 119.712 0.933 . . . . 64.33 112.841 -6.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.424 ' HB2' HD11 ' A' ' 146' ' ' LEU . . . -141.36 156.94 45.78 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 123.454 0.702 . . . . 72.34 110.473 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 43.8 tpp -156.6 110.13 2.66 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.169 -1.789 . . . . 74.42 106.169 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -100.6 155.81 17.66 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.458 0.703 . . . . 63.04 109.54 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.1 t -137.76 139.53 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 107.612 -1.255 . . . . 74.12 107.612 177.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 64.67 -2.63 0.64 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.806 2.043 . . . . 72.25 114.874 171.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.48 -28.1 15.7 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 125.752 1.644 . . . . 63.12 112.169 -173.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.418 ' HG3' ' CD2' ' A' ' 158' ' ' TYR . 0.1 OUTLIER -115.34 -6.67 12.35 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.925 1.863 . . . . 74.42 115.81 -169.501 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.418 ' CD2' ' HG3' ' A' ' 157' ' ' LYS . 72.5 m-85 -121.81 148.82 44.19 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 108.901 -0.777 . . . . 72.33 108.901 -171.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -126.88 143.5 51.25 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.402 -0.962 . . . . 64.02 108.402 169.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -66.77 138.62 57.5 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 106.585 -1.635 . . . . 72.12 106.585 172.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -119.18 85.05 29.23 Favored Pre-proline 0 N--CA 1.452 -0.336 0 N-CA-C 111.7 0.259 . . . . 63.04 111.7 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.32 -21.77 71.78 Favored 'Trans proline' 0 N--CA 1.447 -1.216 0 C-N-CA 121.27 1.313 . . . . 52.14 112.604 173.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -67.25 -10.61 52.39 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.147 0.979 . . . . 74.45 112.011 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -129.05 37.02 2.28 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 126.186 1.851 . . . . 75.02 109.752 171.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 40.4 mtt -114.12 162.37 16.57 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 119.128 1.464 . . . . 71.24 108.122 164.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -77.02 119.85 21.31 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 113.817 -1.538 . . . . 73.42 107.406 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 16.6 p -125.15 35.33 4.79 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.242 2.217 . . . . 72.01 108.795 -172.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 8.6 t -99.28 -12.09 20.67 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.761 -0.587 . . . . 53.23 112.195 178.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.4 -17.15 3.0 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 118.917 -0.564 . . . . 74.43 111.375 -167.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 5.5 mmt 70.78 -50.2 0.67 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.339 1.856 . . . . 72.14 112.076 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.66 -47.73 71.6 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 120.785 -1.197 . . . . 72.25 107.922 -179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 78.6 t -60.18 -32.85 51.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 124.792 1.237 . . . . 74.12 110.672 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -63.29 -62.69 1.52 Allowed 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 118.769 -0.634 . . . . 74.21 109.487 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 2.4 t -71.69 -25.18 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 119.241 0.928 . . . . 73.34 111.685 -175.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.82 -40.04 82.99 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 111.865 0.32 . . . . 74.32 111.865 172.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -75.82 -21.21 57.53 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 118.042 -0.98 . . . . 72.44 113.147 171.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -67.95 -81.05 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 117.008 -1.472 . . . . 73.35 114.642 174.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' A' ' 45' ' ' ASN 0.359 . . -44.85 -18.4 0.02 OUTLIER 'General case' 0 CA--C 1.598 2.799 0 C-N-CA 126.672 1.989 . . . . 52.54 109.241 176.491 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -79.27 -63.98 1.29 Allowed 'General case' 0 C--N 1.382 1.98 0 C-N-CA 128.073 2.549 . . . . 65.45 113.533 169.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.42 ' OG1' HG21 ' A' ' 3' ' ' ILE . 13.2 t -59.01 -30.31 67.9 Favored 'General case' 0 C--N 1.347 0.488 0 CA-C-O 116.915 -1.517 . . . . 72.31 110.047 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 39.9 t -56.72 -44.23 81.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 120.462 1.483 . . . . 63.44 109.139 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 6.3 ptmt -75.15 -33.32 61.5 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-O 118.268 -0.872 . . . . 61.21 112.208 -177.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -62.36 -37.58 86.23 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 120.404 1.456 . . . . 54.51 112.035 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 77.1 mt -67.41 -20.61 65.55 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 119.069 -1.052 . . . . 72.23 111.808 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.03 -23.79 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 O-C-N 121.694 -0.629 . . . . 74.44 110.521 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -106.37 -2.49 22.14 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.364 0.983 . . . . 73.32 111.146 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -123.45 78.09 1.56 Allowed 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.862 1.265 . . . . 73.22 109.971 -176.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.95 0 CA-C-O 115.702 -2.094 . . . . 74.13 107.176 166.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 9.2 m . . . . . 0 C--O 1.236 0.35 0 N-CA-C 108.836 -0.802 . . . . 65.21 108.836 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 16.3 m-20 -106.79 1.68 25.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 118.908 -0.568 . . . . 73.01 111.547 -162.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -67.04 45.06 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.358 2.263 . . . . 74.13 113.131 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -161.84 119.53 2.22 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 127.16 2.184 . . . . 73.13 105.302 166.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.2 pt -124.45 143.15 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 126.108 1.763 . . . . 73.42 106.546 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.6 m -118.07 139.1 51.71 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.416 -1.328 . . . . 73.34 107.416 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -53.13 118.04 3.46 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.31 2.244 . . . . 70.2 108.724 164.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.27 -6.17 65.85 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 118.22 -1.322 . . . . 73.42 113.346 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.7 tptp -103.66 -85.33 0.46 Allowed 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 119.253 1.527 . . . . 65.13 107.304 177.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -89.45 -20.55 23.76 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 124.219 1.008 . . . . 71.01 110.777 -170.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -140.66 163.81 31.87 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.93 -0.767 . . . . 73.04 108.93 175.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.619 HD11 ' CG ' ' A' ' 161' ' ' ASN . 5.4 mm -127.84 159.72 38.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 106.006 -1.85 . . . . 70.02 106.006 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.6 m -90.53 154.25 19.75 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.498 -1.668 . . . . 74.1 106.498 168.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.8 mt -67.22 152.8 45.08 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.117 -1.068 . . . . 54.53 108.117 163.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -73.64 -28.13 61.62 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.67 -0.493 . . . . 65.34 109.67 171.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm -126.37 72.98 72.97 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 126.13 1.772 . . . . 73.03 109.756 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.39 70.53 6.76 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 124.287 3.325 . . . . 70.12 110.869 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.1 mt -105.77 164.98 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 O-C-N 121.444 -0.785 . . . . 74.43 109.083 -175.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 57.81 4.15 0.25 Allowed 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.103 2.161 . . . . 64.3 114.866 -178.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.1 -9.0 3.28 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 116.48 -2.289 . . . . 51.4 113.725 -169.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 53.21 166.67 0.04 OUTLIER Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 127.704 2.402 . . . . 71.33 113.798 -168.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.18 -11.42 31.18 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 121.66 1.573 . . . . 74.1 113.271 -174.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 66.89 11.08 8.1 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 128.344 2.658 . . . . 74.13 113.868 -175.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.434 HG22 ' OG1' ' A' ' 57' ' ' THR . 1.8 p -156.54 97.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.129 -1.063 . . . . 70.33 108.129 -178.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.1 tp -161.19 159.04 28.37 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.588 0.708 . . . . 44.12 112.462 172.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -139.83 150.38 44.61 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 127.567 2.347 . . . . 71.23 106.48 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -135.42 133.07 38.25 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.644 1.578 . . . . 72.03 108.536 173.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -156.6 -176.78 6.16 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.477 1.511 . . . . 65.02 110.858 177.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.1 t -135.38 176.43 8.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.665 1.586 . . . . 53.13 109.032 174.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.843 ' CD1' HD11 ' A' ' 71' ' ' LEU 0.278 0.0 OUTLIER -89.46 -7.5 54.92 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.976 1.102 . . . . 73.42 113.976 164.729 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.424 ' CE2' ' HA3' ' A' ' 65' ' ' GLY . 51.4 m-85 -103.24 0.72 32.0 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 120.146 1.339 . . . . 73.23 112.728 173.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.2 p -78.04 140.57 62.09 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 121.437 1.926 . . . . 74.12 108.857 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -91.45 -25.77 0.3 Allowed 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 120.869 1.046 . . . . 70.1 112.668 -176.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -57.77 -57.39 12.96 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 119.022 0.828 . . . . 73.04 109.813 166.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 24.9 p -65.02 -23.73 67.29 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.448 -0.796 . . . . 73.43 111.648 -170.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -58.07 -54.47 46.54 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 118.883 0.765 . . . . 72.32 110.534 169.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.71 -45.81 77.81 Favored 'General case' 0 C--O 1.221 -0.423 0 N-CA-C 107.894 -1.15 . . . . 52.31 107.894 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.421 ' CD2' HG21 ' A' ' 42' ' ' VAL . 4.3 m-85 -66.26 -10.45 42.34 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 115.647 -2.121 . . . . 63.13 113.858 -176.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -132.19 -2.45 3.55 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 122.044 2.202 . . . . 72.04 112.445 -173.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -133.04 -20.23 2.19 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.432 1.093 . . . . 54.41 112.426 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.0 t -121.35 -76.2 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 107.183 -1.414 . . . . 72.1 107.183 -173.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 27.1 mt -73.99 -18.2 60.9 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.116 2.166 . . . . 70.01 113.022 -177.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 54.5 m-70 43.75 53.87 5.86 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.291 1.836 . . . . 73.41 112.818 172.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 46' ' ' VAL . 86.1 t -62.68 -51.23 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 116.997 -1.478 . . . . 74.22 109.895 -172.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.1 t -45.41 -52.35 10.16 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.061 1.345 . . . . 65.43 110.143 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -63.77 -40.1 95.86 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.246 1.018 . . . . 61.31 110.691 -177.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.81 -35.33 74.74 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.542 1.137 . . . . 63.33 113.156 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 42' ' ' VAL . 1.9 t -67.53 -50.33 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 106.682 -1.599 . . . . 70.41 106.682 174.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 38.3 ttt-85 -47.47 -46.9 27.31 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 124.413 1.085 . . . . 63.13 111.608 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -60.31 -13.57 13.63 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.185 1.18 . . . . 74.0 114.185 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -118.37 -8.83 10.49 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.548 1.939 . . . . 64.23 111.507 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.61 ' HB3' HG21 ' A' ' 54' ' ' THR . 11.8 mt -76.16 143.83 74.17 Favored Pre-proline 0 C--O 1.237 0.401 0 CA-C-N 119.41 1.005 . . . . 62.03 109.579 -169.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.42 ' O ' HG22 ' A' ' 54' ' ' THR . 83.6 Cg_endo -80.01 167.35 20.13 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.043 1.829 . . . . 73.14 111.142 -176.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -73.14 68.4 0.98 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.375 1.07 . . . . 64.31 112.176 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.46 -7.06 0.05 OUTLIER Glycine 0 CA--C 1.524 0.635 0 O-C-N 119.748 -1.845 . . . . 65.2 114.773 176.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.61 HG21 ' HB3' ' A' ' 50' ' ' LEU . 0.7 OUTLIER -58.47 -45.08 89.34 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.042 1.421 . . . . 72.02 110.998 175.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . 0.294 19.0 ttpt 56.91 151.4 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.79 2.036 . . . . 73.04 111.725 -162.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.42 113.09 16.4 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 120.037 -1.664 . . . . 63.04 107.773 -167.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.434 ' OG1' HG22 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -115.92 -177.69 3.22 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.882 1.673 . . . . 65.2 109.347 -174.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -179.23 87.04 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 106.737 -1.579 . . . . 64.31 106.737 -170.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 -95.22 162.74 13.57 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.41 -0.806 . . . . 73.43 109.967 174.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.467 ' CE1' ' HB2' ' A' ' 137' ' ' GLN . 0.1 OUTLIER -100.15 174.39 6.18 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.779 2.031 . . . . 64.31 110.615 -176.724 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.5 m -135.07 145.86 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 120.418 1.463 . . . . 54.51 110.534 164.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -82.42 29.6 0.43 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.468 1.107 . . . . 70.3 111.396 -178.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -134.68 165.91 24.15 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.851 1.66 . . . . 61.13 107.652 -172.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.6 mt 75.79 128.61 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 127.007 2.123 . . . . 65.03 109.766 -172.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.424 ' HA3' ' CE2' ' A' ' 29' ' ' TYR . . . 66.72 171.31 4.46 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 121.944 0.747 . . . . 54.54 112.55 175.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.02 -40.99 1.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 123.069 2.513 . . . . 74.22 112.62 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 88.4 mt -81.88 16.6 1.79 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.248 1.419 . . . . 74.3 112.356 -174.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -55.19 -34.64 58.97 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 117.742 -1.588 . . . . 52.32 113.607 -173.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.2 -35.7 55.45 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 120.473 2.136 . . . . 71.33 110.28 176.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.37 -37.96 86.47 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 120.976 -1.078 . . . . 64.22 108.703 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.843 HD11 ' CD1' ' A' ' 28' ' ' PHE . 22.4 mt -53.91 -45.04 71.04 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 123.82 0.848 . . . . 73.5 111.093 169.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.464 HG23 ' CE1' ' A' ' 60' ' ' HIS . 2.6 m -57.12 -51.07 70.76 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 124.348 1.03 . . . . 73.22 109.314 -177.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -63.22 -49.11 75.46 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 118.587 -0.721 . . . . 72.32 109.919 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.22 -37.87 75.68 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 120.416 1.462 . . . . 65.44 114.363 -177.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.454 ' CD1' HD11 ' A' ' 79' ' ' ILE . 10.6 t-105 -61.09 -37.77 83.88 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.633 0.652 . . . . 65.11 111.371 -172.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.72 -34.68 71.62 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 117.832 -1.08 . . . . 71.22 112.373 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.09 -46.76 84.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 120.198 1.363 . . . . 72.21 109.779 171.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.23 -43.28 82.37 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 118.81 -0.614 . . . . 72.12 111.068 -177.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.454 HD11 ' CD1' ' A' ' 75' ' ' TRP . 75.0 mt -60.23 -41.9 88.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.145 0.978 . . . . 74.24 109.784 176.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.94 -48.23 81.33 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.885 0.474 . . . . 70.42 110.175 -173.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 81' ' ' LEU . 71.7 mt -76.66 -20.89 56.16 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 121.825 -0.547 . . . . 54.22 112.347 174.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.57 70.55 1.13 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 126.937 2.208 . . . . 41.13 110.097 -173.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.6 m -134.18 15.64 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 125.157 1.383 . . . . 70.24 112.804 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -52.43 -48.65 65.65 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.316 1.046 . . . . 74.2 110.66 -178.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.48 -7.93 16.75 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.948 1.699 . . . . 70.51 113.304 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -104.21 -19.92 13.97 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 125.124 1.37 . . . . 72.22 111.283 176.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.6 pp -124.04 28.53 2.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 C-N-CA 125.838 1.655 . . . . 70.4 110.416 -172.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 43.1 m -93.96 -51.15 4.99 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.742 -0.836 . . . . 65.1 108.742 165.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.504 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -57.66 -65.81 1.62 Allowed Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 124.007 0.923 . . . . 71.44 112.006 -171.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 52.3 Cg_endo -66.13 -26.28 50.16 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 121.161 1.241 . . . . 72.21 111.556 -174.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 24.0 tpp -61.76 -50.21 73.29 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.691 -0.855 . . . . 74.53 108.691 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -67.88 -35.13 77.98 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 123.974 0.91 . . . . 70.21 109.685 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -56.47 -45.31 80.97 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.599 0.636 . . . . 65.5 109.615 171.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.28 -1.76 42.24 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 120.727 -1.233 . . . . 64.1 112.993 -174.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.756 HG21 ' CD2' ' A' ' 28' ' ' PHE . 61.2 t -119.26 -33.74 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 C-N-CA 124.614 1.165 . . . . 73.03 110.949 -174.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -113.79 -52.92 2.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.105 1.362 . . . . 74.13 108.725 -173.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -71.99 -51.97 19.33 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 118.027 0.376 . . . . 74.32 110.338 -173.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.8 p -100.89 -27.04 13.53 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.056 0.942 . . . . 63.13 112.531 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 52.28 32.98 11.76 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.646 2.379 . . . . 71.04 114.979 -177.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 t -74.26 -21.02 59.95 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.749 0.82 . . . . 74.12 112.199 178.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.402 HG13 HG12 ' A' ' 107' ' ' ILE . 25.4 t -65.28 122.97 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 O-C-N 121.568 -0.708 . . . . 72.23 109.197 170.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -149.4 -19.99 0.28 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 114.068 -1.424 . . . . 74.43 111.63 -178.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.04 165.88 24.66 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.152 0.981 . . . . 71.34 109.64 173.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 39.1 t -57.57 -42.18 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.744 1.217 . . . . 43.43 108.388 175.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.02 13.89 0.05 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 128.809 2.843 . . . . 73.54 113.155 174.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -115.47 -48.68 2.78 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.42 1.488 . . . . 63.54 109.196 163.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.402 HG12 HG13 ' A' ' 101' ' ' VAL . 2.4 mt -52.66 -45.2 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.99 1.316 . . . . 64.13 110.907 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -22.36 65.72 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.651 0.982 . . . . 74.2 113.651 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -56.05 -56.02 25.9 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 119.981 1.264 . . . . 73.54 110.11 171.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 39.7 t -62.45 -34.55 65.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.83 -0.623 . . . . 71.13 110.789 -171.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -53.19 -58.6 6.5 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.716 -0.846 . . . . 73.24 108.716 171.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.1 t -65.71 -37.51 80.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 119.364 -0.35 . . . . 70.22 111.124 -173.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -60.84 -48.4 82.0 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.679 -0.86 . . . . 73.1 108.679 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.82 -0.39 7.11 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.612 1.565 . . . . 53.2 112.565 177.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.27 58.58 1.14 Allowed Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 124.428 1.013 . . . . 22.44 111.846 172.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.3 t -118.54 149.27 21.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 124.143 0.977 . . . . 70.23 109.832 169.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt -67.34 120.5 13.95 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.413 1.085 . . . . 74.44 110.49 168.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.68 -31.04 78.67 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-O 118.37 -1.239 . . . . 72.42 111.239 170.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -66.72 -36.58 82.82 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.846 1.323 . . . . 74.42 110.194 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -73.32 -42.49 62.28 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 106.766 -1.568 . . . . 65.34 106.766 -174.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -58.45 -55.43 35.07 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.996 0.903 . . . . 74.53 109.202 177.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -70.27 -12.61 61.71 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.004 0.922 . . . . 45.3 112.856 -173.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.98 -64.91 1.01 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.23 1.412 . . . . 34.24 109.946 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.64 -36.56 64.68 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.652 1.581 . . . . 45.02 111.491 -170.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 44.0 t-105 -45.14 -45.9 11.64 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.998 1.319 . . . . 73.5 112.067 176.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -102.35 11.22 38.4 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.206 1.402 . . . . 72.41 112.144 -177.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 7.0 t -99.27 163.79 12.4 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.281 1.832 . . . . 75.3 111.527 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -60.72 -28.31 68.58 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 128.177 2.591 . . . . 71.4 112.553 173.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 23.6 t -50.99 -53.28 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 122.78 1.276 . . . . 53.22 109.256 177.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.3 t -70.04 -32.51 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 114.923 -1.035 . . . . 74.22 110.624 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -56.47 -59.35 5.11 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 119.896 1.225 . . . . 74.5 110.045 176.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 15.0 m -68.45 -20.3 64.62 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 112.995 0.739 . . . . 63.21 112.995 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 26.2 mt -87.98 -33.48 18.39 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 113.642 0.979 . . . . 73.3 113.642 177.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 41.4 t -59.13 -52.77 56.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 107.064 -1.458 . . . . 65.52 107.064 165.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -46.67 -51.41 16.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.679 1.592 . . . . 61.12 112.893 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -58.04 -28.94 64.94 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.129 0.49 . . . . 75.12 112.017 -169.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.467 ' HB2' ' CE1' ' A' ' 60' ' ' HIS . 49.9 mt-30 -97.09 -47.56 5.73 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 128.095 2.558 . . . . 65.43 111.753 -176.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -62.89 -38.7 91.93 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 118.537 0.608 . . . . 74.0 109.653 -177.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -51.36 -45.7 62.48 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 124.486 1.114 . . . . 54.34 110.272 172.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -67.11 -52.97 35.29 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 124.392 1.058 . . . . 54.52 109.677 -175.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -54.29 -43.16 70.84 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.913 0.485 . . . . 34.43 111.42 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.16 7.51 9.15 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.218 1.807 . . . . 64.2 112.686 -177.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -86.18 -8.75 57.59 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.175 -0.953 . . . . 70.3 111.431 169.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 11.9 mt 68.43 58.53 0.42 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.921 1.344 . . . . 72.4 110.908 160.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.448 ' NE2' ' H ' ' A' ' 146' ' ' LEU . 0.1 OUTLIER -144.38 -34.86 0.36 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.646 1.178 . . . . 51.52 112.094 -173.337 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.448 ' H ' ' NE2' ' A' ' 145' ' ' GLN . 2.3 tp -79.12 -85.09 0.08 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 125.437 1.495 . . . . 72.23 109.244 178.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 51.03 37.49 17.97 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.445 1.098 . . . . 73.11 111.852 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.63 132.77 3.29 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 107.803 -2.119 . . . . 65.13 107.803 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.465 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 1.4 m -138.13 160.45 64.17 Favored Pre-proline 0 C--O 1.241 0.632 0 N-CA-C 108.509 -0.923 . . . . 63.22 108.509 171.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.465 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 63.8 Cg_endo -74.21 142.52 75.0 Favored 'Cis proline' 0 N--CA 1.46 -0.494 0 C-N-CA 125.356 -0.685 . . . . 52.42 111.975 -10.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -126.25 138.7 53.64 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 125.516 1.526 . . . . 44.31 108.621 -175.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 34.5 mtp -140.12 108.61 5.87 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 106.471 -1.677 . . . . 73.14 106.471 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -81.36 173.04 12.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.857 -0.61 . . . . 72.34 110.232 -175.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.528 HG11 ' HB2' ' A' ' 184' ' ' LEU . 59.3 t -133.36 -86.05 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 CA-C-O 119.034 -0.508 . . . . 73.4 110.47 160.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -84.57 30.86 0.54 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.859 1.209 . . . . 72.3 110.379 -167.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 68.53 -68.0 0.4 Allowed Glycine 0 C--O 1.22 -0.74 0 C-N-CA 127.882 2.658 . . . . 43.1 109.201 -164.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.433 ' HE2' ' CZ ' ' A' ' 158' ' ' TYR . 36.5 pttt -60.44 -0.7 0.27 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 115.432 1.641 . . . . 70.22 115.432 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.433 ' CZ ' ' HE2' ' A' ' 157' ' ' LYS . 18.0 m-85 -121.68 139.31 53.72 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 120.473 1.488 . . . . 65.12 111.972 -177.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -118.86 132.36 56.1 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.471 2.308 . . . . 71.2 106.378 174.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -67.95 143.76 55.49 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.598 -0.89 . . . . 70.42 108.598 175.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . 0.619 ' CG ' HD11 ' A' ' 10' ' ' ILE . 17.5 t30 -117.56 83.92 18.14 Favored Pre-proline 0 C--O 1.236 0.385 0 N-CA-C 112.406 0.521 . . . . 63.34 112.406 -174.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -62.92 -28.87 75.55 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 120.297 0.665 . . . . 71.02 112.102 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -64.16 -7.25 8.43 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 116.756 2.132 . . . . 64.21 116.756 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -107.69 -3.88 34.52 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-N 119.733 1.151 . . . . 44.44 113.776 170.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.1 mtt -85.82 166.37 16.09 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 119.952 1.876 . . . . 63.44 109.399 -174.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -79.32 65.83 4.61 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 122.674 1.226 . . . . 62.42 111.25 -172.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 41.6 p -67.04 3.57 1.09 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.59 1.956 . . . . 64.0 112.654 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 6.1 t -73.22 -18.63 61.22 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 119.799 1.182 . . . . 72.0 111.827 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.85 -11.74 8.11 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 117.557 -1.211 . . . . 72.2 114.043 -170.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 3.6 mmt 68.98 -63.36 0.37 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.483 1.913 . . . . 73.41 111.809 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.27 -31.07 71.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 122.767 1.27 . . . . 73.2 110.389 -170.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.424 HG12 HE21 ' A' ' 176' ' ' GLN . 76.0 t -75.71 -33.47 26.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 124.546 1.138 . . . . 53.44 111.133 173.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -60.27 -56.88 16.13 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.614 -0.884 . . . . 72.4 108.614 -176.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.0 t -65.01 -35.47 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 109.981 -0.377 . . . . 43.52 109.981 -175.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.09 -27.34 68.29 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.2 1.0 . . . . 74.01 112.301 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.424 HE21 HG12 ' A' ' 172' ' ' VAL . 66.6 mt-30 -93.92 -33.34 13.53 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.148 0.885 . . . . 72.2 112.105 171.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -56.34 -58.05 9.67 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 124.214 1.006 . . . . 72.22 110.277 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.01 -22.27 62.37 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.162 0.585 . . . . 72.04 112.433 -174.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -70.97 -61.65 1.69 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.446 1.098 . . . . 71.22 109.54 178.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.1 t -61.71 -21.11 64.21 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 118.026 -0.988 . . . . 73.22 112.262 -174.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 57.3 t -56.58 -57.14 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 119.364 0.984 . . . . 74.12 108.667 169.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -56.8 -43.93 81.43 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.771 0.828 . . . . 71.13 109.578 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -61.55 -34.03 74.87 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 123.3 0.64 . . . . 65.11 111.318 -171.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.528 ' HB2' HG11 ' A' ' 154' ' ' VAL . 58.4 mt -79.78 -21.89 43.82 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 121.322 -0.861 . . . . 74.2 112.687 -178.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 72.3 t -61.46 -31.38 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 108.78 -0.822 . . . . 44.33 108.78 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -98.04 -14.53 20.47 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.14 0.976 . . . . 70.44 111.149 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -112.52 63.75 0.63 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.695 1.198 . . . . 73.11 111.198 -174.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt . . . . . 0 C--O 1.248 0.987 0 CA-C-O 119.094 -0.479 . . . . 72.04 110.098 160.605 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 106.965 -1.495 . . . . 74.14 106.965 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -117.95 173.03 7.0 Favored 'General case' 0 CA--C 1.516 -0.348 0 O-C-N 123.467 0.48 . . . . 71.31 110.705 -154.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . 46.8 25.23 0.42 Allowed 'General case' 0 C--O 1.236 0.394 0 C-N-CA 127.801 2.44 . . . . 51.43 115.161 171.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -161.57 117.32 2.09 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 107.097 -1.446 . . . . 73.25 107.097 -173.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.4 pt -126.41 150.84 32.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 126.174 1.79 . . . . 65.14 109.671 -172.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.9 m -132.14 133.93 44.84 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 105.965 -1.865 . . . . 74.25 105.965 176.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -59.85 144.14 49.45 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.49 1.516 . . . . 73.25 108.913 169.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.9 4.89 73.27 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 118.363 -1.243 . . . . 51.21 112.662 -174.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -129.28 -70.07 0.67 Allowed 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 119.308 1.554 . . . . 71.23 113.497 -176.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -101.17 -27.52 13.18 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.161 -0.681 . . . . 71.24 109.161 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -132.46 170.89 14.49 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 122.563 0.345 . . . . 75.25 110.505 171.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.72 147.82 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 105.535 -2.024 . . . . 61.14 105.535 177.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.09 169.89 17.2 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.733 -1.21 . . . . 73.03 107.733 163.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 36.2 mt -110.26 150.15 29.13 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.795 -1.557 . . . . 63.35 106.795 168.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -75.83 -30.96 59.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.101 0.477 . . . . 75.34 111.216 -174.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.5 mmmt -126.84 76.51 75.25 Favored Pre-proline 0 N--CA 1.464 0.245 0 C-N-CA 124.298 1.039 . . . . 74.05 108.535 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -79.38 71.54 6.98 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 124.14 3.227 . . . . 64.33 111.157 -175.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.7 tp -160.35 144.2 5.15 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 O-C-N 120.664 -1.272 . . . . 73.24 109.578 172.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 53.62 -161.45 0.12 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.385 1.874 . . . . 50.11 111.637 171.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.58 -24.97 2.12 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.221 1.391 . . . . 64.14 112.905 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -138.82 160.66 62.13 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 119.351 1.575 . . . . 65.45 111.705 -167.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -76.46 -165.15 0.29 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.865 3.043 . . . . 65.43 111.673 172.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -71.06 90.51 0.85 Allowed 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.579 -1.326 . . . . 65.33 108.467 164.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.274 1.4 p 52.07 151.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.544 1 C-N-CA 131.91 4.084 . . . . 74.12 115.387 174.477 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.447 HD11 ' CE2' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -160.17 165.37 31.73 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 120.625 -1.297 . . . . 65.12 110.738 -172.542 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.419 ' H ' ' HG ' ' A' ' 23' ' ' LEU . 2.2 mp0 -137.14 132.85 34.58 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 126.007 1.723 . . . . 73.23 107.48 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.427 ' CD2' HD13 ' A' ' 146' ' ' LEU . 3.4 m-85 -127.41 139.02 53.11 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.466 1.506 . . . . 73.33 109.393 -176.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.67 173.13 11.82 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.354 1.462 . . . . 63.0 109.283 -174.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.75 179.47 6.4 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.404 -0.591 . . . . 63.12 109.404 161.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.503 ' HB2' HD13 ' A' ' 71' ' ' LEU . 32.4 m-85 -100.69 -17.15 17.12 Favored 'General case' 0 C--O 1.226 -0.184 0 C-N-CA 123.733 0.813 . . . . 75.23 111.714 -173.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.433 ' CD1' ' HA3' ' A' ' 65' ' ' GLY . 64.3 m-85 -111.87 8.12 20.31 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 127.547 2.339 . . . . 75.12 111.854 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.9 p -88.47 144.5 33.85 Favored Pre-proline 0 N--CA 1.468 0.455 0 O-C-N 120.237 -1.54 . . . . 64.22 111.561 -176.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -73.38 -50.2 0.19 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.708 2.272 . . . . 75.11 112.371 -168.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -56.11 -35.52 67.16 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.239 0.616 . . . . 71.03 110.4 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.9 m -63.26 -32.72 74.2 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 124.184 0.994 . . . . 73.41 111.557 -174.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -57.27 -61.96 2.1 Favored 'General case' 0 C--O 1.216 -0.701 0 C-N-CA 123.535 0.734 . . . . 75.03 110.784 172.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.75 ' HA ' HE21 ' A' ' 35' ' ' GLN . 0.0 OUTLIER -47.45 -53.12 14.99 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 120.263 -1.523 . . . . 73.41 110.633 173.198 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -65.5 -13.74 59.51 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 116.015 -1.945 . . . . 62.21 110.908 -163.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.425 ' HG2' HG21 ' A' ' 88' ' ' THR . 1.4 tp10 -141.11 20.21 2.27 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 120.667 1.576 . . . . 63.23 113.53 -177.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.425 ' OE2' ' HA ' ' A' ' 89' ' ' ALA . 26.0 mm-40 -142.26 -28.86 0.6 Allowed 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.222 1.009 . . . . 71.04 113.163 177.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.0 t -116.18 -44.02 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 105.796 -1.927 . . . . 73.21 105.796 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.661 HD13 ' HB3' ' A' ' 35' ' ' GLN . 4.4 mp -96.1 -32.89 12.3 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.431 1.892 . . . . 62.2 112.326 -170.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 44.11 60.65 2.67 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.49 1.116 . . . . 72.31 112.272 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.71 -35.52 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 C-N-CA 124.651 1.18 . . . . 64.42 109.163 -175.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.4 t -57.82 -51.25 70.35 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.8 1.182 . . . . 74.44 108.794 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -66.1 -47.28 74.72 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 124.494 1.117 . . . . 73.43 110.53 -177.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -58.26 -56.19 25.32 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 125.157 1.383 . . . . 72.13 111.579 -178.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.545 HG12 ' HG ' ' A' ' 50' ' ' LEU . 19.7 t -67.45 -42.14 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.529 -1.286 . . . . 51.23 107.529 -175.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 61.9 ttt-85 -51.27 -43.26 61.54 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.008 1.276 . . . . 65.4 111.865 174.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -61.71 -13.17 20.64 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.689 1.596 . . . . 74.34 114.778 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -120.58 -11.48 9.06 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.035 1.334 . . . . 71.2 112.912 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.545 ' HG ' HG12 ' A' ' 46' ' ' VAL . 7.7 mt -69.25 143.91 94.34 Favored Pre-proline 0 C--O 1.239 0.529 0 CA-C-N 119.224 0.92 . . . . 73.22 108.921 -163.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.69 145.98 33.44 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.937 2.424 . . . . 62.32 110.565 176.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.58 76.1 6.21 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 114.489 -1.232 . . . . 65.45 109.346 -168.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 166.49 -17.41 0.09 OUTLIER Glycine 0 CA--C 1.525 0.676 0 CA-C-O 117.769 -1.573 . . . . 65.42 112.255 -172.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.473 HG21 HD13 ' A' ' 50' ' ' LEU . 8.0 t -45.18 -46.06 11.9 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.372 1.586 . . . . 73.43 113.742 174.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.8 tptt 66.23 147.15 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.942 2.897 . . . . 62.15 112.964 -149.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 3.2 mtm -135.08 137.61 43.04 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 127.159 2.184 . . . . 64.13 108.378 175.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.8 m -146.82 168.15 22.12 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.006 1.323 . . . . 71.04 108.714 -177.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.93 106.74 3.07 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 120.289 -1.507 . . . . 74.44 109.366 -177.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.447 ' CE2' HD11 ' A' ' 23' ' ' LEU . 9.9 m-30 -112.23 169.48 8.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.194 1.398 . . . . 73.31 111.886 -176.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.691 ' CE1' HG23 ' A' ' 72' ' ' THR . 0.5 OUTLIER -114.82 173.29 6.55 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.04 1.736 . . . . 75.33 109.686 -177.099 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 23.3 m -136.78 169.77 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 119.692 1.133 . . . . 62.0 109.591 163.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -125.37 65.0 1.16 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.794 1.637 . . . . 71.04 109.806 -174.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -146.7 -13.29 0.44 Allowed 'General case' 0 C--N 1.328 -0.362 0 O-C-N 120.733 -1.23 . . . . 74.04 113.168 -168.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mt -128.24 125.45 38.96 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 119.972 1.26 . . . . 75.43 108.904 -176.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' A' ' 29' ' ' TYR . . . 89.06 158.08 33.72 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.442 1.496 . . . . 60.12 110.647 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -64.69 -48.57 3.98 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.415 2.077 . . . . 54.33 110.274 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.715 HD13 HD11 ' A' ' 107' ' ' ILE . 5.1 mt -74.36 10.39 1.31 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.471 1.285 . . . . 75.34 114.471 -175.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -56.23 -2.46 0.41 Allowed Glycine 0 CA--C 1.538 1.501 0 C-N-CA 125.176 1.369 . . . . 73.41 115.751 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -90.87 -42.33 10.68 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 120.172 1.986 . . . . 64.3 112.383 169.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -60.92 -54.73 41.45 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 118.595 0.634 . . . . 72.23 109.826 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.503 HD13 ' HB2' ' A' ' 28' ' ' PHE . 86.3 mt -55.63 -37.68 68.51 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 124.989 1.43 . . . . 62.03 111.682 -164.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.691 HG23 ' CE1' ' A' ' 60' ' ' HIS . 52.3 m -55.74 -49.58 72.68 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 129.506 3.122 . . . . 71.31 110.716 174.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -65.42 -54.73 24.32 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 121.466 -0.771 . . . . 70.32 109.248 174.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.8 -36.6 48.36 Favored 'General case' 0 C--O 1.227 -0.097 0 N-CA-C 114.042 1.127 . . . . 64.41 114.042 -177.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.469 ' CD1' HD11 ' A' ' 79' ' ' ILE . 35.7 t-105 -50.3 -41.43 50.91 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.058 1.343 . . . . 73.42 110.394 176.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.66 -36.57 83.3 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 117.628 -1.177 . . . . 72.23 113.314 179.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.1 t -54.69 -49.28 69.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 120.324 1.42 . . . . 62.21 109.475 169.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.55 -46.2 89.46 Favored 'General case' 0 C--N 1.342 0.242 0 O-C-N 122.007 -0.433 . . . . 65.01 110.495 -175.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.469 HD11 ' CD1' ' A' ' 75' ' ' TRP . 79.4 mt -62.43 -39.52 84.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 123.603 0.761 . . . . 65.44 110.153 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.62 -45.03 85.9 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.076 0.853 . . . . 64.12 110.135 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 89.5 mt -86.96 -11.6 50.09 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 112.945 0.72 . . . . 70.31 112.945 -177.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.77 60.89 6.73 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 126.326 1.917 . . . . 62.12 112.184 -174.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.8 m -134.84 11.74 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.134 0 C-N-CA 125.045 1.338 . . . . 62.44 113.097 -174.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -44.42 -60.71 1.82 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.751 1.62 . . . . 73.03 109.911 175.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.8 -8.06 0.54 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.934 2.093 . . . . 72.23 114.183 176.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -108.2 -29.03 9.14 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.536 1.516 . . . . 74.44 112.311 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.9 pp -100.31 -14.07 8.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 C-N-CA 123.884 0.874 . . . . 72.23 111.619 -175.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.482 HG23 ' HE2' ' A' ' 92' ' ' PHE 0.25 3.2 m -63.31 -41.82 98.98 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-O 116.868 -1.539 . . . . 74.02 112.319 -179.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.585 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -50.76 -64.47 1.31 Allowed Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.477 1.111 . . . . 72.03 112.09 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 48.2 Cg_endo -68.07 -20.46 44.18 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 120.508 0.805 . . . . 73.0 112.387 -177.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 6.1 tpp -59.98 -55.17 37.37 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 126.539 1.935 . . . . 72.23 110.576 174.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.482 ' HE2' HG23 ' A' ' 88' ' ' THR . 41.8 m-85 -69.84 -32.02 70.2 Favored 'General case' 0 CA--C 1.511 -0.552 0 O-C-N 121.348 -0.845 . . . . 74.42 110.96 -177.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.493 ' HA ' ' HB2' ' A' ' 97' ' ' LYS . 1.8 tt0 -60.97 -36.97 80.8 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 117.915 -1.514 . . . . 74.12 108.887 169.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.455 ' HB1' HG23 ' A' ' 101' ' ' VAL . . . -81.17 -15.12 56.68 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 120.376 -1.453 . . . . 61.21 112.408 -171.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 99.1 t -116.91 -22.73 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 125.232 1.413 . . . . 60.41 111.635 -171.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -120.55 -50.89 2.19 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.772 1.169 . . . . 74.01 110.582 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.519 ' HA ' ' HE3' ' A' ' 97' ' ' LYS . 1.7 mmpt? -72.44 -40.89 66.72 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 113.696 0.999 . . . . 74.31 113.696 -171.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.4 p -112.3 -34.98 5.74 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 124.809 1.318 . . . . 64.43 111.221 178.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 57.62 23.65 9.59 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.662 1.985 . . . . 74.22 113.308 -171.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -66.79 -13.42 61.46 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.927 0.785 . . . . 63.22 112.22 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.509 HG13 HG12 ' A' ' 107' ' ' ILE . 27.7 t -64.47 108.73 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 108.44 -0.948 . . . . 74.33 108.44 169.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -135.11 -26.96 1.26 Allowed 'General case' 0 C--O 1.237 0.399 0 CA-C-O 118.558 -0.734 . . . . 73.23 112.618 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.5 m -131.63 169.94 15.46 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 108.63 -0.878 . . . . 41.13 108.63 169.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 87.8 t -55.92 -36.1 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.019 0.928 . . . . 75.13 110.411 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.81 -16.38 16.81 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.504 1.522 . . . . 74.23 114.053 175.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -91.21 -35.12 14.69 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 119.335 0.97 . . . . 42.43 110.142 175.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.715 HD11 HD13 ' A' ' 67' ' ' LEU . 1.2 mt -78.84 -36.79 19.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 121.256 -0.902 . . . . 64.0 109.394 -169.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -54.39 -36.13 63.58 Favored 'General case' 0 C--N 1.341 0.216 0 CA-C-O 117.96 -1.019 . . . . 72.42 111.598 169.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -58.43 -51.63 69.01 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-N 118.853 0.752 . . . . 73.31 109.475 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 18.8 t -49.69 -48.12 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.427 1.091 . . . . 65.4 110.901 -177.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -55.07 -51.85 65.06 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.442 0.697 . . . . 73.1 110.369 178.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.2 t -69.94 -32.0 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 CA-C-O 119.098 -0.477 . . . . 74.2 110.205 -175.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -65.91 -41.57 91.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 118.593 0.633 . . . . 70.04 110.712 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.33 -43.86 92.67 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.538 -0.542 . . . . 73.42 109.538 171.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 144.35 3.94 0.7 Allowed Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.519 1.057 . . . . 53.24 114.869 168.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 65.9 t -62.66 136.6 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 118.763 1.282 . . . . 54.51 108.836 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.4 mtmt -62.32 125.0 22.39 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.443 -0.947 . . . . 73.13 108.443 176.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.71 -27.08 69.34 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-O 118.83 -0.983 . . . . 73.44 111.301 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -70.65 -26.46 63.47 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 118.134 0.967 . . . . 71.23 112.373 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -87.42 -38.65 15.94 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.667 1.987 . . . . 73.13 107.565 -168.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -60.05 -56.05 26.39 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.482 1.513 . . . . 74.22 109.148 166.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -72.04 -8.01 52.11 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.139 0.792 . . . . 45.42 113.139 -173.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -85.89 -61.83 1.66 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.529 1.132 . . . . 71.33 109.598 164.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.09 -37.83 67.31 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 123.435 0.694 . . . . 63.11 112.636 -172.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -49.64 -38.66 33.17 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.097 0.959 . . . . 72.34 111.658 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.56 -11.15 40.91 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 120.487 -1.383 . . . . 73.23 113.965 177.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.7 t -77.07 155.22 32.63 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 126.835 2.054 . . . . 63.2 112.263 -169.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -66.29 -26.17 67.2 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.582 1.553 . . . . 72.34 111.274 175.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 68.0 t -50.04 -52.78 13.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 124.142 0.977 . . . . 63.4 109.19 172.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 27.2 t -69.45 -42.75 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 C-N-CA 123.383 0.673 . . . . 65.34 110.084 -177.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -51.44 -52.53 45.51 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.172 0.896 . . . . 54.41 111.256 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 36.1 t -63.22 -42.68 99.3 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 123.337 0.655 . . . . 43.1 109.714 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.0 mt -60.35 -52.07 66.84 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-O 118.256 -0.878 . . . . 54.3 109.957 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 95.1 t -51.13 -44.18 28.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 118.964 0.802 . . . . 71.0 108.953 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.41 -28.97 70.34 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 114.282 1.216 . . . . 64.02 114.282 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -63.42 -47.67 81.0 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 121.146 -0.971 . . . . 74.3 110.352 177.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.409 ' HG3' ' CD2' ' A' ' 59' ' ' TYR . 3.0 mp0 -78.52 -41.11 33.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 124.189 0.931 . . . . 73.12 110.95 -178.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -54.43 -46.78 73.3 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.385 0.993 . . . . 74.11 108.603 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -63.0 -45.87 90.37 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.517 0.727 . . . . 73.13 112.565 175.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.7 -49.92 74.53 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.707 0.685 . . . . 41.12 109.52 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.73 -30.17 71.22 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.136 -1.603 . . . . 52.54 110.895 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -76.57 -8.04 56.4 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.263 0.938 . . . . 71.42 113.405 173.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.68 -18.49 62.17 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 120.728 -1.232 . . . . 73.22 109.743 162.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 11.6 mt 75.42 -8.36 1.6 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 128.154 2.582 . . . . 73.12 112.394 171.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.456 HE21 ' N ' ' A' ' 146' ' ' LEU . 0.0 OUTLIER -64.13 -0.61 1.24 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.126 2.57 . . . . 75.04 115.008 -176.438 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.456 ' N ' HE21 ' A' ' 145' ' ' GLN . 1.2 tt -152.06 119.67 6.07 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 124.323 1.049 . . . . 75.01 108.692 -172.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -146.23 16.91 1.36 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.491 1.116 . . . . 72.33 110.671 -174.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -152.97 97.55 0.17 Allowed Glycine 0 C--N 1.34 0.798 0 O-C-N 121.084 -1.01 . . . . 55.41 111.611 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.437 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 2.4 m -91.03 174.77 4.15 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.153 0.981 . . . . 64.43 110.161 176.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.437 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 43.9 Cg_endo -64.25 140.94 42.42 Favored 'Cis proline' 0 N--CA 1.456 -0.728 0 N-CA-C 109.218 -1.109 . . . . 62.31 109.218 -19.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -133.8 124.71 27.04 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.264 1.026 . . . . 73.44 108.62 -169.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 28.3 mtp -132.7 107.76 8.6 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 126.222 1.809 . . . . 74.32 106.471 -168.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -97.56 168.48 10.34 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.302 1.041 . . . . 72.14 109.859 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.0 t -125.35 -37.52 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 118.567 -0.73 . . . . 65.02 112.91 171.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.66 13.85 0.35 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.166 1.543 . . . . 73.15 115.166 -175.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 77.22 2.26 78.09 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 121.621 -0.674 . . . . 50.42 112.617 -175.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -128.11 -4.83 5.59 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 121.333 -1.098 . . . . 75.13 113.803 170.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -133.95 140.29 46.66 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.925 0.89 . . . . 74.45 108.688 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -122.11 154.86 36.81 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.934 1.693 . . . . 75.25 106.546 168.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -76.16 157.4 32.79 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.144 -0.973 . . . . 75.23 108.764 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.25 66.36 1.55 Allowed Pre-proline 0 N--CA 1.468 0.434 0 C-N-CA 123.371 0.668 . . . . 75.14 110.176 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -55.47 -36.62 94.54 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.707 1.605 . . . . 71.14 111.302 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -79.17 24.73 0.32 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.99 0.916 . . . . 62.02 112.921 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -136.13 7.55 4.08 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 121.12 -0.987 . . . . 54.41 113.043 161.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 12.6 mtt -92.25 158.84 15.91 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 119.161 1.48 . . . . 55.4 110.628 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.461 ' HB3' HE22 ' A' ' 176' ' ' GLN . 10.4 t0 -62.72 106.01 0.73 Allowed 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.735 1.214 . . . . 72.44 109.935 176.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 24.2 p -106.48 28.84 7.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.008 1.323 . . . . 74.34 110.247 174.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.3 m -72.49 -29.15 63.38 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 120.988 -1.07 . . . . 71.4 111.496 175.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -133.37 -20.45 2.1 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 112.876 0.695 . . . . 75.44 112.876 -171.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . 0.442 ' O ' HG23 ' A' ' 174' ' ' VAL . 39.5 mmm 74.2 -31.26 0.21 Allowed 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 126.423 1.889 . . . . 52.44 112.118 173.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -70.59 -48.16 56.58 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 120.188 1.358 . . . . 72.32 108.322 174.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 59.5 t -65.04 -29.82 48.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 114.825 -1.08 . . . . 60.03 111.172 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -56.56 -51.56 68.13 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.533 -0.914 . . . . 75.22 108.533 174.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 170' ' ' MET . 1.8 t -68.45 -34.53 66.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 118.477 0.58 . . . . 73.41 111.014 -175.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.79 -28.1 68.51 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.103 0.561 . . . . 74.0 112.06 177.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.461 HE22 ' HB3' ' A' ' 166' ' ' ASP . 31.1 mt-30 -91.47 -31.16 16.09 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.376 1.07 . . . . 73.14 111.988 174.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -63.51 -58.63 6.39 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 120.925 -1.109 . . . . 73.32 109.778 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -55.55 -27.84 51.31 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.483 1.113 . . . . 64.32 113.808 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -70.7 -57.76 4.35 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.879 -0.513 . . . . 72.01 110.373 173.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.3 t -66.9 -30.12 70.19 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.43 -0.582 . . . . 71.22 109.43 -169.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 78.1 t -55.74 -56.54 11.84 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 N-CA-C 108.948 -0.76 . . . . 72.04 108.948 170.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -64.14 -39.23 93.59 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-O 119.015 -0.517 . . . . 51.53 111.315 -172.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -52.53 -33.0 43.38 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 122.75 0.42 . . . . 62.15 112.091 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 80.5 mt -81.19 -16.57 52.45 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 120.756 -1.215 . . . . 65.41 113.065 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 91.6 t -69.44 -20.31 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 O-C-N 120.997 -1.064 . . . . 70.21 110.288 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -105.96 -21.17 13.21 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.273 -0.892 . . . . 74.32 109.566 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 35.2 mttt -105.05 74.42 1.11 Allowed 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 125.954 1.702 . . . . 74.13 109.884 -171.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 33.4 tttt . . . . . 0 N--CA 1.432 -1.372 0 C-N-CA 126.879 2.072 . . . . 33.34 107.665 176.261 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.468 0.443 0 CA-C-O 119.843 -0.122 . . . . 61.31 110.678 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 13.3 m-20 -104.82 94.66 5.39 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.661 -1.237 . . . . 63.11 107.661 -173.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -161.76 23.97 0.12 Allowed 'General case' 0 C--O 1.235 0.293 0 O-C-N 120.977 -1.077 . . . . 72.22 112.799 169.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -157.23 122.53 4.59 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 104.884 -2.265 . . . . 73.0 104.884 -178.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.633 HG21 HG23 ' A' ' 180' ' ' THR . 12.5 pt -127.14 152.29 34.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 128.303 2.641 . . . . 75.34 107.203 175.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.2 m -121.3 137.31 54.75 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.081 1.352 . . . . 64.23 107.399 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -57.59 152.09 15.72 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.267 1.427 . . . . 62.3 110.224 166.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.48 -31.56 0.84 Allowed Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.415 1.007 . . . . 73.13 112.693 -171.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -87.33 -71.39 0.56 Allowed 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 106.725 -1.583 . . . . 72.32 106.725 -164.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -123.67 -14.03 7.36 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.081 1.752 . . . . 72.43 110.016 -165.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -138.74 168.72 19.19 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.948 -0.47 . . . . 73.22 110.512 155.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.1 mm -125.79 158.35 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 127.955 2.502 . . . . 74.03 106.046 172.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.53 172.81 8.04 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.476 1.51 . . . . 64.24 108.813 178.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.9 mt -124.11 135.1 53.29 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 119.603 1.092 . . . . 72.02 108.784 162.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -66.33 -38.42 87.63 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 129.377 3.071 . . . . 64.31 110.343 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.22 64.81 7.5 Favored Pre-proline 0 CA--C 1.53 0.205 0 C-N-CA 125.483 1.513 . . . . 55.3 110.362 -177.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -73.15 -9.06 22.98 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 123.335 2.69 . . . . 71.41 113.626 -175.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.4 tt -141.8 105.41 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 O-C-N 121.171 -0.956 . . . . 74.04 110.035 -173.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.03 -53.22 0.29 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.149 1.38 . . . . 53.41 109.914 166.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -160.01 -6.2 0.05 OUTLIER Glycine 0 CA--C 1.526 0.72 0 C-N-CA 123.516 0.579 . . . . 74.13 114.196 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.6 mp0 -68.17 148.31 98.3 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 126.652 1.981 . . . . 74.35 109.676 -173.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -63.99 152.25 81.73 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.309 2.006 . . . . 64.22 109.042 174.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -78.66 -16.31 57.46 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.52 -0.737 . . . . 71.42 111.625 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.25 117.67 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 107.129 -1.434 . . . . 74.21 107.129 -175.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -165.28 161.28 19.07 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.812 0.845 . . . . 74.03 110.467 171.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -139.26 147.02 41.14 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.756 1.222 . . . . 64.01 110.013 174.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -127.22 145.94 50.59 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.397 1.079 . . . . 64.1 109.788 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -161.16 174.82 13.11 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.167 1.387 . . . . 74.33 109.314 177.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.3 t -129.79 179.62 5.74 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.998 1.319 . . . . 72.33 109.22 173.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -94.28 -21.66 18.87 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 128.007 2.523 . . . . 74.42 111.377 176.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.512 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 49.7 m-85 -104.35 9.72 35.71 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.697 1.599 . . . . 70.54 114.642 177.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.5 p -88.42 143.24 32.09 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 121.047 1.749 . . . . 74.22 111.014 175.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -80.44 -43.51 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 120.936 1.091 . . . . 74.51 112.352 -171.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -53.84 -44.81 70.62 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 118.447 0.567 . . . . 73.14 109.708 175.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.5 m -52.54 -42.47 64.43 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 125.092 1.357 . . . . 54.34 111.557 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -61.24 -52.09 66.21 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 110.114 -0.328 . . . . 75.23 110.114 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.22 -45.68 87.25 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.515 -0.92 . . . . 70.11 108.515 177.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -67.77 -6.26 20.29 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 116.319 -1.8 . . . . 73.33 113.691 -177.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -134.44 -1.02 2.88 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 121.901 2.137 . . . . 43.14 113.219 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -136.14 -12.51 1.9 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.854 1.262 . . . . 72.21 112.746 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.8 t -126.96 -79.89 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.089 0 N-CA-C 107.052 -1.462 . . . . 61.1 107.052 -176.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 63.6 mt -65.63 -24.78 67.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.287 2.235 . . . . 73.3 111.993 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 44.36 48.13 8.06 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.99 1.716 . . . . 61.4 111.817 176.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.601 ' O ' HG23 ' A' ' 46' ' ' VAL . 97.7 t -54.44 -49.56 64.3 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.361 0 C-N-CA 125.01 1.324 . . . . 74.21 110.184 -174.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.1 t -48.95 -49.95 37.92 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.4 1.48 . . . . 72.44 110.839 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -73.29 -36.45 66.3 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.654 0.782 . . . . 60.34 112.078 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -57.87 -49.61 76.11 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.486 0.715 . . . . 71.24 109.65 172.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 42' ' ' VAL . 2.1 t -59.02 -49.06 84.6 Favored 'Isoleucine or valine' 0 C--N 1.343 0.313 0 CA-C-N 119.024 0.829 . . . . 73.14 108.874 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.1 ptt180 -61.3 -26.67 67.94 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 121.741 -0.6 . . . . 74.31 112.443 -169.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -64.28 -15.57 60.45 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.391 0.886 . . . . 71.33 113.391 174.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -126.51 -6.13 6.41 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.956 1.702 . . . . 72.44 112.17 -170.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.508 ' HB3' HG21 ' A' ' 54' ' ' THR . 10.5 mt -70.08 144.27 92.5 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-O 118.904 -0.57 . . . . 63.44 110.988 -169.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.599 ' O ' HG22 ' A' ' 54' ' ' THR . 72.9 Cg_endo -74.88 153.25 42.25 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.043 2.495 . . . . 71.4 111.295 178.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -79.24 81.59 5.49 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.834 0.826 . . . . 61.34 109.072 -172.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 166.64 -23.62 0.13 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.11 1.338 . . . . 31.05 113.891 -177.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 51' ' ' PRO . 1.8 t -48.35 -46.79 37.17 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 118.926 1.363 . . . . 75.12 113.991 177.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? 60.01 124.47 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.407 2.283 . . . . 60.22 111.867 -170.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.6 ttm -75.48 102.06 5.07 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 106.286 -1.746 . . . . 53.43 106.286 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.1 m -129.66 101.39 5.89 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 107.649 -1.241 . . . . 54.5 107.649 -167.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.64 105.63 9.88 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.821 1.248 . . . . 72.1 108.151 -162.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -94.86 152.69 18.18 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.185 0.517 . . . . 75.22 109.974 175.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.582 ' NE2' HG23 ' A' ' 72' ' ' THR . 1.6 p-80 -81.62 176.09 9.94 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.513 1.525 . . . . 62.43 108.761 172.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.5 m -145.18 152.09 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 107.659 -1.237 . . . . 73.31 107.659 158.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.4 ' C ' ' H ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER -101.0 -14.7 17.74 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.23 1.012 . . . . 73.14 112.755 -172.09 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -57.8 5.66 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 129.144 2.978 . . . . 74.31 114.719 -177.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.4 ' H ' ' C ' ' A' ' 62' ' ' GLU . 30.5 mt -145.47 110.16 5.08 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 126.763 2.025 . . . . 65.21 106.963 -164.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.512 ' HA3' ' CD2' ' A' ' 29' ' ' TYR . . . 100.85 154.62 26.98 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 126.692 2.091 . . . . 41.31 110.75 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.56 -44.4 0.52 Allowed 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 121.788 1.658 . . . . 65.31 110.093 173.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 95.1 mt -83.26 24.28 0.82 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.782 0.833 . . . . 74.11 111.151 174.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -50.78 -46.46 48.26 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.427 1.013 . . . . 62.25 111.191 176.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.2 tptt -58.75 -47.74 83.59 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.923 0.889 . . . . 64.32 111.689 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.68 -44.12 97.08 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.696 1.598 . . . . 44.32 108.509 -174.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 24.6 mt -61.86 -44.45 96.8 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.464 1.106 . . . . 73.01 111.019 174.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.582 HG23 ' NE2' ' A' ' 60' ' ' HIS . 82.6 m -58.14 -48.89 78.86 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.71 1.604 . . . . 72.32 110.937 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -62.59 -42.86 99.82 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 120.906 -1.121 . . . . 74.35 109.877 175.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.83 -35.74 75.36 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 120.663 -1.273 . . . . 72.05 112.569 178.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 52.9 t-105 -55.09 -34.62 63.8 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.228 1.011 . . . . 71.41 111.08 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.12 -36.73 83.93 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 118.382 -0.818 . . . . 62.04 111.481 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 61.7 t -56.92 -47.31 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 119.445 1.02 . . . . 75.44 109.309 172.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.51 -26.75 61.02 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 117.238 -1.363 . . . . 55.15 112.748 -175.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.12 -42.46 79.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 120.952 1.706 . . . . 75.43 108.937 167.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.04 -40.26 84.52 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.423 1.01 . . . . 75.42 110.771 -176.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 86.2 mt -87.56 -14.59 39.79 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.127 0.417 . . . . 73.23 112.127 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.98 67.03 2.25 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 126.563 2.03 . . . . 75.21 111.089 -176.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.5 m -136.86 17.07 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.628 1.171 . . . . 72.11 112.51 -176.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -49.29 -50.46 39.12 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.026 1.73 . . . . 73.42 111.772 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -80.09 5.77 13.36 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.677 1.591 . . . . 64.1 111.037 -176.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.8 mtpp -104.5 -20.29 13.74 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.604 1.562 . . . . 74.43 110.527 170.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.1 pp -119.25 13.08 6.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 C-N-CA 124.245 1.018 . . . . 74.45 111.487 -170.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 90.2 m -86.97 -42.22 13.3 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 119.542 1.065 . . . . 74.44 111.087 175.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.496 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -55.14 -64.25 2.26 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 118.906 0.776 . . . . 42.53 111.581 -177.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.496 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 90.6 Cg_endo -69.61 -27.75 26.81 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.428 1.419 . . . . 71.11 111.467 -171.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 23.0 tpp -56.16 -49.26 74.48 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.169 0.988 . . . . 71.3 109.038 175.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -73.7 -31.7 63.55 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 118.43 -0.795 . . . . 75.32 110.008 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -60.15 -33.73 72.57 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 119.143 0.883 . . . . 62.22 110.977 170.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -99.45 -12.4 20.25 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.871 1.214 . . . . 62.1 113.438 -174.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.7 t -97.52 -45.52 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.308 1.043 . . . . 72.23 109.216 177.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -98.07 -63.78 1.1 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.886 0.875 . . . . 70.34 109.576 -176.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -63.62 -59.18 4.94 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 119.188 0.904 . . . . 74.1 111.116 -166.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.5 p -95.6 -16.43 22.1 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.884 0.698 . . . . 73.14 112.884 -176.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 55.31 22.57 4.93 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.151 1.381 . . . . 72.4 113.806 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.1 t -68.39 -14.54 63.07 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.4 1.48 . . . . 52.21 112.143 -178.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 38.6 t -66.79 110.84 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 O-C-N 120.52 -1.362 . . . . 64.25 109.094 171.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -139.28 -23.21 0.9 Allowed 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.914 1.686 . . . . 71.42 111.616 -172.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 t -151.44 179.95 7.91 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 121.007 -1.058 . . . . 63.51 109.394 159.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.3 t -54.58 -34.34 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 124.664 1.185 . . . . 72.22 110.064 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.38 -23.86 17.31 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.867 1.667 . . . . 51.23 113.04 176.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -94.08 -37.66 11.51 Favored 'General case' 0 CA--C 1.518 -0.266 0 O-C-N 121.33 -0.856 . . . . 75.05 108.998 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.8 mt -65.4 -47.23 87.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 125.152 1.381 . . . . 71.02 108.096 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -62.51 -26.16 68.4 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.019 0.748 . . . . 74.24 113.019 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -65.08 -51.81 59.27 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 109.577 -0.527 . . . . 71.45 109.577 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.2 t -55.83 -41.7 67.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 123.549 0.53 . . . . 71.25 111.062 -176.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -54.11 -54.4 40.03 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.496 -0.557 . . . . 61.15 109.496 175.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 54.4 t -58.67 -47.34 89.16 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 C-N-CA 123.036 0.534 . . . . 63.25 110.436 -177.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -70.25 -37.91 75.02 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.437 -0.949 . . . . 74.32 108.437 -166.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.89 -9.9 59.21 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.607 1.163 . . . . 73.02 112.354 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 118.4 36.37 0.93 Allowed Glycine 0 C--N 1.336 0.577 0 CA-C-O 117.793 -1.56 . . . . 74.24 115.08 168.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 99.5 t -102.61 144.81 13.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 119.648 1.724 . . . . 44.11 109.204 172.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.555 ' HG3' ' H ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -67.53 133.14 48.92 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.53 -0.759 . . . . 74.04 110.23 171.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -65.42 -21.91 69.01 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-O 118.903 -0.943 . . . . 71.25 111.736 172.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -73.22 -49.8 25.93 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 118.147 -0.93 . . . . 73.02 111.917 175.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.555 ' H ' ' HG3' ' A' ' 117' ' ' LYS . 33.3 t70 -66.07 -40.67 91.05 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.181 -1.414 . . . . 64.43 107.181 -178.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -59.29 -51.38 70.19 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 123.907 0.754 . . . . 72.25 110.105 -174.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -77.88 -12.83 60.02 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 113.002 0.741 . . . . 64.24 113.002 -175.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.43 -61.7 1.46 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.979 1.312 . . . . 73.35 110.387 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.79 -34.22 58.41 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.57 1.548 . . . . 64.41 110.934 -177.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 61.7 t-105 -45.54 -37.02 5.0 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.017 1.727 . . . . 73.01 112.934 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -113.21 2.54 15.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.935 1.294 . . . . 63.44 113.162 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 10.0 t -77.34 156.0 31.58 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.441 1.097 . . . . 73.11 109.887 173.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -58.88 -30.86 68.07 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.448 1.499 . . . . 74.32 111.941 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 84.9 t -54.33 -48.54 67.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 O-C-N 121.606 -0.683 . . . . 64.05 109.391 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.4 t -65.32 -43.47 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-O 119.08 -0.486 . . . . 74.41 110.504 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -53.4 -51.55 62.19 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.68 0.673 . . . . 74.35 111.51 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.0 t -69.63 -38.15 77.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 117.863 -1.065 . . . . 60.04 110.285 -177.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.1 mt -58.92 -56.4 22.78 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-O 117.453 -1.26 . . . . 75.42 110.429 176.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 37.6 t -45.41 -46.72 4.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.245 0 C-N-CA 124.533 1.133 . . . . 63.01 109.98 174.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.02 -35.13 70.83 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 113.038 0.755 . . . . 51.35 113.038 -176.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -61.53 -38.37 87.16 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.048 0.539 . . . . 75.34 110.755 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 10.0 mp0 -85.9 -50.28 7.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.254 1.022 . . . . 72.35 110.746 -177.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -52.72 -44.94 66.71 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.057 0.844 . . . . 75.04 109.69 -176.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -60.89 -61.89 2.26 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.092 0.472 . . . . 72.33 109.878 175.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.55 1.55 3.04 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.792 1.405 . . . . 71.01 114.792 -173.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -129.88 6.12 5.05 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.282 1.433 . . . . 74.23 112.279 174.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -120.81 -6.25 9.62 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 124.714 1.206 . . . . 70.15 113.085 168.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -63.97 5.06 0.25 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.317 2.247 . . . . 70.43 112.781 175.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 73.25 -5.68 1.9 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 131.682 3.993 . . . . 63.12 114.126 -178.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.415 ' HG3' ' H ' ' A' ' 145' ' ' GLN . 0.8 OUTLIER -71.76 -15.92 62.19 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 127.964 2.505 . . . . 73.01 113.468 -164.43 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.4 tp -164.17 125.01 2.17 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 128.16 2.584 . . . . 74.4 105.545 -176.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -142.13 21.95 2.08 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.475 0.655 . . . . 72.44 111.265 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -136.43 158.97 24.28 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 107.498 -2.241 . . . . 73.32 107.498 164.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.486 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 3.7 m -140.46 171.67 7.39 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 107.993 -1.114 . . . . 53.32 107.993 174.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.486 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 68.0 Cg_endo -63.21 156.16 69.21 Favored 'Cis proline' 0 N--CA 1.457 -0.639 0 CA-C-N 120.453 1.197 . . . . 45.3 111.27 -8.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -141.22 144.73 34.9 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.107 0.963 . . . . 71.34 108.766 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 29.2 ttm -151.08 109.94 3.87 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.001 -1.481 . . . . 75.4 107.001 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -93.15 156.23 16.98 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.595 -0.73 . . . . 74.12 109.31 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.6 t -139.48 140.0 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.614 -0.884 . . . . 74.21 108.614 175.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 45.78 28.84 0.61 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.967 2.507 . . . . 74.41 114.562 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 63.53 7.39 20.13 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.88 1.705 . . . . 74.41 113.488 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -141.5 -5.39 1.07 Allowed 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 119.044 1.422 . . . . 75.3 113.648 -165.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -129.45 150.13 50.93 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.38 -0.97 . . . . 74.02 108.38 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.31 123.99 37.65 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 128.401 2.68 . . . . 75.21 107.998 177.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.5 139.73 57.61 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.513 -1.662 . . . . 73.3 106.513 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -114.66 86.09 12.3 Favored Pre-proline 0 C--O 1.235 0.309 0 C-N-CA 123.256 0.622 . . . . 65.24 110.969 174.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.78 -17.9 47.39 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 120.706 0.937 . . . . 72.11 111.705 177.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -78.66 -6.02 54.6 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.09 1.756 . . . . 74.3 112.773 -172.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -130.35 13.46 5.68 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 124.573 1.082 . . . . 72.44 111.366 177.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 45.3 mtt -85.5 163.19 18.57 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.33 1.065 . . . . 61.42 109.192 170.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.57 108.73 6.59 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.705 -1.591 . . . . 71.42 106.705 170.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 31.9 p -102.1 -6.74 22.95 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 127.016 2.127 . . . . 73.2 110.94 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 46.5 m -61.74 -17.9 57.64 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 125.683 1.593 . . . . 64.3 114.491 -170.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -128.78 -6.3 5.09 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 117.76 -1.114 . . . . 75.33 111.197 -164.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 65.92 -63.73 0.22 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.348 1.859 . . . . 74.21 111.865 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.55 -44.49 94.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 119.114 0.87 . . . . 74.33 108.954 -171.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 91.9 t -62.12 -30.0 47.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 125.084 1.354 . . . . 71.11 111.587 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -66.78 -60.11 2.97 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 107.624 -1.25 . . . . 75.44 107.624 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.2 t -68.04 -35.4 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 O-C-N 123.72 0.637 . . . . 61.31 110.664 -174.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.02 -52.18 63.95 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.491 0.716 . . . . 34.44 109.799 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -72.64 -38.32 67.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.245 -0.883 . . . . 71.24 111.598 177.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -55.46 -58.41 7.88 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.745 1.157 . . . . 71.23 109.714 178.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.58 -42.07 61.62 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 125.989 1.716 . . . . 71.33 111.514 -176.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -71.44 -51.0 26.29 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.955 0.902 . . . . 63.21 108.935 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.633 HG23 HG21 ' A' ' 3' ' ' ILE . 31.1 m -59.81 -26.45 65.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.461 1.105 . . . . 64.1 112.229 -177.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 97.2 t -60.05 -51.43 73.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 108.912 -0.773 . . . . 75.02 108.912 169.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 31.1 tttm -61.35 -44.29 97.42 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 118.008 -0.996 . . . . 75.31 110.986 174.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -57.15 -28.98 63.23 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 119.599 1.091 . . . . 60.22 111.426 -169.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 58.5 mt -81.12 -24.61 37.56 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.874 0.694 . . . . 75.03 112.874 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 71.6 t -65.47 -28.22 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 O-C-N 121.027 -1.045 . . . . 75.23 110.508 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -89.28 -29.61 19.07 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 122.048 0.928 . . . . 73.04 109.45 178.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 45.6 mttp -95.64 66.42 2.73 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 125.094 1.358 . . . . 72.44 109.051 -176.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.507 ' H ' ' HD3' ' A' ' 188' ' ' LYS . 1.2 mppt? . . . . . 0 C--O 1.247 0.968 0 N-CA-C 107.427 -1.323 . . . . 62.4 107.427 154.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 31.4 m . . . . . 0 CA--C 1.514 -0.404 0 N-CA-C 108.931 -0.766 . . . . 74.33 108.931 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -140.51 -25.11 0.77 Allowed 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 114.821 1.415 . . . . 74.34 114.821 -174.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . -76.32 28.71 0.12 Allowed 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 125.865 1.666 . . . . 71.32 114.023 -164.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -157.58 122.98 4.55 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 129.153 2.981 . . . . 71.3 103.533 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.711 HG21 HG23 ' A' ' 180' ' ' THR . 9.3 pt -127.85 149.59 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 126.735 2.014 . . . . 64.23 108.152 175.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.0 m -132.03 143.33 49.98 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.054 -1.091 . . . . 60.2 108.054 174.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -59.11 151.91 21.45 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.919 1.287 . . . . 64.13 110.151 170.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.86 -25.82 0.78 Allowed Glycine 0 CA--C 1.532 1.125 0 CA-C-O 118.873 -0.96 . . . . 60.33 112.783 -169.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -98.04 -85.61 0.37 Allowed 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 119.246 1.523 . . . . 75.32 107.565 -170.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -90.05 -17.92 26.89 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.505 0.722 . . . . 71.43 111.751 -176.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -140.76 164.91 28.95 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 118.208 0.458 . . . . 74.22 110.245 173.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.2 mm -127.87 163.12 32.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 105.761 -1.941 . . . . 71.14 105.761 173.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.21 164.26 11.74 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 124.998 1.319 . . . . 71.23 110.058 171.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 27.2 mt -79.67 154.53 28.57 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.929 -1.137 . . . . 74.24 107.929 161.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.62 -27.12 51.06 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.809 -0.812 . . . . 73.4 108.809 171.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -121.81 71.34 29.6 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.774 1.629 . . . . 74.24 108.987 178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -84.19 63.56 6.89 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 124.079 3.186 . . . . 74.21 111.579 -177.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.5 mp -123.29 152.93 28.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 O-C-N 120.054 -1.654 . . . . 54.53 109.046 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.54 110.03 0.46 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.428 1.891 . . . . 71.03 109.111 175.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.65 -37.59 0.05 OUTLIER Glycine 0 CA--C 1.521 0.454 0 N-CA-C 111.02 -0.832 . . . . 75.44 111.02 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.76 165.85 39.35 Favored Pre-proline 0 C--O 1.242 0.674 0 C-N-CA 124.698 1.199 . . . . 71.33 110.332 166.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -58.72 172.37 1.58 Allowed 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.579 2.186 . . . . 73.33 110.671 161.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -120.17 119.15 32.43 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 107.661 -1.237 . . . . 74.12 107.661 -174.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.4 t 69.19 113.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 127.936 2.494 . . . . 63.31 109.655 -170.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 tp -150.64 161.83 41.84 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.374 -0.973 . . . . 74.0 108.374 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -146.15 136.58 23.95 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.496 -1.298 . . . . 75.11 107.496 -169.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -137.22 136.27 37.99 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 123.889 0.876 . . . . 73.11 110.505 -175.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.03 171.64 18.75 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.606 1.962 . . . . 60.2 108.177 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.02 153.78 50.56 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 119.031 -0.509 . . . . 73.02 109.898 169.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.795 ' CD1' HD11 ' A' ' 71' ' ' LEU 0.296 0.0 OUTLIER -67.19 -15.61 63.8 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 113.306 0.854 . . . . 73.33 113.306 177.911 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.466 ' CE2' ' HA3' ' A' ' 65' ' ' GLY . 41.6 m-85 -93.45 -0.52 56.4 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.277 0.944 . . . . 60.24 112.248 176.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.9 t -82.05 141.04 46.52 Favored Pre-proline 0 CA--C 1.534 0.36 0 O-C-N 120.592 -1.317 . . . . 63.34 110.446 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -88.78 -37.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 121.769 1.646 . . . . 74.04 112.542 -175.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -62.95 -48.09 80.4 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 124.702 1.201 . . . . 75.13 108.778 176.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 21.0 m -57.44 -30.54 65.09 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.204 -0.907 . . . . 74.03 111.089 -178.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -59.81 -56.94 15.54 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 119.612 1.096 . . . . 63.42 110.109 173.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.487 ' HA ' HE21 ' A' ' 35' ' ' GLN . 0.0 OUTLIER -53.93 -42.14 68.49 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.065 -0.717 . . . . 64.1 109.065 -179.491 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -69.49 -16.18 63.41 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 116.641 -1.647 . . . . 71.24 112.67 -176.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -124.17 -10.44 7.57 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 121.245 1.839 . . . . 74.31 111.9 -172.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -136.97 -11.8 1.72 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.986 1.715 . . . . 74.13 112.972 -170.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.6 t -127.24 -81.76 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 O-C-N 120.315 -1.49 . . . . 75.34 107.718 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.2 mt -56.9 -28.18 61.59 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.498 1.919 . . . . 74.21 111.67 175.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 67.9 m80 44.57 46.51 8.26 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.942 1.697 . . . . 63.33 110.918 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 46' ' ' VAL . 98.7 t -51.0 -53.78 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 C-N-CA 126.614 1.966 . . . . 61.41 108.631 -175.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.5 t -45.44 -47.95 13.78 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.644 1.978 . . . . 72.04 111.587 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.64 -18.45 27.94 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.011 -1.055 . . . . 74.42 111.835 -176.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.5 -40.94 93.64 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.208 -0.932 . . . . 54.52 109.582 167.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 42' ' ' VAL . 1.9 t -59.61 -46.39 93.23 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 N-CA-C 109.437 -0.579 . . . . 62.3 109.437 178.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -47.93 -44.48 30.07 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.229 1.012 . . . . 71.02 112.033 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -62.57 -10.62 12.71 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 115.001 1.482 . . . . 72.21 115.001 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -125.44 -9.03 6.9 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 126.925 2.09 . . . . 73.34 113.199 -174.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.597 HD13 HG21 ' A' ' 54' ' ' THR . 14.5 mt -72.33 150.43 91.83 Favored Pre-proline 0 C--O 1.234 0.269 0 CA-C-N 119.328 0.967 . . . . 63.01 111.246 -167.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -71.82 156.63 56.59 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.146 1.898 . . . . 72.33 109.402 169.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.28 28.57 0.06 Allowed 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 126.007 1.723 . . . . 73.2 114.974 -174.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -154.19 21.08 0.66 Allowed Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 124.708 1.147 . . . . 21.05 112.979 -168.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.597 HG21 HD13 ' A' ' 50' ' ' LEU . 2.9 t -89.72 -45.3 9.41 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 117.887 0.843 . . . . 51.42 110.908 -177.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? 55.52 95.55 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 124.155 1.931 . . . . 74.14 110.704 -162.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 2.8 mtm -62.29 122.84 16.65 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 113.84 -1.527 . . . . 44.33 108.765 169.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 58' ' ' LYS . 1.3 m -123.24 179.87 4.55 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.317 -0.994 . . . . 74.02 108.317 174.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.461 ' H ' HG22 ' A' ' 57' ' ' THR . 9.8 mtpt -172.35 88.1 0.09 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 106.78 -1.563 . . . . 72.41 106.78 -171.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.516 ' CD2' ' HG3' ' A' ' 137' ' ' GLN . 4.1 m-30 -89.02 176.02 7.17 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.992 1.317 . . . . 74.12 109.299 175.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.623 ' CE1' HE21 ' A' ' 137' ' ' GLN . 2.1 p-80 -117.04 175.42 5.6 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.154 1.381 . . . . 75.12 110.081 174.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.8 m -131.24 175.97 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.255 1.422 . . . . 74.23 109.036 169.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.71 59.74 1.72 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.693 2.397 . . . . 72.14 111.134 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -148.33 -163.71 1.84 Allowed 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.237 1.415 . . . . 75.13 109.82 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.8 mt 75.54 -85.03 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 128.616 2.767 . . . . 61.33 109.175 -176.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.466 ' HA3' ' CE2' ' A' ' 29' ' ' TYR . . . -95.32 174.46 32.36 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 125.43 1.491 . . . . 74.05 111.452 -178.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.88 -36.63 30.39 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 124.945 3.763 . . . . 63.33 113.124 -169.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.2 mt -83.68 24.82 0.83 Allowed 'General case' 0 N--CA 1.462 0.133 0 C-N-CA 124.332 1.053 . . . . 72.13 112.721 -174.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -46.28 -51.6 11.53 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-N 118.72 0.691 . . . . 33.34 111.81 179.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -70.76 -6.38 37.13 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.49 1.116 . . . . 64.11 113.596 -177.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -111.44 -24.57 10.09 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.257 1.423 . . . . 61.31 109.389 -177.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.795 HD11 ' CD1' ' A' ' 28' ' ' PHE . 9.5 mt -63.67 -46.97 83.12 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.912 0.885 . . . . 72.43 109.368 165.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.531 HG22 ' CD2' ' A' ' 60' ' ' HIS . 0.5 OUTLIER -50.86 -52.11 44.82 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.414 1.486 . . . . 71.15 108.75 171.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -62.03 -54.47 41.03 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.551 -0.718 . . . . 72.24 110.5 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.24 -33.38 73.18 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.631 1.105 . . . . 74.45 113.435 -167.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.608 ' HB3' ' HD1' ' A' ' 60' ' ' HIS . 40.5 t-105 -56.73 -38.13 71.95 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 123.1 0.56 . . . . 75.14 110.367 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.27 84.7 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 117.505 -1.236 . . . . 73.45 112.055 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.453 HG22 ' HB3' ' A' ' 124' ' ' ALA . 93.9 t -56.35 -45.22 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 121.072 1.76 . . . . 64.35 110.986 167.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.37 -45.55 90.65 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 118.094 -0.955 . . . . 74.25 111.073 -177.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 60.2 mt -62.54 -40.44 88.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 124.263 1.025 . . . . 72.31 110.207 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.85 -42.17 83.9 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.758 0.708 . . . . 71.35 110.362 -175.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.5 mt -85.18 -29.92 24.34 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 111.732 0.271 . . . . 54.44 111.732 174.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.74 52.08 3.43 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 126.183 1.849 . . . . 74.24 111.853 -175.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -127.25 21.16 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.761 1.224 . . . . 64.32 111.403 -173.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -53.05 -53.2 53.74 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 123.757 0.823 . . . . 72.02 111.074 -175.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.18 -42.7 77.54 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.224 1.409 . . . . 74.15 109.687 -179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.7 mtpm? -72.64 -5.23 35.95 Favored 'General case' 0 N--CA 1.46 0.066 0 C-N-CA 125.012 1.325 . . . . 60.41 112.171 -176.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 1.6 pp -134.1 23.3 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 C-N-CA 125.669 1.587 . . . . 74.31 109.386 173.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 99.5 m -87.53 -57.56 2.9 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.222 -1.399 . . . . 71.41 107.222 168.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.477 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . . . -58.89 -60.15 11.44 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 112.88 0.696 . . . . 53.44 112.88 -164.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 89' ' ' ALA . 37.5 Cg_endo -66.92 -26.61 43.94 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.288 1.325 . . . . 75.31 111.579 -177.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 5.0 ttm -64.92 -43.5 92.59 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.56 0.744 . . . . 55.55 109.258 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -69.69 -40.19 76.5 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.496 1.118 . . . . 72.11 109.473 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.12 -27.25 66.88 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.223 0.465 . . . . 61.24 111.196 172.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -97.59 3.98 50.35 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 120.361 -1.462 . . . . 71.22 113.304 -177.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.69 HG21 ' CD2' ' A' ' 28' ' ' PHE . 65.6 t -119.73 -41.23 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 124.073 0.949 . . . . 73.15 110.067 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -101.4 -51.66 3.43 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 109.404 -0.591 . . . . 41.35 109.404 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.1 mmmt -75.35 -60.02 2.49 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.88 -0.6 . . . . 71.35 109.432 -168.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.3 p -98.1 -19.13 18.13 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.775 0.83 . . . . 62.24 112.491 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 64.95 18.51 11.53 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.869 1.668 . . . . 51.42 114.163 166.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.1 t -74.78 -17.39 60.63 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.991 1.317 . . . . 74.15 113.486 -172.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.6 t -66.84 126.58 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.555 -0.716 . . . . 64.45 109.13 167.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -146.1 -25.71 0.44 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.239 1.415 . . . . 75.05 111.075 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.1 t -143.38 175.81 9.63 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.899 0.772 . . . . 75.05 110.25 171.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.4 t -52.39 -44.82 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.932 1.693 . . . . 72.32 110.028 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -52.77 -23.72 7.39 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.712 1.605 . . . . 75.03 112.862 177.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -94.38 -24.72 17.25 Favored 'General case' 0 CA--C 1.523 -0.078 0 CA-C-N 118.972 0.806 . . . . 73.04 111.123 -178.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.4 mt -82.45 -43.28 19.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.594 -0.891 . . . . 75.35 108.594 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -55.15 -31.79 61.59 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 118.534 -0.746 . . . . 44.42 111.479 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -57.51 -61.76 2.26 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.287 1.435 . . . . 73.22 109.85 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.7 t -55.33 -40.07 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 122.767 0.427 . . . . 64.02 110.756 -175.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -53.79 -53.48 51.8 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.472 0.578 . . . . 73.24 110.65 173.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.24 -41.36 91.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 123.876 0.87 . . . . 63.13 109.99 -178.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -67.27 -37.71 83.9 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.678 -0.86 . . . . 73.44 108.678 -170.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.3 -24.71 61.36 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.443 1.097 . . . . 62.42 112.428 175.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.57 56.47 0.35 Allowed Glycine 0 C--N 1.332 0.315 0 N-CA-C 111.242 -0.743 . . . . 64.42 111.242 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.3 t -118.98 126.36 75.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 109.087 -0.708 . . . . 72.41 109.087 166.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -54.13 128.03 29.19 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.212 -0.662 . . . . 74.45 109.212 176.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -64.41 -21.19 66.34 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-O 117.6 -1.667 . . . . 60.23 110.434 170.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -68.83 -37.57 79.25 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 119.875 1.838 . . . . 75.41 108.826 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.74 -45.51 28.95 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 126.08 1.752 . . . . 72.12 107.164 -171.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -55.93 -57.4 12.27 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 109.501 -0.555 . . . . 72.44 109.501 174.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -66.23 -28.8 69.01 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 119.314 -0.374 . . . . 72.04 111.145 -172.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.27 -64.05 1.1 Allowed 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.859 0.864 . . . . 71.13 110.587 174.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.453 ' HB3' HG22 ' A' ' 77' ' ' VAL . . . -54.99 -36.37 65.33 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.585 1.154 . . . . 64.15 110.572 -171.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 59.9 t-105 -45.62 -42.83 11.78 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.744 1.218 . . . . 75.12 112.57 177.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -105.71 1.25 26.98 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.639 1.176 . . . . 64.05 112.872 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 46.2 t -77.97 150.24 33.99 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.51 1.524 . . . . 62.25 109.805 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -56.45 -35.27 67.7 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 124.429 1.092 . . . . 63.44 111.0 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 43.9 t -51.53 -52.51 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.082 0 CA-C-N 118.847 0.749 . . . . 51.35 109.581 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.13 -45.61 98.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-N 115.942 -0.572 . . . . 72.23 110.269 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -46.22 81.98 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.342 0.657 . . . . 73.35 111.109 -176.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.4 t -67.07 -48.39 68.39 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.638 1.175 . . . . 62.21 110.371 175.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.7 mt -53.8 -50.38 66.24 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-O 117.321 -1.324 . . . . 64.02 110.029 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.8 t -48.27 -51.74 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 120.573 1.533 . . . . 62.35 109.986 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.57 -27.45 64.62 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.514 0.931 . . . . 71.32 113.514 -177.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -63.99 -32.95 74.67 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 113.774 1.027 . . . . 74.13 113.774 172.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.623 HE21 ' CE1' ' A' ' 60' ' ' HIS . 4.1 mp0 -89.72 -35.94 15.48 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 117.652 -1.166 . . . . 75.14 111.85 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -56.64 -51.6 68.07 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 108.041 -1.096 . . . . 63.12 108.041 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 23.9 ttpt -59.66 -16.43 26.4 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 113.765 1.024 . . . . 43.21 113.765 174.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -117.26 -1.86 11.73 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 120.486 1.494 . . . . 54.42 114.828 -174.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.07 -29.86 4.16 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 119.145 0.884 . . . . 73.21 111.038 172.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -107.67 2.04 23.56 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 123.789 0.836 . . . . 63.43 112.034 -170.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -63.62 -85.82 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.504 1.121 . . . . 74.3 111.255 176.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -175.56 50.0 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.032 1.733 . . . . 74.02 109.216 177.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.276 0.6 OUTLIER -143.7 -50.0 0.31 Allowed 'General case' 0 C--N 1.344 0.332 0 N-CA-C 114.071 1.138 . . . . 71.11 114.071 -178.262 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 40.5 tp -70.07 -83.1 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 119.572 1.078 . . . . 72.14 110.071 -176.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 55.15 33.52 20.67 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.618 0.767 . . . . 64.42 112.477 173.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 176.35 159.44 21.93 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.681 1.61 . . . . 74.03 109.587 170.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.407 ' HB ' ' HA ' ' A' ' 150' ' ' PRO . 9.9 m -141.69 159.03 61.49 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 119.61 1.705 . . . . 71.03 110.582 173.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.407 ' HA ' ' HB ' ' A' ' 149' ' ' VAL . 73.7 Cg_endo -74.29 161.57 94.22 Favored 'Cis proline' 0 C--N 1.349 0.572 0 CA-C-N 118.987 0.674 . . . . 63.01 112.897 -4.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -144.36 146.07 32.33 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.858 -1.065 . . . . 64.13 110.055 175.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 38.8 tpp -135.96 105.43 6.07 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 105.006 -2.22 . . . . 74.24 105.006 175.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -82.81 149.51 27.14 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.084 0.953 . . . . 75.13 109.444 175.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.8 t -140.08 145.93 25.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 108.195 -1.039 . . . . 73.34 108.195 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 50.67 24.16 1.59 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.992 2.117 . . . . 60.43 113.765 173.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 68.36 4.29 36.58 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 120.336 -1.478 . . . . 54.32 113.612 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.436 ' HE2' ' CE2' ' A' ' 158' ' ' TYR . 11.1 pttt -147.26 -6.48 0.48 Allowed 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.442 1.621 . . . . 71.21 115.183 -166.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.436 ' CE2' ' HE2' ' A' ' 157' ' ' LYS . 63.0 m-85 -124.04 162.38 23.59 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.332 0.969 . . . . 72.02 110.288 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -129.63 139.94 51.29 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.815 1.646 . . . . 64.22 106.895 165.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.89 142.34 57.94 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 107.946 -1.131 . . . . 72.3 107.946 167.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -118.67 85.52 27.41 Favored Pre-proline 0 C--O 1.235 0.333 0 C-N-CA 123.603 0.761 . . . . 74.41 111.651 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.01 -24.87 52.23 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 CA-C-N 119.544 0.873 . . . . 75.03 111.493 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.99 -8.65 39.13 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.876 1.27 . . . . 75.24 112.642 -178.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -112.9 7.9 25.57 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-O 118.519 -1.156 . . . . 75.03 112.202 176.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 59.1 mtt -98.13 158.91 15.27 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 119.351 1.576 . . . . 54.12 110.528 -176.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -66.94 109.37 2.93 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 106.524 -1.658 . . . . 60.14 106.524 170.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.16 11.91 15.34 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 128.156 2.582 . . . . 75.4 108.632 -171.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.67 -4.33 56.84 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 125.693 1.597 . . . . 54.52 113.189 -169.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.06 -7.28 1.38 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.783 0.833 . . . . 75.1 111.491 -168.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' MET . . . . . . . . . . . . . 8.1 mmt 65.94 -62.78 0.24 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 127.142 2.177 . . . . 75.21 112.23 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.44 -36.65 74.09 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 120.371 1.441 . . . . 61.21 109.803 -171.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 79.9 t -58.68 -37.32 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.687 1.195 . . . . 73.03 110.162 172.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -60.16 -56.52 20.56 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.674 -0.861 . . . . 75.32 108.674 -177.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 3.2 t -64.93 -37.82 81.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 O-C-N 123.314 0.384 . . . . 71.03 110.536 -178.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.42 -47.67 69.39 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.542 1.137 . . . . 63.21 110.657 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -80.75 -40.25 25.54 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 118.504 -0.76 . . . . 73.41 111.882 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -50.38 -59.69 3.74 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.486 1.039 . . . . 75.03 110.2 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.27 -37.48 75.07 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.229 1.012 . . . . 75.23 111.74 -172.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -67.39 -50.4 59.78 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.912 0.885 . . . . 74.53 109.994 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.711 HG23 HG21 ' A' ' 3' ' ' ILE . 22.0 m -57.03 -29.73 63.62 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.647 1.179 . . . . 74.42 111.964 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 3.7 t -60.38 -52.79 57.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 119.396 0.998 . . . . 73.23 109.354 172.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 3.6 tmtm? -62.55 -27.88 69.47 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 121.499 -0.751 . . . . 71.23 112.089 177.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -68.92 -33.62 74.04 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 119.214 0.915 . . . . 74.41 112.528 176.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 66.1 mt -71.21 -32.86 69.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 120.159 1.345 . . . . 71.43 110.98 -177.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 99.3 t -62.36 -23.68 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.163 0.985 . . . . 60.13 112.144 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -99.0 -19.42 17.28 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.453 -0.78 . . . . 74.3 110.203 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -98.89 77.54 2.22 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 125.197 1.399 . . . . 73.53 107.398 -168.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.967 0 C-N-CA 126.923 2.089 . . . . 63.22 111.563 -175.855 . . . . . . . . 1 1 . 1 stop_ save_